Citrus Sinensis ID: 014087

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-
Protein Sequence
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Secondary Structure (PSIPRED)
cccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccHHHHHHccccccccccccccccccccccEEEEEEcccccEEEEEEEEcccccccccEEEEEEcccccHHcccHHHHHHHHHHHHHHcccccEEcccccccccccEEEEEEcccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccc
Secondary Structure Prediction (SSPRO)
cccHccccHHHHHHHHHHHHccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEccHcHcEEEEEEccccccHEEEEEEccccccccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccEccccEcHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccHHHHccHHHccccHHHHHHcccccccccccccccccccccHHHccccccccccccHHHHHHcccccEcccHHHHccc
Coil and Loop (DISEMBL)
mvstsqknLHSLLTTKLkkltitppsasspdfdftevfgpltpcrhnnqspastsaslgdpqvihnrshsfvgpspryalssslplqIQELEHENDaeleaeserkigpgdfeIFRVVGQGAFGKVFQVKkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYrqgifredqaRFYTAEIVSAVSHLHkcgivhrdlkpenilmdsdgheidessrsnsmcgtteymapeillskghnkdadwWSVGILLYEmltgqppfthaNRQKLQQRIINekvklppfltSEAHSLLKGllhkdpskrlgsgpggvdaikhhkwFRSINWKTLearemqpkfkpdvsgkdcianfdkcwttmpaddspaptptagehfkgytyvapnpwlssv
Flexible Loop (DISEMBL)
mvstsqknLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKvfqvkkkgvddgdsdgiyamkvmrkdtiikknHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSgpggvdaikhhkWFRSINWKTLEAREMqpkfkpdvsgkDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTyvapnpwlssv
Low Complexity Region (SEG)
MVSTSQKNLHSllttklkkltITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFgkvfqvkkkgvddgdsdgIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWttmpaddspaptptaGEHFKGYTYVAPNPWLSSV
Disordered region (IsUnstruct)
************************************VF***********************************************************************GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE*I********************TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL*************GVDAIKHHKWFRSINWKTLEARE****FKPDVSGKDCIANFDKCWTTM***************FKGYTYVAP*******
Disordered Region (DISOPRED)
**************************************************************************************************************DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD**********EHFKGYTYVAPNPWL***
Disordered Region (DISEMBL)
*********HSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNN**********GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH**********MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Disordered Region (DISPRO)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTE*******************************************************************ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNP*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	431	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.911	0.834	0.569	1e-140
P42818	465	Serine/threonine-protein	no	no	0.918	0.851	0.538	1e-130
Q6TJY3	527	Ribosomal protein S6 kina	no	no	0.737	0.603	0.480	5e-88
Q9UBS0	482	Ribosomal protein S6 kina	yes	no	0.779	0.697	0.462	6e-88
Q8BSK8	525	Ribosomal protein S6 kina	yes	no	0.737	0.605	0.477	2e-87
P67998	525	Ribosomal protein S6 kina	yes	no	0.737	0.605	0.477	2e-87
P67999	525	Ribosomal protein S6 kina	yes	no	0.737	0.605	0.477	2e-87
P23443	525	Ribosomal protein S6 kina	no	no	0.737	0.605	0.477	2e-87
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.709	0.638	0.483	3e-87
Q9Z1M4	485	Ribosomal protein S6 kina	no	no	0.779	0.692	0.459	8e-87

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  498 bits (1281), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 255/448 (56%), Positives = 316/448 (70%), Gaps = 55/448 (12%)

Query: 20  LTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSP 76
           L+I+PP +   D     F++VFGP+        S  +   +  +P V+++RSHS VGPS 
Sbjct: 24  LSISPPKSVLGDNLELQFSDVFGPMPEA----NSEEACDVAYDEPAVVYSRSHSLVGPS- 78

Query: 77  RYALSSSLP---LQIQELE--------------HEND---AELEAESERK-------IGP 109
              +S SL    L ++E E               END      + +SE+        +G 
Sbjct: 79  -LVVSHSLKMNKLTLRETEDSVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGI 137

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +VVGQGAFGKV+QV+KK     D+  IYAMKVMRKD I++KNH +YMKAERDIL
Sbjct: 138 EDFEVLKVVGQGAFGKVYQVRKK-----DTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 192

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           TK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVS
Sbjct: 193 TKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVS 252

Query: 230 HLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSK 279
           HLH+ GI+HRDLKPENILMD DGH          E +E++RSNSMCGTTEYMAPEI+  K
Sbjct: 253 HLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGK 312

Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL 339
           GH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ +K+KLP FL++EAH+LLKGLL
Sbjct: 313 GHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAHALLKGLL 371

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT 399
            K+P +RLGSGP G + IK HKWF++INWK LEARE+QP FKP VSG+ CIANFDKCWT 
Sbjct: 372 QKEPERRLGSGPSGAEEIKKHKWFKAINWKKLEAREVQPSFKPAVSGRQCIANFDKCWTD 431

Query: 400 MPADDSPAPTPTA---GEHFKGYTYVAP 424
           M   DSPA +P +      F  +TYV P
Sbjct: 432 MSVLDSPASSPNSDAKANPFTNFTYVRP 459

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  466 bits (1200), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 246/457 (53%), Positives = 313/457 (68%), Gaps = 61/457 (13%)

Query: 16  KLKKLTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           K + L+I+P ++   D    +F++VFGPL P   N+        +  +P V+++RSHS V
Sbjct: 14  KQQYLSISPSNSVLKDDVELEFSDVFGPL-PEEAND-------IAYDEPAVVYSRSHSLV 65

Query: 73  GPSPRYALS------------SSLPLQIQELEHE---------------NDAELEAESER 105
           GP    + S             S+ L ++ LE E               N+  LE +  +
Sbjct: 66  GPCSLDSHSLKLTKLTLLETEDSIDL-VECLEGESLKENDDFSGNDDSDNEKALEGDLVK 124

Query: 106 K---IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  DFE+ +VVG+GAFGKV+QV+KK     ++  IYAMKVMRKD I++KNH +YM
Sbjct: 125 VSGVVGIDDFEVMKVVGKGAFGKVYQVRKK-----ETSEIYAMKVMRKDHIMEKNHAEYM 179

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           KAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTA
Sbjct: 180 KAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTA 239

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMA 272
           EIVSAVSHLH+ GI+HRDLKPENILMD+DGH          E +E++RSNSMCGTTEYMA
Sbjct: 240 EIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMA 299

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 332
           PEI+  KGH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ +K+KLP FL++EAH
Sbjct: 300 PEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAH 358

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIAN 392
           ++LKGLL K+P +RLGSG  G + IK HKWF+ INWK LEARE+ P FKP+VSG+ CIAN
Sbjct: 359 AILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMPSFKPEVSGRQCIAN 418

Query: 393 FDKCWTTMPA---DDSPAPTPTAGEHFKGYTYVAPNP 426
           FDKCWT M       S   +      F  +TYV P P
Sbjct: 419 FDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPP 455

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus GN=RPS6KB1 PE=2 SV=1

 Score =  325 bits (833), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 161/335 (48%), Positives = 226/335 (67%), Gaps = 17/335 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 394 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
           D  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2

 Score =  324 bits (831), Expect = 6e-88,   Method: Compositional matrix adjust.
 Identities = 165/357 (46%), Positives = 229/357 (64%), Gaps = 21/357 (5%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY 143
           ++ + H  + EL   S      +IGP  FE+ RV+G+G +GKVFQV+K  V   +   IY
Sbjct: 39  LEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRK--VQGTNLGKIY 96

Query: 144 AMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           AMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG L
Sbjct: 97  AMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGEL 156

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------- 253
           F HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH         
Sbjct: 157 FTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKLTDFGLC 216

Query: 254 --EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 311
              I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K
Sbjct: 217 KESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDMLTGSPPFTAENRKK 276

Query: 312 LQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 371
              +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG    ++ H +FR +NW  L
Sbjct: 277 TMDKIIRGKLALPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAADVQRHPFFRHMNWDDL 336

Query: 372 EAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
            A  + P F+P +  ++ ++ FD  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 337 LAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDTALSESANQAFLGFTYVAPS 393

Phosphorylates specifically ribosomal protein S6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BSK8|KS6B1_MOUSE Ribosomal protein S6 kinase beta-1 OS=Mus musculus GN=Rps6kb1 PE=1 SV=2

 Score =  323 bits (828), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 160/335 (47%), Positives = 225/335 (67%), Gaps = 17/335 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 394 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67998|KS6B1_RABIT Ribosomal protein S6 kinase beta-1 OS=Oryctolagus cuniculus GN=RPS6KB1 PE=2 SV=1

 Score =  323 bits (828), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 160/335 (47%), Positives = 225/335 (67%), Gaps = 17/335 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 394 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  323 bits (828), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 160/335 (47%), Positives = 225/335 (67%), Gaps = 17/335 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 394 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2

 Score =  323 bits (828), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 160/335 (47%), Positives = 225/335 (67%), Gaps = 17/335 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +GKVFQV+K  V   ++  I+AMKV++K  I++      + KA
Sbjct: 85  KIRPECFELLRVLGKGGYGKVFQVRK--VTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 142

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 143 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 202

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT EYMAP
Sbjct: 203 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 262

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 263 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 322

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 323 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 382

Query: 394 DKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
           D  +T     DSP     + +A + F G+TYVAP+
Sbjct: 383 DSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  322 bits (826), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 159/329 (48%), Positives = 219/329 (66%), Gaps = 23/329 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+  V+G+G+FGKV QVKKKG      D I+AMKV+RKD II +  V++ K+E+ IL 
Sbjct: 152 DFELLNVIGKGSFGKVMQVKKKG-----EDKIFAMKVLRKDAIIARKQVNHTKSEKTILQ 206

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            ++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G F E + + Y AEIVSA+ H
Sbjct: 207 CISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALDH 266

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKG 280
           LHK  IV+RDLKPENIL+DS+GH          +I+ +  + + CGT EY+APE+L   G
Sbjct: 267 LHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGHG 326

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 340
           H    DWWS+G LLYEMLTG PPF   N   + Q+I+N ++K+P +++ EA SLL+GLL 
Sbjct: 327 HGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLLEGLLT 386

Query: 341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM 400
           ++  KRLG+  GG   +K H WF++I+W+ L+ +E++  FKP V     I+  D  +T  
Sbjct: 387 REVDKRLGTKGGG--EVKQHPWFKNIDWEKLDRKEVEVHFKPKVKSGTDISQIDPVFTQE 444

Query: 401 PADDSPAPTPTAGE------HFKGYTYVA 423
              DS   T   G+       F+G+TYVA
Sbjct: 445 RPMDSLVETSALGDAMGKDTSFEGFTYVA 473

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z1M4|KS6B2_MOUSE Ribosomal protein S6 kinase beta-2 OS=Mus musculus GN=Rps6kb2 PE=1 SV=1

 Score =  321 bits (822), Expect = 8e-87,   Method: Compositional matrix adjust.
 Identities = 164/357 (45%), Positives = 226/357 (63%), Gaps = 21/357 (5%)

Query: 88  IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY 143
           ++ + H  + EL   S      +IGP  FE+  V+G+G +GKVFQV+K  V   +   IY
Sbjct: 39  LETVGHYEEVELTESSVNLGPERIGPHCFELLSVLGKGGYGKVFQVRK--VQGTNLGKIY 96

Query: 144 AMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           AMKV+RK  I+       + +AER+IL  V HPFIV+L Y+FQT  KLYLIL+ ++GG L
Sbjct: 97  AMKVLRKAKIVCSAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGEL 156

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------- 253
           F HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++ S GH         
Sbjct: 157 FTHLEREGIFLEDTACFYLAEITLALGHLHSHGIIYRDLKPENIMLSSQGHIKLTDFGLC 216

Query: 254 --EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 311
              I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K
Sbjct: 217 KESIHEGAITHTFCGTIEYMAPEILVRTGHNRAVDWWSLGALMYDMLTGSPPFTAENRKK 276

Query: 312 LQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 371
              +II  K+ LPP+LT +A  L K  L ++P++R+G G G    ++ H +FR INW  L
Sbjct: 277 TMDKIIKGKLVLPPYLTPDARDLAKKFLKRNPTQRIGGGLGDAADVQRHPFFRHINWDDL 336

Query: 372 EAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP---APTPTAGEHFKGYTYVAPN 425
            AR + P F+P +  ++ ++ FD  +T     DSP   A + +A + F G+TYVAP+
Sbjct: 337 LARRVDPPFRPSLQSEEDVSQFDARFTRQTPVDSPDDTALSESANQAFLGFTYVAPS 393

Phosphorylates specifically ribosomal protein S6.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	431
225457176	452	PREDICTED: serine/threonine-protein kina	0.979	0.933	0.738	0.0
224119194	470	predicted protein [Populus trichocarpa]	0.986	0.904	0.724	0.0
147817142	463	hypothetical protein VITISV_040765 [Viti	0.979	0.911	0.716	0.0
449440730	483	PREDICTED: serine/threonine-protein kina	0.974	0.869	0.676	1e-178
449527582	486	PREDICTED: serine/threonine-protein kina	0.974	0.864	0.672	1e-177
62183960	466	putative ribosomal-protein S6 kinase-lik	0.979	0.905	0.675	1e-171
358248554	415	uncharacterized protein LOC100798259 [Gl	0.853	0.886	0.774	1e-167
297733856	296	unnamed protein product [Vitis vinifera]	0.663	0.966	0.847	1e-148
167999486	452	predicted protein [Physcomitrella patens	0.916	0.873	0.592	1e-146
255540831	297	ribosomal protein S6 kinase, putative [R	0.663	0.962	0.827	1e-146

>gi|225457176|ref|XP_002280523.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  661 bits (1705), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/448 (73%), Positives = 369/448 (82%), Gaps = 26/448 (5%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR SFQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
           K GIVHRDLKPENILMD+DGH          EIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           KDADWWS+GILLYEMLTGQPPFTHANRQKLQQRII EKVKLP +L+SEAHSLLKGLL K+
Sbjct: 305 KDADWWSIGILLYEMLTGQPPFTHANRQKLQQRIIKEKVKLPSYLSSEAHSLLKGLLQKE 364

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 402
           PS+RLGSGP G D I++HKWFRSINWK LEARE+QPKFKPDVSGKDC ANFD+CWT MP 
Sbjct: 365 PSRRLGSGPTGGDEIQNHKWFRSINWKKLEARELQPKFKPDVSGKDCTANFDQCWTAMPL 424

Query: 403 DDSPAPTPTAGEHFKGYTYVAPNPWLSS 430
           DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 425 DDSPAPTPTAGGHFQGYTYVAPNPWLSS 452

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119194|ref|XP_002318010.1| predicted protein [Populus trichocarpa] gi|222858683|gb|EEE96230.1| predicted protein [Populus trichocarpa]

 Score =  649 bits (1675), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/469 (72%), Positives = 375/469 (79%), Gaps = 44/469 (9%)

Query: 1   MVSTSQK-NLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPL-TPCRHNNQSPASTSASL 58
           +VSTSQK  L SLL+  LKKLTITPP+    D +F++VFGP  TP   N+    STS+S+
Sbjct: 6   LVSTSQKKTLLSLLSINLKKLTITPPN----DLEFSDVFGPSSTPHDPNHSHSPSTSSSV 61

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAES--------------- 103
            DP VIHNRSHSFVGPSPRY L SS PL    ++ +++A +E ES               
Sbjct: 62  LDPPVIHNRSHSFVGPSPRYPLPSS-PLPFHHIQEDDEAVIENESCDNEKGKSEDDEGQV 120

Query: 104 -----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKD 151
                  KIGP DFEI RVVG+GAFGKVFQV+KK  D  +  G       IYAMKVMRKD
Sbjct: 121 GSCGNNNKIGPADFEILRVVGKGAFGKVFQVRKKTGDGKEKGGGGGSGDGIYAMKVMRKD 180

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           TIIKK HVDYMKAERDILTKV HPFIVQLRYSFQT+SKLYLILDF+NGGHLFFHLYRQGI
Sbjct: 181 TIIKKKHVDYMKAERDILTKVVHPFIVQLRYSFQTKSKLYLILDFMNGGHLFFHLYRQGI 240

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRS 261
           F EDQARFYTAEIVSAV+HLHKCGIVHRDLKPENIL+D+DGH          EIDESSRS
Sbjct: 241 FSEDQARFYTAEIVSAVAHLHKCGIVHRDLKPENILLDADGHVLLTDFGLAKEIDESSRS 300

Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
           NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH+NR+KLQ+RII E+V
Sbjct: 301 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHSNRKKLQERIIKERV 360

Query: 322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
           KLPP+L+SEAHSLLKGLL K+PS+RLGSG  G D IK HKW R INWK LEARE+QPK+ 
Sbjct: 361 KLPPYLSSEAHSLLKGLLQKEPSRRLGSGLDGGDEIKGHKWLRPINWKKLEARELQPKYI 420

Query: 382 PDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 430
           PDVSGKDC ANFD+CWTTMP DDSPAPTPTAGEHF+GYTYVAPNPWLSS
Sbjct: 421 PDVSGKDCTANFDQCWTTMPLDDSPAPTPTAGEHFQGYTYVAPNPWLSS 469

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147817142|emb|CAN77683.1| hypothetical protein VITISV_040765 [Vitis vinifera]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/459 (71%), Positives = 367/459 (79%), Gaps = 37/459 (8%)

Query: 6   QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
           +K LHS+L +KLK   +T PS SSPD  DF++VFGPLTP  H       + S +S   +L
Sbjct: 8   KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64

Query: 59  GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
           GDPQVIHNRSHS +GPSPR+A+++ L P +   +     ++ E      E ++GPGDFEI
Sbjct: 65  GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124

Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            RVVG+GAFGKVFQV+KKG  +  GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            HPFIV LR  FQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCFFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244

Query: 233 KCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
           K GIVHRDLKPENILMD+DGH          EIDESSRSNSMCGTTEYMAPEILLSKGHN
Sbjct: 245 KSGIVHRDLKPENILMDADGHVMLTDFGLAKEIDESSRSNSMCGTTEYMAPEILLSKGHN 304

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG----- 337
           KDADWWS+GILLYEMLTGQPPFTHANRQKLQQRII EKVKLP +L+SEAHSLLKG     
Sbjct: 305 KDADWWSIGILLYEMLTGQPPFTHANRQKLQQRIIKEKVKLPSYLSSEAHSLLKGLLTRK 364

Query: 338 ------LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 391
                 LL K+PS+RLGSGP G D I++HKWFRSINWK LE RE+QPKFKPDVSGKDC A
Sbjct: 365 LLSHCQLLQKEPSRRLGSGPTGGDEIQNHKWFRSINWKKLEXRELQPKFKPDVSGKDCTA 424

Query: 392 NFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 430
           NFD+CWT MP DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 425 NFDQCWTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWLSS 463

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440730|ref|XP_004138137.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  629 bits (1622), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 332/491 (67%), Positives = 366/491 (74%), Gaps = 71/491 (14%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP---------DFDFTEVFGPLTPCRHNNQS 50
           MVS S QKN+HSLL   L KLTI   S+SS          DFDF +VFGP  P       
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAVHDFDFNDVFGPTNP------- 53

Query: 51  PASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE-------- 94
             S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +        
Sbjct: 54  --SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEEEEE 110

Query: 95  --NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQVKKK 132
             ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V+KK
Sbjct: 111 EENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLVRKK 170

Query: 133 GVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
           G   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT+SK
Sbjct: 171 GNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQTKSK 230

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           LYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENILMD
Sbjct: 231 LYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENILMD 290

Query: 250 SDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
           +DGH          EIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYEML+
Sbjct: 291 ADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYEMLS 350

Query: 300 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           GQPPFTH NR+KLQ+RII EKVKLPP+L++EAHSLL+GLL K+PSKRLGSGP G D IK+
Sbjct: 351 GQPPFTHTNRKKLQERIIKEKVKLPPYLSTEAHSLLRGLLEKEPSKRLGSGPKGGDEIKN 410

Query: 360 HKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGY 419
           HKWFR +NWK LE RE+QPKFKPDVSG DC ANFD CWT MP DDSPAPTPT G HF+GY
Sbjct: 411 HKWFRPVNWKKLECRELQPKFKPDVSGNDCTANFDHCWTAMPPDDSPAPTPTDGGHFQGY 470

Query: 420 TYVAPNPWLSS 430
           +YVAPN WLSS
Sbjct: 471 SYVAPNLWLSS 481

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449527582|ref|XP_004170789.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus]

 Score =  629 bits (1621), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 332/494 (67%), Positives = 366/494 (74%), Gaps = 74/494 (14%)

Query: 1   MVSTS-QKNLHSLLTTKLKKLTITPPSASSP------------DFDFTEVFGPLTPCRHN 47
           MVS S QKN+HSLL   L KLTI   S+SS             DFDF +VFGP  P    
Sbjct: 1   MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAAAAVHDFDFNDVFGPTNP---- 56

Query: 48  NQSPASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE----- 94
                S S+  GDPQ        VIHNRSHSFVGPSPR    +SLP   +E++ +     
Sbjct: 57  -----SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEE 110

Query: 95  -----NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQV 129
                ND E+      + E +R              KIG GDF+I RVVG+GAFGKVF V
Sbjct: 111 EEEEENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLV 170

Query: 130 KKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
           +KKG   G   D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT
Sbjct: 171 RKKGNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQT 230

Query: 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
           +SKLYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENI
Sbjct: 231 KSKLYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENI 290

Query: 247 LMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 296
           LMD+DGH          EIDESSRSNS+CGTTEYMAPEILLS+GHNKDADWWSVGILLYE
Sbjct: 291 LMDADGHVVLTDFGLAKEIDESSRSNSLCGTTEYMAPEILLSRGHNKDADWWSVGILLYE 350

Query: 297 MLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDA 356
           ML+GQPPFTH NR+KLQ+RII EKVKLPP+L++EAHSLL+GLL K+PSKRLGSGP G D 
Sbjct: 351 MLSGQPPFTHTNRKKLQERIIKEKVKLPPYLSTEAHSLLRGLLQKEPSKRLGSGPKGGDE 410

Query: 357 IKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHF 416
           IK+HKWFR +NWK LE RE+QPKFKPDVSG DC ANFD CWT MP DDSPAPTPT G HF
Sbjct: 411 IKNHKWFRPVNWKKLECRELQPKFKPDVSGNDCTANFDHCWTAMPPDDSPAPTPTDGGHF 470

Query: 417 KGYTYVAPNPWLSS 430
           +GY+YVAPN WLSS
Sbjct: 471 QGYSYVAPNLWLSS 484

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62183960|gb|AAX73301.1| putative ribosomal-protein S6 kinase-like protein [Solanum lycopersicum]

 Score =  606 bits (1563), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 318/471 (67%), Positives = 359/471 (76%), Gaps = 49/471 (10%)

Query: 1   MVSTSQKNLHSLLTTKLKKLTITPPSASSPD------FDFTEVFGPLTPCRHNNQSPAST 54
             +  +K +HS+L  KL  L I   S+SS        FDF++VFG  T       SP+S+
Sbjct: 3   FAAQQKKAIHSMLANKLTHLKIPDSSSSSSPPPTDPDFDFSDVFGAPT-------SPSSS 55

Query: 55  SASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAEL--------------- 99
           S+ L DPQ+IH+RSHSFVGPSPR  LS  LP   QE++ E +++                
Sbjct: 56  SSFLTDPQIIHSRSHSFVGPSPRITLSKPLPFH-QEVDSEGESDSDKVNTHVGTHQTECS 114

Query: 100 ---------EAESERKIGPGDFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMR 149
                    E  +  K GPGDFEI R++G+G+FGKVFQVK K    +G+ DGI AMKVMR
Sbjct: 115 DGIEEISGDEGSAVTKFGPGDFEILRMIGKGSFGKVFQVKMKGYGGEGEGDGILAMKVMR 174

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           KDT+IK NHVDYM+AERDILTKV HPFIVQLRYSFQT+SKLYLILDFINGGHLF+HLYRQ
Sbjct: 175 KDTVIKNNHVDYMRAERDILTKVEHPFIVQLRYSFQTKSKLYLILDFINGGHLFYHLYRQ 234

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESS 259
           GIF EDQAR Y AEIVSAVSHLH+ GIVHRDLKPENILMD DGH          EIDESS
Sbjct: 235 GIFSEDQARIYAAEIVSAVSHLHQRGIVHRDLKPENILMDGDGHVMLTDFGLAKEIDESS 294

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
           RSNSMCGT EYMAPEI+ SKGHNKDADWWSVG+LLYEMLTGQPPFTHANR+KLQ++II+E
Sbjct: 295 RSNSMCGTMEYMAPEIIQSKGHNKDADWWSVGVLLYEMLTGQPPFTHANRKKLQEKIISE 354

Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 379
           K+KL P LT EAHSLLKGLL KDPSKRLGSGP G D IK HKWFR+INWK L+ARE+QPK
Sbjct: 355 KLKLLPRLTGEAHSLLKGLLQKDPSKRLGSGPRGGDEIKSHKWFRTINWKKLDARELQPK 414

Query: 380 FKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 430
           FKPDV G+DC ANFDKCWTTMP DDSPA TPT GEHF+GYTYVAPNPWLSS
Sbjct: 415 FKPDVIGRDCTANFDKCWTTMPPDDSPASTPTTGEHFQGYTYVAPNPWLSS 465

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248554|ref|NP_001239901.1| uncharacterized protein LOC100798259 [Glycine max] gi|255634893|gb|ACU17805.1| unknown [Glycine max]

 Score =  592 bits (1527), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 296/382 (77%), Positives = 320/382 (83%), Gaps = 14/382 (3%)

Query: 62  QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE---AESERKIGPGDFEIFRVV 118
            VI +RSHSFVGPSPR+ + SS PL   E E E + E E        KIGP DF I RVV
Sbjct: 31  HVIFSRSHSFVGPSPRF-VPSSTPLFFLEEEEEEEEEEELPFGPDPPKIGPSDFHILRVV 89

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV 178
           GQGAFGKVF V+KKG    D+DG++AMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIV
Sbjct: 90  GQGAFGKVFLVRKKGDCFDDADGVFAMKVMRKDTIIKKNHVDYMKAERDILTKVLHPFIV 149

Query: 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           QLRYSFQT+SKLYL+LDFINGGHLFF LYRQGIF EDQAR YTAEIVSAVSHLHK GIVH
Sbjct: 150 QLRYSFQTKSKLYLVLDFINGGHLFFQLYRQGIFSEDQARLYTAEIVSAVSHLHKNGIVH 209

Query: 239 RDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 288
           RDLKPENILMD+DGH          EI+E  RSNS CGT EYMAPEILL+KGHNKDADWW
Sbjct: 210 RDLKPENILMDADGHVMLTDFGLSKEINELGRSNSFCGTVEYMAPEILLAKGHNKDADWW 269

Query: 289 SVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLG 348
           SVGILLYEMLTG+ PFTH NR+KLQ++II EKVKLPPFLTSEAHSLLKGLL KDPS RLG
Sbjct: 270 SVGILLYEMLTGKAPFTHNNRKKLQEKIIKEKVKLPPFLTSEAHSLLKGLLQKDPSTRLG 329

Query: 349 SGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP 408
           +GP G   IK HKWFRSINWK LEARE++PKFKPDVS KDC +NFD+CWT MPADDSPAP
Sbjct: 330 NGPNGDGHIKSHKWFRSINWKKLEARELEPKFKPDVSAKDCTSNFDQCWTAMPADDSPAP 389

Query: 409 TPTAGEHFKGYTYVAPNPWLSS 430
           TPTAG+HF+GYTYVAPNPWLSS
Sbjct: 390 TPTAGDHFQGYTYVAPNPWLSS 411

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733856|emb|CBI15103.3| unnamed protein product [Vitis vinifera]

 Score =  531 bits (1368), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 251/296 (84%), Positives = 265/296 (89%), Gaps = 10/296 (3%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           MKVMRKDTII KNH+DYMKAERDIL KV HPFIV LR SFQT SKLYLI+DF+NGGHLFF
Sbjct: 1   MKVMRKDTIISKNHMDYMKAERDILIKVEHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFF 60

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------E 254
           HLYRQGIF EDQAR Y AEIVSAVSHLHK GIVHRDLKPENILMD+DGH          E
Sbjct: 61  HLYRQGIFSEDQARVYIAEIVSAVSHLHKSGIVHRDLKPENILMDADGHVMLTDFGLAKE 120

Query: 255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
           IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWS+GILLYEMLTGQPPFTHANRQKLQQ
Sbjct: 121 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSIGILLYEMLTGQPPFTHANRQKLQQ 180

Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           RII EKVKLP +L+SEAHSLLKGLL K+PS+RLGSGP G D I++HKWFRSINWK LEAR
Sbjct: 181 RIIKEKVKLPSYLSSEAHSLLKGLLQKEPSRRLGSGPTGGDEIQNHKWFRSINWKKLEAR 240

Query: 375 EMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 430
           E+QPKFKPDVSGKDC ANFD+CWT MP DDSPAPTPTAG HF+GYTYVAPNPWLSS
Sbjct: 241 ELQPKFKPDVSGKDCTANFDQCWTAMPLDDSPAPTPTAGGHFQGYTYVAPNPWLSS 296

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|167999486|ref|XP_001752448.1| predicted protein [Physcomitrella patens subsp. patens] gi|162696348|gb|EDQ82687.1| predicted protein [Physcomitrella patens subsp. patens]

 Score =  525 bits (1353), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 268/452 (59%), Positives = 324/452 (71%), Gaps = 57/452 (12%)

Query: 25  PSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLG-----------DPQVIHNRSHSFVG 73
           P   + +FDF++VFGP+ P   +  SP    A  G           DP V+++RSHS VG
Sbjct: 8   PDQCNEEFDFSDVFGPVPP---HPTSPLPAVAEDGETIDWSLELRQDPVVVYSRSHSLVG 64

Query: 74  PSPRYALSSSLPLQIQELEHENDA-----------------ELEAE------SERKIGPG 110
           PSP+ +L+    LQ + +  E D+                 EL ++         K+GP 
Sbjct: 65  PSPKPSLTR---LQSKPVWDEQDSLSLVRVASDSPTVHEVGELTSKDFVNGIGTEKLGPQ 121

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ RVVGQGAFGKVFQV+KKG  +     IYAMKVMRK+ II++NH DYMKAERDILT
Sbjct: 122 DFELLRVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILT 176

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           KV HPFIVQL+YSFQT+SKLYL+LDFINGGHLFF LYRQG F ED AR YTAEIV AV+H
Sbjct: 177 KVVHPFIVQLQYSFQTQSKLYLVLDFINGGHLFFQLYRQGTFNEDLARMYTAEIVLAVAH 236

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKG 280
           LHK GI+HRDLKPENIL+D DG+          E+ E S SNS+CGT EYMAPEI+LSKG
Sbjct: 237 LHKNGIIHRDLKPENILLDGDGYVMLTDFGLAKEVKEDSHSNSLCGTMEYMAPEIILSKG 296

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 340
           H K ADWWSVGILLYEMLTGQPPF H N+QKLQQ+II +K+KLP +LT++A++LLKGLL 
Sbjct: 297 HGKPADWWSVGILLYEMLTGQPPFAHKNKQKLQQKIIKDKIKLPTYLTADANNLLKGLLQ 356

Query: 341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM 400
           KDPSKRLG+GP G + IK +KWF+ INW+ LEAR++ PKF P V+GK C ANFD+ WTT+
Sbjct: 357 KDPSKRLGNGPTGSEDIKQNKWFKGINWRKLEARQVTPKFLPAVNGKQCTANFDEAWTTL 416

Query: 401 PADDSPAPTPTAGEH--FKGYTYVAPNPWLSS 430
           P DDSP  TP +G+   F+GYTYVAPN WL S
Sbjct: 417 PLDDSPVGTPKSGDRDFFRGYTYVAPNVWLKS 448

Source: Physcomitrella patens subsp. patens

Species: Physcomitrella patens

Genus: Physcomitrella

Family: Funariaceae

Order: Funariales

Class: Bryopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255540831|ref|XP_002511480.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223550595|gb|EEF52082.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  525 bits (1352), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 245/296 (82%), Positives = 265/296 (89%), Gaps = 10/296 (3%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           MKVMRKD IIKKNHVDYMKAERDILTKV HPF+VQLRYSFQT+SKLYLI+DF+NGGHLFF
Sbjct: 1   MKVMRKDIIIKKNHVDYMKAERDILTKVVHPFVVQLRYSFQTKSKLYLIMDFMNGGHLFF 60

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------E 254
           HLYRQG+F EDQAR YTAEIVSAVSHLHKCGIVHRDLKPENI++DSDGH          E
Sbjct: 61  HLYRQGLFSEDQARVYTAEIVSAVSHLHKCGIVHRDLKPENIILDSDGHVMLTDFGLAKE 120

Query: 255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
           IDESSRSNSMCGTTEYMAPEIL SKGHNKDADWWS+GILLYEMLTGQPPF H +R+KLQ+
Sbjct: 121 IDESSRSNSMCGTTEYMAPEILQSKGHNKDADWWSIGILLYEMLTGQPPFEHKDRKKLQE 180

Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           RII EK+KLP FL+SEAHSLLKGLL K+PS+RLGSGP G D +K HKWFRSINWK LEAR
Sbjct: 181 RIIKEKIKLPSFLSSEAHSLLKGLLQKEPSRRLGSGPSGGDEVKSHKWFRSINWKKLEAR 240

Query: 375 EMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSS 430
           E+ PKFKPDVSGK C  NFD+CWTTMP DDSPA TPTAGEHF+GYTY+APNPWLSS
Sbjct: 241 ELIPKFKPDVSGKYCTENFDRCWTTMPPDDSPACTPTAGEHFQGYTYIAPNPWLSS 296

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	431
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.763	0.707	0.592	3.3e-115
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.900	0.823	0.539	1.8e-110
UNIPROTKB|J9NU84	482	RPS6KB2 "Uncharacterized prote	0.835	0.746	0.422	1.9e-74
UNIPROTKB|E1BLQ5	485	RPS6KB2 "Uncharacterized prote	0.816	0.725	0.407	1.7e-73
UNIPROTKB|E2R7K9	482	RPS6KB2 "Uncharacterized prote	0.812	0.726	0.423	1.7e-73
UNIPROTKB|F1RUZ0	485	RPS6KB2 "Uncharacterized prote	0.812	0.721	0.412	9.6e-73
UNIPROTKB|Q9UBS0	482	RPS6KB2 "Ribosomal protein S6	0.816	0.730	0.410	1.6e-72
UNIPROTKB|F1MNP4	525	RPS6KB1 "Ribosomal protein S6	0.784	0.643	0.427	6.7e-72
UNIPROTKB|Q6TJY3	527	RPS6KB1 "Ribosomal protein S6	0.784	0.641	0.427	6.7e-72
UNIPROTKB|E2RMD8	525	RPS6KB1 "Uncharacterized prote	0.784	0.643	0.427	6.7e-72

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1078 (384.5 bits), Expect = 3.3e-115, Sum P(2) = 3.3e-115
 Identities = 208/351 (59%), Positives = 254/351 (72%)

Query:    92 EHENDAELEAESERK---IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM 148
             + +N+  LE +  +    +G  DFE+ +VVG+GAF                  IYAMKVM
Sbjct:   111 DSDNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSE-----IYAMKVM 165

Query:   149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
             RKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY 
Sbjct:   166 RKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 225

Query:   209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES 258
             QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD+DGH          E +E+
Sbjct:   226 QGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEEN 285

Query:   259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
             +RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLTG+PPF   ++ K+QQ+I+ 
Sbjct:   286 TRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQKIVK 344

Query:   319 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 378
             +K+KLP FL++EAH++LKGLL K+P +RLGSG  G + IK HKWF+ INWK LEARE+ P
Sbjct:   345 DKIKLPQFLSNEAHAILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMP 404

Query:   379 KFKPDVSGKDCIANFDKCWXXXXXXXXXXXXXXX---GEHFKGYTYVAPNP 426
              FKP+VSG+ CIANFDKCW                     F  +TYV P P
Sbjct:   405 SFKPEVSGRQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPP 455

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
 Identities = 231/428 (53%), Positives = 282/428 (65%)

Query:    31 DFDFTEVFGPLTP------CRHNNQSPA---STSASLGDPQVIHNRSHSFVGPSPRYALS 81
             +  F++VFGP+        C      PA   S S SL  P ++ + S      + R    
Sbjct:    38 ELQFSDVFGPMPEANSEEACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETED 97

Query:    82 SSLPLQIQELEH--END---AELEAESERK-------IGPGDFEIFRVVGQGAFXXXXXX 129
             S   ++  E E   END      + +SE+        +G  DFE+ +VVGQGAF      
Sbjct:    98 SVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQV 157

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                         IYAMKVMRKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +
Sbjct:   158 RKKDTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYR 212

Query:   190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
             LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD
Sbjct:   213 LYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMD 272

Query:   250 SDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
              DGH          E +E++RSNSMCGTTEYMAPEI+  KGH+K ADWWSVGILLYEMLT
Sbjct:   273 VDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLT 332

Query:   300 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             G+PPF   ++ K+QQ+I+ +K+KLP FL++EAH+LLKGLL K+P +RLGSGP G + IK 
Sbjct:   333 GKPPFL-GSKGKIQQKIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKK 391

Query:   360 HKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXXXXXX---XXXGEHF 416
             HKWF++INWK LEARE+QP FKP VSG+ CIANFDKCW                     F
Sbjct:   392 HKWFKAINWKKLEAREVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPF 451

Query:   417 KGYTYVAP 424
               +TYV P
Sbjct:   452 TNFTYVRP 459

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

UNIPROTKB|J9NU84 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
 Identities = 163/386 (42%), Positives = 225/386 (58%)

Query:    57 SLGDPQVIHNRSHSFVGPSPRYALSSSLPL-QIQELE-HENDAELEAESERKIGPGDFEI 114
             S G+P+     S S  GP P      + P+   +E+E  E    L  E   +IGP  FE+
Sbjct:    15 SEGEPEF----SPSVSGPPPPLTSCINRPVGHCEEVELTETSVNLGPE---RIGPHCFEL 67

Query:   115 FRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT 173
              RV+G+G +                  IYAMKV+RK  I++      + +AER+IL  V 
Sbjct:    68 LRVLGKGGYGKVFQVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVK 125

Query:   174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
             HPFIV+L Y+FQT  KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH 
Sbjct:   126 HPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHS 185

Query:   234 CGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
              GI++RDLKPENI+++S GH            I E + +++ CGT EYMAPEIL+  GHN
Sbjct:   186 QGIIYRDLKPENIMLNSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHN 245

Query:   283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
             +  DWWS+G L+Y+MLTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++
Sbjct:   246 RAVDWWSLGALMYDMLTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVKKFLKRN 305

Query:   343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXX 402
             PS+R+G GPG    ++ H +FR INW  L AR + P F+P +  ++ ++ FD  +     
Sbjct:   306 PSQRIGGGPGDSADVQRHPFFRHINWDDLLARRIDPPFRPCLQSEEDVSQFDTHFTRQTP 365

Query:   403 XXX---XXXXXXXGEHFKGYTYVAPN 425
                           + F G+TYVAP+
Sbjct:   366 VDSPDDTALSESANQAFLGFTYVAPS 391

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|E1BLQ5 RPS6KB2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
 Identities = 152/373 (40%), Positives = 218/373 (58%)

Query:    72 VGPSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXX 127
             + P+    L+      ++ + H  + EL   S      +IGP  FE+ RV+G+G +    
Sbjct:    23 LSPADACPLAELRAAGLEPVGHYEEVELTESSVNPGPERIGPHCFELLRVLGKGNYGKVF 82

Query:   128 XXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
                           IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT
Sbjct:    83 QVRKVQGSNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQT 140

Query:   187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
               KLYLIL+ ++GG LF HL R+GIF ED A FY +EI  A+ HLH  GI++RDLKPENI
Sbjct:   141 GGKLYLILECLSGGELFTHLEREGIFLEDTACFYLSEITLALGHLHSQGIIYRDLKPENI 200

Query:   247 LMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY 295
             ++ S GH            I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y
Sbjct:   201 MLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMY 260

Query:   296 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVD 355
             +MLTG PPFT  NR+K   +II  K++LPP+LT +A  L+K  L ++P++R+G GPG   
Sbjct:   261 DMLTGSPPFTAENRKKTMDKIIRGKLELPPYLTPDARDLVKKFLKRNPNQRIGGGPGDAA 320

Query:   356 AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXX 412
              ++ H +FR +NW  L AR + P F+P +  ++ ++ FD  +                  
Sbjct:   321 DVQRHPFFRHVNWDDLLARRVDPPFRPSLQSEEDVSQFDSHFTKQTPVDSPDDTTLSESA 380

Query:   413 GEHFKGYTYVAPN 425
              + F G+TYVAP+
Sbjct:   381 NQAFLGFTYVAPS 393

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2R7K9 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
 Identities = 157/371 (42%), Positives = 217/371 (58%)

Query:    74 PSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXX 129
             PS    L+ S     + + H  + EL   S      +IGP  FE+ RV+G+G +      
Sbjct:    23 PSDVCPLAESRAAGPEPVGHCEEVELTETSVNLGPERIGPHCFELLRVLGKGGYGKVFQV 82

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188
                         IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  
Sbjct:    83 RKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGG 140

Query:   189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
             KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI++
Sbjct:   141 KLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIML 200

Query:   249 DSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
             +S GH            I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+M
Sbjct:   201 NSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDM 260

Query:   298 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 357
             LTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG    +
Sbjct:   261 LTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVKKFLKRNPSQRIGGGPGDSADV 320

Query:   358 KHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGE 414
             + H +FR INW  L AR + P F+P +  ++ ++ FD  +                   +
Sbjct:   321 QRHPFFRHINWDDLLARRIDPPFRPCLQSEEDVSQFDTHFTRQTPVDSPDDTALSESANQ 380

Query:   415 HFKGYTYVAPN 425
              F G+TYVAP+
Sbjct:   381 AFLGFTYVAPS 391

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1RUZ0 RPS6KB2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
 Identities = 153/371 (41%), Positives = 217/371 (58%)

Query:    74 PSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXX 129
             P+    L+ S    ++ + H  + EL   S      +IGP  FE+ RV+G+G +      
Sbjct:    25 PADACPLAESRAAGLEPVGHYEEVELTETSVNPGPERIGPHCFELLRVLGKGNYGKVFQV 84

Query:   130 XXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188
                         IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT  
Sbjct:    85 RKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGG 142

Query:   189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
             KLYLIL+ ++GG LF  L R+GIF ED A FY +EI  A+ HLH  GI++RDLKPEN+++
Sbjct:   143 KLYLILECLSGGELFTRLEREGIFLEDTACFYLSEITLALGHLHSQGIIYRDLKPENVML 202

Query:   249 DSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
              S GH            I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+M
Sbjct:   203 SSQGHIKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDM 262

Query:   298 LTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 357
             LTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG    +
Sbjct:   263 LTGSPPFTAENRKKTMDKIIRGKLVLPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAADV 322

Query:   358 KHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGE 414
             + H +FR INW+ L AR + P F+P +  ++ ++ FD  +                   +
Sbjct:   323 QKHPFFRHINWEDLLARRVDPPFRPCLQSEEDVSQFDTHFTRQTPVDSPDDTALSESANQ 382

Query:   415 HFKGYTYVAPN 425
              F G+TYVAP+
Sbjct:   383 AFLGFTYVAPS 393

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q9UBS0 RPS6KB2 "Ribosomal protein S6 kinase beta-2" [Homo sapiens (taxid:9606)]

 Score = 733 (263.1 bits), Expect = 1.6e-72, P = 1.6e-72
 Identities = 153/373 (41%), Positives = 216/373 (57%)

Query:    72 VGPSPRYALSSSLPLQIQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXX 127
             + P+    L+      ++ + H  + EL   S      +IGP  FE+ RV+G+G +    
Sbjct:    23 LSPADACPLAELRAAGLEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVF 82

Query:   128 XXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
                           IYAMKV+RK  I++      + +AER+IL  V HPFIV+L Y+FQT
Sbjct:    83 QVRKVQGTNLGK--IYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQT 140

Query:   187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
               KLYLIL+ ++GG LF HL R+GIF ED A FY AEI  A+ HLH  GI++RDLKPENI
Sbjct:   141 GGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENI 200

Query:   247 LMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY 295
             ++ S GH            I E + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y
Sbjct:   201 MLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMY 260

Query:   296 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVD 355
             +MLTG PPFT  NR+K   +II  K+ LPP+LT +A  L+K  L ++PS+R+G GPG   
Sbjct:   261 DMLTGSPPFTAENRKKTMDKIIRGKLALPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAA 320

Query:   356 AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXX 412
              ++ H +FR +NW  L A  + P F+P +  ++ ++ FD  +                  
Sbjct:   321 DVQRHPFFRHMNWDDLLAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDTALSESA 380

Query:   413 GEHFKGYTYVAPN 425
              + F G+TYVAP+
Sbjct:   381 NQAFLGFTYVAPS 393

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0004672 "protein kinase activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0006412 "translation" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

UNIPROTKB|F1MNP4 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
 Identities = 154/360 (42%), Positives = 216/360 (60%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------E 254
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GH            
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
             +I+  K+ LPP+LT EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR
Sbjct:   304 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 363

Query:   375 EMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPNPWLSSV 431
             +++P FKP +  ++ ++ FD  +                   + F G+TYVAP+  L SV
Sbjct:   364 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPSV-LESV 422

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q6TJY3 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
 Identities = 154/360 (42%), Positives = 216/360 (60%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------E 254
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GH            
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
             +I+  K+ LPP+LT EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR
Sbjct:   304 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 363

Query:   375 EMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPNPWLSSV 431
             +++P FKP +  ++ ++ FD  +                   + F G+TYVAP+  L SV
Sbjct:   364 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSALSESANQVFLGFTYVAPSV-LESV 422

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005739 "mitochondrion" evidence=ISS

GO:0071363 "cellular response to growth factor stimulus" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0043005 "neuron projection" evidence=IEA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2RMD8 RPS6KB1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
 Identities = 154/360 (42%), Positives = 216/360 (60%)

Query:    91 LEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMK 146
             +EH    E+   S      KI P  FE+ RV+G+G +                  I+AMK
Sbjct:    66 MEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMK 123

Query:   147 VMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
             V++K  I++      + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  
Sbjct:   124 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 183

Query:   206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------E 254
             L R+GIF ED A FY AEI  A+ HLH+ GI++RDLKPENI+++  GH            
Sbjct:   184 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 243

Query:   255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
             I + + +++ CGT EYMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   
Sbjct:   244 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 303

Query:   315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
             +I+  K+ LPP+LT EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR
Sbjct:   304 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 363

Query:   375 EMQPKFKPDVSGKDCIANFDKCWXXXXXXXX---XXXXXXXGEHFKGYTYVAPNPWLSSV 431
             +++P FKP +  ++ ++ FD  +                   + F G+TYVAP+  L SV
Sbjct:   364 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPSV-LESV 422

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.5691	0.9118	0.8343	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	431
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-135
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-124
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-124
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-113
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-106
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-104
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-103
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-101
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-100
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-98
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-95
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-94
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-94
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-94
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-91
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-91
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-89
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-88
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-88
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-86
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-86
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-86
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-86
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-85
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-85
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-84
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-84
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-83
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-83
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-83
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-83
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-83
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-82
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-82
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-81
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-78
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-77
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-77
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-75
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-75
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-72
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-72
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-71
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-69
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-68
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-67
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-67
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-66
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-66
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-64
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-64
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-63
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-62
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-61
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-61
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-61
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-60
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-57
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-57
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-56
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-55
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-54
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-54
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-53
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-53
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-53
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-46
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-38
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-37
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-35
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-34
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-34
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-33
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-33
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-32
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-32
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-32
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-31
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-31
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-30
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-30
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-27
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-27
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-26
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-26
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-24
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-23
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-22
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-21
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-21
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-21
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-20
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-14
smart00133	64	smart00133, S_TK_X, Extension to Ser/Thr-type prot	3e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-06
pfam00433	47	pfam00433, Pkinase_C, Protein kinase C terminal do	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.004

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  388 bits (1000), Expect = e-135
 Identities = 131/257 (50%), Positives = 184/257 (71%), Gaps = 18/257 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV  V+KK     D+  +YAMKV++K  IIK+  V++   ER+IL+++ HPFI
Sbjct: 1   LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L Y+FQT  KLYL+L++  GG LF HL ++G F E++ARFY AEIV A+ +LH  GI+
Sbjct: 56  VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115

Query: 238 HRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 286
           +RDLKPENIL+D+DGH              E SR+N+ CGT EY+APE+LL KG+ K  D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 287 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           WWS+G+LLYEMLTG+PPF   +R+++ ++I+ + ++ P FL+ EA  L+ GLL KDP+KR
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235

Query: 347 LGSGPGGVDAIKHHKWF 363
           LGSG    + IK H +F
Sbjct: 236 LGSGG--AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  361 bits (928), Expect = e-124
 Identities = 127/295 (43%), Positives = 185/295 (62%), Gaps = 17/295 (5%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  + +G G+FG+V  V+ K      S   YA+K++ K  I+K   V+++  E+ IL 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HPF+V L  SFQ  S LYL+++++ GG LF HL + G F E  ARFY A++V A+ +
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKG 280
           LH   IV+RDLKPEN+L+DSDG+           +    R+ ++CGT EY+APEI+LSKG
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKG 174

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 340
           + K  DWW++GIL+YEML G PPF   N  ++ ++I+  KV+ P F + +A  L++ LL 
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234

Query: 341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
            D +KRLG+   GV+ IK+H WF  I+W  L  R+++  F P V G    +NFD 
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  361 bits (929), Expect = e-124
 Identities = 162/325 (49%), Positives = 221/325 (68%), Gaps = 19/325 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDILTKVT 173
           +V+G+G +GKVFQV+K  V   D+  I+AMKV++K TI++ N  D  + KAER+IL  V 
Sbjct: 2   KVLGKGGYGKVFQVRK--VTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVK 58

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPFIV L Y+FQT  KLYLIL++++GG LF HL R+GIF ED A FY +EI  A+ HLH+
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 234 CGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
            GI++RDLKPENIL+D+ GH            I E + +++ CGT EYMAPEIL+  GH 
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           K  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  LLK LL ++
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 402
           PS RLG+GPG    ++ H +FR +NW  L AR+++P FKP +  ++ ++ FD  +T    
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTP 298

Query: 403 DDSPAPT---PTAGEHFKGYTYVAP 424
            DSP  +    +A + F G+TYVAP
Sbjct: 299 VDSPDDSTLSESANQIFLGFTYVAP 323

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  333 bits (856), Expect = e-113
 Identities = 149/320 (46%), Positives = 210/320 (65%), Gaps = 16/320 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +V+GQG+FGKVF V+K  +   D+  +YAMKV++K T+  ++ V   K ERDIL +V HP
Sbjct: 2   KVLGQGSFGKVFLVRK--ITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           FIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY AE+  A+ HLH  G
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 236 IVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKD 284
           I++RDLKPENIL+D +GH            ID   ++ S CGT EYMAPE++  +GH + 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 285 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 344
           ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ EA SLL+ L  ++P+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238

Query: 345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 404
            RLG+GP GV+ IK H +F +I+W  L  RE++P FKP V   D    FD  +T+    D
Sbjct: 239 NRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKD 298

Query: 405 SPAPTPTAGEH--FKGYTYV 422
           SP   P+A  H  F+G+++V
Sbjct: 299 SPGIPPSANAHQLFRGFSFV 318

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  315 bits (809), Expect = e-106
 Identities = 139/329 (42%), Positives = 200/329 (60%), Gaps = 28/329 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K K          YA+KV++K  I+KK    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
            I++RDLKPENIL+DS GH            I+ S  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW +G +LYEML G PPF   +  ++   I+N+ ++L P ++  A  LL+GLL KD 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDR 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 403
           +KRLG+       IK+H +F SINW  L  +++ P F P+VSG   + +FD  +T  P  
Sbjct: 236 TKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVP 294

Query: 404 DSPAPTPT----------AGEHFKGYTYV 422
           +S   +P           A + F G++Y 
Sbjct: 295 NSVGKSPDSVLVSASVKEADDAFLGFSYA 323

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  313 bits (802), Expect = e-104
 Identities = 150/334 (44%), Positives = 217/334 (64%), Gaps = 22/334 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   D+  +YAMKV++K  +++K   V++ + ER++L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD+++GG +F HLY++  F ED+ RFY+ EI+ A+
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMCGTTEYMAPEIL 276
            HLHK GIV+RD+K ENIL+DS+GH +            +E  R+ S CGT EYMAPEI+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 277 LSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLPPFLTSEA 331
             K GH K  DWWS+GIL++E+LTG  PFT    +  Q    +RI+      P F+  EA
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIA 391
             LL  LL KDP KRLG+GP G   IK H +F+ ++W+ L  R++ P F+P +  +  + 
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298

Query: 392 NFDKCWTTMPADDSPAPTPTAGEH-FKGYTYVAP 424
           NF + +T +    SPA TP +G   F+GY++VAP
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFVAP 332

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  308 bits (791), Expect = e-103
 Identities = 129/323 (39%), Positives = 199/323 (61%), Gaps = 21/323 (6%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + V+    E+ +L     H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT+ +L+ +++++NGG L FH+ R G F E +ARFY AEIV  +  LH+ 
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+L+DS+GH            I     +++ CGT +Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+LLYEML GQ PF   +  +L Q I+ ++V+ P +L+ EA S+LK  L K+P
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 403
            KRLG  P G   IK H +FR I+W  LE +E++P FKP + G+  ++NFD  +T     
Sbjct: 236 EKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPV 295

Query: 404 DSPAPTPTAG----EHFKGYTYV 422
            +P           E F+G++Y+
Sbjct: 296 LTPPDEAIIRNIDQEEFRGFSYI 318

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  304 bits (781), Expect = e-101
 Identities = 140/319 (43%), Positives = 203/319 (63%), Gaps = 22/319 (6%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGKV QV+K+     D+  IYA+K +RK  I+ ++ V +  AER +L +V  PFI
Sbjct: 1   IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V L++SFQ+  KLYL+L FINGG LF HL R+G F   +ARFYTAE++ A+ +LHK  ++
Sbjct: 56  VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 238 HRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 286
           +RDLKPENIL+D  GH            + +  ++N+ CGT EY+APE+LL  G+ K  D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 287 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           WW++G+LLYEMLTG PPF   N  ++ ++I+ E ++ P     +A  LL GLL +DP++R
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235

Query: 347 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT-MPAD-- 403
           LG    G   IK+H +F  ++WK L  + +QP FKP VS     +NFD+ +T   P D  
Sbjct: 236 LGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSV 293

Query: 404 -DSPAPTPTAGEHFKGYTY 421
            D    + T  + F G++Y
Sbjct: 294 VDDSHLSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  299 bits (766), Expect = e-100
 Identities = 133/292 (45%), Positives = 189/292 (64%), Gaps = 24/292 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV-DYMKAERDIL 169
           +FE+ RV+G GA+GKVF V+K G    D+  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             V   PF+V L Y+FQT +KL+LILD++NGG LF HLY++  F E + R Y AEIV A+
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMCGTTEYMAPEIL 276
            HLH+ GI++RD+K ENIL+DS+GH +            +E  R+ S CGT EYMAPE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 277 LSK--GHNKDADWWSVGILLYEMLTGQPPFT---HANRQK-LQQRIINEKVKLPPFLTSE 330
                GH+K  DWWS+G+L +E+LTG  PFT     N Q  + +RI+  K   P  +++E
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
           A   ++ LL KDP KRLG+   G D IK+H +F+ I+W  L A+ +   FKP
Sbjct: 239 ARDFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  293 bits (752), Expect = 5e-98
 Identities = 108/266 (40%), Positives = 156/266 (58%), Gaps = 26/266 (9%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G+G+FGKV+  + K      +  + A+KV++K  I K    + +  E  IL K
Sbjct: 1   YEILEKLGEGSFGKVYLARDK-----KTGKLVAIKVIKKKKIKKD--RERILREIKILKK 53

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L   F+   KLYL++++  GG LF  L ++G   ED+ARFY  +I+SA+ +L
Sbjct: 54  LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 232 HKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGH 281
           H  GIVHRDLKPENIL+D DGH          ++D   +  +  GT EYMAPE+LL KG+
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 282 NKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF---LTSEAHSLLKG 337
            K  D WS+G++LYE+LTG+PPF       +L ++I   K   PP    ++ EA  L++ 
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 338 LLHKDPSKRLGSGPGGVDAIKHHKWF 363
           LL KDP KRL       +    H +F
Sbjct: 234 LLVKDPEKRL-----TAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  287 bits (736), Expect = 2e-95
 Identities = 113/272 (41%), Positives = 166/272 (61%), Gaps = 28/272 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           + +GA+G+VF  KKK   D     IYA+KV++K  +I+KN VD +  ERDIL++   P++
Sbjct: 1   ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L YSFQ +  LYL+++++ GG L   L   G   ED AR Y AEIV A+ +LH  GI+
Sbjct: 56  VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 238 HRDLKPENILMDSDGH-------------------EIDESSRSNSMCGTTEYMAPEILLS 278
           HRDLKP+NIL+DS+GH                     D+      + GT +Y+APE++L 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLK 336
           +GH+K  DWWS+G +LYE L G PPF     +++ Q I+N K++ P    ++ EA  L+ 
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235

Query: 337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 368
            LL  DP KRLG+    ++ IK+H +F+ I+W
Sbjct: 236 KLLVPDPEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  286 bits (733), Expect = 3e-94
 Identities = 133/332 (40%), Positives = 195/332 (58%), Gaps = 29/332 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG     +D +YA+K+++KD II+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
            LH  GI++RDLK +N+++D++GH            I     + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KGL
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 398
           L K P+KRLG GP G   I+ H +FR I+W+ LE RE+QP FKP V G+    NFDK +T
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFT 295

Query: 399 TMPADDSPAPTPT--------AGEHFKGYTYV 422
             P    P  TP             F+G+++V
Sbjct: 296 REP----PVLTPPDKLVIANIDQSEFQGFSFV 323

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  286 bits (735), Expect = 5e-94
 Identities = 135/361 (37%), Positives = 197/361 (54%), Gaps = 61/361 (16%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE+ +V+G+GAFG+V+ V+ K     D+  +YAMKV+RK  +IK+N + +++AERDIL
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                P+IV+L YSFQ    LYL+++++ GG L   L R+ +F E+ ARFY AE+V A+ 
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGH---------------------EIDESS--------- 259
            +HK G +HRD+KP+NIL+D+DGH                       D  +         
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 260 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
                     R+NS  GT +Y+APE+L    +  + DWWS+G++LYEML G PPF     
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 310 QKLQQRIINEKVKL--PPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           Q+   +IIN K  L  PP   ++ EA  L+  LL  DP  RLGS     + IK H +F+ 
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGS----FEEIKSHPFFKG 290

Query: 366 INWKTLEAREMQPKFKPDVSGKDCIANFDKC-WTTMPADDSPAPTPTAGEH----FKGYT 420
           I+W+ L  RE +P F P++S     +NFD        +D     +    +     F G+T
Sbjct: 291 IDWENL--RETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFT 348

Query: 421 Y 421
           Y
Sbjct: 349 Y 349

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  285 bits (730), Expect = 9e-94
 Identities = 124/307 (40%), Positives = 191/307 (62%), Gaps = 17/307 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH C 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 236 IVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKD 284
           +V+RDLK EN+++D DGH            I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 285 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 344
            DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L+ EA SLL GLL KDP 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235

Query: 345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 404
           +RLG GP     I  H++F SINW+ +  ++++P FKP V+ +     FD+ +T      
Sbjct: 236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITI 295

Query: 405 SPAPTPT 411
           +P P   
Sbjct: 296 TP-PDRY 301

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  279 bits (716), Expect = 1e-91
 Identities = 135/336 (40%), Positives = 205/336 (61%), Gaps = 38/336 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--- 174
           +G+G FG+V+QV+KK     D+  IYAMKV+ K  I+ K  V +   ER+IL +      
Sbjct: 1   IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PFIV L++SFQT S LYL+ D+++GG LF+HL ++G F ED+A+FY AE+V A+ HLHK 
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILL-SKGHN 282
            IV+RDLKPENIL+D+ GH            + ++  +N+ CGTTEY+APE+LL  KG+ 
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-FLTSEAHSLLKGLLHK 341
           K  D+WS+G+L++EM  G  PF   + Q++ + I   KV+ P   L+ E    +KGLL++
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235

Query: 342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT-- 399
           +P  RLG+    V+ +K H +F  I+W  L  +++ P FKP V   + ++NFD  +T   
Sbjct: 236 NPQHRLGAHRDAVE-LKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSS 294

Query: 400 --------------MPADDSPAPTPTAGEHFKGYTY 421
                         +P  +S   + +  E+F+G+T+
Sbjct: 295 LLNAGIVPWEDVPGLPGANSTPLSSSVQENFRGFTF 330

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  278 bits (712), Expect = 5e-91
 Identities = 123/317 (38%), Positives = 185/317 (58%), Gaps = 14/317 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+   +G G+FG+V   K KG  +      YA+K ++K  I+K   V ++  E+ IL 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HPFIV +  SFQ  +++Y +L+F+ GG LF HL + G F  D A+FY AE+V A  +
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE-------SSRSNSMCGTTEYMAPEILLSKGHN 282
           LH   I++RDLKPEN+L+D+ GH ++ +         R+ ++CGT EY+APE++ SKGH 
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHG 193

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           K  DWW++G+LLYE + G PPF      ++ ++I+  ++K P +    A  L+KGLL  D
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 402
            +KRLG+  GGV  +K+H +F   NW  L AR         V      +NF+K +   P 
Sbjct: 254 HTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEK-YPDSPV 312

Query: 403 DDSPAPTPTAGEHFKGY 419
           D  P  T      F G+
Sbjct: 313 DRLPPLTAAQQAEFAGF 329

Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  272 bits (698), Expect = 5e-89
 Identities = 125/329 (37%), Positives = 196/329 (59%), Gaps = 31/329 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTH 174
           +V+G+G+FGKV   + KG D+     +YA+KV++KD I++ + VD    E+ IL     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L   FQT+ +L+ +++++NGG L F + R   F E ++RFY AE+  A+  LH+ 
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           G+++RDLK +NIL+D++GH            I     + + CGT +Y+APEIL    +  
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+L+YEM+ GQPPF   N   L + I+++ V  P +L+ EA S+LK  + K+P
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235

Query: 344 SKRLGSGP--GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP 401
           +KRLG     GG DAIK H +F+ I+W  LE R+++P FKP +  K  + NFD+ +T   
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTK-- 293

Query: 402 ADDSPAPTPTAG--------EHFKGYTYV 422
             + P  TP           E F+G+++ 
Sbjct: 294 --EEPVLTPVDPAVIKQINQEEFRGFSFF 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  271 bits (694), Expect = 2e-88
 Identities = 139/331 (41%), Positives = 205/331 (61%), Gaps = 28/331 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   + K       +  YA+KV++K  I+KK    ++ +ER++L K V H
Sbjct: 1   KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
            IV+RDLKPENIL+DS GH            I+ +  +++ CGT EY+APE+L  + +++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW +G +LYEML G PPF   N  ++   I+N+ ++L P +T+ A  LL+GLL KD 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD 403
           +KRLG+    ++ IK+H +F  INW  L  +++ P F P+VSG + + +FD  +T  P  
Sbjct: 236 TKRLGAKDDFME-IKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVP 294

Query: 404 DSPAPTP----------TAGEHFKGYTYVAP 424
           +S   +P           A E F G++Y  P
Sbjct: 295 NSIGQSPDSILVTASVKEAAEAFLGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  270 bits (692), Expect = 4e-88
 Identities = 136/328 (41%), Positives = 201/328 (61%), Gaps = 27/328 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTK-VT 173
           +V+G+G+FGKV   K+K      SDG  YA+KV++K TI+KK   +++ AER++L K + 
Sbjct: 1   KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HPF+V L YSFQT  KLY +LD++NGG LFFHL R+  F E +ARFY AE+ SA+ +LH 
Sbjct: 55  HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114

Query: 234 CGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCGTTEYMAPEILLSKGHN 282
             I++RDLKPENIL+DS GH +           +    +++ CGT EY+APE+L  + ++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           +  DWW +G +LYEML G PPF   +  ++   I+++ ++LP   T  A  LL GLLHKD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA 402
             +RLG+    ++ IK+H +F  INW  L  + + P + P+V+G   + +FD  +T    
Sbjct: 235 QRRRLGAKADFLE-IKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAV 293

Query: 403 DDSPAPTP-------TAGEHFKGYTYVA 423
             S   TP       +A   F G++Y  
Sbjct: 294 SSSVGQTPDLTASSSSASSAFLGFSYAP 321

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  265 bits (679), Expect = 1e-86
 Identities = 131/292 (44%), Positives = 191/292 (65%), Gaps = 22/292 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDIL 169
           +FE+ +V+G GA+GKVF V+K  V   DS  +YAMKV++K TI++K    ++ + ER +L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRK--VSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +   PF+V L Y+FQT +KL+LILD+INGG LF HL ++  F+E + + Y+ EIV A+
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMCGTTEYMAPEIL 276
            HLHK GI++RD+K ENIL+DS+GH +            DE  R+ S CGT EYMAP+I+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 277 L--SKGHNKDADWWSVGILLYEMLTGQPPFT----HANRQKLQQRIINEKVKLPPFLTSE 330
                GH+K  DWWS+G+L+YE+LTG  PFT      ++ ++ +RI+  +   P  +++ 
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
           A  +++ LL KDP KRLG GP   D IK H +F+ INW  L A+++   FKP
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  265 bits (680), Expect = 2e-86
 Identities = 121/326 (37%), Positives = 195/326 (59%), Gaps = 24/326 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G+FGKV   + K     +S  +YA+KV++KD I++ + V+    E+ IL+    H
Sbjct: 1   RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY AEI SA+  LH  
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+L+D +GH            I     +++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+LLYEML G  PF   N   L + I+N++V  P +L+ +A  +LK  + K+P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235

Query: 344 SKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT--- 399
           + RLGS   GG +AI  H +F+ ++W+ L  R+++P F+P +  ++ ++NFD  +     
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDP 295

Query: 400 --MPADDSPAPTPTAGEHFKGYTYVA 423
              P ++S  P     + F+ ++Y A
Sbjct: 296 VLTPIEESLLP-MINQDEFRNFSYTA 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  264 bits (676), Expect = 4e-86
 Identities = 114/292 (39%), Positives = 176/292 (60%), Gaps = 13/292 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  + VG G FG+V  V+ +      S+  YA+KVM    +I+     ++  E+ +L 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +V+HPFI++L ++   +  LY++++++ GG LF +L   G F      FY +EIV A+ +
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGH--------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
           LH   IV+RDLKPENIL+D +GH              R+ ++CGT EY+APE++ SKGHN
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHN 176

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           K  DWW++GIL+YEML G PPF   N   + ++I+  K++ P  L   A  L+K LL  D
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
            ++RLG+   G D +K+H+WF+S++W  +  R+++P   P VS     +NFD
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFD 288

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  262 bits (672), Expect = 8e-86
 Identities = 101/265 (38%), Positives = 167/265 (63%), Gaps = 19/265 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FG+V  VK K       +  +A+K ++K  I++    +++ +E++IL +  HPFI
Sbjct: 1   LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           V+L  +F+ +  +Y+++++  GG L+  L  +G+F E  ARFY A +V A  +LH  GI+
Sbjct: 56  VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115

Query: 238 HRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADW 287
           +RDLKPEN+L+DS+G+          ++    ++ + CGT EY+APEI+L+KG++   D+
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Query: 288 WSVGILLYEMLTGQPPFTHANR--QKLQQRII--NEKVKLPPFLTSEAHSLLKGLLHKDP 343
           WS+GILLYE+LTG+PPF   +    ++   I+  N K++ P ++   A  L+K LL ++P
Sbjct: 176 WSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINW 368
            +RLG+  GG+  IK HKWF   +W
Sbjct: 236 EERLGNLKGGIKDIKKHKWFNGFDW 260

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  261 bits (670), Expect = 3e-85
 Identities = 101/285 (35%), Positives = 155/285 (54%), Gaps = 38/285 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F  V   K+K     +++  YA+K++ K  +IK+  V Y+K E+++LT
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++  HP I++L Y+FQ    LY +L++   G L  ++ + G   E   RFY AEI+ A+ 
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH--------------------------EIDES----- 258
           +LH  GI+HRDLKPENIL+D D H                           ID       
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
            R  S  GT EY++PE+L  K   K +D W++G ++Y+MLTG+PPF  +N     Q+I+ 
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236

Query: 319 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
            +   PP    +A  L++ LL  DP  RLG    G D +K H +F
Sbjct: 237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  262 bits (672), Expect = 4e-85
 Identities = 123/327 (37%), Positives = 192/327 (58%), Gaps = 29/327 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           +V+G+G+FGKV   + KG ++      +A+K ++KD +++ + V+    ER +L     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNE-----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+   G F E +ARFY AEI+  +  LHK 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+L+D DGH            ++   ++++ CGT +Y+APEIL  + +N+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWWS G+LLYEML GQ PF   +  +L   I+N++   P +++ EA   L  L  +DP
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP 235

Query: 344 SKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDKCWTTMP 401
           +KRLG  G      I+ H +FR I+W+ LE RE+ P FKP V S  D  +NFD+ +T   
Sbjct: 236 TKRLGVDGD-----IRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDA-SNFDREFTNEK 289

Query: 402 ADDSPAPTPTAG----EHFKGYTYVAP 424
              SP           E F+G+++  P
Sbjct: 290 VRLSPVDKKLLASMDQEQFRGFSFTNP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  261 bits (668), Expect = 1e-84
 Identities = 134/328 (40%), Positives = 196/328 (59%), Gaps = 22/328 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
            LH+ GI++RDLK +N+++DS+GH            + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KGL
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 398
           + K PSKRLG GP G   I+ H +FR I+W  LE RE+QP FKP V GK    NFDK +T
Sbjct: 236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGA-ENFDKFFT 294

Query: 399 -TMPADDSPAPTPTAG---EHFKGYTYV 422
              P    P     A      F+G++YV
Sbjct: 295 RGQPVLTPPDQLVIANIDQADFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  261 bits (667), Expect = 2e-84
 Identities = 122/327 (37%), Positives = 193/327 (59%), Gaps = 24/327 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIVSA+ +LH   
Sbjct: 56  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 236 IVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKD 284
           +V+RD+K EN+++D DGH            I + +   + CGT EY+APE+L    + + 
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 285 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 344
            DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SLL GLL KDP 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235

Query: 345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 404
           +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD  +T      
Sbjct: 236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI 295

Query: 405 SP--------APTPTAGEHFKGYTYVA 423
           +P                HF  ++Y A
Sbjct: 296 TPPDRYDSLGLLELDQRTHFPQFSYSA 322

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  259 bits (662), Expect = 1e-83
 Identities = 136/331 (41%), Positives = 199/331 (60%), Gaps = 28/331 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
           +V+G+G+FGKV   K+K   DG     YA+KV++K  ++ +    ++ AER++L K V H
Sbjct: 1   KVIGKGSFGKVLLAKRK--LDGK---CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L YSFQT  KLY +LDF+NGG LFFHL R+  F E +ARFY AEI SA+ +LH  
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
            IV+RDLKPENIL+DS GH            I +S  + + CGT EY+APE++  + ++ 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW +G +LYEML G PPF   +  ++   I+++ + L P  +  A S+L+ LL KD 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT--TMP 401
            +RLG+       I+ H +F S++W  LE +++ P F P+V G D I+NFD  +T  T+P
Sbjct: 236 QRRLGA-KEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVP 294

Query: 402 ADDSPAPTPT--------AGEHFKGYTYVAP 424
                +   +        A + F G++Y  P
Sbjct: 295 YSVCFSSDYSIVNASVLEADDAFVGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  256 bits (655), Expect = 2e-83
 Identities = 100/266 (37%), Positives = 156/266 (58%), Gaps = 23/266 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+ RV+G+GAFGKV  V+K+     D+  ++AMK M K   ++K  V  +  ER IL +
Sbjct: 2   FELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +YL++D + GG L +HL ++  F E+Q +F+  EIV A+ +L
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 232 HKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGH 281
           H  GI+HRD+KP+NIL+D  GH          ++   + + S  GT  YMAPE+L  +G+
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----LPPFLTSEAHSLLKG 337
           +   DWWS+G+  YE L G+ P+   + + ++ +I  ++       P   ++EA   +  
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235

Query: 338 LLHKDPSKRLGSGPGGVDAIKHHKWF 363
           LL +DP KRLG        +K+H +F
Sbjct: 236 LLERDPQKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  259 bits (664), Expect = 3e-83
 Identities = 124/369 (33%), Positives = 193/369 (52%), Gaps = 68/369 (18%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK +RK  +++K  V +++AERDIL 
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +  +P++V+L YSFQ  + LYLI++++ GG +   L ++  F E++ RFY AE + A+  
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGH---------------------EIDESSRSN------- 262
           +HK G +HRD+KP+N+L+D+ GH                      I   +  +       
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 263 ---------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
                                S  GT +Y+APE+ L  G+NK+ DWWS+G+++YEML G 
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236

Query: 302 PPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 357
           PPF   N Q+  ++IIN  E ++ P    L+ EA  L+K L   +  +RLG+   GV+ I
Sbjct: 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGN--NGVNEI 293

Query: 358 KHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH-- 415
           K H +F+ ++W+ +  RE      P++      +NFD          +    P       
Sbjct: 294 KSHPFFKGVDWEHI--RERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSK 351

Query: 416 ---FKGYTY 421
              F GYTY
Sbjct: 352 DLAFIGYTY 360

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  257 bits (658), Expect = 5e-83
 Identities = 122/302 (40%), Positives = 189/302 (62%), Gaps = 16/302 (5%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  V++K      S   YAMK+++K+ II K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           F+  L+YSFQT+ +L  +++++NGG LFFHL R+ +F ED+ RFY AEIVSA+ +LH   
Sbjct: 56  FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 236 IVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKD 284
           IV+RDLK EN+++D DGH            I +++   + CGT EY+APE+L    + + 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 285 ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS 344
            DWW +G+++YEM+ G+ PF + + +KL + I+ E +K P  L+++A SLL GLL KDP+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235

Query: 345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD 404
           KRLG GP     I  H +F  +NW+ +  +++ P FKP V+ +     FD+ +T      
Sbjct: 236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITI 295

Query: 405 SP 406
           +P
Sbjct: 296 TP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  256 bits (657), Expect = 8e-83
 Identities = 111/330 (33%), Positives = 188/330 (56%), Gaps = 25/330 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-- 169
           F    V+G+G FGKV   + K      +  +YA+K ++K  II ++ V+ +  E+ I   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFET 55

Query: 170 -TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
                HPF+V L   FQT   +  ++++  GG L  H++   +F E +A FY A +V  +
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILL 277
            +LH+  IV+RDLK +N+L+D++G             +    R+++ CGT E++APE+L 
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
              + +  DWW +G+L+YEML G+ PF   + +++   I+N++V+ P FL+ EA S+++ 
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234

Query: 338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW 397
           LL ++P +RLGSG    + +K   +FR INW  L AR+++P F P + G + ++NFD+ +
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEF 294

Query: 398 TTMPADDSPAPTPTA-----GEHFKGYTYV 422
           T+     +P   P        E F+G+ YV
Sbjct: 295 TSEAPVLTPPREPRLLTEEEQELFRGFDYV 324

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  256 bits (655), Expect = 2e-82
 Identities = 128/332 (38%), Positives = 194/332 (58%), Gaps = 30/332 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+FGKV   ++KG D+     +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
                PF+ QL   FQT  +LY +++++NGG L + + + G F+E  A FY AEI   + 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
            LH  GI++RDLK +N+++DS+GH            + +   + + CGT +Y+APEI+  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KGL
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 398
           + K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G+D   NFDK +T
Sbjct: 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDA-ENFDKFFT 294

Query: 399 TMPADDSPAPTPTAGE--------HFKGYTYV 422
             P    P  TP   E         F+G++YV
Sbjct: 295 RHP----PVLTPPDQEVIMNLDQSEFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  254 bits (652), Expect = 3e-82
 Identities = 122/322 (37%), Positives = 171/322 (53%), Gaps = 52/322 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+  +++G+G  G+VF V+ KG     +  ++A+KV+ K  +IK+N V  +  E++IL 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAV 228
            + HPF+  L  SFQT + L L++D+  GG LF  L RQ      E+ ARFY AE++ A+
Sbjct: 57  TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----------------------------------- 253
            +LH  GIV+RDLKPENIL+   GH                                   
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 254 ----EIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
                 +E S RSNS  GT EY+APE++   GH    DWW++GILLYEML G  PF  +N
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 309 RQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           R +    I+ ++V  P  P ++S A  L++ LL KDPSKRLGS  G  + IK H +FR +
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE-IKQHPFFRGV 295

Query: 367 NWKTLEAREMQPKFKPDVSGKD 388
           NW  +  R   P   P      
Sbjct: 296 NWALI--RHTTPPIIPRPDDGI 315

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  254 bits (649), Expect = 1e-81
 Identities = 127/329 (38%), Positives = 195/329 (59%), Gaps = 25/329 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FGKV  VK+K      +   YAMK+++K+ I+ K+ V +   E  +L    HP
Sbjct: 1   KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KC 234
           F+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH + 
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
            +V+RDLK EN+++D DGH            I + +   + CGT EY+APE+L    + +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L+ EA SLL GLL KDP
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT----T 399
            +RLG GP     I  HK+F  I W+ +  +++ P FKP V+ +     FD+ +T    T
Sbjct: 236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMIT 295

Query: 400 MPADDSPAPTPTAGE----HFKGYTYVAP 424
           +   D      T       HF  ++Y A 
Sbjct: 296 ITPPDQDDSMETVDNERRPHFPQFSYSAS 324

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  247 bits (631), Expect = 2e-79
 Identities = 102/282 (36%), Positives = 157/282 (55%), Gaps = 21/282 (7%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + K      +  +YA K + K  + K+        E+ IL KV+  FI
Sbjct: 1   LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG 235
           V L Y+F+T+  L L++  +NGG L +H+Y  G   F E +A FY A+I+  + HLH+  
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 236 IVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 285
           IV+RDLKPEN+L+D  G+          E+    +     GT  YMAPE+L  + ++   
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 286 DWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           DW+++G  LYEM+ G+ PF        +++L++R +   V+ P   + EA  L + LL K
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235

Query: 342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           DP KRLG   G  D ++ H  F+ +NW+ LEA  ++P F PD
Sbjct: 236 DPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  244 bits (624), Expect = 1e-78
 Identities = 99/271 (36%), Positives = 145/271 (53%), Gaps = 30/271 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ R +G G+FG V++ K KG        I A+K+++K +   K      + E  IL +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQ-TARREIRILRR 54

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++HP IV+L  +F+ +  LYL++++  GG LF +L R G   ED+A+    +I+  + +L
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDGHE--ID---------ESSRSNSMCGTTEYMAPEILL-SK 279
           H  GI+HRDLKPENIL+D +G     D          SS   +  GT  YMAPE+LL   
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-------LTSEAH 332
           G+    D WS+G++LYE+LTG+PPF+  N     Q I         F        + EA 
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
            L+K  L+KDPSKR        + I  H WF
Sbjct: 235 DLIKKCLNKDPSKRP-----TAEEILQHPWF 260

Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  243 bits (622), Expect = 1e-77
 Identities = 118/333 (35%), Positives = 194/333 (58%), Gaps = 31/333 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTH 174
           RV+G+G++ KV  V+ K      +  IYAMKV++K+ +     +D+++ E+ +  T   H
Sbjct: 1   RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++F++GG L FH+ RQ    E+ ARFY+AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+L+D++GH            I     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQK---------LQQRIINEKVKLPPFLTSEAHSL 334
             DWW++G+L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235

Query: 335 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LKG L+KDP +RLG  P  G   IK H +FR+I+W  LE +++ P +KP++     + NF
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNF 295

Query: 394 DKCWTTMPADDSPAPTPTAGE----HFKGYTYV 422
           D  +T  P   +P             F+G+ Y+
Sbjct: 296 DPQFTDEPVQLTPDDPDVIARIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  243 bits (623), Expect = 4e-77
 Identities = 123/360 (34%), Positives = 180/360 (50%), Gaps = 72/360 (20%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V  V+K      D++ +YAMK +RK  ++ +N   ++KAERDIL +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGH------------------------------------EI 255
           HK G +HRD+KP+NIL+D DGH                                    E 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 256 DESSR------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
            E  R                  ++S+ GT  Y+APE+LL  G+ +  DWWSVG++LYEM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 298 LTGQPPFTHANRQKLQQRIINEKVKL--PPF--LTSEAHSLLKGLLHKDPSKRLGSGPGG 353
           L GQPPF      + Q ++IN +  L  P    L+ EA  L+  L       RLG    G
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NG 294

Query: 354 VDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD-----KCWTTMPADDSPAP 408
            D IK H +F+ I++ +L  R  +  + P ++     +NFD     K  +    + SP  
Sbjct: 295 ADEIKAHPFFKGIDFASL-IRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDR 353

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  238 bits (609), Expect = 1e-75
 Identities = 115/301 (38%), Positives = 170/301 (56%), Gaps = 28/301 (9%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF+I   VGQG +G+VF  KKK     D+  I A+K M+K  + K N V ++  ERDIL
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T     ++V+L Y+FQ    LYL ++++ GG     L   G+  ED ARFY AE+  AV 
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGH--EIDES------SRSNSMCGTTEYMAPEILLSKGH 281
            LH+ G +HRDLKPEN L+D+ GH    D        + +NS+ G+ +YMAPE+L  KG+
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--------PPFLTSEAHS 333
           +   D+WS+G +LYE L G PPF+ +   +  + +   K  L           L+ EA  
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           L+  L+  DPS+R GS    ++ IK+H +F+ ++W  L  RE++P F P++  +     F
Sbjct: 236 LITKLI-NDPSRRFGS----LEDIKNHPFFKEVDWNEL--RELKPPFVPELESEIDTGYF 288

Query: 394 D 394
           D
Sbjct: 289 D 289

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  236 bits (603), Expect = 9e-75
 Identities = 121/331 (36%), Positives = 196/331 (59%), Gaps = 29/331 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D+++ E+ +  +  ++
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+L+++++NGG L FH+ RQ    E+ ARFY AEI  A++ LH+ 
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+L+D+DGH            +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 284 DADWWSVGILLYEMLTGQPPF-------THANRQKLQQRIINEKVKLPPFLTSEAHSLLK 336
             DWW++G+L++EM+ G+ PF              L Q I+ + +++P FL+ +A  +LK
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK 235

Query: 337 GLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
           G L+KDP +RLG  P  G   IK H +FRSI+W  LE +++ P FKP ++    + NFD 
Sbjct: 236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDT 295

Query: 396 CWTTMPA----DDSPAPTPTAGEHFKGYTYV 422
            +T+ P     DD           F+G+ Y+
Sbjct: 296 QFTSEPVQLTPDDEDVIKRIDQSEFEGFEYI 326

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  229 bits (586), Expect = 3e-72
 Identities = 116/333 (34%), Positives = 199/333 (59%), Gaps = 31/333 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           RV+G+G++ KV  V+ K      ++ IYAMKV++K+ +     +D+++ E+ +  + + H
Sbjct: 1   RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+L+DS+GH            +     +++ CGT  Y+APEIL  + +  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 284 DADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPPFLTSEAHSL 334
             DWW++G+L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235

Query: 335 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++SG+  + NF
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNF 295

Query: 394 DKCWTT----MPADDSPAPTPTAGEHFKGYTYV 422
           D  +T     +  DD           F+G+ Y+
Sbjct: 296 DAQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  227 bits (580), Expect = 6e-72
 Identities = 111/291 (38%), Positives = 162/291 (55%), Gaps = 27/291 (9%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-ERDI 168
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I KK   + M   E+ I
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRI-KKRKGEAMALNEKQI 53

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVS 226
           L KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI  
Sbjct: 54  LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEIL 276
            +  LH+  IV+RDLKPENIL+D  GH          EI E        GT  YMAPE++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173

Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEAH 332
            ++ +    DWW +G L+YEM+ G+ PF        R+++++R+  ++ +     +  A 
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           S+ + LL KDP  RLG    G + +K H +FR+ N+K LEA  ++P F PD
Sbjct: 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  226 bits (578), Expect = 4e-71
 Identities = 112/292 (38%), Positives = 174/292 (59%), Gaps = 21/292 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +++G+G+FGKVF  + KG     ++  +A+K ++KD ++  + V+    E+ +L+    H
Sbjct: 1   KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++++NGG L FH+     F   +A FY AEI+  +  LH  
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GIV+RDLK +NIL+D+DGH            +   +++ + CGT +Y+APEILL + +N 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWWS G+LLYEML GQ PF   + ++L Q I  +    P +LT EA  +L  L  ++P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
            +RLG        I+ H +FR I+W  LE RE++P FKP V   +  +NFDK
Sbjct: 236 ERRLGVK----GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  223 bits (571), Expect = 2e-69
 Identities = 114/334 (34%), Positives = 175/334 (52%), Gaps = 32/334 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
                +IVQL Y+FQ    LY++++++ GG L   +    I  E  ARFYTAE+V A+  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLS 278
           +H  G +HRD+KP+N+L+D  GH            + +   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 279 KGHN----KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           +G +    ++ DWWSVG+ LYEML G  PF   +      +I++ K  L       ++ +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A  L+   L  D   RLG    GVD IK H +F++  W     RE      P++S     
Sbjct: 278 AKDLICAFL-TDREVRLGR--NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDT 334

Query: 391 ANFDKCWT-TMPADDSPAPTPTAGEH--FKGYTY 421
           +NFD         +  P P   AG    F G+TY
Sbjct: 335 SNFDDIEDDDKNEETFPLPKAFAGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  218 bits (557), Expect = 9e-68
 Identities = 117/311 (37%), Positives = 175/311 (56%), Gaps = 14/311 (4%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           ++D+  E + + K+   DF   R +G G+FG+V     K   + D   + A+K   K  I
Sbjct: 14  DSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPPV-AIKRFEKSKI 69

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           IK+  VD++ +ER IL  + HPF V L  SF+  S LYL+L+F+ GG  F  L R   F 
Sbjct: 70  IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------EIDESSRSNSM 264
            D   FY A+IV    +L    IV+RDLKPEN+L+D DG          ++ ++ R+ ++
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTL 188

Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
           CGT EY+APEILL+ GH K ADWW++GI +YE+L G PPF       + Q+I+   +  P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP 248

Query: 325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 384
            FL +    L+K LL  D +KR G+   G   +K H WF +I+W +L  + ++  +KP  
Sbjct: 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308

Query: 385 SGKDCIANFDK 395
                 +NF++
Sbjct: 309 KNVFDSSNFER 319

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  217 bits (553), Expect = 2e-67
 Identities = 108/292 (36%), Positives = 171/292 (58%), Gaps = 21/292 (7%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G+G+FGKV   + KG  +      +A+K ++KD ++  + V+    E+ +L     +
Sbjct: 1   KVLGKGSFGKVLLAELKGKGE-----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           PF+  L  +FQT+  L+ +++F+NGG L FH+  +G F   +A FY AEIV  +  LH  
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 235 GIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
           GI++RDLK +N+++D DGH            +   +R+++ CGT +Y+APEIL    +  
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWWS G+LLYEML GQ PF   +  +L + I  +    P ++T E+  +L+ L  +DP
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235

Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
           ++RLG     V  I+ H +F++INW  LE RE+ P FKP V      +NFD+
Sbjct: 236 TRRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  216 bits (552), Expect = 4e-67
 Identities = 113/331 (34%), Positives = 174/331 (52%), Gaps = 36/331 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  +VG+G FG+V  V++K   D     IYAMKVM+K  ++ +  V + + ERDIL+
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGD-----IYAMKVMKKSVLLAQETVSFFEEERDILS 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
               P+I QL+Y+FQ +  LYL++++  GG L   L R +  F ED A+FY AE+V A+ 
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
            +H+ G VHRD+KPEN+L+D  GH              ++   S    GT +Y+APE+L 
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 278 -----SKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFL 327
                 KG +  + DWWS+G++ YEM+ G+ PF      K    I+N +  +K P  P +
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236

Query: 328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
           +S+   L++ LL     +RL     G + +  H +F  I+W  +  R   P F P +   
Sbjct: 237 SSDFLDLIQSLL-CGQKERL-----GYEGLCCHPFFSKIDWNNI--RNSLPPFVPTLKSD 288

Query: 388 DCIANFDKCWTTMPADDSPAPTPTAGEHFKG 418
           D  +NFD+           + T      F G
Sbjct: 289 DDTSNFDEPEKNSTRRSQSSTTQLKPNGFSG 319

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  211 bits (540), Expect = 3e-66
 Identities = 103/266 (38%), Positives = 153/266 (57%), Gaps = 25/266 (9%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPF 176
           + +GAFG V+  KK+   D      +A+KV++K  +I KN V  +KAER I+  +   P+
Sbjct: 4   ISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           + +L YSFQ++  LYL+++++NGG     +   G   ED A+ Y AE+V  V  LH+ GI
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 237 VHRDLKPENILMDSDGH---------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADW 287
           +HRD+KPEN+L+D  GH              ++     GT +Y+APE +L  G +K +DW
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV--GTPDYLAPETILGVGDDKMSDW 176

Query: 288 WSVGILLYEMLTGQPPFTHANR-----QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           WS+G +++E L G PPF HA         +  R IN   ++  F + EA  L+  LL  D
Sbjct: 177 WSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINW 368
           P+KRLG+   G   IK H +F+SINW
Sbjct: 236 PAKRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  213 bits (543), Expect = 9e-66
 Identities = 117/339 (34%), Positives = 177/339 (52%), Gaps = 38/339 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K         +YAMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQ-----VYAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
            +H+ G VHRD+KP+N+L+D +GH              D + +SN   GT +Y++PEIL 
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 278 S----KGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 328
           +    KG    + DWWS+G+ +YEML G+ PF   +  +   +I+N  E  + PP +T  
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236

Query: 329 -SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
             EA  L++ L+   P  RLG    G+   K H +F  I+W  +  R     + P+VS  
Sbjct: 237 SEEAKDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNI--RNSTAPYVPEVSSP 291

Query: 388 DCIANFD---KCWTTMPADDSPAPTPTAGEH--FKGYTY 421
              +NFD          +    +    +G H  F G+TY
Sbjct: 292 TDTSNFDVDDDDLRNTESLPPSSHGAFSGNHLPFVGFTY 330

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  209 bits (534), Expect = 1e-64
 Identities = 105/314 (33%), Positives = 172/314 (54%), Gaps = 38/314 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DFE  +++  GA+G V+ V+ K     ++   +AMK + K  +I +N +  +  ERDIL
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDIL 55

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           T   +PF+V +  SF+T+  L ++++++ GG     L   G    D AR Y AE V A+ 
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------------------EIDESSRS---NS 263
           +LH  GIVHRDLKP+N+L+ S GH                        I++ +R      
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 323
           +CGT EY+APE++L +G+ K  DWW++GI+LYE L G  PF     ++L  ++I++ ++ 
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 324 P---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 380
           P     L ++A  L+  LL ++P +RLG+  GG   +K H++F  ++W  L     + +F
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGL--LRQKAEF 291

Query: 381 KPDVSGKDCIANFD 394
            P +  +D  + FD
Sbjct: 292 IPQLESEDDTSYFD 305

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  208 bits (531), Expect = 2e-64
 Identities = 110/290 (37%), Positives = 159/290 (54%), Gaps = 25/290 (8%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E++A FY AEI+  
Sbjct: 55  EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILL 277
           +  LH+   V+RDLKPENIL+D  GH          +I E        GT  YMAPE+L 
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHS 333
           ++ +    D+W +G L+YEM+ GQ PF        R+++ +R++  +       + EA S
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           + K LL KDP +RLG    G   +K H +FR++N+K LEA  + P F PD
Sbjct: 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  204 bits (519), Expect = 8e-63
 Identities = 116/291 (39%), Positives = 159/291 (54%), Gaps = 27/291 (9%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILL 277
           +  LH+  IV+RDLKPENIL+D  GH           + E        GT  YMAPE++ 
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE-----AH 332
           ++ +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK      SE     A 
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYSEKFSPDAR 233

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           SL K LL KDP +RLG   GG   +K H  F+ IN+K LEA  ++P FKPD
Sbjct: 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  203 bits (517), Expect = 2e-62
 Identities = 106/290 (36%), Positives = 158/290 (54%), Gaps = 25/290 (8%)

Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           F  +RV+G+G FG+V   QV+  G        +YA K + K  I K+        E+ IL
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGEAMALNEKRIL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
            KV   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AE+   
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILL 277
           +  L +  IV+RDLKPENIL+D  GH          +I E        GT  YMAPE++ 
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHS 333
           ++ +    DWW +G L+YEM+ GQ PF        R+++ +R+  ++ +     + +A S
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           + + LL K+P +RLG    G   +K H  F++IN+K LEA  ++P F PD
Sbjct: 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  199 bits (509), Expect = 2e-61
 Identities = 78/253 (30%), Positives = 138/253 (54%), Gaps = 24/253 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +EI + +G+G+FGKV+ V++K      SDG +Y +K +    + +K   D +  E  IL
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRK------SDGKLYVLKEIDLSNMSEKEREDALN-EVKIL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIV 225
            K+ HP I++   SF+ + KL +++++ +GG L   + +Q      F E+Q   +  ++ 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
            A+ +LH   I+HRD+KP+NI + S+G                   + ++ GT  Y++PE
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHS 333
           +  +K +N  +D WS+G +LYE+ T + PF   N  +L  +I+  +   +P   +SE  +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233

Query: 334 LLKGLLHKDPSKR 346
           L+  LL KDP +R
Sbjct: 234 LVSSLLQKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  203 bits (517), Expect = 3e-61
 Identities = 122/345 (35%), Positives = 178/345 (51%), Gaps = 71/345 (20%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V   +K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R GIF ED ARFY AE+  AV  +
Sbjct: 58  ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGH---------------------EIDESSRSNSM------ 264
           HK G +HRD+KP+NIL+D DGH                     +  +  R +SM      
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 265 -------CG------------------------TTEYMAPEILLSKGHNKDADWWSVGIL 293
                  CG                        T  Y+APE+LL  G+ +  DWWSVG++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 294 LYEMLTGQPPFTHANRQKLQQRIINEKVKL--PP--FLTSEAHSLLKGLLHKDPSKRLGS 349
           LYEML GQPPF      + Q ++IN +  L  PP   L+ EA  L+  L  + P  RLG 
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296

Query: 350 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
              G D IK H +F++I++ + + R+    + P ++     +NFD
Sbjct: 297 --NGADEIKAHPFFKTIDFSS-DLRQQSAPYIPKITHPTDTSNFD 338

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  199 bits (508), Expect = 3e-61
 Identities = 104/285 (36%), Positives = 163/285 (57%), Gaps = 24/285 (8%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+V   + +      +  +YA K + K  + K+   +    E+ IL KV   FI
Sbjct: 1   LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHK 233
           V L Y+FQT++ L L++  +NGG L +H+Y        F E +A FYTA+I+S + HLH+
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 234 CGIVHRDLKPENILMDSDGH----------EI-DESSRSNSMCGTTEYMAPEILLSKGHN 282
             I++RDLKPEN+L+D+DG+          E+ D  S++    GT  +MAPE+L  + ++
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 283 KDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
              D++++G+ LYEM+  + PF         ++L+QRI+N+ V  P   +  + S  + L
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           L KDP KRLG   G  D ++ H  FR +NW+ LEA  + P F PD
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  198 bits (505), Expect = 9e-60
 Identities = 119/368 (32%), Positives = 184/368 (50%), Gaps = 70/368 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  IYAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E+  +FY AE V A+  
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGH------------------------------------- 253
           +H+ G +HRD+KP+N+L+D+ GH                                     
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 254 ---EIDESSRSN------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
                 E+ + N      S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 305 THANRQKLQQRIIN--EKVKLPPFL-TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
                Q+  ++++N  E +  PP +  SE    L      D   R+GS   GV+ IK H 
Sbjct: 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGS--NGVEEIKSHP 294

Query: 362 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH------ 415
           +F  ++W  +  RE       ++   D  +NFD+     P  D   P     E       
Sbjct: 295 FFEGVDWGHI--RERPAAIPIEIKSIDDTSNFDE----FPESDILQPAENTIEPDYKSKD 348

Query: 416 --FKGYTY 421
             F  YTY
Sbjct: 349 WVFLNYTY 356

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  188 bits (479), Expect = 5e-57
 Identities = 106/283 (37%), Positives = 161/283 (56%), Gaps = 23/283 (8%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY AEI+  + H+H 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGH--------EIDESSRS-NSMCGTTEYMAPEILLSKG--HN 282
             +V+RDLKP NIL+D  GH          D S +  ++  GT  YMAPE+ L KG  ++
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQKGVAYD 174

Query: 283 KDADWWSVGILLYEMLTGQPPF-THANRQKLQ--QRIINEKVKLPPFLTSEAHSLLKGLL 339
             ADW+S+G +L+++L G  PF  H  + K +  +  +   V+LP   + E  SLL+GLL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
            +D ++RLG    G   +K H +FRS++W+ +  ++  P   P
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  191 bits (487), Expect = 6e-57
 Identities = 122/377 (32%), Positives = 183/377 (48%), Gaps = 78/377 (20%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   + +G GAFG+V    K      D+  +YAMK +RK  ++ +N V ++KAERDIL +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             + ++V+L YSFQ +  LY ++D+I GG +   L R  +F E  ARFY AE+  A+  +
Sbjct: 58  ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 232 HKCGIVHRDLKPENILMDSDGH-------------------------EIDESSR------ 260
           HK G +HRD+KP+NIL+D DGH                          I + S       
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 261 ---SNSMCG------------------------TTEYMAPEILLSKGHNKDADWWSVGIL 293
              SN  CG                        T  Y+APE+LL KG+ +  DWWSVG++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 294 LYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGS 349
           L+EML GQPPF      + Q ++IN    + +PP   L+ EA  L+   L     +RLG 
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI-TKLCCSAEERLGR 296

Query: 350 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT 409
              G D IK H +F  +++ + + R     + P +S     +NFD      P ++     
Sbjct: 297 --NGADDIKAHPFFSEVDFSS-DIRTQPAPYVPKISHPMDTSNFD------PVEEESPWN 347

Query: 410 PTAGEHFKGY-TYVAPN 425
             +G+  + + T  +PN
Sbjct: 348 DASGDSTRTWDTLCSPN 364

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  188 bits (479), Expect = 5e-56
 Identities = 117/371 (31%), Positives = 188/371 (50%), Gaps = 73/371 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE  +V+G+GAFG+V  V+KK     D+  +YAMK++RK  +++K  V +++AERDIL 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +    ++V++ YSFQ +  LYLI++F+ GG +   L ++    E++ +FY AE V A+  
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------------------EIDESSRSN------ 262
           +H+ G +HRD+KP+N+L+DS GH                       ++ S  S+      
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 263 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
                             S  GT +Y+APE+ +  G+NK  DWWS+G+++YEML G PPF
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 305 THANRQKLQQRIIN--EKVKLPPFL-TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
                Q+  ++++N  E +  PP +  SE    L      +   R+G+   GV+ IK + 
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGA--PGVEEIKTNP 294

Query: 362 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEH------ 415
           +F  ++W+ +  RE       ++   D  +NFD+     P  D   PT     H      
Sbjct: 295 FFEGVDWEHI--RERPAAIPIEIKSIDDTSNFDE----FPDSDILKPTVATSNHPETDYK 348

Query: 416 -----FKGYTY 421
                F  YTY
Sbjct: 349 NKDWVFINYTY 359

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  185 bits (471), Expect = 1e-55
 Identities = 104/283 (36%), Positives = 159/283 (56%), Gaps = 23/283 (8%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
           ++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+ V+   
Sbjct: 1   IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E + RFY  EI+  + H+H 
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115

Query: 234 CGIVHRDLKPENILMDSDGH--------EIDESSRS-NSMCGTTEYMAPEILLSKG--HN 282
             +V+RDLKP NIL+D  GH          D S +  ++  GT  YMAPE+ L KG  ++
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQKGTAYD 174

Query: 283 KDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL 339
             ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  SLL+GLL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
            +D SKRLG    G   +K H +F+ I+W+ +  ++  P   P
Sbjct: 235 QRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  182 bits (462), Expect = 2e-54
 Identities = 99/285 (34%), Positives = 154/285 (54%), Gaps = 27/285 (9%)

Query: 118 VGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+G FG+V   QVK  G        +YA K + K  + KK+       E++IL KV  P
Sbjct: 1   LGKGGFGEVCAVQVKNTG-------KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR--FYTAEIVSAVSHLHK 233
           FIV L Y+F++++ L L++  +NGG L +H+Y  G    +  R   Y+A+I   + HLH 
Sbjct: 54  FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 234 CGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
             IV+RD+KPEN+L+D  G+          E+ +        GT  YMAPEIL  + ++ 
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 284 DADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGL 338
             DW+++G  +YEM+ G+ PF        +++L++R + ++VK      T E+  + +  
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           L K P  RLGS     D  KH  +F++IN+  LEA  + P F PD
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHE-FFKTINFPRLEAGLIPPPFVPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  182 bits (462), Expect = 8e-54
 Identities = 119/344 (34%), Positives = 188/344 (54%), Gaps = 44/344 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      + ERD+L 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
              + +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
            +H+   VHRD+KP+NILMD +GH              D + +S+   GT +Y++PEIL 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 278 S----KG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 328
           +    KG +  + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236

Query: 329 -SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
             +A  L++ L+    S+    G  G++  K H +F  I+W  +  R  +  + P+VS  
Sbjct: 237 SEDAKDLIRRLI---CSREHRLGQNGIEDFKQHPFFTGIDWDNI--RNCEAPYIPEVSSP 291

Query: 388 DCIANFD------KCWTTMPADDSPAPTPTAGEH--FKGYTYVA 423
              +NFD      K   TMP    P+ T  +G H  F G+TY +
Sbjct: 292 TDTSNFDVDDDCLKNSETMP---PPSHTAFSGHHLPFVGFTYTS 332

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  181 bits (460), Expect = 2e-53
 Identities = 116/339 (34%), Positives = 184/339 (54%), Gaps = 38/339 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAFG+V  VK K      ++ IYAMK++ K  ++K+      + ER++L 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLV 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY AE+V A+ 
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEIL- 276
            +H+   VHRD+KP+N+L+D +GH              D + +S+   GT +Y++PEIL 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 277 -LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLT-- 328
            +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236

Query: 329 -SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
             EA  L++ L+     +RLG    G++  K H +F  I+W+ +  R ++  + PDVS  
Sbjct: 237 SEEAKDLIQRLICSR-ERRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSP 291

Query: 388 DCIANFDKCWTTMPADDSPAP---TPTAGEH--FKGYTY 421
              +NFD     +   +   P   T  +G H  F G+TY
Sbjct: 292 SDTSNFDVDDDVLRNPEIAPPSSHTGFSGLHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  182 bits (462), Expect = 2e-53
 Identities = 113/334 (33%), Positives = 177/334 (52%), Gaps = 32/334 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLS 278
           +H  G +HRD+KP+N+L+D  GH              +   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 279 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 278 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 334

Query: 391 ANFDKCWTTMPADDS-PAPTPTAGEH--FKGYTY 421
           +NFD        +++ P P    G    F G+TY
Sbjct: 335 SNFDDIEEDKGEEETFPIPKAFVGNQLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  178 bits (453), Expect = 4e-53
 Identities = 77/249 (30%), Positives = 131/249 (52%), Gaps = 24/249 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
            ++G+G+FG V+      +D  D+  + A+K +      ++  ++ ++ E  IL+ + HP
Sbjct: 6   ELLGRGSFGSVYL----ALDK-DTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59

Query: 176 FIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+   S +   K  L + L++++GG L   L + G   E   R YT +I+  +++LH 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 234 CGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
            GIVHRD+K  NIL+DSDG              +I+    + S+ GT  +MAPE++  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK--LPPFLTSEAHSLLKG 337
           + + AD WS+G  + EM TG+PP++   N      +I +      +P  L+ EA   L+ 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239

Query: 338 LLHKDPSKR 346
            L +DP KR
Sbjct: 240 CLRRDPKKR 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  175 bits (445), Expect = 6e-51
 Identities = 110/334 (32%), Positives = 178/334 (53%), Gaps = 32/334 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAFG+V  V+ K      S  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 157

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDESS--RSNSMCGTTEYMAPEILLS 278
           +H  G++HRD+KP+N+L+D  GH          ++DE+   R ++  GT +Y++PE+L S
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 279 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPFLTSE 330
           +G    + ++ DWWSVG+ L+EML G  PF   +      +I++ K  L       ++  
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A +L+   L  D   RLG    GV+ IK H +F++  W     RE      P++S     
Sbjct: 278 AKNLICAFL-TDREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDS 334

Query: 391 ANFDKCWTTM-PADDSPAPTPTAGEH--FKGYTY 421
           +NFD         +  P P    G    F G+TY
Sbjct: 335 SNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 4e-50
 Identities = 74/243 (30%), Positives = 121/243 (49%), Gaps = 52/243 (21%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG V+  +     D  +    A+K+++K+     + ++ +  E +IL K+ HP I
Sbjct: 1   LGEGGFGTVYLAR-----DKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNI 53

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+L   F+  + LYL++++  GG L   L    G   ED+      +I+  + +LH  GI
Sbjct: 54  VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113

Query: 237 VHRDLKPENILMDSDGHEI------------DESSRSNSMCGTTEYMAPEILLSKGH-NK 283
           +HRDLKPENIL+DSD  ++             + S   ++ GT  YMAPE+LL KG+ ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
            +D WS+G++LYE+                                E   L++ +L KDP
Sbjct: 174 KSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDP 202

Query: 344 SKR 346
            KR
Sbjct: 203 EKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  161 bits (409), Expect = 9e-47
 Identities = 78/259 (30%), Positives = 127/259 (49%), Gaps = 40/259 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            FEI   +G+G FG+V++ + K        G   A+KV++ ++  KK  +     E  IL
Sbjct: 1   LFEILEKIGKGGFGEVYKARHK------RTGKEVAIKVIKLESKEKKEKI---INEIQIL 51

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAE 223
            K  HP IV+   S+  + +L+++++F +GG L     +           E Q  +   E
Sbjct: 52  KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL-----KDLLKSTNQTLTESQIAYVCKE 106

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
           ++  + +LH  GI+HRD+K  NIL+ SDG           ++ ++   N+M GT  +MAP
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL------ 327
           E++  K ++  AD WS+GI   E+  G+PP++     K   +I       PP L      
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATNGPPGLRNPEKW 223

Query: 328 TSEAHSLLKGLLHKDPSKR 346
           + E    LK  L K+P KR
Sbjct: 224 SDEFKDFLKKCLQKNPEKR 242

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  162 bits (410), Expect = 8e-46
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 46/299 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I R +G+G+FG+V+  + +         + A+KV+ K    K   V+    E  IL 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK--------LVALKVLAKKLESKSKEVERFLREIQILA 52

Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVS 226
            + HP  IV+L   FQ    LYL++++++GG    L   + R+G   E +A F  A+I+S
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHEI------------------DESSRSNSMCGTT 268
           A+ +LH  GI+HRD+KPENIL+D DG  +                     +  ++  GT 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 269 EYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPF-------------THANRQKL 312
            YMAPE+LL       +  +D WS+GI LYE+LTG PPF                     
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 371
                      P  ++  A  LLK LL KDP  RL S       +  H   +  +   L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291

Length = 384

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 8e-41
 Identities = 68/143 (47%), Positives = 93/143 (65%), Gaps = 5/143 (3%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF   +V+G+GAFG+V  V+KK  D G    IYAMK + K  + KK+ + ++KAERD+L 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKK--DTGK---IYAMKTLLKSEMFKKDQLAHVKAERDVLA 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P++V L YSFQ    LYLI++F+ GG L   L +   F ED  RFY AE V A+  
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116

Query: 231 LHKCGIVHRDLKPENILMDSDGH 253
           +HK G +HRD+KP+NIL+D  GH
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGH 139

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  139 bits (351), Expect = 2e-38
 Identities = 78/247 (31%), Positives = 126/247 (51%), Gaps = 22/247 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
            ++G G+FG V++    G++  D    +A+K +    D    +  V  ++ E  +L+K+ 
Sbjct: 6   ELLGSGSFGSVYE----GLN-LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IVQ   + +    LY+ L+ + GG L   L + G F E   R YT +I+  + +LH 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 234 CGIVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEYMAPEILLSKG-HN 282
              VHRD+K  NIL+D++G           ++ E S + S  G+  +MAPE++  +G + 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LTSEAHSLLKGLL 339
             AD WS+G  + EM TG+PP++         +I   K  LPP    L+ EA   +   L
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPPIPDHLSDEAKDFILKCL 239

Query: 340 HKDPSKR 346
            +DPS R
Sbjct: 240 QRDPSLR 246

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 5e-38
 Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 23/265 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++  ++G+GAFG V+    KG++  ++    A+K +  + I ++     M  E D+L 
Sbjct: 1   NYQLGDLIGRGAFGVVY----KGLN-LETGDFVAIKQISLEKIKEEALKSIM-QEIDLLK 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+   S +T   LY+IL++   G L   + + G F E     Y  +++  +++
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 231 LHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSK 279
           LH+ G++HRD+K  NIL   DG              D S    S+ GT  +MAPE++   
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKGL 338
           G +  +D WS+G  + E+LTG PP+   N      RI+ +    LP  ++ E    L   
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWF 363
             KDP+ R  +       +  H W 
Sbjct: 235 FQKDPNLRPTA-----KQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  135 bits (343), Expect = 5e-37
 Identities = 73/260 (28%), Positives = 132/260 (50%), Gaps = 31/260 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G+G+FG V +V++K      SDG I   K +    + +K     + +E +IL
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEK-QQLVSEVNIL 53

Query: 170 TKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHL--FFHLYRQ--GIFREDQARFYTAE 223
            ++ HP IV+   R   ++   LY+++++  GG L       ++      E+       +
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGH----------EIDE-SSRSNSMCGT 267
           ++ A+   H        ++HRDLKP NI +D++ +           +   SS + +  GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF 326
             YM+PE L    +++ +D WS+G L+YE+    PPFT  N+ +L  +I   K  ++P  
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233

Query: 327 LTSEAHSLLKGLLHKDPSKR 346
            +SE + ++K +L+ DP KR
Sbjct: 234 YSSELNEVIKSMLNVDPDKR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  131 bits (332), Expect = 2e-35
 Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 26/254 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E  +V+GQG+ G V++V+ K    G    IYA+K +  D   +      +  E   L 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKP--TGK---IYALKKIHVDGDEEFRKQ--LLRELKTLR 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++V+   +F    ++ ++L++++GG L   L + G   E    +   +I+  + +
Sbjct: 55  SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 231 LHKC-GIVHRDLKPENILMDSDGHEI---D-------ESSR--SNSMCGTTEYMAPEILL 277
           LH    I+HRD+KP N+L++S G E+   D       E++    N+  GT  YM+PE + 
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RIIN--EKVKLPPFLTS-EAH 332
            + ++  AD WS+G+ L E   G+ PF    +    +  + I       LP    S E  
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233

Query: 333 SLLKGLLHKDPSKR 346
             +   L KDP KR
Sbjct: 234 DFISACLQKDPKKR 247

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  127 bits (320), Expect = 3e-34
 Identities = 72/231 (31%), Positives = 118/231 (51%), Gaps = 18/231 (7%)

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHL 202
           M    + T I K      +  R+ LT + H  P +V L     +   ++L+L    GG L
Sbjct: 13  MDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------- 253
           + H+ +     E+  + + AE+V A+  LH+ GIV RDL P NIL+D  GH         
Sbjct: 73  WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132

Query: 254 -EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
            E+++S    ++     Y APE+       +  DWWS+G +L+E+LTG+      +   +
Sbjct: 133 SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTGK-TLVECHPSGI 189

Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
                +  + +P +++ EA SLL+ LL  +P++RLG+G  GV+ IK H +F
Sbjct: 190 NT---HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  134 bits (338), Expect = 4e-34
 Identities = 59/145 (40%), Positives = 96/145 (66%), Gaps = 9/145 (6%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F I + + +GAFGKV+  +KK     ++  +YA+KV++K  +I KN V  ++AERD L 
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALA 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
               PFIV L YS Q+ + +YL+++++ GG +    H+Y  G F E+ A  Y +E+  A+
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALAL 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH 253
            +LH+ GI+HRDLKP+N+L+ ++GH
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGH 142

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 6e-34
 Identities = 72/271 (26%), Positives = 130/271 (47%), Gaps = 32/271 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F +   +G+G+FG+V+    K +D   +  + A+KV+  +    ++ ++ ++ E   L++
Sbjct: 3   FTLLECIGKGSFGEVY----KAIDKRTNQ-VVAIKVIDLEE--AEDEIEDIQQEIQFLSQ 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P+I +   SF   SKL++I+++  GG     L + G   E    F   E++  + +L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEYL 114

Query: 232 HKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           H+ G +HRD+K  NIL+  +G                 S+ N+  GT  +MAPE++   G
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LLKGLL 339
           +++ AD WS+GI   E+  G+PP +  +  ++   I       PP L     S   K  +
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFV 231

Query: 340 H----KDPSKRLGSGPGGVDAIKHHKWFRSI 366
                KDP +R    P   + +K HK+ +  
Sbjct: 232 SLCLNKDPKER----PSAKELLK-HKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  127 bits (321), Expect = 1e-33
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)

Query: 96  DAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
           + EL+A  +  +  GD    ++    +G+GA G+V++   +    G      A+K MR  
Sbjct: 1   EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKE---VAIKKMR-- 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QG 210
             ++K + + +  E  I+    HP IV    S+    +L++++++++GG L   + +   
Sbjct: 54  --LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV 111

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EI-DESS 259
              E Q  +   E++  + +LH   ++HRD+K +NIL+  DG           ++  E S
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
           + NS+ GT  +MAPE++  K +    D WS+GI+  EM  G+PP+      +    I  +
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231

Query: 320 ---KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
               +K P   + E    L   L KDP KR
Sbjct: 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  125 bits (316), Expect = 2e-33
 Identities = 67/253 (26%), Positives = 129/253 (50%), Gaps = 22/253 (8%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DF++ + +G+G++G V++VK+       SD   YA+K +   ++ +K   D +   R IL
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKR------LSDNQFYALKEVDLGSMSQKEREDAVNEIR-IL 53

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             V HP I+  + +F   +KL +++++   G L   + ++     +  E +      +++
Sbjct: 54  ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG---------HEIDESSRSNSMCGTTEYMAPEIL 276
             +  LH+  I+HRDLK  NIL+ ++           ++ + + + +  GT  YMAPE+ 
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW 173

Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL 335
             + ++  +D WS+G LLYEM T  PPF   + Q L+ ++   K   +PP  + +  + +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233

Query: 336 KGLLHKDPSKRLG 348
           + +L   P  R  
Sbjct: 234 RSMLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  125 bits (316), Expect = 3e-33
 Identities = 77/256 (30%), Positives = 121/256 (47%), Gaps = 38/256 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV+        + D+  + A+K +R      K     +  E  +L  + HP +
Sbjct: 8   IGGGTFGKVYTAV-----NLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNL 61

Query: 178 VQLRYSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
           V+  Y  +  R K+Y+ +++ +GG L   L    I  E   R YT +++  +++LH  GI
Sbjct: 62  VKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120

Query: 237 VHRDLKPENILMDSDG----------HEIDESSRS-----NSMCGTTEYMAPEILL---S 278
           VHRD+KP NI +D +G           ++  ++ +      S+ GT  YMAPE++     
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPF-----LTSE 330
           KGH + AD WS+G ++ EM TG+ P+      + Q   I   V     PP      L+ E
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPW-SELDNEFQ---IMFHVGAGHKPPIPDSLQLSPE 236

Query: 331 AHSLLKGLLHKDPSKR 346
               L   L  DP KR
Sbjct: 237 GKDFLDRCLESDPKKR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  124 bits (312), Expect = 9e-33
 Identities = 78/250 (31%), Positives = 129/250 (51%), Gaps = 22/250 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   RV+G+GAFG+    ++      + D +   K +    + +K   D +  E  IL+ 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLSEKERRDALN-EIVILSL 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP I+     F   + L + +++ NGG L+  + RQ   +F E+   +Y  +IVSAVS
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 230 HLHKCGIVHRDLKPENILMDSDG---------HEI--DESSRSNSMCGTTEYMAPEILLS 278
           ++HK GI+HRD+K  NI +   G          +I   E S + ++ GT  YM+PE+   
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPFLTSEAHSLLK 336
             +N  +D W++G +LYE+LT +  F   N   L  +I+  N    +  + +SE  SL+ 
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY-SSELISLVH 234

Query: 337 GLLHKDPSKR 346
            LL +DP KR
Sbjct: 235 SLLQQDPEKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (312), Expect = 1e-32
 Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 23/268 (8%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++   +++GQGAFG+V+      VD G    +  +         K   V+ ++ E  +
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYD--VDTGRELAVKQVPFDPDSPETK-KEVNALECEIQL 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L  + H  IVQ     +    L + ++++ GG +   L   G   E   R YT +I+  V
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----EIDESSRSNSMC----------GTTEYMAPE 274
            +LH   IVHRD+K  NIL DS G+    +   S R  ++C          GT  +M+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPFLTSEAH 332
           ++  +G+ + AD WSVG  + EMLT +PP+          +I       +LP  ++ +A 
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
           + L+    ++  KR    P   + ++H 
Sbjct: 238 NFLRRTFVENAKKR----PSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  123 bits (310), Expect = 2e-32
 Identities = 73/254 (28%), Positives = 131/254 (51%), Gaps = 28/254 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
           DFEI   +G+G+FG VF+V +K   D     +YAMK   + + +   ++  +D    E  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRK--ADKR---VYAMKQIDLSKMNRREREEAID----EAR 51

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQA-RFYTAEI 224
           +L K+   +I++   SF  + KL +++++   G  H    + R     EDQ  RF+  +I
Sbjct: 52  VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QI 110

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCGTTEYMAP 273
           +  ++HLH   I+HRD+K  N+ +D+  +             D ++ +N++ GT  Y++P
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAH 332
           E+   K +N+ +D W++G++LYE  TG+ PF   N+  L  +II      +    + +  
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA 230

Query: 333 SLLKGLLHKDPSKR 346
            L+   L KD  +R
Sbjct: 231 QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-32
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 57/296 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           ++    +G+G +G V++ +     D  +  I A+K ++      ++      A R+I  L
Sbjct: 1   YQKLGKIGEGTYGVVYKAR-----DKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ HP I++L   F+ +  LYL+ +F++         RQ    E   + Y  +++  ++
Sbjct: 53  KELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 230 HLHKCGIVHRDLKPENILMDSDG----------HEIDESSRS-NSMCGTTEYMAPEILL- 277
             H  GI+HRDLKPEN+L++++G                 R       T  Y APE+LL 
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANR-------------------QKLQQRIIN 318
            KG++   D WSVG +  E+L+ +P F   +                     K      N
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232

Query: 319 EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
            K   P           P  + +A  LL  +LH DP KR+       +    H +F
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (306), Expect = 7e-32
 Identities = 66/267 (24%), Positives = 128/267 (47%), Gaps = 35/267 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F+I   +G+G++G V++   K     ++  + A+KV+  +  +++     +  E  IL 
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEEDLQE-----IIKEISILK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVS 229
           +   P+IV+   S+   + L++++++   G +   +        E++      + +  + 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
           +LH    +HRD+K  NIL++ +G              D  ++ N++ GT  +MAPE++  
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT------SEAH 332
            G+N  AD WS+GI   EM  G+PP++  +  +    I N   K PP L+       E +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFN 230

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             +K  L KDP +R    P  +  ++H
Sbjct: 231 DFVKKCLVKDPEER----PSAIQLLQH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  120 bits (303), Expect = 1e-31
 Identities = 72/246 (29%), Positives = 124/246 (50%), Gaps = 26/246 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FGK   VK K  +DG    I  + + +    +     +  + E  +L+ + HP I
Sbjct: 8   IGEGSFGKAILVKSK--EDGKQYVIKEINISK----MSPKEREESRKEVAVLSNMKHPNI 61

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GI-FREDQARFYTAEIVSAVSHLHKCG 235
           VQ + SF+    LY+++D+  GG L+  +  Q G+ F EDQ   +  +I  A+ H+H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 236 IVHRDLKPENILMDSDG-------------HEIDESSRSNSMC-GTTEYMAPEILLSKGH 281
           I+HRD+K +NI +  DG             +   E +R+   C GT  Y++PEI  ++ +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART---CIGTPYYLSPEICENRPY 178

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGLLH 340
           N  +D W++G +LYEM T +  F   N + L  +II      +    + +  +L+  L  
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238

Query: 341 KDPSKR 346
           ++P  R
Sbjct: 239 RNPRDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  119 bits (300), Expect = 4e-31
 Identities = 72/250 (28%), Positives = 124/250 (49%), Gaps = 21/250 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI + +G+G+FGK++  K K     DS+     ++      +K+      K E  +L K
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKS----DSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAK 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
           + HP IV    SFQ   +L++++++ +GG L   + RQ   +F EDQ   +  +I   + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 230 HLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMC-GTTEYMAPEILL 277
           H+H   I+HRD+K +NI +  +G            ++++S      C GT  Y++PEI  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK 336
           ++ +N   D WS+G +LYE+ T + PF   N  +L  +I       + P  + +  SL+ 
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235

Query: 337 GLLHKDPSKR 346
            L    P  R
Sbjct: 236 QLFKVSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  117 bits (294), Expect = 4e-30
 Identities = 74/260 (28%), Positives = 123/260 (47%), Gaps = 29/260 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK-------VMRKDTIIKKNHVDYMKA 164
           + +   +G GAFG V++V+KK     +   + A+K          KD   +   +  + +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS 57

Query: 165 ERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARF 219
           E  I+ + + HP IV+   +F    +LY+++D I G  L  H      ++  F E++   
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 220 YTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTT 268
              ++V A+ +LHK   IVHRDL P NI++  D            +    S+  S+ GT 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFL 327
            Y  PEI+ ++ + + AD W+ G +LY+M T QPPF   N   L  +I+    + LP  +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 328 TSE-AHSLLKGLLHKDPSKR 346
            SE    ++   L  D   R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  116 bits (292), Expect = 5e-30
 Identities = 73/251 (29%), Positives = 127/251 (50%), Gaps = 23/251 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
            + + RVVG+G+FG+   V+       +SD  YAMK +R   + K +  V+  + E  +L
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIR---LPKSSSAVEDSRKEAVLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSA 227
            K+ HP IV  + SF+    LY+++++ +GG L     L R  +F ED    +  ++   
Sbjct: 53  AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHE-----------IDESSRSNSMCGTTEYMAPEIL 276
           V H+H+  ++HRD+K +NI +  +G                 + + +  GT  Y+ PEI 
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLL 335
            +  +N  +D WS+G +LYE+ T + PF   + + L  ++     K LP   + E  SL+
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232

Query: 336 KGLLHKDPSKR 346
           K +  ++P  R
Sbjct: 233 KQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 1e-29
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 61/286 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+  VVG+GA+G V + + K    G+   I   K    D  +KK       A R++  L
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKK------TALREVKVL 54

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVS 226
            ++ H  IV L+ +F+ + +LYL+ +++        L      G+   D  R Y  +++ 
Sbjct: 55  RQLRHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQ 111

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSN--SMCGTTEYMAPE 274
           A+++ H   I+HRD+KPENIL+   G            +     S       T  Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 275 ILLSKG-HNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII------------- 317
           +L+    + K  D W++G ++ E+L G+P F   +  ++  L Q+ +             
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 318 ---NEKVKLPPFLTSE-------------AHSLLKGLLHKDPSKRL 347
                 V  P     E             A   LK  L  DP +RL
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  115 bits (290), Expect = 2e-29
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 41/263 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAER 166
            D E    +G G  G V +V  +      +  I A+K +R    + I K+     +  E 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEINEAIQKQ-----ILREL 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           DIL K   P+IV    +F     + + +++++GG L       +  I  E         +
Sbjct: 51  DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILGKIAVAV 109

Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHEID----------ESSRSNSMCGTTEYMAP 273
           +  +++LH K  I+HRD+KP NIL++S G +I            +S + +  GT+ YMAP
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAKTFVGTSSYMAP 168

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----KLQQRIINEKVKLPPFLT 328
           E +    ++  +D WS+G+ L E+ TG+ P+   N       +L Q I+NE    PP L 
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLP 225

Query: 329 S-----EAHSLLKGLLHKDPSKR 346
           S     +    +   L KDP +R
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRER 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 3e-29
 Identities = 69/314 (21%), Positives = 129/314 (41%), Gaps = 89/314 (28%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E    +G+G +G+V++ + K   +     + A+K +R +             E++    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMEN------------EKEGFPI 43

Query: 168 -------ILTKVTHPFIVQLR--YSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFRE 214
                  +L K+ HP IV+L+   + + +  +Y++ +++     G         +  F E
Sbjct: 44  TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTE 99

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSR-S 261
            Q + Y  +++  + +LH  GI+HRD+K  NIL+++DG                 S+  +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-- 318
           N +  T  Y  PE+LL +  +  + D WSVG +L E+  G+P F  +   +  ++I    
Sbjct: 160 NRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218

Query: 319 --------EKVKLPP---------------------FLTSEAHSLLKGLLHKDPSKRLGS 349
                     V   P                      +   A  LL  LL  DP KR+ +
Sbjct: 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278

Query: 350 GPGGVDAIKHHKWF 363
                 A+  H++F
Sbjct: 279 D----QAL-QHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  114 bits (286), Expect = 3e-29
 Identities = 73/257 (28%), Positives = 130/257 (50%), Gaps = 36/257 (14%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM-KAER---- 166
           +E  RVVG+GAFG V   ++K   D            +K  IIK+  V+ M K ER    
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRK--AD------------QKLVIIKQIPVEQMTKDERLAAQ 47

Query: 167 ---DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
               +L  ++HP I++   +F     L +++++  GG L  ++ ++   +  ED    + 
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMD--------SD---GHEIDESSRSNSMCGTTEY 270
            +I+ A+ H+H   I+HRDLK +NIL+D         D      +   S++ ++ GT  Y
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTS 329
           ++PE+   K +N+ +D W++G +LYE+ + +  F  AN   L  +I++     +    + 
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP 227

Query: 330 EAHSLLKGLLHKDPSKR 346
           +   L+  +L+ DPSKR
Sbjct: 228 DLRQLILSMLNLDPSKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 3e-28
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 36/260 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ + +G G +G V++ +     D  +  + A+KV++ +     +  + ++ E  +L 
Sbjct: 4   DYELIQRIGSGTYGDVYKAR-----DIATGELVAIKVIKLE---PGDDFEIIQQEISMLK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
           +  HP IV    S+  R KL++++++  GG L   + + R G   E Q  +   E +  +
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYMAPEILL 277
           ++LH+ G +HRD+K  NIL+  DG           ++  + ++  S  GT  +MAPE+  
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 278 SK---GHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFL----- 327
            +   G++   D W++GI   E+   QPP    H  R      +I++    PP L     
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSNFPPPKLKDKEK 231

Query: 328 -TSEAHSLLKGLLHKDPSKR 346
            +   H  +K  L KDP KR
Sbjct: 232 WSPVFHDFIKKCLTKDPKKR 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 74/275 (26%), Positives = 138/275 (50%), Gaps = 36/275 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++   ++G+GA+G V+  + K V  G    + A+K++  DT    + V  ++ E  +L++
Sbjct: 3   YQRLELIGRGAYGAVY--RGKHVPTGR---VVALKIINLDT--PDDDVSDIQREVALLSQ 55

Query: 172 VTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +     P I +   S+    +L++I+++  GG +   L + G   E        E++ A+
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVAL 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCGTTEYMAPEILL 277
            ++HK G++HRD+K  NIL+ + G+               SS+ ++  GT  +MAPE++ 
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 278 S-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-LL 335
             K ++  AD WS+GI +YEM TG PP++  +  +    I   K   PP L    +S LL
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLL 231

Query: 336 K----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           +      L ++P +RL +     + +   KW ++ 
Sbjct: 232 REFVAACLDEEPKERLSA-----EELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  109 bits (274), Expect = 3e-27
 Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 43/282 (15%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P + +EI   +G GAFGKV++ K K     ++  + A KV+  +T  ++   DYM
Sbjct: 5   RRDLDPNEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVI--ETKSEEELEDYM 57

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARF 219
             E +IL    HP+IV+L  +F    KL+++++F  GG    +   L R     E Q + 
Sbjct: 58  -VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQV 114

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTT 268
              +++ A+ +LH   I+HRDLK  N+L+  DG             +    R +S  GT 
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174

Query: 269 EYMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 323
            +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--- 231

Query: 324 PPFLTS------EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           PP L+       E    LK  L K P  R    P     ++H
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETR----PSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  108 bits (272), Expect = 9e-27
 Identities = 82/304 (26%), Positives = 132/304 (43%), Gaps = 70/304 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
            ++I   +G+GA G VF+ K +      +    A+K   + R +  I    +  +KA   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLEGGIPNQALREIKA--- 52

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQARFYTA 222
            L    HP++V+L   F   S   L+++++        L       +    E Q + Y  
Sbjct: 53  -LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMR 106

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI----------DESSRSNS-MCGTTEY 270
            ++  V+++H  GI+HRDLKP N+L+ +DG  +I          +E  R  S    T  Y
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 271 MAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV-- 321
            APE+L  ++ ++   D W+VG +  E+L G P F   N  +    +       NE+   
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226

Query: 322 ---KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
               LP                   P  + EA  LLKGLL  DPSKRL +     +A++ 
Sbjct: 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA----EALR- 281

Query: 360 HKWF 363
           H +F
Sbjct: 282 HPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 54/272 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDIL 169
           D+E+  V+G GA   V+                A+ +   + + IK+  ++  +   D L
Sbjct: 2   DYELIEVIGVGATAVVYA---------------AICLPNNEKVAIKRIDLEKCQTSVDEL 46

Query: 170 TK-------VTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARF 219
            K         HP +V+   SF    +L+L++ +++GG    +    Y +G   E     
Sbjct: 47  RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI-------------DESSRS-NSM 264
              E++  + +LH  G +HRD+K  NIL+  DG  +I             D + +   + 
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 265 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 323
            GT  +MAPE++    G++  AD WS GI   E+ TG  P++     K+    +      
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---ND 223

Query: 324 PPFLTSEAHS---------LLKGLLHKDPSKR 346
           PP L + A           ++   L KDPSKR
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKR 255

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  107 bits (269), Expect = 1e-26
 Identities = 78/264 (29%), Positives = 118/264 (44%), Gaps = 53/264 (20%)

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN------HV-DYMKAERDILTKVT 173
           G FGKV  +K K             K+  +  I  KN       V   MK          
Sbjct: 27  GKFGKVSVLKHKPTQ----------KLFVQKIIKAKNFNAIEPMVHQLMK---------D 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P  ++L YS  T     LI+D+I  G LF  L ++G   E + +    ++V A++ LHK
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 234 CGIVHRDLKPENILMDSDGHEI---DE--SSRSNSMC---GTTEYMAPEILLSKGHNKDA 285
             I+H D+K EN+L D     I   D        +     GT +Y +PE +  KGHN D 
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKI--KGHNYDV 185

Query: 286 --DWWSVGILLYEMLTGQPPF--------THANRQKLQQRIINEKVKLPPFLTSEAHSLL 335
             DWW+VG+L YE+LTG+ PF           +  K QQ+    K+     ++  A+  +
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNANDFV 241

Query: 336 KGLLHKDPSKRLGSGPGGVDAIKH 359
           + +L  + + RL +     + IKH
Sbjct: 242 QSMLKYNINYRLTN---YNEIIKH 262

Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 39/275 (14%)

Query: 109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D  EI   +G GAFGKV++ + K     ++    A K++      ++   D+M  E D
Sbjct: 3   PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKII--QIESEEELEDFM-VEID 54

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVS 226
           IL++  HP IV L  ++   +KL+++++F +GG L    L  +    E Q R+   +++ 
Sbjct: 55  ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEI 275
           A++ LH   ++HRDLK  NIL+  DG                  + ++  GT  +MAPE+
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174

Query: 276 LL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL--- 327
           +         ++  AD WS+GI L E+   +PP    N  ++  +I+  +   PP L   
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQP 231

Query: 328 ---TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
              +S  +  LK  L KDP  R    P   + +KH
Sbjct: 232 SKWSSSFNDFLKSCLVKDPDDR----PTAAELLKH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 82/309 (26%), Positives = 133/309 (43%), Gaps = 84/309 (27%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + K      +  I A+K +R D        T ++        
Sbjct: 1   YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNEEEGIPSTALR-------- 47

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQAR 218
            E  +L ++ HP IV+L     T  KLYL+ ++ +       L      R G    +  +
Sbjct: 48  -EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIK 101

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---D----ESSRSNSMCGTTE-- 269
               +++  +++ H   I+HRDLKP+NIL++ DG  +   D     +        T E  
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVV 160

Query: 270 ---YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII------ 317
              Y APEILL SK ++   D WSVG +  EM+TG+P F      ++ Q  +I       
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF--PGDSEIDQLFKIFQILGTP 218

Query: 318 NEKV-----KLP------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 354
            E+      KLP                  P L  E   LL  +L  +P+KR+ +     
Sbjct: 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK---- 274

Query: 355 DAIKHHKWF 363
           +A+K H +F
Sbjct: 275 EALK-HPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (265), Expect = 4e-26
 Identities = 69/258 (26%), Positives = 124/258 (48%), Gaps = 26/258 (10%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHP 175
           +G+G+FG V+ VK K     +      +KV+++  +  +  N       E  +L+K+ HP
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQG--IFREDQARFYTAEIVSAVSHL 231
            IV+   SF  R    +I ++  G  L   L   +       E+Q   +  +++  V ++
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 232 HKCGIVHRDLKPENILMDSDGHEIDESSRS----------NSMCGTTEYMAPEILLSKGH 281
           H+  I+HRDLK +NI + ++  +I +   S           +  GT  YM+PE L  +G+
Sbjct: 123 HQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLLH 340
           +  +D WS+G +LYEM      F   N   +  RI+      LP   + + +S+++ +L+
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLN 242

Query: 341 KDPSKRLGSGPGGVDAIK 358
           KDPS R    P   + ++
Sbjct: 243 KDPSLR----PSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  105 bits (264), Expect = 5e-26
 Identities = 72/260 (27%), Positives = 127/260 (48%), Gaps = 30/260 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-DTIIKKNHVDYMKAERDI 168
           G+F+I + +G+G F  V++             + A+K ++  + +  K   D +K E D+
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLK-EIDL 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQG-IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G    +  H  +Q  +  E     Y  ++
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAP 273
            SA+ H+H   I+HRD+KP N+ + + G               +++ ++S+ GT  YM+P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPF----L 327
           E +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  EK   PP      
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EKCDYPPLPADHY 233

Query: 328 TSEAHSLLKGLLHKDPSKRL 347
           + E   L+   ++ DP KR 
Sbjct: 234 SEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  105 bits (264), Expect = 7e-26
 Identities = 66/256 (25%), Positives = 126/256 (49%), Gaps = 29/256 (11%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR----KDTIIKKNHVDYMKAERDILTKV 172
           ++G+G +G+V+      V  G+   +  +++      +    +K+ V  +++E + L  +
Sbjct: 8   LIGKGTYGRVYLALN--VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
            H  IVQ      T   L + L+++ GG +   L   G F E   RF+T +++  +++LH
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 233 KCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLS- 278
             GI+HRDLK +N+L+D+DG              +I ++ ++ SM G+  +MAPE++ S 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 279 -KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-------LTSE 330
            +G++   D WS+G ++ EM  G+ P++         ++ N++   PP        L+  
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNLSPV 244

Query: 331 AHSLLKGLLHKDPSKR 346
           A   L      +P  R
Sbjct: 245 ALDFLNACFTINPDNR 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  104 bits (261), Expect = 2e-25
 Identities = 66/265 (24%), Positives = 125/265 (47%), Gaps = 27/265 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G GAF   +Q +   V  G    +  +  +R  +  ++  V+ ++ E  ++ ++ HP
Sbjct: 6   QQLGTGAFSSCYQARD--VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I+++  +    S   L ++++ GG +   L + G F+E     YT +++  +S+LH+  
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 236 IVHRDLKPENILMDSDGHEI-----DESSRSNS-----------MCGTTEYMAPEILLSK 279
           I+HRD+K  N+L+DS G  +       ++R  +           + GT  +MAPE+L  +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 280 GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRI--INEKVKLPPFLTSEAHSL 334
            + +  D WSVG ++ EM T +PP+    H+N   L  +I        +P  L+     +
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKH 359
               L   P  R    P   + +KH
Sbjct: 244 TLRCLELQPEDR----PPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  101 bits (252), Expect = 2e-24
 Identities = 73/249 (29%), Positives = 120/249 (48%), Gaps = 27/249 (10%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAER 166
           P ++ + +++GQGAFG+V+        D D+    A+K ++   ++      V+ ++ E 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCY-----DADTGRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSF---QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            +L  + H  IVQ  Y          L + ++ + GG +   L   G   E+  R YT +
Sbjct: 56  QLLKNLLHERIVQY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ 114

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----EIDESSRSNSMC----------GTTE 269
           I+  VS+LH   IVHRD+K  NIL DS G+    +   S R  ++C          GT  
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPPFL 327
           +M+PE++  +G+ + AD WSVG  + EMLT +PP+          +I  +     LPP +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV 234

Query: 328 TSEAHSLLK 336
           +      LK
Sbjct: 235 SDHCRDFLK 243

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  101 bits (252), Expect = 3e-24
 Identities = 84/266 (31%), Positives = 128/266 (48%), Gaps = 39/266 (14%)

Query: 107 IGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           + P +F EI   +G GAFGKV++ + K     ++  + A KV+  DT  ++   DYM  E
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVI--DTKSEEELEDYM-VE 52

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQGIFREDQARFYTA 222
            DIL    HP IV+L  +F   + L+++++F  GG +      L R     E Q R    
Sbjct: 53  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCK 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYM 271
           + + A+++LH+  I+HRDLK  NIL   DG                  R +S  GT  +M
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 272 APEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 326
           APE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPT 227

Query: 327 L------TSEAHSLLKGLLHKDPSKR 346
           L      +SE    LK  L K+   R
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 5e-24
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 45/273 (16%)

Query: 117 VVGQGAFGKVF-----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G G+FG V+            VK+  +    +          KD   K++ +D +  E
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--------KDR--KRSMLDALARE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L ++ H  IVQ   S      L + L+++ GG +   L   G F E   R +  +I+
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSN-----SMCGTT 268
             +++LH  GI+HRD+K  NIL+D+ G             E +  S        S+ G+ 
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPF 326
            +MAPE++    + + AD WS+G L+ EMLTG+ PF    + +   + I E     +P  
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENASPEIPSN 235

Query: 327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           ++SEA   L+     D +KR    P   + +KH
Sbjct: 236 ISSEAIDFLEKTFEIDHNKR----PTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 7e-24
 Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 68/298 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +++ + +G G FG V+  + K     ++  + A+K M+K      +  + M   R++  L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKF---YSWEECMN-LREVKSL 51

Query: 170 TKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIV 225
            K+  HP IV+L+  F+   +LY + +++ G    + L +      F E   R    +I+
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEYMAPEI 275
             ++H+HK G  HRDLKPEN+L+               EI           T  Y APEI
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 276 LL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANR----------------------QKL 312
           LL S  ++   D W++G ++ E+ T +P F  ++                        KL
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 313 QQRIINEKVKLPPFL-----------TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             ++     + P F            + EA  L+K +L  DP KR    P    A++H
Sbjct: 230 ASKL---GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR----PTASQALQH 280

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 99.3 bits (247), Expect = 1e-23
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 25/248 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--ILTKVT 173
           RVVG+G++G+V  V+ +      +DG     V++K  +   +  +   AE++  +L+++ 
Sbjct: 6   RVVGKGSYGEVSLVRHR------TDG--KQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57

Query: 174 HPFIVQLRYSFQTRS-KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSH 230
           HP IV  R S++     LY+++ F  GG L+  L  Q   +  E+Q   +  +I  A+ +
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 231 LHKCGIVHRDLKPENILM---------DSDGHEIDES--SRSNSMCGTTEYMAPEILLSK 279
           LH+  I+HRDLK +N+ +         D     + E+    ++++ GT  YM+PE+  +K
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGL 338
            +N  +D W++G  +YEM T +  F   +   L  RII  K+  +P   + E   L+  +
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237

Query: 339 LHKDPSKR 346
           L K P KR
Sbjct: 238 LSKRPEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 71/257 (27%), Positives = 122/257 (47%), Gaps = 33/257 (12%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
               + F  +G+G+ G V     K      +    A+K M    + K+   + +  E  I
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKM---DLRKQQRRELLFNEVVI 69

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           +    HP IV++  S+    +L+++++F+ GG L   +       E+Q       ++ A+
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLAVLKAL 128

Query: 229 SHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILL 277
           S LH  G++HRD+K ++IL+ SDG               E  R  S+ GT  +MAPE++ 
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ--QRIINEKVKLPPFL------TS 329
              +  + D WS+GI++ EM+ G+PP+   N   LQ  +RI +     PP L      + 
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYF--NEPPLQAMKRIRDNL---PPKLKNLHKVSP 243

Query: 330 EAHSLLKGLLHKDPSKR 346
              S L  +L +DP++R
Sbjct: 244 RLRSFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 45/271 (16%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            G FE+  V+G+G +GKV++ + K      +  + A+K+M     I ++  + +K E +I
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMD----IIEDEEEEIKEEYNI 55

Query: 169 LTKVT-HPFIVQLRYSFQTRS------KLYLILDFINGG---HLFFHLYRQG-IFREDQA 217
           L K + HP I     +F  ++      +L+L+++   GG    L   L ++G   +E+  
Sbjct: 56  LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EID-ESSRSNSMCG 266
            +   E +  +++LH+  ++HRD+K +NIL+  +            ++D    R N+  G
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Query: 267 TTEYMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPFT--HANRQKLQQRIIN 318
           T  +MAPE++       DA      D WS+GI   E+  G+PP    H  R   +  I  
Sbjct: 176 TPYWMAPEVIACD-EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--IPR 232

Query: 319 E---KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                +K P   + + +  +   L K+  +R
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQR 263

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  102 bits (255), Expect = 2e-23
 Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 51/288 (17%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           D     E  +K     + I RV+G GA G V   K+  V DG+    +A+KV+  + +  
Sbjct: 23  DEATAKEQAKK-----YWISRVLGSGATGTVLCAKR--VSDGEP---FAVKVVDMEGM-- 70

Query: 156 KNHVDYMKA--ERDILTKVTHPFIVQLRYSFQTR--------SKLYLILDFINGGHLFFH 205
            +  D  +A  E   L       IV+    F  +          + L+LD+ N G L   
Sbjct: 71  -SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL--- 126

Query: 206 LYRQGI---------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---- 252
             RQ I         FRE +A     +++ AV H+H   ++HRD+K  NIL+ S+G    
Sbjct: 127 --RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 253 -----HEIDESSRSN----SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP 303
                 ++  ++ S+    + CGT  Y+APEI   K ++K AD +S+G+LLYE+LT + P
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Query: 304 FTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSG 350
           F   N +++  + +  +   LPP ++ E   ++  LL  DP +R  S 
Sbjct: 245 FDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 72/254 (28%), Positives = 124/254 (48%), Gaps = 25/254 (9%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAER 166
           P ++ + +++G+GAFG+V+        D D+    A+K +  D   ++    V+ ++ E 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 167 DILTKVTHPFIVQLRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
            +L  + H  IVQ     +     KL + ++++ GG +   L   G   E+  R YT +I
Sbjct: 56  QLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI 115

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----EIDESSRSNSMC----------GTTEY 270
           +  VS+LH   IVHRD+K  NIL DS G+    +   S R  ++C          GT  +
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPFLT 328
           M+PE++  +G+ + AD WSV   + EMLT +PP+          +I  +  K  LP  ++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235

Query: 329 SEAHSLLKGLLHKD 342
                 LK +  ++
Sbjct: 236 DACRDFLKQIFVEE 249

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 97.7 bits (243), Expect = 4e-23
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 47/273 (17%)

Query: 117 VVGQGAFGKVF----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           V+G+GA+G V+           VK+  +D  +     A K   K           ++ E 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--AEKEYEK-----------LQEEV 53

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
           D+L  + H  IVQ   +    + + + ++F+ GG +   L R G   E     YT +I+ 
Sbjct: 54  DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDG--HEID------------ESSRSN---SMCGTTE 269
            V++LH   +VHRD+K  N+++  +G    ID              + SN   SM GT  
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 326
           +MAPE++   G+ + +D WS+G  ++EM TG+PP    +R      I   +  +P     
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233

Query: 327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
            ++ A   +   L +D  +R    P  +  ++H
Sbjct: 234 FSAAAIDFVTSCLTRDQHER----PSALQLLRH 262

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 97.8 bits (243), Expect = 4e-23
 Identities = 74/258 (28%), Positives = 127/258 (49%), Gaps = 32/258 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P++
Sbjct: 12  IGKGSFGEVF----KGIDN-RTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L R G F E Q      EI+  + +LH    +
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123

Query: 238 HRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 286
           HRD+K  N+L+   G              D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 287 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPFLTSEAHSLLK----GLLHK 341
            WS+GI   E+  G+PP    N      R++    K  PP LT E     K      L+K
Sbjct: 184 IWSLGITAIELAKGEPP----NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239

Query: 342 DPSKRLGSGPGGVDAIKH 359
           DPS R    P   + +KH
Sbjct: 240 DPSFR----PTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 63/257 (24%), Positives = 115/257 (44%), Gaps = 32/257 (12%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++ K KG D   ++   A+K +++D   ++   D++K E  ++ K+ HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEV--AVKTLKEDASEEE-RKDFLK-EARVMKKLGHP 56

Query: 176 FIVQLR-YSFQTRSKLYLILDFINGGHL----------FFHLYRQGIFREDQARFYTAEI 224
            +V+L          LYL+L+++ GG L          F    +  +  +D   F   +I
Sbjct: 57  NVVRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQI 114

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTE---YM 271
              + +L     VHRDL   N L+  D            ++ +        G      +M
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTS 329
           APE L        +D WS G+LL+E+ T G  P+   + +++ + +    ++  P +   
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234

Query: 330 EAHSLLKGLLHKDPSKR 346
           E + L+      DP  R
Sbjct: 235 ELYELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.5 bits (237), Expect = 3e-22
 Identities = 71/258 (27%), Positives = 127/258 (49%), Gaps = 28/258 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F +V+  +   + DG    +  +++   D +  K   D +K E D+L
Sbjct: 2   ANFRIEKKIGRGQFSEVY--RATCLLDGVPVALKKVQIF--DLMDAKARADCIK-EIDLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPE 274
           SA+ H+H   ++HRD+KP N+ + + G               +++ ++S+ GT  YM+PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPF----LT 328
            +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  E+   PP      +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 234

Query: 329 SEAHSLLKGLLHKDPSKR 346
            E   L+   ++ DP KR
Sbjct: 235 EELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 81/314 (25%), Positives = 134/314 (42%), Gaps = 93/314 (29%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK------NHVDYMKAE 165
           +EI + +G+GA+G V+    K +D          +  ++   +KK      N  D  +  
Sbjct: 9   YEILQKLGKGAYGIVW----KAID----------RRTKEVVALKKIFDAFRNATDAQRTF 54

Query: 166 RDI--LTKVT-HPFIVQLR--YSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARF 219
           R+I  L ++  HP IV+L      +    +YL+ +++       H + R  I  +   R+
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD---LHAVIRANILEDVHKRY 111

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCG 266
              +++ A+ ++H   ++HRDLKP NIL++SD               E++E+  +  +  
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL-- 169

Query: 267 TTEYMA------PEILL-SKGHNKDADWWSVGILLYEMLTGQP----------------- 302
            T+Y+A      PEILL S  + K  D WSVG +L EML G+P                 
Sbjct: 170 -TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228

Query: 303 --------------PFTHANRQKLQQRIINEKVKLPPFLTS---EAHSLLKGLLHKDPSK 345
                         PF       L  R    +  L   L     +A  LLK LL  +P+K
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSR---PRKPLDELLPKASDDALDLLKKLLVFNPNK 285

Query: 346 RLGSGPGGVDAIKH 359
           RL +     +A++H
Sbjct: 286 RLTA----EEALEH 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 5e-22
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 18/172 (10%)

Query: 263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EK 320
           S  GT +Y+APEI L +G+ ++ DWWS+G +++E L G PPF   N  +  ++IIN  E 
Sbjct: 207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET 266

Query: 321 VKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 378
           +  P    L+ EA  L++ L+  +   RLG   GG   IK H +FR ++W T+  R+++ 
Sbjct: 267 LYFPDDIHLSVEAEDLIRRLI-TNAENRLGR--GGAHEIKSHPFFRGVDWDTI--RQIRA 321

Query: 379 KFKPDVSG---------KDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTY 421
            F P +            +     +       A      +      F GYTY
Sbjct: 322 PFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTY 373

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 95.1 bits (236), Expect = 6e-22
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE+  VVG+GA+G V + + K     ++  I A+K   KD+   +   +    E  +L  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKF-KDSEENEEVKETTLRELKMLRT 56

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           +    IV+L+ +F+ R KLYL+ +++    L            ++ R Y  +++ A+   
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 232 HKCGIVHRDLKPENILMDSD----------GHEIDESSRSN--SMCGTTEYMAPEILLSK 279
           HK  IVHRD+KPEN+L+  +             + E S +N      T  Y +PE+LL  
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 280 GHNKDADWWSVGILLYEMLTGQPPF 304
            + K  D WSVG +L E+  GQP F
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 93.3 bits (233), Expect = 1e-21
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 37/256 (14%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+GAFG+V++   KG  +G  +   A+K +++    ++   ++++ E  I+ K++HP
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGT-ETKVAVKTLKEGAS-EEEREEFLE-EASIMKKLSHP 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKC 234
            IV+L         LY++ +++ GG L   L + G             +I   + +L   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 235 GIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTE---YMAPEILLSKGH 281
             VHRDL   N L+  +            +I E        G      +MAPE L     
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 282 NKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL----------PPFLTSE 330
              +D WS G+LL+E+ T G+ P+           + NE+V            P     E
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPY---------PGMSNEEVLELLEDGYRLPRPENCPDE 232

Query: 331 AHSLLKGLLHKDPSKR 346
            + L+      DP  R
Sbjct: 233 LYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 28/264 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           +++GQGAFG+V+        D D+    A K ++   ++      V  ++ E  +L  + 
Sbjct: 8   KLLGQGAFGRVYLCY-----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 174 HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           H  IVQ     + R++  L + ++++ GG +   L   G   E   R YT +I+  +S+L
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 232 HKCGIVHRDLKPENILMDSDGH----EIDESSRSNSMC----------GTTEYMAPEILL 277
           H   IVHRD+K  NIL DS G+    +   S R  ++C          GT  +M+PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-PFLTSEAHSLLK 336
            +G+ + AD WS+G  + EMLT +PP+          +I  +      P   SE      
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 337 GLLHKDPSKRLGSGPGGVDAIKHH 360
           G +  +   R    P   + ++H 
Sbjct: 243 GCIFVEARHR----PSAEELLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 94.0 bits (233), Expect = 1e-21
 Identities = 75/285 (26%), Positives = 133/285 (46%), Gaps = 31/285 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F     +G+G+FG+VF    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++
Sbjct: 6   FTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQ 58

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P++ +   S+   +KL++I++++ GG     L   G   E Q      EI+  + +L
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYL 117

Query: 232 HKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           H    +HRD+K  N+L+   G              D   + N+  GT  +MAPE++    
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK---- 336
           ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L       LK    
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVE 234

Query: 337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
             L+K+PS R    P   + +KH    R    KT    E+  ++K
Sbjct: 235 ACLNKEPSFR----PTAKELLKHKFIVRFAK-KTSYLTELIDRYK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 56/250 (22%), Positives = 103/250 (41%), Gaps = 25/250 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G  DG     A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSH 230
            HP IV+L         L ++++++ GG L  +    R           +  +I   + +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCG--TTEYMAPEILLS 278
           L     +HRDL   N L+  +            ++ +        G     +MAPE L  
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 279 KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEA-HSLLK 336
                 +D WS G+LL+E+ T G+ P+   +  ++ + +        P       + L+ 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 337 GLLHKDPSKR 346
               +DP  R
Sbjct: 239 QCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 28/257 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+I + +G+G F +V+    +     D   +   KV   + +  K   D +K E D+L 
Sbjct: 3   NFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLK 57

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIVS 226
           ++ HP +++   SF   ++L ++L+  + G L     +  +Q  +  E     Y  ++ S
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHE-----------IDESSRSNSMCGTTEYMAPEI 275
           AV H+H   ++HRD+KP N+ + + G               +++ ++S+ GT  YM+PE 
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 276 LLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPFLTSEAHS 333
           +   G+N  +D WS+G LLYEM   Q PF     N   L Q+I  E+   PP  T     
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--EQCDYPPLPTEHYSE 235

Query: 334 LLKGL----LHKDPSKR 346
            L+ L    ++ DP +R
Sbjct: 236 KLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 35/259 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE+ + +G G +G V+  K + V+ G+   + A+KV++ +          ++ E  ++ 
Sbjct: 10  DFELIQRIGSGTYGDVY--KARNVNTGE---LAAIKVIKLE---PGEDFAVVQQEIIMMK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
              H  IV    S+  R KL++ ++F  GG L    +  G   E Q  + + E +  + +
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYMAPEILLSK 279
           LH  G +HRD+K  NIL+  +GH          +I  + ++  S  GT  +MAPE+   +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 280 ---GHNKDADWWSVGILLYEMLTGQPPF--THANR-------QKLQQRIINEKVKLPPFL 327
              G+N+  D W+VGI   E+   QPP    H  R          Q   + +K+K     
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK----W 237

Query: 328 TSEAHSLLKGLLHKDPSKR 346
           ++  H  +K  L K+P KR
Sbjct: 238 SNSFHHFVKMALTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 95.3 bits (237), Expect = 7e-21
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 28/234 (11%)

Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHL 202
           A+K++R D   +++     + E  +  ++ HP IV L  S +     L+ + +++ G  L
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------- 249
              L   G     +      +++ A++  H  GIVHRDLKP+NI++              
Sbjct: 67  REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126

Query: 250 ------SDGHEIDES--SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
                     + D +  +R+  + GT  Y APE L  +    ++D ++ G++  E LTGQ
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

Query: 302 PPFTHANRQK-LQQRIINEKVKLPPFLTSEAHSL---LKGLLHKDPSKRLGSGP 351
                A+  + L Q++    V LPP++    H L   L+  L+KDP +R  S P
Sbjct: 187 RVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKDPRQRAASAP 238

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 66/258 (25%), Positives = 126/258 (48%), Gaps = 32/258 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G+FG+V+    KG+D+  +  + A+K++  D    ++ ++ ++ E  +L++   P+I
Sbjct: 12  IGKGSFGEVY----KGIDN-RTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
            +   S+   +KL++I++++ GG     L + G   E        EI+  + +LH    +
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKI 123

Query: 238 HRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDAD 286
           HRD+K  N+L+   G              D   + N+  GT  +MAPE++    ++  AD
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 287 WWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-----LLKGLLHK 341
            WS+GI   E+  G+PP +  +  ++   I       PP L  + +S      ++  L+K
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQ-YSKPFKEFVEACLNK 239

Query: 342 DPSKRLGSGPGGVDAIKH 359
           DP  R    P   + +KH
Sbjct: 240 DPRFR----PTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 92.4 bits (229), Expect = 3e-20
 Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 47/259 (18%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +VG+      F V  +G D    + + A  VM  D    +    Y ++E   L    H  
Sbjct: 74  LVGRNPTTAAF-VATRGSDP--KEKVVAKFVMLND----ERQAAYARSELHCLAACDHFG 126

Query: 177 IVQLRYSFQTRSKLYLILDFINGG------------HLFFHLYRQGIFREDQARFYTAEI 224
           IV+    F++  KL LI+++ +GG            HL F  Y  G+       FY  +I
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL------FY--QI 178

Query: 225 VSAVSHLHKCGIVHRDLKPENILMD----------------SDGHEIDESSRSNSMCGTT 268
           V A+  +H   ++HRDLK  NI +                 SD   +D +S   S CGT 
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS---SFCGTP 235

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPFL 327
            Y+APE+   K ++K AD WS+G++LYE+LT   PF   + R+ +QQ +  +    P  +
Sbjct: 236 YYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPV 295

Query: 328 TSEAHSLLKGLLHKDPSKR 346
           +S   +LL  LL K+P+ R
Sbjct: 296 SSGMKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 88.7 bits (221), Expect = 4e-20
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 24/249 (9%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           + +G+GAFG+V+    KG   G         A+K +++D   +   ++    E  I+ K+
Sbjct: 5   KKLGEGAFGEVY----KGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHL 231
            HP +V+L         LY++++++ GG L  +L   +          +  +I   + +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 232 HKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLSK 279
                +HRDL   N L+  +                D+  R         +MAPE L   
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 280 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEA-HSLLKG 337
                +D WS G+LL+E+ T G+ P+   + +++ + + N      P       + L+  
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 338 LLHKDPSKR 346
              +DP  R
Sbjct: 239 CWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 88.9 bits (220), Expect = 7e-20
 Identities = 70/262 (26%), Positives = 130/262 (49%), Gaps = 35/262 (13%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           + PGD     + F  +G+G+ G V    +K      +    A+K M    + K+   + +
Sbjct: 15  VSPGDPREYLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVKKM---DLRKQQRRELL 66

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V +  S+    +L+++++F+ GG L   +       E+Q      
Sbjct: 67  FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCL 125

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYM 271
            ++ A+S+LH  G++HRD+K ++IL+ SDG               E  +  S+ GT  +M
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           APE++    +  + D WS+GI++ EM+ G+PP+ +    +  +RI   +  LPP +  ++
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRV-KDS 241

Query: 332 H---SLLKGLLH----KDPSKR 346
           H   S+L+G L     ++PS+R
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQR 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 88.9 bits (220), Expect = 8e-20
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 37/272 (13%)

Query: 98  ELEAESERKIGPGD----FEIFRVVGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKD 151
           +  A  +  + PGD     + F  +G+G+ G V    VK  G           +  ++K 
Sbjct: 4   QFRAALQMVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSG----------KLVAVKKM 53

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
            + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +     
Sbjct: 54  DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIVTHTR 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSR 260
             E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               E  R
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172

Query: 261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 320
             S+ GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I   +
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R 229

Query: 321 VKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
             LPP L +  +    LKG    LL +DP++R
Sbjct: 230 DNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.8 bits (220), Expect = 9e-20
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  +     
Sbjct: 24  FEKIGQGASGTVYTAID--VATGQEVAIKQMNLQQQPKKELII--NEILVMRENK----- 74

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
             HP IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 75  --HPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 131

Query: 232 HKCGIVHRDLKPENILMDSDGH----------EID-ESSRSNSMCGTTEYMAPEILLSKG 280
           H   ++HRD+K +NIL+  DG           +I  E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 32/260 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E+   +G+G +G V++V  +      +    AMK +R +  + ++  + +  E DIL 
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLE--LDESKFNQIIMELDILH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           K   P+IV    +F     +Y+ +++++ G    L+          ED  R  T  +V  
Sbjct: 55  KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 228 VSHL-HKCGIVHRDLKPENILMDSDGHEID----------ESSRSNSMCGTTEYMAPEIL 276
           +  L  +  I+HRD+KP N+L++ +G ++            +S + +  G   YMAPE +
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERI 173

Query: 277 LSKGHNK------DADWWSVGILLYEMLTGQ---PPFTHAN-RQKLQQRIINEKVKLPPF 326
            S G N+       +D WS+G+ + EM  G+   PP T+AN   +L   +  +   LP  
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233

Query: 327 LTSEAHSLLKGLLHKDPSKR 346
            + +A   +   L+K P++R
Sbjct: 234 YSDDAQDFVAKCLNKIPNRR 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 88.7 bits (221), Expect = 1e-19
 Identities = 77/331 (23%), Positives = 135/331 (40%), Gaps = 82/331 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E+ + +G GA+G V         D  +    A+K +     +  + +D  +  R+I  L
Sbjct: 2   YELLKPIGSGAYGVVCSAV-----DKRTGRKVAIKKISN---VFDDLIDAKRILREIKLL 53

Query: 170 TKVTHPFIVQLRYSFQTRSK-----LYLILDFINGGHLFFH--LYRQGIFREDQARFYTA 222
             + H  I+ L    +  S      +Y++ + +       H  +       +D  +++  
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLY 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRSNSMCGTTEY 270
           +I+  + +LH   ++HRDLKP NIL++S+            G + DE  +   +   TEY
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-L---TEY 166

Query: 271 M------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQ--------- 313
           +      APE+LLS   + K  D WSVG +  E+LT +P F       +L          
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226

Query: 314 -----QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPG 352
                + I +EK +     LP           P  + EA  LL+ +L  DP KR+ +   
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD-- 284

Query: 353 GVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
             +A+  H +   ++       E   K   D
Sbjct: 285 --EALA-HPYLAQLH---DPEDEPVAKPPFD 309

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 56/290 (19%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-- 164
           +   D E    +G G  G V +VK           I    VM K  +    H+    +  
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKH----------IPTGTVMAKKVV----HIGAKSSVR 47

Query: 165 -----ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
                E  I+ +   P+IV    +F   + + + ++F++ G L     + G    +    
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK 107

Query: 220 YTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTT 268
               +V  +++L+    I+HRD+KP NIL++S G           E+  +S +++  GT+
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTS 166

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-----------LQQRII 317
            YM+PE +    +   +D WS+GI + E+  G+ PF  +N              L Q+I+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 318 NEKVKLPPFLTSE-----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 362
            E    PP L S          +   L KDP++R    P          +
Sbjct: 227 QEP---PPRLPSSDFPEDLRDFVDACLLKDPTER----PTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 71/282 (25%)

Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVT-HP 175
           G+G F +V   K +    G     YA+K M+K        ++ +   R+I  L +++ HP
Sbjct: 8   GEGTFSEVL--KAQSRKTGKY---YAIKCMKK----HFKSLEQVNNLREIQALRRLSPHP 58

Query: 176 FIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGI----------FREDQARFYTAEI 224
            I++L         + ++ D   G   L F L    +            E + + Y  ++
Sbjct: 59  NILRL---------IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--SSRS-NSMCGTTEYM------APEI 275
           + ++ H+H+ GI HRD+KPENIL+  D  ++ +  S R   S    TEY+      APE 
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 276 LLSKG-HNKDADWWSVGILLYEMLTGQPPFTHAN--------------------RQKLQQ 314
           LL+ G +    D W+VG + +E+L+  P F   N                    ++  + 
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229

Query: 315 RIINEKV---------KLPPFLTSEAHSLLKGLLHKDPSKRL 347
           R +N            KL P  ++E   LLK LL  DP +R+
Sbjct: 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.9 bits (217), Expect = 2e-19
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      V  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 25  FEKIGQGASGTVYTAMD--VATGQEVAIRQMNLQQQPKKELII--NEILVMRENKN---- 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 77  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 232 HKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           H   ++HRD+K +NIL+  DG               E S+ ++M GT  +MAPE++  K 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.7 bits (214), Expect = 4e-19
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
           F  +GQGA G V+      +  G    I  M +    +K+ II  N +  M+  ++    
Sbjct: 24  FEKIGQGASGTVYTAID--IATGQEVAIKQMNLQQQPKKELII--NEILVMRENKN---- 75

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
              P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  L
Sbjct: 76  ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALDFL 131

Query: 232 HKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           H   ++HRD+K +NIL+  DG               E S+ ++M GT  +MAPE++  K 
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 89.2 bits (221), Expect = 5e-19
 Identities = 46/127 (36%), Positives = 70/127 (55%), Gaps = 12/127 (9%)

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP- 324
           GT +Y+APE+LL K H    DWW++G+ L+E LTG PPF     Q++ Q I+N  +  P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 325 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM----QP 378
               L+  A + ++ LL  DP+KR      G+  +K H  F  ++W+ L+ + M    QP
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKR-----AGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656

Query: 379 KFKPDVS 385
             + D S
Sbjct: 657 DDETDTS 663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 85.9 bits (212), Expect = 9e-19
 Identities = 65/262 (24%), Positives = 128/262 (48%), Gaps = 35/262 (13%)

Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  GD     E +  +G+G+ G V   ++K      S    A+K+M    + K+   + +
Sbjct: 14  VDQGDPRSLLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMM---DLRKQQRRELL 65

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q      
Sbjct: 66  FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQTRLNEEQIATVCE 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYM 271
            ++ A+ +LH  G++HRD+K ++IL+  DG           +I +   +  S+ GT  +M
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           APE++    +  + D WS+GI++ EM+ G+PP+   +  +  +R+ +     PP     A
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKLKNA 240

Query: 332 HSL-------LKGLLHKDPSKR 346
           H +       L+ +L ++P +R
Sbjct: 241 HKISPVLRDFLERMLTREPQER 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 67/301 (22%), Positives = 110/301 (36%), Gaps = 70/301 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+GA+G V++ +          KK       +GI  +  +R+  ++K+     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI-PLSTLREIALLKQ----- 54

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRS-----KLYLILDFINGG-HLFFHLYRQGIFRED 215
                  L    HP IV+L             KL L+ + ++     +     +     +
Sbjct: 55  -------LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE 107

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI---------DESSRSNSMC 265
             +    +++  V  LH   IVHRDLKP+NIL+ SDG  +I                S+ 
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF--------------------- 304
            T  Y APE+LL   +    D WSVG +  E+   +P F                     
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227

Query: 305 ------THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 358
                     R               P +  E   LLK +L  +P KR+ +     +A++
Sbjct: 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA----FEALQ 283

Query: 359 H 359
           H
Sbjct: 284 H 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDS-DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +  +GQGA G VF           +   I   K  +K+ II  N +  MK       ++ 
Sbjct: 24  YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII--NEILVMK-------ELK 74

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    SF    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLT-DVVTETCMDEAQIAAVCRECLQALEFLHA 133

Query: 234 CGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGHN 282
             ++HRD+K +N+L+  DG               E S+ ++M GT  +MAPE++  K + 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 283 KDADWWSVGILLYEMLTGQPPFTHAN 308
              D WS+GI+  EM+ G+PP+ + N
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 36/221 (16%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  VVG G +G+V+  K + V  G    + A+KVM     + ++  + +K E ++L
Sbjct: 16  GIFELVEVVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTEDEEEEIKLEINML 66

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  +S      +L+L+++F   G +       +    +ED   + 
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTE 269
             EI+  ++HLH   ++HRD+K +N+L+  +            ++D +  R N+  GT  
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 270 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 304
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 187 WMAPEVIACD-ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 90/293 (30%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMKAERDIL 169
           +G+G +G V++ + K   +     I A+K +R +        T I+         E  +L
Sbjct: 7   IGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIR---------EISLL 52

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSA 227
            ++ HP IV+L     + +KLYL+ +F++             G+      + Y  +++  
Sbjct: 53  KELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQG 111

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG---------------------HEIDESSRSNSMCG 266
           +++ H   ++HRDLKP+N+L+D +G                     HE+           
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---------- 161

Query: 267 TTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII------ 317
           T  Y APEILL S+ ++   D WS+G +  EM+  +P F      ++ Q  RI       
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF--PGDSEIDQLFRIFRTLGTP 219

Query: 318 NEKV-----KLPPF------------------LTSEAHSLLKGLLHKDPSKRL 347
           +E V      LP +                  L  +   LL  +L  DP+KR+
Sbjct: 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 35/268 (13%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +  R+    D+E+ + VG G +G V++ +   +  G+   +  +K+   D          
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARN--LHTGELAAVKIIKLEPGDDF------SL 52

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  ++ +  H  IV    S+ +R KL++ +++  GG L    +  G   E Q  +  
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEY 270
            E +  +++LH  G +HRD+K  NIL+  +G           +I  + ++  S  GT  +
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172

Query: 271 MAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPF--THANR-------QKLQQRIIN 318
           MAPE+   +   G+N+  D W+VGI   E+   QPP    H  R          Q   + 
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232

Query: 319 EKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +K K         H+ +K  L K+P KR
Sbjct: 233 DKTKWSSTF----HNFVKISLTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 41/269 (15%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
                 D E    +G G  G+V++++ K      +  + A+K MR+    ++N    M  
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGNKEENKRILM-- 62

Query: 165 ERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFY 220
           + D++ K +H  P+IV+    F T S +++ ++ +        L +  QG   ED     
Sbjct: 63  DLDVVLK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKM 119

Query: 221 TAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTT 268
           T  IV A+ +L  K G++HRD+KP NIL+D+ G+            +D  +++ S  G  
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCA 178

Query: 269 EYMAPEILLSKGHNKD----ADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKL 323
            YMAPE +     N      AD WS+GI L E+ TGQ P+ +   + ++  +I+ E+   
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--- 235

Query: 324 PPFLTSEAH------SLLKGLLHKDPSKR 346
           PP L           S +   L KD  KR
Sbjct: 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 68/304 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
           +E  + +G+G +  V++ +     D ++  I A+K ++     +        A R+I  L
Sbjct: 2   YEKGKKLGEGTYAVVYKAR-----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL 56

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS--- 226
            ++ HP I+ L   F  +S + L+ +F+    L      + + ++       A+I S   
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFM-ETDL------EKVIKDKSIVLTPADIKSYML 109

Query: 227 ----AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMCGTTEY 270
                + +LH   I+HRDLKP N+L+ SDG  +              + +      T  Y
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNRKMTHQVVTRWY 168

Query: 271 MAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------------------THAN-- 308
            APE+L  ++ +    D WSVG +  E+L   P                     T  N  
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228

Query: 309 -RQKLQQRIINEKVKLPPF------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
               L   +  +     P        + +A  LL+ LL  +P+KR         A++ H 
Sbjct: 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR----ITARQALE-HP 283

Query: 362 WFRS 365
           +F +
Sbjct: 284 YFSN 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 66/301 (21%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI 168
           +E   +VG+G++G V + K K     ++  I A+K       D ++KK       A R+I
Sbjct: 3   YENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDDKMVKK------IAMREI 51

Query: 169 --LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIV 225
             L ++ H  +V L   F+ + +LYL+ +F++   L     Y  G+  E + R Y  +I+
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQIL 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRS-NSMCGTTEYMAPE 274
             +   H   I+HRD+KPENIL+   G            +            T  Y APE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Query: 275 ILLSK-GHNKDADWWSVGILLYEMLTGQPPF--------------THANRQKLQQRIINE 319
           +L+    + +  D W+VG L+ EMLTG+P F                 N     Q I  +
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230

Query: 320 K-----VKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 362
                 ++LP            P L+     L K  L  DP  R  S       + HH++
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS-----QLLHHEF 285

Query: 363 F 363
           F
Sbjct: 286 F 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 79/330 (23%), Positives = 136/330 (41%), Gaps = 93/330 (28%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDI- 168
           +EI   +G+G +G+V++ K+K   +G     YA+K  + D    K         A R+I 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRK---NGKDGKEYAIKKFKGD----KEQYTGISQSACREIA 54

Query: 169 -LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHL---YRQGIFREDQARFY-- 220
            L ++ H  +V L   F   +   +YL+ D+    H  + +   +RQ             
Sbjct: 55  LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------------IDESSRS 261
              +I++ V +LH   ++HRDLKP NIL+  +G E                  +   +  
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ------- 313
           + +  T  Y APE+LL ++ + K  D W++G +  E+LT +P F      K++       
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF-KGREAKIKKSNPFQR 231

Query: 314 ---QRIIN------EK-----VKLPPFLT--------------------------SEAHS 333
              +RI        EK      K+P + T                          S+   
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           LL+ LL  DP+KR+ +     +A++ H +F
Sbjct: 292 LLRKLLEYDPTKRITAE----EALE-HPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 71/296 (23%), Positives = 122/296 (41%), Gaps = 56/296 (18%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ER 166
                   +G+GA G V + + K      +  I+A+K     TI    + D  K    E 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALK-----TITTDPNPDLQKQILREL 50

Query: 167 DILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
           +I      P+IV+   +F  ++ S + + +++  GG L   +Y++   ++   R    E 
Sbjct: 51  EINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGR--IGEK 105

Query: 224 --------IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMC 265
                   ++  +S+LH   I+HRD+KP NIL+   G           E+  S    +  
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-TFT 164

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----KLQQRIINEK 320
           GT+ YMAPE +  K ++  +D WS+G+ L E+   + PF           +L   I+N  
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224

Query: 321 V-------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 369
                         + E    +K  L KDP++R    P   D ++H      +  K
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR----PTPWDMLEHPWIKAQMKKK 276

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 73/298 (24%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + +   +     I A+K +  D       T I+         E  ++ 
Sbjct: 8   LGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIR---------EISLMK 53

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ H  IV+L     T +KL L+ ++++     ++  H  R G    +  + +T +++  
Sbjct: 54  ELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKG 112

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEI 275
           ++  H+  ++HRDLKP+N+L++  G              I  ++ SN +  T  Y AP++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 276 LL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------EKVKL 323
           LL S+ ++   D WSVG ++ EM+TG+P F   N +    +I                +L
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 324 P------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           P                  P        LL  LL  +P  R+       DA+  H WF
Sbjct: 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI----SAHDAL-QHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 68/288 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L +
Sbjct: 2   FQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 55

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++ 
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 231 LHKCGIVHRDLKPENILMDSDG---------------------HEIDESSRSNSMCGTTE 269
            H   ++HRDLKP+N+L++++G                     HE+           T  
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV----------VTLW 165

Query: 270 YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV- 321
           Y APEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V 
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225

Query: 322 ----------------------KLPPFLTSEAHSLLKGLLHKDPSKRL 347
                                 K+ P L  +   LL  +LH DP+KR+
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 85/333 (25%), Positives = 139/333 (41%), Gaps = 49/333 (14%)

Query: 48  NQSPASTSASLGDPQVIHNRSH-----SFVGPSPRYALSSSLPLQIQELEHENDAELEAE 102
            Q P              +R       +   P    +L+  LPL        + +   A 
Sbjct: 4   IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63

Query: 103 SERKIGPGDF---EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
                        E    +G GA G V++V  +      +  +YA+KV      I  NH 
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKV------IYGNHE 112

Query: 160 DYMK----AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           D ++     E +IL  V HP +V+    F    ++ ++L+F++GG L         F  D
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRS----------NSM 264
            AR    +I+S +++LH+  IVHRD+KP N+L++S  + +I +   S          NS 
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 265 CGTTEYMAPEIL---LSKG--HNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQR 315
            GT  YM+PE +   L+ G       D WS+G+ + E   G+ PF    RQ     L   
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG-VGRQGDWASLMCA 287

Query: 316 I-INEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           I +++  + P   + E    +   L ++P+KR 
Sbjct: 288 ICMSQPPEAPATASREFRHFISCCLQREPAKRW 320

Length = 353

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 68/302 (22%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDI 168
           ++    +G GA+G V       +D      +   K+       T+ K+        E  I
Sbjct: 7   YKPIENIGSGAYGVVC----SAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKI 57

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L    H  I+ +R   +         Y+++D +    L   ++      E+  R++  ++
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSM-----CGTTE 269
           +  + ++H   ++HRDLKP N+L++ D             +  S   +         T  
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 270 YMAPEILLS-KGHNKDADWWSVGILLYEML---------------------TGQPPFTHA 307
           Y APE+LLS   +    D WSVG +  EML                      G P     
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 308 NR----------QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 357
           NR          Q L ++      K+ P  + EA  LL  +L  DP +R+        A+
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV----EQAL 292

Query: 358 KH 359
           +H
Sbjct: 293 QH 294

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 74/293 (25%), Positives = 117/293 (39%), Gaps = 70/293 (23%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRK--DTIIKKNHVDYMKAE 165
           P  ++    VG GA+G+V              G   A+K + +   + I   H      E
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPFQSAI---HAKRTYRE 64

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
             +L  + H  ++ L   F   S L      YL+   +  G    ++ +     +D  +F
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF 122

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS--MCG--- 266
              +I+  + ++H  GI+HRDLKP NI ++ D        G      +R     M G   
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG-----LARHTDDEMTGYVA 177

Query: 267 TTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---------------THANRQ 310
           T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F                    +
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 311 KLQQRIINEKVK-----LPPF-----------LTSEAHSLLKGLLHKDPSKRL 347
           +L Q+I +E  +     LP                 A  LL+ +L  DP KR+
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 70/312 (22%), Positives = 121/312 (38%), Gaps = 83/312 (26%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
           +FE    +G+G +G V++ +     D  S  I A+K +R            M  ERD   
Sbjct: 8   EFEKLNRIGEGTYGIVYRAR-----DTTSGEIVALKKVR------------MDNERDGIP 50

Query: 168 --------ILTKVTHPFIVQLRYSFQTRS--KLYLILDFING--GHLFFHLYRQGIFRED 215
                   +L  + HP IV+L+     +    ++L++++       L  ++     F E 
Sbjct: 51  ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSES 108

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNS 263
           Q +    +++  + +LH+  I+HRDLK  N+L+   G              +     +  
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 264 MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---- 318
           +  T  Y APE+LL    +    D W+VG +L E+L  +P     +  +    II     
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227

Query: 319 ---------------EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPG 352
                           K  LP           P+L+     LL  LL  DP KR  +   
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE-- 285

Query: 353 GVDAIKHHKWFR 364
             +A++   +F+
Sbjct: 286 --EALE-SSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 36/221 (16%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+  K + V  G    + A+KVM     +  +  + +K E ++L
Sbjct: 6   GIFELVELVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTGDEEEEIKQEINML 56

Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTE 269
             EI+  +SHLH+  ++HRD+K +N+L+  +            ++D +  R N+  GT  
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 270 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 304
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 177 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 75/311 (24%), Positives = 127/311 (40%), Gaps = 85/311 (27%)

Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +E    +G+G +GKV++ +          KK   + D +GI         T ++      
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI-------PPTALR------ 49

Query: 162 MKAERDILTKVTH-PFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFR- 213
              E  +L  ++   +IV+L        K     LYL+ ++++     F     +G  R 
Sbjct: 50  ---EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP 106

Query: 214 --EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----SRSNSM--- 264
                 + +  +++  V+H HK G++HRDLKP+N+L+D     +  +     R+ S+   
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 265 -----CGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQ---- 314
                  T  Y APE+LL   H     D WSVG +  EM   QP F      +LQQ    
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF--PGDSELQQLLHI 224

Query: 315 -RII---NEKV----------------------KLPPFLTSEAHSLLKGLLHKDPSKRLG 348
            +++    E+V                      +  P L+ E   LL+ +L  DP+KR+ 
Sbjct: 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284

Query: 349 SGPGGVDAIKH 359
           +      A+ H
Sbjct: 285 A----KAALTH 291

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 17/151 (11%)

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--------SDGHEIDESSRSNSM 264
            E    FYT +I+  + +LH   IVHRD+K +N+L++        SD       +  N  
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165

Query: 265 C----GTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRII 317
                GT +YMAPE++    +G+   AD WS+G  + EM TG+PPF      Q    ++ 
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225

Query: 318 NEKV--KLPPFLTSEAHSLLKGLLHKDPSKR 346
             K+  ++P  L++EA + +      DP KR
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 79/301 (26%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDY- 161
           +GP  ++    +G+GA+G V                  +KV      IKK     H  + 
Sbjct: 3   VGP-RYQNLSYIGEGAYGMVCSAT---------HKPTGVKVA-----IKKISPFEHQTFC 47

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +  R+I  L +  H  I+ +       SF++ + +Y++ + +      + L +      
Sbjct: 48  QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSN 105

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSM 264
           D  +++  +I+  + ++H   ++HRDLKP N+L++++              D        
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 265 CGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQ-- 313
              TEY+      APEI+L SKG+ K  D WSVG +L EML+ +P F       Q     
Sbjct: 166 --LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223

Query: 314 -----------QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKR 346
                        II+ + +     LP           P    +A  LL  +L  +P KR
Sbjct: 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283

Query: 347 L 347
           +
Sbjct: 284 I 284

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 81/299 (27%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           F+I   +G+G +G+V++ +     D D+  + A+K +R D        T I+        
Sbjct: 9   FDIIGQIGEGTYGQVYKAR-----DKDTGELVALKKVRLDNEKEGFPITAIR-------- 55

Query: 164 AERDILTKVTHPFIVQLR---------YSFQTRSK-LYLILDFINGGHLFFHLYRQGI-- 211
            E  IL ++ H  IV L+           F+      YL+ ++++  H    L   G+  
Sbjct: 56  -EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVH 112

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESS 259
           F ED  + +  +++  +++ HK   +HRD+K  NIL+++ G               +ES 
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
              +   T  Y  PE+LL +     A D WS G +L E+ T +P F  AN++  Q  +I+
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF-QANQELAQLELIS 231

Query: 319 ------------EKVKLPPFLT-------------------SEAHSLLKGLLHKDPSKR 346
                       + +KLP F T                   + A  LL  +L  DPSKR
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 42/266 (15%)

Query: 116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             +G GAFG+V++     +   G      A+K +RK    ++   +++K E  +++   H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 175 PFIV-QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA----------- 222
           P IV  L          Y+I++ + GG L  +L    +      RF              
Sbjct: 59  PNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARV-----ERFGPPLLTLKELLDIC 112

Query: 223 -EIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNSMCG- 266
            ++     +L +   +HRDL   N L+   G++ D                S      G 
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 267 ---TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV 321
                 +MAPE LL       +D WS G+L++E+LT GQ P+   N Q++ Q +    ++
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232

Query: 322 KLPPFLTSEAHSLLKGLLHKDPSKRL 347
           + P     + + L+     +DPS+R 
Sbjct: 233 QKPENCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 43/281 (15%)

Query: 109 PGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
           P D +EI   +G+G +GKVF+V  K   +G      A+K++     I +     ++AE +
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNK--KNGSKA---AVKILDPIHDIDEE----IEAEYN 66

Query: 168 ILTKVT-HPFIVQL-----RYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQA 217
           IL  ++ HP +V+      +   +   +L+L+L+  NGG +       L R     E   
Sbjct: 67  ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCG 266
            +   E +  + HLH    +HRD+K  NIL+ ++G                  R N+  G
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Query: 267 TTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-- 319
           T  +MAPE++     L   ++   D WS+GI   E+  G PP    +  +   +I     
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246

Query: 320 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             +  P   ++E +  ++  L KD  KR    P   D ++H
Sbjct: 247 PTLHQPELWSNEFNDFIRKCLTKDYEKR----PTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 62/258 (24%), Positives = 110/258 (42%), Gaps = 35/258 (13%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-----AMKVMRKDTIIKKNHVDY 161
           I   + ++   +G+G FG V              G Y     A+K ++ D+         
Sbjct: 3   INSKELKLGATIGKGEFGDVML------------GDYRGQKVAVKCLKDDS----TAAQA 46

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY---RQGIFREDQAR 218
             AE  ++T + HP +VQL       + LY++ +++  G L  +L    R  I    Q  
Sbjct: 47  FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEY 270
           F   ++   + +L +   VHRDL   N+L+  D        G   + S   +S     ++
Sbjct: 107 F-ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKW 165

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
            APE L  K  +  +D WS GILL+E+ + G+ P+     + +   +    +++ P    
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCP 225

Query: 329 SEAHSLLKGLLHKDPSKR 346
            E + ++K     DP+KR
Sbjct: 226 PEVYKVMKDCWELDPAKR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 21/216 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 118

Query: 231 L-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMAPEILLS 278
           L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+PE L  
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG 176

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
             ++  +D WS+G+ L EM  G+ P    + ++L+ 
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 71/311 (22%), Positives = 118/311 (37%), Gaps = 83/311 (26%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +E+ + +GQGA+G V   +     + ++  I      +K T +             IL K
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAI------KKITNVFSK---------KILAK 46

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYR---QGIFREDQA---- 217
                +  LR+ F+    +  + D         N  +L+  L       I R  Q     
Sbjct: 47  RALRELKLLRH-FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105

Query: 218 --RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRSNS 263
             + +  +I+  + ++H   ++HRDLKP N+L+++D            G   +    +  
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 264 MCG---TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--------------- 304
           M     T  Y APEI+LS + + K  D WSVG +L E+L  +P F               
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 305 ---------THANRQKLQQRIIN----EKVKLP---PFLTSEAHSLLKGLLHKDPSKRLG 348
                    +     K Q  I +     K       P     A  LL+ LL  DP+KR+ 
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285

Query: 349 SGPGGVDAIKH 359
                 +A++H
Sbjct: 286 VE----EALEH 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 61/264 (23%), Positives = 116/264 (43%), Gaps = 43/264 (16%)

Query: 107 IGPGDFEIFRVVGQGAFGKV--------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           I P +    + +G G FG V         +V  K +++G          M ++  I+   
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---------AMSEEDFIE--- 48

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
                 E  ++ K++HP +VQL Y   T+ K LY++ +F+  G L  +L  RQG   +D 
Sbjct: 49  ------EAKVMMKLSHPKLVQL-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMC 265
                 ++   + +L +   +HRDL   N L+ S G           + +D+   S+S  
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161

Query: 266 G-TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVK 322
               ++  PE+     ++  +D WS G+L++E+ T G+ PF   +N + ++      ++ 
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221

Query: 323 LPPFLTSEAHSLLKGLLHKDPSKR 346
            P   +   + ++    H+ P  R
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 39/265 (14%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G+GAFGKVF  +   ++  +   + A+K + K+T       D+ + E ++LT   H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EAELLTNFQHE 68

Query: 176 FIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQG-----IFREDQARF---------Y 220
            IV+  Y   T      ++ +++  G L   L   G     +   D              
Sbjct: 69  NIVKF-YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
             +I S + +L     VHRDL   N L             M  D +  D           
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQK---LQQRIINEKVK 322
             +M PE ++ +    ++D WS G++L+E+ T   QP +  +N +    + Q  + ++  
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-- 245

Query: 323 LPPFLTSEAHSLLKGLLHKDPSKRL 347
            P    SE + ++ G   +DP +R+
Sbjct: 246 -PRTCPSEVYDIMLGCWKRDPQQRI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases

 Score = 67.0 bits (164), Expect = 3e-14
 Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 4/64 (6%)

Query: 364 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG----EHFKGY 419
           R I+W  LE +E++P F P +      +NFD  +T      +P  +P +G    E F+G+
Sbjct: 1   RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGF 60

Query: 420 TYVA 423
           +YV 
Sbjct: 61  SYVF 64

Length = 64

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 74/313 (23%), Positives = 126/313 (40%), Gaps = 76/313 (24%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-----------ER 166
           +G+G +GKV +       D  +  I A+K ++   I      D               E 
Sbjct: 17  LGEGTYGKVEKAY-----DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            I+ ++ H  I+ L   +     + L++D +    L   + R+    E Q +    +I++
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDG----------------HEIDESSRSNSMCGTTE- 269
            ++ LHK   +HRDL P NI ++S G                   D  S+  +M    E 
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 270 --------YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-- 318
                   Y APE+L+ ++ ++   D WSVG +  E+LTG+P F   N      RI    
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250

Query: 319 ---------EKVKLP-----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPG 352
                    +  KLP                 P  + +A  LL+ LL  +P +R+ +   
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK-- 308

Query: 353 GVDAIKHHKWFRS 365
             +A+K H++F+S
Sbjct: 309 --EALK-HEYFKS 318

Length = 335

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +EI   +G+G +GKV++V  K   DG    + A+K++  D I   +  + ++AE +IL
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNK--KDGS---LAAVKIL--DPI--SDVDEEIEAEYNIL 72

Query: 170 TKVT-HPFIVQLRYSFQTRSK-----LYLILDFINGG---HLFFHLYRQGIFREDQAR-- 218
             +  HP +V+    F    K     L+L+L+  NGG    L   L   G  R D+A   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMIS 131

Query: 219 --FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMC 265
              Y A +   + HLH   I+HRD+K  NIL+ ++G                  R N+  
Sbjct: 132 YILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 266 GTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPF 304
           GT  +MAPE++  +      ++   D WS+GI   E+  G PP 
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 76/322 (23%), Positives = 140/322 (43%), Gaps = 72/322 (22%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDI 168
             ++I R++G+G  G+V+       D   S  + A+K +R+D          +++ E  I
Sbjct: 2   QRYDIIRLIGKGGMGEVYL----AYDPVCSRRV-ALKKIREDLSENPLLKKRFLR-EAKI 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKL-YLILDFING---GHLFFHLYRQGIFREDQAR------ 218
              + HP IV + YS  +     Y  + +I G     L   ++++    ++ A       
Sbjct: 56  AADLIHPGIVPV-YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114

Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------EID 256
               F+   I + + ++H  G++HRDLKP+NIL+   G                    +D
Sbjct: 115 FLSIFHK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 257 ESSRSNSMC-----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                 ++C           GT +YMAPE LL    ++  D +++G++LY+MLT   P+ 
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Query: 306 HANRQKL--QQRIIN-EKV----KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 358
               +K+  +  I++  +V    ++PPFL+  A   +K  L  DP++R  S       ++
Sbjct: 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIA---MKA-LAVDPAERYSSVQELKQDLE 288

Query: 359 HH-----KWFRSINWKTLEARE 375
            H     +W       TL  ++
Sbjct: 289 PHLQGSPEWTVKA---TLMTKK 307

Length = 932

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 73/307 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E    + +G +G V++ + K      +  I A+K ++ +   +   +  ++ E +IL 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
           K+ HP IV ++         K+Y++++++       H  +  +    Q  F  +E+    
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE------HDLKSLMETMKQ-PFLQSEVKCLM 112

Query: 225 ---VSAVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMCGTTE 269
              +S V+HLH   I+HRDLK  N+L+++ G  +                    +  T  
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLW 171

Query: 270 YMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV- 321
           Y APE+LL       A D WSVG +  E+LT +P F   +      +I        EK+ 
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 322 ----KLP---------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDA 356
               +LP                       L+     LL  LL  DP+KR+ +     DA
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE----DA 287

Query: 357 IKHHKWF 363
           +K H +F
Sbjct: 288 LK-HPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V  +      S  I A K++  +  IK    + +  E  +L 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLE--IKPAIRNQIIRELKVLH 54

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E+     +  ++  +++
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 231 LH-KCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLS 278
           L  K  I+HRD+KP NIL++S G             ID  S +NS  GT  YM+PE L  
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG 172

Query: 279 KGHNKDADWWSVGILLYEMLTGQPP 303
             +   +D WS+G+ L EM  G+ P
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 56/241 (23%)

Query: 115 FRVVGQGAFGKVFQ-----------VKKKGVDDGDS--DGIYAMKVMRK---DTIIKKNH 158
            R +G G+ G VF            VKK  + D  S    +  +K++R+   D I+K   
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 159 VDYMKAERD-----ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
           V              LT++   +IVQ           Y+  D  N       +  QG   
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQE----------YMETDLAN-------VLEQGPLS 112

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----------------DGHEIDE 257
           E+ AR +  +++  + ++H   ++HRDLKP N+ +++                D H   +
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172

Query: 258 SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
              S  +  T  Y +P +LLS  +  K  D W+ G +  EMLTG+P F  A+  +  Q I
Sbjct: 173 GYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231

Query: 317 I 317
           +
Sbjct: 232 L 232

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 78/321 (24%), Positives = 125/321 (38%), Gaps = 111/321 (34%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYM 162
           D+     +G+G +G V++ + K      +  I AMK +R +        T I+       
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESEEEGVPSTAIR------- 48

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN------------GGHLFFHLYRQG 210
             E  +L ++ HP IV L+      S+LYLI +F++            G ++   L +  
Sbjct: 49  --EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS- 105

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG------------------ 252
                    Y  +I+  +   H   ++HRDLKP+N+L+D+ G                  
Sbjct: 106 ---------YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156

Query: 253 ---HEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
              HE+           T  Y APE+LL S  ++   D WS+G +  EM T +P F H +
Sbjct: 157 VYTHEVV----------TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF-HGD 205

Query: 309 RQKLQQ-RII------NEKV-----KLPPF------------------LTSEAHSLLKGL 338
            +  Q  RI        E V      LP +                  L  +   LL+ +
Sbjct: 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKM 265

Query: 339 LHKDPSKRLGSGPGGVDAIKH 359
           L  DP+KR+        A+ H
Sbjct: 266 LIYDPAKRI----SAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 29/263 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
              + R +GQG+FG V++   KGV  G+ +   A+K + ++  +++      +A   ++ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA--SVMK 64

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY---------- 220
           +     +V+L     T     ++++ +  G L  +L R      +               
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQ 123

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCG 266
             AEI   +++L     VHRDL   N ++  D              +E D   +      
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLP 324
              +MAPE L        +D WS G++L+EM T   QP    +N + L+  I    + LP
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243

Query: 325 PFLTSEAHSLLKGLLHKDPSKRL 347
                +   L++     +P  R 
Sbjct: 244 ENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 57/263 (21%), Positives = 120/263 (45%), Gaps = 41/263 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSEDEFIE----EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
            ++ K++H  +VQL      +  +Y++ ++++ G L  +L      RE   RF  ++++ 
Sbjct: 51  KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLE 104

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGT- 267
                   +++L     +HRDL   N L+D  G           + +D+   S+   G+ 
Sbjct: 105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS--VGSK 162

Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
               +  PE+LL    +  +D W+ G+L++E+ + G+ P+   N  +  +++        
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR 222

Query: 325 PFLTSE-AHSLLKGLLHKDPSKR 346
           P L SE  ++++    H+   +R
Sbjct: 223 PHLASEKVYAIMYSCWHEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 81/289 (28%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI--LTKV 172
           +G+G++G VF+ + +     ++  I A+K       D +IKK       A R+I  L ++
Sbjct: 9   IGEGSYGVVFKCRNR-----ETGQIVAIKKFVESEDDPVIKK------IALREIRMLKQL 57

Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVS 229
            HP +V L   F+ + KL+L+ ++ +  H   +      +G+  E   +    + + AV+
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCD--HTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 230 HLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC-------------------GTTEY 270
             HK   +HRD+KPENIL+   G +I        +C                    T  Y
Sbjct: 115 FCHKHNCIHRDVKPENILITKQG-QI-------KLCDFGFARILTGPGDDYTDYVATRWY 166

Query: 271 MAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFT--------HANRQKLQQRIINEK- 320
            APE+L+    +    D W++G +  E+LTGQP +         +  R+ L   I   + 
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226

Query: 321 ----------VKLP------------PFLTSEAHSLLKGLLHKDPSKRL 347
                     + +P            P ++S A S LKG L  DP++RL
Sbjct: 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.5 bits (177), Expect = 2e-13
 Identities = 68/282 (24%), Positives = 133/282 (47%), Gaps = 55/282 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++E+ + +G G FG+VF VK K   +      +  K +     +K+     +  E +++ 
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRG-LKEREKSQLVIEVNVMR 67

Query: 171 KVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHL---YRQ-GIFREDQARFYTAEI 224
           ++ H  IV+   R+  +   KLY++++F + G L  ++   Y+  G   E      T ++
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 225 VSAVSHLHKCG-------IVHRDLKPENILMDS---------------DGHEIDE----- 257
           + A+++ H          ++HRDLKP+NI + +               +G  I +     
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 258 -------SSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
                   S ++S  GT  Y +PE+LL  +K ++  +D W++G ++YE+ +G+ PF  AN
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Query: 309 RQKLQQRIINEKVKLPPF----LTSEAHSLLKGLLHKDPSKR 346
                 ++I+E  + P       + E + L+K LL+    +R
Sbjct: 248 N---FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286

Length = 1021

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 64/264 (24%), Positives = 115/264 (43%), Gaps = 29/264 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDI 168
           F   R +G G+FG V+  +     D  ++ + A+K M    K +  K    D +K E   
Sbjct: 17  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQ--DIIK-EVRF 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L ++ HP  ++ +  +      +L++++ +        ++++ + +E +        +  
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL-QEVEIAAICHGALQG 127

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG--HEIDESSRS-----NSMCGTTEYMAPEILLS-- 278
           +++LH    +HRD+K  NIL+   G     D  S S     NS  GT  +MAPE++L+  
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 279 KGHNKD-ADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEKVKLPPFLTSEA-HSLL 335
           +G      D WS+GI   E+   +PP  + N       I  N+   L     S+   + +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247

Query: 336 KGLLHKDPSKRLGSGPGGVDAIKH 359
              L K P  R    P   + +KH
Sbjct: 248 DSCLQKIPQDR----PSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 58/236 (24%), Positives = 107/236 (45%), Gaps = 34/236 (14%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--DYMKAERDILTKVTH 174
            +G+G FG+VF  K KG+++   + +  +K ++K    K  ++  ++ + E D+  K++H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRR-ELDMFRKLSH 67

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV---- 228
             +V+L    +     Y+IL++ + G L  F    +    +       T + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 229 ---SHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTT---EY------------ 270
               HL     VHRDL   N L+ S   E+  S    S+       EY            
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ-REVKVSLL--SLSKDVYNSEYYKLRNALIPLRW 184

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 325
           +APE +     +  +D WS G+L++E+ T G+ PF   + +++  R+   K++LP 
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 30/227 (13%)

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+KV+  D  ++      + +E +IL K   P+I+    +F   +++ +  +F++GG 
Sbjct: 28  ILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EIDE 257
           L   +YR+ I      R   A +V  +++L    I+HRD+KP N+L+++ G     +   
Sbjct: 86  L--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141

Query: 258 SSR-----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-----THA 307
           S++     + +  GT  YMAPE +  + +   +D WS+GI   E+  G+ P+        
Sbjct: 142 STQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201

Query: 308 NRQKLQ--QRIINEKVKLPPFLTSEAHS-----LLKGLLHKDPSKRL 347
           +   LQ  Q I++E    PP L     S      +   + K P +R 
Sbjct: 202 SLMPLQLLQCIVDED---PPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 27/245 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T+  +  +     E  ++ K+ H  +
Sbjct: 14  LGQGCFGEVW----MGTWNGTTR--VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG 235
           VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I S ++++ +  
Sbjct: 64  VQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 236 IVHRDLKPENILM---------DSDGHEIDESSRSNSMCGTT---EYMAPEILLSKGHNK 283
            VHRDL+  NIL+         D     + E +   +  G     ++ APE  L      
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 284 DADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
            +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP      H L+     K
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 242

Query: 342 DPSKR 346
           +P +R
Sbjct: 243 EPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 58/289 (20%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFR-------- 116
           H  +    G        +   L  +E  H N+A  + + E+ I   D +I R        
Sbjct: 18  HKANKGGSGKFEM----NDKKLDEEERSHNNNAGEDEDEEKMI---DNDINRSPNKSYKL 70

Query: 117 --VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
             ++G G+FG V++     +    S+ +   KV++           Y   E  I+  + H
Sbjct: 71  GNIIGNGSFGVVYE----AICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNH 118

Query: 175 PFIVQLRYSFQTRSK--------LYLILDFINGGHLFFHLYRQGIFREDQA------RFY 220
             I+ L+  + T           L ++++FI       H Y +   R + A      + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT---VHKYMKHYARNNHALPLFLVKLY 175

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---DESSRSNSMCGTTE-------- 269
           + ++  A++++H   I HRDLKP+N+L+D + H +   D  S  N + G           
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 270 YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           Y APE++L +  +    D WS+G ++ EM+ G P F+  +      RII
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 50/231 (21%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPVQLPRGMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------------IDESSRSNS 263
            +I+  + +LH   ++HRDLKP NIL+  +G E                  +   +  + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 264 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H  ++ ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 58/249 (23%), Positives = 112/249 (44%), Gaps = 25/249 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + ++ + +G+G FG V     +G          A+K ++ D   +        AE  ++T
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA-----FLAEASVMT 54

Query: 171 KVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSA 227
           ++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ ++  A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 228 VSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + +L     VHRDL   N+L+  D        G   + SS  ++     ++ APE L  K
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK 174

Query: 280 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKG 337
             +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P       + ++K 
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234

Query: 338 LLHKDPSKR 346
             H D + R
Sbjct: 235 CWHLDAATR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 59/261 (22%), Positives = 122/261 (46%), Gaps = 37/261 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V   K +G  D       A+K++R+  +   +  D+++ E 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKID------VAIKMIREGAM---SEDDFIE-EA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEI 224
            ++ K++HP +VQL Y   T+ + ++++ +++  G L  +L  + G    +      +++
Sbjct: 51  KVMMKLSHPNLVQL-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGT---TEY 270
             A+ +L   G +HRDL   N L+  D            + +D+   S+   GT    ++
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKW 167

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQ---KLQQRIINEKVKLPP 325
             PE+      +  +D WS G+L++E+ + G+ P+   +N +    +       + KL P
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP 227

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
              +E ++++    H+ P  R
Sbjct: 228 ---TEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 52/190 (27%), Positives = 74/190 (38%), Gaps = 49/190 (25%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRSN 262
           D  + +  +I+  + +LH  GI+HRD+KP N+L++S+              E DES    
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 263 SMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTG------QPPFTHAN------- 308
               T  Y APEIL+   H   A D WSVG +  E+L        Q P    +       
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222

Query: 309 ----------RQKLQQRIINEKVKLPPF---------LTSEAHSLLKGLLHKDPSKRLGS 349
                      +  +  I+    K P            T EA  LL  +L  DP KR+  
Sbjct: 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI-- 280

Query: 350 GPGGVDAIKH 359
                DA+ H
Sbjct: 281 --SAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 89/313 (28%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+VF+ + K         I A+K +  +   +   +  ++ E  IL  + H  +
Sbjct: 20  IGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALR-EIKILQLLKHENV 73

Query: 178 VQL------------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI- 224
           V L            RY    +   YL+ +F    H        G+      +F  +EI 
Sbjct: 74  VNLIEICRTKATPYNRY----KGSFYLVFEFCE--HDL-----AGLLSNKNVKFTLSEIK 122

Query: 225 ------VSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCG 266
                 ++ + ++H+  I+HRD+K  NIL+  DG              + ++S+ N    
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 267 ---TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN---- 318
              T  Y  PE+LL  + +    D W  G ++ EM T  P       Q     I      
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242

Query: 319 ---------------EKVKLP------------PFLTS-EAHSLLKGLLHKDPSKRLGSG 350
                          +K++LP            P++    A  L+  LL  DP+KR+ + 
Sbjct: 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA- 301

Query: 351 PGGVDAIKHHKWF 363
               D   +H +F
Sbjct: 302 ----DTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 42/255 (16%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +G G FG+V+     G  +G +    A+K ++  T+  +    +++ E  I+ K+ H 
Sbjct: 12  RKLGAGQFGEVW----MGTWNGTTK--VAVKTLKPGTMSPE---AFLQ-EAQIMKKLRHD 61

Query: 176 FIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--------YTAEIVS 226
            +VQL Y+  +  + +Y++ ++++ G L   L      +  + +           A+I  
Sbjct: 62  KLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAE 114

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTEYMAP 273
            +++L     +HRDL   NIL+  +               E DE +         ++ AP
Sbjct: 115 GMAYLESRNYIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173

Query: 274 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEA 331
           E          +D WS GILL E++T G+ P+    NR+ L+Q     ++  PP    E 
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL 233

Query: 332 HSLLKGLLHKDPSKR 346
           + L+     KDP +R
Sbjct: 234 YDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 40/234 (17%)

Query: 109 PGDFEIFRVVGQGAFGKV---------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 16  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---- 71

Query: 160 DYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            +MK E  I L  V  P       S +  + +YL+   +  G    ++ +     +D  +
Sbjct: 72  -HMKHENVIGLLDVFTP-----ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 123

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNSMCGT 267
           F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +       T
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVAT 180

Query: 268 TEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQ---PPFTHANRQKLQQRII 317
             Y APEI+L+  H N+  D WSVG ++ E+LTG+   P   H ++ KL  R++
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 60/265 (22%), Positives = 111/265 (41%), Gaps = 38/265 (14%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FGKV   +   + D   + + A+K +      ++ H    + E +IL  + H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQV-AVKSLNHSG--EEQHRSDFEREIEILRTLDHE 66

Query: 176 FIVQLRY--SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
            IV+ +          L LI++++  G L  +L R    + +  R   ++++I   + +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEYM-------------APEILL 277
                +HRDL   NIL++S+   +I +   +  +    +Y              APE L 
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTH-----------ANRQKLQQRIIN-----EKV 321
           +   +  +D WS G+ LYE+ T   P              A  Q +  R++      E++
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 322 KLPPFLTSEAHSLLKGLLHKDPSKR 346
             PP    E + L+K     +P  R
Sbjct: 246 PRPPSCPDEVYDLMKLCWEAEPQDR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 50/231 (21%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  +  YA+K +    I        M A R+I  L ++ HP
Sbjct: 9   VGRGTYGHVYKAKRK---DGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHP 58

Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
            ++ L+  F + S  K++L+ D+    H  +H+ +    R  +A            +   
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPMQLPRSMVKSLL 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------------IDESSRSNS 263
            +I+  + +LH   ++HRDLKP NIL+  +G E                  +   +  + 
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 264 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H  ++ ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 64/259 (24%), Positives = 122/259 (47%), Gaps = 31/259 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D E+   +G+GA+G V +++        +  I A+K +R     ++     M  + DI  
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNSQEQKRLLM--DLDISM 54

Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIF-REDQARFYTAEIVS 226
           +    P+ V    +      +++ ++ ++      +  +Y +G+   ED        IV 
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114

Query: 227 AVSHLH-KCGIVHRDLKPENILMDSDGH-EIDESSRS----NSMCGTTE-----YMAPE- 274
           A+ +LH K  ++HRD+KP N+L++ +G  ++ +   S    +S+  T +     YMAPE 
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174

Query: 275 ---ILLSKGHNKDADWWSVGILLYEMLTGQPPFT--HANRQKLQQRIINEKVKLP--PFL 327
               L  KG++  +D WS+GI + E+ TG+ P+       Q+L+Q +     +LP   F 
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF- 233

Query: 328 TSEAHSLLKGLLHKDPSKR 346
           + E    +   L K+  +R
Sbjct: 234 SPEFQDFVNKCLKKNYKER 252

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 58/235 (24%), Positives = 89/235 (37%), Gaps = 49/235 (20%)

Query: 92  EHENDAE----LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           E E+DA+    L AE+   I    F I      GA G  F                    
Sbjct: 70  EDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNKT------------- 116

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
             +  +IK         E  IL  + HP I+QL+ +F       LIL            Y
Sbjct: 117 -CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RY 165

Query: 208 RQGIF--REDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDG------ 252
           +  ++     +      +I++       A+ +LH+  I+HRD+K ENI ++  G      
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGD 225

Query: 253 -----HEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
                  +D  +++     GT    APE+L    +    D WS GI+L+EM T  
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 40/125 (32%), Positives = 64/125 (51%), Gaps = 17/125 (13%)

Query: 214 EDQ-ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSM 264
           E Q  +++  +I+  + ++H  G+VHRDLKP NIL++ +        G    +  +    
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165

Query: 265 CGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEK 320
             T  Y APEI+L+ + ++ + D WS G +  EML G+P F    H N    Q  II + 
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN----QFSIITDL 221

Query: 321 VKLPP 325
           +  PP
Sbjct: 222 LGTPP 226

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 42/201 (20%)

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
            YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ ++
Sbjct: 95  FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152

Query: 250 SD--------GHEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTG 300
            D        G      S       T  Y APE++L+  H  +  D WSVG ++ EMLTG
Sbjct: 153 EDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Query: 301 QPPFT---HANR----------------QKLQQRIINEKVK-LP-----------PFLTS 329
           +P F    H ++                QKLQ       VK LP           P    
Sbjct: 213 KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP 272

Query: 330 EAHSLLKGLLHKDPSKRLGSG 350
            A ++L+ +L  D   R+ + 
Sbjct: 273 LAVNVLEKMLVLDAESRITAA 293

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 62/253 (24%), Positives = 118/253 (46%), Gaps = 31/253 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            ++ + +G G FG+V+     G  +G++    A+K ++  T+  ++ ++    E  I+ K
Sbjct: 8   LQLIKKLGNGQFGEVWM----GTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKK 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAV 228
           + H  +VQL Y+  +   +Y++ ++++ G L   L + G  R           A++ + +
Sbjct: 58  LRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGM 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTEYMAPEI 275
           +++ +   +HRDL+  NIL+  DG              E +E +         ++ APE 
Sbjct: 116 AYIERMNYIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA-NRQKLQQRIINEKVKLPPFLTSEAHS 333
            L       +D WS GILL E++T G+ P+    NR+ L+Q     ++  P       H 
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234

Query: 334 LLKGLLHKDPSKR 346
           L+     KDP +R
Sbjct: 235 LMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 58/258 (22%), Positives = 106/258 (41%), Gaps = 38/258 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F + R +G G FG+V++   K           A+K+++ D        D+ K E   L 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSDD--LLKQQDFQK-EVQALK 57

Query: 171 KVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
           ++ H  ++ L ++  +  + +Y+I + +  G L   L      R  + +           
Sbjct: 58  RLRHKHLISL-FAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMA 110

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGT-TEY 270
            ++   +++L +   +HRDL   NIL+  D             I E    +S      ++
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLT 328
            APE       +  +D WS GILLYEM T GQ P+   N  ++  +I    ++  P    
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP 230

Query: 329 SEAHSLLKGLLHKDPSKR 346
            E + ++      +P  R
Sbjct: 231 QEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 21/215 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G V +V+ K      S  I A K++  +  IK    + +  E  +L 
Sbjct: 6   DFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  ++  +++
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118

Query: 231 L-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMAPEILLS 278
           L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+PE L  
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG 176

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
             ++  +D WS+G+ L E+  G+ P    + ++L+
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 24/197 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +  G+ G+VF   K G  D        +K+ +K T +          E  +L  
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDP-----VVLKIGQKGTTL---------IEAMLLQN 113

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V HP +++++ +  + +   ++L   +     +   R      DQA     +I+  + +L
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 232 HKCGIVHRDLKPENILMDS-DGHEIDE--SSRSN-------SMCGTTEYMAPEILLSKGH 281
           H   I+HRD+K ENI ++  D   I +  +++          + GT E  APE+L    +
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233

Query: 282 NKDADWWSVGILLYEML 298
           N  AD WS GI+L+EML
Sbjct: 234 NSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 62/254 (24%), Positives = 118/254 (46%), Gaps = 34/254 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   + DG++  I  A+KV+R++T  K N    +  E  ++  V  
Sbjct: 13  KVLGSGAFGTVY--KGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGS 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------YTAEIVSA 227
           P++ +L       S + L+   +  G L  ++      RE++ R        +  +I   
Sbjct: 69  PYVCRL-LGICLTSTVQLVTQLMPYGCLLDYV------RENKDRIGSQDLLNWCVQIAKG 121

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH------------EIDESS-RSNSMCGTTEYMAPE 274
           +S+L +  +VHRDL   N+L+ S  H            +IDE+   ++      ++MA E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 275 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAH 332
            +L +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241

Query: 333 SLLKGLLHKDPSKR 346
            ++      D   R
Sbjct: 242 MIMVKCWMIDSECR 255

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 58/287 (20%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G+G +G VF+ K +     ++  I A+K +R D     +      A R+I  L ++ H 
Sbjct: 8   IGEGTYGTVFKAKNR-----ETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHK 59

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            IV+L     +  KL L+ ++ +     +     G    +  + +  +++  ++  H   
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 236 IVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILL-SKGHN 282
           ++HRDLKP+N+L++ +G              I     S  +  T  Y  P++L  +K ++
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 283 KDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII------NEK-----VKLP------ 324
              D WS G +  E+   G+P F   +     +RI        E+      KLP      
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238

Query: 325 ------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
                       P L S    LL+ LL  +P +R+ +     +A++H
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE----EALQH 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/263 (23%), Positives = 121/263 (46%), Gaps = 36/263 (13%)

Query: 118 VGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D D   + +     M KD   +K+  D + +E +++  +  H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFR--EDQARFY---- 220
            I+ L  +      LY+I+++ + G+L  +L         Y   I R  ++Q  F     
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
            T ++   + +L     +HRDL   N+L+               D + ID   ++ +   
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE L  + +   +D WS G+L++E+ T G  P+     ++L  +++ E  ++  
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHRMDK 260

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P   T+E + +++   H  PS R
Sbjct: 261 PANCTNELYMMMRDCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 60/263 (22%), Positives = 107/263 (40%), Gaps = 27/263 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  ++ + A+K M             +  E   L +
Sbjct: 27  FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  ++ +  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 232 HKCGIVHRDLKPENILMDSDGH-------EIDESSRSNSMCGTTEYMAPEILLSKG---H 281
           H   ++HRD+K  NIL+   G            +S +NS  GT  +MAPE++L+     +
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQY 201

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS-----LLK 336
           +   D WS+GI   E+   +PP  + N       I   +    P L S   S      + 
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPTLQSNEWSDYFRNFVD 258

Query: 337 GLLHKDPSKRLGSGPGGVDAIKH 359
             L K P  R    P   + +KH
Sbjct: 259 SCLQKIPQDR----PTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 44/212 (20%)

Query: 118 VGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           VG GA+G V          +V  K +       I+A +  R+ T++K    + +    D+
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYRQGIFREDQARFYT 221
            T            S       YL++ +       I G              ED+ ++  
Sbjct: 83  FTSAV---------SGDEFQDFYLVMPYMQTDLQKIMGHP----------LSEDKVQYLV 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--ID---ESSRSNSMCG---TTEYMAP 273
            +++  + ++H  GI+HRDLKP N+ ++ D     +D          M G   T  Y AP
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAP 183

Query: 274 EILLSKGH-NKDADWWSVGILLYEMLTGQPPF 304
           E++L+  H N+  D WSVG ++ EMLTG+  F
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 44/270 (16%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
           D +   V+G+G FG+V + + K       DG+    A+K M K+   K +H D+   E +
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIK------KDGLRMDAAIKRM-KEYASKDDHRDF-AGELE 59

Query: 168 ILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----------- 215
           +L K+  HP I+ L  + + R  LYL +++   G+L   L +  +   D           
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 216 -----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDES 258
                Q   + A++   + +L +   +HRDL   NIL+             S G E+   
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI- 316
                +     +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++ 
Sbjct: 180 KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237

Query: 317 INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
              +++ P     E + L++    + P +R
Sbjct: 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYER 267

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 48/211 (22%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++ +G FG++F         G  + ++   V    + I+   V  +  E  +L  ++H  
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYGLSHQN 69

Query: 177 IVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA--------EIVSA 227
           I+  L    +     +++  ++N G+L   L +  +   +  +  +         +I   
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM------C-GTTEY-----MAPE 274
           +S+LHK G++H+D+   N ++D +   +I +++ S  +      C G  E      MA E
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189

Query: 275 ILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
            L++K ++  +D WS G+LL+E++T GQ P+
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 23/168 (13%)

Query: 156 KNHVDYMKAERDI--LTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHL-FFHL 206
           +N     +A R++  L  V H  I+ L      + S +    +YL+++ ++       H+
Sbjct: 59  QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM 118

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------GHEIDESSR 260
                   ++  +   +++  + HLH  GI+HRDLKP NI++ SD         +  ++ 
Sbjct: 119 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174

Query: 261 SNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           +N M      T  Y APE++L  G+ ++ D WSVG ++ E++ G   F
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 55/242 (22%), Positives = 115/242 (47%), Gaps = 25/242 (10%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG V Q +  G          A+K ++ D   +         E  ++TK+ H  
Sbjct: 13  IIGEGEFGAVLQGEYTGQK-------VAVKNIKCDVTAQA-----FLEETAVMTKLHHKN 60

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKC 234
           +V+L       + LY++++ ++ G+L   L  +G       +   ++ ++   + +L   
Sbjct: 61  LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 235 GIVHRDLKPENILMDSDG-HEIDES--SRSNSMCGTT-----EYMAPEILLSKGHNKDAD 286
            +VHRDL   NIL+  DG  ++ +   +R  SM         ++ APE L  K  +  +D
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179

Query: 287 WWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPS 344
            WS G+LL+E+ + G+ P+   + +++++ +    +++ P    ++ + L+      +P 
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPK 239

Query: 345 KR 346
           KR
Sbjct: 240 KR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 64/263 (24%), Positives = 120/263 (45%), Gaps = 40/263 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAER 166
            + E  +V+G GAFG V+    KGV   +G+   I  A+KV+R++T   K + + +  E 
Sbjct: 7   TELEKIKVLGSGAFGTVY----KGVWIPEGEKVKIPVAIKVLREETS-PKANKEILD-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF------- 219
            ++  V HP +V+L       S++ LI   +  G L  ++      R  +          
Sbjct: 61  YVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLN 113

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGT 267
           +  +I   +S+L +  +VHRDL   N+L+ +  H            ++DE    ++  G 
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE-YHAEGGK 172

Query: 268 T--EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKL 323
              ++MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           PP  T + + +L      D   R
Sbjct: 233 PPICTIDVYMVLVKCWMIDAESR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 18/140 (12%)

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD---------- 251
           + +   + +  E+         V A+++L +   I+HRD+KP NIL+D +          
Sbjct: 95  YVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154

Query: 252 -GHEIDESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHA 307
            G  +D  +++    G   YMAPE +      G++  +D WS+GI LYE+ TG+ P+   
Sbjct: 155 SGQLVDSIAKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213

Query: 308 NR--QKLQQRIINEKVKLPP 325
           N    +L Q +  +   L  
Sbjct: 214 NSVFDQLTQVVKGDPPILSN 233

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 62/268 (23%), Positives = 110/268 (41%), Gaps = 34/268 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAFGKVF  +   +       + A+K ++  T+  +   D+ + E ++LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE--- 223
            + H  IV+          L ++ +++  G L   L   G    I  + Q R    E   
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 224 ---------IVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRS 261
                    I S + +L     VHRDL   N L             M  D +  D     
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINE 319
                   +M PE ++ +    ++D WS G++L+E+ T   QP F  +N + ++      
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242

Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
            ++ P     E + ++ G   ++P +RL
Sbjct: 243 VLERPRVCPKEVYDIMLGCWQREPQQRL 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 15/207 (7%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +     D  +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGH-------EIDESSRSNSMCGTTEYMAPEILLSKG---H 281
           H   ++HRD+K  NIL+   G             + +N   GT  +MAPE++L+     +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQY 191

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHAN 308
           +   D WS+GI   E+   +PP  + N
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 66/293 (22%), Positives = 129/293 (44%), Gaps = 42/293 (14%)

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           + E E   D   E   +R +      + + +G+G FG+V   +  G+D    + +  + V
Sbjct: 2   VSEYELPEDPRWEVPRDRLV------LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV 55

Query: 148 -MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            M K    +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +
Sbjct: 56  KMLKSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 114

Query: 206 L-----------YRQGIFREDQARFY-----TAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           L           Y      E+Q  F        ++   + +L     +HRDL   N+L+ 
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174

Query: 250 SDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYE 296
            D              H ID   ++ +     ++MAPE L  + +   +D WS G+LL+E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234

Query: 297 MLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           + T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 235 IFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 41/267 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     +I +V+G G FG+V   + K    G  +   A+K + K    +K   D++ +E 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLK--LPGKREIPVAIKTL-KAGYTEKQRRDFL-SEA 56

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            I+ +  HP I+ L     T+SK + ++ +++  G L          R+   +F   ++V
Sbjct: 57  SIMGQFDHPNIIHLE-GVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLV 109

Query: 226 -------SAVSHLHKCGIVHRDLKPENILMDS----------------DGHEIDESSRSN 262
                  S + +L   G VHRDL   NIL++S                D  E   ++R  
Sbjct: 110 GMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV 321
            +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q +  + I E  
Sbjct: 170 KI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGY 226

Query: 322 KLPPFLTSEA--HSLLKGLLHKDPSKR 346
           +LP  +   A  H L+     KD ++R
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E DIL  ++H  I+ L ++++ +S + +++       LF ++ R G    +QA      +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHEI-------------DESSRSNSMCGTTEYM 271
           + A+++LH  GI+HRD+K ENI +D   + +              ++ +     GT E  
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           +PE+L    +    D WS G++L+EM       
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 66/266 (24%), Positives = 125/266 (46%), Gaps = 40/266 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           I P    I +V+G G FG+V +  +K  G  + D     A+K   K     K  +D++  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEID----VAIK-TLKAGSSDKQRLDFL-T 54

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP I++L     T+S+ + +I +++  G L   L      RE+  +F   +
Sbjct: 55  EASIMGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFL------RENDGKFTVGQ 107

Query: 224 IV-------SAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRS-NSMC 265
           +V       S + +L +   VHRDL   NIL++S+             +++S  +  +  
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167

Query: 266 GTT--EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK 322
           G     + APE +  +     +D WS GI+++E+++ G+ P+   + Q + +  + +  +
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYR 226

Query: 323 LPPFLT--SEAHSLLKGLLHKDPSKR 346
           LPP +   S  + L+     KD ++R
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 76/324 (23%), Positives = 125/324 (38%), Gaps = 90/324 (27%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM--KAERD 167
            D+EI   +G+G FG+V++ ++       +  + A+K      I+  N  D     A R+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQI-----KTGRVVALK-----KILMHNEKDGFPITALRE 57

Query: 168 I--LTKVTHPFIVQL------RYSFQTRSK--LYLILDFINGGH-LFFHLYRQGI-FRED 215
           I  L K+ HP +V L      R     R +  +Y++  +++  H L   L    +   E 
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTES 115

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------------------HE 254
           Q + Y  +++  +++LH+  I+HRD+K  NIL+D+ G                       
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 255 IDESSRS-NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF-------- 304
               +R   ++  T  Y  PE+LL  + +    D W +G +  EM T +P          
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 305 --------------THANRQKL-----------QQRIINEKVKLPPFLTSEAHSLLKGLL 339
                         T    + L             R + E+      L  E   LL  LL
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK---LGPEGLDLLSKLL 292

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWF 363
             DP KRL +     DA   H +F
Sbjct: 293 SLDPYKRLTA----SDA-LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 29/246 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +GQG FG+V+     G  +G +    A+K ++  T++ +  +     E  I+ K+ H  +
Sbjct: 14  LGQGCFGEVWM----GTWNGTTK--VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKL 63

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKC 234
           V L Y+  +   +Y++ +F+  G L   L ++G     +  Q     A+I   ++++ + 
Sbjct: 64  VPL-YAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 235 GIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGTT---EYMAPEILLSKGHN 282
             +HRDL+  NIL+         D     + E +   +  G     ++ APE  L     
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 283 KDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH 340
             +D WS GILL E++T G+ P+    NR+ L+Q     ++  P       H L+K    
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK 241

Query: 341 KDPSKR 346
           KDP +R
Sbjct: 242 KDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 61/251 (24%), Positives = 116/251 (46%), Gaps = 28/251 (11%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           ++ R +G G FG+V++    G+ +  +    A+K ++  T+  K+ +    AE  I+ K+
Sbjct: 9   QLLRKLGAGQFGEVWE----GLWNNTTP--VAVKTLKPGTMDPKDFL----AEAQIMKKL 58

Query: 173 THPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
            HP ++QL Y+  T  + +Y++ + +  G L  +L        +  Q     A++ S ++
Sbjct: 59  RHPKLIQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDG---------HEIDESSRSNSMCGT---TEYMAPEILL 277
           +L     +HRDL   N+L+  +            + +     +  G     ++ APE  L
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177

Query: 278 SKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLL 335
               +  +D WS GILL E++T G+ P+    N + LQQ     ++  PP    E + ++
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237

Query: 336 KGLLHKDPSKR 346
                +DP  R
Sbjct: 238 LDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 25/156 (16%)

Query: 168 ILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQAR-- 218
           ++  V H  I+ L      + S +    +YL+++ ++          Q I  + D  R  
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD------ANLCQVIQMDLDHERMS 121

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--HEID-----ESSRSNSMCG---TT 268
           +   +++  + HLH  GI+HRDLKP NI++ SD     +D      +  S  M     T 
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
            Y APE++L  G+ ++ D WSVG ++ EM+ G   F
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 79/349 (22%), Positives = 139/349 (39%), Gaps = 58/349 (16%)

Query: 2   VSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDP 61
              S K  +S  T +    +      S    D        +    +++  A+T  +   P
Sbjct: 28  SGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTP 87

Query: 62  QVIHNRSHSFVGPSP-RYALSSSLPLQIQELEHEN---DAELEAESERKIGPGDFEIFRV 117
                 ++  V P P +  ++ +LP Q +E  H       +++  ++R      F+I  +
Sbjct: 88  T-----TNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQR------FKILSL 136

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDILTKVTH 174
           +G+G FGKV +       D       A+K++R   K T   K  + +M+  R        
Sbjct: 137 LGEGTFGKVVEAW-----DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF 191

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV----SAVSH 230
           P +   RY FQ  +    I+    G  L   + + G F       + A+I+     A+ +
Sbjct: 192 PLMKIQRY-FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR----HLAQIIFQTGVALDY 246

Query: 231 LH-KCGIVHRDLKPENILMDSDGHEID------------------------ESSRSNSMC 265
            H +  ++H DLKPENILM++    +D                        E     ++ 
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIV 306

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQ 313
            T  Y +PE++L  G     D WS+G ++YE+ TG+  + TH N + L 
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355

Length = 467

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 56/225 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
           +E    +G+G +G V++ + +  ++       A+K +R +        T I+        
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIR-------- 50

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ--ARFYT 221
            E  +L ++ H  IV+L+    +  +LYL+ ++++   L  H+     F ++    + Y 
Sbjct: 51  -EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM----------------- 264
            +I+  +++ H   ++HRDLKP+N+L+D          R+N++                 
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLID---------RRTNALKLADFGLARAFGIPVRT 159

Query: 265 ----CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
                 T  Y APEILL S+ ++   D WSVG +  EM+  +P F
Sbjct: 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 49/180 (27%)

Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMC 265
           +D  +++  +++  + ++H   ++HRDLKP N+L++++        G     S + + M 
Sbjct: 107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM- 165

Query: 266 GTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQR 315
             TEY+      APE+LL+   +    D WSVG +  E+L  +P F    + ++ KL   
Sbjct: 166 --TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223

Query: 316 II------------NEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 347
           ++            NEK +     LP           P     A  LL+ +L  DPSKR+
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 35/207 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 13  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 58

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      +      + +  +++  +S+
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL- 277
            HK  I+HRDLKP+N+L++  G              +   + SN +  T  Y  P++LL 
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPF 304
           S  ++   D W VG +LYEM TG+P F
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 10/92 (10%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMA 272
           +++  + HLH  GI+HRDLKP NI++ SD                S        T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           PE++L  G+ ++ D WSVG ++ EM+ G   F
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)

Query: 109 PGDFEIFRVVGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           P  ++    VG GA+G V          +V  K +       I+A +  R+  ++K    
Sbjct: 14  PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK---- 69

Query: 160 DYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
            +MK E      D+ T  T         S +  +++YL+ + +  G    ++ +     +
Sbjct: 70  -HMKHENVIGLLDVFTPAT---------SIENFNEVYLVTNLM--GADLNNIVKCQKLSD 117

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCG 266
           +  +F   +++  + ++H  GI+HRDLKP N+ ++ D        G              
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA 177

Query: 267 TTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 304
           T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 63/263 (23%), Positives = 118/263 (44%), Gaps = 36/263 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V + +  G+D    D    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI-SEMELMKLIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L         LY+I+++   G+L   L         Y   I +  + +    ++VS
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 227 AV-------SHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCG 266
                     +L     +HRDL   N+L+  D              H+ID   ++++   
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE L  + +   +D WS GIL++E+ T G  P+     ++L  +++ E  ++  
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-FKLLREGHRMDK 257

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P   T E + L++   H  P++R
Sbjct: 258 PSNCTHELYMLMRECWHAVPTQR 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 30/205 (14%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G FGKV        +DG  + + A+K ++++    + +    K E +IL  + H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGE-MVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 176 FIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
            IV+ +   S Q    L LI++++  G L  +L +  +    Q   +  +I   +++LH 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHS 125

Query: 234 CGIVHRDLKPENILMDSD----------------GHE---IDESSRSNSMCGTTEYMAPE 274
              +HRDL   N+L+D+D                GHE   + E   S        + A E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVE 180

Query: 275 ILLSKGHNKDADWWSVGILLYEMLT 299
            L     +  +D WS G+ LYE+LT
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 37/208 (17%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  V++ + K  D+     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
            + H  IV L     T   L L+ ++++   L  +L   G        + +  +++  ++
Sbjct: 60  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
           + H+  ++HRDLKP+N+L++  G              I   + SN +  T  Y  P+ILL
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177

Query: 278 -SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S  ++   D W VG + YEM TG+P F
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 59/252 (23%), Positives = 111/252 (44%), Gaps = 37/252 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+G FG+VF  + +       +   A+K  R +T+       +++  R IL + +HP I
Sbjct: 3   IGRGNFGEVFSGRLRA-----DNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNI 55

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV-------SAVSH 230
           V+L      +  +Y++++ + GG            R +  R    E++       + + +
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDF------LTFLRTEGPRLKVKELIQMVENAAAGMEY 109

Query: 231 LHKCGIVHRDLKPENILMD-------SD-GHEIDESSRSNSMCG-----TTEYMAPEILL 277
           L     +HRDL   N L+        SD G   +E     +  G       ++ APE L 
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 278 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP--FLTSEAHSL 334
              ++ ++D WS GILL+E  + G  P+ + + Q+ ++  I + V+LP         + L
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRLPCPELCPDAVYRL 228

Query: 335 LKGLLHKDPSKR 346
           ++     DP +R
Sbjct: 229 MERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 56/258 (21%), Positives = 111/258 (43%), Gaps = 29/258 (11%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           +G G+FG V+        +  ++ + A+K M      K+ +  +    +++  L ++ HP
Sbjct: 29  IGHGSFGAVYFAT-----NSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHP 81

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
             ++ +  +      +L++++  G         +   +E +    T   +  +++LH   
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 236 IVHRDLKPENILMDSDGH-------EIDESSRSNSMCGTTEYMAPEILLSKG---HNKDA 285
           ++HRD+K  NIL+   G           +SS +NS  GT  +MAPE++L+     ++   
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Query: 286 DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL----LHK 341
           D WS+GI   E+   +PP  + N       I       P   ++E     +G     L K
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSFRGFVDYCLQK 259

Query: 342 DPSKRLGSGPGGVDAIKH 359
            P +R    P   + ++H
Sbjct: 260 IPQER----PASAELLRH 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 27/176 (15%)

Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+ +L K V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156

Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--IL 169
           +E    +G+G++  V++ K K      +  + A+KV+R    +++       A R+  +L
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIR----LQEEEGTPFTAIREASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G    +  + +  +++  +S
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
           ++H+  I+HRDLKP+N+L+   G              +   + SN +  T  Y  P++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 278 -SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S  ++   D W VG +  EM+ G   F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 58/274 (21%), Positives = 113/274 (41%), Gaps = 49/274 (17%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMK--AERDILTK 171
           + +G+G FGKV  VK          G    A+K+++++     +  +     +E ++L +
Sbjct: 6   KTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQ 59

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQ--------GIFREDQARF-- 219
           V HP +++L  +      L LI+++   G L  F    R+           R        
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 220 ------------YTAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHE 254
                       +  +I   + +L +  +VHRDL   N+L             +  D +E
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ 313
            D   + +      ++MA E L    +   +D WS G+LL+E++T G  P+     ++L 
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239

Query: 314 QRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             +    +++ P   + E ++L+     ++P KR
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 29/234 (12%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++      + R +G GAFG+V++   +G D    +   A+K + +    +++  D++  E
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-E 59

Query: 166 RDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR---- 218
             I++K  H  IV+L   SF+   + +++L+ + GG L  F    R    R         
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 219 -FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HEIDESSRSNSMCGTTEY--- 270
            F   ++     +L +   +HRD+   N L+   G     +I +   +  +   + Y   
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 271 ---------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQ 313
                    M PE  L        D WS G+LL+E+ + G  P+    N++ ++
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 59/263 (22%), Positives = 119/263 (45%), Gaps = 32/263 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G FG V + + K  +DG    + A+K+++ D     +  ++++ E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLK-SEDGSFQKV-AVKMLKADIFSSSDIEEFLR-EAACMKE 57

Query: 172 VTHPFIVQL-RYSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP +++L   S ++R+K  L     IL F+  G  H F  + R G     +  +   R
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGT- 267
           F   +I S + +L     +HRDL   N +++ +            +I         C + 
Sbjct: 118 FMI-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKL 323
              +++A E L    +   +D W+ G+ ++E++T GQ P+      ++   +I   ++K 
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           PP    + + L+      +P  R
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 43/264 (16%)

Query: 106 KIGPGDFEIFRVVGQGAF----GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           K+G G F    VV +G +    GKV  V              A+K ++ D +      D+
Sbjct: 2   KLGDGSF---GVVRRGEWSTSGGKVIPV--------------AVKCLKSDKL-SDIMDDF 43

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARF 219
           +K E  I+  + H  +++L Y       L ++ +    G L         G F       
Sbjct: 44  LK-EAAIMHSLDHENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDES--SRS---NSMCGTTE---- 269
           Y  +I + + +L     +HRDL   NIL+ SD   +I +    R+   N      E    
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161

Query: 270 ----YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL- 323
               + APE L ++  +  +D W  G+ L+EM T G+ P+   +  ++ ++I  E  +L 
Sbjct: 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE 221

Query: 324 -PPFLTSEAHSLLKGLLHKDPSKR 346
            P     + ++++      +P+ R
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 69/320 (21%), Positives = 124/320 (38%), Gaps = 58/320 (18%)

Query: 18  KKLTITPPSASSPDFDFTEV-----FGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
           +K++I  P  + P      +      G L   R N    AS        +        F 
Sbjct: 64  EKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFD 123

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVG---QGAFGKVF-- 127
              P  A    +PL   +L+H+++                  FRV+     GAFGK+F  
Sbjct: 124 EAPPDAA--GPVPLAQAKLKHDDEF--------------LAHFRVIDDLPAGAFGKIFIC 167

Query: 128 --------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
                      ++GV+  +       +++ K           ++ E   L ++ H  I++
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227

Query: 180 LRYSFQTRSKLYLI---LDFINGGHLFFHLYRQGIFRED-----QARFYTAEIVSAVSHL 231
           +    ++ +  Y+I    DF     L+  +Y +    +D     Q R    +++ AV ++
Sbjct: 228 IEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI 283

Query: 232 HKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLSK 279
           H   ++HRD+K ENI ++ DG             E +  +      GT    +PEIL   
Sbjct: 284 HDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343

Query: 280 GHNKDADWWSVGILLYEMLT 299
           G+ +  D WS G++L +ML+
Sbjct: 344 GYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 14/153 (9%)

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T+  L  + ++++     + +   G       R +  ++
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----SRSNSMCGTTE--------YMA 272
           +  ++++H   I+HRDLKP+N+L+   G E+  +    +R+ S+   T         Y  
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171

Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
           P++LL +  ++   D W  G +  EML GQP F
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 57/260 (21%), Positives = 111/260 (42%), Gaps = 35/260 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKVF  +   +       + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTVLQHQHI 69

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG----IFREDQAR-----------FYT 221
           V+  Y   T  + L ++ +++  G L   L   G    I    +                
Sbjct: 70  VRF-YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGTT 268
           ++I S + +L     VHRDL   N L             M  D +  D            
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPF 326
            +M PE +L +    ++D WS G++L+E+ T   QP +  +N + ++      +++ P  
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248

Query: 327 LTSEAHSLLKGLLHKDPSKR 346
              E +++++G   ++P +R
Sbjct: 249 CPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           R +G+G FGKV   +     +GD+ G   A+K ++ ++    NH+  +K E +IL  + H
Sbjct: 10  RDLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYH 65

Query: 175 PFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHL 231
             IV+ +   +    + + LI++F+  G L  +L R +      Q   Y  +I   + +L
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEYM-------------APEILL 277
                VHRDL   N+L++S+   +I +   + ++    EY              APE L+
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 278 SKGHNKDADWWSVGILLYEMLT 299
                  +D WS G+ LYE+LT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 61/249 (24%), Positives = 115/249 (46%), Gaps = 33/249 (13%)

Query: 118 VGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G G +G+V++ V KK           A+K +++DT+     V+    E  ++ ++ HP 
Sbjct: 14  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPN 63

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYTA-EIVSAVSHLH 232
           +VQL          Y+I +F+  G+L  +L      R++       Y A +I SA+ +L 
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE 121

Query: 233 KCGIVHRDLKPENILMDSDGH--EIDESSRSNSMCGTT-----------EYMAPEILLSK 279
           K   +HRDL   N L+  + H  ++ +   S  M G T           ++ APE L   
Sbjct: 122 KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 280 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKG 337
             +  +D W+ G+LL+E+ T G  P+   +  ++ + +    +++ P     + + L++ 
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240

Query: 338 LLHKDPSKR 346
               +PS R
Sbjct: 241 CWQWNPSDR 249

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 29/254 (11%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV 172
           + +G GAFGKV +    G+   D+     MKV   M K T    +  + + +E  I++ +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDA----VMKVAVKMLKPTA-HSSEREALMSELKIMSHL 95

Query: 173 -THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVS 229
             H  IV L  +      + +I ++   G L  F    R+     +    ++ ++   ++
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 230 HLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMC-GTT----EYMAPEI 275
            L     +HRDL   N+L+ + G  +         D  + SN +  G      ++MAPE 
Sbjct: 156 FLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAH 332
           + +  +  ++D WS GILL+E+ + G  P+          ++I E  ++  P    +E +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY 274

Query: 333 SLLKGLLHKDPSKR 346
            ++K     DP KR
Sbjct: 275 DIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 35/207 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
           +G+G +  VF+ + K  ++     + A+K +R +       T I+         E  +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV L     T   L L+ ++++     +      I      + +  +I+  +++
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL- 277
            H+  ++HRDLKP+N+L++  G              +   + SN +  T  Y  P++LL 
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPF 304
           S  ++   D W VG + +EM +G+P F
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 56/251 (22%), Positives = 103/251 (41%), Gaps = 32/251 (12%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
             +G+G FG V++   KG      +   A+K  R            +K     E +IL +
Sbjct: 1   EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTL------PPDLKRKFLQEAEILKQ 48

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSH 230
             HP IV+L      +  +Y++++ + GG L   L ++       +    + +  + + +
Sbjct: 49  YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108

Query: 231 LHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTT-----EYMAPEILL 277
           L     +HRDL   N L+  +        G   +E     ++         ++ APE L 
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 278 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 335
              +  ++D WS GILL+E  + G  P+   + Q+ ++RI    ++  P     E + L+
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228

Query: 336 KGLLHKDPSKR 346
                 DP  R
Sbjct: 229 LQCWAYDPENR 239

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 21/235 (8%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+VF+   K    G  +   A+K + K    +K   D++ +E
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILK--MPGRKEVAVAIKTL-KPGYTEKQRQDFL-SE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEI 224
             I+ + +H  I++L           +I +++  G L  +L    G F   Q       I
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTT--EY 270
            + + +L     VHRDL   NIL++S+              E D      +  G     +
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
            APE +  +     +D WS GI+++E+++ G+ P+   +  ++  + IN+  +LP
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFRLP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 58/261 (22%), Positives = 104/261 (39%), Gaps = 35/261 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           R +G+GAFGKVF  +   +       + A+K ++   D   K  H      E ++LT + 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-----REAELLTNLQ 65

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-------------FREDQARFY 220
           H  IV+          L ++ +++  G L   L   G                + Q    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
             +I + + +L     VHRDL   N L             M  D +  D           
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 325
             +M PE ++ +    ++D WS+G++L+E+ T G+ P+   +  ++ + I   +V + P 
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR 245

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
               E + L+ G   ++P  R
Sbjct: 246 TCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 39/274 (14%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            + E  R +GQGAFG+VFQ +  G+   +   + A+K M K+        D+ + E  ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALM 62

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYT- 221
            +  HP IV+L         + L+ +++  G L   L                 AR    
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 222 --------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCG 266
                          ++ + +++L +   VHRDL   N L+  +   +I +   S ++  
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 267 TTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKL 312
              Y            M PE +    +  ++D W+ G++L+E+ +   QP +  A+ + +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242

Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                   +  P     E ++L++    K PS R
Sbjct: 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 57/261 (21%), Positives = 111/261 (42%), Gaps = 38/261 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKAERD 167
           +F+  +V+G GAFG V+    KG+   + + +    A+K +R+ T  K N    +  E  
Sbjct: 8   EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAY 61

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           ++  V +P + +L       S + LI   +  G L  ++      RE +          +
Sbjct: 62  VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNW 114

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE----------- 269
             +I   +++L +  +VHRDL   N+L+ +  H          + G  E           
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 270 --YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPP 325
             +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
             T + + ++      D   R
Sbjct: 235 ICTIDVYMIMVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 56/245 (22%), Positives = 112/245 (45%), Gaps = 41/245 (16%)

Query: 118 VGQGAFG----KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           +G G FG     V++++KK +D        A+KV++ +   +K+  D M  E +I+ ++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID-------VAIKVLKNEN--EKSVRDEMMREAEIMHQLD 53

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSAVS-- 229
           +P+IV++    +  + L L+++  +GG  + F    +  I   +       E++  VS  
Sbjct: 54  NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN-----VVELMHQVSMG 107

Query: 230 --HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEYM-------------AP 273
             +L     VHRDL   N+L+ +  + +I +   S ++     Y              AP
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 274 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEA 331
           E +  +  +  +D WS GI ++E  + GQ P+      ++   I   +++  P     E 
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227

Query: 332 HSLLK 336
           ++L+K
Sbjct: 228 YALMK 232

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 59/269 (21%), Positives = 116/269 (43%), Gaps = 42/269 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           D +   V+G+G FG+V +  +KK      D   + A   M K+   + +H D+   E ++
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKK------DGLKMNAAIKMLKEFASENDHRDF-AGELEV 55

Query: 169 LTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED------------ 215
           L K+  HP I+ L  + + R  LY+ +++   G+L   L +  +   D            
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 216 ----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDESS 259
               Q   + +++ + + +L +   +HRDL   N+L+             S G E+    
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 318
               +     +MA E L    +   +D WS G+LL+E+++ G  P+      +L +++  
Sbjct: 176 TMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233

Query: 319 E-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             +++ P     E + L++      P +R
Sbjct: 234 GYRMEKPRNCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 60/263 (22%), Positives = 118/263 (44%), Gaps = 36/263 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKV-MRKDTIIKKNHVDYMKAERDILTKV-THP 175
           +G+G FG+V   +  G+D    +    + V M KD    K+  D + +E +++  +  H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMIGKHK 78

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS 226
            I+ L  +      LY+++++ + G+L  +L         Y     +  + +    ++VS
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCG 266
                   + +L     +HRDL   N+L+  D              H ID   ++ +   
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE L  + +   +D WS G+LL+E+ T G  P+     ++L  +++ E  ++  
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGHRMDK 257

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P   T E + +++   H  PS+R
Sbjct: 258 PANCTHELYMIMRECWHAVPSQR 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 44/264 (16%)

Query: 117 VVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           V+G+G FG+V +  +KK G+       + A     K+   K +H D+   E ++L K+ H
Sbjct: 2   VIGEGNFGQVLKARIKKDGLR------MDAAIKRMKEYASKDDHRDF-AGELEVLCKLGH 54

Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA---------------- 217
            P I+ L  + + R  LYL +++   G+L   L +  +   D A                
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 218 -RFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDESSRSNSM 264
             F  A++   + +L +   +HRDL   NIL+             S G E+        +
Sbjct: 115 LHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVK 322
                +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    +++
Sbjct: 174 --PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231

Query: 323 LPPFLTSEAHSLLKGLLHKDPSKR 346
            P     E + L++    + P +R
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 62/261 (23%), Positives = 117/261 (44%), Gaps = 34/261 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPF 176
           +G+GAFG+V + +  G+D+ +     A+K M KD   +K+  D + +E +++  +  H  
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLV-SEMEMMKMIGKHKN 77

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFREDQARFYTAEIVS- 226
           I+ L         LY+++++   G+L   L               R  +      ++VS 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 227 ------AVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
                  +  L     +HRDL   N+L             +  D H ID   ++ +    
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPP 325
            ++MAPE L  + +   +D WS G+LL+E+ T G  P+     ++L + +    +++ P 
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQ 257

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
             T E + L++   H+ PS+R
Sbjct: 258 NCTQELYHLMRDCWHEVPSQR 278

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 48/217 (22%), Positives = 99/217 (45%), Gaps = 34/217 (15%)

Query: 107 IGPGDFEIFRVVGQGAFGKVF----QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           I P +  + + +G G FG V+      K+K           A+K +R+  + +++     
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRK----------VAIKTIREGAMSEED----F 46

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYT 221
             E  ++ K++HP +VQL      RS + L+ +F+  G L  +L  Q G F ++      
Sbjct: 47  IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-------------DESSRSNSMCGTT 268
            ++   +++L    ++HRDL   N L+  +   +             D+ + S       
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV 165

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
           ++ +PE+     ++  +D WS G+L++E+ + G+ P+
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 44/266 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           +G+G FG V   +   +   D+ G + A+K ++  T     H+   + E +IL  + H  
Sbjct: 12  LGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDN 66

Query: 177 IVQLR---YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
           IV+ +   YS   R  L L+++++  G L  +L +    R D  +   Y ++I   + +L
Sbjct: 67  IVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL 124

Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEYM-------------APEILL 277
                VHRDL   NIL++S+   +I +   +  +    EY              APE L 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 278 SKGHNKDADWWSVGILLYEMLT-----GQPP--FTHA-NRQKLQQRII---------NEK 320
               +  +D WS G++LYE+ T       PP  F       K  Q I+         N +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244

Query: 321 VKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  PP   +E ++++K   + DPS+R
Sbjct: 245 LPAPPGCPAEIYAIMKECWNNDPSQR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 118 VGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +G G FG V     KGV     G    + A+K ++++ I           E  ++ ++ H
Sbjct: 3   LGHGNFGSV----VKGVYLMKSGKEVEV-AVKTLKQEHI--AAGKKEFLREASVMAQLDH 55

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L    +    L L+++    G L  +L ++        +    ++   +++L   
Sbjct: 56  PCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 235 GIVHRDLKPENILMDSDGH-EIDESSRSNSM-CGTTEY------------MAPE-ILLSK 279
             VHRDL   N+L+ +    +I +   S ++  G+  Y             APE I   K
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 280 GHNKDADWWSVGILLYEMLT-GQPPF 304
             +K +D WS G+ L+E  + G  P+
Sbjct: 175 FSSK-SDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
           ++G+G FG+VF   K  + D       A+K  ++D + ++  + ++   R IL +  HP 
Sbjct: 2   LLGKGNFGEVF---KGTLKDKTP---VAVKTCKED-LPQELKIKFLSEAR-ILKQYDHPN 53

Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCG 235
           IV+L      R  +Y++++ + GG     L + +   +  Q   +  +  + +++L    
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 236 IVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTE----YMAPEILLSKGHNK 283
            +HRDL   N L+  +        G    E     S  G  +    + APE L    ++ 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 284 DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 316
           ++D WS GILL+E  + G  P+     Q+ ++++
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 35/208 (16%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDIL 169
            +G+G++  V++ + K         + A+K +R +       T I+         E  +L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQ-----LVALKEIRLEHEEGAPFTAIR---------EASLL 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  IV L     T+  L L+ ++++     +     G       R +  +++  ++
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
           + H+  ++HRDLKP+N+L+   G              +   + SN +  T  Y  P++LL
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176

Query: 278 -SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S  ++   D W VG + YEM TG+P F
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 62/261 (23%), Positives = 121/261 (46%), Gaps = 39/261 (14%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
           +I  V+G G FG+V + + K    G  +   A+K + K    +K   D++ +E  I+ + 
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLP--GKREIFVAIKTL-KSGYTEKQRRDFL-SEASIMGQF 62

Query: 173 THPFIVQLRYSFQTRSKLYLIL-DFINGGHLFFHLYRQGIFREDQARFYTAEIV------ 225
            HP I+ L     T+S+  +I+ +F+  G L          R++  +F   ++V      
Sbjct: 63  DHPNIIHLE-GVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGI 115

Query: 226 -SAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSR----SNSMCGT--T 268
            + + +L +   VHRDL   NIL++S+             +++ +     ++S+ G    
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFL 327
            + APE +  +     +D WS GI+++E+++ G+ P+   + Q +    I +  +LPP +
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIEQDYRLPPPM 234

Query: 328 TSEA--HSLLKGLLHKDPSKR 346
                 H L+     KD + R
Sbjct: 235 DCPTALHQLMLDCWQKDRNAR 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 53/235 (22%), Positives = 95/235 (40%), Gaps = 34/235 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FGKV   +      G S     +K +R  +      + +++ E     ++ HP +
Sbjct: 3   IGNGWFGKVLLGE---AHRGMSKARVVVKELR-ASATPDEQLLFLQ-EVQPYRELNHPNV 57

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFRED-----QARFYTAEIVSAVSHL 231
           +Q            L+L+F   G L  +L   +G+  +        R    E+ S +  L
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVASGLLWL 116

Query: 232 HKCGIVHRDLKPENILMDSD----------GHEI---DESSRSNSMCGTTEYMAPEI--- 275
           H+   +H DL   N  + +D            E    D     +       ++APE+   
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 276 ----LLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLP 324
               LL K   K ++ WS+G+ ++E+ T   QP    ++ Q L+Q +  + +KLP
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 26/213 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDIL 169
           +E    +G+GA+GKVF+ +    D  +     A+K +R  T  +   +  ++  A    L
Sbjct: 3   YECVAEIGEGAYGKVFKAR----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 170 TKVTHPFIVQL----RYSFQTR-SKLYLILDFINGGHLFFHLYR---QGIFREDQARFYT 221
               HP +V+L      S   R +KL L+ + ++   L  +L +    G+  E   +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TIKDMM 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----------IDESSRSNSMCGTTEYM 271
            +++  +  LH   +VHRDLKP+NIL+ S G                    S+  T  Y 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           APE+LL   +    D WSVG +  EM   +P F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 39/113 (34%), Positives = 52/113 (46%), Gaps = 11/113 (9%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------EIDESSRS-NSMCGTTEYMA 272
           + +  +  LH   IVHRDLKPENIL+ S G           I     +   +  T  Y A
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 26/184 (14%)

Query: 147 VMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFINGGH--- 201
            ++K  +   +  D    +++I+T  ++ HP I+    SF   S+LY++   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------- 254
           L    + +G   E    F   ++++A+ ++H  G +HR +K  +IL+  DG         
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147

Query: 255 ----IDESSRSNSMCGTTEY-------MAPEILLS--KGHNKDADWWSVGILLYEMLTGQ 301
               I    R   +    +        ++PE+L    +G+N+ +D +SVGI   E+  G 
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207

Query: 302 PPFT 305
            PF 
Sbjct: 208 VPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 60/239 (25%), Positives = 113/239 (47%), Gaps = 26/239 (10%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
           +V+G GAFG V+  K   V +G++  I  A+K++ + T  K N V++M  E  I+  + H
Sbjct: 13  KVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMD-EALIMASMDH 68

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           P +V+L         + L+   +  G L  + H ++  I  +     +  +I   + +L 
Sbjct: 69  PHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLE 126

Query: 233 KCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTT--EYMAPEILLS 278
           +  +VHRDL   N+L+ S  H            E DE    N+  G    ++MA E +  
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKMPIKWMALECIHY 185

Query: 279 KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 335
           +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + + ++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 244

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 61/253 (24%), Positives = 114/253 (45%), Gaps = 24/253 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D  + R +G+G FG V+Q V     ++  +  +   K     ++ +K        E  I+
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-----FLQEAYIM 61

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSA 227
            +  HP IV+L     T + ++++++    G L  +L +   +  D A    Y+ ++ +A
Sbjct: 62  RQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGT--TEYMAPEI 275
           +++L     VHRD+   N+L+ S              +++ S   +  G    ++MAPE 
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 333
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239

Query: 334 LLKGLLHKDPSKR 346
           L+      DPSKR
Sbjct: 240 LMTKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 47/204 (23%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG+V+          +     A+K M+  ++     V+   AE +++  + H 
Sbjct: 12  KKLGAGQFGEVWMATY------NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 61

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHK 233
            +V+L ++  T+  +Y+I +F+  G L   L      ++   +   ++A+I   ++ + +
Sbjct: 62  KLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 234 CGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGTT---EYMAPEILLSKGH 281
              +HRDL+  NIL+         D     + E +   +  G     ++ APE +     
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 282 NKDADWWSVGILLYEMLT-GQPPF 304
              +D WS GILL E++T G+ P+
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 69/311 (22%), Positives = 114/311 (36%), Gaps = 82/311 (26%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
           +V+G GAFGKV +    G+D   S    A+K M K+      H   M +E  IL  +  H
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVK-MLKEGATASEHKALM-SELKILIHIGNH 70

Query: 175 PFIVQLRYS-FQTRSKLYLILDFINGGHL---------FFHLYRQ--------------- 209
             +V L  +  +    L +I++F   G+L         FF  YR+               
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 210 ---------GIFREDQARF-----------------------------YTAEIVSAVSHL 231
                    G      +RF                             Y+ ++   +  L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 232 HKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCGTTEYMAPEILLS 278
                +HRDL   NIL+               D ++  +  R  S     ++MAPE +  
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 279 KGHNKDADWWSVGILLYEMLT-GQPPF--THANRQKLQQRIINEKVKLPPFLTSEAHSLL 335
           K +   +D WS G+LL+E+ + G  P+     N +  Q+     +++ P   T E + ++
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIM 310

Query: 336 KGLLHKDPSKR 346
                 DP +R
Sbjct: 311 LACWQGDPKER 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 29/221 (13%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNH--V 159
           R +   +    +++G G FG V     KG+   +GDS  I  A+K ++  +  +      
Sbjct: 2   RILKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEIT 57

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQAR 218
           D+M A    +  + H +IV+L       + L L+      G L  H+   +      +  
Sbjct: 58  DHMLA----MGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMC 265
            +  +I   + +L +  +VHR+L   NIL+ SD              +  D+    +   
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT 305
              ++MA E +L   +   +D WS G+ ++EM++ G  P+ 
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 55/262 (20%), Positives = 112/262 (42%), Gaps = 37/262 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAFGKV++ +  G ++  S    A+K ++++   K       + E ++++ + HP I
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR----------------QGIFREDQARFYT 221
           V L           ++ +++  G L   L R                +            
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----SR-----------SNSMCG 266
            +I + + +L     VHRDL   N L+  +G  +  S    SR           S S+  
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRVQSKSLL- 188

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLP 324
              +M PE +L      ++D WS G++L+E+ + G  P+   + Q++ + I + ++   P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP 248

Query: 325 PFLTSEAHSLLKGLLHKDPSKR 346
               +  ++L+    ++ P++R
Sbjct: 249 EDCPARVYALMIECWNEIPARR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain

 Score = 43.8 bits (104), Expect = 2e-06
 Identities = 13/46 (28%), Positives = 20/46 (43%), Gaps = 4/46 (8%)

Query: 384 VSGKDCIANFDKCWTTMPADDSPAPTPTAG----EHFKGYTYVAPN 425
           V      +NFD  +T+ P   SP  +          F+G++YV P 
Sbjct: 2   VKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNPE 47

Length = 47

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 30/177 (16%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           HP I+     F T S L++I  F+  G    L    + +G+  E          +  +++
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNY 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC-------------------GTTEYM 271
           LH+ G +HR++K  +IL+  DG  +  S  S+                          ++
Sbjct: 117 LHQNGYIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175

Query: 272 APEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 326
           +PE+L     G+N  +D +SVGI   E+ TG+ PF    R ++    + +K+K PP+
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPY 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 40/177 (22%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARFYTAEIVSAVS 229
           HP I+Q            L+ ++   G L  +L ++   R +      +    EI + V+
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 230 HLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMCGTTEYMAPEI- 275
           H+HK   +H DL   N  + SD              ++ D     +  C    ++APE+ 
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173

Query: 276 ------LLSKGHNKDADWWSVGILLYEML-TGQPPFTH-ANRQKLQQRIINEKVKLP 324
                 L++    K ++ W++G+ L+E+      P++H ++R+ L   I +++VKL 
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 50/225 (22%), Positives = 95/225 (42%), Gaps = 31/225 (13%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           R +GQG+FG V++   KGV   + +   A+K + +   +++  ++++  E  ++ +    
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLN-EASVMKEFNCH 69

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA------------E 223
            +V+L           +I++ +  G L  +L  + +  E +     A            E
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 224 IVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGTTEY 270
           I   +++L+    VHRDL   N +             M  D +E D   +         +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 313
           M+PE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 26/202 (12%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G G FG+V+     G  +G +    A+K +++ ++      +   AE +++ ++ HP +
Sbjct: 14  LGAGQFGEVWM----GYYNGHTK--VAIKSLKQGSM----SPEAFLAEANLMKQLQHPRL 63

Query: 178 VQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCG 235
           V+L Y+  T+  +Y+I +++ NG  + F    +GI    ++     A+I   ++ + +  
Sbjct: 64  VRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 236 IVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLSKGHNK 283
            +HRDL+  NIL+                 E +E +         ++ APE +       
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 284 DADWWSVGILLYEMLT-GQPPF 304
            +D WS GILL E++T G+ P+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 31/143 (21%), Positives = 63/143 (44%), Gaps = 16/143 (11%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF--THANRQKLQQRIINEKVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+     + +  ++     +++ 
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 304 PDYTTPEMYQTMLDCWHGEPSQR 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 13/87 (14%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSN----SMCGTTE 269
           +++SA+ ++H  GI+HRD+K EN+L+         D         S S      + GT +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYE 296
             APE+L    +    D WS G++++E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 37/255 (14%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHV------DYMKAERDIL 169
           +G G FG V    KKG+        Y MK   K   +K  KN        D +  E +++
Sbjct: 3   LGSGNFGTV----KKGM--------YKMKKSEKTVAVKILKNDNNDPALKDELLREANVM 50

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            ++ +P+IV++    +  S   L+++    G L   L +     E        ++   + 
Sbjct: 51  QQLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK 109

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEYM-------------APEI 275
           +L +   VHRDL   N+L+ +  + +I +   S ++     Y              APE 
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 333
           +     +  +D WS G+L++E  + GQ P+      ++ Q I + E+++ P     E + 
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD 229

Query: 334 LLKGLLHKDPSKRLG 348
           L+K        +R G
Sbjct: 230 LMKLCWTYGVDERPG 244

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 18/111 (16%)

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRS- 261
           +  +F+  +++ A+ ++H   + HRDLKP+NIL ++D                D  +   
Sbjct: 103 EHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162

Query: 262 -NSMCGTTEYMAPEI---LLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
                 T  Y APE+     SK +    D WS+G +  E+LTG+P F   N
Sbjct: 163 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKN 212

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 55/264 (20%), Positives = 110/264 (41%), Gaps = 41/264 (15%)

Query: 118 VGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +G+ AFGK+++  +   G+D      + A+K ++   I         + E  ++ ++ HP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ---LVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ------------GIFRE--DQARFY 220
            IV L         + ++ +++N G L  F + R             G  +   D   F 
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 221 --TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESS----RSNSM 264
               +I + + +L     VH+DL   NIL+    H          EI  +     +  S+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG--QPPFTHANRQKLQQRIINEKVK 322
                +M PE ++    + D+D WS G++L+E+ +   QP +  +N++ ++     + + 
Sbjct: 188 L-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP 246

Query: 323 LPPFLTSEAHSLLKGLLHKDPSKR 346
                    +SL+     + PS+R
Sbjct: 247 CSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 34/130 (26%), Positives = 58/130 (44%), Gaps = 18/130 (13%)

Query: 233 KCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCGTTEYMAPEILLSK 279
           KC  +HRDL   NIL+               D ++  +  R        ++MAPE +  K
Sbjct: 193 KC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 280 GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 336
            +   +D WS G+LL+E+ + G  P+      +   R + E  ++  P + T E +S++ 
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310

Query: 337 GLLHKDPSKR 346
              H +P  R
Sbjct: 311 DCWHNNPEDR 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 48/214 (22%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY------AMKVMRKDTIIKKNHVDYMKAER 166
           ++ + +G G FG+V+             G Y      A+K ++  T+     V     E 
Sbjct: 9   KLVKKLGAGQFGEVWM------------GYYNNSTKVAVKTLKPGTM----SVQAFLEEA 52

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--YTAE 223
           +++  + H  +V+L Y+  T+ + +Y+I +++  G L   L      +    +   ++A+
Sbjct: 53  NLMKTLQHDKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGTT---EYM 271
           I   ++++ +   +HRDL+  N+L+         D     + E +   +  G     ++ 
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
           APE +        +D WS GILLYE++T G+ P+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 24/169 (14%)

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 43  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-SEL 101

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN-SMCGTTE----- 269
              +    ++ A+ ++H  G VHR +K  +IL+  DG       RSN SM    +     
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161

Query: 270 ------------YMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF 304
                       +++PE+L    +G++  +D +SVGI   E+  G  PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 54/261 (20%), Positives = 105/261 (40%), Gaps = 33/261 (12%)

Query: 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
           + R +GQG+FG V++   + +  G+++   A+K + +   +++  ++++  E  ++   T
Sbjct: 10  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-RIEFLN-EASVMKGFT 67

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----QARF---------Y 220
              +V+L           ++++ +  G L  +L      R +      R           
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS---LRPEAENNPGRPPPTLQEMIQM 124

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
            AEI   +++L+    VHRDL   N +             M  D +E D   +       
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQQRIINEKVKLPP 325
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+  +    +  P 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
                   L++     +P  R
Sbjct: 245 NCPERVTDLMRMCWQFNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 36/216 (16%)

Query: 118 VGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           +G+G FG+V   + +G+ +              + A+K++R D + K    D++K E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE------------DQ 216
           ++++ +P I++L     +   L +I +++  G L   L ++ I                 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHEIDESSRSNSMCGTTEY----- 270
             +   +I S + +L     VHRDL   N L+ +    +I +   S ++     Y     
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 271 -------MAPEILLSKGHNKDADWWSVGILLYEMLT 299
                  MA E +L       +D W+ G+ L+EM T
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 57/269 (21%), Positives = 110/269 (40%), Gaps = 37/269 (13%)

Query: 98  ELEAES---ERKIGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           EL+ +S   ER +G G F E+ R   +    +   V    +  G SD             
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD------------- 47

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIF 212
             K    ++ AE   L +  H  IV+L       + + ++ ++++ G L   L + +G  
Sbjct: 48  --KQRRGFL-AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL 104

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSN 262
              Q       + S + +L + G VH+ L    +L++SD            E    +   
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164

Query: 263 SMCGTTE--YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE 319
           +M G +   + APE +     +  +D WS GI+++E+++ G+ P+   + Q +  + + +
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVED 223

Query: 320 KVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
             +LP         H L+     K+  +R
Sbjct: 224 GFRLPAPRNCPNLLHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 31/124 (25%), Positives = 56/124 (45%), Gaps = 22/124 (17%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMCGTTE 269
           EI   + HLHK   +H DL   N L+ +D              ++ D     + +     
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167

Query: 270 YMAPEI-------LLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQQRIINEK 320
           ++APE+       LL     K+++ WS+G+ ++E+  L  QP    ++ Q L   +  ++
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227

Query: 321 VKLP 324
           +KLP
Sbjct: 228 LKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 53/248 (21%), Positives = 102/248 (41%), Gaps = 44/248 (17%)

Query: 134 VDDGDSDGIYAMKVMRKDTIIK------KNH---VDYMKAERDILTKVTHPFIVQLRYSF 184
           + + D + IY      K+ II+      K H   +D  + E   L ++    I+++ Y F
Sbjct: 28  IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI-YGF 86

Query: 185 -----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-----EIVSAVSHLHK- 233
                    +L LIL++   G+L     R+ + +E    F T      +    + +L+K 
Sbjct: 87  IIDIVDDLPRLSLILEYCTRGYL-----REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141

Query: 234 CGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEYMAPEILL---SKGHN 282
               +++L   + L+  +        G E   SS          Y + ++L    S+ + 
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE-YT 200

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL---- 338
              D +S+G++L+E+ TG+ PF +   +++   IIN+   L   L  +    +K +    
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--LPLDCPLEIKCIVEAC 258

Query: 339 LHKDPSKR 346
              D  KR
Sbjct: 259 TSHDSIKR 266

Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 54/262 (20%), Positives = 100/262 (38%), Gaps = 38/262 (14%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           +++G+G FG V + +    DDG S    A+K M+ D        +++  E   +    HP
Sbjct: 5   KILGEGEFGSVMEGQLSQ-DDG-SQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDHP 61

Query: 176 FIVQL-RYSFQTRS-----KLYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
            +++L    F+  S     K  +IL F+  G L   L    +                  
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFM 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD---------------GHEIDESSRSNSMCG 266
            +I   + +L     +HRDL   N ++  D                 +     R   M  
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-- 177

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLP 324
             +++A E L  + +   +D W+ G+ ++E+ T GQ P+      ++   + +  ++K P
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237

Query: 325 PFLTSEAHSLLKGLLHKDPSKR 346
                E + L+      DP  R
Sbjct: 238 EDCLDELYDLMYSCWRADPKDR 259

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 17/39 (43%), Positives = 23/39 (58%), Gaps = 7/39 (17%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS 261
           +I+ A+  LH  GIVHRD+KP+NI+         E S S
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIF-------SEGSGS 294

Length = 566

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 12/144 (8%)

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           + K+ HP IV+L    ++    YLI ++I G +L   L  + +  E + +     I  A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG-IAKAL 793

Query: 229 SHLH-KCG--IVHRDLKPENILMDSDGHEIDESSRSNSMC------GTTEYMAPEILLSK 279
             LH +C   +V  +L PE I++D         S    +C       ++ Y+APE   +K
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETK 853

Query: 280 GHNKDADWWSVGILLYEMLTGQPP 303
              + +D +  G++L E+LTG+ P
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 51/251 (20%), Positives = 107/251 (42%), Gaps = 27/251 (10%)

Query: 119 GQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DILTKVTH 174
           GQG F  +++  ++ +   D    G     V++   ++  +H D +       ++++++H
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK---VLGSDHRDSLAFFETASLMSQLSH 60

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA-EIVSAVSHLHK 233
             +V+L Y    R +  ++ +++  G L   L+R+        +   A ++ SA+ +L  
Sbjct: 61  KHLVKL-YGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 234 CGIVHRDLKPENILMDSDGHE------IDESSRSNSMC-GTTEY-------MAPEIL--L 277
             +VH ++  +NIL+   G        I  S     +   + E        +APE +   
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNG 179

Query: 278 SKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 336
                  AD WS G  L E+ +    P +  +  + ++R   ++ +LP    +E  +L+ 
Sbjct: 180 QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQDQHRLPMPDCAELANLIN 238

Query: 337 GLLHKDPSKRL 347
                DP+KR 
Sbjct: 239 QCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 118 VGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G+G FG+V   + +G++            G+   + A+K++R+D   K    D++K E 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLK-EI 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA--------- 217
            I++++  P I++L     T   L +I +++  G L   L R    +E            
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE-PQEAAEKADVVTISY 129

Query: 218 ---RFYTAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRS 261
               F   +I S + +L     VHRDL   N L             M  + +  D     
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 262 NSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT--GQPPFTH 306
                   +M+ E ILL K     +D W+ G+ L+E+LT   + P++ 
Sbjct: 190 GRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 16/143 (11%)

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCG----- 266
           ++ ++   +S L     +HRDL   NIL+           G   D  + SN +       
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL-- 323
             ++MAPE + +  +  ++D WS GILL+E+ + G  P+          ++I E  ++  
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS 338

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P    SE + ++K     DP KR
Sbjct: 339 PECAPSEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 32/238 (13%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+  FGKV++    G   G+     A+K ++          +  K E  + +++ HP I
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70

Query: 178 VQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ-----GIFREDQ--------ARFY--T 221
           V L         L +I  + +   L  F + R      G   +D+        A F    
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEIDE--------SSRSNSMCGTT---- 268
            +I + +  L    +VH+DL   N+L+ D    +I +        ++    + G +    
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 325
            +M+PE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.1 bits (94), Expect = 7e-04
 Identities = 28/113 (24%), Positives = 49/113 (43%), Gaps = 21/113 (18%)

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------EID 256
           +  + +  E++     A  +  +  L +    HR  K  NIL+  DG          +  
Sbjct: 9   VRGRPL-NEEEI---WAVCLQCLGALREL---HRQAKSGNILLTWDGLLKLDGSVAFKTP 61

Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
           E SR +       +MAPE++  + + + AD +S+GI LYE L  + P+     
Sbjct: 62  EQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 15/31 (48%), Positives = 24/31 (77%)

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
           ++++ +  LH+ GIVHRD+KPEN+L+  DG 
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ 347

Length = 507

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 25/63 (39%), Positives = 31/63 (49%), Gaps = 8/63 (12%)

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDS 250
           L+  +  G  L  HL R      D A F +A    A+  LH+ GI H DL KP+N LM  
Sbjct: 95  LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 251 DGH 253
           DG 
Sbjct: 148 DGE 150

Length = 365

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 49/267 (18%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G FG V + +   ++  DS    A+K M K  I  ++ ++   +E   + +  HP
Sbjct: 5   KTLGEGEFGSVMEGQ---LNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 176 FIVQL-RYSFQ-TRSKLY----LILDFINGG--HLFFHLYRQGIFREDQARF-------- 219
            +++L     Q   S+ Y    +IL F+  G  H F    R G    D  ++        
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVK 116

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------------GHEIDESSRSNSM 264
           +  +I S + +L     +HRDL   N +++ +                 +     R   M
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK----LQQRIINE 319
               +++A E L  + +   +D WS G+ ++E+ T GQ P+      +    L+Q     
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GN 231

Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           ++K PP      +SL+      +P  R
Sbjct: 232 RLKQPPDCLDGLYSLMSSCWLLNPKDR 258

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	431
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
PRK10345	210	hypothetical protein; Provisional	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
smart00090	237	RIO RIO-like kinase.	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
KOG3087	229	consensus Serine/threonine protein kinase [General	99.06
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.0
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.88
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
COG4248	637	Uncharacterized protein with protein kinase and he	98.61
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.56
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.46
PRK09902	216	hypothetical protein; Provisional	98.44
smart00133	64	S_TK_X Extension to Ser/Thr-type protein kinases.	98.42
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.41
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.41
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.9
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.89
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.88
PLN02876	822	acyl-CoA dehydrogenase	97.81
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.62
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.58
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.57
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.32
PF00433	48	Pkinase_C: Protein kinase C terminal domain; Inter	97.19
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.14
PF01636	239	APH: Phosphotransferase enzyme family This family	97.12
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.0
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.96
PRK10593	297	hypothetical protein; Provisional	96.89
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.83
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.83
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.45
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.3
KOG2270	520	consensus Serine/threonine protein kinase involved	96.27
PLN02756	418	S-methyl-5-thioribose kinase	96.06
PRK05231	319	homoserine kinase; Provisional	96.03
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.56
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.15
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.63
PRK12396	409	5-methylribose kinase; Reviewed	94.59
PLN02236	344	choline kinase	94.59
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.49
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.47
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	91.52
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	90.89
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	89.45
PTZ00384	383	choline kinase; Provisional	89.21
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	88.77
PRK11768	325	serine/threonine protein kinase; Provisional	88.5
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	88.3
PHA03111	444	Ser/Thr kinase; Provisional	87.27
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	85.25

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-75  Score=542.67  Aligned_cols=313  Identities=54%  Similarity=0.983  Sum_probs=288.9

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|+++++||+|+||+||+|+.+.     +++.||||+++|..+.....++....|..||..++||+||+++..|+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~d-----t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKD-----TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcc-----cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            3456789999999999999999999985     99999999999999999999999999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc----------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI----------  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~----------  255 (431)
                      +.+++|||+||+.||+|+.+|.+++.|+|..+++|+++|+.||.|||++|||||||||+|||||.+||..          
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999832          


Q ss_pred             -CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCCCCCHHHHH
Q 014087          256 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHS  333 (431)
Q Consensus       256 -~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~  333 (431)
                       .....+.++|||+.|||||++.+.+|+..+|||||||++|||++|.+||.+.+..+++++|..++.. .|..++.++++
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ard  255 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARD  255 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHH
Confidence             3345667899999999999999999999999999999999999999999999999999999999954 45569999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC--C--
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP--T--  409 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~--~--  409 (431)
                      ||+++|.+||.+|+| +..++++|++||||+++||+.+.++++.|||+|.+.+..|+++||.+|+.+..+.++..  +  
T Consensus       256 ll~~LL~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~  334 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDM  334 (357)
T ss_pred             HHHHHhccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCccc
Confidence            999999999999998 45689999999999999999999999999999999999999999999999865555442  1  


Q ss_pred             -------CCCCCCccCeEeeCC
Q 014087          410 -------PTAGEHFKGYTYVAP  424 (431)
Q Consensus       410 -------~~~~~~f~~~~~~~~  424 (431)
                             ......|.+|+|+.+
T Consensus       335 ~~~~~~~~~~~~~f~gft~~~~  356 (357)
T KOG0598|consen  335 SAFTAFSRTYNKIFPGFTYVAS  356 (357)
T ss_pred             ccccccccccccccCCccccCC
Confidence                   134678999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-72  Score=555.49  Aligned_cols=315  Identities=37%  Similarity=0.797  Sum_probs=295.9

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (431)
                      ..+..++|.++++||+|+||+|+++..++     +++.||||+++|+.+...+.++..+.|.+|+...+ ||+++.|+.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            46778899999999999999999999997     88999999999999999999999999999999885 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc---------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE---------  254 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~---------  254 (431)
                      |++.+++|+||||+.||++ .++...+.|++..+++|+++|+.||.|||++||||||||.+|||||.+|+.         
T Consensus       438 fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999999994 444555789999999999999999999999999999999999999999983         


Q ss_pred             --cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014087          255 --IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  332 (431)
Q Consensus       255 --~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  332 (431)
                        +.....+.++|||+.|||||++.+..|+.++|||||||+|||||.|..||.+++.++++..|++..+.+|.++|.|+.
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence              234457789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC--
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--  410 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--  410 (431)
                      ++|+++|.+||++|+|+++.++++|+.||||++|||+.|++|+++|||+|.+.++.|.+|||++||.+++..++....  
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l  676 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPL  676 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCcccc
Confidence            999999999999999999889999999999999999999999999999999999999999999999999988873222  


Q ss_pred             --CCCCCccCeEeeCCC
Q 014087          411 --TAGEHFKGYTYVAPN  425 (431)
Q Consensus       411 --~~~~~f~~~~~~~~~  425 (431)
                        ..+++|.||+|+++.
T Consensus       677 ~~~~q~~F~~Fs~~~~~  693 (694)
T KOG0694|consen  677 TEEEQEAFRDFSFVAEW  693 (694)
T ss_pred             chhhHHHhcCccccCCC
Confidence              578999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-70  Score=495.79  Aligned_cols=285  Identities=44%  Similarity=0.846  Sum_probs=273.6

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...++|++++.||.|+||+|.+++.+.     ++..||+|+++++.+.+-.++++..+|..+|+.+.||++++|++.|.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~-----~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKH-----SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEcc-----CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            667899999999999999999999997     899999999999999999999999999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc--------CCC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI--------DES  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~--------~~~  258 (431)
                      .+.+|+||||++||.|+.++++.++|++..+++|++||+.||+|||+++|++|||||+|||||.+|+..        ...
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999999999999999999999999999999999999999999999999999999999832        234


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ..+.+.||||.|+|||++..++|+.++|||||||++|||+.|.+||...++..++++|+.+++.+|..++.++++||+++
T Consensus       196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKL  275 (355)
T ss_pred             CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc-CCCCCcccCCCCcc
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP-DVSGKDCIANFDKC  396 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p-~~~~~~~~~~f~~~  396 (431)
                      |+.|-.+|.|+..++.++|+.||||++++|.++..|+++|||.| .+.+..|++|||..
T Consensus       276 L~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y  334 (355)
T KOG0616|consen  276 LQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDY  334 (355)
T ss_pred             HhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCccccccccc
Confidence            99999999999988999999999999999999999999999998 77889999999974

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.1e-68  Score=512.40  Aligned_cols=311  Identities=41%  Similarity=0.771  Sum_probs=274.1

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (431)
                      ..++..++|++++.||+|+||.||+|+.+.     +|.+||||+++|......+++..++.|..+|...++|+||+||..
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~-----Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs  209 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKD-----TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS  209 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEcc-----CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence            335788999999999999999999999987     999999999999999999999999999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-------  256 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-------  256 (431)
                      |++.+++||||||++||++..+|.+.+.|+|..+++|+++++.||+.||+.|+|||||||+|+|||..||...       
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998110       


Q ss_pred             --------------------------CC-------------------------CCcccccCCCCCCchhhhccCCCCCcc
Q 014087          257 --------------------------ES-------------------------SRSNSMCGTTEYMAPEILLSKGHNKDA  285 (431)
Q Consensus       257 --------------------------~~-------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~  285 (431)
                                                ..                         ....+.+|||.|||||++.+++|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence                                      00                         012245899999999999999999999


Q ss_pred             hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCC
Q 014087          286 DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK  361 (431)
Q Consensus       286 DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~  361 (431)
                      |||||||||||||.|.+||.+.++.+++.+|++.+  +.+|.  .++.+++|||.+||. ||.+|+|+.  +++||+.||
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~--G~~EIK~HP  446 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK--GAEEIKKHP  446 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc--cHHHHhcCC
Confidence            99999999999999999999999999999998876  55664  578999999999999 999999864  999999999


Q ss_pred             CCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCC----C-CC----------CCCCCccCeEeeCCC
Q 014087          362 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----P-TP----------TAGEHFKGYTYVAPN  425 (431)
Q Consensus       362 ~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~----~-~~----------~~~~~f~~~~~~~~~  425 (431)
                      ||++++|+.+....  |||+|.+.+..|+.|||+ |++.......+    + ..          ..+..|.||+|.+.+
T Consensus       447 fF~~v~W~~l~~~~--apfvP~v~~~~DT~yFdd-F~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~  522 (550)
T KOG0605|consen  447 FFKGVDWDHLREMP--APFVPQVNSELDTQYFDD-FPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFD  522 (550)
T ss_pred             ccccCCcchhhcCC--CCCCCCCCCccccccccc-CcccccCcccccccccchhhhhcccccCCcccccccceeeeccc
Confidence            99999999997655  999999999999999994 44422111100    0 00          123569999998765

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-68  Score=485.22  Aligned_cols=319  Identities=41%  Similarity=0.797  Sum_probs=300.8

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ...++..++|..+++||+|+||+|.+|+.+.     +++.||||+++|+.+..++.+..-..|-++|+.++||++..|..
T Consensus       161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKa-----t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY  235 (516)
T KOG0690|consen  161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKA-----TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY  235 (516)
T ss_pred             ccceeccchhhHHHHhcCCccceEEEEeecc-----cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence            3455678899999999999999999999987     99999999999999999999999999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--------
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------  254 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--------  254 (431)
                      .|++.+++|+||||+.||.|+.+|.+...|+|..+++|.++|+.||.|||+++||+||||.+|+|+|.+|+.        
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999983        


Q ss_pred             ---cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 014087          255 ---IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA  331 (431)
Q Consensus       255 ---~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  331 (431)
                         +.......++||||.|+|||++....|+.++|||.+||+||||++|+.||...+.+.++..|+.+.+++|..+++++
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eA  395 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEA  395 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHH
Confidence               44556778999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC-
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP-  410 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~-  410 (431)
                      +.|+..+|.+||.+|+|.++.++.+|.+|+||.+++|+++..+++.|||+|.+.+..|+++||++||..+....|+... 
T Consensus       396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~  475 (516)
T KOG0690|consen  396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYG  475 (516)
T ss_pred             HHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998877765432 


Q ss_pred             -------CCCCCccCeEeeCCCc
Q 014087          411 -------TAGEHFKGYTYVAPNP  426 (431)
Q Consensus       411 -------~~~~~f~~~~~~~~~~  426 (431)
                             ..+.+|..|+|.+...
T Consensus       476 ~~~~~~~e~~~~FpQFsy~~~~~  498 (516)
T KOG0690|consen  476 STVDEDEERRPHFPQFSYSASMG  498 (516)
T ss_pred             cccchhhhhccCCcceeeecchh
Confidence                   2468999999987643

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-65  Score=477.54  Aligned_cols=315  Identities=42%  Similarity=0.826  Sum_probs=296.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+...+|.++.+||+|+||+|.++..++     +.+.||||+++++.+...+.++.-+.|.++|... +-|++++|+.+|
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            3456689999999999999999999887     8899999999999999988899889999999877 578999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----------  254 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----------  254 (431)
                      ++-+++|+||||+.||+|..++++-+.|.|..+.+|+++|+-||-+||++|||+||||.+|||||.+|+.          
T Consensus       420 QTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  420 QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             hhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999983          


Q ss_pred             -cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          255 -IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       255 -~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                       +.....+.++|||+.|+|||++..++|+.++||||+||+|||||.|++||++.+..++++.|...+..+|..+|.|+.+
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~  579 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVA  579 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHH
Confidence             3344566789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC---
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP---  410 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---  410 (431)
                      +++.+|.+.|.+|+|+++.+-++|..||||+.|||+.++.++++|||+|.+..-.+.+|||+.||..+.+..|+..-   
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~  659 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMM  659 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHh
Confidence            99999999999999999999999999999999999999999999999999988889999999999999888876432   


Q ss_pred             -CCCCCccCeEeeCCC
Q 014087          411 -TAGEHFKGYTYVAPN  425 (431)
Q Consensus       411 -~~~~~f~~~~~~~~~  425 (431)
                       -++..|.||+|+|+.
T Consensus       660 nldq~eF~gFsfvNpe  675 (683)
T KOG0696|consen  660 NLDQSEFEGFSFVNPE  675 (683)
T ss_pred             cCchhhcCceeeeChh
Confidence             478999999999986

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-61  Score=453.43  Aligned_cols=276  Identities=40%  Similarity=0.722  Sum_probs=251.4

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++++.||.|.-|+||+|+.++     ++..+|||+|.+..+.....+.++..|.+||+.++||+++.||..|
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            44566789999999999999999999987     7799999999999998888899999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc-------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-------  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~-------  255 (431)
                      +.++..|||||||.||+|..+++++  +.|++..+++|+++|+.||+|||-.|||+|||||+||||-++||..       
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence            9999999999999999999988876  5799999999999999999999999999999999999999998710       


Q ss_pred             ------------------------------------------------------------CCCCCcccccCCCCCCchhh
Q 014087          256 ------------------------------------------------------------DESSRSNSMCGTTEYMAPEI  275 (431)
Q Consensus       256 ------------------------------------------------------------~~~~~~~~~~Gt~~y~aPE~  275 (431)
                                                                                  ....++.+++||-+|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence                                                                        00123456789999999999


Q ss_pred             hccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCC
Q 014087          276 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGG  353 (431)
Q Consensus       276 ~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~  353 (431)
                      +.+.+++.++|||+|||+|||||.|..||.+.+..+.+.+|+.....+|.  .++..++|||+++|.+||.+|+|+. .+
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~-rG  385 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK-RG  385 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc-cc
Confidence            99999999999999999999999999999999999999999999999885  5789999999999999999999875 47


Q ss_pred             HHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCc
Q 014087          354 VDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD  388 (431)
Q Consensus       354 ~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~  388 (431)
                      +.||++||||++++|.  .-|..+||++|......
T Consensus       386 A~eIK~HpFF~gVnWa--Lir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  386 AAEIKRHPFFEGVNWA--LIRCARPPEIPKPVDGG  418 (459)
T ss_pred             hHHhhcCccccCCChh--heeccCCCcCCCccccC
Confidence            8999999999999999  34678899999776543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-61  Score=441.01  Aligned_cols=318  Identities=38%  Similarity=0.801  Sum_probs=294.1

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceee
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (431)
                      ..+.+...+|.++++||+|+|++|.+++++.     +.++||+|+++|..+.+.+.++++..|..+.... +||++|-|+
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~-----t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh  317 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH  317 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcc-----cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence            3455678899999999999999999999987     8999999999999988888999999999998876 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc-------
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------  254 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~-------  254 (431)
                      .+|+++.++++|.||++||+|..+++++..++|+.+++|..+|+.||.|||++|||+||||.+|+|||..|+.       
T Consensus       318 scfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             hhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999983       


Q ss_pred             ----cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcccC
Q 014087          255 ----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--------ANRQKLQQRIINEKVK  322 (431)
Q Consensus       255 ----~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~--------~~~~~~~~~i~~~~~~  322 (431)
                          +.....+.++||||.|+|||++.+..|+.++|||+|||+|+||+.|+.||+-        .+...+++-|+...++
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence                3445667899999999999999999999999999999999999999999952        2345678888999999


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCC-CHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCC
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPG-GVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP  401 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~-~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~  401 (431)
                      +|..+|-.+..+++..|.+||.+|+||.+. ++.+++.|+||+.+||+.++++++.|||.|.+++..+..|||..||.++
T Consensus       478 iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~  557 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEP  557 (593)
T ss_pred             ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCC
Confidence            999999999999999999999999999874 7999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCC----CCCCCccCeEeeCCC
Q 014087          402 ADDSPAPTP----TAGEHFKGYTYVAPN  425 (431)
Q Consensus       402 ~~~~~~~~~----~~~~~f~~~~~~~~~  425 (431)
                      ...+|....    .++..|.||.|+|+-
T Consensus       558 ~qltpdd~d~i~ridqsefegfeyinpl  585 (593)
T KOG0695|consen  558 VQLTPDDEDAIKRIDQSEFEGFEYINPL  585 (593)
T ss_pred             cccCCCCHHHHHhcchhhcCcceecchh
Confidence            888876543    578899999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-60  Score=459.60  Aligned_cols=260  Identities=41%  Similarity=0.725  Sum_probs=244.4

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .-...||.+++.||+|+|++|++|+.+.     +++.||||++.|..+..+..++.+..|..+|..| .||.|++|+..|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-----t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKA-----TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecC-----CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            4456789999999999999999999987     8999999999999999999999999999999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--------  256 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--------  256 (431)
                      +++..+|+|+||+++|+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||+|||||.||+...        
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999987211        


Q ss_pred             ----------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 014087          257 ----------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       257 ----------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~  320 (431)
                                      ......+++||..|++||++.....+..+|+|+||||||+|+.|.+||.+.+..-++++|+.-.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence                            0111256899999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhccc
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  375 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~  375 (431)
                      +.+|+.+++.+.+||+++|..||.+|+     ++++|++||||.++||+.+.+..
T Consensus       304 y~fp~~fp~~a~dLv~KLLv~dp~~Rl-----t~~qIk~HpFF~~Vdw~nlw~~~  353 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKKLLVRDPSDRL-----TSQQIKAHPFFEGVDWENLWQQT  353 (604)
T ss_pred             ccCCCCCCHHHHHHHHHHHccCccccc-----cHHHHhhCcccccCChhhhhhcC
Confidence            999999999999999999999999999     88999999999999999987543

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-60  Score=450.73  Aligned_cols=319  Identities=38%  Similarity=0.701  Sum_probs=280.7

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..+.|...++||+||||.||-|+.+.     +|+.||+|.+.|..+..+.......+|..||.+++.++||.|-..|
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvra-----TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRA-----TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEec-----chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            34567789999999999999999999887     9999999999999888777778889999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc-------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-------  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~-------  255 (431)
                      ++.+.+||||..|.||+|..+|.+.+  .|+|..+++|+++|+.||++||+.+||+|||||+|||+|+.|+..       
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999999999876  799999999999999999999999999999999999999999942       


Q ss_pred             ---CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccCCCCCCC
Q 014087          256 ---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLT  328 (431)
Q Consensus       256 ---~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s  328 (431)
                         .........+||.+|||||++.++.|+.+.|||||||+||||+.|+.||...    ..+++-++++.....+|+.+|
T Consensus       335 vei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS  414 (591)
T KOG0986|consen  335 VEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFS  414 (591)
T ss_pred             EecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccC
Confidence               2333445559999999999999999999999999999999999999999753    345788888999999999999


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcc-cCCCCCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC-WTTMPADDSPA  407 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~-~~~~~~~~~~~  407 (431)
                      +++++|++.+|++||.+|+||...+++++++||||+++||..++...+.|||+|+.....+..-||-. |.+..-   -.
T Consensus       415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKG---V~  491 (591)
T KOG0986|consen  415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKG---VK  491 (591)
T ss_pred             HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccc---ee
Confidence            99999999999999999999998999999999999999999999999999999998765544433311 112111   11


Q ss_pred             CCCCCCCCccCeEe-eCCCccccCC
Q 014087          408 PTPTAGEHFKGYTY-VAPNPWLSSV  431 (431)
Q Consensus       408 ~~~~~~~~f~~~~~-~~~~~~~~~~  431 (431)
                      ....+++-|++|.- +.+-+||+|+
T Consensus       492 ld~~D~~fy~~F~tg~vsipWQnE~  516 (591)
T KOG0986|consen  492 LDDTDTDFYKNFATGSVSIPWQNEM  516 (591)
T ss_pred             cccccHHHHHhccCCcccchHHHHH
Confidence            23357888999999 8888999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-59  Score=481.49  Aligned_cols=312  Identities=38%  Similarity=0.702  Sum_probs=273.8

Q ss_pred             hhhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceee
Q 014087          102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR  181 (431)
Q Consensus       102 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  181 (431)
                      ....++..++|+++++||+|+||.|.+|+++.     ++++||||++.|...........|+.|..+|...+.+.|+.|+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~-----t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS-----TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeec-----cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            34556778899999999999999999999997     9999999999998888888888999999999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----  256 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----  256 (431)
                      ..|+++.++|+|||||+||+|..++.+.++++|+.+++|+++|+.||+-||+.|+|||||||+|||||..||...     
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999432     


Q ss_pred             -------CCCCcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccC
Q 014087          257 -------ESSRSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVK  322 (431)
Q Consensus       257 -------~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~  322 (431)
                             ..-.+..-+|||.|++||++..     +.|+..+||||+||++|||++|..||..++..+.+.+|++.  .+.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence                   2223456789999999999983     45899999999999999999999999999999999999976  677


Q ss_pred             CC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCC
Q 014087          323 LP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  400 (431)
Q Consensus       323 ~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  400 (431)
                      ||  ..+|+++++||+++|. +|+.|+|-  +++++|+.||||.+++|+.+  |...|||+|.+++.+|++|||..-...
T Consensus       302 FP~~~~VSeeakdLI~~ll~-~~e~RLgr--ngiedik~HpFF~g~~W~~i--R~~~pP~vPevssd~DTsnFd~~~dd~  376 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALLC-DREVRLGR--NGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVSSDDDTSNFDVDEDDL  376 (1317)
T ss_pred             CCcccccCHHHHHHHHHHhc-Chhhhccc--ccHHHHHhCccccCCChhhh--hhcCCCCCCcCCCCCcccccccccccc
Confidence            88  5699999999999996 89999964  48999999999999999877  567799999999999999996543222


Q ss_pred             CCCC-CC----CCCCCCCCCccCeEeeC
Q 014087          401 PADD-SP----APTPTAGEHFKGYTYVA  423 (431)
Q Consensus       401 ~~~~-~~----~~~~~~~~~f~~~~~~~  423 (431)
                      .... .+    .......-.|.||+|..
T Consensus       377 ~~~e~~p~~~~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  377 RDAETFPPRIPKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             chhhccCCCCCCCCcCCcCCeeeeeecc
Confidence            2211 12    11113456799999996

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-58  Score=430.19  Aligned_cols=252  Identities=32%  Similarity=0.585  Sum_probs=224.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh----hHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .+.|.+.+.||+|+||.|-+|..+.     +++.||||++.+......    .....+.+|+++|++|+|||||+++++|
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~-----tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK-----TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc-----cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            4568999999999999999999987     999999999998876542    2334467999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------  253 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----------  253 (431)
                      +..+..|+||||++||+|++.+..++.+.|..-+.+++|++.||.|||++||+||||||+|||+..+..           
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999999999999999999999999999999999999999999999999999988732           


Q ss_pred             --ccCCCCCcccccCCCCCCchhhhccCCC---CCcchhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCCC---
Q 014087          254 --EIDESSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKVKLP---  324 (431)
Q Consensus       254 --~~~~~~~~~~~~Gt~~y~aPE~~~~~~~---~~~~DvwslGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~~p---  324 (431)
                        .......+.++|||+.|.|||++.++++   ..++|+||+||+||-+|+|.+||.+..... +.++|..+++.+-   
T Consensus       326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~  405 (475)
T KOG0615|consen  326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ  405 (475)
T ss_pred             hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence              1234566789999999999999997764   457899999999999999999998866555 8999999988764   


Q ss_pred             -CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       325 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                       ..+++++++||.+||..||++|+     +++++++||||+.+....
T Consensus       406 w~~Iseea~dlI~~mL~VdP~~R~-----s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  406 WDRISEEALDLINWMLVVDPENRP-----SADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hhhhhHHHHHHHHHhhEeCcccCc-----CHHHHhcChhhhcccccc
Confidence             35899999999999999999999     889999999999876544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-57  Score=441.98  Aligned_cols=245  Identities=30%  Similarity=0.600  Sum_probs=233.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      .+|+..+.||+|||++||.+++..     +|+.||+|++.+..+.+....+.+.+|++|.+.|+|||||+++++|++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~-----tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD-----TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC-----CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            469999999999999999999976     899999999999999899999999999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc-----------CCC
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DES  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~-----------~~~  258 (431)
                      +|||+|+|..++|..++++++.++|.+++.|+.||+.||.|||+++|||||||..||||+++-+..           ...
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999999999999999999999999999999999999999999999999999985522           233


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      .+..++||||.|+|||++...+++..+||||+||+||.||+|++||...+..+++.+|....+.+|..++.++++||.+|
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHH
Confidence            56678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      |..||.+||     ++++|+.|+||+
T Consensus       253 L~~~P~~Rp-----sl~~vL~h~Ff~  273 (592)
T KOG0575|consen  253 LRPNPSERP-----SLDEVLDHPFFK  273 (592)
T ss_pred             hcCCcccCC-----CHHHHhcCHhhh
Confidence            999999999     999999999994

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.4e-55  Score=428.01  Aligned_cols=304  Identities=41%  Similarity=0.815  Sum_probs=269.1

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|+++.     +++.||||++++...........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence            469999999999999876     889999999988765556666778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCcccc
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNSM  264 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~~  264 (431)
                      |+.||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.....+           ......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            999999999999988999999999999999999999999999999999999999987632211           122346


Q ss_pred             cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcC
Q 014087          265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  344 (431)
Q Consensus       265 ~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  344 (431)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|..++.++.+||.+||++||+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            79999999999999999999999999999999999999999988888999998888999999999999999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC--------CCCCCc
Q 014087          345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--------TAGEHF  416 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--------~~~~~f  416 (431)
                      +|++....++++|++||||.+++|..+..+++.|++.|.+....++.+|+..++.......++...        .....|
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  315 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHF  315 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCcccccccccccccccC
Confidence            999877778999999999999999999999999999999988889999988777754443333211        245689


Q ss_pred             cCeEeeCC
Q 014087          417 KGYTYVAP  424 (431)
Q Consensus       417 ~~~~~~~~  424 (431)
                      .+|+|.+.
T Consensus       316 ~~~~~~~~  323 (323)
T cd05571         316 PQFSYSAS  323 (323)
T ss_pred             CCCeeeCC
Confidence            99999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7e-55  Score=425.82  Aligned_cols=307  Identities=40%  Similarity=0.766  Sum_probs=269.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKG-----TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            345789999999999999999999886     789999999988766555667788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      ++.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+        
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999999999999988999999999999999999999999999999999999999988633221        


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+...+|..++.++++||.+|
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  249 (329)
T PTZ00263        170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL  249 (329)
T ss_pred             CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCCCCCCCccC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKG  418 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~f~~  418 (431)
                      |+.||.+|+++...++++|+.||||++++|..+..+.+.+|+.+......+..+|+. +.+-+....++.....+..|.|
T Consensus       250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~~~~~~~~~~  328 (329)
T PTZ00263        250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEK-YPDSPVDRLPPLTAAQQAEFAG  328 (329)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccC-CcccccccCCCCchhhhhhcCC
Confidence            999999999887778999999999999999999999888888887777778888874 2332222233333446677777


Q ss_pred             e
Q 014087          419 Y  419 (431)
Q Consensus       419 ~  419 (431)
                      |
T Consensus       329 ~  329 (329)
T PTZ00263        329 F  329 (329)
T ss_pred             C
Confidence            6

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-55  Score=408.04  Aligned_cols=248  Identities=29%  Similarity=0.494  Sum_probs=225.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++.+.++.||+|..|+||+|+|+.     +++.||+|++...  .+....+++.+|+++++.++|||||++|+.|..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~-----t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKP-----TGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcC-----CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            555688999999999999999999997     9999999999433  355667789999999999999999999999999


Q ss_pred             CCE-EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCcc---------
Q 014087          187 RSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEI---------  255 (431)
Q Consensus       187 ~~~-~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~---------  255 (431)
                      +.. ++++||||+||+|...+.+.++++|..+..|+.+|++||.|||+ ++||||||||+||||+..|...         
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            994 99999999999999999998999999999999999999999995 9999999999999999999843         


Q ss_pred             CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc-ccCCCCC-CC
Q 014087          256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLPPF-LT  328 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s  328 (431)
                      .....+.+++||..|||||.+.+..|+.++||||||++++||.+|+.||...     +..+++..|..+ ...+|.. +|
T Consensus       229 lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS  308 (364)
T KOG0581|consen  229 LVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS  308 (364)
T ss_pred             hhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence            2233567899999999999999999999999999999999999999999874     778899999885 5567886 99


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +++++||.+||++||.+|+     +++++++|||++..
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~-----s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERP-----SAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHHHHHHHhcCCcccCC-----CHHHHhcCHHHhhc
Confidence            9999999999999999999     89999999999853

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.5e-54  Score=419.76  Aligned_cols=307  Identities=40%  Similarity=0.804  Sum_probs=268.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  189 (431)
                      +|++++.||+|+||.||+|+++.     +++.||||++++...........+..|..++..+ +|++|+++++++.+.+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence            58999999999999999999876     7889999999887655555566677788888877 58999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+||||++||+|..++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+|.....+           
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999999999999888899999999999999999999999999999999999999988633211           


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+||.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence            12235679999999999999999999999999999999999999999999999999999988899999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC----CCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP----TAGE  414 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~----~~~~  414 (431)
                      |++||.+|+++.....+++++|+||+.++|+.+..+.++||+.|.... .+..+|+..+...++...+....    ..+.
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKFFTRHPPVLTPPDQEVIMNLDQS  314 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCchhccCCccCCCCCcccccccccc
Confidence            999999999887778899999999999999999999999999998764 67778887766554433333222    2457


Q ss_pred             CccCeEeeC
Q 014087          415 HFKGYTYVA  423 (431)
Q Consensus       415 ~f~~~~~~~  423 (431)
                      .|+||+|++
T Consensus       315 ~~~~~~~~~  323 (323)
T cd05616         315 EFEGFSYVN  323 (323)
T ss_pred             ccCCCcccC
Confidence            899999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.9e-54  Score=420.53  Aligned_cols=305  Identities=36%  Similarity=0.753  Sum_probs=268.9

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHH---HhcCCCCcceeeEEEEeCC
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL---TKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~  188 (431)
                      |++++.||+|+||.||+|+++.     +++.||||++++.........+.+.+|++++   +.++||||+++++++.+.+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence            7889999999999999999876     8899999999887655555666777777766   4567999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+.||+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+          
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999999999888754 5799999999999999999999999999999999999999988633211          


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.+||.+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  234 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR  234 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence             1223567999999999999999999999999999999999999999999989999999888888999999999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC-----CCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-----TPTA  412 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~-----~~~~  412 (431)
                      ||+.||.+|+++...+++++++||||++++|..+..+.+.|++.|.+....+.++|+..++...+..++..     .+..
T Consensus       235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (324)
T cd05589         235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPREPRLLTEEE  314 (324)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCccccccchhh
Confidence            99999999998887899999999999999999999999999999999988999999988777655444432     3357


Q ss_pred             CCCccCeEee
Q 014087          413 GEHFKGYTYV  422 (431)
Q Consensus       413 ~~~f~~~~~~  422 (431)
                      ++.|.+|+|+
T Consensus       315 ~~~~~~~~~~  324 (324)
T cd05589         315 QELFRGFDYV  324 (324)
T ss_pred             hcccCCcccC
Confidence            8999999985

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-54  Score=419.38  Aligned_cols=308  Identities=42%  Similarity=0.834  Sum_probs=270.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC-CCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~  189 (431)
                      +|++++.||+|+||.||+|+++.     +++.||||++.+.........+.+..|+.++..+.| ++|+++++++.+.+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence            58999999999999999999876     788999999988765555666778889999999976 568889999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+           
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999999999999888899999999999999999999999999999999999999987632211           


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            12234579999999999999999999999999999999999999999999999999999888889999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC----CCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PTAGE  414 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~----~~~~~  414 (431)
                      |.+||.+|+++.....+++++||||+.++|..+..+.+.+++.|.+....+..+|+..+........+...    ...+.
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKLVIANIDQS  315 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCCcccccccccc
Confidence            99999999987666789999999999999999999999999999998888899999877665544443322    23567


Q ss_pred             CccCeEeeC
Q 014087          415 HFKGYTYVA  423 (431)
Q Consensus       415 ~f~~~~~~~  423 (431)
                      .|.+|+|++
T Consensus       316 ~~~~~~~~~  324 (324)
T cd05587         316 EFQGFSFVN  324 (324)
T ss_pred             ccCCCcccC
Confidence            899999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.3e-54  Score=418.91  Aligned_cols=306  Identities=41%  Similarity=0.794  Sum_probs=269.3

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence            469999999999999876     889999999988766556667778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCcccc
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNSM  264 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~~  264 (431)
                      |+++|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+           ......
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            999999999998888899999999999999999999999999999999999999887632211           122345


Q ss_pred             cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcC
Q 014087          265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  344 (431)
Q Consensus       265 ~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  344 (431)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+......+|..++.++.+||.+||.+||+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence            79999999999999999999999999999999999999999988888888888888889999999999999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC----------CCCCC
Q 014087          345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----------PTAGE  414 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~----------~~~~~  414 (431)
                      +|++..+.++++|++|+||.+++|..+..+.+.|++.|......+...|+..++.......++..          .....
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRP  315 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCCcccCCcccccccccccccccccc
Confidence            99988888999999999999999999999999999999998888888898877665433222211          12357


Q ss_pred             CccCeEeeCCCc
Q 014087          415 HFKGYTYVAPNP  426 (431)
Q Consensus       415 ~f~~~~~~~~~~  426 (431)
                      .|.+|+|.++++
T Consensus       316 ~~~~~~~~~~~~  327 (328)
T cd05593         316 HFPQFSYSASGR  327 (328)
T ss_pred             ccCCceeeCCCC
Confidence            899999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-56  Score=429.24  Aligned_cols=286  Identities=36%  Similarity=0.729  Sum_probs=270.6

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+...+++.+..||-||||.|-+++.++     ....+|+|+++|..+.+..+.+++..|.+||..++.|+||+||-.|.
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr  490 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR  490 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence            4566789999999999999999999875     34469999999999999999999999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----------c
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----------I  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----------~  255 (431)
                      +.+.+|++||-|-||+|+..|++++.|++..+++|+.++++|++|||++|||+|||||+|+|+|.+|..          +
T Consensus       491 d~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  491 DSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             cchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            999999999999999999999999999999999999999999999999999999999999999999973          3


Q ss_pred             CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHH
Q 014087          256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHS  333 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~  333 (431)
                      .....+.++|||+.|+|||++.+++++.++|.||||+++||||+|.+||.+.++..+++.|+.+  .+.+|..++..+.+
T Consensus       571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~  650 (732)
T KOG0614|consen  571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD  650 (732)
T ss_pred             ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence            4556778999999999999999999999999999999999999999999999999999999986  67899999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcc
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  396 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~  396 (431)
                      ||+++...+|.+|+|....++.+|++|.||.+.||+.+..+.+.||++|.+.+..|++|||..
T Consensus       651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~  713 (732)
T KOG0614|consen  651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF  713 (732)
T ss_pred             HHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence            999999999999999888899999999999999999999999999999999999999999963

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-54  Score=414.87  Aligned_cols=282  Identities=40%  Similarity=0.773  Sum_probs=257.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||+||+|+++.     +++.||+|++...........+.+.+|+.+|+.++||||+++++++.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            369999999999999999999876     789999999987655455556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------CCc
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------SRS  261 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------~~~  261 (431)
                      +|+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+        ...
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999999999999999988999999999999999999999999999999999999999887632211        122


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK  341 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  341 (431)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++++||++||+.
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCC
Confidence            35679999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcc
Q 014087          342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  396 (431)
Q Consensus       342 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~  396 (431)
                      ||.+|+++...++++++.|+||+.++|..+..++..|++.|.+....++.||+.+
T Consensus       236 dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  290 (291)
T cd05612         236 DRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDY  290 (291)
T ss_pred             CHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccCC
Confidence            9999998877789999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6e-54  Score=420.85  Aligned_cols=287  Identities=40%  Similarity=0.711  Sum_probs=258.9

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||.||+|.++.    ..+..||+|++.+.........+.+.+|+.+++.++||||+++++++
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKN----EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEEC----CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            44566789999999999999999998764    13468999999887665666677888999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      .+.+.+|+||||+.||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+      
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999999999999988999999999999999999999999999999999999999888643211      


Q ss_pred             --CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+..+...+|..++.+++++|+
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK  260 (340)
T ss_pred             cCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence              123456899999999999999999999999999999999999999999998889999999988899999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCc
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  395 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~  395 (431)
                      +||+.||.+|++....+++++++||||++++|..+..+.+.+|+.|......+.++|+.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  319 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFER  319 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCC
Confidence            99999999999877779999999999999999999999999999999888877788764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.1e-54  Score=418.14  Aligned_cols=303  Identities=39%  Similarity=0.781  Sum_probs=265.1

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||||++++...........+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE-----SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence            469999999999999876     7889999999887655556667778898888876 6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+           .....
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9999999999999888999999999999999999999999999999999999999987632211           12234


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++++||++||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence            67999999999999999999999999999999999999999999999999999998888999999999999999999999


Q ss_pred             CCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCC----CCCCCCCCccC
Q 014087          344 SKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTAGEHFKG  418 (431)
Q Consensus       344 ~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~----~~~~~~~~f~~  418 (431)
                      .+|+++.. .+.++++.||||++++|+.+..+.+.|||.|.+....+..+|+..+.......++.    .....++.|++
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRN  315 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCCCCcccccccccccCcCC
Confidence            99996532 24599999999999999999999999999999999999999998776654433321    23356789999


Q ss_pred             eEeeC
Q 014087          419 YTYVA  423 (431)
Q Consensus       419 ~~~~~  423 (431)
                      |+|.+
T Consensus       316 ~~~~~  320 (320)
T cd05590         316 FSYTA  320 (320)
T ss_pred             CcccC
Confidence            99863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-53  Score=414.20  Aligned_cols=297  Identities=46%  Similarity=0.859  Sum_probs=262.7

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||+|+||+||+|+++.     +++.||+|++++...........+.+|+.+|+.++||||+++++++.+.+.+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRD-----TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            7999999999999875     78899999998766555666777889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCcccccC
Q 014087          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNSMCG  266 (431)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~~~G  266 (431)
                      +||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           .......+|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            999999999988899999999999999999999999999999999999999988763211           112334679


Q ss_pred             CCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCc
Q 014087          267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR  346 (431)
Q Consensus       267 t~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R  346 (431)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+......+|..++.++++||.+||..||.+|
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----CCCCCCCccCeEe
Q 014087          347 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTY  421 (431)
Q Consensus       347 ~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----~~~~~~~f~~~~~  421 (431)
                      ++..  ++++++.||||+..+|..+..+.+++++.|.+....++++|+..++...+..+...    ....+..|.+|+|
T Consensus       236 ~~~~--~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (312)
T cd05585         236 LGYN--GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQFGGWSY  312 (312)
T ss_pred             CCCC--CHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccccccccCCCccccccchhccccCCCCC
Confidence            9753  78999999999999999999999999999999888899999987766433222221    2245788988876

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-53  Score=413.96  Aligned_cols=302  Identities=42%  Similarity=0.842  Sum_probs=266.8

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||||++++...........+..|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG-----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            469999999999999876     7889999999987665666677788899999887 7999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||+.||+|..++.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.+|.....+           .....
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9999999999999888999999999999999999999999999999999999999987632211           12234


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+......+|..++.++.+||.+||+.||
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCH
Confidence            57999999999999999999999999999999999999999998888888999888888899999999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----CCCCCCCccCe
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGY  419 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----~~~~~~~f~~~  419 (431)
                      .+|+++......+++.||||+.++|.....+.+.|+++|.+....+..+|+..+...+...++..    ....++.|.||
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGF  315 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCcccccccccccccCCC
Confidence            99996655556999999999999999999999999999999998999999987766555444333    22578999999


Q ss_pred             Eee
Q 014087          420 TYV  422 (431)
Q Consensus       420 ~~~  422 (431)
                      .|+
T Consensus       316 ~~~  318 (318)
T cd05570         316 SYI  318 (318)
T ss_pred             CCC
Confidence            985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.6e-53  Score=412.73  Aligned_cols=307  Identities=43%  Similarity=0.827  Sum_probs=267.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (431)
                      +|++.+.||+|+||+||+|+++.     +++.||||++.+.........+.+..|..+++.+. |++|+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence            48899999999999999999886     88999999998876555556677888999998885 5788899999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+||||++||+|..++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+           
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999999999999888999999999999999999999999999999999999999988632211           


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+|+.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            11234579999999999999999999999999999999999999999999999999999988899999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCC----CCCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----PTPTAGE  414 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~----~~~~~~~  414 (431)
                      |++||.+|+++.....+++++|+||+.++|..+..+.+.+|++|....+ ...+|++.++......+++    -...+..
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQLVIANIDQA  314 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCccccccCCCCCCCccccccccccc
Confidence            9999999998776678999999999999999999999999999987664 4788888776543333221    2224567


Q ss_pred             CccCeEeeC
Q 014087          415 HFKGYTYVA  423 (431)
Q Consensus       415 ~f~~~~~~~  423 (431)
                      .|.+|+|++
T Consensus       315 ~~~~~~~~~  323 (323)
T cd05615         315 DFEGFSYVN  323 (323)
T ss_pred             ccCCCcccC
Confidence            899999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-53  Score=414.37  Aligned_cols=303  Identities=40%  Similarity=0.808  Sum_probs=264.8

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      ++||+|+||.||+|+++.     +++.||+|++++.........+.+..|.+++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG-----TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence            469999999999999876     7889999999887665566667778899999866 7999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            999999999999988899999999999999999999999999999999999999998863221           112334


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....+.+......+|..++.++.+||.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCH
Confidence            57999999999999999999999999999999999999999999999999999998888999999999999999999999


Q ss_pred             CCcCCCCCC--CHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC----CCCCCCcc
Q 014087          344 SKRLGSGPG--GVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PTAGEHFK  417 (431)
Q Consensus       344 ~~R~~~~~~--~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~----~~~~~~f~  417 (431)
                      ++|+++...  +++++++||||.+++|..+..++..++|.|.+....+..+|+..++.......+..+    ...++.|.
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAVIKQINQEEFR  315 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCccccCCCCccccccccccccC
Confidence            999977543  899999999999999999999999999999988888888888776654433333221    24567899


Q ss_pred             CeEeeC
Q 014087          418 GYTYVA  423 (431)
Q Consensus       418 ~~~~~~  423 (431)
                      ||+|.+
T Consensus       316 ~~~~~~  321 (321)
T cd05591         316 GFSFFN  321 (321)
T ss_pred             CCcccC
Confidence            999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-53  Score=412.15  Aligned_cols=299  Identities=39%  Similarity=0.773  Sum_probs=262.1

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||||++++..............|..+++.+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            469999999999999886     7889999999887544444455666788888764 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||++||+|..++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.....+           .....
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9999999999998888899999999999999999999999999999999999999987632211           12234


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+......+|..++.++++||.+||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCH
Confidence            57999999999999999999999999999999999999999998888888888877778888999999999999999999


Q ss_pred             CCcCCCCCCCH-HHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----CCCCCCCccC
Q 014087          344 SKRLGSGPGGV-DAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKG  418 (431)
Q Consensus       344 ~~R~~~~~~~~-~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----~~~~~~~f~~  418 (431)
                      ++|+     ++ +++++||||+.++|..+..+.+.|++.|......+.++|++.+.+.....+...    ...+++.|+|
T Consensus       236 ~~R~-----~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (316)
T cd05619         236 ERRL-----GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFEN  310 (316)
T ss_pred             hhcC-----CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCCCcccccccccccccCC
Confidence            9999     55 489999999999999999999999999999999999999999887765544322    2367899999


Q ss_pred             eEeeCC
Q 014087          419 YTYVAP  424 (431)
Q Consensus       419 ~~~~~~  424 (431)
                      |+|.++
T Consensus       311 ~~~~~~  316 (316)
T cd05619         311 FSFINP  316 (316)
T ss_pred             CcccCc
Confidence            999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.8e-53  Score=412.51  Aligned_cols=303  Identities=40%  Similarity=0.792  Sum_probs=266.7

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|+++.     +++.||+|++++...........+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence            469999999999999876     789999999988765555666778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCcccc
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNSM  264 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~~  264 (431)
                      |++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+           ......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            999999999998888899999999999999999999999999999999999999987632211           122346


Q ss_pred             cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcC
Q 014087          265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPS  344 (431)
Q Consensus       265 ~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~  344 (431)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||..||+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence            79999999999999999999999999999999999999999988888888988888889999999999999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC--------CCCCCCc
Q 014087          345 KRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT--------PTAGEHF  416 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~--------~~~~~~f  416 (431)
                      +|++..+.++.++++|+||.+++|..+..+.+.|++.|......+...|+..++.......++..        ......|
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHF  315 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCCccCCCCccccccccccccccccc
Confidence            99988878999999999999999999999999999999999999999999888775433222211        1234678


Q ss_pred             cCeEeeC
Q 014087          417 KGYTYVA  423 (431)
Q Consensus       417 ~~~~~~~  423 (431)
                      ..|+|..
T Consensus       316 ~~~~~~~  322 (323)
T cd05595         316 PQFSYSA  322 (323)
T ss_pred             CCCcccC
Confidence            8888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4e-53  Score=411.11  Aligned_cols=300  Identities=40%  Similarity=0.822  Sum_probs=264.5

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||+|++++.........+.+..|..++..+ +||||+++++++..++.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG-----TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            469999999999999876     7889999999887654555556666777777654 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||++||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            999999999999888899999999999999999999999999999999999999988763221           122335


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||.+||..||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            67999999999999999999999999999999999999999999988888888888888899999999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----CCCCCCCccCe
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGY  419 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----~~~~~~~f~~~  419 (431)
                      ++|++.    .+++++|+||+.++|..+..+++.|+|.|......+..+|+..++......++..    ...++..|.+|
T Consensus       236 ~~R~~~----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (316)
T cd05592         236 TKRLGV----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASMDQEQFRGF  311 (316)
T ss_pred             HHcCCC----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCCccccccccccccccCCC
Confidence            999932    4689999999999999999999999999999888899999999888776666554    33678999999


Q ss_pred             EeeCC
Q 014087          420 TYVAP  424 (431)
Q Consensus       420 ~~~~~  424 (431)
                      +|.++
T Consensus       312 ~~~~~  316 (316)
T cd05592         312 SFTNP  316 (316)
T ss_pred             cccCc
Confidence            99885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.7e-53  Score=411.05  Aligned_cols=303  Identities=38%  Similarity=0.795  Sum_probs=261.6

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||.||+|+++.     +++.||+|++++.........+.+..|..+++.+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK-----TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence            469999999999999886     7899999999987665566677788999999988 7999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            999999999999888899999999999999999999999999999999999999988763221           122345


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...         ....+.+.+......+|..++.++.+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  235 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            68999999999999999999999999999999999999999631         223456667777888999999999999


Q ss_pred             HHhhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC----
Q 014087          335 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----  409 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~----  409 (431)
                      |++||+.||.+|+++.. .++++++.||||++++|..+..+...|++.|.+....+..+|+..+...+....+...    
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  315 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDVIA  315 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCCCccccc
Confidence            99999999999997533 3689999999999999999999999999999998888888999888776554444322    


Q ss_pred             CCCCCCccCeEeeC
Q 014087          410 PTAGEHFKGYTYVA  423 (431)
Q Consensus       410 ~~~~~~f~~~~~~~  423 (431)
                      ...+..|.+|.|.+
T Consensus       316 ~~~~~~~~~~~~~~  329 (329)
T cd05588         316 RIDQSEFEGFEYIN  329 (329)
T ss_pred             cccccccCCCcccC
Confidence            34678899999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-52  Score=408.90  Aligned_cols=308  Identities=51%  Similarity=0.934  Sum_probs=267.0

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (431)
                      ++.||+|+||.||+|+....  ..+++.||+|++++.... .......+.+|+.+|+.++||||+++++++..++.+|+|
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTG--ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             CceeeecCCeEEEEEEEccc--CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            36899999999999987431  136889999999876542 223345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCcc
Q 014087          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSN  262 (431)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~  262 (431)
                      |||+.||+|.+++.+.+.+.+..+..++.||+.||.|||++||+||||||+|||++.+|.....           .....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence            9999999999999998899999999999999999999999999999999999999988763221           11223


Q ss_pred             cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccC
Q 014087          263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD  342 (431)
Q Consensus       263 ~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  342 (431)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..+...+|..++.++.+||.+||++|
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence            45799999999999999999999999999999999999999999988888899998888999999999999999999999


Q ss_pred             cCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC---CCCCCCCccCe
Q 014087          343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP---TPTAGEHFKGY  419 (431)
Q Consensus       343 P~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~---~~~~~~~f~~~  419 (431)
                      |++|+++.+.++++++.||||+..+|..+..+...+++.+......+.+.|+..++...+..++..   .......|.||
T Consensus       239 p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFLGF  318 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccccccccccCcCCC
Confidence            999998888899999999999999999999999999999988888888889887766544333322   22356899999


Q ss_pred             EeeCC
Q 014087          420 TYVAP  424 (431)
Q Consensus       420 ~~~~~  424 (431)
                      +|+++
T Consensus       319 ~~~~~  323 (323)
T cd05584         319 TYVAP  323 (323)
T ss_pred             eecCC
Confidence            99864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.8e-53  Score=408.40  Aligned_cols=300  Identities=37%  Similarity=0.755  Sum_probs=261.7

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      ++||+|+||.||+|+++.     +++.||+|++++...........+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG-----KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            469999999999999886     8889999999886554444556677788888754 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||+.||+|..++...+.+++.++..++.||+.||+|||++||+||||||+|||++.+|.....+           .....
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9999999999998888899999999999999999999999999999999999999987632221           12235


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+......+|..++.++++||.+||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            67999999999999999999999999999999999999999998888888888888888899999999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC----CCCCCCccCe
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PTAGEHFKGY  419 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~----~~~~~~f~~~  419 (431)
                      ++|+++    .+++++||||++++|..+..+++.+++.|......+.++|+..+.......+....    ..++..|.+|
T Consensus       236 ~~R~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (316)
T cd05620         236 TRRLGV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGF  311 (316)
T ss_pred             HHcCCC----hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccCCCcccccccccccCcCCC
Confidence            999932    36899999999999999999999999999998888999999887766554443322    2467899999


Q ss_pred             EeeCC
Q 014087          420 TYVAP  424 (431)
Q Consensus       420 ~~~~~  424 (431)
                      +|.++
T Consensus       312 ~~~~~  316 (316)
T cd05620         312 SFINP  316 (316)
T ss_pred             cccCC
Confidence            99875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-52  Score=408.94  Aligned_cols=303  Identities=40%  Similarity=0.816  Sum_probs=261.3

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      ++||+|+||+||+|+.+.     +++.||+|++++.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK-----NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            479999999999999886     7889999999987666666677888999999888 6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            999999999999888889999999999999999999999999999999999999998763221           112335


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-------ANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                      .+||+.|+|||++.+..++.++|||||||+||||++|+.||..       .....+.+.+......+|..++.++.++|.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            6799999999999999999999999999999999999999953       233456666777777889999999999999


Q ss_pred             hhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC----CC
Q 014087          337 GLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT----PT  411 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~----~~  411 (431)
                      +||..||.+|+++.+ .++++++.||||++++|+.+..+++.|+|+|......+..+|+..+...+...++...    ..
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDEDVIKRI  315 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCccccccc
Confidence            999999999997532 3689999999999999999999999999999998888889998877665544443322    24


Q ss_pred             CCCCccCeEeeC
Q 014087          412 AGEHFKGYTYVA  423 (431)
Q Consensus       412 ~~~~f~~~~~~~  423 (431)
                      ++..|.||+|.+
T Consensus       316 ~~~~~~~~~~~~  327 (327)
T cd05617         316 DQSEFEGFEYIN  327 (327)
T ss_pred             cccccCCCcCCC
Confidence            677899998875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-54  Score=419.22  Aligned_cols=307  Identities=38%  Similarity=0.699  Sum_probs=263.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...+-|..++.||-|+||.|.+|+...     +..+||+|.++|..+..++++..++.|.+||...+.+.||+||..|++
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvD-----T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVD-----TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecc-----hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            556679999999999999999999875     889999999999999999999999999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------  256 (431)
                      ++.+|+||||++||++..+|.+.+.|.|+.+++|++++.+|+++.|+.|+|||||||+|||||.+|+...          
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999999999999999999999999999999999999999999999999999999999987210          


Q ss_pred             -------------------------------------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHH
Q 014087          257 -------------------------------------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL  293 (431)
Q Consensus       257 -------------------------------------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvi  293 (431)
                                                                 .......++||+.|+|||++...+|+..+||||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                                                       0112345689999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          294 LYEMLTGQPPFTHANRQKLQQRIINE--KVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       294 l~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ||||+.|+.||...++.+...+|++-  .+.+|  ..++.|+.++|.++. .+++.|+|..  +.++|+.||||++|||.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkn--g~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKN--GADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhccc--chhhhhcCccccccchH
Confidence            99999999999988888877777643  33344  579999999999876 5899999764  78889999999999999


Q ss_pred             hHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC---CC----CCCCCccCeEeeC
Q 014087          370 TLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP---TP----TAGEHFKGYTYVA  423 (431)
Q Consensus       370 ~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~---~~----~~~~~f~~~~~~~  423 (431)
                      .+  |+.+.+|+|.++-..|++|||....+....+....   ..    ....+|-+|+|-.
T Consensus       938 sl--Rkq~ApYIP~ItHptDTSNFdpvdpeklwnddses~~~~~~~nkhpehaFyEFTfRr  996 (1034)
T KOG0608|consen  938 SL--RKQRAPYIPRITHPTDTSNFDPVDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRR  996 (1034)
T ss_pred             hh--hhccCCcCccccCCCccccCCcCCccccccccccCCCcccccccCCccceeEeeeeh
Confidence            95  56678899999999999999976544333222111   11    1236788888754

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-52  Score=412.35  Aligned_cols=304  Identities=36%  Similarity=0.687  Sum_probs=251.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++++...........+.+|+.++..++||||+++++.+++...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD-----TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence            479999999999999999999876     789999999988766566667788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      +|+||||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+..         
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999999999998899999999999999999999999999999999999999988763211110         


Q ss_pred             -------------------------------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCC
Q 014087          261 -------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  303 (431)
Q Consensus       261 -------------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~P  303 (431)
                                                           ....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                 1245899999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCC
Q 014087          304 FTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  379 (431)
Q Consensus       304 f~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~  379 (431)
                      |.+.+..+...++...  ...+|+  .+++++++||.+|+. +|.+|++.  .++++|++||||++++|+.+..+...+|
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~~~~~  312 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERPAAIP  312 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCCCCCC
Confidence            9998888888888763  344554  478999999999885 67777642  3899999999999999999987765555


Q ss_pred             cccCCCCCcccCCCCcccCCC--CC-CC-CCCC---CCCCCCCccCeEeeC
Q 014087          380 FKPDVSGKDCIANFDKCWTTM--PA-DD-SPAP---TPTAGEHFKGYTYVA  423 (431)
Q Consensus       380 ~~p~~~~~~~~~~f~~~~~~~--~~-~~-~~~~---~~~~~~~f~~~~~~~  423 (431)
                      +  .+.+..++++|+......  ++ .. +..+   -......|.||+|..
T Consensus       313 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (363)
T cd05628         313 I--EIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKR  361 (363)
T ss_pred             c--cCCCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeec
Confidence            4  445677788887533221  11 11 1011   013457799999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.7e-52  Score=406.96  Aligned_cols=312  Identities=46%  Similarity=0.897  Sum_probs=265.7

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      +|++++.||+|+||+||+|+...  ...+++.||+|++.+..... ....+.+..|+.+|+.+ +||||+++++++..++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT--GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc--cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            58999999999999999998753  12378899999998754332 33456678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+.||+|.+++.+++.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+          
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            9999999999999999999888899999999999999999999999999999999999999987632211          


Q ss_pred             --CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCC----CCHHHHHHHHHhcccCCCCCCCHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPFLTSEA  331 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~----~~~~~~~~~i~~~~~~~p~~~s~~~  331 (431)
                        ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||..    .....+...+......+|..++.++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence              122346799999999999875 478999999999999999999999964    2344566667777777888899999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC-CC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-TP  410 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~-~~  410 (431)
                      .+||.+||+.||++|+++...+++++++||||++.+|..+..+++.++|.|......+..+|...+....+..+++. ++
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPP  318 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCCCc
Confidence            99999999999999998877899999999999999999999999999999998888888888877776655555554 34


Q ss_pred             CCCCCccCeEeeCC
Q 014087          411 TAGEHFKGYTYVAP  424 (431)
Q Consensus       411 ~~~~~f~~~~~~~~  424 (431)
                      .....|.+|+|+.+
T Consensus       319 ~~~~~~~~~~~~~~  332 (332)
T cd05614         319 SGARVFQGYSFVAP  332 (332)
T ss_pred             ccccccCCceecCC
Confidence            56789999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-52  Score=406.75  Aligned_cols=301  Identities=45%  Similarity=0.833  Sum_probs=260.4

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA-----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence            469999999999999876     88999999998766544444455555555 567899999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999998763211           122334


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+++.++.++.+||.+||+.||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            67999999999999999999999999999999999999999999989999999988888888899999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----------CCCCC
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----------TPTAG  413 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----------~~~~~  413 (431)
                      .+|+++. ..++++++||||++++|..+..+++.+|+.|......+..+|+..+++.+...+...          .....
T Consensus       236 ~~R~~~~-~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (323)
T cd05575         236 TKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD  314 (323)
T ss_pred             HhCCCCC-CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccccccccCCCcccccccccccccc
Confidence            9999764 467899999999999999999999999999998888888889888776654333222          11457


Q ss_pred             CCccCeEee
Q 014087          414 EHFKGYTYV  422 (431)
Q Consensus       414 ~~f~~~~~~  422 (431)
                      ..|.||+|.
T Consensus       315 ~~~~~~~~~  323 (323)
T cd05575         315 DAFLGFSYA  323 (323)
T ss_pred             cccCCCccC
Confidence            889999883

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.1e-52  Score=406.30  Aligned_cols=303  Identities=38%  Similarity=0.797  Sum_probs=257.9

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||+|++++.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK-----TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            469999999999999886     7889999999987655556667788899988876 8999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+           .....
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9999999999998888999999999999999999999999999999999999999988632211           12235


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+......+|..++.++.+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  235 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV  235 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            6799999999999999999999999999999999999999952         2233456667778888999999999999


Q ss_pred             HHhhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----C
Q 014087          335 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----T  409 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----~  409 (431)
                      |.+||+.||++|+++.+ .+++++++||||++++|..+..++..|+++|...+..+..+|+..++..+....+..    .
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVR  315 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCCcccccc
Confidence            99999999999997532 257999999999999999999999999999999888788888876666544333222    1


Q ss_pred             CCCCCCccCeEeeC
Q 014087          410 PTAGEHFKGYTYVA  423 (431)
Q Consensus       410 ~~~~~~f~~~~~~~  423 (431)
                      ...+..|.||.|.+
T Consensus       316 ~~~~~~~~~~~~~~  329 (329)
T cd05618         316 KIDQSEFEGFEYIN  329 (329)
T ss_pred             cccccccCCCcccC
Confidence            23567789998875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.5e-52  Score=406.04  Aligned_cols=303  Identities=43%  Similarity=0.795  Sum_probs=260.9

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL-----DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence            469999999999999875     78999999998765544444455555655 567789999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            999999999999988899999999999999999999999999999999999999998863221           112335


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+......+++..+.++.++|++||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCH
Confidence            67999999999999999999999999999999999999999999888999999888888888899999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCC----------CCCCCC
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA----------PTPTAG  413 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~----------~~~~~~  413 (431)
                      .+|++.. .++++++.||||++++|..+..+++.+++.|......+.++|+..+.+.....+..          ......
T Consensus       236 ~~R~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (325)
T cd05604         236 QRRLGAK-EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEAD  314 (325)
T ss_pred             HhcCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccccccccc
Confidence            9999763 47889999999999999999999999999999888888999998776654333321          111357


Q ss_pred             CCccCeEeeCC
Q 014087          414 EHFKGYTYVAP  424 (431)
Q Consensus       414 ~~f~~~~~~~~  424 (431)
                      .+|.||+|.++
T Consensus       315 ~~~~~~~~~~~  325 (325)
T cd05604         315 DAFVGFSYAPP  325 (325)
T ss_pred             cccCCCEecCC
Confidence            88999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.7e-52  Score=413.90  Aligned_cols=302  Identities=38%  Similarity=0.676  Sum_probs=251.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD-----THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence            59999999999999999999876     8899999999887766666778899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----------  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----------  260 (431)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.....+..          
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999999999988889999999999999999999999999999999999999988763211110          


Q ss_pred             ------------------------------------------------cccccCCCCCCchhhhccCCCCCcchhHhHHH
Q 014087          261 ------------------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  292 (431)
Q Consensus       261 ------------------------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGv  292 (431)
                                                                      ..+.+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                            12457999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCC--CCCHHHHHHHHhhccc--CcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          293 LLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHK--DPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       293 il~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~--dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++|||++|+.||...+..+....+..  ....+|.  .+++++++||.+||..  ++..|+     ++++|+.||||+++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~-----~~~~~l~hp~f~~~  311 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN-----GADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC-----CHHHHhcCcccCCC
Confidence            99999999999998877776666654  2344444  5899999999996654  444487     89999999999999


Q ss_pred             ChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCC-CC---------CC--CCCCCCCccCeEeeC
Q 014087          367 NWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD-SP---------AP--TPTAGEHFKGYTYVA  423 (431)
Q Consensus       367 ~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~-~~---------~~--~~~~~~~f~~~~~~~  423 (431)
                      +|.... +...+|+.|.+....++++|+....+.+... +.         ..  .......|.+|+|..
T Consensus       312 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (381)
T cd05626         312 DFSSDI-RTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRR  379 (381)
T ss_pred             ChhHHh-hcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeec
Confidence            998865 3556789999988889999986543332110 00         01  112368899999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.5e-52  Score=406.07  Aligned_cols=303  Identities=41%  Similarity=0.791  Sum_probs=262.9

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||+||+|+++.     +++.||+|++++...........+.+|+++++.++||||+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence            469999999999999876     889999999988765555566777889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      |+.||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.....+           .....
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            99999999999888889999999999999999999997 8999999999999999988632211           12234


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|..+++++.+||.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            57999999999999999999999999999999999999999998888888999888889999999999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC--------CCCCC
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--------TAGEH  415 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--------~~~~~  415 (431)
                      ++|++..+.+++++++|+||.++.|..+..+.+.|++.|......+...|+..++.......+....        .....
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDNERRPH  315 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcCccccCCCcccccccccccccccc
Confidence            9999877779999999999999999999999999999999888888889987776543322222111        23456


Q ss_pred             ccCeEeeC
Q 014087          416 FKGYTYVA  423 (431)
Q Consensus       416 f~~~~~~~  423 (431)
                      |..++|..
T Consensus       316 ~~~~~~~~  323 (325)
T cd05594         316 FPQFSYSA  323 (325)
T ss_pred             cCCceecC
Confidence            66666654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-53  Score=396.24  Aligned_cols=247  Identities=33%  Similarity=0.628  Sum_probs=222.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|.+.+.||+|+||+||+|+++.     ++..||||.+.+..+ .+..++.+..|+.+|+.++|||||.|+++..+++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~-----~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK-----SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc-----CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            4689999999999999999999997     789999999998765 5667788899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCc-------------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHE-------------  254 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-g~~-------------  254 (431)
                      .+|||||||.||+|.+++++++.++|..++.++.||+.||++||+++||||||||+||||+.. +..             
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999999999999999999999999999999999999999999999999886 321             


Q ss_pred             --cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---CCCCCCH
Q 014087          255 --IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTS  329 (431)
Q Consensus       255 --~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~  329 (431)
                        ........+.||++.|||||++..+.|+.|+|+||+|++||+|++|+.||...+..+++..+..+.-.   ++..++.
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence              12233456789999999999999999999999999999999999999999999999999988876543   3456788


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ...+|+..+|.+++..|.     +..+-..|++...-
T Consensus       243 ~~~~Ll~~ll~~~~~~~~-----~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRI-----SFEDFFDHPFLAAN  274 (429)
T ss_pred             chhhhhhHHHhcCccccC-----chHHhhhhhhcccC
Confidence            888999999999999998     77888888888653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-52  Score=410.15  Aligned_cols=249  Identities=38%  Similarity=0.704  Sum_probs=228.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh--hHHHHHHHHHHHHHhcC-CCCcceeeEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVT-HPFIVQLRYS  183 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (431)
                      ...+.|.+++.||+|+||+|++|++..     ++..||+|++++......  ...+.+.+|+.+++.++ ||||++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~-----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL-----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc-----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            345789999999999999999999986     789999998877633212  34566778999999998 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCcc-------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHEI-------  255 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-g~~~-------  255 (431)
                      +.....+|+||||+.||+|++++.+.+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ ++..       
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999998 6521       


Q ss_pred             ----CCCCCcccccCCCCCCchhhhccCC-CC-CcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC-C
Q 014087          256 ----DESSRSNSMCGTTEYMAPEILLSKG-HN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL-T  328 (431)
Q Consensus       256 ----~~~~~~~~~~Gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s  328 (431)
                          .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++..|..+.+.+|.++ |
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S  248 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLS  248 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCC
Confidence                2345667889999999999999988 85 889999999999999999999999999999999999999999999 9


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .++++||.+||..||.+|+     ++++|+.||||+.
T Consensus       249 ~~~~~Li~~mL~~~P~~R~-----t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRI-----TLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCC-----CHHHHhhChhhcc
Confidence            9999999999999999999     9999999999986

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-52  Score=411.77  Aligned_cols=305  Identities=39%  Similarity=0.718  Sum_probs=254.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+++++.++||||+++++++.+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD-----TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence            369999999999999999999886     889999999988765566667888999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.....+..         
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999988763211110         


Q ss_pred             -------------------------------------------------cccccCCCCCCchhhhccCCCCCcchhHhHH
Q 014087          261 -------------------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVG  291 (431)
Q Consensus       261 -------------------------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslG  291 (431)
                                                                       ....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                             0125799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          292 ILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       292 vil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      |++|||++|+.||.+.+..+.+..+..  ....+|.  .++.++++||.+||. +|.+|++.  .++++++.||||++++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~  312 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVD  312 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCC
Confidence            999999999999998888777777765  3344554  478999999999997 88888754  3899999999999999


Q ss_pred             hhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCC----C-----CCCCCCCCCCccCeEeeCC
Q 014087          368 WKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADD----S-----PAPTPTAGEHFKGYTYVAP  424 (431)
Q Consensus       368 ~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~----~-----~~~~~~~~~~f~~~~~~~~  424 (431)
                      |+.+  +.+.+|+.|......+..+|...........    .     .......+..|-||+|...
T Consensus       313 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (377)
T cd05629         313 WDTI--RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRF  376 (377)
T ss_pred             HHHH--ccCCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCC
Confidence            9988  4677899998887777777765433211110    0     0112245678899998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-52  Score=403.92  Aligned_cols=305  Identities=48%  Similarity=0.889  Sum_probs=260.7

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      ++.||+|+||.||++++..  ...+++.||+|++++.... ......+.+|+++|+.++||||+++++++.+++.+|+||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKIT--GPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL   77 (318)
T ss_pred             CceeeeCCCEEEEEEEEec--cCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence            3679999999999998642  1137889999999876542 223445678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||+.+|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+           .....
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            9999999999998888899999999999999999999999999999999999999887632111           12335


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......+|..++.++.+||++||+.||
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P  237 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP  237 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            67999999999999999999999999999999999999999999888888999888888999999999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCC--CCCCCCCCccCeEe
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPA--PTPTAGEHFKGYTY  421 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~--~~~~~~~~f~~~~~  421 (431)
                      ++|+++....+++++.|+||+.++|..+..++..|++.|......+..+++..+....+...+.  ..+.....|.+|+|
T Consensus       238 ~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~  317 (318)
T cd05582         238 ANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLFRGFSF  317 (318)
T ss_pred             hHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccCCCCccccccccccCCCEe
Confidence            9999876556999999999999999999999999999998877777777777665433322222  22346788999998


Q ss_pred             e
Q 014087          422 V  422 (431)
Q Consensus       422 ~  422 (431)
                      +
T Consensus       318 ~  318 (318)
T cd05582         318 V  318 (318)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.8e-52  Score=408.92  Aligned_cols=304  Identities=36%  Similarity=0.702  Sum_probs=253.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++++...........+.+|+.++..++||||+++++.+.+.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD-----TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            369999999999999999999886     889999999987766566667888999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.....+..         
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999988763221110         


Q ss_pred             -------------------------------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCC
Q 014087          261 -------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP  303 (431)
Q Consensus       261 -------------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~P  303 (431)
                                                           ....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                 1245799999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCC
Q 014087          304 FTHANRQKLQQRIINE--KVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  379 (431)
Q Consensus       304 f~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~  379 (431)
                      |.+.+.......+...  ...+|+  .++.++++||.+|+ .||.+|++..  ++++++.||||++++|..+..+...+|
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~--~~~ei~~hp~f~~~~~~~~~~~~~~~~  312 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN--GVEEIKSHPFFEGVDWGHIRERPAAIP  312 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCC--CHHHHhcCCCCCCCCHHHHhcCCCCCC
Confidence            9998888888888753  344554  37899999999987 4999999753  799999999999999999987766555


Q ss_pred             cccCCCCCcccCCCCcccCCC----CCCCCCCCCCCCCCCccCeEeeC
Q 014087          380 FKPDVSGKDCIANFDKCWTTM----PADDSPAPTPTAGEHFKGYTYVA  423 (431)
Q Consensus       380 ~~p~~~~~~~~~~f~~~~~~~----~~~~~~~~~~~~~~~f~~~~~~~  423 (431)
                      +  .+....+.++|+..-...    ......+........|.+|+|..
T Consensus       313 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (360)
T cd05627         313 I--EIKSIDDTSNFDEFPESDILQPAENTIEPDYKSKDWVFLNYTYKR  358 (360)
T ss_pred             c--cCCCcchhhhcCCCCcccccCCCccccccccCcCCcccCCceeec
Confidence            4  455677888887421111    11111111224567799999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-51  Score=407.84  Aligned_cols=304  Identities=40%  Similarity=0.762  Sum_probs=254.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD-----TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence            379999999999999999999886     788999999988765556667778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.          
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999999999998889999999999999999999999999999999999999998876321111          


Q ss_pred             ---------------------------------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhC
Q 014087          260 ---------------------------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG  300 (431)
Q Consensus       260 ---------------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg  300 (431)
                                                             .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                   11135799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcc--cCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccC
Q 014087          301 QPPFTHANRQKLQQRIINEK--VKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM  376 (431)
Q Consensus       301 ~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~  376 (431)
                      ..||.+.+..+....+....  ..+|.  .+++++++||.+||. +|.+|++.  .++++++.||||++++|+.+.  ..
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~--~~  310 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIR--ER  310 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hc
Confidence            99999988888777776543  33443  478999999999996 99999953  269999999999999999875  34


Q ss_pred             CCCcccCCCCCcccCCCCcccCCCCCC--CC----CCCCCCCCCCccCeEeeCC
Q 014087          377 QPKFKPDVSGKDCIANFDKCWTTMPAD--DS----PAPTPTAGEHFKGYTYVAP  424 (431)
Q Consensus       377 ~p~~~p~~~~~~~~~~f~~~~~~~~~~--~~----~~~~~~~~~~f~~~~~~~~  424 (431)
                      .+++.|......+.++|+.. .+.+..  .+    .......+..|.||+|.+.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (364)
T cd05599         311 PAPIIPELKSITDTSNFDDF-EEIDLDVPTSPGPPRGKIKSKDLAFIGYTYKRF  363 (364)
T ss_pred             CCCCCCCCCCchhhhhcccc-ccccccccCCCccccccccccCCCCCCCeeeCC
Confidence            67888888888888888752 222111  11    1112245788999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-51  Score=410.43  Aligned_cols=277  Identities=42%  Similarity=0.770  Sum_probs=242.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+++++||+|+||+||+|+++.     +++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD-----TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence            59999999999999999999876     8899999999887666666778899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----------  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----------  260 (431)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+..          
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            9999999999999999888889999999999999999999999999999999999999988763211110          


Q ss_pred             ------------------------------------------------cccccCCCCCCchhhhccCCCCCcchhHhHHH
Q 014087          261 ------------------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGI  292 (431)
Q Consensus       261 ------------------------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGv  292 (431)
                                                                      ..+.+||+.|+|||++.+..|+.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                            12357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          293 LLYEMLTGQPPFTHANRQKLQQRIINE--KVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       293 il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      +||||++|+.||.+.+..+....+...  ...+|  ..+++++.+||.+|+ .+|.+|++.  .++++|++||||++++|
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcCh
Confidence            999999999999988887777777653  23344  358999999999986 599999953  36999999999999999


Q ss_pred             hhHhcccCCCCcccCCCCCcccCCCCcc
Q 014087          369 KTLEAREMQPKFKPDVSGKDCIANFDKC  396 (431)
Q Consensus       369 ~~l~~~~~~p~~~p~~~~~~~~~~f~~~  396 (431)
                      .... ++..+|+.|.+....++++|+..
T Consensus       314 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
T cd05625         314 SSDL-RQQSAPYIPKITHPTDTSNFDPV  340 (382)
T ss_pred             HHHH-hcCCCCccCcCCCcchhhhcCCC
Confidence            8765 45678999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-51  Score=394.15  Aligned_cols=267  Identities=37%  Similarity=0.691  Sum_probs=233.2

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++.+.||+|+||.||+|.++.     +++.||+|++.+...........+.+|+.+|+.++|+||+++++++.+.+.+|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec-----CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEE
Confidence            8899999999999999999886     88999999998766544444556788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------C
Q 014087          192 LILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------S  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------~  259 (431)
                      +||||+.+|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.....+          .
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999999998887653  3689999999999999999999999999999999999999887632211          1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                      .....+||..|+|||++.+..++.++|||||||++|||++|+.||.+.+.    ..+...+......++..++.++.+||
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            22345789999999999999999999999999999999999999987543    33444455555667788999999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      ++||..||.+|+++...+++++++||||++++|+.++.+.++|||+|+
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD  284 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence            999999999999876668999999999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-53  Score=371.31  Aligned_cols=251  Identities=34%  Similarity=0.625  Sum_probs=235.8

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .....++|++++.||+|-||.||+|+.+.     ++-+||+|++-|..+...+...++++|++|-..|+||||+++|++|
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekk-----s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKK-----SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeecc-----CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            34567789999999999999999999987     8999999999999988888888999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------  254 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--------  254 (431)
                      .+..++||++||..+|+|+..|.  +...+++..+..|+.|++.||.|+|.++||||||||+|+|++.+|..        
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            99999999999999999999999  66789999999999999999999999999999999999999998762        


Q ss_pred             -cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          255 -IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       255 -~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                       ........++|||..|.+||+..+..++..+|+|++||+.||++.|.+||...+..+++++|..-.+.+|..++.++.|
T Consensus       172 V~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d  251 (281)
T KOG0580|consen  172 VHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD  251 (281)
T ss_pred             eecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence             2235566789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ||.+||.++|.+|+     ...+++.|||...
T Consensus       252 lI~~ll~~~p~~r~-----~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  252 LISRLLVKNPIERL-----ALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHhccCccccc-----cHHHHhhhHHHHh
Confidence            99999999999999     8999999999854

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.5e-51  Score=398.23  Aligned_cols=302  Identities=45%  Similarity=0.827  Sum_probs=257.7

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHH-HHHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||+||+|+++.     +++.||+|++.+...........+..|. .+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence            469999999999999876     7889999999876544433334444444 4567889999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+           .....
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9999999999999888899999999999999999999999999999999999999887632211           12345


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+++.++.++.++|.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence            67999999999999999999999999999999999999999998888888998888888888899999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----------CCCCC
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----------TPTAG  413 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----------~~~~~  413 (431)
                      .+|+++. ..+.++++|+||..++|+.+..++..+++.|......+...|+..++..+...+...          .....
T Consensus       236 ~~R~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (325)
T cd05602         236 TKRLGAK-DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAA  314 (325)
T ss_pred             HHCCCCC-CCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcccccccc
Confidence            9999764 467899999999999999999999999999999888888889877766554333211          11356


Q ss_pred             CCccCeEeeC
Q 014087          414 EHFKGYTYVA  423 (431)
Q Consensus       414 ~~f~~~~~~~  423 (431)
                      ..|.||+|-.
T Consensus       315 ~~~~g~~~~~  324 (325)
T cd05602         315 EAFLGFSYAP  324 (325)
T ss_pred             cccCCCccCC
Confidence            7789998865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-51  Score=404.69  Aligned_cols=300  Identities=44%  Similarity=0.806  Sum_probs=257.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++++...........+.+|+.++..++||||+++++++.+++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD-----TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence            369999999999999999999876     789999999998766666677788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+||||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+           
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999999999888899999999999999999999999999999999999999987632111           


Q ss_pred             -----------------------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH
Q 014087          259 -----------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  309 (431)
Q Consensus       259 -----------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~  309 (431)
                                                   ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                         112345799999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHh--cccCCCCC--CCHHHHHHHHhhcccCcCCcCCCCCCC-HHHHHhCCCCCCCChhhHhcccCCCCcccCC
Q 014087          310 QKLQQRIIN--EKVKLPPF--LTSEAHSLLKGLLHKDPSKRLGSGPGG-VDAIKHHKWFRSINWKTLEAREMQPKFKPDV  384 (431)
Q Consensus       310 ~~~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~R~~~~~~~-~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~  384 (431)
                      .....++..  ....+|..  +++++.+||.+||. ||.+|+     + ++++++||||++++|+...  ...|++.|.+
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~-----~s~~~ll~hp~~~~~~~~~~~--~~~~~~~~~~  307 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRL-----GSFEEIKSHPFFKGIDWENLR--ETKPPFVPEL  307 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcC-----CCHHHHhcCCCcCCCCHHHHh--hCCCCcCCCC
Confidence            888888876  45555543  59999999999997 999999     5 9999999999999999887  5668899998


Q ss_pred             CCCcccCCCCcccCCCCCCC-----CCCCCCCCCCCccCeEee
Q 014087          385 SGKDCIANFDKCWTTMPADD-----SPAPTPTAGEHFKGYTYV  422 (431)
Q Consensus       385 ~~~~~~~~f~~~~~~~~~~~-----~~~~~~~~~~~f~~~~~~  422 (431)
                      ....+..+|+..-...+...     +.......+..|.+|+|.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (350)
T cd05573         308 SSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTYK  350 (350)
T ss_pred             CCchhhhhcCCCCcccccccccccccccccccccCccCCCccC
Confidence            88888888887544333222     111222467899999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-52  Score=411.07  Aligned_cols=249  Identities=30%  Similarity=0.548  Sum_probs=231.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .+-|++++.||.|+-|.|-+|++..     ||+..|||++.+...........+.+|+.||+.+.||||++||+++++..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~-----TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAE-----TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhccc-----ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            3559999999999999999999886     99999999999886556666777899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------CC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------ES  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------~~  258 (431)
                      ++|||+||++||.|++++.++|+++|.++..++.||+.|+.|||..+|+||||||+|+|||.+++...          .+
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999887221          22


Q ss_pred             CCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      ....+-||++.|.|||++.|..| +.++||||.|||||.||||+.||++++...++.++..+.+.+|..++.++++||++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence            33457799999999999999999 57899999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ||..||++|+     +.++|+.|||+.+..
T Consensus       246 ml~VDp~~Ri-----T~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  246 MLDVDPSTRI-----TTEEILKHPFLSGYT  270 (786)
T ss_pred             HhccCccccc-----cHHHHhhCchhhcCC
Confidence            9999999999     999999999998765

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.7e-51  Score=395.51  Aligned_cols=301  Identities=44%  Similarity=0.813  Sum_probs=257.8

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      ++||+|+||+||+|+++.     +++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS-----DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence            469999999999999876     78999999998766544444445555554 678899999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~  263 (431)
                      ||++||+|..++.+...+++.+++.++.||+.||.|||++||+||||||+||||+.+|.....+           .....
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9999999999998888899999999999999999999999999999999999999988633211           12234


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|...+.++.++|.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            57999999999999999999999999999999999999999999888889999988888898999999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC-------CCCCCCc
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT-------PTAGEHF  416 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~-------~~~~~~f  416 (431)
                      .+|+++. .++.++++|+||..++|..+..+.+.|++.|..........|+..++......+....       ......|
T Consensus       236 ~~R~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (321)
T cd05603         236 RRRLGAK-ADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAF  314 (321)
T ss_pred             hhcCCCC-CCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccccccCCCCccccccccccccc
Confidence            9999764 3688999999999999999999999999999888888888888777655443332221       1345668


Q ss_pred             cCeEee
Q 014087          417 KGYTYV  422 (431)
Q Consensus       417 ~~~~~~  422 (431)
                      .||+|.
T Consensus       315 ~~~~~~  320 (321)
T cd05603         315 LGFSYA  320 (321)
T ss_pred             CCCccC
Confidence            888874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-50  Score=401.26  Aligned_cols=309  Identities=34%  Similarity=0.648  Sum_probs=257.8

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|++.++||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~  110 (370)
T cd05596          36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS-----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY  110 (370)
T ss_pred             ccCCCCHHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3455667899999999999999999999886     88999999998765555555666888999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      ++.++..+|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+    
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            999999999999999999999988654 689999999999999999999999999999999999999988632111    


Q ss_pred             --------CCcccccCCCCCCchhhhccC----CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCC
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  324 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p  324 (431)
                              ......+||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+.+....+..+....  ..+|
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  269 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP  269 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC
Confidence                    112346799999999999754    37899999999999999999999999988888888887643  4555


Q ss_pred             C--CCCHHHHHHHHhhcccCcCC--cCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCC
Q 014087          325 P--FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  400 (431)
Q Consensus       325 ~--~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  400 (431)
                      .  .++.++++||.+||..+|.+  |+     ++++|++||||++.+|.....+...+++.|......+..+|++.....
T Consensus       270 ~~~~~s~~~~~li~~~L~~~p~r~~R~-----s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  344 (370)
T cd05596         270 DDIEISKQAKDLICAFLTDREVRLGRN-----GVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDD  344 (370)
T ss_pred             CcCCCCHHHHHHHHHHccChhhccCCC-----CHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccc
Confidence            5  57999999999999999987  77     899999999999999998888888899999988888888888654443


Q ss_pred             CCCCC---CCCCCCCCCCccCeEee
Q 014087          401 PADDS---PAPTPTAGEHFKGYTYV  422 (431)
Q Consensus       401 ~~~~~---~~~~~~~~~~f~~~~~~  422 (431)
                      .....   +.........|.||+|.
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~  369 (370)
T cd05596         345 KNEETFPLPKAFAGNQLPFIGFTYS  369 (370)
T ss_pred             cccccCCCccccccccCccCCCeec
Confidence            21111   11122345569999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-50  Score=400.11  Aligned_cols=312  Identities=34%  Similarity=0.645  Sum_probs=254.6

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|++.+.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3455667899999999999999999999986     78999999998765555555667888999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      ++.+++.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+    
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999999999988654 589999999999999999999999999999999999999987632111    


Q ss_pred             --------CCcccccCCCCCCchhhhccCC----CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCC
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  324 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p  324 (431)
                              ....+.+||+.|+|||++.+..    ++.++|||||||+||||++|+.||.+.+.......+....  +.+|
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence                    1123567999999999998653    7889999999999999999999999988888888887643  4555


Q ss_pred             C--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCC
Q 014087          325 P--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA  402 (431)
Q Consensus       325 ~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~  402 (431)
                      .  .++..++++|.+||..++ +|++-  .+++++++||||++..|.....+...+|+.|.+....+.++|+........
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~-~r~~R--~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  346 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDRE-VRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGD  346 (370)
T ss_pred             CcccCCHHHHHHHHHHccCch-hccCC--CCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCccccccc
Confidence            4  469999999999998444 43321  289999999999998887776677889999999888888999753322211


Q ss_pred             CCC-CCCC--CCCCCCccCeEeeC
Q 014087          403 DDS-PAPT--PTAGEHFKGYTYVA  423 (431)
Q Consensus       403 ~~~-~~~~--~~~~~~f~~~~~~~  423 (431)
                      ..+ +.+.  ...+..|.||+|+.
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~  370 (370)
T cd05621         347 VETFPIPKAFVGNQLPFIGFTYYR  370 (370)
T ss_pred             cccCCCCccccccccccCCCEecC
Confidence            111 1111  13468899999973

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-50  Score=402.05  Aligned_cols=278  Identities=41%  Similarity=0.766  Sum_probs=241.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++.+.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD-----TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            479999999999999999999886     789999999987665555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+..         
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999999999999998889999999999999999999999999999999999999988763211111         


Q ss_pred             ---------------------------------------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHH
Q 014087          261 ---------------------------------------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLY  295 (431)
Q Consensus       261 ---------------------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~  295 (431)
                                                                   ....+||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                         12357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcc--cCCC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          296 EMLTGQPPFTHANRQKLQQRIINEK--VKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       296 elltg~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      ||++|+.||.+.+..+....+....  ..+|  ..++.++.+||.+|+ .+|.+|++..  +++++++||||++++|..+
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~--t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN--GADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC--CHHHHhCCCCcCCCCHHHH
Confidence            9999999999888777766665432  2333  358999999999976 5999999642  7999999999999999988


Q ss_pred             hcccCCCCcccCCCCCcccCCCCcc
Q 014087          372 EAREMQPKFKPDVSGKDCIANFDKC  396 (431)
Q Consensus       372 ~~~~~~p~~~p~~~~~~~~~~f~~~  396 (431)
                      . +...+++.|.+....+.++|+..
T Consensus       313 ~-~~~~~~~~~~~~~~~~~~~~~~~  336 (376)
T cd05598         313 I-RRQKAPYIPKITHPTDTSNFDPV  336 (376)
T ss_pred             h-hcCCCCCCCcCCCcchhhhcCCC
Confidence            7 56678888988888888888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-51  Score=397.32  Aligned_cols=276  Identities=46%  Similarity=0.852  Sum_probs=241.5

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc---CCCCcceeeEEEEeCCEEEEEE
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      ||+|+||+||+|+++.     +++.||+|++.+..............|..++..+   +||||+++++++.+...+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECC-----CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            7999999999999876     7899999999876655544555566677777665   6999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCCccc
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSRSNS  263 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~~~~  263 (431)
                      ||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....           ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            999999999999988899999999999999999999999999999999999999988763211           112335


Q ss_pred             ccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-CCCHHHHHHHHhhccc
Q 014087          264 MCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP-FLTSEAHSLLKGLLHK  341 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~~L~~  341 (431)
                      .+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..++...+..+...+|. .++.++.+||++||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            6799999999999764 5899999999999999999999999999888888888888777775 4799999999999999


Q ss_pred             CcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCC
Q 014087          342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT  399 (431)
Q Consensus       342 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~  399 (431)
                      ||.+|+++. .+++++++||||++++|..+..+.+.+++.|......+.++|+..++.
T Consensus       236 ~P~~R~~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (330)
T cd05586         236 NPQHRLGAH-RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTN  292 (330)
T ss_pred             CHHHCCCCC-CCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCccccc
Confidence            999999763 479999999999999999999999999999988888888888776544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-49  Score=394.85  Aligned_cols=314  Identities=35%  Similarity=0.662  Sum_probs=256.2

Q ss_pred             HhhhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCccee
Q 014087          101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL  180 (431)
Q Consensus       101 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  180 (431)
                      ......+..++|++.+.||+|+||.||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            344556677899999999999999999999986     889999999987655555556678889999999999999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--
Q 014087          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--  258 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--  258 (431)
                      ++++.+++.+|+||||++||+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+  
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999999999988654 589999999999999999999999999999999999999988632111  


Q ss_pred             ----------CCcccccCCCCCCchhhhccCC----CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cC
Q 014087          259 ----------SRSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VK  322 (431)
Q Consensus       259 ----------~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~  322 (431)
                                ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.+.......|....  ..
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence                      1223567999999999998643    7899999999999999999999999988888888887643  44


Q ss_pred             CCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCC
Q 014087          323 LPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  400 (431)
Q Consensus       323 ~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  400 (431)
                      +|.  .++.++++||.+||. +|.+|++.  .++++|++|+||++..|.....+...+|+.|......+.++|++.-.+.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDK  344 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccc
Confidence            443  589999999999998 66666543  3899999999999977766666788889999988888888887543322


Q ss_pred             CCCCC-CCC--CCCCCCCccCeEeeC
Q 014087          401 PADDS-PAP--TPTAGEHFKGYTYVA  423 (431)
Q Consensus       401 ~~~~~-~~~--~~~~~~~f~~~~~~~  423 (431)
                      ..... +.+  .......|.||+|++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T cd05622         345 GEEETFPIPKAFVGNQLPFVGFTYYS  370 (371)
T ss_pred             cccccCCCCccccccccccCCCeecC
Confidence            21111 111  112347899999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-51  Score=397.63  Aligned_cols=244  Identities=33%  Similarity=0.595  Sum_probs=226.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|.+.+.||+|+||+||+++.+.     +.+.||+|.+.|..- .+..+..+.+|++|++.++|||||.++++|++..+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~-----t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY-----TIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc-----ceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            579999999999999999999887     899999999988654 34456779999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------C
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------S  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~  258 (431)
                      +|+|.|||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++.+|....-           .
T Consensus        76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9999999988 999999999999999999999999999999999999999999999999999874321           1


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ...+.+-|||.|||||++.++.|+..+|+|||||++|||++|++||.......+.+.|..+...+|...+.++..||..+
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence            23345679999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.+||.+|+     +..+++.|||.++
T Consensus       235 L~kdP~~Rl-----tW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  235 LIKDPAQRL-----TWTDLLGHPFWKG  256 (808)
T ss_pred             hhcChhhcc-----cHHHHhcChHHhh
Confidence            999999999     9999999999986

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-49  Score=387.62  Aligned_cols=274  Identities=39%  Similarity=0.700  Sum_probs=239.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||||++++...........+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD-----TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence            469999999999999999999876     788999999988765555566778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------CCc
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------SRS  261 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------~~~  261 (431)
                      +|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+        ...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~  155 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA  155 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence            999999999999999999888999999999999999999999999999999999999999988643221        123


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCC------CCCHHHHH
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP------FLTSEAHS  333 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~  333 (431)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....  ...|.      .++.++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            45689999999999999999999999999999999999999999988888777765432  22222      45899999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCc
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  395 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~  395 (431)
                      ||.+||..+|.+|+     ++++++.||||++++|..+.  ...|++.|......+..+|+.
T Consensus       236 li~~~l~~~~~rr~-----s~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  290 (333)
T cd05600         236 LITKLINDPSRRFG-----SLEDIKNHPFFKEVDWNELR--ELKPPFVPELESEIDTGYFDD  290 (333)
T ss_pred             HHHHHhhChhhhcC-----CHHHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcchhhhccC
Confidence            99999999999999     89999999999999999886  678899998776666666654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-52  Score=365.76  Aligned_cols=247  Identities=31%  Similarity=0.582  Sum_probs=224.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .+.|++.++||+|.|+.|+++.++.     +|+.+|+|+++-...... ..+.+.+|+.|-+.|+|||||+|++.+...+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~-----tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc-----chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            3569999999999999999998886     899999999987766544 5667899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-------------cc
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EI  255 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-------------~~  255 (431)
                      ..|+|+|+|.|++|..-+.++..++|..+..+++||++||.|+|.+||||||+||+|+|+.....             .+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999999888888788999999999999999999999999999999999999987533             11


Q ss_pred             CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHH
Q 014087          256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  331 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  331 (431)
                      .........+|||.|||||++...+|+..+|||+-||+||-||.|++||.+.+...++++|+.+.+.+|.    .+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            2333455678999999999999999999999999999999999999999999999999999999888874    689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++||++||..||.+|+     ++.|.++|||.++-
T Consensus       244 k~LvrrML~~dP~kRI-----ta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRI-----TADEALKHPWICNR  273 (355)
T ss_pred             HHHHHHHhccChhhhc-----cHHHHhCCchhcch
Confidence            9999999999999999     89999999999863

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-49  Score=376.44  Aligned_cols=268  Identities=38%  Similarity=0.692  Sum_probs=232.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|++.++||+|+||+||++.+..     +++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC-----CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence            48999999999999999999875     7889999999876554444455677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      |+||||+.||+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+          
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999999999888654  4589999999999999999999999999999999999999887632111          


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcccCCCCCCCHHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK----LQQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                      ......+|+..|+|||++.+..++.++||||+||++|||++|+.||.+.+...    +...+......++..++..+.+|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence            11234578999999999999999999999999999999999999998765433    33444445556677899999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      |.+||..||++|+++...+++++++|+||...+|+.+.++++.|||+|+
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD  284 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence            9999999999999887778999999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5e-49  Score=384.54  Aligned_cols=300  Identities=36%  Similarity=0.698  Sum_probs=249.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||+||+|+++.     +++.||+|++++.........+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA-----TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            369999999999999999999886     788999999998766555667778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      +|+||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999999999876 67999999999999999999999999999999999999999886432211         


Q ss_pred             ---CcccccCCCCCCchhhhc------cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCC--CC
Q 014087          260 ---RSNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP--PF  326 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p--~~  326 (431)
                         .....+||+.|+|||++.      ...++.++|||||||++|||++|+.||...+......++....  ..+|  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence               112346899999999997      4567899999999999999999999999888887777776542  3344  35


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSP  406 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~  406 (431)
                      ++.++.+||.+||. ||.+|+     ++++++.||||+.++|..+..  ..|++.|......+..+|+......+.....
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~-----t~~~l~~h~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERL-----GYEGLCCHPFFSKIDWNNIRN--SLPPFVPTLKSDDDTSNFDEPEKNSTRRSQS  307 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCC-----CHHHHhCCCCcCCCCHHHHhh--CCCCccCcCCCcchhhhcCCCcccccccccc
Confidence            79999999999998 999999     899999999999999998864  5578888888888888887644333222211


Q ss_pred             CCC-------CCCCCCccCeEee
Q 014087          407 APT-------PTAGEHFKGYTYV  422 (431)
Q Consensus       407 ~~~-------~~~~~~f~~~~~~  422 (431)
                      ...       ......|-+|+|.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd05601         308 STTQLKPNGFSGKDLPFVGFSFI  330 (330)
T ss_pred             ccccCCCcCCCCCCCCccCceeC
Confidence            111       1234678888773

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-48  Score=371.74  Aligned_cols=281  Identities=46%  Similarity=0.855  Sum_probs=253.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||++.+..     +++.+|+|++.+.........+.+.+|+++|+.++||||+++++++.+++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence            369999999999999999999876     788999999987766556667788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--------CCCc
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------SSRS  261 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--------~~~~  261 (431)
                      +|+||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....        ....
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  155 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT  155 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence            99999999999999999988899999999999999999999999999999999999999998763211        1123


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK  341 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  341 (431)
                      ...+|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.....+.+..+...+|..++..++++|.+||..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccC
Confidence            45578999999999998889999999999999999999999999888888888888888889999999999999999999


Q ss_pred             CcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCc
Q 014087          342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  395 (431)
Q Consensus       342 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~  395 (431)
                      ||.+|++....++++++.||||+.++|..+....+.+|+.|......+.++|++
T Consensus       236 ~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (290)
T cd05580         236 DLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD  289 (290)
T ss_pred             CHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence            999999888889999999999999999999999999999998877667777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-48  Score=373.60  Aligned_cols=260  Identities=39%  Similarity=0.721  Sum_probs=225.8

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||+|+||+||+|.++.     +++.||+|++.+.........+.+..|+++++.++|+||+++++++..+..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEcc-----CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            7999999999999886     78899999998766555555567788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCcc
Q 014087          198 NGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSN  262 (431)
Q Consensus       198 ~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~  262 (431)
                      +||+|..++..    +..+++..+..++.||+.||.|||++||+||||||+||+++.++.....+           ....
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            99999887753    34689999999999999999999999999999999999999887632211           1122


Q ss_pred             cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       263 ~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....    .......+......++..++.++.+|+.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            4578999999999999999999999999999999999999997643    234455555566677788999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      |+.||++|++....+++++++||||++++|..++.....+||.|
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~  279 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP  279 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence            99999999988767899999999999999999999999889887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.8e-48  Score=378.04  Aligned_cols=304  Identities=36%  Similarity=0.671  Sum_probs=243.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.++||+|+||.||+++++.     +++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence            379999999999999999999886     788999999987655555566678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      +|+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....+.         
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999999999987 467999999999999999999999999999999999999998876321111         


Q ss_pred             ---CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCC---C
Q 014087          260 ---RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP---F  326 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~---~  326 (431)
                         .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+....  ..+|.   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence               112357999999999997     3467899999999999999999999999988888888887653  23343   5


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCC--CCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP--ADD  404 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~--~~~  404 (431)
                      ++.++++||++||..++. |++.  .+++++++||||.+++|+.+..  ..+++.|......+.++++..-...+  ...
T Consensus       236 ~s~~~~~li~~ll~~~~~-r~~r--~~~~~~~~h~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (332)
T cd05623         236 VSEDAKDLIRRLICSREH-RLGQ--NGIEDFKQHPFFTGIDWDNIRN--CEAPYIPEVSSPTDTSNFDVDDDCLKNSETM  310 (332)
T ss_pred             CCHHHHHHHHHHccChhh-hcCC--CCHHHHhCCCCcCCCCHHHHhh--CCCCccCCCCCCcccccCCCCcccccccCCC
Confidence            799999999999986554 4322  2899999999999999998864  45678888777777776643211111  111


Q ss_pred             CCC---CCCCCCCCccCeEeeC
Q 014087          405 SPA---PTPTAGEHFKGYTYVA  423 (431)
Q Consensus       405 ~~~---~~~~~~~~f~~~~~~~  423 (431)
                      .++   ........|.+|+|.+
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~  332 (332)
T cd05623         311 PPPSHTAFSGHHLPFVGFTYTS  332 (332)
T ss_pred             CCCCccccccCCCCcCCeeecC
Confidence            111   1113456788888863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-48  Score=378.87  Aligned_cols=278  Identities=37%  Similarity=0.703  Sum_probs=235.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||.||+++++.     +++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH-----TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            479999999999999999999876     788999999987655555556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .|+||||+.||+|..++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.....+.         
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999999987 467999999999999999999999999999999999999998876322111         


Q ss_pred             ---CcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCC---C
Q 014087          260 ---RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPP---F  326 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~---~  326 (431)
                         .....+||+.|+|||++.+     ..++.++|||||||+||||++|+.||...+..+....+....  ..+|.   .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence               1123579999999999976     467889999999999999999999999888888888776643  33443   3


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCccc
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  397 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~  397 (431)
                      ++.++++||.+||..++ +|++.  .++++++.|+||++++|+.+.  ...+++.|......+..+|+...
T Consensus       236 ~~~~~~~li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~  301 (331)
T cd05624         236 VSEEAKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENIR--NLEAPYIPDVSSPSDTSNFDVDD  301 (331)
T ss_pred             CCHHHHHHHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHHh--hCCCCccCCCCCcchhhhcCCcc
Confidence            68999999999998655 55432  389999999999999999884  56788999888777777876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-50  Score=376.45  Aligned_cols=242  Identities=31%  Similarity=0.578  Sum_probs=226.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||+|-+|....     .|+.||||.++++.+.+++.+-.+++|++||..|+||||+.+|.+|++.+.+
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~-----sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHK-----SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhcc-----CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            59999999999999999998765     8999999999999999988889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------CCCC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------ESSR  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------~~~~  260 (431)
                      .|||||..+|+|++++.+.+.++|.+++.+++||+.|+.|||+++++|||||.+|||+|.+++...          ....
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            999999999999999999999999999999999999999999999999999999999999987432          2334


Q ss_pred             cccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 014087          261 SNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  339 (431)
                      ..++||++-|.+||++++.+| +..+|-|||||+||.|+.|..||++.+...+..+|..+.+.-|+ -+.++.-||+.||
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWML  287 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHH
Confidence            578999999999999999999 68899999999999999999999999999999999999887766 4678899999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          340 HKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ..||++|.     |+++|-.|.|.
T Consensus       288 mVNP~RRA-----TieDiAsHWWv  306 (668)
T KOG0611|consen  288 MVNPERRA-----TIEDIASHWWV  306 (668)
T ss_pred             hcCcccch-----hHHHHhhhhee
Confidence            99999997     99999999997

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-48  Score=376.67  Aligned_cols=278  Identities=38%  Similarity=0.718  Sum_probs=233.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+++++.     +++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN-----TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence            479999999999999999999886     788999999987665566667778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      +|+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999999999976 457999999999999999999999999999999999999998876321110         


Q ss_pred             ---CcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCC---CC
Q 014087          260 ---RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP---PF  326 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p---~~  326 (431)
                         .....+||+.|+|||++..     ..++.++|||||||++|||++|+.||.+.+..+....+....  ..++   ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence               1122469999999999973     457889999999999999999999999888877777776543  3333   34


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCccc
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  397 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~  397 (431)
                      ++.++++||++||.. |.+|++.  .++++++.||||++++|..+..  ..+++.|......++++|+..-
T Consensus       236 ~~~~~~~li~~ll~~-~~~r~~r--~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  301 (331)
T cd05597         236 VSEEAKDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTDTSNFDVDD  301 (331)
T ss_pred             CCHHHHHHHHHHccC-cccccCC--CCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcchhhhcCCcc
Confidence            799999999999975 4444422  2899999999999999998864  3567888877777777776543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=376.76  Aligned_cols=249  Identities=30%  Similarity=0.553  Sum_probs=215.6

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh-----------hHHHHHHHHHHHHHhcCC
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----------NHVDYMKAERDILTKVTH  174 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~h  174 (431)
                      +...++|++++.||+|.||+|-+|++..     +++.||||++.+......           ..++.+.+|+.+|++|+|
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~-----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEV-----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecC-----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            3456789999999999999999999876     899999999988664331           224678899999999999


Q ss_pred             CCcceeeEEEEeC--CEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          175 PFIVQLRYSFQTR--SKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       175 pnIv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      ||||+|+++..+.  +.+|||+|||..|.+... ...+. +++.+++.|+++++.||+|||.+|||||||||+|+||+.+
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            9999999999865  579999999999987432 23334 8999999999999999999999999999999999999999


Q ss_pred             CCccCCCCC----------------cccccCCCCCCchhhhccCC---C-CCcchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 014087          252 GHEIDESSR----------------SNSMCGTTEYMAPEILLSKG---H-NKDADWWSVGILLYEMLTGQPPFTHANRQK  311 (431)
Q Consensus       252 g~~~~~~~~----------------~~~~~Gt~~y~aPE~~~~~~---~-~~~~DvwslGvil~elltg~~Pf~~~~~~~  311 (431)
                      |.....+..                ....+|||.|||||++.+..   + +.+.||||+||+||+|+.|+.||-+....+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            884322211                12357999999999998732   2 678899999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCC--CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          312 LQQRIINEKVKLPPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       312 ~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ++.+|++..+.+|..  +.++++|||.+||.+||++|+     ++.+|+.|||...
T Consensus       327 l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri-----~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI-----TLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee-----ehhhheecceecc
Confidence            999999999999975  799999999999999999999     8999999999853

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-50  Score=361.53  Aligned_cols=233  Identities=28%  Similarity=0.478  Sum_probs=207.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE-EEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~  188 (431)
                      .+|+++++||+|+||.||+|.+..     +|..+|.|.+.-+.+ +....+.+..|+.+|+.|+|||||++++ .|.++.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~-----~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL-----DGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc-----Ccchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            469999999999999999999986     899999999986655 4455667778999999999999999998 566655


Q ss_pred             E-EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEeCCCCCccCCC-
Q 014087          189 K-LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK--CG--IVHRDLKPENILMDSDGHEIDES-  258 (431)
Q Consensus       189 ~-~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~~--iiHrDlKp~NILl~~~g~~~~~~-  258 (431)
                      . ++||||||.+|+|...++.    +..++|..++.++.|++.||.++|.  ..  |+||||||.||+|+.+|.+...+ 
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 9999999999999988864    3579999999999999999999998  44  99999999999999998754332 


Q ss_pred             ----------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CC-CC
Q 014087          259 ----------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-PF  326 (431)
Q Consensus       259 ----------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~p-~~  326 (431)
                                ..+.+.+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+-.++.++|.++.++ +| ..
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence                      2345779999999999999999999999999999999999999999999999999999998775 67 67


Q ss_pred             CCHHHHHHHHhhcccCcCCcCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLG  348 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~  348 (431)
                      +|.++..||..|+..||+.||+
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCC
Confidence            9999999999999999999994

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=366.96  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=222.1

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .....++|++.++||.|..++||+|+++.     ++.+||||++..+....  .++.+++|+..|+.++||||++++.+|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            44556789999999999999999999997     78999999999877543  388999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                      ..+..+|+||.||.+|++.+++...  ..|.|..+..|++++++||.|||.+|.||||||+.||||+.+|.+...+.   
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999999864  45999999999999999999999999999999999999999997432111   


Q ss_pred             ------------CcccccCCCCCCchhhhc--cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Q 014087          260 ------------RSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-  324 (431)
Q Consensus       260 ------------~~~~~~Gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p-  324 (431)
                                  ...+++||+.|||||++.  ..+|+.|+||||||++..||.+|..||....+.++.-.-+++.++.+ 
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence                        116779999999999965  46899999999999999999999999999888887777777666532 


Q ss_pred             ---------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          325 ---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       325 ---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                               ..++..++.+|..||++||.+||     ++.++++|+||+...-.
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp-----tAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRP-----TASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCC-----CHHHHhccHHHhhccch
Confidence                     23677899999999999999999     88999999999876544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-49  Score=358.01  Aligned_cols=246  Identities=26%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +.|+.+.++|+|+||+||+|+++.     +|++||||.+.... .+....+-..+|+++|+.++|+|+|.|+++|....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~-----TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD-----TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC-----cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            469999999999999999999986     99999999986543 233334556789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------CC
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------ES  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~~  258 (431)
                      ++||+|||+..-|.++-.....++++.++.|++|++.|+.|+|++++|||||||+||||+.+|....           ..
T Consensus        76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9999999988555443333356899999999999999999999999999999999999999986321           23


Q ss_pred             CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 014087          259 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------  319 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------  319 (431)
                      ...+..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+.+.-+....|...                  
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            34455678999999999998 78999999999999999999999999998776665555321                  


Q ss_pred             -ccCCC------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 -KVKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 -~~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                       .+.+|            +.++.-+.||+++||+.||.+|+     +-+++++|+||.++
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~-----sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL-----SCEQLLHHPYFDGF  290 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc-----cHHHHhcChHHHHH
Confidence             11222            23567789999999999999999     66999999999553

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-47  Score=364.08  Aligned_cols=268  Identities=40%  Similarity=0.711  Sum_probs=226.7

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+..+.||+|+||.||++.++.     +++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcC-----CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            38889999999999999999986     8899999999876554444456677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      |+||||+.|++|.+++...  ..+++.++..++.|++.||.|||++||+||||||+||+++.++.....+          
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999999999888654  3589999999999999999999999999999999999999887632211          


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH-HhcccCCCCCCCHHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---KLQQRI-INEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~l  334 (431)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......   +....+ ......++..++.++.+|
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            1123357899999999999999999999999999999999999999864321   122222 222334567789999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      |.+||+.||++|+++...+++++++||||+.++|..+...+..|+|+|.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD  284 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence            9999999999999654445999999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=380.94  Aligned_cols=243  Identities=29%  Similarity=0.482  Sum_probs=217.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ...|....+||+|+.|.||.|+...     +++.||||.|......   ..+-+.+|+.+|+..+|+|||.+++.|--++
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~-----~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKIS-----TKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhhcchhhhccccccceeeeeecc-----CCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            4569999999999999999999887     8889999999876533   3456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------E  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~  257 (431)
                      .+|+|||||+||+|.+.+... .++|.++..|+++++.||+|||.+||||||||.+|||++.+|....           .
T Consensus       344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999999999998888664 5999999999999999999999999999999999999999987321           2


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                      .....+++||++|||||++..+.|+.++||||||++++||+-|++||-..++......|...   .+..|+.+|.++++|
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            22456789999999999999999999999999999999999999999988888877777654   345678899999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.+||+.|+++|+     ++.+||+||||+-
T Consensus       503 L~~cL~~dv~~Ra-----sA~eLL~HpFl~~  528 (550)
T KOG0578|consen  503 LDRCLVVDVEQRA-----SAKELLEHPFLKM  528 (550)
T ss_pred             HHHHhhcchhcCC-----CHHHHhcChhhhh
Confidence            9999999999998     8899999999954

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=368.05  Aligned_cols=244  Identities=30%  Similarity=0.518  Sum_probs=206.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      .++...+.||+|+||.||++.+..     +|..+|||.+.....   ...+.+.+|+.+|+.++|||||++++...... 
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~-----~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK-----TGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC-----CCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            358889999999999999999886     689999999876522   12677899999999999999999999755544 


Q ss_pred             -EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCccCC--------
Q 014087          189 -KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHEIDE--------  257 (431)
Q Consensus       189 -~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-~g~~~~~--------  257 (431)
                       .++++|||+.||+|.+++.+.+ .++|..++.+.+||++||.|||++|||||||||+|||++. +|.....        
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence             6999999999999999999987 7999999999999999999999999999999999999999 5542111        


Q ss_pred             ------CCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc--ccCCCCCC
Q 014087          258 ------SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINE--KVKLPPFL  327 (431)
Q Consensus       258 ------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~  327 (431)
                            ........||+.|||||++... ..+.++|||||||++.||+||+.||.. .......-.|...  .+.+|..+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~l  248 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSL  248 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCccc
Confidence                  1223457899999999999963 334599999999999999999999987 3444444444433  35788999


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +.++++||.+||.+||.+||     ++++++.|||.+..
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rp-----ta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRP-----TAEELLEHPFLKQN  282 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCc-----CHHHHhhChhhhcc
Confidence            99999999999999999999     89999999999763

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=375.47  Aligned_cols=246  Identities=33%  Similarity=0.606  Sum_probs=224.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (431)
                      ..|++.+.||+|.||.||+|+.+.     +|+.+|+|++.+.........+.+.+|+.+|+.+. |||||.++++|++..
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~-----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKS-----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecC-----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            469999999999999999999987     79999999999988766666778999999999998 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----c----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----E----------  254 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----~----------  254 (431)
                      .+|+|||+|.||+|++.+.+. .++|..+..++.|++.|+.|||+.||+||||||+|+|+.....    .          
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999887 4999999999999999999999999999999999999976532    1          


Q ss_pred             cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHH
Q 014087          255 IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE  330 (431)
Q Consensus       255 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  330 (431)
                      ..........|||+.|+|||++...+|+..+||||+||++|.|++|.+||.+.+.......|..+.+.++    +.++..
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            1113356678999999999999999999999999999999999999999999999999999999988765    357999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +++||++||..||.+|+     ++.++++|||+++.
T Consensus       269 akd~i~~ll~~dp~~R~-----ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRL-----TAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCC-----CHHHHhcCccccCC
Confidence            99999999999999999     89999999999874

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-46  Score=359.32  Aligned_cols=268  Identities=38%  Similarity=0.686  Sum_probs=230.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+..+.||+|+||+||++.+..     +++.+|+|.+.+...........+.+|+++|+.++|+||+.+++.+..++..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECC-----CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            37889999999999999999886     7889999999876554444456677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      |+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+          
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999999998888654  3699999999999999999999999999999999999999887532111          


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccCCCCCCCHHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                      .......|+..|+|||++.+..++.++|+|||||++|||++|+.||.+......    ...+......++..++.++.+|
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            112345789999999999999999999999999999999999999987654433    3333444445667789999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      +.+||+.||++|+++....+++++.|+||+.++|+.++.+++.|+|.|.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD  284 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence            9999999999999876667999999999999999999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.1e-47  Score=359.54  Aligned_cols=260  Identities=36%  Similarity=0.677  Sum_probs=217.6

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||+|+||.||+++.+.     +++.||+|.+.+...........+..|+++++.++||||++++++++++..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKN-----TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEcc-----CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            7999999999999886     78999999998765544444455667999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------CCccccc
Q 014087          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------SRSNSMC  265 (431)
Q Consensus       198 ~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------~~~~~~~  265 (431)
                      .|++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+          .......
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            9999988886543  588999999999999999999999999999999999999887632111          1122357


Q ss_pred             CCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCCC-CCCCHHHHHHHHhhcc
Q 014087          266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLP-PFLTSEAHSLLKGLLH  340 (431)
Q Consensus       266 Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~  340 (431)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||....    ...+...+.......+ ..++.++++||.+||+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence            8999999999999899999999999999999999999997643    2334444444444433 4689999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      +||++|+++. .-+++++.|+||++++|..++.+.+.|||.|+
T Consensus       236 ~~P~~R~~~~-~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05607         236 KKPEDRLGSR-EKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD  277 (277)
T ss_pred             cCHhhCCCCc-cchhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence            9999999552 22478999999999999999999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-48  Score=369.35  Aligned_cols=248  Identities=32%  Similarity=0.553  Sum_probs=225.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +=|.+.+.||+|-|++|-+|++--     +|..||||++.|..+.+ -....+..|++.|+.++|||||+||++..+...
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF-----TGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc-----ccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            348899999999999999999875     99999999999987643 344567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----------ccCC
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDE  257 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----------~~~~  257 (431)
                      +|||+|+=.+|+|+++|.++ ..+.|+.++.|++||+.|+.|+|+..||||||||+|+.+.+.-.           ....
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999999999886 46999999999999999999999999999999999998766522           2334


Q ss_pred             CCCcccccCCCCCCchhhhccCCCC-CcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                      .....+.||+..|-|||++.+..|+ +++||||||||||-|++|++||...+..+.+..|+..++..|..++.++++||.
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence            4556788999999999999999996 578999999999999999999999999999999999999999999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      .||.+||++|.     ++++|..|+|++.+|-
T Consensus       252 sMLvRdPkkRA-----slEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  252 SMLVRDPKKRA-----SLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHhcCchhhc-----cHHHHhccccccCCCC
Confidence            99999999997     9999999999998874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-47  Score=363.53  Aligned_cols=244  Identities=28%  Similarity=0.453  Sum_probs=210.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .+.|+.+++||+|+||.||+|++..     +|+.||+|.++.+.. +.+......+||.||++|+|||||+|.+...+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~-----tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLE-----TGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecc-----cCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            4569999999999999999999886     999999999998764 456667778899999999999999999998877 


Q ss_pred             -CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          188 -SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       188 -~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                       ..+|||+|||+. ||.-++... -.|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.....+       
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence             689999999987 787777664 3699999999999999999999999999999999999999999743222       


Q ss_pred             -----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------ccC
Q 014087          259 -----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------KVK  322 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~----------~~~  322 (431)
                           ...+..+-|.+|.|||+++| ..|+.++|+||.||||.||+.|++.|.+.+..+....|..-          ...
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence                 12445567999999999997 46999999999999999999999999999988888887531          112


Q ss_pred             CC-------------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          323 LP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       323 ~p-------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      +|                   ..++..+.+|+..||..||.+|.     ++.++++|+||.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~-----tA~~aL~seyF~  404 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG-----TASSALQSEYFT  404 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc-----cHHHHhcCcccc
Confidence            22                   23678899999999999999999     889999999994

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.8e-45  Score=354.06  Aligned_cols=276  Identities=37%  Similarity=0.724  Sum_probs=237.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      .+|++.+.||+|+||.||++.++.     +++.||+|.+.+.........+.+.+|+++++.++||||+++++.+..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE-----TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC-----CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            369999999999999999999886     788999999987755455556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      +|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.....+..         
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999999999999888889999999999999999999999999999999999999988763221111         


Q ss_pred             -----------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 014087          261 -----------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  323 (431)
Q Consensus       261 -----------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~  323 (431)
                                       .....|+..|+|||.+....++.++|+|||||++|||++|..||.+.+..++...+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                             112467889999999998899999999999999999999999999888888888877765544


Q ss_pred             CC---CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCC
Q 014087          324 PP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  394 (431)
Q Consensus       324 p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~  394 (431)
                      |.   .++.++.+||.+||+.||++||++.  ++.+++.||||.+.+|.....++  ..+.|.....++.++||
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  305 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLRQK--AEFIPQLESEDDTSYFD  305 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhhcC--CCCCCCCCCccccccCC
Confidence            43   5789999999999999999999764  78999999999999999977553  46777776666665553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=364.04  Aligned_cols=245  Identities=30%  Similarity=0.503  Sum_probs=207.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  187 (431)
                      .++|.++++||.|+||.||+|+.+.     ++..||||.|++.-. .-+..- -.+|+..|++++ |||||+|.+++.+.
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~-----~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKE-----TGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecC-----CCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            4579999999999999999999886     889999999987643 222222 246999999998 99999999999998


Q ss_pred             C-EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----------cc
Q 014087          188 S-KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EI  255 (431)
Q Consensus       188 ~-~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----------~~  255 (431)
                      + .+|+|||||+. +|+++++.+ ..|++..++.|+.||++||+|+|++|+.|||+||||||+..+..          .+
T Consensus        82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence            8 99999999987 898888765 56999999999999999999999999999999999999994322          22


Q ss_pred             CCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Q 014087          256 DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN----------------  318 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~----------------  318 (431)
                      ......+..+.|.+|.|||+++. ..|+.++||||+|||++|+.+-++.|.|.+..+.+.+|..                
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            33344566788999999999875 5689999999999999999999999999888777766642                


Q ss_pred             ---cccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          319 ---EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       319 ---~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                         -.+.+|           +..+.++.+||.+||.+||++||     |++++++||||+..
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp-----TA~~al~~pffq~~  297 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP-----TASQALQHPFFQVG  297 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc-----cHHHHhcCcccccc
Confidence               112232           23789999999999999999999     89999999999753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-45  Score=352.67  Aligned_cols=243  Identities=28%  Similarity=0.440  Sum_probs=202.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE-----TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC-----CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            369999999999999999999986     788999999976532 23345667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.....+           
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999999999987766655556799999999999999999999999999999999999999887532111           


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  320 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------------  320 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....                 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence             11223578999999999999999999999999999999999999998766544333322110                 


Q ss_pred             --cCC-------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 --VKL-------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 --~~~-------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                        ...             ...++.++++||++||++||++|+     +++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~-----s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY-----LTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence              011             123688899999999999999999     88999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.1e-45  Score=348.73  Aligned_cols=261  Identities=39%  Similarity=0.732  Sum_probs=225.5

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||+|+||+||+|.++.     +++.||+|++.+...........+.+|+++|+.++||||+++++++...+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKA-----TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcC-----CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            6999999999999876     78899999998765444445556778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------CCccccc
Q 014087          198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------SRSNSMC  265 (431)
Q Consensus       198 ~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------~~~~~~~  265 (431)
                      +|++|.+++.+.+  .+++.++..++.|++.||.|||++||+||||||+||+++.++.....+          .......
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            9999999998766  799999999999999999999999999999999999999987632211          1122346


Q ss_pred             CCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 014087          266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK  341 (431)
Q Consensus       266 Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  341 (431)
                      |+..|+|||++.+..++.++|||||||++|+|++|+.||.....    ..+...+......++..+++++.++|.+||+.
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            78899999999988899999999999999999999999976543    34444555556667778899999999999999


Q ss_pred             CcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       342 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      ||.+|++....++++++.||||+.++|..+......|||.|+
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD  277 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence            999999887668999999999999999999988889999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-47  Score=339.73  Aligned_cols=245  Identities=28%  Similarity=0.529  Sum_probs=216.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .|.-.+.||+|..++|-+|.++.     +++.+|+|++......     -....+....|+.||+++ .||+|+++.++|
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~-----t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKE-----TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcc-----cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            57788899999999999998886     8899999998653221     233455667899999988 699999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc---------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~---------  255 (431)
                      +++..+++|+|.|+.|.|+++|...-.++|.+.+.|++|++.|++|||.++||||||||+|||+|++-+..         
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence            99999999999999999999999998999999999999999999999999999999999999999986532         


Q ss_pred             -CCCCCcccccCCCCCCchhhhc------cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC--C-
Q 014087          256 -DESSRSNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--P-  325 (431)
Q Consensus       256 -~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--~-  325 (431)
                       .........||||+|+|||.+.      ..+|+..+|+|++|||||.|+.|.+||-+....-+...|+.+++.+.  + 
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence             2334456789999999999987      35789999999999999999999999998888888999999988774  2 


Q ss_pred             -CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          326 -FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       326 -~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                       .++.+.+|||.+||+.||.+|+     ++++.+.||||..
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ri-----take~LaHpff~q  288 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRI-----TAKEALAHPFFIQ  288 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcc-----cHHHHhcChHHHH
Confidence             5899999999999999999999     8999999999954

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=342.44  Aligned_cols=241  Identities=32%  Similarity=0.549  Sum_probs=212.3

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||.|-.|....     ++..||||++.|..   .....++.+|++++..++ |+||++|+++|+++.++||||
T Consensus        84 e~LGeGAyasVqtcv~i~-----t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ-----TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhcCccceeeeeeeeec-----cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            579999999999998876     89999999998863   344567888999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc-------------c------
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------------I------  255 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~-------------~------  255 (431)
                      |.|.||.|..+|.++..|+|.++..++.+|+.||+|||.+||.||||||+|||-....+.             +      
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999999999999999999999999999999999999999999999999999998654331             1      


Q ss_pred             --CCCCCcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCC---------------HHHHH
Q 014087          256 --DESSRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHAN---------------RQKLQ  313 (431)
Q Consensus       256 --~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~---------------~~~~~  313 (431)
                        .......+.||+..|||||+..     ...|++++|.||||||||-||+|.+||.+.-               .+.++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence              1112335678999999999876     3468999999999999999999999997531               46789


Q ss_pred             HHHHhcccCCCC----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          314 QRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       314 ~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      +.|..+.+.||+    .+|.+++|||..+|.+|+..|+     .+.++++|||+..+.-+
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl-----sa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL-----SAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh-----hhhhccCCccccccchh
Confidence            999999999996    4899999999999999999999     77899999999987644

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6e-45  Score=347.43  Aligned_cols=261  Identities=38%  Similarity=0.730  Sum_probs=215.3

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH---hcCCCCcceeeEEEEeCCEEEEE
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT---KVTHPFIVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lv  193 (431)
                      .||+|+||.||++++..     +++.+|+|++.+.............+|..+++   ..+||||+.+++++...+..|+|
T Consensus         1 ~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECC-----CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            48999999999999875     78899999997765433332333444544444   34799999999999999999999


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------CCcccc
Q 014087          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------SRSNSM  264 (431)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------~~~~~~  264 (431)
                      |||+.||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.....+         ......
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  155 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  155 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCc
Confidence            99999999999998888899999999999999999999999999999999999999887632211         112234


Q ss_pred             cCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 014087          265 CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH  340 (431)
Q Consensus       265 ~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  340 (431)
                      .|+..|+|||.+. +..++.++|||||||++|+|++|..||...   ....+..........+|..++.++.++|.+||.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            6899999999987 466899999999999999999999999653   233333333444556778899999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      .||++|+++...+++++++||||++++|......+..+|.+|
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  277 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP  277 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence            999999987777899999999999999999887777777655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.6e-45  Score=370.67  Aligned_cols=244  Identities=25%  Similarity=0.431  Sum_probs=195.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC------CCccee
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL  180 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l  180 (431)
                      +..++|+++++||+|+||+||+|.+..     +++.||||+++...    ........|+.+++.++|      .+|+++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRK-----RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcC-----CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            345789999999999999999999876     78899999996532    122334567777776654      458889


Q ss_pred             eEEEEeC-CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCc----
Q 014087          181 RYSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHE----  254 (431)
Q Consensus       181 ~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~----  254 (431)
                      +++|... .++|+|||++ |++|.+++.+.+.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++..    
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            9988765 5789999988 77899999888899999999999999999999998 599999999999999877631    


Q ss_pred             -------------cC-------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 014087          255 -------------ID-------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ  314 (431)
Q Consensus       255 -------------~~-------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~  314 (431)
                                   +.       ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             cccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                         11       1112345689999999999999999999999999999999999999998877655444


Q ss_pred             HHHhcccCCCC------------------------------------------CCCHHHHHHHHhhcccCcCCcCCCCCC
Q 014087          315 RIINEKVKLPP------------------------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPG  352 (431)
Q Consensus       315 ~i~~~~~~~p~------------------------------------------~~s~~~~~li~~~L~~dP~~R~~~~~~  352 (431)
                      .+......+|.                                          ..++.+.|||.+||++||.+|+     
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~-----  430 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL-----  430 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC-----
Confidence            33221111100                                          0135577999999999999999     


Q ss_pred             CHHHHHhCCCCCC
Q 014087          353 GVDAIKHHKWFRS  365 (431)
Q Consensus       353 ~~~~i~~h~~f~~  365 (431)
                      +++|+++||||..
T Consensus       431 ta~e~L~Hp~~~~  443 (467)
T PTZ00284        431 NARQMTTHPYVLK  443 (467)
T ss_pred             CHHHHhcCccccc
Confidence            8999999999975

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=357.13  Aligned_cols=242  Identities=28%  Similarity=0.459  Sum_probs=207.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+...+..+.+.||+|+||+||++.+++      ...+|+|++......... .+.|.+|+.+|.+++|||||+++|++.
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g------~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~  109 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRG------TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT  109 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCC------ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3444556777779999999999999974      223999999876654444 778999999999999999999999999


Q ss_pred             eCC-EEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEeCCCC-CccC----
Q 014087          186 TRS-KLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENILMDSDG-HEID----  256 (431)
Q Consensus       186 ~~~-~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-iiHrDlKp~NILl~~~g-~~~~----  256 (431)
                      +.. .+++||||+++|+|..++.+  ++.++...+..++.||+.||.|||+++ ||||||||+|||++.++ +...    
T Consensus       110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence            988 79999999999999999988  578999999999999999999999999 99999999999999997 4211    


Q ss_pred             ------CC-CCcccccCCCCCCchhhhc--cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCC
Q 014087          257 ------ES-SRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPP  325 (431)
Q Consensus       257 ------~~-~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~  325 (431)
                            .. ...+...||+.|||||++.  ...|+.++|||||||+||||+||+.||.+.........+..  .+..+|.
T Consensus       190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence                  11 2333468999999999999  66999999999999999999999999999887666666653  3556677


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+++.+..||.+||..||.+||     ++.+|..
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP-----~f~ei~~  298 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRP-----SFLEIVS  298 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCC-----CHHHHHH
Confidence            8999999999999999999999     7777765

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-45  Score=351.77  Aligned_cols=247  Identities=24%  Similarity=0.392  Sum_probs=199.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||+||+|+++.     +++.||||+++....  ......+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC-----CCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence            3579999999999999999999875     788999999875432  222335678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..|+||||+. ++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.        
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9999999996 5777777654 56899999999999999999999999999999999999998876322111        


Q ss_pred             ---CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc--c------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINE--K------------  320 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~--~------------  320 (431)
                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... .+....+...  .            
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence               1234568999999999875 4588999999999999999999999987432 2222222110  0            


Q ss_pred             -------cC--CC---------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          321 -------VK--LP---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       321 -------~~--~p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                             ..  .+         ...+.++++||.+||+.||.+|+     +++++++||||+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~-----s~~~~l~h~~f~~~~~  296 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL-----SAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc-----CHHHHhcCcccccCCh
Confidence                   00  00         02356899999999999999999     8999999999998875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.2e-45  Score=348.88  Aligned_cols=242  Identities=25%  Similarity=0.413  Sum_probs=202.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.++||+|+||.||+|+++.     +++.||+|+++....  ......+.+|+.+++.++||||+++++++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER   76 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECC-----CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            4579999999999999999999876     788999999875432  222345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..|+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.        
T Consensus        77 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          77 CLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99999999986 8988887654 5799999999999999999999999999999999999999876332211        


Q ss_pred             ---CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  320 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------  320 (431)
                         ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....               
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence               1234568999999999875 568999999999999999999999999877666555443210               


Q ss_pred             ----cCC-----------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 ----VKL-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 ----~~~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                          ..+           ...++.++++||++||+.||.+|+     +++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~-----t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI-----SAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCCCC
Confidence                001           124688999999999999999999     89999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-44  Score=353.70  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=210.4

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||.||+|+++.     ++..+|+|++....  .....+.+.+|+++|+.++||||+++++++..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKP-----SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   75 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            45789999999999999999999886     78899999987642  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      +.+++||||++||+|.+++.+...+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.....+        
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999999999999888899999999999999999999986 699999999999999987633221        


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--------------------  317 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~--------------------  317 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.                    
T Consensus       156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence             12234579999999999999999999999999999999999999997665544332211                    


Q ss_pred             --------------------------hcc-cCCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          318 --------------------------NEK-VKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       318 --------------------------~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                                                ... ...+ ..++.++++||.+||++||++||     ++++|+.||||+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp-----t~~ell~h~~~~~~~~~  310 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA-----DLKMLMNHTFIKRSEVE  310 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC-----CHHHHhcChHHhhcccc
Confidence                                      110 1111 24688999999999999999999     89999999999875443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.9e-46  Score=339.34  Aligned_cols=247  Identities=28%  Similarity=0.447  Sum_probs=208.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      ..++|+.+..|++|+||.||+|+++.     ++++||+|.++.+.. ....--.-.+|+.+|.+++|||||.+-.+... 
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~-----t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~  147 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKK-----TDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGS  147 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCC-----cceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence            34579999999999999999999987     999999999987763 23333334579999999999999999888764 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                       -+.+|+|||||+. +|..++..-+ +|...+++.++.|++.||+|||.+.|+|||||++|+|++..|.....+.     
T Consensus       148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence             4579999999986 8988888765 8999999999999999999999999999999999999999987432222     


Q ss_pred             ------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 014087          260 ------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  319 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------  319 (431)
                            ..+..+-|.+|.|||++.+ ..|+.++|+||+|||+.||+++++.|.+....+...+|...             
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence                  2455667899999999997 56999999999999999999999999999888877777531             


Q ss_pred             ------ccCCC------------CC-CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 ------KVKLP------------PF-LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 ------~~~~p------------~~-~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                            .+.++            .. +++...+|+..+|..||.+|.     ++++.+.|.||.+.
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~-----tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI-----TAEDGLKHEYFRET  367 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc-----cHHHhhcccccccC
Confidence                  11121            11 568999999999999999999     88999999999874

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=351.12  Aligned_cols=266  Identities=44%  Similarity=0.794  Sum_probs=227.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      .+|++.+.||+|+||.||+|.+..     +++.||+|.+.+...........+..|+++++.++||||+++++.+.....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC-----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence            369999999999999999999876     788999999987765544566778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      .|+||||+.|++|.+++.+.  ..+++..++.++.||+.||.|||+.||+||||||+||+++.+|.....+         
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999999998764  5689999999999999999999999999999999999999886522111         


Q ss_pred             -------------------------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 014087          259 -------------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  307 (431)
Q Consensus       259 -------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~  307 (431)
                                                     .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                           0112346889999999999999999999999999999999999999988


Q ss_pred             CHHHHHHHHHhcccCCCCC--CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccC
Q 014087          308 NRQKLQQRIINEKVKLPPF--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD  383 (431)
Q Consensus       308 ~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~  383 (431)
                      +.......+......++..  ++.++.++|.+||..||++|+++. .++++++.||||++++|..+..  ..||-.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-~~~~~ll~~~~~~~~~~~~~~~--~~~~~~~~  310 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWALIRH--TTPPIIPR  310 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCch-hhHHHHHcCchhhcCChhhccc--CCCCCCCC
Confidence            8888888777766666654  699999999999999999999321 1289999999999999988865  33444443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-45  Score=328.71  Aligned_cols=244  Identities=25%  Similarity=0.413  Sum_probs=207.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      .+|..+++||+|+||.||+|++..     +|+.||||.++.....+.-.. ...+|+++|+.++|+||+.|+++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~-----t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE-----TGKRVAIKKIKLGNAKDGINR-TALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC-----CCcEEEEEEeeccccccCccH-HHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            468899999999999999999886     999999999988765433333 45679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc-------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS-------  261 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~-------  261 (431)
                      +.||+|||+- +|...++.+ ..++..+++.|+.++++||+|||++.|+||||||.|+||+.+|.....+...       
T Consensus        76 l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9999999975 898888765 4689999999999999999999999999999999999999998743322222       


Q ss_pred             ----ccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--c---------C---
Q 014087          262 ----NSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--V---------K---  322 (431)
Q Consensus       262 ----~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~---------~---  322 (431)
                          ...+-|.+|.|||.+.| +.|+..+||||.|||+.||+-|.+-|.+.+.-+....|...-  .         .   
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence                22256899999999986 579999999999999999999999999988887777775310  0         0   


Q ss_pred             ------CC--------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          323 ------LP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       323 ------~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                            +|        ...+.++.||+.+||..||.+|+     ++.|++.|+||+.
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri-----ta~qaL~~~yf~~  286 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI-----TASQALKHPYFKS  286 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc-----cHHHHhcchhhhc
Confidence                  11        22577899999999999999999     8899999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-44  Score=353.60  Aligned_cols=242  Identities=27%  Similarity=0.433  Sum_probs=199.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+.+++||+|+||.||+|+++.     +++.||||++....  .......+.+|+++|+.++|+||+++++++...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECC-----CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            4568899999999999999999875     78899999986543  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .+|+||||+.+|+|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.....+.         
T Consensus       146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999999999998542    34578888999999999999999999999999999999999876332211         


Q ss_pred             --CcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hcccCCCCCCC
Q 014087          260 --RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRII-NEKVKLPPFLT  328 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s  328 (431)
                        .....+||..|+|||++..     ...+.++|||||||++|||++|+.||.....   ......+. ......+..++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence              1234579999999999853     2345689999999999999999999974322   22222332 23344567789


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .++++||.+||..||++||     ++++|++||||.+.
T Consensus       302 ~~l~~li~~~l~~~P~~Rp-----t~~ell~hp~~~~~  334 (353)
T PLN00034        302 REFRHFISCCLQREPAKRW-----SAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHhcCcccccC
Confidence            9999999999999999999     89999999999874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-47  Score=358.51  Aligned_cols=246  Identities=23%  Similarity=0.448  Sum_probs=217.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ..|..+++||+|+||.||+|.+..     +++.||+|++.-+.  ....++.+..|+.+|..++++||.++|+.|..+..
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~-----t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNK-----TKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             cccccchhccccccceeeeeeecc-----ccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            358888999999999999999886     89999999998765  35567788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------CC
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------ES  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~~  258 (431)
                      ++++||||.||++.+.+.....+.|..+..++++++.||.|||.++.+|||||+.|||+..+|....           ..
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999999999999998888899999999999999999999999999999999999999876321           12


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~  337 (431)
                      ....+++||+.|||||++...+|+.++||||||++.|||++|.+||....+......|-.. .+.+...+++.+++||..
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence            2347899999999999999999999999999999999999999999988775544444333 333445789999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ||.+||+.||     ++.+++.|+|.+...
T Consensus       246 CL~k~P~~Rp-----sA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  246 CLDKNPEFRP-----SAKELLKHKFIKRAK  270 (467)
T ss_pred             HhhcCcccCc-----CHHHHhhhHHHHhcC
Confidence            9999999999     889999999998743

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.1e-44  Score=340.24  Aligned_cols=261  Identities=37%  Similarity=0.723  Sum_probs=216.9

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHH---HHHhcCCCCcceeeEEEEeCCEEEEE
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---ILTKVTHPFIVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~---il~~l~hpnIv~l~~~~~~~~~~~lv  193 (431)
                      .||+|+||.||+|++..     +++.||+|++.+..............|..   +++...||||+++++++...+..|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEec-----CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence            48999999999999875     78899999998754332222222333433   44456899999999999999999999


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------CCcccc
Q 014087          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------SRSNSM  264 (431)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------~~~~~~  264 (431)
                      |||+.||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.....+         ......
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~  155 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  155 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCc
Confidence            99999999999998888899999999999999999999999999999999999999887632211         122345


Q ss_pred             cCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 014087          265 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH  340 (431)
Q Consensus       265 ~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  340 (431)
                      +|+..|+|||++.+. .++.++||||+||++|||++|+.||...   ........+......+|..++.++.++|.+||.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  235 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ  235 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence            799999999999754 6899999999999999999999999865   444455555555667777889999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      .||.+|+.+...+++++++||||++++|..+..++..++.+|
T Consensus       236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~  277 (278)
T cd05606         236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP  277 (278)
T ss_pred             cCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence            999999988777999999999999999999987776666554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-44  Score=351.41  Aligned_cols=246  Identities=24%  Similarity=0.381  Sum_probs=199.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC---
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  187 (431)
                      +|++.++||+|+||.||+|+++.     +++.||||.+..... .......+.+|+.+|+.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            59999999999999999999876     789999999875322 222345678899999999999999999988543   


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                        ..+|+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.      
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence              35899999995 689999988888999999999999999999999999999999999999999876322111      


Q ss_pred             --------CcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 014087          260 --------RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------  318 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~-----------  318 (431)
                              .....+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..           
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence                    1123478999999999876  6789999999999999999999999987654332221110           


Q ss_pred             ---------------cccCCC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          319 ---------------EKVKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       319 ---------------~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                     .....+     +.+++++.+||.+||..||++||     +++++++||||+++..
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~e~l~hp~f~~~~~  298 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP-----TAEEALADPYFKGLAK  298 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC-----CHHHHhcCchhhhcCc
Confidence                           000000     24678899999999999999999     8999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-43  Score=338.46  Aligned_cols=270  Identities=47%  Similarity=0.891  Sum_probs=228.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      +|++.+.||+|+||.||+|+.....  .+++.||+|+++...... ....+.+.+|+++|+.+ +|+||++++++++.+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            4899999999999999999875321  267889999997654322 23346678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.....+          
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            9999999999999999999888899999999999999999999999999999999999999887632111          


Q ss_pred             --CCcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTSE  330 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~  330 (431)
                        ......+|+..|+|||.+.+  ..++.++|||||||++|+|++|..||...    ...++...+......+|..++..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL  238 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence              11224568999999999875  34788999999999999999999999643    33455555656666777889999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      +.+|+.+||..||++|+++++.++++++.||||+.++|+.+..+..+++|+|
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  290 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP  290 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence            9999999999999999998888999999999999999999988887777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.4e-44  Score=335.35  Aligned_cols=247  Identities=41%  Similarity=0.807  Sum_probs=217.6

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||.|+||.||+|++..     +++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||+
T Consensus         1 lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECC-----CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            7999999999999875     78899999998766555556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------CCCcccccCC
Q 014087          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------SSRSNSMCGT  267 (431)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------~~~~~~~~Gt  267 (431)
                      ++++|.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.....          ........|+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            999999999988889999999999999999999999999999999999999988753211          1122345689


Q ss_pred             CCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRII--NEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       268 ~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      ..|++||.+.+..++.++|+||||+++|+|++|..||....  ..+....+.  .....+|...+.++.++|.+||..||
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999999998889999999999999999999999998766  666677776  45667777789999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ++|++.....++++++||||++.+|+
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99996555569999999999999996

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.4e-44  Score=360.48  Aligned_cols=244  Identities=25%  Similarity=0.400  Sum_probs=197.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...++|+++++||+|+||+||+|.++.     +++.||||++....       ....+|+.+|+.++|||||+++++|..
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICID-----TSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            345689999999999999999999876     78899999886432       123469999999999999999888753


Q ss_pred             C--------CEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc
Q 014087          187 R--------SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       187 ~--------~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      .        ..+++||||+.+ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+||||+.++..
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence            2        247899999986 5666554    34679999999999999999999999999999999999999977542


Q ss_pred             c--CC---------CCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---
Q 014087          255 I--DE---------SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---  319 (431)
Q Consensus       255 ~--~~---------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---  319 (431)
                      +  .+         .......+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.+..+...++...   
T Consensus       210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            1  11         1122345789999999998764 6899999999999999999999999987766555444321   


Q ss_pred             --------------cc------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          320 --------------KV------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       320 --------------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                    .+            .+|...+.++++||.+||++||.+|+     ++.+++.||||..+..
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~-----ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL-----NPIEALADPFFDDLRD  359 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc-----CHHHHhCChhHHhhhc
Confidence                          01            12345788999999999999999999     8899999999987654

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=356.15  Aligned_cols=251  Identities=32%  Similarity=0.563  Sum_probs=229.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..+.|.+.+.||+|.|++|.++++.-     ++..||||++++....... ...+.+|+++|+.++|||||+++.+.+..
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~-----t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHIL-----TGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETE  127 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecC-----CCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence            35679999999999999999999986     8889999999998765444 34488899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----------cCC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----------IDE  257 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----------~~~  257 (431)
                      ..+|+||||+.+|++++++.+++++.+..++.++.|++.|++|||+++|||||||.+||||+.+-+.          ...
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999999999999999999999999999999999999999999999999999988642          223


Q ss_pred             CCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                      .....++||++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++.+..++..+.+.+++.+|..++.++.++|+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr  287 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR  287 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence            345568899999999999999888 5789999999999999999999999999999999999999999999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ++|..+|.+|+     +.++|+.|.|.....-.
T Consensus       288 k~lvl~Pskr~-----~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRG-----PCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccC-----CHHHhhhhcccchhhhh
Confidence            99999999999     88999999999754433

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-45  Score=352.34  Aligned_cols=245  Identities=32%  Similarity=0.529  Sum_probs=221.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|.+++++|+|+||.+++++++.     .+..|++|.+.-........ +....|+.++++++|||||.+.+.|..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            3579999999999999999999987     77799999998776555443 35678999999999999999999999998


Q ss_pred             E-EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC---------
Q 014087          189 K-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID---------  256 (431)
Q Consensus       189 ~-~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~---------  256 (431)
                      . +||||+||+||+|.+.+.+.+  .|+|+.+..++.|++.|+.|||+++|+|||||+.|||++.++....         
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            8 999999999999999998653  6999999999999999999999999999999999999999876421         


Q ss_pred             -C-CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 014087          257 -E-SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  333 (431)
Q Consensus       257 -~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~  333 (431)
                       . .....+.+||+.||+||++.+.+|+.++|||||||++|||++-+.+|.+.+...+..+|.... .++|..++.+++.
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~  236 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRS  236 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHH
Confidence             1 125667899999999999999999999999999999999999999999999999999999887 5788899999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      +|+.||.++|..||     ++.+++.+|...
T Consensus       237 lv~~~l~~~P~~RP-----sa~~LL~~P~l~  262 (426)
T KOG0589|consen  237 LVKSMLRKNPEHRP-----SALELLRRPHLL  262 (426)
T ss_pred             HHHHHhhcCCccCC-----CHHHHhhChhhh
Confidence            99999999999999     889999998765

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-43  Score=354.05  Aligned_cols=241  Identities=25%  Similarity=0.332  Sum_probs=197.9

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|+++++||+|+||.||+|.++.     +++.||+|....         ..+.+|+++|+.++|||||+++++|.
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~-----~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNK-----TCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECC-----CCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            3556789999999999999999999886     889999997542         23567999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                      .+...|+|||++. ++|..++.....+++.+++.++.||+.||.|||++|||||||||+|||++.+|.....+       
T Consensus       154 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             ECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9999999999995 68989998888899999999999999999999999999999999999999887632211       


Q ss_pred             -----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh--------
Q 014087          259 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-------RQKLQQRIIN--------  318 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~-------~~~~~~~i~~--------  318 (431)
                           ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+..        
T Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence                 12234579999999999999999999999999999999999998874321       1111111111        


Q ss_pred             ------------------cccCCC---------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          319 ------------------EKVKLP---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       319 ------------------~~~~~p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                        .....+         ..++.++.+||.+||+.||.+||     +++++++||||+.+
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~  382 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP-----SAEALLDFAAFQDI  382 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC-----CHHHHhcChhhccC
Confidence                              000001         12466899999999999999999     89999999999764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-43  Score=345.32  Aligned_cols=247  Identities=29%  Similarity=0.449  Sum_probs=206.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.++||+|+||.||++.++.     ++..+|+|++....  .......+.+|+++|+.++||||+++++++.++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKP-----SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   75 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence            45689999999999999999999876     78899999887642  233456688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      +.+|+||||+.||+|.+++.+.+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.....+        
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999999999999888899999999999999999999975 799999999999999887633211        


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH----------------------
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR----------------------  315 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~----------------------  315 (431)
                       ......+||..|+|||++.+..++.++|||||||++|||++|+.||.......+...                      
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence             112345789999999999998999999999999999999999999976544333211                      


Q ss_pred             ----------------------HHhcc-cCCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          316 ----------------------IINEK-VKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       316 ----------------------i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                            +.... ..++ ..++.++++||.+||++||++||     ++++++.|+||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp-----t~~ell~h~~~~~~  305 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRS  305 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc-----CHHHHhhCHHHhcC
Confidence                                  11111 1111 13678999999999999999999     89999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.7e-43  Score=335.50  Aligned_cols=268  Identities=48%  Similarity=0.905  Sum_probs=226.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      +|++.+.||+|+||.||++++....  ..+..||||++++..... ....+.+.+|+.++..+ +||||+++++.+..+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            4899999999999999999865422  257789999998654322 33446678899999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+.+|+|.+++.+...+++..++.++.|++.||.|||+.|++||||||+||+++.++.....+          
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            9999999999999999998888899999999999999999999999999999999999999887622111          


Q ss_pred             --CCcccccCCCCCCchhhhccCC--CCCcchhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFLTSE  330 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~  330 (431)
                        ......+|+..|+|||.+.+..  .+.++||||||+++|||++|..||...    ...++.+.+.......|..++.+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE  238 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence              1122346899999999987654  788999999999999999999999643    23445555666666777889999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      +.++|.+||+.||++||++.  +++++++|+||++++|+.+.++.+.|+|.|
T Consensus       239 l~~li~~~l~~~p~~R~t~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  288 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAKRIPAPFKP  288 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcc--hHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence            99999999999999999764  789999999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-43  Score=336.67  Aligned_cols=242  Identities=26%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc---CCCCcceeeEEEE--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ--  185 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~--  185 (431)
                      +|++++.||+|+||+||+|++..    .+++.||+|+++...... .....+.+|+.+++.+   +||||+++++++.  
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            69999999999999999999753    246789999987644322 2233455677777665   6999999999885  


Q ss_pred             ---eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--
Q 014087          186 ---TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--  258 (431)
Q Consensus       186 ---~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--  258 (431)
                         ....+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+  
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence               3456999999997 5898888764  3589999999999999999999999999999999999999887632221  


Q ss_pred             --------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------  321 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------  321 (431)
                              .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+.....         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence                    123345789999999999999999999999999999999999999998877766666643210         


Q ss_pred             ------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          322 ------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       322 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                        .+.+.++..+++||.+||+.||++||     ++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC-----CHHHHhcCCCC
Confidence                              01134678899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=332.38  Aligned_cols=245  Identities=28%  Similarity=0.441  Sum_probs=204.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe---
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (431)
                      ..|..++.||+|+||.|+.|.++.     +|+.||||.+... ....-..++..+|+++|+.++|+||+.+.+++..   
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~-----t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKR-----TGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcC-----CCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            457778999999999999999987     8899999988632 2344556778889999999999999999999876   


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--------
Q 014087          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--------  256 (431)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--------  256 (431)
                        -..+|+|+|+| +.+|...++.+..+++..++.+++||+.||.|+|+.||+||||||.|+|++.+.....        
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              35699999999 5589999988888999999999999999999999999999999999999998854211        


Q ss_pred             -----CCCCcccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Q 014087          257 -----ESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN------------  318 (431)
Q Consensus       257 -----~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~------------  318 (431)
                           .....+..+-|.+|.|||++. ...|+.++||||+|||+.||++|++.|.+.+.-...+.|+.            
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence                 133345667799999999987 57899999999999999999999999998775544444431            


Q ss_pred             -----------cccCCC--------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          319 -----------EKVKLP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       319 -----------~~~~~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                 .....|        +..++++.+|+.+||..||.+|+     |+++++.||||...
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi-----ta~eAL~hPYl~~~  316 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI-----TAEEALAHPYLAPY  316 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC-----CHHHHhcChhhhhh
Confidence                       111111        36789999999999999999999     89999999999753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.7e-43  Score=348.12  Aligned_cols=246  Identities=25%  Similarity=0.321  Sum_probs=204.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (431)
                      +|++++.||+|+||.||+|.+..     +++.||||.+.... ........+.+|+.+|+.++||||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR-----DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC-----CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            48899999999999999999875     78899999986532 12233456788999999999999999999998877  


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                         .+|+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.....+.      
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence               8999999997 578888888888999999999999999999999999999999999999999876332111      


Q ss_pred             ------CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014087          260 ------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------  318 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--------------  318 (431)
                            ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..              
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence                  12234678999999999874 579999999999999999999999988776655544422              


Q ss_pred             ---------ccc---------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          319 ---------EKV---------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       319 ---------~~~---------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                               ...         .+....++++.+||.+||+.||.+||     ++++++.||||++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~~~~  296 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI-----SAADALAHPYLDEGRL  296 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc-----CHHHHhcCHhhCCCcc
Confidence                     111         12234688999999999999999999     8999999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=330.80  Aligned_cols=247  Identities=40%  Similarity=0.775  Sum_probs=210.5

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHH-HhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||.||+|.++.     +++.||+|++.+...........+..|..++ ...+|+||+++++++..++.+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS-----TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecC-----CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            569999999999999875     7889999999775543333344445555554 4558999999999999999999999


Q ss_pred             eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------CcccccCC
Q 014087          195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------RSNSMCGT  267 (431)
Q Consensus       195 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------~~~~~~Gt  267 (431)
                      ||+.|++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.....+.       ......|+
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGT  156 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCC
Confidence            99999999999988888999999999999999999999999999999999999998876322111       12345689


Q ss_pred             CCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHHHHhhcccCc
Q 014087          268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       268 ~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP  343 (431)
                      ..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|.+||+.||
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence            999999999988899999999999999999999999998888887777766554433    3578999999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          344 SKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ++|+++.  ++++++.||||++++|+
T Consensus       237 ~~R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         237 AKRLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             HHccCCC--cHHHHHcChHhhcCCCC
Confidence            9999775  88999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-43  Score=344.09  Aligned_cols=243  Identities=21%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             EEeeeccc--CceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          114 IFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       114 ~~~~LG~G--~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      ++++||+|  +||+||+++++.     +++.||+|.++.... .....+.+.+|+.+++.++||||+++++++..++..|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP-----TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecc-----cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            56789999  789999999886     899999999976543 2344567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          192 LILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+.          
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999999998753  45899999999999999999999999999999999999998765321110          


Q ss_pred             --------CcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------
Q 014087          260 --------RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------  322 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-------  322 (431)
                              ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..................       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence                    0112356778999999976  46899999999999999999999999865544433332221110       


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          323 ---------------------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       323 ---------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                                             ....+++++.+||.+||+.||++||     +++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~ell~~p~f  310 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP-----SASTLLNHSFF  310 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC-----CHHHHhcChhh
Confidence                                                   1123567899999999999999999     88999999999


Q ss_pred             CCCC
Q 014087          364 RSIN  367 (431)
Q Consensus       364 ~~~~  367 (431)
                      +.+.
T Consensus       311 ~~~~  314 (327)
T cd08227         311 KQIK  314 (327)
T ss_pred             hhcc
Confidence            8764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-43  Score=344.63  Aligned_cols=247  Identities=24%  Similarity=0.388  Sum_probs=200.0

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++.++||+|+||.||+|.+....+..+++.||||+++...  .......+.+|+.+|+.+ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            45667899999999999999999987654444467789999987542  233446688899999999 899999999988


Q ss_pred             EeC-CEEEEEEeccCCCChHHHHHHc------------------------------------------------------
Q 014087          185 QTR-SKLYLILDFINGGHLFFHLYRQ------------------------------------------------------  209 (431)
Q Consensus       185 ~~~-~~~~lv~E~~~gg~L~~~l~~~------------------------------------------------------  209 (431)
                      ... ..+|+||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            764 4689999999999999998753                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------------CcccccCCC
Q 014087          210 --------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------------RSNSMCGTT  268 (431)
Q Consensus       210 --------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------------~~~~~~Gt~  268 (431)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.             ......++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    23778889999999999999999999999999999999998875322111             111234567


Q ss_pred             CCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCC
Q 014087          269 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSK  345 (431)
Q Consensus       269 ~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~  345 (431)
                      .|+|||++.+..++.++|||||||+||||++ |..||.+....+ +...+..+ ....|..+++++.+||.+||+.||++
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999997 999998755433 33334333 34456778999999999999999999


Q ss_pred             cCCCCCCCHHHHHh
Q 014087          346 RLGSGPGGVDAIKH  359 (431)
Q Consensus       346 R~~~~~~~~~~i~~  359 (431)
                      ||     ++.+|++
T Consensus       321 RP-----s~~el~~  329 (338)
T cd05102         321 RP-----TFSALVE  329 (338)
T ss_pred             Cc-----CHHHHHH
Confidence            99     7888875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-43  Score=358.02  Aligned_cols=245  Identities=27%  Similarity=0.448  Sum_probs=211.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ..|.+.+.||+|+||.||+|....    ..++.+|+|.+...   .......+.+|+.+|+.++|||||++++++..++.
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~----~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGS----DPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcC----CCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            349999999999999999998764    12677888876543   23344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                      +||||||++||+|.+++..    ...+++.++..++.||+.||.|||++||+||||||+|||++.+|.....+       
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            9999999999999887754    34689999999999999999999999999999999999999887632111       


Q ss_pred             ------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHH
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEA  331 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~  331 (431)
                            ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+.. .+|..++.++
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence                  113456799999999999999999999999999999999999999999888888888776654 3566789999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+||.+||..||++||     ++++++.|+|++.+
T Consensus       300 ~~li~~~L~~dP~~Rp-----s~~~~l~~~~~~~~  329 (478)
T PTZ00267        300 KALLDPLLSKNPALRP-----TTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHhccChhhCc-----CHHHHHhCHHHHHH
Confidence            9999999999999999     88999999998643

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-43  Score=358.95  Aligned_cols=248  Identities=29%  Similarity=0.473  Sum_probs=214.0

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||+||+|+++.     +++.||||++..... .......+.+|+.+|..++|+||++++..+...
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS-----DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC-----CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            34689999999999999999999876     789999999976543 334456678899999999999999998877543


Q ss_pred             C--------EEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          188 S--------KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       188 ~--------~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                      +        .+++||||+.+|+|.+++...    ..+++..+..++.|++.||+|||++||+||||||+|||++.++...
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        378999999999999988653    4689999999999999999999999999999999999999887632


Q ss_pred             CCC-------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Q 014087          256 DES-------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-  321 (431)
Q Consensus       256 ~~~-------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-  321 (431)
                      ..+             ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+.. 
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            111             122356799999999999999999999999999999999999999999888888887776544 


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+|..+++++.+||.+||+.||.+||     ++.++++|||++..
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RP-----s~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRP-----SSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCc-----CHHHHHhCHHHHHh
Confidence            46788999999999999999999999     88999999998764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-43  Score=328.15  Aligned_cols=246  Identities=28%  Similarity=0.441  Sum_probs=207.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC-cceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~  188 (431)
                      ..|+.+++||+|+||+||+|+.+.     +|+.||+|.++-+... +..-....+|+.+|+.++|+| ||.|++++.+.+
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~-----~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR-----TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec-----CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            358888999999999999999987     8899999999865432 223344578999999999999 999999999887


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--
Q 014087          189 ------KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--  256 (431)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--  256 (431)
                            .+++|+||++. +|..++....    .++...++.+++||+.||+|||++||+||||||+||||+++|....  
T Consensus        85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence                  89999999975 8999998765    4788899999999999999999999999999999999999987321  


Q ss_pred             ---------CCCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------
Q 014087          257 ---------ESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------  319 (431)
Q Consensus       257 ---------~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-------  319 (431)
                               .....+..++|.+|.|||++.+. .|+..+||||+|||++||++++..|.+....+...+|..-       
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence                     12234566889999999999986 7999999999999999999999999999888777777531       


Q ss_pred             -----------ccCCCC------------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          320 -----------KVKLPP------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       320 -----------~~~~p~------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                                 +..++.            ..++++.+++.+||+.+|.+|.     +++.++.||||....
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~-----Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI-----SAKGALTHPYFSELP  309 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc-----CHHHHhcChhhcccc
Confidence                       111211            1335899999999999999999     889999999998864

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.4e-43  Score=337.81  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.+|+|.++....  ......+.+|+.+++.++||||+++++++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK   77 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecC-----CCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence            3579999999999999999999875     788999999875432  222345667999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+.        
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99999999986 788877664 45899999999999999999999999999999999999998876322111        


Q ss_pred             ---CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------------  319 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~----------------  319 (431)
                         ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...                
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence               1223467899999999875 45889999999999999999999999887765554443221                


Q ss_pred             ---ccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 ---KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                         ...++           ..++.++++||.+||+.||.+|+     +++++++||||+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  292 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI-----SAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC-----CHHHHhcChhhhhc
Confidence               01111           24788999999999999999999     89999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=346.52  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=202.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|++++.||+|+||.||+|..++.   ..++.||+|.+....        ...+|+++|+.++||||+++++++...
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            345799999999999999999986532   256789999886432        245799999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..+|+|||++. ++|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.++.....+.        
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99999999996 588888877788999999999999999999999999999999999999998876432211        


Q ss_pred             -----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----cc-------
Q 014087          260 -----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRIIN----EK-------  320 (431)
Q Consensus       260 -----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~---~~~~~~i~~----~~-------  320 (431)
                           .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   ......+..    ..       
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence                 12245799999999999999999999999999999999999999976431   111111111    00       


Q ss_pred             ------------------cCCC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHh
Q 014087          321 ------------------VKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  372 (431)
Q Consensus       321 ------------------~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~  372 (431)
                                        ...|     ..++.++.+||++||..||++||     ++.+++.||||+...|+.+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp-----sa~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP-----SAQDILSLPLFTKEPINLLN  387 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC-----CHHHHhhCchhhccchhhhc
Confidence                              0111     12467899999999999999999     88999999999998887664

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=327.64  Aligned_cols=244  Identities=29%  Similarity=0.457  Sum_probs=210.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ++|++.+.||+|+||.||+|.+..     +++.+|+|.+......  .....+.+.+|+++++.++||||+++++++.++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD-----TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC-----CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence            469999999999999999998775     7889999998754321  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      +.+|+|+||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.....+.        
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999999999998888999999999999999999999999999999999999998876321110        


Q ss_pred             ------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHH
Q 014087          260 ------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEA  331 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~  331 (431)
                            ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...  ...+|..++.++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence                  012356788999999999999999999999999999999999999876665555444433  345677889999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      .+||.+||..+|.+||     ++++++.|+||
T Consensus       237 ~~li~~~l~~~p~~Rp-----t~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRP-----SAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCC-----CHHHHhhCCCC
Confidence            9999999999999999     89999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.5e-43  Score=328.08  Aligned_cols=245  Identities=41%  Similarity=0.769  Sum_probs=214.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||.|+||.||+|++..     +++.||+|++.+.........+.+.+|+++++.++||||+++++.+.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD-----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc-----CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence            48999999999999999999875     7889999999887655556678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------CCC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------SSR  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------~~~  260 (431)
                      |+|+||+.|++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.....          ...
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            9999999999999999888789999999999999999999999999999999999999998763211          112


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+   ...+.+........+|..++.++.++|.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK  235 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence            234568899999999998889999999999999999999999998766   44444444445667788899999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ||..||.+|+++.   +++++.||||
T Consensus       236 ~l~~~p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         236 LLERDPQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             HccCChhHcCCcc---HHHHhcCCCC
Confidence            9999999999331   4999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-42  Score=334.27  Aligned_cols=245  Identities=27%  Similarity=0.426  Sum_probs=205.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||++++..     ++..+|+|.+....  .......+.+|+++++.++||||+++++++.+++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP-----SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC-----CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence            369999999999999999999876     78889999987542  23345568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCC---------C
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDES---------S  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~---------~  259 (431)
                      +|+||||++|++|.+++.+.+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.+|.....+         .
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999999999999988889999999999999999999997 6999999999999999887632211         1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------------
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--------------------  319 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--------------------  319 (431)
                      .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...                    
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            124457899999999999888999999999999999999999999765543332222110                    


Q ss_pred             -----------------ccCCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 -----------------KVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 -----------------~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                       ....| ..++.++++||.+||..||++||     ++++|++||||.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA-----DLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc-----CHHHHhcChhhhhc
Confidence                             11111 13678899999999999999999     89999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-42  Score=342.99  Aligned_cols=243  Identities=26%  Similarity=0.408  Sum_probs=196.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.+... .......+.+|+.+++.++||||+++++++...+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV-----LGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC-----CCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            3679999999999999999999876     789999999876432 2334456778999999999999999999987543


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                            .+|+||||+.+ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.   
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence                  57999999976 5656554  34899999999999999999999999999999999999999876332211   


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------  318 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--------------  318 (431)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..              
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence                   12345789999999999999999999999999999999999999987664433222211              


Q ss_pred             --------cccCC--------------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          319 --------EKVKL--------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       319 --------~~~~~--------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                              ....+                    ....+.++++||.+||..||++||     +++++++||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~  320 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI-----SVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC-----CHHHHhcCchhhh
Confidence                    11111                    112467899999999999999999     8999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-44  Score=322.45  Aligned_cols=239  Identities=31%  Similarity=0.567  Sum_probs=206.9

Q ss_pred             CCCceEE-eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEe
Q 014087          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (431)
                      .++|.+- ++||-|-.|+|..|.++.     +++.+|+|++...        ...++|+++--.. .|||||.++++|++
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~-----T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKR-----TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEecc-----chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            4567664 689999999999999987     8999999988532        2356788876555 69999999998864


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc------
Q 014087          187 ----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------  254 (431)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~------  254 (431)
                          ..++.+|||.|+||+|+..+..++.  |+|.++..|+.||..|+.|||+.+|.||||||+|+|....+..      
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                5678999999999999999998865  9999999999999999999999999999999999999876531      


Q ss_pred             -----c--CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCC
Q 014087          255 -----I--DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKL  323 (431)
Q Consensus       255 -----~--~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~  323 (431)
                           .  .......+.|-|+.|.|||++..+.|+..+|+||+||+||-||+|.+||....    ...+..+|..+.+.|
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence                 1  11234567789999999999999999999999999999999999999997643    356789999999999


Q ss_pred             CC----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          324 PP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       324 p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.    .+|++++|+|+++|..+|.+|+     ++++++.|||...
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRl-----TI~~~m~hpwi~~  327 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERL-----TIEEVMDHPWINQ  327 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhhe-----eHHHhhcCchhcc
Confidence            84    5899999999999999999999     9999999999975

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-42  Score=343.55  Aligned_cols=243  Identities=25%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++++.||+|+||.||+|.++.     +++.||||++.+... .......+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC-----CCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            4579999999999999999999875     788899999876432 233345677899999999999999999987643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                           ..+|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.....+    
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence                 358999999976 67676653  478999999999999999999999999999999999999887632211    


Q ss_pred             ------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------------  320 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------  320 (431)
                            .......||..|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....++...            
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence                  11234578999999999999999999999999999999999999998877665555443210            


Q ss_pred             ----------cCC--------------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          321 ----------VKL--------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       321 ----------~~~--------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                ..+                    ....+.++++||.+||+.||.+||     +++++++||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~-----t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccc
Confidence                      000                    011346789999999999999999     8999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-42  Score=331.59  Aligned_cols=241  Identities=27%  Similarity=0.391  Sum_probs=195.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc---CCCCcceeeEEEEe-
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT-  186 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-  186 (431)
                      +|++.+.||+|+||+||+|+++.     +++.||+|.++..... ......+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            48999999999999999999886     8899999998764322 22223345677777655   79999999998864 


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--
Q 014087          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--  258 (431)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--  258 (431)
                          ...+++||||+.+ +|..++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+  
T Consensus        75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence                3468999999985 888888764  3489999999999999999999999999999999999999888643221  


Q ss_pred             --------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------  320 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------  320 (431)
                              .......||..|+|||++.+..++.++|||||||++|||++|++||.+........++....          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence                    11234568999999999999999999999999999999999999998877666555543210          


Q ss_pred             -c----------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 -V----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 -~----------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       .                ...+.++.++.+||.+||+.||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~l~hp~f  288 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI-----SAFRALQHPFF  288 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC-----CHHHHhcCCCC
Confidence             0                01124678899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.3e-42  Score=329.87  Aligned_cols=255  Identities=18%  Similarity=0.280  Sum_probs=211.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||.||+|..+....+..+..||+|.+.....  ......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            45678999999999999999999877544444567899998865432  2223457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ....|+||||+.+|+|.+++.+.+          .++...+..++.||+.||.|||++||+||||||+|||++.++....
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999997532          2456788999999999999999999999999999999998876332


Q ss_pred             CCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cc
Q 014087          257 ESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV  321 (431)
Q Consensus       257 ~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~  321 (431)
                      .+..             .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            2211             112245678999999999899999999999999999999 89999988887777776654 34


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh------CCCCCCCCh
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH------HKWFRSINW  368 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~------h~~f~~~~~  368 (431)
                      ..+..++.+++++|.+||+.||++||     +++++++      ||||++++|
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRP-----TFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHHhhcCCCCCCCCC
Confidence            55677889999999999999999999     7777765      999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-42  Score=327.71  Aligned_cols=244  Identities=45%  Similarity=0.855  Sum_probs=216.6

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||.|+||.||+|++..     +++.+++|++...........+.+.+|+++++.++||||+++++.+..+...|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKS-----TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECC-----CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            6899999999999875     78899999998766555566778899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------------------
Q 014087          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------------------  259 (431)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------------------  259 (431)
                      .+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.....+.                  
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99999999988888999999999999999999999999999999999999999876321110                  


Q ss_pred             -CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC--CHHHHHHHH
Q 014087          260 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL--TSEAHSLLK  336 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~  336 (431)
                       ......++..|+|||.+....++.++||||||+++|+|++|..||......+....+..+....+...  +.++.+||.
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHH
Confidence             22334678899999999988899999999999999999999999998888888888887777777665  999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      +||+.+|++||++.  ++.++++||||++++|
T Consensus       236 ~~l~~~p~~Rpt~~--~~~~~l~~~~~~~~~~  265 (265)
T cd05579         236 KLLVPDPEKRLGAK--SIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHhcCCHhhcCCCc--cHHHHhcCccccCCCC
Confidence            99999999999543  5599999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.5e-43  Score=328.12  Aligned_cols=241  Identities=34%  Similarity=0.610  Sum_probs=203.9

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++++.||+|+||+||++++..     +++.||+|++......... .....+|+.+++.++||||+++++++.+....+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK-----NGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT-----TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC-----CCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccc
Confidence            7899999999999999999986     7889999999887643333 233455999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CCC
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SSR  260 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~~  260 (431)
                      +||||+.+++|.+++.+.+.+++..+..++.||+.||.+||++||+||||||+||+++.++.....           ...
T Consensus        75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999988889999999999999999999999999999999999999988763211           222


Q ss_pred             cccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          261 SNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      .....|+..|+|||++. +..++.++||||||+++|+|++|..||....   ................    .....++.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            33457899999999998 8889999999999999999999999999873   3333333333222211    12248999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ++|.+||+.||++||     +++++++||||
T Consensus       235 ~li~~~l~~~p~~R~-----~~~~l~~~~~~  260 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRP-----SAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHSSSSGGGST-----THHHHHTSGGG
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCCCC
Confidence            999999999999999     89999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.6e-43  Score=347.00  Aligned_cols=241  Identities=29%  Similarity=0.480  Sum_probs=203.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-C-----CCcceeeEEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H-----PFIVQLRYSF  184 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~  184 (431)
                      +|++++.||+|+||+|.+|.+.+     +++.||||++++.    +....+...|+.+|..|+ |     -|||+++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~-----T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK-----TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC-----CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            68899999999999999999987     9999999999865    345566777999999997 4     3899999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----cC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----ID--  256 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----~~--  256 (431)
                      ...+++|||+|++. .+|+++++.+.  .|+...++.|+.||+.||.+||+.||||+|||||||||..-+..    ++  
T Consensus       258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999999995 49999999874  58899999999999999999999999999999999999876541    11  


Q ss_pred             ----CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014087          257 ----ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------  318 (431)
Q Consensus       257 ----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--------------  318 (431)
                          ......+.+.+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+.+..|+.              
T Consensus       337 SSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  337 SSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence                11222355678899999999999999999999999999999999999999988877777642              


Q ss_pred             --------------------------------------cccCCCC-----------CCCHHHHHHHHhhcccCcCCcCCC
Q 014087          319 --------------------------------------EKVKLPP-----------FLTSEAHSLLKGLLHKDPSKRLGS  349 (431)
Q Consensus       319 --------------------------------------~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~~~  349 (431)
                                                            .....|.           .-...+.|||++||..||.+|+  
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~--  494 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI--  494 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC--
Confidence                                                  0000120           1124578999999999999999  


Q ss_pred             CCCCHHHHHhCCCCCCC
Q 014087          350 GPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       350 ~~~~~~~i~~h~~f~~~  366 (431)
                         +..++++||||.+.
T Consensus       495 ---tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 ---TPAQALNHPFLTGT  508 (586)
T ss_pred             ---CHHHHhcCcccccc
Confidence               88999999999864

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.6e-42  Score=320.39  Aligned_cols=242  Identities=29%  Similarity=0.502  Sum_probs=208.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-CCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~  189 (431)
                      +|++++.||+|++|.||++.++.     +++.+|+|.+..... .....+.+.+|+++++.++|+||+++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT-----DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC-----CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            49999999999999999999875     778899999876543 23345668889999999999999999998874 446


Q ss_pred             EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      +|+||||+++++|.+++...  ..+++.+++.++.|++.||.|||++||+||||||+||+++.++.....+         
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            89999999999999998763  4589999999999999999999999999999999999999887532111         


Q ss_pred             --CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  335 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  335 (431)
                        .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+.. ..+..++.++.+||
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI  234 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence              122345789999999999999999999999999999999999999998877777666666544 45667899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      .+||..||++||     ++.+++.||||
T Consensus       235 ~~~l~~~p~~Rp-----~~~~~l~~~~~  257 (257)
T cd08223         235 ATMLSKRPEKRP-----SVKSILRQPYI  257 (257)
T ss_pred             HHHhccCcccCC-----CHHHHhcCCCC
Confidence            999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-42  Score=330.30  Aligned_cols=238  Identities=17%  Similarity=0.202  Sum_probs=203.4

Q ss_pred             CCceEE--eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          110 GDFEIF--RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       110 ~~y~~~--~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      ++++..  ..||+|++|.||++++       +++.||||++++.........+.+.+|+.+|++++||||+++++++.+ 
T Consensus        18 ~~i~~~~~~~i~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   90 (283)
T PHA02988         18 DDIDKYTSVLIKENDQNSIYKGIF-------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI   90 (283)
T ss_pred             HHcCCCCCeEEeeCCceEEEEEEE-------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence            344444  6799999999999987       567899999987654445556788899999999999999999999877 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCCC---
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                         ...+++||||+.||+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.+|.....+.   
T Consensus        91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         91 VDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             ccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence               45789999999999999999988889999999999999999999998 59999999999999999886432211   


Q ss_pred             -----CcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHH
Q 014087          260 -----RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSE  330 (431)
Q Consensus       260 -----~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~  330 (431)
                           ......|+..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..++...+...  ...+|..++.+
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  250 (283)
T PHA02988        171 KILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLE  250 (283)
T ss_pred             hhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHH
Confidence                 1234568999999999976  68999999999999999999999999998888888877544  44556578999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++||.+||+.||++||     +++++++
T Consensus       251 l~~li~~cl~~dp~~Rp-----s~~ell~  274 (283)
T PHA02988        251 IKCIVEACTSHDSIKRP-----NIKEILY  274 (283)
T ss_pred             HHHHHHHHhcCCcccCc-----CHHHHHH
Confidence            99999999999999999     8888875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-42  Score=363.76  Aligned_cols=138  Identities=41%  Similarity=0.717  Sum_probs=127.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|.+..     +++.||||++++...........+..|+.+++.++||||+++++++....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN-----NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            4679999999999999999999876     78899999998766556666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      .+|+||||+.|++|.+++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~  140 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE  140 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC
Confidence            999999999999999999888889999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=342.11  Aligned_cols=237  Identities=24%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..+.+++++.||+|-||.||++++++      ...||+|.++......    +.+.+|+++|++|+|+|||+|++++..
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~------~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNG------STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcC------CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            444567788999999999999999974      3358999987654332    456689999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCcccc
Q 014087          187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM  264 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~~~~  264 (431)
                      ++.+|||||||+.|+|.++|+.  .+.+...+...++.||++|++||+++++|||||...||||++++.....+......
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence            9999999999999999999997  46789999999999999999999999999999999999999998644333333222


Q ss_pred             cC------------CCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          265 CG------------TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       265 ~G------------t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                      .+            ...|.|||.+....++.++|||||||+||||+| |+.||.+.+..+..+.+..+ +++-|+.++++
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE  432 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence            21            457999999999999999999999999999999 99999999999999999776 77889999999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHH
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIK  358 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~  358 (431)
                      +.+++..||+.+|++||     |++.+.
T Consensus       433 vY~lM~~CW~~~P~~RP-----tF~~L~  455 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRP-----TFETLR  455 (468)
T ss_pred             HHHHHHHHhhCCcccCC-----CHHHHH
Confidence            99999999999999999     777554

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.4e-42  Score=327.97  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=211.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..+.|+++++||+|+||.||+|++..     +++.+++|++...   .....+.+.+|+.+++.++||||+++++.+..+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKE-----TGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD   81 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECC-----CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence            34569999999999999999999875     7889999998754   234456688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      +.+|+||||++|++|..++.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.+|.....+.       
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999887765 456899999999999999999999999999999999999998775322111       


Q ss_pred             ----CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCC
Q 014087          260 ----RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFL  327 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~  327 (431)
                          ......|+..|+|||++.     ...++.++|||||||++|||++|..||...+......++.....   ..+..+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW  241 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCccc
Confidence                122346788999999985     34568899999999999999999999988776665555544322   234567


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      +.++.+||.+||..||++||     +++++++||||..++|...
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~~~  280 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRP-----SAAQLLEHPFVSSVTSNRP  280 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCc-----CHHHHhcCccccccccchh
Confidence            89999999999999999999     8999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-41  Score=318.14  Aligned_cols=242  Identities=29%  Similarity=0.487  Sum_probs=210.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|.+.+.||+|+||.||+|.++.     +++.|++|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA-----DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC-----CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            58899999999999999999876     7889999998765432 34456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      |+||||++|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+          
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999999999774  5689999999999999999999999999999999999999887632211          


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  336 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  336 (431)
                       ......+|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..+.. .++..++.++.++|.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence             112234688999999999999999999999999999999999999998887777777766543 345578899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +||+.+|++||     ++.++++|||+
T Consensus       235 ~~l~~~p~~Rp-----~~~~ll~~~~~  256 (256)
T cd08529         235 QCLTKDYRQRP-----DTFQLLRNPSL  256 (256)
T ss_pred             HHccCCcccCc-----CHHHHhhCCCC
Confidence            99999999999     88999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=327.16  Aligned_cols=246  Identities=29%  Similarity=0.491  Sum_probs=210.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||.|+||.||++.++.     ++..+|+|++...   .....+.+..|+.+++.++||||+++++.+..+..
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE-----TGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC-----CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            469999999999999999999875     7889999998654   23345678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .|+||||+++++|..++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.....+          
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999999999998764 5699999999999999999999999999999999999999887632211          


Q ss_pred             -CCcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCH
Q 014087          259 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTS  329 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~  329 (431)
                       .......|++.|+|||++.     ...++.++|||||||++|||++|+.||...+.......+....   ...+..++.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS  236 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence             1123346899999999985     3456789999999999999999999998887777666666543   234567899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      ++.+||.+||+.||.+||     +++++++|+||++...
T Consensus       237 ~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~~  270 (280)
T cd06611         237 SFNDFLKSCLVKDPDDRP-----TAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHHHHHHhccChhhCc-----CHHHHhcChhhcccch
Confidence            999999999999999999     8999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.2e-42  Score=338.42  Aligned_cols=243  Identities=25%  Similarity=0.404  Sum_probs=196.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++++.||+|+||.||+|.+..     +++.||+|++..... .......+.+|+.+++.++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecC-----CCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            4579999999999999999999875     788999999875432 233445677899999999999999999998654 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                           ...|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.+|.....+    
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence                 357999999976 56666643  489999999999999999999999999999999999999887632211    


Q ss_pred             ------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  319 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------  319 (431)
                            .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...             
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence                  1123457899999999999999999999999999999999999999887654433322110             


Q ss_pred             ---------cc-----C---------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          320 ---------KV-----K---------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       320 ---------~~-----~---------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                               ..     .               .+...+.++++||.+||..||++||     +++++++||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----s~~ell~hp~~~~  316 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDEALQHPYINV  316 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC-----CHHHHhcCcchhc
Confidence                     00     0               1112456789999999999999999     8999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-42  Score=329.10  Aligned_cols=246  Identities=24%  Similarity=0.410  Sum_probs=202.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|.++....  ......+.+|+.+++.++||||+++++++..++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKL-----TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcC-----CCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence            4679999999999999999999875     788999999875432  222345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      .+|+||||+.+ +|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+.        
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          78 SLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99999999974 888887764 56899999999999999999999999999999999999999876322111        


Q ss_pred             ---CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------------  319 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~----------------  319 (431)
                         ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+...                
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence               11234578899999998754 5788999999999999999999999887766554443221                


Q ss_pred             ---ccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          320 ---KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       320 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                         ...+|           ..++.++++||.+||+.||.+|+     +++++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~eil~h~~f~~~~  293 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI-----SAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc-----CHHHHhcCccccccc
Confidence               01111           24688999999999999999999     899999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.2e-42  Score=322.99  Aligned_cols=244  Identities=20%  Similarity=0.300  Sum_probs=204.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +...+|++.+.||+|+||.||++.++..  ...+..||+|.++...  .......+.+|+.+++.++||||+++++++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~--~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLP--SKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecC--CCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            3456799999999999999999987531  1256789999987643  23334668889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-----  260 (431)
                      ++..|+||||+++|+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.....+..     
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999999999874 578999999999999999999999999999999999999988753221111     


Q ss_pred             -------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          261 -------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       261 -------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                             .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.+..+ ..+.|..++..+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL  237 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence                   012234678999999999999999999999999999775 99999988888777777654 345567789999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+++.+||+.+|.+||     ++++|++
T Consensus       238 ~~li~~c~~~~p~~RP-----~~~~i~~  260 (266)
T cd05064         238 HQLMLDCWQKERGERP-----RFSQIHS  260 (266)
T ss_pred             HHHHHHHcCCCchhCC-----CHHHHHH
Confidence            9999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.7e-42  Score=322.17  Aligned_cols=242  Identities=27%  Similarity=0.432  Sum_probs=206.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh---hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI---IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      +|++.+.||+|+||.||+|...      +++.+|+|.+.....   ........+.+|+++|+.++|+||+++++++.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            4888999999999999999753      678899998875421   2234456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      +..|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.....+         
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999999999998888899999999999999999999999999999999999999877532211         


Q ss_pred             --------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCC
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFL  327 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~  327 (431)
                              .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF  234 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence                    1122356889999999999999999999999999999999999999876655444444332   23456678


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +.++.+||++||..+|++||     ++++++.||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp-----~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERP-----SALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence            99999999999999999999     89999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-41  Score=322.02  Aligned_cols=243  Identities=28%  Similarity=0.456  Sum_probs=207.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh------hhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +|.+...||+|+||.||+|.+..     +++.+|+|.+......      .....+.+.+|+.+++.++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS-----SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC-----CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            37788999999999999999875     7788999988654322      223456788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      .+.+..++||||+++++|..++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++.....+.     
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999999999998888999999999999999999999999999999999999998875321111     


Q ss_pred             ------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCC
Q 014087          260 ------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF  326 (431)
Q Consensus       260 ------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~  326 (431)
                                  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+... ...+|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN  235 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence                        112346889999999999988999999999999999999999999876655544444433 3456677


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ++.++.++|.+||+.||.+||     ++++|++|+||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp-----~~~~il~~~~~  267 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRP-----TAAELLKHPFL  267 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCc-----CHHHHhhCCCC
Confidence            899999999999999999999     89999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-42  Score=337.56  Aligned_cols=245  Identities=24%  Similarity=0.392  Sum_probs=199.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++++.||+|+||+||+|.+..     +++.||||++.+... .......+.+|+.+|+.++||||+++++++... 
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTR-----LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-----CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            4679999999999999999999875     788999999876432 223345577899999999999999999888643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                           ..+|+++|++ +++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.....+    
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                 3579999998 778877664 45699999999999999999999999999999999999999887632211    


Q ss_pred             ----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------
Q 014087          259 ----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-------------  320 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------  320 (431)
                          ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....             
T Consensus       166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence                22345678999999999987 568999999999999999999999998766555444432210             


Q ss_pred             ----------cCCC--------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          321 ----------VKLP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       321 ----------~~~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                ...+        ...++.+.+||.+||+.||.+|+     ++++++.||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~-----s~~ell~hp~~~~~  304 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI-----SASEALAHPYFSQY  304 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhcc
Confidence                      0011        13567789999999999999999     89999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=343.28  Aligned_cols=235  Identities=36%  Similarity=0.587  Sum_probs=200.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      ..+|++...+|.|+|+.|-.+.++.     +++.+++|++.+....       ..+|+.++... +||||+++++.+.+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~-----t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP-----TDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc-----cccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCC
Confidence            4568888999999999999999886     8889999999876221       23466555554 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe-CCCCCccC--------CC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID--------ES  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl-~~~g~~~~--------~~  258 (431)
                      .+.|+|||++.|+.|.+.+.....+. .++..|++||+.|++|||++|||||||||+|||+ +..|+...        ..
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999999999999999998877666 8888999999999999999999999999999999 46665221        11


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      ....+.|-|..|.|||++...+|+.++||||||++||+||+|+.||..... .++..+|..+.+.  .++|.++++||++
T Consensus       468 ~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  468 RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQ  545 (612)
T ss_pred             hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHH
Confidence            123456778999999999999999999999999999999999999976444 4667776555443  8899999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ||+.||.+|+     ++.+|+.|+||
T Consensus       546 LL~~dP~~Rl-----~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRL-----GADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCc-----ChhhhccCcch
Confidence            9999999999     88999999999

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-41  Score=322.01  Aligned_cols=244  Identities=25%  Similarity=0.466  Sum_probs=205.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh---hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      +|+..+.||+|+||.||+++.+.     +++.+|+|++......   .....+.+..|+++++.++|+||+++++++.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK-----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC-----CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence            48889999999999999998865     7889999998754321   123457788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--C--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--E--------  257 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--~--------  257 (431)
                      +..++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++..+.  .        
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999999999988888999999999999999999999999999999999999988764211  0        


Q ss_pred             ------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH--hcccCCCCC
Q 014087          258 ------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---LQQRII--NEKVKLPPF  326 (431)
Q Consensus       258 ------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~---~~~~i~--~~~~~~p~~  326 (431)
                            ........|+..|+|||++.+..++.++|||||||++|+|++|..||.......   ....+.  .....+|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence                  011123468889999999998889999999999999999999999997543322   222221  223456677


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      ++.++.++|.+||..||++||     ++.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~-----~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRP-----PSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCc-----CHHHHhcCcccC
Confidence            899999999999999999999     889999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-41  Score=338.03  Aligned_cols=237  Identities=22%  Similarity=0.280  Sum_probs=192.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ...|.+.+.||+|+||.||+|++..     +++.||||....         ..+.+|+++|+.++|+|||++++++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~  233 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG  233 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            4579999999999999999999886     788999996432         22457999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..|+|||++. ++|..++... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.++.....+.        
T Consensus       234 ~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        234 LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9999999995 6888887664 56999999999999999999999999999999999999998876322111        


Q ss_pred             -----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcccC---C
Q 014087          260 -----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--------NRQKLQQRIINEKVK---L  323 (431)
Q Consensus       260 -----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~--------~~~~~~~~i~~~~~~---~  323 (431)
                           .....+||..|+|||++.+..++.++|||||||+||||++|..|+...        ....+.+.+......   +
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence                 112457999999999999999999999999999999999987654321        122233333221110   1


Q ss_pred             C-------------------------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          324 P-------------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       324 p-------------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +                               ..++.++.+||.+||+.||.+||     +++|+++||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP-----sa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP-----SAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc-----CHHHHhhCcccCC
Confidence            1                               02456899999999999999999     8999999999974

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-41  Score=322.91  Aligned_cols=242  Identities=24%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|+++++||+|+||.||+|.+..     +++.||+|++..+.  .......+.+|+++++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL-----TRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            368999999999999999999876     78899999987643  23344568889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------CC
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------SR  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------~~  260 (431)
                      .++||||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+|.....+         ..
T Consensus        74 ~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          74 ISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             EEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            9999999999998544    3578999999999999999999999999999999999999987632211         12


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcc-cCC-CCCCCHHH
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-------QKLQQRIINEK-VKL-PPFLTSEA  331 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~  331 (431)
                      ....+||..|+|||++.+..++.++|||||||++|+|++|+.||.....       ....+.+.... ... ....+.++
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            3345789999999999999999999999999999999999999965321       12223332222 222 23578899


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      .+||.+||+.||++||     ++++++.||||...+
T Consensus       230 ~~li~~~l~~~P~~Rp-----~~~eil~~~~~~~~~  260 (279)
T cd06619         230 VHFITQCMRKQPKERP-----APENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHhhCChhhCC-----CHHHHhcCccccccc
Confidence            9999999999999999     899999999998654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.8e-42  Score=322.48  Aligned_cols=241  Identities=27%  Similarity=0.457  Sum_probs=201.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|++..     +++.||+|+++...   ......+.+|+.+++.++||||+++++++...+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVN-----TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcC-----CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            3479999999999999999999875     78899999987543   223345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.....+          
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999999999998888999999999999999999999999999999999999999887532211          


Q ss_pred             -CCcccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-----CCCCH
Q 014087          259 -SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-----PFLTS  329 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~  329 (431)
                       .......|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+.......+     ..++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence             1123457899999999985   45688999999999999999999999976554433333333322221     24678


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  362 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  362 (431)
                      .+.+||.+||..||++||     ++++|++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~-----~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRP-----TAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCc-----CHHHHhcCCC
Confidence            999999999999999999     8999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-42  Score=323.32  Aligned_cols=239  Identities=30%  Similarity=0.498  Sum_probs=195.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (431)
                      .|.-.+++|.|+||.||+|....     +++.+|||.+-.+.-.       -.+|+++|+.++|||||+|..+|....  
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            48889999999999999999886     6889999987654321       235999999999999999988886432  


Q ss_pred             ---EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc------
Q 014087          189 ---KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI------  255 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~------  255 (431)
                         .+.||||||+. +|.+.++.    +..++...++.|..||++||.|||+.||+||||||.|||+|.+....      
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence               35689999986 88888874    56799999999999999999999999999999999999999984422      


Q ss_pred             -----CCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 014087          256 -----DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------  318 (431)
Q Consensus       256 -----~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~-----------  318 (431)
                           .......+..-|..|.|||.+.+ ..|+.++||||.||++.||+-|++.|.+.+..+....|..           
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence                 12222333445889999999986 5799999999999999999999999999887766655542           


Q ss_pred             -c-----ccC------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          319 -E-----KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       319 -~-----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                       -     ...            +...+++++.+|+.++|..+|.+|.     ++.+++.||||....
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~-----~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL-----SALEALAHPFFDELR  313 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC-----CHHHHhcchhhHHhh
Confidence             0     111            1234789999999999999999999     889999999997643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.5e-42  Score=339.96  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++.+.||+|+||.||+|++....+..++..||+|+++....  ......+.+|+.+++.+ +|+|||++++++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            345567999999999999999999987654445667899999976432  23356788899999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-------------------------------------------------------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ-------------------------------------------------------  209 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-------------------------------------------------------  209 (431)
                      ...+.+|+||||+.+|+|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999988642                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------------c
Q 014087          210 ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------------S  261 (431)
Q Consensus       210 ---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------------~  261 (431)
                                     ..+++.++..|+.||+.||.|||++||+||||||+|||++.++.....+..             .
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                           247888999999999999999999999999999999999987652211110             1


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHHHhh
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~  338 (431)
                      ....++..|||||++.+..++.++|||||||++|||++ |+.||...........+...  ....|..++.+++++|.+|
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            12234567999999999999999999999999999997 99999876554444343333  3345667899999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHh
Q 014087          339 LHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      |+.||.+||     ++++|.+
T Consensus       352 l~~dp~~RP-----s~~~l~~  367 (374)
T cd05106         352 WNLEPTERP-----TFSQISQ  367 (374)
T ss_pred             cCCChhhCc-----CHHHHHH
Confidence            999999999     7888865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.4e-41  Score=315.55  Aligned_cols=242  Identities=27%  Similarity=0.481  Sum_probs=209.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+|....     +++.+|+|.+..... .......+.+|+.+|+.++||||+++++.+..++..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA-----DQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC-----CCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58999999999999999999875     788999999976543 334467788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc--C---------C
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI--D---------E  257 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~--~---------~  257 (431)
                      ++||||++|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++...  .         .
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999999999764  3589999999999999999999999999999999999998765421  1         1


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLK  336 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  336 (431)
                      ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.... ..++..++.+++++|.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  234 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL  234 (256)
T ss_pred             CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence            112234568899999999998889999999999999999999999999887777766665543 3466778999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +||..||++||     ++++++.||||
T Consensus       235 ~~l~~~p~~Rp-----t~~~ll~~p~~  256 (256)
T cd08220         235 SMLNLDPSKRP-----QLSQIMAQPIC  256 (256)
T ss_pred             HHccCChhhCC-----CHHHHhhCCCC
Confidence            99999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.3e-41  Score=318.98  Aligned_cols=244  Identities=28%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      .+|++.+.||+|+||.||+|.+..     ++..||+|++.....  ........+.+|+.+++.++||||+++++++.+ 
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD-----TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC-----CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence            369999999999999999999875     788999998875432  123445678899999999999999999999876 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                       ...++++|||+++++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.++.....+.      
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence             3678999999999999999988888999999999999999999999999999999999999998875322111      


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCH
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  329 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~  329 (431)
                              ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+...  ...+|..+++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE  236 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence                    112345888999999999988999999999999999999999999876555444443322  3445667889


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      .+++|| +||..+|++||     ++++|++||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp-----~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRP-----SAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCc-----CHHHHhcCcccc
Confidence            999999 56678999999     899999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-41  Score=360.38  Aligned_cols=251  Identities=26%  Similarity=0.464  Sum_probs=204.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...++|++++.||+|+||+||+|+++.     +++.+|+|++..... .......+..|+.+|+.++|||||+++++|.+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~-----tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKR-----TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECC-----CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            345689999999999999999999986     788999999876543 33345678889999999999999999998864


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEeCCCCC
Q 014087          187 --RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKC-------GIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-------~iiHrDlKp~NILl~~~g~  253 (431)
                        ...+||||||+.+|+|.++|...    +.+++..++.|+.||+.||.|||+.       +||||||||+||||+.+..
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              45799999999999999988753    5799999999999999999999984       4999999999999975321


Q ss_pred             ------------------ccCC---------CCCcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCC
Q 014087          254 ------------------EIDE---------SSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF  304 (431)
Q Consensus       254 ------------------~~~~---------~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf  304 (431)
                                        .+.+         .......+||+.|+|||++.+  ..++.++||||||||||||++|+.||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                              0101         111234579999999999964  45889999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          305 THANRQKLQQRIINEKVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       305 ~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      ...+.......++.....+| ...+.++.+||..||..+|.+||     ++.+++.|+|++.+..
T Consensus       244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRP-----Sa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP-----SALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCc-----CHHHHhccHHHhhcCC
Confidence            76544333333333333333 45789999999999999999999     8899999999987643

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=346.42  Aligned_cols=247  Identities=29%  Similarity=0.489  Sum_probs=215.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +.++++..||.|+||+||+|..+.     ++-.-|-|++.-.   ....++.+..|++||..|+||+||+|++.|.-++.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            347889999999999999999875     7777888888643   45667778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      +|++.|||.||-....+..- ..+.+.++..+++|++.||.|||+++|||||||..|||++.+|.....+          
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999999987776654 5699999999999999999999999999999999999999998743222          


Q ss_pred             -CCcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---CCCCCCH
Q 014087          259 -SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTS  329 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~  329 (431)
                       ....++.|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...++...+-+|....++   .|..++.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence             2235789999999999976     568999999999999999999999999998888888777654432   4678899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      .+.|||.+||.+||..||     ++.+|+.||||.+++-.
T Consensus       264 ~F~DfLk~cL~Knp~~Rp-----~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRP-----PAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHHHHhcCCccCC-----CHHHHhhCcccccCCcc
Confidence            999999999999999999     78999999999987654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-41  Score=335.96  Aligned_cols=239  Identities=25%  Similarity=0.386  Sum_probs=190.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|++++.||+|+||.||+|+++.     +++.||+|+..+..         ...|+.+|+.++||||+++++++...
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~  129 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSG  129 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC-----CCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeC
Confidence            34579999999999999999999876     77889999865432         24589999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      ...|+|||++. ++|..++.+ ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.....+        
T Consensus       130 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        130 AITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             CeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99999999996 478777765 46799999999999999999999999999999999999999887632211        


Q ss_pred             --CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCC-CCCCCCH---------HHHHHHHHhc----ccC
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANR---------QKLQQRIINE----KVK  322 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~-Pf~~~~~---------~~~~~~i~~~----~~~  322 (431)
                        .......||..|+|||++.+..++.++|||||||++|||+++.. +|.....         ......+...    ...
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence              12234579999999999999999999999999999999998544 4443111         0111111110    001


Q ss_pred             CC------------------------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          323 LP------------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       323 ~p------------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++                              ..++.++.+||.+||+.||.+||     +++++++||||+.+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----ta~e~l~hp~f~~~  357 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP-----SAEEILNYPMFAQL  357 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc-----CHHHHhcCchhccC
Confidence            11                              13567788899999999999999     89999999999863

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-41  Score=322.45  Aligned_cols=244  Identities=41%  Similarity=0.749  Sum_probs=218.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (431)
                      ++|++.+.||+|+||.||+|..+.     +++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE-----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC-----CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            369999999999999999999876     78999999998866555555677888999999998 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      ..|+||||+.+++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.+|.....+          
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999999999999988899999999999999999999999999999999999999887622111          


Q ss_pred             ---------------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014087          259 ---------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  317 (431)
Q Consensus       259 ---------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~  317 (431)
                                           .......|+..|+|||++....++.++|+||||+++|+|++|+.||...+.....+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence                                 11223467899999999998889999999999999999999999999888777778887


Q ss_pred             hcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCH----HHHHhCCCC
Q 014087          318 NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGV----DAIKHHKWF  363 (431)
Q Consensus       318 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~----~~i~~h~~f  363 (431)
                      .....+|..+++++.+||.+||+.||++||     ++    +++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRL-----GVNEGYDELKAHPFF  280 (280)
T ss_pred             hcCCCCCCccCHHHHHHHHHHhcCCHhhCC-----CcccCHHHHhcCCCC
Confidence            777888889999999999999999999999     67    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.8e-41  Score=315.07  Aligned_cols=242  Identities=29%  Similarity=0.517  Sum_probs=210.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+++...     +++.||+|.+...... ......+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE-----DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC-----CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            58999999999999999999875     7889999998765432 33445788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      |+||||+.+++|.+++....  .+++.++..++.|++.||.|||++|++|+||+|+|||++.++.....+.         
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999999999987643  5799999999999999999999999999999999999998776322111         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  336 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  336 (431)
                        ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+..+.. ..+..++.++.++|.
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence              11234588899999999998899999999999999999999999998888877777766544 356778999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +||+.+|++||     ++.+++.||||
T Consensus       235 ~~l~~~p~~Rp-----~~~~vl~~~~~  256 (256)
T cd08218         235 QLFKRNPRDRP-----SVNSILEKNFI  256 (256)
T ss_pred             HHhhCChhhCc-----CHHHHhhCcCC
Confidence            99999999999     89999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.4e-41  Score=317.18  Aligned_cols=244  Identities=29%  Similarity=0.465  Sum_probs=205.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      .+|++.+.||+|+||.||++.++.     +++.||||.+.....  ......+.+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD-----TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC-----CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence            479999999999999999999875     788999998864321  1234467888999999999999999999998764


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                        ..+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.....+.      
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence              568999999999999999988888999999999999999999999999999999999999998876322111      


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCH
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  329 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~  329 (431)
                              ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...  ....|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence                    123356889999999999888999999999999999999999999876555544444332  2335667888


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      .+.++|.+||. +|++||     ++++|++|+|+.
T Consensus       237 ~~~~~i~~~l~-~p~~Rp-----~~~~il~~~~~~  265 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRP-----SADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHhc-ChhhCC-----CHHHHhcCcccC
Confidence            99999999995 999999     899999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.3e-41  Score=321.70  Aligned_cols=242  Identities=31%  Similarity=0.492  Sum_probs=205.3

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++.+.||+|+||.||++++..     ++..+++|.+....   ....+.+.+|+++++.++||||+++++++..+...|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   78 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE-----TGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   78 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC-----CCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence            7888999999999999999876     78889999986542   234566788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------C
Q 014087          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------S  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~  259 (431)
                      +||||+.+++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.....+           .
T Consensus        79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999999999888765 46789999999999999999999999999999999999999887632211           1


Q ss_pred             CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCHHH
Q 014087          260 RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEA  331 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~  331 (431)
                      ......|+..|+|||++.     +..++.++|||||||++|||++|+.||...+..+....+....   ...|..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            123456899999999984     4457789999999999999999999998877666655554432   23456688999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+||.+||+.||.+||     +++++++||||+..
T Consensus       239 ~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARW-----TTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhcCCCEecc
Confidence            9999999999999999     89999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-41  Score=319.93  Aligned_cols=241  Identities=26%  Similarity=0.423  Sum_probs=201.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.+|+|++....   ......+.+|+.+++.++||||+++++++..++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH-----TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC-----CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            4579999999999999999999875     78899999987542   223456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+.+++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.....+          
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            9999999999999999998888899999999999999999999999999999999999999887632211          


Q ss_pred             -CCcccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-----CCCCCH
Q 014087          259 -SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----PPFLTS  329 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~  329 (431)
                       .......|+..|+|||.+.   ...++.++|||||||++|||++|+.||...........+.......     +..++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence             1123456889999999985   3457889999999999999999999997654443333332222221     234688


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  362 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  362 (431)
                      ++.+||++||..||++||     ++++|++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp-----~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRP-----TAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCc-----CHHHHhcCCC
Confidence            999999999999999999     8999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-41  Score=321.41  Aligned_cols=241  Identities=28%  Similarity=0.420  Sum_probs=197.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+|+++.     +++.||+|+++.... .......+.+|+.+++.++||||+++++++.++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK-----TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC-----CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            58999999999999999999875     788999999875432 233345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------
Q 014087          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------  260 (431)
                      |+||||+. ++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+..       
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            99999997 5788887653   468999999999999999999999999999999999999998864322211       


Q ss_pred             ----cccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 014087          261 ----SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  320 (431)
Q Consensus       261 ----~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------  320 (431)
                          .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....               
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence                1233568899999998754 57889999999999999999999998765443322221100               


Q ss_pred             --------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 --------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 --------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                    ......++.++++||++||+.||.+||     ++++|+.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI-----SAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC-----CHHHHhcCCCC
Confidence                          001234789999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=337.61  Aligned_cols=242  Identities=24%  Similarity=0.336  Sum_probs=206.3

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ..+.|..+++.+...||+|.||+||+++|-+        .||||+++.+.. ..+..+.|++|+.+|++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            5567788889999999999999999999865        499999988765 4458899999999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      ++..... .+|..+|+|.+|+.+|+.. ..|.....+.|++||++|+.|||.++|||||||..||||.+++.++..+.  
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence            9998887 9999999999999999754 56999999999999999999999999999999999999999877543322  


Q ss_pred             -----------CcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---
Q 014087          260 -----------RSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---  322 (431)
Q Consensus       260 -----------~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---  322 (431)
                                 ......|...|||||++..   .+|+..+|||||||++|||++|..||.....+.++-.+-.+...   
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence                       2233457889999999985   46899999999999999999999999977776666555444221   


Q ss_pred             --CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          323 --LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       323 --~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                        .-...+.++++|+..||..++++||     .+.+|+.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP-----~F~~il~  648 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERP-----LFPQLLS  648 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCc-----cHHHHHH
Confidence              2235677999999999999999999     7788875

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.3e-41  Score=322.98  Aligned_cols=244  Identities=25%  Similarity=0.426  Sum_probs=206.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ..+|++++.||+|+||.||++.++.     +++.+|+|.+.....   ...+.+.+|+.+++.++|+||+++++.+....
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECC-----CCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            4589999999999999999999875     788999999876442   22456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      ..|+||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.....+.         
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999999998865 46899999999999999999999999999999999999998875322111         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                        ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..++..+.+|
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence              122357889999999999988999999999999999999999999877654433333222   223456688999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      |.+||..||++||     ++++|+.|+||...
T Consensus       250 i~~~l~~~p~~Rp-----t~~eil~~~~~~~~  276 (296)
T cd06654         250 LNRCLDMDVEKRG-----SAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHCcCCcccCc-----CHHHHhhChhhhcc
Confidence            9999999999999     89999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-41  Score=322.34  Aligned_cols=246  Identities=20%  Similarity=0.333  Sum_probs=208.4

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||.||+|.............+|+|.++...  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            345799999999999999999998764433455789999987543  233456688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      +..|++|||+++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999765                457889999999999999999999999999999999999988


Q ss_pred             CCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014087          252 GHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  317 (431)
Q Consensus       252 g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~  317 (431)
                      +.....+.             ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            75322111             1123456788999999998899999999999999999998 999999988888888776


Q ss_pred             hcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          318 NEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       318 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ... ...|..++.++.+|+.+||..||.+||     ++++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIECWNEIPARRP-----RFKDIHTR  279 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            554 345678899999999999999999999     88998763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=320.17  Aligned_cols=245  Identities=27%  Similarity=0.502  Sum_probs=211.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||.|+||.||+|++..     +++.+|+|++....  .......+.+|+++++.++|+||+++++++.++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR-----TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC-----CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence            368999999999999999999875     78899999987653  23345667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+|+||+.+++|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.+|.....+           
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999999999998765 789999999999999999999999999999999999999987632111           


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCC-CCHHHHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF-LTSEAHSLLK  336 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li~  336 (431)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++.. ++.++.++|.
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence            122345788899999999998899999999999999999999999987776666555554432 33444 7899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      +||..||++||     +++++++|+||++..
T Consensus       233 ~~l~~~p~~Rp-----t~~~il~~~~~~~~~  258 (274)
T cd06609         233 LCLNKDPKERP-----SAKELLKHKFIKKAK  258 (274)
T ss_pred             HHhhCChhhCc-----CHHHHhhChhhcCCC
Confidence            99999999999     899999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=336.73  Aligned_cols=245  Identities=34%  Similarity=0.578  Sum_probs=216.9

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      .++||.|.||+||-+++++     +|+.||||++.|-....++ .+.+++|+.||+.++||.||.|-..|++.+++++||
T Consensus       569 devLGSGQFG~VYgg~hRk-----tGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK-----TGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecc-----cCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            3789999999999999997     9999999999998775554 478999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-------------ccCCCCC
Q 014087          195 DFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSR  260 (431)
Q Consensus       195 E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-------------~~~~~~~  260 (431)
                      |.+.|.-|.-.|. ..+++++...++++.||+.||.|||-++|+|.||||+|||+.....             .+.+...
T Consensus       643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            9998755544444 3578999999999999999999999999999999999999987632             3445556


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHHHHH
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLK  336 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  336 (431)
                      ..+++||+.|+|||++.+++|...-|+||+|||+|--|+|..||..  .+++-.+|.+..+.+|+    .+++++.|||.
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence            6788999999999999999999999999999999999999999964  35677888888887775    48999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCC-hhhHh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN-WKTLE  372 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~-~~~l~  372 (431)
                      .+|+..-.+|+     +++..+.|||+++.. |-++.
T Consensus       801 ~LLqVkm~kRy-----svdk~lsh~Wlq~yq~w~DLR  832 (888)
T KOG4236|consen  801 NLLQVKMRKRY-----SVDKSLSHPWLQDYQTWLDLR  832 (888)
T ss_pred             HHHHHHHHHhc-----chHhhccchhhhcchHHHHHH
Confidence            99999999999     899999999999864 77664

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.5e-41  Score=321.98  Aligned_cols=244  Identities=25%  Similarity=0.434  Sum_probs=208.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ..+|++.+.||.|+||.||++.+..     +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVA-----TGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcC-----CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            4579999999999999999998875     78899999987543   233466788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .+|+|+||+.+++|..++... .+++.++..++.|++.||.|||++|++||||||+||+++.+|.....+.         
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999999999888654 6899999999999999999999999999999999999998876322211         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                        ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+...   ....+..++..+.+|
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence              122356889999999999988999999999999999999999999887765554444332   223456789999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      |.+||..||.+||     ++++|+.|+||+..
T Consensus       249 i~~~l~~dp~~Rp-----t~~~il~~~~~~~~  275 (296)
T cd06655         249 LNRCLEMDVEKRG-----SAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHhhcChhhCC-----CHHHHhhChHhhhc
Confidence            9999999999999     89999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=325.76  Aligned_cols=244  Identities=24%  Similarity=0.421  Sum_probs=212.1

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |.++.+||+|+||.||+|.++.     +|+++|+|.+.-+     ..++++..|+.||++++.|+||++|+.|-....+|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E-----sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE-----SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc-----cCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            8889999999999999999986     9999999988643     33567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------CC
Q 014087          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------SS  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~~  259 (431)
                      +|||||..|++.+.++. ++.++|.++..+++..++||+|||...-||||||..|||++.+|+....           ..
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999999999875 5789999999999999999999999999999999999999999984322           12


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCHHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSLLK  336 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~  336 (431)
                      ...++.||+.|||||++..-+|+.++||||||++..||..|++||.+..+....-.|-...   ++-|+.+|.++.|||+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~  264 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR  264 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence            3467889999999999999999999999999999999999999998766554433332221   2235668999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                      +||.++|++|-     ++-++++|+|.++..-..
T Consensus       265 ~CLiK~PE~R~-----TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  265 SCLIKKPEERK-----TALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             HHhcCCHHHHH-----HHHHHhhhhhhcCCCccc
Confidence            99999999997     889999999999865443

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.6e-41  Score=319.71  Aligned_cols=243  Identities=27%  Similarity=0.419  Sum_probs=200.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE-----TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC-----CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            369999999999999999999875     788999999875432 22233557789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +|+||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.....+.          
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999999999988887777778999999999999999999999999999999999999998876322111          


Q ss_pred             -CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 014087          260 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  320 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------------  320 (431)
                       ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....                 
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1123457889999999876 457899999999999999999999998766544433332100                 


Q ss_pred             --cCCC------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 --VKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 --~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                        ...|            +.++.++.+||.+||+.||++||     ++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL-----SCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC-----CHHHHhcCCCC
Confidence              0011            24678899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-41  Score=314.49  Aligned_cols=241  Identities=27%  Similarity=0.464  Sum_probs=206.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|.+..     +++.+++|++....   ....+.+.+|+.+++.++||||+++++++.+..
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIA-----TGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecC-----CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            3579999999999999999999875     67889999997643   224577889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      .+|++|||+.+++|.+++... ..+++.++..++.|++.||.|||++||+||||||+||+++.+|.....+.        
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999999998876 78999999999999999999999999999999999999998876322211        


Q ss_pred             ---CcccccCCCCCCchhhhccC---CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----CCCCCC
Q 014087          260 ---RSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----LPPFLT  328 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s  328 (431)
                         ......|+..|+|||.+.+.   .++.++|||||||++|||++|+.||...+.......+....+.     .+..++
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence               12345688899999999877   8899999999999999999999999887665555544444222     233467


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  362 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  362 (431)
                      .++.+||.+||..||.+||     ++++|+.|+|
T Consensus       234 ~~~~~li~~~l~~~p~~Rp-----t~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRP-----TATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCC-----CHHHHhcCCC
Confidence            8899999999999999999     8999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.8e-41  Score=336.91  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=200.1

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|++.+.||+|+||+||+|++.+.....++..||||+++....  ....+.+.+|+.+|+.+ +||||++++++
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            3445567999999999999999999875544444778899999875432  23346688899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC-----------------------------------------------------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------  210 (431)
                      +...+..|+|||||+||+|.+++....                                                     
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            999999999999999999999886532                                                     


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------
Q 014087          211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------  260 (431)
Q Consensus       211 ----------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------  260 (431)
                                            .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..        
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                  36788899999999999999999999999999999999987652211111        


Q ss_pred             -----cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhc-ccCCCCCCCHHHH
Q 014087          261 -----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIINE-KVKLPPFLTSEAH  332 (431)
Q Consensus       261 -----~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~  332 (431)
                           .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+..+ ....|...+.++.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  347 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY  347 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence                 111234567999999999999999999999999999998 999998765443 33333333 2334566789999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +||.+||+.||++||     ++.+|++
T Consensus       348 ~li~~cl~~dP~~RP-----s~~eil~  369 (375)
T cd05104         348 DIMKSCWDADPLKRP-----TFKQIVQ  369 (375)
T ss_pred             HHHHHHccCChhHCc-----CHHHHHH
Confidence            999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.6e-41  Score=315.70  Aligned_cols=242  Identities=27%  Similarity=0.451  Sum_probs=206.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||.|+||+||+|....     ++..+|+|++.......  ..+.+.+|+.+|+.++|+||+++++.+.....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP-----NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC-----CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence            369999999999999999999875     77889999987654322  56778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      .|+|||+++|++|.+++...   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+        
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999999999999764   4589999999999999999999999999999999999999887532111        


Q ss_pred             -------CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCC-----
Q 014087          259 -------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLP-----  324 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p-----  324 (431)
                             ......+|+..|+|||++... .++.++|+|||||++|+|++|+.||...+..+....+..... .++     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY  233 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccc
Confidence                   012344689999999999877 789999999999999999999999988776666655554422 121     


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ..++.++.+||.+||..||++||     ++++|+.||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp-----~~~~ll~~p~~  267 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRP-----TAEELLKHKFF  267 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCc-----CHHHHhhCCCC
Confidence            25678999999999999999999     89999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-41  Score=321.96  Aligned_cols=245  Identities=26%  Similarity=0.462  Sum_probs=204.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||.||+|++..     +++.||+|.++...  .......+.+|+.+++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP-----TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC-----CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence            368999999999999999999876     78899999886532  23334678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                      +|+||||++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.....+       
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999998888763   378999999999999999999997 5999999999999999987632221       


Q ss_pred             --CCcccccCCCCCCchhhhccC------CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-cccCCCCC
Q 014087          259 --SRSNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR---IIN-EKVKLPPF  326 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~---i~~-~~~~~p~~  326 (431)
                        .......|+..|+|||++.+.      .++.++|||||||++|+|++|+.||...........   +.. ....++..
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         154 VASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             cCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence              122344688899999998654      358899999999999999999999976554443333   322 23456677


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++.++.+||.+||+.+|++||     ++++++.||||...
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp-----~~~~l~~~~~~~~~  268 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRP-----TYAQLLEHPWLVKY  268 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCC-----CHHHHhcChhhhhc
Confidence            899999999999999999999     89999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-40  Score=321.36  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=197.4

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCC-----------CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  176 (431)
                      ..++|++.++||+|+||.||+|.++...           ...++..||+|++....  .......+.+|+.+|+.++|||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence            4568999999999999999999865321           11245579999987643  2334567889999999999999


Q ss_pred             cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 014087          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------IFREDQARFYTAEIVSAVSHLHKCGIV  237 (431)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~ii  237 (431)
                      |+++++++.+.+..|+||||+.+|+|.+++....                   .+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   367788999999999999999999999


Q ss_pred             eccCCCCceEeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh--CCC
Q 014087          238 HRDLKPENILMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQP  302 (431)
Q Consensus       238 HrDlKp~NILl~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~  302 (431)
                      ||||||+|||++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999998763322211             112345778999999998899999999999999999986  678


Q ss_pred             CCCCCCHHHHHHHHHh--------cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          303 PFTHANRQKLQQRIIN--------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       303 Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ||...+..+....+..        .....++.++..+.+||.+||..||++||     ++++|..
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~~i~~  300 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP-----SFSDIHA  300 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc-----CHHHHHH
Confidence            8987666655544321        11223556889999999999999999999     7888843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-41  Score=322.31  Aligned_cols=241  Identities=23%  Similarity=0.402  Sum_probs=196.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+|+++.     +|+.+|+|.++.... .......+.+|+.+++.++||||+++++++.+...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~-----~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC-----CCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            48999999999999999999886     788999999876432 223345577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      |+|+||+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.....+.          
T Consensus        75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            999999975 78777765 567999999999999999999999999999999999999998876422111          


Q ss_pred             -CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcc----------------
Q 014087          260 -RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEK----------------  320 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf-~~~~~~~~~~~i~~~~----------------  320 (431)
                       ......++..|+|||++.+. .++.++|||||||++|||++|..|| .+.+..+....+....                
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             11234578899999998764 4789999999999999999988885 4455444444332110                


Q ss_pred             -c------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 -V------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 -~------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       .            ...+.++.++++||.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI-----SAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC-----CHHHHhcCCCC
Confidence             0            01134688999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8e-41  Score=313.76  Aligned_cols=239  Identities=26%  Similarity=0.456  Sum_probs=205.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+++++.     +++.+++|.+.....     .+.+.+|+++++.++||||+++++.+.+...
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   72 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE-----TGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD   72 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC-----CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence            579999999999999999999875     678999999875432     5678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      +|+++||+.+++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.....+.         
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999999999876 456899999999999999999999999999999999999999876322111         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...   ....+..++.++.++
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence              122345888999999999999999999999999999999999999876655444333322   223345678899999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      |.+||+.||++||     ++++++.||||
T Consensus       233 i~~~l~~~P~~Rp-----s~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERP-----SAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCc-----CHHHHhcCCCC
Confidence            9999999999999     89999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-40  Score=312.20  Aligned_cols=237  Identities=30%  Similarity=0.557  Sum_probs=205.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||++.++.     +++.+|+|.++...  .....+.+.+|+.+++.++|+||+++++.+.+++.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN-----SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC-----CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            58999999999999999999876     78899999987543  233456778899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.....+          
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999999999988653  4589999999999999999999999999999999999999887633211          


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  336 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  336 (431)
                       .......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+.. .++..++.++.+||.
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK  233 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence             112235688999999999999999999999999999999999999998888777777766544 356778999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +||+.||++||     ++++|+.
T Consensus       234 ~~l~~~P~~Rp-----~~~~il~  251 (255)
T cd08219         234 QMFKRNPRSRP-----SATTILS  251 (255)
T ss_pred             HHHhCCcccCC-----CHHHHhh
Confidence            99999999999     8889876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3e-40  Score=310.26  Aligned_cols=242  Identities=30%  Similarity=0.487  Sum_probs=210.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++++.||+|+||.||.++...     +++.+++|.+...... ......+.+|+++++.++|+||+++++++.+.+.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE-----DDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            59999999999999999999875     7889999998765432 33455678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      ++||||+++++|.+++.+.  ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.....+.         
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999999999875  46899999999999999999999999999999999999998876322111         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCCCCCHHHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLK  336 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~  336 (431)
                        ......|++.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..+... .+..++.++.++|.
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH  234 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence              123457899999999999888999999999999999999999999988888888887765443 34567899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +||..+|.+||     ++++++.|+|+
T Consensus       235 ~~l~~~p~~R~-----s~~~ll~~~~l  256 (256)
T cd08221         235 SLLQQDPEKRP-----TADEVLDQPLL  256 (256)
T ss_pred             HHcccCcccCC-----CHHHHhhCcCC
Confidence            99999999999     89999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-41  Score=320.25  Aligned_cols=246  Identities=26%  Similarity=0.391  Sum_probs=206.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||+||++.+..     +++.||+|++....  .......+.+|+++++.++||||+++++.+...
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIP-----TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcC-----CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            34579999999999999999999875     78899999887542  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      ..+|+||||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.....+.       
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999999999888889999999999999999999997 69999999999999998876322111       


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhc-ccCCCC
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-----------KLQQRIINE-KVKLPP  325 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~-----------~~~~~i~~~-~~~~p~  325 (431)
                        .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||......           +....+... ...++.
T Consensus       156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence              123457899999999999889999999999999999999999999865431           233333332 222333


Q ss_pred             -CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          326 -FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       326 -~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                       .++.++.+||.+||+.||++||     +++++++|+||..
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rp-----t~~e~~~~~~~~~  271 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERP-----TPQQLCAMPPFIQ  271 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCc-----CHHHHhcCccccc
Confidence             3788999999999999999999     8999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.7e-41  Score=320.34  Aligned_cols=243  Identities=29%  Similarity=0.424  Sum_probs=201.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.++||+|+||.||+|.++.     +++.||+|++.+.... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE-----TGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC-----CCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            369999999999999999999875     7889999998764432 2344567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      .|+||||++++.|..+......+++.+++.++.||+.||.|||+.||+||||+|+||+++.++.....+           
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999999999988777766799999999999999999999999999999999999999987632211           


Q ss_pred             CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 014087          259 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------  319 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------  319 (431)
                      .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...                  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            11223468889999999875 44788999999999999999999999876654433333210                  


Q ss_pred             -ccC------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 -KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 -~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       ...            ..+.++..+.+||.+||..||++||     ++++|++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  286 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP-----SSSQLLHHEFF  286 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch-----hHHHHhcCCCC
Confidence             000            1235688999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.2e-41  Score=316.89  Aligned_cols=238  Identities=27%  Similarity=0.489  Sum_probs=194.2

Q ss_pred             CceEEeee--cccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          111 DFEIFRVV--GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~L--G~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      +|++.+.+  |+|+||.||++..+.     +++.+|+|++.......        .|+.+...+ +||||+++++.+...
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKP-----TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcC-----CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            46666665  999999999999876     78899999987643211        122222222 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CccCCC-------C
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HEIDES-------S  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g-~~~~~~-------~  259 (431)
                      +.+|+||||++|++|.+++..+..+++.++..++.||+.||.|||+.||+||||||+||+++.++ .....+       .
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            99999999999999999998888899999999999999999999999999999999999999988 321111       1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccCCCCCCCHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......+    ...........+..++..+.+||
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        162 TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV  241 (267)
T ss_pred             CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHH
Confidence            12234689999999999999999999999999999999999999975443322    11222344455667899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .+||+.||.+|++    ++++|++||||++
T Consensus       242 ~~~l~~~p~~R~~----~~~~~l~h~~~~~  267 (267)
T PHA03390        242 QSMLKYNINYRLT----NYNEIIKHPFLKI  267 (267)
T ss_pred             HHHhccChhhCCc----hHHHHhcCCcccC
Confidence            9999999999982    3699999999974

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.8e-41  Score=325.57  Aligned_cols=235  Identities=28%  Similarity=0.428  Sum_probs=180.4

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--CCEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL  192 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l  192 (431)
                      .++||+|+||+||+|+++..   .+++.||+|.+.....     ...+.+|+.+|+.++||||+++++++..  +..+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~---~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG---KDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccC---CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence            46899999999999997632   2567899999865422     2346679999999999999999999854  467899


Q ss_pred             EEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC----CCCccCCC-
Q 014087          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHEIDES-  258 (431)
Q Consensus       193 v~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~----~g~~~~~~-  258 (431)
                      ||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||++.    ++.....+ 
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9999865 787777532         24899999999999999999999999999999999999943    23211110 


Q ss_pred             -------------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------QKLQQR  315 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~---------~~~~~~  315 (431)
                                   ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.....         ......
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence                         11234578999999999987 4589999999999999999999999964321         111111


Q ss_pred             HHhc----------------------------ccC----------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHH
Q 014087          316 IINE----------------------------KVK----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI  357 (431)
Q Consensus       316 i~~~----------------------------~~~----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i  357 (431)
                      +...                            ...          .....+.++.+||++||+.||.+|+     +++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~-----t~~e~  311 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----TSEQA  311 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC-----CHHHH
Confidence            1110                            000          0012356789999999999999999     89999


Q ss_pred             HhCCCC
Q 014087          358 KHHKWF  363 (431)
Q Consensus       358 ~~h~~f  363 (431)
                      ++||||
T Consensus       312 l~hp~f  317 (317)
T cd07868         312 MQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.1e-41  Score=318.26  Aligned_cols=244  Identities=22%  Similarity=0.365  Sum_probs=206.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|.+.+.||+|+||.||+|.+.......+++.||+|+++...  .....+.+.+|+++|+.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            45799999999999999999988654333467889999987643  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc
Q 014087          189 KLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      ..|+||||++|++|.+++...+              .+++..+..++.|++.||.|||++||+||||||+||+++.++..
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999997643              37889999999999999999999999999999999999988763


Q ss_pred             cCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014087          255 IDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       255 ~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~  320 (431)
                      ...+..             .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            321111             122345678999999999999999999999999999998 999998888888888877665


Q ss_pred             cC-CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          321 VK-LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       321 ~~-~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .. .+..++.++.++|.+||..||++||     ++++++.
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~  276 (280)
T cd05049         242 LLQRPRTCPSEVYDIMLGCWKRDPQQRI-----NIKDIHE  276 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            43 3557899999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-40  Score=317.76  Aligned_cols=244  Identities=23%  Similarity=0.383  Sum_probs=205.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|.+.+.||+|+||+||++.+.......++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            445799999999999999999987553333356779999887542   33456688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      +..|+||||+.+++|.+++...+             .+++..+..++.||+.||.|||++||+||||||+|||++.++..
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997643             38999999999999999999999999999999999999998863


Q ss_pred             cCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014087          255 IDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       255 ~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~  320 (431)
                      ...+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+..+.
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            222111             112334678999999999999999999999999999998 999999888888888887765


Q ss_pred             c-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          321 V-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       321 ~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      . ..+..++.++.+|+.+||+.||.+||     +++++..
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRL-----NIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            3 45667899999999999999999999     7788754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-40  Score=311.34  Aligned_cols=243  Identities=30%  Similarity=0.476  Sum_probs=207.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      +|+..+.||+|+||+||+|..+.     +++.|++|.+.....  ......+.+.+|+.+++.++|+||+++++++.+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD-----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC-----CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence            47788999999999999999875     788999999875432  12345567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .+|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.....+.         
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999999999988888999999999999999999999999999999999999998876322111         


Q ss_pred             -CcccccCCCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHHHH
Q 014087          260 -RSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li  335 (431)
                       ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....++..+++++.+||
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence             123456899999999998776 89999999999999999999999987665444444433  23345677899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      .+||..+|.+||     ++++++.|||+
T Consensus       236 ~~~l~~~p~~Rp-----~~~~~l~~~~~  258 (258)
T cd06632         236 LKCLQRDPSLRP-----TAAELLEHPFV  258 (258)
T ss_pred             HHHhhcCcccCc-----CHHHHhcCCCC
Confidence            999999999999     89999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-40  Score=316.26  Aligned_cols=246  Identities=19%  Similarity=0.252  Sum_probs=204.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||.||++.+++......+..||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3456799999999999999999998754333456789999986532  22234567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ....++||||+.+|+|.+++.+..          .+++..+..++.|++.||.|||++|++||||||+|||++.++....
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999987632          2567888999999999999999999999999999999998876432


Q ss_pred             CCCCc-------------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-c
Q 014087          257 ESSRS-------------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-V  321 (431)
Q Consensus       257 ~~~~~-------------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~  321 (431)
                      .+...             ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            22111             12245678999999999899999999999999999999 799999888877777666543 3


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+..++..+.++|.+||+.||++||     ++.+++.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~  273 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIIS  273 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            55677899999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.4e-41  Score=321.41  Aligned_cols=244  Identities=25%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||.||++.+..     +++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++...+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIA-----TGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECC-----CCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3579999999999999999999875     788999999875432   22356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      ..|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.+|.....+.         
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999998865 45899999999999999999999999999999999999998876322211         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                        ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+...   ....+..++..+++|
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF  248 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence              122356889999999999998999999999999999999999999876544332222221   122456688999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      |.+||..||++||     ++++++.||||+..
T Consensus       249 i~~~l~~~p~~Rp-----s~~~il~~~~~~~~  275 (297)
T cd06656         249 LNRCLEMDVDRRG-----SAKELLQHPFLKLA  275 (297)
T ss_pred             HHHHccCChhhCc-----CHHHHhcCchhccc
Confidence            9999999999999     89999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-40  Score=315.30  Aligned_cols=241  Identities=25%  Similarity=0.451  Sum_probs=199.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .+.|++.+.||+|+||.||+|.++.     +++.+|+|++....    .....+..|+.+++.+ +|+||+++++++...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcC-----CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            3569999999999999999999876     78899999987542    2234577899999988 799999999998753


Q ss_pred             ------CEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-
Q 014087          188 ------SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-  258 (431)
Q Consensus       188 ------~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-  258 (431)
                            ..+|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+ 
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence                  4689999999999999998864  4689999999999999999999999999999999999999887532111 


Q ss_pred             ----------CCcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--
Q 014087          259 ----------SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--  321 (431)
Q Consensus       259 ----------~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--  321 (431)
                                .......|+..|+|||++.     +..++.++|||||||++|||++|+.||...........+.....  
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence                      1223457899999999986     34688899999999999999999999987665554444433221  


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ..+..++.++.+||.+||..||.+||     ++++++.||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRP-----TTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCC-----CHHHHhhCCCC
Confidence            12345789999999999999999999     89999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-40  Score=313.84  Aligned_cols=243  Identities=27%  Similarity=0.469  Sum_probs=202.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-------hhhHHHHHHHHHHHHHhcCCCCcceeeEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (431)
                      +|.+.+.||+|+||.||+|....     +++.+|+|.++.....       .....+.+..|+.+++.++||||++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT-----TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecC-----CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            48889999999999999999775     7889999988643211       12234568889999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                      +...+..++||||+.|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.....+     
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999999999888899999999999999999999999999999999999999887532111     


Q ss_pred             --------CCcccccCCCCCCchhhhccCC--CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCC-
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPP-  325 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~-  325 (431)
                              .......|+..|+|||++....  ++.++|+||||+++|||++|..||...+.......+...  ...++. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence                    1122346889999999998754  789999999999999999999999765544433333222  222332 


Q ss_pred             ---CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          326 ---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       326 ---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                         .++.++.+||.+||..||++||     +++++++||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~  272 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRP-----TARELLQHPFI  272 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCC-----CHHHHhhCCCC
Confidence               4688999999999999999999     89999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-40  Score=310.92  Aligned_cols=242  Identities=29%  Similarity=0.533  Sum_probs=207.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||++..+.     ++..+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS-----DSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC-----CCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            48999999999999999999876     788899999977543 223345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc--CCC--------
Q 014087          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI--DES--------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~--~~~--------  258 (431)
                      |+|+||+.+++|.+++.+..  .+++..+..++.|++.||.|||+++|+|+||||+||+++.++...  ...        
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999999999987654  479999999999999999999999999999999999999886421  110        


Q ss_pred             --CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLL  335 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  335 (431)
                        .......|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+....+..... ..++.++.++.++|
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence              011233588899999999988899999999999999999999999988777666666655433 34556889999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      .+||..+|++||     ++++++.||||
T Consensus       235 ~~~l~~~p~~Rp-----t~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRP-----SITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCc-----CHHHHhhCCCC
Confidence            999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-40  Score=310.96  Aligned_cols=242  Identities=28%  Similarity=0.507  Sum_probs=208.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--CC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  188 (431)
                      +|++++.||.|+||.||+|.+..     +++.+|+|++..... .....+.+..|+++++.++||||+++++.+..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS-----DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC-----CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            58999999999999999999876     788999999876543 33445678889999999999999999997754  45


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEeCCCCCccCCC-
Q 014087          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLH-----KCGIVHRDLKPENILMDSDGHEIDES-  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-----~~~iiHrDlKp~NILl~~~g~~~~~~-  258 (431)
                      ..|++|||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+|+||||||+||+++.++.....+ 
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            78999999999999999875    357899999999999999999999     89999999999999999887632111 


Q ss_pred             ----------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCC
Q 014087          259 ----------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFL  327 (431)
Q Consensus       259 ----------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~  327 (431)
                                .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+...+.+.+..... .++..+
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd08217         155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY  234 (265)
T ss_pred             cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence                      112345789999999999998899999999999999999999999998887777777766544 456778


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +.++.+++.+||..+|++||     ++++|++|||+
T Consensus       235 ~~~~~~l~~~~l~~~p~~Rp-----~~~~il~~~~~  265 (265)
T cd08217         235 SSELNEVIKSMLNVDPDKRP-----STEELLQLPLI  265 (265)
T ss_pred             CHHHHHHHHHHccCCcccCC-----CHHHHhhCCCC
Confidence            99999999999999999999     89999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-40  Score=311.33  Aligned_cols=236  Identities=22%  Similarity=0.377  Sum_probs=200.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+++++      .+..+|+|.+......    .+.+.+|+.+|+.++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~------~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR------AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec------cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            457999999999999999999876      3457999988654322    245778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------  260 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------  260 (431)
                      ..|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.....+..       
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999999999999998754 568999999999999999999999999999999999999988753221111       


Q ss_pred             -----cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 014087          261 -----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  333 (431)
Q Consensus       261 -----~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~  333 (431)
                           .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+. ...|...+.++.+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  232 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE  232 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence                 111234567999999998899999999999999999999 999999888888888877653 3446668899999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      |+.+||..||++||     ++++|++
T Consensus       233 li~~c~~~~p~~Rp-----s~~~l~~  253 (256)
T cd05114         233 VMYSCWHEKPEGRP-----TFAELLR  253 (256)
T ss_pred             HHHHHccCCcccCc-----CHHHHHH
Confidence            99999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-40  Score=316.21  Aligned_cols=245  Identities=25%  Similarity=0.448  Sum_probs=209.1

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+.++.||.|+||.||+|.++.     ++..+|+|++.....  ......+.+|+.+++.++||||+++++.+.++...
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc-----CCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            58889999999999999999875     788999999875432  33456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------C
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------S  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~  259 (431)
                      |+||||+.||+|.+++.. +.+++.++..++.|++.||.|||+++++|+||+|+||+++.++.....+           .
T Consensus        78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999999998865 5689999999999999999999999999999999999999887532211           1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhh
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~  338 (431)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|..||...+.......+... ...++..++.++.+||.+|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            122346788999999999888999999999999999999999999887766655555333 2334456788999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      |+.+|++||     ++++++.|+||.....
T Consensus       237 l~~~p~~Rp-----~~~~il~~~~~~~~~~  261 (277)
T cd06640         237 LNKDPSFRP-----TAKELLKHKFIVKNAK  261 (277)
T ss_pred             cccCcccCc-----CHHHHHhChHhhhcch
Confidence            999999999     8999999999976554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-40  Score=315.92  Aligned_cols=242  Identities=29%  Similarity=0.465  Sum_probs=201.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++..... .......+.+|+.+++.++||||+++++++.....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC-----CCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58999999999999999999876     788999999876543 233456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      |+||||+ +++|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+||+++.++.....+           
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9999999 99999988653 5689999999999999999999999999999999999999877532111           


Q ss_pred             -CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------
Q 014087          259 -SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  320 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------------  320 (431)
                       .......|+..|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+....                
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             012345689999999998754 46899999999999999999999998776655554443210                


Q ss_pred             ---cCC-----------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          321 ---VKL-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       321 ---~~~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                         ..+           .+..+.++.+||.+||..||.+||     ++++++.||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL-----SAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC-----CHHHHhhCcCcC
Confidence               001           124578999999999999999999     889999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=309.28  Aligned_cols=239  Identities=54%  Similarity=1.017  Sum_probs=213.6

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||+|+||.||++.+..     +++.+|+|++.+.........+.+..|+.+++.++|+||+++++.++.+...|+||||+
T Consensus         1 lg~G~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKD-----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECC-----CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            6999999999999875     68899999998877666666778899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CCcccccC
Q 014087          198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SRSNSMCG  266 (431)
Q Consensus       198 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~~~~~~G  266 (431)
                      .+++|.+++.....+++..+..++.|++.||.|||+++++|+||||+||+++.++.....+           .......|
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            9999999999888899999999999999999999999999999999999999987632211           12334568


Q ss_pred             CCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCc
Q 014087          267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR  346 (431)
Q Consensus       267 t~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R  346 (431)
                      +..|++||.+.+...+.++|+||||+++|+|++|..||...+.......+......+|..++.++.++|++||..||++|
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            89999999999888899999999999999999999999888888888888888888899999999999999999999999


Q ss_pred             CCCCCCCHHHHHhCCCC
Q 014087          347 LGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       347 ~~~~~~~~~~i~~h~~f  363 (431)
                      |++.  .+++++.||||
T Consensus       236 ~~~~--~~~~l~~~~~f  250 (250)
T cd05123         236 LGSG--GAEEIKAHPFF  250 (250)
T ss_pred             CCcc--cHHHHHhCCCC
Confidence            9432  14999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.7e-40  Score=314.60  Aligned_cols=242  Identities=26%  Similarity=0.440  Sum_probs=200.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .++|++.+.||+|+||.||+|..+.     +++.+|+|++....    .....+.+|+.+++.+ +||||+++++++...
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKK-----DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            4679999999999999999999875     78899999986532    1234567899999988 899999999998754


Q ss_pred             -----CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC
Q 014087          188 -----SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES  258 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~  258 (431)
                           +..|+||||++|++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++.....+
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence                 368999999999999988753    35689999999999999999999999999999999999999887532211


Q ss_pred             -----------CCcccccCCCCCCchhhhccC-----CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--
Q 014087          259 -----------SRSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--  320 (431)
Q Consensus       259 -----------~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--  320 (431)
                                 .......|+..|+|||++...     .++.++|||||||++|||++|+.||...+.......+....  
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence                       112345688999999998643     36889999999999999999999998776655555554332  


Q ss_pred             -cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          321 -VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       321 -~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                       ...+..++.++++||.+||+.||++||     ++++|++||||+
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~  291 (291)
T cd06639         252 TLLHPEKWCRSFNHFISQCLIKDFEARP-----SVTHLLEHPFIK  291 (291)
T ss_pred             CCCcccccCHHHHHHHHHHhhcChhhCc-----CHHHHhcCcccC
Confidence             223456778999999999999999999     899999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-40  Score=319.00  Aligned_cols=245  Identities=25%  Similarity=0.376  Sum_probs=202.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      +|++.+.||+|+||.||+|.++.     +++.||+|.++.....  .......+..|+++++.++|+||+++++++.+.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE-----TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC-----CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence            48899999999999999999875     7889999999865433  1223455678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      ..|+||||+ +|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+         
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999999999 899999998776 799999999999999999999999999999999999999988633221         


Q ss_pred             --CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------------
Q 014087          259 --SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  321 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------------  321 (431)
                        .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||.+.+..+....+.....              
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence              11122346788999999865 4578999999999999999999999987766555544432100              


Q ss_pred             ---------C-----CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 ---------K-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 ---------~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                               .     .....+.++.+||.+||..||++||     ++++++.|+||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~e~l~~~~~~~~  288 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI-----TARQALEHPYFSND  288 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc-----CHHHHhhCccccCC
Confidence                     0     0123578899999999999999999     89999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-40  Score=310.39  Aligned_cols=245  Identities=29%  Similarity=0.496  Sum_probs=212.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|++|.||+|+++.     +++.|++|++......  .....+.+|+.++..++|+||+++++++......
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKP-----TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            69999999999999999999886     7899999998765421  4456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.....+           
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999999999988889999999999999999999999 9999999999999999887632211           


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhc-ccCCCCC-CCHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINE-KVKLPPF-LTSEAHS  333 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~  333 (431)
                      .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...   ...+....+... ....+.. ++..+.+
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            1112456789999999999999999999999999999999999999776   455555555543 3334555 8899999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      +|.+||..+|++||     +++++++||||+.++
T Consensus       235 li~~~l~~~p~~R~-----~~~~ll~~~~~~~~~  263 (264)
T cd06623         235 FISACLQKDPKKRP-----SAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHccCChhhCC-----CHHHHHhCHHHHhcc
Confidence            99999999999999     899999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.1e-41  Score=326.02  Aligned_cols=240  Identities=21%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             eeeccc--CceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEE
Q 014087          116 RVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       116 ~~LG~G--~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (431)
                      ..||+|  +||+||+|++..     +++.||+|++...... ....+.+.+|+.+++.++||||++++++|..++..|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP-----TGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC-----CCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            356666  999999999876     8899999998765432 34457889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------C
Q 014087          194 LDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------R  260 (431)
Q Consensus       194 ~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------~  260 (431)
                      |||+.+++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.           .
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999999988865  34899999999999999999999999999999999999998764221100           0


Q ss_pred             -------cccccCCCCCCchhhhccC--CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---------
Q 014087          261 -------SNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------  322 (431)
Q Consensus       261 -------~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------  322 (431)
                             .....++..|+|||++.+.  .++.++|||||||++|||++|+.||.+.........+......         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence                   0112345679999999763  5789999999999999999999999876654444333221110         


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          323 --------------------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       323 --------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                                                            .+..++.++++||++||+.||++||     +++++++|+||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----ta~e~l~~~~~~  312 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP-----SASSLLSHAFFK  312 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC-----CHHHHhhCHHHH
Confidence                                                  1123567899999999999999999     899999999997


Q ss_pred             CC
Q 014087          365 SI  366 (431)
Q Consensus       365 ~~  366 (431)
                      .+
T Consensus       313 ~~  314 (328)
T cd08226         313 QV  314 (328)
T ss_pred             HH
Confidence            64

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-40  Score=314.64  Aligned_cols=244  Identities=28%  Similarity=0.446  Sum_probs=207.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|.++.     +++.+|+|.+.....  ......+.+|+++++.++||||+++++.+.....
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC-----CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence            368889999999999999999876     789999999876542  2445667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDESSR-------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~~~-------  260 (431)
                      +|+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.+|.....+..       
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999999876 789999999999999999999999 999999999999999998763222111       


Q ss_pred             --cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc-ccCCCCC-CCHHH
Q 014087          261 --SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLPPF-LTSEA  331 (431)
Q Consensus       261 --~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~  331 (431)
                        .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...     ...+..+.+... ....+.. ++.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         154 SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence              11267889999999999999999999999999999999999999754     233344444433 3334444 88999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .+||.+||..||++||     ++++++.||||+.
T Consensus       234 ~~li~~~l~~~p~~Rp-----t~~~ll~~~~~~~  262 (265)
T cd06605         234 QDFVNLCLIKDPRERP-----SYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHcCCCchhCc-----CHHHHhhCchhhc
Confidence            9999999999999999     8999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.4e-40  Score=319.53  Aligned_cols=242  Identities=23%  Similarity=0.353  Sum_probs=200.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCc--EEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +..++|++.+.||+|+||.||+|.++.     ++.  .+|+|.++..  ........+.+|+.++.++ +||||++++++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~-----~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~   76 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGA   76 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEcc-----CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            445689999999999999999999865     443  4577766532  2334456788899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                      +..++..|+||||+++|+|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil  156 (303)
T cd05088          77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  156 (303)
T ss_pred             ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence            999999999999999999999997643                4789999999999999999999999999999999999


Q ss_pred             eCCCCCccCCCCCc----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014087          248 MDSDGHEIDESSRS----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  316 (431)
Q Consensus       248 l~~~g~~~~~~~~~----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i  316 (431)
                      ++.++.....+...          ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            99887633222111          11223567999999998889999999999999999998 99999888777777666


Q ss_pred             Hhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          317 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       317 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ... ....+..++.++.+||.+||+.+|++||     ++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~il~~  276 (303)
T cd05088         237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  276 (303)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            544 2345566889999999999999999999     78888874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.9e-40  Score=310.41  Aligned_cols=239  Identities=22%  Similarity=0.335  Sum_probs=203.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +...+|.+.+.||+|+||.||+|.++.     .++.+|+|++..+.    .....+.+|+++++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEec-----CCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            445679999999999999999999875     78889999987542    224567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc---
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS---  261 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~---  261 (431)
                      ++.+++||||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.....+...   
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            99999999999999999998764  3589999999999999999999999999999999999999887632222111   


Q ss_pred             ---------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          262 ---------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       262 ---------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                               ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... ....+..++.+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK  233 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence                     11123567999999999999999999999999999998 99999988888777777654 45667788999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++|.+||..||++||     ++.++++
T Consensus       234 ~~~li~~cl~~~p~~Rp-----~~~~l~~  257 (263)
T cd05052         234 VYELMRACWQWNPSDRP-----SFAEIHQ  257 (263)
T ss_pred             HHHHHHHHccCCcccCC-----CHHHHHH
Confidence            99999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.4e-40  Score=319.06  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=201.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||.||+|.++.     +++.||+|+++..... ......+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTT-----SGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECC-----CCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            45689999999999999999999875     7899999998754322 22223456799999999999999999998765


Q ss_pred             --CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          188 --SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                        +.+|+||||+.+ +|.+++... ..+++.++..++.||+.||.|||++||+||||||+||+++.++.....+.     
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          79 HLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             CCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence              568999999975 788877753 67899999999999999999999999999999999999998876322111     


Q ss_pred             ------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 014087          260 ------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  319 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------  319 (431)
                            ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...             
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence                  1122345778999999875 56789999999999999999999999988877766665431             


Q ss_pred             ------ccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 ------KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 ------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                            ...++           ..+++++.+||.+||+.||++||     ++++++.||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA-----TAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc-----CHHHHhcChhhccC
Confidence                  11111           12588999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=300.44  Aligned_cols=248  Identities=29%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      ....++.+.+..||.|+.|+|++++++.     +|.++|||.|.+..  .++..+++...++++... ++|+||+.+++|
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs-----~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyF  160 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRS-----TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYF  160 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcc-----cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence            3455678888999999999999999997     89999999998765  355567777788877665 499999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCcc-------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEI-------  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~-------  255 (431)
                      ..+..+++.||.|.- -+..++.+ .++++|..+-.+...++.||.||.+ +||||||+||+|||+|+.|+..       
T Consensus       161 i~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  161 ITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             eeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence            999999999999843 23334433 4689999999999999999999986 6899999999999999999732       


Q ss_pred             ---CCCCCcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccC-CCC--
Q 014087          256 ---DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKVK-LPP--  325 (431)
Q Consensus       256 ---~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~~-~p~--  325 (431)
                         .+....+...|.+.|||||.+.-   ..|+..+|||||||+|+||.||+.||.+. ...++...|+++..+ +|.  
T Consensus       240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~  319 (391)
T KOG0983|consen  240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM  319 (391)
T ss_pred             ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc
Confidence               12233345679999999999973   46899999999999999999999999884 455667777765443 332  


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+|+++.+|+..||.+|+.+||     ...++++|||.+..
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP-----~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRP-----KYNKLLEHPFIKRY  355 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCc-----chHHHhcCcceeec
Confidence            4899999999999999999999     78999999999753

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.6e-40  Score=325.58  Aligned_cols=249  Identities=22%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +.+..++|++.+.||+|+||.||+|.+.+..+..+++.||+|+++...  .....+.+..|+.+++++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            345567899999999999999999987765555577899999987533  223345677899999999 89999999998


Q ss_pred             EEe-CCEEEEEEeccCCCChHHHHHHc-----------------------------------------------------
Q 014087          184 FQT-RSKLYLILDFINGGHLFFHLYRQ-----------------------------------------------------  209 (431)
Q Consensus       184 ~~~-~~~~~lv~E~~~gg~L~~~l~~~-----------------------------------------------------  209 (431)
                      +.. +..++++|||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            764 46789999999999999888642                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------------cccccCCC
Q 014087          210 --------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------------SNSMCGTT  268 (431)
Q Consensus       210 --------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------------~~~~~Gt~  268 (431)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..             .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    257889999999999999999999999999999999999987753221111             12234567


Q ss_pred             CCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCC
Q 014087          269 EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ-QRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSK  345 (431)
Q Consensus       269 ~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~  345 (431)
                      .|+|||++.+..++.++|||||||+||||++ |..||.+....+.. ..+... ....|...++++.+++.+||+.+|++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999998 99999875433333 333222 33445678899999999999999999


Q ss_pred             cCCCCCCCHHHHHhC
Q 014087          346 RLGSGPGGVDAIKHH  360 (431)
Q Consensus       346 R~~~~~~~~~~i~~h  360 (431)
                      ||     ++++|++|
T Consensus       320 RP-----s~~ell~~  329 (337)
T cd05054         320 RP-----TFSELVEI  329 (337)
T ss_pred             Cc-----CHHHHHHH
Confidence            99     88888763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.2e-40  Score=308.70  Aligned_cols=242  Identities=29%  Similarity=0.496  Sum_probs=204.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||++....     +++.||+|+++..... ....+.+.+|+.+++.++|+||+++++.+.+.+.+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD-----TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC-----CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            48999999999999999999875     7889999999866432 45677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----------  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----------  260 (431)
                      ++|+||+.+++|.+++.+...+++..++.++.|++.||.|||++||+||||||+||+++.++.....+..          
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999999999999888789999999999999999999999999999999999999988753211110          


Q ss_pred             -----cccccCCCCCCchhhhccCC---CCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-cccCCCCC--CC
Q 014087          261 -----SNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN-EKVKLPPF--LT  328 (431)
Q Consensus       261 -----~~~~~Gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~-~~~~~p~~--~s  328 (431)
                           .....|+..|+|||++.+..   ++.++||||||+++|+|++|+.||...+ .......+.. ....+|..  ++
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS  234 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence                 11346788999999998766   8899999999999999999999997653 3333333332 23345554  48


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      .++.+||.+||+.+|.+||     ++++++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~-----~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRP-----TASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence            9999999999999999999     88999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4e-40  Score=324.76  Aligned_cols=243  Identities=26%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++.+.||+|+||.||+|++..     +++.||+|++.+... .......+.+|+.+++.++||||++++++|... 
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTV-----TGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK   88 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECC-----CCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence            3579999999999999999999876     788999999865422 233345577899999999999999999998644 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                           ...|+||||+.+ +|.+.+...  +++..+..++.|++.||.|||++||+||||||+|||++.+|.....+.   
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          89 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence                 357999999965 787877654  899999999999999999999999999999999999999876322111   


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  319 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------  319 (431)
                             ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...             
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence                   123346788999999999999999999999999999999999999877654444333210             


Q ss_pred             ---------ccC--------------C-------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          320 ---------KVK--------------L-------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       320 ---------~~~--------------~-------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                               ...              +       +...+.++.+||.+||+.||++||     ++++++.||||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~eiL~~~~~~~  316 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI-----SVDDALQHPYINV  316 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc-----CHHHHhcChhHhh
Confidence                     000              0       112456789999999999999999     8999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-40  Score=311.71  Aligned_cols=246  Identities=21%  Similarity=0.299  Sum_probs=208.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||.||++.++....+.++..+|+|.+....  .......+.+|+.+|+.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4556899999999999999999998865544567889999986543  22334567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ....|+||||+++|+|.+++....          .+++..+..++.||+.||.|||++||+||||||+|||++.+|....
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999987532          3678899999999999999999999999999999999999886432


Q ss_pred             CCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cc
Q 014087          257 ESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV  321 (431)
Q Consensus       257 ~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~  321 (431)
                      .+.             ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+..+.+... ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            111             1223456788999999998889999999999999999998 99999988888877777644 34


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..|..++.++.+||.+||+.+|++||     ++.+|+.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~l~~  273 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRP-----TFLEIVS  273 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            56778899999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-40  Score=329.95  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceee
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLR  181 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~  181 (431)
                      ..+.+..++|+++++||+|+||.||+|.+........+..||||+++...  .....+.+.+|+++|+.+. ||||++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            34455677899999999999999999998654444456679999997543  2334567889999999996 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHc----------------------------------------------------
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQ----------------------------------------------------  209 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------------------------------------------  209 (431)
                      +++.+.+.+|+|||||++|+|.+++.++                                                    
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            9999999999999999999999888653                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          210 --------------------------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       210 --------------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                                                                  ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        136788889999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.++.....+.             ......|+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99998765321110             1123356788999999999999999999999999999997 999998754433


Q ss_pred             -HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 -LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 -~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                       ....+..+ ....+..++.++.++|.+||+.||++||     ++.+|.+
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  392 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP-----SFLHLSD  392 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc-----CHHHHHH
Confidence             33333333 3445667899999999999999999999     6666654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.2e-40  Score=314.97  Aligned_cols=241  Identities=28%  Similarity=0.448  Sum_probs=197.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|+.++.||.|+||.||+|+++.     +++.||||.+..... .......+.+|+++++.++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC-----CCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            48999999999999999999875     788999998875432 223345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 YLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      |+||||+. ++|..++..  ...+++..+..++.|++.||.|||++|++||||||+||+++.++.....+          
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999996 588888865  35689999999999999999999999999999999999999987632211          


Q ss_pred             -CCcccccCCCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  320 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------------  320 (431)
                       .......++..|+|||++.+.. ++.++|||||||++|||+||+.||.+.+......++....                
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             1112335688999999887644 5889999999999999999999998766544333332110                


Q ss_pred             --c-----------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 --V-----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 --~-----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                        .           ...+.++.+++++|.+||+.||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI-----SAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC-----CHHHHhcCCCC
Confidence              0           01234788999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=343.52  Aligned_cols=300  Identities=45%  Similarity=0.783  Sum_probs=267.9

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCEEEEEEe
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      .+|+|+||.|++++..+..  +.+..||+|+.++......... ....|..++..++ ||++|+++..|+.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccc--cccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            4799999999998765433  3788999999988765444433 6677899999987 9999999999999999999999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc-------ccccCCC
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS-------NSMCGTT  268 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~-------~~~~Gt~  268 (431)
                      +..||+|+..+.+...+.+...+.+.+.++.+++++|+.||+|||+|++||+++.+|+....+...       ...|||.
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~  157 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY  157 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence            999999999999999999999999999999999999999999999999999999999744332211       1229999


Q ss_pred             CCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCC
Q 014087          269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLG  348 (431)
Q Consensus       269 ~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~  348 (431)
                      .|||||++.  ++...+||||||++++||+||..||..    ++..+|....+..|..++.++.+++..++.++|..|++
T Consensus       158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg  231 (612)
T KOG0603|consen  158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLG  231 (612)
T ss_pred             hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhc
Confidence            999999998  788999999999999999999999987    78889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC--CCCCCccCeEeeCCC
Q 014087          349 SGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--TAGEHFKGYTYVAPN  425 (431)
Q Consensus       349 ~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--~~~~~f~~~~~~~~~  425 (431)
                      +++..+.+|++|+||..++|..+..++.+|+|+|.+....++.+||.+|+...+.+++...+  .+...|.+|+|+.+.
T Consensus       232 ~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~  310 (612)
T KOG0603|consen  232 AGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPG  310 (612)
T ss_pred             cCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChH
Confidence            99999999999999999999999999999999999999999999999999998888766544  344899999999875

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.7e-40  Score=312.87  Aligned_cols=245  Identities=19%  Similarity=0.312  Sum_probs=202.7

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|++.+.||+|+||+||+|...... ...++.+|+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            3457999999999999999999864321 1256789999987533  233456788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  250 (431)
                      ...|+||||+.+++|.+++...                 ..+++.++..++.|++.||.|||++||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998643                 23788899999999999999999999999999999999998


Q ss_pred             CCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014087          251 DGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  316 (431)
Q Consensus       251 ~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i  316 (431)
                      ++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.....+.+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8753221111             123345677999999998889999999999999999998 99999887777776666


Q ss_pred             Hhcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          317 INEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       317 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .... ...+..++.++.++|.+||+.||.+||     ++++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP-----RFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHH
Confidence            5543 345677899999999999999999999     77888763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=314.40  Aligned_cols=243  Identities=29%  Similarity=0.486  Sum_probs=203.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|+++.... .....+.+.+|+++++.++|+||+++++++..++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA-----TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC-----CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            369999999999999999999876     788999999876432 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      .|+||||+.++.+..++.+...+++.++..++.||+.||.|||++||+||||||+||+++.++.....+           
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999999999987777776667799999999999999999999999999999999999999887632111           


Q ss_pred             -CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------
Q 014087          259 -SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-----------------  319 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-----------------  319 (431)
                       .......|+..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+....+...                 
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence             122345678999999999988 8899999999999999999999999876554433322110                 


Q ss_pred             --c-------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 --K-------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 --~-------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                        .             ..++..++.++.+||++||..+|++||     ++++++.|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL-----TCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc-----cHHHHhcCCCC
Confidence              0             012334589999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=310.85  Aligned_cols=241  Identities=25%  Similarity=0.451  Sum_probs=200.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .++|++.+.||+|+||.||+|.++.     +++.+++|++.....    ..+.+.+|+.+++.+ +|+||+++++++...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKK-----TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECC-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            4689999999999999999999875     778999999876432    335688999999998 799999999999764


Q ss_pred             C------EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          188 S------KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       188 ~------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                      .      .+|+||||+.+++|.+++..    ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.....
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence            4      58999999999999988865    3578999999999999999999999999999999999999988763222


Q ss_pred             CC-----------CcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 014087          258 SS-----------RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV  321 (431)
Q Consensus       258 ~~-----------~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~  321 (431)
                      +.           ......|+..|+|||++..     ..++.++|||||||+||+|++|+.||...........+.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            11           1234568899999999864     3467889999999999999999999987665555555544322


Q ss_pred             ---CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          322 ---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       322 ---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                         ..+..++.++++||.+||..||++||     ++++++.|||+
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~ll~~~~~  275 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRP-----FMEELLEHPFI  275 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCc-----CHHHHhcCCCC
Confidence               22334778999999999999999999     89999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.4e-40  Score=312.15  Aligned_cols=246  Identities=21%  Similarity=0.358  Sum_probs=202.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|.+.+.||+|+||.||+|.++......++..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            345799999999999999999998753222356789999886432  223345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----cC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----ID  256 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----~~  256 (431)
                      +..|+||||+.|++|.+++.+.+       .+++..+..++.||+.||.|||++|++||||||+|||++.++..    +.
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       48999999999999999999999999999999999999876531    11


Q ss_pred             CCCCc------------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccC
Q 014087          257 ESSRS------------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVK  322 (431)
Q Consensus       257 ~~~~~------------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~  322 (431)
                      .....            ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+... ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            11000            11223457999999998999999999999999999997 99999988877776666543 455


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .|..++.++.+++.+||+.||++||     +++++++|
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rp-----s~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRP-----NFATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence            6778899999999999999999999     88999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.3e-40  Score=313.68  Aligned_cols=244  Identities=23%  Similarity=0.382  Sum_probs=204.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|.+.+.||+|+||.||+|++.......++..+++|.+....   ....+.+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            446799999999999999999987654444466779999886543   23345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      +..++||||+++++|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997643                37899999999999999999999999999999999999988


Q ss_pred             CCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014087          252 GHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  317 (431)
Q Consensus       252 g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~  317 (431)
                      +.....+.             ......|+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+..+.+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            75322111             1123346788999999999999999999999999999999 999998888777777776


Q ss_pred             hccc-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          318 NEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       318 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+.. ..+...+.++.+++.+||+.||++||     +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~v~~  277 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRL-----NIKEIYK  277 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCc-----CHHHHHH
Confidence            6544 34556789999999999999999999     7788865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5e-40  Score=313.44  Aligned_cols=241  Identities=26%  Similarity=0.442  Sum_probs=198.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEe-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT-  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  186 (431)
                      .+.|++.+.||+|+||.||+|+++.     +++.+|+|++....    .....+..|+.+++.+ +|+||+++++++.. 
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4579999999999999999999876     78899999986542    2234577899999988 79999999999853 


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-
Q 014087          187 -----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-  258 (431)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-  258 (431)
                           ...+|++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.....+ 
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence                 46799999999999999988763  4588999999999999999999999999999999999999887632211 


Q ss_pred             ----------CCcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-C
Q 014087          259 ----------SRSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-K  322 (431)
Q Consensus       259 ----------~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~  322 (431)
                                .......|+..|+|||++.     ...++.++|||||||++|||++|..||...........+..... .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence                      1123456899999999986     34678899999999999999999999977655444433332211 1


Q ss_pred             -CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          323 -LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       323 -~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       .+..++.++.+||.+||..||.+||     ++.+|+.||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRP-----STEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCc-----CHHHHhcCCCC
Confidence             1235789999999999999999999     89999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.7e-41  Score=318.77  Aligned_cols=247  Identities=24%  Similarity=0.437  Sum_probs=207.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+..+.||+|+||.||+|.+..     +++.||+|.+....  .....+.+.+|+.+++.++||||+++++.+..+...
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC-----CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            47788899999999999998875     78899999987543  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------  259 (431)
                      |+||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.....+.           
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999999999988865 56899999999999999999999999999999999999998876322111           


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhh
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~  338 (431)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|+.||...........+... ...++..++.++.++|.+|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence            112346788999999999999999999999999999999999999876655555444333 2234456788999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                      |..+|++||     ++.++++|+||....+..
T Consensus       237 l~~~p~~Rp-----~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         237 LNKDPRFRP-----TAKELLKHKFITRYTKKT  263 (277)
T ss_pred             ccCCcccCc-----CHHHHHHhHHHHHHhhhH
Confidence            999999999     899999999998765543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-39  Score=311.36  Aligned_cols=242  Identities=26%  Similarity=0.455  Sum_probs=207.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|...+.||+|++|.||++.++.     +++.+++|++....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS-----TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC-----CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            46667899999999999999875     77889999886432   23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------  259 (431)
                      |+|+||+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.....+.           
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            999999999999999877 67899999999999999999999999999999999999998876322111           


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL---PPFLTSEAHSLLK  336 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~  336 (431)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.......   +..++.++.+||.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence            1123468999999999998889999999999999999999999998877777776666553222   2347899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +||..+|++||     +++++++|+||+..
T Consensus       251 ~~l~~~p~~Rp-----t~~~il~~~~~~~~  275 (285)
T cd06648         251 RMLVRDPAQRA-----TAAELLNHPFLAKA  275 (285)
T ss_pred             HHcccChhhCc-----CHHHHccCcccccC
Confidence            99999999999     88999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-40  Score=317.77  Aligned_cols=241  Identities=26%  Similarity=0.461  Sum_probs=203.7

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |.....||+|+||.||++....     ++..||||.+....   ....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH-----TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC-----CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            5556789999999999998875     78899999986533   233456788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CC
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SR  260 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~  260 (431)
                      +||||+++++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||+++.++.....+           ..
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            99999999999888754 5689999999999999999999999999999999999999887632211           11


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHHHHh
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~  337 (431)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...   .......++..+.++|.+
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            23456899999999999889999999999999999999999999887766655554432   222233578899999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||..||.+||     +++++++|+||+..
T Consensus       255 ~l~~~P~~Rp-----t~~~il~~~~~~~~  278 (292)
T cd06658         255 MLVREPSQRA-----TAQELLQHPFLKLA  278 (292)
T ss_pred             HccCChhHCc-----CHHHHhhChhhhcc
Confidence            9999999999     89999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.4e-40  Score=313.19  Aligned_cols=242  Identities=27%  Similarity=0.443  Sum_probs=197.3

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEE-
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ-  185 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-  185 (431)
                      ..++|++.+.||+|+||.||+|+++.     +++.+|+|++.....    ....+.+|+.+++.+ +||||+++++++. 
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKK-----NGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECC-----CCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34679999999999999999999876     788999998765321    224577899999999 6999999999874 


Q ss_pred             ----eCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          186 ----TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                          .+...|+||||++|++|.+++..    ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.....
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                45679999999999999887753    3568999999999999999999999999999999999999998753211


Q ss_pred             C-----------CCcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Q 014087          258 S-----------SRSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--  319 (431)
Q Consensus       258 ~-----------~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--  319 (431)
                      +           .......|++.|+|||++..     ..++.++|||||||++|||++|+.||...........+...  
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            1           11233468999999999853     45788999999999999999999999876554443333222  


Q ss_pred             -ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       ....|..++.++.+||.+||+.||++||     ++++|++|+||
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~~~~  286 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRP-----TVSDLLQHVFI  286 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCC-----CHHHHhhcccC
Confidence             1223455788999999999999999999     89999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8e-40  Score=311.91  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=196.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHH-HHhcCCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~  188 (431)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|.++..... .... .+..|+.+ ++.++||||+++++++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP-----TGTIMAVKRIRATVNS-QEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC-----CCcEEEEEEEecCCCc-HHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            369999999999999999999886     7899999998765321 2222 34445554 66779999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccCCCC----
Q 014087          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      ..|+||||++ |+|..++..    ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.....+.    
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999997 577776654    24689999999999999999999997 9999999999999998876322111    


Q ss_pred             ------CcccccCCCCCCchhhhcc----CCCCCcchhHhHHHHHHHHHhCCCCCCCC-C-HHHHHHHHHhcccCCC-CC
Q 014087          260 ------RSNSMCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQPPFTHA-N-RQKLQQRIINEKVKLP-PF  326 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~Pf~~~-~-~~~~~~~i~~~~~~~p-~~  326 (431)
                            ......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||... . ...+...+......++ ..
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence                  1123568899999999865    45788999999999999999999999642 2 2333333322233344 35


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ++.++.+||.+||..+|++||     ++++|+.|+||....++
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~  270 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERP-----NYPELLQHPFFELHLSK  270 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCc-----CHHHHhcCchhhhcccc
Confidence            789999999999999999999     89999999999986654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.8e-40  Score=316.00  Aligned_cols=247  Identities=22%  Similarity=0.338  Sum_probs=205.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ...|++.+.||+|+||.||+|....     +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            4569999999999999999999875     78899999987554434445567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------CC
Q 014087          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------SR  260 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------~~  260 (431)
                      ..|+||||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.+|.....+       ..
T Consensus        89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99999999975 66666654 45789999999999999999999999999999999999999987633221       12


Q ss_pred             cccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCC-CCCCCHHHHHHH
Q 014087          261 SNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKL-PPFLTSEAHSLL  335 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~-p~~~s~~~~~li  335 (431)
                      .....|+..|+|||++.   ...++.++|||||||++|||++|+.||.+.+.......+... .... +..++.++++||
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV  247 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence            23456889999999985   356788999999999999999999999887766655555433 2222 234688999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+||..||++||     ++++|+.|+||..-
T Consensus       248 ~~~l~~~p~~Rp-----~~~~il~~~~~~~~  273 (307)
T cd06607         248 DSCLQKIPQDRP-----SSEELLKHRFVLRE  273 (307)
T ss_pred             HHHhcCChhhCc-----CHHHHhcChhhccc
Confidence            999999999999     89999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=308.51  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=203.7

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||+||+|+++..  +.+...+|+|+++...  .......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLP--GKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS   77 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccC--CCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence            346799999999999999999998642  1145679999987543  233455678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR------  260 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~------  260 (431)
                      +..|+||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.....+..      
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999999998764 478999999999999999999999999999999999999988753211111      


Q ss_pred             -------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          261 -------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       261 -------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                             .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+... ....+..++.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL  237 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence                   111234578999999999999999999999999999998 99999887777777777654 334566789999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+|+.+||+.+|++||     ++++|++
T Consensus       238 ~~li~~cl~~~p~~Rp-----~~~ei~~  260 (266)
T cd05033         238 YQLMLDCWQKDRNERP-----TFSQIVS  260 (266)
T ss_pred             HHHHHHHcCCCcccCc-----CHHHHHH
Confidence            9999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=306.91  Aligned_cols=243  Identities=28%  Similarity=0.450  Sum_probs=205.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhh--hhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      .+|++.+.||+|+||.||+++++.     +++.||+|++....  .........+.+|+.+++.++|+||+++++++.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD-----TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC-----CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            479999999999999999999875     78899999875432  12234556788999999999999999999998764


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                        ..+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.....+       
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence              56899999999999999998888899999999999999999999999999999999999999887532111       


Q ss_pred             -------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCH
Q 014087          259 -------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTS  329 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~  329 (431)
                             .......|+..|+|||++.+..++.++|||||||++|+|++|+.||..........++...  ...+|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence                   1112356889999999999988999999999999999999999999877655555555432  3446788999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ++.++|.+||. +|.+||     ++.+++.|||.
T Consensus       237 ~~~~~i~~~l~-~~~~r~-----~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRP-----TAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCc-----cHHHHhcCCCC
Confidence            99999999999 579999     88999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-39  Score=308.11  Aligned_cols=241  Identities=26%  Similarity=0.431  Sum_probs=196.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ..+.....||+|+||.||+++++.     ++..+|+|.+....   ....+.+.+|+.+++.++|+||+++++++..++.
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLS-----TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecC-----CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            345555789999999999999875     77889999886543   2334578899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCccCC--------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHEIDE--------  257 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-g~~~~~--------  257 (431)
                      .|+|+||+.+++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.+ +.....        
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999999999864 455  888999999999999999999999999999999999863 321111        


Q ss_pred             ---CCCcccccCCCCCCchhhhccC--CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHhcccCCCCCCCH
Q 014087          258 ---SSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQK--LQQR-IINEKVKLPPFLTS  329 (431)
Q Consensus       258 ---~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~  329 (431)
                         ........|+..|+|||++.+.  .++.++|||||||++|+|++|+.||.......  .... .......+|..+++
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA  239 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence               1112234588999999998764  47899999999999999999999997543221  1111 22334456778899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ++++|+.+||..+|.+||     ++++++.||||
T Consensus       240 ~~~~li~~~l~~~p~~Rp-----t~~~ll~~~~~  268 (268)
T cd06624         240 EAKNFILRCFEPDPDKRA-----SAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHcCCCchhCC-----CHHHHHhCCCC
Confidence            999999999999999999     89999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.1e-40  Score=311.11  Aligned_cols=244  Identities=23%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||.||+|+.+........+.+++|.+....  .....+.+.+|+++++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            46799999999999999999998765444467789999886543  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQG---------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                      ..|+||||+++|+|.+++....         .+++..+..++.||+.||.|||++||+||||||+|||++.++.......
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998765         6899999999999999999999999999999999999998876421111


Q ss_pred             ------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC--CC
Q 014087          260 ------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LP  324 (431)
Q Consensus       260 ------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~--~p  324 (431)
                                  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......  .+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence                        1122345677999999998889999999999999999999 89999887777777777655543  35


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..++..+.++|.+||..||++||     ++.+++.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp-----~~~~~l~  271 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRP-----SFSELVS  271 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            56889999999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1e-39  Score=308.58  Aligned_cols=240  Identities=26%  Similarity=0.422  Sum_probs=200.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|+++.     +++.||||.+.............+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL-----DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC-----CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence            579999999999999999999876     788999998876544455556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-----
Q 014087          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-----  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-----  260 (431)
                      .|+||||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.....+..     
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999999999999888753    3458999999999999999999999999999999999999988763221111     


Q ss_pred             ------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccc-CC-CCCCCHH
Q 014087          261 ------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINEKV-KL-PPFLTSE  330 (431)
Q Consensus       261 ------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~-~~-p~~~s~~  330 (431)
                            .....|++.|+|||.+.+..++.++|+|||||++|||++|+.||....  ...+...+..... .. +..++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence                  123468899999999999889999999999999999999999996543  3344444443221 22 2357789


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++|.+||..+|++||     +++++++
T Consensus       237 ~~~li~~cl~~~p~~Rp-----~~~~vl~  260 (267)
T cd08228         237 LRELVSMCIYPDPDQRP-----DIGYVHQ  260 (267)
T ss_pred             HHHHHHHHCCCCcccCc-----CHHHHHH
Confidence            99999999999999999     8889876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.6e-40  Score=311.86  Aligned_cols=240  Identities=25%  Similarity=0.454  Sum_probs=198.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.++||.|++|.||+|+++.     +++.||+|+++....  ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT-----TGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC-----CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence            58999999999999999999875     788999999976532  22345567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      |+||||+.+ +|.+++...   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.....+.        
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999999985 888887654   35899999999999999999999999999999999999998876322111        


Q ss_pred             ---CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------------  320 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------  320 (431)
                         ......++..|++||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence               11234578899999998764 57889999999999999999999998877665555443210               


Q ss_pred             ---cC-----------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 ---VK-----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 ---~~-----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                         ..           +.+.++.+++++|.+||+.||.+||     +++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI-----SAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence               00           1124578899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=330.14  Aligned_cols=237  Identities=25%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ..+.|..+...-++-||.|+-|.||+++.+       ++.||||.++.-          -..+|+-|++|+||||+.+.+
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-------netVAVKKV~el----------kETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-------NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc-------CceehhHHHhhh----------hhhhHHHHHhccCcceeeEee
Confidence            345566666667788999999999999974       567999977432          134788999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC------
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------  256 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~------  256 (431)
                      +|.....+|||||||..|.|...|+....+.......+..+|+.|+.|||.+.|||||||.-||||..+..+..      
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence            99999999999999999999999999999999999999999999999999999999999999999987754322      


Q ss_pred             ----CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHH
Q 014087          257 ----ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTSE  330 (431)
Q Consensus       257 ----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~  330 (431)
                          .......++||..|||||++..++.+.|+|||||||||||||||..||.+.+...++--+-.+.  +..|..+++.
T Consensus       260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence                2233457899999999999999999999999999999999999999998877666555544443  4567889999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK  361 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~  361 (431)
                      ++=||++||+-.|..||     ++.+|+.|-
T Consensus       340 fklL~Kqcw~sKpRNRP-----SFrqil~Hl  365 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRP-----SFRQILLHL  365 (904)
T ss_pred             HHHHHHHHHhcCCCCCc-----cHHHHHHHH
Confidence            99999999999999999     889999984

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.1e-40  Score=311.44  Aligned_cols=242  Identities=25%  Similarity=0.464  Sum_probs=207.6

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++++.||.|+||.||++.++.     ++..+|+|++.....  ......+.+|+.+++.++||||+++++++..+...|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECC-----CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            8889999999999999998875     788999999865432  334567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------C
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------R  260 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------~  260 (431)
                      +||||+.+++|..++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.+|.....+.           .
T Consensus        79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999999999988864 56899999999999999999999999999999999999998876322111           1


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhc
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  339 (431)
                      .....|+..|+|||.+.+...+.++|+|||||++|+|++|..||...........+... ...++..++.++.++|.+||
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence            22346889999999999888899999999999999999999999887766666665443 23355678899999999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          340 HKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +.+|.+||     ++++++.|+||...
T Consensus       238 ~~~p~~Rp-----~~~~~l~~~~~~~~  259 (277)
T cd06641         238 NKEPSFRP-----TAKELLKHKFIVRF  259 (277)
T ss_pred             cCChhhCc-----CHHHHHhCHHHhhh
Confidence            99999999     89999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-39  Score=310.70  Aligned_cols=245  Identities=22%  Similarity=0.370  Sum_probs=204.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +...+|.+.++||+|+||.||+|.........++..+|+|.+....   ....+.+.+|+++++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            3456799999999999999999986543333467789999886532   3345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG---------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      ....|+||||+.+|+|.+++...+               .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999997653               47899999999999999999999999999999999999988


Q ss_pred             CCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014087          252 GHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  317 (431)
Q Consensus       252 g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~  317 (431)
                      +.....+..             .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            753322111             112234678999999999999999999999999999998 999998877777666665


Q ss_pred             hc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          318 NE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       318 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .. ....+..++.++.+||.+||+.||.+||     ++++|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----~~~~l~~  276 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRM-----VIKDIHS  276 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            54 3455677899999999999999999999     7788864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=334.91  Aligned_cols=237  Identities=26%  Similarity=0.463  Sum_probs=203.2

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEec
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (431)
                      +||+|+||+||.|+++.     +....|||.+...   +...++-+.+|+.+-+.++|.|||+++|.+..++.+-+.||-
T Consensus       582 VLGKGTYG~VYA~RD~~-----tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq  653 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD-----TQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ  653 (1226)
T ss_pred             EeecCceeEEEeecccc-----ceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence            79999999999999987     7888999998654   345567889999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc------------cCCCCCc
Q 014087          197 INGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------IDESSRS  261 (431)
Q Consensus       197 ~~gg~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~------------~~~~~~~  261 (431)
                      ++||+|..+|+.. |++  .|..+.+|..||++||.|||++.|||||||-+|+||+.-...            ......+
T Consensus       654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            9999999999865 677  889999999999999999999999999999999999764221            1223345


Q ss_pred             ccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCC-CHHH-HHHH-HHhcccCCCCCCCHHHHHHHH
Q 014087          262 NSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQK-LQQR-IINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~-~~~~-~~~~-i~~~~~~~p~~~s~~~~~li~  336 (431)
                      .++.||..|||||++..  .+|+.++|||||||++.||.||++||... ++.. +++- +..-.+++|..++.+++.||.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence            67889999999999985  57999999999999999999999999753 2222 2222 233456788999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +|+..||..||     ++++++..||++.-
T Consensus       814 rcFepd~~~R~-----sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  814 RCFEPDPCDRP-----SAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHcCCCcccCc-----cHHHhccCcccccC
Confidence            99999999999     78999999999864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-39  Score=307.44  Aligned_cols=239  Identities=20%  Similarity=0.330  Sum_probs=200.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|+++++||+|+||.||+|...      .+..+|+|.+.....    ..+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN------NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec------CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            355678999999999999999999865      456799998765332    2456888999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      +.+..|+||||+.+++|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.....+.    
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence            999999999999999999998763  46889999999999999999999999999999999999998876321111    


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                              ......++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ..+.+..++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD  231 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence                    0112234668999999998889999999999999999998 99999988877777776644 2333456889


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.++|.+||..+|++||     +++++.+
T Consensus       232 ~~~~li~~~l~~~p~~Rp-----~~~~i~~  256 (261)
T cd05072         232 ELYDIMKTCWKEKAEERP-----TFDYLQS  256 (261)
T ss_pred             HHHHHHHHHccCCcccCc-----CHHHHHH
Confidence            999999999999999999     7777754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-39  Score=311.00  Aligned_cols=248  Identities=26%  Similarity=0.447  Sum_probs=211.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..+.|++.+.||+|+||.||++.+..     +++.+++|++.....    ....+.+|+++++.++|+||+++++.+...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA-----TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            34569999999999999999999875     678899999976432    355678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      ...|+|+||+.|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.....+.       
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999999999998876 8999999999999999999999999999999999999998876322111       


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-C--CCCCCCHHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-K--LPPFLTSEAH  332 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~  332 (431)
                          ......|+..|++||++.+..++.++|+|||||++|+|++|+.||...+.......+..... .  .+..++.+++
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence                11334578899999999988899999999999999999999999988776665555543322 2  2234789999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      +||.+||+.+|.+||     ++.+|+.|+||+...|.
T Consensus       248 ~li~~~l~~~p~~Rp-----t~~~il~~~~~~~~~~~  279 (286)
T cd06614         248 DFLNKCLVKDPEKRP-----SAEELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHhccChhhCc-----CHHHHhhChHhhccCch
Confidence            999999999999999     89999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=312.31  Aligned_cols=242  Identities=23%  Similarity=0.404  Sum_probs=194.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|..+.     +++.||+|.+.....  ......+.+|+++++.++|+||+++++++.+++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKL-----TGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcC-----CCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence            3579999999999999999999875     788999999876432  122234567999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------  260 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------  260 (431)
                      ..|+||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+..       
T Consensus        77 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          77 TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             eEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99999999985 898888764 468999999999999999999999999999999999999998763222111       


Q ss_pred             ----cccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc---------------
Q 014087          261 ----SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE---------------  319 (431)
Q Consensus       261 ----~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~~---------------  319 (431)
                          .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+...               
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence                122346888999999875 458899999999999999999999997654 22222222110               


Q ss_pred             ----ccCC-----------CCCCC--HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 ----KVKL-----------PPFLT--SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 ----~~~~-----------p~~~s--~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                          ....           ...++  .++.++|.+||+.||++||     ++++++.|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp-----s~~e~l~~~~f  291 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI-----SAAEAMKHPYF  291 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc-----CHHHHhcCCCC
Confidence                0000           01234  7889999999999999999     88999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-39  Score=312.24  Aligned_cols=243  Identities=27%  Similarity=0.441  Sum_probs=195.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (431)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|+++.... .......+.+|+.+++.+. ||||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN-----TGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC-----CCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            369999999999999999999876     788999999876432 2233456778999999995 699999999998766


Q ss_pred             E-----EEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCccCC
Q 014087          189 K-----LYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHEIDE  257 (431)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-~g~~~~~  257 (431)
                      .     .|+||||+.+ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.....
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence            6     8999999986 788887653     35799999999999999999999999999999999999998 5432111


Q ss_pred             C-----------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Q 014087          258 S-----------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----  321 (431)
Q Consensus       258 ~-----------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----  321 (431)
                      +           .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....    
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            1           11122356788999998865 4578999999999999999999999988766554444332100    


Q ss_pred             -------------CC-----------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          322 -------------KL-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       322 -------------~~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                                   .+           .+.++.++.+||.+||..||.+||     ++++++.||||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~-----~~~eil~~~~~~  295 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI-----SAKAALTHPYFD  295 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC-----CHHHHhcCCCcC
Confidence                         00           134788999999999999999999     899999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.7e-40  Score=346.87  Aligned_cols=234  Identities=25%  Similarity=0.365  Sum_probs=192.6

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.++||+|+||.||+|++..     +++.||+|+++..........+.+.+|+++++.++||||+++++++.+.+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~-----tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV-----CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC-----CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence            679999999999999999999876     788999999976544344455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC
Q 014087          190 LYLILDFINGGHLFFHLYRQ-----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~  258 (431)
                      .|+||||++||+|.+++...           ..++...+..++.||+.||.|||++||+||||||+|||++.+|.....+
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            99999999999999988642           2345667888999999999999999999999999999999887521100


Q ss_pred             -----------------------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH
Q 014087          259 -----------------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR  309 (431)
Q Consensus       259 -----------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~  309 (431)
                                                   ......+||+.|||||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence                                         011235799999999999999999999999999999999999999987654


Q ss_pred             HHHHHHH-HhcccCC--CCCCCHHHHHHHHhhcccCcCCcCC
Q 014087          310 QKLQQRI-INEKVKL--PPFLTSEAHSLLKGLLHKDPSKRLG  348 (431)
Q Consensus       310 ~~~~~~i-~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~~  348 (431)
                      ..+.... .......  ...+++.+.+++.+||..||++|++
T Consensus       237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence            4433221 1111111  1357889999999999999999984

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-39  Score=312.27  Aligned_cols=246  Identities=26%  Similarity=0.432  Sum_probs=199.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|++|.||+++++.     +++.||+|.+..... .....+.+.+|+++++.++||||+++++++.+...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV-----TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC-----CCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            579999999999999999999875     788999999866432 22334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--cCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--IDES-------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--~~~~-------  258 (431)
                      .|+||||+. ++|..++.....  +++..++.++.||+.||.|||++||+||||||+||+++.++..  +...       
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            999999996 478887765443  5788999999999999999999999999999999999865432  1110       


Q ss_pred             ---CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Q 014087          259 ---SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------------  320 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------  320 (431)
                         .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...++....              
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence               11123456889999999876 457899999999999999999999998776655544432110              


Q ss_pred             -------cC--------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          321 -------VK--------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       321 -------~~--------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                             ..        ..+.++.++.++|.+||+.||++||     ++++++.|+||++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~~~l~~~~~~~~~  291 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI-----TARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc-----CHHHHhcCchHhHHh
Confidence                   00        1234688999999999999999999     899999999998754

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=334.51  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=189.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCC----------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcc
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG----------DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv  178 (431)
                      .++|+++++||+|+||+||+|..+.....          ..+...+.+++.+...........+.+|+.+|+.++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            45799999999999999999986541100          00111111122222112233456688999999999999999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      ++++++...+..|+|+|++.+ +|..++...     ......+++.|+.||+.||.|||++|||||||||+||||+.+|.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999964 677766543     22446778899999999999999999999999999999998876


Q ss_pred             ccCCC------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCC-CCCC--CHHHHHHHHHh
Q 014087          254 EIDES------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP-FTHA--NRQKLQQRIIN  318 (431)
Q Consensus       254 ~~~~~------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~P-f~~~--~~~~~~~~i~~  318 (431)
                      ....+            ......+||..|+|||++.+..++.++|||||||+||||++|..+ |...  ........++.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            32211            112246799999999999999999999999999999999998754 4322  22121211111


Q ss_pred             c----------------------cc-----CCC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          319 E----------------------KV-----KLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       319 ~----------------------~~-----~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .                      .+     .++     ..++.++.++|.+||+.||.+||     +++|++.||||.+.
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp-----sa~elL~hp~f~~~  460 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP-----GAAELLALPLFSAE  460 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc-----CHHHHhhChhhhcC
Confidence            0                      00     000     12566788999999999999999     88999999999988


Q ss_pred             ChhhHh
Q 014087          367 NWKTLE  372 (431)
Q Consensus       367 ~~~~l~  372 (431)
                      ..+.+.
T Consensus       461 ~~~~~~  466 (501)
T PHA03210        461 EEEEIL  466 (501)
T ss_pred             CchHHH
Confidence            766553

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-39  Score=310.11  Aligned_cols=238  Identities=28%  Similarity=0.485  Sum_probs=192.3

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeC--C
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR--S  188 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~  188 (431)
                      |++++.||+|+||.||+|.++.     +++.+|+|++++... ..... ...+|+.++.++. |+||+++++++.+.  +
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK-----TGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcC-----CCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence            7889999999999999999875     788999999876432 22222 2346888888885 99999999999988  8


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------E  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------~  257 (431)
                      .+++||||+.+ +|.+.+... ..+++.++..++.||+.||.|||++||+||||||+||+++. |....          .
T Consensus        74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99999999975 777777653 57899999999999999999999999999999999999998 54221          1


Q ss_pred             CCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------
Q 014087          258 SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-----------------  319 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-----------------  319 (431)
                      ........++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+....+...                 
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            112233467899999998754 45688999999999999999999999887765554444321                 


Q ss_pred             -ccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 -KVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       ...+|           ..++.++.+||.+||.+||++||     ++++++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI-----TAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc-----CHHHHhhCCCC
Confidence             11111           24678999999999999999999     89999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-39  Score=305.80  Aligned_cols=232  Identities=22%  Similarity=0.372  Sum_probs=194.4

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|+++.     +++.+|+|.+....  .......+.+|+++++.++||||+++++++......|+|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~-----~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA-----DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEec-----CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence            469999999999999875     78899999886432  23345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCcc------------
Q 014087          196 FINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN------------  262 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~~------------  262 (431)
                      |+.+++|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.....+....            
T Consensus        74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            999999999997654 5899999999999999999999999999999999999998876322221110            


Q ss_pred             -cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhc
Q 014087          263 -SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       263 -~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  339 (431)
                       ...++..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+... ....+..++.++.+|+.+||
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW  233 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence             0112356999999999889999999999999999998 99999877766666655443 44566778999999999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHh
Q 014087          340 HKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.||++||     +++++++
T Consensus       234 ~~~p~~Rp-----s~~~~~~  248 (252)
T cd05084         234 EYDPGQRP-----SFSTVHQ  248 (252)
T ss_pred             CCChhhCc-----CHHHHHH
Confidence            99999999     7888864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=310.48  Aligned_cols=244  Identities=27%  Similarity=0.516  Sum_probs=203.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeEEEEeC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  187 (431)
                      .|++.+.||+|+||.||+|.+..     +++.+|+|+++...  .......+.+|+.+++.++   ||||+++++++..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP-----TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC-----CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            48889999999999999999875     78899999987542  2334566788999999986   99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      ...|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.....+         
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999999999998865 4789999999999999999999999999999999999999887632211         


Q ss_pred             --CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC-CCCHHHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPP-FLTSEAHS  333 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~  333 (431)
                        .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+.... ..++. .++.++.+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence              11233468899999999875 456899999999999999999999998876655444433321 22333 37889999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      +|.+||+.||++||     ++++++.|+||+...
T Consensus       234 ~i~~~l~~~p~~R~-----~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERL-----SAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCc-----CHHHHhhChHhhccc
Confidence            99999999999999     899999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.3e-40  Score=313.80  Aligned_cols=242  Identities=27%  Similarity=0.456  Sum_probs=199.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      ++|++.+.||+|+||.||+|.++.     +++.+|+|.++..... ......+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK-----TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC-----CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            469999999999999999999875     7889999999765432 23334566899999999999999999999877  


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      ...|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+        
T Consensus        79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            899999999975 8988887643 589999999999999999999999999999999999999987632211        


Q ss_pred             ---CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Q 014087          259 ---SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------------  320 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------  320 (431)
                         .......++..|+|||.+.+. .++.++|+|||||++|||++|..||...+......++....              
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence               112234578899999998764 46889999999999999999999998876655554443210              


Q ss_pred             -----------------cCCCCC-CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 -----------------VKLPPF-LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 -----------------~~~p~~-~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                       ..++.. ++..+.+||++||+.||++||     ++++++.|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI-----SAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC-----CHHHHhcCCCC
Confidence                             112222 588899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-39  Score=306.25  Aligned_cols=238  Identities=21%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||+||+++++.      +..+|+|.+.....    ..+.+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ   71 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            34579999999999999999998753      34599998875432    134578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR------  260 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~------  260 (431)
                      ...|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..      
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence            9999999999999999999764 468999999999999999999999999999999999999988753221111      


Q ss_pred             ------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHH
Q 014087          261 ------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAH  332 (431)
Q Consensus       261 ------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~  332 (431)
                            .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+..... ..+...+.++.
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY  231 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence                  111234567999999998889999999999999999999 9999988777777777766533 34556789999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +++.+||+.||.+||     ++.+|+.+
T Consensus       232 ~li~~cl~~~p~~Rp-----~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERP-----TFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCC-----CHHHHHHh
Confidence            999999999999999     88888763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-39  Score=308.52  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=201.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      ++|+..+.||.|++|.||+|.+..     +++.+|+|.+.....  ......+.+|+++++.++||||+++++++.+.  
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC-----CCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            369999999999999999999875     788999999876432  23456688899999999999999999988653  


Q ss_pred             CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      +.+|+||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.....+.    
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            479999999999999887653    345899999999999999999999999999999999999998875322111    


Q ss_pred             -----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc-ccCCC----
Q 014087          260 -----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----NRQKLQQRIINE-KVKLP----  324 (431)
Q Consensus       260 -----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~-----~~~~~~~~i~~~-~~~~p----  324 (431)
                           ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...     ...+....+... ...++    
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence                 122346788999999999999999999999999999999999999765     233444444432 11121    


Q ss_pred             --CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          325 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       325 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                        ..+++++.+||.+||..||++||     ++++++.|+||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRP-----TPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCC-----CHHHHHhCccccccc
Confidence              12467899999999999999999     899999999997654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=301.24  Aligned_cols=242  Identities=29%  Similarity=0.531  Sum_probs=209.7

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|++|.||+++++.     +++.||+|.+...... ....+.+.+|+++++.++|+||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE-----TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC-----CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            48999999999999999999875     7788999999876432 34567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------C
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------S  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~  259 (431)
                      |+||||+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.....+           .
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999999999998888899999999999999999999999999999999999999877532111           1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccCCCCCCCHHHHHHHHhh
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ......|+..|+|||.+.+..++.++|||+||+++|+|++|+.||...+.......+. .....++..++.++.++|.+|
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence            1134568899999999988889999999999999999999999998766544444433 344456778899999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      |..+|++||     ++++++.|+||
T Consensus       235 l~~~p~~R~-----~~~~~l~~~~~  254 (254)
T cd06627         235 FQKDPNLRP-----TAKQLLKHPWI  254 (254)
T ss_pred             HhCChhhCc-----CHHHHhcCCCC
Confidence            999999999     88999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-39  Score=311.23  Aligned_cols=241  Identities=22%  Similarity=0.346  Sum_probs=191.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|.++.     +++.||+|++.....  ......+.+|+.+++.++|+||+++++++.+++.
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcC-----CCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            579999999999999999999876     788999999875432  2222346679999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .|+||||+. ++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            999999996 567666654 356889999999999999999999999999999999999998876322111         


Q ss_pred             --CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc--------------cc
Q 014087          260 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINE--------------KV  321 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~-~~~~~i~~~--------------~~  321 (431)
                        ......++..|+|||++.+. .++.++|||||||++|||++|+.||.+.+.. +....+...              ..
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              12234578899999998764 5788999999999999999999999764432 222222110              00


Q ss_pred             ---------CCC---------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          322 ---------KLP---------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       322 ---------~~p---------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                               ..+         ...+.++.++|.+||..||.+||     ++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~-----t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI-----SAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc-----CHHHHhcCCCC
Confidence                     000         01256889999999999999999     89999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.5e-39  Score=302.11  Aligned_cols=242  Identities=31%  Similarity=0.555  Sum_probs=211.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||++.+..     +++.||+|++..... .......+.+|+++++.++|||++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS-----DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC-----CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            58999999999999999999875     788999999876543 234456688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      ++|+||+++++|.+++.+.    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.....+.       
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            9999999999999999874    67999999999999999999999999999999999999998766322111       


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSL  334 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l  334 (431)
                          ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+...+...+.... ..+|..++.++.++
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence                2233568889999999999999999999999999999999999998887777777766543 34566789999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      |.+||..+|++||     ++++++.||||
T Consensus       235 i~~~l~~~p~~Rp-----~~~~ll~~~~~  258 (258)
T cd08215         235 VSSLLQKDPEERP-----SIAQILQSPFI  258 (258)
T ss_pred             HHHHcCCChhhCc-----CHHHHhcCCCC
Confidence            9999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=306.58  Aligned_cols=236  Identities=20%  Similarity=0.385  Sum_probs=199.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ..+|++.+.||+|+||.||+++++      .+..+|+|++.+....    .+.+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR------GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec------CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            346999999999999999999875      4557999998654322    234677999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS------  261 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~------  261 (431)
                      ..|+||||++|++|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||+++.+|.....+...      
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            999999999999999999764 4689999999999999999999999999999999999999887632221110      


Q ss_pred             ---ccc---cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 014087          262 ---NSM---CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  333 (431)
Q Consensus       262 ---~~~---~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  333 (431)
                         ...   .++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+... ....|..++.++.+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT  232 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence               111   23357999999999999999999999999999999 89999887777777776654 34556778999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+||..+|++||     +++++++
T Consensus       233 li~~cl~~~p~~Rp-----t~~~~l~  253 (256)
T cd05059         233 IMYSCWHEKPEDRP-----AFKKLLS  253 (256)
T ss_pred             HHHHHhcCChhhCc-----CHHHHHH
Confidence            99999999999999     8899876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.8e-39  Score=301.77  Aligned_cols=242  Identities=31%  Similarity=0.519  Sum_probs=209.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--C
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (431)
                      +|+..+.||+|++|.||+|..+.     +++.+++|++..... .....+.+.+|+.++++++||||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD-----TGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            48889999999999999999875     788999999876543 245567889999999999999999999999988  8


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+++|+||+.+++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.....+          
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999999999999888899999999999999999999999999999999999999876532111          


Q ss_pred             C---CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHH--hcccCCCCCCCHHHH
Q 014087          259 S---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRII--NEKVKLPPFLTSEAH  332 (431)
Q Consensus       259 ~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~  332 (431)
                      .   ......++..|+|||.+.+...+.++||||||+++|+|++|..||.... .......+.  .....+|..++.++.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence            1   1344578899999999998889999999999999999999999998765 333333333  234456778899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +||.+||..||++||     ++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp-----~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRP-----TADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCC-----CHHHHhhCCCC
Confidence            999999999999999     89999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.3e-40  Score=320.45  Aligned_cols=245  Identities=24%  Similarity=0.383  Sum_probs=200.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe---
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (431)
                      ++|++.+.||+|+||.||+|..+.     +++.||+|++..... .......+.+|+.+|+.++||||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR-----SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            579999999999999999999886     788999999876432 23345667789999999999999999988763   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                       ...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.....+       
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence             357899999996 58999998888899999999999999999999999999999999999999988632111       


Q ss_pred             --------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 014087          259 --------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  319 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~----------  319 (431)
                              ......+|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence                    11124478999999999875 46899999999999999999999999876544332222110          


Q ss_pred             ----------------ccCC-----CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 ----------------KVKL-----PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 ----------------~~~~-----p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                      ....     .+..+.++.++|++||+.||.+||     ++++++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~~~~~  300 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI-----TVEQALQHPFLAQY  300 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc-----CHHHHHhChhhhhc
Confidence                            0011     134688999999999999999999     88999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=305.08  Aligned_cols=238  Identities=23%  Similarity=0.377  Sum_probs=200.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||.||+|.+.      .++.||+|.++....    ..+.+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN------NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec------CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            44567999999999999999999865      456799999876432    23457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      .+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.....+..    
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            999999999999999999997754  68999999999999999999999999999999999999998863222211    


Q ss_pred             -----cccccC---CCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          261 -----SNSMCG---TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       261 -----~~~~~G---t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                           .....|   +..|+|||++.+..++.++|||||||++|||++ |+.||.+.+...+...+... ....+..++..
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE  232 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence                 111222   347999999999999999999999999999999 99999988877777776544 33455678999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+++.+||+.+|.+||     ++++|..
T Consensus       233 ~~~li~~~l~~~P~~Rp-----~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRP-----TFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCC-----CHHHHHH
Confidence            99999999999999999     7788764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-39  Score=313.74  Aligned_cols=246  Identities=21%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCC--CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +..++|.+.+.||+|+||.||+|++.+....  .....+|+|.++...  .......+.+|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3446799999999999999999987643221  234679999997642  223345677899999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                      +...+..|+||||+.+|+|.+++....                .+++.++..++.||+.||.|||++|++||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                4788999999999999999999999999999999999


Q ss_pred             eCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014087          248 MDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ  313 (431)
Q Consensus       248 l~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~  313 (431)
                      ++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            9988753221111             111123468999999999999999999999999999998 99999988877777


Q ss_pred             HHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          314 QRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       314 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+.... ...+..++.++++||.+||..+|.+||     ++++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~  294 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  294 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc-----CHHHHHH
Confidence            7766553 356677899999999999999999999     7888866

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-39  Score=311.51  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=205.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|++.+.||+|+||.||++.+........++.+|||+++...  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            345688999999999999999998764434457889999997543  233456688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      ...++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998532                347888899999999999999999999999999999999987


Q ss_pred             CCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014087          252 GHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  317 (431)
Q Consensus       252 g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~  317 (431)
                      +.....+..             .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            653221111             122345678999999998889999999999999999998 999999888888888887


Q ss_pred             hccc-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          318 NEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       318 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .... ..+..++.++.+|+.+||+.+|.+||     ++++|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~i~~  278 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRP-----RFKDIHS  278 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHH
Confidence            6654 45678999999999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-39  Score=315.60  Aligned_cols=245  Identities=20%  Similarity=0.285  Sum_probs=198.6

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +...+|++.+.||+|+||+||+|++..... .....||+|+++...  .....+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            345679999999999999999999764211 123458999986432  23345668889999999999999999999876


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-----  260 (431)
                      . ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.....+..     
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence            5 578999999999999999875 468899999999999999999999999999999999999988763221111     


Q ss_pred             --------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          261 --------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                              .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+... ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence                    111223568999999999999999999999999999998 99999887776655444332 33445678899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +.+++.+||..||.+||     ++.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rp-----s~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRP-----KFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            99999999999999999     78888874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-39  Score=313.07  Aligned_cols=243  Identities=27%  Similarity=0.389  Sum_probs=193.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.++||+|+||.||+|+++.     +++.||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKK-----TKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECC-----CCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            4579999999999999999999876     789999998865432 2222334567999999999999999999887654


Q ss_pred             --------EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          189 --------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       189 --------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                              ..|+||||+.+ +|...+... ..+++.+++.++.||+.||.|||++||+||||||+||+++.++.....+.
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                    46999999975 787777654 36899999999999999999999999999999999999998875321110


Q ss_pred             ---------------CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---
Q 014087          260 ---------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---  320 (431)
Q Consensus       260 ---------------~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---  320 (431)
                                     ......++..|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..-.   
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           11234578889999998764 47889999999999999999999998876554433322210   


Q ss_pred             ----------------cCCC-------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 ----------------VKLP-------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 ----------------~~~p-------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                      ..++             ...+..+.+||.+||..||.+||     +++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~-----t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI-----DADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc-----CHHHHhcCCCC
Confidence                            0111             11356788999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.5e-39  Score=312.24  Aligned_cols=247  Identities=21%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|.+.+.||+|+||.||++.+........+..+|+|+++...  .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            34456799999999999999999987543333467789999987543  233456788999999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                      ...+..|+||||+.+|+|.+++....  .+++.++..++.||+.||.|||++||+||||||+|||++.++.....+.   
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999997643  3899999999999999999999999999999999999988765321111   


Q ss_pred             ----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc--cCCCCC
Q 014087          260 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK--VKLPPF  326 (431)
Q Consensus       260 ----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~p~~  326 (431)
                                ......++..|+|||++.+..++.++|||||||++|||++ |..||................  ...+..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence                      0112245678999999999999999999999999999998 999998766555444444332  234556


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+.++.+|+.+||..+|++||     ++++++.
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rp-----t~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRP-----TFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            889999999999999999999     7888865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-39  Score=313.23  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=204.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||++....     +++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+...+.
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA-----TGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC-----CCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            579999999999999999998765     67889999986432   2234567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      .|+|+||+++++|.+++.+. .+++.++..++.|++.||.|||++|++||||||+||+++.++.....+           
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999999999988764 578999999999999999999999999999999999999887532211           


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccc--CCCCCCCHHHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-EKV--KLPPFLTSEAHSLL  335 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~-~~~--~~p~~~s~~~~~li  335 (431)
                      .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ...  ..+..++..++++|
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence            112234688899999999988899999999999999999999999987655443333322 222  22345788999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      .+||..+|++||     ++++++.|+||+..+
T Consensus       250 ~~~l~~~p~~Rp-----~~~~il~h~~~~~~~  276 (293)
T cd06647         250 NRCLEMDVEKRG-----SAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHccCChhhCc-----CHHHHhcCHHHhcCc
Confidence            999999999999     899999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.8e-39  Score=304.26  Aligned_cols=233  Identities=21%  Similarity=0.308  Sum_probs=194.9

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEec
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (431)
                      +||+|+||.||+|.++..   .++..+|+|+++... ......+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK---KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecC---CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            689999999999976532   267789999987543 23445677889999999999999999999875 4567999999


Q ss_pred             cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------------cc
Q 014087          197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------------SN  262 (431)
Q Consensus       197 ~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------------~~  262 (431)
                      +.+|+|.+++.+...+++..+..++.|++.||.|||++||+||||||.|||++.++.....+..              ..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999999999888889999999999999999999999999999999999999988753211110              11


Q ss_pred             cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcc
Q 014087          263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLH  340 (431)
Q Consensus       263 ~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~  340 (431)
                      ...++..|+|||.+....++.++|||||||++|||++ |+.||...+..++...+..+ ....|..++.++.+||.+||+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2234578999999988889999999999999999998 99999988887777777654 345677899999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHh
Q 014087          341 KDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~  359 (431)
                      .||++||     ++++|..
T Consensus       237 ~~p~~Rp-----~~~~i~~  250 (257)
T cd05116         237 YGVDERP-----GFAVVEL  250 (257)
T ss_pred             cCchhCc-----CHHHHHH
Confidence            9999999     6677644

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-39  Score=317.71  Aligned_cols=245  Identities=25%  Similarity=0.404  Sum_probs=200.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||.||++.+..     ++..||||++.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECC-----CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            4679999999999999999999875     78899999986532 22333456778999999999999999999997654


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                            .+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.....+    
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                  469999999 7788877754 5789999999999999999999999999999999999999887632211    


Q ss_pred             ----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------------
Q 014087          259 ----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------  321 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------  321 (431)
                          .......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.....            
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         166 RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence                12233467899999999976 4588999999999999999999999987765544443322111            


Q ss_pred             -------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                         .+...++.++.++|.+||+.||++||     ++.+++.||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----t~~~~l~~~~~~~~  304 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI-----TAAEALAHPYFEEF  304 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC-----CHHHHhcCccHhhh
Confidence                               01235788899999999999999999     88999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-39  Score=312.92  Aligned_cols=242  Identities=24%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|.....||+|+||.||+|.+..     +++.||+|++.....   ...+.+.+|+.+++.++||||+++++.+..++..
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKH-----SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcC-----CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            35666789999999999999875     788999999865432   2345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------C
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------S  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~  259 (431)
                      |+||||+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+           .
T Consensus        94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999999999887755 5689999999999999999999999999999999999999887632211           1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCCCHHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLLK  336 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~  336 (431)
                      .....+|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+.....   ..+..++.++.++|.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence            22345789999999999988899999999999999999999999988776666655544322   223457889999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +||+.+|++||     +++++++|+||...
T Consensus       253 ~~l~~~P~~Rp-----s~~~ll~~~~~~~~  277 (297)
T cd06659         253 RMLTREPQERA-----TAQELLDHPFLLQT  277 (297)
T ss_pred             HHhcCCcccCc-----CHHHHhhChhhccC
Confidence            99999999999     89999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.1e-39  Score=310.85  Aligned_cols=248  Identities=21%  Similarity=0.377  Sum_probs=206.4

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|++.+.||+|+||.||++.++..........+|+|.+.....  ......+.+|+.+++.+ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3455678999999999999999999987643333557899999876432  23345688899999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                      +..++.+|+||||+.+|+|..++...                +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999998652                35889999999999999999999999999999999999


Q ss_pred             eCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014087          248 MDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ  313 (431)
Q Consensus       248 l~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~  313 (431)
                      ++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++.
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            9988763222111             111234567999999999999999999999999999998 99999988877777


Q ss_pred             HHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          314 QRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       314 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+.... ...+...+.++.+|+.+||..||++||     +++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~eil~  286 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP-----TFKQLVE  286 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHH
Confidence            7765543 345667889999999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.7e-40  Score=304.67  Aligned_cols=226  Identities=31%  Similarity=0.540  Sum_probs=190.0

Q ss_pred             cCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEeccCCC
Q 014087          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG  200 (431)
Q Consensus       121 G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg  200 (431)
                      |.||.||+|+++.     +++.||+|.+.+...        ...|...+....||||+++++++.+.+..|+||||+.||
T Consensus         4 g~~~~v~~~~~~~-----~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTR-----TQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEcc-----CCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence            8999999999986     889999999976531        223455555667999999999999999999999999999


Q ss_pred             ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------CcccccCCCCCCc
Q 014087          201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------RSNSMCGTTEYMA  272 (431)
Q Consensus       201 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------~~~~~~Gt~~y~a  272 (431)
                      +|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.....+.        ......++..|+|
T Consensus        71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a  150 (237)
T cd05576          71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA  150 (237)
T ss_pred             CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence            99999988888999999999999999999999999999999999999999876322211        1223456778999


Q ss_pred             hhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCC
Q 014087          273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPG  352 (431)
Q Consensus       273 PE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~  352 (431)
                      ||.+.+..++.++||||+||++|||++|+.||...... ..   ......+|..++.++++||.+||+.||++|++++..
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence            99998888999999999999999999999988643211 00   112345678899999999999999999999988777


Q ss_pred             CHHHHHhCCCC
Q 014087          353 GVDAIKHHKWF  363 (431)
Q Consensus       353 ~~~~i~~h~~f  363 (431)
                      ++++++.||||
T Consensus       227 ~~~~~~~h~~~  237 (237)
T cd05576         227 GVEDIKSHPFF  237 (237)
T ss_pred             chHHHHcCCCC
Confidence            89999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-39  Score=310.75  Aligned_cols=240  Identities=22%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      ++|++.+.||+|+||.||+|..+...   ....+++|.++...  .....+.+.+|+.+++++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            57999999999999999999886511   12347888776321  233345688899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      .+|+||||+++|+|.+++.+..                .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            9999999999999999997642                478899999999999999999999999999999999999887


Q ss_pred             CccCCCCCc----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-c
Q 014087          253 HEIDESSRS----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-K  320 (431)
Q Consensus       253 ~~~~~~~~~----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~  320 (431)
                      .....+...          ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+ .
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            532221111          11122457999999999999999999999999999997 99999988888777777654 3


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+..++.++.+||.+||..||.+||     ++++|++
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~i~~  270 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERP-----PFAQISV  270 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            345667899999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=303.25  Aligned_cols=236  Identities=25%  Similarity=0.405  Sum_probs=203.5

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|......  ..+..+|+|++.......  ..+.+.+|+++++.++|+||+++++++.+...+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999987511  137889999997654322  46778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          196 FINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       196 ~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      |+++++|.+++...         ..+++.++..++.|++.||.|||++||+||||||+||+++.++.....+        
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999885         7799999999999999999999999999999999999999987632211        


Q ss_pred             -----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          259 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                           .......++..|+|||.+....++.++|||||||++|||++ |..||...+..++.+.+... ....+..++.++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL  236 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence                 11234457889999999998899999999999999999999 69999998888887777753 445677889999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+++.+||..||++||     ++++++++
T Consensus       237 ~~li~~~l~~~p~~Rp-----s~~~l~~~  260 (262)
T cd00192         237 YELMLSCWQLDPEDRP-----TFSELVER  260 (262)
T ss_pred             HHHHHHHccCCcccCc-----CHHHHHHh
Confidence            9999999999999999     88998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=317.43  Aligned_cols=243  Identities=25%  Similarity=0.409  Sum_probs=194.6

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      ++|++.++||+|+||.||+|.++.     +++.||+|++....  .......+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKP-----TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcC-----CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            579999999999999999999876     78899999986422  233445677899999999999999999887644  


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                         ...|+|+||+.+ +|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.     
T Consensus        78 ~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          78 ESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             cccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence               358999999975 7877774 456999999999999999999999999999999999999998876321110     


Q ss_pred             ---------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 014087          260 ---------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-----------  318 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~-----------  318 (431)
                               .....+||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..           
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence                     1123468999999998765 5689999999999999999999999977654332222210           


Q ss_pred             ----cc-----------cC-----CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          319 ----EK-----------VK-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       319 ----~~-----------~~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                          ..           ..     ..+.++.++.+||.+||+.||++||     ++.+++.||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~e~l~hp~~~~~  298 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI-----TVEEALAHPYLEQY  298 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc-----CHHHHhcCcccccc
Confidence                00           00     0124678899999999999999999     89999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-39  Score=306.12  Aligned_cols=240  Identities=26%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+++++.     +++.+|||.+.............+.+|+.+++.++||||+++++++..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC-----CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            469999999999999999999875     788999998876554455556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      .++||||++|++|.+++..    ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.....+.      
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999999999999998864    346899999999999999999999999999999999999998876322111      


Q ss_pred             -----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccc-CC-CCCCCHH
Q 014087          260 -----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQRIINEKV-KL-PPFLTSE  330 (431)
Q Consensus       260 -----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~  330 (431)
                           .....+|+..|+|||.+.+..++.++||||||+++|+|++|..||.+...  ......+..... .. +..++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence                 12235788999999999999999999999999999999999999976433  334444433222 12 2357889


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++||.+||..||++||     ++++|++
T Consensus       237 ~~~li~~~l~~~p~~Rp-----t~~~i~~  260 (267)
T cd08229         237 LRQLVNMCINPDPEKRP-----DITYVYD  260 (267)
T ss_pred             HHHHHHHhcCCCcccCC-----CHHHHHH
Confidence            99999999999999999     7887754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.4e-39  Score=302.33  Aligned_cols=240  Identities=27%  Similarity=0.458  Sum_probs=202.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|..+.     +++.||+|.++..........+.+.+|+++++.++|+||+++++++...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL-----DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC-----CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            579999999999999999999875     788999999876554455556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                      .++||||+++|+|..++..    ...+++.++..++.|++.||.|||+.||+||||||+||+++.+|.....+       
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9999999999999988864    24589999999999999999999999999999999999999887632211       


Q ss_pred             ----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccc-CCCC-CCCHH
Q 014087          259 ----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN--RQKLQQRIINEKV-KLPP-FLTSE  330 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~  330 (431)
                          .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....  ..+....+..+.. ..|. .++.+
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence                11223568899999999999999999999999999999999999996543  3344444444322 2343 67889


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++|.+||..+|++||     ++.+|++
T Consensus       237 ~~~~i~~cl~~~p~~Rp-----~~~~il~  260 (267)
T cd08224         237 LRDLVSRCINPDPEKRP-----DISYVLQ  260 (267)
T ss_pred             HHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            99999999999999999     7787765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-39  Score=315.77  Aligned_cols=235  Identities=27%  Similarity=0.427  Sum_probs=178.8

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE--eCCEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ--TRSKLYL  192 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~l  192 (431)
                      ..+||+|+||+||+|+.+..   .++..||+|.+.....     ...+.+|+.+|+.++||||+++++++.  .+..+|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~---~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG---KDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC---CccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            36899999999999997642   2567899998865422     234678999999999999999999885  4567899


Q ss_pred             EEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC----CCCccCCC-
Q 014087          193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHEIDES-  258 (431)
Q Consensus       193 v~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~----~g~~~~~~-  258 (431)
                      ||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..    +|.....+ 
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9999875 777776421         24889999999999999999999999999999999999943    33211110 


Q ss_pred             -------------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH---------HHHHH
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------KLQQR  315 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~---------~~~~~  315 (431)
                                   ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||......         .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence                         11234578999999999986 45799999999999999999999999753211         00111


Q ss_pred             HHh----------------------------ccc----------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHH
Q 014087          316 IIN----------------------------EKV----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI  357 (431)
Q Consensus       316 i~~----------------------------~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i  357 (431)
                      +..                            ...          ......+..+.+||.+||+.||.+||     +++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-----t~~e~  311 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI-----TSEQA  311 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc-----CHHHH
Confidence            000                            000          00112356788999999999999999     89999


Q ss_pred             HhCCCC
Q 014087          358 KHHKWF  363 (431)
Q Consensus       358 ~~h~~f  363 (431)
                      ++||||
T Consensus       312 l~hp~f  317 (317)
T cd07867         312 LQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-39  Score=318.50  Aligned_cols=243  Identities=25%  Similarity=0.416  Sum_probs=195.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      ++|++.+.||.|+||.||+|.++.     +++.||+|++.....   ...+.+.+|+++++.++||||+++++++...  
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~-----~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD-----CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC-----CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            579999999999999999999876     889999999865432   3456678899999999999999998776554  


Q ss_pred             ------------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          188 ------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       188 ------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                                  ...|+||||+. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++..+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                        35899999997 488877754 5689999999999999999999999999999999999998654321


Q ss_pred             --CCC-------------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014087          256 --DES-------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE  319 (431)
Q Consensus       256 --~~~-------------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~  319 (431)
                        ...             .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence              100             01122357889999998764 56889999999999999999999999876655444433221


Q ss_pred             c-------------------------cC-----CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          320 K-------------------------VK-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       320 ~-------------------------~~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      .                         ..     +.+.++.++.+||.+||..||.+||     ++++++.|+||+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~h~~~~~~~  307 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL-----TAEEALMHPYMSCYS  307 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc-----CHHHHhCCCcccccc
Confidence            0                         00     1135788999999999999999999     899999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4e-39  Score=309.22  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=202.0

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCC-----------CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  176 (431)
                      ..++|++++.||+|+||.||+|......           ....+..+|+|.+.....  ....+.+.+|+++++.++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3467999999999999999999876422           112346799999876532  345667889999999999999


Q ss_pred             cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      |+++++++..++..++||||+.+++|..++.+..           .+++..+..++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999998765           68999999999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh--CCCCCCCCCHH
Q 014087          246 ILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ  310 (431)
Q Consensus       246 ILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~Pf~~~~~~  310 (431)
                      |+++.++.....+.             ......++..|+|||++.+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99998865322111             1123345778999999998889999999999999999998  78899877766


Q ss_pred             HHHHHHHhc--------ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          311 KLQQRIINE--------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       311 ~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+...+...        ....+..++.++.+||.+||+.||.+||     ++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP-----TFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC-----CHHHHHH
Confidence            666555432        1223456789999999999999999999     8888864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=327.03  Aligned_cols=246  Identities=22%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             CCCc-eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      .++| +...+||+|+|-+||+|.+..     +|..||--.++...+. ....+++|..|+.+|+.|+|||||++|++|.+
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~-----~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEE-----EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccc-----cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            4445 445789999999999998854     7777776655544433 35557899999999999999999999999987


Q ss_pred             CCE--EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCc--------
Q 014087          187 RSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHE--------  254 (431)
Q Consensus       187 ~~~--~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~~--------  254 (431)
                      ...  +-+|+|++.+|+|..|+++.+.++...++.|++||++||.|||++.  |||||||-+||+|+.+...        
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence            765  8899999999999999999999999999999999999999999986  9999999999999877331        


Q ss_pred             --cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccC--CCCCCCH
Q 014087          255 --IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK--LPPFLTS  329 (431)
Q Consensus       255 --~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~  329 (431)
                        +........+.|||.|||||++. ..|+..+||||||++|+||+|+..||.. .+..++++++..+.-+  +..--.+
T Consensus       193 Atl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  193 ATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             HHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence              22334556689999999999998 8899999999999999999999999975 6788899999887543  2233478


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++++||.+||.. .++|+     ++.|+|.|+||..-
T Consensus       272 evr~fIekCl~~-~~~R~-----sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERL-----SAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHhcC-chhcc-----CHHHHhhChhhccc
Confidence            999999999998 99999     88999999999864

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.2e-39  Score=308.15  Aligned_cols=245  Identities=21%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||.||+|++.+...+.++..+|+|++....  .......+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            346799999999999999999998654334467889999987543  233446688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      ...|+||||+.+|+|.+++....                      .+++.++..++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                      36788899999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999988763322111             112234567999999999999999999999999999998 899998888888


Q ss_pred             HHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ....+..+.. ..+..++.++.+||.+||+.||++||     ++++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP-----SFASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHH
Confidence            7777765543 34667889999999999999999999     7778764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.8e-39  Score=303.02  Aligned_cols=237  Identities=20%  Similarity=0.339  Sum_probs=198.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|+++++||+|+||.||+|..+      .++.||+|.+.....    ....+.+|+.+++.++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            45568999999999999999999865      567799999875432    2346788999999999999999998874 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      .+..|+||||+.+++|.+++...  ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.....+.     
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence            56789999999999999998764  36899999999999999999999999999999999999998875322111     


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                             ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... ....+...+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05067         152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE  231 (260)
T ss_pred             cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHH
Confidence                   1112345678999999998889999999999999999999 99999988777777666544 33456678899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++|.+||..+|++||     ++++++.
T Consensus       232 ~~~li~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05067         232 LYELMRLCWKEKPEERP-----TFEYLRS  255 (260)
T ss_pred             HHHHHHHHccCChhhCC-----CHHHHHH
Confidence            99999999999999999     7888865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.9e-39  Score=308.10  Aligned_cols=242  Identities=21%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+|.............+|+|.+....  .......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            488999999999999999987654433345679999887543  223356788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          191 YLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      |+||||+.+|+|.+++...                        ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478889999999999999999999999999999999


Q ss_pred             EeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 014087          247 LMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  312 (431)
Q Consensus       247 Ll~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~  312 (431)
                      |++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99988753221111             122345678999999999999999999999999999998 9999998888877


Q ss_pred             HHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+.+... ....+..++.++.+||.+||+.||++||     ++++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp-----~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP-----TFADISK  281 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCC-----CHHHHHH
Confidence            7766543 3445677899999999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-39  Score=310.92  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=199.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (431)
                      ++|+..+.||+|+||.||++.++.     +++.+|+|.+.+....  .....+.+|+.++.++. |+||+++++++..++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~   76 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKP-----SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG   76 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECC-----CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence            467788899999999999999886     7899999998764322  34556788999999996 999999999999999


Q ss_pred             EEEEEEeccCCCChHHH---HH--HcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCC----
Q 014087          189 KLYLILDFINGGHLFFH---LY--RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~---l~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      ..+++|||+.+ +|.++   +.  ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++.....+    
T Consensus        77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999999865 44332   22  23679999999999999999999997 5999999999999999887532111    


Q ss_pred             ------CCcccccCCCCCCchhhhccC---CCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc-cCCC---
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEK-VKLP---  324 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~p---  324 (431)
                            .......|+..|+|||++.+.   .++.++|||||||++|||++|+.||..... .+....+.... ..++   
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence                  112334688999999999876   689999999999999999999999976542 12222222221 1222   


Q ss_pred             -CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhc
Q 014087          325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  373 (431)
Q Consensus       325 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~  373 (431)
                       ..++.++.+||.+||+.||++||     ++++|+.||||+...|.....
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~i~~~~~~~~~~~~~~~~  280 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVDV  280 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCc-----CHHHHhcChhhhchhhcchhH
Confidence             24789999999999999999999     899999999999877765543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-38  Score=309.26  Aligned_cols=245  Identities=23%  Similarity=0.357  Sum_probs=203.8

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |...+.||+|+||+||+|++..     +++.|++|++.............+.+|+.+++.++||||+++++++.+....|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH-----TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC-----CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            7778889999999999999875     78899999987654444455567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------CCccc
Q 014087          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------SRSNS  263 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------~~~~~  263 (431)
                      +||||+.| +|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++.....+       .....
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~  176 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS  176 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence            99999965 67777655 45689999999999999999999999999999999999999887532211       12234


Q ss_pred             ccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CC-CCCCCHHHHHHHHhh
Q 014087          264 MCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL-PPFLTSEAHSLLKGL  338 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~li~~~  338 (431)
                      ..|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.......+..... .. ...++..+++||.+|
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence            57889999999985   35678899999999999999999999988766555555544322 22 235678899999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      |+.+|.+||     ++.+++.||||+..+
T Consensus       257 l~~~P~~Rp-----~~~~~l~~~~~~~~~  280 (313)
T cd06633         257 LQKIPQERP-----ASAELLRHDFVRRDR  280 (313)
T ss_pred             ccCChhhCc-----CHHHHhcCcccCCCc
Confidence            999999999     899999999998755

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=308.19  Aligned_cols=240  Identities=28%  Similarity=0.440  Sum_probs=197.7

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++.+.||.|++|.||+|.++.     ++..||+|++..... .......+.+|+++++.++||||+++++++.+.+..|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL-----TGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC-----CCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6788999999999999999875     788999999876532 2233456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          192 LILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +||||+. ++|..++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.....+.          
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            9999995 68999887765  6899999999999999999999999999999999999998876322111          


Q ss_pred             -CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 014087          260 -RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  320 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------------  320 (431)
                       ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....                 
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             11223568899999988764 57889999999999999999999998776544433332210                 


Q ss_pred             ------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 ------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                  ......++.++.++|.+||+.||.+||     ++++++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI-----SAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHhcCCCC
Confidence                        011245778999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-39  Score=323.62  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=202.1

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  183 (431)
                      +.+..++|.+.++||+|+||.||+|++++......++.||||+++...  .....+.+.+|+.+|..+. |||||+++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            445566799999999999999999998754333466789999997643  2233456888999999997 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC-----------------------------------------------------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------------------------------------  210 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------  210 (431)
                      +...+.+|+||||+.+|+|.+++.+.+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999997532                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          211 ---------------------------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       211 ---------------------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                                                                   .+++..+..|+.||+.||.|||++||+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25667788999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.++.....+.             ......|+..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            99998765221110             1123456788999999999889999999999999999998 999998755544


Q ss_pred             HHHHH-Hhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRI-INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i-~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..... ..+ ....|..++.++.+||.+||..+|.+||     ++++|++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~  394 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP-----DFSQLVH  394 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            44333 332 3445677899999999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.7e-39  Score=299.74  Aligned_cols=242  Identities=27%  Similarity=0.491  Sum_probs=209.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+++++.     +++.+|+|.+...... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS-----DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC-----CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            48999999999999999998875     7889999999865432 33456677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      |+||||+++++|..++.+    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.....+        
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            999999999999998876    35689999999999999999999999999999999999999876532111        


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSLLK  336 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  336 (431)
                       .......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+..++...+..... ..+..++.+++++|.
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         155 KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             cCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence             122334688999999999999999999999999999999999999998888777777765543 355678899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +||..+|++||     +++++++||+.
T Consensus       235 ~~l~~~p~~Rp-----~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRP-----NCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCC-----CHHHHhcCCCC
Confidence            99999999999     89999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.5e-39  Score=302.60  Aligned_cols=237  Identities=22%  Similarity=0.359  Sum_probs=197.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.++||+|+||.||+|.+.      .+..+|+|.+.....    ..+.+.+|+.+++.++|+||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN------GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-   71 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec------CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence            44568999999999999999999865      456699999876432    1345788999999999999999998875 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      ....|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+..    
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~  151 (260)
T cd05070          72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL  151 (260)
T ss_pred             CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence            45689999999999999998764  358999999999999999999999999999999999999988753221111    


Q ss_pred             --------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          261 --------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                              .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ..+.+...+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd05070         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS  231 (260)
T ss_pred             ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence                    111234567999999998889999999999999999999 99999988877777777654 44566778999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+||.+||.+||++||     +++++..
T Consensus       232 ~~~li~~~l~~~p~~Rp-----t~~~l~~  255 (260)
T cd05070         232 LHELMLQCWKKDPEERP-----TFEYLQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCc-----CHHHHHH
Confidence            99999999999999999     7777753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-40  Score=319.60  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=197.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  185 (431)
                      +....|+++++||+||.+.||+|...      ..+.||+|.+.... .+...++-+.+|+.+|.+++ |.+||+|+++-.
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s------~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNS------DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecC------CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            45667999999999999999999864      45678887665443 35667888999999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc---------c
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE---------I  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~-~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~---------~  255 (431)
                      .++.+|+||||=+ .+|..+|.+.+.. +...+++|..|++.|+.++|..||||.||||.|+|+-.+--.         +
T Consensus       431 ~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  431 TDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAI  509 (677)
T ss_pred             cCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhccc
Confidence            9999999999854 4898999887653 436899999999999999999999999999999998654221         1


Q ss_pred             CCC---CCcccccCCCCCCchhhhccCC-----------CCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-
Q 014087          256 DES---SRSNSMCGTTEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE-  319 (431)
Q Consensus       256 ~~~---~~~~~~~Gt~~y~aPE~~~~~~-----------~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~~-  319 (431)
                      ..+   ....+.+||+.||+||.+....           .+.++||||||||||+|+.|++||.... ...-+..|... 
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~  589 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN  589 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence            111   1223568999999999997433           3578999999999999999999997532 33334445444 


Q ss_pred             -ccCCCCCCCH-HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 -KVKLPPFLTS-EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 -~~~~p~~~s~-~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                       .++||..-+. ++.++++.||.+||++|+     ++.++|+|||+..+
T Consensus       590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~-----si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  590 HEIEFPDIPENDELIDVMKCCLARDPKKRW-----SIPELLQHPFLQIQ  633 (677)
T ss_pred             ccccccCCCCchHHHHHHHHHHhcCcccCC-----CcHHHhcCcccccc
Confidence             3466654443 399999999999999999     88999999999763

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.4e-39  Score=310.19  Aligned_cols=246  Identities=21%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCC--CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +..++|.+.+.||+|+||.||+|++.+...  ......+|+|.++...  .......+..|+.+++.+ +||||++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            445679999999999999999998754321  1245679999987542  233456688899999999 69999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                      +...+.+|+||||+.+|+|.+++...                ..+++.++..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99999999999999999999999763                24788999999999999999999999999999999999


Q ss_pred             eCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014087          248 MDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQ  313 (431)
Q Consensus       248 l~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~  313 (431)
                      ++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9988763221111             111123457999999999999999999999999999999 99999988888888


Q ss_pred             HHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          314 QRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       314 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+.... ...+..++.++++||.+||..||++||     ++++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~  288 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP-----TFKQLVE  288 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            7776553 355677889999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.3e-39  Score=309.49  Aligned_cols=247  Identities=20%  Similarity=0.353  Sum_probs=204.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCC--CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (431)
                      .+...+|.+.+.||+|+||.||+|++....  ....+..+|+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            355668999999999999999999865322  12245679999987542  233456788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      ++......|+||||+.+|+|.+++.+.                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999999764                2467788999999999999999999999999999999


Q ss_pred             EeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 014087          247 LMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  312 (431)
Q Consensus       247 Ll~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~  312 (431)
                      |++.++.....+.             ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9998875322111             1122345678999999999899999999999999999998 8999998888888


Q ss_pred             HHHHHhcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRIINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+.+.... ...+..++.++++||.+||..+|++||     ++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~l~  291 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP-----TFKQLVE  291 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC-----CHHHHHH
Confidence            88776543 345667899999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-39  Score=316.25  Aligned_cols=245  Identities=22%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      .+|.+.+.||+|+||+||+|++..     +++.||||.+..... .......+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   78 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSE-----TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR   78 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecC-----CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence            469999999999999999999875     889999999875432 233345667899999999999999999988654  


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                         ..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.....+      
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence               35899999996 68999998888899999999999999999999999999999999999999887532111      


Q ss_pred             -----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 014087          259 -----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-------------  319 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------  319 (431)
                           .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+...             
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence                 11233467889999999875 46899999999999999999999999876543322222110             


Q ss_pred             ---------------cc---CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 ---------------KV---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 ---------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                     ..   ...+.++.++.+||++||+.||++||     +++++++||||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----s~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI-----TVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc-----CHHHHHcCcchhhh
Confidence                           00   01235789999999999999999999     89999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-39  Score=300.31  Aligned_cols=237  Identities=24%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||.|+||.||+|..       .++.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~-------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY-------RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ   71 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe-------cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence            3456899999999999999999986       467899999976532    45678889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      ....|+||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.+|.....+..    
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence            999999999999999999998765  68999999999999999999999999999999999999988763222111    


Q ss_pred             ----cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 014087          261 ----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL  334 (431)
Q Consensus       261 ----~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  334 (431)
                          .....++..|+|||.+....++.++|||||||++|||++ |+.||...+...+...+... ....+..+++++.++
T Consensus       152 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (256)
T cd05039         152 ASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV  231 (256)
T ss_pred             cccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence                112234567999999998889999999999999999997 99999988877777766554 344566789999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      |.+||..+|++||     ++++++.
T Consensus       232 i~~~l~~~p~~Rp-----~~~~l~~  251 (256)
T cd05039         232 MKDCWELDPAKRP-----TFKQLRE  251 (256)
T ss_pred             HHHHhccChhhCc-----CHHHHHH
Confidence            9999999999999     7788875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=300.67  Aligned_cols=238  Identities=23%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||.||+|..+      .++.+|||.+.....    ..+.+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~------~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN------GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc------CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            45678999999999999999999875      346799999875432    23457889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc---
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS---  261 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~---  261 (431)
                      ....++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++.....+...   
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence            999999999999999999997653  689999999999999999999999999999999999999987643322111   


Q ss_pred             ---------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          262 ---------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       262 ---------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                               ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+... ....+...+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05034         153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE  232 (261)
T ss_pred             ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence                     11223567999999999899999999999999999999 99999988877777777654 33456677899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+++.+||..+|++||     +++++.+
T Consensus       233 ~~~~i~~~l~~~p~~Rp-----~~~~l~~  256 (261)
T cd05034         233 LYDLMLQCWDKDPEERP-----TFEYLQS  256 (261)
T ss_pred             HHHHHHHHcccCcccCC-----CHHHHHH
Confidence            99999999999999999     7788764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-39  Score=317.40  Aligned_cols=245  Identities=26%  Similarity=0.390  Sum_probs=206.1

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (431)
                      +|++.+.||+|+||.||+|++..     +++.||+|.+.+.. ......+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR-----TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC-----CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            58999999999999999999875     78899999987643 12344567888999999999999999999998775  


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                         .+|+||||+.+ +|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+       
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          75 DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             cccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence               79999999984 8989998878899999999999999999999999999999999999999987632211       


Q ss_pred             -------CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Q 014087          259 -------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------  322 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------  322 (431)
                             .......|+..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence                   112344678899999999987 8899999999999999999999999988776665555432110        


Q ss_pred             -----------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          323 -----------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       323 -----------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                                             ..+.++.++.+||.+||++||.+||     ++++++.||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~~  296 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-----TADEALAHPYLAQLH  296 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC-----CHHHHHhCccHHhhc
Confidence                                   1123678899999999999999999     899999999998743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-38  Score=308.93  Aligned_cols=245  Identities=22%  Similarity=0.352  Sum_probs=205.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ..|...+.||+|+||.||++++..     ++..+|+|++.............+.+|+++++.++||||+++++++.++..
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            348889999999999999999875     788999999876544344455678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------Cc
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------RS  261 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------~~  261 (431)
                      .|+||||+.| +|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++.....+.       ..
T Consensus       100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9999999975 67676654 466899999999999999999999999999999999999998876332211       22


Q ss_pred             ccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CC-CCCCCHHHHHHHH
Q 014087          262 NSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL-PPFLTSEAHSLLK  336 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~li~  336 (431)
                      ....|+..|+|||++.   ...++.++|||||||++|||++|+.||...+.......+..... .. +..++..+++||.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  258 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  258 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence            3456889999999984   45688999999999999999999999988776666666655432 22 3457889999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +||+.+|.+||     +++++++|+|+..
T Consensus       259 ~~l~~~p~~Rp-----t~~~il~~~~~~~  282 (317)
T cd06635         259 SCLQKIPQDRP-----TSEELLKHMFVLR  282 (317)
T ss_pred             HHccCCcccCc-----CHHHHHhChhhhc
Confidence            99999999999     8999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-39  Score=305.06  Aligned_cols=239  Identities=29%  Similarity=0.480  Sum_probs=196.3

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  192 (431)
                      ++.+.||.|.||.||+|.++. .....+..|+||+++...  .....+.+.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEecccc--ccccceeeeecccccccccccccccccccccccccccc
Confidence            467899999999999999984 223367889999995532  33346778899999999999999999999998888999


Q ss_pred             EEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------
Q 014087          193 ILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------  259 (431)
Q Consensus       193 v~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------  259 (431)
                      ||||+++|+|.+++...  ..+++.++..|+.||+.||.|||+++|+|+||+++|||++.++.....+.           
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999987  67999999999999999999999999999999999999999875321111           


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLL  335 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  335 (431)
                        ......+...|+|||.+....++.++||||||+++|||++ |+.||...+..++...+.... ...+..++..+.++|
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence              1122345678999999999989999999999999999999 789999988888888875553 345667899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHh
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+||..||++||     ++++|++
T Consensus       239 ~~C~~~~p~~RP-----s~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRP-----SFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS-------HHHHHH
T ss_pred             HHHcCCChhhCc-----CHHHHHh
Confidence            999999999999     8888875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-39  Score=317.52  Aligned_cols=248  Identities=21%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++.+.||+|+||+||+|.+.+.....+++.||||+++...  .......+.+|+.+|..+ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            34567899999999999999999997765554578899999997543  233356678899999999 689999999987


Q ss_pred             EeC-CEEEEEEeccCCCChHHHHHHc------------------------------------------------------
Q 014087          185 QTR-SKLYLILDFINGGHLFFHLYRQ------------------------------------------------------  209 (431)
Q Consensus       185 ~~~-~~~~lv~E~~~gg~L~~~l~~~------------------------------------------------------  209 (431)
                      ... ..+++||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 5689999999999999988653                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------------ccc
Q 014087          210 -------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------------SNS  263 (431)
Q Consensus       210 -------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------------~~~  263 (431)
                                   ..+++.++..++.||+.||.|||++||+||||||+|||++.++.....+..             ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         136778889999999999999999999999999999999987753221111             112


Q ss_pred             ccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhc-ccCCCCCCCHHHHHHHHhhcc
Q 014087          264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ-KLQQRIINE-KVKLPPFLTSEAHSLLKGLLH  340 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~  340 (431)
                      ..++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+..+ ....|..+++++.+++.+||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            234667999999999999999999999999999997 99999765433 333333332 345566788999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHhC
Q 014087          341 KDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .||++||     ++.+|++|
T Consensus       321 ~~p~~Rp-----s~~eil~~  335 (343)
T cd05103         321 GEPSQRP-----TFSELVEH  335 (343)
T ss_pred             CChhhCc-----CHHHHHHH
Confidence            9999999     88999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=324.38  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=210.4

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |.-++.||.|+||.||-|++..     +.++||||.|.-..-...+.-+.+..|+..|+.++|||+|.+.++|-.+...|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~-----n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC-----ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            7778899999999999999886     88999999997654444445567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------CCccc
Q 014087          192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------SRSNS  263 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------~~~~~  263 (431)
                      ||||||-| +-.+++.- .+++.+.++..|+.+.+.||.|||+.+.||||||..|||+++.|.+...+       ....+
T Consensus       103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns  181 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS  181 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence            99999976 56666653 35799999999999999999999999999999999999999998754433       34578


Q ss_pred             ccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCC-CCCCHHHHHHHHhh
Q 014087          264 MCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLP-PFLTSEAHSLLKGL  338 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p-~~~s~~~~~li~~~  338 (431)
                      ++|||+|||||++.   .+.|+-++|||||||+..||.-.++|+-..+......-|-.+ .+.++ ..+|..+..||..|
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C  261 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  261 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence            89999999999997   467999999999999999999999999888877776666554 44444 45889999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |++-|.+||     +.++++.|+|...
T Consensus       262 LqKipqeRp-----tse~ll~H~fv~R  283 (948)
T KOG0577|consen  262 LQKIPQERP-----TSEELLKHRFVLR  283 (948)
T ss_pred             HhhCcccCC-----cHHHHhhcchhcc
Confidence            999999999     7899999999864

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=334.81  Aligned_cols=238  Identities=24%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  184 (431)
                      .+..-++++.+.|.+|||+.||+|+...     .+..||+|.+-..   ++..++.+++|+++|+.|. |+|||.+++..
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~-----~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVK-----GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecC-----CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            3445578999999999999999999875     5588999987543   5677888999999999996 99999999932


Q ss_pred             -Ee------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCC
Q 014087          185 -QT------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH  253 (431)
Q Consensus       185 -~~------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~  253 (431)
                       ..      .-.++|+||||.||.|-+++..+  ..|+|.++..|++|+++|+.+||...  |||||||-|||||..+|+
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence             21      13588999999999999999854  56999999999999999999999998  999999999999999996


Q ss_pred             ccCCCCCcc--------------------cccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH
Q 014087          254 EIDESSRSN--------------------SMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ  310 (431)
Q Consensus       254 ~~~~~~~~~--------------------~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~  310 (431)
                      ...-+..+.                    ...-|+.|+|||++.   +.+.++|+|||+|||+||-|+....||.+..  
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--  262 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--  262 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--
Confidence            332221111                    113489999999986   6788999999999999999999999997643  


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          311 KLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       311 ~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                        .-.|+++++.+|+  .++..+++||+.||+.||++||     ++-+++.+
T Consensus       263 --~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP-----nI~Qv~~~  307 (738)
T KOG1989|consen  263 --KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP-----NIYQVLEE  307 (738)
T ss_pred             --ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCC-----CHHHHHHH
Confidence              3468888898886  6899999999999999999999     78777653

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.7e-39  Score=303.65  Aligned_cols=237  Identities=23%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ..+|+++++||.|+||.||+|.++      .++.+|+|++.....   .....+..|+.+++.++|+||+++++++.+..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~------~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWK------NRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEec------CCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            346999999999999999999986      467799999876532   23456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      ..|+||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.....+.       
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999999999763  46899999999999999999999999999999999999998875322111       


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  333 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  333 (431)
                          ......++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..++...+... ....+..++.++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK  235 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence                1112235678999999998899999999999999999998 89999988877777777654 34556778999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +|.+||+.||.+||     ++++|.+
T Consensus       236 ~i~~~l~~~p~~Rp-----t~~~l~~  256 (261)
T cd05148         236 IMLECWAAEPEDRP-----SFKALRE  256 (261)
T ss_pred             HHHHHcCCCchhCc-----CHHHHHH
Confidence            99999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-38  Score=301.47  Aligned_cols=237  Identities=24%  Similarity=0.365  Sum_probs=195.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.++||+|+||.||+|++..     + ..+|+|++++...    ..+.+.+|+++++.++||||+++++.+. 
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNG-----T-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-   71 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecC-----C-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-
Confidence            445679999999999999999998753     3 4599999875432    2245788999999999999999998875 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      ....|+||||+.+|+|.+++.+.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+..    
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence            45689999999999999999764  357999999999999999999999999999999999999988763221111    


Q ss_pred             --------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          261 --------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                              .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+... ....+..++.+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05071         152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  231 (262)
T ss_pred             ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence                    112335667999999998899999999999999999999 99999888777777766544 23445678899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+||.+||++||++||     ++++++.
T Consensus       232 l~~li~~~l~~~p~~Rp-----~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERP-----TFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCC-----CHHHHHH
Confidence            99999999999999999     6777654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-39  Score=302.94  Aligned_cols=240  Identities=20%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE--
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK--  189 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--  189 (431)
                      |++.+.||+|+||.||+|....  +..++..+|+|.++.+.. .....+.+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQ--DDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEec--CCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            5788999999999999998764  112457899999876432 23445678899999999999999999998866554  


Q ss_pred             ----EEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          190 ----LYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       190 ----~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                          .++||||+++|+|..++...      ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+.
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                89999999999999888542      35899999999999999999999999999999999999998875322211


Q ss_pred             C-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCC
Q 014087          260 R-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  324 (431)
Q Consensus       260 ~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p  324 (431)
                      .             .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+... ....|
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            1             111234568999999998999999999999999999999 99999988877777777654 44567


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..++.++.++|.+||+.||++||     ++.+++.
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp-----~~~e~~~  267 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRP-----TFTKLRE  267 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            78999999999999999999999     7888876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-38  Score=298.99  Aligned_cols=236  Identities=23%  Similarity=0.402  Sum_probs=198.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE-E
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-Q  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~  185 (431)
                      +...+|++.+.||+|+||.||++..       .+..+|+|.++...     ..+.+.+|+.+++.++|+||+++++++ .
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~-------~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY-------RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE   70 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE-------cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence            3456799999999999999999976       35679999886432     245678899999999999999999875 4


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      .+...|+||||+++++|.+++.+.+  .+++..+..++.||+.||.|||++||+||||||+||+++.++.....+.    
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence            5667999999999999999998654  4889999999999999999999999999999999999998886332221    


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  333 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  333 (431)
                          ......++..|+|||++.+..++.++|||||||++|||++ |+.||...+...+...+..+ ....+..++..+.+
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05082         151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD  230 (256)
T ss_pred             eccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence                1122345668999999999999999999999999999998 99999988877777776554 33456678999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +|.+||+.||++||     +++++++
T Consensus       231 li~~~l~~~p~~Rp-----t~~~l~~  251 (256)
T cd05082         231 VMKQCWHLDAATRP-----SFLQLRE  251 (256)
T ss_pred             HHHHHhcCChhhCc-----CHHHHHH
Confidence            99999999999999     7888865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-38  Score=303.18  Aligned_cols=244  Identities=20%  Similarity=0.309  Sum_probs=198.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +...+|+++++||+|+||+||+|++..... .....||+|+++...  .......+.+|+.+++.++||||+++++++..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGE-NVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCC-ccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            345679999999999999999999765111 012358999987543  23344668889999999999999999998875


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS----  261 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~----  261 (431)
                      . ..++++||+++|+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+...    
T Consensus        81 ~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            4 578999999999999999774 5699999999999999999999999999999999999998877633221111    


Q ss_pred             ---------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          262 ---------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       262 ---------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                               ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+... ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence                     11224568999999999999999999999999999998 99999887776666655543 33455678999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++|.+||..||++||     ++.++++
T Consensus       240 ~~~li~~~l~~dp~~Rp-----~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRP-----RFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.9e-40  Score=334.14  Aligned_cols=246  Identities=23%  Similarity=0.390  Sum_probs=213.0

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+...+.++.+.||+|+||+||+|+..+..-+.....||||.++...  +.+....|++|+++|..++|||||+|+|++.
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            35567788899999999999999998776655577889999998764  3446678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      .++.+|+|+|||..|||.++|+...              .++..+...|+.||+.|++||-++.+|||||...|+||.++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            9999999999999999999997532              27888999999999999999999999999999999999988


Q ss_pred             CCccCCCCCc---------ccc----cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014087          252 GHEIDESSRS---------NSM----CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII  317 (431)
Q Consensus       252 g~~~~~~~~~---------~~~----~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~  317 (431)
                      -.+...+...         ..+    .-...||+||.|....++.++||||+||+|||+++ |+.||.+.+.++.++.|.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            6533222111         111    12568999999999999999999999999999999 999999999999999999


Q ss_pred             hccc-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHH
Q 014087          318 NEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  358 (431)
Q Consensus       318 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  358 (431)
                      .+++ .-|+.++.++.+||..||+.+|++||     ++.||-
T Consensus       720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP-----sF~eI~  756 (774)
T KOG1026|consen  720 AGQLLSCPENCPTEVYSLMLECWNENPKRRP-----SFKEIH  756 (774)
T ss_pred             cCCcccCCCCCCHHHHHHHHHHhhcCcccCC-----CHHHHH
Confidence            8765 56789999999999999999999999     677764

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.8e-39  Score=314.09  Aligned_cols=246  Identities=26%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             CCceE-EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhh-----------HHHHHHHHHHHHHhcCCCCc
Q 014087          110 GDFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------HVDYMKAERDILTKVTHPFI  177 (431)
Q Consensus       110 ~~y~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~hpnI  177 (431)
                      ++|.. .+.||+|+||+||+|.++.     +++.||||+++........           ....+.+|+++++.++|+||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTL-----TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECC-----CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            35654 5779999999999999875     7889999998764332210           11246789999999999999


Q ss_pred             ceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                      +++++++..++..|+||||+. |+|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.....
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            999999999999999999997 5899999888889999999999999999999999999999999999999988753211


Q ss_pred             CC-------------------------CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 014087          258 SS-------------------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQK  311 (431)
Q Consensus       258 ~~-------------------------~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~  311 (431)
                      +.                         ......++..|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            11                         11123467889999999764 46899999999999999999999999887766


Q ss_pred             HHHHHHhccc----------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          312 LQQRIINEKV----------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       312 ~~~~i~~~~~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ....+.....                            ......+.++.++|.+||..||++|+     ++++++.|+||
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~~~~~  316 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI-----SAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc-----CHHHHhcCccc
Confidence            5555432100                            00123578899999999999999999     89999999999


Q ss_pred             CCC
Q 014087          364 RSI  366 (431)
Q Consensus       364 ~~~  366 (431)
                      ++.
T Consensus       317 ~~~  319 (335)
T PTZ00024        317 KSD  319 (335)
T ss_pred             CCC
Confidence            864

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=310.03  Aligned_cols=244  Identities=27%  Similarity=0.426  Sum_probs=192.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--C
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (431)
                      +|++.+.||+|+||.||+|.++..   ..++.||+|.+.............+.+|+.+++.++||||+++++++.+.  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence            489999999999999999998641   15789999999875433344456677899999999999999999999988  8


Q ss_pred             EEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC----CCCccCCC-
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHEIDES-  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~----~g~~~~~~-  258 (431)
                      .+|+||||+.+ +|.+.+...     ..+++..++.++.||+.||.|||++||+||||||+|||++.    +|.....+ 
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            89999999975 666666432     36899999999999999999999999999999999999998    54422111 


Q ss_pred             -------------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH---------HHHH
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQK---------LQQR  315 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~---------~~~~  315 (431)
                                   ......+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....         ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence                         11223467889999998876 457899999999999999999999997643321         0111


Q ss_pred             HHh--------------------------cccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHH
Q 014087          316 IIN--------------------------EKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  358 (431)
Q Consensus       316 i~~--------------------------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  358 (431)
                      +..                          ....++           ...+.++.++|.+||+.||++||     ++++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~eil  311 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI-----TAEEAL  311 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc-----CHHHHh
Confidence            100                          001111           14677899999999999999999     899999


Q ss_pred             hCCCC
Q 014087          359 HHKWF  363 (431)
Q Consensus       359 ~h~~f  363 (431)
                      .||||
T Consensus       312 ~~~~f  316 (316)
T cd07842         312 EHPYF  316 (316)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-38  Score=301.30  Aligned_cols=242  Identities=23%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++...  ..+..+|+|.++...  .......+.+|+.+++.++||||+++++++.+++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            457999999999999999999876411  134579999987543  2334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS------  261 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~------  261 (431)
                      ..|+||||+++++|.+++.+. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.....+...      
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999999875 4689999999999999999999999999999999999999887632211110      


Q ss_pred             --------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          262 --------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       262 --------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                              ....++..|+|||.+.+..++.++|+|||||++|||++ |..||...+..+....+... ..+.+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence                    11123467999999999899999999999999999887 99999887777777776654 233445678999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+++.+||+++|.+||     +++++++
T Consensus       239 ~~li~~~l~~~p~~Rp-----~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERP-----KFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCC-----CHHHHHH
Confidence            9999999999999999     7778765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-38  Score=294.84  Aligned_cols=239  Identities=31%  Similarity=0.525  Sum_probs=203.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|++|.||++.+..     +++.+++|++.....   .....+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR-----TGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC-----CCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            58899999999999999999875     788999999976542   3456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------CC-
Q 014087          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------SR-  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------~~-  260 (431)
                      ++++||+.|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.....+        .. 
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999999999998876 5799999999999999999999999999999999999999887522111        11 


Q ss_pred             -cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCC--CCCHHHHHHHH
Q 014087          261 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPP--FLTSEAHSLLK  336 (431)
Q Consensus       261 -~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~~li~  336 (431)
                       .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... ....+.  .++.++.++|.
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence             24567889999999999888999999999999999999999999877544444333322 222332  34899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKW  362 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~  362 (431)
                      +||..||++||     ++++++.|||
T Consensus       233 ~~l~~~p~~R~-----t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRP-----TAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCC-----CHHHHhcCCC
Confidence            99999999999     8999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-39  Score=304.71  Aligned_cols=235  Identities=19%  Similarity=0.307  Sum_probs=190.3

Q ss_pred             eeecccCceEEEEEEEcCCCCC--CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  193 (431)
                      +.||+|+||.||+|.++.....  .....+|+|.+....   ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            4699999999999988652211  123458888775432   33455678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc---------cCC------
Q 014087          194 LDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE---------IDE------  257 (431)
Q Consensus       194 ~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~---------~~~------  257 (431)
                      |||+.+|+|..++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.++..         +..      
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 58999999999999999999999999999999999999887642         111      


Q ss_pred             CCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                      ........|+..|+|||++.+ ..++.++|||||||++|||++| ..||...+.... ..+......+|...+.++.+||
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  236 (258)
T cd05078         158 VLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPAPKWTELANLI  236 (258)
T ss_pred             cCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCCCCcHHHHHHH
Confidence            011223568899999999986 4579999999999999999998 577766554443 3344456677777889999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHh
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+||+.||++||     ++++|++
T Consensus       237 ~~~l~~~p~~Rp-----s~~~il~  255 (258)
T cd05078         237 NQCMDYEPDFRP-----SFRAIIR  255 (258)
T ss_pred             HHHhccChhhCC-----CHHHHHH
Confidence            999999999999     8899876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=313.63  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=196.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++.+.||+|+||.||++.+..     +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcC-----CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            4679999999999999999998875     788999999876432 222345677899999999999999999988643 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                           ...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.....+    
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                 3478888887 7789777754 4689999999999999999999999999999999999999987633211    


Q ss_pred             ----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------
Q 014087          259 ----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-------------  320 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------  320 (431)
                          .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+....             
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         168 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence                12234568899999999876 568899999999999999999999998766544433332110             


Q ss_pred             ----------cCCC--------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          321 ----------VKLP--------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       321 ----------~~~p--------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                ...|        ...++++++||.+||+.||.+|+     ++.+++.||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~f~~  305 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQ  305 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC-----CHHHHhcChhhhh
Confidence                      0011        13578899999999999999999     8899999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-38  Score=300.46  Aligned_cols=243  Identities=22%  Similarity=0.311  Sum_probs=200.1

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|+..+.||+|+||.||+|+.+..  +.....+|+|.++...  .....+.+..|+++++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMP--GRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF   78 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecC--CCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence            445799999999999999999998641  1134479999986543  223345688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCcc----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN----  262 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~~----  262 (431)
                      +..|+||||+.+++|.+++... +.+++.++..++.|++.||.|||+.||+||||||+||+++.++.....+....    
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999999998764 57899999999999999999999999999999999999998875322111100    


Q ss_pred             ----------cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          263 ----------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       263 ----------~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                                ....+..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ....+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence                      1112356999999998889999999999999999998 99999887777777777654 22334567899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+|+.+||..+|++||     ++++|++
T Consensus       239 ~~~li~~c~~~~p~~Rp-----~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRP-----RFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            99999999999999999     7788865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.3e-39  Score=311.28  Aligned_cols=235  Identities=22%  Similarity=0.369  Sum_probs=187.4

Q ss_pred             CceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEeccCCCC
Q 014087          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (431)
Q Consensus       122 ~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  201 (431)
                      ++|.||.++.+.     +++.||||++..... .....+.+..|+.+++.++|+||+++++++.+.+..|++|||+.+|+
T Consensus        12 ~~~~v~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216          12 DLMIVHLAKHKP-----TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             CCceEEEEEecC-----CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            445566666554     788999999987532 34456789999999999999999999999999999999999999999


Q ss_pred             hHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------------------CCc
Q 014087          202 LFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------------------SRS  261 (431)
Q Consensus       202 L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------------------~~~  261 (431)
                      |.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+                  ...
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            99999864  4589999999999999999999999999999999999999877522111                  111


Q ss_pred             ccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcc------------------
Q 014087          262 NSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINEK------------------  320 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~-~~i~~~~------------------  320 (431)
                      ....++..|+|||++..  ..++.++|||||||++|||++|+.||......... +.+....                  
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence            23456788999999976  46889999999999999999999999875543322 2221100                  


Q ss_pred             ---------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          321 ---------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       321 ---------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                                     ...+..++.++.+||.+||+.||++||     ++++++.||||+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~p~~~~~~  302 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP-----SASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc-----CHHHHhcCchHhhhc
Confidence                           001122456889999999999999999     899999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-38  Score=301.40  Aligned_cols=242  Identities=23%  Similarity=0.321  Sum_probs=200.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|.++...  ..+..||||++.+..  .......+..|+.+++.++||||+++++++.++.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCC--CCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            456999999999999999999987521  134579999987542  2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS------  261 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~------  261 (431)
                      ..++||||+.+|+|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++.++.....+...      
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999999998764 5689999999999999999999999999999999999998876532211110      


Q ss_pred             -------cccc---CCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          262 -------NSMC---GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       262 -------~~~~---Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                             ....   ++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+... ..+.+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT  238 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence                   0011   1347999999999999999999999999999887 99999888777777776543 3344567889


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+++.+||..+|.+||     ++++|+.
T Consensus       239 ~~~~li~~~l~~~p~~Rp-----~~~~i~~  263 (269)
T cd05065         239 ALHQLMLDCWQKDRNARP-----KFGQIVS  263 (269)
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=292.84  Aligned_cols=242  Identities=26%  Similarity=0.409  Sum_probs=196.8

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..++.++|++.++||+|||+-||+++...     +++.||+|.+....   .+..+..++|++..++++||||++++++.
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s-----~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLS-----TGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccC-----cccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            45677899999999999999999999765     88999999987654   44567788999999999999999997765


Q ss_pred             Ee-----CCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCC
Q 014087          185 QT-----RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH  253 (431)
Q Consensus       185 ~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~  253 (431)
                      ..     ....||+++|...|+|.+.+.+.    ..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            43     34599999999999999998753    36999999999999999999999999  999999999999999776


Q ss_pred             ccCCCCCcccc--------------------cCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCC--
Q 014087          254 EIDESSRSNSM--------------------CGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN--  308 (431)
Q Consensus       254 ~~~~~~~~~~~--------------------~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~--  308 (431)
                      .+..+..+.+.                    .-|..|.|||.+.-   ...+.++|||||||+||+|+.|..||...-  
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            43322221111                    13789999999974   445899999999999999999999995311  


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          309 RQKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       309 ~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+.-.+.++++.+|.  .+|+.+.+||+.||+.||.+||     ++.+++.
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP-----~i~~ll~  295 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP-----TIPELLS  295 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC-----CHHHHHH
Confidence            11122234455666664  4899999999999999999999     8888876

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-38  Score=298.02  Aligned_cols=237  Identities=21%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|++.+.||+|+||.||++.+.      .+..+|+|.+......    ...+.+|+++++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL------EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTER   71 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe------CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence            3457999999999999999999875      3567999988754332    24577899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR------  260 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~------  260 (431)
                      ...|+||||+.+++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.....+..      
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999999999999998764 568999999999999999999999999999999999999987753221111      


Q ss_pred             ------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHH
Q 014087          261 ------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  332 (431)
Q Consensus       261 ------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  332 (431)
                            .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......+.+.+..+ ....|...+.++.
T Consensus       152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd05112         152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY  231 (256)
T ss_pred             cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence                  112234568999999998889999999999999999998 99999988877777777654 3334566789999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +|+.+||+.+|++||     +++++++
T Consensus       232 ~l~~~~l~~~p~~Rp-----~~~~~l~  253 (256)
T cd05112         232 ELMQHCWKERPEDRP-----SFSLLLH  253 (256)
T ss_pred             HHHHHHcccChhhCC-----CHHHHHH
Confidence            999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=298.20  Aligned_cols=234  Identities=18%  Similarity=0.279  Sum_probs=194.6

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      ++||+|+||.||+|.+....  ..+..+|+|.+......  ...+.+.+|+.+++.++|+||+++++++. ....++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~--~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS--GKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccC--CCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            47999999999999876421  13478999998866532  34567888999999999999999999876 456899999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------------c
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------------S  261 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------------~  261 (431)
                      |+.+|+|.+++.+...+++..+..++.|++.||.|||.+||+||||||+|||++.++.....+..              .
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999999999988889999999999999999999999999999999999999998863221110              0


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhc
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  339 (431)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..++...+... ....+..++..++++|.+||
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            11123457999999999999999999999999999998 99999888877777766554 33556778999999999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHh
Q 014087          340 HKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..||++||     ++.++.+
T Consensus       236 ~~~p~~Rp-----~~~~l~~  250 (257)
T cd05060         236 KYRPEDRP-----TFSELES  250 (257)
T ss_pred             cCChhhCc-----CHHHHHH
Confidence            99999999     7777765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.8e-39  Score=306.68  Aligned_cols=241  Identities=26%  Similarity=0.450  Sum_probs=202.1

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |....+||+|+||.||++..+.     +++.+|+|.+....   ......+.+|+.+++.++|+||+++++.+...+..|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   93 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKS-----SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW   93 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcC-----CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence            4445789999999999999876     78899999875432   233456888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------CC
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------SR  260 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~~  260 (431)
                      +||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.....+           ..
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~  172 (292)
T cd06657          94 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  172 (292)
T ss_pred             EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc
Confidence            99999999999887654 5689999999999999999999999999999999999999887632211           11


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCHHHHHHHHh
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~  337 (431)
                      .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+....   ......++.++.++|.+
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence            223568899999999988888999999999999999999999998877666555554322   12234578999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||..||.+|+     ++.+++.|+||...
T Consensus       253 ~l~~~P~~R~-----~~~~ll~~~~~~~~  276 (292)
T cd06657         253 LLVRDPAQRA-----TAAELLKHPFLAKA  276 (292)
T ss_pred             HHhCCcccCc-----CHHHHhcChHHhcc
Confidence            9999999999     89999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.9e-39  Score=301.80  Aligned_cols=243  Identities=28%  Similarity=0.470  Sum_probs=200.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      +|.+.+.||+|+||.||++++..     ++..+++|+++.....  .......+..|+.+++.++||||+++++++.+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK-----AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC-----CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence            48999999999999999999875     4445666665432211  1223345667999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-------
Q 014087          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-------  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-------  257 (431)
                      ..++||||+++++|.+++..    ...+++.+++.++.|++.||.|||++|++|+||||+||+++.+...+..       
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~  155 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLL  155 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeec
Confidence            99999999999999888864    3568999999999999999999999999999999999999864321111       


Q ss_pred             ---CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHH
Q 014087          258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHS  333 (431)
Q Consensus       258 ---~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~  333 (431)
                         ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.... ...+..++.++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS  235 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHH
Confidence               111224568889999999998889999999999999999999999998877766666665543 3445678899999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +|.+||..||++||     +++++++||||
T Consensus       236 li~~~l~~~p~~Rp-----~~~~il~~~~~  260 (260)
T cd08222         236 IMQSMLNKDPSLRP-----SAAEILRNPFI  260 (260)
T ss_pred             HHHHHhcCChhhCc-----CHHHHhhCCCC
Confidence            99999999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=354.82  Aligned_cols=244  Identities=30%  Similarity=0.511  Sum_probs=210.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      ++.-...||.|.||.||.|....     +|...|||.++-.... ......+.+|..+|..++|||+|++|++-...+.+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~-----tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLD-----TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCC-----ccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            45567789999999999998875     9999999998776654 45566788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------------
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------------  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------------  258 (431)
                      +|.||||+||+|.+.+...+..+|-..+-|..|++.||.|||+.|||||||||+||||+.+|-....+            
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            99999999999999999888889999999999999999999999999999999999999998522111            


Q ss_pred             ---CCcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHH-HhcccCCCCCCCHH
Q 014087          259 ---SRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRI-INEKVKLPPFLTSE  330 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i-~~~~~~~p~~~s~~  330 (431)
                         .......||+.|||||++.+   ++...+.||||||||+.||+||+.||...+ ...+...+ ....+.+|..++.+
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence               12235679999999999985   567789999999999999999999997643 33444444 45577899999999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .++||.+||+.||++|.     ++.||+.|.|-+.
T Consensus      1470 g~dFle~Cl~~dP~~Rw-----~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRW-----TASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHHHHHhcCchhhh-----HHHHHHHhhcccc
Confidence            99999999999999998     8889999998765

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-38  Score=301.62  Aligned_cols=237  Identities=19%  Similarity=0.317  Sum_probs=194.3

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCC--cEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSD--GIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      |.+.++||+|+||.||+|++..     ++  ..+|+|.++.... .....+.+.+|+.+++.++|+||+++++.+...  
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~-----~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQ-----DDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE   74 (272)
T ss_pred             CccccccCcccCceEEEeEEcc-----CCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence            3567899999999999999865     33  3689998876432 344466788899999999999999999876432  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                          ...++||||+.+|+|..++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....
T Consensus        75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence                2578999999999998887432      348899999999999999999999999999999999999988753221


Q ss_pred             CCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cC
Q 014087          258 SSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VK  322 (431)
Q Consensus       258 ~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~  322 (431)
                      +..             .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+....++...+..+. ..
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  234 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK  234 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            111             112245678999999999999999999999999999999 899999888777777776653 35


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+..++..+.++|.+||+.||++||     ++++|++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~l~~  266 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRP-----SFETLRC  266 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            5677889999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-39  Score=315.72  Aligned_cols=247  Identities=25%  Similarity=0.394  Sum_probs=198.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      .+|.+.+.||+|+||.||+|.++.     +++.||+|++.+... .......+.+|+.+++.++||||+++++++...  
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKR-----TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCC-----CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            579999999999999999999875     788999999876432 223345677899999999999999999998754  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                          ..+|+|+||+.+ +|..++  ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.....+     
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence                357999999964 666554  34689999999999999999999999999999999999999987632211     


Q ss_pred             ---CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Q 014087          259 ---SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------------  320 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------  320 (431)
                         .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+....              
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         166 HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence               12233567889999999876 468899999999999999999999998876555444333210              


Q ss_pred             ---------cCC--------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          321 ---------VKL--------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       321 ---------~~~--------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                               ...        .+..+.++.+||.+||+.||++||     ++++++.||||+.+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL-----TATEALEHPYFDSFRDAD  307 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc-----CHHHHhcCcchhhccccc
Confidence                     000        124678899999999999999999     899999999999876533

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-38  Score=313.61  Aligned_cols=245  Identities=27%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|++..     +++.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTK-----TGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECC-----CCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            4579999999999999999999876     788999999865422 2334456778999999999999999998887665


Q ss_pred             E------EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          189 K------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       189 ~------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      .      +|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.....+    
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence            4      99999999 6699888865 5699999999999999999999999999999999999999987633221    


Q ss_pred             ----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----------
Q 014087          259 ----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----------  322 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  322 (431)
                          .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+......           
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         166 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             ccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence                12234567889999999875 46789999999999999999999999887766555554332100           


Q ss_pred             --------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          323 --------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       323 --------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                          ....++.++.+||.+||..||++||     ++++|+.||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp-----t~~ell~h~~~~~~  304 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI-----TAAEALAHPYLAEY  304 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC-----CHHHHhcCCCcccc
Confidence                                1123588999999999999999999     89999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-38  Score=310.68  Aligned_cols=249  Identities=20%  Similarity=0.350  Sum_probs=204.3

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCC--CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceee
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (431)
                      +.+...+|++++.||+|+||.||+|++......  .....+|+|+++...  .....+.+.+|+++++.+ +||||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            344455799999999999999999987643221  133468999887532  233456788899999999 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      +++...+.+|+||||+.+|+|.+++.+..                .++..++..++.||+.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999997642                36778889999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999988763221111             111223567999999999999999999999999999998 999999988888


Q ss_pred             HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          312 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       312 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ....+... ....+..++.++.+||.+||+.+|.+||     ++++|+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP-----TFKQLVED  289 (334)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc-----CHHHHHHH
Confidence            87777654 3345667889999999999999999999     88888874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=305.68  Aligned_cols=245  Identities=20%  Similarity=0.321  Sum_probs=196.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCC---------CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcc
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV  178 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv  178 (431)
                      ...+|++.+.||+|+||.||+|++.....         ......||+|.++...  .....+.+.+|+++++.++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            34579999999999999999998754211         1133469999987643  233456788999999999999999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCChHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       179 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      ++++++...+..|+||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986542            368889999999999999999999999999999999


Q ss_pred             EeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh--CCCCCCCCCHHH
Q 014087          247 LMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQK  311 (431)
Q Consensus       247 Ll~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~Pf~~~~~~~  311 (431)
                      |++.++.....+..             .....++..|+|||++.+..++.++|||||||++|||++  |..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99988653221111             112234678999999998899999999999999999988  778998776666


Q ss_pred             HHHHHHh--------cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRIIN--------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ....+..        .....++.++..+++||.+||..||++||     ++++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP-----TFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            5554422        11223456789999999999999999999     7888864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-38  Score=304.15  Aligned_cols=245  Identities=21%  Similarity=0.343  Sum_probs=195.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCC-----------CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF  176 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  176 (431)
                      ..++|++.+.||+|+||.||+|++....           ...+...+|+|++....  .......+.+|+.+|+.++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence            3457999999999999999998765321           11245579999987542  2334567889999999999999


Q ss_pred             cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      |+++++++...+..|+||||+.+|+|.+++....           .+++..+..++.||+.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987643           36678899999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh--CCCCCCCCCHH
Q 014087          246 ILMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ  310 (431)
Q Consensus       246 ILl~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~Pf~~~~~~  310 (431)
                      ||++.++.....+..             .....++..|+|||+..+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999987763322111             111233578999999988889999999999999999998  88999876665


Q ss_pred             HHHHHHHh--------cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          311 KLQQRIIN--------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       311 ~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.......        .....+..++..+.+|+.+||+.||.+||     ++++|.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP-----SFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            55443311        12233456789999999999999999999     7777754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-38  Score=301.78  Aligned_cols=244  Identities=18%  Similarity=0.268  Sum_probs=195.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|.+...... ....+++|.+....  .......+..|+.+++.++||||+++++++. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCc-eeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            3456799999999999999999998651110 12247778775322  2334456778888999999999999999875 


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      ....++++||+.+|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.....+.      
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            45678999999999999999764 57899999999999999999999999999999999999998875322111      


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHH
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSE  330 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~  330 (431)
                             ......|+..|+|||.+.+..++.++|||||||++|||++ |+.||.+.....+.+.+..+. ...+...+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence                   1123346778999999998899999999999999999998 999998877766655554433 3345567889


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+++.+||..||++||     +++++++
T Consensus       240 ~~~li~~c~~~~p~~Rp-----s~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRP-----TFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            99999999999999999     7888865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.4e-39  Score=308.54  Aligned_cols=243  Identities=27%  Similarity=0.402  Sum_probs=193.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++.++||+|+||.||+|.++.     +++.+|+|++...... ......+.+|+++++.++||||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK-----TGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            4689999999999999999999876     7889999998764322 22223466899999999999999999887543 


Q ss_pred             -------CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          188 -------SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       188 -------~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                             ..+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence                   357999999976 67666654 357999999999999999999999999999999999999999876321110


Q ss_pred             ----------------------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014087          260 ----------------------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI  316 (431)
Q Consensus       260 ----------------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i  316 (431)
                                            ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                  1123356888999998875 45789999999999999999999999887766555554


Q ss_pred             Hhccc-----------------------CCC-------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          317 INEKV-----------------------KLP-------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       317 ~~~~~-----------------------~~p-------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      .....                       ..+       ..++.++.+||.+||+.||.+||     ++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL-----TASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc-----CHHHHhcCCCC
Confidence            32100                       000       12457889999999999999999     89999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3e-38  Score=297.70  Aligned_cols=236  Identities=23%  Similarity=0.349  Sum_probs=195.4

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||.||+|.+..      +..+|+|.+.....    ..+.+.+|+.+++.++|+||+++++++. .
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   72 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-E   72 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence            34579999999999999999998763      34589998765432    2345778999999999999999998875 4


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS----  261 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~----  261 (431)
                      +..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.....+...    
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            56899999999999999997643  478999999999999999999999999999999999999887632211111    


Q ss_pred             --------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          262 --------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       262 --------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                              ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+... ....+..++..+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL  232 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence                    12234567999999998889999999999999999999 99999988777777766554 334566789999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+|+.+||.+||++||     ++++|++
T Consensus       233 ~~li~~~l~~~p~~Rp-----~~~~i~~  255 (260)
T cd05069         233 HELMKLCWKKDPDERP-----TFEYIQS  255 (260)
T ss_pred             HHHHHHHccCCcccCc-----CHHHHHH
Confidence            9999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=319.65  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=209.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++..+.++||+|+||.||+++.+..... ....||+|..+.........+..+.+|+++|+.++|||||++||+...
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCc-eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            4455677789999999999999998752210 112289999886554567778889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCcccc-
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM-  264 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~~~~-  264 (431)
                      +..+|+|||+|.||+|.++|++++ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.....+...... 
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999999999999999999987 499999999999999999999999999999999999999987622222111111 


Q ss_pred             ----------cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHH
Q 014087          265 ----------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEA  331 (431)
Q Consensus       265 ----------~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~  331 (431)
                                --...|+|||.+....|+.++|||||||++||+++ |..||.+....++..+|...  ....|...+.++
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~  392 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL  392 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence                      12368999999999999999999999999999999 89999999999999999554  345667788999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..++.+|+..||+.|+     ++.++.+
T Consensus       393 ~~~~~~c~~~~p~~R~-----tm~~i~~  415 (474)
T KOG0194|consen  393 AKVMKQCWKKDPEDRP-----TMSTIKK  415 (474)
T ss_pred             HHHHHHhccCChhhcc-----CHHHHHH
Confidence            9999999999999999     7777765

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=302.38  Aligned_cols=240  Identities=28%  Similarity=0.485  Sum_probs=199.1

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--CE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK  189 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  189 (431)
                      |++.+.||+|+||.||+|.+..     +++.+|+|.+.... ........+.+|+.+++.++|+||+++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK-----TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC-----CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            7889999999999999999876     78899999998764 2334455677899999999999999999999988  89


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .|+||||+.+ +|..++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.+|.....+.         
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9999999975 888888765 57999999999999999999999999999999999999999876322110         


Q ss_pred             ---CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-------------  322 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-------------  322 (431)
                         ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+......             
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence               1223456888999998775 45789999999999999999999999887766655554331100             


Q ss_pred             ------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          323 ------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       323 ------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                        +...++.++.++|++||..||.+||     ++++++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI-----SADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc-----CHHHHhhCcCC
Confidence                              0111388999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-38  Score=298.20  Aligned_cols=232  Identities=21%  Similarity=0.290  Sum_probs=190.6

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEec
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF  196 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~  196 (431)
                      .||+|+||.||+|.++...   .+..+|+|++....  .....+.+.+|+.+++.++||||++++++++ ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCC---CceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence            3899999999999876321   45579999987543  3344567889999999999999999999876 4578999999


Q ss_pred             cCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------------c
Q 014087          197 INGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------------S  261 (431)
Q Consensus       197 ~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------------~  261 (431)
                      +++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.....+..              .
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999999999875 4578999999999999999999999999999999999999987652211110              0


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhc
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  339 (431)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+ ....|...++++.++|.+||
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            11123568999999998889999999999999999996 99999988777776666553 44567788999999999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHh
Q 014087          340 HKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..||++||     ++++|.+
T Consensus       236 ~~~~~~Rp-----~~~~i~~  250 (257)
T cd05115         236 IYKWEDRP-----NFAKVEE  250 (257)
T ss_pred             CCChhhCc-----CHHHHHH
Confidence            99999999     6666654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-38  Score=306.42  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ..|...+.||+|+||.||+|+++.     +++.+|+|.+.............+.+|+++++.++|+||+++++++.....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcC-----CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence            348888999999999999999875     788899999875433334445667789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------Cc
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------RS  261 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------~~  261 (431)
                      .|+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.....+.       ..
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            999999997 477776654 456899999999999999999999999999999999999998876332221       12


Q ss_pred             ccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CC-CCCCCHHHHHHHH
Q 014087          262 NSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KL-PPFLTSEAHSLLK  336 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~li~  336 (431)
                      ....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+..... .. +..++..+.+||.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence            3456889999999985   34578899999999999999999999987665555554444332 22 3468889999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +||..+|++||     ++++++.|+|+...
T Consensus       249 ~cl~~~P~~Rp-----~~~~ll~~~~~~~~  273 (308)
T cd06634         249 SCLQKIPQDRP-----TSEVLLKHRFVLRE  273 (308)
T ss_pred             HHhhCCcccCC-----CHHHHhhCcccccc
Confidence            99999999999     89999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-38  Score=295.82  Aligned_cols=238  Identities=21%  Similarity=0.336  Sum_probs=197.8

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.++||+|+||.||++...      .+..+|+|.+....    ...+.+.+|+.+++.++|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec------CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            345678999999999999999999865      34569999887542    23456788999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---  260 (431)
                      . ...|++|||+.+++|.+++.+.  ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.....+..   
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence            7 7889999999999999999764  357888999999999999999999999999999999999988763222111   


Q ss_pred             ---------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          261 ---------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       261 ---------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                               .....++..|+|||++....++.++|+|||||++|+|++ |+.||.+.+...+...+... ....+...+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE  230 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCH
Confidence                     111234567999999998889999999999999999999 99999988877777766554 3344567889


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+++.+||+.||++||     ++.+++.
T Consensus       231 ~~~~~i~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERP-----TFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCc-----CHHHHHH
Confidence            999999999999999999     7777654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=301.43  Aligned_cols=240  Identities=27%  Similarity=0.409  Sum_probs=196.8

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc---CCCCcceeeEEEEeCC
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRS  188 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~  188 (431)
                      |++.+.||+|+||.||+|+++.     +++.||+|+++.... .......+.+|+.+++.+   +||||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN-----TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC-----CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            7889999999999999999875     788999999975433 222234456688777666   5999999999999877


Q ss_pred             E-----EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---
Q 014087          189 K-----LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---  258 (431)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---  258 (431)
                      .     +|++|||+.+ +|.+++.+..  .+++..++.++.||+.||.|||++|++|+||||+||+++.++.....+   
T Consensus        75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence            6     9999999975 7888887643  589999999999999999999999999999999999999987632211   


Q ss_pred             -------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----C----
Q 014087          259 -------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----K----  322 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----~----  322 (431)
                             .......|+..|+|||++.+..++.++|||||||++|||++|++||.+.+..+...++.....     .    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence                   112234578899999999999999999999999999999999999998877776666543110     0    


Q ss_pred             -------C-----------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          323 -------L-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       323 -------~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                             +           .+.++.++.+||.+||+.||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~il~~~~~  287 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI-----SAFEALQHPYF  287 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC-----CHHHHhcCcCC
Confidence                   0           013467889999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.9e-38  Score=294.11  Aligned_cols=231  Identities=21%  Similarity=0.361  Sum_probs=193.7

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      ++||+|+||.||++...      .++.+|+|++....  .......+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec------CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence            46999999999999854      56789999987543  22334467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc------------c
Q 014087          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS------------N  262 (431)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~------------~  262 (431)
                      |+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.....+...            .
T Consensus        73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            99999999988764 4689999999999999999999999999999999999999887632221110            1


Q ss_pred             cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcc
Q 014087          263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLH  340 (431)
Q Consensus       263 ~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~  340 (431)
                      ...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+... ....+..++.++.+|+.+||.
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  232 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            1234567999999998889999999999999999998 99999988777776666544 345567789999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHh
Q 014087          341 KDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+|++||     +++++.+
T Consensus       233 ~~p~~Rp-----~~~~l~~  246 (250)
T cd05085         233 YKPENRP-----KFSELQK  246 (250)
T ss_pred             cCcccCC-----CHHHHHH
Confidence            9999999     8888865

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=298.72  Aligned_cols=232  Identities=24%  Similarity=0.366  Sum_probs=192.0

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCc--EEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYL  192 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  192 (431)
                      +.||+|+||.||+|+.+.     ++.  .+|+|.++...  .....+.+.+|+.++.++ +||||+++++++...+..|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-----~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcC-----CCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            368999999999999875     443  46888876432  233455688899999999 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC
Q 014087          193 ILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       193 v~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ||||+++|+|.+++.+..                .+++.++..++.|++.||.|||++|++||||||+|||++.++....
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence            999999999999997643                4788999999999999999999999999999999999998876332


Q ss_pred             CCCCc----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCC
Q 014087          257 ESSRS----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  324 (431)
Q Consensus       257 ~~~~~----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p  324 (431)
                      .+...          ....++..|+|||++....++.++|||||||++|||++ |..||.+.+..+..+.+... ....+
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP  233 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence            22111          11223567999999999999999999999999999997 99999888777777766554 34456


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..++.++.+|+.+||..||.+||     ++++++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~  263 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERP-----SFAQILV  263 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCC-----CHHHHHH
Confidence            67889999999999999999999     7788865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9e-39  Score=313.06  Aligned_cols=245  Identities=29%  Similarity=0.464  Sum_probs=197.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .++|++.+.||+|+||.||+|.++.     +++.+|+|.+.+... .......+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR-----TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC-----CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            3579999999999999999999875     788999998865321 222345567899999999 999999999998654


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                        ...|+||||+.+ +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+       
T Consensus        80 ~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          80 NDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             CCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence              468999999974 898888765 789999999999999999999999999999999999999988622111       


Q ss_pred             ---------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-------
Q 014087          259 ---------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-------  321 (431)
Q Consensus       259 ---------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------  321 (431)
                               .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+........++.....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence                     11223468899999998865 4578999999999999999999999987655444333321100       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 ------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 ------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                              ...+.++.++.+||.+||+.||++||     +++++++|+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----s~~~il~~~~~~~~  301 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL-----TAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc-----CHHHHhhChhhhhh
Confidence                                    01123688999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-38  Score=300.79  Aligned_cols=235  Identities=19%  Similarity=0.293  Sum_probs=187.2

Q ss_pred             eecccCceEEEEEEEcCCC-------------------CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc
Q 014087          117 VVGQGAFGKVFQVKKKGVD-------------------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI  177 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~-------------------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI  177 (431)
                      .||+|+||.||++......                   +......+|+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            6999999999998753211                   11123458999886543   2234567789999999999999


Q ss_pred             ceeeEEEEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--
Q 014087          178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--  254 (431)
Q Consensus       178 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--  254 (431)
                      +++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++..|..  
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999988876 4678999999999999999999999999999999999999875431  


Q ss_pred             ------cCCCC------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcc
Q 014087          255 ------IDESS------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       255 ------~~~~~------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell-tg~~Pf~~~~~~~~~~~i~~~~  320 (431)
                            +....      ......|+..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+... .....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~  237 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKK  237 (274)
T ss_pred             ccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhc
Confidence                  11100      1123357889999999875 56899999999999999995 6999998766555433 33344


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..+|...+.++.++|.+||+.+|++||     ++++|+++
T Consensus       238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~il~~  272 (274)
T cd05076         238 HRLPEPSCKELATLISQCLTYEPTQRP-----SFRTILRD  272 (274)
T ss_pred             cCCCCCCChHHHHHHHHHcccChhhCc-----CHHHHHHh
Confidence            456666778999999999999999999     88998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.6e-38  Score=306.85  Aligned_cols=245  Identities=26%  Similarity=0.363  Sum_probs=195.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEe---
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT---  186 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---  186 (431)
                      +|++.+.||+|+||.||++++....   .+..||+|.+.... ......+.+.+|+.+++.+ +||||+++++.+..   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4899999999999999999987511   27789999986532 1223345677899999999 59999999987543   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                       ...+|+++||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.      
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence             246889999986 589999988888999999999999999999999999999999999999998876322111      


Q ss_pred             ---------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 014087          260 ---------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  319 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~----------  319 (431)
                               ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...          
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence                     1223478999999998875 56899999999999999999999999876654443332211          


Q ss_pred             ------------------ccCC---CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          320 ------------------KVKL---PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       320 ------------------~~~~---p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                        ...+   .+.++.++.+||.+||+.||.+||     ++++++.||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~~ll~~~~~~~  297 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI-----SVEEALEHPYLAI  297 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC-----CHHHHhcChhhhh
Confidence                              0011   123578999999999999999999     8999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.6e-38  Score=294.93  Aligned_cols=234  Identities=22%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      ++||+|+||.||+|.+...  +.....+|+|.+......  ...+.+.+|+.+++.++||||+++++.+.+ ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            4689999999999998642  123446999999876543  556788899999999999999999999988 89999999


Q ss_pred             ccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------------
Q 014087          196 FINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------------  260 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------------  260 (431)
                      |+++++|.+++.+..  .+++..+..++.|++.||.|||++|++||||||+||+++.++.....+..             
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999998764  68999999999999999999999999999999999999988763221111             


Q ss_pred             -cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHHH
Q 014087          261 -SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       261 -~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  336 (431)
                       .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+...  ....+..++.++.+++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence             112356788999999999999999999999999999998 99999888877777766542  33345667899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +||..+|++||     +++++++
T Consensus       236 ~~l~~~p~~Rp-----s~~~~~~  253 (257)
T cd05040         236 QCWAHNPADRP-----TFAALRE  253 (257)
T ss_pred             HHCCCCcccCC-----CHHHHHH
Confidence            99999999999     7888875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.7e-38  Score=299.51  Aligned_cols=239  Identities=22%  Similarity=0.301  Sum_probs=188.7

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--CE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK  189 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  189 (431)
                      |++++.||+|+||+||++..+... ..+++.+|+|+++...  .......+.+|+++|+.++||||+++++++...  ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            499999999999999998765322 2367889999987542  223345677899999999999999999987653  46


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      +|+||||+.+++|.+++... .+++.++..++.|++.||.|||++||+||||||+|||++.++.....+..         
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            89999999999999998764 58999999999999999999999999999999999999988753221111         


Q ss_pred             -----cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH--H-------------HHHHHH-hc
Q 014087          261 -----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ--K-------------LQQRII-NE  319 (431)
Q Consensus       261 -----~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~--~-------------~~~~i~-~~  319 (431)
                           .....++..|+|||.+.+..++.++|||||||++|||++|..||......  +             ..+.+. ..
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence                 11223566799999999888999999999999999999999998643211  0             011111 11


Q ss_pred             ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       320 ~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ....+..++.++.+++.+||+.||++||     ++++|+.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~i~~  276 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRP-----TFRSLIP  276 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            2234566789999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3e-38  Score=304.01  Aligned_cols=243  Identities=26%  Similarity=0.409  Sum_probs=195.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~   79 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKD-----TGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECC-----CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence            4579999999999999999999875     788999999876532 2223345678999999999999999999987655


Q ss_pred             ----------EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          189 ----------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       189 ----------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                                .+|+|+||+++ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.....
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence                      89999999987 666666653 468999999999999999999999999999999999999998763221


Q ss_pred             CC------------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---
Q 014087          258 SS------------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---  321 (431)
Q Consensus       258 ~~------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---  321 (431)
                      +.            ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....   
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            11            1112345778999998875 3578899999999999999999999987665554444432100   


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          322 ---------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       322 ---------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                                                 .....++..+.++|.+||..||.+||     ++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC-----TAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC-----CHHHHhcCCCC
Confidence                                       00123688999999999999999999     89999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.3e-38  Score=298.21  Aligned_cols=245  Identities=19%  Similarity=0.331  Sum_probs=201.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||.||+|.+.... ...+..+++|.+....  .......+.+|+.+++.++|+||+++++++..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            44568999999999999999999987422 1236789999886432  34456778899999999999999999998765


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                       ....++++||+.+++|.+++...        ..+++..+..++.||+.||.|||++|++||||||+||+++.++.....
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             56789999999999999998764        358899999999999999999999999999999999999988753221


Q ss_pred             CCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccC
Q 014087          258 SSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVK  322 (431)
Q Consensus       258 ~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~  322 (431)
                      +..             .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..+ ...
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            111             112345678999999999999999999999999999999 99999988877776666544 233


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+..+++++.+++.+||..||++||     ++.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERP-----SFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            4556789999999999999999999     7788775

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.6e-38  Score=296.57  Aligned_cols=236  Identities=20%  Similarity=0.288  Sum_probs=186.0

Q ss_pred             eeecccCceEEEEEEEcCCCC-------CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          116 RVVGQGAFGKVFQVKKKGVDD-------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~-------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      +.||+|+||.||+++......       ......+++|++....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999998642110       0123458889876542   233456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--------cCCCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------IDESS  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--------~~~~~  259 (431)
                      ..++||||+.+|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++..        +....
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 568999999999999999999999999999999999999876531        11111


Q ss_pred             ------CcccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 014087          260 ------RSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA  331 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  331 (431)
                            ......|+..|+|||.+. +..++.++|||||||++|||+ +|..||......+.. .+...........+.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (262)
T cd05077         158 IPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSCKEL  236 (262)
T ss_pred             CCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCChHHH
Confidence                  112345788999999987 567899999999999999998 599999876544432 33333334444456889


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+||.+||+.||.+||     ++++|+++
T Consensus       237 ~~li~~cl~~dp~~Rp-----~~~~il~~  260 (262)
T cd05077         237 ADLMTHCMNYDPNQRP-----FFRAIMRD  260 (262)
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHHh
Confidence            9999999999999999     88999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.9e-38  Score=305.00  Aligned_cols=244  Identities=25%  Similarity=0.403  Sum_probs=196.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-C
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-R  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  187 (431)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++.+... .......+..|+.+++.++||||++++++|.. .
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQL-----TGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECC-----CCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            4679999999999999999999876     888999998865432 23344567789999999999999999999876 5


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------C
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------S  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------~  259 (431)
                      ...|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+        .
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            6799999998 5688777754 4689999999999999999999999999999999999999887532221        1


Q ss_pred             CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Q 014087          260 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--------------------  318 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--------------------  318 (431)
                      ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..                    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            2234467889999999876 5689999999999999999999999987654332211110                    


Q ss_pred             ------cccCCC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          319 ------EKVKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       319 ------~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                            .....|     +.++.++.++|.+||+.+|++||     ++++++.|+||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~ell~~~~~~~  293 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI-----SAAEALAHPYLAP  293 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCCcccc
Confidence                  000111     34678999999999999999999     8999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=299.90  Aligned_cols=240  Identities=30%  Similarity=0.478  Sum_probs=199.6

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++.+.||+|+||.||+|+...     +++.||+|++.... ......+.+..|+.+++.++|+||+++++++.+.+..|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK-----TGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecC-----CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            6778999999999999999876     78999999998754 23334456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------
Q 014087          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------  259 (431)
                      +||||+.+ +|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.....+.           
T Consensus        75 ~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          75 LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            99999985 899999876 57999999999999999999999999999999999999999875322111           


Q ss_pred             CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------c
Q 014087          260 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------K  320 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------~  320 (431)
                      ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+...++...                  .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            12233457789999999876 7899999999999999999999999887765554444321                  0


Q ss_pred             cCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 VKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 ~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ..++           +.++.++.++|++||..||++||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI-----SAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCC-----CHHHHhhCcCC
Confidence            0011           13478899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=296.92  Aligned_cols=243  Identities=22%  Similarity=0.304  Sum_probs=201.2

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||+||+|.++.... .....+|+|.+.+...  ......+.+|+.+++.++||||+++++++.. 
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            44679999999999999999999865221 1234699998876532  3345668889999999999999999999887 


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc-----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS-----  261 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~-----  261 (431)
                      ...++||||+.+|+|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+...     
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999999874 4689999999999999999999999999999999999999877532211110     


Q ss_pred             --------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          262 --------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       262 --------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                              ....++..|+|||.+....++.++|||||||++|||++ |+.||.+....++.+.+... ....|...+.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence                    11123567999999998899999999999999999998 99999998888877777654 345566788999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+++.+||..||.+||     ++.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp-----~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRP-----TFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCC-----CHHHHHH
Confidence            9999999999999999     7777765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.8e-38  Score=296.07  Aligned_cols=242  Identities=23%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|.+.++||+|+||.||+|.+....  .....+|+|......  .....+.+.+|+.+++.++||||+++++++.+ 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            4457999999999999999999876421  134569999886543  23345678899999999999999999998875 


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR------  260 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~------  260 (431)
                      ...|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+|||++.++.....+..      
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            45789999999999999998754 58999999999999999999999999999999999999988763322111      


Q ss_pred             ------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHH
Q 014087          261 ------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  332 (431)
Q Consensus       261 ------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  332 (431)
                            .....++..|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+..+ ....+..++.++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  238 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence                  111223467999999998899999999999999999996 99999888777766666554 4456778899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++|.+||..+|++||     ++.+++.
T Consensus       239 ~li~~~l~~~P~~Rp-----t~~~~~~  260 (270)
T cd05056         239 SLMTKCWAYDPSKRP-----RFTELKA  260 (270)
T ss_pred             HHHHHHcCCChhhCc-----CHHHHHH
Confidence            999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9e-38  Score=300.32  Aligned_cols=248  Identities=29%  Similarity=0.440  Sum_probs=197.6

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++.+.||+|+||.||+|.++.     +++.||||.+++...  ......+..|+.++... .||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKK-----TGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECC-----CCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            4556789999999999999999999875     688999999976432  22234455577666666 599999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                      .+....|+||||+.+ +|..++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.....+.   
T Consensus        84 ~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          84 ITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             ecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccc
Confidence            999999999999854 67666655 4578999999999999999999997 69999999999999998876322211   


Q ss_pred             -------CcccccCCCCCCchhhhccCC----CCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc-cCCC--
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEK-VKLP--  324 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~p--  324 (431)
                             ......|+..|+|||++.+..    ++.++|||||||++|+|++|+.||..... .+....+.... ...+  
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN  242 (296)
T ss_pred             hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence                   112335778999999997654    78899999999999999999999976332 33444444432 2233  


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ..++.++.+||.+||..||++||     ++++++.|+||...
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  279 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRP-----KYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCC-----CHHHHhcChhhhcc
Confidence            24789999999999999999999     89999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=292.40  Aligned_cols=240  Identities=22%  Similarity=0.376  Sum_probs=201.6

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      +++.+.||.|+||.||++++..... ..+..+|+|++.....  ....+.+..|+.+++.++|+||+++++++.+.+..|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            4577899999999999999875221 1348899999965532  225567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          192 LILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      ++|||+++++|.+++.....  +++.++..++.|++.||.|||++|++||||||+||+++.++.....+..         
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999999977554  8999999999999999999999999999999999999998752211110         


Q ss_pred             ---cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHH
Q 014087          261 ---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLL  335 (431)
Q Consensus       261 ---~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  335 (431)
                         .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+...+.+.+.... ...+..++.++.+++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence               001236789999999988889999999999999999998 899999888888777776543 345667899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHh
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+||..||++||     +++++++
T Consensus       238 ~~~l~~~p~~Rp-----t~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRP-----TFSELVE  256 (258)
T ss_pred             HHHCcCChhhCc-----CHHHHHh
Confidence            999999999999     8888875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-38  Score=292.23  Aligned_cols=231  Identities=23%  Similarity=0.354  Sum_probs=194.7

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      ++||+|+||.||+|.+.      .++.||+|.+......  .....+.+|+++++.++|+||+++++++.+....|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~------~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK------GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEe------CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence            46999999999999875      3778999988765432  345678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc-------------
Q 014087          196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS-------------  261 (431)
Q Consensus       196 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~-------------  261 (431)
                      |+.|++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.....+...             
T Consensus        73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99999999999764 4689999999999999999999999999999999999999887632211110             


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhc
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  339 (431)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+... ....+..++.++.+||.+||
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  232 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW  232 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence            11223557999999998899999999999999999999 89999887777766666543 34556778999999999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHh
Q 014087          340 HKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+|++||     +++++++
T Consensus       233 ~~~p~~Rp-----~~~ell~  247 (251)
T cd05041         233 AYDPENRP-----SFSEIYN  247 (251)
T ss_pred             ccChhhCc-----CHHHHHH
Confidence            99999999     8888876

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=300.15  Aligned_cols=240  Identities=28%  Similarity=0.481  Sum_probs=198.6

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |++.+.||+|++|.||+|.+..     +++.+++|.++.... .......+..|+.+|+.++|+||+++++++..+...|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL-----TGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC-----CCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            6778999999999999999865     788999999876543 2234566778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------
Q 014087          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------  259 (431)
                      +||||+.+ +|...+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.....+.           
T Consensus        75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            99999976 787777664 57899999999999999999999999999999999999998775321110           


Q ss_pred             CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------------
Q 014087          260 RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK------------------  320 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------  320 (431)
                      ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+....+....                  
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            11234578899999999876 78999999999999999999999998877655544443210                  


Q ss_pred             -cC-----------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          321 -VK-----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       321 -~~-----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       ..           ..+.++.++.+||.+||..||.+||     ++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc-----CHHHHhhCCCC
Confidence             00           1124678999999999999999999     89999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-37  Score=297.61  Aligned_cols=241  Identities=24%  Similarity=0.338  Sum_probs=191.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--C
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  188 (431)
                      -|++++.||+|+||.||+|+..... ..++..||+|.++...  .......+.+|+.+++.++||||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            4899999999999999999864321 2368889999987543  233456788999999999999999999998875  5


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..++||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.....+.        
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999998765 35899999999999999999999999999999999999998876321111        


Q ss_pred             ------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHHh
Q 014087          260 ------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---------------RQKLQQRIIN  318 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~---------------~~~~~~~i~~  318 (431)
                            ......|+..|+|||++.+..++.++|||||||++|||++++.|+....               .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence                  1123456778999999998889999999999999999999877653211               1111111211


Q ss_pred             -cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          319 -EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       319 -~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                       ...+.+..++.++.+||.+||+.||++||     ++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  278 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRT-----TFQNLIE  278 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCc-----CHHHHHH
Confidence             12334567899999999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-38  Score=297.86  Aligned_cols=239  Identities=29%  Similarity=0.486  Sum_probs=194.4

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  190 (431)
                      |++.+.||+|+||+||+|+...     +++.||||.+......  .......+|+..++.++ |+||+++++++.+++..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE-----TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC-----CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence            6788999999999999999875     7889999998754321  11223446889999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------C
Q 014087          191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------S  258 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------~  258 (431)
                      |+||||+ +|+|.+++....  .+++.++..++.|++.+|.|||++|++|+||||+||+++.++.....          .
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999999 789999888765  78999999999999999999999999999999999999998763221          1


Q ss_pred             CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 014087          259 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE------------------  319 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------  319 (431)
                      .......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||...+..+....+...                  
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            12234568889999998854 45789999999999999999999999876655444333210                  


Q ss_pred             -ccC-----------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 -KVK-----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 -~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       ...           ..+..+.++.+||++||+.||++||     ++++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP-----TASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC-----CHHHHhhCCCC
Confidence             000           0122368899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.5e-37  Score=291.75  Aligned_cols=234  Identities=22%  Similarity=0.402  Sum_probs=195.0

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||.||++..       +++.||+|.++...     ..+.+.+|+.+++.++||||+++++++..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc-------CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            345799999999999999998763       56779999986532     234678899999999999999999998765


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-----  260 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-----  260 (431)
                       ..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.....+..     
T Consensus        72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence             4799999999999999997653  47999999999999999999999999999999999999988763322211     


Q ss_pred             ---cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHH
Q 014087          261 ---SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLL  335 (431)
Q Consensus       261 ---~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li  335 (431)
                         .....++..|+|||.+.+..++.++|+|||||++|||++ |+.||...+..+....+..+ ....+..++.++.+++
T Consensus       151 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         151 SMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             cccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence               112234567999999998899999999999999999998 99999988877777666554 2334567889999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHh
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+||+.+|++||     ++++|+.
T Consensus       231 ~~~l~~~p~~Rp-----~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRP-----SFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCc-----CHHHHHH
Confidence            999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-39  Score=269.70  Aligned_cols=244  Identities=25%  Similarity=0.449  Sum_probs=204.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|...++||+|+||+||+++.+.     ++++||+|.++.+.. ++..-....+|+-+|+.++|.|||+++++...++.+
T Consensus         3 ~ydkmekigegtygtvfkarn~~-----t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC-----ccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            47778899999999999999886     999999999987653 333445567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---------
Q 014087          191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---------  260 (431)
                      -+|+|||.. +|..+... ++.++.+.++.++.|++.||.|+|++++.||||||.|+||+.+|.....+..         
T Consensus        77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            999999975 67766654 5789999999999999999999999999999999999999999984332221         


Q ss_pred             --cccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc-----------CCC-
Q 014087          261 --SNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-----------KLP-  324 (431)
Q Consensus       261 --~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~-----------~~p-  324 (431)
                        ....+-|.+|.+|.++.+. -|+.+.|+||.||++.|+.. |++.|.+.+..+...+|...-.           .+| 
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence              1233458899999999874 58999999999999999988 9999999998888888853100           111 


Q ss_pred             -----------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          325 -----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       325 -----------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                       +.++...+||++++|.-+|.+|+     ++++.++||||.+.
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri-----saeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI-----SAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc-----CHHHHhcCcccccc
Confidence                             22455678999999999999999     88999999999763

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.6e-38  Score=295.36  Aligned_cols=237  Identities=25%  Similarity=0.408  Sum_probs=194.2

Q ss_pred             eeecccCceEEEEEEEcCCC-CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~-~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      +.||+|+||.||+|+++... .+..++.+|+|.+.+..  .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999886533 12244679999886542  1233456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-----CccCCCC---
Q 014087          195 DFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HEIDESS---  259 (431)
Q Consensus       195 E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g-----~~~~~~~---  259 (431)
                      ||+++++|.+++.+.       ..+++.++..++.||+.||.|||+++++|+||||+||+++.++     .....+.   
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998753       3478899999999999999999999999999999999999876     2111110   


Q ss_pred             ----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 014087          260 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  327 (431)
Q Consensus       260 ----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  327 (431)
                                ......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+ ....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence                      1112245678999999999999999999999999999998 99999887777766666543 44566778


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++.+||.+||..+|.+||     ++++|++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp-----~~~~i~~  265 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERP-----TFDRIQE  265 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            99999999999999999999     7888765

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.6e-37  Score=291.24  Aligned_cols=235  Identities=20%  Similarity=0.314  Sum_probs=189.8

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE-eCCEEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSKLYLIL  194 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lv~  194 (431)
                      +.||+|+||.||+|.+....  .....+|+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCC--CceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999875311  245679999875422  2334567888999999999999999999765 456689999


Q ss_pred             eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------------
Q 014087          195 DFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------------  260 (431)
Q Consensus       195 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------------  260 (431)
                      ||+.+|+|.+++.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.....+..             
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999999764 456778888999999999999999999999999999999988763221111             


Q ss_pred             --cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHH
Q 014087          261 --SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLK  336 (431)
Q Consensus       261 --~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  336 (431)
                        .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+..+. ...+..++..+.+++.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  236 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML  236 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence              112345678999999998899999999999999999999 577888777777766665543 3445667899999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +||..+|++||     ++.+|+.
T Consensus       237 ~cl~~~p~~Rp-----~~~~il~  254 (262)
T cd05058         237 SCWHPKPEMRP-----TFSELVS  254 (262)
T ss_pred             HHcCCChhhCC-----CHHHHHH
Confidence            99999999999     7888875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-39  Score=295.42  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=195.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-CC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  188 (431)
                      ..|+.+..||+|+||.||+|..+.+.+. ..+.||+|.++.... ....-....+|+.+++.++||||+.|..+|.+ +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3599999999999999999977664432 245799998876532 22233446789999999999999999999887 88


Q ss_pred             EEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----cc----
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EI----  255 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----~~----  255 (431)
                      .+++++||.+. +|...|+-.     ..++...++.|+.||+.|+.|||++-|+||||||.|||+..+|.    +.    
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999987 888887632     45899999999999999999999999999999999999998854    11    


Q ss_pred             ----------CCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q 014087          256 ----------DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------QKLQQR  315 (431)
Q Consensus       256 ----------~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~---------~~~~~~  315 (431)
                                ........++-|.+|.|||++.+ ..|+.++|||++|||+.||+|-++.|.+...         .+...+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence                      11123345667999999999997 5689999999999999999999999975321         122333


Q ss_pred             HHh--ccc---------CCCC--------------------------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHH
Q 014087          316 IIN--EKV---------KLPP--------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  358 (431)
Q Consensus       316 i~~--~~~---------~~p~--------------------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  358 (431)
                      |..  +..         .+|+                          .-++.+.+|+.+||+.||-+|+     ++++.+
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI-----ta~qAl  335 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI-----TAEQAL  335 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc-----cHHHHh
Confidence            321  000         1111                          1245588999999999999999     889999


Q ss_pred             hCCCCCCC
Q 014087          359 HHKWFRSI  366 (431)
Q Consensus       359 ~h~~f~~~  366 (431)
                      +|+||..-
T Consensus       336 eh~yF~~d  343 (438)
T KOG0666|consen  336 EHPYFTED  343 (438)
T ss_pred             cccccccC
Confidence            99999864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=301.01  Aligned_cols=245  Identities=27%  Similarity=0.496  Sum_probs=198.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--C----Cccee
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--P----FIVQL  180 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----nIv~l  180 (431)
                      +-..+|.+++++|+|+||+|..|.++.     ++..||||+++.-    ....+..+-|+++|.++.+  |    -+|++
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~-----~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRE-----TKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecC-----CCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            346789999999999999999999886     6889999999742    2344556779999999942  3    27888


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----
Q 014087          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----  253 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----  253 (431)
                      .++|+-.++.|+|+|.+ |-++++++..++  +++...++.|++|++.++.|||+.+++|-||||+|||+.....     
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            89999999999999998 569999998864  6899999999999999999999999999999999999865422     


Q ss_pred             -----------------------ccCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH
Q 014087          254 -----------------------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ  310 (431)
Q Consensus       254 -----------------------~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~  310 (431)
                                             .........+++.|..|.|||++.+-+++..+||||+||||+|+.+|...|+..+..
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                                   001111224567899999999999999999999999999999999999999875533


Q ss_pred             H---HHHHHHh------------------cccCCCCC-------------------------CCHHHHHHHHhhcccCcC
Q 014087          311 K---LQQRIIN------------------EKVKLPPF-------------------------LTSEAHSLLKGLLHKDPS  344 (431)
Q Consensus       311 ~---~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~li~~~L~~dP~  344 (431)
                      +   +.++|+.                  +.+.+|+.                         -..++.|||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            3   4555542                  11222211                         123578999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCCCC
Q 014087          345 KRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +|+     |+.|++.||||+..
T Consensus       396 ~Ri-----Tl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  396 RRI-----TLREALSHPFFARL  412 (415)
T ss_pred             ccc-----cHHHHhcCHHhhcC
Confidence            999     89999999999864

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-37  Score=293.01  Aligned_cols=233  Identities=19%  Similarity=0.303  Sum_probs=183.6

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|.....   .....+|+|.+....  .......+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG---MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecC---CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence            3699999999999976431   245678999876432  23334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----------
Q 014087          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----------  260 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----------  260 (431)
                      |+.+|+|.+++....     ..++..+..++.||+.||.|||++||+||||||+|||++.++.....+..          
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            999999999997643     24678889999999999999999999999999999999998763222111          


Q ss_pred             ---cccccCCCCCCchhhhcc-------CCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-cccC-----C
Q 014087          261 ---SNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVK-----L  323 (431)
Q Consensus       261 ---~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~-~~~~-----~  323 (431)
                         .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+....+.. ...+     .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence               112345678999999853       356789999999999999999 8899988766665555433 3222     2


Q ss_pred             CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          324 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       324 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +..++....+++..|+ .||++||     ++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rp-----t~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRP-----TAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCccccc-----CHHHHHH
Confidence            3457889999999998 5999999     6777764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.7e-37  Score=291.01  Aligned_cols=233  Identities=20%  Similarity=0.304  Sum_probs=183.4

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+|....   +.++..+|+|.++....  ......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcC---CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence            468999999999998753   12567799998875432  2233467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------
Q 014087          196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------  259 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------  259 (431)
                      |+++|+|.+++....     ..++..++.++.|++.||.|||++||+||||||+||+++.++.....+.           
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            999999999987532     3567788899999999999999999999999999999998765322211           


Q ss_pred             --CcccccCCCCCCchhhhccC-------CCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hcccCCC----
Q 014087          260 --RSNSMCGTTEYMAPEILLSK-------GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLP----  324 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~-~~~~~~p----  324 (431)
                        ......|+..|+|||++.+.       .++.++|||||||++|||++ |+.||......+...... .....++    
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL  235 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence              11234577889999998643       35789999999999999996 999998766555443332 2222222    


Q ss_pred             -CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                       ...+..+.+++.+|+ .+|++||     ++++|..
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rp-----t~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRP-----SAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCC-----CHHHHHH
Confidence             246788999999998 6899999     7888864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=327.25  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=210.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +.....++.+.||+|.||.||.+...+.........||||.+++.  .+.+.+..|.+|..+|+.++|||||+++|++-+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            456788999999999999999999886433222445888888764  356777889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                      ....++++|||+||+|..+|++.       ..++..++..++.||++|++||+++++|||||..+|+||+....+...+.
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       34889999999999999999999999999999999999998854322111


Q ss_pred             C---------cccccC----CCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH-HHHhcccCCC
Q 014087          260 R---------SNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQ-RIINEKVKLP  324 (431)
Q Consensus       260 ~---------~~~~~G----t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~-~i~~~~~~~p  324 (431)
                      .         ..+.-|    ...|||||.+....++.++|||||||+|||++| |..||.+.+..++.. -...++++.|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            1         111112    358999999999999999999999999999999 999999988888877 4455688889


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..++..+.++|.+||+.+|++||     ++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP-----~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRP-----SFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCc-----cHHHHHh
Confidence            99999999999999999999999     7888876

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-37  Score=289.97  Aligned_cols=233  Identities=20%  Similarity=0.257  Sum_probs=183.9

Q ss_pred             eeecccCceEEEEEEEcCCCC-----CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDD-----GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +.||+|+||.||++.++....     ......+++|++.....    ....+.+|+.+|+.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            469999999999999875221     11124578887764432    14667889999999999999999999988 778


Q ss_pred             EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-------ccCCCCC--
Q 014087          191 YLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------EIDESSR--  260 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-------~~~~~~~--  260 (431)
                      ++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.       ....+..  
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 7899999999999999999999999999999999999998872       1111111  


Q ss_pred             -----cccccCCCCCCchhhhccC--CCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014087          261 -----SNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  332 (431)
Q Consensus       261 -----~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  332 (431)
                           .....++..|+|||++.+.  .++.++|||||||++|||++ |..||...+......... .....+.....++.
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (259)
T cd05037         156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAELA  234 (259)
T ss_pred             cccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCchHHH
Confidence                 1134577889999999876  78999999999999999999 688887765433333222 22223333448999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++|.+||..+|.+||     ++.+|++
T Consensus       235 ~li~~~l~~~p~~Rp-----t~~~il~  256 (259)
T cd05037         235 NLINQCWTYDPTKRP-----SFRAILR  256 (259)
T ss_pred             HHHHHHhccChhhCC-----CHHHHHH
Confidence            999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-37  Score=291.61  Aligned_cols=241  Identities=22%  Similarity=0.359  Sum_probs=189.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--C
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (431)
                      .+|++++.||+|+||.||++..+.... .+++.||+|.+....   ....+.+.+|+++|+.++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcC-CCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            479999999999999999998653222 267889999986542   3345678899999999999999999988653  3


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc-----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS-----  261 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~-----  261 (431)
                      ..+|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.....+...     
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            5689999999999999999764 4689999999999999999999999999999999999999887632221111     


Q ss_pred             ---------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHH
Q 014087          262 ---------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL---------------QQRII  317 (431)
Q Consensus       262 ---------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~---------------~~~i~  317 (431)
                               ....++..|+|||++.+..++.++|||||||++|||++|..++........               ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence                     011233459999999988999999999999999999998877643321100               01112


Q ss_pred             hc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          318 NE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       318 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..  ....+..++.++.+||.+||..+|++||     ++++|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP-----SFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            22  2234456889999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=305.15  Aligned_cols=235  Identities=23%  Similarity=0.335  Sum_probs=185.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      ++|.-...||+|+||.||++...      .+..||||.+.......   ..+|.+|+.+|.+++|||+|+|+|+|.+.+ 
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~------~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~  145 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS------DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE  145 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC------CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence            56888899999999999999876      44889999776543221   344999999999999999999999999998 


Q ss_pred             EEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeCCCCCccCCCC----
Q 014087          189 KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      ..+||+|||.+|+|.++|....  .++|.....|+.+++.||+|||...   |||||||++|||||.+......+.    
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            5999999999999999998765  8999999999999999999999854   999999999999998876332211    


Q ss_pred             -----C--cccc-cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHhccc---
Q 014087          260 -----R--SNSM-CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQ----RIINEKV---  321 (431)
Q Consensus       260 -----~--~~~~-~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~---~~~~~~----~i~~~~~---  321 (431)
                           .  ..+. .||.+|+|||++.....+.++|||||||+|.||+||+.+.+...   ...+..    .+..+.+   
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence                 1  1111 79999999999999889999999999999999999999887432   111111    1111111   


Q ss_pred             ---CCC-CCCC--HH---HHHHHHhhcccCcCCcCCCCCCCHHHHH
Q 014087          322 ---KLP-PFLT--SE---AHSLLKGLLHKDPSKRLGSGPGGVDAIK  358 (431)
Q Consensus       322 ---~~p-~~~s--~~---~~~li~~~L~~dP~~R~~~~~~~~~~i~  358 (431)
                         .+. ....  .+   +..+..+|++.+|.+||     ++.++.
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP-----~m~~Vv  346 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERP-----TMSQVV  346 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCc-----CHHHHH
Confidence               111 1222  23   45677799999999999     666653

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.1e-37  Score=295.19  Aligned_cols=244  Identities=19%  Similarity=0.288  Sum_probs=195.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|+..+.||+|+||.||+|.+...... ....+|+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGET-VKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCc-ceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            3456799999999999999999998752111 12357889886543  22333467889999999999999999999875


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      . ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.....+.      
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 4779999999999999987754 6899999999999999999999999999999999999988765321111      


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                             ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..+ ....+...+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence                   1112334678999999999999999999999999999997 99999887666555554433 23345567899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+++.+||..+|++||     ++++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp-----~~~~l~~  263 (303)
T cd05110         240 VYMVMVKCWMIDADSRP-----KFKELAA  263 (303)
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     7888776

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-37  Score=292.23  Aligned_cols=243  Identities=22%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .++|++.+.||+|+||.||+|++....+ .++..+|+|++......  ...+.+.+|+++++.++|+||+++++++..  
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~-~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGD-NTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCC-CCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            3568999999999999999998764222 26789999999765432  345678999999999999999999999887  


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS----  261 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~----  261 (431)
                      ....++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.....+...    
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            568999999999999999998754 689999999999999999999999999999999999999887633221110    


Q ss_pred             ----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHH
Q 014087          262 ----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK--------------LQQRII  317 (431)
Q Consensus       262 ----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~--------------~~~~i~  317 (431)
                                ....++..|+|||.+.+..++.++|||||||++|||++|..||.......              ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence                      11234556999999998899999999999999999999999986532211              111222


Q ss_pred             hc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          318 NE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       318 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..  ....+..++.++.+|+.+||..+|++||     ++++|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP-----SFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            22  2233456788999999999999999999     7888875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-36  Score=287.97  Aligned_cols=233  Identities=20%  Similarity=0.314  Sum_probs=183.9

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      +.||+|+||.||+++....   .....+++|.+....  .....+.+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTD---TGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcC---CCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEe
Confidence            3699999999999976431   134456777765432  22335678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------------
Q 014087          196 FINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------------  259 (431)
Q Consensus       196 ~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------------  259 (431)
                      |+++|+|.+++.+.    ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.....+.            
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            99999999999764    34677788899999999999999999999999999999998876322111            


Q ss_pred             -CcccccCCCCCCchhhhcc-------CCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-c-----CCC
Q 014087          260 -RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-V-----KLP  324 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~-----~~p  324 (431)
                       .....+|+..|+|||++..       ..++.++|||||||++|||++ |..||...+..+....+..+. .     .++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1124467889999999853       245788999999999999997 678998777666666554332 2     233


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+++.+.+++..|| .+|++||     ++++|++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp-----~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRA-----TAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCC-----CHHHHHH
Confidence            457889999999999 6899999     7888864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-36  Score=287.67  Aligned_cols=240  Identities=20%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC---
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS---  188 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  188 (431)
                      |++.+.||+|+||.||+|.++..  ..+++.+|||++..+.. .....+.+.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            67788999999999999987641  12678899999876432 3334567888999999999999999999886532   


Q ss_pred             ---EEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                         ..++++||+.+|+|..++...      ..+++..+..++.||+.||.|||++||+||||||+||+++.++.....+.
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               247899999999998877532      24788999999999999999999999999999999999998765322111


Q ss_pred             C-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCC
Q 014087          260 R-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP  324 (431)
Q Consensus       260 ~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p  324 (431)
                      .             .....++..|++||.+....++.++|||||||++|||++ |+.||.+.+..++...+... ....+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            1             112234578999999999999999999999999999999 99999988877777766544 34455


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+.++.+++.+||..+|++||     ++.+++.
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rp-----s~~~~~~  267 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRP-----SFQHLRD  267 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            67889999999999999999999     7788765

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-36  Score=286.99  Aligned_cols=240  Identities=29%  Similarity=0.516  Sum_probs=197.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-------hhhhHHHHHHHHHHHHHh-cCCCCcceeeE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTK-VTHPFIVQLRY  182 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~  182 (431)
                      +|++.+.||+|+||.||++.++.    .+++.+|+|.+.....       ........+..|+.++.. ++||||+++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            48889999999999999999864    2567899998864321       123344556778888875 79999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCC
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                      ++..++..|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.....
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            99999999999999999999888743    3468999999999999999999996 789999999999999988753211


Q ss_pred             C----------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CC-C
Q 014087          258 S----------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LP-P  325 (431)
Q Consensus       258 ~----------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~p-~  325 (431)
                      +          .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...... .+ .
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            1          1223456899999999999888999999999999999999999999887777766666655433 22 2


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.++.+||.+||+.||++||     ++.++..
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp-----~~~e~~~  265 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARP-----DIIQVSA  265 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCC-----CHHHHHH
Confidence            5789999999999999999999     7788765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3e-36  Score=289.71  Aligned_cols=244  Identities=15%  Similarity=0.153  Sum_probs=180.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhH--------HHHHHHHHHHHHhcCCCCcc
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------VDYMKAERDILTKVTHPFIV  178 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~--------~~~~~~E~~il~~l~hpnIv  178 (431)
                      +..++|++.++||+|+||+||+|++....  ..+..+|+|+...........        ......+...+..++|+||+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            44568999999999999999999987511  125667777643322110000        01112233445667899999


Q ss_pred             eeeEEEEeCC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc
Q 014087          179 QLRYSFQTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       179 ~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      ++++++....    ..++++|++.. ++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++..
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            9998766543    35778888744 666677666667899999999999999999999999999999999999987653


Q ss_pred             cCCC------------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-H-----
Q 014087          255 IDES------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-Q-----  310 (431)
Q Consensus       255 ~~~~------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~-----  310 (431)
                      ...+                  .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .     
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            2111                  111234699999999999999999999999999999999999999987522 2     


Q ss_pred             ---HHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          311 ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       311 ---~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                         +...++......+ ...+.++.+++..|+..+|++||     +.++|++
T Consensus       246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp-----~~~~l~~  291 (294)
T PHA02882        246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKP-----DYDALIK  291 (294)
T ss_pred             hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCC-----CHHHHHH
Confidence               2233344444333 34689999999999999999999     7888865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=297.57  Aligned_cols=247  Identities=27%  Similarity=0.473  Sum_probs=202.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh----hhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----KKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .++|-++.+||+|||+.||+|.+..     ..+.||+|+-......    ..+..+...+|.+|-+.|+||-||++|++|
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~-----EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLT-----EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccc-----hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            4578899999999999999998875     7789999986543222    345567788999999999999999999999


Q ss_pred             E-eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCC--------
Q 014087          185 Q-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH--------  253 (431)
Q Consensus       185 ~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~--------  253 (431)
                      . +.+.+|-|+|||+|.+|..+|..+..++|.+++.|+.||+.||.||.+..  |||-||||.||||-....        
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            7 45678999999999999999999999999999999999999999999764  999999999999965422        


Q ss_pred             ----c---------cCCCCCcccccCCCCCCchhhhccC----CCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHH-
Q 014087          254 ----E---------IDESSRSNSMCGTTEYMAPEILLSK----GHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQ-  314 (431)
Q Consensus       254 ----~---------~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~-  314 (431)
                          .         ......+....||.+|++||.+.-.    ..+.++||||+|||+|.++.|+.||.... ..++++ 
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence                0         1112234456899999999998743    35889999999999999999999998643 223322 


Q ss_pred             -HHHh-cccCCC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          315 -RIIN-EKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       315 -~i~~-~~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                       .|+. ..+.||  +.++.++++||++||.+.-+.|.     ++.++-.||||.-
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~-----DV~qLA~dpyllP  746 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI-----DVQQLACDPYLLP  746 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhh-----hHHHHccCccccc
Confidence             2332 234555  57999999999999999999998     8999999999953

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=310.03  Aligned_cols=230  Identities=33%  Similarity=0.497  Sum_probs=186.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (431)
                      -+...+.||+|+||.||+++++.     +|+.||||.+++..  ....++...+|+++|++++|+|||+++++-++..  
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnke-----tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKE-----TGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             ceeehhhhcCCccceeeeecccc-----cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            36677899999999999999886     99999999998765  3444677788999999999999999998876654  


Q ss_pred             ----EEEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CC------
Q 014087          189 ----KLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GH------  253 (431)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~--g~------  253 (431)
                          .-.+|||||.||+|+..+.+-   ..++|.++..++.++..||.|||++|||||||||.||++-..  |.      
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence                468999999999999999753   459999999999999999999999999999999999998544  32      


Q ss_pred             ------ccCCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc---
Q 014087          254 ------EIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINE---  319 (431)
Q Consensus       254 ------~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~----~~~~~~i~~~---  319 (431)
                            .+..+....+++||..|++||++.. +.|+..+|.|||||++|+++||..||.....    .++...+...   
T Consensus       167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence                  2344556778999999999999995 8899999999999999999999999964221    2233333211   


Q ss_pred             ------------------ccCCCCCCCHH----HHHHHHhhcccCcCCcC
Q 014087          320 ------------------KVKLPPFLTSE----AHSLLKGLLHKDPSKRL  347 (431)
Q Consensus       320 ------------------~~~~p~~~s~~----~~~li~~~L~~dP~~R~  347 (431)
                                        .+++|..++..    +-..+..+|..+|.+|-
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                              12233344443    45678889999999997

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-36  Score=318.02  Aligned_cols=240  Identities=29%  Similarity=0.467  Sum_probs=196.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE----
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ----  185 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----  185 (431)
                      .+|+.++.||+||||.||+|+.+-     .|+.||||.+....  .......+.+|+.+|.+|+|||||+++..|.    
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKl-----DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKL-----DGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecc-----cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            468899999999999999999985     89999999998765  4455567888999999999999999976330    


Q ss_pred             --------------------------------------------------------------------------e-----
Q 014087          186 --------------------------------------------------------------------------T-----  186 (431)
Q Consensus       186 --------------------------------------------------------------------------~-----  186 (431)
                                                                                                +     
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                      0     


Q ss_pred             ----------------------------C--------CEEEEEEeccCCCChHHHHHHcCCC-CHHHHHHHHHHHHHHHH
Q 014087          187 ----------------------------R--------SKLYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAVS  229 (431)
Q Consensus       187 ----------------------------~--------~~~~lv~E~~~gg~L~~~l~~~~~~-~~~~~~~i~~qi~~aL~  229 (431)
                                                  +        ..+||-||||+...|.+++.++... ....++.+++||++||.
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence                                        0        2378999999998787777776554 57889999999999999


Q ss_pred             HHHHCCceeccCCCCceEeCCCCCcc-----------------------------CCCCCcccccCCCCCCchhhhccCC
Q 014087          230 HLHKCGIVHRDLKPENILMDSDGHEI-----------------------------DESSRSNSMCGTTEYMAPEILLSKG  280 (431)
Q Consensus       230 ~LH~~~iiHrDlKp~NILl~~~g~~~-----------------------------~~~~~~~~~~Gt~~y~aPE~~~~~~  280 (431)
                      |+|++|||||||||.||++++++.+.                             ......++.+||.-|+|||++.+..
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99999999999999999999875421                             1122345678999999999998755


Q ss_pred             ---CCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCCCC----CCHHHHHHHHhhcccCcCCcCCCCCC
Q 014087          281 ---HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPF----LTSEAHSLLKGLLHKDPSKRLGSGPG  352 (431)
Q Consensus       281 ---~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~p~~----~s~~~~~li~~~L~~dP~~R~~~~~~  352 (431)
                         |+.|+|+||||||++||+.   ||.. .....+...+..+.++.|..    --+.-..+|+.||+.||.+||     
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP-----  863 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP-----  863 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC-----
Confidence               9999999999999999995   5753 44556677777666666622    234568899999999999999     


Q ss_pred             CHHHHHhCCCCC
Q 014087          353 GVDAIKHHKWFR  364 (431)
Q Consensus       353 ~~~~i~~h~~f~  364 (431)
                      ++.+++++.||-
T Consensus       864 tA~eLL~s~llp  875 (1351)
T KOG1035|consen  864 TATELLNSELLP  875 (1351)
T ss_pred             CHHHHhhccCCC
Confidence            889999999997

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=280.19  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=197.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHH-HhcCCCCcceeeEEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~  185 (431)
                      +...+.+-+..||.|+||+|++..++.     +|+.+|||.++....  .....++..|.+.. +.-++||||++||..-
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~-----sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKP-----SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCc-----cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            334556667889999999999999987     999999999987654  33445677777755 4557999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCC--
Q 014087          186 TRSKLYLILDFINGGHLFFHL-----YRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDE--  257 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l-----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~--  257 (431)
                      .++..|+.||+|.- +|..+-     .++..++|..+..|....+.||+||-. .+||||||||+||||+..|....-  
T Consensus       134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence            99999999999964 553222     134679999999999999999999985 689999999999999999874321  


Q ss_pred             --------CCCcccccCCCCCCchhhhc--cCCCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccCC---
Q 014087          258 --------SSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEKVKL---  323 (431)
Q Consensus       258 --------~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~~---  323 (431)
                              +...+.-.|...|||||.+.  +.+|+.++||||||++|||+.||+.||.+-+ ..+....+..+.++.   
T Consensus       213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence                    11223446889999999997  4579999999999999999999999998743 334444445554332   


Q ss_pred             CC---CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          324 PP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       324 p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +.   .++..++.||..||.+|-+.||     ...+++.++|++..
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rp-----ky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRP-----KYDDLKKFPFYRMY  333 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCc-----chhhhhcCchhhhh
Confidence            22   3788999999999999999999     78999999999753

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=289.85  Aligned_cols=241  Identities=20%  Similarity=0.309  Sum_probs=202.2

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..+...+.++||+|-||.|.+|.-.      .+..||||.++.+.  ..+....|..|+++|.+|+|||||+|+++|.
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve------g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE------GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec------CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            455667899999999999999999864      46789999998765  3445678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc--
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS--  261 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~--  261 (431)
                      .++.+++|+|||++|+|..++.++.  ...-.....|+.||+.||.||.+.++|||||.+.|+|++.+++....+..+  
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence            9999999999999999999998873  334566677999999999999999999999999999999998754333221  


Q ss_pred             -------ccc----cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh--CCCCCCCCCHHHHHHHHHh---c-----c
Q 014087          262 -------NSM----CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIIN---E-----K  320 (431)
Q Consensus       262 -------~~~----~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~Pf~~~~~~~~~~~i~~---~-----~  320 (431)
                             ...    +-...|||+|.+....++.++|+|+|||+|||+++  ...||...+.++..++...   .     .
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence                   122    22578999999999999999999999999999876  8899998877776665432   1     2


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +..|..++.++.++|.+||.+|-++||     ++++|-.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RP-----sFe~lh~  799 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRP-----SFEQLHL  799 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCC-----CHHHHHH
Confidence            235677899999999999999999999     8888743

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=302.81  Aligned_cols=245  Identities=25%  Similarity=0.443  Sum_probs=208.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEe-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT-  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  186 (431)
                      .+.|++.++||.|.+|.||+++.+.     +++..|+|++.....    .-+++..|.++|+.. +|||++.+|++|.. 
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~-----~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVK-----TGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeee-----cCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            4569999999999999999999987     888999999876542    234577799999977 69999999999863 


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC---
Q 014087          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE---  257 (431)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~---  257 (431)
                          ++.+|||||||.||+.-+++++-  .++.|..+..|++.++.||.+||.+.+||||||-.|||++.+|.+...   
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence                46899999999999999988753  579999999999999999999999999999999999999999874322   


Q ss_pred             --------CCCcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---
Q 014087          258 --------SSRSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---  321 (431)
Q Consensus       258 --------~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---  321 (431)
                              .....+.+||+.|||||++..     ..|+..+|+||||++..||.-|.+|+-+..+...+-.|-.+..   
T Consensus       169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL  248 (953)
T KOG0587|consen  169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  248 (953)
T ss_pred             eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence                    234567789999999999974     3578899999999999999999999988877766555544322   


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      .-|...+.++.+||..||.+|-.+||     .+.+++.|||.+...
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP-----~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRP-----STEELLKHPFITEQP  289 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCc-----chhhhccCCcccccc
Confidence            23567899999999999999999999     889999999998543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=281.97  Aligned_cols=134  Identities=24%  Similarity=0.433  Sum_probs=114.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----C---CCcc
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----H---PFIV  178 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---pnIv  178 (431)
                      +..++|.+.++||.|-|++||+|.+.+     ..+.||||+.+...    .+.+....||++|++++     |   ..||
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq-----~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQ-----NKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeecc-----CCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            445899999999999999999999987     88999999998654    33455667999999883     3   3699


Q ss_pred             eeeEEEEe----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCC
Q 014087          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (431)
Q Consensus       179 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~  250 (431)
                      +|++.|..    +.++|+|+|++ |.+|..+|.+.  ..++...++.|++||+.||.|||. .||||-||||+|||+..
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS  223 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence            99999974    56899999998 66888888764  459999999999999999999996 79999999999999854

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-34  Score=267.22  Aligned_cols=230  Identities=45%  Similarity=0.771  Sum_probs=198.3

Q ss_pred             CceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEeccCCCC
Q 014087          122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH  201 (431)
Q Consensus       122 ~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  201 (431)
                      +||.||+|.+..     +++.+|+|++........  .+.+.+|+++++.++|+||+++++.+......++++||+.+++
T Consensus         1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECC-----CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            689999999875     788999999876543221  5678899999999999999999999999999999999999999


Q ss_pred             hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------CCcccccCCCCCC
Q 014087          202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------SRSNSMCGTTEYM  271 (431)
Q Consensus       202 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------~~~~~~~Gt~~y~  271 (431)
                      |..++.....+++..+..++.+++.+|.|||+.||+|+||+|.||+++.++.....+          .......|+..|+
T Consensus        74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            999998876689999999999999999999999999999999999999887632111          1234566889999


Q ss_pred             chhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCCCC---CCHHHHHHHHhhcccCcCCcC
Q 014087          272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVKLPPF---LTSEAHSLLKGLLHKDPSKRL  347 (431)
Q Consensus       272 aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~  347 (431)
                      +||.+.+..++.++|||+||+++|+|++|..||.. .+...+.+.+..........   ++.++.+++.+||..+|++||
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99999988899999999999999999999999987 66666666666555544333   889999999999999999999


Q ss_pred             CCCCCCHHHHHhCCCC
Q 014087          348 GSGPGGVDAIKHHKWF  363 (431)
Q Consensus       348 ~~~~~~~~~i~~h~~f  363 (431)
                           ++.++++||||
T Consensus       234 -----~~~~~~~~~~~  244 (244)
T smart00220      234 -----TAEEALQHPFF  244 (244)
T ss_pred             -----CHHHHhhCCCC
Confidence                 89999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.6e-35  Score=302.24  Aligned_cols=253  Identities=18%  Similarity=0.272  Sum_probs=171.8

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (431)
                      ...+..++|++.++||+|+||.||+|++..... ..+..||+|.+.....     .+...+|  .++...+.+++.++..
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~  197 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYG  197 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHh
Confidence            345567899999999999999999999875111 1278999998754321     1111111  1122222233322221


Q ss_pred             ------EEeCCEEEEEEeccCCCChHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCce
Q 014087          184 ------FQTRSKLYLILDFINGGHLFFHLYRQGI--------------------FREDQARFYTAEIVSAVSHLHKCGIV  237 (431)
Q Consensus       184 ------~~~~~~~~lv~E~~~gg~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~aL~~LH~~~ii  237 (431)
                            ...+..+++||||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+
T Consensus       198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi  277 (566)
T PLN03225        198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV  277 (566)
T ss_pred             hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence                  2456689999999999999998875421                    12345678999999999999999999


Q ss_pred             eccCCCCceEeCCC-CCccCC------------CCCcccccCCCCCCchhhhccC----------------------CCC
Q 014087          238 HRDLKPENILMDSD-GHEIDE------------SSRSNSMCGTTEYMAPEILLSK----------------------GHN  282 (431)
Q Consensus       238 HrDlKp~NILl~~~-g~~~~~------------~~~~~~~~Gt~~y~aPE~~~~~----------------------~~~  282 (431)
                      ||||||+|||++.+ +.....            .......+||+.|||||.+...                      .++
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            99999999999864 432111            1122456789999999976532                      234


Q ss_pred             CcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---------------------CCCCCCHHHHHHHHhhccc
Q 014087          283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------------------LPPFLTSEAHSLLKGLLHK  341 (431)
Q Consensus       283 ~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------------------~p~~~s~~~~~li~~~L~~  341 (431)
                      .++|||||||+||||+++..++... .......+......                     ........+.+||.+||++
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            5679999999999999987776432 11111111111110                     0111233456999999999


Q ss_pred             CcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          342 DPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       342 dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                      ||++||     +++++++||||.+..+..
T Consensus       437 dP~kR~-----ta~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        437 KGRQRI-----SAKAALAHPYFDREGLLG  460 (566)
T ss_pred             CcccCC-----CHHHHhCCcCcCCCCccc
Confidence            999999     899999999999987753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=328.75  Aligned_cols=229  Identities=21%  Similarity=0.284  Sum_probs=180.1

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|...+.||+|+||.||+|+++.     ++..||||.++.....       ...|++++++++|||||++++++.+.+..
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIK-----NGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECC-----CCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            46667889999999999999875     7889999988643211       12468889999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEeCCCCCccCC------CCCc
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH---KCGIVHRDLKPENILMDSDGHEIDE------SSRS  261 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~g~~~~~------~~~~  261 (431)
                      |+||||+++|+|.+++..   +++.++..|+.||+.||+|||   +.+|+||||||+||+++.++.....      ....
T Consensus       759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~  835 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD  835 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccC
Confidence            999999999999999853   789999999999999999999   6799999999999999987653210      0112


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH---------hccc----CC
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-----RQKLQQRII---------NEKV----KL  323 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~-----~~~~~~~i~---------~~~~----~~  323 (431)
                      ....||+.|||||++.+..++.++|||||||++|||++|+.||....     ..+......         ....    ..
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            23467899999999999999999999999999999999999995321     111111110         0000    01


Q ss_pred             CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          324 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       324 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.....++.+++.+||+.||++||     +++++++
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~  946 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARP-----CANDVLK  946 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCc-----CHHHHHH
Confidence            111123577899999999999999     7888876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-37  Score=272.64  Aligned_cols=245  Identities=28%  Similarity=0.404  Sum_probs=197.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .+.|+.+.+||+|.||.||+|+.+.     +++.||+|++-.+. ....+-....+|+++|..+.|+|++.+++.+..  
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n-----~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~   89 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKN-----TGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcC-----ccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence            4568889999999999999999886     88889998764432 233344445679999999999999998877643  


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC---
Q 014087          187 ------RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID---  256 (431)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~---  256 (431)
                            ...+|+|+.+|+. +|.-+|... -+|+..+++.++.+++.||.|+|+..|+|||+|++|+||+.+|....   
T Consensus        90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence                  3359999999986 888888765 57999999999999999999999999999999999999999876221   


Q ss_pred             ------------CCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cc-
Q 014087          257 ------------ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EK-  320 (431)
Q Consensus       257 ------------~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~--~~-  320 (431)
                                  ...+.+..+-|.+|.+||.+.+ ..|+.+.|||+.||||.||+||.+.|.+.+.......|..  +. 
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence                        1122334456999999999986 5799999999999999999999999999887766665532  10 


Q ss_pred             ----------------c---CCCC-------------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          321 ----------------V---KLPP-------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       321 ----------------~---~~p~-------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                      +   ++|.             .-.+++.+|+.+||..||.+|+     +++++++|.||..
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~-----~ad~alnh~~F~k  320 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI-----DADQALNHDFFWK  320 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc-----chHhhhchhhhhc
Confidence                            0   0111             0135889999999999999999     8899999999964

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=294.51  Aligned_cols=243  Identities=22%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      |..++..+.++||+|+||.|+++.|+...  .+...||||+++.+....  ..+.|.+|+.+|.+|+|||+|+||++..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            45566888899999999999999998621  244569999998765432  57789999999999999999999999988


Q ss_pred             CCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc---------
Q 014087          187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------  255 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~---------  255 (431)
                       ..+.+|||++++|+|.+.|++  ...|....+..|+.||+.||.||..+++|||||...||||.....+.         
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence             788999999999999999987  35688899999999999999999999999999999999997643211         


Q ss_pred             -CCCCCccccc----CCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-cccCCCCCCC
Q 014087          256 -DESSRSNSMC----GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLT  328 (431)
Q Consensus       256 -~~~~~~~~~~----Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s  328 (431)
                       ........+.    -...|+|||.+....++.++|||++||+||||++ |+.||.+.....++++|-. +.++-|+.++
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs  341 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS  341 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence             1111112121    1457999999999999999999999999999999 9999999999999999863 3566788999


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++.+++.+||..+|.+||     ++.+|..
T Consensus       342 edIY~imk~cWah~paDRp-----tFsair~  367 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRP-----TFSAIRE  367 (1039)
T ss_pred             HHHHHHHHHhccCCccccc-----cHHHHHH
Confidence            9999999999999999999     6666653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=287.38  Aligned_cols=235  Identities=23%  Similarity=0.347  Sum_probs=196.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +...+.++||.|-||.||.+.+.....+ ..--||||+.+.+..  .+..+.|..|..+|+.++|||||+|+|++.+. .
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kg-e~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKG-ERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccC-cceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            3445567899999999999998754322 344599999887653  33367789999999999999999999998764 6


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------  260 (431)
                      .|+|||+++-|.|..+|..+ ..++...+..|+.||+.||.|||++.+|||||...|||+.....+...+..        
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            89999999999999999876 468999999999999999999999999999999999999877543222211        


Q ss_pred             --c--ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 014087          261 --S--NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL  334 (431)
Q Consensus       261 --~--~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  334 (431)
                        .  +...-...|||||.++...++.++|||-|||+|||++. |..||.+....+.+-.|.++ +++.|+.+++.+..|
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl  624 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL  624 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence              1  11222567999999999999999999999999999998 99999987766666666554 788999999999999


Q ss_pred             HHhhcccCcCCcCC
Q 014087          335 LKGLLHKDPSKRLG  348 (431)
Q Consensus       335 i~~~L~~dP~~R~~  348 (431)
                      +.+||..||.+||.
T Consensus       625 mskcWayeP~kRPr  638 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPR  638 (974)
T ss_pred             HHHHhccCcccCCc
Confidence            99999999999993

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=284.42  Aligned_cols=239  Identities=23%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+...+.....+||-|.||.||.+.|+.     -.-.||||.++.+.    -.+++|..|+.+|+.++|||+|+|+++|
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKk-----yslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeec-----cceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            33445567788999999999999999987     45569999997654    3467788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                      ..+..+|||.|||..|+|.++|++..  .++.-.+..++.||..|++||..+++|||||...|+|+.++..+...+.   
T Consensus       333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchh
Confidence            99999999999999999999998753  4677788899999999999999999999999999999998754322211   


Q ss_pred             ------CcccccC---CCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          260 ------RSNSMCG---TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       260 ------~~~~~~G---t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                            ..+...|   .+.|.|||-+....++.++|||+|||+|||+.| |..||.+.+....+..+..+ ++.-|+.++
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP  492 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP  492 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence                  1222233   467999999999999999999999999999999 99999999988888777654 677899999


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHH
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAI  357 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i  357 (431)
                      +....|++.||+++|..||     ++.+|
T Consensus       493 pkVYeLMraCW~WsPsDRP-----sFaei  516 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRP-----SFAEI  516 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCc-----cHHHH
Confidence            9999999999999999999     55555

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=295.16  Aligned_cols=250  Identities=23%  Similarity=0.349  Sum_probs=214.0

Q ss_pred             HhhhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCccee
Q 014087          101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL  180 (431)
Q Consensus       101 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  180 (431)
                      .+....|......+.++||.|.||.||+++.+...  .....||||.++...  ...+...|..|+.||-+.+||||++|
T Consensus       620 reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrL  695 (996)
T KOG0196|consen  620 REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRL  695 (996)
T ss_pred             HHhhhhcChhheEEEEEEecccccceecccccCCC--CcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEE
Confidence            34445677788999999999999999999987522  355679999998764  34455678899999999999999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC---
Q 014087          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID---  256 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~---  256 (431)
                      -++.....-+.+|.|||++|+|..+|+++ +.|...++.-+++.|+.|+.||-+.|+|||||...|||++.+-....   
T Consensus       696 EGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  696 EGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             EEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence            99999999999999999999999999876 67999999999999999999999999999999999999998743211   


Q ss_pred             -------CC--CCcccccC--CCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCC
Q 014087          257 -------ES--SRSNSMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKL  323 (431)
Q Consensus       257 -------~~--~~~~~~~G--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~  323 (431)
                             ++  ...++.-|  ...|.|||.+....++.++||||+||+|||.++ |..||-+.+.++.++.|..+ +++.
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP  855 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence                   11  11222223  368999999999999999999999999999888 99999999999999998765 5666


Q ss_pred             CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          324 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       324 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      |-.++..+.+|+..||++|-.+||     .+.+|..
T Consensus       856 PmDCP~aL~qLMldCWqkdR~~RP-----~F~qiV~  886 (996)
T KOG0196|consen  856 PMDCPAALYQLMLDCWQKDRNRRP-----KFAQIVS  886 (996)
T ss_pred             CCCCcHHHHHHHHHHHHHHhhcCC-----CHHHHHH
Confidence            678999999999999999999999     8888876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.7e-34  Score=287.48  Aligned_cols=256  Identities=21%  Similarity=0.254  Sum_probs=180.9

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCC-----------CCCCCcEEEEEEeehhhhhh-----------hhHHHHH
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIK-----------KNHVDYM  162 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----------~~~~~~~~avK~~~~~~~~~-----------~~~~~~~  162 (431)
                      .++..++|++.++||+|+||+||++......           ....++.||||.+.......           ....+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            3466789999999999999999999753211           12245789999986432110           0111233


Q ss_pred             HHHHHHHHhcCCCCc-----ceeeEEEEe--------CCEEEEEEeccCCCChHHHHHHc--------------------
Q 014087          163 KAERDILTKVTHPFI-----VQLRYSFQT--------RSKLYLILDFINGGHLFFHLYRQ--------------------  209 (431)
Q Consensus       163 ~~E~~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~--------------------  209 (431)
                      ..|+.++.+++|.++     ++++++|..        .+..||||||+.+++|.+++...                    
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            457777777766554     566666643        35689999999999999888642                    


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------Cccc--ccCCCCCCch
Q 014087          210 ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------RSNS--MCGTTEYMAP  273 (431)
Q Consensus       210 ----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------~~~~--~~Gt~~y~aP  273 (431)
                          ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.....+.          ....  ..+|+.|+||
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                12356778899999999999999999999999999999998875321111          1111  2347899999


Q ss_pred             hhhccCC--------------------CC--CcchhHhHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHHhc
Q 014087          274 EILLSKG--------------------HN--KDADWWSVGILLYEMLTGQP-PFTHANRQ-----------KLQQRIINE  319 (431)
Q Consensus       274 E~~~~~~--------------------~~--~~~DvwslGvil~elltg~~-Pf~~~~~~-----------~~~~~i~~~  319 (431)
                      |++....                    |+  .+.||||+||++|+|++|.. ||......           .....+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9986432                    22  34799999999999999885 77542111           111122223


Q ss_pred             ccCCC--CCCCHHHHHHHHhhcccCc---CCcCCCCCCCHHHHHhCCCCCC
Q 014087          320 KVKLP--PFLTSEAHSLLKGLLHKDP---SKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       320 ~~~~p--~~~s~~~~~li~~~L~~dP---~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .+.++  +.+++.++|||.+||.++|   .+|+     +++++++||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl-----Sa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRL-----SVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCC-----CHHHHhCCCCcCC
Confidence            33333  4578999999999999876   6899     8999999999953

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.1e-35  Score=255.87  Aligned_cols=240  Identities=25%  Similarity=0.445  Sum_probs=189.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEe
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (431)
                      ..++|++++++|+|-|+.||.+....     +++.++||+++.-.      .+.+.+|+.||..|. ||||++|+++..+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~-----~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINIT-----NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccC-----CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            45689999999999999999998765     77889999986432      345889999999997 9999999999987


Q ss_pred             CC--EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--------
Q 014087          187 RS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--------  256 (431)
Q Consensus       187 ~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--------  256 (431)
                      ..  ...||+||+.+.+...+.   ..++...++.++.|+++||+|||++||+|||+||.|++||.......        
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence            64  478999999887654333   45788899999999999999999999999999999999998754221        


Q ss_pred             ---CCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHH-------------Hh
Q 014087          257 ---ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI-------------IN  318 (431)
Q Consensus       257 ---~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i-------------~~  318 (431)
                         .....+..+.+..|--||++.. +.|+.+-|+|||||+|..|+..+.||-. .+..+..-+|             ..
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence               1223344566888999999875 6789999999999999999999999843 2222222111             11


Q ss_pred             cccCCC------------------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          319 EKVKLP------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       319 ~~~~~p------------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ..+.++                        ..+++++.|||.++|..|-.+|+     |++|.+.||||..+
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl-----TakEam~HpyF~~~  328 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL-----TAKEAMAHPYFAPV  328 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc-----chHHHhcCchHHHH
Confidence            111111                        12579999999999999999999     88999999999754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.1e-35  Score=281.57  Aligned_cols=244  Identities=27%  Similarity=0.440  Sum_probs=199.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC------CCccee
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL  180 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l  180 (431)
                      +--++|.+....|+|-|++|..|++..     .++.||||+|+...+..+.    =..|++||++|+.      -++++|
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~-----r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQA-----RGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccC-----CCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHH
Confidence            345689999999999999999999876     7779999999887654433    3459999999952      479999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                      +-.|...+++|||+|-+.. +|.+.|.+.|   .+....++.|+.|+..||..|-.+||+|.||||+|||+++....+..
T Consensus       500 ~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             HHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence            9999999999999999854 8999998865   37889999999999999999999999999999999999988664322


Q ss_pred             C-CCcccc---------cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC--
Q 014087          258 S-SRSNSM---------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP--  325 (431)
Q Consensus       258 ~-~~~~~~---------~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--  325 (431)
                      . ..+...         .-+..|.|||++.|..|+...|+||+||+||||.||+..|.+.+.+.++...+.-+.++|.  
T Consensus       579 CDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  579 CDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             ccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            1 111112         2345799999999999999999999999999999999999998877776555432222220  


Q ss_pred             ---------------------------------------------------CC-------CHHHHHHHHhhcccCcCCcC
Q 014087          326 ---------------------------------------------------FL-------TSEAHSLLKGLLHKDPSKRL  347 (431)
Q Consensus       326 ---------------------------------------------------~~-------s~~~~~li~~~L~~dP~~R~  347 (431)
                                                                         .+       -..+++||.+||..||++|+
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence                                                               01       13578999999999999999


Q ss_pred             CCCCCCHHHHHhCCCCCC
Q 014087          348 GSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       348 ~~~~~~~~~i~~h~~f~~  365 (431)
                           ++.++|.||||.+
T Consensus       739 -----t~nqAL~HpFi~~  751 (752)
T KOG0670|consen  739 -----TVNQALKHPFITE  751 (752)
T ss_pred             -----CHHHHhcCCcccC
Confidence                 8899999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=263.41  Aligned_cols=240  Identities=26%  Similarity=0.446  Sum_probs=191.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      .+|.-++.+|.|.- .|..|-+.-     .++.||+|.+... ........+..+|..++..++|+||++++.+|.-.. 
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v-----~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQV-----LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhh-----ccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            46888888999988 565555443     7888999987665 233444566778999999999999999999997544 


Q ss_pred             -----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc--------
Q 014087          189 -----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI--------  255 (431)
Q Consensus       189 -----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~--------  255 (431)
                           .+|+|||||.. +|...+..  .++-+.+.+|+.|+++|+.|||+.||+||||||+||++..++...        
T Consensus        90 l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence                 58999999975 78777763  468899999999999999999999999999999999998875421        


Q ss_pred             --CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 014087          256 --DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--------------  319 (431)
Q Consensus       256 --~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--------------  319 (431)
                        ..+...+..+.|..|.|||++.+.+|...+||||+||++.||++|+..|.+.+.-+.+.++...              
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence              1223455667899999999999999999999999999999999999999987765544444210              


Q ss_pred             -------------ccC----CCC-----------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          320 -------------KVK----LPP-----------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       320 -------------~~~----~p~-----------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                                   ...    +|+           .-...+.+++.+||..||++|.     +++++++||||+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri-----sv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI-----SVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc-----cHHHHhcCCeee
Confidence                         001    121           1134588999999999999999     899999999999

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=290.97  Aligned_cols=233  Identities=30%  Similarity=0.456  Sum_probs=186.9

Q ss_pred             ceEEeeecccCceE-EEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCCE
Q 014087          112 FEIFRVVGQGAFGK-VFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK  189 (431)
Q Consensus       112 y~~~~~LG~G~fg~-Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  189 (431)
                      |.-.+.+|.|+.|+ ||++..       .++.||||.+-.      +..+...+|+.+|+.. +|||||++|+.-++...
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-------e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-------EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-------CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            33446799999987 688887       567899997643      3445678899999988 59999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCc---c----
Q 014087          190 LYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHE---I----  255 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~g~~---~----  255 (431)
                      +|++.|.|.. +|.+++...+.    ......+..+.|+++||.+||+.+||||||||.||||+.   +|..   +    
T Consensus       578 ~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  578 LYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            9999999976 89999987311    111456788999999999999999999999999999987   3421   0    


Q ss_pred             ---------CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCCC-
Q 014087          256 ---------DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-  324 (431)
Q Consensus       256 ---------~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p-  324 (431)
                               .......+..||-+|+|||++....-+.++|||||||++|..++ |..||...  .+...+|+.+...+- 
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~  734 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVH  734 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceee
Confidence                     11122456679999999999999888889999999999999999 59999653  344566777665432 


Q ss_pred             --CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          325 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       325 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                        +....++.+||.+||+.+|..||     ++.+++.||||.+
T Consensus       735 L~~~~d~eA~dLI~~ml~~dP~~RP-----sa~~VL~HPlFW~  772 (903)
T KOG1027|consen  735 LEPLPDCEAKDLISRMLNPDPQLRP-----SATDVLNHPLFWD  772 (903)
T ss_pred             eccCchHHHHHHHHHhcCCCcccCC-----CHHHHhCCCccCC
Confidence              22223899999999999999999     8899999999954

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=278.33  Aligned_cols=193  Identities=31%  Similarity=0.494  Sum_probs=171.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHH-----HHHHHHHHHHhcC---CCCccee
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD-----YMKAERDILTKVT---HPFIVQL  180 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~-----~~~~E~~il~~l~---hpnIv~l  180 (431)
                      ..+|..++.||+|+||.|++|.++.     ....|+||.+.|.++....+++     .+..|++||..++   |+||+++
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~-----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKE-----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             cccceeeeeccccccceEEEeeecc-----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            4579999999999999999999986     7888999999998776544432     3567999999997   9999999


Q ss_pred             eEEEEeCCEEEEEEecc-CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--
Q 014087          181 RYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--  257 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~-~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--  257 (431)
                      +++|++++.+||+||-- +|.+|+++|..+..++|.+++.|++||+.|+++||++||||||||-+|+.++.+|.....  
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            99999999999999974 577999999999999999999999999999999999999999999999999999974332  


Q ss_pred             -------CCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCC
Q 014087          258 -------SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTH  306 (431)
Q Consensus       258 -------~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~  306 (431)
                             ......++||..|.|||++.+..| +..-|||+||++||.++....||..
T Consensus       715 gsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  715 GSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence                   233457789999999999999888 6778999999999999999999864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-32  Score=281.46  Aligned_cols=249  Identities=23%  Similarity=0.400  Sum_probs=205.5

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCC--CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCccee
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGD--SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQL  180 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l  180 (431)
                      .+.+..++..+.+.||+|.||+|+++..++.....  ....||||.++....  ....+.+..|+++|+.+ .|+||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            34455566777889999999999999876544321  256799999877653  35677899999999998 69999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 014087          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE  244 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~  244 (431)
                      ++++..++.+++|+||+..|+|..+++.++                .++..++..++.||+.|++||+++.+|||||-..
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998766                3888999999999999999999999999999999


Q ss_pred             ceEeCCCCCccC-C--------CCCcc---cccC--CCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCC-
Q 014087          245 NILMDSDGHEID-E--------SSRSN---SMCG--TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN-  308 (431)
Q Consensus       245 NILl~~~g~~~~-~--------~~~~~---~~~G--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~-  308 (431)
                      |||+..+..... +        .....   .-.|  ...|||||.+....|+.++|||||||+|||+++ |..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999998843111 0        00111   1122  235999999999999999999999999999999 999999855 


Q ss_pred             HHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          309 RQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       309 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..++.+.+..+ +...|..++.++.++++.||+.+|++||     ++.++..
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP-----~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP-----TFSECVE  574 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHH
Confidence            66677766665 5578999999999999999999999999     7777765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-34  Score=280.25  Aligned_cols=246  Identities=27%  Similarity=0.444  Sum_probs=209.7

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...+|+++..+|.|+||.||+++++.     +++..|+|+++...   .....-+..|+-+++.++|||||.+++.|-..
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~-----s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKR-----SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccc-----cCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            34689999999999999999999986     89999999998654   33345567799999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      +.++++||||.||+|.+.-.-.++++|.++....++.+.||+|||++|-+|||||-.|||+++.|.+...+         
T Consensus        85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999999999999888889999999999999999999999999999999999999999998743322         


Q ss_pred             --CCcccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-----CCCCC
Q 014087          259 --SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----PPFLT  328 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s  328 (431)
                        .....+.||++|||||+..   ..+|...+|||++|++..|+---++|-....+...........+.-     +...+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence              2345678999999999875   5689999999999999999999888876655554444333333322     24578


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +.+.+|++.+|.++|++||     +++-++.|||...-
T Consensus       245 ~~fh~fvK~altknpKkRp-----taeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRP-----TAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCC-----Chhhheeceeeccc
Confidence            8999999999999999999     78899999998653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=237.56  Aligned_cols=204  Identities=26%  Similarity=0.424  Sum_probs=166.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .++...+..||+|+||.|-+.++..     +|..+|+|.++....  .+...++.+|+++..+. .+|++|++|+.+...
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~-----sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQ-----SGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeecc-----CCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            3456677889999999999999987     999999999876542  34456677788876655 799999999999999


Q ss_pred             CEEEEEEeccCCCChHH----HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCC-----
Q 014087          188 SKLYLILDFINGGHLFF----HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDE-----  257 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~----~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~-----  257 (431)
                      ..+++.||.|.- +|..    .+.+.+.++|..+-.|+..++.||.|||+ ..|||||+||+||||+.+|+...-     
T Consensus       118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence            999999999964 5533    23445789999999999999999999997 589999999999999999984321     


Q ss_pred             ----CCCccc-ccCCCCCCchhhhcc----CCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcc
Q 014087          258 ----SSRSNS-MCGTTEYMAPEILLS----KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEK  320 (431)
Q Consensus       258 ----~~~~~~-~~Gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~~  320 (431)
                          +....+ -.|...|||||.+..    .+|+.++||||||+++.||.+++.||.. .++.+.+.++..+.
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence                122222 468889999999873    4899999999999999999999999975 45666667766553

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=9.4e-32  Score=251.47  Aligned_cols=248  Identities=16%  Similarity=0.269  Sum_probs=205.5

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+...++++..++-+|+||.||.+.++..++-...+.+-+|.++...  .+-++..+..|.-+|..+.|||+..+.++.
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            345556789999999999999999998865554455667788776543  466678889999999999999999998887


Q ss_pred             EeC-CEEEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          185 QTR-SKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       185 ~~~-~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                      ..+ ...+.++.++.-|+|..+|...        ..++-.++..++.|++.|++|||+.||||.||...|++||+.-...
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence            654 5678889999999999988731        2467788999999999999999999999999999999999864421


Q ss_pred             CC-------------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-c
Q 014087          256 DE-------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-K  320 (431)
Q Consensus       256 ~~-------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~  320 (431)
                      ..             ............||+||.+....|+.++|+|||||+||||+| |+.||...++.++...+..+ +
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            11             111112223568999999999999999999999999999999 99999999999999988876 6


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +..|.+++.++..++..||..+|++||     +++++..
T Consensus       517 laQP~NCPDeLf~vMacCWallpeeRP-----sf~Qlv~  550 (563)
T KOG1024|consen  517 LAQPFNCPDELFTVMACCWALLPEERP-----SFSQLVI  550 (563)
T ss_pred             ecCCCCCcHHHHHHHHHHHhcCcccCC-----CHHHHHH
Confidence            678889999999999999999999999     7777754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-32  Score=272.71  Aligned_cols=238  Identities=19%  Similarity=0.270  Sum_probs=198.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      ..+..++||+|+||+||++.+... ...-+..||+|++.....  ...-..+..|+-+|.+++|||+++|++++.... +
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            355568999999999999998753 222456799999876553  333466888999999999999999999998876 8


Q ss_pred             EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------CC
Q 014087          191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------SS  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------~~  259 (431)
                      -||++||++|.|.++++.+ +.+.......|..||++||.|||.+++|||||-..|||+..-.++...          +.
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            8999999999999999875 578899999999999999999999999999999999999876552211          11


Q ss_pred             C-cccc--cCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHH
Q 014087          260 R-SNSM--CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSL  334 (431)
Q Consensus       260 ~-~~~~--~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  334 (431)
                      . ....  .-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++-..+..+ ++..|+..+-++..+
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~  932 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV  932 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence            1 1111  12467999999999999999999999999999999 99999999888887777553 678889999999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHH
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAI  357 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i  357 (431)
                      +.+||..|+..||     +++++
T Consensus       933 mvkCwmid~~~rp-----~fkel  950 (1177)
T KOG1025|consen  933 MVKCWMIDADSRP-----TFKEL  950 (1177)
T ss_pred             HHHHhccCcccCc-----cHHHH
Confidence            9999999999999     55554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.97  E-value=7.1e-32  Score=279.20  Aligned_cols=239  Identities=38%  Similarity=0.716  Sum_probs=200.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      ..+|..+++|..|+||.||+++++.     +.+.+|+| ++++.+.-+       +   +|.....|++|          
T Consensus        82 e~df~~IklisngAygavylvrh~~-----trqrfa~k-iNkq~lilR-------n---ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKE-----TRQRFAMK-INKQNLILR-------N---ILTFAGNPFVV----------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccc-----cccchhhc-ccccchhhh-------c---cccccCCccee----------
Confidence            4689999999999999999999986     78899995 444332211       1   44455666666          


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC------------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------------  256 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~------------  256 (431)
                                 |+-...+..-+.++...        +.+++|||+.||+|||+||+|+||+.-|+...            
T Consensus       136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       45555565556666543        88999999999999999999999998876211            


Q ss_pred             --------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 014087          257 --------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  322 (431)
Q Consensus       257 --------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~  322 (431)
                                    .......+|||+.|+|||++..++|++.+|||++|+|+||.+.|..||.++++++++..++...+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                          112345679999999999999999999999999999999999999999999999999999999988


Q ss_pred             CCC---CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcc
Q 014087          323 LPP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKC  396 (431)
Q Consensus       323 ~p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~  396 (431)
                      +|+   .+.+|++++|.++|+.+|..|++.+  ++-++++|.||+.+||..|..++  ..|+|.....+++++||+.
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyfdTR  349 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYFDTR  349 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccchhhhhh--ccccccccccccchhhccc
Confidence            885   4789999999999999999999876  88899999999999999988766  5699999999999999975

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-33  Score=247.74  Aligned_cols=245  Identities=27%  Similarity=0.401  Sum_probs=195.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (431)
                      +.+-.+-||.|+||+||.+.+-.     .|+.||+|.+..-. ..-...+.+-+|+++|...+|.|++..++..+...  
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPR-----dgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPR-----SGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCC-----CccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            35556789999999999988765     89999999886421 22333456778999999999999999999887654  


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc----------
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI----------  255 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~----------  255 (431)
                         .+|+|.|+|.. +|...+..-..++.+.++-+++||+.||+|||+.||.||||||.|+|++.+-...          
T Consensus       128 fFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  128 FFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence               47889999964 8888888878899999999999999999999999999999999999999885421          


Q ss_pred             --CCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------
Q 014087          256 --DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII---------------  317 (431)
Q Consensus       256 --~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~---------------  317 (431)
                        ......+..+-|.+|.|||++.+ ..|+.++||||+|||+.||+..+..|...++.+..+.|.               
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence              11222344466899999999986 568999999999999999999999998877665555443               


Q ss_pred             --------hcccCCC-----------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          318 --------NEKVKLP-----------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       318 --------~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                              .+..+.|           ..-..+..+++.++|..||++|.     +.++.+.|++.....
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri-----s~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI-----SVEEALQHRYLEEGR  350 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc-----cHhhhcccccccccc
Confidence                    1112222           12345788999999999999998     889999999987644

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-31  Score=250.70  Aligned_cols=227  Identities=22%  Similarity=0.404  Sum_probs=179.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh--cCCCCcceeeEEEEe
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~  186 (431)
                      ....+++++||+|.||.||+|+.       .++.||||++...      ..+.+.+|.+|.+.  ++|+||+++++.-..
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-------~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-------DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-------cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence            45678889999999999999986       5688999999643      34567788888774  589999999988766


Q ss_pred             CC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEeCCCCC
Q 014087          187 RS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       187 ~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~iiHrDlKp~NILl~~~g~  253 (431)
                      ..    .++||+||.+.|+|.++|..+ .+++.....|+..++.||.|||+-         .|+|||||..||||..|+.
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            55    799999999999999999876 579999999999999999999963         4999999999999999875


Q ss_pred             cc-------------CCCCCcccccCCCCCCchhhhccCCC------CCcchhHhHHHHHHHHHhCCC------------
Q 014087          254 EI-------------DESSRSNSMCGTTEYMAPEILLSKGH------NKDADWWSVGILLYEMLTGQP------------  302 (431)
Q Consensus       254 ~~-------------~~~~~~~~~~Gt~~y~aPE~~~~~~~------~~~~DvwslGvil~elltg~~------------  302 (431)
                      ..             .........+||..|||||++.+..-      -.+.||||+|.|||||++...            
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            21             12223445789999999999987432      246899999999999998543            


Q ss_pred             CCC-----CCCHHHHHHHHHhc--ccCCCCCC-----CHHHHHHHHhhcccCcCCcCCC
Q 014087          303 PFT-----HANRQKLQQRIINE--KVKLPPFL-----TSEAHSLLKGLLHKDPSKRLGS  349 (431)
Q Consensus       303 Pf~-----~~~~~~~~~~i~~~--~~~~p~~~-----s~~~~~li~~~L~~dP~~R~~~  349 (431)
                      ||.     +.+.+++...+.+.  ++.+|..+     -.-+++.+..||..|++.|+++
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence            332     23455666666554  44455432     3457899999999999999954

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=246.66  Aligned_cols=227  Identities=25%  Similarity=0.401  Sum_probs=175.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh--cCCCCcceeeEEEEe
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~  186 (431)
                      ..+..+.+.||+|.||.||+++++       |+.||||++...     ++ ....+|.+|.+.  |+|+||+.+++.-..
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-------Ge~VAVKiF~sr-----dE-~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-------GEDVAVKIFSSR-----DE-RSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-------CCceEEEEeccc-----ch-hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            457899999999999999999996       467999999643     22 234457777764  599999999887654


Q ss_pred             CC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeCCCCCc
Q 014087          187 RS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       187 ~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDlKp~NILl~~~g~~  254 (431)
                      +.    .+|||.+|-+.|+|+++|.+ ..++.+....++..++.||.|||..        .|.|||||..|||+..+|..
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            43    69999999999999999988 5689999999999999999999953        39999999999999999761


Q ss_pred             ---------------cCCCCCcccccCCCCCCchhhhccCCC------CCcchhHhHHHHHHHHHhC----------CCC
Q 014087          255 ---------------IDESSRSNSMCGTTEYMAPEILLSKGH------NKDADWWSVGILLYEMLTG----------QPP  303 (431)
Q Consensus       255 ---------------~~~~~~~~~~~Gt~~y~aPE~~~~~~~------~~~~DvwslGvil~elltg----------~~P  303 (431)
                                     ...+...+..+||..|||||++...-.      -..+||||||.|+||++..          ++|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence                           112234566799999999999975321      2468999999999999763          578


Q ss_pred             CCC-----CCHHHHHHHHHhc--ccCCCCCC-C----HHHHHHHHhhcccCcCCcCCC
Q 014087          304 FTH-----ANRQKLQQRIINE--KVKLPPFL-T----SEAHSLLKGLLHKDPSKRLGS  349 (431)
Q Consensus       304 f~~-----~~~~~~~~~i~~~--~~~~p~~~-s----~~~~~li~~~L~~dP~~R~~~  349 (431)
                      |.+     .+.+++.+-+.-.  ++.+|... +    ..+..+|+.||..||.-|+++
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            864     3445555555433  33445433 2    235678999999999999943

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=4.1e-31  Score=250.17  Aligned_cols=244  Identities=22%  Similarity=0.431  Sum_probs=188.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      ...|.++++||+|+|++||++.+...  ....+.||+|.+....     ...++.+|+++|..+ .+.||+++.+++..+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34699999999999999999987652  2267889999886533     345688999999998 589999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--------------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------------  253 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~--------------  253 (431)
                      +.+.+||||++..+-.++...   ++..+++.|+..++.||.++|.+|||||||||.|+|.+....              
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999877666644   568899999999999999999999999999999999875411              


Q ss_pred             -----------------c-----------cC--------------CCCCcccccCCCCCCchhhhccCC-CCCcchhHhH
Q 014087          254 -----------------E-----------ID--------------ESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSV  290 (431)
Q Consensus       254 -----------------~-----------~~--------------~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~Dvwsl  290 (431)
                                       .           ..              .........||++|.|||++...+ .+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence                             0           00              000112346999999999998654 5889999999


Q ss_pred             HHHHHHHHhCCCCCCCCC--HH------------HHHHH-HHhcc---------------------c-------------
Q 014087          291 GILLYEMLTGQPPFTHAN--RQ------------KLQQR-IINEK---------------------V-------------  321 (431)
Q Consensus       291 Gvil~elltg~~Pf~~~~--~~------------~~~~~-i~~~~---------------------~-------------  321 (431)
                      |||+..+++++.||-...  ..            ++.+. ...+.                     +             
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999994321  00            00000 00000                     0             


Q ss_pred             ---CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          322 ---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       322 ---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                         ...+..+..+.+|+.+||..||.+|.     ++++.|.||||...+
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRi-----tAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRI-----TAEDALKHPFFDEAD  388 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcc-----cHHHHhcCcCCcchh
Confidence               00122456889999999999999999     889999999998654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=7.1e-29  Score=227.37  Aligned_cols=204  Identities=38%  Similarity=0.628  Sum_probs=173.7

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      |.+.+.||.|++|.||++....     +++.+|+|.+......  ...+.+.+|++.++.++|+||+++++.+......+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence            6778999999999999999875     6788999999865422  24567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------C---
Q 014087          192 LILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------S---  259 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------~---  259 (431)
                      +++||+.+++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.....+        .   
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999999999999988766 89999999999999999999999999999999999999876532111        0   


Q ss_pred             -CcccccCCCCCCchhhh-ccCCCCCcchhHhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcccC
Q 014087          260 -RSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKLQQRIINEKVK  322 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~Pf~~--~~~~~~~~~i~~~~~~  322 (431)
                       ......++..|++||++ ....++.++|||+||+++|||++|+.||..  .+...+.+.|..+...
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence             22445788899999999 667788899999999999999999999977  4455677777766543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=9.9e-29  Score=222.72  Aligned_cols=201  Identities=37%  Similarity=0.636  Sum_probs=174.2

Q ss_pred             ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEecc
Q 014087          118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI  197 (431)
Q Consensus       118 LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~  197 (431)
                      ||+|++|.||++....     +++.+++|++.......  ..+.+.+|+.+++.+.|++|+++++++......++++|++
T Consensus         1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecC-----CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            6899999999999865     68899999987654321  3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCccCCCC-----------Ccccc
Q 014087          198 NGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHEIDESS-----------RSNSM  264 (431)
Q Consensus       198 ~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-~g~~~~~~~-----------~~~~~  264 (431)
                      .|++|..++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.....+.           .....
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            999999998876 57899999999999999999999999999999999999998 554221111           12335


Q ss_pred             cCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCc
Q 014087          265 CGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP  343 (431)
Q Consensus       265 ~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  343 (431)
                      .+...|++||.+... .++.+.|+|++|+++++|                               ..+.+++.+||..||
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCc
Confidence            578899999999887 888999999999999999                               678999999999999


Q ss_pred             CCcCCCCCCCHHHHHhCC
Q 014087          344 SKRLGSGPGGVDAIKHHK  361 (431)
Q Consensus       344 ~~R~~~~~~~~~~i~~h~  361 (431)
                      ++||     +++++++|+
T Consensus       203 ~~R~-----~~~~l~~~~  215 (215)
T cd00180         203 EKRP-----SAKEILEHL  215 (215)
T ss_pred             ccCc-----CHHHHhhCC
Confidence            9999     889998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.2e-29  Score=271.58  Aligned_cols=187  Identities=18%  Similarity=0.194  Sum_probs=140.8

Q ss_pred             hcCC-CCcceeeEEE-------EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 014087          171 KVTH-PFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDL  241 (431)
Q Consensus       171 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDl  241 (431)
                      .++| .||++++++|       .....+++++|++ +++|.++|... ..+++.+++.|+.||+.||.|||++|||||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3445 5777788877       2334678889987 56999999753 56999999999999999999999999999999


Q ss_pred             CCCceEeCCCCCc-------------------cCCCC---------------------------CcccccCCCCCCchhh
Q 014087          242 KPENILMDSDGHE-------------------IDESS---------------------------RSNSMCGTTEYMAPEI  275 (431)
Q Consensus       242 Kp~NILl~~~g~~-------------------~~~~~---------------------------~~~~~~Gt~~y~aPE~  275 (431)
                      ||+||||+..|..                   ...+.                           .....+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999643210                   00000                           0012468899999999


Q ss_pred             hccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCH
Q 014087          276 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGV  354 (431)
Q Consensus       276 ~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~  354 (431)
                      +.+..|+.++|||||||+||||++|..|+....  .....+.....+ .......+..+++.+||++||.+||     ++
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp-----s~  259 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP-----SM  259 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc-----Ch
Confidence            999999999999999999999999999885421  222222221111 0111245678999999999999999     88


Q ss_pred             HHHHhCCCCCC
Q 014087          355 DAIKHHKWFRS  365 (431)
Q Consensus       355 ~~i~~h~~f~~  365 (431)
                      .+|++||||..
T Consensus       260 ~eil~h~~~~~  270 (793)
T PLN00181        260 SELLQSEFINE  270 (793)
T ss_pred             HHHhhchhhhh
Confidence            99999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.6e-29  Score=223.03  Aligned_cols=228  Identities=24%  Similarity=0.343  Sum_probs=176.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeE-EEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY-SFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~  187 (431)
                      +.|.+.+.||+|.||.+-+|++++     +...+++|.+.+.....    ..|.+|...--.| .|.||+.-|+ .|++.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~-----s~t~ivlKavp~p~tt~----~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQ-----SKTRIVLKAVPRPQTTQ----ADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccC-----CceEEEeeccCcchhhH----HHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            359999999999999999999998     88899999998765433    3456666654445 5899998764 58899


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-c-cCCCCCccccc
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-E-IDESSRSNSMC  265 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-~-~~~~~~~~~~~  265 (431)
                      +.++++|||++.|+|..-+...| +-|...+.++.|+++||+|||++++||||||.+||||-.... . ..-+...+...
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999999999988776654 789999999999999999999999999999999999855432 1 11222233333


Q ss_pred             C--------CCCCCchhhhccC-----CCCCcchhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHH-hcccCCCC--
Q 014087          266 G--------TTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRII-NEKVKLPP--  325 (431)
Q Consensus       266 G--------t~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~-~~~~~~p~--  325 (431)
                      |        +..|.+||++...     ...+.+|+|.||+++|.+|||++||....    ...-+.+.. ......|.  
T Consensus       174 g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  174 GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence            4        4579999988643     23678999999999999999999997422    111222222 23344554  


Q ss_pred             -CCCHHHHHHHHhhcccCcCCcC
Q 014087          326 -FLTSEAHSLLKGLLHKDPSKRL  347 (431)
Q Consensus       326 -~~s~~~~~li~~~L~~dP~~R~  347 (431)
                       .+++.+..+.++-|..++++|-
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccc
Confidence             4789999999999999999993

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.9e-27  Score=208.71  Aligned_cols=154  Identities=20%  Similarity=0.233  Sum_probs=122.4

Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----CcccccCCCCCCchh
Q 014087          200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----RSNSMCGTTEYMAPE  274 (431)
Q Consensus       200 g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----~~~~~~Gt~~y~aPE  274 (431)
                      |+|.+++..+ ..+++.+++.|+.||+.||.|||+++      ||+|||++.++.......    ......||+.|||||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~fG~~~~~~~~~~~g~~~y~aPE   74 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKLDGSVAFKTPEQSRVDPYFMAPE   74 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceeeccceEeeccccCCCcccccChH
Confidence            6899999874 46999999999999999999999998      999999999886443110    012336899999999


Q ss_pred             hhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccCC-------CCCCCH--HHHHHHHhhcccCcC
Q 014087          275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKL-------PPFLTS--EAHSLLKGLLHKDPS  344 (431)
Q Consensus       275 ~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~li~~~L~~dP~  344 (431)
                      ++.+..|+.++|||||||++|||++|+.||..... ......+.......       +..++.  +++++|.+||..||.
T Consensus        75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~  154 (176)
T smart00750       75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQ  154 (176)
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccc
Confidence            99999999999999999999999999999976433 23333333322211       122333  699999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCC
Q 014087          345 KRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~  364 (431)
                      +||     ++.+++.|+|+.
T Consensus       155 ~Rp-----~~~~ll~~~~~~  169 (176)
T smart00750      155 RRE-----AANHYLAHCRAL  169 (176)
T ss_pred             ccc-----CHHHHHHHHHHH
Confidence            999     889999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.9e-24  Score=207.24  Aligned_cols=241  Identities=38%  Similarity=0.636  Sum_probs=196.4

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC-CcceeeEEEEeCCEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSKL  190 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~  190 (431)
                      |.+.+.||.|+||.||++.+.        ..+++|.+.............+.+|+.++..+.|+ +|+++++.+......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence            788999999999999999875        56899999887654444577788999999999988 799999999888889


Q ss_pred             EEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-c-cC---------
Q 014087          191 YLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-E-ID---------  256 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-~-~~---------  256 (431)
                      +++++++.+++|.+.+....   .+.+..+..++.|++.++.|+|+.|++|||+||+||+++..+. . +.         
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999999997777664   7999999999999999999999999999999999999998872 1 10         


Q ss_pred             CC-------CCcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccC
Q 014087          257 ES-------SRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVK  322 (431)
Q Consensus       257 ~~-------~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~  322 (431)
                      ..       ......+||..|+|||.+.+   ..+....|+|++|++++++++|..||....    .......+......
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            00       12356789999999999998   578899999999999999999999988765    34555555544433


Q ss_pred             -CCCCCC--------HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          323 -LPPFLT--------SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       323 -~p~~~s--------~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                       ......        ..+.+++.+++..+|..|.     +..+...+.|...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~-----~~~~~~~~~~~~~  280 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRL-----SSSSDLSHDLLAH  280 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcC-----CHHHHhhchHhhC
Confidence             222221        5789999999999999999     5555555544443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.8e-27  Score=244.95  Aligned_cols=249  Identities=27%  Similarity=0.429  Sum_probs=191.8

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeeh---hhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ....++|.|++|.|+.+....     ....++.|..+.   ...........+..|.-+-..+.||||+..+..+.+...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~-----~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS-----DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecC-----CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            456789999999888877664     333344443331   111122222236667777788899999988777777777


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-------------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-------------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-------------  256 (431)
                      .+-+||||++ +|+..+...+.+...++-.++.|++.||.|||..||.|||||++|++++.+|....             
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            6667999999 99999999888999999999999999999999999999999999999999875211             


Q ss_pred             CC--CCcccccCCCCCCchhhhccCCCCC-cchhHhHHHHHHHHHhCCCCCCCCCHHHHH-HH--------HHhcccCCC
Q 014087          257 ES--SRSNSMCGTTEYMAPEILLSKGHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQ-QR--------IINEKVKLP  324 (431)
Q Consensus       257 ~~--~~~~~~~Gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltg~~Pf~~~~~~~~~-~~--------i~~~~~~~p  324 (431)
                      ..  .....++|+..|+|||++.+..|+. .+||||.||+++.|.+|+.||......+-. ..        +..+...+-
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence            11  3456778999999999999999976 589999999999999999999754333221 11        111111222


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHh
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  372 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~  372 (431)
                      ..++.+.+.+|.+||+.||.+|.     ++++|++.+||+.++-+.+.
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~-----ti~~i~~d~W~~~i~~c~v~  597 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRI-----TIEQILNDEWIRSIECCHVD  597 (601)
T ss_pred             HhchhhHHHHHHHHccCChhhee-----cHHHHhhChHhhhcceEEec
Confidence            35788899999999999999999     99999999999998765443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-24  Score=189.12  Aligned_cols=260  Identities=19%  Similarity=0.248  Sum_probs=199.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC-CCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~  184 (431)
                      .+..+.|.++++||.|+||.+|++....     .|..||||+-....-     -..+..|..+.+.+++ ..|..+..++
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~-----~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISIT-----SGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeecc-----CCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhc
Confidence            3556789999999999999999999886     899999998765431     1246679999998874 7888888888


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc---------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE---------  254 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~---------  254 (431)
                      .+...-.+||+++ |-+|.+++.- ...|+...+..++-|++.-++|+|.+++|||||||+|+|+.-+-+.         
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence            9999999999998 6788887763 4579999999999999999999999999999999999998765331         


Q ss_pred             ------------cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhc
Q 014087          255 ------------IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINE  319 (431)
Q Consensus       255 ------------~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~  319 (431)
                                  ...-.....+.||..|.+-....+...+...|+=|+|.+|..+.-|..||.+.   +..+-+++|...
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK  239 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence                        01112345678999999999888888899999999999999999999999874   344556777777


Q ss_pred             ccCCC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh-------CCCCCCCChhhHhcccCCC
Q 014087          320 KVKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH-------HKWFRSINWKTLEAREMQP  378 (431)
Q Consensus       320 ~~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~-------h~~f~~~~~~~l~~~~~~p  378 (431)
                      +...|     ..++.|+.-.|.-|-..-=++-|...  -+.++..       |.+=--.||..++++.-+.
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~--ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~  308 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM--YLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQS  308 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH--HHHHHHHHHHhhccccCCeEeeHHHHHHHhhcc
Confidence            76665     35788888888877544444444211  1344433       2222236899998665443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.6e-23  Score=199.04  Aligned_cols=229  Identities=22%  Similarity=0.338  Sum_probs=176.7

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC----CCcceeeEEE-E
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----PFIVQLRYSF-Q  185 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~  185 (431)
                      +|.+.++||+|+||.||+|.+...    ....+|+|+.........   ..+..|+.+|..+..    .++..+++.+ .
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~----~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE----KNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC----CCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence            799999999999999999998751    145799998765432111   146779999998863    6899999999 5


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----Cc---c-
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HE---I-  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g----~~---~-  255 (431)
                      .+..-|+||+.+ |-+|.++....  +.|+...+..++.|++.+|++||+.|+|||||||+|+++...+    ..   + 
T Consensus        92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            788899999988 77999887654  5799999999999999999999999999999999999998764    10   0 


Q ss_pred             -------C---CC------C-C-cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014087          256 -------D---ES------S-R-SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  317 (431)
Q Consensus       256 -------~---~~------~-~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~  317 (431)
                             .   ..      . . ...+.||..|+++.+..+...+.+.|+||++.++.||+.|..||.+.........+.
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence                   0   00      0 0 123459999999999999999999999999999999999999997654322222222


Q ss_pred             h---c-ccC-CCCCCCHHHHHHHHhhcccCcCCcC
Q 014087          318 N---E-KVK-LPPFLTSEAHSLLKGLLHKDPSKRL  347 (431)
Q Consensus       318 ~---~-~~~-~p~~~s~~~~~li~~~L~~dP~~R~  347 (431)
                      .   . ... +....+.++.++...+-..+...+|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  285 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP  285 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence            1   1 111 2334567778888777778888888

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.2e-23  Score=205.11  Aligned_cols=157  Identities=22%  Similarity=0.207  Sum_probs=118.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHhcCCCCcce-eeEEE
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQ-LRYSF  184 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~  184 (431)
                      ..++|.+.+.||+|+||+||+|+++.    .+++.+|||++.....  ........+.+|+++|+.++|+||+. +++  
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAG----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcC----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            34679999999999999999998764    2567789998753311  12334566899999999999999985 443  


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeCCCCCccCCC-----
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHEIDES-----  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDl-Kp~NILl~~~g~~~~~~-----  258 (431)
                        .+..|+||||++|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.....+     
T Consensus        90 --~~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             --cCCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence              246899999999999962 211   11   1467899999999999999999999 99999998876521111     


Q ss_pred             --------------CCcccccCCCCCCchhhhccC
Q 014087          259 --------------SRSNSMCGTTEYMAPEILLSK  279 (431)
Q Consensus       259 --------------~~~~~~~Gt~~y~aPE~~~~~  279 (431)
                                    ....+.+|+..|+|||++.-.
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence                          111356788899999999743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.8e-24  Score=223.18  Aligned_cols=285  Identities=32%  Similarity=0.569  Sum_probs=242.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...+++.+.+-+-+|+++.++.++-..     ++...+.|+..+.........+..+.+..++-..++|.++.....+..
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~-----sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAG-----SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccc-----cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            456678888899999999999887665     666777887766655556556666667777776778998887777778


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------  256 (431)
                      ....+||++|+.|++|...++.-+..+++-++.++..+..+++|||...++|||++|.|+|+..+|+...          
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence            8899999999999999999999888999999999999999999999999999999999999988765100          


Q ss_pred             --------------------------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCC
Q 014087          257 --------------------------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF  304 (431)
Q Consensus       257 --------------------------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf  304 (431)
                                                      .........||+.|.+||.+.+......+|||++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                                            001123457899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCCC---CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcc
Q 014087          305 THANRQKLQQRIINEKVKLPP---FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK  381 (431)
Q Consensus       305 ~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~  381 (431)
                      .....+.+++.|.+..+.+|.   ..+.++++++.++|..+|.+|.++.  ...++..|+||+.++|+.+..+.  ..|.
T Consensus      1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~--~~~~ 1111 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQK--AEFV 1111 (1205)
T ss_pred             CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc--cccccccCCccCCCCcccccccc--CccC
Confidence            999999999999999888764   5899999999999999999999775  56789999999999999998765  4678


Q ss_pred             cCCCCCcccCCCCcccCCC
Q 014087          382 PDVSGKDCIANFDKCWTTM  400 (431)
Q Consensus       382 p~~~~~~~~~~f~~~~~~~  400 (431)
                      |...+..|+++|...|...
T Consensus      1112 p~~~s~~dtS~~~~r~~~~ 1130 (1205)
T KOG0606|consen 1112 PQPESTQDTSYFESRFSEE 1130 (1205)
T ss_pred             CCCCCCCccchhhcccccc
Confidence            8888889999999888743

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1e-22  Score=185.34  Aligned_cols=175  Identities=16%  Similarity=0.165  Sum_probs=129.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHH------HHHHHHHHHhcCCCCccee
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVTHPFIVQL  180 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l  180 (431)
                      +-.++|+++++||.|+||.||++..       +++.+|+|+++............      +.+|+..+.++.|++|..+
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            4467899999999999999998643       34469999998665444444333      6789999999999999999


Q ss_pred             eEEEEeC--------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          181 RYSFQTR--------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       181 ~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      .+++...        +..+|||||++|.+|.+..    .+++.    ...+++.+|..||+.|++|||+||+||+++.+|
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence            8886643        3589999999999997763    23332    456999999999999999999999999999888


Q ss_pred             CccCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHH
Q 014087          253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML  298 (431)
Q Consensus       253 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  298 (431)
                       ....+..... ........-.++....|+.++|+|+|||++.-+.
T Consensus       173 -i~liDfg~~~-~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKR-CTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcc-cccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence             3222211111 1111111122444567888999999999876554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1e-21  Score=181.20  Aligned_cols=197  Identities=20%  Similarity=0.316  Sum_probs=163.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (431)
                      .|+++++||+|+||+++.++..-     +++.||||.-....     ..-+++.|.+..+.|. .++|...|.+.+++.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~-----nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLY-----NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             cceeccccccCcceeeecccccc-----cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            59999999999999999998764     78999999754322     2345777888888884 7999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc-------c------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------I------  255 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~-------~------  255 (431)
                      -.||||++ |-+|.+++.-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||..-|..       +      
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99999998 66888877644 469999999999999999999999999999999999999876541       0      


Q ss_pred             ----------CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh
Q 014087          256 ----------DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIIN  318 (431)
Q Consensus       256 ----------~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~  318 (431)
                                ..-....++.||..||+-....+...+...|+=|||-++...|-|..||.+.   +..+-+++|-.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence                      0112335678999999999999999999999999999999999999999873   44455566643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-23  Score=216.38  Aligned_cols=225  Identities=24%  Similarity=0.384  Sum_probs=170.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhh-hhh-hhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-IIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~-~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      +|...+.||.+.|=+|.+|+++      .| .|+||++-+.. ... ....+++ +|++ ...++|||++.+.-+..++.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~------eG-~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR------EG-LVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC------Cc-eEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhH
Confidence            6888999999999999999875      34 48999986653 222 2233333 3555 66679999999988888888


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc------------cC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------ID  256 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~------------~~  256 (431)
                      ..|||-+|+.. +|++.+.-+..+..-+.+-|+.||+.||.-+|+.||+|+|||.+||||+.=.=.            +.
T Consensus        95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            89999999976 899999988888999999999999999999999999999999999999753210            00


Q ss_pred             CC--CCcccccC----CCCCCchhhhccCC-----------CCCcchhHhHHHHHHHHHh-CCCCCCC-----------C
Q 014087          257 ES--SRSNSMCG----TTEYMAPEILLSKG-----------HNKDADWWSVGILLYEMLT-GQPPFTH-----------A  307 (431)
Q Consensus       257 ~~--~~~~~~~G----t~~y~aPE~~~~~~-----------~~~~~DvwslGvil~ellt-g~~Pf~~-----------~  307 (431)
                      .+  ....-+..    -..|+|||.+....           .+++.||||+||++.||++ |++||.-           .
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            00  01111112    23699999987532           4577899999999999999 8999942           1


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          308 NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       308 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +.+.+.+.|          -+..++.+|..|++.||++|+     ++++.++.
T Consensus       254 ~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~Rl-----SAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKI----------EDVSLRNLILSMIQRDPSKRL-----SAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhC----------cCccHHHHHHHHHccCchhcc-----CHHHHHHh
Confidence            222223322          234789999999999999999     77898874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.2e-23  Score=184.85  Aligned_cols=233  Identities=22%  Similarity=0.338  Sum_probs=188.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++..++.+|.+.-.|..|++++.+       .-++.|++.-....... ...|.+|.-.|+...||||+.+++.+..
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqg-------ndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQG-------NDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccC-------cchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccC
Confidence            444567778889999999999999964       33666777655443322 2347778888999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCccC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHEID------  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~~~~------  256 (431)
                      ..++.++..||+.|+|+..+.....  ++..++..++.+|+.|+.|||+..  |.---|....++||++-....      
T Consensus       259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence            9999999999999999999987643  678899999999999999999864  444478889999998854211      


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCC---CcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFLTSEA  331 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~  331 (431)
                      .........-.+.||+||.+..++.+   .++|+|||+++||||.|...||....+.+.--+|.-+  ++.+|+.++...
T Consensus       339 fsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  339 FSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             eeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence            11112223347899999999987664   5789999999999999999999988888776666433  667899999999


Q ss_pred             HHHHHhhcccCcCCcC
Q 014087          332 HSLLKGLLHKDPSKRL  347 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~  347 (431)
                      ..|+.-|+..||.+||
T Consensus       419 ~klm~icmnedpgkrp  434 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRP  434 (448)
T ss_pred             HHHHHHHhcCCCCcCC
Confidence            9999999999999999

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.4e-21  Score=183.11  Aligned_cols=226  Identities=23%  Similarity=0.329  Sum_probs=143.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC----------CCccee
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----------PFIVQL  180 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h----------pnIv~l  180 (431)
                      .+...+.||.|+++.||.|++..     +++.+|||+............+.+++|.-....+.+          -.++.-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~-----t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE-----TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEEcc-----CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            36778999999999999999986     899999998876554455567777777654444322          112222


Q ss_pred             eEEE---------EeC---C-----EEEEEEeccCCCChHHHHH---HcCCC---CHHHH-HHHHHHHHHHHHHHHHCCc
Q 014087          181 RYSF---------QTR---S-----KLYLILDFINGGHLFFHLY---RQGIF---REDQA-RFYTAEIVSAVSHLHKCGI  236 (431)
Q Consensus       181 ~~~~---------~~~---~-----~~~lv~E~~~gg~L~~~l~---~~~~~---~~~~~-~~i~~qi~~aL~~LH~~~i  236 (431)
                      ++..         ...   .     ..+++|+-+. ++|.+.+.   .....   ....+ ..+..|++..+.+||..||
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl  166 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL  166 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence            2222         111   1     2367788774 47876654   22222   11223 3455899999999999999


Q ss_pred             eeccCCCCceEeCCCCCccCCCCCc--------ccccCCCCCCchhhhccC--------CCCCcchhHhHHHHHHHHHhC
Q 014087          237 VHRDLKPENILMDSDGHEIDESSRS--------NSMCGTTEYMAPEILLSK--------GHNKDADWWSVGILLYEMLTG  300 (431)
Q Consensus       237 iHrDlKp~NILl~~~g~~~~~~~~~--------~~~~Gt~~y~aPE~~~~~--------~~~~~~DvwslGvil~elltg  300 (431)
                      ||+||||+|+|++.+|.....+...        .....+..|.+||.....        .++.+.|.|+||+++|.|+||
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999854332211        112345779999987542        468889999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCc
Q 014087          301 QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR  346 (431)
Q Consensus       301 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R  346 (431)
                      +.||..............   ... .+++..++||+++|++||.+|
T Consensus       247 ~lPf~~~~~~~~~~~~f~---~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEWDFS---RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGGGGT---TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccccch---hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999986433222111111   112 578899999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.5e-22  Score=188.05  Aligned_cols=259  Identities=28%  Similarity=0.385  Sum_probs=174.8

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCC-----C-------------------------CCCcEEEEEEeehhhhhh
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD-----G-------------------------DSDGIYAMKVMRKDTIIK  155 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~-----~-------------------------~~~~~~avK~~~~~~~~~  155 (431)
                      .+..++|++++.||+|..+.||.++......     +                         ...-..|||.|-.-...+
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            4567889999999999999999987654100     0                         011135667653221111


Q ss_pred             --hhHHHHHHHHHH------H-----------HH----h-cCCCCcceeeEEEEe-------------------------
Q 014087          156 --KNHVDYMKAERD------I-----------LT----K-VTHPFIVQLRYSFQT-------------------------  186 (431)
Q Consensus       156 --~~~~~~~~~E~~------i-----------l~----~-l~hpnIv~l~~~~~~-------------------------  186 (431)
                        ...++.+-+|..      +           +.    . -.|||||++..+|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence              111122222221      1           11    1 259999999887743                         


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CC---------
Q 014087          187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GH---------  253 (431)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~--g~---------  253 (431)
                        ...+|+||...+. +|..++-.+. .+....+-|+.|+++|+.|||++||.|||+|.+||||.-+  +.         
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence              2358999988765 8888887665 4777888899999999999999999999999999998543  22         


Q ss_pred             ----------ccCCCCCcccccCCCCCCchhhhccCCC------CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Q 014087          254 ----------EIDESSRSNSMCGTTEYMAPEILLSKGH------NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-  316 (431)
Q Consensus       254 ----------~~~~~~~~~~~~Gt~~y~aPE~~~~~~~------~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i-  316 (431)
                                ...........-|...-||||+....+-      -.++|.|+.|.+.||+++...||.+....-+-.+- 
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence                      0111112223357778999999975432      35789999999999999999999874332221111 


Q ss_pred             -HhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          317 -INEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       317 -~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                       ...-..+|+.+++.+++|+..+|++||++|++..  -+..+++--.|..-+|
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~--iAANvl~LsLw~~~~~  521 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN--IAANVLNLSLWRMGED  521 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc--HHHhHHHHHHhcCchH
Confidence             1234457888999999999999999999999753  4455555444444444

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.8e-21  Score=174.52  Aligned_cols=128  Identities=17%  Similarity=0.255  Sum_probs=99.8

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhh-----------------------HHHHHHHHHHHHHh
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------------------HVDYMKAERDILTK  171 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~E~~il~~  171 (431)
                      ...||+|+||.||+|.+.      +|+.||||+++........                       .......|+++|..
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05147           2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR   75 (190)
T ss_pred             CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            467999999999999874      6889999999865321111                       01233469999999


Q ss_pred             cCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEeCC
Q 014087          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       172 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDlKp~NILl~~  250 (431)
                      +.+++|.........  ..+|||||+.|+++...+.+.+.+++..+..++.|++.+|.+| |+.||+||||||+|||++.
T Consensus        76 l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~  153 (190)
T cd05147          76 LVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD  153 (190)
T ss_pred             HHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC
Confidence            988776443332222  2389999999988866655567899999999999999999999 7999999999999999984

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=5.6e-20  Score=166.64  Aligned_cols=126  Identities=18%  Similarity=0.190  Sum_probs=99.5

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-----CCCCcceeeEEEEeC
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTR  187 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~  187 (431)
                      .-.+.||+|+||.||.  +..     ++. .+||++....   ....+.+.+|+.+++.+     +||||++++++++++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~-----~~~-k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~   73 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE-----DAQ-RCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD   73 (210)
T ss_pred             CCcceecCCCceEEEE--CCC-----CcC-eEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence            3457899999999995  443     333 3799887643   22345688999999999     579999999999987


Q ss_pred             C---EEE-EEEec--cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCceEeCCCC
Q 014087          188 S---KLY-LILDF--INGGHLFFHLYRQGIFREDQARFYTAEIVSAV-SHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       188 ~---~~~-lv~E~--~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      .   .++ +|+||  +.+|+|.+++.+. .+++.  ..++.|++.++ +|||+++||||||||+|||++..+
T Consensus        74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~  142 (210)
T PRK10345         74 CGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS  142 (210)
T ss_pred             CCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC
Confidence            4   434 78999  5589999999664 56666  35678888888 999999999999999999998643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=7.4e-20  Score=164.41  Aligned_cols=131  Identities=19%  Similarity=0.246  Sum_probs=101.7

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-----------------------hhHHHHHHHHHHHHHh
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKAERDILTK  171 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~E~~il~~  171 (431)
                      .+.||+|+||+||+|++.      +|+.||||+++......                       ......+..|...+.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999999864      67899999998753110                       0012334679999999


Q ss_pred             cCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCC
Q 014087          172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (431)
Q Consensus       172 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~  250 (431)
                      +.|++|.....+....  .||||||++|+++.........+++.++..++.|++.+|.+||. +||+||||||+|||++ 
T Consensus        76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-  152 (190)
T cd05145          76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence            9999875544433332  48999999998665443345678899999999999999999999 9999999999999998 


Q ss_pred             CCCc
Q 014087          251 DGHE  254 (431)
Q Consensus       251 ~g~~  254 (431)
                      ++..
T Consensus       153 ~~~~  156 (190)
T cd05145         153 DGKP  156 (190)
T ss_pred             CCCE
Confidence            5543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.5e-19  Score=159.92  Aligned_cols=178  Identities=16%  Similarity=0.185  Sum_probs=127.1

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh-hHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (431)
                      +.+...|++|+||+||++..       .+..++.+.+........ -....+.+|+++|+++. |++|++++++    +.
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             cccceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            34578899999999997654       455666665554332111 11225789999999995 5889999886    45


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeCCCCCccCCCCCccc-----
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHEIDESSRSNS-----  263 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDl-Kp~NILl~~~g~~~~~~~~~~~-----  263 (431)
                      .|++|||+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.....+.....     
T Consensus        73 ~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             EEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            7999999999998654321      1 2357789999999999999999999 7999999988763221111100     


Q ss_pred             -------------------ccCCCCCCchhhhccC--CCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 014087          264 -------------------MCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHA  307 (431)
Q Consensus       264 -------------------~~Gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~Pf~~~  307 (431)
                                         ..+++.|+.|+.....  .--...+|++.|+-+|.++|+..++-++
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                               1246778888765432  2225679999999999999999887554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=3e-20  Score=196.82  Aligned_cols=185  Identities=19%  Similarity=0.359  Sum_probs=150.4

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRY  182 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~  182 (431)
                      .+....|.+-+.||+|+||+||+|...      .++.||||+-+.....+--...      +++.+|+   -+-|+.+..
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHH
Confidence            355678999999999999999999876      4899999998765543322222      2333333   345666777


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---------
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------  253 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---------  253 (431)
                      .+.-.+..+||+||.+.|+|.+++...+.+++..+.+++.|++..+++||..||||+||||+|+||...-.         
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence            77777888999999999999999998889999999999999999999999999999999999999965321         


Q ss_pred             ------c-----cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCC
Q 014087          254 ------E-----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP  302 (431)
Q Consensus       254 ------~-----~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~  302 (431)
                            .     ..........++|-.+-++|+..|+.++..+|.|.|+.+++.||.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence                  1     112234456688999999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=2.1e-18  Score=159.95  Aligned_cols=133  Identities=23%  Similarity=0.217  Sum_probs=102.5

Q ss_pred             CceEEeeecccCceEEEEEE-EcCCCCCCCCcEEEEEEeehhhhhh---------------------hhHHHHHHHHHHH
Q 014087          111 DFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRKDTIIK---------------------KNHVDYMKAERDI  168 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~-~~~~~~~~~~~~~avK~~~~~~~~~---------------------~~~~~~~~~E~~i  168 (431)
                      .|.+.+.||+|+||.||+|. +..     +|+.||||+++......                     ......+..|+.+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDG-----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCC-----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            48899999999999999998 443     78899999997643110                     0011345789999


Q ss_pred             HHhcCCCC--cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCc
Q 014087          169 LTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPEN  245 (431)
Q Consensus       169 l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-iiHrDlKp~N  245 (431)
                      ++.+.+.+  +.++++   . ...|+||||+.|++|.........+...++..++.||+.+|.+||++| |+||||||+|
T Consensus       104 L~~L~~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      104 LQRLYEAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             HHHHHhcCCCCCeeeE---e-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            99997533  333333   2 235899999999888766545556677778899999999999999999 9999999999


Q ss_pred             eEeCCCCC
Q 014087          246 ILMDSDGH  253 (431)
Q Consensus       246 ILl~~~g~  253 (431)
                      |+++ ++.
T Consensus       180 Ili~-~~~  186 (237)
T smart00090      180 ILVH-DGK  186 (237)
T ss_pred             EEEE-CCC
Confidence            9998 443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=2.5e-17  Score=150.28  Aligned_cols=123  Identities=17%  Similarity=0.263  Sum_probs=101.5

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +.||+|++|.||+|++       .+..+++|+......     ........+.+|+.++..+.|++|.....++.+.+..
T Consensus         2 ~~l~~G~~~~vy~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEee-------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            5799999999999986       345688997653221     1122234677899999999999988877777778889


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~  249 (431)
                      ++||||++|++|.+.+.....    ....++.+++.+|.+||+.|++|||++|.|||++
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~  129 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS  129 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence            999999999999998865432    7888999999999999999999999999999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=5.9e-20  Score=190.57  Aligned_cols=245  Identities=27%  Similarity=0.467  Sum_probs=194.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (431)
                      .|.+.+.||+|+|+.|-++....    .....+|+|.+.... ........+..|..+-+.+. |.|++++++.....+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~----~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSR----DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcC----CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            48888889999999998776543    245567777665443 23445566667888888886 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCC-Ccc----------
Q 014087          190 LYLILDFINGGHLFFHL-YRQG-IFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDG-HEI----------  255 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l-~~~~-~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDlKp~NILl~~~g-~~~----------  255 (431)
                      .+++++|..|++++..+ .... .++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ ...          
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999999988 5544 6788899999999999999999 99999999999999999988 311          


Q ss_pred             ----CCCCCcccccC-CCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc----ccCCC
Q 014087          256 ----DESSRSNSMCG-TTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRIINE----KVKLP  324 (431)
Q Consensus       256 ----~~~~~~~~~~G-t~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~-~~i~~~----~~~~p  324 (431)
                          .........+| ++.|+|||...+.. .....|+||.|+++.-|++|..|+......... ......    .....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence                11112234578 99999999999854 467899999999999999999999764433211 111111    12334


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ..++....+++.++|..+|..|.     +++++..++|+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~-----s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRL-----SIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhcc-----ccccccccccccc
Confidence            56889999999999999999999     8899999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=4.2e-18  Score=166.70  Aligned_cols=163  Identities=25%  Similarity=0.340  Sum_probs=123.0

Q ss_pred             CEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc---------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------  255 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~---------  255 (431)
                      .++|+.|++|.-.+|.++|.++.   ..+....+.++.|++.|++|   +|.+|||+||.||+...+....         
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35899999999999999998653   35667888999999999999   9999999999999988775311         


Q ss_pred             -C-------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC--CC
Q 014087          256 -D-------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK--LP  324 (431)
Q Consensus       256 -~-------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~--~p  324 (431)
                       .       .....+..+||..||+||.+.++.|+.++||||||++|+||+. -...|.   .......+..+.++  +-
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFL  482 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHh
Confidence             0       1123456689999999999999999999999999999999998 444442   22334444444433  11


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW  362 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~  362 (431)
                      .. -++-.+|+..||.+.|.+||     .+.+.-.|.|
T Consensus       483 ~d-~p~e~~ll~~lls~~p~~RP-----~~~~~~~~~~  514 (516)
T KOG1033|consen  483 QD-YPEEYTLLQQLLSPSPEERP-----SAIEVALHEF  514 (516)
T ss_pred             hc-CcHHHHHHHHhcCCCcccCc-----hHHHHhhhhh
Confidence            11 23456999999999999999     4445444554

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=9.8e-17  Score=145.02  Aligned_cols=122  Identities=19%  Similarity=0.192  Sum_probs=96.0

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEE
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  191 (431)
                      .||+|+||.||++.+       .+..+++|+......     ........+.+|+++++.+.|+++.....++......+
T Consensus         1 ~ig~G~~~~vy~~~~-------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec-------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            489999999999985       456689998654321     11223466788999999999887665555556677789


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      +||||++|++|.+.+.....       .++.+++.+|.+||+.|++|||+||.||+++ ++.
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~  127 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK  127 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc
Confidence            99999999999888755321       7889999999999999999999999999998 444

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=4.7e-16  Score=161.46  Aligned_cols=124  Identities=19%  Similarity=0.194  Sum_probs=98.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehh-----hhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-----TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .|...+.||+|+||+||++.+..       ..+++|+....     ........+.+.+|+++++.++|++|+....++.
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~-------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG-------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC-------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            35678999999999999988753       22344432211     1112233466889999999999999998877777


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~  249 (431)
                      +....++||||++|++|.+++.        ....++.|++.+|.+||+.||+||||||+|||++
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~  462 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR  462 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE
Confidence            7778899999999999988875        3567899999999999999999999999999994

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=4e-16  Score=141.05  Aligned_cols=128  Identities=19%  Similarity=0.166  Sum_probs=97.2

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-------------------hhHHHHHHHHHHHHHhc
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------KNHVDYMKAERDILTKV  172 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------~~~~~~~~~E~~il~~l  172 (431)
                      |.+.+.||+|+||.||++...      +++.+|||+++.....-                   .........|..++..+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            888899999999999999864      68889999876532100                   00112356788899998


Q ss_pred             CCCC--cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q 014087          173 THPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       173 ~hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  250 (431)
                      .|++  +...++    ....++||||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.
T Consensus        91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence            8774  444443    2456899999999998654321      346678899999999999999999999999999998


Q ss_pred             CCCcc
Q 014087          251 DGHEI  255 (431)
Q Consensus       251 ~g~~~  255 (431)
                      ++...
T Consensus       161 ~~~~~  165 (198)
T cd05144         161 DEKIY  165 (198)
T ss_pred             CCcEE
Confidence            76543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.65  E-value=9.7e-16  Score=152.72  Aligned_cols=186  Identities=22%  Similarity=0.271  Sum_probs=143.4

Q ss_pred             HHhcCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCce
Q 014087          169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI-VHRDLKPENI  246 (431)
Q Consensus       169 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i-iHrDlKp~NI  246 (431)
                      |+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+... -.++.--...++++|+.||.|||.--| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45689999999999999999999999999999999999874 457777888899999999999998655 9999999999


Q ss_pred             EeCCCCCccCCCCCcccc-------------cCCCCCCchhhhccCC-------CCCcchhHhHHHHHHHHHhCCCCCCC
Q 014087          247 LMDSDGHEIDESSRSNSM-------------CGTTEYMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQPPFTH  306 (431)
Q Consensus       247 Ll~~~g~~~~~~~~~~~~-------------~Gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~elltg~~Pf~~  306 (431)
                      ++|..-.....+......             .-..-|.|||++....       .+.+.||||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999875432221111111             1234689999998642       35679999999999999999999975


Q ss_pred             ----CCHHHHHHHHHh-cccCC-CC-----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          307 ----ANRQKLQQRIIN-EKVKL-PP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       307 ----~~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                          .+..++..++.. +...+ |.     .+.+++..++++||..+|.+||     +++.|..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rP-----s~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRP-----SIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCc-----cHHHHHh
Confidence                233456666665 22211 21     3455799999999999999999     6666543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=1.7e-15  Score=135.49  Aligned_cols=127  Identities=20%  Similarity=0.264  Sum_probs=87.3

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHH---------------------HHHHHHHHHHhcC
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD---------------------YMKAERDILTKVT  173 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~---------------------~~~~E~~il~~l~  173 (431)
                      .+.||+|+||+||+|.+.      +++.||||+++...........                     ....|...+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            467999999999999864      5788999998764321111111                     1135666666665


Q ss_pred             CCC--cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCC
Q 014087          174 HPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS  250 (431)
Q Consensus       174 hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~  250 (431)
                      +..  +.+.++.    ...++||||+.|+.+........... .++..++.+++.++.++|. .||+||||||+||+++ 
T Consensus        76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence            433  4444443    24589999999964422111111111 6788999999999999999 9999999999999999 


Q ss_pred             CCC
Q 014087          251 DGH  253 (431)
Q Consensus       251 ~g~  253 (431)
                      ++.
T Consensus       150 ~~~  152 (187)
T cd05119         150 DGK  152 (187)
T ss_pred             CCc
Confidence            544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=1.8e-14  Score=133.86  Aligned_cols=126  Identities=24%  Similarity=0.341  Sum_probs=93.0

Q ss_pred             eeec-ccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh----------hhhHHHHHHHHHHHHHhcCCCCc--ceeeE
Q 014087          116 RVVG-QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----------KKNHVDYMKAERDILTKVTHPFI--VQLRY  182 (431)
Q Consensus       116 ~~LG-~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~~~~~E~~il~~l~hpnI--v~l~~  182 (431)
                      ..|| .||.|+||.+..       .+..++||.+....+.          .......+.+|+.++..++|++|  ++.++
T Consensus        37 ~~lg~~~g~gtv~~v~~-------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~  109 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA  109 (239)
T ss_pred             ceeecCCCCccEEEEEe-------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence            4576 778888887765       3567999988653221          11233567889999999998875  66666


Q ss_pred             EEEeCC----EEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          183 SFQTRS----KLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       183 ~~~~~~----~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      +.....    ..++|||+++| .+|.+++.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK  180 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC
Confidence            644332    23599999998 688887755 4566543    568999999999999999999999999998764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=4.4e-14  Score=120.68  Aligned_cols=121  Identities=21%  Similarity=0.298  Sum_probs=100.3

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--CCcceeeEEEEeCCEEE
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~  191 (431)
                      +++.||+|.++.||++...       +..+++|.......     ...+..|+.+++.+.|  .++++++.++...+..+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-------~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~   69 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-------DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSY   69 (155)
T ss_pred             cceecccccccceEEEEec-------CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence            4578999999999999874       25699998865432     3457789999999976  58999999988888999


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeCCCCC
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~g~  253 (431)
                      ++|||+.|+.+..+       +......++.+++.+|.+||..   +++|+|+||+||+++..+.
T Consensus        70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~  127 (155)
T cd05120          70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI  127 (155)
T ss_pred             EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE
Confidence            99999999877543       5566778899999999999984   7999999999999987444

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=6.4e-14  Score=139.95  Aligned_cols=243  Identities=23%  Similarity=0.223  Sum_probs=176.4

Q ss_pred             CceEEeeecc--cCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          111 DFEIFRVVGQ--GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~LG~--G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .+.+.+.+|.  |.+|.||.++...   ...+..+|+|.-+.... ....-..-.+|....+.+ .|+|.++.+..+++.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence            4677888999  9999999988722   12778899987432211 011111123456555666 499999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEeCCCCC-c-------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVS----AVSHLHKCGIVHRDLKPENILMDSDGH-E-------  254 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~----aL~~LH~~~iiHrDlKp~NILl~~~g~-~-------  254 (431)
                      +..|+-+|+|. .+|..+...... +++..++.++.+...    ||.++|..+++|-|+||+||++..++. .       
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            99999999996 678777776554 899999999999999    999999999999999999999988832 1       


Q ss_pred             ---cCCC------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccC
Q 014087          255 ---IDES------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVK  322 (431)
Q Consensus       255 ---~~~~------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~  322 (431)
                         +...      ......-|...|++||.+.+. ++...|+|++|.++.+..+|..++...   ...++.+..  -..+
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e  346 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLE  346 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchh
Confidence               1111      111223577889999998654 788999999999999999987766432   111111111  1111


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +-...+.++...+..|+..+|-.|+     +.+.++.|.+....
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~-----~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRL-----TAQILTALNVIHSK  385 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhh-----HHHHHhccccccch
Confidence            2234566777799999999999999     88999999998743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.1e-13  Score=138.26  Aligned_cols=243  Identities=25%  Similarity=0.301  Sum_probs=178.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEe
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (431)
                      ...+|..+..||.|.|+.|+.+..+.    .++..|++|...+........+..+ .|+.+...+ .|.+++..+..|..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~----~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRP----EGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecC----CCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCccc
Confidence            35679999999999999999887542    3677899998876654443333333 466666655 58999999888888


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc-CCC-------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-DES-------  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~-~~~-------  258 (431)
                      ....|+-.|||+++++...+.-...+++...+.+..|++.++.++|++.++|+|+||+||++..+|... ...       
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence            888899999999998876665455688999999999999999999999999999999999999875211 100       


Q ss_pred             -CCcccccCCCCCC--chhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          259 -SRSNSMCGTTEYM--APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       259 -~~~~~~~Gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                       .......+.-.++  +++......+..+.|++|||..++|.++|..-=..   ......|..+.....+....++..+.
T Consensus       418 ~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~~~  494 (524)
T KOG0601|consen  418 AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQVLL  494 (524)
T ss_pred             ceecccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhhhh
Confidence             0111112233444  55566677788999999999999999998653221   11234455555555555568899999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +.++..++..|+     .+.++..|.=|
T Consensus       495 kv~~~~~~~~~~-----l~~~l~~~~~~  517 (524)
T KOG0601|consen  495 KVMINPDRKRRP-----SAVELSLHSEF  517 (524)
T ss_pred             hhhcCCccccch-----hhhhhcccchh
Confidence            999999999998     55666665544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.42  E-value=2.1e-12  Score=130.42  Aligned_cols=152  Identities=20%  Similarity=0.331  Sum_probs=115.2

Q ss_pred             CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHH
Q 014087          139 SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR  218 (431)
Q Consensus       139 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~  218 (431)
                      .+..+.|.+.+...-   ...+...+-++-|+.++||||+++++.++.++.+|||+|-+.  -|..++.+.+   ...+.
T Consensus        36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHH
Confidence            667788877765432   445567778889999999999999999999999999999985  5666776654   67788


Q ss_pred             HHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCCCccCCCCCc-ccccCCC----------CCCchhhhccCCCCCcch
Q 014087          219 FYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHEIDESSRS-NSMCGTT----------EYMAPEILLSKGHNKDAD  286 (431)
Q Consensus       219 ~i~~qi~~aL~~LH-~~~iiHrDlKp~NILl~~~g~~~~~~~~~-~~~~Gt~----------~y~aPE~~~~~~~~~~~D  286 (431)
                      ..+.||+.||.||| +++++|++|.-+-|+++..|+.+...... ....|+.          .|..|+.+....  -..|
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence            88999999999998 67899999999999999999854322111 1111221          245555443222  4579


Q ss_pred             hHhHHHHHHHHHhC
Q 014087          287 WWSVGILLYEMLTG  300 (431)
Q Consensus       287 vwslGvil~elltg  300 (431)
                      .|-|||+++|++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=4.4e-13  Score=124.36  Aligned_cols=194  Identities=19%  Similarity=0.288  Sum_probs=142.6

Q ss_pred             HHhcCCCCcceeeEEEEeC-----CEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ce
Q 014087          169 LTKVTHPFIVQLRYSFQTR-----SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--IV  237 (431)
Q Consensus       169 l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ii  237 (431)
                      |-.+.|.|||+++.++.+.     .+..++.|||..|+|..+|++.    ..+.....++++.||+.||.|||+..  |+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            4445799999999888654     3588999999999999988763    45888999999999999999999875  99


Q ss_pred             eccCCCCceEeCCCCCccCCCC---------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCC
Q 014087          238 HRDLKPENILMDSDGHEIDESS---------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP  302 (431)
Q Consensus       238 HrDlKp~NILl~~~g~~~~~~~---------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~  302 (431)
                      |+.+..+-|++..+|-......               ......|-++|.+||.=.....+..+|||+||....||..|..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            9999999999998875221110               1112245688999998777777889999999999999998775


Q ss_pred             CCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          303 PFT-HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       303 Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                      --. +.........|.+-.+-+..   .--.+++.+||+-.|..||     ++.+++.||..-++--..
T Consensus       281 q~tnseS~~~~ee~ia~~i~~len---~lqr~~i~kcl~~eP~~rp-----~ar~llfHpllfeVhslk  341 (458)
T KOG1266|consen  281 QSTNSESKVEVEENIANVIIGLEN---GLQRGSITKCLEGEPNGRP-----DARLLLFHPLLFEVHSLK  341 (458)
T ss_pred             ccCCCcceeehhhhhhhheeeccC---ccccCcCcccccCCCCCCc-----chhhhhcCceeeecchHH
Confidence            422 22222222222222111111   1225789999999999999     889999999876655443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=1.2e-12  Score=133.66  Aligned_cols=129  Identities=18%  Similarity=0.317  Sum_probs=83.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-------------------------------hhHH
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHV  159 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~  159 (431)
                      +|+. +.||.|++|+||+|+.+.     +|+.||||+++++....                               .+..
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            4666 789999999999999874     68999999998642100                               1222


Q ss_pred             HHHHHHHHHHHhc----------CCCCcceeeEEEEe-CCEEEEEEeccCCCChHHH--HHHcC----CCCHHHHHHHHH
Q 014087          160 DYMKAERDILTKV----------THPFIVQLRYSFQT-RSKLYLILDFINGGHLFFH--LYRQG----IFREDQARFYTA  222 (431)
Q Consensus       160 ~~~~~E~~il~~l----------~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--l~~~~----~~~~~~~~~i~~  222 (431)
                      +.+.+|+++++..          .+.+.+.+-.++.+ ....+|||||+.|+.|.+.  +...+    .+.+..+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            3344444444333          12222332222222 3346799999999999764  33333    244444555555


Q ss_pred             HHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       223 qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      |++       ..|++|+|+||.||+++.+|
T Consensus       275 Qif-------~~GffHaDpHPGNIlv~~~g  297 (537)
T PRK04750        275 QVF-------RDGFFHADMHPGNIFVSYDP  297 (537)
T ss_pred             HHH-------hCCeeeCCCChHHeEEecCC
Confidence            543       58999999999999999887

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=2.8e-11  Score=122.16  Aligned_cols=131  Identities=18%  Similarity=0.221  Sum_probs=85.3

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-------------------------------hhHHH----
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVD----  160 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~~----  160 (431)
                      +.||.|++|+||+|+.+      +|+.||||+.+......                               .+...    
T Consensus       123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            56999999999999976      67899999987542100                               00001    


Q ss_pred             --HHHHHHHHHHhc----CCCCcceeeEEE-EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHH
Q 014087          161 --YMKAERDILTKV----THPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVS-AVSHL  231 (431)
Q Consensus       161 --~~~~E~~il~~l----~hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~-aL~~L  231 (431)
                        .+.+|...+..+    .|.+-+.+-.++ .-.+..+|||||++|++|.+..... ....   ...++.+++. .+..+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV  273 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence              133455544444    222222222222 2234579999999999998776532 1222   3345555555 47889


Q ss_pred             HHCCceeccCCCCceEeCCCCCcc
Q 014087          232 HKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       232 H~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                      |..|++|+|+||.||+++.+|...
T Consensus       274 ~~~g~~H~D~hPgNilv~~~g~i~  297 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFVLKDGKII  297 (437)
T ss_pred             HhCCceeCCCCcccEEECCCCcEE
Confidence            999999999999999999887643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.20  E-value=6.5e-11  Score=103.84  Aligned_cols=115  Identities=22%  Similarity=0.268  Sum_probs=84.1

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcc-eeeEEEEeCCEEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLI  193 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv  193 (431)
                      ++.|+.|.++.||+++.       .++.|++|+......    ....+..|+.+++.+.+.+++ +++...  ....++|
T Consensus         3 ~~~l~~G~~~~vy~~~~-------~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv   69 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-------ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI   69 (170)
T ss_pred             eeecCCcccCceEEEEE-------CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence            46789999999999885       356799998765421    112356789999988655544 444443  2345899


Q ss_pred             EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEeCC
Q 014087          194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI-----VHRDLKPENILMDS  250 (431)
Q Consensus       194 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i-----iHrDlKp~NILl~~  250 (431)
                      |||++|.++...        ......++.+++.+|..||+.++     +|+|++|.||+++.
T Consensus        70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~  123 (170)
T cd05151          70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD  123 (170)
T ss_pred             EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC
Confidence            999999887542        11123456789999999999885     99999999999983

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=2.1e-10  Score=102.42  Aligned_cols=132  Identities=17%  Similarity=0.236  Sum_probs=92.1

Q ss_pred             eeecccCceEEEEEEEcCCC-CCCCCcEEEEEEeehhhh--------h-----------hhhHHHH----HHHHHHHHHh
Q 014087          116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTI--------I-----------KKNHVDY----MKAERDILTK  171 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~-~~~~~~~~avK~~~~~~~--------~-----------~~~~~~~----~~~E~~il~~  171 (431)
                      ..||.|--+.||.|...... ....+..+|||+.+-...        .           ..+....    .++|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            56899999999999743200 000246899999874211        0           0111223    3489999998


Q ss_pred             cCC--CCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEe
Q 014087          172 VTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILM  248 (431)
Q Consensus       172 l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDlKp~NILl  248 (431)
                      +..  -++.+.+++    ..-+|||||+.++.+.....+...+++.++..+..+++.+|..| |+.||||+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            853  456666654    46789999998765533333334566677888889999999999 89999999999999999


Q ss_pred             CCC
Q 014087          249 DSD  251 (431)
Q Consensus       249 ~~~  251 (431)
                      +.+
T Consensus       159 ~~~  161 (197)
T cd05146         159 HDG  161 (197)
T ss_pred             ECC
Confidence            754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=2.7e-09  Score=92.24  Aligned_cols=135  Identities=24%  Similarity=0.250  Sum_probs=100.7

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEe-----ehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~-----~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .+..|-+|+-+.|+++.+       .|+.+.||.-     +...+..+-...+..+|+++|.++.--.|.--.-+|.+..
T Consensus        11 ~l~likQGAEArv~~~~~-------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc-------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            577889999999999987       4566777742     3333444444567788999999886545544444566777


Q ss_pred             EEEEEEeccCC-CChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          189 KLYLILDFING-GHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       189 ~~~lv~E~~~g-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                      .-+|+|||++| .++.+++....  .........++.+|-..|.-||.++|||+||..+||+|..+|...
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~  153 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI  153 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC
Confidence            77899999988 46677776542  223333368888999999999999999999999999999988754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.00  E-value=8.3e-09  Score=101.80  Aligned_cols=213  Identities=18%  Similarity=0.256  Sum_probs=146.1

Q ss_pred             ceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe----CCEEEEEEeccC
Q 014087          123 FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLYLILDFIN  198 (431)
Q Consensus       123 fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~  198 (431)
                      -.+.|+|...-     +|..|++|.+.-......+   ....-+++++++.|+|||++.++|.+    +..++||++|.+
T Consensus       289 ~~Ttyk~~s~~-----DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  289 SITTYKATSNV-----DGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             cceeEeeeecc-----CCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            35678888765     7889999998443322221   12235678999999999999999874    346999999987


Q ss_pred             C-CChHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCcc
Q 014087          199 G-GHLFFHLYR---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN  262 (431)
Q Consensus       199 g-g~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~~  262 (431)
                      + ++|.++-..               +...+|..++.|+.|+..||.++|+.|..-+-|.|.+||++.+-+...      
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIri------  434 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRI------  434 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEE------
Confidence            6 466554432               224678999999999999999999999999999999999987743211      


Q ss_pred             cccCCCCCCch---hhhccCCCCCcchhHhHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          263 SMCGTTEYMAP---EILLSKGHNKDADWWSVGILLYEMLTGQPP-FTHANRQKL-QQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       263 ~~~Gt~~y~aP---E~~~~~~~~~~~DvwslGvil~elltg~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      ..||-..-+-+   |-+.   ...+-|.=.||.+++.|.||..- +........ ...|       ...++.++.++|.-
T Consensus       435 S~C~i~Dvl~~d~~~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~rn~v~y  504 (655)
T KOG3741|consen  435 SGCGIMDVLQEDPTEPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDLRNVVEY  504 (655)
T ss_pred             ecccceeeecCCCCcchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHHHHHHHH
Confidence            11221111111   1121   12456888999999999998543 222222222 2222       24478899999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhC---CCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHH---KWFRS  365 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h---~~f~~  365 (431)
                      +...++.+|      ++++++.|   .||..
T Consensus       505 l~s~~~~~k------sI~~llp~~~~~ff~v  529 (655)
T KOG3741|consen  505 LESLNFREK------SIQDLLPMIGSRFFTV  529 (655)
T ss_pred             HHhcCcccc------cHHHHHHHHHHHHHHH
Confidence            999888864      67888765   45544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=1.9e-09  Score=98.67  Aligned_cols=109  Identities=10%  Similarity=0.169  Sum_probs=78.6

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--CCcceeeEEEEeC---CEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTR---SKL  190 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~  190 (431)
                      +.||.|.++.||++...      .|+.+++|+.......  .....+..|..+++.+.+  .++.+++.+....   +..
T Consensus         4 ~~l~~G~~n~~~~v~~~------~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~   75 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG------GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP   75 (223)
T ss_pred             eecCCCccceEEEEEec------CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence            56899999999999864      3467999987654321  123457889999999875  3456677766554   367


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  233 (431)
                      ++||||++|.++...+.. ..+++.+...++.+++.+|..||+
T Consensus        76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            899999999888665432 346677777777777777777773

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=7.4e-09  Score=89.90  Aligned_cols=124  Identities=22%  Similarity=0.199  Sum_probs=91.8

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeeh-----hhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-----DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~-----~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      ..+++|+-+.||.+.+.+       ..+++|.-.+     ..+..+-...+..+|+.+|..+.--.|..-+-++.+....
T Consensus         2 ~~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            457899999999986642       3356664322     2333344455677899999988655555544556677788


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      .|+|||++|-.|.+.+...       ...++..+-.-+.-||..||||+||.++||++..++-
T Consensus        75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i  130 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRI  130 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcE
Confidence            8999999999888888765       1456666777778899999999999999999988763

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=9.5e-10  Score=111.92  Aligned_cols=145  Identities=22%  Similarity=0.341  Sum_probs=107.9

Q ss_pred             HHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCC--------CC------------CcccccCCCCCCchhhhccCCC
Q 014087          223 EIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDE--------SS------------RSNSMCGTTEYMAPEILLSKGH  281 (431)
Q Consensus       223 qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~--------~~------------~~~~~~Gt~~y~aPE~~~~~~~  281 (431)
                      +++.||.|+|. .++||+.|.|++|.++.+|.....        ..            ......-...|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            45599999996 689999999999999998742110        00            0011123568999999999888


Q ss_pred             CCcchhHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHH----hcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHH
Q 014087          282 NKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRII----NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDA  356 (431)
Q Consensus       282 ~~~~DvwslGvil~ell-tg~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~  356 (431)
                      +.++|+||+||++|.+. .|+.-+........+..-.    .....++..++.|+++-|.++|..++..||     ++..
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp-----~~~~  261 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP-----TLDL  261 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc-----chhh
Confidence            99999999999999999 5777665543222211111    123345577999999999999999999999     8899


Q ss_pred             HHhCCCCCCCChhhHh
Q 014087          357 IKHHKWFRSINWKTLE  372 (431)
Q Consensus       357 i~~h~~f~~~~~~~l~  372 (431)
                      +...+||.+..-.+|.
T Consensus       262 l~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  262 LLSIPFFSDPGLKALR  277 (700)
T ss_pred             hhcccccCCchhhhhh
Confidence            9999999987666554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.80  E-value=9.6e-08  Score=90.01  Aligned_cols=112  Identities=15%  Similarity=0.057  Sum_probs=79.1

Q ss_pred             CCcEEEEEEeehhhhh---hh-----hHHHHHHHHHHHHHhcCCCCc--ceeeEEEEe-----CCEEEEEEeccCCC-Ch
Q 014087          139 SDGIYAMKVMRKDTII---KK-----NHVDYMKAERDILTKVTHPFI--VQLRYSFQT-----RSKLYLILDFINGG-HL  202 (431)
Q Consensus       139 ~~~~~avK~~~~~~~~---~~-----~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~-----~~~~~lv~E~~~gg-~L  202 (431)
                      .|+.|.||........   ..     .-...+.+|...+..|..-+|  ...+++++.     ....+||+|++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            4567888866432210   00     111136688888888743333  334455543     23578999999986 78


Q ss_pred             HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q 014087          203 FFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       203 ~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  250 (431)
                      .+++..  ....++.....++.+++..+.-||..||+|+|+++.|||++.
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHL  173 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence            888754  344567788899999999999999999999999999999985

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=1e-06  Score=80.05  Aligned_cols=93  Identities=27%  Similarity=0.310  Sum_probs=73.8

Q ss_pred             HHHHHHHHHHHhcCCCC--cceeeEEEEeC----CEEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 014087          160 DYMKAERDILTKVTHPF--IVQLRYSFQTR----SKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH  232 (431)
Q Consensus       160 ~~~~~E~~il~~l~hpn--Iv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH  232 (431)
                      ....+|...+..|..-+  +.+.+++.+..    ...+||+|+++|. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            45667888877774332  34445555542    2468999999984 79888887555778888999999999999999


Q ss_pred             HCCceeccCCCCceEeCCCC
Q 014087          233 KCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       233 ~~~iiHrDlKp~NILl~~~g  252 (431)
                      .+||+|+|+++.|||++.++
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCC
Confidence            99999999999999999887

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.61  E-value=2.8e-07  Score=89.15  Aligned_cols=223  Identities=16%  Similarity=0.244  Sum_probs=141.9

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE-------E
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS-------F  184 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~-------~  184 (431)
                      ...+.||+|+-+.+|..-.-        .-.+-|++.+.......   .   .+..|... .||-+-.=+.+       -
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--------~d~VAKIYh~Pppa~~a---q---k~a~la~~p~~p~~~~rvaWPqa~L~G~   79 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--------RDQVAKIYHAPPPAAQA---Q---KVAELAATPDAPLLNYRVAWPQATLHGG   79 (637)
T ss_pred             CCCccccCCccceeeecchh--------hchhheeecCCCchHHH---H---HHHHhccCCCCcchhhhhcccHHHhhCC
Confidence            34577999999999964321        12345777654321111   1   12222222 45543321111       1


Q ss_pred             EeCCEEEEEEeccCCCChHHHHH----Hc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC
Q 014087          185 QTRSKLYLILDFINGGHLFFHLY----RQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~----~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                      .....+-++|..+.|..--..+.    ++   ....+.-+...++.++.+...||..|.+-+|+.++|+|+.+++.+...
T Consensus        80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence            12233788999888753211121    12   236778899999999999999999999999999999999998874332


Q ss_pred             CC----------CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhC-CCCCCCCC-----HHHHHHHH
Q 014087          258 SS----------RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTG-QPPFTHAN-----RQKLQQRI  316 (431)
Q Consensus       258 ~~----------~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg-~~Pf~~~~-----~~~~~~~i  316 (431)
                      +.          .....+|...|.+||.-.     +..-+...|-|.|||+++++|.| +.||.+..     ..-....|
T Consensus       160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            22          223446899999999876     34456789999999999999995 99997631     11122233


Q ss_pred             HhcccC-----------CC-----CCCCHHHHHHHHhhcccC--cCCcCCC
Q 014087          317 INEKVK-----------LP-----PFLTSEAHSLLKGLLHKD--PSKRLGS  349 (431)
Q Consensus       317 ~~~~~~-----------~p-----~~~s~~~~~li~~~L~~d--P~~R~~~  349 (431)
                      -.+.+.           -|     ..+++++..|..+|+..-  +.-||++
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a  290 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA  290 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence            332221           11     236788999999998643  4578854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=3.4e-07  Score=81.50  Aligned_cols=118  Identities=22%  Similarity=0.272  Sum_probs=75.5

Q ss_pred             EEEEEEEcCCCCCCCCcEEEEEEeehhhh-----------------------hhhhHHHHHHHHHHHHHhcCCC--Ccce
Q 014087          125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----------------------IKKNHVDYMKAERDILTKVTHP--FIVQ  179 (431)
Q Consensus       125 ~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-----------------------~~~~~~~~~~~E~~il~~l~hp--nIv~  179 (431)
                      .||.|...      .+..+|||+.+....                       .......+..+|.+.|..+..-  ++.+
T Consensus         1 ~Vy~~~~~------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~   74 (188)
T PF01163_consen    1 DVYHAIDP------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK   74 (188)
T ss_dssp             EEEEEEEC------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred             CEEEEECC------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence            37888764      577899998874311                       0112235677899999999765  4556


Q ss_pred             eeEEEEeCCEEEEEEeccC--CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEeCCCCCc
Q 014087          180 LRYSFQTRSKLYLILDFIN--GGHLFFHLYRQGIFREDQARFYTAEIVSAVSH-LHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~--gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      .+++.    .-+|||||+.  |..+.. +.... ++......++.+++..+.. +|..||||+||.+.|||++.++..
T Consensus        75 p~~~~----~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~  146 (188)
T PF01163_consen   75 PYDYN----RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVY  146 (188)
T ss_dssp             EEEEE----TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEE
T ss_pred             EEEEe----CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEE
Confidence            65442    3479999998  655543 33321 2245567788888886655 579999999999999999988443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.46  E-value=1.2e-06  Score=80.84  Aligned_cols=132  Identities=19%  Similarity=0.183  Sum_probs=94.2

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh------------h-------hhHHHHHHHHHHHHHhc
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------------K-------KNHVDYMKAERDILTKV  172 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~------------~-------~~~~~~~~~E~~il~~l  172 (431)
                      +.++..||.|--+.||.|...      .|..+|||.=+-....            +       .-......+|.++|..|
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             HhhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            456789999999999999865      5888999975532110            0       01123456788899888


Q ss_pred             CCC--CcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q 014087          173 THP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       173 ~hp--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  250 (431)
                      ...  .|.+-++    -++-.+||||++|-.|...-     +..+.+..++..|++-+.-+-..||||+|+.+-|||+++
T Consensus       167 ~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         167 YPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             hhcCCCCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            644  5555443    35678999999997763322     245566667777777777777999999999999999999


Q ss_pred             CCCccCCC
Q 014087          251 DGHEIDES  258 (431)
Q Consensus       251 ~g~~~~~~  258 (431)
                      +|.....+
T Consensus       238 dg~~~vID  245 (304)
T COG0478         238 DGDIVVID  245 (304)
T ss_pred             CCCEEEEe
Confidence            97754433

>PRK09902 hypothetical protein; Provisional

Probab=98.44  E-value=2.9e-06  Score=76.23  Aligned_cols=128  Identities=9%  Similarity=0.125  Sum_probs=90.6

Q ss_pred             cccCceEEEEEEEcCCCCCCCCcEEEEEEeehhh---hhhhhHHHHHHHHHHHHHhcCCC--CcceeeEEEEe----CCE
Q 014087          119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT---IIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQT----RSK  189 (431)
Q Consensus       119 G~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~----~~~  189 (431)
                      |+||-+.|+.....       |+.|-+|......   ..-..-...+.+|...|..+..-  .+.+....-..    .-+
T Consensus        27 ~rgG~SgV~r~~~~-------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~r   99 (216)
T PRK09902         27 RRNGMSGVQCVERN-------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWR   99 (216)
T ss_pred             CCCCcceEEEEEeC-------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceE
Confidence            67899999987763       3467888654211   11022345688899999988532  24444422222    124


Q ss_pred             EEEEEeccCC-CChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          190 LYLILDFING-GHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       190 ~~lv~E~~~g-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      .+||+|-+.| .+|.+++.+.  .+.++.+...++.+|+..|.-||+.|+.|+|+.+.|||++.+|.
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCC
Confidence            7899997764 4787777653  34577778899999999999999999999999999999986663

>smart00133 S_TK_X Extension to Ser/Thr-type protein kinases

Probab=98.42  E-value=2.7e-07  Score=67.05  Aligned_cols=60  Identities=33%  Similarity=0.710  Sum_probs=49.4

Q ss_pred             CCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCCCC----CCCccCeEeeC
Q 014087          364 RSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTA----GEHFKGYTYVA  423 (431)
Q Consensus       364 ~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~----~~~f~~~~~~~  423 (431)
                      ++++|+.|..++++|||+|.+.+..++++|+..|+......++......    +..|.||+|+.
T Consensus         1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~~~~~F~gfsy~~   64 (64)
T smart00133        1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDSPASGGSQQEPFRGFSYVF   64 (64)
T ss_pred             CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCccccccccccccCCCcccC
Confidence            4799999999999999999999999999999988887766665443221    47899999963

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.41  E-value=5.4e-06  Score=74.83  Aligned_cols=135  Identities=21%  Similarity=0.260  Sum_probs=87.8

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHH------HHHHHHHHHhcC---CCC
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVT---HPF  176 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~il~~l~---hpn  176 (431)
                      .+..++|.+.+++-......|.+..-       .++.+++|..+............      ..+++..+..+.   .-.
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~   99 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE   99 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence            34567899999999988888887764       56789999887643222221111      223333333332   222


Q ss_pred             cceeeEEEEe-----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC
Q 014087          177 IVQLRYSFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       177 Iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~  251 (431)
                      +..++.+.+.     ....+|||||++|..|.+...    +++    .+...|..+|.-||+.|++|+|..|.|++++.+
T Consensus       100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             cccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC
Confidence            3332322222     234568999999988755432    333    244567788999999999999999999999987


Q ss_pred             CCcc
Q 014087          252 GHEI  255 (431)
Q Consensus       252 g~~~  255 (431)
                      +-.+
T Consensus       172 ~i~i  175 (229)
T PF06176_consen  172 GIRI  175 (229)
T ss_pred             cEEE
Confidence            7543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.41  E-value=3.8e-08  Score=99.45  Aligned_cols=232  Identities=18%  Similarity=0.194  Sum_probs=151.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC-cceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~  187 (431)
                      ...|....-+++|+++++++.+...     +. ....+.+...        ....-++++|.+++||| .+..++.++.+
T Consensus       241 ~kws~~fh~fvK~altknpKkRpta-----ek-lL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTA-----EK-LLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGE  306 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCCh-----hh-heeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence            3457778889999999999876542     22 2235554332        23455899999999999 77778888888


Q ss_pred             CEEEEEEeccCCC-C-hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc---------C
Q 014087          188 SKLYLILDFINGG-H-LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------D  256 (431)
Q Consensus       188 ~~~~lv~E~~~gg-~-L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~---------~  256 (431)
                      ...+++++++.++ + ....-...-.+.+-+...+.+.-+++|++||+---+|||    ||+..+.....         .
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLT  382 (829)
T ss_pred             cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccC
Confidence            8999999999887 2 211111112244455566677788899999988778999    88877654321         1


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC-----CCH-H
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-----LTS-E  330 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~-~  330 (431)
                      ......+..||+.++|||+.....++...|+|++|+-..+|.-|-+|-...  ......+-.+. .-|..     .+. +
T Consensus       383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p-~s~~L~~~~aw~~~~  459 (829)
T KOG0576|consen  383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGP-NSPMLTDKSAWSPVF  459 (829)
T ss_pred             cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCC-CccccchhhhcCccc
Confidence            111345678999999999999999999999999999888888887776431  00000000000 00000     000 1


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      -.++...|+..-|..|.     ..-....|.+|++.
T Consensus       460 ~~~~~~~~~~g~P~~pk-----v~mgacfsKvfngC  490 (829)
T KOG0576|consen  460 HRDFPAPCLNGLPPTPK-----VHMGACFSKVFNGC  490 (829)
T ss_pred             ccCCcccccCCCCCCCc-----chhhHHHHHHhccC
Confidence            11456667777777776     45566666777664

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.20  E-value=1.4e-05  Score=86.40  Aligned_cols=195  Identities=20%  Similarity=0.228  Sum_probs=131.2

Q ss_pred             hHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 014087          157 NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH  232 (431)
Q Consensus       157 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH  232 (431)
                      ..+.....|...+..+.|+|++.++.+.-....    +.+..|+|...++...+..-+.++...++.+..++++||.|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            334455567778888999999999887655433    3345688999999999999899999999999999999999999


Q ss_pred             HCCceeccCCCC---ceEeCCCCCc-cC-----------CCCCcccccCCCCCCchhhhccCCCCCc--chhHhHHHHHH
Q 014087          233 KCGIVHRDLKPE---NILMDSDGHE-ID-----------ESSRSNSMCGTTEYMAPEILLSKGHNKD--ADWWSVGILLY  295 (431)
Q Consensus       233 ~~~iiHrDlKp~---NILl~~~g~~-~~-----------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~--~DvwslGvil~  295 (431)
                      +....|.-+...   +--.+..+.. +.           .........-+..+.++|......++.+  .|+|.+|..+.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            985444433222   1111111110 00           0011111223456778888877766655  69999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          296 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       296 elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .+..|..+=.-   ......++      +.....+..+++.+|+..+.++|+     .+.+++.|+|.+-
T Consensus       384 ~~~~~~~i~~~---~~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl-----~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  384 QLSQGEDISEK---SAVPVSLL------DVLSTSELLDALPKCLDEDSEERL-----SALELLTHPFLRF  439 (1351)
T ss_pred             hhhhcCccccc---ccchhhhh------ccccchhhhhhhhhhcchhhhhcc-----chhhhhhchhccc
Confidence            99887654311   11111111      111122678899999999999999     6789999999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.02  E-value=9.1e-05  Score=66.54  Aligned_cols=126  Identities=24%  Similarity=0.233  Sum_probs=88.3

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-------------hhhHHHHHHHHHHHHHhcC------CC
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------------KKNHVDYMKAERDILTKVT------HP  175 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~~~~E~~il~~l~------hp  175 (431)
                      ...||+|+.-.||.-  .      .+....||++......             .........+|+.....+.      +.
T Consensus         6 ~~~i~~G~~R~cy~H--P------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~   77 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS   77 (199)
T ss_pred             CcccccCCCceEEEC--C------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence            357999999999952  2      3445789998776500             0112344556666555554      78


Q ss_pred             CcceeeEEEEeCCEEEEEEeccCC------CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q 014087          176 FIVQLRYSFQTRSKLYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (431)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~E~~~g------g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~  249 (431)
                      +|.+++|+.+++...-+|+|.+..      -+|.+++.+ +.+++ .+..   .+-.-..||-+.+|+.+||+|.||++.
T Consensus        78 ~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   78 HIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             ccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            899999999999999999998643      257777744 44665 3333   334445678899999999999999997


Q ss_pred             CCCC
Q 014087          250 SDGH  253 (431)
Q Consensus       250 ~~g~  253 (431)
                      ..+.
T Consensus       153 ~~~~  156 (199)
T PF10707_consen  153 RRDS  156 (199)
T ss_pred             ecCC
Confidence            6643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=8.1e-05  Score=66.49  Aligned_cols=118  Identities=25%  Similarity=0.367  Sum_probs=83.0

Q ss_pred             CCceEEeeecccCc-eEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh------------------hhHHHHHHHHHHHHH
Q 014087          110 GDFEIFRVVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------------------KNHVDYMKAERDILT  170 (431)
Q Consensus       110 ~~y~~~~~LG~G~f-g~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~------------------~~~~~~~~~E~~il~  170 (431)
                      .+++.++.||.|+- |.||+++.       .|+.||||+.+.-....                  ....+.|..|.+...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg  109 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG  109 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence            46999999999999 99999987       56799999943211000                  023445667777766


Q ss_pred             hc---CCCCc--ceeeEEEEeC------------------CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHH
Q 014087          171 KV---THPFI--VQLRYSFQTR------------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA  227 (431)
Q Consensus       171 ~l---~hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~a  227 (431)
                      +|   .+.++  |+++|+..=.                  ....||.||+....         .+...    -+.+|++-
T Consensus       110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~d  176 (207)
T PF13095_consen  110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRD  176 (207)
T ss_pred             HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHH
Confidence            55   45566  8888887311                  12467888876643         22333    34567788


Q ss_pred             HHHHHHCCceeccCCCCceE
Q 014087          228 VSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       228 L~~LH~~~iiHrDlKp~NIL  247 (431)
                      |..+|..||+-+|+|+.|..
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYR  196 (207)
T ss_pred             HHHHHHCCeeeccCcccccc
Confidence            88999999999999999975

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.90  E-value=7e-05  Score=76.67  Aligned_cols=135  Identities=17%  Similarity=0.196  Sum_probs=83.0

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-------------------------------hhHHHHHH-
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVDYMK-  163 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-------------------------------~~~~~~~~-  163 (431)
                      .-|+.++-|+||+|+.+      +|+.||||+.+.+-...                               .+..+.+. 
T Consensus       131 ~PiAsASIaQVH~A~L~------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         131 EPIASASIAQVHRAVLK------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             CchhhhhHhhheeEEec------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            56899999999999987      68999999998642110                               11112222 


Q ss_pred             -----HHHHHHHhc-----CCCCcceeeEEEEeCCEEEEEEeccCCCChHHHH--HHcCCCCHHHHHHHHHHHHHHHHHH
Q 014087          164 -----AERDILTKV-----THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQGIFREDQARFYTAEIVSAVSHL  231 (431)
Q Consensus       164 -----~E~~il~~l-----~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~L  231 (431)
                           +|..-+.++     +.++|.--.-+++-.+.-.|+|||++|..+.+..  .. ..++.+.+.....++.  +..+
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~  281 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQL  281 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHH
Confidence                 233333333     1233322122223345668999999999887764  34 3355433333322221  2334


Q ss_pred             HHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          232 HKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       232 H~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                      -..|++|.|..|.||+++.+|..+..+.
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDf  309 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDF  309 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcC
Confidence            4589999999999999999988655443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.89  E-value=0.00015  Score=66.43  Aligned_cols=130  Identities=21%  Similarity=0.197  Sum_probs=85.2

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---------------------hHHHHHHHHHHHHHhcC
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---------------------NHVDYMKAERDILTKVT  173 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---------------------~~~~~~~~E~~il~~l~  173 (431)
                      ...|+.|--+.||+|...      .+..+|+|+++.....-+                     ....+...|..-|+++.
T Consensus        53 ~g~istGKEA~Vy~a~~~------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~  126 (268)
T COG1718          53 VGCISTGKEANVYLAETG------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAY  126 (268)
T ss_pred             EeeecCCcceEEEeeccC------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            347778888899998753      578899999976433211                     11234556777777663


Q ss_pred             --CCCcceeeEEEEeCCEEEEEEeccCCCCh-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeC
Q 014087          174 --HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD  249 (431)
Q Consensus       174 --hpnIv~l~~~~~~~~~~~lv~E~~~gg~L-~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~  249 (431)
                        +=.+.+-+.+.    +-.|||||+....+ .-.|.. -.+..+++..+..+++..+.-|-. .|+||+||..=|||+.
T Consensus       127 eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         127 EAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             HcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence              22333333332    34799999855311 111111 123344788889999999998877 9999999999999999


Q ss_pred             CCCCcc
Q 014087          250 SDGHEI  255 (431)
Q Consensus       250 ~~g~~~  255 (431)
                      .+...+
T Consensus       202 ~~~p~i  207 (268)
T COG1718         202 DGEPYI  207 (268)
T ss_pred             CCeEEE
Confidence            555433

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.88  E-value=0.00018  Score=66.23  Aligned_cols=72  Identities=21%  Similarity=0.233  Sum_probs=53.0

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC--cceeeEEEEeCCEEEEE
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lv  193 (431)
                      ..||+|..+.||+.         .+..+++|......     ....+.+|.++++.+..-.  +.+.+++....+...+|
T Consensus         7 ~~i~~G~t~~~y~~---------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv   72 (226)
T TIGR02172         7 TQTGEGGNGESYTH---------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI   72 (226)
T ss_pred             eeecCCCCcceeEe---------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence            57899999999973         23347889876432     1234678999999886433  46677777788888999


Q ss_pred             EeccCCCC
Q 014087          194 LDFINGGH  201 (431)
Q Consensus       194 ~E~~~gg~  201 (431)
                      ||+++|..
T Consensus        73 ~e~i~G~~   80 (226)
T TIGR02172        73 YELIVGKR   80 (226)
T ss_pred             eeecCCcc
Confidence            99999963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.81  E-value=0.00017  Score=78.99  Aligned_cols=83  Identities=13%  Similarity=0.278  Sum_probs=57.0

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCc--ceeeEEEEeC---
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFI--VQLRYSFQTR---  187 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---  187 (431)
                      .++.|+.|.++.+|++....   +.....+++|+........  ....+.+|.++|+.+. |.+|  .+++.++.+.   
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~---~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~  116 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGN---GGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI  116 (822)
T ss_pred             eEEEeCCCCcCceEEEEECC---CCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence            46788999999999987642   1111357777764432211  1235778999999995 6665  6777777654   


Q ss_pred             CEEEEEEeccCCCC
Q 014087          188 SKLYLILDFINGGH  201 (431)
Q Consensus       188 ~~~~lv~E~~~gg~  201 (431)
                      +..|+||||++|..
T Consensus       117 G~~flVME~v~G~~  130 (822)
T PLN02876        117 GTAFYIMEYLEGRI  130 (822)
T ss_pred             CCceEEEEecCCcc
Confidence            46899999999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.62  E-value=0.00049  Score=64.02  Aligned_cols=73  Identities=12%  Similarity=0.119  Sum_probs=50.7

Q ss_pred             ecccCc-eEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCEEEEEEe
Q 014087          118 VGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       118 LG~G~f-g~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      |-.|.. ..||++...       +..+.||+.....      ...+.+|+++++.+. +--+.+++++....+..++|||
T Consensus         6 ~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   72 (244)
T cd05150           6 VTEGQSGATVYRLDGK-------NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS   72 (244)
T ss_pred             cCCCCCcCeEEEEcCC-------CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence            444555 789988642       3468888775432      224567898888874 4445677787777777899999


Q ss_pred             ccCCCChH
Q 014087          196 FINGGHLF  203 (431)
Q Consensus       196 ~~~gg~L~  203 (431)
                      +++|.+|.
T Consensus        73 ~i~G~~l~   80 (244)
T cd05150          73 AVPGVPAA   80 (244)
T ss_pred             eeCCccHh
Confidence            99998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.58  E-value=0.00052  Score=70.26  Aligned_cols=126  Identities=16%  Similarity=0.222  Sum_probs=76.3

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh----------------------------hhHHHHHHHHHH
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------------------------KNHVDYMKAERD  167 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~----------------------------~~~~~~~~~E~~  167 (431)
                      +.||.-+.|+||+|+.+      .|+.||||+-+.+--..                            ++..+.+..|++
T Consensus       167 ~piaaASlaQVhrA~L~------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             chhhhcchhheEEEEec------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            57999999999999987      58899999987542110                            111111222222


Q ss_pred             ----------HHHhcCCCC------cceeeEEEEeCCEEEEEEeccCCCChH--HHHHHcCCCCHHHHHHHHHHHHHHHH
Q 014087          168 ----------ILTKVTHPF------IVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSAVS  229 (431)
Q Consensus       168 ----------il~~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~--~~l~~~~~~~~~~~~~i~~qi~~aL~  229 (431)
                                +.+.+.|-+      |.++|.  .-...-.|+||||+|..+.  +.+.+.+ ++...+..-+.++..  +
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~  315 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--E  315 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--H
Confidence                      223334444      333322  2234568999999998664  4455554 455544433333222  2


Q ss_pred             HHHHCCceeccCCCCceEeCCCC
Q 014087          230 HLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       230 ~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      -|=..|++|.|=.|.||++..++
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~  338 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNP  338 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCC
Confidence            23356899999999999999653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.57  E-value=0.0004  Score=60.31  Aligned_cols=116  Identities=19%  Similarity=0.304  Sum_probs=77.7

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcce-eeEEEEeCCEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRSKL  190 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~  190 (431)
                      .++.+.||+|++|.||++.++       +..+|+|+-+.+.     ....+..|+++|..+.-.++-. +|.+..    .
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-------~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~   87 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-------GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----D   87 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-------CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence            455688999999999999985       4579999876543     2345788999999998766654 444332    2


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CC-ceEeCC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK-PE-NILMDS  250 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlK-p~-NILl~~  250 (431)
                      ++.|||+.|-.|.+.-...   +...+    ..++++---|-..||-|..|. |. ||++..
T Consensus        88 ~i~me~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~  142 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVND  142 (201)
T ss_pred             hhhhhhhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecC
Confidence            4459999998885544321   22222    335555445667899888874 33 455544

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.32  E-value=0.0052  Score=61.24  Aligned_cols=81  Identities=12%  Similarity=0.149  Sum_probs=54.4

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh--h--hhHHHHHHHHHHHHHhcC---CCCcceeeEEEEe
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--K--KNHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~--~--~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~  186 (431)
                      -.+.||.|.+..||++...+     .++.++||.-......  .  .-..++...|.+.|+.+.   ..++.+++.+  +
T Consensus        30 ~~~elggGn~N~VyrV~~~~-----g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D  102 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTE-----GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D  102 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCC-----CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence            45789999999999998752     3357999975321100  1  123456777888888763   2456667665  4


Q ss_pred             CCEEEEEEeccCCCC
Q 014087          187 RSKLYLILDFINGGH  201 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~  201 (431)
                      .+..++||||+++..
T Consensus       103 ~~~~~lVME~L~~~~  117 (401)
T PRK09550        103 EELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCCEEEEecCCCcc
Confidence            466889999998743

>PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.19  E-value=0.00015  Score=49.23  Aligned_cols=41  Identities=37%  Similarity=0.686  Sum_probs=28.7

Q ss_pred             CCCCcccCCCCcccCCCCCCCCCC-C----CCCCCCCccCeEeeCC
Q 014087          384 VSGKDCIANFDKCWTTMPADDSPA-P----TPTAGEHFKGYTYVAP  424 (431)
Q Consensus       384 ~~~~~~~~~f~~~~~~~~~~~~~~-~----~~~~~~~f~~~~~~~~  424 (431)
                      +.+..|++|||.+|+.+++..++. .    ....++.|.||+|+++
T Consensus         2 v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~   47 (48)
T PF00433_consen    2 VKSETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNP   47 (48)
T ss_dssp             -SSTT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETC
T ss_pred             CCchhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCC
Confidence            567789999999999999888774 1    2245667999999986

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.14  E-value=6.6e-05  Score=83.18  Aligned_cols=243  Identities=13%  Similarity=0.044  Sum_probs=145.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      ..+++.--+|.|.+++--..+.+-     .  -+.+|+.+.-..  ..+-..+....|.+.++...|+++...+.-... 
T Consensus      1229 e~~EV~l~i~~~~~~R~k~Lr~ki-----d--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNKWLRSKI-----D--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPS 1301 (2724)
T ss_pred             hhhheeeecccceeeccchHhhhh-----c--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCC
Confidence            456666666666665442222111     1  144555433211  112233445556666777789988776544432 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC-----CceeccCCCCceEeCCCCCccC
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKC-----GIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~-----~iiHrDlKp~NILl~~~g~~~~  256 (431)
                       ....|.+++|+.+|.++..|.+.-    .+.+.-+.....+.+.+..-+|+.     -.+|+++|+-|.+|..+-++..
T Consensus      1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~ 1381 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKL 1381 (2724)
T ss_pred             CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccc
Confidence             345789999999999999997642    233333333333447777777753     2789999999999987653211


Q ss_pred             C-----------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCC
Q 014087          257 E-----------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLP  324 (431)
Q Consensus       257 ~-----------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p  324 (431)
                      .           .......++++.|+.+++.+.-.++.++|+|..|+.+|+..-|..+|..-....+...+.++. ..++
T Consensus      1382 gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe 1461 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIE 1461 (2724)
T ss_pred             cccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccc
Confidence            1           112234567889999999999999999999999999999999988884322221111111111 1223


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      ...+.++......+|-..-..||     ....++..+.|.
T Consensus      1462 ~l~pgdaNve~~~~Ll~K~~~rp-----~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1462 KLKPGDANVEALHRLLWKYMERP-----GQYISLSRDHFA 1496 (2724)
T ss_pred             ccCCCcccHHHHHHHHHHhhhcc-----hhhhhccccccc
Confidence            33344455555555555667788     445566555553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.12  E-value=0.0063  Score=55.51  Aligned_cols=78  Identities=21%  Similarity=0.342  Sum_probs=55.4

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC--CcceeeEEEE---eCCE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQ---TRSK  189 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~---~~~~  189 (431)
                      ++.|+.|..+.||++...       ++.+++|+....     .....+..|..+++.+...  -+.+++....   ....
T Consensus         2 i~~l~~G~~n~~~~v~~~-------~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD-------DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEET-------TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             CccCCCCCeeeEEEEEEC-------CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            578999999999999864       257999987654     2345567888888887533  2455665432   3345


Q ss_pred             EEEEEeccCCCChHH
Q 014087          190 LYLILDFINGGHLFF  204 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~  204 (431)
                      .+++|++++|..+..
T Consensus        70 ~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEEEEEESSEEHHH
T ss_pred             ceEEEEEeccccccc
Confidence            799999999988766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.00  E-value=0.0026  Score=63.95  Aligned_cols=158  Identities=15%  Similarity=0.185  Sum_probs=99.5

Q ss_pred             HHHHHHHHHhcCCCCcceeeEEEEeC-CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 014087          162 MKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (431)
Q Consensus       162 ~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (431)
                      +.-...+++.+.|+|....+++-... .+..+|||++. .+|.+.+..+. +......              .+|+.|  
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~~~~--   90 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHGVLH--   90 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccccce--
Confidence            34456789999999999988877654 45888999984 58888887654 2211111              223322  


Q ss_pred             CCCCceEeCCCCCccCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 014087          241 LKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       241 lKp~NILl~~~g~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~  320 (431)
                         -||+...+-.. ..   .....                .+++|||++|.++.|+.-|..-+......+....|..- 
T Consensus        91 ---~~~~~~td~~~-t~---~~~~~----------------~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~-  146 (725)
T KOG1093|consen   91 ---LNIIYITDHFL-TK---YPSPI----------------GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY-  146 (725)
T ss_pred             ---ehhhhcccccc-cc---CCCCC----------------CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh-
Confidence               23333322100 00   01111                14999999999999999998887654444333333221 


Q ss_pred             cCCC-------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          321 VKLP-------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       321 ~~~p-------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ...+             -.++....+++.+|+-..|..||     ...+++.++-|..+
T Consensus       147 ~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~-----l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  147 YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP-----LPMELSKRCSFTEV  200 (725)
T ss_pred             ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc-----chhHHhcCccHHHH
Confidence            1111             12456678899999999999999     67788888888665

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.96  E-value=0.0048  Score=57.10  Aligned_cols=72  Identities=8%  Similarity=0.107  Sum_probs=44.1

Q ss_pred             eeecccCce-EEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC---CcceeeEEEEeC---C
Q 014087          116 RVVGQGAFG-KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQTR---S  188 (431)
Q Consensus       116 ~~LG~G~fg-~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~---~  188 (431)
                      +.|+.|+.. .||++.          ..+++|+.+...     ....+.+|.++|..+...   -+.+.++.....   .
T Consensus         3 ~~~~~gG~~n~vy~~~----------~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~   67 (235)
T cd05155           3 EPVDSGGTDNATFRLG----------DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYP   67 (235)
T ss_pred             eeccCCCcccceEEcC----------CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCC
Confidence            457777776 588652          237778755321     234578899999887531   233344433322   2


Q ss_pred             EEEEEEeccCCCCh
Q 014087          189 KLYLILDFINGGHL  202 (431)
Q Consensus       189 ~~~lv~E~~~gg~L  202 (431)
                      ..|++|++++|.++
T Consensus        68 ~~~~l~~~i~G~~l   81 (235)
T cd05155          68 WPWSVYRWLEGETA   81 (235)
T ss_pred             cceEEEEeecCCCC
Confidence            35889999999766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=96.89  E-value=0.008  Score=57.79  Aligned_cols=106  Identities=9%  Similarity=0.066  Sum_probs=74.8

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC---CCcceeeEEEEe--
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT--  186 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~--  186 (431)
                      ..-.+.||.|..+.||.....       +..+.+|..+..     .....+..|...|+.+.-   -.+.++++++..  
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-------~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-------QGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-------CCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            455678999999999988642       234677774321     112467889999998853   357777877654  


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC  234 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~  234 (431)
                       .+..+||||+++|+++.+.     .........+..+++.+|.-||+.
T Consensus        84 ~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         84 SPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             cCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence             3678999999999887551     133445666778888999999974

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.83  E-value=0.01  Score=54.74  Aligned_cols=76  Identities=25%  Similarity=0.249  Sum_probs=47.4

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC-cceeeEEEEeCCEEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lv  193 (431)
                      ++.|..|-...||++....    ..++.|++|+......   .. -...+|..+++.+...+ ..++++.+. .   .+|
T Consensus         3 i~~l~gG~tN~~~~v~~~~----~~~~~~vlR~~~~~~~---~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKE----DNQDAVLVRVYGNKTE---LI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCC----CCCCeEEEEEccCCcc---ce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEE
Confidence            4678888889999986431    0146788997754321   11 12346888888885333 444544432 2   379


Q ss_pred             EeccCCCCh
Q 014087          194 LDFINGGHL  202 (431)
Q Consensus       194 ~E~~~gg~L  202 (431)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999999765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.83  E-value=0.0033  Score=56.12  Aligned_cols=88  Identities=16%  Similarity=0.165  Sum_probs=69.0

Q ss_pred             HHHHHHHhcCC-CCcceeeEEEEeCCEEEEEEeccCCCChHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q 014087          164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFF---HLYRQGIFREDQARFYTAEIVSAVSHLHK---CGI  236 (431)
Q Consensus       164 ~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~---~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i  236 (431)
                      +|.-+|+.+++ +++.+++|++-    -++|.||...+++..   .+..-...++.....|+.+++..+++|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47888888876 69999999982    367899998776642   12222346899999999999999999987   346


Q ss_pred             eeccCCCCceEeCCCCCcc
Q 014087          237 VHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       237 iHrDlKp~NILl~~~g~~~  255 (431)
                      .-.|++++|+-++.+|...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk  102 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLK  102 (188)
T ss_pred             EEeecchHHeEEeCCCcEE
Confidence            6689999999999888743

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.45  E-value=0.022  Score=54.53  Aligned_cols=79  Identities=15%  Similarity=0.224  Sum_probs=51.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC--cceeeE------
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRY------  182 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~------  182 (431)
                      +..-++.|..|....+|++...       +..+++|+....      ....+..|+.++..+.+.+  +.+.+.      
T Consensus        15 ~~~~i~~i~~G~~n~~y~v~~~-------~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~   81 (296)
T cd05153          15 ELLSFEGISAGIENTNYFVTTD-------SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEY   81 (296)
T ss_pred             chhheecccCccccceEEEEeC-------CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence            3444677888888999988642       345899987641      1234566888887774322  444433      


Q ss_pred             EEEeCCEEEEEEeccCCCCh
Q 014087          183 SFQTRSKLYLILDFINGGHL  202 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L  202 (431)
                      +....+..++|+++++|..+
T Consensus        82 ~~~~~~~~~~l~~~i~G~~~  101 (296)
T cd05153          82 LSELAGKPAALVEFLAGEHL  101 (296)
T ss_pred             eeeeCCceEEEEEeCCCCCC
Confidence            22345567899999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.38  E-value=0.045  Score=52.77  Aligned_cols=81  Identities=12%  Similarity=0.183  Sum_probs=49.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC--cceeeEE----
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS----  183 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~----  183 (431)
                      +....++.++.|....||++...       +..+++|+.....     ..+.+..|.+++..|....  +.+.+..    
T Consensus        22 ~~~~~i~~~~~G~~n~~y~v~t~-------~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~   89 (307)
T TIGR00938        22 GELLSLKGIAEGVENSNYLLTTD-------VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGR   89 (307)
T ss_pred             CCceeccccCCccccceEEEEeC-------CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCC
Confidence            34556778888888999988642       3358889875421     1223455777777764222  3343332    


Q ss_pred             --EEeCCEEEEEEeccCCCCh
Q 014087          184 --FQTRSKLYLILDFINGGHL  202 (431)
Q Consensus       184 --~~~~~~~~lv~E~~~gg~L  202 (431)
                        ....+..++|+||++|..+
T Consensus        90 ~~~~~~g~~~~l~e~i~G~~~  110 (307)
T TIGR00938        90 QLSTLAGKPACLVEFLQGLSV  110 (307)
T ss_pred             eehhcCCeEEEEEEeCCCCCC
Confidence              1234668999999998643

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.30  E-value=0.017  Score=54.04  Aligned_cols=72  Identities=10%  Similarity=0.148  Sum_probs=44.0

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCEEEEEEe
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~E  195 (431)
                      .+..|-.+.+|++..       .++.+++|+......  .-.+ ...+|..+++.+..-.+ .+++....    -++|||
T Consensus         3 ~~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e   68 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-------PGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVE   68 (256)
T ss_pred             cCCCcCcCCeEEEEe-------CCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence            355678888998863       455688887654311  1001 24568889988864333 33443332    268999


Q ss_pred             ccCCCCh
Q 014087          196 FINGGHL  202 (431)
Q Consensus       196 ~~~gg~L  202 (431)
                      |++|..+
T Consensus        69 ~i~G~~~   75 (256)
T TIGR02721        69 WLEGEVI   75 (256)
T ss_pred             eccCccc
Confidence            9998664

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.27  E-value=0.033  Score=54.13  Aligned_cols=132  Identities=17%  Similarity=0.253  Sum_probs=87.4

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-----------------------hhHHHHHHHHHHHHH
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKAERDILT  170 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~E~~il~  170 (431)
                      +-..|..|--+.||.|...      .|..+|||+++-.-+.-                       +-..-+...|++-|+
T Consensus       148 inGCiSTGKEANVYHat~~------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk  221 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK  221 (520)
T ss_pred             cccccccCccceeEeeecC------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence            4467889999999998754      67789999987432110                       111234566777788


Q ss_pred             hcCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeC
Q 014087          171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMD  249 (431)
Q Consensus       171 ~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDlKp~NILl~  249 (431)
                      +++...|..---..  -..-.|||+|+.+...-.-..+.-.++...+..+-.|++.-+.-|. .+++||.||.=-|+|+.
T Consensus       222 Rl~~aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  222 RLNNAGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH  299 (520)
T ss_pred             HHHhcCCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence            87644432110000  0234789999964332222223445788888888888988888775 57999999999999987


Q ss_pred             CCCC
Q 014087          250 SDGH  253 (431)
Q Consensus       250 ~~g~  253 (431)
                      .+..
T Consensus       300 dG~l  303 (520)
T KOG2270|consen  300 DGKL  303 (520)
T ss_pred             CCEE
Confidence            6654

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.06  E-value=0.078  Score=52.90  Aligned_cols=77  Identities=12%  Similarity=0.094  Sum_probs=50.3

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh----hHHHHHHHHHHHHHhcC---CCCcceeeEEEEe
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDYMKAERDILTKVT---HPFIVQLRYSFQT  186 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~  186 (431)
                      ..+.||-|....||++...       ++.++||.-........    ...++...|...|+.+.   ...+.+++.+.. 
T Consensus        36 ~~~eiggGn~N~VyrV~~~-------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            4778999999999998752       23488887552211111    12344455677777653   246777777665 


Q ss_pred             CCEEEEEEeccCC
Q 014087          187 RSKLYLILDFING  199 (431)
Q Consensus       187 ~~~~~lv~E~~~g  199 (431)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             456788999977

>PRK05231 homoserine kinase; Provisional

Probab=96.03  E-value=0.15  Score=49.36  Aligned_cols=78  Identities=10%  Similarity=0.133  Sum_probs=45.8

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC--cceeeE------E
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRY------S  183 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~------~  183 (431)
                      ..-++.|+.|....+|++...       +..+++|++.. .  ..   +.+..|..+++.|...+  +.+.+.      +
T Consensus        24 ~~~~~~l~~G~~n~~y~v~t~-------~g~~vLK~~~~-~--~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~   90 (319)
T PRK05231         24 LLSLKGIAEGIENSNFFLTTT-------QGEYVLTLFER-L--TA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAAL   90 (319)
T ss_pred             hhccchhccccccceEEEEeC-------CCcEEEEEecc-C--Ch---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEe
Confidence            344566778888899998743       23589998751 1  11   22334556665553111  223222      1


Q ss_pred             EEeCCEEEEEEeccCCCCh
Q 014087          184 FQTRSKLYLILDFINGGHL  202 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L  202 (431)
                      ....+..++++||++|..+
T Consensus        91 ~~~~g~~~~l~~~l~G~~~  109 (319)
T PRK05231         91 GELAGKPAAIVTFLEGKWP  109 (319)
T ss_pred             eeeCCEEEEEEEecCCCCC
Confidence            2335678999999999743

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.69  E-value=0.012  Score=56.23  Aligned_cols=127  Identities=13%  Similarity=0.207  Sum_probs=84.7

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh------h-----------hHHH--HHHHHHHHHHhc
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------K-----------NHVD--YMKAERDILTKV  172 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~------~-----------~~~~--~~~~E~~il~~l  172 (431)
                      +.++..||-|--+.||.+-+.      .|+..++|+-+.....-      .           -.+.  ...+|...|+.+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL  167 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL  167 (465)
T ss_pred             hhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence            667889999999999999865      57788888654322110      0           0011  234577778877


Q ss_pred             C-CCC-cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q 014087          173 T-HPF-IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       173 ~-hpn-Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  250 (431)
                      . |-+ |.+.+    +..+.++|||++.|-.|...-.-      ..+..+...++.-+.-|-..|+||+|..=-||++++
T Consensus       168 ~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  168 YERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             HHcCCCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            3 433 22222    34578999999999777433211      223344555666667788999999999999999998


Q ss_pred             CCCc
Q 014087          251 DGHE  254 (431)
Q Consensus       251 ~g~~  254 (431)
                      ++..
T Consensus       238 d~~i  241 (465)
T KOG2268|consen  238 DDKI  241 (465)
T ss_pred             CCCE
Confidence            7753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.56  E-value=0.16  Score=49.90  Aligned_cols=77  Identities=16%  Similarity=0.186  Sum_probs=48.2

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-h---hhHHHHHHHHHHHHHhcC--CC-CcceeeEEEEeCCE
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-K---KNHVDYMKAERDILTKVT--HP-FIVQLRYSFQTRSK  189 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-~---~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~  189 (431)
                      .||.|....||++....     .++.++||.-....-. .   .-..++...|...|+...  -| .+.++|  +.+.+.
T Consensus         2 EigdGnlN~VfrV~~~~-----g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE-----GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCC-----CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEcccc
Confidence            57999999999998532     3356899865432111 1   223455667888887763  34 344443  235556


Q ss_pred             EEEEEeccCCC
Q 014087          190 LYLILDFINGG  200 (431)
Q Consensus       190 ~~lv~E~~~gg  200 (431)
                      ..+|||+++..
T Consensus        75 ~~~vMEdL~~~   85 (370)
T TIGR01767        75 AVTVMEDLSHH   85 (370)
T ss_pred             ceehHhhCccc
Confidence            67999998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.34  E-value=0.089  Score=49.98  Aligned_cols=44  Identities=18%  Similarity=0.246  Sum_probs=27.0

Q ss_pred             cccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC
Q 014087          119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT  173 (431)
Q Consensus       119 G~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~  173 (431)
                      ++|-...|+.+...      .|+.+++|.-+....     ...+.+|.++|+.+.
T Consensus        20 ~~g~~~~v~~i~~~------~g~~~VlR~p~~~~~-----~~~l~rE~~vL~~L~   63 (276)
T cd05152          20 ESGLDFQVVFAKDT------DGVPWVLRIPRRPDV-----SERAAAEKRVLALVR   63 (276)
T ss_pred             CCcceeEEEEEEcC------CCCeEEEEecCCHHH-----HHHHHHHHHHHHHHH
Confidence            44444455655322      466788887654322     345688999999885

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.15  E-value=0.12  Score=49.59  Aligned_cols=80  Identities=15%  Similarity=0.145  Sum_probs=48.3

Q ss_pred             EeeecccCceEEEEEEEcCC-CCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYL  192 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~-~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~l  192 (431)
                      ++.|..|-...||++..... .....++.+++|+.....    .......+|..+++.+...++ .++++.+..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            45667777789998875320 001135779999976532    112235668888888753333 345555542    35


Q ss_pred             EEeccCCCCh
Q 014087          193 ILDFINGGHL  202 (431)
Q Consensus       193 v~E~~~gg~L  202 (431)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.63  E-value=0.34  Score=44.32  Aligned_cols=76  Identities=17%  Similarity=0.302  Sum_probs=53.3

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeEEEEeCCEE
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~  190 (431)
                      ..+.+.-|.--..|.+.+       ....|-||+-.      ......+..|+.=|+.+.   .-.|.+.+.+....++.
T Consensus        20 er~~v~gG~inea~~v~d-------g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~s   86 (286)
T COG3001          20 EREEVSGGDINEAWRLRD-------GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHS   86 (286)
T ss_pred             cccccCCccccceeEeec-------CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCee
Confidence            334555565566666654       34568888643      444566778887776663   45677888999999999


Q ss_pred             EEEEeccCCCCh
Q 014087          191 YLILDFINGGHL  202 (431)
Q Consensus       191 ~lv~E~~~gg~L  202 (431)
                      |+||||++-|.+
T Consensus        87 ylVle~L~~~~~   98 (286)
T COG3001          87 YLVLEYLPTGPL   98 (286)
T ss_pred             EEEEeeccCCCC
Confidence            999999987655

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.59  E-value=0.3  Score=48.59  Aligned_cols=78  Identities=15%  Similarity=0.230  Sum_probs=50.9

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh---hhHHHHHHHHHHHHHhcC--CC-CcceeeEEEEeCC
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVT--HP-FIVQLRYSFQTRS  188 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~  188 (431)
                      .+.||-|.-.-||++....     .++-++||.-..-.-..   .-..++...|..+|+...  .| .+.++|.  .+..
T Consensus        34 ~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH
Confidence            7789999999999998742     24568888643221111   223566677888888763  34 4455543  3555


Q ss_pred             EEEEEEeccCC
Q 014087          189 KLYLILDFING  199 (431)
Q Consensus       189 ~~~lv~E~~~g  199 (431)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            67789999854

>PLN02236 choline kinase

Probab=94.59  E-value=0.29  Score=48.05  Aligned_cols=82  Identities=15%  Similarity=0.109  Sum_probs=50.2

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcc-eeeEEEEeCCEE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKL  190 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~  190 (431)
                      ..-+..|-.|-...+|++...... ...++.|++|+.....   ...+++ .+|..+++.+..-++. ++++.+...   
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc---
Confidence            334455656888899998753211 1134678999886542   222333 5688888888544443 455665432   


Q ss_pred             EEEEeccCCCCh
Q 014087          191 YLILDFINGGHL  202 (431)
Q Consensus       191 ~lv~E~~~gg~L  202 (431)
                       .|.||++|.+|
T Consensus       110 -~v~efi~g~~l  120 (344)
T PLN02236        110 -RVEEFIHARTL  120 (344)
T ss_pred             -eEEEeeCCCCC
Confidence             57999988665

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.49  E-value=0.11  Score=51.43  Aligned_cols=62  Identities=21%  Similarity=0.238  Sum_probs=44.2

Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEeCCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDSD  251 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDlKp~NILl~~~  251 (431)
                      ...||-+|+.|-++..++...+ .+|...+.++.-.+.||--+ --.+.+|.|+.|.||++-.+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3566778899988887776543 46656666665555665444 35789999999999998644

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.47  E-value=0.88  Score=43.66  Aligned_cols=64  Identities=14%  Similarity=0.249  Sum_probs=37.4

Q ss_pred             EEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC--CcceeeEE------EEeCCEEEEEEec
Q 014087          125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYS------FQTRSKLYLILDF  196 (431)
Q Consensus       125 ~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~------~~~~~~~~lv~E~  196 (431)
                      .||++...       +..+++|++...       ...+..|..++..|...  .|++++..      ...++..++|+||
T Consensus        11 ~v~~v~t~-------~g~~~LK~~~~~-------~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~   76 (313)
T TIGR02906        11 NVYKVETD-------SGNKCLKKINYP-------PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEW   76 (313)
T ss_pred             cEEEEEeC-------CCCeEEEEcCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehh
Confidence            48887642       335899987532       12244466666665322  33333322      2346678999999


Q ss_pred             cCCCCh
Q 014087          197 INGGHL  202 (431)
Q Consensus       197 ~~gg~L  202 (431)
                      ++|..+
T Consensus        77 i~G~~~   82 (313)
T TIGR02906        77 IEGREC   82 (313)
T ss_pred             ccCcCC
Confidence            998554

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=91.52  E-value=0.041  Score=55.36  Aligned_cols=71  Identities=25%  Similarity=0.386  Sum_probs=54.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ..+|+.++.+|.|+||+|+.+..+.     .+..+|||.+.....  ........+|..-+..+.|++|+++...|..
T Consensus        48 a~~~e~~~~~~~~g~~~~~~~~n~~-----d~~~~avkritlkn~--e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   48 ANDFEPGQCLGRGGFGVVFSAQNKA-----DENKYAVKRITLKNR--EESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hccccccccccccCccccCCccccc-----cchhhHHHHhcccch--hhhhhhhhccccchhhhcccchhhheeceec
Confidence            4579999999999999999888764     455789997765432  2333456678888999999999998776653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=90.89  E-value=1.6  Score=42.54  Aligned_cols=81  Identities=19%  Similarity=0.272  Sum_probs=48.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~  189 (431)
                      +.++. .|..|-...+|++...+..  ..+..|.+|+.....   ...++ -.+|..+++.+..-++ .++++++. .+ 
T Consensus        16 ~i~i~-~l~gGlTN~~~~v~~~~~~--~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G-   86 (330)
T PLN02421         16 DFSVE-RISGGITNLLLKVSVKEEN--GNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG-   86 (330)
T ss_pred             ceEEE-EeCCcccceEEEEEecCCC--CCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc-
Confidence            44444 4444777889988754311  123468899876532   11222 3468888888865444 34566553 22 


Q ss_pred             EEEEEeccCCCCh
Q 014087          190 LYLILDFINGGHL  202 (431)
Q Consensus       190 ~~lv~E~~~gg~L  202 (431)
                        +|.+|++|..|
T Consensus        87 --~i~~fi~g~~l   97 (330)
T PLN02421         87 --MIQSFINARTL   97 (330)
T ss_pred             --EeehhhcCCCC
Confidence              58999987655

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=89.45  E-value=3  Score=40.34  Aligned_cols=81  Identities=9%  Similarity=0.116  Sum_probs=45.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--CCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~  188 (431)
                      ...+++.+-.|..-.+|....       +++.++|. ... ............+|..+++.+.-  --+...++.+.++.
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~-------~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~   96 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGD-------TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY   96 (321)
T ss_pred             CCceeeeccCCcccceEEEec-------CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC
Confidence            344555554444444454432       36677777 321 11223334556678888887743  22333455555554


Q ss_pred             --EEEEEEeccCCC
Q 014087          189 --KLYLILDFINGG  200 (431)
Q Consensus       189 --~~~lv~E~~~gg  200 (431)
                        ..|.||+|++|.
T Consensus        97 ~g~pf~v~~~veGe  110 (321)
T COG3173          97 LGTPFYVMEWVEGE  110 (321)
T ss_pred             CCCceEEEEEecce
Confidence              679999999983

>PTZ00384 choline kinase; Provisional

Probab=89.21  E-value=1.7  Score=43.28  Aligned_cols=81  Identities=12%  Similarity=0.149  Sum_probs=45.6

Q ss_pred             EEeeecccCceEEEEEEEcCCCC-CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCEEE
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLY  191 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~  191 (431)
                      .++.|..|-...+|++....... .-..+.|.+++....   ..-.++ -.+|.++++.+...++ .++++.+..    +
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            34556568889999987542110 001122444443211   111122 2458899998865444 456666643    5


Q ss_pred             EEEeccCCCCh
Q 014087          192 LILDFINGGHL  202 (431)
Q Consensus       192 lv~E~~~gg~L  202 (431)
                      +|.||++|..|
T Consensus       126 ~l~efIeGr~l  136 (383)
T PTZ00384        126 TIQEWVEGNTM  136 (383)
T ss_pred             EEEEEeccccC
Confidence            99999998766

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=88.77  E-value=0.25  Score=40.48  Aligned_cols=44  Identities=20%  Similarity=0.301  Sum_probs=32.5

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK  171 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~  171 (431)
                      .-||.|+.|+||+|+.+      .|+.||||+.+.+.      .+.+...+.+|+.
T Consensus        17 ~PlasASiaQVh~a~l~------~g~~VaVKV~rP~i------~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   17 EPLASASIAQVHRARLK------DGEEVAVKVQRPGI------EEQIEADLRILRR   60 (119)
T ss_pred             chhhheehhhheeeeec------ccchhhhhhcchHH------HHHHHHHHHHHHH
Confidence            56999999999999987      58899999987643      2334455555554

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=88.50  E-value=16  Score=35.44  Aligned_cols=72  Identities=10%  Similarity=0.092  Sum_probs=42.4

Q ss_pred             ccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC--Ccce---eeE--EEEeCCEEEE
Q 014087          120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQ---LRY--SFQTRSKLYL  192 (431)
Q Consensus       120 ~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~---l~~--~~~~~~~~~l  192 (431)
                      .+.-..||++...      .+..+++|+.+....    ....+..|.+++..+...  .++.   .-+  ....++..+.
T Consensus        35 ~s~eN~vy~v~~~------~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~  104 (325)
T PRK11768         35 NSYENRVYQFGDE------DGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA  104 (325)
T ss_pred             ccccceEEEEecC------CCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence            3455678988753      456799998864321    234456677777766321  1222   111  2233567888


Q ss_pred             EEeccCCCC
Q 014087          193 ILDFINGGH  201 (431)
Q Consensus       193 v~E~~~gg~  201 (431)
                      |+++++|..
T Consensus       105 l~~~~~G~~  113 (325)
T PRK11768        105 LFPRRGGRA  113 (325)
T ss_pred             EEeeeCCCC
Confidence            999998864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=88.30  E-value=2.9  Score=39.91  Aligned_cols=95  Identities=17%  Similarity=0.244  Sum_probs=57.4

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeEEEEeCC
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~  188 (431)
                      .+-.+.|+-|....+|++.  .     .++.+.||+-...      ....+..|..-|+.|.   --.+.+.+++....+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~-----~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~   85 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--T-----DGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD   85 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--T-----TS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred             eeeeEecCCCChhheEEEE--C-----CCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence            4556789999999999887  2     6778999987632      1245677888888773   345778888888877


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  233 (431)
                      .-||||||++.+..       .. .      -..++...|..||+
T Consensus        86 ~~fLlle~l~~~~~-------~~-~------~~~~lg~~LA~LH~  116 (288)
T PF03881_consen   86 DAFLLLEFLEMGSP-------SP-P------DWEELGRQLAALHQ  116 (288)
T ss_dssp             CCEEEEE---------------C-C------HHHHHHHHHHHHHH
T ss_pred             CceEEEEeecCCCC-------Cc-h------hHHHHHHHHHHHhh
Confidence            88999999976511       11 1      12456677788998

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PHA03111 Ser/Thr kinase; Provisional

Probab=87.27  E-value=0.7  Score=44.58  Aligned_cols=39  Identities=26%  Similarity=0.388  Sum_probs=28.9

Q ss_pred             HHHHHHHHHHHHHHHHHHH----CCceeccCCCCceEeCCCCC
Q 014087          215 DQARFYTAEIVSAVSHLHK----CGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       215 ~~~~~i~~qi~~aL~~LH~----~~iiHrDlKp~NILl~~~g~  253 (431)
                      +-++.++.||+.-.-.+-+    .+.+|-||||+||||-+...
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~  321 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDE  321 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCC
Confidence            4577788888776544433    36999999999999976643

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=85.25  E-value=2.4  Score=40.35  Aligned_cols=123  Identities=11%  Similarity=0.154  Sum_probs=74.8

Q ss_pred             cccCceEEEEEEEcC--C-CCCCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHhcC-------------CCCccee
Q 014087          119 GQGAFGKVFQVKKKG--V-DDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVT-------------HPFIVQL  180 (431)
Q Consensus       119 G~G~fg~Vy~~~~~~--~-~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~-------------hpnIv~l  180 (431)
                      |.|-.|.+|++....  . ........+.||.........  ......+.+|+.+.+.+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            778889999887654  1 112234558899876322211  123456778887765441             1234556


Q ss_pred             eEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      +....+....+||||-+...- +....+...++.+++..    ++..|.-+|...+.....+|+.+
T Consensus        82 ~~~~~~~~~~~lvlEDL~~~g-~~~~~~~~~l~~~~~~~----~l~~LA~fHA~s~~~~~~~~~~~  142 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLSEKG-YRMGDRRDGLDLEHAEL----VLKKLAKFHAASWALEEKDPELF  142 (294)
T ss_pred             EEeccCCCceeeehhhhhhcC-CcccccccCCCHHHHHH----HHHHHHHHHHHHHHHHHhCchhh
Confidence            666555557899999764311 12222334577777665    67778889999888887766654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	431
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-77
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-77
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-74
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-73
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-73
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-73
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-68
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-65
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-65
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-65
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-64
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-64
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-64
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-64
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-64
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-63
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-62
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-62
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-61
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-61
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-61
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-59
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-59
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-59
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-59
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-59
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-59
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-59
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-59
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-59
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-59
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-59
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-59
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-59
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-59
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-59
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-59
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-59
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-59
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-59
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-59
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-59
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-59
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-59
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-59
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-59
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-59
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-59
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-59
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-59
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-59
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-59
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-59
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-59
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-59
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-59
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-59
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-58
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-58
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-58
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-58
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-58
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-58
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-58
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-58
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-58
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-58
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-58
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-58
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-58
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-58
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-58
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-58
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-58
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-58
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-58
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-58
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-57
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-57
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-57
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-57
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-52
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-51
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-49
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-49
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-49
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-49
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-49
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-49
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-48
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-48
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-48
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-48
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-48
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-48
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-48
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-48
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-48
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-48
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-48
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-48
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-48
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-47
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-47
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-44
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-44
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-44
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-44
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-43
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-43
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-43
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-43
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-43
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-43
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-42
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-42
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-42
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-42
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-42
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-41
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-40
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-39
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-39
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-36
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-36
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-36
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-34
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-34
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-34
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-33
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-33
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-33
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-33
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-33
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-33
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-33
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-33
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-33
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-33
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-33
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-33
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-33
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-33
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-33
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-33
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-33
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-33
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-33
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-33
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-32
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-32
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-32
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-32
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-32
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-32
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-32
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-32
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-32
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-32
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-31
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-31
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-31
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-31
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-31
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-30
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-29
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-29
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-29
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-29
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-29
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-29
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-29
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-29
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-28
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-28
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-28
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-28
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-28
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-27
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-27
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-27
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-27
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-27
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-27
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-27
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-27
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-27
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-27
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-27
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-26
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-26
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-26
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-26
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-26
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-26
3soa_A	444	Full-Length Human Camkii Length = 444		4e-26
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-26
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-26
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-26
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-26
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-26
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-26
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-25
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-25
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-25
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-25
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-25
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-24
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-24
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-23
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-23
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-23
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-23
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-23
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-23
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-23
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-23
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-22
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-22
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-22
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-22
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-22
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-22
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-22
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-22
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-22
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-22
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-22
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-22
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-21
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-21
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-21
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-21
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-20
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-18
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-17
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-17
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-17
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-17
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-17
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-17
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-17
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-17
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-17
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-17
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-17
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-17
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-17
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-17
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-17
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-17
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-17
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-17
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-17
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-17
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-17
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-17
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-17
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-17
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-17
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-17
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-17
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-16
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-16
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-16
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-16
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-12
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-08
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-08
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-08
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-08
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-08
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-08
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-08
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-08
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-08
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-08
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-07
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-06
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-05
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-05
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-04

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  285 bits (730), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 140/301 (46%), Positives = 196/301 (65%), Gaps = 14/301 (4%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
Query: 394 D 394
           D
Sbjct: 311 D 311

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  285 bits (728), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 140/301 (46%), Positives = 195/301 (64%), Gaps = 14/301 (4%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKK-NHVDYMKA 164
           KI P  FE+ RV+G+G +                  I+AMKV++K  I++      + KA
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY AEI
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
             A+ HLH+ GI++RDLKPENI+++  GH            I + + ++  CGT EYMAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT EA  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ ++ F
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
Query: 394 D 394
           D
Sbjct: 311 D 311

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  274 bits (700), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 135/304 (44%), Positives = 187/304 (61%), Gaps = 14/304 (4%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AE+  A+ HLH  GI++RDLKPENIL+D +GH            ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP     +  
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDT 312
Query: 391 ANFD 394
             FD
Sbjct: 313 FYFD 316

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  273 bits (699), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 133/292 (45%), Positives = 184/292 (63%), Gaps = 14/292 (4%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 17  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 73
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 74  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AE+  A+ HLH  GI++RDLKPENIL+D +GH            ID   ++ S CGT EY
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 253
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
           A SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP
Sbjct: 254 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 305

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  273 bits (698), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 133/292 (45%), Positives = 184/292 (63%), Gaps = 14/292 (4%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDY 161
           E   K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ V  
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVR- 72
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
            K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +FY 
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AE+  A+ HLH  GI++RDLKPENIL+D +GH            ID   ++ S CGT EY
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           MAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
           A SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P FKP
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  271 bits (694), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 136/307 (44%), Positives = 192/307 (62%), Gaps = 15/307 (4%)
Query: 99  LEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNH 158
           ++A SE K  P  FE+ +V+GQG+F                  +YAMKV++K T+  ++ 
Sbjct: 18  VKAGSE-KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGH--LYAMKVLKKATLKVRDR 74
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           V   K ERDIL  V HPF+V+L Y+FQT  KLYLILDF+ GG LF  L ++ +F E+  +
Sbjct: 75  VR-TKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGT 267
           FY AE+   + HLH  GI++RDLKPENIL+D +GH            ID   ++ S CGT
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGT 193
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 327
            EYMAPE++  +GH+  ADWWS G+L++EMLTG  PF   +R++    I+  K+ +P FL
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253
Query: 328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
           ++EA SLL+ L  ++P+ RLGSGP G + IK H ++ +I+W  L  RE++P FKP V+  
Sbjct: 254 STEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQP 313
Query: 388 DCIANFD 394
           D    FD
Sbjct: 314 DDTFYFD 320

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  254 bits (648), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 129/298 (43%), Positives = 187/298 (62%), Gaps = 18/298 (6%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P DF   +V+G+G+F                   YA+KV++K  I+KK    ++ +ER++
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEV-----FYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           L K V HPF+V L +SFQT  KLY +LD+INGG LF+HL R+  F E +ARFY AEI SA
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEIL 276
           + +LH   IV+RDLKPENIL+DS GH            I+ +S +++ CGT EY+APE+L
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 336
             + +++  DWW +G +LYEML G PPF   N  ++   I+N+ ++L P +T+ A  LL+
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271
Query: 337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           GLL KD +KRLG+    ++ IK H +F  INW  L  +++ P F P+VSG + + +FD
Sbjct: 272 GLLQKDRTKRLGAKDDFME-IKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFD 328

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  244 bits (623), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 180/300 (60%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 118
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +   + CGT EY+APE
Sbjct: 119 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 238
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 239 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 298

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  244 bits (623), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 180/300 (60%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  244 bits (622), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 180/300 (60%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 179/300 (59%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  243 bits (620), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 179/300 (59%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  243 bits (620), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 179/300 (59%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +     CGT EY+APE
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 240
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 241 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 300

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  243 bits (619), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 179/300 (59%), Gaps = 16/300 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G F                   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRY-----YAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +     CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  242 bits (617), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 134/328 (40%), Positives = 198/328 (60%), Gaps = 24/328 (7%)
Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAM 145
           Q+  ++HE   A L   +E K+G  +FE+ +V+G GA+                  +YAM
Sbjct: 31  QLLTVKHELRTANLTGHAE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK--LYAM 87
Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 88  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-------- 255
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GH +        
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 256 ----DESSRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFT---H 306
               DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT    
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267
Query: 307 ANRQ-KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
            N Q ++ +RI+  +   P  +++ A  L++ LL KDP KRLG GP   D IK H +F+ 
Sbjct: 268 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
Query: 366 INWKTLEAREMQPKFKPDVSGKDCIANF 393
           INW  L A+++   FKP +  +  ++NF
Sbjct: 328 INWDDLAAKKVPAPFKPVIRDELDVSNF 355

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  237 bits (605), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 119/297 (40%), Positives = 176/297 (59%), Gaps = 18/297 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
            +  P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E QA FY AEI   + 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
            LHK GI++RDLK +N+++DS+GH            + +   +   CGT +Y+APEI+  
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + + K  DWW+ G+LLYEML GQPPF   +  +L Q I+   V  P  L+ EA S+ KGL
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 254
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
           + K P+KRLG GP G   ++ H +FR I+W+ LE RE+QP FKP V GK    NFDK
Sbjct: 255 MTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGA-ENFDK 310

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  234 bits (598), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 114/307 (37%), Positives = 181/307 (58%), Gaps = 17/307 (5%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 193
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTT 268
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH            I + +   + CGT 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 328
           EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
            EA SLL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ + 
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSET 433
Query: 389 CIANFDK 395
               FD+
Sbjct: 434 DTRYFDE 440

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  234 bits (598), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 114/307 (37%), Positives = 181/307 (58%), Gaps = 17/307 (5%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A+ + ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V 
Sbjct: 142 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVA 196
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTT 268
            AEIVSA+ +LH +  +V+RDLK EN+++D DGH            I + +   + CGT 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 328
           EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L 
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 376
Query: 329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
            EA SLL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ + 
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSET 436
Query: 389 CIANFDK 395
               FD+
Sbjct: 437 DTRYFDE 443

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  233 bits (594), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 113/302 (37%), Positives = 177/302 (58%), Gaps = 17/302 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 61  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
           SA+ +LH +  +V+RDLK EN+++D DGH            I + +     CGT EY+AP
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 240
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +     F
Sbjct: 241 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 300
Query: 394 DK 395
           D+
Sbjct: 301 DE 302

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  233 bits (593), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 113/302 (37%), Positives = 177/302 (58%), Gaps = 17/302 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTE 59
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
           SA+ +LH +  +V+RDLK EN+++D DGH            I + +     CGT EY+AP
Sbjct: 120 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 239
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +     F
Sbjct: 240 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 299
Query: 394 DK 395
           D+
Sbjct: 300 DE 301

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  233 bits (593), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 113/302 (37%), Positives = 177/302 (58%), Gaps = 17/302 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   +FE  +++G+G F                   YAMK+++K+ I+ K+ V +   E
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRY-----YAMKILKKEVIVAKDEVAHTLTE 58
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R+ +F ED+ARFY AEIV
Sbjct: 59  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 226 SAVSHLH-KCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
           SA+ +LH +  +V+RDLK EN+++D DGH            I + +     CGT EY+AP
Sbjct: 119 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I+ E+++ P  L  EA S
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 238
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LL GLL KDP +RLG G      I  H++F  I W+ +  +++ P FKP V+ +     F
Sbjct: 239 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 298
Query: 394 DK 395
           D+
Sbjct: 299 DE 300

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 115/305 (37%), Positives = 179/305 (58%), Gaps = 18/305 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S  ++G  +FE  RV+G+G+F                  +YA+KV++KD I++ + V+  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGD-----LYAVKVLKKDVILQDDDVECT 70
Query: 163 KAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +   F E +ARFY 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AEI+SA+  LH  GI++RDLK +N+L+D +GH            I     + + CGT +Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           +APEIL    +    DWW++G+LLYEML G  PF   N   L + I+N++V  P +L  +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 331 AHSLLKGLLHKDPSKRLGS-GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC 389
           A  +LK  + K+P+ RLGS   GG  AI  H +F+ I+W  L  R+++P F+P +  ++ 
Sbjct: 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSRED 310
Query: 390 IANFD 394
           ++NFD
Sbjct: 311 VSNFD 315

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 165/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 150 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 210 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 269
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 270 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 329
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 330 KVEAPFIPKFKGPGDTSNFD 349

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+ P GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +N D
Sbjct: 309 KVEAPFIPKFKGPGDTSNAD 328

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  226 bits (575), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 56  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 115
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 116 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA 175
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 176 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 235
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 236 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 295
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 296 KVEAPFIPKFKGPGDTSNFD 315

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  226 bits (575), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  226 bits (575), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 64  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 123
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 124 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 183
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 184 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 243
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 244 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 303
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 304 KVEAPFIPKFKGPGDTSNFD 323

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  226 bits (575), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 122 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 182 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 241
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 242 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 301
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 302 KVEAPFIPKFKGPGDTSNFD 321

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 165/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 55  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 114
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 115 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 174
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+ ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 175 KRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 234
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 235 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQR 294
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 295 KVEAPFIPKFKGPGDTSNFD 314

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 210 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 269
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 270 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 329
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 330 KVEAPFIPKFKGPGDTSNFD 349

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  225 bits (574), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 62  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 121
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 122 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 182 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 241
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 242 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 301
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 302 KVEAPFIPKFKGPGDTSNFD 321

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  225 bits (573), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  225 bits (573), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  225 bits (573), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           +AMK++ K  ++K   +++   E+ IL  V  PF+V+L YSF+  S LY++++++ GG +
Sbjct: 69  FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  225 bits (573), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+Y+M  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  225 bits (573), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 13/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDE-------SSRSNSMCGTTEYMAPEILLSKGHNK 283
           H   +++RDLKPEN+L+D  G+ ++ +         R+  +CGT EY+APEI+LSKG+NK
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  D 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  224 bits (572), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 90  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 149
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EIDES 258
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+    +   +
Sbjct: 150 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 259 SRSN----SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
            R      ++CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 210 KRVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 269
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 270 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 329
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 330 KVEAPFIPKFKGPGDTSNFD 349

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  224 bits (571), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 164/260 (63%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI++SKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  224 bits (570), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+AP I+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  224 bits (570), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 13/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDE-------SSRSNSMCGTTEYMAPEILLSKGHNK 283
           H   +++RDLKPEN+L+D  G+ ++ +         R+  +CGT EY+APEI+LSKG+NK
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  D 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  224 bits (570), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 13/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  + +G G+F                   YAMK++ K  ++K   +++   E+ IL  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++++++ GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDE-------SSRSNSMCGTTEYMAPEILLSKGHNK 283
           H   +++RDLKPEN+L+D  G+ ++ +         R+  +CGT EY+APEI+LSKG+NK
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  D 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ I +HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +K  G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 171/297 (57%), Gaps = 18/297 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
            L   GI++RDLK +N+++DS+GH            I +   +   CGT +Y+APEI+  
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KGL
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
           + K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP  SG++   NFD+
Sbjct: 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNA-ENFDR 632

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  222 bits (566), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY+++++  GG +
Sbjct: 69  YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  222 bits (565), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 110/291 (37%), Positives = 170/291 (58%), Gaps = 13/291 (4%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FE  R +G G+F                   YAMK++ K  ++K   +++   E+ I   
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNH-----YAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           V  PF+V+L +SF+  S LY++L++  GG +F HL R G F E  ARFY A+IV    +L
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 232 HKCGIVHRDLKPENILMDSDGH-EIDE-------SSRSNSMCGTTEYMAPEILLSKGHNK 283
           H   +++RDLKPEN+L+D  G+ ++ +         R+  +CGT EY+APEI+LSKG+NK
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDP 343
             DWW++G+L+YEM  G PPF      ++ ++I++ KV+ P   +S+   LL+ LL  D 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 278
Query: 344 SKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           +KR G+   GV+ IK+HKWF + +W  +  R+++  F P   G    +NFD
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 329

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  222 bits (565), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 113/329 (34%), Positives = 195/329 (59%), Gaps = 30/329 (9%)
Query: 91  LEHENDAELEAESER---KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKV 147
           +E E +A    ES +    +G  DF++ RV+G+G++                  IYAM+V
Sbjct: 30  IEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMRV 84
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++K+ +     +D+++ E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EI 255
            RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK +N+L+DS+GH            +
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF---------TH 306
                +++ CGT  Y+APEIL  + +    DWW++G+L++EM+ G+ PF           
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 307 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRS 365
                L Q I+ +++++P  L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 366 INWKTLEAREMQPKFKPDVSGKDCIANFD 394
           ++W  +E +++ P FKP++SG+  + NFD
Sbjct: 325 VDWDMMEQKQVVPPFKPNISGEFGLDNFD 353

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  222 bits (565), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 163/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG +
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+ ++ +    
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  + GT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 189 KRVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 309 KVEAPFIPKFKGPGDTSNFD 328

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  221 bits (564), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 111/297 (37%), Positives = 170/297 (57%), Gaps = 18/297 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF    V+G+G+F                  +YA+K+++KD +I+ + V+    E+ +L 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               P F+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY AEI   + 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
            L   GI++RDLK +N+++DS+GH            I +   +   CGT +Y+APEI+  
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ EA ++ KGL
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK 395
           + K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G++   NFD+
Sbjct: 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRNA-ENFDR 311

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  221 bits (562), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 162/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  221 bits (562), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 162/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  221 bits (562), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 162/260 (62%), Gaps = 8/260 (3%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YAMK++ K  ++K   +++   E+ IL  V  PF+ +L +SF+  S LY+++++  GG +
Sbjct: 70  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM 129
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE---- 257
           F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+++D  G+ ++ +    
Sbjct: 130 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
                R+  +CGT EY+APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ +
Sbjct: 190 KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249
Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
           +I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  R
Sbjct: 250 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 309
Query: 375 EMQPKFKPDVSGKDCIANFD 394
           +++  F P   G    +NFD
Sbjct: 310 KVEAPFIPKFKGPGDTSNFD 329

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 109/310 (35%), Positives = 186/310 (60%), Gaps = 27/310 (8%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 56
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 57  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
            A+++LH+ GI++RDLK +N+L+DS+GH            +     ++  CGT  Y+APE
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 325
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 236
Query: 326 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 384
            L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 296
Query: 385 SGKDCIANFD 394
           SG+  + NFD
Sbjct: 297 SGEFGLDNFD 306

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 108/294 (36%), Positives = 177/294 (60%), Gaps = 14/294 (4%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+F                   YAMKV++K+ +++   V++   ER +L+
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRY-----YAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDESSRSN-------SMCGTTEYMAPEILLSKGHN 282
           LH   I++RDLKPENIL+D +GH +I +   +         +CGT +Y+APE++ +K +N
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           K  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL  L+ +D
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDK 395
            S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + FDK
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK 295

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 109/310 (35%), Positives = 186/310 (60%), Gaps = 27/310 (8%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
            A+++LH+ GI++RDLK +N+L+DS+GH            +     ++  CGT  Y+APE
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 325
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 326 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 384
            L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 300
Query: 385 SGKDCIANFD 394
           SG+  + NFD
Sbjct: 301 SGEFGLDNFD 310

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 108/310 (34%), Positives = 186/310 (60%), Gaps = 27/310 (8%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           +G  DF++ RV+G+G++                  IYAMKV++K+ +     +D+++ E+
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMKVVKKELVNDDEDIDWVQTEK 71
Query: 167 DILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
            A+++LH+ GI++RDLK +N+L+DS+GH            +     ++  CGT  Y+APE
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPF---------THANRQKLQQRIINEKVKLPP 325
           IL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++++P 
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 251
Query: 326 FLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 384
            ++ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++
Sbjct: 252 SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 311
Query: 385 SGKDCIANFD 394
           SG+  + NFD
Sbjct: 312 SGEFGLDNFD 321

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  201 bits (511), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 166/302 (54%), Gaps = 21/302 (6%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DFE+ +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 68
Query: 166 RDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
           +  +  LH  GIV+RDLK +NIL+D DGH            +   +++N  CGT +Y+AP
Sbjct: 129 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAP 188
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LL  L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +NF
Sbjct: 249 LLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 304
Query: 394 DK 395
           DK
Sbjct: 305 DK 306

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  198 bits (503), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 165/302 (54%), Gaps = 21/302 (6%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF + +++G+G+F                   +A+K ++KD ++  + V+    E
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVE 67
Query: 166 RDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           + +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAP 273
           +  +  LH  GIV+RDLK +NIL+D DGH            +   +++N  CGT +Y+AP
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           EILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           LL  L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +NF
Sbjct: 248 LLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 303
Query: 394 DK 395
           DK
Sbjct: 304 DK 305

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 158/281 (56%), Gaps = 19/281 (6%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 58
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYM 271
           VSA+ +LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y+
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 238
Query: 332 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 239 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 279

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 158/281 (56%), Gaps = 19/281 (6%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 59
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYM 271
           VSA+ +LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y+
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 239
Query: 332 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 240 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 280

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 158/281 (56%), Gaps = 19/281 (6%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 56
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYM 271
           VSA+ +LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y+
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 236
Query: 332 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 237 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 277

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 158/281 (56%), Gaps = 19/281 (6%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYM 271
           VSA+ +LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 332 HSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
             L++ LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  191 bits (484), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+NS  GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K  +K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  191 bits (484), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 156/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+NS  GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 156/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+NS  GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 156/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N+  GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 90
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEK 270
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 271 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 305

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 69
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 249
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 250 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 284

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  189 bits (479), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 155/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 154/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 92
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L + FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A  L++ 
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 272
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 273 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 307

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 154/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   +  +II  +   P     +A  L++ 
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 154/275 (56%), Gaps = 19/275 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+  +++G+G+F                   YA+K++ K  IIK+N V Y+  ERD+++
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSRE-----YAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEIVSA+ +
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE------------SSRSNSMCGTTEYMAPEILL 277
           LH  GI+HRDLKPENIL++ D H +I +             +R+N   GT +Y++PE+L 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
            K   K +D W++G ++Y+++ G PPF   N   +  +II  +   P     +A  L++ 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 338 LLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTL 371
           LL  D +KRLG     G   +K H +F S+ W+ L
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 158/291 (54%), Gaps = 24/291 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYMAPEIL 276
           + HLH+  I++RDLKPEN+L+D DG+          E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 332
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 158/291 (54%), Gaps = 24/291 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYMAPEIL 276
           + HLH+  I++RDLKPEN+L+D DG+          E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 332
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 158/291 (54%), Gaps = 24/291 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYMAPEIL 276
           + HLH+  I++RDLKPEN+L+D DG+          E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 332
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 158/291 (54%), Gaps = 24/291 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  FRV+G+G F                  +YA K + K  + K+        E+ IL K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSA 227
           V   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FYTA+IVS 
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTEYMAPEIL 276
           + HLH+  I++RDLKPEN+L+D DG+          E+    +++    GT  +MAPE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQKLQQRIINEKVKLPPFLTSEAH 332
           L + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P   +  + 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
              + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 110/300 (36%), Positives = 153/300 (51%), Gaps = 23/300 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSK 279
            LH+  IV+RDLKPENIL+D  GH           + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE-----AHSL 334
            +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK  P   SE     A SL
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
              LL KDP++RLG   G    +K H  F+ +N+K L A  ++P FKPD     C    D
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLD 479

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 110/300 (36%), Positives = 153/300 (51%), Gaps = 23/300 (7%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F  +RV+G+G F                  +YA K + K  I K+        E+ IL K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
           V   F+V L Y+++T+  L L+L  +NGG L FH+Y  G   F E +A FY AEI   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 230 HLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSK 279
            LH+  IV+RDLKPENIL+D  GH           + E        GT  YMAPE++ ++
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE-----AHSL 334
            +    DWW++G LLYEM+ GQ PF    ++K+++  +   VK  P   SE     A SL
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
              LL KDP++RLG   G    +K H  F+ +N+K L A  ++P FKPD     C    D
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLD 479

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 164/307 (53%), Gaps = 28/307 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH--------EIDESSRS-NSMCGTTEYMAPEILLS 278
           + H+H   +V+RDLKP NIL+D  GH          D S +  ++  GT  YMAPE+ L 
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQ 362
Query: 279 KG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHS 333
           KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  S
Sbjct: 363 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 422
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC- 389
           LL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D  
Sbjct: 423 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 482
Query: 390 -IANFDK 395
            I +FD+
Sbjct: 483 DIGSFDE 489

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 164/307 (53%), Gaps = 28/307 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH--------EIDESSRS-NSMCGTTEYMAPEILLS 278
           + H+H   +V+RDLKP NIL+D  GH          D S +  ++  GT  YMAPE+ L 
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQ 363
Query: 279 KG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHS 333
           KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  S
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC- 389
           LL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D  
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 483
Query: 390 -IANFDK 395
            I +FD+
Sbjct: 484 DIGSFDE 490

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 164/307 (53%), Gaps = 28/307 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH--------EIDESSRS-NSMCGTTEYMAPEILLS 278
           + H+H   +V+RDLKP NIL+D  GH          D S +  ++  GT  YMAPE+ L 
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQ 363
Query: 279 KG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHS 333
           KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  S
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC- 389
           LL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D  
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 483
Query: 390 -IANFDK 395
            I +FD+
Sbjct: 484 DIGSFDE 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 164/307 (53%), Gaps = 28/307 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G F                  +YAMK + K  I  K        ER +L+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 171 KVTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH--------EIDESSRS-NSMCGTTEYMAPEILLS 278
           + H+H   +V+RDLKP NIL+D  GH          D S +  ++  GT  YMAPE+ L 
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQ 363
Query: 279 KG--HNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTSEAHS 333
           KG  ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  S
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP---DVSGKDC- 389
           LL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P   +V+  D  
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 483
Query: 390 -IANFDK 395
            I +FD+
Sbjct: 484 DIGSFDE 490

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/314 (32%), Positives = 165/314 (52%), Gaps = 33/314 (10%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  IYAMK++ K  ++K+      +
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFR 138
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTA 222
            ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  
Sbjct: 139 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEY 270
           E+V A+  +H+   VHRD+KP+N+L+D +GH              D + +S+   GT +Y
Sbjct: 199 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 271 MAPEIL--LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL 323
           ++PEIL  +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + 
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 318
Query: 324 PPFLTS---EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 380
           P  +T    EA  L++ L+    S+    G  G++  K H +F  +NW+ +  R ++  +
Sbjct: 319 PSHVTDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGLNWENI--RNLEAPY 373
Query: 381 KPDVSGKDCIANFD 394
            PDVS     +NFD
Sbjct: 374 IPDVSSPSDTSNFD 387

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 103/314 (32%), Positives = 165/314 (52%), Gaps = 33/314 (10%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  IYAMK++ K  ++K+      +
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-----IYAMKILNKWEMLKRAETACFR 122
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTA 222
            ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    ED ARFY  
Sbjct: 123 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEY 270
           E+V A+  +H+   VHRD+KP+N+L+D +GH              D + +S+   GT +Y
Sbjct: 183 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 271 MAPEIL--LSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKL 323
           ++PEIL  +  G  K   + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + 
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 302
Query: 324 PPFLTS---EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 380
           P  +T    EA  L++ L+    S+    G  G++  K H +F  +NW+ +  R ++  +
Sbjct: 303 PSHVTDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGLNWENI--RNLEAPY 357
Query: 381 KPDVSGKDCIANFD 394
            PDVS     +NFD
Sbjct: 358 IPDVSSPSDTSNFD 371

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 159/304 (52%), Gaps = 29/304 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLS 278
           +H  G +HRD+KP+N+L+D  GH              +   R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 279 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 309 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 365
Query: 391 ANFD 394
           +NFD
Sbjct: 366 SNFD 369

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 159/304 (52%), Gaps = 29/304 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLS 278
           +H  G +HRD+KP+N+L+D  GH              +   R ++  GT +Y++PE+L S
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 279 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 304 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 360
Query: 391 ANFD 394
           +NFD
Sbjct: 361 SNFD 364

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 159/304 (52%), Gaps = 29/304 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL Y+FQ    LY++++++ GG L  +L       E  ARFYTAE+V A+  
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 231 LHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILLS 278
           +H  G +HRD+KP+N+L+D  GH              +   R ++  GT +Y++PE+L S
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 279 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           +G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L       ++ E
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 308
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A +L+   L  D   RLG    GV+ IK H +F++  W     R+      PD+S     
Sbjct: 309 AKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDT 365
Query: 391 ANFD 394
           +NFD
Sbjct: 366 SNFD 369

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 106/316 (33%), Positives = 158/316 (50%), Gaps = 35/316 (11%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E ++   DFEI +V+G+GAF                  +YAMK+M K  ++K+  V   +
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ-----VYAMKIMNKWDMLKRGEVSCFR 109
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTA 222
            ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY A
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEY 270
           EIV A+  +H+ G VHRD+KP+NIL+D  GH              D + RS    GT +Y
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 271 MAPEILLS-------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKV 321
           ++PEIL +         +  + DWW++G+  YEM  GQ PF   +  +   +I++  E +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 322 KLPPF---LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 378
            LP     +  EA   ++ LL   P  RLG   GG    + H +F  ++W  L  R+  P
Sbjct: 290 SLPLVDEGVPEEARDFIQRLLCP-PETRLGR--GGAGDFRTHPFFFGLDWDGL--RDSVP 344
Query: 379 KFKPDVSGKDCIANFD 394
            F PD  G     NFD
Sbjct: 345 PFTPDFEGATDTCNFD 360

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 107/341 (31%), Positives = 170/341 (49%), Gaps = 38/341 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI +V+G+GAF                  ++AMK++ K  ++K+      + ERD+L 
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
                +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY AE+V A+ 
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
            +H+   VHRD+KP+NILMD +GH              D + +S+   GT +Y++PEIL 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 278 S----KG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPFLTS- 329
           +    KG +  + DWWS+G+ +YEML G+ PF   +  +   +I+N  E+ + P  +T  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 330 --EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
              A  L++ L+    S+    G  G++  K H +F  I+W  +  R  +  + P+VS  
Sbjct: 310 SENAKDLIRRLI---CSREHRLGQNGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSP 364
Query: 388 DCIANF---DKCWXXXXXXXXXXXXXXXGEH--FKGYTYVA 423
              +NF   D C                G H  F G+TY +
Sbjct: 365 TDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTS 405

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 151/299 (50%), Gaps = 25/299 (8%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           FEI R +G+G+F                  +YAMK M K   +++N V  +  E  I+  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKK-----MYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + +  E+V A+ +L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 232 HKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSK-- 279
               I+HRD+KP+NIL+D  GH           +   ++  +M GT  YMAPE+  S+  
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 280 -GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHSLL 335
            G++   DWWS+G+  YE+L G+ P+   +  + +++        V  P   + E  SLL
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251
Query: 336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           K LL  +P +R       +  +++  +   INW  +  + + P F P+    +C   F+
Sbjct: 252 KKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE 306

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 97/304 (31%), Positives = 161/304 (52%), Gaps = 29/304 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ +V+G+GAF                  +YAMK++ K  +IK++   +   ERDI+ 
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
               P++VQL  +FQ    LY++++++ GG L  +L       E  A+FYTAE+V A+  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 231 LHKCGIVHRDLKPENILMDSDGH----------EIDESS--RSNSMCGTTEYMAPEILLS 278
           +H  G++HRD+KP+N+L+D  GH          ++DE+     ++  GT +Y++PE+L S
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 279 KG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPFLTSE 330
           +G    + ++ DWWSVG+ L+EML G  PF   +      +I++ K  L       ++  
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKH 309
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A +L+   L  D   RLG    GV+ IK H +F++  W     RE      P++S     
Sbjct: 310 AKNLICAFL-TDREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDS 366
Query: 391 ANFD 394
           +NFD
Sbjct: 367 SNFD 370

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 142/277 (51%), Gaps = 19/277 (6%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 62
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           +  A+ + H+  ++HRD+KPEN+LM   G  +I +        S R   MCGT +Y+ PE
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPE 182
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+  +  L
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 371
           +  LL   P +RL      +  +  H W ++ + + L
Sbjct: 243 ISKLLRYHPPQRL-----PLKGVMEHPWVKANSRRVL 274

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 142/277 (51%), Gaps = 19/277 (6%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +RK    DF+I R +G+G F                  I A+KV+ K  + K+     ++
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKF-----IMALKVLFKSQLEKEGVEHQLR 63
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++  +  E
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           +  A+ + H+  ++HRD+KPEN+LM   G  +I +        S R   MCGT +Y+ PE
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPE 183
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+  +  L
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 243
Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 371
           +  LL   P +RL      +  +  H W ++ + + L
Sbjct: 244 ISKLLRYHPPQRL-----PLKGVMEHPWVKANSRRVL 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 144/283 (50%), Gaps = 18/283 (6%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 H-EIDE--------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP 303
             +I +        SSR  ++CGT +Y+ PE++  + H++  D WS+G+L YE L G+PP
Sbjct: 172 ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 304 FTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           F     Q+  +RI   +   P F+T  A  L+  LL  +PS+R
Sbjct: 232 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 144/283 (50%), Gaps = 18/283 (6%)
Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXX 132
           GP P      S P    E E  +  + E   +R+    DFEI R +G+G F         
Sbjct: 1   GPQP----LPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK 56
Query: 133 XXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                    I A+KV+ K  + K      ++ E +I + + HP I++L   F   +++YL
Sbjct: 57  QSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           IL++   G ++  L +   F E +   Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 171
Query: 253 H-EIDE--------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP 303
             +I +        SSR + +CGT +Y+ PE++  + H++  D WS+G+L YE L G+PP
Sbjct: 172 ELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 304 FTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           F     Q+  +RI   +   P F+T  A  L+  LL  +PS+R
Sbjct: 232 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 274

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 135/256 (52%), Gaps = 14/256 (5%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           E   +R+    DFEI R +G+G F                  I A+KV+ K  + K    
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVE 69
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEY 270
           Y  E+ +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY 189
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           + PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 249
Query: 331 AHSLLKGLLHKDPSKR 346
           A  L+  LL  +PS+R
Sbjct: 250 ARDLISRLLKHNPSQR 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 135/253 (53%), Gaps = 14/253 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAP 273
           E+ +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ P
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 179
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 239
Query: 334 LLKGLLHKDPSKR 346
           L+  LL  +PS+R
Sbjct: 240 LISRLLKHNPSQR 252

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 135/252 (53%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR +++CGT +Y+ PE
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPE 177
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 238 ISRLLKHNPSQR 249

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 131/245 (53%), Gaps = 14/245 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPEILLSKGH 281
            H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE++  + H
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           ++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 243
Query: 342 DPSKR 346
           +PS+R
Sbjct: 244 NPSQR 248

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 14/255 (5%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A   R+    DFEI R +G+G F                  I A+KV+ K  + K     
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEH 56
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYM 271
             E+ +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYL 176
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
            PE++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 332 HSLLKGLLHKDPSKR 346
             L+  LL  +PS+R
Sbjct: 237 RDLISRLLKHNPSQR 251

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 135/253 (53%), Gaps = 14/253 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAP 273
           E+ +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ P
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPP 175
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 334 LLKGLLHKDPSKR 346
           L+  LL  +PS+R
Sbjct: 236 LISRLLKHNPSQR 248

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I          SSR  ++CGT +Y+ PE
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPE 178
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 238
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 239 ISRLLKHNPSQR 250

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
            +  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 131/245 (53%), Gaps = 14/245 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPEILLSKGH 281
            H   ++HRD+KPEN+L+ S G  +I +        SSR + +CGT +Y+ PE++  + H
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           ++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL  
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 246
Query: 342 DPSKR 346
           +PS+R
Sbjct: 247 NPSQR 251

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 134/253 (52%), Gaps = 14/253 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           ++R+    DFEI R +G+G F                  I A+KV+ K  + K      +
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKF-----ILALKVLFKAQLEKAGVEHQL 55
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAP 273
           E+ +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ P
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPP 175
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++  + H++  D WS+G+L YE L G+PPF     Q   +RI   +   P F+T  A  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARD 235
Query: 334 LLKGLLHKDPSKR 346
           L+  LL  +PS+R
Sbjct: 236 LISRLLKHNPSQR 248

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 55
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE
Sbjct: 116 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 175
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 235
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 236 ISRLLKHNPSQR 247

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 181
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 176
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 177
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 238 ISRLLKHNPSQR 249

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 130/245 (53%), Gaps = 14/245 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPEILLSKGH 281
            H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE++  + H
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMH 183
Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           ++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL  
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 243
Query: 342 DPSKR 346
           +PS+R
Sbjct: 244 NPSQR 248

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 176
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 131/245 (53%), Gaps = 14/245 (5%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  + K      ++ E +I +
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 231 LHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPEILLSKGH 281
            H   ++HRD+KPEN+L+ S G  +I +        SSR  ++CGT +Y+ PE++  + H
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           ++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL  
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 240
Query: 342 DPSKR 346
           +PS+R
Sbjct: 241 NPSQR 245

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 58
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPE 178
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 238
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 239 ISRLLKHNPSQR 250

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I          SSR  ++CGT +Y+ PE
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 142/272 (52%), Gaps = 19/272 (6%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAP 273
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G  +I +        SSR +++CGT +Y+ P
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPP 179
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++  + H++  D WS+G+L YE L G PPF     Q+  +RI   +   P F+T  A  
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARD 239
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L+  LL  + S+RL      +  +  H W ++
Sbjct: 240 LISRLLKHNASQRL-----TLAEVLEHPWIKA 266

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPE 176
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 154/290 (53%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPE 176
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 237 ISRLLKHNPSQR 248

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 141/272 (51%), Gaps = 19/272 (6%)
Query: 103 SERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM 162
           S+R+    DF+I R +G+G F                  I A+KV+ K  + K      +
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKF-----ILALKVLFKTQLEKAGVEHQL 59
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAP 273
           E+ +A+S+ H   ++HRD+KPEN+L+ S+G  +I +        SSR  ++CGT +Y+ P
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 179
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++  + H++  D WS+G+L YE L G PPF     Q+  +RI   +   P F+T  A  
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARD 239
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L+  LL  + S+RL      +  +  H W ++
Sbjct: 240 LISRLLKHNASQRL-----TLAEVLEHPWIKA 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 144/265 (54%), Gaps = 22/265 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWF 363
           L  +PSKR     G ++ I   +W 
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWM 267

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   +CGT +Y+ PE
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPE 179
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 240 ISRLLKHNPSQR 251

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 154/290 (53%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 60
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ ++ CG+  Y APE+   K
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 180
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 240
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 241 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 281

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 153/290 (52%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 65
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 125
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E     + ++ CG+  Y APE+   K
Sbjct: 126 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 245
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +P KR     G ++ I   +W  + +    E  E++P  +P++   D
Sbjct: 246 LVLNPIKR-----GTLEQIMKDRWINAGH----EEDELKPFVEPELDISD 286

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 153/290 (52%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 152/290 (52%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREV-----AIKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E     + ++ CG   Y APE+   K
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +P KR     G ++ I   +W  + +    E  E++P  +P++   D
Sbjct: 249 LVLNPIKR-----GTLEQIMKDRWINAGH----EEDELKPFVEPELDISD 289

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 154/290 (53%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ ++ CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 135/276 (48%), Gaps = 19/276 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G F                  I A+KV+ K  I K+     ++ E +I  
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHF-----IVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F  R ++YLIL++   G L+  L +   F E +      E+  A+ +
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 231 LHKCGIVHRDLKPENI---------LMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGH 281
            H   ++HRD+KPEN+         + D        S R  +MCGT +Y+ PE++  + H
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMH 198
Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           N+  D W +G+L YE+L G PPF  A+  +  +RI+   +K P  + + A  L+  LL  
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 342 DPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 377
           +PS+RL      +  +  H W R+ + + L    +Q
Sbjct: 259 NPSERL-----PLAQVSAHPWVRANSRRVLPPSALQ 289

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 153/290 (52%), Gaps = 26/290 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A++++ K T +  + +  +  E  I+
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVRIIDK-TQLNSSSLQKLFREVRIM 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ +  CG+  Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGK 187
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
           L  +PSKR     G ++ I   +W    +    E  E++P  +P    KD
Sbjct: 248 LILNPSKR-----GTLEQIMKDRWMNVGH----EDDELKPYVEPLPDYKD 288

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 133/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR  ++ GT +Y+ PE
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPE 177
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 238 ISRLLKHNPSQR 249

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 132/252 (52%), Gaps = 14/252 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G F                  I A+KV+ K  + K      ++
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLR 61
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDE--------SSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G  +I +        SSR   + GT +Y+ PE
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPE 181
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 335 LKGLLHKDPSKR 346
           +  LL  +PS+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 22/264 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +  + +  +  E  I 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEV-----AVKIIDK-TQLNSSSLQKLFREVRIX 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL+ ++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D+D           +E    ++ ++ CG   Y APE+   K
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P + +++  +LLK  
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKF 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKW 362
           L  +PSKR     G ++ I   +W
Sbjct: 248 LILNPSKR-----GTLEQIXKDRW 266

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 28/265 (10%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHEI----------DESSRSNSMCG 266
              +++ AV +LH  GIVHRDLKPEN+L   +D D   +          D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 325
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 326 F---LTSEAHSLLKGLLHKDPSKRL 347
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 28/265 (10%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHEI----------DESSRSNSMCG 266
              +++ AV +LH  GIVHRDLKPEN+L   +D D   +          D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 325
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 326 F---LTSEAHSLLKGLLHKDPSKRL 347
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 28/265 (10%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K+ +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKEALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHEI----------DESSRSNSMCG 266
              +++ AV +LH  GIVHRDLKPEN+L   +D D   +          D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 325
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 326 F---LTSEAHSLLKGLLHKDPSKRL 347
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 28/265 (10%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  R I    ++   V+G GAF                  + A+K + K  +  K   
Sbjct: 12  QAEDIRDI----YDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKKALEGKEGS 62
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             M+ E  +L K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A  
Sbjct: 63  --MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENIL---MDSDGHEI----------DESSRSNSMCG 266
              +++ AV +LH  GIVHRDLKPEN+L   +D D   +          D  S  ++ CG
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 180
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 325
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 240
Query: 326 F---LTSEAHSLLKGLLHKDPSKRL 347
           +   ++  A   ++ L+ KDP KR 
Sbjct: 241 YWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 135/264 (51%), Gaps = 28/264 (10%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           +AE  +KI    FE    +G GAF                  ++A+K + K  +  K   
Sbjct: 16  QAEDIKKI----FEFKETLGTGAFSEVVLAEEKATGK-----LFAVKCIPKKAL--KGKE 64
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E  +L K+ H  IV L   +++ + LYL++  ++GG LF  +  +G + E  A  
Sbjct: 65  SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST 124
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----IDESSRS---------NSMCG 266
              +++ AV +LH+ GIVHRDLKPEN+L  S   E    I +   S         ++ CG
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PP 325
           T  Y+APE+L  K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +   P
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244
Query: 326 F---LTSEAHSLLKGLLHKDPSKR 346
           +   ++  A   ++ L+ KDP+KR
Sbjct: 245 YWDDISDSAKDFIRNLMEKDPNKR 268

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 128/251 (50%), Gaps = 24/251 (9%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F    V+G GAF                  ++A+K ++K    + +    ++ E  +L K
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGK-----LFALKCIKKSPAFRDSS---LENEIAVLKK 62
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +L
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 232 HKCGIVHRDLKPENIL------------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSK 279
           H+ GIVHRDLKPEN+L             D    +++++   ++ CGT  Y+APE+L  K
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-PPF---LTSEAHSLL 335
            ++K  D WS+G++ Y +L G PPF      KL ++I     +   PF   ++  A   +
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242
Query: 336 KGLLHKDPSKR 346
             LL KDP++R
Sbjct: 243 CHLLEKDPNER 253

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 151/285 (52%), Gaps = 26/285 (9%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G++ + + +G+G F                    A+K++ K T +    +  +  E  I+
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREV-----AVKIIDK-TQLNPTSLQKLFREVRIM 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+L    +T   LYL++++ +GG +F +L   G  +E +AR    +IVSAV 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 128
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           + H+  IVHRDLK EN+L+D D           +E    ++ ++ CG+  Y APE+   K
Sbjct: 129 YCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 280 GHNK-DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P +++++  +LLK L
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKL 248
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           L  +P KR     G ++ I   +W    +    E  E++P  +PD
Sbjct: 249 LVLNPIKR-----GSLEQIMKDRWMNVGH----EEEELKPYTEPD 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 31/248 (12%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK----TLEAREM 376
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K     L + E 
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKRKFQDLLSEEN 295
Query: 377 QPKFKPDV 384
           +   KP V
Sbjct: 296 ESTAKPQV 303

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 123/229 (53%), Gaps = 27/229 (11%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 246
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 369
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 247 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 290

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 123/229 (53%), Gaps = 27/229 (11%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 369
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 123/229 (53%), Gaps = 27/229 (11%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 239
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 369
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 240 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 283

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 123/229 (53%), Gaps = 27/229 (11%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 369
           P + +E    A  L+K LL  DP  R  +     +    H W +  + K
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK 284

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/225 (33%), Positives = 126/225 (56%), Gaps = 23/225 (10%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV++K T+ KK     ++ E  +L +++HP I++L+  F+T +++ L+L+ + GG L
Sbjct: 81  YALKVLKK-TVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------- 254
           F  +  +G + E  A     +I+ AV++LH+ GIVHRDLKPEN+L  +   +        
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 255 -----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THAN 308
                ++      ++CGT  Y APEIL    +  + D WSVGI+ Y +L G  PF     
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 309 RQKLQQRIIN-EKVKLPPF---LTSEAHSLLKGLLHKDPSKRLGS 349
            Q + +RI+N E   + P+   ++  A  L++ L+  DP KRL +
Sbjct: 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT 300

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 130/245 (53%), Gaps = 35/245 (14%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 379
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 380
           P + +E    A  L+K LL  DP  R  +     +    H W        L+  +M+ KF
Sbjct: 380 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPW--------LQDEDMKRKF 426
Query: 381 KPDVS 385
           +  +S
Sbjct: 427 QDLLS 431

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 118/216 (54%), Gaps = 30/216 (13%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           HP IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 234 CGIVHRDLKPENILM--DSDGHEID------------ESSRSNSMCGTTEYMAPEILLSK 279
            G+VHRDLKPEN+L   ++D  EI             ++    + C T  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN--EKVKLPPF---------LT 328
           G+++  D WS+G++LY ML+GQ PF   +R       +   +K+K   F         ++
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            EA  L++GLL  DP+KRL      +  +++++W +
Sbjct: 245 QEAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQ 275

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 130/245 (53%), Gaps = 35/245 (14%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHE--IDESSRSNSMCGTT 268
            +++ AV +LH+ GI+HRDLKPEN+L+ S            GH   + E+S   ++CGT 
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 269 EYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP 324
            Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K    
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365
Query: 325 PFLTSE----AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKF 380
           P + +E    A  L+K LL  DP  R  +     +    H W        L+  +M+ KF
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPW--------LQDEDMKRKF 412
Query: 381 KPDVS 385
           +  +S
Sbjct: 413 QDLLS 417

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 124/232 (53%), Gaps = 16/232 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  ++ E   L    HP I++L     T S +++++++++GG LF
Sbjct: 45  AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELF 104
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSN 262
            ++ + G   E ++R    +I+S V + H+  +VHRDLKPEN+L+D+  + +I +   SN
Sbjct: 105 DYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164
Query: 263 SM---------CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
            M         CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 165 MMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224
Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            ++I +     P +L     SLLK +L  DP KR       +  I+ H+WF+
Sbjct: 225 FKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKR-----ATIKDIREHEWFK 271

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 123/232 (53%), Gaps = 16/232 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSN 262
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  + +I +   SN
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 263 SM---------CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
            M         CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            ++I      +P +L     +LL  +L  DP KR       +  I+ H+WF+
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 123/232 (53%), Gaps = 16/232 (6%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++ +  I   + V  +K E   L    HP I++L     T +  ++++++++GG LF
Sbjct: 40  AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF 99
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSN 262
            ++ + G   E +AR    +I+SAV + H+  +VHRDLKPEN+L+D+  + +I +   SN
Sbjct: 100 DYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 263 SM---------CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
            M         CG+  Y APE++  + +   + D WS G++LY +L G  PF   +   L
Sbjct: 160 MMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            ++I      +P +L     +LL  +L  DP KR       +  I+ H+WF+
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 64/170 (37%), Positives = 96/170 (56%), Gaps = 18/170 (10%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
           ++  +  LHK  IVHRDLKPENIL+D D +          ++D   +  S+CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAP 192
Query: 274 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 241

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++F  +G+GAF                   YA K++    +  ++H   ++ E  I   
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQE-----YAAKIINTKKLSARDH-QKLEREARICRL 77
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 232 HKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNS---MCGTTEYMAPEILL 277
           H+ G+VHRDLKPEN+L+ S            G  I+      +     GT  Y++PE+L 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHS 333
              + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA  
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 257
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKH 359
           L+  +L  +PSKR+ +     +A+KH
Sbjct: 258 LINKMLTINPSKRITAA----EALKH 279

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 37/273 (13%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDES--SRSNSMCGTTEYMAPEILL 277
           + H   + HRDLK EN L+D            G+       S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 278 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 330
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 37/273 (13%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 68
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDES--SRSNSMCGTTEYMAPEILL 277
           + H   + HRDLK EN L+D            G+       S+  S  GT  Y+APE+LL
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 278 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 330
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 248
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 249 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 63/170 (37%), Positives = 95/170 (55%), Gaps = 18/170 (10%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
           ++  +  LHK  IVHRDLKPENIL+D D +          ++D   +   +CGT  Y+AP
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 179
Query: 274 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 63/170 (37%), Positives = 95/170 (55%), Gaps = 18/170 (10%)
Query: 165 ERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
           ++  +  LHK  IVHRDLKPENIL+D D +          ++D   +   +CGT  Y+AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 274 EILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           EI+         G+ K+ D WS G+++Y +L G PPF H  +Q L  R+I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 241

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 133/273 (48%), Gaps = 37/273 (13%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I  N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIAAN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDES--SRSNSMCGTTEYMAPEILL 277
           + H   + HRDLK EN L+D            G+       S+  S  GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 278 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 330
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 118/223 (52%), Gaps = 18/223 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 50  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 109
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------- 254
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   +         
Sbjct: 110 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 255 ----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
                +   +     GT  Y+APE+ L K +++  D WS G++LY +L G PPF     Q
Sbjct: 170 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 228
Query: 311 KLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGS 349
           ++ +R+   K    P     ++ EA  L+K +L  +PSKR+ +
Sbjct: 229 EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISA 271

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 37/273 (13%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDES--SRSNSMCGTTEYMAPEILL 277
           + H   + HRDLK EN L+D            G+       S+  S  GT  Y+APE+LL
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 278 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 330
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 118/223 (52%), Gaps = 18/223 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K+++K ++   ++   +  E  +L ++ HP I++L   F+ +   YL+++   GG LF
Sbjct: 33  AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELF 92
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------- 254
             +  +  F E  A     +++S  ++LHK  IVHRDLKPEN+L++S   +         
Sbjct: 93  DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 255 ----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
                +   +     GT  Y+APE+ L K +++  D WS G++LY +L G PPF     Q
Sbjct: 153 LSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ 211
Query: 311 KLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGS 349
           ++ +R+   K    P     ++ EA  L+K +L  +PSKR+ +
Sbjct: 212 EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISA 254

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 133/273 (48%), Gaps = 37/273 (13%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT- 170
           +E+ + +G G F                  + A+K + +   I +N       +R+I+  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNE-----LVAVKYIERGEKIDEN------VKREIINH 69
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +++++ +GG LF  +   G F ED+ARF+  +++S VS
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDES--SRSNSMCGTTEYMAPEILL 277
           + H   + HRDLK EN L+D            G+       S+     GT  Y+APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 278 SKGHN-KDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPPF--LTSE 330
            K ++ K AD WS G+ LY ML G  PF       N +K   RI+N +  +P +  ++ E
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
              L+  +   DP+KR+      +  I++H+WF
Sbjct: 250 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 277

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 47  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSM 264
                +I+ ++++ H  GIVHR+LKPEN+L+ S                E+++S   +  
Sbjct: 107 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 226
Query: 325 P----FLTSEAHSLLKGLLHKDPSKRLGS 349
                 +T EA SL+  +L  +P KR+ +
Sbjct: 227 SPEWDTVTPEAKSLIDSMLTVNPKKRITA 255

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSM 264
                +I+ ++++ H  GIVHR+LKPEN+L+ S                E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 325 P----FLTSEAHSLLKGLLHKDPSKRLGS 349
                 +T EA SL+  +L  +P KR+ +
Sbjct: 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITA 256

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 130
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSM 264
                +I+ ++++ H  GIVHR+LKPEN+L+ S                E+++S   +  
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 250
Query: 325 P----FLTSEAHSLLKGLLHKDPSKRL 347
                 +T EA SL+  +L  +P KR+
Sbjct: 251 SPEWDTVTPEAKSLIDSMLTVNPKKRI 277

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 160 DYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
           D+ K ER+  I  K+ HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSM 264
                +I+ ++++ H  GIVHR+LKPEN+L+ S                E+++S   +  
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
            GT  Y++PE+L    ++K  D W+ G++LY +L G PPF   ++ +L  +I       P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 325 P----FLTSEAHSLLKGLLHKDPSKRLGS 349
                 +T EA SL+  +L  +P KR+ +
Sbjct: 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITA 256

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 140/276 (50%), Gaps = 28/276 (10%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+F                    + ++++K  +       
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM------- 52
Query: 161 YMKAERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           +M+ ER+I  L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R
Sbjct: 53  HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTT 268
            +  +I+ A+ + H+  IVHRDLKPEN+L+D + + +I +   SN M         CG+ 
Sbjct: 112 RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 269 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 327
            Y APE++  K +   + D WS GI+LY ML G+ PF       L +++ +    +P FL
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231
Query: 328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +  A SL++ ++  DP +R+      +  I+   WF
Sbjct: 232 SPGAQSLIRRMIVADPMQRI-----TIQEIRRDPWF 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 28/267 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQE-----YAAMIINTKKLSARDH-QKLEREARICR 65
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 231 LHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNS---MCGTTEYMAPEIL 276
            H+ G+VHR+LKPEN+L+ S            G  I+      +     GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 332
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKH 359
            L+  +L  +PSKR+ +     +A+KH
Sbjct: 246 DLINKMLTINPSKRITAA----EALKH 268

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 28/267 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQE-----YAAKIINTKKLSARDH-QKLEREARICR 85
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNH 145
Query: 231 LHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNS---MCGTTEYMAPEIL 276
           +H+  IVHRDLKPEN+L+ S            G  I+      +     GT  Y++PE+L
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL 205
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 332
               + K  D W+ G++LY +L G PPF   ++ KL Q+I       P      +T EA 
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 265
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           +L+  +L  +P+KR+ +      A+KH
Sbjct: 266 NLINQMLTINPAKRITAD----QALKH 288

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 129/249 (51%), Gaps = 17/249 (6%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF++  ++G+G+F                    A+K++ K  + K   V  ++ E  I  
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEV-----AIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVS 229
           ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ + 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSN----------SMCGTTEYMAPEILLS 278
           +LH  GI+HRDL   N+L+  + + +I +   +           ++CGT  Y++PEI   
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
             H  ++D WS+G + Y +L G+PPF     +    +++    ++P FL+ EA  L+  L
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 339 LHKDPSKRL 347
           L ++P+ RL
Sbjct: 247 LRRNPADRL 255

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNS---MCGTTEYMAPEIL 276
            H  GIVHRDLKPEN+L+ S            G  I+      +     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 332
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKH 359
            L+  +L  +P+KR+ +     +A+KH
Sbjct: 239 DLINKMLTINPAKRITAS----EALKH 261

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D          
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +I+ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ +V+H
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 231 LHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNS---MCGTTEYMAPEIL 276
            H  GIVHRDLKPEN+L+ S            G  I+      +     GT  Y++PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 332
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKH 359
            L+  +L  +P+KR+ +     +A+KH
Sbjct: 239 DLINKMLTINPAKRITAS----EALKH 261

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D          
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D          
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 189 ATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 249 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D          
Sbjct: 108 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 168 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 227
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 228 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 263

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A KV+ K  ++K +  + M  E  I   + +P +V     F+    +Y++L+      
Sbjct: 53  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 112
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR++  + +  V +LH   ++HRDLK  N+ ++ D          
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 172
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +I+ +  R   +CGT  Y+APE+L  KGH+ + D WS+G +LY +L G+PPF  +  +
Sbjct: 173 ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 232
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A +L++ +LH DP+ R
Sbjct: 233 ETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 268

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D          
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 28/267 (10%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +++++  +G+GAF                   YA K++    +  ++H   ++ E  I  
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHE-----YAAKIINTKKLSARDH-QKLEREARICR 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + H  IV+L  S       YL+ D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 231 LHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNS---MCGTTEYMAPEIL 276
            H+ G+VHRDLKPEN+L+ S            G  I+      +     GT  Y++PE+L
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH 332
             + + K  D W+ G++LY +L G PPF   ++ KL Q+I       P      +T EA 
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           +L+  +L  +P+KR+ +     +A+KH
Sbjct: 239 NLINQMLTINPAKRITAH----EALKH 261

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 112/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D          
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +++ +  R  ++CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 164 ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 68
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTEYMAPEILLSK 279
           + H+  IVHRDLKPEN+L+D   + +I +   SN M         CG+  Y APE++  K
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 187
Query: 280 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 247
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFR 364
           L  +P  R+      +  I    WF+
Sbjct: 248 LIVNPLNRI-----SIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 67
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTEYMAPEILLSK 279
           + H+  IVHRDLKPEN+L+D   + +I +   SN M         CG+  Y APE++  K
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 186
Query: 280 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFR 364
           L  +P  R+      +  I    WF+
Sbjct: 247 LIVNPLNRI-----SIHEIMQDDWFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 58
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTEYMAPEILLSK 279
           + H+  IVHRDLKPEN+L+D   + +I +   SN M         CG+  Y APE++  K
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 280 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 237
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFR 364
           L  +P  R+      +  I    WF+
Sbjct: 238 LIVNPLNRI-----SIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G+++I + +G+G+F                    A+K++ K  + K +    ++ E   L
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKV-----ALKIINKKVLAKSDMQGRIEREISYL 62
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP I++L    +++ ++ +++++  G  LF ++ ++    E +AR +  +I+SAV 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 230 HLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTEYMAPEILLSK 279
           + H+  IVHRDLKPEN+L+D   + +I +   SN M         CG+  Y APE++  K
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 181
Query: 280 GH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
            +   + D WS G++LY ML  + PF   +   L + I N    LP FL+  A  L+K +
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 241
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFR 364
           L  +P  R+      +  I    WF+
Sbjct: 242 LIVNPLNRI-----SIHEIMQDDWFK 262

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E  IL +V  HP I+ L  S+++ S ++L+ D +  G LF +L  +    E + R   
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYM 271
             ++ AVS LH   IVHRDLKPENIL+D +             ++   +   +CGT  Y+
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 272 APEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVK 322
           APEIL         G+ K+ D W+ G++L+ +L G PPF H  RQ L  R+I E   +  
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFS 325
Query: 323 LPPF--LTSEAHSLLKGLLHKDPSKRLGS 349
            P +   +S    L+  LL  DP  RL +
Sbjct: 326 SPEWDDRSSTVKDLISRLLQVDPEARLTA 354

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D          
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 248 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 283

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 123/243 (50%), Gaps = 32/243 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFING 199
           + A+K + +   I +N       +R+I+    + HP IV+ +    T + L +I+++ +G
Sbjct: 47  LVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------- 251
           G L+  +   G F ED+ARF+  +++S VS+ H   I HRDLK EN L+D          
Sbjct: 101 GELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC 160
Query: 252 --GHEIDES--SRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTH 306
             G+       S+  S  GT  Y+APE+LL + ++ K AD WS G+ LY ML G  PF  
Sbjct: 161 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
Query: 307 A----NRQKLQQRIINEKVKLPP--FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
                + +K  QRI++ K  +P    ++ E   L+  +   DP+ R+      +  IK H
Sbjct: 221 PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI-----SIPEIKTH 275
Query: 361 KWF 363
            WF
Sbjct: 276 SWF 278

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D          
Sbjct: 126 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 185
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 186 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 245
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 246 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 50  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 109
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-----ID--------ESSRSNSMC 265
               +++SAV++ HK  + HRDLKPEN L  +D  +     ID              +  
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           GT  Y++P++ L   +  + D WS G+++Y +L G PPF+     ++  +I       P 
Sbjct: 170 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 228
Query: 326 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
                ++ +A SL++ LL K P +R+ S    + A++ H+WF
Sbjct: 229 KDWLNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWF 265

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 23/222 (10%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           VD  K E +I+  + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A 
Sbjct: 67  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA 126
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMC 265
               +++SAV++ HK  + HRDLKPEN L  +D                        +  
Sbjct: 127 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           GT  Y++P++ L   +  + D WS G+++Y +L G PPF+     ++  +I       P 
Sbjct: 187 GTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 245
Query: 326 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
                ++ +A SL++ LL K P +R+ S    + A++ H+WF
Sbjct: 246 KDWLNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWF 282

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 11/216 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A K++ K  ++K +  + M  E  I   + H  +V     F+    ++++L+      
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++ D          
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 252 GHEID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
             +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L G+PPF  +  +
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 311 KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +   RI   +  +P  +   A SL++ +L  DP+ R
Sbjct: 222 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 257

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 134/267 (50%), Gaps = 28/267 (10%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 55  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 236 IVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLSKGHN 282
           IVHRDLKPEN+L++S   +              + S +     GT  Y+APE+L    ++
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 228
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 338
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 229 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 288
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L   PS R+ +     DA+  H+W ++
Sbjct: 289 LTYVPSMRISA----RDAL-DHEWIQT 310

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 134/267 (50%), Gaps = 28/267 (10%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 38  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 236 IVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLSKGHN 282
           IVHRDLKPEN+L++S   +              + S +     GT  Y+APE+L    ++
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 211
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 338
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 212 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 271
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L   PS R+ +     DA+  H+W ++
Sbjct: 272 LTYVPSMRISAR----DAL-DHEWIQT 293

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 134/267 (50%), Gaps = 28/267 (10%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 56  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 236 IVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLSKGHN 282
           IVHRDLKPEN+L++S   +              + S +     GT  Y+APE+L    ++
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 229
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 338
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 230 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 289
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L   PS R+ +     DA+  H+W ++
Sbjct: 290 LTYVPSMRISA----RDAL-DHEWIQT 311

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 120/224 (53%), Gaps = 19/224 (8%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------ 256
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   + D      
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 257 -------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
                  ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 310 QKLQQRIINEK--VKLPPF--LTSEAHSLLKGLLHKDPSKRLGS 349
             + +R+   K    LP +  ++ +A  L++ +L   PS R+ +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 120/224 (53%), Gaps = 19/224 (8%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------ 256
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   + D      
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 257 -------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
                  ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 310 QKLQQRIINEK--VKLPPF--LTSEAHSLLKGLLHKDPSKRLGS 349
             + +R+   K    LP +  ++ +A  L++ +L   PS R+ +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 134/267 (50%), Gaps = 28/267 (10%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S ++++HK  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 236 IVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLSKGHN 282
           IVHRDLKPEN+L++S   +              + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YD 205
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 338
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++ +
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 265
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L   PS R+ +     DA+  H+W ++
Sbjct: 266 LTYVPSMRISAR----DAL-DHEWIQT 287

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 120/224 (53%), Gaps = 19/224 (8%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV+ K +   K+    ++ E ++L K+ HP I++L    +  S  Y++ +   GG L
Sbjct: 50  YAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------ 256
           F  + ++  F E  A     ++ S ++++HK  IVHRDLKPENIL++S   + D      
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 257 -------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
                  ++++     GT  Y+APE+L    +++  D WS G++LY +L+G PPF   N 
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 310 QKLQQRIINEK--VKLPPF--LTSEAHSLLKGLLHKDPSKRLGS 349
             + +R+   K    LP +  ++ +A  L++ +L   PS R+ +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 28/267 (10%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           RV+G+G+F                    A+KV+ K  + +K   + +  E  +L ++ HP
Sbjct: 32  RVLGKGSFGEVILCKDKITGQEC-----AVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            I +L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++ HK  
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 236 IVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLSKGHN 282
           IVHRDLKPEN+L++S   +              + S +     GT  Y+APE+L    ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YD 205
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPF--LTSEAHSLLKGL 338
           +  D WS G++LY +L+G PPF  AN   + +++   K   +LP +  ++  A  L++  
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKX 265
Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           L   PS R+ +     DA+  H+W ++
Sbjct: 266 LTYVPSXRISAR----DAL-DHEWIQT 287

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/316 (27%), Positives = 146/316 (46%), Gaps = 42/316 (13%)
Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXX 140
           SS + L  + L  ++  E   E   ++G G F I R   Q                    
Sbjct: 8   SSGVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKE-------------- 53
Query: 141 XIYAMKVMRKDTIIK-KNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197
             YA K ++K  +   +  V   + ER+  IL ++ HP I+ L   F+ ++ + LIL+ +
Sbjct: 54  --YAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 111
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD----- 251
           +GG LF  L  +    ED+A  +  +I+  V +LH   I H DLKPENI L+D +     
Sbjct: 112 SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 171
Query: 252 --------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP 303
                    H+I+  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  P
Sbjct: 172 IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231
Query: 304 FTHANRQKLQQRI--INEKVKLPPFL-TSE-AHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           F    +Q+    I  +N       F  TSE A   ++ LL KDP +R+      +     
Sbjct: 232 FLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM-----XIAQSLE 286
Query: 360 HKWFRSINWKTLEARE 375
           H W ++I  + +   +
Sbjct: 287 HSWIKAIRRRNVRGED 302

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 34/270 (12%)
Query: 104 ERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           E KIG   F++ R +G GA+                    A+KV++K    K  + D  K
Sbjct: 31  EGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEK-----AIKVIKKSQFDKGRYSDDNK 84
Query: 164 A----------ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
                      E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  F 
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-------------ESSR 260
           E  A     +I+S + +LHK  IVHRD+KPENIL+++    ++             +  +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 320
                GT  Y+APE+ L K +N+  D WS G+++Y +L G PPF   N Q + +++   K
Sbjct: 205 LRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 321 VKLP----PFLTSEAHSLLKGLLHKDPSKR 346
                     ++ EA  L+K +L  D +KR
Sbjct: 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKR 293

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  + 
Sbjct: 55  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSD-------------GHEIDESSRSNSMCGT 267
            +I+  V +LH   I H DLKPENI L+D +              H+I+  +   ++ GT
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPP 325
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I  +N       
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 326 FL-TSE-AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 375
           F  TSE A   ++ LL KDP +R+      +     H W ++I  + +   +
Sbjct: 235 FSNTSELAKDFIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRRNVRGED 281

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 118/223 (52%), Gaps = 19/223 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K++RK ++   ++   ++ E  +L  + HP I++L   F+ +   YL+++   GG LF
Sbjct: 66  AIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------- 254
             +  +  F E  A     +++S V++LHK  IVHRDLKPEN+L++S   +         
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 255 ----IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
                +   +     GT  Y+APE+ L K +++  D WS+G++L+ +L G PPF     Q
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243
Query: 311 KLQQRIINEKVKL--PPF--LTSEAHSLLKGLLHKDPSKRLGS 349
           ++ +++   K     P +  ++  A  L+K +L  D  +R+ +
Sbjct: 244 EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 41/258 (15%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ + + GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM-------- 264
            E +A      I   V +LH  G+VHRDLKP NIL       +DES    S+        
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY------VDESGNPESIRICDFGFA 167
Query: 265 -------------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---N 308
                        C T  ++APE+L  +G++   D WS+G+LLY MLTG  PF +     
Sbjct: 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
Query: 309 RQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            +++  RI + K  L       ++  A  L+  +LH DP +RL +       +  H W  
Sbjct: 228 PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA-----LVLRHPWI- 281
Query: 365 SINWKTLEAREMQPKFKP 382
            ++W  L   ++  +  P
Sbjct: 282 -VHWDQLPQYQLNRQDAP 298

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 40/233 (17%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN 262
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL       +DES    
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY------VDESGNPE 162
Query: 263 SM---------------------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
            +                     C T  ++APE+L  +G+++  D WS+GILLY ML G 
Sbjct: 163 CLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGY 222
Query: 302 PPFTHA---NRQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRL 347
            PF +      +++  RI + K  L       ++  A  L+  +LH DP +RL
Sbjct: 223 TPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 40/233 (17%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           YA+KV      I K+  D  +    +L    HP I+ L+  +     +YL+ + + GG L
Sbjct: 55  YAVKV------IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN 262
              + RQ  F E +A F    I   V +LH  G+VHRDLKP NIL       +DES    
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY------VDESGNPE 162
Query: 263 SM---------------------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
            +                     C T  ++APE+L  +G+++  D WS+GILLY ML G 
Sbjct: 163 CLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGY 222
Query: 302 PPFTHA---NRQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRL 347
            PF +      +++  RI + K  L       ++  A  L+  +LH DP +RL
Sbjct: 223 TPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 110/204 (53%), Gaps = 18/204 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E +IL ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  + 
Sbjct: 62  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSD-------------GHEIDESSRSNSMCGT 267
            +I+  V +LH   I H DLKPENI L+D +              H+I+  +   ++ GT
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 181
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPP 325
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I  +N       
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 326 FL-TSE-AHSLLKGLLHKDPSKRL 347
           F  TSE A   ++ LL KDP +R+
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRM 265

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 130/260 (50%), Gaps = 30/260 (11%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM--RKDTIIKKNHVDYMKAERDIL 169
           +E+  V+G+GAF                   +A+K++   K T       + +K E  I 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQ-----FAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSR-SNSMCGTTEYM 271
            A+ + H   I+HRD+KPEN+L+ S  +             ++ ES   +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FL 327
           APE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+ P     +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHI 259
Query: 328 TSEAHSLLKGLLHKDPSKRL 347
           +  A  L++ +L  DP++R+
Sbjct: 260 SESAKDLVRRMLMLDPAERI 279

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 38  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 97
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 110/204 (53%), Gaps = 18/204 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  IL ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  + 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSD-------------GHEIDESSRSNSMCGT 267
            +I++ V +LH   I H DLKPENI L+D +              H+ID  +   ++ GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPP 325
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    +  +N + +   
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 326 F--LTSEAHSLLKGLLHKDPSKRL 347
           F   ++ A   ++ LL KDP KR+
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 119/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 117/227 (51%), Gaps = 28/227 (12%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++AE ++L  + HP I+++   F+    +Y++++   GG L   +       +  + 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 219 FYTAEIV----SAVSHLHKCGIVHRDLKPENILM-DSDGHE----ID--------ESSRS 261
            Y AE++    +A+++ H   +VH+DLKPENIL  D+  H     ID            S
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII---- 317
            +  GT  YMAPE+   +      D WS G+++Y +LTG  PFT  + +++QQ+      
Sbjct: 184 TNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
Query: 318 NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           N  V+  P LT +A  LLK +L KDP +R    P     + HH+WF+
Sbjct: 243 NYAVECRP-LTPQAVDLLKQMLTKDPERR----PSAAQVL-HHEWFK 283

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           ++ E  IL +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  + 
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENI-LMDSD-------------GHEIDESSRSNSMCGT 267
            +I+  V++LH   I H DLKPENI L+D +              HEI++     ++ GT
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL 327
            E++APEI+  +    +AD WS+G++ Y +L+G  PF    +Q+    I           
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 328 TSE----AHSLLKGLLHKDPSKRL 347
            S+    A   ++ LL K+  KRL
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRL 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  +  Q   +F+EDQ   +
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNSMC-GTTE 269
             +I  A+ H+H   I+HRD+K +NI +  DG            ++ +      C GT  
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 326
           Y++PEI  +K +N  +D W++G +LYE+ T +  F   + + L  +II+     PP    
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SFPPVSLH 248
Query: 327 LTSEAHSLLKGLLHKDPSKR 346
            + +  SL+  L  ++P  R
Sbjct: 249 YSYDLRSLVSQLFKRNPRDR 268

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 113/258 (43%), Gaps = 41/258 (15%)
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           II K+  D  +    +L    HP I+ L+  +     +Y++ +   GG L   + RQ  F
Sbjct: 54  IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFF 113
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM-------- 264
            E +A      I   V +LH  G+VHRDLKP NIL       +DES    S+        
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY------VDESGNPESIRICDFGFA 167
Query: 265 -------------CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---N 308
                        C T  ++APE+L  +G++   D WS+G+LLY  LTG  PF +     
Sbjct: 168 KQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDT 227
Query: 309 RQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            +++  RI + K  L       ++  A  L+   LH DP +RL +       +  H W  
Sbjct: 228 PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAA-----LVLRHPWI- 281
Query: 365 SINWKTLEAREMQPKFKP 382
            ++W  L   ++  +  P
Sbjct: 282 -VHWDQLPQYQLNRQDAP 298

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 118/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LIL+ + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT  ++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 118/226 (52%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRKD-TIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  T   +  V     ER+  IL ++ HP ++ L   ++ ++ + LI + + G
Sbjct: 39  YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAG 98
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L  +    E++A  +  +I++ V +LH   I H DLKPENI L+D +       
Sbjct: 99  GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  H+ID  +   ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 306 HANRQKLQQRI--INEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +Q+    +  +N + +   F   ++ A   ++ LL KDP KR+
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 109 PGDFEIF-----RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           PG FE        ++G+GA+                   YA+K++ K     ++ V   +
Sbjct: 7   PGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKE-----YAVKIIEKQAGHSRSRV--FR 59
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
               +     +  I++L   F+  ++ YL+ + + GG +  H+ +Q  F E +A     +
Sbjct: 60  EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRD 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDS---------------DGHEIDESS------RSN 262
           + +A+  LH  GI HRDLKPENIL +S                G +++ S          
Sbjct: 120 VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 263 SMCGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPFT------------ 305
           + CG+ EYMAPE++      +  ++K  D WS+G++LY ML+G PPF             
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRG 239
Query: 306 ---HANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 358
                 + KL + I   K + P      ++SEA  L+  LL +D  +RL +       + 
Sbjct: 240 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAA-----QVL 294
Query: 359 HHKWFR 364
            H W +
Sbjct: 295 QHPWVQ 300

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +       
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  HEI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 306 HANRQKLQQRIINEKVKLPPFL---TSE-AHSLLKGLLHKDPSKRL 347
              +Q+    I +            TSE A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +       
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  HEI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 306 HANRQKLQQRIINEKVKLPPFL---TSE-AHSLLKGLLHKDPSKRL 347
              +Q+    I +            TSE A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +       
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  HEI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 306 HANRQKLQQRIINEKVKLPPFL---TSE-AHSLLKGLLHKDPSKRL 347
              +Q+    I +            TSE A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +       
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  HEI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 306 HANRQKLQQRIINEKVKLPPFLTSE----AHSLLKGLLHKDPSKRL 347
              +Q+    I            S+    A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 21/226 (9%)
Query: 143 YAMKVMRK-DTIIKKNHVDYMKAERD--ILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           YA K ++K  +   +  V   + ER+  IL +V H  ++ L   ++ R+ + LIL+ ++G
Sbjct: 40  YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LMDSD------- 251
           G LF  L ++    E++A  +  +I+  V++LH   I H DLKPENI L+D +       
Sbjct: 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
                  HEI++     ++ GT E++APEI+  +    +AD WS+G++ Y +L+G  PF 
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 306 HANRQKLQQRIINEKVKLPPFLTSE----AHSLLKGLLHKDPSKRL 347
              +Q+    I            S+    A   ++ LL K+  KRL
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 23/208 (11%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSR-SNS 263
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +             ++ ES   +  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 323
             GT  +MAPE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKM 253
Query: 324 PP----FLTSEAHSLLKGLLHKDPSKRL 347
            P     ++  A  L++ +L  DP++R+
Sbjct: 254 NPRQWSHISESAKDLVRRMLMLDPAERI 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 23/208 (11%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQA 217
           +K E  I   + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSR-SNS 263
             Y  +I+ A+ + H   I+HRD+KP  +L+ S  +             ++ ES   +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL 323
             GT  +MAPE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKM 251
Query: 324 PP----FLTSEAHSLLKGLLHKDPSKRL 347
            P     ++  A  L++ +L  DP++R+
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERI 279

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 117/261 (44%), Gaps = 47/261 (18%)
Query: 143 YAMKVMRKDTIIK-----------------------KNHVDYMKAERDILTKVTHPFIVQ 179
           YAMKV+ K  +I+                       +  ++ +  E  IL K+ HP +V+
Sbjct: 41  YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK 100
Query: 180 LRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L           LY++ + +N G +   +       EDQARFY  +++  + +LH   I+
Sbjct: 101 LVEVLDDPNEDHLYMVFELVNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKII 159
Query: 238 HRDLKPENILMDSDGH-EIDESSRSN----------SMCGTTEYMAPEILLSKGH---NK 283
           HRD+KP N+L+  DGH +I +   SN          +  GT  +MAPE L         K
Sbjct: 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219
Query: 284 DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHK 341
             D W++G+ LY  + GQ PF       L  +I ++ ++ P  P +  +   L+  +L K
Sbjct: 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK 279
Query: 342 DPSKRLGSGPGGVDAIKHHKW 362
           +P  R+      V  IK H W
Sbjct: 280 NPESRI-----VVPEIKLHPW 295

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 118/266 (44%), Gaps = 35/266 (13%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYM 271
           + + A+++LH   I+HRDLK  NIL   DG                  R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 272 APEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 326
           APE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 327 L------TSEAHSLLKGLLHKDPSKR 346
           L      +S     LK  L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 118/266 (44%), Gaps = 35/266 (13%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYM 271
           + + A+++LH   I+HRDLK  NIL   DG                  R +S  GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 272 APEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 326
           APE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 327 L------TSEAHSLLKGLLHKDPSKR 346
           L      +S     LK  L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            +F I + +G+G F                  +   KV   D +  K   D +K E D+L
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVP----VALKKVQIFDLMDAKARADCIK-EIDLL 86
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
            ++ HP +++   SF   ++L ++L+  + G L     H  +Q  +  E     Y  ++ 
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPE 274
           SA+ H+H   ++HRD+KP N+ + + G               +++ ++S+ GT  YM+PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPF--THANRQKLQQRIINEKVKLPPF----LT 328
            +   G+N  +D WS+G LLYEM   Q PF     N   L ++I  E+   PP      +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYS 264
Query: 329 SEAHSLLKGLLHKDPSKR 346
            E   L+   ++ DP KR
Sbjct: 265 EELRQLVNMCINPDPEKR 282

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 82/147 (55%), Gaps = 12/147 (8%)
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 230 HLHKCGIVHRDLKPENILMDSD----------GHEIDESS--RSNSMCGTTEYMAPEILL 277
           H H   IVHRD+KP+NIL+DS+             + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPF 304
            +  ++  D +S+GI+LYEML G+PPF
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 117/266 (43%), Gaps = 35/266 (13%)
Query: 105 RKIGPGDF-EIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P DF EI   +G GAF                  + A KV+  DT  ++   DYM 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVI--DTKSEEELEDYM- 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
            E DIL    HP IV+L  +F   + L+++++F  GG +    L  +    E Q +    
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYM 271
           + + A+++LH   I+HRDLK  NIL   DG                  R +   GT  +M
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 272 APEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF 326
           APE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I   +   PP 
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT 259
Query: 327 L------TSEAHSLLKGLLHKDPSKR 346
           L      +S     LK  L K+   R
Sbjct: 260 LAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+ +     LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 183
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 237
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 238 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 111/216 (51%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V +  S+    +L+++++F+ GG L   + 
Sbjct: 75  VKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT-DIV 133
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S+LH  G++HRD+K ++IL+ SDG               
Sbjct: 134 THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 193
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  +   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    +  +RI
Sbjct: 194 EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP +    +  S+L+G    +L ++PS+R
Sbjct: 254 ---RDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQR 286

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 157
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 217
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 218 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 277
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 278 TEPTQRM-----TITEFMNHPWI 295

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 149
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 210 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 269
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 270 TEPTQRM-----TITEFMNHPWI 287

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 148
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 208
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 209 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 268
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 269 TEPTQRM-----TITEFMNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 147
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 208 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 267
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 268 TEPTQRM-----TITEFMNHPWI 285

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 262 TEPTQRM-----TITEFMNHPWI 279

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 198
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 252
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 253 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 142
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 202
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 203 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 262
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 263 TEPTQRM-----TITEFMNHPWI 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 199
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 253
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 254 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 141
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 262 TEPTQRM-----TITEFMNHPWI 279

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINA 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 264 TEPTQRM-----TITEFMNHPWI 281

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 308 TEPTQRM-----TITEFMNHPWI 325

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 184
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 238
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 239 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------ESSRSNSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E+           + +      GT  Y  PE
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 226
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 280
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 281 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 239
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               
Sbjct: 240 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 300 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 360 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 392

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 123
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 183
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 237
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 238 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 211
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQH 265
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 266 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 184
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 238
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 239 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 212
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQH 266
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 267 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 184
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 238
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 239 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 212
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQH 266
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 267 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 218
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 272
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 273 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 300

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 211
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQH 265
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 266 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 117
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 238 ALLHKILVENPSARI-----TIPDIKKDRWY 263

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 264 TEPTQRM-----TITEFMNHPWI 281

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 226
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 280
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 281 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 211
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 265
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 266 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 193
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 253
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G+++Y +L G PPF      A    ++ RI   + + P      ++ E   L++ LL 
Sbjct: 254 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 313
Query: 341 KDPSKRLGSGPGGVDAIKHHKWF 363
            +P++R+      +    +H W 
Sbjct: 314 TEPTQRM-----TITEFMNHPWI 331

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 122
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 182
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 236
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 237 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 264

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSSECQH 233
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 234 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++SE   
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQH 233
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 234 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 162
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 223 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 283 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 315

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 116/235 (49%), Gaps = 28/235 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A K+++   +  K  V   K E  ++ ++ H  ++QL  +F++++ + L++++++GG LF
Sbjct: 118 AAKIIKTRGMKDKEEV---KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 204 FHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGHEID----- 256
             +  +     E     +  +I   + H+H+  I+H DLKPENIL ++ D  +I      
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 257 --------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
                   E  + N   GT E++APE++     +   D WSVG++ Y +L+G  PF   N
Sbjct: 235 LARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
Query: 309 RQKLQQRIINEKVKLPPF----LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             +    I+  +  L       ++ EA   +  LL K+ S R+ +     +A+KH
Sbjct: 293 DAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISAS----EALKH 343

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 119
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               
Sbjct: 120 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 179
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 180 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 240 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 272

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 117
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               
Sbjct: 118 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 177
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 178 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 238 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 270

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  I+ ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRSNSMCGTT 268
             +    + H+H+  IVH D+KPENI+ ++               +++          T 
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 326
           E+ APEI+  +      D W++G+L Y +L+G  PF   +  +  Q +   + +     F
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274
Query: 327 --LTSEAHSLLKGLLHKDPSKRL 347
             ++ EA   +K LL K+P KRL
Sbjct: 275 SSVSPEAKDFIKNLLQKEPRKRL 297

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 108
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               
Sbjct: 109 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 169 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 229 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 261

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++    ++ +   S+   SKL++I++++ GG     L R G F E Q      EI
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEI 129
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAP 273
           +  + +LH    +HRD+K  N+L+   G              D   + N+  GT  +MAP
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL----TS 329
           E++    ++  AD WS+GI   E+  G+PP +  +  ++   I       PP L    T 
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLVGDFTK 246
Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
                +   L+KDPS R    P   + +K HK+    + KT    E+  +FK
Sbjct: 247 SFKEFIDACLNKDPSFR----PTAKELLK-HKFIVKNSKKTSYLTELIDRFK 293

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++K  + K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   + 
Sbjct: 54  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV 112
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEID 256
                 E+Q       ++ A+S LH  G++HRD+K ++IL+  DG               
Sbjct: 113 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 172
Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           E  R   + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+ +    K  + I
Sbjct: 173 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232
Query: 317 INEKVKLPPFLTS--EAHSLLKG----LLHKDPSKR 346
              +  LPP L +  +    LKG    LL +DP++R
Sbjct: 233 ---RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 265

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 D---------------SDGHEIDESSRSNSM------CGTTEYMAPEILLSKG-----HN 282
           +                 G +++      S       CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 283 KDADWWSVGILLYEMLTGQPPFTH---------------ANRQKLQQRIINEKVKLP--- 324
           K  D WS+G++LY +L+G PPF                 A +  L + I   K + P   
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
              ++  A  L+  LL +D  +RL +       +  H W +
Sbjct: 265 WAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
           + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  GI HRDLKPENIL 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 249 D---------------SDGHEIDESSRSNSM------CGTTEYMAPEILLSKG-----HN 282
           +                 G +++      S       CG+ EYMAPE++ +       ++
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 283 KDADWWSVGILLYEMLTGQPPFTH---------------ANRQKLQQRIINEKVKLP--- 324
           K  D WS+G++LY +L+G PPF                 A +  L + I   K + P   
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
              ++  A  L+  LL +D  +RL +       +  H W +
Sbjct: 265 WAHISCAAKDLISKLLVRDAKQRLSAA-----QVLQHPWVQ 300

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 199
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 253
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 254 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 162 MKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDF-INGGHLFFHLYRQGIFREDQAR 218
           +K E  +L ++ H  ++QL      + + K+Y+++++ + G         +  F   QA 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------------HEIDESSRSNS 263
            Y  +++  + +LH  GIVH+D+KP N+L+ + G                  D++ R++ 
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 264 MCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
             G+  +  PEI   L        D WS G+ LY + TG  PF   N  KL + I     
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
Query: 322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            +P         LLKG+L  +P+KR       +  I+ H WFR
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRF-----SIRQIRQHSWFR 268

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 138
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 198
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 252
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 253 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 212
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQH 266
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 267 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 151
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 211
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQH 265
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 266 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 293

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 152
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 212
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIGGQVFFRQRVSXECQH 266
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 267 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 294

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 171
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 172 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 231
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 285
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 286 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 313

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 166
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 226
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 280
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 281 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 308

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 87  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 146
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 147 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 206
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 260
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 261 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 288

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           +K E  I   + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGT 267
             ++++ V +LH  GI HRD+KPEN+L+D  D  +I +   +            N MCGT
Sbjct: 111 H-QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 268 TEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPP 325
             Y+APE+L  +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 229
Query: 326 F--LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +  + S   +LL  +L ++PS R+      +  IK  +W+
Sbjct: 230 WKKIDSAPLALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------IDESSRSNSMCGTT 268
             ++   + H+H+   VH DLKPENI+  +                +D         GT 
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 320
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI----INEKVKLP 324
           E+ APE+   K      D WSVG+L Y +L+G  PF   N  +  + +     N      
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380
Query: 325 PFLTSEAHSLLKGLLHKDPSKRL 347
             ++ +    ++ LL  DP+ R+
Sbjct: 381 SGISEDGKDFIRKLLLADPNTRM 403

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 12/146 (8%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 234 CGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGHN 282
             ++HRD+K +NIL+  DG               E S+ ++M GT  +MAPE++  K + 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 283 KDADWWSVGILLYEMLTGQPPFTHAN 308
              D WS+GI+  EM+ G+PP+ + N
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 95/181 (52%), Gaps = 24/181 (13%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 248 MDSDGHE---------IDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWWSVGILLY 295
             S   +           + +  N++   C T  Y+APE+L  + ++K  D WS+G+++Y
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 296 EMLTGQPPFTHANRQKLQQRIINEKVKLPPF---------LTSEAHSLLKGLLHKDPSKR 346
            +L G PPF ++N  +     +  +++L  +         ++ +A  L++ LL  DP++R
Sbjct: 221 ILLCGFPPF-YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
Query: 347 L 347
           L
Sbjct: 280 L 280

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 95/181 (52%), Gaps = 24/181 (13%)
Query: 190 LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           L +I++ + GG LF  +  +G   F E +A     +I +A+  LH   I HRD+KPEN+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 248 MDSDGHE---------IDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWWSVGILLY 295
             S   +           + +  N++   C T  Y+APE+L  + ++K  D WS+G+++Y
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 201
Query: 296 EMLTGQPPFTHANRQKLQQRIINEKVKLPPF---------LTSEAHSLLKGLLHKDPSKR 346
            +L G PPF ++N  +     +  +++L  +         ++ +A  L++ LL  DP++R
Sbjct: 202 ILLCGFPPF-YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 260
Query: 347 L 347
           L
Sbjct: 261 L 261

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFY 220
           ++ E   ++ + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------IDESSRSNSMCGTT 268
             ++   + H+H+   VH DLKPENI+  +                +D         GT 
Sbjct: 155 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 214
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI----INEKVKLP 324
           E+ APE+   K      D WSVG+L Y +L+G  PF   N  +  + +     N      
Sbjct: 215 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 274
Query: 325 PFLTSEAHSLLKGLLHKDPSKRL 347
             ++ +    ++ LL  DP+ R+
Sbjct: 275 SGISEDGKDFIRKLLLADPNTRM 297

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEIL 276
           +  LH   ++HRD+K +NIL+  DG               E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHS 333
             K +    D WS+GI+  EM+ G+PP+ + N  +    I      +++ P  L++    
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            L   L  D  KR     G    +  H++ +
Sbjct: 249 FLNRCLEMDVEKR-----GSAKELLQHQFLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           ++ +  +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQA 128
Query: 228 VSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEIL 276
           +  LH   ++HRD+K +NIL+  DG               E S+ + M GT  +MAPE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
             K +    D WS+GI+  EM+ G+PP+ + N
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHS 135
Query: 234 CGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGHN 282
             ++HRD+K +NIL+  DG               E S+ + M GT  +MAPE++  K + 
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 195
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKGLL 339
              D WS+GI+  EM+ G+PP+ + N  +    I      +++ P  L++     L   L
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 255
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFR 364
             D  KR     G    +  H++ +
Sbjct: 256 EMDVEKR-----GSAKELIQHQFLK 275

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 139
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H CG++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 199
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 253
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   P  R        + I++H W + +
Sbjct: 254 LIRWCLALRPXDR-----PTFEEIQNHPWMQDV 281

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 43/281 (15%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 5   RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 56
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 114
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTE 269
             +++ A++ LH   I+HRDLK  N+LM  +G             +    + +S  GT  
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 270 YMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
           +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I       P
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---P 231
Query: 325 PFLTS------EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           P L +      E    LK  L K+P  R    P     ++H
Sbjct: 232 PTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 268

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 104 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC------- 265
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG         +++C       
Sbjct: 164 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 266 ----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 315
                     GT  +MAPE++L +  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283
Query: 316 IINEK---VKLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
           I +E     ++PP         ++  L K+P  R+ +
Sbjct: 284 IASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSA 320

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  +AE  +    +T P IV L  + +    + + ++ + GG L   +  QG  
Sbjct: 123 VKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 182
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC------- 265
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG         +++C       
Sbjct: 183 PEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 266 ----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 315
                     GT  +MAPE++L +  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302
Query: 316 IINEK---VKLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
           I +E     ++PP         ++  L K+P  R+ +
Sbjct: 303 IASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSA 339

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 43/281 (15%)
Query: 105 RKIGPGD-FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK 163
           R + P + +EI   +G GAF                  + A KV+  +T  ++   DY+ 
Sbjct: 13  RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVI--ETKSEEELEDYI- 64
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARFY 220
            E +IL    HP+IV+L  ++    KL+++++F  GG    +   L R     E Q +  
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVV 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTE 269
             +++ A++ LH   I+HRDLK  N+LM  +G             +    + +S  GT  
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 270 YMAPEILLSKG-----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
           +MAPE+++ +      ++  AD WS+GI L EM   +PP    N  ++  +I       P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---P 239
Query: 325 PFLTS------EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
           P L +      E    LK  L K+P  R    P     ++H
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 276

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           +P IV    S+    +L+++++++ GG L   +  +    E Q      E + A+  LH 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHS 135
Query: 234 CGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGHN 282
             ++HR++K +NIL+  DG               E S+ ++M GT  +MAPE++  K + 
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 195
Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKGLL 339
              D WS+GI+  EM+ G+PP+ + N  +    I      +++ P  L++     L   L
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 255
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFR 364
             D  KR     G    +  H++ +
Sbjct: 256 EMDVEKR-----GSAKELIQHQFLK 275

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 20/195 (10%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 229 SHLHKCGIVHRDLKPENILMDSDG-----HEIDESSR-------SNSMCGTTEYMAPEIL 276
            +LH   IVHRD+K +N+L+++        +   S R       + +  GT +YMAPEI+
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 277 LS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV--KLPPFLTSEA 331
               +G+ K AD WS+G  + EM TG+PPF      Q    ++   KV  ++P  +++EA
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255
Query: 332 HSLLKGLLHKDPSKR 346
            + +      DP KR
Sbjct: 256 KAFILKCFEPDPDKR 270

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 23/186 (12%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++ + ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 128 YAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDV 187
Query: 242 KPENILMDS----------DGHEIDESSRSNSM---CGTTEYMAPEILLSKGHNKDADWW 288
           KPEN+L  S          D     E++  NS+   C T  Y+APE+L  + ++K  D W
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247
Query: 289 SVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLH 340
           S+G++ Y +L G PPF      A     + RI   + + P      ++ E   L++ LL 
Sbjct: 248 SLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLK 307
Query: 341 KDPSKR 346
            +P++R
Sbjct: 308 TEPTQR 313

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEIXINK 60
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 119
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N M GT  Y+APE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 240 ALLHKILVENPSARI-----TIPDIKKDRWY 265

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 20/195 (10%)
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQAR--FYTAEIVSAV 228
           + H  IVQ   SF     + + ++ + GG L   L  + G  ++++    FYT +I+  +
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 229 SHLHKCGIVHRDLKPENILMDSDG-----HEIDESSR-------SNSMCGTTEYMAPEIL 276
            +LH   IVHRD+K +N+L+++        +   S R       + +  GT +YMAPEI+
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 181
Query: 277 LS--KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKV--KLPPFLTSEA 331
               +G+ K AD WS+G  + EM TG+PPF      Q    ++   KV  ++P  +++EA
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 241
Query: 332 HSLLKGLLHKDPSKR 346
            + +      DP KR
Sbjct: 242 KAFILKCFEPDPDKR 256

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 91/185 (49%), Gaps = 18/185 (9%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP +++L   F+T+    L+L+  +    LF ++  +G   E  +R +  ++V+A+ H H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 233 KCGIVHRDLKPENILMD---SDGHEIDESSRS-------NSMCGTTEYMAPE-ILLSKGH 281
             G+VHRD+K ENIL+D        ID  S +           GT  Y  PE I   + H
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYH 216
Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
              A  WS+GILLY+M+ G  PF         Q I+  ++  P  ++ +  +L++  L  
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCCALIRRCLAP 270
Query: 342 DPSKR 346
            PS R
Sbjct: 271 KPSSR 275

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ + +G+GA+                  I  MK   +     +N    +K E  I  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPEN----IKKEICINK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + H  +V+     +  +  YL L++ +GG LF  +    G+   D  RF+  ++++ V 
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVV 118
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRS------------NSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D  D  +I +   +            N M GT  Y+APE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE-KVKLPPF--LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     E K  L P+  + S   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
           +LL  +L ++PS R+      +  IK  +W+
Sbjct: 239 ALLHKILVENPSARI-----TIPDIKKDRWY 264

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMAP 273
           +  + +LH    +HRD+K  N+L+              G   D   + N+  GT  +MAP
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 230
Query: 334 LLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
            LK      L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 231 PLKEFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 277

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK 150
           +E E  A  E E  +K     +     +G GAF                      + + +
Sbjct: 10  VELEGLAACEGEYSQK-----YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQ 209
           D  I+   +  +  E  IL++V H  I+++   F+ +    L+++    G  LF  + R 
Sbjct: 65  DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESS 259
               E  A +   ++VSAV +L    I+HRD+K ENI++  D             ++   
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 260 RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
              + CGT EY APE+L+   +   + + WS+G+ LY ++  + PF      +L++ +  
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC-----ELEETV-- 237
Query: 319 EKVKLPPFLTS-EAHSLLKGLLHKDPSKR 346
           E    PP+L S E  SL+ GLL   P +R
Sbjct: 238 EAAIHPPYLVSKELMSLVSGLLQPVPERR 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILR 131
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYM 271
           EI+  + +LH    +HRD+K  N+L+              G   D   + N+  GT  +M
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           APE++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L    
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNY 248
Query: 332 HSLLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
              LK      L+K+PS R    P   + +KH    R+
Sbjct: 249 SKPLKEFVEACLNKEPSFR----PTAKELLKHKFILRN 282

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           K+   + +  E  I+    H  +V++  S+    +L+++++F+ GG L   +  Q    E
Sbjct: 82  KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNE 140
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESS-RSNS 263
           +Q       ++ A+++LH  G++HRD+K ++IL+  DG           +I +   +   
Sbjct: 141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX 200
Query: 264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---K 320
           + GT  +MAPE++    +  + D WS+GI++ EM+ G+PP+   +  +  +R+ +    K
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK 260
Query: 321 VKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +K    ++      L+ +L +DP +R
Sbjct: 261 LKNSHKVSPVLRDFLERMLVRDPQER 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 24/232 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMAP 273
           +  + +LH    +HRD+K  N+L+              G   D   + N   GT  +MAP
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 245
Query: 334 LLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
            LK      L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 246 PLKEFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 292

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 121/230 (52%), Gaps = 32/230 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------ 251
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +       
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 252 ----GHEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 301
                  I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 302 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 346
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 24/232 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L++   P++ +   S+   +KL++I++++ GG     L   G   E Q      EI
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREI 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMAP 273
           +  + +LH    +HRD+K  N+L+              G   D   + N   GT  +MAP
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
           E++    ++  AD WS+GI   E+  G+PP +  +  K+   I       PP L      
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSK 230
Query: 334 LLK----GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
            LK      L+K+PS R    P   + +KH    R+   KT    E+  ++K
Sbjct: 231 PLKEFVEACLNKEPSFR----PTAKELLKHKFILRNAK-KTSYLTELIDRYK 277

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 119/230 (51%), Gaps = 32/230 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------ 251
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NIL+ +       
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVV 158
Query: 252 ----GHEIDESSRS----NSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 301
                  I +S  S     ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVXQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 302 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 346
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 121/230 (52%), Gaps = 32/230 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------ 251
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +       
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 252 ----GHEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 301
                  I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 302 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 346
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPDSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 168 ILTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAEI 224
           +L KV+  F  +++L   F+      LIL+       LF  +  +G  +E+ AR +  ++
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE---IDESSRS-------NSMCGTTEYMAPE 274
           + AV H H  G++HRD+K ENIL+D +  E   ID  S +           GT  Y  PE
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 275 -ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS 333
            I   + H + A  WS+GILLY+M+ G  PF H       + II  +V     ++ E   
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSXECQH 233
Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           L++  L   PS R        + I++H W + +
Sbjct: 234 LIRWCLALRPSDR-----PTFEEIQNHPWMQDV 261

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 121/230 (52%), Gaps = 32/230 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------ 251
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +       
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 252 ----GHEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 301
                  I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 302 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 346
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 121/230 (52%), Gaps = 32/230 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 41  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------ 251
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +       
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 252 ----GHEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 301
                  I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 302 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 346
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 217 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHL--FFHLYRQGI-FRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  + + +      +E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSN 262
             R   ++I SA+ +LH+  I+HRDLKPENI++                  E+D+     
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
              GT +Y+APE+L  K +    D+WS G L +E +TG  PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH 232
           P ++ L   ++  S++ LIL++  GG +F     +   +  E+       +I+  V +LH
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 233 KCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMCGTTEYMAPEILLSK 279
           +  IVH DLKP+NIL+ S                +I  +     + GT EY+APEIL   
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 280 GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF--LTSEAHSLL 335
                 D W++GI+ Y +LT   PF   + Q+    I  +N       F  ++  A   +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFI 268
Query: 336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL 371
           + LL K+P KR    P   +    H W +  +++ L
Sbjct: 269 QSLLVKNPEKR----PTA-EICLSHSWLQQWDFENL 299

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHL--FFHLYRQGI-FRED 215
           E  I+ K+ HP +V  R       KL       L +++  GG L  + + +      +E 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSN 262
             R   ++I SA+ +LH+  I+HRDLKPENI++                  E+D+     
Sbjct: 123 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182
Query: 263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
              GT +Y+APE+L  K +    D+WS G L +E +TG  PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 121/230 (52%), Gaps = 32/230 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL----YLILDFI 197
           A+KV+R D  + ++   Y++  R+      + HP IV +  + +  +      Y++++++
Sbjct: 58  AVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 115
Query: 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------ 251
           +G  L   ++ +G     +A    A+   A++  H+ GI+HRD+KP NI++ +       
Sbjct: 116 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 175
Query: 252 ----GHEIDES----SRSNSMCGTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQ 301
                  I +S    +++ ++ GT +Y++PE   ++G + DA  D +S+G +LYE+LTG+
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGE 233
Query: 302 PPFTHANRQKLQQRIINEKVKLPPF-----LTSEAHSLLKGLLHKDPSKR 346
           PPFT  +   +  + + E   +PP      L+++  +++   L K+P  R
Sbjct: 234 PPFTGDSPVSVAYQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/306 (22%), Positives = 124/306 (40%), Gaps = 52/306 (16%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I   D+E+  V+G GA                      + + R +    +  +D +  E 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEK-------VAIKRINLEKCQTSMDELLKEI 64
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--------YRQGIFREDQAR 218
             +++  HP IV    SF  + +L+L++  ++GG +   +        ++ G+  E    
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------------EIDESSRSN 262
               E++  + +LHK G +HRD+K  NIL+  DG                 +I  +    
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 263 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
           +  GT  +MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +    
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243
Query: 322 KLPPFLTSEAH-------------SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 368
             PP L +                 ++   L KDP KR    P   + ++H  + ++ N 
Sbjct: 244 --PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLRHKFFQKAKNK 297
Query: 369 KTLEAR 374
           + L+ +
Sbjct: 298 EFLQEK 303

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 53/296 (17%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I   D+E+  V+G GA                      + + R +    +  +D +  E 
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEK-------VAIKRINLEKCQTSMDELLKEI 59
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--------YRQGIFREDQAR 218
             +++  HP IV    SF  + +L+L++  ++GG +   +        ++ G+  E    
Sbjct: 60  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 119
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------------EIDESSRSN 262
               E++  + +LHK G +HRD+K  NIL+  DG                 +I  +    
Sbjct: 120 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 263 SMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
           +  GT  +MAPE++   +G++  AD WS GI   E+ TG  P+      K+    +    
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 238
Query: 322 KLPPFLTSEAH-------------SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
             PP L +                 ++   L KDP KR    P   + ++ HK+F+
Sbjct: 239 --PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLR-HKFFQ 287

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 65/273 (23%)
Query: 142 IYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
           I A+K+M K+ I  I    V+ +K E  ++ K+ HP I +L   ++    + L+++  +G
Sbjct: 53  IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 200 GHLF-------------------------------------FHLYRQG---IFREDQARF 219
           GHL                                       H +R+    + RE     
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHEID----------------ESSRSN 262
              +I SA+ +LH  GI HRD+KPEN L  ++   EI                 E     
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 263 SMCGTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 320
           +  GT  ++APE+L   ++ +    D WS G+LL+ +L G  PF   N      +++N+K
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
Query: 321 VKL--PPF--LTSEAHSLLKGLLHKDPSKRLGS 349
           +    P +  L+  A  LL  LL+++  +R  +
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 18/174 (10%)
Query: 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           +  R  L ++++ ++GG LF  +  +G   F E +A      I  A+ +LH   I HRD+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
           KPEN+L  S         R N++   T++   +    + ++K  D WS+G+++Y +L G 
Sbjct: 144 KPENLLYTS--------KRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCGY 195
Query: 302 PPFTH----ANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRL 347
           PPF      A    ++ RI   + + P      ++ E   L++ LL  +P++R+
Sbjct: 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ +   P +V+   S+   + L++++++   G +   +  R     ED+       
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHE-----------IDESSRSNSMCGTTEYMA 272
            +  + +LH    +HRD+K  NIL++++GH             D  ++ N + GT  +MA
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFT 305
           PE++   G+N  AD WS+GI   EM  G+PP+ 
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 26/235 (11%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           + E  +L++   P+I +   S+   +KL++I++++ GG     L + G   E        
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILR 123
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYM 271
           EI+  + +LH    +HRD+K  N+L+   G              D   + N   GT  +M
Sbjct: 124 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           APE++    ++  AD WS+GI   E+  G+PP +  +  ++   I       PP L  + 
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQ- 239
Query: 332 HS-----LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
           HS      ++  L+KDP  R    P   + +K HK+      KT    E+  ++K
Sbjct: 240 HSKPFKEFVEACLNKDPRFR----PTAKELLK-HKFITRYTKKTSFLTELIDRYK 289

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 22/199 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  IDE   +N   GT  YM+
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE--MANEFVGTRSYMS 174
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 332
           PE L    ++  +D WS+G+ L EM  G+ P       +L   I+NE    PP L S   
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP---PPKLPSAVF 231
Query: 333 SL-----LKGLLHKDPSKR 346
           SL     +   L K+P++R
Sbjct: 232 SLEFQDFVNKCLIKNPAER 250

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 29/229 (12%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           + A+K MR+    ++N    M  +  +L     P+IVQ   +F T + +++ ++ +    
Sbjct: 52  VIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA 110
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS---------- 250
                  QG   E      T  IV A+ +L  K G++HRD+KP NIL+D           
Sbjct: 111 EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170
Query: 251 -DGHEIDESSRSNSMCGTTEYMAPEIL-----LSKGHNKDADWWSVGILLYEMLTGQPPF 304
             G  +D+ ++  S  G   YMAPE +         ++  AD WS+GI L E+ TGQ P+
Sbjct: 171 ISGRLVDDKAKDRS-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229
Query: 305 THANRQ-KLQQRIINEKVKLPPFL------TSEAHSLLKGLLHKDPSKR 346
            +     ++  +++ E+   PP L      + +  S +K  L KD  KR
Sbjct: 230 KNCKTDFEVLTKVLQEE---PPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 18/183 (9%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 104 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 163
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC------- 265
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG         +++C       
Sbjct: 164 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 266 ----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 315
                     GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283
Query: 316 IIN 318
           I +
Sbjct: 284 IAS 286

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 18/183 (9%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 88  VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC------- 265
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG         +++C       
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 266 ----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 315
                     GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267
Query: 316 IIN 318
           I +
Sbjct: 268 IAS 270

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 18/183 (9%)
Query: 154 IKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
           +KK  ++  + E  +    ++ P IV L  + +    + + ++ + GG L   + + G  
Sbjct: 102 VKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 161
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC------- 265
            ED+A +Y  + +  + +LH   I+H D+K +N+L+ SDG         +++C       
Sbjct: 162 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 266 ----------GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 315
                     GT  +MAPE+++ K  +   D WS   ++  ML G  P+T   R  L  +
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281
Query: 316 IIN 318
           I +
Sbjct: 282 IAS 284

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 24/190 (12%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHEI-----------DESSR 260
            R  T ++  A+   H+       ++HRDLKP N+ +D   +              ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 320
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 321 VKLPPFLTSE 330
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 24/190 (12%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHEI-----------DESSR 260
            R  T ++  A+   H+       ++HRDLKP N+ +D   +              ++S 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK 320
           + +  GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 321 VKLPPFLTSE 330
            +  P+  S+
Sbjct: 233 FRRIPYRYSD 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 190
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKLPPFLT 328
           PE L    ++  +D WS+G+ L EM  G+ P    +      +L   I+NE    PP L 
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEP---PPKLP 247
Query: 329 SEAHSL-----LKGLLHKDPSKR 346
           S   SL     +   L K+P++R
Sbjct: 248 SGVFSLEFQDFVNKCLIKNPAER 270

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 57/284 (20%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVMLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++ +++   G L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------------DGHEID 256
             R +  +I+ A+S++H  GI+HRDLKP NI +D                    D  ++D
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 257 ------ESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 309
                  S    S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMER 234
Query: 310 QKLQQRIINEKVKLPPFLTSEA----HSLLKGLLHKDPSKRLGS 349
             + +++ +  ++ PP            +++ L+  DP+KR G+
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 171
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------KLQQRIINEKVK 322
           PE L    ++  +D WS+G+ L EM  G+ P    + +          +L   I+NE   
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEP-- 229
Query: 323 LPPFLTSEAHSL-----LKGLLHKDPSKR 346
            PP L S   SL     +   L K+P++R
Sbjct: 230 -PPKLPSGVFSLEFQDFVNKCLIKNPAER 257

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
           ++ ++ E  +   + HP I+ LR        L L+++F  GG L   L  + I   D   
Sbjct: 50  IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILV 108
Query: 219 FYTAEIVSAVSHLHKCGIV---HRDLKPENILMDSDGHEIDESSR--------------- 260
            +  +I   +++LH   IV   HRDLK  NIL+       D S++               
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 261 --SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
               S  G   +MAPE++ +   +K +D WS G+LL+E+LTG+ PF   +   +   +  
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 319 EKVKLP-PFLTSEAHS-LLKGLLHKDPSKR 346
            K+ LP P    E  + L++   + DP  R
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 233
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 234 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 274

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 30/193 (15%)
Query: 164 AERDILTKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQ 216
           +E ++L ++ HP IV+   R   +T + LY+++++  GG L   +      RQ +  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 217 ARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSD--------------GHEIDE 257
            R  T ++  A+   H+       ++HRDLKP N+ +D                 H+ D 
Sbjct: 114 LRVMT-QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED- 171
Query: 258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
              +    GT  YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I 
Sbjct: 172 --FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229
Query: 318 NEKVKLPPFLTSE 330
             K +  P+  S+
Sbjct: 230 EGKFRRIPYRYSD 242

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 171
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 171
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMA 272
           +  V+H H+  I+HRDLKP+N+L++SDG              I   S ++ +  T  Y A
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
           P++L+ SK ++   D WS+G +  EM+TG+P F
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSD--------GHEIDESS---RSNSMCGTT 268
            ++   +++LH     IVHR+LK  N+L+D          G    ++S    S S  GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 326
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q P+ + N  ++   +    +++++P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 327 LTSEAHSLLKGLLHKDPSKR 346
           L  +  ++++G    +P KR
Sbjct: 264 LNPQVAAIIEGCWTNEPWKR 283

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ HP IV L     +   L L+ +F+           +   ++ Q + Y  ++
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMA 272
           +  V+H H+  I+HRDLKP+N+L++SDG              I   S ++ +  T  Y A
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
           P++L+ SK ++   D WS+G +  EM+TG+P F
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +                  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMD----VTGDEEEEIKQEINML 74
Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K +H   +   Y +F  ++      +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTE 269
             EI+  +SHLH+  ++HRD+K +N+L+  +            ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 270 YMAPEILLSKGHNKDA------DWWSVGILLYEMLTGQPPF 304
           +MAPE++     N DA      D WS+GI   EM  G PP 
Sbjct: 195 WMAPEVIACD-ENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--DQARFYTA 222
           E  I+ ++ HP IV    +      L ++ ++++ G L+  L++ G   +  ++ R   A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 223 -EIVSAVSHLHKCG--IVHRDLKPENILMDSD--------GHEIDESSR---SNSMCGTT 268
            ++   +++LH     IVHRDLK  N+L+D          G    ++S    S    GT 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI--INEKVKLPPF 326
           E+MAPE+L  +  N+ +D +S G++L+E+ T Q P+ + N  ++   +    +++++P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 327 LTSEAHSLLKGLLHKDPSKR 346
           L  +  ++++G    +P KR
Sbjct: 264 LNPQVAAIIEGCWTNEPWKR 283

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 198
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 171
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YM+
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 171
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L EM  G+ P    + ++L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 127/286 (44%), Gaps = 57/286 (19%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
             DFE   V+GQGAF                   YA+K +R      +  +  + +E  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVML 55
Query: 169 LTKVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--R 213
           L  + H ++V+       R +F       + +S L++ +++     L+  ++ + +   R
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------------DGHE 254
           ++  R +  +I+ A+S++H  GI+HRDLKP NI +D                    D  +
Sbjct: 116 DEYWRLFR-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 255 ID------ESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHA 307
           +D       S    S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T  
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM 232
Query: 308 NRQKLQQRIINEKVKLPPFLTSEA----HSLLKGLLHKDPSKRLGS 349
            R  + +++ +  ++ PP            +++ L+  DP+KR G+
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 40/258 (15%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 10  EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 53
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 54  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGTTEYM 271
               V++LH      ++HRDLKP N+L+ + G  +         D  +   +  G+  +M
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWM 171
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LT 328
           APE+     +++  D +S GI+L+E++T + PF        +          PP    L 
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 329 SEAHSLLKGLLHKDPSKR 346
               SL+     KDPS+R
Sbjct: 232 KPIESLMTRCWSKDPSQR 249

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 40/258 (15%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMK----AER 166
           + E+  VVG+GAF                  +   K   KD  IK+   +  +     E 
Sbjct: 9   EIEVEEVVGRGAFGV----------------VCKAKWRAKDVAIKQIESESERKAFIVEL 52
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAE 223
             L++V HP IV+L  +    + + L++++  GG L+  L+       +    A  +  +
Sbjct: 53  RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 224 IVSAVSHLHKC---GIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGTTEYM 271
               V++LH      ++HRDLKP N+L+ + G  +         D  +   +  G+  +M
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWM 170
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LT 328
           APE+     +++  D +S GI+L+E++T + PF        +          PP    L 
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 329 SEAHSLLKGLLHKDPSKR 346
               SL+     KDPS+R
Sbjct: 231 KPIESLMTRCWSKDPSQR 248

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           Y  + +R+  I+ +   + +   RDIL   T           +    +Y++ D +     
Sbjct: 84  YCQRTLREIQILLRFRHENVIGIRDILRAST----------LEAMRDVYIVQDLMETD-- 131
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------- 253
            + L +      D   ++  +I+  + ++H   ++HRDLKP N+L+++            
Sbjct: 132 LYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA 191
Query: 254 -----EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
                E D +        T  Y APEI+L SKG+ K  D WSVG +L EML+ +P F
Sbjct: 192 RIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 132/329 (40%), Gaps = 70/329 (21%)
Query: 110 GDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK--------------DTIIK 155
            D+ I R + QG F                   YA+K   K              D I  
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFRE 214
           K+  D  K E  I+T + + + +          ++Y+I +++ N   L F  Y   +  +
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF-FVLDK 142
Query: 215 DQARFYTAEIVSAV--------SHLH-KCGIVHRDLKPENILMDSDGH-EIDESSRSNSM 264
           +   F   +++  +        S++H +  I HRD+KP NILMD +G  ++ +   S  M
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 265 C--------GTTEYMAPEILLSKGHNKDA--DWWSVGILLYEMLTGQPPFT-HANRQKLQ 313
                    GT E+M PE   ++     A  D WS+GI LY M     PF+   +  +L 
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 314 QRIINEKVKLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 354
             I  + ++ P                    FL++E    LK  L K+P++R+ S     
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE---- 318
Query: 355 DAIKHHKWFRSINWKTLE--AREMQPKFK 381
           DA+KH  W    N + L   ++E+  K K
Sbjct: 319 DALKHE-WLADTNIEDLREFSKELYKKRK 346

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 31/191 (16%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 ------------EIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 293
                       E+++  +  S+ GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 294 LYEMLTGQPPF 304
            Y   TG  PF
Sbjct: 213 FYHAATGSLPF 223

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFY 220
           +K E  IL    H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDS------------DGHEIDESSRSNSMCGTT 268
             ++  A+  LH   I H D++PENI+  +               ++        +    
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPF 326
           EY APE+      +   D WS+G L+Y +L+G  PF     Q++ + I+N +       F
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 327 --LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             ++ EA   +  LL K+   R+ +     +A++H
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTAS----EALQH 258

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 118/264 (44%), Gaps = 62/264 (23%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LY 207
           D +IKK  +  ++    +L ++ HP +V L   F+ + +L+L+ ++ +  H   H    Y
Sbjct: 42  DPVIKKIALREIR----MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD--HTVLHELDRY 95
Query: 208 RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE---------- 257
           ++G+  E   +  T + + AV+  HK   +HRD+KPENIL+    H + +          
Sbjct: 96  QRGV-PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLL 152
Query: 258 ---SSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF--------T 305
              S   +    T  Y +PE+L+    +    D W++G +  E+L+G P +         
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212
Query: 306 HANRQKLQQRIINEK-----------VKLP------------PFLTSEAHSLLKGLLHKD 342
           +  R+ L   I   +           VK+P            P ++  A  LLKG LH D
Sbjct: 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 343 PSKRLGSGPGGVDAIKHHKWFRSI 366
           P++RL       + + HH +F +I
Sbjct: 273 PTERLTC-----EQLLHHPYFENI 291

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +   P+IV    +F +  ++ + ++ ++GG L   L       E+     +  +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 225 VSAVSHL-HKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGTTEYMA 272
           +  +++L  K  I+HRD+KP NIL++S            G  ID  S +NS  GT  YMA
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMA 181
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           PE L    ++  +D WS+G+ L E+  G+ P    + ++L+
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELE 222

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 35/193 (18%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKA----ERDILTKVTHPFIVQLRYSFQTRSK------LY 191
           +Y  K+     ++    V   KA    E  I+ K+ H  IV+LRY F +  +      L 
Sbjct: 36  VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 192 LILDFINGGHLFFHLYRQG--IFREDQ------ARFYTAEIVSAVSHLHKCGIVHRDLKP 243
           L+LD++        +YR      R  Q       + Y  ++  +++++H  GI HRD+KP
Sbjct: 96  LVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150
Query: 244 ENILMDSD-----------GHEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVG 291
           +N+L+D D             ++     + S   +  Y APE++  +  +    D WS G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 292 ILLYEMLTGQPPF 304
            +L E+L GQP F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y+++++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L   L  +     R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 238
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 239 ESLHDLMCQCWRKEPEER 256

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 230 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGT--TEY 270
           +I S ++++ +   VHRDL+  NIL+  +          G  I+++  +         ++
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 408
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 409 ESLHDLMCQCWRKDPEER 426

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 153
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 214 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 198
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 259 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ +++N G L   L  +     R  Q    +A
Sbjct: 60  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 238
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 239 ESLHDLMCQCWRKEPEER 256

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKIRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 157
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 217
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 218 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 147
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 207
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 208 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 31/191 (16%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL---RYSFQTRSKLYLILDFIN 198
           ++A+KV    + ++   VD    E ++L K+ H  IV+L        TR K+ LI++F  
Sbjct: 36  LFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCP 92
Query: 199 GGHLFFHLYR-QGIFREDQARFYTA--EIVSAVSHLHKCGIVHRDLKPENIL--MDSDGH 253
            G L+  L      +   ++ F     ++V  ++HL + GIVHR++KP NI+  +  DG 
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152
Query: 254 ------------EIDESSRSNSMCGTTEYMAPEI----LLSKGHNKD----ADWWSVGIL 293
                       E+++  +   + GT EY+ P++    +L K H K      D WS+G+ 
Sbjct: 153 SVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 294 LYEMLTGQPPF 304
            Y   TG  PF
Sbjct: 213 FYHAATGSLPF 223

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH-YSRAKQTL 155
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 216 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 153
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 131
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 131
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 191
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 57/284 (20%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE   V+GQGAF                   YA+K +R      +  +  + +E  +L 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRY-----YAIKKIRH----TEEKLSTILSEVXLLA 57
Query: 171 KVTHPFIVQL------RYSF-------QTRSKLYLILDFINGGHLFFHLYRQGIF--RED 215
            + H ++V+       R +F       + +S L++  ++     L+  ++ + +   R++
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS------------------------D 251
             R +  +I+ A+S++H  GI+HR+LKP NI +D                         D
Sbjct: 118 YWRLFR-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 252 GHEIDESSRS-NSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 309
              +  SS +  S  GT  Y+A E+L   GH N+  D +S+GI+ +E +   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXER 234
Query: 310 QKLQQRIINEKVKLPPFLTSEA----HSLLKGLLHKDPSKRLGS 349
             + +++ +  ++ PP            +++ L+  DP+KR G+
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGA 278

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 127
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 187
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 188 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 62  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 115
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------GHEIDESSR 260
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD         +  ++ 
Sbjct: 116 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS 175
Query: 261 SNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           +N M      T  Y APE++L  G+ ++ D WSVG ++ E++ G   F
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 138
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 198
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 199 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 54/277 (19%)
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQ 209
           D ++KK  +  +K    +L ++ H  +V L    + + + YL+ +F++   L    L+  
Sbjct: 64  DKMVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN 119
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HEIDESSRSNSMCGTT 268
           G+  +   + Y  +I++ +   H   I+HRD+KPENIL+   G  ++ +   + ++    
Sbjct: 120 GLDYQVVQK-YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 269 E----------YMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPF------------- 304
           E          Y APE+L+    + K  D W++G L+ EM  G+P F             
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238
Query: 305 -THANRQKLQQRIINEK-----VKLP------------PFLTSEAHSLLKGLLHKDPSKR 346
               N     Q + N+      V+LP            P L+     L K  LH DP KR
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298
Query: 347 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
               P   + + HH +F+   +    ++E+Q K + D
Sbjct: 299 ----PFCAELL-HHDFFQMDGFAERFSQELQLKVQKD 330

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 49/238 (20%)
Query: 156 KNHVDYMKAERDI--LTKVT-HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQG 210
           +N  D  +  R+I  LT+++ H  IV L    +  +   +YL+ D++        + R  
Sbjct: 47  QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRAN 104
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------------- 253
           I      ++   +++  + +LH  G++HRD+KP NIL++++ H                 
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 254 -------EIDESSRS--------NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEM 297
                   I+E++ +             T  Y APEILL S  + K  D WS+G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 298 LTGQPPFTHANRQKLQQRII-------NEKVK--LPPFLTSEAHSLLKGLLHKDPSKR 346
           L G+P F  ++     +RII       NE V+    PF  +   SL + +  +  +KR
Sbjct: 225 LCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 ------HEIDESSRSNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                   +  ++ ++ M      T  Y APE++L  G+ ++ D WSVG+++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 124
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 185 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG+++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 120
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 180
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 132
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 193 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 123
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 183
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 184 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 31/191 (16%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKA----ERDILTKVTHPFIVQLRYSFQTRSK------LY 191
           +Y  K+     ++    V   KA    E  I+ K+ H  IV+LRY F +  +      L 
Sbjct: 36  VYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 192 LILDFINGGHLFFHLYRQGIFREDQ------ARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245
           L+LD++      + + R    R  Q       + Y  ++  +++++H  GI HRD+KP+N
Sbjct: 96  LVLDYV--PETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 246 ILMDSD-----------GHEIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGIL 293
           +L+D D             ++     + S   +  Y APE++  +  +    D WS G +
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
Query: 294 LYEMLTGQPPF 304
           L E+L GQP F
Sbjct: 213 LAELLLGQPIF 223

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 54  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 232
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 233 ESLHDLMCQCWRKDPEER 250

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 34/185 (18%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+          
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 252 GHEIDESSRSNS-----MCGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLT 299
              IDES+  NS       G TEY+      APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 300 GQPPF 304
            +P F
Sbjct: 219 RRPIF 223

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ-- 216
           E  I+ K+ H  IV+LRY F +  +      L L+LD++      + + R    R  Q  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARH-YSRAKQTL 119
Query: 217 ----ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRS 261
                + Y  ++  +++++H  GI HRD+KP+N+L+D D             ++     +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 262 NSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            S   +  Y APE++  +  +    D WS G +L E+L GQP F
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 52  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 230
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 231 ESLHDLMCQCWRKDPEER 248

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
           +  YL++ F+  G     L +     ED+ +F   +++  + ++H  GI+HRDLKP N+ 
Sbjct: 103 TDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160
Query: 248 MDSD--------GHEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEML 298
           ++ D        G      S       T  Y APE++L+   + +  D WSVG ++ EM+
Sbjct: 161 VNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 299 TGQPPFTHANRQKLQQRIINEKVKLPP------FLTSEAHSLLKGL 338
           TG+  F  ++    Q + I +    PP        + EA + +KGL
Sbjct: 221 TGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 56/305 (18%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMA 272
           ++  ++  H   ++HRDLKP+N+L++++G  ++ +   + +             T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 273 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 321
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 362
                              K+ P L  +  SLL  +LH DP+KR+ +      A   H +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPF 289
Query: 363 FRSIN 367
           F+ + 
Sbjct: 290 FQDVT 294

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 233 --KCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE----------YMAPEILLSKG 280
             +  I+H DLKPENIL+ +      +     S C   +          Y +PE+LL   
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLGMP 215
Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 216 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 259

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G   ++S  S S     + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 9/102 (8%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS 263
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D        G      +    
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 264 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 304
              T  Y APE++LS  H N+  D WSVG ++ EMLTG+  F
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE----------YMAPEILLSKG 280
             +  I+H DLKPENIL+ +      +     S C   +          Y +PE+LL   
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLGMP 234
Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 235 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 278

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 9/102 (8%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS 263
           F E++ ++   +++  + ++H  G+VHRDLKP N+ ++ D        G      +    
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 200
Query: 264 MCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF 304
              T  Y APE++LS  H N+  D WSVG ++ EMLTG+  F
Sbjct: 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLH 232
           +IV L+  F  R+ L L+ + ++  +  + L R   FR    +  R +  ++ +A+  L 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 233 --KCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE----------YMAPEILLSKG 280
             +  I+H DLKPENIL+ +      +     S C   +          Y +PE+LL   
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLLGMP 234
Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           ++   D WS+G +L EM TG+P F+ AN      +I+ E + +PP
Sbjct: 235 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPP 278

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 56/305 (18%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMA 272
           ++  ++  H   ++HRDLKP+N+L++++G  ++ +   + +             T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 273 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 321
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 362
                              K+ P L  +  SLL  +LH DP+KR+ +      A   H +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPF 289
Query: 363 FRSIN 367
           F+ + 
Sbjct: 290 FQDVT 294

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 25/183 (13%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQ 209
           + H      E  +L  V H  I+ L   F  +  L      YL+++ ++          Q
Sbjct: 64  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC------Q 117
Query: 210 GIFRE---DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMC 265
            I  E   ++  +   +++  + HLH  GI+HRDLKP NI++ SD   +I +   + + C
Sbjct: 118 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 177
Query: 266 G---------TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
                     T  Y APE++L  G+  + D WSVG ++ E++ G   F   +      ++
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKV 237
Query: 317 INE 319
           I +
Sbjct: 238 IEQ 240

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--- 187
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--- 187
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 34/185 (18%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+          
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 252 GHEIDESSRSNS-----MCGTTE------YMAPEILL-SKGHNKDADWWSVGILLYEMLT 299
              IDES+  NS       G TE      Y APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 300 GQPPF 304
            +P F
Sbjct: 219 RRPIF 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 ------HEIDESSRSNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                   +  ++ ++ M      T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 46/211 (21%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRSKLYLILDFI 197
           YA+KV+R    IKK +    K E DIL K+      +  IV+    F     + LI + +
Sbjct: 63  YAVKVVRN---IKK-YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118
Query: 198 NGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------ 249
            G  L+  + R     F  +  + Y  EI+ A+++L K  + H DLKPENIL+D      
Sbjct: 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177
Query: 250 --------SDGHEID-------------------ESSRSNSMCGTTEYMAPEILLSKGHN 282
                   +DG +I                    +S    S+  T +Y APE++L+ G +
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWD 237
Query: 283 KDADWWSVGILLYEMLTGQPPF-THANRQKL 312
             +D WS G +L E+ TG   F TH + + L
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--- 187
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 20/150 (13%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  + +YL+   +  G    ++ +     +D  +F   +I+  + ++H   I+HRDLK
Sbjct: 95  SLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 152
Query: 243 PENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSV 290
           P N+ ++ D            H  DE +       T  Y APEI+L+  H N+  D WSV
Sbjct: 153 PSNLAVNEDSELKILDFGLCRHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 291 GILLYEMLTGQPPF---THANRQKLQQRII 317
           G ++ E+LTG+  F    H ++ KL  R++
Sbjct: 210 GCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 63  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL   NIL+         D     + E +   +  G     ++
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 241
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     KDP +R
Sbjct: 242 ESLHDLMCQCWRKDPEER 259

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEYMA 272
           + ++  A+ +L     VHRDL   N+L+  D        G   + SS  ++     ++ A
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 354
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSE 330
           PE L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P      
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 414
Query: 331 AHSLLKGLLHKDPSKR 346
            + ++K   H D + R
Sbjct: 415 VYDVMKNCWHLDAATR 430

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--- 182
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 21/219 (9%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL- 202
           A+K ++  T+  +  +     E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L 
Sbjct: 295 AIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLL 349
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDG 252
            F         R  Q     A+I S ++++ +   VHRDL+  NIL+         D   
Sbjct: 350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409
Query: 253 HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THA 307
             + E +   +  G     ++ APE  L       +D WS GILL E+ T G+ P+    
Sbjct: 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469
Query: 308 NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           NR+ L Q     ++  PP      H L+     K+P +R
Sbjct: 470 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDA 163
Query: 253 ------HEIDESSRSNSMCG----TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                   +  ++ ++ M      T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--- 186
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G  ++ +  
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 151
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--- 176
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 177 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 156
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 157 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 216
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 257

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G  ++ +  
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 150
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G  ++ +  
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 270 HYDPNKRISA-----KAALAHPFFQDVT 292

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G  ++ +  
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 149
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 176
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 160
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 221 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 114 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 171
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 172 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 231
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 232 WSVGCILAEMLSNRPIF 248

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 96  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 153
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 154 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 213
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 214 WSVGCILAEMLSNRPIF 230

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 210 WSVGCILAEMLSNRPIF 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--- 185
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 177
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 178
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 237

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 20/150 (13%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S +  + +YL+   +  G    ++ +     +D  +F   +I+  + ++H   I+HRDLK
Sbjct: 91  SLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148
Query: 243 PENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSV 290
           P N+ ++ D            H  DE +       T  Y APEI+L+  H N+  D WSV
Sbjct: 149 PSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSV 205
Query: 291 GILLYEMLTGQPPF---THANRQKLQQRII 317
           G ++ E+LTG+  F    H ++ KL  R++
Sbjct: 206 GCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--- 185
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 48  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 155
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 92  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 149
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 150 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 209
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 210 WSVGCILAEMLSNRPIF 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 177
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 185
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 155
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 176
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 99  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 156
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 157 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 216
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 217 WSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 100 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 157
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 158 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 217
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 218 WSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 91  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 148
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 149 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 208
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 209 WSVGCILAEMLSNRPIF 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 185
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 179
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 238

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 56  EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 234
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 235 ESLHDLMCQCWRKEPEER 252

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--- 191
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 182
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 164 TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 102 TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 159
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 160 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 219
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 220 WSVGCILAEMLSNRPIF 236

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 87/185 (47%), Gaps = 34/185 (18%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           ++A++ +R+  I+K     + K E  I       F +Q   SF+  +++Y+I + +    
Sbjct: 51  LFALRTLREIKILK-----HFKHENIITI-----FNIQRPDSFENFNEVYIIQELMQTD- 99
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
               +    +  +D  +++  + + AV  LH   ++HRDLKP N+L++S+          
Sbjct: 100 -LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
Query: 252 GHEIDESSRSNS-----------MCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT 299
              IDES+  NS              T  Y APE++L S  +++  D WS G +L E+  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 300 GQPPF 304
            +P F
Sbjct: 219 RRPIF 223

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 94  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 151
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 211
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 212 WSVGCILAEMLSNRPIF 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 49  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 108
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 109 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 165
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ G
Sbjct: 166 TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 182
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 192
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 186
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 182
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 192
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 187
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 200
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 199
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 186
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 192
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 69  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 117
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GH 253
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D        G 
Sbjct: 118 DLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 254 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
                        T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++    
Sbjct: 178 ARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQ 237
Query: 313 QQRIIN 318
            +RI+ 
Sbjct: 238 LKRIME 243

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 200
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 190
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 249

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT--- 180
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 203
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 99  TIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 156
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 157 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDI 216
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 217 WSVGCILAEMLSNRPIF 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 191
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 186
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 18/119 (15%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 199
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
               T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKPEN+L++++G  ++ +  
Sbjct: 89  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  +S  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I++F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 153
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 154 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 214 IDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 68  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G   ++S  S S     + G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEYMA 272
           + ++  A+ +L     VHRDL   N+L+  D        G   + SS  ++     ++ A
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 167
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSE 330
           PE L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P      
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 227
Query: 331 AHSLLKGLLHKDPSKR 346
            + ++K   H D + R
Sbjct: 228 VYEVMKNCWHLDAAMR 243

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEYMA 272
           + ++  A+ +L     VHRDL   N+L+  D        G   + SS  ++     ++ A
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 182
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSE 330
           PE L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P      
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242
Query: 331 AHSLLKGLLHKDPSKR 346
            + ++K   H D + R
Sbjct: 243 VYEVMKNCWHLDAAMR 258

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +YL+   +  G   + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 114 TIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 171
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 172 PSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 231
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 232 WSVGCILAEMLSNRPIF 248

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 26/169 (15%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----M 264
           R    +    + +LH   I+HRDLK  NI +  D        G   ++S  S S     +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 265 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 72  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 130
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G   ++S  S S     + G+ 
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 235

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R  + + +     +  + D++ + +  P+IVQ   +       ++ ++ ++     
Sbjct: 50  MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDK 109
Query: 204 FHLYRQGIFR----EDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGH----- 253
           F+ Y   +      E+     T   V A++HL +   I+HRD+KP NIL+D  G+     
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD 169
Query: 254 -----EIDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPF 304
                ++ +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+ P+
Sbjct: 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
Query: 305 THANR--QKLQQRIINEKVKLPPFLTSEAH--------SLLKGLLHKDPSKR 346
              N    +L Q +  +    PP L++           + +   L KD SKR
Sbjct: 230 PKWNSVFDQLTQVVKGD----PPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           + +    +Y++ D +      + L +      D   ++  +I+  + ++H   ++HRDLK
Sbjct: 98  TIEQMKDVYIVQDLMETD--LYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155
Query: 243 PENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILL-SKGHNKDADW 287
           P N+L+++                 + D +        T  Y APEI+L SKG+ K  D 
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 288 WSVGILLYEMLTGQPPF 304
           WSVG +L EML+ +P F
Sbjct: 216 WSVGCILAEMLSNRPIF 232

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 160
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 161 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 221 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G   ++S  S S     + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 156
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMC 265
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D        G             
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV 206
Query: 266 GTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
            T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 260 RSNSM----------CGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 275
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 276 HYDPNKRISA-----KAALAHPFFQDVT 298

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 145 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 160
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 221 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 157
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 158 GLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 218 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 258

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMC 265
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D        G             
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV 203
Query: 266 GTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRII 317
            T  Y APEI+L+  H N+  D WSVG ++ E+LTG+  F    H ++ KL  R++
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 56  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G    +S  S S     + G+ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 219

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 43  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 99  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 156
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 157 GLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 216
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 217 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 257

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 260 RSNSM----------CGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 153 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 272
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 273 HYDPNKRISA-----KAALAHPFFQDVT 295

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 103 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 160
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 221 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 37  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 95
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 96  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 260 RSNSM----------CGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 275
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 276 HYDPNKRISA-----KAALAHPFFQDVT 298

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 46  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 102 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 159
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFY 220
           AE  ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    +
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTTEYMA 272
           + ++  A+ +L     VHRDL   N+L+  D        G   + SS  ++     ++ A
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 173
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSE 330
           PE L     +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P      
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 233
Query: 331 AHSLLKGLLHKDPSKR 346
            + ++K   H D + R
Sbjct: 234 VYEVMKNCWHLDAAMR 249

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 34  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 92
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 93  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 260 RSNSM----------CGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 153 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 272
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 273 HYDPNKRISA 282

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 47  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 103 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 160
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 221 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 261

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 271 HYDPNKRISA 280

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 108 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 105
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 106 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 162
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 163 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 69  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 117
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GH 253
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D        G 
Sbjct: 118 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 254 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
                        T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++    
Sbjct: 178 ARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQ 237
Query: 313 QQRIIN 318
            +RI+ 
Sbjct: 238 LKRIME 243

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDI--LTKVTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R++  +  V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDX 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 157
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 158 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 218 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 258

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 155
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 98  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 155
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 92  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 91  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 271 HYDPNKRISA-----KAALAHPFFQDVT 293

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           V+ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      YL
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 33  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 91
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 92  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 151
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 272 HYDPNKRISA-----KAALAHPFFQDVT 294

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I+A +  R+  ++K    + +    D+ T  T         S +  S++YL+   +  G 
Sbjct: 61  IHARRTYRELRLLKHLKHENVIGLLDVFTPAT---------SIEDFSEVYLVTTLM--GA 109
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GH 253
              ++ +     ++  +F   +++  + ++H  GI+HRDLKP N+ ++ D        G 
Sbjct: 110 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 169
Query: 254 EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
                        T  Y APEI+L+  H N+  D WSVG ++ E+L G+  F  ++    
Sbjct: 170 ARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQ 229
Query: 313 QQRIIN 318
            +RI+ 
Sbjct: 230 LKRIME 235

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 44  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 100 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 157
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 158 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 218 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 258

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A
Sbjct: 229 EAQVMKKLRHEKLVQL-YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 155
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 55  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 111 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 168
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 169 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 228
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 229 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 269

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 31  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 89
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 90  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 149
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 270 HYDPNKRISA 279

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 42  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 98  DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 155
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 30  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 89  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
Query: 260 RSNSM----------CGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 268
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 269 HYDPNKRISA 278

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
           + E  +L K  H  I+ L   + T+  L ++  +  G  L+ HL+ Q   F+  Q     
Sbjct: 80  RNEVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSM-----CGTT 268
            +    + +LH   I+HRD+K  NI +           G    +S  S S       G+ 
Sbjct: 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  + +N     +D +S GI+LYE++TG+ P++H N +
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR 243

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ +F++   
Sbjct: 32  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDL 90
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 91  KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 150
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           H DP+KR+ +      A   H +F+ + 
Sbjct: 271 HYDPNKRISA-----KAALAHPFFQDVT 293

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 153
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 154 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 214 IDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 40  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 96  DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHLVKVADF 153
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 154 GLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 214 IDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMAP 273
           ++ +++ H   ++HRDLKP+N+L++ +G  +I +   + +             T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMAP 273
           ++ +++ H   ++HRDLKP+N+L++ +G  +I +   + +             T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRI 213

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  IL ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMAP 273
           ++ +++ H   ++HRDLKP+N+L++ +G  +I +   + +             T  Y AP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           ++L+ SK ++   D WSVG +  EM+ G P F   +      RI
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 51/287 (17%)
Query: 108 GPGDFEIFRVV---GQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           GPG  E F+ V   G+G +                  + A+K +R DT  +      ++ 
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIR- 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ + ++     F              + Y  +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMA 272
           ++  ++  H   ++HRDLKP+N+L++++G  ++ +   + +             T  Y A
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 273 PEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 321
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 111/253 (43%), Gaps = 62/253 (24%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR------QGIFREDQAR 218
           E  ++ ++ H  IV+L     T +KL L+ +F++     +   R      +G+   +  +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVK 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCG 266
           ++  +++  ++  H+  I+HRDLKP+N+L++  G              I  ++ S+ +  
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV- 170
Query: 267 TTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-------N 318
           T  Y AP++L+ S+ ++   D WS G +L EM+TG+P F   N ++ Q ++I       N
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPN 229
Query: 319 EKV-----KLPPF-----------------------LTSEAHSLLKGLLHKDPSKRLGSG 350
           E +     KLP +                       L       L GLL  +P  RL + 
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA- 288
Query: 351 PGGVDAIKHHKWF 363
                   HH WF
Sbjct: 289 ----KQALHHPWF 297

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 27/177 (15%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 52  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 111
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 112 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 168
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+ 
Sbjct: 169 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 249 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  + H  ++ + 
Sbjct: 305 DYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV-GENHLVKVADF 362
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 423 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G    +S  S S     + G+ 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 27/182 (14%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 41  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 100
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 101 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 157
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 302
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+  + 
Sbjct: 158 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 217
Query: 303 PF 304
            F
Sbjct: 218 LF 219

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y+I +F+  G+L 
Sbjct: 288 AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+   +E  A    +   +I SA+ +L K   +HR+L   N L+  + H  ++ + 
Sbjct: 344 DYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV-GENHLVKVADF 401
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH 306
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+  
Sbjct: 402 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 461
Query: 307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +  ++ + +  + +++ P     + + L++     +PS R
Sbjct: 462 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 502

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 54  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 112
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G    +S  S S     + G+ 
Sbjct: 113 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 217

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 26/169 (15%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 57  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----M 264
           R    +    + +LH   I+HRDLK  NI +  D        G    +S  S S     +
Sbjct: 116 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 265 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 26/169 (15%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----M 264
           R    +    + +LH   I+HRDLK  NI +  D        G    +S  S S     +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 265 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 80  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 138
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G    +S  S S     + G+ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMA 272
           ++  ++  H   ++HRDLKP+N+L++++G  ++ +   + +             T  Y A
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 321
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAE 223
           E  +L ++ HP IV+L     T +KLYL+ +F++     F              + Y  +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM----------CGTTEYMA 272
           ++  ++  H   ++HRDLKP+N+L++++G  ++ +   + +             T  Y A
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV---- 321
           PEILL  K ++   D WS+G +  EM+T +  F   +      RI       +E V    
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
                              K+ P L  +  SLL  +LH DP+KR+ +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           K E  +L K  H  I+ L   + T+ +L ++  +  G  L+ HL+  +  F   +     
Sbjct: 79  KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 137
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----MCGTT 268
            +    + +LH   I+HRDLK  NI +  D        G    +S  S S     + G+ 
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 269 EYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 242

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTA 222
           E  ++ K+ H  +VQL Y+  +   + ++ ++++ G L   L  +     R  Q     A
Sbjct: 53  EAQVMKKLRHEKLVQL-YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I S ++++ +   VHRDL+  NIL+         D     + E +   +  G     ++
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE  L       +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP   
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 231
Query: 329 SEAHSLLKGLLHKDPSKR 346
              H L+     K+P +R
Sbjct: 232 ESLHDLMCQCWRKEPEER 249

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 27/182 (14%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 302
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+  + 
Sbjct: 164 TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 223
Query: 303 PF 304
            F
Sbjct: 224 LF 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 27/182 (14%)
Query: 147 VMRKDTIIKK------NHVDYMKAERDILTK--VTHPFIVQLRYSFQTRSKL------YL 192
           ++ ++  IKK      N     +A R+++    V H  I+ L   F  +  L      Y+
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD- 251
           +++ ++          Q     ++  +   +++  + HLH  GI+HRDLKP NI++ SD 
Sbjct: 107 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163
Query: 252 ---------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 302
                          S        T  Y APE++L  G+ ++ D WSVG ++ EM+  + 
Sbjct: 164 TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI 223
Query: 303 PF 304
            F
Sbjct: 224 LF 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 15/116 (12%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSN 262
           +D  +F   +I+  + ++H   I+HRDLKP N+ ++ D            H  DE +   
Sbjct: 153 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--- 209
Query: 263 SMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
               T  Y APEI+L+  H N   D WSVG ++ E+LTG+  F   +     Q+I+
Sbjct: 210 GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIM 265

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 41/240 (17%)
Query: 143 YAMKVMRKDTIIKKNHVDYMKAER--DILTKVTHPFIVQL-RYSFQTRS---KLYLILDF 196
           YA+K      I+     D  +A+R  D+     HP I++L  Y  + R    + +L+L F
Sbjct: 57  YALK-----RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 197 INGGHLFFHLYR---QGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
              G L+  + R   +G F  EDQ  +    I   +  +H  G  HRDLKP NIL+  +G
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171
Query: 253 HEI-DESSRSNSMC-------------------GTTEYMAPEILLSKGH---NKDADWWS 289
             +  +    N  C                    T  Y APE+   + H   ++  D WS
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231
Query: 290 VGILLYEMLTGQPPFTHANRQKLQQRI-INEKVKLP--PFLTSEAHSLLKGLLHKDPSKR 346
           +G +LY M+ G+ P+    ++     + +  ++ +P  P  +S    LL  ++  DP +R
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQA 217
           K E  +L K  H  I+ L   + T  +L ++  +  G  L+ HL+      + I   D A
Sbjct: 52  KNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNS-----M 264
           R    +    + +LH   I+HRDLK  NI +  D        G    +S  S S     +
Sbjct: 111 R----QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 265 CGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQ 310
            G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G+F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----ID------ESSRSNSMCGTTEYM 271
             I+  +  LHK  I+H DLKPENIL+   G      ID      E  R  +   +  Y 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR 266
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           APE++L   +    D WS+G +L E+LTG P
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G+F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----ID------ESSRSNSMCGTTEYM 271
             I+  +  LHK  I+H DLKPENIL+   G      ID      E  R  +   +  Y 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR 266
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           APE++L   +    D WS+G +L E+LTG P
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 43/250 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG- 200
           + A+K +R DT  +      ++ E  +L ++ HP IV+L     T +KLYL+ + ++   
Sbjct: 29  VVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDL 87
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS 259
             F              + Y  +++  ++  H   ++HRDLKP+N+L++++G  ++ +  
Sbjct: 88  KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 260 RSNSM----------CGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
            + +             T  Y APEILL  K ++   D WS+G +  EM+T +  F   +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 309 RQKLQQRII------NEKV-----------------------KLPPFLTSEAHSLLKGLL 339
                 RI       +E V                       K+ P L  +  SLL  +L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 340 HKDPSKRLGS 349
           H DP+KR+ +
Sbjct: 268 HYDPNKRISA 277

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++  P +V +    +   +LY+    ING  L   L RQG     +A     +I SA+  
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 231 LHKCGIVHRDLKPENILMDSD-----------GHEIDES-SRSNSMCGTTEYMAPEILLS 278
            H  G  HRD+KPENIL+ +D               DE  ++  +  GT  Y APE    
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSE 209
Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
                 AD +++  +LYE LTG PP+   ++  +    IN+ +  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPY-QGDQLSVXGAHINQAIPRP 254

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K ++  T+  ++ ++    E  I+ K+ H  +VQL Y+  +   +Y++ +++N G L 
Sbjct: 37  AIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQL-YAVVSEEPIYIVTEYMNKGSLL 91
Query: 204 FHLYRQGIFREDQARFY--------TAEIVSAVSHLHKCGIVHRDLKPENILM------- 248
             L      ++ + R           A++ + ++++ +   +HRDL+  NIL+       
Sbjct: 92  DFL------KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICK 145
Query: 249 --DSDGHEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQP 302
             D     + E +   +  G     ++ APE  L       +D WS GILL E++T G+ 
Sbjct: 146 IADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 205
Query: 303 PFTHA-NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           P+    NR+ L+Q     ++  P       H L+     KDP +R
Sbjct: 206 PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEER 250

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L  + H  IV L     T   L L+ ++++     +      I      + +  ++
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMA 272
           +  +++ H+  ++HRDLKP+N+L++  G              I   +  N +  T  Y  
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
           P+ILL S  ++   D W VG + YEM TG+P F
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 171
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 172 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 231
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 232 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 269

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 167
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 168 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 227
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 228 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 265

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM----------- 264
           + + Y   ++ AV  +H+ GIVH DLKP N L+     ++ +   +N M           
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDXXXVVKDS 187
Query: 265 -CGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLH 232
           HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  + + A++HLH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 233 KCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
             G+VH D+KP NI +   G           E+  +       G   YMAPE LL   + 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQGSYG 233
Query: 283 KDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLKG 337
             AD +S+G+ + E+    + P      Q+L+Q        LPP     L+SE  S+L  
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVM 287
Query: 338 LLHKDPSKR 346
           +L  DP  R
Sbjct: 288 MLEPDPKLR 296

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             GT  YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/220 (19%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 38  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +           
Sbjct: 94  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153
Query: 253 -HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-TH 306
              +D+   S++  GT    ++ +PE+     ++  +D WS G+L++E+ + G+ P+   
Sbjct: 154 RFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211
Query: 307 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +N + ++      ++  P   ++  + ++     + P  R
Sbjct: 212 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 251

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/189 (21%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +           
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 253 -HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 307
              +D+   S++  GT    ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + 
Sbjct: 151 RFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208
Query: 308 NRQKLQQRI 316
           +  ++ + I
Sbjct: 209 SNSEVVEDI 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L +++HP I+ L  +F  +S + L+ DF+             +      + Y    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG-HEIDESSRSNSMCG----------TTEYMAP 273
           +  + +LH+  I+HRDLKP N+L+D +G  ++ +   + S             T  Y AP
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQP 302
           E+L  ++ +    D W+VG +L E+L   P
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYM-------KA 164
           +E+ +V+G+G F                    A+K++R +    +   + +       K 
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHV-----ALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYT 221
           ++D    V H     +  +F  R+ + +  + ++     + L ++  F+       R + 
Sbjct: 154 DKDNTMNVIH-----MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFA 206
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----ID------ESSRSNSMCGTTEYM 271
             I+  +  LHK  I+H DLKPENIL+   G      ID      E  R      +  Y 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYR 266
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           APE++L   +    D WS+G +L E+LTG P
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/189 (21%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 35  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +           
Sbjct: 91  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 150
Query: 253 -HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 307
              +D+   S++  GT    ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + 
Sbjct: 151 RFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208
Query: 308 NRQKLQQRI 316
           +  ++ + I
Sbjct: 209 SNSEVVEDI 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 60/223 (26%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTI-IKKNHVD--YMKAERDILTKV 172
           +V+G G+F                  ++  K++  D + IKK   D  +   E  I+  V
Sbjct: 46  KVIGNGSFGV----------------VFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIV 89
Query: 173 THPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQ---------- 216
            HP +V L+  F +         L L+L+++           + ++R  +          
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMP 139
Query: 217 ---ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HEIDESSRSNSMCG---- 266
               + Y  +++ +++++H  GI HRD+KP+N+L+D        ID  S    + G    
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 267 ----TTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
               +  Y APE++  +  +  + D WS G ++ E++ GQP F
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/189 (21%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 33  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +           
Sbjct: 89  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148
Query: 253 -HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 307
              +D+   S++  GT    ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + 
Sbjct: 149 RFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 308 NRQKLQQRI 316
           +  ++ + I
Sbjct: 207 SNSEVVEDI 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/220 (19%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +R+  + +++ ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 36  AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +           
Sbjct: 92  DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
Query: 253 -HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-TH 306
              +D+   S++  GT    ++ +PE+     ++  +D WS G+L++E+ + G+ P+   
Sbjct: 152 RFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209
Query: 307 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +N + ++      ++  P   ++  + ++     + P  R
Sbjct: 210 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 249

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 233 KCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEILLSKG 280
               VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE +  + 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 281 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 338
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 339 LHKDPSKR 346
              DPS+R
Sbjct: 249 WAYDPSRR 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 75  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 233 KCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEILLSKG 280
               VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE +  + 
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 281 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 338
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 253
Query: 339 LHKDPSKR 346
              DPS+R
Sbjct: 254 WAYDPSRR 261

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 98  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 233 KCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEILLSKG 280
               VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE +  + 
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 281 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 338
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 276
Query: 339 LHKDPSKR 346
              DPS+R
Sbjct: 277 WAYDPSRR 284

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 16/193 (8%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 228 VSHLHKCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEI 275
           +++L     VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE 
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 333
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 245
Query: 334 LLKGLLHKDPSKR 346
           L+      DPS+R
Sbjct: 246 LMTKCWAYDPSRR 258

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 82
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 83  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 135
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS--------------- 250
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S               
Sbjct: 136 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 251 -DGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 308
            D  E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   +
Sbjct: 196 EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 253
Query: 309 RQKLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            Q +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 254 NQDV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 292

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 16/193 (8%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 228 VSHLHKCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEI 275
           +++L     VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE 
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 333
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 246
Query: 334 LLKGLLHKDPSKR 346
           L+      DPS+R
Sbjct: 247 LMTKCWAYDPSRR 259

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS--------------- 250
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S               
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 251 -DGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 308
            D  E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   +
Sbjct: 198 EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 309 RQKLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            Q +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 256 NQDV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTT-----------EYMAPEILL 277
           +L     VHRD+   N+L+ S D  ++ +   S  M  +T           ++MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 278 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 335
            +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 336 KGLLHKDPSKR 346
                 DPS+R
Sbjct: 246 TKCWAYDPSRR 256

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV--AIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ +++  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS--------------- 250
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S               
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 251 -DGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 308
            D  E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   +
Sbjct: 198 EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 309 RQKLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            Q +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 256 NQDV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 229 S----HLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMCGTTEYM 271
           +    +LH   I+HRD+K  NIL+D +             G E+D++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
            PE  +     + +D +S G++L+E+L  +        Q L + ++N
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVN 251

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A+++L 
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 233 KCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEILLSKG 280
               VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE +  + 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 281 HNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGL 338
               +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+   
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 339 LHKDPSKR 346
              DPS+R
Sbjct: 249 WAYDPSRR 256

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 63/128 (49%), Gaps = 15/128 (11%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 112 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 252 GHEID-----------ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 299
             ++             +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 300 GQPPFTHA 307
            + PF H 
Sbjct: 229 RREPFFHG 236

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 16/193 (8%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSA 227
           + +  HP IV+L     T + +++I++    G L  F   R+          Y  ++ +A
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 228 VSHLHKCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MAPEI 275
           +++L     VHRD+   N+L+ S D  ++ +   S  M  +T Y           MAPE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHS 333
           +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +S
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 334 LLKGLLHKDPSKR 346
           L+      DPS+R
Sbjct: 241 LMTKCWAYDPSRR 253

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 63/128 (49%), Gaps = 15/128 (11%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
           L+ ++IN    F  LY+  I  +   RFY  E++ A+ + H  GI+HRD+KP N+++D  
Sbjct: 117 LVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 252 GHEID-----------ESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT 299
             ++             +   N    +  +  PE+L+  + ++   D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 300 GQPPFTHA 307
            + PF H 
Sbjct: 234 RREPFFHG 241

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEIVSAVS 229
           HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++ +A++
Sbjct: 70  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALA 125
Query: 230 HLHKCGIVHRDLKPENILMD-SDGHEIDESSRSNSMCGTTEY-----------MAPEILL 277
           +L     VHRD+   N+L+  +D  ++ +   S  M  +T Y           MAPE + 
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 278 SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLL 335
            +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      +SL+
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 336 KGLLHKDPSKR 346
                 DPS+R
Sbjct: 246 TKCWAYDPSRR 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDS-DGHEIDESSRSNSMCGTTEY-----------MA 272
            +A+++L     VHRD+   N+L+ S D  ++ +   S  M  +T Y           MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 330
           PE +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP     
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 331 AHSLLKGLLHKDPSKR 346
            +SL+      DPS+R
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 84/215 (39%), Gaps = 75/215 (34%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI--------DESS-------- 259
           Q R    ++  AV  LH   + H DLKPENIL  +  +E+        DE S        
Sbjct: 138 QVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRV 197
Query: 260 -----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THA 307
                        +++  T  Y APE++L  G ++  D WS+G +++E   G   F TH 
Sbjct: 198 VDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHD 257
Query: 308 NRQKLQQ------------------------------------RIINEKVK-LPPFLTSE 330
           NR+ L                                      R + E  K L  +LTSE
Sbjct: 258 NREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSE 317
Query: 331 AHS------LLKGLLHKDPSKRLGSGPGGVDAIKH 359
           A        L++ +L  +P+KRL  G    +A++H
Sbjct: 318 AEEHHQLFDLIESMLEYEPAKRLTLG----EALQH 348

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 200 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 11/159 (6%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 100 DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HEIDESSRSNSMCGTTEYMA 272
            T   +  +++LH   ++HRD+K  NIL+   G             + +N   GT  +MA
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMA 218
Query: 273 PEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN 308
           PE++L+     ++   D WS+GI   E+   +PP  + N
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
           S    + +Y++ +++       ++  QG   E+ AR +  +++  + ++H   ++HRDLK
Sbjct: 90  SLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK 147
Query: 243 PENILMDS----------------DGHEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDA 285
           P N+ +++                D H   +   S  +  T  Y +P +LLS   + K  
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI 206
Query: 286 DWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           D W+ G +  EMLTG+  F  A+  +  Q I+
Sbjct: 207 DMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D  + R +G+GAF                  + A+K ++  T+  +   D+ + E ++LT
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 72
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQAR-------- 218
            + H  IV+          L ++ +++  G L   L   G    I  + Q R        
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRS 261
                  ++I S + +L     VHRDL   N L             M  D +  D     
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINE 319
                   +M PE ++ +    ++D WS G++L+E+ T   QP F  +N + ++      
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
            ++ P     E + ++ G   ++P +RL
Sbjct: 253 VLERPRVCPKEVYDVMLGCWQREPQQRL 280

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 75  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 127
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 128 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 188 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 245
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 246 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 282

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 200 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 200 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 11/159 (6%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D +K  R  L K+ HP  +Q R  +      +L++++  G         +   +E +   
Sbjct: 61  DIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HEIDESSRSNSMCGTTEYMA 272
            T   +  +++LH   ++HRD+K  NIL+   G             + +N   GT  +MA
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMA 179
Query: 273 PEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHAN 308
           PE++L+     ++   D WS+GI   E+   +PP  + N
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 171 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 229 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 265

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 200 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ +++  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 200 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 26/158 (16%)
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEID-----------ESSRSNS 263
           + + Y   ++ AV  +H+ GIVH DLKP N L+ D     ID            S   +S
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 264 MCGTTEYMAPEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTHANRQKL 312
             G   YM PE +     +++           +D WS+G +LY M  G+ PF     Q  
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 313 QQRII---NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   I   N +++ P     +   +LK  L +DP +R+
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARF--YTAEI 224
           + +  HP IV+L     T + +++I++    G L  F  + +   F  D A    Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHEIDESSRSNSMCGTTEY-----------MA 272
            +A+++L     VHRD+   N+L+  +D  ++ +   S  M  +T Y           MA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 330
           PE +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP     
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 331 AHSLLKGLLHKDPSKR 346
            +SL+      DPS+R
Sbjct: 621 LYSLMTKCWAYDPSRR 636

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+L+D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 16/149 (10%)
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
           R  L +V HP IVQ+ ++F   +        Y++++++ G  L     ++    E  A  
Sbjct: 130 RQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA-- 186
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EIDESSRSNS---MCGTTEYMAP 273
           Y  EI+ A+S+LH  G+V+ DLKPENI++  +     ++   SR NS   + GT  + AP
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAP 246
Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQP 302
           EI+ + G     D ++VG  L  +    P
Sbjct: 247 EIVRT-GPTVATDIYTVGRTLAALTLDLP 274

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 39/224 (17%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG F                    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSV-----AIKKVIQDPRFRNRELQIMQD----LAV 75
Query: 172 VTHPFIVQLRYSFQT-----RSKLYL--ILDFINGGHLFFHLYRQGIFREDQA------R 218
           + HP IVQL+  F T     R  +YL  +++++       H   +  +R   A      +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT---LHRCCRNYYRRQVAPPPILIK 132
Query: 219 FYTAEIVSAVSHLH--KCGIVHRDLKPENILM-DSDG----------HEIDESSRSNSMC 265
            +  +++ ++  LH     + HRD+KP N+L+ ++DG           ++  S  + +  
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 266 GTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHAN 308
            +  Y APE++    H   A D WSVG +  EM+ G+P F   N
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/189 (20%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++ ++ + + ++    E +++ K++HP +VQL      ++ + L+ +F+  G L 
Sbjct: 55  AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 110
Query: 204 FHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
            +L  Q G+F  +       ++   +++L +  ++HRDL   N L+  +           
Sbjct: 111 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 170
Query: 253 -HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 307
              +D+   S++  GT    ++ +PE+     ++  +D WS G+L++E+ + G+ P+ + 
Sbjct: 171 RFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 228
Query: 308 NRQKLQQRI 316
           +  ++ + I
Sbjct: 229 SNSEVVEDI 237

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------ESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 36/164 (21%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENIL-----------------MDSDGHE------IDESS 259
           +I  AV  LH  G++HRDLKP NI                  MD D  E      +   +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIIN 318
           R     GT  YM+PE +    ++   D +S+G++L+E+L    PF T   R +    + N
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242
Query: 319 EKVKLPPFLTSE---AHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             +K PP  T +    + +++ +L   P +R    P  ++ I++
Sbjct: 243 --LKFPPLFTQKYPCEYVMVQDMLSPSPMER----PEAINIIEN 280

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 51/113 (45%), Gaps = 11/113 (9%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEYMA 272
           + +  +  LH   IVHRDLKPENIL+ S G                   + +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           +E  I+ +  HP I++L         + ++ +F+  G L  F     G F   Q      
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESS----RSNSMCGT- 267
            I S + +L +   VHRDL   NIL++S+             ++E+S     ++S+ G  
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 268 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLP 324
              + APE +  +     +D WS GI+++E+++ G+ P+   + Q +   I  + ++  P
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPP 245
Query: 325 PFLTSEAHSLLKGLLHKDPSKR 346
           P   +  H L+     KD + R
Sbjct: 246 PDCPTSLHQLMLDCWQKDRNAR 267

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 116/280 (41%), Gaps = 39/280 (13%)
Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDT 152
           +E+  +   E  +++   +  I +VVG G F                    A+K + K  
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTL-KVG 84
Query: 153 IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIF 212
             +K   D++  E  I+ +  HP I++L         + ++ + +  G L          
Sbjct: 85  YTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFL 137
Query: 213 REDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS--------------- 250
           R+  A+F   ++V       S + +L   G VHRDL   NIL++S               
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 251 -DGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 308
            D  E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   +
Sbjct: 198 EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 309 RQKLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            Q +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 256 NQDV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 72  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 124
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------DG 252
             RF   ++V       S + +L     VHRDL   NIL++S                D 
Sbjct: 125 DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 311
            E   ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 185 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 242
Query: 312 LQQRIINEKVKLPPFLTS--EAHSLLKGLLHKDPSKR 346
           +  + I E  +LPP +      H L+     K+ S R
Sbjct: 243 V-IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDR 278

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           +E  I+ +  HP I++L         + ++ +F+  G L  F  L   G F   Q     
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGML 122
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSR----SNSMCGT 267
             I S + +L +   VHRDL   NIL++S+             ++E+S     ++S+ G 
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKL 323
               + APE +  +     +D WS GI+++E+++ G+ P+   + Q +   I  + ++  
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPP 242
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           PP   +  H L+     KD + R
Sbjct: 243 PPDCPTSLHQLMLDCWQKDRNAR 265

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 50/113 (44%), Gaps = 11/113 (9%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEYMA 272
           + +  +  LH   IVHRDLKPENIL+ S G                     +  T  Y A
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 239

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 139 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 198
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 199 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 108 GPGDFEIF--------RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHV 159
           GPGD  +F        R +G+G F                  + A+K ++ D      H 
Sbjct: 21  GPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKADA--GPQHR 77
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTR--SKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              K E DIL  + H  I++ +   +    + L L+++++  G L  +L R  I    Q 
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA-QL 136
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------------GHEIDESSRS 261
             +  +I   +++LH    +HRDL   N+L+D+D                GHE       
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
                   + APE L        +D WS G+ LYE+LT
Sbjct: 197 GD--SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCG 266
           RFY  EI+ A+ + H  GI+HRD+KP N+++D +  ++                 N    
Sbjct: 134 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 193
Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           +  +  PE+L+  + ++   D WS+G +L  M+  + PF H +
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 51  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 103
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------DG 252
             RF   ++V       S + +L     VHRDL   NIL++S                D 
Sbjct: 104 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 311
            E   ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 164 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 221
Query: 312 LQQRIINEKVKLPPFLTS--EAHSLLKGLLHKDPSKR 346
           +  + I E  +LPP +      H L+     K+ S R
Sbjct: 222 V-IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDR 257

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 79  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 136
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDS------- 250
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++       
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 196
Query: 251 ----DGHEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQP 302
                G+ +D  +++    G   YMAPE     L  KG++  +D WS+GI + E+   + 
Sbjct: 197 DFGISGYLVDSVAKTID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 255
Query: 303 PFTHANR--QKLQQRIINEKVKLP 324
           P+       Q+L+Q +     +LP
Sbjct: 256 PYDSWGTPFQQLKQVVEEPSPQLP 279

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 87  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 139
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 200 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 258 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 89/182 (48%), Gaps = 28/182 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 98  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 148
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRS 261
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +   +I +   +
Sbjct: 149 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 206
Query: 262 NSMCGT--------TEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH 306
             +C +        TEY+      APE++LS   + +  D WSVG +  EML  +  F  
Sbjct: 207 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 266
Query: 307 AN 308
            N
Sbjct: 267 KN 268

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
           K   D++ +E  I+ +  HP I+ L         + +I +++  G L          R++
Sbjct: 57  KQRRDFL-SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKN 109
Query: 216 QARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------DG 252
             RF   ++V       S + +L     VHRDL   NIL++S                D 
Sbjct: 110 DGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK 311
            E   ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+   + Q 
Sbjct: 170 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 227
Query: 312 LQQRIINEKVKLPPFLTS--EAHSLLKGLLHKDPSKR 346
           +  + I E  +LPP +      H L+     K+ S R
Sbjct: 228 V-IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDR 263

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 63  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 122 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 181
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 182 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 54/113 (47%), Gaps = 11/113 (9%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSN---------SMCGTTEYMA 272
           + +  +  LH   IVHRDLKPENIL+ S G  ++ +   +           +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
           +K   D++  E  I+ +  HP I++L         + ++ + +  G L          R+
Sbjct: 58  EKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRK 110
Query: 215 DQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDS----------------D 251
             A+F   ++V       S + +L   G VHRDL   NIL++S                D
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 252 GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
             E   ++R   +     + +PE +  +     +D WS GI+L+E+++ G+ P+   + Q
Sbjct: 171 DPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228
Query: 311 KLQQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
            +  + ++E  +LPP +   A  + L+     KD + R
Sbjct: 229 DV-IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 265

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 66  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 125 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 184
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 245 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 295

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 50/113 (44%), Gaps = 11/113 (9%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEYMA 272
           + +  +  LH   IVHRDLKPENIL+ S G                     +  T  Y A
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           PE+LL   +    D WSVG +  EM   +P F   N +  Q   I + + LPP
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 89/182 (48%), Gaps = 28/182 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HL 202
           A + +R+  I+K    D + A +DIL + T P+       F++   +Y++LD +    H 
Sbjct: 97  AKRTLRELKILKHFKHDNIIAIKDIL-RPTVPY-----GEFKS---VYVVLDLMESDLHQ 147
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRS 261
             H  +      +  R++  +++  + ++H   ++HRDLKP N+L++ +   +I +   +
Sbjct: 148 IIHSSQPLTL--EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205
Query: 262 NSMCGT--------TEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH 306
             +C +        TEY+      APE++LS   + +  D WSVG +  EML  +  F  
Sbjct: 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265
Query: 307 AN 308
            N
Sbjct: 266 KN 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L+   HP +V L      R+++ LI  ++  G+L  HLY   +     +     EI    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 229 S----HLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMCGTTEYM 271
           +    +LH   I+HRD+K  NIL+D +             G E+ ++     + GT  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
            PE  +     + +D +S G++L+E+L  +        Q L + ++N
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV----QSLPREMVN 251

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 61  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 120 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTE 179
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 180 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 240 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 290

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           M V R    +       +  + DI +  V  PF V    +      +++ ++ ++     
Sbjct: 35  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--L 92
Query: 204 FHLYRQGIFR-----EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDS------- 250
              Y+Q I +     ED        IV A+ HLH K  ++HRD+KP N+L+++       
Sbjct: 93  DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152
Query: 251 ----DGHEIDESSRSNSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQP 302
                G+ +D+ ++     G   YMAPE     L  KG++  +D WS+GI + E+   + 
Sbjct: 153 DFGISGYLVDDVAKDID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
Query: 303 PFTHANR--QKLQQRIINEKVKLP 324
           P+       Q+L+Q +     +LP
Sbjct: 212 PYDSWGTPFQQLKQVVEEPSPQLP 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+          
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 252 --GHEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-T 305
               E D  +   +  G     + APE +  +  +  +D WS G++++E+L  G+ P+  
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 306 HANRQKLQQRIINEKVKLP-PFLTSEA-HSLLKGLLHKDPSKR 346
             NR  +    + E  +LP P     A H L+    HKD ++R
Sbjct: 258 MTNRDVISS--VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 105/232 (45%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 -----------YRQGIFREDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                      Y      E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K +++DT+     V+    E  ++ ++ HP +VQL          Y++ +++  G+L 
Sbjct: 61  AVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 204 FHLYRQGIFREDQA---RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDES 258
            +L R+    E  A    +   +I SA+ +L K   +HRDL   N L+  + H  ++ + 
Sbjct: 117 DYL-RECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-GENHVVKVADF 174
Query: 259 SRSNSMCGTT-----------EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
             S  M G T           ++ APE L     +  +D W+ G+LL+E+ T G  P+
Sbjct: 175 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 87/187 (46%), Gaps = 40/187 (21%)
Query: 162 MKAERDI--LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA 217
           M A R+I  L ++ HP ++ L+  F + +  K++L+ D+    H  +H+ +    R  +A
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY--AEHDLWHIIK--FHRASKA 118
Query: 218 ------------RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----------- 254
                       +    +I+  + +LH   ++HRDLKP NIL+  +G E           
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 255 -------IDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTH 306
                  +   +  + +  T  Y APE+LL   H  K  D W++G +  E+LT +P F H
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-H 237
Query: 307 ANRQKLQ 313
             ++ ++
Sbjct: 238 CRQEDIK 244

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 120 MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 299 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 80
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDESSRS 261
             Q   + A++   + +L +   +HRDL   NIL+             S G E+      
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INE 319
             +     +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    
Sbjct: 201 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258
Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +++ P     E + L++    + P +R
Sbjct: 259 RLEKPLNCDDEVYDLMRQCWREKPYER 285

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 70
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDESSRS 261
             Q   + A++   + +L +   +HRDL   NIL+             S G E+      
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INE 319
             +     +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    
Sbjct: 191 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 248
Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +++ P     E + L++    + P +R
Sbjct: 249 RLEKPLNCDDEVYDLMRQCWREKPYER 275

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/293 (20%), Positives = 121/293 (41%), Gaps = 37/293 (12%)
Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXX 139
           ++  + + I     E+  E   E  ++I     +I +V+G G F                
Sbjct: 3   MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI 62
Query: 140 XXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
               A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  
Sbjct: 63  --FVAIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 118
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIV-------SAVSHLHKCGIVHRDLKPENILMDSD- 251
           G L          R++  +F   ++V       + + +L     VHRDL   NIL++S+ 
Sbjct: 119 GSL------DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL 172
Query: 252 -------------GHEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYE 296
                          +  + + ++++ G     + APE +  +     +D WS GI+++E
Sbjct: 173 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 232
Query: 297 MLT-GQPPFTHANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGLLHKDPSKR 346
           +++ G+ P+     Q +    I +  +LPP +   S  H L+     KD + R
Sbjct: 233 VMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 284

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGT-----TEY 270
             + + +L     +HRDL   N L+           G   +E+    +  G       ++
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW 281
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-PFLT 328
            APE L    ++ ++D WS GILL+E  + G  P+ + + Q+ ++  + +  +LP P L 
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPELC 340
Query: 329 SEA-HSLLKGLLHKDPSKR 346
            +A   L++     +P +R
Sbjct: 341 PDAVFRLMEQCWAYEPGQR 359

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+R++T  K N    +  E  ++  V  P++ +L       S + L+   +  G L 
Sbjct: 50  AIKVLRENTSPKANK--EILDEAYVMAGVGSPYVSRL-LGICLTSTVQLVTQLMPYGCLL 106
Query: 204 FHLYRQGIFREDQARF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--- 253
            H+      RE++ R        +  +I   +S+L    +VHRDL   N+L+ S  H   
Sbjct: 107 DHV------RENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKI 160
Query: 254 ---------EIDESS-RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQP 302
                    +IDE+   ++      ++MA E +L +     +D WS G+ ++E++T G  
Sbjct: 161 TDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAK 220
Query: 303 PFTHANRQKLQQRI-INEKVKLPPFLTSEAHSLL 335
           P+     +++   +   E++  PP  T + + ++
Sbjct: 221 PYDGIPAREIPDLLEKGERLPQPPICTIDVYMIM 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL-DFINGGHL 202
           A+K + K    ++   D++ +E  I+ +  HP I++L     TR +L +I+ +++  G L
Sbjct: 81  AIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLE-GVVTRGRLAMIVTEYMENGSL 137
Query: 203 -FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
             F     G F   Q       + + + +L   G VHRDL   N+L+DS+          
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 252 --GHEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-T 305
               E D  +   +  G     + APE +  +  +  +D WS G++++E+L  G+ P+  
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 306 HANRQKLQQRIINEKVKLP-PFLTSEA-HSLLKGLLHKDPSKR 346
             NR  +    + E  +LP P     A H L+    HKD ++R
Sbjct: 258 MTNRDVISS--VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 12/111 (10%)
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----------DGHEIDESSRSNSMCGT 267
            Y  ++  AV  +H  GI HRD+KP+N+L++S              ++  S  S +   +
Sbjct: 145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICS 204
Query: 268 TEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
             Y APE++L +  +    D WS+G +  E++ G+P F+         RII
Sbjct: 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFH 205
           +D  + K+     K E + L  + HP IV+   S+++  K    + L+ +    G L  +
Sbjct: 60  QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTY 119
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILM----------DSDGH 253
           L R  + +    R +  +I+  +  LH     I+HRDLK +NI +          D    
Sbjct: 120 LKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 254 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKL 312
            +  +S + ++ GT E+ APE    K +++  D ++ G    E  T + P++   N  ++
Sbjct: 180 TLKRASFAKAVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQI 238
Query: 313 QQRIIN-------EKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +R+ +       +KV +P     E   +++G + ++  +R
Sbjct: 239 YRRVTSGVKPASFDKVAIP-----EVKEIIEGCIRQNKDER 274

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           +K   D++  E  I+ +  HP +V L         + ++++F+  G L   L +  G F 
Sbjct: 85  EKQRRDFL-CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRS 261
             Q       I + + +L   G VHRDL   NIL++S+              E D  +  
Sbjct: 144 VIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 262 NSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 318
            +  G     + APE +  +     +D WS GI+++E+++ G+ P+   + Q +  + I 
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIE 262
Query: 319 EKVKLPPFLTSEA--HSLLKGLLHKDPSKR 346
           E  +LP  +   A  H L+     K+ ++R
Sbjct: 263 EGYRLPAPMDCPAGLHQLMLDCWQKERAER 292

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID    + +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
           E  IL + +HP IV+L      +  +Y++++ + GG     L  +G   R         +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGT-----TEY 270
             + + +L     +HRDL   N L+           G   +E+    +  G       ++
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP-PFLT 328
            APE L    ++ ++D WS GILL+E  + G  P+ + + Q+ ++  + +  +LP P L 
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPELC 340
Query: 329 SEA-HSLLKGLLHKDPSKR 346
            +A   L++     +P +R
Sbjct: 341 PDAVFRLMEQCWAYEPGQR 359

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +K+  D + +E +++  +  H  I+ L  +      LY+I+ + + G+L  +L
Sbjct: 74  MLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRS---------NSMCGTTEYMA 272
           +++  +  LH   +VHRDLKP+NIL+ S G  ++ +   +          S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 63/136 (46%), Gaps = 30/136 (22%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGHEI-------DESSRSN- 262
           FR D  R    +I  +V+ LH   + H DLKPENIL + SD  E        DE +  N 
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 263 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
                             ++  T  Y APE++L+ G ++  D WS+G +L E   G   F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 305 -THANRQKL--QQRII 317
            TH +++ L   +RI+
Sbjct: 235 PTHDSKEHLAMMERIL 250

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 148 MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           M KD   +++  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L
Sbjct: 74  MLKDDATEEDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 207 ---------YRQGIFR--EDQARF-----YTAEIVSAVSHLHKCGIVHRDLKPENIL--- 247
                    Y   I R  E+Q  F      T ++   + +L     +HRDL   N+L   
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 248 ----------MDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM 297
                     +  D + ID   ++ +     ++MAPE L  + +   +D WS G+L++E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 298 LT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 253 FTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRS---------NSMCGTTEYMA 272
           +++  +  LH   +VHRDLKP+NIL+ S G  ++ +   +          S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRS---------NSMCGTTEYMA 272
           +++  +  LH   +VHRDLKP+NIL+ S G  ++ +   +          S+  T  Y A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           PE+LL   +    D WSVG +  EM   +P F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 56  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 173
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 174 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 233
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 234 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 288

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 105 AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 283 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 53  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 170
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 171 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 230
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 231 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 285

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/267 (21%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D +   V+G+G F                  I  MK    +   K +H D+   E ++L 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDF-AGELEVLC 77
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED-------------- 215
           K+ H P I+ L  + + R  LYL +++   G+L   L +  +   D              
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 216 --QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDESSRS 261
             Q   + A++   + +L +   +HR+L   NIL+             S G E+      
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INE 319
             +     +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++    
Sbjct: 198 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 255
Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +++ P     E + L++    + P +R
Sbjct: 256 RLEKPLNCDDEVYDLMRQCWREKPYER 282

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 23/174 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D          
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
                 GHE               + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGD--SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 23/174 (13%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGH 201
           A+K ++ D      H    K E DIL  + H  I++ +     Q    L L+++++  G 
Sbjct: 47  AVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251
           L  +L R  I    Q   +  +I   +++LH    +HR+L   N+L+D+D          
Sbjct: 105 LRDYLPRHSIGLA-QLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGL 163
Query: 252 ------GHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
                 GHE               + APE L        +D WS G+ LYE+LT
Sbjct: 164 AKAVPEGHEYYRVREDGD--SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 57  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 174
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 175 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 234
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 235 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 289

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 54  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-NEL 112
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN-SMCGTTE----- 269
              +    ++ A+ ++H  G VHR +K  +IL+  DG       RSN SM    +     
Sbjct: 113 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 172
Query: 270 ------------YMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF 304
                       +++PE+L    +G++  +D +SVGI   E+  G  PF
Sbjct: 173 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA-- 189
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 190 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
           V +++ E  +     HP IV  R +F   ++L+++  F+  G    L    +  G+  E 
Sbjct: 70  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-NEL 128
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN-SMCGTTE----- 269
              +    ++ A+ ++H  G VHR +K  +IL+  DG       RSN SM    +     
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 270 ------------YMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPF 304
                       +++PE+L    +G++  +D +SVGI   E+  G  PF
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 49  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 227 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 150 KDTIIKKNHVDYMKAERDI--LTKVTHPFIVQ-------LRYSFQTRSK---------LY 191
           K  +IK+   +  KAER++  L K+ H  IV          Y  +T SK         L+
Sbjct: 37  KTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96
Query: 192 LILDFINGGHLFFHLYRQGIFREDQ--ARFYTAEIVSAVSHLHKCGIVHRDLKPENI-LM 248
           + ++F + G L   + ++   + D+  A     +I   V ++H   +++RDLKP NI L+
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 249 DSDGHEIDESSRSNSMC---------GTTEYMAPEILLSKGHNKDADWWSVGILLYEML- 298
           D+   +I +     S+          GT  YM+PE + S+ + K+ D +++G++L E+L 
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
Query: 299 TGQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                F T      L+  II++          +  +LL+ LL K P  R
Sbjct: 217 VCDTAFETSKFFTDLRDGIISD------IFDKKEKTLLQKLLSKKPEDR 259

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA-- 179
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 180 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 165 ERDILTKVTHPFIVQLR-YSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARF--Y 220
           E  IL  +   FIV+ R  S+   R +L L+++++  G L   L R    R D +R   Y
Sbjct: 58  EIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTT 268
           +++I   + +L     VHRDL   NIL++S+ H             +D+        G +
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 269 E--YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII----- 317
              + APE L     ++ +D WS G++LYE+ T       P     R    +R +     
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCR 236
Query: 318 -------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                   +++  PP   +E H L+K      P  R
Sbjct: 237 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 272

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 162 MKAERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
            + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R 
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRL 116
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY------ 270
             Y+++I   + +L     VHRDL   NIL++S+ H +I +   +  +    +Y      
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 271 -------MAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII-- 317
                   APE L     ++ +D WS G++LYE+ T       P     R    +R +  
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPA 236
Query: 318 ----------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                      +++  PP   +E H L+K      P  R
Sbjct: 237 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 275

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 165 ERDILTKVTHPFIVQLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGTTE 269
           ++   I+  +  LH+ G+VHRDL P NIL+ +D ++I         ++++ +N     T 
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 270 --YMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF 304
             Y APE+++  KG  K  D WS G ++ EM   +  F
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHL---------YRQGIFREDQARFYTAEIVSA-------VSHLHKCGIVHRDLKPENI 246
             +L         Y        + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 165 ERDILTKVTHPFIVQLRYSFQ-----TRSKLYLILDFINGGHLFFHLYRQGIFREDQ-AR 218
           E  +L    HP I+ LR  F         KLYL+ + +    L   ++ Q I    Q  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGTTE 269
           ++   I+  +  LH+ G+VHRDL P NIL+ +D ++I         ++++ +N     T 
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 270 --YMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF 304
             Y APE+++  KG  K  D WS G ++ EM   +  F
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 41  AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 97
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMD---------- 249
             L  +   RE+      AE++  VS    +L +   VHRDL   N+L+           
Sbjct: 98  KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 250 --SDGHEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
             S     D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ P+
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 305 THANRQKLQQRI-INEKVKLPPFLTSEAHSLL 335
                 ++   I   ++++ PP    E ++L+
Sbjct: 215 KKMKGPEVMAFIEQGKRMECPPECPPELYALM 246

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 72
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 73  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-- 189
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 190 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-- 183
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 184 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 108/263 (41%), Gaps = 32/263 (12%)
Query: 112 FEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F + R++G+G F                    A+K+++ D I   +  ++++ E   + +
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 172 VTHPFIVQLR-YSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
             HP + +L   S ++R+K  L     IL F+  G  H F    R G     +  +   R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNSMCGT- 267
           F   +I   + +L     +HRDL   N ++  D            +I         C + 
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKL 323
              +++A E L    +   +D W+ G+ ++E++T GQ P+      ++   +I   ++K 
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           PP    E + L+      DP +R
Sbjct: 261 PPECMEEVYDLMYQCWSADPKQR 283

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 38/165 (23%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENIL-----------------MDSDGHE------IDESS 259
           +I  AV  LH  G++HRDLKP NI                  MD D  E      +   +
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
                 GT  YM+PE +    ++   D +S+G++L+E+L         + Q  + RII +
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERVRIITD 285
Query: 320 --KVKLPPFLTS---EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
              +K P   T    + H +++ +L   P++R    P   D I++
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER----PEATDIIEN 326

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 162 MKAERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
            + E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R 
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRL 117
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY------ 270
             Y+++I   + +L     VHRDL   NIL++S+ H +I +   +  +    +Y      
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 271 -------MAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII-- 317
                   APE L     ++ +D WS G++LYE+ T       P     R    +R +  
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 237
Query: 318 ----------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                      +++  PP   +E H L+K      P  R
Sbjct: 238 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 276

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 20/137 (14%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENI-LMDSDGHEI----------DESSRSNSMCGTTEYM 271
           +I   V ++H   ++HRDLKP NI L+D+   +I          ++  R+ S  GT  YM
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-GTLRYM 202
Query: 272 APEILLSKGHNKDADWWSVGILLYEML-TGQPPF-THANRQKLQQRIINEKVKLPPFLTS 329
           +PE + S+ + K+ D +++G++L E+L      F T      L+  II++          
Sbjct: 203 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD------IFDK 256
Query: 330 EAHSLLKGLLHKDPSKR 346
           +  +LL+ LL K P  R
Sbjct: 257 KEKTLLQKLLSKKPEDR 273

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHL 202
           A+K+++ D   +K+  D + +E +++  +  H  I+ L  +      LY+I+++ + G+L
Sbjct: 64  AVKMLKSDAT-EKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 203 FFHLYRQ---GI------FREDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENI 246
             +L  +   G+          + +  + ++VS        + +L     +HRDL   N+
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 181
Query: 247 LMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGIL 293
           L+  D              H ID   ++ +     ++MAPE L  + +   +D WS G+L
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 294 LYEMLT-GQPPFTHANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           L+E+ T G  P+     ++L  +++ E  ++  P   T+E + +++   H  PS+R
Sbjct: 242 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 296

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+KV+++ T  +K   + M  E  I+ ++ +P+IV+L    Q  + L L+++   GG L 
Sbjct: 367 AIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLH 423
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVS----HLHKCGIVHRDLKPENILMD---------- 249
             L  +   RE+      AE++  VS    +L +   VHR+L   N+L+           
Sbjct: 424 KFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 250 --SDGHEIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
             S     D+S  +    G    ++ APE +  +  +  +D WS G+ ++E L+ GQ P+
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 305 THANRQKLQQRI-INEKVKLPPFLTSEAHSLL 335
                 ++   I   ++++ PP    E ++L+
Sbjct: 541 KKMKGPEVMAFIEQGKRMECPPECPPELYALM 572

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 66
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 67  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-- 183
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 184 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 165 ERDILTKVTHPFIVQLR-YSFQ-TRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--Y 220
           E  IL  +   FIV+ R  S+   R  L L+++++  G L   L R    R D +R   Y
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 132
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY--------- 270
           +++I   + +L     VHRDL   NIL++S+ H +I +   +  +    +Y         
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 271 ----MAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPFTHANRQKLQQRII----- 317
                APE L     ++ +D WS G++LYE+ T       P     R    +R +     
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 318 -------NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                   +++  PP   +E H L+K      P  R
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-- 179
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 180 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 17/100 (17%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHEID------------ESSRSNSM 264
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  + I             +   +NS+
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
             T EY +PE+LL       AD WS   L++E++TG   F
Sbjct: 197 -QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 17/100 (17%)
Query: 221 TAEIVSAVSHLHK-CGIVHRDLKPENILM---DSDGHEID------------ESSRSNSM 264
           + +++  + ++H+ CGI+H D+KPEN+LM   DS  + I             +   +NS+
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 265 CGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
             T EY +PE+LL       AD WS   L++E++TG   F
Sbjct: 197 -QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+F                    A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L + QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILM------------------DSDGHEIDESSRSNSMCGT 267
             + +L     +HRDL   N+L+                   +D H + +  R       
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-- 179
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
             + APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +LP
Sbjct: 180 --WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 50/217 (23%)
Query: 174 HPFIVQL-------RYSFQTRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAE 223
           HP IVQ        +    T    +L+L  +  G L   L +   +G    D       +
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 224 IVSAVSHLH--KCGIVHRDLKPENILMDSDG--------------------------HEI 255
              AV H+H  K  I+HRDLK EN+L+ + G                            +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 256 DESSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQKL 312
           +E    N+   T  Y  PEI+    +    +  D W++G +LY +   Q PF    +   
Sbjct: 205 EEEITRNT---TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--- 258
Query: 313 QQRIINEKVKLPPFLTSEA--HSLLKGLLHKDPSKRL 347
             RI+N K  +PP  T     HSL++ +L  +P +RL
Sbjct: 259 -LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 62/136 (45%), Gaps = 30/136 (22%)
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL-MDSDGHEI-------DESSRSN- 262
           FR D  R    +I  +V+ LH   + H DLKPENIL + SD  E        DE +  N 
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 263 ------------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
                             ++     Y APE++L+ G ++  D WS+G +L E   G   F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 305 -THANRQKL--QQRII 317
            TH +++ L   +RI+
Sbjct: 235 PTHDSKEHLAMMERIL 250

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/263 (20%), Positives = 111/263 (42%), Gaps = 39/263 (14%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMC 265
           +        A+ +L     +HRDL   N L++  G               DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSK 182
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 325 PFLTSE-AHSLLKGLLHKDPSKR 346
           P L SE  ++++    H+   +R
Sbjct: 243 PHLASEKVYTIMYSCWHEKADER 265

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL- 202
           A+K + K    +K   D++ +E  I+ +  HP ++ L       + + +I +F+  G L 
Sbjct: 39  AIKTL-KSGYTEKQRRDFL-SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------- 251
            F     G F   Q       I + + +L     VHR L   NIL++S+           
Sbjct: 97  SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLS 156
Query: 252 ---GHEIDESSRSNSMCGTT--EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT 305
                +  + + ++++ G     + APE +  +     +D WS GI+++E+++ G+ P+ 
Sbjct: 157 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 216
Query: 306 HANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGLLHKDPSKR 346
               Q +    I +  +LPP +   S  H L+     KD + R
Sbjct: 217 DMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 258

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFR 213
           +K  VD++  E  I+ + +H  I++L         + +I +++  G L  F   + G F 
Sbjct: 87  EKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS 145
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRS 261
             Q       I + + +L     VHRDL   NIL++S+              E D  +  
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 262 NSMCGTT--EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN 318
            +  G     + APE +  +     +D WS GI+++E++T G+ P+   +  ++  + IN
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAIN 264
Query: 319 EKVKLP 324
           +  +LP
Sbjct: 265 DGFRLP 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQARFYTAE 223
           E   + K++HP +V+          +Y++ ++I+ G L  +L   G   E  Q      +
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD-----------GHEIDESSRSNSMCGT---TE 269
           +   ++ L     +HRDL   N L+D D            + +D+   S+   GT    +
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVK 170
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFL 327
           + APE+     ++  +D W+ GIL++E+ + G+ P+  + N + + +     ++  P   
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA 230
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           +   + ++    H+ P KR
Sbjct: 231 SDTIYQIMYSCWHELPEKR 249

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/265 (20%), Positives = 115/265 (43%), Gaps = 43/265 (16%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDE---SSRSNS 263
           +        A+ +L     +HRDL   N L++  G           + +D+   SSR + 
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK 167
Query: 264 MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK 322
                 +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I      
Sbjct: 168 F--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 225
Query: 323 LPPFLTSE-AHSLLKGLLHKDPSKR 346
             P L SE  ++++    H+   +R
Sbjct: 226 YRPHLASEKVYTIMYSCWHEKADER 250

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/263 (20%), Positives = 111/263 (42%), Gaps = 39/263 (14%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 69
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 70  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 122
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMC 265
           +        A+ +L     +HRDL   N L++  G               DE + S    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242
Query: 325 PFLTSE-AHSLLKGLLHKDPSKR 346
           P L SE  ++++    H+   +R
Sbjct: 243 PHLASEKVYTIMYSCWHEKADER 265

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/259 (19%), Positives = 102/259 (39%), Gaps = 33/259 (12%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 105
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 223 EIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGTTE 269
           ++ + + +L     VHRDL   N L             M  D +  D             
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPFL 327
           +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P   
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC 285
Query: 328 TSEAHSLLKGLLHKDPSKR 346
             E +++++G   ++P +R
Sbjct: 286 PPEVYAIMRGCWQREPQQR 304

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 81/188 (43%), Gaps = 22/188 (11%)
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFR 213
           +K   D++  E  I+ +  HP I+ L         + ++ +++  G L   L +  G F 
Sbjct: 64  EKQRRDFL-GEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----------------DGHEIDE 257
             Q       I + + +L   G VHRDL   NIL++S                D  E   
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI 316
           ++R   +     + APE +  +     +D WS GI+++E+++ G+ P+     Q +  + 
Sbjct: 183 TTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-IKA 239
Query: 317 INEKVKLP 324
           + E  +LP
Sbjct: 240 VEEGYRLP 247

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/259 (19%), Positives = 102/259 (39%), Gaps = 33/259 (12%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 76
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 223 EIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGTTE 269
           ++ + + +L     VHRDL   N L             M  D +  D             
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPFL 327
           +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P   
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC 256
Query: 328 TSEAHSLLKGLLHKDPSKR 346
             E +++++G   ++P +R
Sbjct: 257 PPEVYAIMRGCWQREPQQR 275

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 82/170 (48%), Gaps = 15/170 (8%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCG--IVHRDLKPENIL 247
           LI  ++  G L+  L+    F  DQ++   +  ++   ++ LH     I    L   +++
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145
Query: 248 MDSDG------HEIDESSRSNSMCGTTEYMAPEILLSKGHN---KDADWWSVGILLYEML 298
           +D D        ++  S +S        ++APE L  K  +   + AD WS  +LL+E++
Sbjct: 146 IDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 299 TGQPPFTHANRQKLQQRIINEKVK--LPPFLTSEAHSLLKGLLHKDPSKR 346
           T + PF   +  ++  ++  E ++  +PP ++     L+K  +++DP+KR
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 31/136 (22%)
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------IDESSRSNS----- 263
            R    ++  A+  LH+  + H DLKPENIL  +   E         +E S  N+     
Sbjct: 134 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 264 --------------MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THAN 308
                         +  T  Y  PE++L  G  +  D WS+G +L+E   G   F TH N
Sbjct: 194 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 253
Query: 309 RQKLQQRIINEKVKLP 324
           R+ L   ++ EK+  P
Sbjct: 254 REHL---VMMEKILGP 266

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/259 (19%), Positives = 102/259 (39%), Gaps = 33/259 (12%)
Query: 118 VGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
           +G+GAF                  + A+K +++ +  +    D+ + E ++LT + H  I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHI 82
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------IFRED---------QARFYTA 222
           V+          L ++ +++  G L   L   G         ED         Q     +
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 223 EIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGTTE 269
           ++ + + +L     VHRDL   N L             M  D +  D             
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKLQQRIINEKVKLPPFL 327
           +M PE +L +    ++D WS G++L+E+ T   QP +  +N + +       +++ P   
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC 262
Query: 328 TSEAHSLLKGLLHKDPSKR 346
             E +++++G   ++P +R
Sbjct: 263 PPEVYAIMRGCWQREPQQR 281

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/263 (20%), Positives = 111/263 (42%), Gaps = 39/263 (14%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 60
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 61  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 113
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMC 265
           +        A+ +L     +HRDL   N L++  G               DE + S    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 173
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 233
Query: 325 PFLTSE-AHSLLKGLLHKDPSKR 346
           P L SE  ++++    H+   +R
Sbjct: 234 PHLASEKVYTIMYSCWHEKADER 256

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 31/136 (22%)
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------IDESSRSNS----- 263
            R    ++  A+  LH+  + H DLKPENIL  +   E         +E S  N+     
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 264 --------------MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THAN 308
                         +  T  Y  PE++L  G  +  D WS+G +L+E   G   F TH N
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 309 RQKLQQRIINEKVKLP 324
           R+ L   ++ EK+  P
Sbjct: 245 REHL---VMMEKILGP 257

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 31/136 (22%)
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------IDESSRSNS----- 263
            R    ++  A+  LH+  + H DLKPENIL  +   E         +E S  N+     
Sbjct: 157 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 264 --------------MCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THAN 308
                         +  T  Y  PE++L  G  +  D WS+G +L+E   G   F TH N
Sbjct: 217 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 276
Query: 309 RQKLQQRIINEKVKLP 324
           R+ L   ++ EK+  P
Sbjct: 277 REHL---VMMEKILGP 289

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/263 (20%), Positives = 111/263 (42%), Gaps = 39/263 (14%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 54
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 55  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 107
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMC 265
           +        A+ +L     +HRDL   N L++  G               DE + S    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 167
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227
Query: 325 PFLTSE-AHSLLKGLLHKDPSKR 346
           P L SE  ++++    H+   +R
Sbjct: 228 PHLASEKVYTIMYSCWHEKADER 250

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/263 (20%), Positives = 111/263 (42%), Gaps = 39/263 (14%)
Query: 106 KIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P D    + +G G F                    A+K++++ ++ +   ++    E
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----E 53
Query: 166 RDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T ++
Sbjct: 54  AKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQL 106
Query: 225 VS-------AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMC 265
           +        A+ +L     +HRDL   N L++  G               DE + S    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 166
Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLP 324
               +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        
Sbjct: 167 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 226
Query: 325 PFLTSE-AHSLLKGLLHKDPSKR 346
           P L SE  ++++    H+   +R
Sbjct: 227 PHLASEKVYTIMYSCWHEKADER 249

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 34/141 (24%)
Query: 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHR 239
           ++LYLI D+   G L+ +L    +  +   +   +  VS + HLH        K  I HR
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAHR 166
Query: 240 DLKPENILMD-----------------SDGHEIDESSRSNSMCGTTEYMAPEIL---LSK 279
           DLK +NIL+                  SD +E+D     N+  GT  YM PE+L   L++
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP--PNTRVGTKRYMPPEVLDESLNR 224
Query: 280 GHNKD---ADWWSVGILLYEM 297
            H +    AD +S G++L+E+
Sbjct: 225 NHFQSYIMADMYSFGLILWEV 245

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 52/297 (17%)
Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKD 151
           E+E D + E   E      + E  +V+G GAF                    A+K++++ 
Sbjct: 33  EYEYDLKWEFPRE------NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 152 TIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQ 209
                +  + + +E  ++T++ +H  IV L  +      +YLI ++   G L  +L  ++
Sbjct: 87  A--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 210 GIFREDQARF----------------------YTAEIVSAVSHLHKCGIVHRDLKPENIL 247
             F ED+  +                      +  ++   +  L     VHRDL   N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 248 MDSD--------GHEIDESSRSNSMCGT-----TEYMAPEILLSKGHNKDADWWSVGILL 294
           +           G   D  S SN +         ++MAPE L    +   +D WS GILL
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 295 YEMLT-GQPPF----THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +E+ + G  P+      AN  KL Q     K+  P + T E + +++     D  KR
Sbjct: 265 WEIFSLGVNPYPGIPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKR 319

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 130 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 186
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 187 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 238

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 17/157 (10%)
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DG 252
            Y++ I  ED    Y+ ++   +  L     +HRDL   NIL+               D 
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQP-PFTHANR 309
           ++  +  R        ++MAPE +  K ++  +D WS G+LL+E+  L G P P    + 
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 310 QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
               +     +++ P + T E + ++    H+DP +R
Sbjct: 310 DFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER 346

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 149 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 205
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 206 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 257

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 128 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------------SSRSNS 263
           R+Y  E++ A+ + H  GI+HRD+KP N+++D   HE+ +                  N 
Sbjct: 129 RYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 264 MCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPF--THANRQKL 312
              +  +  PE+L+  + ++   D WS+G +   M+  + PF   H N  +L
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENIL-------------MDSDG 252
             D+      +++S        + +L +  +VHRDL   NIL             +  D 
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-------GQPPFT 305
           +E D   + +      ++MA E L    +   +D WS G+LL+E++T       G PP  
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 306 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             N  K   R+     + P   + E + L+     ++P KR
Sbjct: 261 LFNLLKTGHRM-----ERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 214 EDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDS-----------DGHEIDESSRS 261
           ED        IV A+ HLH K  ++HRD+KP N+L+++            G+ +D+ ++ 
Sbjct: 135 EDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKD 194
Query: 262 NSMCGTTEYMAPEI----LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQQR 315
               G   Y APE     L  KG++  +D WS+GI   E+   + P+       Q+L+Q 
Sbjct: 195 ID-AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
Query: 316 IINEKVKLP 324
           +     +LP
Sbjct: 254 VEEPSPQLP 262

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 45/176 (25%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS----------------------------DGHE 254
           +I S V+HLH   I+HRDLKP+NIL+ +                            D  +
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 255 IDESSRSNSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+ G+ PF   ++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 311 KLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 310

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 45/176 (25%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS----------------------------DGHE 254
           +I S V+HLH   I+HRDLKP+NIL+ +                            D  +
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 255 IDESSRSNSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQ 310
                  N+  GT+ + APE+L     +   +  D +S+G + Y +L+ G+ PF   ++ 
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 258
Query: 311 KLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
             +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 259 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 310

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 49/180 (27%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------------------EIDESS 259
           +I S V+HLH   I+HRDLKP+NIL+ +                          ++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 260 RS-----NSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT-GQPPFTH 306
            S     N+  GT+ + APE+L    +        +  D +S+G + Y +L+ G+ PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 307 ANRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
            ++   +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 296

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/262 (20%), Positives = 110/262 (41%), Gaps = 39/262 (14%)
Query: 107 IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G F                    A+K++++ ++ +   ++    E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV------AIKMIKEGSMSEDEFIE----EA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L      RE + RF T +++
Sbjct: 51  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLL 103
Query: 226 S-------AVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSNSMCG 266
                   A+ +L     +HRDL   N L++  G               DE + S     
Sbjct: 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPP 325
              +  PE+L+    +  +D W+ G+L++E+ + G+ P+      +  + I        P
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223
Query: 326 FLTSE-AHSLLKGLLHKDPSKR 346
            L SE  ++++    H+   +R
Sbjct: 224 HLASEKVYTIMYSCWHEKADER 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENIL-------------MDSDG 252
             D+      +++S        + +L +  +VHRDL   NIL             +  D 
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-------GQPPFT 305
           +E D   + +      ++MA E L    +   +D WS G+LL+E++T       G PP  
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 306 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             N  K   R+     + P   + E + L+     ++P KR
Sbjct: 261 LFNLLKTGHRM-----ERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 43  AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 97
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDG 252
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+         D   
Sbjct: 98  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 157
Query: 253 HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
             + E +   +  G     ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 158 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE---- 269
             Q   Y  +I   + +L     VHRDL   N+L++S+ H++       +    T+    
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXX 183
Query: 270 -----------YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPF---------T 305
                      + APE L+       +D WS G+ L+E+LT       P          T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
Query: 306 HANRQKLQQRIIN-----EKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           H   Q    R++N     +++  PP    E + L++      PS R
Sbjct: 244 HG--QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G+G F                    A+K+++++     + +  + +E ++L +V HP
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHP 86
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE--------------------- 214
            +++L  +      L LI+++   G L      +G  RE                     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 215 --DQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENIL-------------MDSDG 252
             D+      +++S        + +L +  +VHRDL   NIL             +  D 
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 253 HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-------GQPPFT 305
           +E D   + +      ++MA E L    +   +D WS G+LL+E++T       G PP  
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 306 HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             N  K   R+     + P   + E + L+     ++P KR
Sbjct: 261 LFNLLKTGHRM-----ERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 157 NHVDYMKAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFR 213
           NH+  +K E +IL  + H  IV+ +   +    + + LI++F+  G L  +L + +    
Sbjct: 53  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 112
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE---- 269
             Q   Y  +I   + +L     VHRDL   N+L++S+ H++       +    T+    
Sbjct: 113 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXX 171
Query: 270 -----------YMAPEILLSKGHNKDADWWSVGILLYEMLT----GQPPF---------T 305
                      + APE L+       +D WS G+ L+E+LT       P          T
Sbjct: 172 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 231
Query: 306 HANRQKLQQRIIN-----EKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           H   Q    R++N     +++  PP    E + L++      PS R
Sbjct: 232 HG--QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 275

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 270
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDG 252
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+         D   
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 253 HEIDESSRSNSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
             + E +   +  G     ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/261 (20%), Positives = 98/261 (37%), Gaps = 35/261 (13%)
Query: 116 RVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
           R +G+GAF                  + A+K ++   D   K  H      E ++LT + 
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-----REAELLTNLQ 73
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFY 220
           H  IV+          L ++ +++  G L   L   G                + Q    
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
             +I + + +L     VHRDL   N L             M  D +  D           
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 325
             +M PE ++ +    ++D WS+G++L+E+ T G+ P+   +  ++ + I   +V + P 
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR 253
Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
               E + L+ G   ++P  R
Sbjct: 254 TCPQEVYELMLGCWQREPHMR 274

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/166 (21%), Positives = 74/166 (44%), Gaps = 38/166 (22%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF----- 219
           E  ++  + HP +++         +L  I ++I GG L      +GI +   +++     
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL------RGIIKSMDSQYPWSQR 110
Query: 220 --YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESS------- 259
             +  +I S +++LH   I+HRDL   N L+  + +            +DE +       
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
                  +  ++ G   +MAPE++  + +++  D +S GI+L E++
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 49/180 (27%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS----------------------------DGHE 254
           +I S V+HLH   I+HRDLKP+NIL+ +                            D  +
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 255 IDESSRSNSMCGTTEYMAPEILLSKGH-------NKDADWWSVGILLYEMLT-GQPPFTH 306
                  N+  GT+ + APE+L    +        +  D +S+G + Y +L+ G+ PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 307 ANRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH 359
            ++   +  II     L          L +EA  L+  ++  DP KR    P  +  ++H
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMKVLRH 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQR 291

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 322
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 323 PDYTTPEMYQTMLDCWHGEPSQR 345

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 315
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 316 PDYTTPEMYQTMLDCWHGEPSQR 338

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 324
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 325 PDYTTPEMYQTMLDCWHGEPSQR 347

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 318 PDYTTPEMYQTMLDCWHGEPSQR 340

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 45/198 (22%)
Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           +I  +H   + AE   LT       ++ ++Y F+    + + + ++     F  +     
Sbjct: 57  LIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHES-FLDILNSLS 115
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL------------------------ 247
           F+E   R Y   +  A+  +H+ GIVHRD+KP N L                        
Sbjct: 116 FQE--VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173
Query: 248 -----MDSDGHEIDESSRSNSMC-----------GTTEYMAPEILLSKGHNKDA-DWWSV 290
                + S+  +   S    S+C           GT  + APE+L    +   A D WS 
Sbjct: 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233
Query: 291 GILLYEMLTGQPPFTHAN 308
           G++   +L+G+ PF  A+
Sbjct: 234 GVIFLSLLSGRYPFYKAS 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 309
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 310 PDYTTPEMYQTMLDCWHGEPSQR 332

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 274
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 275 PDYTTPEMYQTMLDCWHGEPSQR 297

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K M+  ++     V+   AE +++  + H  +V+L ++  T+  +Y+I +F+  G L 
Sbjct: 210 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLL 264
Query: 204 FHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS 261
             L      ++   +   ++A+I   ++ + +   +HRDL+  NIL+ S       +   
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV-SASLVCKIADFG 323
Query: 262 NSMCGT---TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
            +  G     ++ APE +        +D WS GILL E++T G+ P+
Sbjct: 324 LARVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 61  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 119
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 120 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 239
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 240 PDNCPEELYQLMRLCWKERPEDR 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDR 260

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/153 (21%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM-----CGTTE-----YMAPEIL 276
           +   H   ++HRDLKP+N+L++ +G  ++ +   + +      C + E     Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 277 L-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
             +K ++   D WS G +  E+     P    N
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D ++  +  R      
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQR 291

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 62  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 120
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 121 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 240
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 241 PDNCPEELYQLMRLCWKERPEDR 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 55  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 113
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 114 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 233
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 234 PDNCPEELYQLMRLCWKERPEDR 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 54  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 112
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 113 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 232
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 233 PDNCPEELYQLMRLCWKERPEDR 255

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 30/141 (21%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 169
Query: 238 HRDLKPENILMDSDG----HEIDESSRSNSM-----------CGTTEYMAPEIL---LSK 279
           HRDLK +NIL+  +G     ++  + R +S             GT  YMAPE+L   ++ 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 280 GH---NKDADWWSVGILLYEM 297
            H    K AD +++G++ +E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEI 250

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 62/143 (43%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D  +  +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 62/143 (43%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D  +  +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 62/143 (43%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D  +  +  R      
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 264 PDYTTPEMYQTMLDCWHGEPSQR 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/224 (20%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           +L ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM-----CGTTE-----YMAPEIL 276
           +   H   ++HRDLKP+N+L++ +G  ++     + +      C + E     Y  P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 277 L-SKGHNKDADWWSVGILLYEML-TGQPPFTHANRQKLQQRIIN-----------EKVKL 323
             +K ++   D WS G +  E+   G+P F   +     +RI                KL
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 324 P------------------PFLTSEAHSLLKGLLHKDPSKRLGS 349
           P                  P L +    LL+ LL  +P +R+ +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 30/141 (21%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 98  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 156
Query: 238 HRDLKPENILMDSDG----HEIDESSRSNSM-----------CGTTEYMAPEIL---LSK 279
           HRDLK +NIL+  +G     ++  + R +S             GT  YMAPE+L   ++ 
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 216
Query: 280 GH---NKDADWWSVGILLYEM 297
            H    K AD +++G++ +E+
Sbjct: 217 KHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 30/141 (21%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 78  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 136
Query: 238 HRDLKPENILMDSDG----HEIDESSRSNSM-----------CGTTEYMAPEIL---LSK 279
           HRDLK +NIL+  +G     ++  + R +S             GT  YMAPE+L   ++ 
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 196
Query: 280 GH---NKDADWWSVGILLYEM 297
            H    K AD +++G++ +E+
Sbjct: 197 KHFESFKRADIYAMGLVFWEI 217

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 18/218 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 56  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 112
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----------D 251
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S            
Sbjct: 113 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 252 GHEIDESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 308
            +  DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 173 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232
Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  +      +++  P       ++L+      DPS R
Sbjct: 233 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 270

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 30/141 (21%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 130
Query: 238 HRDLKPENILMDSDG----HEIDESSRSNSM-----------CGTTEYMAPEIL---LSK 279
           HRDLK +NIL+  +G     ++  + R +S             GT  YMAPE+L   ++ 
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 280 GH---NKDADWWSVGILLYEM 297
            H    K AD +++G++ +E+
Sbjct: 191 KHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 30/141 (21%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 75  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 133
Query: 238 HRDLKPENILMDSDG----HEIDESSRSNSM-----------CGTTEYMAPEIL---LSK 279
           HRDLK +NIL+  +G     ++  + R +S             GT  YMAPE+L   ++ 
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 193
Query: 280 GH---NKDADWWSVGILLYEM 297
            H    K AD +++G++ +E+
Sbjct: 194 KHFESFKRADIYAMGLVFWEI 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 54/226 (23%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGH--------EIDESSRSNSM-------CGTTEYMA 272
                K  I HRDLK +NIL+  +G          +  S  +N +        GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 273 PEILLSK------GHNKDADWWSVGILLYE----MLTG------QPPF--------THAN 308
           PE+L            K  D W+ G++L+E    M++       +PPF        +  +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 309 RQKL----QQR-IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
            +K+    QQR  I  +    P LTS A  L+K   +++PS RL +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTA 290

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 63  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 121
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 122 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 241
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 242 PDNCPEELYQLMRLCWKERPEDR 264

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 30/141 (21%)
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIV 237
           T ++L+L+ D+   G LF +L R  +  E   +   +   S ++HLH        K  I 
Sbjct: 73  TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVGTQGKPAIA 131
Query: 238 HRDLKPENILMDSDG----HEIDESSRSNSM-----------CGTTEYMAPEIL---LSK 279
           HRDLK +NIL+  +G     ++  + R +S             GT  YMAPE+L   ++ 
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 191
Query: 280 GH---NKDADWWSVGILLYEM 297
            H    K AD +++G++ +E+
Sbjct: 192 KHFESFKRADIYAMGLVFWEI 212

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 62/143 (43%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D  +  +  R      
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 109/259 (42%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTE------------- 269
           I   +++L    +VHRDL   N+L+ +  H +I +  R+  + G  E             
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK-LLGAEEKEYHAEGGKVPIK 186
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 246
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + +++     D   R
Sbjct: 247 TIDVYMIMRKCWMIDADSR 265

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 54/226 (23%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 233 -----KCGIVHRDLKPENILMDSDGH--------EIDESSRSNSM-------CGTTEYMA 272
                K  I HRDLK +NIL+  +G          +  S  +N +        GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 273 PEILLSK------GHNKDADWWSVGILLYE----MLTG------QPPF--------THAN 308
           PE+L            K  D W+ G++L+E    M++       +PPF        +  +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 309 RQKL----QQR-IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
            +K+    QQR  I  +    P LTS A  L+K   +++PS RL +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTA 290

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 76/156 (48%), Gaps = 17/156 (10%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E +++  + H  +V+L Y+  TR + +Y+I +++  G L  F      G     +   ++
Sbjct: 58  EANLMKTLQHDKLVRL-YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS 116
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TE 269
           A+I   ++++ +   +HRDL+  N+L+         D     + E +   +  G     +
Sbjct: 117 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 176
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
           + APE +        +D WS GILLYE++T G+ P+
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIV 225
           I++ + HP IV+L        ++  +++F+  G L+  L  +   I    + R    +I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 226 SAVSHLHKCG--IVHRDLKPENILMDSDGHEIDESS-----------------RSNSMCG 266
             + ++      IVHRDL+  NI + S    +DE++                   + + G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQS----LDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 267 TTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
             ++MAPE + ++   + + AD +S  ++LY +LTG+ PF   +  K++   +  +  L 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 325 PFLTSEAHSLLKGLLH----KDPSKR 346
           P +  +    L+ ++      DP KR
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 58  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 116
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 117 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 236
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 237 PDNCPEELYQLMRLCWKERPEDR 259

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 118 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDR 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIV 225
           I++ + HP IV+L        ++  +++F+  G L+  L  +   I    + R    +I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 226 SAVSHLHKCG--IVHRDLKPENILMDS------------DGHEIDESSRSNS-MCGTTEY 270
             + ++      IVHRDL+  NI + S            D     +S  S S + G  ++
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQW 192
Query: 271 MAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 328
           MAPE + ++   + + AD +S  ++LY +LTG+ PF   +  K++   +  +  L P + 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 329 SEAHSLLKGLLH----KDPSKR 346
            +    L+ ++      DP KR
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKR 274

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 62/143 (43%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------------DGHEIDESSRSNSMCG 266
           Y+ ++   +  L     +HRDL   NIL+               D  +  +  R      
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE--KVKL 323
             ++MAPE +  + +   +D WS G+LL+E+ + G  P+      +   R + E  +++ 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P + T E +  +    H +PS+R
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQR 295

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++F+ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEFLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 100 YGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 18/218 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 40  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 96
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----------D 251
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S            
Sbjct: 97  HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 252 GHEIDESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 308
            +  DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 157 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216
Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  +      +++  P       ++L+      DPS R
Sbjct: 217 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 254

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 54/224 (24%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+ +L    +      R   + I S ++HLH   
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 154
Query: 233 -----KCGIVHRDLKPENILMDSDGH--------EIDESSRSNSM-------CGTTEYMA 272
                K  I HRDLK +NIL+  +G          +  S  +N +        GT  YMA
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 273 PEILLSK------GHNKDADWWSVGILLYE----MLTG------QPPF--------THAN 308
           PE+L            K  D W+ G++L+E    M++       +PPF        +  +
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 274
Query: 309 RQKL----QQR-IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
            +K+    QQR  I  +    P LTS A  L+K   +++PS RL
Sbjct: 275 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARL 317

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIV 225
           I++ + HP IV+L        ++  +++F+  G L+  L  +   I    + R    +I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 226 SAVSHLHKCG--IVHRDLKPENILMDSDGHEIDESS-----------------RSNSMCG 266
             + ++      IVHRDL+  NI + S    +DE++                   + + G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQS----LDENAPVCAKVADFSLSQQSVHSVSGLLG 188
Query: 267 TTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
             ++MAPE + ++   + + AD +S  ++LY +LTG+ PF   +  K++   +  +  L 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 325 PFLTSEAHSLLKGLLH----KDPSKR 346
           P +  +    L+ ++      DP KR
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDR 254

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 18/218 (8%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           A+K  +KD  +  N   +M +E  I+  + HP IV+L          ++I++    G L 
Sbjct: 44  AVKTCKKDCTLD-NKEKFM-SEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELG 100
Query: 204 FHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----------D 251
            +L R +   +      Y+ +I  A+++L     VHRD+   NIL+ S            
Sbjct: 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 252 GHEIDESSRSNSMCGT-TEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 308
            +  DE     S+     ++M+PE +  +     +D W   + ++E+L+   QP F   N
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220
Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  +      +++  P       ++L+      DPS R
Sbjct: 221 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 48  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 106
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HRDL+  NIL+         D     + E +   +  G  
Sbjct: 107 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 226
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 227 PDNCPEELYQLMRLCWKERPEDR 249

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 97  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 256 DESSRSNSMCGTTEYM-------------APEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E+              APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 14/90 (15%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMD-------SD------GHEIDESSRSNSMCGTTEYMA 272
           + ++ LH+   +HRD+K  NIL+D       SD        +  ++   + + GTT YMA
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           PE L  +   K +D +S G++L E++TG P
Sbjct: 204 PEALRGEITPK-SDIYSFGVVLLEIITGLP 232

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 21/153 (13%)
Query: 165 ERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +  
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLFAQ 119
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD----------------GHEIDESSRSNSMCG 266
           +I   +++LH    +HR L   N+L+D+D                GHE            
Sbjct: 120 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--S 177
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
              + APE L        +D WS G+ LYE+LT
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 21/153 (13%)
Query: 165 ERDILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           E +IL  + H  IV+ +     Q    + L+++++  G L  +L R  +    Q   +  
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA-QLLLFAQ 118
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD----------------GHEIDESSRSNSMCG 266
           +I   +++LH    +HR L   N+L+D+D                GHE            
Sbjct: 119 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD--S 176
Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
              + APE L        +D WS G+ LYE+LT
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 14/90 (15%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMD-------SD------GHEIDESSRSNSMCGTTEYMA 272
           + ++ LH+   +HRD+K  NIL+D       SD        +  ++     + GTT YMA
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           PE L  +   K +D +S G++L E++TG P
Sbjct: 204 PEALRGEITPK-SDIYSFGVVLLEIITGLP 232

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 108/259 (41%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTE------------- 269
           I   +++L    +VHRDL   N+L+ +  H +I +  R+  + G  E             
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK-LLGAEEKEYHAEGGKVPIK 186
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 246
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + +++     D   R
Sbjct: 247 TIDVYMIMRKCWMIDADSR 265

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 42  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 97
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HR+L   NIL++++   +I
Sbjct: 98  YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKI 156
Query: 256 DESSRSNSMCGTTEYM-------------APEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    EY              APE L     +  +D WS G++LYE+ T
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 48  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 103
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 104 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 162
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 95/238 (39%), Gaps = 57/238 (23%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +EI  ++G G++                  +   K++R    + ++ +D  +  R+I
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRV----VAIKKILR----VFEDLIDCKRILREI 103
Query: 169 --LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIF-REDQARFY 220
             L ++ H  +V++         +   +LY++L+  +    F  L+R  ++  E   +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTL 161
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD----------GHEIDESSRSNS------- 263
              ++  V ++H  GI+HRDLKP N L++ D             +D     NS       
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 264 ------------------MCG---TTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLT 299
                             + G   T  Y APE ILL + + +  D WS+G +  E+L 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 71/155 (45%), Gaps = 15/155 (9%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E +++  + H  +V+L         +Y+I +F+  G L  F      G     +   ++A
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT---TEY 270
           +I   ++++ +   +HRDL+  N+L+         D     + E +   +  G     ++
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
            APE +        ++ WS GILLYE++T G+ P+
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 46  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 101
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 102 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 160
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 72  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 127
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 128 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 45  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 100
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 101 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 159
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 47  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 102
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 103 YGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 161
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 100 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 39  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 94
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 95  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 153
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 108/259 (41%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTE------------- 269
           I   +++L    +VHRDL   N+L+ +  H +I +  R+  + G  E             
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK-LLGAEEKEYHAEGGKVPIK 186
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 246
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + ++      D   R
Sbjct: 247 TIDVYMIMVKCWMIDADSR 265

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 97  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 40  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 95
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 96  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 154
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 41  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 96
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 97  YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 59  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 114
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L +    R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 115 YGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 173
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGI-FREDQA 217
           D   AE +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F     GI    ++ 
Sbjct: 49  DAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 107
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM---------DSDGHEIDESSRSNSMCGT- 267
               A+I   ++ + +   +HR+L+  NIL+         D     + E +   +  G  
Sbjct: 108 LDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++ APE +        +D WS GILL E++T G+ P+    N + +Q      ++  
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 227
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P     E + L++    + P  R
Sbjct: 228 PDNCPEELYQLMRLCWKERPEDR 250

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 14/90 (15%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMD-------SD------GHEIDESSRSNSMCGTTEYMA 272
           + ++ LH+   +HRD+K  NIL+D       SD        +  +      + GTT YMA
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           PE L  +   K +D +S G++L E++TG P
Sbjct: 198 PEALRGEITPK-SDIYSFGVVLLEIITGLP 226

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 108/259 (41%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 71  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTE------------- 269
           I   +++L    +VHRDL   N+L+ +  H +I +  R+  + G  E             
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK-LLGAEEKEYHAEGGKVPIK 188
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 248
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + ++      D   R
Sbjct: 249 TIDVYMIMVKCWMIDADSR 267

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 24/177 (13%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFIN 198
           + A+K ++  T   + H+   + E +IL  + H  IV+ +   YS   R  L LI++++ 
Sbjct: 44  VVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLKLIMEYLP 99
Query: 199 GGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI 255
            G L  +L      R D  +   YT++I   + +L     +HRDL   NIL++++   +I
Sbjct: 100 YGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 158
Query: 256 DESSRSNSMCGTTE-------------YMAPEILLSKGHNKDADWWSVGILLYEMLT 299
            +   +  +    E             + APE L     +  +D WS G++LYE+ T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 47/193 (24%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I   +++R+ TI+ +   DY+    D++          +        +LY++L+  +   
Sbjct: 67  IDCKRILREITILNRLKSDYIIRLYDLI----------IPDDLLKFDELYIVLEIADSD- 115
Query: 202 LFFHLYRQGIF-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------- 251
               L++  IF  E+  +     ++   + +H+ GI+HRDLKP N L++ D         
Sbjct: 116 -LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174
Query: 252 -GHEIDESSRSNSMCGTTE-----------------------YMAPE-ILLSKGHNKDAD 286
               I+    +N +    E                       Y APE ILL + + K  D
Sbjct: 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234
Query: 287 WWSVGILLYEMLT 299
            WS G +  E+L 
Sbjct: 235 IWSTGCIFAELLN 247

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGT---- 267
           ++ ++   ++ L     +HRDL   NIL+           G   D  + SN +       
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 268 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL-- 323
             ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++  
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 292
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P    +E + ++K     DP KR
Sbjct: 293 PEHAPAEMYDIMKTCWDADPLKR 315

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGT---- 267
           ++ ++   ++ L     +HRDL   NIL+           G   D  + SN +       
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 268 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL-- 323
             ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++  
Sbjct: 228 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 287
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P    +E + ++K     DP KR
Sbjct: 288 PEHAPAEMYDIMKTCWDADPLKR 310

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 185 QTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL 241
           + ++ +YL+ DF      G L   L +   F   + +     +++ + ++H+  I+HRD+
Sbjct: 95  RCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDM 151
Query: 242 KPENILMDSDG---------------HEIDESSRSNSMCGTTEYMAPEILLS-KGHNKDA 285
           K  N+L+  DG                +  + +R  +   T  Y  PE+LL  + +    
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 286 DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
           D W  G ++ EM T + P    N ++ Q  +I++
Sbjct: 212 DLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 70
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 71  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 250 IDVYMIMVKCWMIDADSR 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGT---- 267
           ++ ++   ++ L     +HRDL   NIL+           G   D  + SN +       
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 268 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL-- 323
             ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++  
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P    +E + ++K     DP KR
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKR 292

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEIDE--------SSRSNSMCGTT--- 268
            A+I + + +L    +VH+DL   N+L+ D    +I +        ++    + G +   
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 269 -EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 325
             +MAPE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P 
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 253
Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
              +  ++L+    ++ PS+R
Sbjct: 254 DCPAWVYALMIECWNEFPSRR 274

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 67
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 68  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 247 IDVYMIMVKCWMIDADSR 264

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  +L ++ H  I++L+       +L+LI ++     L  ++ +         + +  ++
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQL 141
Query: 225 VSAVSHLHKCGIVHRDLKPENILMD-SDGHE-----IDESSRSNSM----------CGTT 268
           ++ V+  H    +HRDLKP+N+L+  SD  E     I +   + +             T 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 269 EYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            Y  PEILL S+ ++   D WS+  +  EML   P F
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 270 YMAPEILLSKGHN---KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LP 324
           ++APE L  K  +   + AD WS  +LL+E++T + PF   +  ++  ++  E ++  +P
Sbjct: 174 WVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIP 233
Query: 325 PFLTSEAHSLLKGLLHKDPSKR 346
           P ++     L K   ++DP+KR
Sbjct: 234 PGISPHVSKLXKICXNEDPAKR 255

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGT---- 267
           ++ ++   ++ L     +HRDL   NIL+           G   D  + SN +       
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 268 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL-- 323
             ++MAPE + +  +  ++D WS GI L+E+ + G  P+          ++I E  ++  
Sbjct: 226 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 285
Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P    +E + ++K     DP KR
Sbjct: 286 PEHAPAEMYDIMKTCWDADPLKR 308

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 474
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 475 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 594
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 595 PAGCPREMYDLMNLCWTYDVENRPG 619

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + +++     D   R
Sbjct: 249 IDVYMIMRKCWMIDADSR 266

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 107/259 (41%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTE------------- 269
           I   +++L    +VHRDL   N+L+ +  H +I +  R+  + G  E             
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK-LLGAEEKEYHAEGGKVPIK 184
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + ++      D   R
Sbjct: 245 TIDVYMIMVKCWMIDADSR 263

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 248 IDVYMIMVKCWMIDADSR 265

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 20  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 76
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 77  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 135
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 136 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 255
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + +++     D   R
Sbjct: 256 IDVYMIMRKCWMIDADSR 273

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 473
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 474 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 593
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 594 PAGCPREMYDLMNLCWTYDVENRPG 618

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 31/182 (17%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------------HEIDES 258
             + +     +++ + ++H+  I+HRD+K  N+L+  DG                +  + 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 259 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242
Query: 318 NE 319
           ++
Sbjct: 243 SQ 244

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 107/259 (41%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 73
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 74  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTE------------- 269
           I   +++L    +VHRDL   N+L+ +  H +I +  R+  + G  E             
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK-LLGAEEKEYHAEGGKVPIK 191
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 251
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + ++      D   R
Sbjct: 252 TIDVYMIMVKCWMIDADSR 270

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 67
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 68  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 247 IDVYMIMVKCWMIDADSR 264

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 69
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 70  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 249 IDVYMIMVKCWMIDADSR 266

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 31/182 (17%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------------HEIDES 258
             + +     +++ + ++H+  I+HRD+K  N+L+  DG                +  + 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 259 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242
Query: 318 NE 319
           ++
Sbjct: 243 SQ 244

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHEIDE--------SSRSNSMCGTT--- 268
            A+I + + +L    +VH+DL   N+L+ D    +I +        ++    + G +   
Sbjct: 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 269 -EYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPP 325
             +MAPE ++    + D+D WS G++L+E+ + G  P+   + Q + + I N +V   P 
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 270
Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
              +  ++L+    ++ PS+R
Sbjct: 271 DCPAWVYALMIECWNEFPSRR 291

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI+  +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 103/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + +++     D   R
Sbjct: 246 IDVYMIMRKCWMIDADSR 263

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 31/182 (17%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK--------LYLILDFIN---GGHLFFHLYRQGIFR 213
           E  IL  + H  +V L    +T++         +YL+ DF      G L   L +   F 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 122
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------------HEIDES 258
             + +     +++ + ++H+  I+HRD+K  N+L+  DG                +  + 
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 259 SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII 317
           +R  +   T  Y  PE+LL  + +    D W  G ++ EM T + P    N ++ Q  +I
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 241
Query: 318 NE 319
           ++
Sbjct: 242 SQ 243

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 105/242 (43%), Gaps = 22/242 (9%)
Query: 111 DFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + +  +V+G GAF                  + A+K++ + T  K N V++M  E  I+ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD-EALIMA 95
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            + HP +V+L         + L+   +  G L  + H ++  I  +     +  +I   +
Sbjct: 96  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGM 153
Query: 229 SHLHKCGIVHRDLKPENILMDSDGH------------EIDESS-RSNSMCGTTEYMAPEI 275
            +L +  +VHRDL   N+L+ S  H            E DE    ++      ++MA E 
Sbjct: 154 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLTSEAHS 333
           +  +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  T + + 
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 273
Query: 334 LL 335
           ++
Sbjct: 274 VM 275

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 14/90 (15%)
Query: 226 SAVSHLHKCGIVHRDLKPENILMD-------SD------GHEIDESSRSNSMCGTTEYMA 272
           + ++ LH+   +HRD+K  NIL+D       SD        +  +    + + GTT Y A
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           PE L  +   K +D +S G++L E++TG P
Sbjct: 195 PEALRGEITPK-SDIYSFGVVLLEIITGLP 223

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 129
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 249
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 250 PAGCPREMYDLMNLCWTYDVENRPG 274

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/205 (20%), Positives = 86/205 (41%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMD------------SDGHEIDESSRSNSMCGT 267
              ++   + +L +   VHRDL   N+L+             S     DE+       G 
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
              ++ APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 235
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 236 PAGCPREMYDLMNLCWTYDVENRPG 260

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 251
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 252 PAGCPREMYDLMNLCWTYDVENRPG 276

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 251
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 252 PAGCPREMYDLMNLCWTYDVENRPG 276

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 30/151 (19%)
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--- 232
           FI     S  + ++L+LI  +   G L+  L RQ +      R   +     ++HLH   
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSA-ACGLAHLHVEI 125
Query: 233 -----KCGIVHRDLKPENILMDSD--------GHEIDESSRS-------NSMCGTTEYMA 272
                K  I HRD K  N+L+ S+        G  +  S  S       N   GT  YMA
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 273 PEILLSKGHN------KDADWWSVGILLYEM 297
           PE+L  +         K  D W+ G++L+E+
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 15/108 (13%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
            AEI   +++L+    VHRDL   N +             M  D +E D   +       
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 313
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/253 (20%), Positives = 103/253 (40%), Gaps = 45/253 (17%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRSKLYLILDFIN 198
           IYA+K  +K        VD   A R++        H  +V+   ++     + +  ++ N
Sbjct: 34  IYAIKRSKKPL---AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 90
Query: 199 GGHLFFHL---YR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM------ 248
           GG L   +   YR    F+E + +    ++   + ++H   +VH D+KP NI +      
Sbjct: 91  GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIP 150
Query: 249 DSDGHEIDESSRSNSMC--------------------GTTEYMAPEILLSK-GHNKDADW 287
           ++   E DE   +++                      G + ++A E+L     H   AD 
Sbjct: 151 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADI 210
Query: 288 WSVGILLYEMLTGQP-PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +++ + +      +P P       +++Q       ++P  L+ E   LLK ++H DP +R
Sbjct: 211 FALALTVVXAAGAEPLPRNGDQWHEIRQ---GRLPRIPQVLSQEFTELLKVMIHPDPERR 267
Query: 347 LGSGPGGVDAIKH 359
               P  +  +KH
Sbjct: 268 ----PSAMALVKH 276

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 15/108 (13%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
            AEI   +++L+    VHRDL   N +             M  D +E D   +       
Sbjct: 135 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 313
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 45/108 (41%), Gaps = 15/108 (13%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
            AEI   +++L+    VHRDL   N +             M  D  E D   +       
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 313
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 235
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 236 PAGCPREMYDLMNLCWTYDVENRPG 260

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 45/108 (41%), Gaps = 15/108 (13%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
            AEI   +++L+    VHRDL   N +             M  D  E D   +       
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 313
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 45/108 (41%), Gaps = 15/108 (13%)
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENIL-------------MDSDGHEIDESSRSNSMCGT 267
            AEI   +++L+    VHRDL   N +             M  D  E D   +       
Sbjct: 133 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEM--LTGQPPFTHANRQKLQ 313
             +MAPE L        +D WS G++L+E+  L  QP    +N Q L+
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 109
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 110 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 229
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 230 PAGCPREMYDLMNLCWTYDVENRPG 254

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/259 (21%), Positives = 109/259 (42%), Gaps = 22/259 (8%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   + +  +V+G GAF                  + A+K++ + T  K N V++M  
Sbjct: 10  RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV-AIKILNETTGPKAN-VEFMD- 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
           E  I+  + HP +V+L         + L+   +  G L  + H ++  I  +     +  
Sbjct: 67  EALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCV 124
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESS-RSNSMCGTTE 269
           +I   + +L +  +VHRDL   N+L+ S  H            E DE    ++      +
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFL 327
           +MA E +  +     +D WS G+ ++E++T G  P+     +++   +   E++  PP  
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 244
Query: 328 TSEAHSLLKGLLHKDPSKR 346
           T + + ++      D   R
Sbjct: 245 TIDVYMVMVKCWMIDADSR 263

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPG 266

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/205 (20%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           D + AE +++ ++ +P+IV++    +  S + L+++    G L  +L +    ++     
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSMCGTTEY-------- 270
              ++   + +L +   VHRDL   N+L+ +  + +I +   S ++     Y        
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKL 323
                 APE +     +  +D WS G+L++E  + GQ P+      ++   +   E++  
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 324 PPFLTSEAHSLLKGLLHKDPSKRLG 348
           P     E + L+      D   R G
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPG 256

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 102/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 66
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 67  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 246 IDVYMIMVKCWMIDADSR 263

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 102/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 68
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 69  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 248 IDVYMIMVKCWMIDADSR 265

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 102/258 (39%), Gaps = 20/258 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAF                  + A+K +R+ T  K N    +  
Sbjct: 16  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANK--EILD 72
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-YTAE 223
           E  ++  V +P + +L       S + LI   +  G L  ++         Q    +  +
Sbjct: 73  EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 131
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE-------------Y 270
           I   +++L    +VHRDL   N+L+ +  H          + G  E             +
Sbjct: 132 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI-INEKVKLPPFLT 328
           MA E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 251
Query: 329 SEAHSLLKGLLHKDPSKR 346
            + + ++      D   R
Sbjct: 252 IDVYMIMVKCWMIDADSR 269
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	431
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	0.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-179
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-177
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-177
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-176
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-176
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-173
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-172
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-172
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-165
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-165
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-164
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-162
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-160
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-160
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-160
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-159
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-157
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-157
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-157
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-156
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-154
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-109
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-105
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-87
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-86
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-82
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-79
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-79
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-73
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-70
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-68
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-68
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-68
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-68
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-67
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-67
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-66
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-66
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-66
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-66
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-65
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-65
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-65
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-65
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-65
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-64
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-64
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-64
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-64
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-63
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-63
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-63
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-63
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-63
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-63
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-63
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-63
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-63
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-63
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-63
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-63
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-63
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-62
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-62
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-62
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-62
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-62
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-61
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-61
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-61
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-61
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-61
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-61
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-61
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-61
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-60
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-60
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-60
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-60
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-59
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-59
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-59
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-58
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-58
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-58
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-56
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-56
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-55
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-55
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-55
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-54
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-51
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-47
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-43
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-39
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-39
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-38
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-38
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-35
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-35
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-35
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-31
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-29
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-27
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-24
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-23
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-21
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-15
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-14
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  505 bits (1304), Expect = 0.0
 Identities = 151/320 (47%), Positives = 212/320 (66%), Gaps = 14/320 (4%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVD 160
               KI P  FE+ RV+G+G +GKVFQV+K      ++  I+AMKV++K  I++      
Sbjct: 9   RGPEKIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           + KAER+IL +V HPFIV L Y+FQT  KLYLIL++++GG LF  L R+GIF ED A FY
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTE 269
            AEI  A+ HLH+ GI++RDLKPENI+++  GH            I + + +++ CGT E
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 329
           YMAPEIL+  GHN+  DWWS+G L+Y+MLTG PPFT  NR+K   +I+  K+ LPP+LT 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC 389
           EA  LLK LL ++ + RLG+GPG    ++ H +FR INW+ L AR+++P FKP +  ++ 
Sbjct: 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEED 306

Query: 390 IANFDKCWTTMPADDSPAPT 409
           ++ FD  +T     DSP  +
Sbjct: 307 VSQFDSKFTRQTPVDSPDDS 326

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  503 bits (1298), Expect = e-179
 Identities = 146/375 (38%), Positives = 209/375 (55%), Gaps = 28/375 (7%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           G S                       L   S     P DF   +V+G+G+FGKV   + K
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLY 191
                  +  YA+KV++K  I+KK    ++ +ER++L K V HPF+V L +SFQT  KLY
Sbjct: 61  -----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
            +LD+INGG LF+HL R+  F E +ARFY AEI SA+ +LH   IV+RDLKPENIL+DS 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175

Query: 252 GH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG 300
           GH            I+ +S +++ CGT EY+APE+L  + +++  DWW +G +LYEML G
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

Query: 301 QPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
            PPF   N  ++   I+N+ ++L P +T+ A  LL+GLL KD +KRLG+       IK H
Sbjct: 236 LPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA-KDDFMEIKSH 294

Query: 361 KWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP---------- 410
            +F  INW  L  +++ P F P+VSG + + +FD  +T  P  ++    P          
Sbjct: 295 VFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVK 354

Query: 411 TAGEHFKGYTYVAPN 425
            A E F G++Y  P 
Sbjct: 355 EAAEAFLGFSYAPPT 369

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  497 bits (1282), Expect = e-177
 Identities = 144/324 (44%), Positives = 200/324 (61%), Gaps = 14/324 (4%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
            ++         E   K  P  FE+ +V+GQG+FGKVF VKK      D+  +YAMKV++
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLK 61

Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
           K T+  ++ V   K ERDIL +V HPFIV+L Y+FQT  KLYLILDF+ GG LF  L ++
Sbjct: 62  KATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDES 258
            +F E+  +FY AE+  A+ HLH  GI++RDLKPENIL+D +GH            ID  
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
            ++ S CGT EYMAPE++  +GH + ADWWS G+L++EMLTG  PF   +R++    I+ 
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

Query: 319 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 378
            K+ +P FL+ EA SLL+ L  ++P+ RLG+GP GV+ IK H +F +I+W  L  RE+ P
Sbjct: 241 AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHP 300

Query: 379 KFKPDVSGKDCIANFDKCWTTMPA 402
            FKP     +    FD  +T    
Sbjct: 301 PFKPATGRPEDTFYFDPEFTAKTP 324

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  496 bits (1280), Expect = e-177
 Identities = 122/339 (35%), Positives = 194/339 (57%), Gaps = 22/339 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+++KD +I+ + V+  
Sbjct: 13  NRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECT 67

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+ + G F+E  A FY 
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AEI   +  L   GI++RDLK +N+++DS+GH            I +   + + CGT +Y
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 187

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           +APEI+  + + K  DWW+ G+LLYEML GQ PF   +  +L Q I+   V  P  ++ E
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A ++ KGL+ K P KRLG GP G   IK H +FR I+W+ LE +E+QP +KP   G++  
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRN-A 306

Query: 391 ANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 425
            NFD+ +T  P   +P             F+G+++V   
Sbjct: 307 ENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 345

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  494 bits (1275), Expect = e-176
 Identities = 125/340 (36%), Positives = 199/340 (58%), Gaps = 27/340 (7%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

Query: 395 KCWTTMPADDSPAPTP-----------TAGEHFKGYTYVA 423
             +T      +P                  E F+ + Y+A
Sbjct: 296 DEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  494 bits (1275), Expect = e-176
 Identities = 124/351 (35%), Positives = 199/351 (56%), Gaps = 22/351 (6%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
             +    +   S  ++G  +FE  RV+G+G+FGKV   + K     ++  +YA+KV++KD
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKD 59

Query: 152 TIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            I++ + V+    E+ IL+    HPF+ QL   FQT  +L+ +++F+NGG L FH+ +  
Sbjct: 60  VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR 119

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESS 259
            F E +ARFY AEI+SA+  LH  GI++RDLK +N+L+D +GH            I    
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
            + + CGT +Y+APEIL    +    DWW++G+LLYEML G  PF   N   L + I+N+
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQP 378
           +V  P +L  +A  +LK  + K+P+ RLGS   GG  AI  H +F+ I+W  L  R+++P
Sbjct: 240 EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP 299

Query: 379 KFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 425
            F+P +  ++ ++NFD  +       +P           + F+ + YV+P 
Sbjct: 300 PFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPE 350

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  488 bits (1259), Expect = e-173
 Identities = 125/388 (32%), Positives = 221/388 (56%), Gaps = 32/388 (8%)

Query: 65  HNRSHSFVGPSP-RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           H+  H +  P+        ++   I+E +   +     ++   +G  DF++ RV+G+G++
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY 182
            KV  V+ K      +D IYAM+V++K+ +     +D+++ E+ +  + + HPF+V L  
Sbjct: 66  AKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120

Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
            FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+AEI  A+++LH+ GI++RDLK
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180

Query: 243 PENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 291
            +N+L+DS+GH            +     +++ CGT  Y+APEIL  + +    DWW++G
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240

Query: 292 ILLYEMLTGQPPFTHA---------NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           +L++EM+ G+ PF                L Q I+ +++++P  L+ +A S+LK  L+KD
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD 300

Query: 343 PSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMP 401
           P +RLG  P  G   I+ H +FR+++W  +E +++ P FKP++SG+  + NFD  +T  P
Sbjct: 301 PKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEP 360

Query: 402 ADDSPAPTP----TAGEHFKGYTYVAPN 425
              +P             F+G+ Y+ P 
Sbjct: 361 VQLTPDDDDIVRKIDQSEFEGFEYINPL 388

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  484 bits (1249), Expect = e-172
 Identities = 111/324 (34%), Positives = 190/324 (58%), Gaps = 19/324 (5%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K    DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   E
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           R +L+ VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+ 
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEI 275
            A+ +LH   I++RDLKPENIL+D +GH           + +   + ++CGT +Y+APE+
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV 174

Query: 276 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL 335
           + +K +NK  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234

Query: 336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFD 394
             L+ +D S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + FD
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD 294

Query: 395 KCWTTMPADDSPAPTPTAGEHFKG 418
           K +     +          + F+ 
Sbjct: 295 K-YPEEDINYGVQGEDPYADLFRD 317

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  485 bits (1252), Expect = e-172
 Identities = 121/348 (34%), Positives = 207/348 (59%), Gaps = 31/348 (8%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +G  DF++ RV+G+G++ KV  V+ K      +D IYAMKV++K+ +     +D++
Sbjct: 2   AMDPLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWV 56

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           + E+ +  + + HPF+V L   FQT S+L+ +++++NGG L FH+ RQ    E+ ARFY+
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AEI  A+++LH+ GI++RDLK +N+L+DS+GH            +     +++ CGT  Y
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------NRQKLQQRIINEKV 321
           +APEIL  + +    DWW++G+L++EM+ G+ PF                L Q I+ +++
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKF 380
           ++P  L+ +A S+LK  L+KDP +RLG  P  G   I+ H +FR+++W  +E +++ P F
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 296

Query: 381 KPDVSGKDCIANFDKCWTTMPADDSPAPTP----TAGEHFKGYTYVAP 424
           KP++SG+  + NFD  +T  P   +P             F+G+ Y+ P
Sbjct: 297 KPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  468 bits (1207), Expect = e-165
 Identities = 136/327 (41%), Positives = 201/327 (61%), Gaps = 22/327 (6%)

Query: 87  QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           Q+  ++HE           K+G  +FE+ +V+G GA+GKVF V+K      D+  +YAMK
Sbjct: 31  QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMK 88

Query: 147 VMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
           V++K TI+ K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF 
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------- 253
           HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GH           
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208

Query: 254 -EIDESSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFT----H 306
              DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT     
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268

Query: 307 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
            ++ ++ +RI+  +   P  +++ A  L++ LL KDP KRLG GP   D IK H +F+ I
Sbjct: 269 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

Query: 367 NWKTLEAREMQPKFKPDVSGKDCIANF 393
           NW  L A+++   FKP +  +  ++NF
Sbjct: 329 NWDDLAAKKVPAPFKPVIRDELDVSNF 355

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  466 bits (1201), Expect = e-165
 Identities = 119/357 (33%), Positives = 196/357 (54%), Gaps = 20/357 (5%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
              + + +   S+   + + + +   + E  S+       F+  + +G G+FG+V  VK 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 132 KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191
           K     +S   YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY
Sbjct: 63  K-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
           ++++++ GG +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

Query: 252 GH----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
           G+           +    R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G 
Sbjct: 178 GYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

Query: 302 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
           PPF      ++ ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HK
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 362 WFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKG 418
           WF + +W  +  R+++  F P   G    +NFD  +       S       G+ F  
Sbjct: 296 WFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVS--INEKCGKEFTE 349

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  477 bits (1228), Expect = e-164
 Identities = 129/414 (31%), Positives = 210/414 (50%), Gaps = 23/414 (5%)

Query: 29  SPDFDFTEVFGPLTPCRHNNQSPASTSA-SLGDPQVIHNRSHSFVGPSPRYALSSSLPLQ 87
           S  F  +E+            S       ++  P      +        R  +       
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318

Query: 88  IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
            ++  +         +  ++   DF    V+G+G+FGKV   ++K      +D +YA+K+
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKI 373

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
           ++KD +I+ + V+    E+ +L      PF+ QL   FQT  +LY +++++NGG L +H+
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EI 255
            + G F+E  A FY AEI   +  L   GI++RDLK +N+++DS+GH            I
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493

Query: 256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR 315
            +   + + CGT +Y+APEI+  + + K  DWW+ G+LLYEML GQ PF   +  +L Q 
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553

Query: 316 IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 375
           I+   V  P  ++ EA ++ KGL+ K P KRLG GP G   IK H +FR I+W+ LE +E
Sbjct: 554 IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613

Query: 376 MQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTAGEHFKGYTYVAPN 425
           +QP +KP  SG++   NFD+ +T  P   +P             F+G+++V   
Sbjct: 614 IQPPYKPKASGRN-AENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 666

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  458 bits (1180), Expect = e-162
 Identities = 116/339 (34%), Positives = 185/339 (54%), Gaps = 25/339 (7%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + K+   DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECT 64

Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             E+ +L+    HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
           AEI+  +  LH  GIV+RDLK +NIL+D DGH            +   +++N+ CGT +Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSE 330
           +APEILL + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  E
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCI 390
           A  LL  L  ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      
Sbjct: 245 AKDLLVKLFVREPEKRLGVRG----DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 300

Query: 391 ANFDKCWTTMPADDSPAPTP----TAGEHFKGYTYVAPN 425
           +NFDK +       S A            F+ ++++ P 
Sbjct: 301 SNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPG 339

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  459 bits (1183), Expect = e-160
 Identities = 122/322 (37%), Positives = 192/322 (59%), Gaps = 17/322 (5%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
                E      A+ + ++   +FE  +++G+G FGKV  VK+K      +   YAMK++
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKIL 181

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
           +K+ I+ K+ V +   E  +L    HPF+  L+YSFQT  +L  ++++ NGG LFFHL R
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 209 QGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH-----------EID 256
           + +F ED+ARFY AEIVSA+ +LH +  +V+RDLK EN+++D DGH            I 
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301

Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI 316
           + +   + CGT EY+APE+L    + +  DWW +G+++YEM+ G+ PF + + +KL + I
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

Query: 317 INEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM 376
           + E+++ P  L  EA SLL GLL KDP +RLG G      I  H++F  I W+ +  +++
Sbjct: 362 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421

Query: 377 QPKFKPDVSGKDCIANFDKCWT 398
            P FKP V+ +     FD+ +T
Sbjct: 422 SPPFKPQVTSETDTRYFDEEFT 443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  457 bits (1178), Expect = e-160
 Identities = 115/351 (32%), Positives = 184/351 (52%), Gaps = 32/351 (9%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   D+E+ +V+G+GAFG+V  V+ K      +  +YAMK++ K  +IK++   + 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERDI+     P++VQL Y+FQ    LY++++++ GG L   +       E  ARFYTA
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA 175

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEY 270
           E+V A+  +H  G +HRD+KP+N+L+D  GH              +   R ++  GT +Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235

Query: 271 MAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-- 324
           ++PE+L S+G    + ++ DWWSVG+ LYEML G  PF   +      +I+N K  L   
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295

Query: 325 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
               ++ EA +L+   L  D   RLG    GV+ IK H +F++  W     R+      P
Sbjct: 296 DDNDISKEAKNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352

Query: 383 DVSGKDCIANFDKCWTTMPADDS-PAPTPTAGEH--FKGYTYVAPNPWLSS 430
           D+S     +NFD        +++ P P    G    F G+TY +   +LSS
Sbjct: 353 DLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSS 403

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  463 bits (1194), Expect = e-160
 Identities = 125/436 (28%), Positives = 197/436 (45%), Gaps = 39/436 (8%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
              + LT    S + PD         +T C    +            ++ H   +  V P
Sbjct: 100 ACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE--YLSVAP 157

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
              Y  S      +Q    E          + +    F  +RV+G+G FG+V   + +  
Sbjct: 158 FADYLDSIYFNRFLQWKWLER---------QPVTKNTFRQYRVLGKGGFGEVCACQVR-- 206

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194
               +  +YA K + K  I K+        E+ IL KV   F+V L Y+++T+  L L+L
Sbjct: 207 ---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263

Query: 195 DFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
             +NGG L FH+Y  G   F E +A FY AEI   +  LH+  IV+RDLKPENIL+D  G
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323

Query: 253 H----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP 302
           H           + E        GT  YMAPE++ ++ +    DWW++G LLYEM+ GQ 
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

Query: 303 PFTHANRQ----KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 358
           PF    ++    ++++ +     +     + +A SL   LL KDP++RLG   G    +K
Sbjct: 384 PFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443

Query: 359 HHKWFRSINWKTLEAREMQPKFKPDVSGKDC--IANFDKCWTTMPADDSPAPTPTAGEHF 416
            H  F+ +N+K L A  ++P FKPD     C  + + ++  T           PT  + +
Sbjct: 444 EHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKG----VELEPTDQDFY 499

Query: 417 KGYTYVA-PNPWLSSV 431
           + +   + P PW + +
Sbjct: 500 QKFATGSVPIPWQNEM 515

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  464 bits (1196), Expect = e-159
 Identities = 110/352 (31%), Positives = 174/352 (49%), Gaps = 33/352 (9%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           E    +   DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETL 235

Query: 162 MKAERDILTKV---THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ER +L+ V     PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   R
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTT 268
           FY AEI+  + H+H   +V+RDLKP NIL+D  GH          +  +  + ++  GT 
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTH 354

Query: 269 EYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLP 324
            YMAPE+L     ++  ADW+S+G +L+++L G  PF       + ++ +  +   V+LP
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

Query: 325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV 384
              + E  SLL+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P  
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474

Query: 385 SGKDC-----IANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV 431
              +      I +FD+  T               E ++ +       W   V
Sbjct: 475 GEVNAADAFDIGSFDEEDTKGIKLLDS-----DQELYRNFPLTISERWQQEV 521

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  449 bits (1158), Expect = e-157
 Identities = 118/364 (32%), Positives = 174/364 (47%), Gaps = 45/364 (12%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            E ++   DFEI +V+G+GAF +V  VK K      +  +YAMK+M K  ++K+  V   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYT 221
           + ERD+L      +I QL ++FQ  + LYL++++  GG L   L + G     + ARFY 
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTE 269
           AEIV A+  +H+ G VHRD+KP+NIL+D  GH              D + RS    GT +
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228

Query: 270 YMAPEILLSKG-------HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 322
           Y++PEIL + G       +  + DWW++G+  YEM  GQ PF   +  +   +I++ K  
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288

Query: 323 LP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 377
           L        +  EA   ++ LL   P  RLG   GG    + H +F  ++W  L  R+  
Sbjct: 289 LSLPLVDEGVPEEARDFIQRLL-CPPETRLGR--GGAGDFRTHPFFFGLDWDGL--RDSV 343

Query: 378 PKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAG----------EHFKGYTYVAPNPW 427
           P F PD  G     NFD     + A  S      +             F GY+Y      
Sbjct: 344 PPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALR 403

Query: 428 LSSV 431
            S V
Sbjct: 404 DSEV 407

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  453 bits (1168), Expect = e-157
 Identities = 111/343 (32%), Positives = 175/343 (51%), Gaps = 27/343 (7%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           + +G   F  FRV+G+G FG+VF  + K      +  +YA K + K  + K+        
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFY 220
           E+ IL KV   FIV L Y+F+T++ L L++  +NGG + +H+Y        F+E +A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTE 269
           TA+IVS + HLH+  I++RDLKPEN+L+D DG+                +++    GT  
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPP 325
           +MAPE+LL + ++   D++++G+ LYEM+  + PF         ++L+QR++ + V  P 
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414

Query: 326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 385
             +  +    + LL KDP KRLG   G  D ++ H  FR I+W+ LEA  + P F PD  
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474

Query: 386 GKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAP-NPW 427
                   D    +       A      E F+ +       PW
Sbjct: 475 TVYAKNIQDVGAFS--TVKGVAFEKADTEFFQEFASGTCPIPW 515

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  444 bits (1144), Expect = e-157
 Identities = 106/293 (36%), Positives = 164/293 (55%), Gaps = 20/293 (6%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYV 77

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTA
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTE 269
           EIVSA+ +LH  GI+HRDLKPENIL++ D H                + +R+NS  GT +
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 329
           Y++PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 257

Query: 330 EAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
           +A  L++ LL  D +KRLG     G   +K H +F S+ W+ L  +   PK  
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT-PPKLT 309

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  446 bits (1149), Expect = e-156
 Identities = 97/321 (30%), Positives = 164/321 (51%), Gaps = 27/321 (8%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
           +    +    FEI R +G+G+FGKV  V+K      D+  +YAMK M K   +++N V  
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRN 61

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
           +  E  I+  + HPF+V L YSFQ    +++++D + GG L +HL +   F+E+  + + 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYM 271
            E+V A+ +L    I+HRD+KP+NIL+D  GH           +   ++  +M GT  YM
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 272 APEILLSK---GHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPP 325
           APE+  S+   G++   DWWS+G+  YE+L G+ P+   +  + +++        V  P 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241

Query: 326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 385
             + E  SLLK LL  +P +R       +  +++  +   INW  +  + + P F P+  
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRF----SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297

Query: 386 GKDCIANFDKCWTTMPADDSP 406
             +C   F+     M  +  P
Sbjct: 298 RLNCDPTFE--LEEMILESKP 316

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  441 bits (1137), Expect = e-154
 Identities = 112/351 (31%), Positives = 181/351 (51%), Gaps = 38/351 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            + ++   DFEI +V+G+GAFG+V  VK K     ++D ++AMK++ K  ++K+      
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACF 121

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
           + ERD+L      +I  L Y+FQ  + LYL++D+  GG L   L + +    E+ ARFY 
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTE 269
           AE+V A+  +H+   VHRD+KP+NILMD +GH              D + +S+   GT +
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 270 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
           Y++PEIL +       +  + DWWS+G+ +YEML G+ PF   +  +   +I+N K +  
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

Query: 325 -----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK 379
                  ++  A  L++ L+      RLG    G++  K H +F  I+W  +  R  +  
Sbjct: 302 FPTQVTDVSENAKDLIRRLI-CSREHRLGQ--NGIEDFKKHPFFSGIDWDNI--RNCEAP 356

Query: 380 FKPDVSGKDCIANFDK---CWTTMPADDSPAPTPTAGEH--FKGYTYVAPN 425
           + P+VS     +NFD    C         P  T  +G H  F G+TY +  
Sbjct: 357 YIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSC 407

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  321 bits (825), Expect = e-109
 Identities = 90/298 (30%), Positives = 149/298 (50%), Gaps = 25/298 (8%)

Query: 99  LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
           L    +RK    DF+I R +G+G FG V+  ++K      +  I A+KV+ K  + K+  
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGV 57

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
              ++ E +I + + HP I+++   F  R ++YL+L+F   G L+  L + G F E ++ 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------EIDESSRSNSMCGTTE 269
            +  E+  A+ + H+  ++HRD+KPEN+LM   G              S R  +MCGT +
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD 177

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 329
           Y+ PE++  K H++  D W  G+L YE L G PPF   +  +  +RI+N  +K PPFL+ 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGK 387
            +  L+  LL   P +RL      +  +  H W +        +R + P        K
Sbjct: 238 GSKDLISKLLRYHPPQRL-----PLKGVMEHPWVK------ANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  312 bits (802), Expect = e-105
 Identities = 87/281 (30%), Positives = 145/281 (51%), Gaps = 19/281 (6%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           +R+    DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLR 57

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
            E +I + + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH---------EIDESSRSNSMCGTTEYMAPE 274
           + +A+S+ H   ++HRD+KPEN+L+ S G              SSR   +CGT +Y+ PE
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 177

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           ++  + H++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 375
           +  LL  +PS+R       +  +  H W  + + K    + 
Sbjct: 238 ISRLLKHNPSQRP-----MLREVLEHPWITANSSKPSNCQN 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  268 bits (686), Expect = 2e-87
 Identities = 77/332 (23%), Positives = 127/332 (38%), Gaps = 38/332 (11%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +         S     PR      +  + +  E       +     
Sbjct: 3   HHHHHSSGVDLGTENLYF-----QSMHQLQPR-----RVSFRGEASETLQSPGYDPSRPE 52

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 F+    +G G++G+VF+V+ K  +DG    +YA+K         K+    +  E
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSK--EDGR---LYAVKRSMSPFRGPKDRARKLA-E 106

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
                KV  HP  V+L  +++    LYL  +   G  L  H    G    E Q   Y  +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRD 165

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
            + A++HLH  G+VH D+KP NI +   G           E+  +       G   YMAP
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINEKVKLPPFLTSEAH 332
           E+ L   +   AD +S+G+ + E+      P      Q+L+Q  +    +    L+SE  
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--PPEFTAGLSSELR 282

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           S+L  +L  DP  R        +A+      R
Sbjct: 283 SVLVMMLEPDPKLRA-----TAEALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  266 bits (683), Expect = 1e-86
 Identities = 72/336 (21%), Positives = 127/336 (37%), Gaps = 68/336 (20%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----- 156
             E+     D+ I R + QG F K+   +K           YA+K   K  + KK     
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-------KFYALKKYEKSLLEKKRDFTK 75

Query: 157 ---------NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
                    +  D  K E  I+T + + + +          ++Y+I +++    +     
Sbjct: 76  SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135

Query: 208 RQGI--------FREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH----- 253
              +              +     ++++ S++H +  I HRD+KP NILMD +G      
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195

Query: 254 ----EIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTH- 306
               E     +     GT E+M PE   ++   +    D WS+GI LY M     PF+  
Sbjct: 196 FGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255

Query: 307 ANRQKLQQRIINEKVKLP-------------------PFLTSEAHSLLKGLLHKDPSKRL 347
            +  +L   I  + ++ P                    FL++E    LK  L K+P++R+
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315

Query: 348 GSGPGGVDAIKHHKWFRSINWKTLE--AREMQPKFK 381
                  +    H+W    N + L   ++E+  K K
Sbjct: 316 -----TSEDALKHEWLADTNIEDLREFSKELYKKRK 346

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  252 bits (646), Expect = 7e-82
 Identities = 69/267 (25%), Positives = 135/267 (50%), Gaps = 22/267 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            DF++  ++G+G+F  V++ +        +    A+K++ K  + K   V  ++ E  I 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAV 228
            ++ HP I++L   F+  + +YL+L+  + G +  +L  R   F E++AR +  +I++ +
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 229 SHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAPEILL 277
            +LH  GI+HRDL   N+L+  +                   +  ++CGT  Y++PEI  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG 337
              H  ++D WS+G + Y +L G+PPF     +    +++    ++P FL+ EA  L+  
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245

Query: 338 LLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           LL ++P+ RL      + ++  H +  
Sbjct: 246 LLRRNPADRL-----SLSSVLDHPFMS 267

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  246 bits (631), Expect = 5e-79
 Identities = 76/307 (24%), Positives = 144/307 (46%), Gaps = 24/307 (7%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP---GDFEIFRVVGQGAFGKVFQV 129
           GP+P     + +P              +   E  + P     +   R +G+G F K F++
Sbjct: 1   GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60

Query: 130 KKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
                 D D+  ++A K++ K  ++K +  + M  E  I   + H  +V     F+    
Sbjct: 61  S-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
           ++++L+      L     R+    E +AR+Y  +IV    +LH+  ++HRDLK  N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 250 SDGH----------EID-ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEML 298
            D            +++ +  R   +CGT  Y+APE+L  KGH+ + D WS+G ++Y +L
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235

Query: 299 TGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 358
            G+PPF  +  ++   RI   +  +P  +   A SL++ +L  DP+ R       ++ + 
Sbjct: 236 VGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP-----TINELL 290

Query: 359 HHKWFRS 365
           + ++F S
Sbjct: 291 NDEFFTS 297

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  245 bits (627), Expect = 8e-79
 Identities = 73/291 (25%), Positives = 140/291 (48%), Gaps = 26/291 (8%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +   R +G+G F K F++      D D+  ++A K++ K  ++K +  + M  E  I 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V     F+    ++++L+      L     R+    E +AR+Y  +IV    
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 230 HLHKCGIVHRDLKPENILMDSDGH----------EID-ESSRSNSMCGTTEYMAPEILLS 278
           +LH+  ++HRDLK  N+ ++ D            +++ +  R   +CGT  Y+APE+L  
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           KGH+ + D WS+G ++Y +L G+PPF  +  ++   RI   +  +P  +   A SL++ +
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWK----TLEAREMQPKFKPDVS 385
           L  DP+ R       ++ + + ++F S  +      +    + P+F    S
Sbjct: 250 LQTDPTARP-----TINELLNDEFFTS-GYIPARLPITCLTIPPRFSIAPS 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  230 bits (589), Expect = 4e-73
 Identities = 69/306 (22%), Positives = 131/306 (42%), Gaps = 62/306 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           DFE   V+GQGAFG+V + +         D   YA+K +R      +  +  + +E  +L
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNA------LDSRYYAIKKIRH----TEEKLSTILSEVMLL 56

Query: 170 TKVTHPFIVQLRYSFQ-------------TRSKLYLILDFINGGHLFFHLYRQGIF-RED 215
             + H ++V+   ++               +S L++ +++   G L+  ++ + +  + D
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------------------- 253
           +      +I+ A+S++H  GI+HRDLKP NI +D   +                      
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 254 ---EIDESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANR 309
                  S    S  GT  Y+A E+L   GH N+  D +S+GI+ +EM+   P  T   R
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234

Query: 310 QKLQQRIINEKVKLPPFL----TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
             + +++ +  ++ PP            +++ L+  DP+KR      G   + +  W   
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPV 289

Query: 366 INWKTL 371
            +   +
Sbjct: 290 KHQDEV 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  224 bits (574), Expect = 3e-70
 Identities = 80/314 (25%), Positives = 142/314 (45%), Gaps = 27/314 (8%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKV 147
               H +  +L  E+        +   + +G+G+FGK   VK         DG  Y +K 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST------EDGRQYVIKE 56

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           +    +  K   +  + E  +L  + HP IVQ R SF+    LY+++D+  GG LF  + 
Sbjct: 57  INISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115

Query: 208 RQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EI 255
            Q   +F+EDQ   +  +I  A+ H+H   I+HRD+K +NI +  DG            +
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 256 DES-SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ 314
           + +   + +  GT  Y++PEI  +K +N  +D W++G +LYE+ T +  F   + + L  
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

Query: 315 RIINEKVK-LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 373
           +II+     +    + +  SL+  L  ++P  R       V++I    +      K L  
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP-----SVNSILEKGFIAKRIEKFLSP 290

Query: 374 REMQPKFKPDVSGK 387
           + +  +F      K
Sbjct: 291 QLIAEEFCLKTFSK 304

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  219 bits (560), Expect = 1e-68
 Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 41/287 (14%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 76

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYM 271
           ++ AV  +H+ GIVH DLKP N L+                     S   +S  GT  YM
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 272 APEILLSKG-----------HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN- 318
            PE +                +  +D WS+G +LY M  G+ PF    N+      II+ 
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255

Query: 319 -EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
             +++ P     +   +LK  L +DP +R+      +  +  H + +
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 297

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  220 bits (562), Expect = 2e-68
 Identities = 42/306 (13%), Positives = 110/306 (35%), Gaps = 49/306 (16%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN 157
            ++ ++E ++G     +  ++G+GAF +V++  +  ++D  +   + +KV +     +  
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-----YRQGIF 212
                    + L        ++   +   ++   L+ +  + G L   +       + + 
Sbjct: 113 I---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN---------- 262
            +     +   ++  +  +H C I+H D+KP+N ++ +   E D+    +          
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 263 --------------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
                         + C T+ +   E+L +K  N   D++ V   +Y ML G        
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

Query: 309 RQKLQQR--------------IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 354
             + +                  +  + +P      +  LL+  L K   +   +    +
Sbjct: 290 GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN---KI 346

Query: 355 DAIKHH 360
            A+++ 
Sbjct: 347 RALRNR 352

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  218 bits (558), Expect = 2e-68
 Identities = 69/317 (21%), Positives = 116/317 (36%), Gaps = 68/317 (21%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILM--DSDGH------------EIDESSRSNS 263
                ++V  ++HL + GIVHR++KP NI+     DG             E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 264 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQK 311
           + GT EY+ P++           K +    D WS+G+  Y   TG  PF         ++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 312 LQQRIINEKV-------------------------KLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  +II  K                           L   L      +L  +L  D  K 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 347 LGSGPGGVDAIKHHKWF 363
                 G D        
Sbjct: 295 W-----GFDQFFAETSD 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  221 bits (564), Expect = 3e-68
 Identities = 66/302 (21%), Positives = 113/302 (37%), Gaps = 63/302 (20%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             +      + +  ++GQGA   VF+ + K      +  ++A+KV    + ++   VD  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54

Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
             E ++L K+ H  IV+L       T     LI++F   G L+  L          E + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------------EIDESSRSNS 263
                ++V  ++HL + GIVHR++KP NI+                    E+++  +  S
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 264 MCGTTEYMAPEIL--------LSKGHNKDADWWSVGILLYEMLTGQPPF----THANRQK 311
           + GT EY+ P++           K +    D WS+G+  Y   TG  PF         ++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 312 LQQRIINEKV-------------------------KLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  +II  K                           L   L      +L  +L  D  K 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 347 LG 348
            G
Sbjct: 295 WG 296

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  218 bits (556), Expect = 1e-67
 Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 41/287 (14%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +    + I + +G G   KVFQV  +         IYA+K +  +    +    Y   E
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 57

Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
              L K+      I++L     T   +Y++++      L   L ++      + + Y   
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 116

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYM 271
           ++ AV  +H+ GIVH DLKP N L+                     S   +S  GT  YM
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 272 APEILLSKGHNKD-----------ADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN- 318
            PE +     +++           +D WS+G +LY M  G+ PF    N+      II+ 
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 319 -EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
             +++ P     +   +LK  L +DP +R+      +  +  H + +
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 278

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  219 bits (561), Expect = 8e-67
 Identities = 79/303 (26%), Positives = 143/303 (47%), Gaps = 33/303 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  RV+G+G+FG+V   K K      +    A+KV+ K  + +K   + +  E  +L 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ HP I++L   F+ +   YL+ +   GG LF  +  +  F E  A     +++S +++
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 231 LHKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILL 277
           +HK  IVHRDLKPEN+L++S   +              + S +     GT  Y+APE+ L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-L 200

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 333
              +++  D WS G++LY +L+G PPF  AN   + +++   K          ++  A  
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           L++ +L   PS R+ +     DA+  H+W ++         ++        +    I  F
Sbjct: 261 LIRKMLTYVPSMRISA----RDALD-HEWIQTYT-----KEQISVDVPSLDNAILNIRQF 310

Query: 394 DKC 396
              
Sbjct: 311 QGT 313

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  219 bits (560), Expect = 1e-66
 Identities = 76/303 (25%), Positives = 144/303 (47%), Gaps = 30/303 (9%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +        +       + I  ++G+G+FG+V + K +      +   YA+KV+ K 
Sbjct: 5   HHHSSGRENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKA 58

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
           +   K+    +  E ++L K+ HP I++L    +  S  Y++ +   GG LF  + ++  
Sbjct: 59  SAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------------IDES 258
           F E  A     ++ S ++++HK  IVHRDLKPENIL++S   +               ++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN 318
           ++     GT  Y+APE+ L   +++  D WS G++LY +L+G PPF   N   + +R+  
Sbjct: 178 TKMKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236

Query: 319 EKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR 374
            K          ++ +A  L++ +L   PS R+ +       ++ H W +  + +T    
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQKYSSETPTIS 291

Query: 375 EMQ 377
           ++ 
Sbjct: 292 DLP 294

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  212 bits (541), Expect = 3e-66
 Identities = 82/276 (29%), Positives = 139/276 (50%), Gaps = 23/276 (8%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G        + A+K++ +  I   + V
Sbjct: 3   KHDGRVKIGH--YVLGDTLGVGTFGKV----KIGEHQLTGHKV-AVKILNRQKIRSLDVV 55

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             +K E   L    HP I++L     T +  ++++++++GG LF ++ + G   E +AR 
Sbjct: 56  GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTE 269
              +I+SAV + H+  +VHRDLKPEN+L+D+  + +I +   SN M         CG+  
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175

Query: 270 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 328
           Y APE++  +     + D WS G++LY +L G  PF   +   L ++I      +P +L 
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

Query: 329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
               +LL  +L  DP KR       +  I+ H+WF+
Sbjct: 236 RSVATLLMHMLQVDPLKRA-----TIKDIREHEWFK 266

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  215 bits (550), Expect = 3e-66
 Identities = 73/338 (21%), Positives = 127/338 (37%), Gaps = 51/338 (15%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERK----------IGPGDFEI 114
           H+  H   G  PR +          E +H +  +L  + + K          +    + I
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
            + +G G   KVFQV  +         IYA+K +  +    +    Y   E   L K+  
Sbjct: 61  LKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQ 113

Query: 175 P--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
               I++L     T   +Y++++      L   L ++      + + Y   ++ AV  +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 233 KCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           + GIVH DLKP N L+                     S   +S  G   YM PE +    
Sbjct: 173 QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 281 -----------HNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIIN--EKVKLPPF 326
                       +  +D WS+G +LY M  G+ PF    N+      II+   +++ P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
              +   +LK  L +DP +R+      +  +  H + +
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 325

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  211 bits (540), Expect = 5e-66
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 28/271 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +++   +G+GAF  V +   K      +   +A K++    +  ++    ++ E  I  K
Sbjct: 8   YDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQK-LEREARICRK 61

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP IV+L  S Q  S  YL+ D + GG LF  +  +  + E  A     +I+ ++++ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 232 HKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGTTEYMAPEILLS 278
           H  GIVHR+LKPEN+L+ S                E+++S   +   GT  Y++PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 334
             ++K  D W+ G++LY +L G PPF   ++ +L  +I       P      +T EA SL
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           +  +L  +P KR+ +      A+K   W  +
Sbjct: 242 IDSMLTVNPKKRITA----DQALK-VPWICN 267

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  213 bits (544), Expect = 1e-65
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 37/310 (11%)

Query: 73  GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
           GP            +  E       +             +++   +G+GAF  V +   K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDN---------YDVKEELGKGAFSVVRRCVHK 51

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
                 +   +A K++    +  ++    ++ E  I  K+ HP IV+L  S Q  S  YL
Sbjct: 52  -----TTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYL 105

Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           + D + GG LF  +  +  + E  A     +I+ ++++ H  GIVHR+LKPEN+L+ S  
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165

Query: 253 -------------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT 299
                         E+++S   +   GT  Y++PE+L    ++K  D W+ G++LY +L 
Sbjct: 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 300 GQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVD 355
           G PPF   ++ +L  +I       P      +T EA SL+  +L  +P KR+ +      
Sbjct: 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA----DQ 281

Query: 356 AIKHHKWFRS 365
           A+K   W  +
Sbjct: 282 ALK-VPWICN 290

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  211 bits (539), Expect = 2e-65
 Identities = 91/303 (30%), Positives = 157/303 (51%), Gaps = 36/303 (11%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG--VDDGDSDGIYAMKVMRKDTIIKKNH 158
           A+ +  IG   + + + +G+G F KV    K    +  G      A+K++ K    + N 
Sbjct: 8   ADEQPHIGN--YRLLKTIGKGNFAKV----KLARHILTGRE---VAIKIIDKT---QLNP 55

Query: 159 VDYMKAER--DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ 216
               K  R   I+  + HP IV+L    +T   LYLI+++ +GG +F +L   G  +E +
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CG 266
           AR    +IVSAV + H+  IVHRDLK EN+L+D+D + +I +   SN           CG
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175

Query: 267 TTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
              Y APE+   K ++  + D WS+G++LY +++G  PF   N ++L++R++  K ++P 
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 235

Query: 326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 385
           +++++  +LLK  L  +P KR       ++ I   +W         E  E++P  +P++ 
Sbjct: 236 YMSTDCENLLKRFLVLNPIKRG-----TLEQIMKDRWIN----AGHEEDELKPFVEPELD 286

Query: 386 GKD 388
             D
Sbjct: 287 ISD 289

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  216 bits (551), Expect = 3e-65
 Identities = 74/284 (26%), Positives = 139/284 (48%), Gaps = 29/284 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++  + +G GA+G+V   + K      +    A+K++RK ++   ++   +  E  +L 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVSTSSNSK-LLEEVAVLK 91

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F+ +   YL+++   GG LF  +  +  F E  A     +++S V++
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 231 LHKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILL 277
           LHK  IVHRDLKPEN+L++S   +              +   +     GT  Y+APE+ L
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-L 210

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 333
            K +++  D WS+G++L+ +L G PPF     Q++ +++   K          ++  A  
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 377
           L+K +L  D  +R+ +      A++ H W + +  K     E+ 
Sbjct: 271 LIKQMLQFDSQRRISAQ----QALE-HPWIKEMCSKKESGIELP 309

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  212 bits (541), Expect = 4e-65
 Identities = 52/377 (13%), Positives = 103/377 (27%), Gaps = 70/377 (18%)

Query: 46  HNNQSPASTSASLGDP-----QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE 100
           H++ S    +     P     + + NR       +    + S+    +            
Sbjct: 4   HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFR 63

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            ESE    P       V+GQ       +   +  + G+    + + V         N + 
Sbjct: 64  VESELGERPRTLVRGTVLGQEDPYAYLEATDQ--ETGE---SFEVHVPYFTERPPSNAIK 118

Query: 161 YMKAER-------------------------DILTKVTHPFIVQLRYSFQTRSKLYLIL- 194
            MK E                          D++       ++++R   +    L     
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 195 -------DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                      G  L  H               T +++  ++ LH  G+VH  L+P +I+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238

Query: 248 MDSDGH-------EIDESSRSNSMCGTTEYMAPEILLSKG-----------HNKDADWWS 289
           +D  G         +           +  +  PE+   +                 D W+
Sbjct: 239 LDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 290 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
           +G+++Y +     P T        + I      +P        +LL+G L      RL  
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRL-- 352

Query: 350 GPGGVDAIKHHKWFRSI 366
                        +  +
Sbjct: 353 ---LPLQAMETPEYEQL 366

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  209 bits (534), Expect = 8e-65
 Identities = 76/253 (30%), Positives = 133/253 (52%), Gaps = 24/253 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            F    V+G GAF +VF VK++      +  ++A+K ++K    + + +   + E  +L 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPAFRDSSL---ENEIAVLK 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ H  IV L   +++ +  YL++  ++GG LF  +  +G++ E  A     +++SAV +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGHE------------IDESSRSNSMCGTTEYMAPEILLS 278
           LH+ GIVHRDLKPEN+L  +                ++++   ++ CGT  Y+APE+L  
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQ 181

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 334
           K ++K  D WS+G++ Y +L G PPF      KL ++I     +        ++  A   
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241

Query: 335 LKGLLHKDPSKRL 347
           +  LL KDP++R 
Sbjct: 242 ICHLLEKDPNERY 254

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  207 bits (530), Expect = 3e-64
 Identities = 75/299 (25%), Positives = 132/299 (44%), Gaps = 35/299 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-MKAERDI 168
           G + +  ++G+G++GKV     K V D ++    A+K+++K  + +  + +  +K E  +
Sbjct: 5   GKYLMGDLLGEGSYGKV-----KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59

Query: 169 LTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGH--LFFHLYRQGIFREDQARFYTAEI 224
           L ++ H  ++QL      + + K+Y+++++   G   +   +  +  F   QA  Y  ++
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH---------EIDESSRSNSM----CGTTEYM 271
           +  + +LH  GIVH+D+KP N+L+ + G          E      ++       G+  + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 272 APEILL-SKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 329
            PEI            D WS G+ LY + TG  PF   N  KL + I      +P     
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKD 388
               LLKG+L  +P+KR       +  I+ H WFR    K     E      P    KD
Sbjct: 239 PLSDLLKGMLEYEPAKRF-----SIRQIRQHSWFR----KKHPPAEAPVPIPPSPDTKD 288

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  205 bits (525), Expect = 8e-64
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 31/271 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + +   +G+G++G+V    +KG     +    A K + K        VD  K E +I+  
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKY---FVEDVDRFKQEIEIMKS 62

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L  +F+  + +YL+++   GG LF  +  + +FRE  A     +++SAV++ 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 232 HKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLS 278
           HK  + HRDLKPEN L  +D  +                     +  GT  Y++P++ L 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LE 181

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 334
             +  + D WS G+++Y +L G PPF+     ++  +I       P      ++ +A SL
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           ++ LL K P +R+ S          H+WF  
Sbjct: 242 IRRLLTKSPKQRITS-----LQALEHEWFEK 267

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  207 bits (528), Expect = 9e-64
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 42/276 (15%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
           + +G+G+F    +   K      S+  +A+K      II K      + E   L     H
Sbjct: 17  KPLGEGSFSICRKCVHK-----KSNQAFAVK------IISKRMEANTQKEITALKLCEGH 65

Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
           P IV+L   F  +   +L+++ +NGG LF  + ++  F E +A +   ++VSAVSH+H  
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 235 GIVHRDLKPENILMDSDGHE-----ID---------ESSRSNSMCGTTEYMAPEILLSKG 280
           G+VHRDLKPEN+L   +        ID         ++    + C T  Y APE+L   G
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQ-------KLQQRIINEKVKLP----PFLTS 329
           +++  D WS+G++LY ML+GQ PF   +R        ++ ++I              ++ 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           EA  L++GLL  DP+KRL      +  +++++W + 
Sbjct: 246 EAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQD 276

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  205 bits (525), Expect = 1e-63
 Identities = 74/270 (27%), Positives = 136/270 (50%), Gaps = 29/270 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I  ++G+G+FG+V + K +      +   YA+KV+ K +   K+    +  E ++L K
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLKK 77

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP I++L    +  S  Y++ +   GG LF  + ++  F E  A     ++ S ++++
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 232 HKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILLS 278
           HK  IVHRDLKPENIL++S   +               ++++     GT  Y+APE+ L 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LR 196

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 334
             +++  D WS G++LY +L+G PPF   N   + +R+   K          ++ +A  L
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           ++ +L   PS R+ +       ++ H W +
Sbjct: 257 IRKMLTFHPSLRITA----TQCLE-HPWIQ 281

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  205 bits (523), Expect = 1e-63
 Identities = 62/260 (23%), Positives = 125/260 (48%), Gaps = 31/260 (11%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+E+   +G G++G+  ++++K      SDG I   K +   ++ +      + +E ++L
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAE-KQMLVSEVNLL 59

Query: 170 TKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE 223
            ++ HP IV+       R+   LY+++++  GG L   + +         E+       +
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHE--ID---------ESSRSNSMCGT 267
           +  A+   H+       ++HRDLKP N+ +D   +    D         ++S + +  GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF 326
             YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K  ++P  
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239

Query: 327 LTSEAHSLLKGLLHKDPSKR 346
            + E + ++  +L+     R
Sbjct: 240 YSDELNEIITRMLNLKDYHR 259

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  206 bits (527), Expect = 2e-63
 Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 75/319 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DI 168
            + +   +GQG++G V    +       +  I A+K+M K+ I + N  D  + +    +
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------------ 210
           + K+ HP I +L   ++    + L+++  +GGHL   L                      
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
                                 + RE        +I SA+ +LH  GI HRD+KPEN L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 249 DSDG-----------------HEIDESSRSNSMCGTTEYMAPEIL--LSKGHNKDADWWS 289
            ++                      E     +  GT  ++APE+L   ++ +    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 290 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSK 345
            G+LL+ +L G  PF   N      +++N+K+         L+  A  LL  LL+++  +
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321

Query: 346 RLGSGPGGVDAIKHHKWFR 364
           R             H W  
Sbjct: 322 RF-----DAMRALQHPWIS 335

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  205 bits (523), Expect = 2e-63
 Identities = 74/296 (25%), Positives = 136/296 (45%), Gaps = 40/296 (13%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           +E+   +G G F  V + ++K      +   YA K ++K  +         + ++ E +I
Sbjct: 7   YEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP I+ L   F+ ++ + LIL+ ++GG LF  L  +    ED+A  +  +I+  V
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHE--------------IDESSRSNSMCGTTEYMAPE 274
            +LH   I H DLKPENI++                    I+  +   ++ GT E++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I               +  
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG 386
           A   ++ LL KDP +R+        +++ H W ++I  + +         + + SG
Sbjct: 242 AKDFIRRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNV---------RGEDSG 283

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  206 bits (526), Expect = 2e-63
 Identities = 70/287 (24%), Positives = 133/287 (46%), Gaps = 31/287 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++    +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 13  YDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHE--------------IDESSRSNSMCGTTEYMAPE 274
            +LH   I H DLKPENI++                    ID  +   ++ GT E++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    +     +         ++ 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ 377
           A   ++ LL KDP KR+       D+++ H W +  + +   +R+  
Sbjct: 248 AKDFIRRLLVKDPKKRMTI----QDSLQ-HPWIKPKDTQQALSRKAS 289

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  210 bits (537), Expect = 4e-63
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 38/284 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVD 160
            +   R +G GA+G+V   K+K           A+KV++K    K          +   +
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            +  E  +L  + HP I++L   F+ +   YL+ +F  GG LF  +  +  F E  A   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGT 267
             +I+S + +LHK  IVHRD+KPENIL+++                   +  +     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--- 324
             Y+APE+ L K +N+  D WS G+++Y +L G PPF   N Q + +++   K       
Sbjct: 212 AYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270

Query: 325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
              ++ EA  L+K +L  D +KR  +     +A+   +W +   
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAE----EALN-SRWIKKYA 309

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  206 bits (527), Expect = 4e-63
 Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 31/275 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V HP I+ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDSDG--------------HEIDESSRSNSMCGTTEYMAPE 274
           ++LH   I H DLKPENI++                  HEI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I               +  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           A   ++ LL K+  KRL       +A++ H W   
Sbjct: 249 AKDFIRKLLVKETRKRLTI----QEALR-HPWITP 278

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  209 bits (533), Expect = 4e-63
 Identities = 80/273 (29%), Positives = 128/273 (46%), Gaps = 29/273 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           ++++F  +G+GAF  V +  K       +   YA  ++    +  ++H   ++ E  I  
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLSARDHQK-LEREARICR 65

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP IV+L  S       YLI D + GG LF  +  +  + E  A     +I+ AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 231 LHKCGIVHRDLKPENILMDSDGHE-----ID---------ESSRSNSMCGTTEYMAPEIL 276
            H+ G+VHR+LKPEN+L+ S          D         E        GT  Y++PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH 332
               + K  D W+ G++LY +L G PPF   ++ +L Q+I       P      +T EA 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
            L+  +L  +PSKR+ +     +A+K H W   
Sbjct: 246 DLINKMLTINPSKRITA----AEALK-HPWISH 273

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  203 bits (519), Expect = 6e-63
 Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 33/273 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G GAFG V  V+++      S     +K + KD    +  ++ ++AE ++L  
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRS--QVPMEQIEAEIEVLKS 76

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQARFYTAEIVSA 227
           + HP I+++   F+    +Y++++   GG L         R     E        ++++A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPE 274
           +++ H   +VH+DLKPENIL                          S +  GT  YMAPE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP---FLTSEA 331
           +   +      D WS G+++Y +LTG  PFT  + +++QQ+   ++         LT +A
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255

Query: 332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
             LLK +L KDP +R          + HH+WF+
Sbjct: 256 VDLLKQMLTKDPERRP-----SAAQVLHHEWFK 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  204 bits (522), Expect = 6e-63
 Identities = 72/275 (26%), Positives = 129/275 (46%), Gaps = 31/275 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
           ++I   +G G F  V + ++K      +   YA K ++K            + ++ E  I
Sbjct: 14  YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L +V H  ++ L   ++ R+ + LIL+ ++GG LF  L ++    E++A  +  +I+  V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 229 SHLHKCGIVHRDLKPENILMDSDG--------------HEIDESSRSNSMCGTTEYMAPE 274
           ++LH   I H DLKPENI++                  HEI++     ++ GT E++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSE 330
           I+  +    +AD WS+G++ Y +L+G  PF    +Q+    I +             +  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           A   ++ LL K+  KRL       +A++ H W   
Sbjct: 249 AKDFIRKLLVKETRKRLTI----QEALR-HPWITP 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  205 bits (524), Expect = 7e-63
 Identities = 84/320 (26%), Positives = 145/320 (45%), Gaps = 42/320 (13%)

Query: 46  HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
           H++   +       +       S +        +L     +     +  +D         
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD--------- 53

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
                 FE+   +G+GA   V++ K+KG     +   YA+KV     + K      ++ E
Sbjct: 54  -----FFEVESELGRGATSIVYRCKQKG-----TQKPYALKV-----LKKTVDKKIVRTE 98

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L +++HP I++L+  F+T +++ L+L+ + GG LF  +  +G + E  A     +I+
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGTTEYMA 272
            AV++LH+ GIVHRDLKPEN+L  +                 ++      ++CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP----PFL 327
           PEIL    +  + D WSVGI+ Y +L G  PF      Q + +RI+N +          +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 328 TSEAHSLLKGLLHKDPSKRL 347
           +  A  L++ L+  DP KRL
Sbjct: 279 SLNAKDLVRKLIVLDPKKRL 298

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  205 bits (524), Expect = 8e-63
 Identities = 64/277 (23%), Positives = 132/277 (47%), Gaps = 35/277 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DIL 169
           +E+  V+G+G F  V +   +     ++   +A+K++          +     +R   I 
Sbjct: 26  YELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
             + HP IV+L  ++ +   LY++ +F++G  L F + ++     ++ E  A  Y  +I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDS--DGHEI------------DESSRSNSMCGTTEYM 271
            A+ + H   I+HRD+KP  +L+ S  +   +            +    +    GT  +M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFL 327
           APE++  + + K  D W  G++L+ +L+G  PF +  +++L + II  K K+       +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHI 259

Query: 328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           +  A  L++ +L  DP++R+       +A+  H W +
Sbjct: 260 SESAKDLVRRMLMLDPAERITVY----EALN-HPWLK 291

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  204 bits (521), Expect = 8e-63
 Identities = 70/286 (24%), Positives = 125/286 (43%), Gaps = 30/286 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F I + +G+G F +V++           DG   A+K ++   ++          E D+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEI 224
           L ++ HP +++   SF   ++L ++L+  + G L   +        +  E     Y  ++
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG-----------HEIDESSRSNSMCGTTEYMAP 273
            SA+ H+H   ++HRD+KP N+ + + G               +++ ++S+ GT  YM+P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKLQQRIINEKVK-LPP-FLTS 329
           E +   G+N  +D WS+G LLYEM   Q PF     N   L ++I       LP    + 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE 375
           E   L+   ++ DP KR    P         K   +    +LE   
Sbjct: 266 ELRQLVNMCINPDPEKR----PDVTYVYDVAKRMHACTASSLEHHH 307

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  204 bits (520), Expect = 1e-62
 Identities = 85/336 (25%), Positives = 141/336 (41%), Gaps = 40/336 (11%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H   G  PR +  +            +  +L    E++     +++  ++G G FG
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCN-------DLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM---KAERDILTKVTH--PFIVQ 179
            V+   +  V D       A+K + KD I     +        E  +L KV+     +++
Sbjct: 58  SVYSGIR--VSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
           L   F+      LIL+       LF  +  +G  +E+ AR +  +++ AV H H CG++H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 239 RDLKPENILMDSDGHEI---D-------ESSRSNSMCGTTEYMAPEILLSKG-HNKDADW 287
           RD+K ENIL+D +  E+   D       + +      GT  Y  PE +     H + A  
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232

Query: 288 WSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
           WS+GILLY+M+ G  PF H       + II  +V     ++SE   L++  L   PS R 
Sbjct: 233 WSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286

Query: 348 GSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
                  + I++H W + +      A        P 
Sbjct: 287 -----TFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  204 bits (521), Expect = 1e-62
 Identities = 82/275 (29%), Positives = 142/275 (51%), Gaps = 24/275 (8%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           A S+R IGP  + I   +G+G+FGKV    K          + A+K + +  + K +   
Sbjct: 2   AISKRHIGP--YIIRETLGEGSFGKV----KLATHYKTQQKV-ALKFISRQLLKKSDMHM 54

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
            ++ E   L  + HP I++L     T + + +++++  GG LF ++  +    ED+ R +
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTEY 270
             +I+ A+ + H+  IVHRDLKPEN+L+D + + +I +   SN M         CG+  Y
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173

Query: 271 MAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS 329
            APE++  K +   + D WS GI+LY ML G+ PF       L +++ +    +P FL+ 
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            A SL++ ++  DP +R+      +  I+   WF 
Sbjct: 234 GAQSLIRRMIVADPMQRI-----TIQEIRRDPWFN 263

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  211 bits (539), Expect = 4e-62
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 58/304 (19%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G +E+   +G G FG V +   +     D+    A+K  R++   K  + +    E  I+
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQELSPK--NRERWCLEIQIM 66

Query: 170 TKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLY---RQGIFREDQARFY 220
            K+ HP +V  R       KL       L +++  GG L  +L         +E   R  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGT 267
            ++I SA+ +LH+  I+HRDLKPENI++                  E+D+        GT
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------ 321
            +Y+APE+L  K +    D+WS G L +E +TG  PF    +       + EK       
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 322 ------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF 363
                              L   L  +    L+ +L     +R     G      +   F
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDPQNPNVGCF 301

Query: 364 RSIN 367
           ++++
Sbjct: 302 QALD 305

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  202 bits (515), Expect = 4e-62
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 37/288 (12%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
           +E   ++G+G    V +   K      +   YA+K++        +  +  +        
Sbjct: 19  YEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 168 --ILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
             IL KV+ HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     +
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPE 274
           +  +  LHK  IVHRDLKPENIL+D D +          ++D   +   +CGT  Y+APE
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 275 IL------LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---- 324
           I+         G+ K+ D WS G+++Y +L G PPF H  +  + + I++   +      
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE 372
              +     L+   L   P KR        +    H +F+    + + 
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR 296

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  200 bits (512), Expect = 6e-62
 Identities = 60/285 (21%), Positives = 104/285 (36%), Gaps = 55/285 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DF+   ++G G FG+VF+ K +       DG  Y +K ++ +           KAER   
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN---------EKAEREVK 56

Query: 168 ILTKVTHPFIVQLRYSFQ----------------TRSKLYLILDFINGGHLFFHL--YRQ 209
            L K+ H  IV     +                     L++ ++F + G L   +   R 
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESS 259
               +  A     +I   V ++H   +++RDLKP NI +                +    
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
           +     GT  YM+PE + S+ + K+ D +++G++L E+L            K    +   
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLR-- 232

Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
              +      +  +LL+ LL K P  R          I       
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTVW 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  206 bits (525), Expect = 1e-61
 Identities = 82/276 (29%), Positives = 142/276 (51%), Gaps = 23/276 (8%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
           + +   KIG   + +   +G G FGKV    K G  +     + A+K++ +  I   + V
Sbjct: 8   KHDGRVKIGH--YILGDTLGVGTFGKV----KVGKHELTGHKV-AVKILNRQKIRSLDVV 60

Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
             ++ E   L    HP I++L     T S +++++++++GG LF ++ + G   E ++R 
Sbjct: 61  GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESSRSNSM---------CGTTE 269
              +I+S V + H+  +VHRDLKPEN+L+D+  + +I +   SN M         CG+  
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180

Query: 270 YMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT 328
           Y APE++  + +   + D WS G++LY +L G  PF   +   L ++I +     P +L 
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

Query: 329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
               SLLK +L  DP KR       +  I+ H+WF+
Sbjct: 241 PSVISLLKHMLQVDPMKRA-----TIKDIREHEWFK 271

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  199 bits (509), Expect = 2e-61
 Identities = 73/293 (24%), Positives = 137/293 (46%), Gaps = 35/293 (11%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTE 269
           ++++ V +LH  GI HRD+KPEN+L+D   +               +     N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 270 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF- 326
           Y+APE+L  +  H +  D WS GI+L  ML G+ P+   ++  +       +K  L P+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 327 -LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP 378
            + S   +LL  +L ++PS R+      +  IK  +W+     K L+    +P
Sbjct: 233 KIDSAPLALLHKILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRP 276

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  201 bits (513), Expect = 3e-61
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 40/277 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E+   +G G++    +   K      ++  +A+K      II K+  D    E +IL 
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVK------IIDKSKRD-PTEEIEILL 70

Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +   HP I+ L+  +     +Y++ + + GG L   + RQ  F E +A      I   V 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 230 HLHKCGIVHRDLKPENILMDSDGHE------ID---------ESSRSNSMCGTTEYMAPE 274
           +LH  G+VHRDLKP NIL   +          D         E+    + C T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVKLP----PFL 327
           +L  +G++   D WS+G+LLY MLTG  PF +      +++  RI + K  L       +
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

Query: 328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           +  A  L+  +LH DP +RL         +  H W  
Sbjct: 251 SDTAKDLVSKMLHVDPHQRL-----TAALVLRHPWIV 282

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  200 bits (510), Expect = 4e-61
 Identities = 76/317 (23%), Positives = 133/317 (41%), Gaps = 39/317 (12%)

Query: 81  SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             + PLQ                +R+    ++ +  ++G+G FG VF   +  + D    
Sbjct: 2   MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHR--LTDRLQ- 58

Query: 141 GIYAMKVMRKDTIIKKNHVDYM---KAERDILTKV----THPFIVQLRYSFQTRSKLYLI 193
              A+KV+ ++ ++  + +        E  +L KV     HP +++L   F+T+    L+
Sbjct: 59  --VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116

Query: 194 LDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           L+  +    LF ++  +G   E  +R +  ++V+A+ H H  G+VHRD+K ENIL+D   
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176

Query: 253 HEI---D-------ESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQ 301
                 D                GT  Y  PE +     H   A  WS+GILLY+M+ G 
Sbjct: 177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

Query: 302 PPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
            PF         Q I+  ++  P  ++ +  +L++  L   PS R       ++ I    
Sbjct: 237 IPFER------DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP-----SLEEILLDP 285

Query: 362 WFRSINWKTLEAREMQP 378
           W +       E   + P
Sbjct: 286 WMQ----TPAEDVPLNP 298

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  200 bits (510), Expect = 5e-61
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 31/271 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKV----KGTDQVLVKKEISILNI 57

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             H  I+ L  SF++  +L +I +FI+G  +F           E +   Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 231 LHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILLS 278
           LH   I H D++PENI+  +               ++        +    EY APE+   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPF--LTSEAHSL 334
              +   D WS+G L+Y +L+G  PF     Q++ + I+N +       F  ++ EA   
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           +  LL K+   R+ +     +A++ H W + 
Sbjct: 238 VDRLLVKERKSRMTA----SEALQ-HPWLKQ 263

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  199 bits (509), Expect = 5e-61
 Identities = 75/331 (22%), Positives = 146/331 (44%), Gaps = 35/331 (10%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           +   +    +++ + +G+GA+G+V    +  V+   ++   A+K++     +     + +
Sbjct: 2   AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           K E  I   + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTE 269
           ++++ V +LH  GI HRD+KPEN+L+D   +               +     N MCGT  
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 270 YMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPPF- 326
           Y+APE+L  +  H +  D WS GI+L  ML G+ P+   ++  +       +K  L P+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 327 -LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 385
            + S   +LL  +L ++PS R+      +  IK  +W+     K L+    +P+      
Sbjct: 233 KIDSAPLALLHKILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRPRVTSGGV 283

Query: 386 GKDCIANFDKCWTTMPADDSPAPTPTAGEHF 416
            +          + +      + + T G  +
Sbjct: 284 SESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  201 bits (512), Expect = 5e-61
 Identities = 80/274 (29%), Positives = 130/274 (47%), Gaps = 33/274 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++  + +G G FG       + + D  +  + A+K + +   I +N    ++ E    
Sbjct: 20  DRYDFVKDIGSGNFGVA-----RLMRDKLTKELVAVKYIERGAAIDEN----VQREIINH 70

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + HP IV+ +    T + L +I+++ +GG L+  +   G F ED+ARF+  +++S VS
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
           + H   I HRDLK EN L+D                     S+  S  GT  Y+APE+LL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190

Query: 278 SKGHN-KDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLPP--FLTSE 330
            + ++ K AD WS G+ LY ML G  PF         +K  QRI++ K  +P    ++ E
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250

Query: 331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
              L+  +   DP+ R+      +  IK H WF 
Sbjct: 251 CCHLISRIFVADPATRI-----SIPEIKTHSWFL 279

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  198 bits (506), Expect = 9e-61
 Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 54/304 (17%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               ++    + +   +G+G++G V    K   ++ D+   YAMKV+ K  +I++     
Sbjct: 7   GDCVQLNQ--YTLKDEIGKGSYGVV----KLAYNENDNT-YYAMKVLSKKKLIRQAGFPR 59

Query: 162 MKAERD-----------------------ILTKVTHPFIVQLR--YSFQTRSKLYLILDF 196
               R                        IL K+ HP +V+L           LY++ + 
Sbjct: 60  RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119

Query: 197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-- 254
           +N G +   +       EDQARFY  +++  + +LH   I+HRD+KP N+L+  DGH   
Sbjct: 120 VNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178

Query: 255 ID-----ESSRSNSM----CGTTEYMAPEILLSKGHN---KDADWWSVGILLYEMLTGQP 302
            D     E   S+++     GT  +MAPE L         K  D W++G+ LY  + GQ 
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 303 PFTHANRQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
           PF       L  +I ++ ++ P  P +  +   L+  +L K+P  R+      V  IK H
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLH 293

Query: 361 KWFR 364
            W  
Sbjct: 294 PWVT 297

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  199 bits (507), Expect = 1e-60
 Identities = 77/281 (27%), Positives = 138/281 (49%), Gaps = 37/281 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---- 166
           ++ + + +G GA G+V    ++      +    A+K++ K      +  +   A      
Sbjct: 11  EYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 167 -DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
            +IL K+ HP I++++  F      Y++L+ + GG LF  +      +E   + Y  +++
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMA 272
            AV +LH+ GI+HRDLKPEN+L+ S   +             + E+S   ++CGT  Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 273 PEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQQRIINEKVKLP---- 324
           PE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+ +I + K        
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
             ++ +A  L+K LL  DP  R        +    H W + 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQD 280

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  201 bits (513), Expect = 2e-60
 Identities = 77/296 (26%), Positives = 140/296 (47%), Gaps = 41/296 (13%)

Query: 100 EAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
               ++ + P        + + +G GA G+V    ++      +    A++++ K     
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAI 175

Query: 156 KNHVDYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
            +  +   A       +IL K+ HP I++++  F      Y++L+ + GG LF  +    
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK 234

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-------------IDE 257
             +E   + Y  +++ AV +LH+ GI+HRDLKPEN+L+ S   +             + E
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 258 SSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFT-HANRQKLQ 313
           +S   ++CGT  Y+APE+L+S    G+N+  D WS+G++L+  L+G PPF+ H  +  L+
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354

Query: 314 QRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
            +I + K          ++ +A  L+K LL  DP  R        +    H W + 
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQD 405

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  198 bits (506), Expect = 2e-60
 Identities = 68/292 (23%), Positives = 128/292 (43%), Gaps = 34/292 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--- 166
             +     +G GAFG V       VD   +  +  +K ++K+ +++   ++  K  +   
Sbjct: 24  QKYSTMSPLGSGAFGFV----WTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 167 --DILTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAE 223
              IL++V H  I+++   F+ +    L+++   +G  LF  + R     E  A +   +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
           +VSAV +L    I+HRD+K ENI++  D             ++      + CGT EY AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

Query: 274 EILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 332
           E+L+   +   + + WS+G+ LY ++  + PF         +  +   +  P  ++ E  
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------EETVEAAIHPPYLVSKELM 252

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR-SINWKTLEAREMQPKFKPD 383
           SL+ GLL   P +R       ++ +    W    +N       E+    KP+
Sbjct: 253 SLVSGLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  199 bits (507), Expect = 6e-60
 Identities = 69/270 (25%), Positives = 125/270 (46%), Gaps = 30/270 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+ +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPLDKYTV---KNEISIMNQ 104

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSH 230
           + HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    + H
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 164

Query: 231 LHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILLS 278
           +H+  IVH D+KPENI+ ++               +++          T E+ APEI+  
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 334
           +      D W++G+L Y +L+G  PF   +  +  Q +     +        ++ EA   
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           +K LL K+P KRL       DA++ H W +
Sbjct: 285 IKNLLQKEPRKRLTV----HDALE-HPWLK 309

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  196 bits (501), Expect = 1e-59
 Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 36/309 (11%)

Query: 92  EHENDAELEAESERKIGPGDFEIF-----RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
            H +  +L  E+       +F  F     + +G+G F  V Q   K      +   YA K
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-----STGQEYAAK 60

Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            ++K    +    + +  E  +L      P ++ L   ++  S++ LIL++  GG +F  
Sbjct: 61  FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 206 LY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----------- 252
                  +  E+       +I+  V +LH+  IVH DLKP+NIL+ S             
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179

Query: 253 --HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ 310
              +I  +     + GT EY+APEIL         D W++GI+ Y +LT   PF   + Q
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239

Query: 311 KLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           +    I    V         ++  A   ++ LL K+P KR  +       +  H W +  
Sbjct: 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA----EICLS-HSWLQQW 294

Query: 367 NWKTLEARE 375
           +++ L   E
Sbjct: 295 DFENLFHPE 303

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  196 bits (499), Expect = 5e-59
 Identities = 83/353 (23%), Positives = 139/353 (39%), Gaps = 38/353 (10%)

Query: 26  SASSPDFDFT-EVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSL 84
            +S  D  F  E        RH          +            + +    +    +  
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK--LNDA 64

Query: 85  PLQIQELEHENDAELEAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
             +  E  +      E E        +F    +   V+G+G    V +   +      + 
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-----ATG 119

Query: 141 GIYAMKVMRKDTIIKKNHV-----DYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194
             +A+K+M                +  + E  IL +V  HP I+ L  S+++ S ++L+ 
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179

Query: 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH- 253
           D +  G LF +L  +    E + R     ++ AVS LH   IVHRDLKPENIL+D +   
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239

Query: 254 ---------EIDESSRSNSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEML 298
                     ++   +   +CGT  Y+APEIL         G+ K+ D W+ G++L+ +L
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

Query: 299 TGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRL 347
            G PPF H  +  + + I+  + +         +S    L+  LL  DP  RL
Sbjct: 300 AGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  200 bits (511), Expect = 9e-59
 Identities = 66/273 (24%), Positives = 121/273 (44%), Gaps = 30/273 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++ 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTP---HESDKETVRKEIQTMSV 210

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
           + HP +V L  +F+  +++ +I +F++GG LF           ED+A  Y  ++   + H
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 231 LHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILLS 278
           +H+   VH DLKPENI+  +                +D         GT E+ APE+   
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSL 334
           K      D WSVG+L Y +L+G  PF   N  +  + + +    +       ++ +    
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
           ++ LL  DP+ R+        A++ H W    N
Sbjct: 391 IRKLLLADPNTRMTI----HQALE-HPWLTPGN 418

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  190 bits (486), Expect = 5e-58
 Identities = 56/291 (19%), Positives = 110/291 (37%), Gaps = 45/291 (15%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F     +G G FG VF+  K+   DG    IYA+K  +K      +  + ++       
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKR--LDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG----HLFFHLYRQGIFREDQARFYTAEIVS 226
              H  +V+   ++     + +  ++ NGG     +  +      F+E + +    ++  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------------------------SR 260
            + ++H   +VH D+KP NI +         S                          S 
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 261 SNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
                G + ++A E+L  +  H   AD +++ + +      +P   + +       I   
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG 243

Query: 320 KV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK 369
           ++ ++P  L+ E   LLK ++H DP +R    P    A+  H    S + K
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERR----P-SAMALVKHSVLLSASRK 289

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  192 bits (489), Expect = 5e-58
 Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 42/276 (15%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            I    +   + +G+G F  V  V+            YA+K +      ++   +  + E
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH---EQQDREEAQRE 76

Query: 166 RDILTKVTHPFIVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ----GIFREDQA 217
            D+     HP I++L            + +L+L F   G L+  + R         EDQ 
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--------------------HEIDE 257
            +    I   +  +H  G  HRDLKP NIL+  +G                     +   
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 258 SSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQ 313
                +   T  Y APE+   + H   ++  D WS+G +LY M+ G+ P+    ++    
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 314 QRIINEKVKLPPF--LTSEAHSLLKGLLHKDPSKRL 347
              +  ++ +P     +S    LL  ++  DP +R 
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP 292

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  193 bits (492), Expect = 7e-58
 Identities = 60/254 (23%), Positives = 118/254 (46%), Gaps = 25/254 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
                 ++G G FG+V + ++       +    A K+++          + +K E  ++ 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTR---GMKDKEEVKNEISVMN 141

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
           ++ H  ++QL  +F++++ + L++++++GG LF  +  +     E     +  +I   + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201

Query: 230 HLHKCGIVHRDLKPENILMDS-DGHEI-----------DESSRSNSMCGTTEYMAPEILL 277
           H+H+  I+H DLKPENIL  + D  +I               +     GT E++APE++ 
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 333
               +   D WSVG++ Y +L+G  PF   N  +    I+  +  L       ++ EA  
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321

Query: 334 LLKGLLHKDPSKRL 347
            +  LL K+ S R+
Sbjct: 322 FISKLLIKEKSWRI 335

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  189 bits (482), Expect = 4e-56
 Identities = 56/399 (14%), Positives = 100/399 (25%), Gaps = 75/399 (18%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
           + NR       +    + S+    +             ESE    P       V+GQ   
Sbjct: 32  LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 91

Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER----------------- 166
               +       D ++   + + V         N +  MK E                  
Sbjct: 92  YAYLEAT-----DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 167 --------DILTKVTHPFIVQLRYSFQTRSKLYLILDFIN--------GGHLFFHLYRQG 210
                   D++       ++++R   +    L     +          G  L  H     
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDES 258
                     T +++  ++ LH  G+VH  L+P +I++D  G                  
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKD-----ADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
           S         E  A  +L    H+        D W++G+ +Y +     P T        
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 314 QRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 373
           + I      +P        +LL+G L      RL               +  +       
Sbjct: 327 EWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQL------- 370

Query: 374 REMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTA 412
           R       P                  P   +  P    
Sbjct: 371 RTELSAALPLYQTDGEPTREG----GAPPSGTSQPDEAG 405

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  186 bits (473), Expect = 7e-56
 Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 59/299 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
           DFE  + +G+G FG VF+ K K       D   YA+K +R    +    +   K  R   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNK------VDDCNYAIKRIR----LPNRELAREKVMREVK 55

Query: 168 ILTKVTHPFIVQLRYSF------------QTRSKLYLILDFINGGHLFFHLYRQG---IF 212
            L K+ HP IV+   ++              +  LY+ +      +L   +  +      
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------------- 253
                     +I  AV  LH  G++HRDLKP NI    D                     
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 254 ----EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
                +   +R     GT  YM+PE +    ++   D +S+G++L+E+L   P  T   R
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMER 233

Query: 310 QKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
            +    + N K   L        + +++ +L   P +R    P     I  +  F  ++
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER----P-EAINIIENAVFEDLD 287

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  185 bits (473), Expect = 1e-55
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 59/294 (20%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G+GA  +V            +   YA+K++ K      +    +  E ++L +   H 
Sbjct: 20  VLGEGAHARVQTCINLI-----TSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHR 71

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
            +++L   F+   + YL+ + + GG +  H++++  F E +A     ++ SA+  LH  G
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 236 IVHRDLKPENILMDSDGHE-----ID----------------ESSRSNSMCGTTEYMAPE 274
           I HRDLKPENIL +           D                 +    + CG+ EYMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 275 IL-----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---------------QKLQQ 314
           ++      +  ++K  D WS+G++LY +L+G PPF                      L +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 315 RIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            I   K + P      ++  A  L+  LL +D  +RL         +  H W +
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL-----SAAQVLQHPWVQ 300

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  187 bits (477), Expect = 2e-55
 Identities = 74/346 (21%), Positives = 146/346 (42%), Gaps = 51/346 (14%)

Query: 48  NQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKI 107
           + S   +            +  +   P P        P Q  +   ++  +++  +    
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61

Query: 108 GPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
              D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E 
Sbjct: 62  ---DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EV 105

Query: 167 DILTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARF 219
           ++  + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A  
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCG 266
               I  A+ +LH   I HRD+KPEN+L  S                E    +   + C 
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ----RIINEKVK 322
           T  Y+APE+L  + ++K  D WS+G+++Y +L G PPF   +   +      RI   + +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285

Query: 323 LP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            P      ++ E   L++ LL  +P++R+      +    +H W  
Sbjct: 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 326

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  185 bits (471), Expect = 3e-55
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 45/275 (16%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
           V+G G  GKV +   +      +    A+K++      ++        E D   + +  P
Sbjct: 36  VLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPKARQ--------EVDHHWQASGGP 82

Query: 176 FIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
            IV +   ++     +  L +I++ + GG LF  +  +G   F E +A     +I +A+ 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 230 HLHKCGIVHRDLKPENILMDSDGHE-----ID-------ESSRSNSMCGTTEYMAPEILL 277
            LH   I HRD+KPEN+L  S   +      D         +   + C T  Y+APE+L 
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG 202

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ----QRIINEKVKLP----PFLTS 329
            + ++K  D WS+G+++Y +L G PPF     Q +     +RI   +   P      ++ 
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           +A  L++ LL  DP++RL      +    +H W  
Sbjct: 263 DAKQLIRLLLKTDPTERL-----TITQFMNHPWIN 292

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  186 bits (473), Expect = 2e-54
 Identities = 68/320 (21%), Positives = 119/320 (37%), Gaps = 54/320 (16%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E D   E  S   +G   F    V+G GA G +     +G+ D       A+K       
Sbjct: 8   EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV---YRGMFDNRD---VAVK------R 55

Query: 154 IKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI- 211
           I      +   E  +L +   HP +++   + + R   Y+ ++      L  ++ ++   
Sbjct: 56  ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------------E 254
               +      +  S ++HLH   IVHRDLKP NIL+                       
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 255 IDESS--RSNSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLT-GQPPFTHAN 308
           +   S  R + + GT  ++APE+L     +      D +S G + Y +++ G  PF  + 
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 309 RQKLQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           +++    +    +            A  L++ ++  DP KR          +  H +F S
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWS 289

Query: 366 INWKTLEAREMQPKFKPDVS 385
                    E Q +F  DVS
Sbjct: 290 --------LEKQLQFFQDVS 301

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  181 bits (459), Expect = 4e-53
 Identities = 43/322 (13%), Positives = 89/322 (27%), Gaps = 61/322 (18%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
           +AE   +S    G    ++   +  G    VF V+       +    +A+KV        
Sbjct: 48  NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENS 102

Query: 156 KNHVDYMKAERDILTKVTHPFIVQLR--------------------------YSFQTRSK 189
           ++ ++ +        ++      + R                                + 
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 190 LYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP 243
             L++   +         L F    +G          TA+++   ++L   G+VH    P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222

Query: 244 ENILMDSDGH--------EIDESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGIL 293
           +N+ +  DG              +R  +      Y   E L +         + W +G+ 
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282

Query: 294 LYEMLTGQPPFTHAN--RQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPS 344
           +Y +     PF       +   +R                  L     +L+   L+ D  
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342

Query: 345 KRLGSGPGGVDAIKHHKWFRSI 366
           +RL               F  +
Sbjct: 343 RRL-----LPLEAMETPEFLQL 359

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  179 bits (457), Expect = 4e-53
 Identities = 66/315 (20%), Positives = 123/315 (39%), Gaps = 34/315 (10%)

Query: 52  ASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD 111
            S S S G    + + + ++   S +            E     +     + E +     
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETED-NEGVLLTEKLKPVDYEYREEVHW 59

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
                 VG+G+FG+V     +  D   +    A+K +R +    +        E      
Sbjct: 60  MTHQPRVGRGSFGEVH----RMKD-KQTGFQCAVKKVRLEVFRVE--------ELVACAG 106

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           ++ P IV L  + +    + + ++ + GG L   + + G   ED+A +Y  + +  + +L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166

Query: 232 HKCGIVHRDLKPENILMDSDGHEI-----------------DESSRSNSMCGTTEYMAPE 274
           H   I+H D+K +N+L+ SDG                          + + GT  +MAPE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEA 331
           +++ K  +   D WS   ++  ML G  P+T   R  L  +I +E     ++PP      
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286

Query: 332 HSLLKGLLHKDPSKR 346
              ++  L K+P  R
Sbjct: 287 AQAIQEGLRKEPVHR 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  178 bits (452), Expect = 2e-51
 Identities = 70/325 (21%), Positives = 117/325 (36%), Gaps = 79/325 (24%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
               +++G G+ G V     +G   G      A+K       +  +  D    E  +LT+
Sbjct: 17  VVSEKILGYGSSGTV---VFQGSFQGRP---VAVK------RMLIDFCDIALMEIKLLTE 64

Query: 172 VT-HPFIVQLRYSFQTRSKLYLILDFINGGHLF-------FHLYRQGIFREDQARFYTAE 223
              HP +++   S  T   LY+ L+  N   L               + +E        +
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDS----------------------------DGHEI 255
           I S V+HLH   I+HRDLKP+NIL+ +                            D  + 
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 256 DESSRSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFTHA 307
              +  N+  GT+ + APE+L         +   +  D +S+G + Y +L+ G+ PF   
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 308 NRQKLQQRIINEKVKLPPF-------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
             +  +  II     L          L +EA  L+  ++  DP KR          +  H
Sbjct: 244 YSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP-----TAMKVLRH 296

Query: 361 KWFRSINWKTLEAREMQPKFKPDVS 385
             F          +  + +F   VS
Sbjct: 297 PLFWP--------KSKKLEFLLKVS 313

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  164 bits (417), Expect = 1e-47
 Identities = 63/254 (24%), Positives = 123/254 (48%), Gaps = 39/254 (15%)

Query: 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++ 
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EVELH 64

Query: 170 TKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTA 222
            + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A     
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEY-MAPEILLSKGH 281
            I  A+ +LH   I HRD+KPEN+L  S           N++   T++  A E    + +
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKR--------PNAILKLTDFGFAKET-TGEKY 175

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANR----QKLQQRIINEKVKLP----PFLTSEAHS 333
           +K  D WS+G+++Y +L G PPF   +       ++ RI   + + P      ++ E   
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235

Query: 334 LLKGLLHKDPSKRL 347
           L++ LL  +P++R+
Sbjct: 236 LIRNLLKTEPTQRM 249

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  164 bits (416), Expect = 1e-47
 Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 33/272 (12%)

Query: 100 EAESERKIGPGDFEIFR-----VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           E + E  +   D+E        V+G+G +G V+     G D   +    A+K + +    
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY----AGRD-LSNQVRIAIKEIPER--- 58

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGI 211
              +   +  E  +   + H  IVQ   SF     + + ++ + GG    L    +    
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESS 259
             E    FYT +I+  + +LH   IVHRD+K +N+L+++    +              + 
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178

Query: 260 RSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI 316
            + +  GT +YMAPEI+    +G+ K AD WS+G  + EM TG+PPF      Q    ++
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 238

Query: 317 INEKV--KLPPFLTSEAHSLLKGLLHKDPSKR 346
              KV  ++P  +++EA + +      DP KR
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  164 bits (417), Expect = 3e-47
 Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 53/283 (18%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++G     + RV+ +G F  V++ +     D  S   YA+K +  +   ++     +  E
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQ-----DVGSGREYALKRLLSN---EEEKNRAIIQE 75

Query: 166 RDILTKVT-HPFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYR---QGIFRE 214
              + K++ HP IVQ   +         T    +L+L  +  G L   L +   +G    
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135

Query: 215 DQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG-------------------- 252
           D       +   AV H+H+    I+HRDLK EN+L+ + G                    
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 253 ---HEIDESSRSNSMCGTTEYMAPEILLSKGH---NKDADWWSVGILLYEMLTGQPPFTH 306
                        +   T  Y  PEI+    +    +  D W++G +LY +   Q PF  
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

Query: 307 ANRQKLQQRIINEKVKLPPFLT--SEAHSLLKGLLHKDPSKRL 347
                 + RI+N K  +PP  T  +  HSL++ +L  +P +RL
Sbjct: 256 GA----KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  155 bits (394), Expect = 5e-44
 Identities = 58/333 (17%), Positives = 105/333 (31%), Gaps = 84/333 (25%)

Query: 111 DFEIFRVVGQGAFGKVFQVK----------KK---------------------------- 132
           DFE  + +G+G FG VF+ K          K+                            
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 133 ------------GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
                            + D I+         +   + +D    +   +   +    V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIV 237
                 +  LY+ +      +L   + R+                +I  AV  LH  G++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 238 HRDLKPENILMDSDGH-----------------------EIDESSRSNSMCGTTEYMAPE 274
           HRDLKP NI    D                          +   +      GT  YM+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHS 333
            +    ++   D +S+G++L+E+L      T   R ++   + N K   L      + H 
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM 304

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
           +++ +L   P++R    P     I  +  F ++
Sbjct: 305 MVQDMLSPSPTER----P-EATDIIENAIFENL 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  152 bits (385), Expect = 5e-43
 Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 27/271 (9%)

Query: 92  EHENDAELEAESERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
                + L      K  P + F     +G+G+FG+VF    KG+D+  +  + A+K++  
Sbjct: 3   HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKIIDL 57

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
           +    ++ ++ ++ E  +L++   P++ +   S+   +KL++I++++ GG     L   G
Sbjct: 58  EEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG 114

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESS 259
              E Q      EI+  + +LH    +HRD+K  N+L+   G              D   
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
           + N+  GT  +MAPE++    ++  AD WS+GI   E+  G+PP +  +  K+   I   
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234

Query: 320 KVKLPPFL----TSEAHSLLKGLLHKDPSKR 346
               PP L    +      ++  L+K+PS R
Sbjct: 235 N---PPTLEGNYSKPLKEFVEACLNKEPSFR 262

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  151 bits (383), Expect = 7e-43
 Identities = 61/279 (21%), Positives = 124/279 (44%), Gaps = 27/279 (9%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +  + ++  ELE ++      G F  F   +G+G+F  V+    KG+D   +    A   
Sbjct: 4   RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVY----KGLDTETTV-EVAWCE 58

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF----QTRSKLYLILDFINGGHLF 203
           + +D  + K+     K E ++L  + HP IV+   S+    + +  + L+ + +  G L 
Sbjct: 59  L-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHEI------ 255
            +L R  + +    R +  +I+  +  LH     I+HRDLK +NI +      +      
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 256 ----DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 311
                 +S + ++ GT E+MAPE +  + +++  D ++ G+ + EM T + P++      
Sbjct: 178 LATLKRASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236

Query: 312 LQQRIINEKVK---LPPFLTSEAHSLLKGLLHKDPSKRL 347
              R +   VK          E   +++G + ++  +R 
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  148 bits (375), Expect = 2e-41
 Identities = 70/307 (22%), Positives = 141/307 (45%), Gaps = 45/307 (14%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD----FEIFRVVG 119
           +H+  H   G       + +L  Q   + HE   + +A     +  GD     + +  +G
Sbjct: 1   MHHHHHHSSGVDLG---TENLYFQSGVVTHE---QFKAALRMVVDQGDPRLLLDSYVKIG 54

Query: 120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVM------RKDTIIKKNHVDYMKAERDILTKVT 173
           +G+ G V   ++K      S    A+K+M      R++ +           E  I+    
Sbjct: 55  EGSTGIVCLAREK-----HSGRQVAVKMMDLRKQQRRELLFN---------EVVIMRDYQ 100

Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
           H  +V++  S+    +L+++++F+ GG L   +  Q    E+Q       ++ A+++LH 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 234 CGIVHRDLKPENILMDSDGHE-----------IDESSRSNSMCGTTEYMAPEILLSKGHN 282
            G++HRD+K ++IL+  DG               +  +  S+ GT  +MAPE++    + 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSLLKGLL 339
            + D WS+GI++ EM+ G+PP+   +  +  +R+ +    K+K    ++      L+ +L
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279

Query: 340 HKDPSKR 346
            +DP +R
Sbjct: 280 VRDPQER 286

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  146 bits (370), Expect = 6e-41
 Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 39/276 (14%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-- 148
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 149 ----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
               +K+ II          E  ++ +  +P IV    S+    +L+++++++ GG L  
Sbjct: 56  QQQPKKELIIN---------EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT- 105

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------- 253
            +  +    E Q      E + A+  LH   ++HRD+K +NIL+  DG            
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165

Query: 254 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
              E S+ ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+PP+ + N  +  
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

Query: 314 QRIINE---KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             I      +++ P  L++     L   L  D  KR
Sbjct: 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  143 bits (364), Expect = 8e-40
 Identities = 64/302 (21%), Positives = 132/302 (43%), Gaps = 41/302 (13%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+  H    P   Y + ++  L  Q     +  +++      I   D  I   +G G+FG
Sbjct: 3   HHHHHH---PMSDYDIPTTENLYFQGAM--DGDDMD------IPWCDLNIKEKIGAGSFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184
            V + +  G D        A+K++ +     +   ++++ E  I+ ++ HP IV    + 
Sbjct: 52  TVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHPNIVLFMGAV 103

Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLHKCG--IVHR 239
                L ++ ++++ G L+  L++ G   +    +      ++   +++LH     IVHR
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163

Query: 240 DLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWW 288
           +LK  N+L+D               +      S S  GT E+MAPE+L  +  N+ +D +
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223

Query: 289 SVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL----HKDPS 344
           S G++L+E+ T Q P+ + N  ++   +  +  +L   +    +  +  ++      +P 
Sbjct: 224 SFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPW 281

Query: 345 KR 346
           KR
Sbjct: 282 KR 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  143 bits (363), Expect = 8e-40
 Identities = 68/264 (25%), Positives = 119/264 (45%), Gaps = 36/264 (13%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S   I   + E+  VVG+GAFG V + K +  D        A+K +  ++  K     ++
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIESESERK----AFI 49

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
             E   L++V HP IV+L  +    + + L++++  GG L+  L+         A    +
Sbjct: 50  V-ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 223 ---EIVSAVSHLHKC---GIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGT 267
              +    V++LH      ++HRDLKP N+L+ + G  +         D  +   +  G+
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 166

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII-----NEKVK 322
             +MAPE+     +++  D +S GI+L+E++T + PF          RI+       +  
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPP 224

Query: 323 LPPFLTSEAHSLLKGLLHKDPSKR 346
           L   L     SL+     KDPS+R
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQR 248

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  142 bits (360), Expect = 3e-39
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 36/270 (13%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
               +    D E    +G G  G+V++++ +      +  + A+K MR+     K     
Sbjct: 17  GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRS--GNKEENKR 69

Query: 162 MKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +  + D++ K    P+IVQ   +F T + +++ ++ +           QG   E      
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129

Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTE 269
           T  IV A+ +L  K G++HRD+KP NIL+D  G            + +    +   G   
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 270 YMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFT--HANRQKLQQRIINEKVK 322
           YMAPE +         ++  AD WS+GI L E+ TGQ P+     + + L + ++ E+  
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK-VLQEE-- 246

Query: 323 LPPFL------TSEAHSLLKGLLHKDPSKR 346
            PP L      + +  S +K  L KD  KR
Sbjct: 247 -PPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  142 bits (359), Expect = 4e-39
 Identities = 63/280 (22%), Positives = 127/280 (45%), Gaps = 25/280 (8%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
           S   +Q++        +L+ +S  K     F++   +G+G++G V++   K     ++  
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQ 55

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
           I A+K +  ++ +++     +  E  I+ +   P +V+   S+   + L++++++   G 
Sbjct: 56  IVAIKQVPVESDLQE-----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110

Query: 202 LF-FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------- 253
           +      R     ED+        +  + +LH    +HRD+K  NIL++++GH       
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170

Query: 254 ----EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
                 D  ++ N++ GT  +MAPE++   G+N  AD WS+GI   EM  G+PP+   + 
Sbjct: 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

Query: 310 QKLQQRIINE---KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +    I        + P   +      +K  L K P +R
Sbjct: 231 MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  140 bits (355), Expect = 1e-38
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 48/288 (16%)

Query: 97  AELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK 156
           +E  +     I   D+E+  V+G GA   V                 A+K +  +    +
Sbjct: 2   SEDSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCA-PKKEKVAIKRINLEKC--Q 54

Query: 157 NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQ---- 209
             +D +  E   +++  HP IV    SF  + +L+L++  ++GG    +  H+  +    
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------------- 253
            G+  E        E++  + +LHK G +HRD+K  NIL+  DG                
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174

Query: 254 -EIDESSRSNSMCGTTEYMAPE-ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK 311
            +I  +    +  GT  +MAPE +   +G++  AD WS GI   E+ TG  P+      K
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234

Query: 312 LQQRIINEKVKLPPFLTSEA-------------HSLLKGLLHKDPSKR 346
           +    +      PP L +                 ++   L KDP KR
Sbjct: 235 VLMLTLQND---PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  141 bits (357), Expect = 2e-38
 Identities = 57/253 (22%), Positives = 100/253 (39%), Gaps = 29/253 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+       D   +  + A+K M             +  E   L K
Sbjct: 56  FSDLREIGHGSFGAVY----FARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 232 HKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAPEILLS--- 278
           H   ++HRD+K  NIL+   G            +   + +NS  GT  +MAPE++L+   
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDE 227

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL-----TSEAHS 333
             ++   D WS+GI   E+   +PP  + N       I   +    P L     +    +
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPALQSGHWSEYFRN 284

Query: 334 LLKGLLHKDPSKR 346
            +   L K P  R
Sbjct: 285 FVDSCLQKIPQDR 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  138 bits (350), Expect = 6e-38
 Identities = 71/255 (27%), Positives = 119/255 (46%), Gaps = 28/255 (10%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +EI   +G GAFGKV++ K K     ++  + A KV+       +  ++    E +IL  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVI---ETKSEEELEDYIVEIEILAT 72

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
             HP+IV+L  ++    KL+++++F  GG +    L       E Q +    +++ A++ 
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 231 LHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS- 278
           LH   I+HRDLK  N+LM  +G             +    + +S  GT  +MAPE+++  
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 279 ----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEA 331
                 ++  AD WS+GI L EM   +PP    N  ++  +I       +  P   + E 
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252

Query: 332 HSLLKGLLHKDPSKR 346
              LK  L K+P  R
Sbjct: 253 RDFLKIALDKNPETR 267

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (349), Expect = 1e-37
 Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 41/286 (14%)

Query: 91  LEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +E     ++  E        D +    +G+GA+G V ++  K      S  I A+K +R 
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRS 57

Query: 151 DTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF----H 205
              + +     +  + D++ +    P+IVQ   +       ++ ++ ++     F    +
Sbjct: 58  T--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY 115

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH----------E 254
                +  E+     T   V A++HL     I+HRD+KP NIL+D  G+          +
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 255 IDESSRSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFT--HAN 308
           + +S       G   YMAPE +      +G++  +D WS+GI LYE+ TG+ P+   ++ 
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

Query: 309 RQKLQQRIINEKVKLPPFL--------TSEAHSLLKGLLHKDPSKR 346
             +L Q ++      PP L        +    + +   L KD SKR
Sbjct: 236 FDQLTQ-VVKGD---PPQLSNSEEREFSPSFINFVNLCLTKDESKR 277

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  136 bits (344), Expect = 3e-37
 Identities = 56/263 (21%), Positives = 111/263 (42%), Gaps = 29/263 (11%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           ++   D E    +G+GA+G V +++        S  I A+K +R    +       +  +
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRAT--VNSQEQKRLLMD 55

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFF---HLYRQGIFREDQARFYT 221
            DI  +    PF V    +      +++ ++ ++     F    + +     ED      
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 222 AEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY 270
             IV A+ HLH K  ++HRD+KP N+L+++ G            + +    +   G   Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175

Query: 271 MAPEILLSKGHNKD----ADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKV-KLP 324
           MAPE +  + + K     +D WS+GI + E+   + P+ +     +  ++++ E   +LP
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235

Query: 325 P-FLTSEAHSLLKGLLHKDPSKR 346
               ++E        L K+  +R
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKER 258

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  137 bits (346), Expect = 6e-37
 Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 26/283 (9%)

Query: 87  QIQELEHENDAELEAESERKIG-------PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           +++ELE +       E+              DFE    +G G  G VF+V  K      S
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-----S 57

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
             + A K++  +  IK    + +  E  +L +   P+IV    +F +  ++ + ++ ++G
Sbjct: 58  GLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHEI--- 255
           G L   L + G   E      +  ++  +++L  K  I+HRD+KP NIL++S G EI   
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLC 174

Query: 256 D-------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
           D         S +NS  GT  YM+PE L    ++  +D WS+G+ L EM  G+ P    +
Sbjct: 175 DFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGP 351
            ++L+     +             +  + L       R     
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  135 bits (341), Expect = 1e-36
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 41/282 (14%)

Query: 92  EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
            H +    +A  + +I  G   + + +G G+FG V+    KG   GD     A+K++   
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVY----KGKWHGD----VAVKMLNVT 57

Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
               +    + K E  +L K  H  I+     + T  +L ++  +  G  L+ HL+    
Sbjct: 58  APTPQQLQAF-KNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASET 115

Query: 212 -FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDE 257
            F   +      +    + +LH   I+HRDLK  NI +  D                   
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 258 SSRSNSMCGTTEYMAPEILLSKGHNKD---ADWWSVGILLYEMLTGQPPFTHAN------ 308
           S +   + G+  +MAPE++  +  N     +D ++ GI+LYE++TGQ P+++ N      
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

Query: 309 ----RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
               R  L   +   +   P  +      L+   L K   +R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRM----KRLMAECLKKKRDER 273

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  134 bits (340), Expect = 1e-36
 Identities = 54/284 (19%), Positives = 110/284 (38%), Gaps = 47/284 (16%)

Query: 96  DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-------AMKVM 148
            +E        +   + E  + +G+G FG V +            G         A+K +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHK------------GRLVKDKSVVAIKSL 52

Query: 149 RKDTIIKKNHVDYM----KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
                  +  +       + E  I++ + HP IV+L       +   ++++F+  G L+ 
Sbjct: 53  ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYH 110

Query: 205 HLYRQGIFREDQARFYTA-EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHEID----- 256
            L  +    +   +     +I   + ++      IVHRDL+  NI + S           
Sbjct: 111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

Query: 257 --------ESSRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTH 306
                        + + G  ++MAPE + ++   + + AD +S  ++LY +LTG+ PF  
Sbjct: 171 ADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

Query: 307 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLL----HKDPSKR 346
            +  K++   +  +  L P +  +    L+ ++      DP KR
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  138 bits (350), Expect = 9e-36
 Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 47/269 (17%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
           ++ PGD     +E+   +  G  G ++      +D   +     +K +           +
Sbjct: 71  QLNPGDIVAGQYEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGLVHS-----GDAE 121

Query: 161 YMK---AERDILTKVTHPFIVQLRYSF------QTRSKLYLILDFINGGHLFFHLYRQGI 211
                 AER  L +V HP IVQ+ ++F            Y++++++ G  L     +   
Sbjct: 122 AQAMAMAERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQK 178

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------HEIDESSRSN 262
               +A  Y  EI+ A+S+LH  G+V+ DLKPENI++  +            I+      
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRIN---SFG 235

Query: 263 SMCGTTEYMAPEILLSKGHNKDA-DWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
            + GT  + APEI+  +     A D ++VG  L  +    P         L +      +
Sbjct: 236 YLYGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PVL 291

Query: 322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSG 350
           K           LL+  +  DP +R  + 
Sbjct: 292 KTYDSY----GRLLRRAIDPDPRQRFTTA 316

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  130 bits (328), Expect = 4e-35
 Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 31/263 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAE 165
           I   +  +  ++G G FGKV++    G +        A+K  R D        ++ ++ E
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQE 56

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +   + HP I+ LR        L L+++F  GG L   L  + I   D    +  +I 
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIA 115

Query: 226 SAVSHLHKCG---IVHRDLKPENILMDSDGHEIDES-----------SR------SNSMC 265
             +++LH      I+HRDLK  NIL+       D S           +R        S  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-- 323
           G   +MAPE++ +   +K +D WS G+LL+E+LTG+ PF   +   +   +   K+ L  
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P         L++   + DP  R
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSR 258

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 4e-35
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 42/267 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G FE+  +VG G +G+V+    KG     +  + A+KVM     +  +  + +K E ++L
Sbjct: 24  GIFELVELVGNGTYGQVY----KGRHV-KTGQLAAIKVMD----VTGDEEEEIKQEINML 74

Query: 170 TKV-THPFIVQLRYSF------QTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
            K   H  I     +F          +L+L+++F   G +       +    +E+   + 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES-SRSNSMCGTTE 269
             EI+  +SHLH+  ++HRD+K +N+L+  +            ++D +  R N+  GT  
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 270 YMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP 324
           +MAPE++         ++  +D WS+GI   EM  G PP    +  +    I        
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---A 251

Query: 325 PFL-----TSEAHSLLKGLLHKDPSKR 346
           P L     + +  S ++  L K+ S+R
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQR 278

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  132 bits (333), Expect = 7e-35
 Identities = 56/313 (17%), Positives = 107/313 (34%), Gaps = 33/313 (10%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGA--FGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           H  +   +  S      G +E+  V+G+G      V   + K      +     ++ +  
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINL 62

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYR 208
           +       V +++ E  +     HP IV  R +F   ++L+++  F+  G        + 
Sbjct: 63  EAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDE 257
                E    +    ++ A+ ++H  G VHR +K  +IL+  DG             I  
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

Query: 258 SSRSNSMC-------GTTEYMAPEIL--LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN 308
             R   +            +++PE+L    +G++  +D +SVGI   E+  G  PF    
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241

Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW 368
             ++    +N      P L   +    + L          SG          +     + 
Sbjct: 242 ATQMLLEKLNGT---VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298

Query: 369 KTLEAREMQPKFK 381
                R   P F 
Sbjct: 299 SHPYHRTFSPHFH 311

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  127 bits (321), Expect = 5e-34
 Identities = 52/257 (20%), Positives = 107/257 (41%), Gaps = 25/257 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          + +   G++++ + +G D         +KV++      +   D+ + E 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 167 DILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED--QARFYTA 222
             L   +HP ++ +             LI  ++  G L+  L+    F  D  QA  +  
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 223 EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHE------IDESSRSNSMCGTTEYMAPE 274
           ++   ++ LH     I    L   ++++D D         +  S +S        ++APE
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPE 178

Query: 275 ILLSKGHNKD---ADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLPPFLTS 329
            L  K  + +   AD WS  +LL+E++T + PF   +  ++  ++  E     +PP ++ 
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238

Query: 330 EAHSLLKGLLHKDPSKR 346
               L+K  +++DP+KR
Sbjct: 239 HVSKLMKICMNEDPAKR 255

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 6e-34
 Identities = 50/269 (18%), Positives = 101/269 (37%), Gaps = 40/269 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     EI  ++G+G FG+V+     G   G+     A++++  +   +     + K E 
Sbjct: 30  IPFEQLEIGELIGKGRFGQVY----HGRWHGE----VAIRLIDIERDNEDQLKAF-KREV 80

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIV 225
               +  H  +V    +  +   L +I     G  L+  +    I    ++ R    EIV
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSD------------GHEIDESSRSNSM---CGTTEY 270
             + +LH  GI+H+DLK +N+  D+                +    R + +    G   +
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 271 MAPEIL---------LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
           +APEI+              +K +D +++G + YE+   + PF     + +  ++     
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GTG 258

Query: 322 KLPPFLTSEAHSLLKGLL----HKDPSKR 346
             P          +  +L      +  +R
Sbjct: 259 MKPNLSQIGMGKEISDILLFCWAFEQEER 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  124 bits (314), Expect = 1e-32
 Identities = 50/275 (18%), Positives = 99/275 (36%), Gaps = 41/275 (14%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
             R   P D     V+G+G FG+  +V  +      +  +  MK + +     +      
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD---EETQRTF 54

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
             E  ++  + HP +++         +L  I ++I GG L   +      +   Q   + 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD-------------------------GHEID 256
            +I S +++LH   I+HRDL   N L+  +                           +  
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQR 315
           +  +  ++ G   +MAPE++  + +++  D +S GI+L E++           R      
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT--MDF 232

Query: 316 IINEKVKLPPFLTSEAHSLLKGLL----HKDPSKR 346
            +N +  L  +           +       DP KR
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (307), Expect = 8e-32
 Identities = 65/256 (25%), Positives = 117/256 (45%), Gaps = 26/256 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G G    V+  +     D   +   A+K +      K+  +   + E    
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAE-----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++++H  IV +    +     YL++++I G  L  ++   G    D A  +T +I+  + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 230 HLHKCGIVHRDLKPENILMDSDGH----------EIDESS--RSNSMCGTTEYMAPEILL 277
           H H   IVHRD+KP+NIL+DS+             + E+S  ++N + GT +Y +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--Q 183

Query: 278 SKGHNKDA--DWWSVGILLYEMLTGQPPFTHAN-----RQKLQQRIINEKVKLPPFLTSE 330
           +KG   D   D +S+GI+LYEML G+PPF          + +Q  + N    +   +   
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243

Query: 331 AHSLLKGLLHKDPSKR 346
             +++     KD + R
Sbjct: 244 LSNVILRATEKDKANR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (304), Expect = 2e-31
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 30/261 (11%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + + R+VG+G  G V++ +     D   + I A+K+M +           M+ E    
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAE-----DTVRERIVALKLMSETLSSDPVFRTRMQREARTA 88

Query: 170 TKVTHPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
            ++  P +V + + F +   +LY+ +  ING  L   L RQG     +A     +I SA+
Sbjct: 89  GRLQEPHVVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----------EIDESS--RSNSMCGTTEYMAPEIL 276
              H  G  HRD+KPENIL+ +D               +    +  +  GT  YMAPE  
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK 336
                   AD +++  +LYE LTG PP+       +   I        P  ++    +  
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IPRPSTVRPGIPV 263

Query: 337 GL-------LHKDPSKRLGSG 350
                    + K+P  R  + 
Sbjct: 264 AFDAVIARGMAKNPEDRYVTC 284

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  120 bits (303), Expect = 2e-31
 Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 71/294 (24%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
           D  +   VG+G +G+V++   +G +        A+K      I           E ++  
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGEN-------VAVK------IFSSRDEKSWFRETELYN 55

Query: 169 LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
              + H  I+        S  + ++L+LI  +   G L+ +L    +      R     I
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSI 114

Query: 225 VSAVSHLH--------KCGIVHRDLKPENILMDSDGH---------------EIDESSRS 261
            S ++HLH        K  I HRDLK +NIL+  +G                       +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 262 NSMCGTTEYMAPEIL------LSKGHNKDADWWSVGILLYEMLTG----------QPPF- 304
           N   GT  YMAPE+L            K  D W+ G++L+E+             +PPF 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 305 ----THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLL----HKDPSKRL 347
                  + + +++ +  ++ +      + +    + L  L+    +++PS RL
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  119 bits (300), Expect = 1e-30
 Identities = 72/322 (22%), Positives = 126/322 (39%), Gaps = 66/322 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E   +VG+G++G V + + K     D+  I A+K   +      + +    A R+I  
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLES---DDDKMVKKIAMREIKL 77

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ H  +V L    + + + YL+ +F++   L               + Y  +I++ +
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTE-----YMAP 273
              H   I+HRD+KPENIL+   G            +  ++         E     Y AP
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY--DDEVATRWYRAP 193

Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV----- 321
           E+L+    + K  D W++G L+ EM  G+P F   +       I+        +      
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 322 KLP--------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
           K P                    P L+     L K  LH DP KR        + + HH 
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC----AELL-HHD 308

Query: 362 WFRSINWKTLEAREMQPKFKPD 383
           +F+   +    ++E+Q K + D
Sbjct: 309 FFQMDGFAERFSQELQLKVQKD 330

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 1e-29
 Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 71/298 (23%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                 ++ + +G+G +G+V+  K +G          A+K      +           E 
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWRGEK-------VAVK------VFFTTEEASWFRET 80

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           + ++LYLI D+   G L+ +L    +  +   +  
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL- 139

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGH---------------EIDE 257
               VS + HLH        K  I HRDLK +NIL+  +G                  + 
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 258 SSRSNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------Q 301
               N+  GT  YM PE+L    +         AD +S G++L+E+             Q
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 302 PPF-----THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLL----HKDPSKRL 347
            P+     +  + + +++ +  +K++      + + E    +  L+      +P+ RL
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  116 bits (293), Expect = 1e-29
 Identities = 54/318 (16%), Positives = 114/318 (35%), Gaps = 72/318 (22%)

Query: 88  IQELEHENDAELEAESER-KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
           +    H + + ++  +E         ++  V  +G FG V++ +             A+K
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVK 53

Query: 147 VMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGG 200
           +               + E ++  L  + H  I+Q     +        L+LI  F   G
Sbjct: 54  IF------PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107

Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH----------KCGIVHRDLKPENILMDS 250
            L   L    +   +        +   +++LH          K  I HRD+K +N+L+ +
Sbjct: 108 SLSDFLKANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166

Query: 251 DG------------HEIDESS-RSNSMCGTTEYMAPEIL-----LSKGHNKDADWWSVGI 292
           +              E  +S+  ++   GT  YMAPE+L       +      D +++G+
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226

Query: 293 LLYEMLTG-----------QPPF-----THANRQKLQQRIINEKVKLPP---FLTSEAHS 333
           +L+E+ +              PF      H + + +Q+ ++++K +      +      +
Sbjct: 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286

Query: 334 LLKGLL----HKDPSKRL 347
           +L   +      D   RL
Sbjct: 287 MLCETIEECWDHDAEARL 304

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  116 bits (292), Expect = 1e-29
 Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 66/317 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+G++G VF+ + +     D+  I A+K   +    + + V    A R+I  
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLES---EDDPVIKKIALREIRM 55

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
           L ++ HP +V L   F+ + +L+L+ ++ +   L      Q    E   +  T + + AV
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTE-----YMAP 273
           +  HK   +HRD+KPENIL+                +   S         E     Y +P
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----DDEVATRWYRSP 171

Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQPPF---------------------------- 304
           E+L+    +    D W++G +  E+L+G P +                            
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231

Query: 305 THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK 361
           T+     ++     +   L    P ++  A  LLKG LH DP++RL         +  H 
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC----EQLLH-HP 286

Query: 362 WFRSINWKTLEAREMQP 378
           +F +I      A+E   
Sbjct: 287 YFENIREIEDLAKEHDK 303

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  116 bits (292), Expect = 2e-29
 Identities = 64/317 (20%), Positives = 112/317 (35%), Gaps = 84/317 (26%)

Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
            A SE  +   + ++  ++G+G +G V++        G  D    A+KV          +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYK--------GSLDERPVAVKVF------SFAN 48

Query: 159 VDYMKAERDI--LTKVTHPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
                 E++I  +  + H  I +      R +   R +  L++++   G L  +L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS 108

Query: 212 FREDQARFYTAEIVSAVSHLH---------KCGIVHRDLKPENILMDSDGH--------- 253
                 R     +   +++LH         K  I HRDL   N+L+ +DG          
Sbjct: 109 DWVSSCRL-AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 254 ----------EIDESSRSNSMCGTTEYMAPEIL-------LSKGHNKDADWWSVGILLYE 296
                       +E + + S  GT  YMAPE+L         +   K  D +++G++ +E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 297 MLTG-------------QPPF-----THANRQKLQQRIINEKV--KLPP--FLTSEAHSL 334
           +                Q  F      H   + +Q  +  EK   K P      S A   
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 335 LKGLL----HKDPSKRL 347
           LK  +     +D   RL
Sbjct: 288 LKETIEDCWDQDAEARL 304

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  116 bits (292), Expect = 2e-29
 Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 71/298 (23%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
                  +   +G+G FG+V++ K +G +        A+K      I           E 
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWRGEE-------VAVK------IFSSREERSWFREA 85

Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
           +I     + H  I+           T ++L+L+ D+   G LF +L R  +  E   +  
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL- 144

Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGH---------------EIDE 257
                S ++HLH        K  I HRDLK +NIL+  +G                    
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 258 SSRSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------Q 301
               N   GT  YMAPE+L            K AD +++G++ +E+             Q
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

Query: 302 PPF-----THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLL----HKDPSKRL 347
            P+     +  + +++++ +  +K++      + + EA  ++  ++    + + + RL
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (288), Expect = 4e-29
 Identities = 63/267 (23%), Positives = 121/267 (45%), Gaps = 35/267 (13%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +     D       A+KV+R D     +     + E    
Sbjct: 12  DRYELGEILGFGGMSEVHLAR-----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66

Query: 170 TKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +              Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESS----RSNSMCGTTEYM 271
            A++  H+ GI+HRD+KP NI++ +              I +S     ++ ++ GT +Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 272 APEILLSKGHNKDA--DWWSVGILLYEMLTGQPPFTHANRQK--LQQRIINEKVKLP--- 324
           +PE   ++G + DA  D +S+G +LYE+LTG+PPFT  +      Q   + E    P   
Sbjct: 187 SPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPIPPSAR 242

Query: 325 -PFLTSEAHSLLKGLLHKDPSKRLGSG 350
              L+++  +++   L K+P  R  + 
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTA 269

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  114 bits (287), Expect = 5e-29
 Identities = 67/317 (21%), Positives = 125/317 (39%), Gaps = 91/317 (28%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G V++ +            +A+K +R            ++ E +   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIR------------LEKEDEGIP 44

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   IL ++ H  IV+L     T+ +L L+ + ++      L      +G      
Sbjct: 45  STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVT 101

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGT 267
           A+ +  ++++ +++ H   ++HRDLKP+N+L++ +G E+                    T
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKY--T 158

Query: 268 TE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII-- 317
            E     Y AP++L+ SK ++   D WSVG +  EM+ G P F      +  Q  RI   
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRI 216

Query: 318 ----NEKV-----KLP------------------PFLTSEAHSLLKGLLHKDPSKRLGSG 350
               N K      +LP                    L      LL  +L  DP++R+ + 
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA- 275

Query: 351 PGGVDAIKHHKWFRSIN 367
                A++ H +F+  N
Sbjct: 276 ---KQALE-HAYFKENN 288

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  114 bits (288), Expect = 7e-29
 Identities = 58/317 (18%), Positives = 111/317 (35%), Gaps = 87/317 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +     +G+G +G+V++          ++   A+K +R            ++ E +   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIR------------LEHEEEGVP 77

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQAR 218
                   +L ++ H  I++L+       +L+LI ++    + L  ++ +         +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-------------SSRSNSMC 265
            +  ++++ V+  H    +HRDLKP+N+L+                              
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF- 194

Query: 266 GTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT-------------- 305
            T E     Y  PEILL S+ ++   D WS+  +  EML   P F               
Sbjct: 195 -THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253

Query: 306 ----------------HANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS 349
                              +   + R    K  L   L  E   LL  +L  DP KR+ +
Sbjct: 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313

Query: 350 GPGGVDAIKHHKWFRSI 366
                +A++ H +F   
Sbjct: 314 ----KNALE-HPYFSHN 325

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  113 bits (285), Expect = 1e-28
 Identities = 76/318 (23%), Positives = 130/318 (40%), Gaps = 92/318 (28%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            ++    VG+G +G V++ K           I A+K +R            + AE +   
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIR------------LDAEDEGIP 63

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ HP IV L     +   L L+ +F+       L  +   +   ++ Q
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQ 120

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGT 267
            + Y  +++  V+H H+  I+HRDLKP+N+L++SDG  +                S   T
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSY--T 177

Query: 268 TE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII-- 317
            E     Y AP++L+ SK ++   D WS+G +  EM+TG+P F         Q  +I   
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF--PGVTDDDQLPKIFSI 235

Query: 318 ----NEKV-----KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGS 349
               N +      +LP                   P    E   LL  +L  DP+KR+ +
Sbjct: 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295

Query: 350 GPGGVDAIKHHKWFRSIN 367
                DA+  H +F+ ++
Sbjct: 296 ----RDAMN-HPYFKDLD 308

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  113 bits (284), Expect = 3e-28
 Identities = 68/321 (21%), Positives = 118/321 (36%), Gaps = 64/321 (19%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T   +  +  +   R++  
Sbjct: 12  QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQT--GEEGMP-LSTIREVAV 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L            +KL L+ + ++       +     +     +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTYLDKVPEPGVPTETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGT 267
           +    +++  +  LH   +VHRDLKP+NIL+ S G                    S+  T
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV 321
             Y APE+LL   +    D WSVG +  EM   +P F  ++      +I+       E+ 
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

Query: 322 -----KLP----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
                 LP                  +      LL   L  +P+KR+ +      A+  H
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA----YSALS-H 297

Query: 361 KWFRSINWKTLEAREMQPKFK 381
            +F+ +           P  +
Sbjct: 298 PYFQDLERCKENLDSHLPPSQ 318

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  110 bits (277), Expect = 2e-27
 Identities = 64/306 (20%), Positives = 104/306 (33%), Gaps = 62/306 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
            +E    +G GA+G V++ +     D  S    A+K +R            +   R++  
Sbjct: 10  RYEPVAEIGVGAYGTVYKAR-----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
              L    HP +V+L             K+ L+ + ++       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGT 267
           +    + +  +  LH   IVHRDLKPENIL+ S G                     +  T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII------NEKV 321
             Y APE+LL   +    D WSVG +  EM   +P F   +      +I        E  
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242

Query: 322 -----KLP----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
                 LP                P +      LL  +L  +P KR+ +      A++ H
Sbjct: 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA----FRALQ-H 297

Query: 361 KWFRSI 366
            +    
Sbjct: 298 SYLHKD 303

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  109 bits (276), Expect = 2e-27
 Identities = 61/337 (18%), Positives = 120/337 (35%), Gaps = 91/337 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            F+    +G G +  V++       +  +    A+K ++ D       T I+        
Sbjct: 6   QFKQLEKLGNGTYATVYKGL-----NKTTGVYVALKEVKLDSEEGTPSTAIR-------- 52

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHL--FFHLYRQGIFREDQAR 218
            E  ++ ++ H  IV+L     T +KL L+ +F++     ++              +  +
Sbjct: 53  -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGTTE 269
           ++  +++  ++  H+  I+HRDLKP+N+L++  G ++               N+   ++E
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTF--SSE 168

Query: 270 -----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQP--------------------- 302
                Y AP++L+ S+ ++   D WS G +L EM+TG+P                     
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228

Query: 303 ----------------PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                                  + L+Q +          L       L GLL  +P  R
Sbjct: 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLNPDMR 285

Query: 347 LGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
           L +      A+  H WF         +          
Sbjct: 286 LSAK----QALH-HPWFAEYYHHA--SMGGSRSHHHH 315

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (274), Expect = 3e-27
 Identities = 62/316 (19%), Positives = 119/316 (37%), Gaps = 87/316 (27%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +G+G +G VF+ K     + ++  I A+K +R            +  + +   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAK-----NRETHEIVALKRVR------------LDDDDEGVP 45

Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
                   +L ++ H  IV+L     +  KL L+ +F +     +        G    + 
Sbjct: 46  SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEI 102

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGT 267
            + +  +++  +   H   ++HRDLKP+N+L++ +G E+                    +
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCY--S 159

Query: 268 TE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-QRII--- 317
            E     Y  P++L  +K ++   D WS G +  E+     P    N    Q +RI    
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 318 ---NEKV-----KLP------------------PFLTSEAHSLLKGLLHKDPSKRLGSGP 351
               E+      KLP                  P L +    LL+ LL  +P +R+ +  
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-- 277

Query: 352 GGVDAIKHHKWFRSIN 367
              +A++ H +F    
Sbjct: 278 --EEALQ-HPYFSDFC 290

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  109 bits (274), Expect = 5e-27
 Identities = 70/327 (21%), Positives = 126/327 (38%), Gaps = 84/327 (25%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
            +     +G+G +  V++ K K      +D + A+K +R +       T I+        
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEEGAPCTAIR-------- 49

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFY 220
            E  +L  + H  IV L     T   L L+ ++++     +L        I      + +
Sbjct: 50  -EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLF 105

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---------DESSRSNSMCGTTE-- 269
             +++  +++ H+  ++HRDLKP+N+L++  G E+          +S  + +     E  
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTY--DNEVV 162

Query: 270 ---YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII------ 317
              Y  P+ILL S  ++   D W VG + YEM TG+P F        +Q   I       
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF--PGSTVEEQLHFIFRILGTP 220

Query: 318 NEKV-----KLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGG 353
            E+                            P L S+   LL  LL  +   R+ +    
Sbjct: 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA---- 276

Query: 354 VDAIKHHKWFRSINWKTLEAREMQPKF 380
            DA+K H +F S+  +  +  +    F
Sbjct: 277 EDAMK-HPFFLSLGERIHKLPDTTSIF 302

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  109 bits (275), Expect = 6e-27
 Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 80/311 (25%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
            +E    +G+G F  V++ + K     +++ I A+K   K   IK  H    K      A
Sbjct: 11  RYEKLDFLGEGQFATVYKARDK-----NTNQIVAIK---K---IKLGHRSEAKDGINRTA 59

Query: 165 ERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGI-FREDQARFY 220
            R+I  L +++HP I+ L  +F  +S + L+ DF+     L   +    +       + Y
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAY 117

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTE- 269
               +  + +LH+  I+HRDLKP N+L+D +G                +R+     T + 
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----THQV 173

Query: 270 ----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ--RII----- 317
               Y APE+L  ++ +    D W+VG +L E+L   P         L Q  RI      
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGT 231

Query: 318 -NEKV-----KLP-----------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGV 354
             E+       LP                      +   L++GL   +P  R+ +     
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA----T 287

Query: 355 DAIKHHKWFRS 365
            A+K  K+F +
Sbjct: 288 QALK-MKYFSN 297

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  108 bits (272), Expect = 4e-26
 Identities = 69/289 (23%), Positives = 112/289 (38%), Gaps = 68/289 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG V+Q K       DS  + A+K + +D         +   E  I+ K
Sbjct: 56  YTDTKVIGNGSFGVVYQAK-----LCDSGELVAIKKVLQDK-------RFKNRELQIMRK 103

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFINGG-HLFFHLYRQG--IFREDQARFYTA 222
           + H  IV+LRY F +         L L+LD++    +     Y +          + Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---D-----ESSRSNSMCGTTEYM--- 271
           ++  +++++H  GI HRD+KP+N+L+D D   +   D     +  R         Y+   
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSR 220

Query: 272 ---APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF----------------------- 304
              APE++  +  +    D WS G +L E+L GQP F                       
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280

Query: 305 -----THANRQKLQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
                 +    K  Q           P    EA +L   LL   P+ RL
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (269), Expect = 7e-26
 Identities = 67/325 (20%), Positives = 119/325 (36%), Gaps = 77/325 (23%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +   +V+G G+FG VFQ K             A+K + +D         +   E  I+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLV------ESDEVAIKKVLQDK-------RFKNRELQIMRI 88

Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFING---GHLFFHLYRQGIFREDQARFYTA 222
           V HP +V L+  F +         L L+L+++          +   +        + Y  
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI---D-----ESSRSNSMCGTTEYM--- 271
           +++ +++++H  GI HRD+KP+N+L+D     +   D                  Y+   
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSR 205

Query: 272 ---APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF----------------------- 304
              APE++  +  +  + D WS G ++ E++ GQP F                       
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265

Query: 305 -----THANRQKLQQRI-INEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK 358
                 +    K  Q           P    +A  L+  LL   PS R       ++A+ 
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR----LTAIEALC 321

Query: 359 HHKWF---RSINWKTLEAREMQPKF 380
           H  +F   R+   +    RE+ P F
Sbjct: 322 HP-FFDELRTGEARMPNGRELPPLF 345

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  105 bits (265), Expect = 1e-25
 Identities = 64/326 (19%), Positives = 113/326 (34%), Gaps = 97/326 (29%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
            +E    +GQG FG+VF+ +        +    A+K +             M+ E++   
Sbjct: 18  KYEKLAKIGQGTFGEVFKAR-----HRKTGQKVALKKVL------------MENEKEGFP 60

Query: 168 --------ILTKVTHPFIVQLR--------YSFQTRSKLYLILDFIN---GGHLFFHLYR 208
                   IL  + H  +V L            + +  +YL+ DF      G L      
Sbjct: 61  ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNV 117

Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES 258
              F   + +     +++ + ++H+  I+HRD+K  N+L+  DG               +
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177

Query: 259 SRSNSMCGTTE-----YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFT------- 305
             S     T       Y  PE+LL  + +    D W  G ++ EM T  P          
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237

Query: 306 -----------------------HANRQKLQQ---RIINEKVKLPPFLTSEAHSLLKGLL 339
                                     + +L +   R + +++K        A  L+  LL
Sbjct: 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLL 296

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRS 365
             DP++R+ S     DA+  H +F S
Sbjct: 297 VLDPAQRIDS----DDALN-HDFFWS 317

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  103 bits (260), Expect = 6e-25
 Identities = 57/253 (22%), Positives = 89/253 (35%), Gaps = 77/253 (30%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +EI   +G+G FGKV +      D        A+K++R       N   Y +A   E ++
Sbjct: 21  YEIVGNLGEGTFGKVVECL----DHARGKSQVALKIIR-------NVGKYREAARLEINV 69

Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLF----------FHLYRQG 210
           L K+             V +   F               GH+           F   ++ 
Sbjct: 70  LKKIKEKDKENKFL--CVLMSDWFNFH------------GHMCIAFELLGKNTFEFLKEN 115

Query: 211 IFR---EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN----- 262
            F+       R    ++  A+  LH+  + H DLKPENIL  +   E   +   +     
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 263 ------------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLYEMLTG 300
                       S     E+            PE++L  G  +  D WS+G +L+E   G
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

Query: 301 QPPF-THANRQKL 312
              F TH NR+ L
Sbjct: 236 FTLFQTHENREHL 248

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  103 bits (259), Expect = 7e-25
 Identities = 59/258 (22%), Positives = 94/258 (36%), Gaps = 70/258 (27%)

Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
               GD     +EI   +G+GAFGKV +      D        A+K+++       N   
Sbjct: 5   ICQSGDVLSARYEIVDTLGEGAFGKVVECI----DHKAGGRHVAVKIVK-------NVDR 53

Query: 161 YMKA---ERDILTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-- 207
           Y +A   E  +L  +             VQ+   F+    + ++ +      L    Y  
Sbjct: 54  YCEAARSEIQVLEHLNTTDPNSTFR--CVQMLEWFEHHGHICIVFEL-----LGLSTYDF 106

Query: 208 -----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSN 262
                    FR D  R    +I  +V+ LH   + H DLKPENIL     +    + +  
Sbjct: 107 IKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165

Query: 263 -----------------SMCGTTEYM----------APEILLSKGHNKDADWWSVGILLY 295
                            S     E+           APE++L+ G ++  D WS+G +L 
Sbjct: 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225

Query: 296 EMLTGQPPF-THANRQKL 312
           E   G   F TH +++ L
Sbjct: 226 EYYLGFTVFPTHDSKEHL 243

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (255), Expect = 5e-24
 Identities = 76/326 (23%), Positives = 124/326 (38%), Gaps = 93/326 (28%)

Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
           VG+G +G V++ K+K   DG  D  YA+K +    I        M A R+I  L ++ HP
Sbjct: 29  VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHP 78

Query: 176 FIVQLR--YSFQTRSKLYLILDF--------INGGHLFFHLYRQGIFREDQARFYTAEIV 225
            ++ L+  +      K++L+ D+        I          +         +    +I+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHEIDE------------SSRSNSMCGTTE---- 269
             + +LH   ++HRDLKP NIL+  +G E               +S    +         
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

Query: 270 --YMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPF-------THANRQKLQQ--RII 317
             Y APE+LL ++ + K  D W++G +  E+LT +P F         +N     Q  RI 
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258

Query: 318 ------NEKV-----KLP---------------------------PFLTSEAHSLLKGLL 339
                  +K      K+P                               S+A  LL+ LL
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRS 365
             DP KR+ S      A++   +F  
Sbjct: 319 TMDPIKRITS----EQAMQ-DPYFLE 339

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  102 bits (255), Expect = 6e-24
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 41/238 (17%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           +E+ +V+G+G+FG+V +       D       A+K++R       N   + +    E  I
Sbjct: 99  YEVLKVIGKGSFGQVVKAY-----DHKVHQHVALKMVR-------NEKRFHRQAAEEIRI 146

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQAR 218
           L  +       T   ++ +  +F  R+ + +   F       + L ++  F+       R
Sbjct: 147 LEHLRKQDKDNTM-NVIHMLENFTFRNHICMT--FELLSMNLYELIKKNKFQGFSLPLVR 203

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----ID-ESSRSNSMCGTTE---- 269
            +   I+  +  LHK  I+H DLKPENIL+   G      ID  SS        T     
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263

Query: 270 -YMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKVKLPP 325
            Y APE++L   +    D WS+G +L E+LTG P         +L    + E + +P 
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL--ACMIELLGMPS 319

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  100 bits (252), Expect = 8e-24
 Identities = 66/252 (26%), Positives = 98/252 (38%), Gaps = 71/252 (28%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           F + R +G G FG+V   +       D+   YA+KV+R       N   Y ++   E DI
Sbjct: 37  FLVIRKMGDGTFGRVLLCQ-----HIDNKKYYAVKVVR-------NIKKYTRSAKIEADI 84

Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFRE 214
           L K+        +  IV+    F     + LI +      L   LY         G F  
Sbjct: 85  LKKIQNDDINNNN--IVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNG-FHI 136

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTE----- 269
           +  + Y  EI+ A+++L K  + H DLKPENIL+D    E    +      G        
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 270 ----------------------------YMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
                                       Y APE++L+ G +  +D WS G +L E+ TG 
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

Query: 302 PPF-THANRQKL 312
             F TH + + L
Sbjct: 257 LLFRTHEHMEHL 268

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  100 bits (251), Expect = 1e-23
 Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 62/235 (26%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
           + + R +G G F  V+  K     D  ++   AMK++R           Y +A   E  +
Sbjct: 21  YILVRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVR-------GDKVYTEAAEDEIKL 68

Query: 169 LTKVT-----------HPFIVQLRYSFQTRSKLYLILDFINGGHL-------------FF 204
           L +V               I++L   F  +          NG H+               
Sbjct: 69  LQRVNDADNTKEDSMGANHILKLLDHFNHKGP--------NGVHVVMVFEVLGENLLALI 120

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHE--------I 255
             Y          +  + +++  + ++H+ CGI+H D+KPEN+LM+              
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180

Query: 256 DESSRS---NSMCG---TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF 304
           D  +             T EY +PE+LL       AD WS   L++E++TG   F
Sbjct: 181 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 79/299 (26%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F++ R+ GQG FG V   K     +  +    A+K + +D   +   +  M+     L  
Sbjct: 25  FQVERMAGQGTFGTVQLGK-----EKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAV 75

Query: 172 VTHPFIVQLRYSFQTRSK-------LYLILDFING---GHLFFHLYRQGIFREDQARFYT 221
           + HP IVQL+  F T  +       L ++++++          +  RQ        + + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 222 AEIVSAVSHLHKC--GIVHRDLKPENILMDSDGHEI---D-----ESSRSNSMCGTTEYM 271
            +++ ++  LH     + HRD+KP N+L++     +   D     + S S        Y+
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYI 192

Query: 272 ------APEILL-SKGHNKDADWWSVGILLYEMLTGQP---------------------- 302
                 APE++  ++ +    D WSVG +  EM+ G+P                      
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

Query: 303 --------------PFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
                            ++          +  +K       EA+ LL  LL   P +R+
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK----EAYDLLSALLQYLPEERM 307

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 97.1 bits (242), Expect = 6e-23
 Identities = 33/244 (13%), Positives = 74/244 (30%), Gaps = 30/244 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
           G + +    G     + +Q       D   D   A+  +    ++  + +    +    L
Sbjct: 31  GRYRLLIFHGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           +++  P + ++     TR+   ++ ++I GG L   +          A      + +A  
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSP-SPVGAIRAMQSLAAAAD 143

Query: 230 HLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWS 289
             H+ G+      P  + +  DG           +      M          N   D   
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGD---------VVLAYPATMPDA-------NPQDDIRG 187

Query: 290 VGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKD 342
           +G  LY +L  + P       +     +R    +   P      +  +  ++    +  D
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247

Query: 343 PSKR 346
              R
Sbjct: 248 GGIR 251

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 62/265 (23%), Positives = 112/265 (42%), Gaps = 54/265 (20%)

Query: 95  NDAELEAESERKIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           ND   +   +  +  G+     +EI  ++G+G+FG+V +       D       A+K+++
Sbjct: 34  NDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-----DRVEQEWVAIKIIK 88

Query: 150 KDTIIKKNHVDYMKA---ERDILTKVTHP------FIVQLRYSFQTRSKLYLILDFINGG 200
                  N   ++     E  +L  +         +IV L+  F  R+ L L+ +     
Sbjct: 89  -------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----- 136

Query: 201 HLFFHLY-------RQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDSD 251
            L ++LY        +G    +  R +  ++ +A+  L   +  I+H DLKPENIL+ + 
Sbjct: 137 MLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195

Query: 252 GHE----ID------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ 301
                  +D         R      +  Y +PE+LL   ++   D WS+G +L EM TG+
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

Query: 302 PPF-THANRQKLQQRIINEKVKLPP 325
           P F       ++    I E + +PP
Sbjct: 256 PLFSGANEVDQM--NKIVEVLGIPP 278

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 59/302 (19%), Positives = 107/302 (35%), Gaps = 76/302 (25%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + +G G  G VF        D D D   A+K   K  I+  +      A R+I
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAV-----DNDCDKRVAIK---K--IVLTDPQSVKHALREI 59

Query: 169 --LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLY--------RQGIFRE 214
             + ++ H  IV++      S    +     L  +N  ++              QG   E
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI------------DESSRSN 262
           + AR +  +++  + ++H   ++HRDLKP N+ ++++   +               S   
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 263 SMCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF----------- 304
            +   +E +      +P +LLS   + K  D W+ G +  EMLTG+  F           
Sbjct: 180 HL---SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236

Query: 305 ----------------THANRQKLQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSK 345
                                  ++  +      L    P ++ EA   L+ +L   P  
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 346 RL 347
           RL
Sbjct: 297 RL 298

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 57/297 (19%), Positives = 112/297 (37%), Gaps = 77/297 (25%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
             D+++ R +G+G + +VF+       +  ++    +K+++         V   K +R+I
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAI-----NITNNEKVVVKILKP--------VKKKKIKREI 81

Query: 169 --LTKVT-HPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             L  +   P I+ L    +        L+ + +N          Q    +   RFY  E
Sbjct: 82  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQ-TLTDYDIRFYMYE 138

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCGTTEYMA 272
           I+ A+ + H  GI+HRD+KP N+++D +  ++                 N    +  +  
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 273 PEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN----------------------- 308
           PE+L+  + ++   D WS+G +L  M+  + PF H +                       
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258

Query: 309 ------------------RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRL 347
                             R++ ++ + +E       ++ EA   L  LL  D   RL
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQ---HLVSPEALDFLDKLLRYDHQSRL 312

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 61/304 (20%), Positives = 107/304 (35%), Gaps = 80/304 (26%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKDTIIKKNHVDY 161
              + + R +  G++G V           DS+G       ++      +   I  +    
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYR-----Q 209
            +  R+I  L    HP I+ LR     +      KLYL+ + +        L +     +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128

Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI-D-----ESSRSN 262
            +      +++   I+  +  LH+ G+VHRDL P NIL+  +    I D     E +   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 263 SMCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKL 312
           +    T Y+      APE+++  KG  K  D WS G ++ EM   +  F   T  N+   
Sbjct: 189 NK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245

Query: 313 Q------------QRIINEKVK------LP-----------PFLTSEAHSLLKGLLHKDP 343
                            +   +      L            P     A  L+  +L  +P
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305

Query: 344 SKRL 347
            +R+
Sbjct: 306 QRRI 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 60/309 (19%), Positives = 119/309 (38%), Gaps = 90/309 (29%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
             DF++  ++G+GA+G V            +  I A         IKK       +  ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSAT-----HKPTGEIVA---------IKKIEPFDKPLFALR 55

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L    H  I+ +    +  S      +Y+I + +    H    +    +  +D
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDD 112

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------------GHEIDE 257
             +++  + + AV  LH   ++HRDLKP N+L++S+                      + 
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 258 SSRSNSMCGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THA 307
           + + + M    E++      APE++L+   +++  D WS G +L E+   +P F    + 
Sbjct: 173 TGQQSGM---VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

Query: 308 N-------------RQKLQQRIINEKVK-----LP-----------PFLTSEAHSLLKGL 338
           +                  + I + + +     LP           P +  +   LL+ +
Sbjct: 230 HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289

Query: 339 LHKDPSKRL 347
           L  DP+KR+
Sbjct: 290 LVFDPAKRI 298

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.5 bits (230), Expect = 8e-21
 Identities = 62/321 (19%), Positives = 112/321 (34%), Gaps = 100/321 (31%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           + + + +G G+FG V +V      D +S   +A+K   K     +    Y   E DI+  
Sbjct: 9   YSLGKTLGTGSFGIVCEVF-----DIESGKRFALK---KVLQDPR----YKNRELDIMKV 56

Query: 172 VTHPFIVQLRYSFQTRSK--------------------------------------LYLI 193
           + H  I++L   F T                                         L +I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 194 LDFINGG-HLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
           ++++    H     + +       +    Y  ++  AV  +H  GI HRD+KP+N+L++S
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 251 DGHEI---D-----ESSRSNSMCGTTEYM------APEILL-SKGHNKDADWWSVGILLY 295
             + +   D     +   S        Y+      APE++L +  +    D WS+G +  
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 296 EMLTGQPPF----------------------------THANRQKLQQRI-INEKVKLPPF 326
           E++ G+P F                             H    +       + +  LP  
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG 293

Query: 327 LTSEAHSLLKGLLHKDPSKRL 347
             S A  LL+ +L  +P  R+
Sbjct: 294 TPSLAIDLLEQILRYEPDLRI 314

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 67/301 (22%), Positives = 116/301 (38%), Gaps = 82/301 (27%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
              +     +G+GA+G V         D  +    A         IKK     +     +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVA---------IKKISPFEHQTYCQR 71

Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
             R+I  L +  H  I+ +    +  +      +Y++ D +    +    L +      D
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY---KLLKTQHLSND 128

Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSM 264
              ++  +I+  + ++H   ++HRDLKP N+L+++                 +   +  +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 265 CGTTEYM------APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR-------- 309
              TEY+      APEI+L+ KG+ K  D WSVG +L EML+ +P F   +         
Sbjct: 189 ---TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

Query: 310 -------QKLQQRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKR 346
                  Q+    IIN K +     LP           P   S+A  LL  +L  +P KR
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305

Query: 347 L 347
           +
Sbjct: 306 I 306

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.3 bits (224), Expect = 9e-20
 Identities = 60/299 (20%), Positives = 110/299 (36%), Gaps = 71/299 (23%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   D   A+K   K +   +N     +A R++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAY-----DAVLDRNVAIK---KLSRPFQNQTHAKRAYREL 112

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        + +    +YL+++ +        + +  +   ++  + 
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYL 169

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY 270
             +++  + HLH  GI+HRDLKP NI++ SD                S        T  Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-------------- 316
            APE++L  G+ ++ D WSVG ++ EM+  +  F   +      ++              
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 317 INEKVK----------------------------LPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   V+                                  S+A  LL  +L  DP+KR+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 66/291 (22%), Positives = 122/291 (41%), Gaps = 66/291 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K   K     ++ +   +A R++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIK---KLYRPFQSELFAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARF 219
             L  + H  ++ L        +    +  YL++ F+         L +     ED+ +F
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQF 132

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI-D---ESSRSNSMCGTTEYM--- 271
              +++  + ++H  GI+HRDLKP N+ ++ D   +I D        + M   T Y+   
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTR 189

Query: 272 ---APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ----------- 313
              APE++L+   + +  D WSVG ++ EM+TG+  F    H ++ K             
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 314 -QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 347
            QR+ +++ K     LP              +  A +LL+ +L  D  +R+
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 65/290 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  +     VG GA+G V         D  S    A+K   K +   ++ +   +A R++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIK---KLSRPFQSEIFAKRAYREL 74

Query: 169 --LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L   F   S        YL++ F+    L         F E++ ++ 
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL--QKIMGLKFSEEKIQYL 131

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--ID---ESSRSNSMCGTTEYM---- 271
             +++  + ++H  G+VHRDLKP N+ ++ D     +D          M   T Y+    
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRW 188

Query: 272 --APEILLS-KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQ------------ 313
             APE++LS   +N+  D WSVG ++ EMLTG+  F    + ++                
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248

Query: 314 QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 347
           Q++ ++  K     LP           P  + +A  LL+ +L  D  KRL
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 61/296 (20%), Positives = 124/296 (41%), Gaps = 24/296 (8%)

Query: 68  SHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVF 127
           ++   G        S      + ++ E+   + +  + +I     E+ R +G+G FG V 
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVH 407

Query: 128 QVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185
               +G+     +     A+K  +  T        +++ E   + +  HP IV+L     
Sbjct: 408 ----QGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQ-EALTMRQFDHPHIVKL-IGVI 460

Query: 186 TRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
           T + +++I++    G L   L  R+          Y  ++ +A+++L     VHRD+   
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520

Query: 245 NILMDSDGH----------EIDESSRSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGI 292
           N+L+ S+             +++S+   +  G    ++MAPE +  +     +D W  G+
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580

Query: 293 LLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            ++E+L  G  PF    N   + +    E++ +PP      +SL+      DPS+R
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 64/290 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V         D  +    A+K   K +   ++ +   +  R++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVK---KLSRPFQSIIHAKRTYREL 79

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             L  + H  ++ L        S +  + +YL+   +  G    ++ +     +D  +F 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--ID---ESSRSNSMCGTTEYM---- 271
             +I+  + ++H   I+HRDLKP N+ ++ D     +D       ++ M   T Y+    
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGYVATRW 194

Query: 272 --APEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANR---------------QKLQ 313
             APEI+L+   +N+  D WSVG ++ E+LTG+  F   +                 +L 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254

Query: 314 QRIINEKVK-----LP-----------PFLTSEAHSLLKGLLHKDPSKRL 347
           ++I +E  +     L                  A  LL+ +L  D  KR+
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 71/299 (23%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V         D   +   A+K   K +   +N     +A R++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAIK---KLSRPFQNQTHAKRAYREL 75

Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             +  V H  I+ L        S +    +Y++++ +        + +  +   ++  + 
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMEL-DHERMSYL 132

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY 270
             +++  + HLH  GI+HRDLKP NI++ SD                S        T  Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-------------- 316
            APE++L  G+ ++ D WSVG ++ EM+ G   F   +      ++              
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 317 INEKVK----------------------------LPPFLTSEAHSLLKGLLHKDPSKRL 347
           +   V+                                  S+A  LL  +L  D SKR+
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 56/266 (21%), Positives = 110/266 (41%), Gaps = 36/266 (13%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTT 268
             +I   +++L    +VHRDL   N+L+ +  H              +E           
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-----AE 177

Query: 269 E------YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFT-HANRQKLQQRIINEK 320
                  +MA E +L + +   +D WS G+ ++E++T G  P+      +        E+
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

Query: 321 VKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +  PP  T + + +++     D   R
Sbjct: 238 LPQPPICTIDVYMIMRKCWMIDADSR 263

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 53/263 (20%), Positives = 104/263 (39%), Gaps = 28/263 (10%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMK 163
           KI   D      +GQG F K+F+  ++ V D          +KV+ K      N+ +   
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFF 60

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
               +++K++H  +V   Y          L+ +F+  G L  +L + +            
Sbjct: 61  EAASMMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---------SNSMCGTTEY-- 270
            ++ +A+  L +  ++H ++  +NIL+  +      +           S ++        
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179

Query: 271 ----MAPE-ILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
               + PE I   K  N   D WS G  L+E+ + G  P     +++KLQ     ++ +L
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF--YEDRHQL 237

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P    +E  +L+   +  +P  R
Sbjct: 238 PAPKAAELANLINNCMDYEPDHR 260

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 48/277 (17%), Positives = 98/277 (35%), Gaps = 50/277 (18%)

Query: 101 AESERKIGPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
              E  +      +  + +G G FG V     KG           A+K+++ +       
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVK----KGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
            + +  E +++ ++ +P+IV++           L+++    G L  +L +    ++    
Sbjct: 63  DELLA-EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCG 266
               ++   + +L +   VHRDL   N+L+ +  +              DE+        
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-------- 172

Query: 267 TTEY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANR 309
              Y             APE +    + K    +D WS G+L++E  + GQ P+      
Sbjct: 173 --YYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227

Query: 310 QKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +        E++  P     E + L+      D   R
Sbjct: 228 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 58/270 (21%), Positives = 109/270 (40%), Gaps = 44/270 (16%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
           + +I     E+ R +G+G FG V     +G+     +     A+K  +  T        +
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTS-DSVREKF 63

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           ++ E   + +  HP IV+L     T + +++I++    G L   L  R+          Y
Sbjct: 64  LQ-EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY 270
             ++ +A+++L     VHRD+   N+L+ S+             +++S           Y
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----------TY 171

Query: 271 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRI 316
                       MAPE +  +     +D W  G+ ++E+L  G  PF    N   + +  
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

Query: 317 INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             E++ +PP      +SL+      DPS+R
Sbjct: 232 NGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 57/263 (21%), Positives = 111/263 (42%), Gaps = 30/263 (11%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R +   +F+  +V+G GAFG V+    KG+   +G+   I  A+K +R+ T   K + + 
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
           +  E  ++  V +P + +L       S + LI   +  G L  ++   +          +
Sbjct: 65  LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGT- 267
             +I   +++L    +VHRDL   N+L+ +  H              +E        G  
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGK 180

Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++MA E +L + +   +D WS G+ ++E++T G  P+      +        E++  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           PP  T + + ++      D   R
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSR 263

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 31/266 (11%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
              IG  D  +   +G G+FG V     +G  D  S      A+K ++ D + +   +D 
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVR----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
              E + +  + H  +++L Y       + ++ +    G L   L   QG F       Y
Sbjct: 68  FIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY 270
             ++   + +L     +HRDL   N+L+ +              + ++     M    + 
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 271 ----MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVK 322
                APE L           +D W  G+ L+EM T GQ P+   N  ++  +I  E  +
Sbjct: 187 PFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243

Query: 323 L--PPFLTSEAHSLLKGLLHKDPSKR 346
           L  P     + ++++       P  R
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDR 269

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 69/310 (22%), Positives = 129/310 (41%), Gaps = 51/310 (16%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 143 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 194

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 195 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 244

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 245 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 233 KCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           +   VHRDL+  NIL+  +              E +E +         ++ APE  L   
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 281 HNKDADWWSVGILLYEMLT-GQPPFTH-ANRQKLQQRIINEKVKLP-PFLTSEA-HSLLK 336
               +D WS GILL E+ T G+ P+    NR+ L Q  +    ++P P    E+ H L+ 
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VERGYRMPCPPECPESLHDLMC 415

Query: 337 GLLHKDPSKR 346
               K+P +R
Sbjct: 416 QCWRKEPEER 425

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 68/310 (21%), Positives = 118/310 (38%), Gaps = 39/310 (12%)

Query: 64  IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEA--ESERKIGPGDFEIFRVVGQG 121
           +H+  H   G    Y        Q     H  +    A     R+I      I +++G G
Sbjct: 1   MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 122 AFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
             G+V      G            A+K ++     ++   D++  E  I+ +  HP I++
Sbjct: 61  DSGEVC----YGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLS-EASIMGQFDHPNIIR 114

Query: 180 LRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
           L     TR +   ++ +++  G L   L    G F   Q       + + + +L   G V
Sbjct: 115 L-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173

Query: 238 HRDLKPENILMDSDGH------------EIDESSRSNSMCGT--TEYMAPEILLSKGHNK 283
           HRDL   N+L+DS+              E D  +   +  G     + APE +       
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA---FRT 230

Query: 284 ---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL--PPFLTSEAHSLLK 336
               +D WS G++++E+L  G+ P+    NR  +    + E  +L  P       H L+ 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEEGYRLPAPMGCPHALHQLML 288

Query: 337 GLLHKDPSKR 346
              HKD ++R
Sbjct: 289 DCWHKDRAQR 298

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 54/263 (20%), Positives = 102/263 (38%), Gaps = 30/263 (11%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
           R     +    +V+G G FG V     KGV   +G+S  I   +KV+   +  +++    
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVH----KGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAV 62

Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
                  +  + H  IV+L       S L L+  ++  G L  H+   +G         +
Sbjct: 63  TD-HMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGT- 267
             +I   + +L + G+VHR+L   N+L+ S                 D+     S     
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAK 178

Query: 268 --TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKL 323
              ++MA E +    +   +D WS G+ ++E++T G  P+      +        E++  
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ 238

Query: 324 PPFLTSEAHSLLKGLLHKDPSKR 346
           P   T + + ++      D + R
Sbjct: 239 PQICTIDVYMVMVKCWMIDENIR 261

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 61/271 (22%), Positives = 116/271 (42%), Gaps = 38/271 (14%)

Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNH 158
           +   +I P      +V+G G FG+V+    KG+     G  +   A+K ++     +K  
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVY----KGMLKTSSGKKEVPVAIKTLKAGYT-EKQR 90

Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
           VD++  E  I+ + +H  I++L     ++ K + +I +++  G L   L  + G F   Q
Sbjct: 91  VDFLG-EAGIMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--------GHEIDESSRSNSMCGTT 268
                  I + + +L     VHRDL   NIL++S+        G      SR        
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL-----SRVLEDDPEA 203

Query: 269 EY-----------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQR 315
            Y            APE +  +     +D WS GI+++E++T G+ P+   +N + ++  
Sbjct: 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

Query: 316 IINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
               ++  P    S  + L+     ++ ++R
Sbjct: 264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARR 294

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 44/267 (16%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKA 164
           I   D  + R++G+G FG+V+    +GV           A+K  +KD     N   +M  
Sbjct: 9   IAREDVVLNRILGEGFFGEVY----EGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMS- 62

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+  + HP IV+L          ++I++    G L  +L   +   +      Y+ +
Sbjct: 63  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY--- 270
           I  A+++L     VHRD+   NIL+ S              I++           +Y   
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----------DYYKA 171

Query: 271 ---------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINE 319
                    M+PE +  +     +D W   + ++E+L+ G+ PF    N+  +      +
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231

Query: 320 KVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           ++  P       ++L+      DPS R
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDR 258

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 56/257 (21%), Positives = 112/257 (43%), Gaps = 27/257 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 217 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 267

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 268 AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYM 271
           I SA+ +L K   +HR+L   N L+  +                D  +         ++ 
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTS 329
           APE L     +  +D W+ G+LL+E+ T G  P+      Q  +    + +++ P     
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 446

Query: 330 EAHSLLKGLLHKDPSKR 346
           + + L++     +PS R
Sbjct: 447 KVYELMRACWQWNPSDR 463

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 64/273 (23%), Positives = 121/273 (44%), Gaps = 27/273 (9%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
           E+  +   E  +++   +  I +VVG G FG+V   + K     +     A+K ++    
Sbjct: 29  EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGY- 85

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGI 211
            +K   D++  E  I+ +  HP I++L     T+SK + ++ +++  G L   L      
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESS 259
           F   Q       I S + +L   G VHRDL   NIL++S+              E D  +
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203

Query: 260 RSNSMCGT--TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQR 315
              +  G     + +PE +  +     +D WS GI+L+E+++ G+ P+   +N+  ++  
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA- 262

Query: 316 IINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 346
            ++E  +L  P    +  + L+     KD + R
Sbjct: 263 -VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 68/308 (22%), Positives = 126/308 (40%), Gaps = 47/308 (15%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++   S    G   R  L++  P    + +       E      I      +   +GQ
Sbjct: 226 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 277

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG+V+     G          A+K ++  T+  +    +++ E  ++ K+ H  +VQL
Sbjct: 278 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 327

Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
            Y+  +   +Y++ ++++ G L   L      + +  ++          A+I S ++++ 
Sbjct: 328 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 233 KCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILLSKG 280
           +   VHRDL+  NIL+  +              E +E +         ++ APE  L   
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 281 HNKDADWWSVGILLYEMLT-GQPPFTH-ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
               +D WS GILL E+ T G+ P+    NR+ L Q     ++  PP      H L+   
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500

Query: 339 LHKDPSKR 346
             K+P +R
Sbjct: 501 WRKEPEER 508

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 49/259 (18%), Positives = 116/259 (44%), Gaps = 33/259 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V        D        A+K +R+  + ++   D+++ E 
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE---DFIE-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
           +++ K++HP +VQL Y        + L+ +F+  G L  +L  ++G+F  +       ++
Sbjct: 55  EVMMKLSHPKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGT--TEYMA 272
              +++L +  ++HRDL   N L+  +             + +   ++S       ++ +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173

Query: 273 PEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFL 327
           PE+      ++    +D WS G+L++E+ + G+ P+   +N + ++      ++  P   
Sbjct: 174 PEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 230

Query: 328 TSEAHSLLKGLLHKDPSKR 346
           ++  + ++     + P  R
Sbjct: 231 STHVYQIMNHCWRERPEDR 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 52/278 (18%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I    F + R++G+G FG V + + K  D        A+K+++ D I   +  ++++ E 
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK--VAVKMLKADIIASSDIEEFLR-EA 76

Query: 167 DILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
             + +  HP + +L        +        +IL F+  G L   L       E+     
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLP 135

Query: 220 ------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNS 263
                 +  +I   + +L     +HRDL   N ++  D            +I        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----- 190

Query: 264 MCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THAN 308
                +Y             +A E L    +   +D W+ G+ ++E++T GQ P+    N
Sbjct: 191 -----DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245

Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
            +     I   ++K PP    E + L+      DP +R
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 29/220 (13%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
                +      +  + +G+G FG V   +   + D   + + A+K ++  T  +++  D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHST--EEHLRD 57

Query: 161 YMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQ 216
           + + E +IL  + H  IV+ +   YS   R+ L LI++++  G L  +L + +      +
Sbjct: 58  FER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIK 115

Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCG 266
              YT++I   + +L     +HRDL   NIL++++             + +      +  
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175

Query: 267 TTEY----MAPEILLSKGHNK---DADWWSVGILLYEMLT 299
             E      APE L     +K    +D WS G++LYE+ T
Sbjct: 176 PGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYELFT 212

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 55/258 (21%), Positives = 103/258 (39%), Gaps = 27/258 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G+G FG+VF     G    D+  + A+K  R+          +++ E 
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVF----SGRLRADNTLV-AVKSCRETLP-PDLKAKFLQ-EA 163

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            IL + +HP IV+L     T+ + +Y++++ + GG     L       R         + 
Sbjct: 164 RILKQYSHPNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY---- 270
            + + +L     +HRDL   N L+               E  +     +  G  +     
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKW 281

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLT 328
            APE L    ++ ++D WS GILL+E  + G  P+   +N+Q  +      ++  P    
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341

Query: 329 SEAHSLLKGLLHKDPSKR 346
                L++     +P +R
Sbjct: 342 DAVFRLMEQCWAYEPGQR 359

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 51/264 (19%), Positives = 113/264 (42%), Gaps = 31/264 (11%)

Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
            +   +I     ++ + +G G FG+V+                A+K M+  ++  +    
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK------VAVKTMKPGSMSVE---A 229

Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR 218
           ++  E +++  + H  +V+L ++  T+  +Y+I +F+  G L  F            +  
Sbjct: 230 FLA-EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCG 266
            ++A+I   ++ + +   +HRDL+  NIL+ +               E +E +       
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347

Query: 267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLP 324
             ++ APE +        +D WS GILL E++T G+ P+   +N + ++   +    ++P
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--LERGYRMP 405

Query: 325 -PFLTSEA-HSLLKGLLHKDPSKR 346
            P    E  ++++       P +R
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEER 429

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 51/244 (20%), Positives = 102/244 (41%), Gaps = 29/244 (11%)

Query: 77  RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD 136
            +        +    +    +  E     +      +  + +G+G FG V   +   + D
Sbjct: 8   HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67

Query: 137 GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLI 193
              + + A+K ++  T  +++  D+ + E +IL  + H  IV+ +   YS   R+ L LI
Sbjct: 68  NTGEVV-AVKKLQHST--EEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLI 122

Query: 194 LDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++++  G L  +L + +      +   YT++I   + +L     +HRDL   NIL++++ 
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182

Query: 253 H----------EIDESSRSNSMCGTTEY----MAPEILLSKGHNK---DADWWSVGILLY 295
                       + +      +    E      APE L     +K    +D WS G++LY
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLY 239

Query: 296 EMLT 299
           E+ T
Sbjct: 240 ELFT 243

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 39/212 (18%)

Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAERDILTKVTH 174
            +G+G FG V+    KG  +       A+K +     I        +   E  ++ K  H
Sbjct: 38  KMGEGGFGVVY----KGYVNN---TTVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQH 89

Query: 175 PFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA------RFYTAE-IVS 226
             +V+L  +S        L+  ++  G L   L       +         R   A+   +
Sbjct: 90  ENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAAN 144

Query: 227 AVSHLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSMCGTTEYMAP 273
            ++ LH+   +HRD+K  NIL+D                 +  ++  ++ + GTT YMAP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204

Query: 274 EILLSKGH-NKDADWWSVGILLYEMLTGQPPF 304
           E L  +G     +D +S G++L E++TG P  
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLPAV 234

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 48/234 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +E+ + +G+GA+G V++       D  +  + A+K   K     +N  D  +  R+I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSI-----DRRTGEVVAVK---KIFDAFQNSTDAQRTFREI 59

Query: 169 --LTK-VTHPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
             LT+   H  IV L    +  +   +YL+ D++        + R  I      ++   +
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQ 117

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------------------EIDESSRS 261
           ++  + +LH  G++HRD+KP NIL++++ H                       +  +  +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 262 NSMCGTTEYM----------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPF 304
            +       +          APEILL S  + K  D WS+G +L E+L G+P F
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 65/303 (21%), Positives = 106/303 (34%), Gaps = 68/303 (22%)

Query: 93  HENDAELEAESERK-IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVM 148
           H + A+L A  +         +    +G+G FG V         D   D      A+K +
Sbjct: 5   HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVE----LCRYDPLGDNTGALVAVKQL 60

Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFH 205
           +     ++   D+ + E  IL  +   FIV+ R   Y    +S L L+++++  G L   
Sbjct: 61  QHSGPDQQR--DFQR-EIQILKALHSDFIVKYRGVSYGPGRQS-LRLVMEYLPSGCLRDF 116

Query: 206 LYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------E 254
           L R +      +   Y+++I   + +L     VHRDL   NIL++S+ H           
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

Query: 255 IDESSRSNSMCGTTEY------------MAPEILLSKGHNK---DADWWSVGILLYEMLT 299
           +              Y             APE L     N     +D WS G++LYE+ T
Sbjct: 177 LPLDK--------DYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVVLYELFT 225

Query: 300 -GQPPFTHANRQKLQQRIINEKVKL---------------PPFLTSEAHSLLKGLLHKDP 343
                 + +           +   L               PP   +E H L+K      P
Sbjct: 226 YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285

Query: 344 SKR 346
             R
Sbjct: 286 QDR 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 48/274 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D  +DG     A+K ++ D    ++   + + E D
Sbjct: 32  YLKKIRDLGEGHFGKVS----LYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQ-EID 85

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
           IL  + H  I++ +        + L L+++++  G L  +L R  I       F   +I 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF-AQQIC 144

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY----M 271
             +++LH    +HRDL   N+L+D+D             + E      +    +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 272 APEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFTHANRQKL-----QQRIINEKV- 321
           APE L      K    +D WS G+ LYE+LT      +   +        Q ++   ++ 
Sbjct: 205 APECLK---EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 322 ---------KLPPFLTSEAHSLLKGLLHKDPSKR 346
                      P    +E + L+K     + S R
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 53/268 (19%), Positives = 118/268 (44%), Gaps = 51/268 (19%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G  D       A+K++++ ++ +    ++++ E 
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSED---EFIE-EA 70

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
            ++  ++H  +VQL Y   T+ + +++I +++  G L  +L   +  F+  Q      ++
Sbjct: 71  KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY---- 270
             A+ +L     +HRDL   N L++  G            + +           EY    
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----------DEYTSSV 179

Query: 271 --------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEK 320
                     PE+L+    +  +D W+ G+L++E+ + G+ P+    N +  +   I + 
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQG 237

Query: 321 VKL--PPFLTSEAHSLLKGLLHKDPSKR 346
           ++L  P   + + ++++    H+   +R
Sbjct: 238 LRLYRPHLASEKVYTIMYSCWHEKADER 265

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 56/306 (18%), Positives = 114/306 (37%), Gaps = 61/306 (19%)

Query: 80  LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
           ++S  P      +     E E      +      + R +GQG+FG V++   KGV   + 
Sbjct: 1   MASVNPEYFSAADVYVPDEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEP 54

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFIN 198
           +   A+K + +     +  ++++  E  ++ +     +V+L     ++ +   +I++ + 
Sbjct: 55  ETRVAIKTVNEAA-SMRERIEFLN-EASVMKEFNCHHVVRL-LGVVSQGQPTLVIMELMT 111

Query: 199 GGHL--FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILM 248
            G L  +    R  +         +         EI   +++L+    VHRDL   N ++
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171

Query: 249 DSDGH----------EIDESSRSNSMCGTTEY-------------MAPEILLSKGHNKDA 285
             D            +I E          T+Y             M+PE L        +
Sbjct: 172 AEDFTVKIGDFGMTRDIYE----------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221

Query: 286 DWWSVGILLYEMLT-GQPPF-THANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLH 340
           D WS G++L+E+ T  + P+   +N Q    + +  + +K   P         L++    
Sbjct: 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQ 278

Query: 341 KDPSKR 346
            +P  R
Sbjct: 279 YNPKMR 284

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 74.5 bits (184), Expect = 5e-15
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 46/220 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYM------K 163
           +F+   ++G G FGKV+    KGV  DG        KV      +K+   +        +
Sbjct: 40  NFDHKFLIGHGVFGKVY----KGVLRDG-------AKVA-----LKRRTPESSQGIEEFE 83

Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARF 219
            E + L+   HP +V L  +  + R+++ LI  ++  G+L  HLY   +       + R 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 220 YTAEIVSA--VSHLHKCGIVHRDLKPENILMDSD-------------GHEIDESSRSNSM 264
               I +A  + +LH   I+HRD+K  NIL+D +             G E+D++  S  +
Sbjct: 143 EIC-IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 265 CGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPP 303
            GT  Y+ PE  +  G   + +D +S G++L+E+L  +  
Sbjct: 202 KGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSA 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 36/280 (12%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKV 147
           EL       +   S   +         V+G+G FG V+     G   D+       A+K 
Sbjct: 10  ELVQAVQHVVIGPSSLIV-----HFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKS 60

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FF 204
           +            ++  E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 61  L-NRITDIGEVSQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------E 254
                    +D   F   ++   + +L     VHRDL   N ++D              +
Sbjct: 119 RNETHNPTVKDLIGF-GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 255 IDESSRSNSMCGTTE------YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHA 307
           + +     S+   T       +MA E L ++     +D WS G+LL+E++T G PP+   
Sbjct: 178 MYDKE-YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

Query: 308 NRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           N   +   ++   ++  P +     + ++    H     R
Sbjct: 237 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 52/278 (18%), Positives = 106/278 (38%), Gaps = 47/278 (16%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +   +++ +D++ 
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM 82

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT- 221
            E  I++K  H  IV+       +S   +++++ + GG L   L R+   R  Q      
Sbjct: 83  -EALIISKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139

Query: 222 -------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMC-----G--- 266
                   +I     +L +   +HRD+   N L+   G           +      G   
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--------PGRVAKIGDFGMAR 191

Query: 267 ---TTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHAN 308
                 Y             M PE  +        D WS G+LL+E+ +    P  + +N
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

Query: 309 RQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           ++ L+      ++  P       + ++       P  R
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 58/322 (18%), Positives = 112/322 (34%), Gaps = 31/322 (9%)

Query: 49  QSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIG 108
             P  +    G   +    +  +                  +L   N   ++A     IG
Sbjct: 26  LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85

Query: 109 PGDFEI--FRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           P    +    V+G+G FG V+     G   D+       A+K +            ++  
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT- 139

Query: 165 ERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
           E  I+   +HP ++ L     ++     ++L ++  G L  F          +D   F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-G 198

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGT- 267
            ++   +  L     VHRDL   N ++D                ++ +  S  N      
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 268 -TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLP 324
             ++MA E L ++     +D WS G+LL+E++T G PP+   N   +   ++   ++  P
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318

Query: 325 PFLTSEAHSLLKGLLHKDPSKR 346
            +     + ++    H     R
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMR 340

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 65/300 (21%)

Query: 50  SPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP 109
           S  + +A   +    H  S S      R    SS P           +     S+ +I  
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTA---------SMPRPHSDWQIPD 53

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             +EI  ++G G++G V +       D     + A+K   K   + ++ +D  +  R+I 
Sbjct: 54  -RYEIRHLIGTGSYGHVCEAY-----DKLEKRVVAIK---KILRVFEDLIDCKRILREIA 104

Query: 169 -LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            L ++ H  +V++         +   +LY++L+                  E   +    
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY 163

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGT----- 267
            ++  V ++H  GI+HRDLKP N L++ D             +D     NS         
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 268 -----------------TEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPP 303
                            T ++      APE++L  + + +  D WS+G +  E+L     
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 54/261 (20%), Positives = 119/261 (45%), Gaps = 37/261 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   +  + + +G G FG V   K KG  D       A+K++++ ++ +    ++ + E 
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYD------VAVKMIKEGSMSED---EFFQ-EA 54

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
             + K++HP +V+  Y   ++   +Y++ ++I+ G L  +L          Q      ++
Sbjct: 55  QTMMKLSHPKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGT--TEYMA 272
              ++ L     +HRDL   N L+D D             + +    +S+      ++ A
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173

Query: 273 PEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLP-PF 326
           PE+     + K    +D W+ GIL++E+ + G+ P+  + N + + +  +++  +L  P 
Sbjct: 174 PEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--VSQGHRLYRPH 228

Query: 327 LTSEA-HSLLKGLLHKDPSKR 346
           L S+  + ++    H+ P KR
Sbjct: 229 LASDTIYQIMYSCWHELPEKR 249

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 59/313 (18%), Positives = 98/313 (31%), Gaps = 75/313 (23%)

Query: 85  PLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYA 144
            + I   +   D + E               + +G GAFGKV +    G+   D+    A
Sbjct: 4   YVYIDPTQLPYDHKWE------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA 57

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K M K +         M  E  +L+ +  H  IV L     T      +I ++   G L
Sbjct: 58  VK-MLKPSAHLTEREALMS-ELKVLSYLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDL 114

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                     F          ED               ++   ++ L     +HRDL   
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174

Query: 245 NILMDSDG-------------HEIDESSRSNSMCGTTEY------------MAPEILLSK 279
           NIL+                                  Y            MAPE + + 
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDS------------NYVVKGNARLPVKWMAPESIFNC 222

Query: 280 GHNKDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEAHS 333
            +  ++D WS GI L+E+ +    P P    + +    +++         P    +E + 
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS---PEHAPAEMYD 279

Query: 334 LLKGLLHKDPSKR 346
           ++K     DP KR
Sbjct: 280 IMKTCWDADPLKR 292

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 50/257 (19%), Positives = 109/257 (42%), Gaps = 29/257 (11%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++       ++  E 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTK------VAVKSLKQGSMSPD---AFLA-EA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L  F           ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGTTEYM 271
              ++ + +   +HRDL+  NIL+                  + + ++R  +     ++ 
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWT 177

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTS 329
           APE +        +D WS GILL E++T G+ P+    N + +Q      ++  P     
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

Query: 330 EAHSLLKGLLHKDPSKR 346
           E + L++    + P  R
Sbjct: 238 ELYQLMRLCWKERPEDR 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 64/360 (17%), Positives = 130/360 (36%), Gaps = 52/360 (14%)

Query: 15  TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
             LK+      ++++       +    +   H  +   + ++    P+     S     P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
            P   + +S+         E   +        +   D E+    G G FG V     +GV
Sbjct: 308 MP---MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVR----QGV 356

Query: 135 DDGDSDGIY-AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193
                  I  A+KV+++ T  K +  + M+ E  I+ ++ +P+IV+L         L L+
Sbjct: 357 YRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQLDNPYIVRL-IGVCQAEALMLV 413

Query: 194 LDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
           ++   GG L   L  ++             ++   + +L +   VHR+L   N+L+ +  
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473

Query: 253 H------------EIDESSRSNSMCGTTEY------------MAPEILLSKGHNKDADWW 288
           +              D+S           Y             APE +  +  +  +D W
Sbjct: 474 YAKISDFGLSKALGADDS----------YYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523

Query: 289 SVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           S G+ ++E L+ GQ P+      + +      ++++ PP    E ++L+          R
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 583

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 56/272 (20%), Positives = 104/272 (38%), Gaps = 52/272 (19%)

Query: 107 IGPGDFEIFRVV-GQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNHVDYMKA 164
           +   +  I  +  G G FG V     +GV       I  A+KV+++ T  K +  + M+ 
Sbjct: 6   LKRDNLLIADIELGCGNFGSVR----QGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR- 59

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
           E  I+ ++ +P+IV+L         L L+++   GG L   L  ++             +
Sbjct: 60  EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEY- 270
           +   + +L +   VHRDL   N+L+ +  +              D+S           Y 
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS----------YYT 168

Query: 271 -----------MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPF-THANRQKLQQ 314
                       APE +      K    +D WS G+ ++E L+ GQ P+      + +  
Sbjct: 169 ARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225

Query: 315 RIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
               ++++ PP    E ++L+          R
Sbjct: 226 IEQGKRMECPPECPPELYALMSDCWIYKWEDR 257

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 57/257 (22%), Positives = 112/257 (43%), Gaps = 27/257 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V+    +GV    S  + A+K +++DT+  +   +++K E 
Sbjct: 10  MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 60

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
            ++ ++ HP +VQL     TR    Y+I +F+  G+L  +     +         +   +
Sbjct: 61  AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYM 271
           I SA+ +L K   +HRDL   N L+  +                D  +         ++ 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTS 329
           APE L     +  +D W+ G+LL+E+ T G  P+      Q  +    + +++ P     
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239

Query: 330 EAHSLLKGLLHKDPSKR 346
           + + L++     +PS R
Sbjct: 240 KVYELMRACWQWNPSDR 256

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 47/244 (19%), Positives = 95/244 (38%), Gaps = 50/244 (20%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P ++ I  ++G+G++G V+        D +++   A+K   K   + ++ +D  +  R+I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAY-----DKNTEKNVAIK---KVNRMFEDLIDCKRILREI 76

Query: 169 --LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             L ++   +I++L             +LY++L+      L           E+  +   
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD---------------------------GHE 254
             ++   + +H+ GI+HRDLKP N L++ D                            +E
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 255 IDESSRSNSMCGTTEYM------APEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHA 307
                  N     T ++      APE++L  + + K  D WS G +  E+L       + 
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 308 NRQK 311
              +
Sbjct: 256 PTNR 259

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 48/275 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
             +  R +G+G FGKV         D + D      A+K ++ ++    +  D  K E +
Sbjct: 22  FLKRIRDLGEGHFGKVE----LCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKK-EIE 75

Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEI 224
           IL  + H  IV+ +   +    + + LI++F+  G L  +L + +      Q   Y  +I
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY---- 270
              + +L     VHRDL   N+L++S+             I+      ++    +     
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 271 MAPEILLSKGHNK---DADWWSVGILLYEMLT-GQPPFTHANRQKLQQR-----IINEKV 321
            APE L+    +K    +D WS G+ L+E+LT      +               +   ++
Sbjct: 196 YAPECLM---QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252

Query: 322 --KL--------PPFLTSEAHSLLKGLLHKDPSKR 346
              L        PP    E + L++      PS R
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 59/310 (19%), Positives = 113/310 (36%), Gaps = 45/310 (14%)

Query: 75  SPRYALSSSLPLQIQ--ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
            P+Y +   +    +       +  +L    + +    + +  + +G GAFGKV +    
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 68

Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-L 190
           G+   D+    A+K M K T         M  E  I++ +  H  IV L     T    +
Sbjct: 69  GLGKEDAVLKVAVK-MLKSTAHADEKEALMS-ELKIMSHLGQHENIVNL-LGACTHGGPV 125

Query: 191 YLILDFINGGHLFFHLYRQGIFREDQARFYT--------------AEIVSAVSHLHKCGI 236
            +I ++   G L   L R+    E    F                +++   ++ L     
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185

Query: 237 VHRDLKPENILMDSDG-------------HEIDE-SSRSNSMCGTTEYMAPEILLSKGHN 282
           +HRD+   N+L+ +                       + N+     ++MAPE +    + 
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYT 244

Query: 283 KDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLK 336
             +D WS GILL+E+ +    P P    N +    ++      +   P F     +S+++
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ---PAFAPKNIYSIMQ 301

Query: 337 GLLHKDPSKR 346
                +P+ R
Sbjct: 302 ACWALEPTHR 311

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 53/287 (18%), Positives = 105/287 (36%), Gaps = 45/287 (15%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
                      +++   +  + R +G GAFG+V++ +  G+ +  S    A+K +  +  
Sbjct: 55  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVC 113

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIF 212
            +++ +D++  E  I++K  H  IV+       +S   +++L+ + GG L   L R+   
Sbjct: 114 SEQDELDFLM-EALIISKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFL-RETRP 170

Query: 213 REDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSM 264
           R  Q              +I     +L +   +HRD+   N L+   G            
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG-------RVA 223

Query: 265 C----G------TTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT-- 299
                G         Y             M PE  +        D WS G+LL+E+ +  
Sbjct: 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283

Query: 300 GQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             P  + +N++ L+      ++  P       + ++       P  R
Sbjct: 284 YMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 65/316 (20%), Positives = 121/316 (38%), Gaps = 65/316 (20%)

Query: 75  SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
           SP     S L   I E    N           I   D  +   +G+GAFGKVF  +   +
Sbjct: 10  SPTEGKGSGLQGHIIE----NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLI 193
                  + A+K +++ +  +    D+ + E ++LT + H  IV+  +   T  + L ++
Sbjct: 66  LPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHIVRF-FGVCTEGRPLLMV 121

Query: 194 LDFINGGHLFFHLYRQGIFREDQARFYT---------------AEIVSAVSHLHKCGIVH 238
            +++  G L   L   G   +  A                   +++ + + +L     VH
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181

Query: 239 RDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY-------------MAPEI 275
           RDL   N L+               +I            T+Y             M PE 
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYS----------TDYYRVGGRTMLPIRWMPPES 231

Query: 276 LLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSE 330
           +L +    ++D WS G++L+E+ T   QP +  +N +    + Q    E+   P     E
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER---PRACPPE 288

Query: 331 AHSLLKGLLHKDPSKR 346
            +++++G   ++P +R
Sbjct: 289 VYAIMRGCWQREPQQR 304

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 53/259 (20%), Positives = 106/259 (40%), Gaps = 37/259 (14%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +     ++  E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EA 65

Query: 167 DILTKVTHPFIVQLRYSFQTRSK--LYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
            ++T++ H  +VQL        K  LY++ +++  G L  +     + +   D    ++ 
Sbjct: 66  SVMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGT---TE 269
           ++  A+ +L     VHRDL   N+L+  D            E   +             +
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVK 179

Query: 270 YMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFL 327
           + APE L  K  +  +D WS GILL+E+ + G+ P+     +  + +     K+  P   
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 239

Query: 328 TSEAHSLLKGLLHKDPSKR 346
               + ++K   H D + R
Sbjct: 240 PPAVYEVMKNCWHLDAAMR 258

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 51/270 (18%), Positives = 97/270 (35%), Gaps = 49/270 (18%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
            + +++G+G FG V +   K  D        A+K M+ D   ++   +++  E   +   
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREIEEFLS-EAACMKDF 93

Query: 173 THPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
           +HP +++L       S Q   K  +IL F+  G L  +L                    +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKF 152

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEY 270
             +I   + +L     +HRDL   N ++  D            +I              Y
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---------YY 203

Query: 271 ------------MAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRI 316
                       +A E L  + +   +D W+ G+ ++E+ T G  P+    N +     +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263

Query: 317 INEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
              ++K P     E + ++      DP  R
Sbjct: 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 67/334 (20%), Positives = 124/334 (37%), Gaps = 70/334 (20%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
               H+  H +  P+        +   + E E   D   E      +      + + +G+
Sbjct: 26  GYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWE------LPRDRLVLGKPLGE 79

Query: 121 GAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFI 177
           GAFG+V   +  G+D    + +   A+K M K    +K+  D +  E +++  +  H  I
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLIS-EMEMMKMIGKHKNI 137

Query: 178 VQLRYSFQTRSK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARF 219
           + L     T+   LY+I+++ + G+L                   H   + +  +D    
Sbjct: 138 INL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCG 266
              ++   + +L     +HRDL   N+L+  D              H ID          
Sbjct: 197 -AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---------- 245

Query: 267 TTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQKL 312
              Y            MAPE L  + +   +D WS G+LL+E+ T  G P       +  
Sbjct: 246 --YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303

Query: 313 QQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           +      ++  P   T+E + +++   H  PS+R
Sbjct: 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 62/312 (19%), Positives = 116/312 (37%), Gaps = 67/312 (21%)

Query: 82  SSLPL--QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
             LPL    + L ++   + E            ++ + +G+GAFG+V +    G+D   +
Sbjct: 4   DELPLDEHCERLPYDAS-KWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT 56

Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY--SFQTRSKLYLILDF 196
               A+K M K+      H   M  E  IL  +  H  +V L      +    L +I++F
Sbjct: 57  CRTVAVK-MLKEGATHSEHRALMS-ELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEF 113

Query: 197 INGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR 239
              G+L                    LY+  +  E    + + ++   +  L     +HR
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHR 172

Query: 240 DLKPENILMDSDG-------------HEIDESSRSNSMCGTTE------YMAPEILLSKG 280
           DL   NIL+                 ++  +           +      +MAPE +  + 
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRV 226

Query: 281 HNKDADWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSL 334
           +   +D WS G+LL+E+ +    P P    + +   +L++         P + T E +  
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQT 283

Query: 335 LKGLLHKDPSKR 346
           +    H +PS+R
Sbjct: 284 MLDCWHGEPSQR 295

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 27/255 (10%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
              RV+G+G FG V+  +             A+K + + T   +    +++ E  ++  +
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRIT-EMQQVEAFLR-EGLLMRGL 79

Query: 173 THPFIVQLRY--SFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
            HP ++ L            +++L ++  G L  F    ++    +D   F   ++   +
Sbjct: 80  NHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGM 137

Query: 229 SHLHKCGIVHRDLKPENILMDSDG-------------HEIDESSRSNSMCGT--TEYMAP 273
            +L +   VHRDL   N ++D                 + +  S           ++ A 
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 274 EILLSKGHNKDADWWSVGILLYEMLT-GQPPF-THANRQKLQQRIINEKVKLPPFLTSEA 331
           E L +      +D WS G+LL+E+LT G PP+                ++  P +     
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257

Query: 332 HSLLKGLLHKDPSKR 346
           + +++     DP+ R
Sbjct: 258 YQVMQQCWEADPAVR 272

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 60/288 (20%), Positives = 114/288 (39%), Gaps = 62/288 (21%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
            + I   D  + R +G+GAFGKVF  +   +       + A+K ++  T       D+ +
Sbjct: 9   VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQR 66

Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------FFHLYRQGIFR 213
            E ++LT + H  IV+  Y        L ++ +++  G L            +   G  R
Sbjct: 67  -EAELLTNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 214 EDQARFYT-------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EID 256
           + +            ++I S + +L     VHRDL   N L+ ++            ++ 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 257 ESSRSNSMCGTTEY-------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQ 301
                      T+Y             M PE ++ +    ++D WS G++L+E+ T   Q
Sbjct: 185 S----------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 302 PPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           P F  +N +    + Q  + E+   P     E + ++ G   ++P +R
Sbjct: 235 PWFQLSNTEVIECITQGRVLER---PRVCPKEVYDVMLGCWQREPQQR 279

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 68/321 (21%), Positives = 128/321 (39%), Gaps = 64/321 (19%)

Query: 72  VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
           +G S  +   S  P+     E+E   + + E  R        + + +G+GAFG+V   + 
Sbjct: 1   MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRD----KLTLGKPLGEGAFGQVVMAEA 56

Query: 132 KGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187
            G+D        A+ V   M KD   +K+  D +  E +++  +  H  I+ L     T+
Sbjct: 57  VGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNIINL-LGACTQ 112

Query: 188 SK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVS 229
              LY+I+++ + G+L                    +  + +  +D     T ++   + 
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC-TYQLARGME 171

Query: 230 HLHKCGIVHRDLKPENILMDSDG-------------HEIDE-SSRSNSMCGTTEY----- 270
           +L     +HRDL   N+L+  +              + ID     +N             
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR------LPVKW 225

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPP 325
           MAPE L  + +   +D WS G+L++E+ T  G P       +    L++    +K   P 
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK---PA 282

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
             T+E + +++   H  PS+R
Sbjct: 283 NCTNELYMMMRDCWHAVPSQR 303

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 71/348 (20%), Positives = 132/348 (37%), Gaps = 73/348 (20%)

Query: 45  RHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESE 104
           +    + +S+S +   P V      S    +P  A  S       E E   D + E    
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-------EYELPEDPKWE---- 77

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDY 161
                    + + +G+G FG+V   +  G+D        A+ V   M KD   +K+  D 
Sbjct: 78  --FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDL 133

Query: 162 MKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----------------- 202
           +  E +++  +  H  I+ L     T+   LY+I+++ + G+L                 
Sbjct: 134 VS-EMEMMKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191

Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------- 252
              +  + +  +D     T ++   + +L     +HRDL   N+L+  +           
Sbjct: 192 INRVPEEQMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

Query: 253 ---HEIDE-SSRSNSMCGTTEY-----MAPEILLSKGHNKDADWWSVGILLYEMLT--GQ 301
              + ID     +N             MAPE L  + +   +D WS G+L++E+ T  G 
Sbjct: 251 RDINNIDYYKKTTNGR------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304

Query: 302 PPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           P       +    L++    +K   P   T+E + +++   H  PS+R
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQR 349

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 51/260 (19%), Positives = 108/260 (41%), Gaps = 38/260 (14%)

Query: 61  PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
            Q++ + +    G   R      +   +   +    +         +   + ++ + +G+
Sbjct: 150 MQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWA------LNMKELKLLQTIGK 203

Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
           G FG V     +G          A+K ++ D   +     ++  E  ++T++ H  +VQL
Sbjct: 204 GEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EASVMTQLRHSNLVQL 251

Query: 181 RY--SFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCG 235
                 + +  LY++ +++  G L  +L    R  +  +   +F + ++  A+ +L    
Sbjct: 252 -LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNN 309

Query: 236 IVHRDLKPENILMDSDG----------HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDA 285
            VHRDL   N+L+  D            E   +  +  +    ++ APE L  K  +  +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKS 367

Query: 286 DWWSVGILLYEMLT-GQPPF 304
           D WS GILL+E+ + G+ P+
Sbjct: 368 DVWSFGILLWEIYSFGRVPY 387

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 53/283 (18%), Positives = 108/283 (38%), Gaps = 57/283 (20%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I          +G+  FGKV++    G   G+     A+K ++          ++   E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRH-EA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT---- 221
            +  ++ HP +V L     T+ + L +I  + + G L   L  +    +  +        
Sbjct: 64  MLRARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 222 ------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESS 259
                       A+I + + +L    +VH+DL   N+L+    +          E+  + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 260 RSNSMCGTTEY------------MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFT 305
                     Y            MAPE ++    + D+D WS G++L+E+ +   QP   
Sbjct: 183 ---------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233

Query: 306 HANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 346
           ++N+  ++   I  +  L  P    +  ++L+    ++ PS+R
Sbjct: 234 YSNQDVVEM--IRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 56/235 (23%), Positives = 111/235 (47%), Gaps = 33/235 (14%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            +F    ++G+G FGKV+    KG   DG    + A+K + K+   +   + + + E ++
Sbjct: 30  DNFSNKNILGRGGFGKVY----KGRLADGT---LVAVKRL-KEERTQGGELQF-QTEVEM 80

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARFYTAEIV 225
           ++   H  +++LR    T ++  L+  ++  G +   L  +   +       R   A + 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LG 139

Query: 226 SA--VSHLH-KCG--IVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTT 268
           SA  +++LH  C   I+HRD+K  NIL+D +              +  ++  + ++ GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 269 EYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK 322
            ++APE L + G  ++  D +  G++L E++TGQ  F  A        ++ + VK
Sbjct: 200 GHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 65/307 (21%), Positives = 109/307 (35%), Gaps = 62/307 (20%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
           E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K M 
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-ML 83

Query: 150 KDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----- 202
           K+          M  E  ++T++ +H  IV L     T S  +YLI ++   G L     
Sbjct: 84  KEKADSSEREALMS-ELKMMTQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLR 141

Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
                       +  ++ +  E+     T         ++   +  L     VHRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 245 NILMDSDG-------------HEIDE-SSRSNSMCGTTEY-----MAPEILLSKGHNKDA 285
           N+L+                         R N+            MAPE L    +   +
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR------LPVKWMAPESLFEGIYTIKS 255

Query: 286 DWWSVGILLYEMLT--GQP-PFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLL 339
           D WS GILL+E+ +    P P    +      +Q     ++   P + T E + +++   
Sbjct: 256 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCW 312

Query: 340 HKDPSKR 346
             D  KR
Sbjct: 313 AFDSRKR 319

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 55/310 (17%), Positives = 90/310 (29%), Gaps = 107/310 (34%)

Query: 85  PLQIQELEHENDAELEAESERKIG------PGD-----FEIFRVVGQGAFGKVFQVKKKG 133
           P Q +E+   +D E E  ++   G       GD     + + R +G G F  V+      
Sbjct: 1   PEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW--- 57

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THP---FIVQLRYSFQ 185
             D       AMKV++      +++ +    E  +L  V       P    +VQL   F+
Sbjct: 58  --DIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111

Query: 186 TRSKLYLILDFINGGHL-------------FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
                       NG H+             +              +    +++  + +LH
Sbjct: 112 ISGV--------NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 233 -KCGIVHRDLKPENILMDSDGHEIDE---------------------SSRSNSMCGTTEY 270
            KC I+H D+KPENIL+  +   I                       S+   +       
Sbjct: 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVN 223

Query: 271 MAPEILLSKGHNKDADW------------------------------------WSVGILL 294
                   K   K AD                                     WS   + 
Sbjct: 224 PLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMA 283

Query: 295 YEMLTGQPPF 304
           +E+ TG   F
Sbjct: 284 FELATGDYLF 293

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 45/265 (16%), Positives = 93/265 (35%), Gaps = 48/265 (18%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G   +++ R +G+G+FG +F+       +  ++   A+K   + +      +   
Sbjct: 4   QNNVVG-VHYKVGRRIGEGSFGVIFEGT-----NLLNNQQVAIKFEPRRS--DAPQLRD- 54

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E      +     I  + Y  Q      L++D +  +   L     R+  F       
Sbjct: 55  --EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAM 110

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILM-----------------------DSDGHEID 256
              ++++ V  +H+  +V+RD+KP+N L+                       D    +  
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

Query: 257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTHANRQKLQ 313
                 ++ GT  YM+    L +  ++  D  ++G +    L G  P      A  ++  
Sbjct: 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230

Query: 314 QRIINEKVKLPPFLTSEAHSLLKGL 338
           +RI  +K   P         L  G 
Sbjct: 231 ERIGEKKQSTPL------RELCAGF 249

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 49/262 (18%), Positives = 94/262 (35%), Gaps = 46/262 (17%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++        D  +    A+K+    T  K   +    
Sbjct: 4   ELRVG-NRYRLGRKIGSGSFGDIYLGT-----DIAAGEEVAIKLECVKT--KHPQLHI-- 53

Query: 164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         ++++ +  +   LF    R+  F        
Sbjct: 54  -ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLL 110

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--------------IDESSRS----- 261
             +++S + ++H    +HRD+KP+N LM                     D  +       
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 262 --NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPP---FTHANRQKLQQRI 316
              ++ GT  Y +    L    ++  D  S+G +L     G  P      A +++  +RI
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230

Query: 317 INEKVKLPPFLTSEAHSLLKGL 338
             +K+  P         L KG 
Sbjct: 231 SEKKMSTPI------EVLCKGY 246

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 61/309 (19%), Positives = 111/309 (35%), Gaps = 75/309 (24%)

Query: 94  ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
            +  ++  + + +    +  + + +G+G FGKV +     +         A+K M K+  
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENA 65

Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------- 202
                 D +  E ++L +V HP +++L Y   ++   L LI+++   G L          
Sbjct: 66  SPSELRDLLS-EFNVLKQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 203 ---------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
                            H   + +   D   F   +I   + +L +  +VHRDL   NIL
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNIL 182

Query: 248 MDSDG-------------HEIDESSRSNSMCGTTEY------------MAPEILLSKGHN 282
           +                 +E D             Y            MA E L    + 
Sbjct: 183 VAEGRKMKISDFGLSRDVYEED------------SYVKRSQGRIPVKWMAIESLFDHIYT 230

Query: 283 KDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKG 337
             +D WS G+LL+E++T  G P       +    L+     E+   P   + E + L+  
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQ 287

Query: 338 LLHKDPSKR 346
              ++P KR
Sbjct: 288 CWKQEPDKR 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 50/262 (19%), Positives = 99/262 (37%), Gaps = 46/262 (17%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   F + R +G G+FG+++        +  ++   A+K+    T  K   + Y  
Sbjct: 2   EPRVG-NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKT--KHPQLLY-- 51

Query: 164 AERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
            E  I   +     I  +R+         L++D +  +   LF    R+           
Sbjct: 52  -ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILM---------------------DSDGHEIDESS 259
             ++++ V  +H    +HRD+KP+N LM                     D+  H+     
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRI 316
            + ++ GT  Y +    L    ++  D  S+G +L   L G  P+       +++  ++I
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228

Query: 317 INEKVKLPPFLTSEAHSLLKGL 338
             +KV           +L +G 
Sbjct: 229 SEKKVATSI------EALCRGY 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 61/326 (18%), Positives = 117/326 (35%), Gaps = 82/326 (25%)

Query: 74  PSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG 133
           P+P Y     L L  + L  E                + E  R +G+GAFG+VFQ +  G
Sbjct: 24  PNPMYQ-RMPLLLNPKLLSLE------------YPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYL 192
           +   +   + A+K M K+        D+ + E  ++ +  +P IV+L        K + L
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKL-LGVCAVGKPMCL 127

Query: 193 ILDFINGGHL----------------FFHLYRQGIFREDQARFYT--------AEIVSAV 228
           + +++  G L                   L  +           +         ++ + +
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEY-------- 270
           ++L +   VHRDL   N L+  +             I             +Y        
Sbjct: 188 AYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS----------ADYYKADGNDA 237

Query: 271 -----MAPEILLSKGHNKDADWWSVGILLYEMLT--GQPPFTHANRQ---KLQQRIINEK 320
                M PE +    +  ++D W+ G++L+E+ +   QP +  A+ +    ++   I   
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC 297

Query: 321 VKLPPFLTSEAHSLLKGLLHKDPSKR 346
              P     E ++L++    K P+ R
Sbjct: 298 ---PENCPLELYNLMRLCWSKLPADR 320

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 4e-11
 Identities = 30/190 (15%), Positives = 58/190 (30%), Gaps = 55/190 (28%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
             +    +G+G FG+VFQ               A+K++  +     N   + K   +IL 
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVN-GSHQKTFEEILP 72

Query: 171 KVT---------------HP--------FIVQLRY----------------------SFQ 185
           ++                            VQ  Y                       F 
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE 244
              +L+++L+F  GG       R  +     A+    ++ ++++         HRDL   
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 245 NILMDSDGHE 254
           N+L+     +
Sbjct: 192 NVLLKKTSLK 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 50/272 (18%), Positives = 97/272 (35%), Gaps = 62/272 (22%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
               +G  +F + + +G G FG++   K     +  ++   A+K+        K+    +
Sbjct: 3   GVLMVG-PNFRVGKKIGCGNFGELRLGK-----NLYTNEYVAIKLEPM-----KSRAPQL 51

Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
             E     ++     I Q+ Y         ++L+ +  +   LF    R          F
Sbjct: 52  HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR---------TF 102

Query: 220 --YTA-----EIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HEID-------ES 258
              T      +++S + ++H   +++RD+KPEN L+   G       H ID         
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162

Query: 259 SRSN---------SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--- 306
             +          S+ GT  YM+    L K  ++  D  ++G +    L G  P+     
Sbjct: 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222

Query: 307 ANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
              ++  Q+I + K   P         L +  
Sbjct: 223 DTLKERYQKIGDTKRATPI------EVLCENF 248

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 66/301 (21%), Positives = 116/301 (38%), Gaps = 58/301 (19%)

Query: 88  IQELEHENDAELEAESERK--IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-A 144
           +++  H +  +   +      +   D +   V+G+G FG+V     K     D   +  A
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVL----KARIKKDGLRMDAA 56

Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
           +K   K+   K +H D+   E ++L K+  HP I+ L          LYL +++   G+L
Sbjct: 57  IK-RMKEYASKDDHRDFAG-ELEVLCKLGHHPNIINL-LGACEHRGYLYLAIEYAPHGNL 113

Query: 203 FFHLYRQGIFREDQARFYT----------------AEIVSAVSHLHKCGIVHRDLKPENI 246
              L +  +   D A                    A++   + +L +   +HRDL   NI
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173

Query: 247 LMDSDGHEIDES----SRSNSMCGTTEY------------MAPEILLSKGHNKDADWWSV 290
           L+  + +    +    SR         Y            MA E L    +  ++D WS 
Sbjct: 174 LV-GENYVAKIADFGLSRGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227

Query: 291 GILLYEMLT--GQPPFTHANRQ---KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSK 345
           G+LL+E+++  G P       +   KL Q    EK   P     E + L++    + P +
Sbjct: 228 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYE 284

Query: 346 R 346
           R
Sbjct: 285 R 285

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 41/259 (15%), Positives = 84/259 (32%), Gaps = 50/259 (19%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDY 161
             +++   +GQG FG ++       +   SD    +KV   D           ++     
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 162 MKAERDILTKVTHPFIVQLRYS----FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
              +     K+ +  + +   S       +S  ++I+D   G  L      Q I+  +  
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAK 147

Query: 218 RF-------YTAEIVSAVSHLHKCGIVHRDLKPENILM--------------------DS 250
           RF        +  I+  + ++H+   VH D+K  N+L+                      
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 251 DGH-EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR 309
             H       +     GT E+ + +       ++  D   +G  + + LTG  P+    +
Sbjct: 208 GVHKAYAADPKR-CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266

Query: 310 QKLQQRI--INEKVKLPPF 326
                R   I  +  +   
Sbjct: 267 DPKYVRDSKIRYRENIASL 285

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 38/252 (15%), Positives = 81/252 (32%), Gaps = 36/252 (14%)

Query: 112 FEIFRVVGQGAFGKVF---QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD- 167
           +++     +   G ++          D G     +++K+  KD  +      + +A +  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 168 ------ILTKVTHPFIVQLRYSFQTRSKL-YLILDFINGGHL--FFHLYRQGIFREDQAR 218
                  L       I         + K  +L+L  + G  L     +  + +  E    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162

Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILM--------------------DSDGHEIDES 258
                ++ A+  LH+   VH ++  ENI +                     S  H     
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI-- 316
              +   G  E+++ ++    G ++ +D  S+G  + + L G  P+T+            
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK 282

Query: 317 INEKVKLPPFLT 328
                K  PF+ 
Sbjct: 283 QKFVDKPGPFVG 294

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 40/300 (13%), Positives = 97/300 (32%), Gaps = 57/300 (19%)

Query: 65  HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
           H+ S   +G    Y  S   P              E +    +    + + + +G G FG
Sbjct: 6   HHSSGVDLGTENLYFQSMPFP--------------EGKVLDDMEGNQWVLGKKIGSGGFG 51

Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDYMKAERDILTKVTHPF 176
            ++       +  + D  + +KV  ++           ++        +     ++ +  
Sbjct: 52  LIYLAFP--TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109

Query: 177 IVQLRYS--FQTRSKLY--LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
           I     S   + + + Y  ++++ + G  L     + G F++         ++  + ++H
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH 168

Query: 233 KCGIVHRDLKPENILM--------------------DSDGH-EIDESSRSNSMCGTTEYM 271
           +   VH D+K  N+L+                     +  H +  E+ R     GT E+ 
Sbjct: 169 ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR-KGHNGTIEFT 227

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPP------FTHANRQKLQQRIINEKVKLPP 325
           + +       ++ +D   +G  +   L G+ P         A +      +      +  
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLK 287

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 5e-08
 Identities = 51/379 (13%), Positives = 110/379 (29%), Gaps = 93/379 (24%)

Query: 30  PDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQ 89
            ++ F      ++P +   + P+  +    +     +R ++      +Y +S        
Sbjct: 89  INYKFL-----MSPIKTEQRQPSMMTRMYIEQ---RDRLYNDNQVFAKYNVSR--LQPYL 138

Query: 90  ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGK---VFQV-KKKGVDDGDSDGIYAM 145
           +L     A LE    + +         + G    GK      V     V       I+ +
Sbjct: 139 KLR---QALLELRPAKNVL--------IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 146 KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
            +   ++         ++  + +L ++   +  +  +S   + +++ I   +    L   
Sbjct: 188 NLKNCNS-----PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKS 240

Query: 206 -LYRQG--IFREDQARFYTAEIVSAVSHLHKCGIV--HRDLKPENILMDSDGHEIDESSR 260
             Y     +          A+  +A +    C I+   R  +  + L  +    I     
Sbjct: 241 KPYENCLLVLLN----VQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAATTTHISLDHH 294

Query: 261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP------------------ 302
           S ++   T      +LL     +  D      L  E+LT  P                  
Sbjct: 295 SMTL---TPDEVKSLLLKYLDCRPQD------LPREVLTTNPRRLSIIAESIRDGLATWD 345

Query: 303 PFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKD---PSKRLGSGPGGVDAIK 358
            + H N  KL   II   +  L P    +    L  +       P+  L           
Sbjct: 346 NWKHVNCDKL-TTIIESSLNVLEPAEYRKMFDRL-SVFPPSAHIPTILL----------- 392

Query: 359 HHKWFRSINWKTLEAREMQ 377
                 S+ W  +   ++ 
Sbjct: 393 ------SLIWFDVIKSDVM 405

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 37/182 (20%), Positives = 60/182 (32%), Gaps = 15/182 (8%)

Query: 109 PGDFEIFR-------VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
              +E  R        +G+GAFG+V +    G+D   +    A+K M K+      H   
Sbjct: 14  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRAL 72

Query: 162 MKAERDILTKV-THPFIVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
           M  E  IL  +  H  +V  L    +    L +I++F   G+L  +L      + ++   
Sbjct: 73  MS-ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVP 127

Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILLSK 279
           Y  +           G +  DLK     + S                  E       L K
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 280 GH 281
             
Sbjct: 188 DF 189

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 32/159 (20%), Positives = 66/159 (41%), Gaps = 17/159 (10%)

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----------- 252
             LY+  +  E    + + ++   +  L     +HRDL   NIL+               
Sbjct: 183 EDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 253 --HEIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT--GQP-PFTHA 307
             ++  +  R        ++MAPE +  + +   +D WS G+LL+E+ +    P P    
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301

Query: 308 NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
           + +  ++     +++ P + T E +  +    H +PS+R
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	431
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.92
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.13
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.06
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.91
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.48
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.39
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.3
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.98
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.5
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.32
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.26
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.3
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.62
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.61
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.34
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.75
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	82.64

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-69  Score=561.93  Aligned_cols=321  Identities=32%  Similarity=0.614  Sum_probs=275.3

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHH---HHHHHhcCCCCcceee
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLR  181 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~  181 (431)
                      ..+..++|+++++||+|+||+||+|+++.     +|+.||||++++..+........+.+|   +.+++.++|||||+++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~-----tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            35678899999999999999999999986     899999999998876655555555555   4556677899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----  256 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----  256 (431)
                      ++|++.+.+|||||||.||+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|+...     
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998422     


Q ss_pred             ----CCCCcccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcccCCCCCCC
Q 014087          257 ----ESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLT  328 (431)
Q Consensus       257 ----~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s  328 (431)
                          ......+.|||+.|||||++. +..|+.++|||||||+||||++|++||.+   .+..++...+....+.+|..+|
T Consensus       339 A~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S  418 (689)
T 3v5w_A          339 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  418 (689)
T ss_dssp             CEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             eeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence                223456789999999999997 46899999999999999999999999975   3456778888889999999999


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP  408 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~  408 (431)
                      +++++||.+||++||.+|+|+...++++|++||||+++||+.+..+++.|||+|.+....++++||..............
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~~~~~  498 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKL  498 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC---------CCCCC
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCccccCCCCC
Confidence            99999999999999999999877789999999999999999999999999999988877777666643222111112223


Q ss_pred             CCCCCCCccCeEeeCCCccccC
Q 014087          409 TPTAGEHFKGYTYVAPNPWLSS  430 (431)
Q Consensus       409 ~~~~~~~f~~~~~~~~~~~~~~  430 (431)
                      ...+++.|++|+|..+.+|+.|
T Consensus       499 ~~~d~~~f~~Fs~~~~~~~q~e  520 (689)
T 3v5w_A          499 LDSDQELYRNFPLTISERWQQE  520 (689)
T ss_dssp             CHHHHTTTTTCCEECHHHHHHH
T ss_pred             CchHHHHHhCCCccCccchhhh
Confidence            3357899999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-69  Score=518.57  Aligned_cols=274  Identities=50%  Similarity=0.949  Sum_probs=243.8

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      ++..++|++++.||+|+||+||+|++..  +..+++.||||++++....... ...+.+|+++|+.++|||||+++++|+
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECS--STTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEE
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEcc--CCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            3445689999999999999999999753  2237889999999876543322 335778999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc----------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI----------  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~----------  255 (431)
                      +++.+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|...          
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999999999999999999999999999999999999999999999999999999998732          


Q ss_pred             -CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014087          256 -DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       256 -~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                       .......+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++...|....+.+|..+|+++++|
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL  256 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence             1223445789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      |.+||++||++|+++...+++||++||||+++||+.+..++++|||+|
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            999999999999998777899999999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.6e-68  Score=510.12  Aligned_cols=262  Identities=39%  Similarity=0.724  Sum_probs=240.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+....+....+.+.+|+++|+.++|||||+++++|++++
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3579999999999999999999986     89999999999887777777888999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC------------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------------  256 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~------------  256 (431)
                      .+|||||||+||+|.+++.+.+.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|+...            
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999987321            


Q ss_pred             -CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                       ......+.|||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++..+|....+.+|..+++++++||
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV  265 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence             1123456799999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhccc
Q 014087          336 KGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEARE  375 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~  375 (431)
                      .+||++||++|+++.. ....+|++||||+++||+.+.+++
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~  306 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT  306 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSC
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCC
Confidence            9999999999996532 134558999999999999997653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.5e-64  Score=489.51  Aligned_cols=313  Identities=39%  Similarity=0.784  Sum_probs=281.4

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|+++.     +++.||||++++...........+.+|+.+|+.++||||+++++++++
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            345689999999999999999999886     889999999998776666677888999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC---------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE---------  257 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~---------  257 (431)
                      .+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+....         
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999999999999998899999999999999999999999999999999999999998873221         


Q ss_pred             --CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          258 --SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       258 --~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                        .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+......+|..+++++++||
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  236 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              223456789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC-----
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP-----  410 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~-----  410 (431)
                      .+||++||.+|+|+++.++++|++||||++++|+.+..+++.|||+|.+.+..++++||.+|+..+...+++...     
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~  316 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGL  316 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC------------
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999888776554433211     


Q ss_pred             ------CCCCCccCeEeeCC
Q 014087          411 ------TAGEHFKGYTYVAP  424 (431)
Q Consensus       411 ------~~~~~f~~~~~~~~  424 (431)
                            ..++.|.||+|+++
T Consensus       317 ~~~~~~~~~~~f~~f~~~~~  336 (337)
T 1o6l_A          317 LELDQREEQEMFEDFDYIAD  336 (337)
T ss_dssp             --------CCTTTTCCEECC
T ss_pred             cccccccccccCCCceecCC
Confidence                  14689999999976

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.5e-64  Score=491.78  Aligned_cols=315  Identities=39%  Similarity=0.785  Sum_probs=278.6

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|+.+ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKE-----TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcC-----CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            4556789999999999999999999986     8899999999988766777778889999999988 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      ++.+.+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|+....+      
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999999999999989999999999999999999999999999999999999999998743221      


Q ss_pred             -----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          259 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                           ....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......+|..++.++++
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  253 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG  253 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence                 223467899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCC-CCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC--
Q 014087          334 LLKGLLHKDPSKRLGSG-PGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP--  410 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~-~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--  410 (431)
                      ||++||.+||.+|+++. ..++++|++||||++++|+.+..+++.|||+|.+.+..+++|||..++..++..++....  
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~  333 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHL  333 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSG
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCcccccc
Confidence            99999999999999762 235699999999999999999999999999999999999999999998877666554322  


Q ss_pred             --CCCCCccCeEeeCCC
Q 014087          411 --TAGEHFKGYTYVAPN  425 (431)
Q Consensus       411 --~~~~~f~~~~~~~~~  425 (431)
                        ..++.|.||+|+++.
T Consensus       334 ~~~~~~~f~~f~~~~~~  350 (353)
T 3txo_A          334 PMINQDEFRNFEYVSPE  350 (353)
T ss_dssp             GGSCGGGGTTCCEECC-
T ss_pred             CcccccccCCceeeCcc
Confidence              346789999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.8e-64  Score=499.39  Aligned_cols=317  Identities=38%  Similarity=0.793  Sum_probs=278.5

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|..+|..+ +|||||+++++
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            34566789999999999999999999986     8899999999987766666667788999999887 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-------  256 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-------  256 (431)
                      |++.+.+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|+...       
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            9999999999999999999999999899999999999999999999999999999999999999999987322       


Q ss_pred             ----CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcccCC
Q 014087          257 ----ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKL  323 (431)
Q Consensus       257 ----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~  323 (431)
                          ......+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .....+.+.+....+.+
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  281 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  281 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred             ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence                22334567999999999999999999999999999999999999999963         23455788888899999


Q ss_pred             CCCCCHHHHHHHHhhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCC
Q 014087          324 PPFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPA  402 (431)
Q Consensus       324 p~~~s~~~~~li~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~  402 (431)
                      |..++.++++||++||++||.+|+++.+ .++++|++||||++++|+.+..+++.|||+|.+.+..+++|||..|+..+.
T Consensus       282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~  361 (396)
T 4dc2_A          282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV  361 (396)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCC
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCC
Confidence            9999999999999999999999998743 358999999999999999999999999999999999999999999999877


Q ss_pred             CCCCCCC----CCCCCCccCeEeeCCCc
Q 014087          403 DDSPAPT----PTAGEHFKGYTYVAPNP  426 (431)
Q Consensus       403 ~~~~~~~----~~~~~~f~~~~~~~~~~  426 (431)
                      ..++...    ..+++.|.||+|+++..
T Consensus       362 ~~~~~~~~~~~~~~~~~f~~f~~~~~~~  389 (396)
T 4dc2_A          362 QLTPDDDDIVRKIDQSEFEGFEYINPLL  389 (396)
T ss_dssp             CCCCCCHHHHTTSCGGGGTTCCEECC--
T ss_pred             ccCCCcchhhccccccccCCcEeECccc
Confidence            6665432    24567899999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-63  Score=491.04  Aligned_cols=319  Identities=38%  Similarity=0.770  Sum_probs=284.2

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++++.||+|+||+||+|+++.     +++.||||++++.........+.+..|..+|..+ +||||+++++++
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            4567899999999999999999999986     7899999999988766666778888999999987 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-------  257 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-------  257 (431)
                      ++.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+....       
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999999999999988899999999999999999999999999999999999999999873221       


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                          .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|......+|..++.++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                2234567899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCC---
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTP---  410 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---  410 (431)
                      ||.+||.+||.+|++++..++++|++||||++++|+.+..++++|||+|.+.+. +++|||..++..+...++....   
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~~~~~~  329 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEVIR  329 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCCHHHHH
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCccccccc
Confidence            999999999999999887789999999999999999999999999999999888 9999999888776655543321   


Q ss_pred             -CCCCCccCeEeeCCCccccC
Q 014087          411 -TAGEHFKGYTYVAPNPWLSS  430 (431)
Q Consensus       411 -~~~~~f~~~~~~~~~~~~~~  430 (431)
                       ..+..|.||+|+++..+..|
T Consensus       330 ~~~~~~f~~f~~~~~~~~~~~  350 (353)
T 2i0e_A          330 NIDQSEFEGFSFVNSEFLKPE  350 (353)
T ss_dssp             HSCTTTTCSCCEECTTCCCC-
T ss_pred             cccccccCCCeeeCccccChh
Confidence             35688999999998765443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.9e-63  Score=467.07  Aligned_cols=246  Identities=30%  Similarity=0.557  Sum_probs=213.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++++....+......+.+|+.+|+.++|||||++++++++++
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTT-----TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTT-----TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            3689999999999999999999876     89999999998877666666778999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------S  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------~  258 (431)
                      .+|+||||| +|+|.+++.+++.+++.+++.++.||+.||+|||++|||||||||+||||+.+|.....          .
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999999999 67999999999999999999999999999999999999999999999999999873221          2


Q ss_pred             CCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      ....+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+..++.+.|..+...+|..+++++++||.+
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  245 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR  245 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            23346799999999999999887 57999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ||++||++||     +++|+++||||+.
T Consensus       246 ~L~~dP~~R~-----s~~eil~hpw~k~  268 (275)
T 3hyh_A          246 MLIVNPLNRI-----SIHEIMQDDWFKV  268 (275)
T ss_dssp             HSCSSGGGSC-----CHHHHHHCHHHHT
T ss_pred             HccCChhHCc-----CHHHHHcCccccc
Confidence            9999999999     8999999999963

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.5e-62  Score=479.68  Aligned_cols=310  Identities=38%  Similarity=0.732  Sum_probs=249.4

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++++.||+|+||+||+|+++.     +++.||||++++.........+.+..|..+|+.+ +||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            4567899999999999999999999986     8899999999987765566677888999999977 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-------  257 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-------  257 (431)
                      ++.+.+|+||||+.||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|+....       
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999999999988899999999999999999999999999999999999999998873221       


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                          .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......+|..++.++++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence                2234567899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHH-HHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC---
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVD-AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  409 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~-~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~---  409 (431)
                      ||.+||..||.+||     +++ +|++||||++++|+.+..+++.|||+|.+.+..+++|||..|+...+..++...   
T Consensus       248 li~~lL~~dp~~R~-----~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~  322 (345)
T 1xjd_A          248 LLVKLFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALI  322 (345)
T ss_dssp             HHHHHSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC----------------------------------
T ss_pred             HHHHHhcCCHhHcC-----CChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCccccccc
Confidence            99999999999999     445 999999999999999999999999999999999999999988887654444322   


Q ss_pred             -CCCCCCccCeEeeCCC
Q 014087          410 -PTAGEHFKGYTYVAPN  425 (431)
Q Consensus       410 -~~~~~~f~~~~~~~~~  425 (431)
                       ...+..|.||+|+++.
T Consensus       323 ~~~~~~~f~~f~~~~~~  339 (345)
T 1xjd_A          323 NSMDQNMFRNFSFMNPG  339 (345)
T ss_dssp             ----CCTTTTCCC----
T ss_pred             ccccccccCCCeeeChh
Confidence             2357899999999865

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.8e-62  Score=483.32  Aligned_cols=312  Identities=45%  Similarity=0.834  Sum_probs=241.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHH-HHhcCCCCcceeeEEEEe
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~  186 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++++...........+..|..+ ++.++||||+++++++++
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKA-----EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETT-----TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            34579999999999999999999986     889999999998876666666677778877 567899999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------  256 (431)
                      .+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|+...          
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999999999999889999999999999999999999999999999999999999987322          


Q ss_pred             -CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                       ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|......++..++.++++||
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence             1223456789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC------
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT------  409 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~------  409 (431)
                      .+||++||.+|+++. ..+++|++||||++++|+.+..+++.|||+|.+.+..+++|||..|+.++...+....      
T Consensus       271 ~~lL~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~  349 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLV  349 (373)
T ss_dssp             HHHTCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-----------------------------
T ss_pred             HHHcccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCcccccc
Confidence            999999999999875 5789999999999999999999999999999999999999999988887643322111      


Q ss_pred             ----CCCCCCccCeEeeCCC
Q 014087          410 ----PTAGEHFKGYTYVAPN  425 (431)
Q Consensus       410 ----~~~~~~f~~~~~~~~~  425 (431)
                          ...++.|.||+|+++.
T Consensus       350 ~~~~~~~~~~f~~f~~~~~~  369 (373)
T 2r5t_A          350 TASVKEAAEAFLGFSYAPPT  369 (373)
T ss_dssp             --------------------
T ss_pred             ccccccccccCCCCcccCch
Confidence                1235779999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-61  Score=473.28  Aligned_cols=315  Identities=38%  Similarity=0.801  Sum_probs=278.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+..++|++++.||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|+.+ +||||+++++++
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            3455789999999999999999999986     8899999999987766667778889999999988 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--------  256 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--------  256 (431)
                      ++.+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+...        
T Consensus        80 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           80 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            999999999999999999999998889999999999999999999999999999999999999999887321        


Q ss_pred             ---CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcccCCC
Q 014087          257 ---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---------ANRQKLQQRIINEKVKLP  324 (431)
Q Consensus       257 ---~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~p  324 (431)
                         ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .....+.+.+......+|
T Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  239 (345)
T 3a8x_A          160 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  239 (345)
T ss_dssp             SCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred             ccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence               12234567899999999999999999999999999999999999999975         345567788888889999


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPAD  403 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~  403 (431)
                      ..++.++++||.+||++||.+|+++.+ .++++|++||||++++|+.+..+++.|||+|.+.+..++++|+..++..+..
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~  319 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ  319 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSS
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCccc
Confidence            999999999999999999999997632 2579999999999999999999999999999999999999999988877655


Q ss_pred             CCCCCC----CCCCCCccCeEeeCCC
Q 014087          404 DSPAPT----PTAGEHFKGYTYVAPN  425 (431)
Q Consensus       404 ~~~~~~----~~~~~~f~~~~~~~~~  425 (431)
                      .++...    ...+..|.||+|+++.
T Consensus       320 ~~~~~~~~~~~~~~~~f~~f~~~~~~  345 (345)
T 3a8x_A          320 LTPDDDDIVRKIDQSEFEGFEYINPL  345 (345)
T ss_dssp             CCCCCHHHHTTSCGGGGTTCCEECCC
T ss_pred             CCCccccccccccccccCCCEeeCCC
Confidence            544332    1356789999999873

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.8e-62  Score=515.32  Aligned_cols=321  Identities=39%  Similarity=0.770  Sum_probs=288.7

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+..|..+|..+ +||||++++++
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESS-----SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECC-----CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            34567899999999999999999999986     8899999999987766666777888999999987 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-------  256 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-------  256 (431)
                      +++.+.+||||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|+...       
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            9999999999999999999999999899999999999999999999999999999999999999999987322       


Q ss_pred             ----CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014087          257 ----ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  332 (431)
Q Consensus       257 ----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  332 (431)
                          ......+.+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..++++.|....+.+|..++.+++
T Consensus       491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  570 (674)
T 3pfq_A          491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV  570 (674)
T ss_dssp             ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred             ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence                1223456789999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCC---
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPT---  409 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~---  409 (431)
                      +||++||++||.+|+++++.++++|++||||++++|+.+..++++|||+|.+.+ .+++|||..|+..++..++...   
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~~~~  649 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQEVI  649 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCHHHH
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCchhhh
Confidence            999999999999999887778899999999999999999999999999999988 8999999999998776665432   


Q ss_pred             -CCCCCCccCeEeeCCCccccCC
Q 014087          410 -PTAGEHFKGYTYVAPNPWLSSV  431 (431)
Q Consensus       410 -~~~~~~f~~~~~~~~~~~~~~~  431 (431)
                       ..+++.|.||+|+++..+..++
T Consensus       650 ~~~~~~~f~~f~~~~~~~~~~~~  672 (674)
T 3pfq_A          650 RNIDQSEFEGFSFVNSEFLKPEV  672 (674)
T ss_dssp             TTCCGGGGTTCCEECSSCCCC--
T ss_pred             hcccccccCCCcccChhhhchhh
Confidence             2357889999999998776553

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.6e-62  Score=471.72  Aligned_cols=243  Identities=26%  Similarity=0.432  Sum_probs=217.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +.|+++++||+|+||+||+|+++.     +|+.||||++++....   ..+.+.+|+.+|+.++|||||+++++|++++.
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  145 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE  145 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC-----CCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999986     8999999999865432   23457889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------CC
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------ES  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~~  258 (431)
                      +|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|....           ..
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999999999998876 56999999999999999999999999999999999999999987321           12


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCCCHHHHHHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLL  335 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li  335 (431)
                      ....+.|||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++...|.....   ..+..+++++++||
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            234578999999999999999999999999999999999999999999999999888876532   33457899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+||++||++|+     +++|+++||||+..
T Consensus       305 ~~~L~~dP~~R~-----ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          305 DRLLVRDPAQRA-----TAAELLKHPFLAKA  330 (346)
T ss_dssp             HHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             HHHcCCChhHCc-----CHHHHhcCHhhcCC
Confidence            999999999999     89999999999753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-61  Score=464.19  Aligned_cols=307  Identities=36%  Similarity=0.736  Sum_probs=263.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|+.++||||+++++++++
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            345689999999999999999999886     889999999998766666667888999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                      .+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+....+        
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999999999999988999999999999999999999999999999999999999998743222        


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......|......+|..++.++++||.+|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          158 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            23346789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCC-CCcccCCCCcccCCCCCCCCCCCCCCCCCCcc
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS-GKDCIANFDKCWTTMPADDSPAPTPTAGEHFK  417 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~-~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~f~  417 (431)
                      |..||.+|+++...++++|++||||++++|+.+..+++.|||.|.+. +..++++||. +.+.............++.|.
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~f~  316 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEEDINYGVQGEDPYADLFR  316 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCSCCTTGGGSC
T ss_pred             hccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCC-CCccccccCccCCchhhhhcc
Confidence            99999999988777999999999999999999999999999999987 5889999986 444333333322334557788


Q ss_pred             Ce
Q 014087          418 GY  419 (431)
Q Consensus       418 ~~  419 (431)
                      +|
T Consensus       317 ~f  318 (318)
T 1fot_A          317 DF  318 (318)
T ss_dssp             CC
T ss_pred             CC
Confidence            87

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-61  Score=471.76  Aligned_cols=246  Identities=28%  Similarity=0.501  Sum_probs=216.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++.... ....+.+.+|+.+|+.++|||||+++++|++++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   96 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTE-----DGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENG   96 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETT-----TCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            4689999999999999999999986     8999999999876543 345678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR------  260 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~------  260 (431)
                      .+|||||||+||+|.++|..+  ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.....+..      
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999999999765  357999999999999999999999999999999999999999874332221      


Q ss_pred             -----cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHH
Q 014087          261 -----SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFLTSEAHSL  334 (431)
Q Consensus       261 -----~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l  334 (431)
                           ..+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++..+|..+.+ .++..+++++++|
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence                 2346899999999999999999999999999999999999999999999999999988765 4667899999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.+||++||++||     ++++|++||||+.
T Consensus       257 i~~~L~~dP~~R~-----s~~e~l~hp~~~~  282 (350)
T 4b9d_A          257 VSQLFKRNPRDRP-----SVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHHTSHHHHT
T ss_pred             HHHHccCChhHCc-----CHHHHhcCHHhhc
Confidence            9999999999999     8999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3e-61  Score=482.16  Aligned_cols=318  Identities=34%  Similarity=0.630  Sum_probs=270.8

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|+.++|||||++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECC-----CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456778899999999999999999999986     88999999998876655555667889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                      +|++.+.+|+|||||+||+|.+++.+ ..+++..++.++.||+.||.|||++|||||||||+||||+.+|+....+.   
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999999998876 46899999999999999999999999999999999999999987432221   


Q ss_pred             ---------CcccccCCCCCCchhhhccCC----CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCC
Q 014087          260 ---------RSNSMCGTTEYMAPEILLSKG----HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKLP  324 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p  324 (431)
                               ...+.+||+.|+|||++.+..    |+.++|||||||+||||++|+.||.+.+...+..+|....  +.+|
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence                     123678999999999998766    7899999999999999999999999999999999998653  4555


Q ss_pred             C--CCCHHHHHHHHhhcccCcCC--cCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCC
Q 014087          325 P--FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  400 (431)
Q Consensus       325 ~--~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  400 (431)
                      .  .++.++++||++||..+|.+  |+     ++++|++||||++++|+.+..+++.|||+|.+.+..|++|||...+..
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~-----~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~  370 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRN-----GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDK  370 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSS-----CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCC
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCC-----CHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccccc
Confidence            4  69999999999999987777  76     899999999999999999999999999999999999999999877654


Q ss_pred             CCCCCCCCC---CCCCCCccCeEeeCCCccccCC
Q 014087          401 PADDSPAPT---PTAGEHFKGYTYVAPNPWLSSV  431 (431)
Q Consensus       401 ~~~~~~~~~---~~~~~~f~~~~~~~~~~~~~~~  431 (431)
                      ......+.+   ...+..|.||+|+++..|+.++
T Consensus       371 ~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~  404 (410)
T 3v8s_A          371 GEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSA  404 (410)
T ss_dssp             SCCCCCCCCSSCCCTTGGGTTCCEECC-------
T ss_pred             cccccCCCchhhcccccccccceEeCcccccccC
Confidence            333222211   1357889999999999998763

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.9e-60  Score=466.20  Aligned_cols=307  Identities=38%  Similarity=0.738  Sum_probs=276.5

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .....++|++++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34566789999999999999999999986     8899999999987766666778889999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      .+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+      
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence            99999999999999999999999988999999999999999999999999999999999999999998743221      


Q ss_pred             --CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...|..+...+|..++.++++||.
T Consensus       191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  270 (350)
T 1rdq_E          191 VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             CSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              233467899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCCCCCCCc
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHF  416 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~f  416 (431)
                      +||+.||.+|+++...++++|++||||++++|..+..+++.|||+|.+.+..++++|| .|+......+.  ....++.|
T Consensus       271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~-~~~~~~~~~~~--~~~~~~~f  347 (350)
T 1rdq_E          271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD-DYEEEEIRVSI--NEKCGKEF  347 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC-CCCCCCCCCCS--SCCSTTTT
T ss_pred             HHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc-cccccccccCC--Ccchhhhc
Confidence            9999999999987667799999999999999999999999999999999999999999 56665543332  22345678


Q ss_pred             cCe
Q 014087          417 KGY  419 (431)
Q Consensus       417 ~~~  419 (431)
                      .+|
T Consensus       348 ~~f  350 (350)
T 1rdq_E          348 TEF  350 (350)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            876

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.5e-61  Score=477.83  Aligned_cols=244  Identities=26%  Similarity=0.437  Sum_probs=218.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .+.|+++++||+|+||+||+|+++.     +|+.||||++.+...   ...+.+.+|+.+|+.++|||||+++++|.+++
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECC-----CCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            3569999999999999999999986     899999999986543   22345788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------E  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~  257 (431)
                      .+|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|....           .
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            99999999999999998865 56999999999999999999999999999999999999999987321           1


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAHSL  334 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l  334 (431)
                      .....+.|||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..|....   ...+..+++++++|
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence            223457799999999999999999999999999999999999999999999999988887753   33456799999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      |.+||++||++|+     +++||++||||+..
T Consensus       381 i~~~L~~dP~~R~-----ta~ell~Hp~~~~~  407 (423)
T 4fie_A          381 LDRLLVRDPAQRA-----TAAELLKHPFLAKA  407 (423)
T ss_dssp             HHHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             HHHHcCCChhHCc-----CHHHHhcCHHhcCC
Confidence            9999999999999     89999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-59  Score=445.83  Aligned_cols=245  Identities=22%  Similarity=0.428  Sum_probs=211.4

Q ss_pred             CCCc-eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       109 ~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      .++| ++.++||+|+||+||+|+++.     +++.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|++ 
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence            3455 788899999999999999986     889999999987654 34456789999999999999999999999975 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCC-CCCcc-----
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHEI-----  255 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~-~g~~~-----  255 (431)
                         ++.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|...     
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence               3568999999999999999999999999999999999999999999998  999999999999985 56521     


Q ss_pred             ----CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccc--CCCCCCC
Q 014087          256 ----DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKV--KLPPFLT  328 (431)
Q Consensus       256 ----~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s  328 (431)
                          .......+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+. +...+...+..+..  .++..++
T Consensus       178 la~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (290)
T 3fpq_A          178 LATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             GGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             CCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence                22334557799999999999875 6999999999999999999999999764 45566666665533  3456789


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +++++||.+||++||++||     +++++++||||+.
T Consensus       257 ~~~~~li~~~L~~dP~~R~-----s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCc-----CHHHHhcCccccC
Confidence            9999999999999999999     8999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-59  Score=472.07  Aligned_cols=314  Identities=33%  Similarity=0.636  Sum_probs=264.7

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||||++++...........+.+|+.+|..++||||+++++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcC-----CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3456677899999999999999999999986     88999999998876655555566889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      +|++.+.+|+|||||.||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|+....+.  
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999999987 478999999999999999999999999999999999999999987432211  


Q ss_pred             ----------CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccC
Q 014087          260 ----------RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVK  322 (431)
Q Consensus       260 ----------~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~  322 (431)
                                .....+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+.+..++...|...  .+.
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence                      123468999999999997     456899999999999999999999999999999999998764  355


Q ss_pred             CCC---CCCHHHHHHHHhhcccCcCC--cCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCccc
Q 014087          323 LPP---FLTSEAHSLLKGLLHKDPSK--RLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  397 (431)
Q Consensus       323 ~p~---~~s~~~~~li~~~L~~dP~~--R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~  397 (431)
                      +|.   .+++++++||++||..+|++  |+     ++++|++||||++++|+.+  +++.|||+|.+.+..+++|||..+
T Consensus       302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~-----~~~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~~fd~~~  374 (437)
T 4aw2_A          302 FPTQVTDVSENAKDLIRRLICSREHRLGQN-----GIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTSNFDVDD  374 (437)
T ss_dssp             CCSSCCCSCHHHHHHHHTTSSCGGGCTTTT-----TTHHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCTTSCCC-
T ss_pred             CCcccccCCHHHHHHHHHHhcccccccCCC-----CHHHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchhhcCCcc
Confidence            664   48999999999999988877  66     8899999999999999999  578899999999999999999887


Q ss_pred             CCCCCCCCCCCC-----CCCCCCccCeEeeCCCccc
Q 014087          398 TTMPADDSPAPT-----PTAGEHFKGYTYVAPNPWL  428 (431)
Q Consensus       398 ~~~~~~~~~~~~-----~~~~~~f~~~~~~~~~~~~  428 (431)
                      +..+...+.++.     ......|.||+|+++..+.
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~  410 (437)
T 4aw2_A          375 DCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLS  410 (437)
T ss_dssp             -----------------CCTTGGGTTCCEESSCTTS
T ss_pred             cccccccCCCCCccccccccCccccCCCcCCchhhc
Confidence            665443332221     1245679999999987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-59  Score=453.64  Aligned_cols=233  Identities=26%  Similarity=0.389  Sum_probs=208.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.++||+|+||+||+|+++.     +++.||||+++++..        ..+|+.+|+.++|||||+++++|++++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~-----~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQ-----TGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hhheEeCcEeccCCCeEEEEEEECC-----CCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4579999999999999999999986     899999999986543        235999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-ccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-~~~~~~--------  259 (431)
                      .+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|. ....+.        
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            99999999999999999999999999999999999999999999999999999999999999874 211111        


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCCC
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLT  328 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s  328 (431)
                              ....++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++..+|..+..   .+|+.++
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence                    12346899999999999999999999999999999999999999998887778888887654   4678899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++++||.+||++||.+||     +++||++
T Consensus       284 ~~~~~li~~~L~~dP~~R~-----sa~el~~  309 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRA-----SAMELRR  309 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCc-----CHHHHHH
Confidence            9999999999999999999     8888853

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-58  Score=463.83  Aligned_cols=313  Identities=36%  Similarity=0.650  Sum_probs=258.7

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|+++++||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|..++||||+++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~-----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ-----TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            3456778899999999999999999999986     88999999998876656666677889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      +|++.+.+|+||||++||+|.+++.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|+....+.  
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence            9999999999999999999999998754 7999999999999999999999999999999999999999987432211  


Q ss_pred             ----------CcccccCCCCCCchhhhc-------cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--c
Q 014087          260 ----------RSNSMCGTTEYMAPEILL-------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--K  320 (431)
Q Consensus       260 ----------~~~~~~Gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~  320 (431)
                                .....+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.+.+..+++.+|...  .
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence                      123468999999999998       356899999999999999999999999999999998888764  3


Q ss_pred             cCCC---CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCccc
Q 014087          321 VKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCW  397 (431)
Q Consensus       321 ~~~p---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~  397 (431)
                      ..+|   ..++.++++||++||. +|.+|++.  .++++|++||||++++|+.+.  +..|||+|.+.+..|++|||...
T Consensus       289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~  363 (412)
T 2vd5_A          289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLR--DSVPPFTPDFEGATDTCNFDLVE  363 (412)
T ss_dssp             CCCC----CCCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTST--TSCCSCCCC-----CCSSCC--C
T ss_pred             cCCCccccCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCCCcCCCcccccccCccc
Confidence            4444   5799999999999999 99999864  389999999999999999995  56899999999999999999753


Q ss_pred             CCCCCC-------CCC--CC-CCCCCCCccCeEeeCCC
Q 014087          398 TTMPAD-------DSP--AP-TPTAGEHFKGYTYVAPN  425 (431)
Q Consensus       398 ~~~~~~-------~~~--~~-~~~~~~~f~~~~~~~~~  425 (431)
                      ......       .+.  .. ....+..|.||+|+++.
T Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~  401 (412)
T 2vd5_A          364 DGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMA  401 (412)
T ss_dssp             CCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCC
T ss_pred             ccccccccccCCCcccccCCCccccCCCCCCCcccCcc
Confidence            221110       110  01 11245679999999865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.8e-58  Score=463.00  Aligned_cols=290  Identities=41%  Similarity=0.805  Sum_probs=251.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||.||+|+++.     +++.||||++++...........+.+|+.+|+.++||||+++++++.
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcC-----CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            4556789999999999999999999886     88999999999876656666677889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCC-------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDE-------  257 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~-------  257 (431)
                      +.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|.....       
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999999999999998899999999999999999999998 999999999999999998863221       


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                          .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+...+...+......+|..+++++.+
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  378 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS  378 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence                1223457899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTM  400 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  400 (431)
                      ||.+||+.||.+||+++.++++++++||||++++|+.+..+++.|||+|.+.+..++.+||++||.+
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~  445 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ  445 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence            9999999999999988878999999999999999999999999999999999999999999998864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.6e-57  Score=438.77  Aligned_cols=298  Identities=50%  Similarity=0.918  Sum_probs=241.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .+..++|++++.||+|+||+||+|++..  ...+++.||+|++++..... ......+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECS--STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEec--cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            4556789999999999999999999852  11378999999998754322 23445678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      .+.+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+      
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999988643221      


Q ss_pred             -----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          259 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                           ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|..++.++.+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  250 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD  250 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                 123456899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDS  405 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~  405 (431)
                      ||.+||..||.+||++.+.+++++++||||++++|+.+..+++.|||+|.+....+.++|+..++...+..+
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~  322 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDS  322 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC----------------------
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhccccCCC
Confidence            999999999999999887899999999999999999999999999999999999999999988777554444

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-57  Score=449.76  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=213.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe---
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (431)
                      ++|++++.||+|+||+||+|+++.     +|+.||||++++... .....+.+.+|+++|+.++|||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~-----t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRL-----TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            579999999999999999999986     899999999976543 33445678899999999999999999999764   


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC------
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE------  257 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~------  257 (431)
                         .+.+|||||||. |+|.+++.+.+.+++.+++.|+.||+.||.|||++|||||||||+|||++.+|.....      
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence               367999999996 6799999998999999999999999999999999999999999999999998863211      


Q ss_pred             ---------CCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC----
Q 014087          258 ---------SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----  323 (431)
Q Consensus       258 ---------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----  323 (431)
                               .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....|.......    
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence                     1233467999999999999875 56999999999999999999999999999888888876432211    


Q ss_pred             ---------------------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          324 ---------------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       324 ---------------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                                 .+.+++++++||.+||++||.+|+     +++|+++||||+....
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI-----SAAAALRHPFLAKYHD  353 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCHhhCcCCC
Confidence                                       124789999999999999999999     8999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-57  Score=467.70  Aligned_cols=314  Identities=36%  Similarity=0.670  Sum_probs=269.5

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|+++++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKA-----TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            45677899999999999999999999986     8999999999988766666677889999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--  258 (431)
                      ++.+.+|+||||++||+|..++.+.    ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|+....+  
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            9999999999999999999999864    3699999999999999999999999999999999999999998732211  


Q ss_pred             ---------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccCCCC
Q 014087          259 ---------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPP  325 (431)
Q Consensus       259 ---------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~p~  325 (431)
                               ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    ...++.+.+......+|.
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence                     1233468999999999999999999999999999999999999999875    467788888888889999


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCC-----CcccCCCCcccCCC
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG-----KDCIANFDKCWTTM  400 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~-----~~~~~~f~~~~~~~  400 (431)
                      .++.++++||.+||++||.+||++...++++|++||||++++|..+..+++.|||+|....     ..+..+|+..    
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~~~----  490 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTV----  490 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC------
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcccc----
Confidence            9999999999999999999999886667899999999999999999999999999998653     3344555431    


Q ss_pred             CCCCCCCCCCCCCCCccCeEeeC-CCccccC
Q 014087          401 PADDSPAPTPTAGEHFKGYTYVA-PNPWLSS  430 (431)
Q Consensus       401 ~~~~~~~~~~~~~~~f~~~~~~~-~~~~~~~  430 (431)
                      +   .......+++.|.+|++.+ +.+|+.|
T Consensus       491 ~---~~~~~~~~~~~f~~f~~~~~~~~~~~~  518 (543)
T 3c4z_A          491 K---GVAFEKADTEFFQEFASGTCPIPWQEE  518 (543)
T ss_dssp             ----CCCCCHHHHHHHHHHCCEECHHHHHHH
T ss_pred             C---CCCCCcchhhHhhcCCCCCCChhHHHh
Confidence            1   1112234568899999976 4578765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-55  Score=438.01  Aligned_cols=280  Identities=34%  Similarity=0.682  Sum_probs=250.9

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++|||||+++++|.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKND-----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4556789999999999999999999986     88999999999887667777788999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC---------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID---------  256 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~---------  256 (431)
                      +.+.+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|....         
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            99999999999999999999999889999999999999999999999999999999999999999987322         


Q ss_pred             -CCCCcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcccCCCCCCCH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLPPFLTS  329 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~  329 (431)
                       ........+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..   .....+...+......+|..++.
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~  245 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ  245 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence             2233456789999999999974   4689999999999999999999999974   45667778888888899999999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD  394 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~  394 (431)
                      ++.+||.+||..||.+||+    ++++|++||||++++|+.+..+++.|||+|.....++...|+
T Consensus       246 ~~~~li~~lL~~dP~~R~s----~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~~~~~~  306 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFS----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE  306 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCC----SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCCCCCCC
T ss_pred             HHHHHHHHHhcCCHhHhcc----cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCCCCccC
Confidence            9999999999999999994    389999999999999999999999999999876555444444

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-57  Score=464.46  Aligned_cols=315  Identities=35%  Similarity=0.649  Sum_probs=264.3

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (431)
                      ...+..++|+++++||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++|||||+++++
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            344677899999999999999999999986     899999999998776666667788899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----  257 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----  257 (431)
                      +++.+.+|+||||+.||+|.+++...+.  +++..++.|+.||+.||.|||++|||||||||+||||+.+|+....    
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence            9999999999999999999999987643  9999999999999999999999999999999999999999874321    


Q ss_pred             ------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccCCCCCC
Q 014087          258 ------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRIINEKVKLPPFL  327 (431)
Q Consensus       258 ------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~p~~~  327 (431)
                            .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    ....+...+......+|..+
T Consensus       333 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~  412 (576)
T 2acx_A          333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF  412 (576)
T ss_dssp             CEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             ceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccC
Confidence                  12234568999999999999999999999999999999999999999875    45677788888888889999


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCC-----CcccCCCCcccCCCCC
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSG-----KDCIANFDKCWTTMPA  402 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~-----~~~~~~f~~~~~~~~~  402 (431)
                      +.++++||.+||++||.+|+|+...++++|++||||++++|+.+..+++.|||+|....     ..+..+|+..    . 
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~~----~-  487 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTV----K-  487 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCCCC------------------
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccccccCCcccHhhcccc----C-
Confidence            99999999999999999999887778999999999999999999999999999998653     2334444321    1 


Q ss_pred             CCCCCCCCCCCCCccCeEeeC-CCccccC
Q 014087          403 DDSPAPTPTAGEHFKGYTYVA-PNPWLSS  430 (431)
Q Consensus       403 ~~~~~~~~~~~~~f~~~~~~~-~~~~~~~  430 (431)
                        .....+.+++.|.+|...+ +-+|+.|
T Consensus       488 --~~~~~~~~~~~f~~f~~~~~~~~~~~e  514 (576)
T 2acx_A          488 --GVELEPTDQDFYQKFATGSVPIPWQNE  514 (576)
T ss_dssp             ------CHHHHHHHHHHCCEECHHHHHHH
T ss_pred             --CCCCCccHHHHHhhhccCCCCcccchh
Confidence              1122234567788887754 4467643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.7e-57  Score=431.33  Aligned_cols=243  Identities=26%  Similarity=0.417  Sum_probs=195.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC--
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  188 (431)
                      +|++++.||+|+||+||+|+++.     +++.||||+++...  .....+.+.+|+.+|+.++|||||+++++|.+.+  
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETT-----TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hCEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            69999999999999999999986     88999999997643  3344567889999999999999999999997644  


Q ss_pred             ----------EEEEEEeccCCCChHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          189 ----------KLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       189 ----------~~~lv~E~~~gg~L~~~l~~~~~~---~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                                .+|+|||||.||+|.+++...+.+   ++..++.|+.||+.||+|||++|||||||||+||||+.+|...
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence                      479999999999999999877653   4567889999999999999999999999999999999998632


Q ss_pred             CCCC-----------------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HH
Q 014087          256 DESS-----------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QK  311 (431)
Q Consensus       256 ~~~~-----------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~  311 (431)
                      ..+.                       ...+.+||+.|||||++.+..|+.++|||||||+||||++   ||.+... ..
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            2211                       1234689999999999999999999999999999999996   8865322 22


Q ss_pred             HHHHHHhcccCCC---CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          312 LQQRIINEKVKLP---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       312 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                      ....+..  ..+|   ...++++++||.+||++||++||     ++++|++||||++++|..
T Consensus       236 ~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERP-----EAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGCCC----
T ss_pred             HHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCc-----CHHHHhcCHhhCCCCCCC
Confidence            2333333  2333   24567889999999999999999     899999999999999843

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-56  Score=427.10  Aligned_cols=249  Identities=21%  Similarity=0.363  Sum_probs=214.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|.+.++||+|+||+||+|+++......++..||||+++..   .....+.+.+|+++|++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3555689999999999999999999876555557889999999754   2344577999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      +++.+|||||||+||+|.++|.+.             ..+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999864             3699999999999999999999999999999999999999987


Q ss_pred             CccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014087          253 HEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  318 (431)
Q Consensus       253 ~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~  318 (431)
                      .....+..             ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            63322211             223468999999999999999999999999999999999 9999999999999998887


Q ss_pred             cc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          319 EK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       319 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      +. ...|..+++++.+||.+||+.||++||     ++++|.  +|++
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~~i~--~~L~  285 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRK-----NIKGIH--TLLQ  285 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHH--HHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHH--HHHH
Confidence            64 567889999999999999999999999     889984  4554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.9e-56  Score=429.46  Aligned_cols=246  Identities=21%  Similarity=0.357  Sum_probs=214.0

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|.+.++||+|+||+||+|+++......+++.||||+++..   .....+.|.+|+++|++++|||||++++++.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3455689999999999999999999886555557899999999754   3344577999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS  250 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~  250 (431)
                      +.+.+|||||||+||+|.+++.+.               +.+++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999764               35899999999999999999999999999999999999999


Q ss_pred             CCCccCCC-------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014087          251 DGHEIDES-------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  316 (431)
Q Consensus       251 ~g~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i  316 (431)
                      ++.....+             ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            87632211             12234679999999999999999999999999999999999 99999999999888888


Q ss_pred             Hhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          317 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       317 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+ .+..|..+++++.+||.+||+.||++||     ++++|+.
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~  312 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRH-----SIKDVHA  312 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCc-----CHHHHHH
Confidence            775 5678889999999999999999999999     8899976

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-55  Score=430.47  Aligned_cols=243  Identities=23%  Similarity=0.400  Sum_probs=198.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      ++|+++++||+|+||+||+|+++..  ..+++.||||++.+..     ....+.+|+++|+.+ +|||||+++++|++.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            5799999999999999999987631  1267899999986542     234577899999988 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCccCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHEIDES---------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-g~~~~~~---------  258 (431)
                      ++|+|||||+||+|.+++   +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+ |.....+         
T Consensus        94 ~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999999999988   359999999999999999999999999999999999999876 4321111         


Q ss_pred             ------------------------------CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCC-
Q 014087          259 ------------------------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-  306 (431)
Q Consensus       259 ------------------------------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~-  306 (431)
                                                    ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.. 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence                                          112345899999999999875 589999999999999999999999954 


Q ss_pred             CCHHHHHHHHHhc--------------------------------------c----------------cCCCCCCCHHHH
Q 014087          307 ANRQKLQQRIINE--------------------------------------K----------------VKLPPFLTSEAH  332 (431)
Q Consensus       307 ~~~~~~~~~i~~~--------------------------------------~----------------~~~p~~~s~~~~  332 (431)
                      .+..+....|..-                                      .                ......++++++
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            4444444333210                                      0                011235789999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      |||++||++||++|+     |++|+++||||++++
T Consensus       331 DLl~~lL~~dP~~R~-----ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          331 DLLDKLLDLNPASRI-----TAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHTCSCTTTSC-----CHHHHHTSGGGTTC-
T ss_pred             HHHHHHCcCChhHCc-----CHHHHhcCcccCCCC
Confidence            999999999999999     899999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-55  Score=456.25  Aligned_cols=249  Identities=26%  Similarity=0.492  Sum_probs=223.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +|+.||||++.+...   ...+.+.+|+.+|+.++|||||+++++|++.+.
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~-----tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            579999999999999999999986     899999999976542   234568899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CCcc----------C
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHEI----------D  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~--g~~~----------~  256 (431)
                      +|||||||.||+|++++.+ .+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+  |...          .
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999999864 4679999999999999999999999999999999999999865  4321          1


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      ......+.|||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..|......++    ..++++++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            12233466899999999999999999999999999999999999999999999999999998877665    46899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      +||++||++||.+||     +++|+++||||+..+|...
T Consensus       389 dli~~~L~~dp~~R~-----t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          389 DFIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             HHHHTTSCSSGGGSC-----CHHHHHHSTTTSCCCCTTT
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCcCcCCCCCCCc
Confidence            999999999999999     8999999999999888643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-55  Score=422.83  Aligned_cols=248  Identities=21%  Similarity=0.318  Sum_probs=212.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++++++++||+|+||+||+|++.+..+..+++.||||+++...  .....+.|.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            35567799999999999999999998765555578899999997543  3344577999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~  249 (431)
                      +++.+|||||||++|+|.++|..+                ..+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999753                3589999999999999999999999999999999999999


Q ss_pred             CCCCccCCC-------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014087          250 SDGHEIDES-------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQR  315 (431)
Q Consensus       250 ~~g~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~  315 (431)
                      .++.....+             ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            987632111             12345689999999999999999999999999999999998 9999999999999988


Q ss_pred             HHhcc-cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          316 IINEK-VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       316 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +..+. .+.|..++.++.+||.+||+.||++||     ++++|+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP-----s~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP-----RFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHcCCCCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            87764 567889999999999999999999999     88888763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-54  Score=412.58  Aligned_cols=241  Identities=23%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (431)
                      .+.+..+++++.++||+|+||+||+|++++        .||||+++.... .....+.|.+|+.+|++++|||||+++++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            456778899999999999999999998542        489999875432 34556789999999999999999999998


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      +. ++.+|||||||+||+|.++|... +.+++.++..|+.||+.||+|||++|||||||||+||||+.++.....+    
T Consensus       101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence            75 46789999999999999999764 5799999999999999999999999999999999999999987632111    


Q ss_pred             ---------CCcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----
Q 014087          259 ---------SRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-----  321 (431)
Q Consensus       259 ---------~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----  321 (431)
                               ....+.+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+.......+.....     
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence                     12345689999999999974   3589999999999999999999999988655444444433322     


Q ss_pred             -CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          322 -KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       322 -~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                       ..+..+++++.+||.+||+.||++||     ++++|++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ei~~  293 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERP-----LFPQILS  293 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSC-----CHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCc-----CHHHHHH
Confidence             23467899999999999999999999     7887754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.1e-54  Score=418.43  Aligned_cols=250  Identities=22%  Similarity=0.381  Sum_probs=212.9

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC-CCcceeeE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRY  182 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~  182 (431)
                      .+.+..++|+++++||+|+||+||+|++++.....+++.||||+++...  .....+.+.+|+.+|++++| ||||++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            4567778999999999999999999999876655577899999997654  23345678899999999965 99999999


Q ss_pred             EEEe-CCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          183 SFQT-RSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       183 ~~~~-~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      ++.+ ++.+|||||||++|+|.++|++.                ..+++.++..|+.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9866 46799999999999999999763                348999999999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCH-H
Q 014087          246 ILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR-Q  310 (431)
Q Consensus       246 ILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~-~  310 (431)
                      |||+.++.....+.             ...+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+. .
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999876321111             1234679999999999999999999999999999999998 9999988654 4


Q ss_pred             HHHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          311 KLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       311 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+...+..+ .+..|..+++++.+||.+||+.||++||     ++++|++|
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP-----t~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc-----CHHHHHHH
Confidence            444555443 5678889999999999999999999999     89999886

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5e-52  Score=404.09  Aligned_cols=250  Identities=31%  Similarity=0.571  Sum_probs=227.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++.+... .....+.+.+|+++|+.++||||+++++++.+.
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHIL-----TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            35689999999999999999999976     889999999987653 344566788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------  257 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------  257 (431)
                      +.+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....          
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999999999999998999999999999999999999999999999999999999998863221          


Q ss_pred             CCCcccccCCCCCCchhhhccCCCC-CcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                      .......+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+..++...+..+...+|..++.++.+||+
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK  246 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            2233566899999999999988875 789999999999999999999999999999999999999999999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      +||..||.+||     +++++++||||+...+
T Consensus       247 ~~L~~dP~~R~-----t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          247 RFLVLNPIKRG-----TLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHCCSSTTTSC-----CHHHHTTCTTTTTTCT
T ss_pred             HHCCCChhHCc-----CHHHHhcCHhhcCCCc
Confidence            99999999999     8999999999987543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-52  Score=410.12  Aligned_cols=286  Identities=46%  Similarity=0.850  Sum_probs=242.7

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      .+..++|++++.||+|+||+||+|++...  ..+++.||||++++.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            34456899999999999999999998531  137899999999764321 122234466799999999 69999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      +...+.+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.....+.    
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999999999998889999999999999999999999999999999999999999886432221    


Q ss_pred             --------CcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCC----CCHHHHHHHHHhcccCCCC
Q 014087          260 --------RSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRIINEKVKLPP  325 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~----~~~~~~~~~i~~~~~~~p~  325 (431)
                              .....+||+.|+|||++.+  ..++.++|||||||+||||++|+.||..    .....+...+......+|.
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  287 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  287 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence                    1234579999999999986  4578999999999999999999999964    3456677777777888889


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCC
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF  393 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f  393 (431)
                      .++..+++||.+||..||.+||++.+.+++++++|+||+.++|+.+..+++.+||.|.+....+.+||
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~  355 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF  355 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence            99999999999999999999999888899999999999999999999999999999999887777766

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-51  Score=406.03  Aligned_cols=255  Identities=28%  Similarity=0.473  Sum_probs=228.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||+|++++......   ...+.+.+|+.+|+.++||||+++++++.+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hceEEeeEEeeCcCEEEEEEEECC-----CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            469999999999999999999986     889999999987643221   235678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----cc-------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EI-------  255 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----~~-------  255 (431)
                      .+.+|+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.    ..       
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999999999988889999999999999999999999999999999999999988762    11       


Q ss_pred             ---CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCC
Q 014087          256 ---DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  328 (431)
Q Consensus       256 ---~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s  328 (431)
                         .........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...|......++    ..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence               111223566899999999999999999999999999999999999999999999999999988877766    4689


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcc
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  374 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~  374 (431)
                      .++++||.+||..||.+||     +++++++||||++++|.....+
T Consensus       247 ~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~~~~~~~~~  287 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRL-----TIQEALRHPWITPVDTQQAMVR  287 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTSCSSHHHHHHH
T ss_pred             HHHHHHHHHHCCCChhHCc-----CHHHHhcCcCcCCCchhhhhhc
Confidence            9999999999999999999     8999999999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-51  Score=401.51  Aligned_cols=271  Identities=29%  Similarity=0.523  Sum_probs=231.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++.+....       ..+|+++|.++ +||||+++++++.+.+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKA-----TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            359999999999999999999986     8899999999875421       34588888877 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CC---c-c--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GH---E-I--------  255 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-g~---~-~--------  255 (431)
                      .+|+||||+.||+|.+++.+.+.+++.++..++.||+.||.|||++||+||||||+|||+..+ +.   . +        
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999999999998899999999999999999999999999999999999998543 32   1 1        


Q ss_pred             --CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcccCCC----CC
Q 014087          256 --DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEKVKLP----PF  326 (431)
Q Consensus       256 --~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~~p----~~  326 (431)
                        .......+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+   .+..++...+..+.+.++    ..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence              111233466899999999999988899999999999999999999999975   567788888888877665    46


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTT  399 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~  399 (431)
                      ++.++++||++||..||++||     +++++++||||.  +|+.+..+++.+++.|........++|+...+.
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  315 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRL-----TAALVLRHPWIV--HWDQLPQYQLNRQDAPHLVKGAMAATYSALNRN  315 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSC-----CHHHHTTSHHHH--TGGGSCCSCCCCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             CCHHHHHHHHHHCCCChhHCc-----CHHHHhcCCeec--CccccccccCCCccchhhhhhHHHHHHhhhccc
Confidence            899999999999999999999     889999999994  699998889988888765433344455544433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=384.66  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=225.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ceEeceEEeeCCCeEEEEEEECC-----CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            59999999999999999999886     889999999986543221   2356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----cc--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EI--------  255 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----~~--------  255 (431)
                      ..+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.    ..        
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            999999999999999999988888999999999999999999999999999999999999998772    11        


Q ss_pred             --CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Q 014087          256 --DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS  329 (431)
Q Consensus       256 --~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  329 (431)
                        .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..++.
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  246 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence              111223456799999999999999999999999999999999999999999998888888887766655    46899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhccc
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  375 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~  375 (431)
                      ++++||.+||..||.+||     +++++++||||+..+|.....+.
T Consensus       247 ~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~~~~~~  287 (326)
T 2y0a_A          247 LAKDFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSRK  287 (326)
T ss_dssp             HHHHHHHHHSCSSGGGSC-----CHHHHHHSTTTSCCSHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCC-----CHHHHhcCCCccCCcchhhhhhh
Confidence            999999999999999999     89999999999999987765443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.9e-51  Score=396.73  Aligned_cols=246  Identities=29%  Similarity=0.534  Sum_probs=220.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||+||+|++..     +++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK-----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            4689999999999999999999976     88999999998876555555667889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----------S  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----------~  258 (431)
                      .+|+||||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.....          .
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999999999 78999999988899999999999999999999999999999999999999998763221          1


Q ss_pred             CCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....+...+......+|..+++++.+||++
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            22345689999999999998876 68999999999999999999999887666666666666777889999999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ||..||.+||     ++++|++||||+.
T Consensus       242 ~L~~dP~~Rp-----t~~eil~hp~~~~  264 (336)
T 3h4j_B          242 MIVADPMQRI-----TIQEIRRDPWFNV  264 (336)
T ss_dssp             TSCSSGGGSC-----CHHHHTTCHHHHT
T ss_pred             HcCCChhHCc-----CHHHHHhChhhcc
Confidence            9999999999     8999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.8e-50  Score=396.71  Aligned_cols=252  Identities=21%  Similarity=0.388  Sum_probs=210.5

Q ss_pred             CCCCceEEeeeccc--CceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          108 GPGDFEIFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       108 ~~~~y~~~~~LG~G--~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      ..++|+++++||+|  +||+||+|+++.     +++.||||+++.... .....+.+.+|+.+|+.++|||||++++++.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcC-----CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            45679999999999  999999999986     889999999987653 3455678889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                      +.+.+|+|||||.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.....+     
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            999999999999999999999876  6799999999999999999999999999999999999999887632211     


Q ss_pred             -------------CCcccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--  321 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--  321 (431)
                                   ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..+..  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence                         11223478999999999987  6799999999999999999999999987554443333222111  


Q ss_pred             --------------------------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHH
Q 014087          322 --------------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI  357 (431)
Q Consensus       322 --------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i  357 (431)
                                                                  .++..+++++++||.+||+.||++||     +++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~el  331 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP-----SASTL  331 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSC-----CHHHH
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC-----CHHHH
Confidence                                                        23456889999999999999999999     89999


Q ss_pred             HhCCCCCCCChhh
Q 014087          358 KHHKWFRSINWKT  370 (431)
Q Consensus       358 ~~h~~f~~~~~~~  370 (431)
                      ++||||+.+.|..
T Consensus       332 l~hp~f~~~~~~~  344 (389)
T 3gni_B          332 LNHSFFKQIKRRA  344 (389)
T ss_dssp             TTSGGGGGC---C
T ss_pred             hcCHHHHHHhhcc
Confidence            9999999987754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-49  Score=391.87  Aligned_cols=244  Identities=30%  Similarity=0.567  Sum_probs=219.4

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++.+.||+|+||.||+|.++.     +++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CeEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            59999999999999999999886     889999999987654 334456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---c-c---------CC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---E-I---------DE  257 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~-~---------~~  257 (431)
                      |+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   . +         ..
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999999999999998888999999999999999999999999999999999999987643   1 1         11


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHS  333 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~  333 (431)
                      .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+..+...+|.    .+++++++
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            12234568999999999999999999999999999999999999999999999999999888777663    58999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ||.+||..||.+||     +++++++||||..
T Consensus       264 li~~~L~~dP~~R~-----t~~e~l~hp~~~~  290 (362)
T 2bdw_A          264 LIDSMLTVNPKKRI-----TADQALKVPWICN  290 (362)
T ss_dssp             HHHHHSCSSGGGSC-----CHHHHTTSHHHHT
T ss_pred             HHHHHcCCChhhCc-----CHHHHhcCcccCC
Confidence            99999999999999     8999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-49  Score=376.23  Aligned_cols=261  Identities=33%  Similarity=0.658  Sum_probs=232.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||.||+|++..     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQ-----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcC-----CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            4556789999999999999999999876     78899999998776555555677899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                      +.+.+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+       
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999999999999999888999999999999999999999999999999999999999887633221       


Q ss_pred             --CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          259 --SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..++.++++||.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (284)
T 2vgo_A          165 PSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS  244 (284)
T ss_dssp             SSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             cccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence              123456799999999999999999999999999999999999999999998888889988888899999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      +||..||.+||     +++++++||||+..      .++..||..+
T Consensus       245 ~~l~~~p~~Rp-----s~~~ll~h~~~~~~------~~~~~p~~~~  279 (284)
T 2vgo_A          245 KLLRYHPPQRL-----PLKGVMEHPWVKAN------SRRVLPPVYQ  279 (284)
T ss_dssp             HHSCSSGGGSC-----CHHHHHTCHHHHHH------CCCCCCCCC-
T ss_pred             HHhhcCHhhCC-----CHHHHhhCHHHHhh------ccccCCCccc
Confidence            99999999999     89999999999742      2444555444

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.1e-49  Score=374.06  Aligned_cols=250  Identities=33%  Similarity=0.610  Sum_probs=227.0

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||+||+|+++.     +++.||+|++.+...........+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEcc-----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            4556789999999999999999999886     78899999998876656666778899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      +.+..|+||||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.      
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999999999998889999999999999999999999999999999999999999886432221      


Q ss_pred             ---CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          260 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                         .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..++.++.+||.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (279)
T 3fdn_A          160 PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS  239 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence               22456799999999999999999999999999999999999999999999999999999888999999999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +||..||.+||     ++++|++||||++
T Consensus       240 ~~l~~~p~~Rp-----s~~e~l~h~~~~~  263 (279)
T 3fdn_A          240 RLLKHNPSQRP-----MLREVLEHPWITA  263 (279)
T ss_dssp             HHCCSSGGGSC-----CHHHHHHCHHHHH
T ss_pred             HHhccChhhCC-----CHHHHhhCccccC
Confidence            99999999999     8999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-49  Score=405.30  Aligned_cols=250  Identities=30%  Similarity=0.557  Sum_probs=228.2

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|.+++.||+|+||+||+|+++.     +++.||||++.+...........+.+|+.+|+.++||||+++++++.
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHEL-----TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETT-----TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4456789999999999999999999886     88999999998876655566778999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------  257 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--------  257 (431)
                      +.+.+|+||||+.||+|.+++.+++.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....        
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            999999999999999999999988899999999999999999999999999999999999999998763221        


Q ss_pred             --CCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014087          258 --SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       258 --~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                        .....+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...+...+..+....|..+++++.+|
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence              223346689999999999998876 68999999999999999999999999888999999999888999999999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.+||+.||.+||     ++++|++||||+.
T Consensus       247 i~~~L~~dP~~Rp-----t~~eil~hp~~~~  272 (476)
T 2y94_A          247 LKHMLQVDPMKRA-----TIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHHTCSSTTTSC-----CHHHHHTCHHHHT
T ss_pred             HHHHcCCCchhCc-----CHHHHHhCHHhhh
Confidence            9999999999999     8999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=397.35  Aligned_cols=245  Identities=31%  Similarity=0.557  Sum_probs=217.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|.++.     +++.||+|++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~-----~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETT-----TTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECC-----CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            359999999999999999999886     889999999987654 33345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCccC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHEID----------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---g~~~~----------  256 (431)
                      .|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +....          
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999999999999999999999999999999999999999999999999999853   32111          


Q ss_pred             -CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  331 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  331 (431)
                       ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+..+...++.    .+++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence             111224568999999999999999999999999999999999999999999999999999988777653    689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ++||.+||+.||.+||     +++++++||||+.
T Consensus       245 ~~li~~~L~~dP~~Rp-----ta~e~L~hp~~~~  273 (444)
T 3soa_A          245 KDLINKMLTINPSKRI-----TAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHHHSCTTHH
T ss_pred             HHHHHHHcCCChhHCC-----CHHHHhcCccccC
Confidence            9999999999999999     8999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-49  Score=388.70  Aligned_cols=248  Identities=26%  Similarity=0.535  Sum_probs=214.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh--hHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++........  ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cceEEeeEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            359999999999999999999886     889999999987543322  2356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---c-cC---
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---E-ID---  256 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~-~~---  256 (431)
                      +.+|+|||||+||+|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   . +.   
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998887653    35899999999999999999999999999999999999987654   1 11   


Q ss_pred             -------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----C
Q 014087          257 -------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----P  325 (431)
Q Consensus       257 -------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~  325 (431)
                             ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+. ...+...+..+...++    .
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence                   111134568999999999999999999999999999999999999999874 4567777777766655    4


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      .++.++++||.+||..||++||     +++++++||||++.++
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~-----s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERI-----TVYEALNHPWLKERDR  295 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHTHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCc-----CHHHHhcChhhcCCcc
Confidence            6899999999999999999999     8999999999987554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.1e-49  Score=375.73  Aligned_cols=244  Identities=25%  Similarity=0.434  Sum_probs=214.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|++..     +++.||||++.....   ...+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC-----CCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            4579999999999999999999875     889999999976542   23456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+.||+|.+++.+. .+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+          
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999999999999775 689999999999999999999999999999999999999887633221          


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...   ....+..++.++.+|
T Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred             ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence             1234568999999999999999999999999999999999999999988877766665543   334567899999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      |.+||+.||.+||     +++++++||||+..
T Consensus       250 i~~~l~~dp~~Rp-----s~~ell~h~~~~~~  276 (297)
T 3fxz_A          250 LNRCLEMDVEKRG-----SAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHSCSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             HHHHccCChhHCc-----CHHHHhhChhhccc
Confidence            9999999999999     89999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-49  Score=381.84  Aligned_cols=244  Identities=25%  Similarity=0.421  Sum_probs=216.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||+||+|+++.     +++.||+|++....    .....+.+|+.+|+.++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC-----CCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence            4689999999999999999999886     88999999987542    23456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC--CCCccCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHEIDE--------  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~g~~~~~--------  257 (431)
                      .+|+||||++||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.  ++.....        
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999999999999999999765 47999999999999999999999999999999999999997  4442211        


Q ss_pred             --CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHH
Q 014087          258 --SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEA  331 (431)
Q Consensus       258 --~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  331 (431)
                        .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+......++    ..++.++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence              1122345799999999999998899999999999999999999999999999999999998887766    3689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++||.+||..||.+||     +++++++||||+..
T Consensus       235 ~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  264 (321)
T 1tki_A          235 MDFVDRLLVKERKSRM-----TASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSC-----CHHHHHHSHHHHSC
T ss_pred             HHHHHHHcCCChhHCc-----CHHHHhcChhhccC
Confidence            9999999999999999     89999999999763

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-48  Score=377.79  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=226.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      +|++.+.||+|+||.||+|+++.     +++.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cEEEeeEeeecCCEEEEEEEECC-----CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            59999999999999999999886     789999999987543221   1356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----ccC-------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EID-------  256 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----~~~-------  256 (431)
                      +.+|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.    ...       
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            999999999999999999998888999999999999999999999999999999999999998872    111       


Q ss_pred             ---CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Q 014087          257 ---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS  329 (431)
Q Consensus       257 ---~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  329 (431)
                         ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..++.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE  247 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence               11123456799999999999999999999999999999999999999999998888888887766655    46899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhccc
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEARE  375 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~  375 (431)
                      ++.+||.+||..||.+||     +++++++||||++++|.....+.
T Consensus       248 ~~~~li~~~l~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~~~~~  288 (321)
T 2a2a_A          248 LAKDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRR  288 (321)
T ss_dssp             HHHHHHHTTSCSSTTTSC-----CHHHHHHSTTTSCSSHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHhcCccccCCCcccccccc
Confidence            999999999999999999     89999999999999998776543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-48  Score=377.00  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=205.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|++.      +++.||+|++..... .......+.+|+.+|+.++||||+++++++.+++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            467999999999999999999975      578999999976542 3444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      .+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+         
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 787777765 4599999999999999999999999999999999999999988633221         


Q ss_pred             --CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------------
Q 014087          259 --SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------------  321 (431)
Q Consensus       259 --~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------------  321 (431)
                        ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....              
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence              12234578999999999986 5689999999999999999999999988766655555533100              


Q ss_pred             ----------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          322 ----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       322 ----------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                                      ...+.++.++.+||.+||+.||++||     +++++++||||++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI-----SARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTSCTT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC-----CHHHHhcCcccccCCcc
Confidence                            01234788999999999999999999     89999999999998864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.4e-48  Score=366.38  Aligned_cols=252  Identities=29%  Similarity=0.525  Sum_probs=224.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|.++.     +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC-----CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            4689999999999999999999886     789999999987654 3444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---ccC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EID---------  256 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~~---------  256 (431)
                      ..|+||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   ...         
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999999999999998889999999999999999999999999999999999999987654   111         


Q ss_pred             -CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEA  331 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  331 (431)
                       .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+...++    ..+++++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence             11122346799999999999999999999999999999999999999999999999998888776665    3689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      .+||.+||+.||++||     +++++++||||++..+..-
T Consensus       239 ~~li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRI-----TADQALKVPWICNRERVAS  273 (284)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHTTSHHHHSCCCGGG
T ss_pred             HHHHHHHcccChhhCC-----CHHHHhcCccccCChhHHh
Confidence            9999999999999999     8999999999988765443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.3e-48  Score=369.58  Aligned_cols=246  Identities=23%  Similarity=0.407  Sum_probs=206.6

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++..... .......+.+|+.+++.++||||+++++++.+++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC-----CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            579999999999999999999986     889999999986543 34445678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      +|+||||+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+           
T Consensus        76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            999999998754444444467899999999999999999999999999999999999999988632221           


Q ss_pred             CCcccccCCCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccc---------------
Q 014087          259 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPP-FTHANRQKLQQRIINEKV---------------  321 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~P-f~~~~~~~~~~~i~~~~~---------------  321 (431)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+....+.....               
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            1223457899999999998765 89999999999999999987777 666777776666643111               


Q ss_pred             --------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                    ...+.++.++++||.+||+.||++||     +++++++||||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC-----CHHHHhcCcccccC
Confidence                          11235789999999999999999999     89999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-48  Score=383.19  Aligned_cols=244  Identities=32%  Similarity=0.570  Sum_probs=205.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++.+.....    +.+.+|+.+++.++||||+++++++.+.
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKL-----TKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETT-----TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            34679999999999999999999986     88999999997654322    4577899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--cc-CC-------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EI-DE-------  257 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~--~~-~~-------  257 (431)
                      +.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  .. ..       
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999999999998889999999999999999999999999999999999999987764  21 11       


Q ss_pred             --CCCcccccCCCCCCchhhhccCCCCCc-chhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCCCC--CCC
Q 014087          258 --SSRSNSMCGTTEYMAPEILLSKGHNKD-ADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPP--FLT  328 (431)
Q Consensus       258 --~~~~~~~~Gt~~y~aPE~~~~~~~~~~-~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s  328 (431)
                        .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..    .....+.+......+|.  .++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence              112245679999999999998888655 899999999999999999998643    35566677766666665  589


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +++++||.+||+.||.+||     ++++|++||||..
T Consensus       249 ~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~~  280 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRI-----SIPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSC-----CHHHHHTSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCc-----CHHHHHhCcchhc
Confidence            9999999999999999999     8999999999943

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-48  Score=395.22  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=200.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++|||||++++++..  
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL-----EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC-----CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            4689999999999999999999886     88999999987643 234456678899999999999999999999943  


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                         ...+|+||||+. |+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.....+.    
T Consensus       126 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          126 VEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence               357999999985 689999988888999999999999999999999999999999999999999876321111    


Q ss_pred             ----------------------------------CcccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHh-----
Q 014087          260 ----------------------------------RSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLT-----  299 (431)
Q Consensus       260 ----------------------------------~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ellt-----  299 (431)
                                                        .....+||+.|+|||++. ...|+.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence                                              123457899999999874 6679999999999999999999     


Q ss_pred             ------CCCCCCCCCH--------------------HHHHHHHHhc--c-----------------------------cC
Q 014087          300 ------GQPPFTHANR--------------------QKLQQRIINE--K-----------------------------VK  322 (431)
Q Consensus       300 ------g~~Pf~~~~~--------------------~~~~~~i~~~--~-----------------------------~~  322 (431)
                            |+++|.+.+.                    ......|...  .                             ..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  7788866431                    1112222110  0                             00


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      ..+.+++++.+||.+||..||.+|+     +++++++||||++++|...+.....+...|
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~-----t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~  419 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRI-----TINECLAHPFFKEVRIAEVETNATEKVRLP  419 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred             HCCCCCHHHHHHHHHHhccCccccC-----CHHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence            1134689999999999999999999     899999999999999998876655554444

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-48  Score=371.15  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=208.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD-----TGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            579999999999999999999876     789999999866532 33445677889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      .|+||||+.+++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.          
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999999999999888888999999999999999999999999999999999999998876332211          


Q ss_pred             -CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 014087          260 -RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-----------------  320 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------------  320 (431)
                       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             1234578999999999986 668999999999999999999999999887776655543210                 


Q ss_pred             --cCCC------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCC
Q 014087          321 --VKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPK  379 (431)
Q Consensus       321 --~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~  379 (431)
                        ...+            +.++.++.+||.+||+.||.+||     +++++++||||+++.+.....+..+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~  304 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-----TCEQLLHHPYFENIREIEDLAKEHDKP  304 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHTSGGGTTCC------------
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC-----CHHHHhcChHHHhccCHHHHHHhhccH
Confidence              0111            35788999999999999999999     899999999999998876655554433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-48  Score=385.62  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=204.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  188 (431)
                      ++|++++.||+|+||+||+|.++.     +++.||||++.+.. ........+.+|+.+|+.+. ||||+++++++...+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRR-----TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETT-----TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             CceEEEEEeeeCCCeEEEEEEECC-----CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            579999999999999999999886     88999999986543 23344566778999999997 999999999998654


Q ss_pred             --EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       189 --~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                        .+|+|||||. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.       
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence              7999999998 589888876 57899999999999999999999999999999999999999886322211       


Q ss_pred             -------------------------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 014087          260 -------------------------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ  313 (431)
Q Consensus       260 -------------------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~  313 (431)
                                               .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                                     1234589999999999987 67899999999999999999999999998888777


Q ss_pred             HHHHhccc-----------------------------------------------CCCCCCCHHHHHHHHhhcccCcCCc
Q 014087          314 QRIINEKV-----------------------------------------------KLPPFLTSEAHSLLKGLLHKDPSKR  346 (431)
Q Consensus       314 ~~i~~~~~-----------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R  346 (431)
                      ..|.....                                               ..+..+++++.+||.+||+.||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            77653110                                               0112678999999999999999999


Q ss_pred             CCCCCCCHHHHHhCCCCCCC---ChhhHhcccCCCCccc
Q 014087          347 LGSGPGGVDAIKHHKWFRSI---NWKTLEAREMQPKFKP  382 (431)
Q Consensus       347 ~~~~~~~~~~i~~h~~f~~~---~~~~l~~~~~~p~~~p  382 (431)
                      |     +++++++||||+.+   +|+....+.+.+||.+
T Consensus       321 ~-----t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~  354 (388)
T 3oz6_A          321 I-----SANDALKHPFVSIFHNPNEEPNCDHIITIPIND  354 (388)
T ss_dssp             C-----CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---
T ss_pred             C-----CHHHHhCCHHHHHhcCCccCCCCCCCCCCCccc
Confidence            9     89999999998765   3444444455555544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-49  Score=377.48  Aligned_cols=233  Identities=23%  Similarity=0.309  Sum_probs=183.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      .+|.+.++||+|+||+||+|++       +|+.||||+++.....    ......|+..+..++|||||++++++.+++ 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-------~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-------TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            3589999999999999999987       4678999999764321    122345666677889999999999998654 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeCCCCCccCC
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                         .+|||||||+||+|.+++.+. .++++.+..++.|++.||.|||++        +||||||||+||||+.+|.....
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence               689999999999999999765 589999999999999999999987        99999999999999999873322


Q ss_pred             CC---------------CcccccCCCCCCchhhhccC------CCCCcchhHhHHHHHHHHHhCCCCCCC----------
Q 014087          258 SS---------------RSNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTGQPPFTH----------  306 (431)
Q Consensus       258 ~~---------------~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg~~Pf~~----------  306 (431)
                      +.               .....+||+.|||||++.+.      .|+.++|||||||+||||+||..||..          
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            11               12245899999999999865      367799999999999999999776632          


Q ss_pred             -----CCHHHHHHHHHhccc--CCCCC-----CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          307 -----ANRQKLQQRIINEKV--KLPPF-----LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       307 -----~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                           .....+...+.....  .+|..     ....+.+||.+||+.||++||     ++++|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence                 123445555554433  34432     235688999999999999999     8888876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-48  Score=383.53  Aligned_cols=246  Identities=27%  Similarity=0.486  Sum_probs=215.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|.++.     +++.||+|++.....   .....+.+|+.+|+.++||||+++++++.+...
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCEEEEEEEECC-----CCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            479999999999999999999886     889999999976432   223467899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CCccC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHEID----------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~--g~~~~----------  256 (431)
                      +|+||||+.||+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++.+  +....          
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999999999987654 79999999999999999999999999999999999999854  32211          


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++    ..++.+++
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            11122345799999999999999999999999999999999999999999998888888887765544    46899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      +||.+||..||.+||     +++++++||||++..+
T Consensus       283 ~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  313 (387)
T 1kob_A          283 DFIKNLLQKEPRKRL-----TVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHTTSCSSGGGSC-----CHHHHHTSTTTSSCCT
T ss_pred             HHHHHHcCCChhHCc-----CHHHHhhCccccCCcc
Confidence            999999999999999     8999999999987544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-47  Score=366.88  Aligned_cols=248  Identities=27%  Similarity=0.532  Sum_probs=225.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC-----CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            4579999999999999999999886     78899999998876555666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------  257 (431)
                      ..|+||||+.|++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+|.....           
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999999999999999888899999999999999999999999999999999999999998763221           


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......+|..++.++.+||.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  248 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  248 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence            12233457899999999999999999999999999999999999999999888888888888888999999999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||+.||++||     +++++++||||++.
T Consensus       249 ~l~~~p~~Rp-----s~~~ll~~~~~~~~  272 (294)
T 2rku_A          249 MLQTDPTARP-----TINELLNDEFFTSG  272 (294)
T ss_dssp             HTCSSGGGSC-----CGGGGGGSHHHHTS
T ss_pred             HcccChhhCc-----CHHHHhhChheecC
Confidence            9999999999     88999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.9e-48  Score=375.02  Aligned_cols=248  Identities=27%  Similarity=0.532  Sum_probs=226.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3579999999999999999999886     78999999998876555666778899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+||||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+          
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999999999999888999999999999999999999999999999999999999987632211          


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+......+|..++.++.+||.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  274 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence             1233457999999999999999999999999999999999999999998888888888888888999999999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||+.||++||     +++++++|+||...
T Consensus       275 ~l~~dp~~Rp-----s~~ell~~~~~~~~  298 (335)
T 2owb_A          275 MLQTDPTARP-----TINELLNDEFFTSG  298 (335)
T ss_dssp             HTCSSGGGSC-----CGGGGGGSHHHHTS
T ss_pred             HccCChhHCc-----CHHHHhcCccccCC
Confidence            9999999999     88999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.4e-48  Score=365.37  Aligned_cols=251  Identities=29%  Similarity=0.546  Sum_probs=218.4

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||.||+|+++.     +++.||||++...........+.+.+|+.+++.++||||+++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQL-----TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECC-----CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            34556789999999999999999999875     7889999999877655556677889999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      .+.+..|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+      
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999887632221      


Q ss_pred             ----CCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 014087          259 ----SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHS  333 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  333 (431)
                          ......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+...+.+.+......+|..++.++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  240 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT  240 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence                11234578999999999988766 6899999999999999999999999998889999988888889999999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ||.+||+.||.+||     +++++++||||+.
T Consensus       241 li~~~l~~~p~~Rp-----s~~~~l~h~~~~~  267 (276)
T 2h6d_A          241 LLMHMLQVDPLKRA-----TIKDIREHEWFKQ  267 (276)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             HHHHHccCChhhCC-----CHHHHHhChhhcc
Confidence            99999999999999     8999999999965

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-48  Score=377.17  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=204.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTV-----TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECC-----CCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3579999999999999999999886     889999999976542 3334456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----ccCC------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----EIDE------  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----~~~~------  257 (431)
                      .+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.     ....      
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999985 99999999889999999999999999999999999999999999999965442     1111      


Q ss_pred             -----CCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---------
Q 014087          258 -----SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---------  322 (431)
Q Consensus       258 -----~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------  322 (431)
                           .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+......         
T Consensus       186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence                 1223445789999999999874 4899999999999999999999999998887777766542110         


Q ss_pred             ---------C------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          323 ---------L------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       323 ---------~------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                               +            +..++.++.+||.+||+.||.+||     +++++++||||++++|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI-----SAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC-----CHHHHhCCcccCCCCCC
Confidence                     0            112789999999999999999999     89999999999999985

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.1e-48  Score=373.86  Aligned_cols=250  Identities=24%  Similarity=0.420  Sum_probs=197.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||+|+++...  .....+.+.+|+.+|+.++||||+++++++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT-----TGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECSS-----SCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC-----CCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            3579999999999999999999875     78999999997654  2233456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          189 KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      .+|+||||+. |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+    
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999999998 5899888764      3589999999999999999999999999999999999999988632221    


Q ss_pred             -------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 014087          259 -------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------  321 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------  321 (431)
                             ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....         
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence                   12234578999999999986 4689999999999999999999999999888877776643110         


Q ss_pred             -------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          322 -------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       322 -------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                                               ..+..++.++++||.+||+.||++||     +++++++||||++..|...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL-----SAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCC---
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC-----CHHHHhCChhhhcccchhh
Confidence                                     11235789999999999999999999     8999999999998776543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1e-47  Score=370.79  Aligned_cols=247  Identities=29%  Similarity=0.531  Sum_probs=208.2

Q ss_pred             CCceEE-eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      +.|++. +.||+|+||+||+|+++.     +++.||||++.+..   ....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI-----TSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS-----SCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             eeEEecCceecCCceEEEEEEEEcC-----CCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            469985 789999999999999875     78999999997653   23356688899999985 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---c-cCCCC----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---E-IDESS----  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~-~~~~~----  259 (431)
                      +.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   . +.+..    
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999999998889999999999999999999999999999999999999998765   1 11110    


Q ss_pred             -------------CcccccCCCCCCchhhhcc-----CCCCCcchhHhHHHHHHHHHhCCCCCCCCC-------------
Q 014087          260 -------------RSNSMCGTTEYMAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHAN-------------  308 (431)
Q Consensus       260 -------------~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~Pf~~~~-------------  308 (431)
                                   .....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..             
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence                         1123469999999999975     558899999999999999999999997653             


Q ss_pred             --HHHHHHHHHhcccCCC----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          309 --RQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       309 --~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                        ...+...+......+|    ..++.++++||.+||..||.+||     +++++++||||++..++
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL-----SAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSTTCC-----
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCC-----CHHHHhcChhhcCCCCc
Confidence              3456777777777776    35899999999999999999999     89999999999987664

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=366.42  Aligned_cols=248  Identities=27%  Similarity=0.552  Sum_probs=196.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|++..     +++.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIH-----TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEcc-----CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            3579999999999999999999875     78999999998776555556678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      ..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+.        
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999999999875 67999999999999999999999999999999999999998876322211        


Q ss_pred             ---CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014087          260 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLK  336 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  336 (431)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......|..++.++.+||.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence               12345789999999999999999999999999999999999999988766666666666677788889999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +||+.||++||     +++++++||||...
T Consensus       245 ~~l~~dp~~Rp-----s~~~~l~h~~~~~~  269 (278)
T 3cok_A          245 QLLRRNPADRL-----SLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHSCSSGGGSC-----CHHHHTTSTTTC--
T ss_pred             HHcccCHhhCC-----CHHHHhcCccccCC
Confidence            99999999999     89999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-48  Score=376.53  Aligned_cols=246  Identities=28%  Similarity=0.468  Sum_probs=207.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC-----CCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4689999999999999999999886     889999999975542  222356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      ..|+||||+.||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.....+.         
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999999999988888999999999999999999999999999999999999999876432221         


Q ss_pred             ----CcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCCC--CCCCHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP--PFLTSEA  331 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~  331 (431)
                          .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.. .....+.......+  ..++.++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence                1235689999999999988776 77899999999999999999999875543 22333333333322  4689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+||.+||..||.+||     +++++++||||+..
T Consensus       239 ~~li~~~L~~dP~~R~-----t~~eil~h~~~~~~  268 (323)
T 3tki_A          239 LALLHKILVENPSARI-----TIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhhChhhccc
Confidence            9999999999999999     89999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-47  Score=365.35  Aligned_cols=245  Identities=24%  Similarity=0.394  Sum_probs=204.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|++.      +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57999999999999999999874      688999999976542 23334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      +|+||||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9999999986 898888764 67999999999999999999999999999999999999999887432221         


Q ss_pred             --CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------------
Q 014087          260 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------  321 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------------  321 (431)
                        .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.....               
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence              22345789999999999764 589999999999999999999999999887776666643100               


Q ss_pred             --------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          322 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       322 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                                    .+...+++++.+||.+||+.||++||     +++++++||||++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFKENN  288 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC--
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC-----CHHHHhcCcchhhcC
Confidence                          11235789999999999999999999     899999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-47  Score=394.04  Aligned_cols=246  Identities=32%  Similarity=0.545  Sum_probs=215.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh----------hHHHHHHHHHHHHHhcCCCCcce
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----------NHVDYMKAERDILTKVTHPFIVQ  179 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~  179 (431)
                      ++|+++++||+|+||+||+|+++.     +++.||||++.+......          ...+.+.+|+.+|+.++||||++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             cceEEEeEecccCCeEEEEEEECC-----CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            579999999999999999999986     889999999987543321          34567889999999999999999


Q ss_pred             eeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----c
Q 014087          180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----I  255 (431)
Q Consensus       180 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----~  255 (431)
                      +++++.+...+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..    +
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999999999988899999999999999999999999999999999999999987631    1


Q ss_pred             ---------CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC--
Q 014087          256 ---------DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--  324 (431)
Q Consensus       256 ---------~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--  324 (431)
                               .........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..++...+..+...++  
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence                     1112334568999999999987 4699999999999999999999999999999999999998877665  


Q ss_pred             --CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          325 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       325 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                        ..++.++++||++||+.||.+||     +++++++||||+..
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRC-----TAEEALNSRWIKKY  308 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHT
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCC-----CHHHHhcCHhhhhc
Confidence              56899999999999999999999     89999999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-48  Score=395.95  Aligned_cols=249  Identities=31%  Similarity=0.532  Sum_probs=221.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.++||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECC-----CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            359999999999999999999886     889999999987765555567788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCccC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHEID----------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~g~~~~----------  256 (431)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++....          
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999999999999899999999999999999999999999999999999999953   343221          


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      ........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..++++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence            1222345679999999999976 699999999999999999999999999999999999988876554    46899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      +||.+||+.||.+||     +++++++||||+...++
T Consensus       260 ~li~~~L~~dp~~R~-----s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRI-----SARDALDHEWIQTYTKE  291 (484)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHTSHHHHHHTC-
T ss_pred             HHHHHHCCCChhHCc-----CHHHHhhChhhcccccc
Confidence            999999999999999     89999999999875543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=376.56  Aligned_cols=244  Identities=34%  Similarity=0.562  Sum_probs=202.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++++..     ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKG-----TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECC-----CCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            469999999999999999999986     78899999997643     23457789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCccCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHEIDE---------  257 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~g~~~~~---------  257 (431)
                      +|+||||+.||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.....         
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999999999998888999999999999999999999999999999999999975   4432111         


Q ss_pred             -CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccCCC----CCCCHHH
Q 014087          258 -SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLP----PFLTSEA  331 (431)
Q Consensus       258 -~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~p----~~~s~~~  331 (431)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+......++    ..++.++
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence             1122456799999999999999999999999999999999999999976544 446777776655443    4689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      ++||.+||..||++||     +++++++||||.+..+
T Consensus       283 ~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRL-----TTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HHHHHTTSCSSGGGSC-----CHHHHHHSTTTTSTTC
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhcCcccCCCcc
Confidence            9999999999999999     8999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=369.44  Aligned_cols=247  Identities=30%  Similarity=0.557  Sum_probs=208.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-----------------------hhHHHHHH
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMK  163 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~  163 (431)
                      +..++|++.+.||+|+||.||+|+++.     +++.||||++.+.....                       ....+.+.
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNEN-----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETT-----TTEEEEEEEEECC-------------------------------CHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            335689999999999999999999876     88999999997654321                       12245688


Q ss_pred             HHHHHHHhcCCCCcceeeEEEEe--CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 014087          164 AERDILTKVTHPFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL  241 (431)
Q Consensus       164 ~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDl  241 (431)
                      +|+.+|+.++||||+++++++.+  .+.+|+||||+++++|.+++ ..+.+++.+++.++.||+.||.|||++||+||||
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99999999999999999999987  67899999999999997754 3457999999999999999999999999999999


Q ss_pred             CCCceEeCCCCCccCCCC-----------CcccccCCCCCCchhhhccCC---CCCcchhHhHHHHHHHHHhCCCCCCCC
Q 014087          242 KPENILMDSDGHEIDESS-----------RSNSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHA  307 (431)
Q Consensus       242 Kp~NILl~~~g~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~Pf~~~  307 (431)
                      ||+|||++.+|.....+.           .....+||+.|+|||++.+..   ++.++|||||||++|||++|+.||.+.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999876322111           123457999999999998765   377899999999999999999999998


Q ss_pred             CHHHHHHHHHhcccCCC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          308 NRQKLQQRIINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       308 ~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      +...+...+......+|  ..+++++.+||.+||+.||++||     +++++++||||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~-----s~~e~l~hp~~~  297 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLHPWVT  297 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC-----CHHHHTTCHHHH
T ss_pred             cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCC-----CHHHHhcCcccc
Confidence            88888888877766665  46899999999999999999999     899999999995

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.8e-47  Score=359.97  Aligned_cols=242  Identities=30%  Similarity=0.552  Sum_probs=216.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|+++.     ++..+|+|++.+...   ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCC-----CCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            359999999999999999999886     788999999986542   235678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCccC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHEID----------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~g~~~~----------  256 (431)
                      .|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++....          
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999988899999999999999999999999999999999999999   55554221          


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  332 (431)
                      ........+||+.|+|||++.+. ++.++|||||||++|||++|+.||...+..+....+..+...+|.    .+++++.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            12223456799999999998765 899999999999999999999999999999999999888877774    6899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +||.+||+.||.+||     ++.++++||||++
T Consensus       240 ~li~~~l~~dp~~R~-----s~~~~l~h~~~~~  267 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRI-----TSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHHTCSSTTTSC-----CHHHHTTSHHHHH
T ss_pred             HHHHHHccCChhhCc-----CHHHHhcCHHHhc
Confidence            999999999999999     8999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9e-47  Score=360.99  Aligned_cols=254  Identities=29%  Similarity=0.498  Sum_probs=219.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh------hhhhHHHHHHHHHHHHHhcC-CCCcceee
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI------IKKNHVDYMKAERDILTKVT-HPFIVQLR  181 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~-hpnIv~l~  181 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||||+++....      ......+.+.+|+.+|+.+. ||||++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhccceeeeecCCCceEEEEEEEcC-----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            4679999999999999999999986     889999999975431      11234567789999999995 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----  257 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----  257 (431)
                      +++.+.+..|+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.....    
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999999999988889999999999999999999999999999999999999998763221    


Q ss_pred             ------CCCcccccCCCCCCchhhhc------cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Q 014087          258 ------SSRSNSMCGTTEYMAPEILL------SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-  324 (431)
Q Consensus       258 ------~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p-  324 (431)
                            .......+||+.|+|||++.      ...++.++|||||||++|+|++|+.||...+.......+......++ 
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence                  12234567999999999986      45688999999999999999999999999888888888887766554 


Q ss_pred             ---CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHh
Q 014087          325 ---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  372 (431)
Q Consensus       325 ---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~  372 (431)
                         ..++.++.+||.+||..||.+||     +++++++||||++..|+.+.
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCTTC-----
T ss_pred             ccccccCHHHHHHHHHHccCCcccCC-----CHHHHHhChHhhhccchhhc
Confidence               35899999999999999999999     89999999999999887664

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-47  Score=392.74  Aligned_cols=245  Identities=30%  Similarity=0.566  Sum_probs=215.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|+++++||+|+||+||+|+++.     +++.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETT-----TCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            59999999999999999999886     8899999999876532 33456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---cc----------CC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EI----------DE  257 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~----------~~  257 (431)
                      |+|||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   ..          ..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            999999999999999998889999999999999999999999999999999999999965432   11          11


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS  333 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  333 (431)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..+++++++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            122345679999999999976 499999999999999999999999999999999999988766543    358999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ||.+||+.||.+||     +++++++||||+...
T Consensus       256 li~~~L~~dp~~R~-----t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRI-----TATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCc-----CHHHHhcCHhhccCc
Confidence            99999999999999     899999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-47  Score=372.40  Aligned_cols=240  Identities=32%  Similarity=0.608  Sum_probs=190.4

Q ss_pred             CceEE---eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEe
Q 014087          111 DFEIF---RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (431)
Q Consensus       111 ~y~~~---~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (431)
                      +|++.   +.||+|+||+||+|+++.     +++.||||++.+..      ...+.+|+.+++.+. ||||+++++++.+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKK-----SNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETT-----TCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECC-----CCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            36664   789999999999999986     88999999997542      345678999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---ccC-------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EID-------  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~~-------  256 (431)
                      ....|+||||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.   ...       
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            9999999999999999999999999999999999999999999999999999999999999987652   111       


Q ss_pred             ----CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcccCCCC
Q 014087          257 ----ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN-------RQKLQQRIINEKVKLPP  325 (431)
Q Consensus       257 ----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~p~  325 (431)
                          ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+       ..++...+..+...++.
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence                1112345678999999999999999999999999999999999999997643       35677788777776653


Q ss_pred             ----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          326 ----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       326 ----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                          .+++++++||.+||+.||.+||     +++++++||||++.
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~ell~h~w~~~~  277 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCC-----CTTTSTTCGGGCTT
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCC-----CHHHHhcChhhccC
Confidence                5899999999999999999999     78999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.9e-47  Score=382.01  Aligned_cols=253  Identities=24%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN-----TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            4689999999999999999999986     88999999997643 2344556788999999999999999999999876 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                          ..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.....+     
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence                57999999997 49999998888899999999999999999999999999999999999999987632111     


Q ss_pred             ----------------------------CCcccccCCCCCCchhhh-ccCCCCCcchhHhHHHHHHHHHh----------
Q 014087          259 ----------------------------SRSNSMCGTTEYMAPEIL-LSKGHNKDADWWSVGILLYEMLT----------  299 (431)
Q Consensus       259 ----------------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DvwslGvil~ellt----------  299 (431)
                                                  ......+||+.|+|||++ ....|+.++|||||||++|||++          
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence                                        113567899999999987 45679999999999999999998          


Q ss_pred             -CCCCCCCCC-----------------HHHHHHHHH------------------------hcccCCC-------CCCCHH
Q 014087          300 -GQPPFTHAN-----------------RQKLQQRII------------------------NEKVKLP-------PFLTSE  330 (431)
Q Consensus       300 -g~~Pf~~~~-----------------~~~~~~~i~------------------------~~~~~~p-------~~~s~~  330 (431)
                       |+++|.+.+                 .......|.                        ......+       +.++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence             444554432                 111111111                        1111111       358999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhc
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  373 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~  373 (431)
                      +.+||.+||+.||.+||     +++++++||||++++|...+.
T Consensus       338 ~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRI-----TIDQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HHHHHHHHSCSSTTTSC-----CHHHHHTCGGGTTTCCTTTC-
T ss_pred             HHHHHHHHhcCCcccCC-----CHHHHhcChhhhhccCcccCc
Confidence            99999999999999999     899999999999999987765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-47  Score=364.26  Aligned_cols=249  Identities=25%  Similarity=0.345  Sum_probs=203.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHhc---CCCCcceee
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKV---THPFIVQLR  181 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l---~hpnIv~l~  181 (431)
                      +..++|++++.||+|+||+||+|+++.     +++.||||++......  .......+.+|+.+++.+   +||||++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT-----TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            345689999999999999999999875     8899999998754321  111123455677777666   599999999


Q ss_pred             EEEEeCC-----EEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc
Q 014087          182 YSFQTRS-----KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       182 ~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      +++....     .+++||||+. |+|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++..
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred             eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            9998765     5899999997 499999987654  9999999999999999999999999999999999999988763


Q ss_pred             cCC----------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--
Q 014087          255 IDE----------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--  322 (431)
Q Consensus       255 ~~~----------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--  322 (431)
                      ...          .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......  
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            221          22234568999999999999999999999999999999999999999998888877777542110  


Q ss_pred             -------------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          323 -------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       323 -------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                               ..+.+++++.+||.+||+.||++||     +++++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~h~~~~~~  303 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI-----SAFRALQHSYLHKD  303 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSTTC---
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC-----CHHHHhcCccccCC
Confidence                                     1135789999999999999999999     89999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-47  Score=374.79  Aligned_cols=248  Identities=28%  Similarity=0.472  Sum_probs=212.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      +|++.+.||+|+||+||+|+++.     +++.||+|++.+....  .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQ-----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             heeecceeeecCCeEEEEEEECC-----CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            59999999999999999999876     8899999999876542  3455678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 014087          189 KLYLILDFINGGHLFFHLYR----------------------------------------QGIFREDQARFYTAEIVSAV  228 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~aL  228 (431)
                      ..|+||||++||+|.+++..                                        ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999998842                                        11246788999999999999


Q ss_pred             HHHHHCCceeccCCCCceEeCCCCC--ccCCCC---------------CcccccCCCCCCchhhhcc--CCCCCcchhHh
Q 014087          229 SHLHKCGIVHRDLKPENILMDSDGH--EIDESS---------------RSNSMCGTTEYMAPEILLS--KGHNKDADWWS  289 (431)
Q Consensus       229 ~~LH~~~iiHrDlKp~NILl~~~g~--~~~~~~---------------~~~~~~Gt~~y~aPE~~~~--~~~~~~~Dvws  289 (431)
                      .|||++||+||||||+|||++.++.  ....+.               .....+||+.|+|||++.+  ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            9999999999999999999987762  211111               1235679999999999975  67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          290 VGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       290 lGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |||++|||++|+.||.+.+..+....+......++.    .+++++.+||.+||..||.+||     +++++++||||++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~hp~~~~  336 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF-----DAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC-----CHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC-----CHHHHhcChhhcc
Confidence            999999999999999999988888888877665543    4799999999999999999999     8999999999988


Q ss_pred             CCh
Q 014087          366 INW  368 (431)
Q Consensus       366 ~~~  368 (431)
                      +.|
T Consensus       337 ~~~  339 (345)
T 3hko_A          337 FSD  339 (345)
T ss_dssp             TSS
T ss_pred             ChH
Confidence            765

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-47  Score=362.38  Aligned_cols=250  Identities=29%  Similarity=0.510  Sum_probs=217.6

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||+|+++.......   ...+.+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG-----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC-----CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence            359999999999999999999886     789999999987543221   235678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC----ccCC-----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----EIDE-----  257 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~----~~~~-----  257 (431)
                      .+..|+||||+.+++|.+++.+...+++..+..++.||+.||.|||++||+||||||+||+++.++.    ....     
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            9999999999999999999998888999999999999999999999999999999999999998762    1111     


Q ss_pred             -----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCC
Q 014087          258 -----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  328 (431)
Q Consensus       258 -----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s  328 (431)
                           ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence                 1122345689999999999999999999999999999999999999999988888888877666554    4689


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      .++.+||.+||..||.+||     +++++++||||+.+.+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSC-----CHHHHHHCHHHHHHHHC
T ss_pred             HHHHHHHHHHccCCHhHCc-----CHHHHHhCHHHHHHHHH
Confidence            9999999999999999999     89999999999876554

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-47  Score=389.62  Aligned_cols=245  Identities=29%  Similarity=0.546  Sum_probs=212.3

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|++++.||+|+||+||+|+++.     ++..||+|++.+..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETT-----TCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECC-----CCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            59999999999999999999986     88999999998765322 2346688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---cc----------CC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EI----------DE  257 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~----------~~  257 (431)
                      |+|||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..+.   ..          ..
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            999999999999999998889999999999999999999999999999999999999987543   11          11


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS  333 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  333 (431)
                      .......+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..++.++++
T Consensus       192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence            12234568999999999986 5699999999999999999999999999999999999988877654    358999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ||++||+.||.+||     +++++++||||+...
T Consensus       271 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          271 LIKQMLQFDSQRRI-----SAQQALEHPWIKEMC  299 (494)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHTCHHHHHHH
T ss_pred             HHHHHCCCChhhCc-----cHHHHhcCcccccCc
Confidence            99999999999999     899999999998643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=377.77  Aligned_cols=246  Identities=24%  Similarity=0.452  Sum_probs=209.7

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL  192 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  192 (431)
                      ...+.||+|+||.||+|+++.     +++.||+|+++....   ...+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEEECC-----CEEEEEETT-----TCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcC-----CCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            346789999999999999876     789999999986532   334578899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CCCCccC----------CCC
Q 014087          193 ILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHEID----------ESS  259 (431)
Q Consensus       193 v~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~--~~g~~~~----------~~~  259 (431)
                      ||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++  .++....          ...
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            99999999999988765 4699999999999999999999999999999999999994  4443211          112


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHSLL  335 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  335 (431)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++    ..+++++++||
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            23445799999999999999999999999999999999999999999999988888888766554    46899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      .+||+.||.+||     +++++++||||++..|...
T Consensus       324 ~~~L~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~  354 (373)
T 2x4f_A          324 SKLLIKEKSWRI-----SASEALKHPWLSDHKLHSR  354 (373)
T ss_dssp             HTTSCSSGGGSC-----CHHHHHHSHHHHCHHHHHH
T ss_pred             HHHcCCChhhCC-----CHHHHhcCcCcCCCchhhh
Confidence            999999999999     8999999999998876544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-47  Score=369.65  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=215.8

Q ss_pred             CceEE-eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      +|.+. +.||+|+||+||+|+++.     +++.||+|++.+... .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKS-----TGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             EEeeccceeCCCCCeEEEEEEECC-----CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            47777 899999999999999886     789999999987543 233456688899999999 5699999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCccCC------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHEIDE------  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~g~~~~~------  257 (431)
                      .+|+||||+.||+|.+++...  +.+++.+++.++.||+.||.|||++||+||||||+|||++.   +|.....      
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            999999999999999988653  67999999999999999999999999999999999999998   4442211      


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS  329 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  329 (431)
                          .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++    ..++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence                1123456799999999999999999999999999999999999999999988888888876655443    45899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  377 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~  377 (431)
                      ++.+||.+||+.||.+||     +++++++||||++++|+.+......
T Consensus       263 ~~~~li~~~L~~dP~~Rp-----t~~~ll~h~~~~~~~~~~~~~~~~~  305 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRP-----TAEICLSHSWLQQWDFENLFHPEET  305 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSC-----CHHHHTTCGGGCCCCTTCC------
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHhCCHhhcccccccccCccCC
Confidence            999999999999999999     8999999999999999877554433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.9e-47  Score=387.39  Aligned_cols=243  Identities=26%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.+.. ......+.+.+|+.+|+.++|||||++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            4679999999999999999999886     88999999998653 2344566788999999999999999999999654 


Q ss_pred             -----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       188 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                           ..+|+||||+.++ |...+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.....+    
T Consensus       135 ~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             ccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence                 4689999999875 656653  3589999999999999999999999999999999999999988643221    


Q ss_pred             ------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----------
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------  322 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----------  322 (431)
                            ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....|......          
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence                  1234578999999999999999999999999999999999999999998887777666542110          


Q ss_pred             ---------------------CCCC-----------CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          323 ---------------------LPPF-----------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       323 ---------------------~p~~-----------~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                           +|..           .++++++||.+||+.||++||     +++++++||||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGG
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC-----CHHHHhcChhhhh
Confidence                                 0110           156799999999999999999     8999999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-47  Score=382.36  Aligned_cols=239  Identities=28%  Similarity=0.535  Sum_probs=196.8

Q ss_pred             CCCceEE-eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH-hcCCCCcceeeEEEEe
Q 014087          109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~  186 (431)
                      .++|.+. ++||+|+||+||+|+++.     +++.||||+++..        ..+.+|+.++. ..+||||++++++|..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECC-----CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            3468887 789999999999999886     8899999998643        23567888874 4589999999999876


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCccCC
Q 014087          187 ----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHEIDE  257 (431)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~g~~~~~  257 (431)
                          ...+|+|||||.||+|.+++...+  .+++.+++.|+.||+.||.|||++||+||||||+|||++.   ++.....
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence                667999999999999999998754  5999999999999999999999999999999999999997   4432111


Q ss_pred             ----------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcccCC
Q 014087          258 ----------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKVKL  323 (431)
Q Consensus       258 ----------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~  323 (431)
                                .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..    .+...+..+...+
T Consensus       207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence                      12234568999999999999999999999999999999999999999765432    2456666666665


Q ss_pred             C----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          324 P----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       324 p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +    ..++.++++||++||+.||.+||     ++++|++||||..
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~  327 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  327 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCc-----CHHHHhcCccccC
Confidence            5    46899999999999999999999     8999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-46  Score=358.93  Aligned_cols=242  Identities=30%  Similarity=0.528  Sum_probs=207.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +|.+.+.||+|+||+||+|+++.     +++.+|+|++.+..  .....+.+.+|+++|+.++||||+++++++.+.+..
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             heeecceeccCCCeEEEEEEEcc-----CCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            59999999999999999999876     78899999998764  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCccC-------
Q 014087          191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHEID-------  256 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---g~~~~-------  256 (431)
                      |+||||+.||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +....       
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999988643    679999999999999999999999999999999999999543   33211       


Q ss_pred             ---CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHH
Q 014087          257 ---ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---PFLTSE  330 (431)
Q Consensus       257 ---~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~  330 (431)
                         ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+....+......++   ..++++
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence               111234567999999999986 5689999999999999999999999999988888887776655443   347899


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +.+||.+||+.||++||     +++++++||||+.
T Consensus       255 ~~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRP-----SAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSC-----CHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHhcCHHhhc
Confidence            99999999999999999     8999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.4e-46  Score=369.37  Aligned_cols=245  Identities=31%  Similarity=0.538  Sum_probs=215.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ++|++.+.||+|+||.||+|+++.     +|+.||||+++....     ......+.+.+|+.+++.+ +||||++++++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRA-----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhcccceEEecCCCEEEEEEEECC-----CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            359999999999999999999875     789999999976431     1123356788999999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC------
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE------  257 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~------  257 (431)
                      +...+..|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.....      
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            99999999999999999999999988889999999999999999999999999999999999999998863221      


Q ss_pred             ----CCCcccccCCCCCCchhhhcc------CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP---  324 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p---  324 (431)
                          .......+||+.|+|||++.+      ..++.++|||||||++|||++|+.||.+.+.......+..+...++   
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence                122345689999999999974      3588999999999999999999999999888888888887766654   


Q ss_pred             -CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       325 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                       ..++.++.+||.+||..||++||     +++++++||||+
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~  364 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARL-----TAEQALQHPFFE  364 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCc-----CHHHHhcCcccC
Confidence             46889999999999999999999     899999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-46  Score=369.69  Aligned_cols=243  Identities=29%  Similarity=0.446  Sum_probs=205.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----CCCcceee
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR  181 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~  181 (431)
                      +..++|+++++||+|+||+||+|+++.     +++.||||+++..    ......+..|+.+++.+.     ||||++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHID-----NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECC-----CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            345689999999999999999999976     7899999999743    223445677999999986     99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---------
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---------  250 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---------  250 (431)
                      +++...+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.         
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence            9999999999999999 899999998764  5999999999999999999999999999999999999985         


Q ss_pred             ----------------CCCccC--------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 014087          251 ----------------DGHEID--------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH  306 (431)
Q Consensus       251 ----------------~g~~~~--------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~  306 (431)
                                      ++....        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                            333111        11223456899999999999999999999999999999999999999998


Q ss_pred             CCHHHHHHHHHhcccCCCC----------------------------------------------CCCHHHHHHHHhhcc
Q 014087          307 ANRQKLQQRIINEKVKLPP----------------------------------------------FLTSEAHSLLKGLLH  340 (431)
Q Consensus       307 ~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~li~~~L~  340 (431)
                      .+..+....+......+|.                                              ..++++.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            8877776666543222221                                              123778899999999


Q ss_pred             cCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          341 KDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      .||.+||     +++++++||||+
T Consensus       342 ~dP~~Rp-----ta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRP-----SPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSC-----CHHHHTTSGGGC
T ss_pred             CChhhCC-----CHHHHhcCcccC
Confidence            9999999     899999999996

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=373.69  Aligned_cols=248  Identities=26%  Similarity=0.481  Sum_probs=212.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh-----hHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++++......     ...+.+.+|+.+|+.++||||+++++++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKE-----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETT-----TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceEEEeEEEecCCEEEEEEEECC-----CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            369999999999999999999886     889999999987643221     1334566799999999999999999999


Q ss_pred             EeCCEEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC------
Q 014087          185 QTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE------  257 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~------  257 (431)
                      .+.+.+|+||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....      
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999999776 999999998899999999999999999999999999999999999999998763222      


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  332 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  332 (431)
                          .......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..........|..++.++.
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------EETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG------GGGTTTCCCCSSCCCHHHH
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH------HHHHhhccCCCcccCHHHH
Confidence                222345679999999999998877 78999999999999999999999763      2233445566778999999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC------CChhhHhc
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS------INWKTLEA  373 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~------~~~~~l~~  373 (431)
                      +||.+||..||++||     +++++++||||+.      .+|+.+..
T Consensus       253 ~li~~~L~~dP~~Rp-----s~~ell~hp~~~~~~~~~~~~~~~~~~  294 (335)
T 3dls_A          253 SLVSGLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFR  294 (335)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHHCTTTTCCCCGGGCCHHHHC-
T ss_pred             HHHHHHccCChhhCc-----CHHHHhcCccccCCccccccCHHHHhh
Confidence            999999999999999     8999999999965      56666543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=369.70  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||+++.....  .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL-----TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC-----CCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence            579999999999999999999886     7899999999754321  111234469999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      +|+||||+.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9999999985 888888775 45999999999999999999999999999999999999999886432221         


Q ss_pred             --CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------------
Q 014087          260 --RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------------  322 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  322 (431)
                        .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......              
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence              2234578999999999986 56899999999999999999999999998888777666542110              


Q ss_pred             ----------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          323 ----------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       323 ----------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                      ..+.++.++.+||.+||+.||.+||     +++++++||||.++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI-----SAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCS
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC-----CHHHHhcChhhhhccc
Confidence                            1134788999999999999999999     8999999999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=371.96  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=204.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEECC-----CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            3579999999999999999999876     88999999986543 23445567889999999999999999999998763


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                            .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+    
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence                  469999999 8899988876 5799999999999999999999999999999999999999988633221    


Q ss_pred             ----CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------------
Q 014087          259 ----SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------  321 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------  321 (431)
                          ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.....            
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence                22345689999999999987 7899999999999999999999999999887776666643111            


Q ss_pred             -------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       322 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                                         .+...+++++.+||.+||..||.+|+     +++++++||||+.+.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~-----t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC---
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC-----CHHHHhcChHHHhhcCCc
Confidence                               12245789999999999999999999     899999999999876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-46  Score=362.10  Aligned_cols=244  Identities=32%  Similarity=0.605  Sum_probs=213.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||.||+|+++.     +++.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRL-----TGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeccCCCCceEEEEEECC-----CCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            359999999999999999999876     789999999986432   223467889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCccCCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHEIDESS-------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~g~~~~~~~-------  259 (431)
                      +|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.....+.       
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999988899999999999999999999999999999999999999   55554222111       


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS  333 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  333 (431)
                        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+..+...++    ..++.++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence              12334699999999999999999999999999999999999999999998888888887765543    468999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||.+||..||.+||     +++++++||||++.
T Consensus       241 li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~  268 (304)
T 2jam_A          241 FICHLLEKDPNERY-----TCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHCSSTTTSC-----CHHHHHTSHHHHSS
T ss_pred             HHHHHcCCChhHCc-----CHHHHhcCccccCC
Confidence            99999999999999     89999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-46  Score=361.89  Aligned_cols=243  Identities=24%  Similarity=0.430  Sum_probs=212.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+..+.||+|+||+||+|+++.     +++.||||++....   ....+.+.+|+.+|+.++||||+++++++...+..
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~-----~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKH-----SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhhccEEeccCCCeEEEEEEECC-----CCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            38888999999999999999875     78999999997643   23356688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------C
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------S  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------~  259 (431)
                      |+||||++|++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+           .
T Consensus       118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            999999999999998764 5699999999999999999999999999999999999999887632211           1


Q ss_pred             CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCCCHHHHHHHH
Q 014087          260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHSLLK  336 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~  336 (431)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.....   ..+..+++++.+||.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            23456899999999999999999999999999999999999999999888887777766533   223468999999999


Q ss_pred             hhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          337 GLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       337 ~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      +||+.||++||     +++++++||||....
T Consensus       277 ~~l~~dp~~Rp-----s~~ell~hp~~~~~~  302 (321)
T 2c30_A          277 RMLVRDPQERA-----TAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHSCSSTTTSC-----CHHHHHTSGGGGGCC
T ss_pred             HHccCChhhCc-----CHHHHhcChhhccCC
Confidence            99999999999     899999999997643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-47  Score=383.31  Aligned_cols=253  Identities=30%  Similarity=0.574  Sum_probs=205.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-----hhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ++|++.+.||+|+||+||+|.++.     +++.||||++.+.....     ......+.+|+.+|+.++||||+++++++
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECC-----CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            579999999999999999999886     88999999998764321     22223477899999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---cc------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EI------  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~------  255 (431)
                      .. +.+|+||||+.+|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.   ..      
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            54 568999999999999999988889999999999999999999999999999999999999986553   11      


Q ss_pred             ----CCCCCcccccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccCCC---
Q 014087          256 ----DESSRSNSMCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQQRIINEKVKLP---  324 (431)
Q Consensus       256 ----~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~p---  324 (431)
                          .........+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..... ..+...+..+...++   
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence                11122345689999999999864   6678899999999999999999999976433 344555666555543   


Q ss_pred             -CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhc
Q 014087          325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  373 (431)
Q Consensus       325 -~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~  373 (431)
                       ..++.++.+||.+||+.||.+||     +++++++||||++.+|.....
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~~~~~  413 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQ  413 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGCCHHHHHHHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCc-----CHHHHhCCcccCChhHHHHHH
Confidence             45899999999999999999999     899999999999988876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-47  Score=369.34  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=212.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||||+++............+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR-----DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC-----CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            4579999999999999999999876     88999999998876556666778899999999999999999999987654


Q ss_pred             ----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                          ..|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+.     
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                35999999999999999998889999999999999999999999999999999999999998876432221     


Q ss_pred             ---------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CC
Q 014087          260 ---------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PF  326 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~  326 (431)
                               .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+    ..
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence                     12235689999999999999999999999999999999999999999888887777666544332    45


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ++.++.+||.+||+.||.+||     +..+++.|+|++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~-----~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRY-----QTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSC-----SSHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhCh-----hhHHHHHHHHHHH
Confidence            899999999999999999999     6688888898864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.3e-47  Score=371.52  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=218.3

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|++++.||+|+||+||+|+++.     +++.||+|++....  .....+.+.+|+.+|+.++||||+++++
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~   98 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYG   98 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECC-----CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeE
Confidence            3445667899999999999999999999886     88999999997653  3445567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccCCCCC-
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEIDESSR-  260 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~~~~~-  260 (431)
                      ++.+++.+|+||||++|++|.+++.+.+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.....+.. 
T Consensus        99 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A           99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence            9999999999999999999999999988999999999999999999999996 99999999999999998874433222 


Q ss_pred             --------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------
Q 014087          261 --------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR-----------------  315 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~-----------------  315 (431)
                              ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+...                 
T Consensus       179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          179 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             CHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             CcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence                    2345899999999999999999999999999999999999999987665543222                 


Q ss_pred             -------------------------HHhccc-CCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          316 -------------------------IINEKV-KLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       316 -------------------------i~~~~~-~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                               +..... ..+ ..++.++.+||.+||+.||.+||     +++++++||||++.+|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSHHHHHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC-----CHHHHhhChHhhcchH
Confidence                                     222211 122 34789999999999999999999     8999999999988776


Q ss_pred             hhHh
Q 014087          369 KTLE  372 (431)
Q Consensus       369 ~~l~  372 (431)
                      +.+.
T Consensus       334 ~~~~  337 (360)
T 3eqc_A          334 EEVD  337 (360)
T ss_dssp             SCCC
T ss_pred             hhhh
Confidence            6543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.4e-47  Score=368.70  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=216.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||.||+|+++.     +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKD-----TGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETT-----TCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECC-----CCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            4579999999999999999999886     789999999876532 3344566788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      ..|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999999999888887788999999999999999999999999999999999999999876332221         


Q ss_pred             --CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------
Q 014087          260 --RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------------  320 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------------  320 (431)
                        .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence              12345789999999999875 78999999999999999999999999888776665554211                


Q ss_pred             ---cCCC------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccC
Q 014087          321 ---VKLP------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREM  376 (431)
Q Consensus       321 ---~~~p------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~  376 (431)
                         ..++            +.+++++.+||.+||+.||.+||     +++++++||||+...|.....+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~  323 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-----FCAELLHHDFFQMDGFAERFSQEL  323 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-----CGGGGGGSHHHHGGGHHHHHHHHH
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC-----CHHHHhcCchhccCChhhhhhHHH
Confidence               1111            25789999999999999999999     889999999999887776554443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.2e-46  Score=354.96  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=208.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||.||+|++..     +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTI-----LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETT-----TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECC-----CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            35689999999999999999999876     7899999999766555566677899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------  259 (431)
                      +.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.        
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999999999999889999999999999999999999999999999999999999886332211        


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----CCCCCCHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----LPPFLTSE  330 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~  330 (431)
                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..............     .+..++..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence                123457999999999999999999999999999999999999999998877766665554332     34678999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++|.+||..||.+||+    +++++++
T Consensus       244 l~~li~~~l~~dp~~R~~----~~~~l~~  268 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYK----TIQEMKD  268 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCS----SHHHHHH
T ss_pred             HHHHHHHHhcCCHhHccc----cHHHHHH
Confidence            999999999999999983    4555544

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=359.47  Aligned_cols=249  Identities=28%  Similarity=0.469  Sum_probs=214.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHhcCCCCcceeeEEEE--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ--  185 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--  185 (431)
                      .++|++++.||+|+||.||+|.++.     +++.||+|++++..... ......+.+|+.+++.++||||+++++++.  
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE-----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT-----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC-----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            3679999999999999999999875     88899999998765432 345677899999999999999999999984  


Q ss_pred             eCCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                      +....|+||||+.++ |.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+     
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            456899999999987 7777765  35699999999999999999999999999999999999999887632211     


Q ss_pred             --------CCcccccCCCCCCchhhhccCCC--CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKGH--NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT  328 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~~--~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  328 (431)
                              .......||+.|+|||++.+...  +.++|||||||++|||++|+.||.+.+..++...+......++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  237 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG  237 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence                    11234568999999999986543  77999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      .++.+||.+||..||.+||     +++++++||||+....
T Consensus       238 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          238 PPLSDLLKGMLEYEPAKRF-----SIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHHHHTCSSTTTSC-----CHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHHHHccCChhhCC-----CHHHHhcCcccccCCC
Confidence            9999999999999999999     8999999999987544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-46  Score=370.57  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=207.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC-----CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            3579999999999999999999876     78999999997643 23445567889999999999999999999998765


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                            .+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.   
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence                  79999999986 6877775  45899999999999999999999999999999999999999876432221   


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----------
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------  322 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----------  322 (431)
                             .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......          
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence                   223467999999999999999999999999999999999999999998887777666542110          


Q ss_pred             ------------C--------------CC------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          323 ------------L--------------PP------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       323 ------------~--------------p~------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                                  +              |.      ..+.++++||.+||..||.+||     +++++++||||+..  ..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~~--~~  327 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINVW--YD  327 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHTT--CC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC-----CHHHHhCCcchhhh--cC
Confidence                        0              00      0156899999999999999999     89999999999853  33


Q ss_pred             HhcccCCCCcccC
Q 014087          371 LEAREMQPKFKPD  383 (431)
Q Consensus       371 l~~~~~~p~~~p~  383 (431)
                      .......||..|.
T Consensus       328 ~~~~~~~~~~~~~  340 (371)
T 2xrw_A          328 PSEAEAPPPKIPD  340 (371)
T ss_dssp             HHHHTCCCCCCCT
T ss_pred             ccccCCCCCCCCC
Confidence            3333444555554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-46  Score=356.86  Aligned_cols=248  Identities=30%  Similarity=0.558  Sum_probs=216.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcC-----CCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            469999999999999999999875     788999999977543 23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---ccC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EID----------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~~----------  256 (431)
                      +|+||||+.+++|.+.+.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.++.   ...          
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999999999999988888999999999999999999999999999999999999987643   111          


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      .........||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..++.++.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            11122344688999999998764 89999999999999999999999999998888888887765543    46899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      +||.+||..||.+||     +++++++||||+...|+
T Consensus       255 ~li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          255 DLIRKMLTFHPSLRI-----TATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHHSHHHHHHCCC
T ss_pred             HHHHHHcccChhhCc-----CHHHHhcCHHHhccccC
Confidence            999999999999999     89999999999876553

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-45  Score=351.86  Aligned_cols=246  Identities=22%  Similarity=0.397  Sum_probs=208.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      ....|++.+.||+|+||.||+|.+..     ++..||+|++..... .....+.+.+|+.+|+.++||||+++++++.. 
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecC-----CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence            34458999999999999999999876     888999999987654 34456778899999999999999999999875 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeC-CCCCccCC---
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHEIDE---  257 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~g~~~~~---  257 (431)
                         ...+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.....   
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence               4569999999999999999998888999999999999999999999999  99999999999998 55543211   


Q ss_pred             ------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCC
Q 014087          258 ------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEK--VKLPPFLT  328 (431)
Q Consensus       258 ------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s  328 (431)
                            .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+....  ..++...+
T Consensus       178 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (290)
T 1t4h_A          178 LATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             GGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             CcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence                  122345679999999998874 589999999999999999999999987 44455555555432  23455678


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +++.+||.+||..||.+||     +++++++||||++
T Consensus       257 ~~l~~li~~~l~~dp~~Rp-----s~~ell~h~~f~~  288 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhhCC-----CHHHHhhCccccc
Confidence            9999999999999999999     8999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-46  Score=369.17  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=207.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++..... .......+.+|+.+|+.++||||+++++++..  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETT-----TCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccceeEEEEEecCCCcEEEEEEECC-----CCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3579999999999999999999976     889999999876543 22334456789999999999999999999987  


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-
Q 014087          187 ------RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-  258 (431)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-  258 (431)
                            .+.+|+||||+.| +|...+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+ 
T Consensus        90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence                  4579999999986 676766654 6799999999999999999999999999999999999999887632211 


Q ss_pred             --------------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 014087          259 --------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL  323 (431)
Q Consensus       259 --------------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~  323 (431)
                                    ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence                          12244578999999999986 458999999999999999999999999988888777775432222


Q ss_pred             CCC--------------------------------CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          324 PPF--------------------------------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       324 p~~--------------------------------~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      +..                                .++++.+||.+||+.||.+||     +++++++||||++..+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGSSSCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC-----CHHHHhCCCCcCCCCCc
Confidence            211                                277899999999999999999     89999999999875543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.4e-47  Score=369.32  Aligned_cols=254  Identities=27%  Similarity=0.487  Sum_probs=221.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhH--------------HHHHHHHHHHHHhcC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------------VDYMKAERDILTKVT  173 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~--------------~~~~~~E~~il~~l~  173 (431)
                      ..++|++++.||+|+||.||+|++       +++.||||++..........              .+.+.+|+.+++.++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            356899999999999999999987       57889999998765433221              267889999999999


Q ss_pred             CCCcceeeEEEEeCCEEEEEEeccCCCChHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCC
Q 014087          174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFH------LYR--QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE  244 (431)
Q Consensus       174 hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------l~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~  244 (431)
                      ||||+++++++.+.+.+|+||||++||+|.++      +.+  ...+++..++.++.||+.||.|||+ +||+||||||+
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            99999999999999999999999999999988      665  5679999999999999999999999 99999999999


Q ss_pred             ceEeCCCCCccCCC---------CCcccccCCCCCCchhhhccC-CCCC-cchhHhHHHHHHHHHhCCCCCCCCCH-HHH
Q 014087          245 NILMDSDGHEIDES---------SRSNSMCGTTEYMAPEILLSK-GHNK-DADWWSVGILLYEMLTGQPPFTHANR-QKL  312 (431)
Q Consensus       245 NILl~~~g~~~~~~---------~~~~~~~Gt~~y~aPE~~~~~-~~~~-~~DvwslGvil~elltg~~Pf~~~~~-~~~  312 (431)
                      |||++.++.....+         .......||+.|+|||++.+. .++. ++|||||||++|||++|+.||...+. .++
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             hEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999988643222         123445799999999999887 6666 99999999999999999999988766 778


Q ss_pred             HHHHHhcccCCC-------------------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhc
Q 014087          313 QQRIINEKVKLP-------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  373 (431)
Q Consensus       313 ~~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~  373 (431)
                      ...+......+|                   ..++.++.+||.+||+.||.+||     +++++++||||++.+|+.+..
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~~~~~~~~~  336 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-----TSEDALKHEWLADTNIEDLRE  336 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGTTCCHHHHHH
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC-----CHHHHhcCccccCCCHHHHHH
Confidence            888887777777                   67899999999999999999999     899999999999999988753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.3e-46  Score=358.58  Aligned_cols=242  Identities=25%  Similarity=0.416  Sum_probs=208.7

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||+||+|++       .++.||||++..... .....+.+.+|+.+|+.++||||+++++++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-------HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-------CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            445667899999999999999999986       467799999976543 344566788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCccCCCC
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                      .+.+.+|+||||+.||+|.+++.+.+.   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.....+.
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999999987653   999999999999999999999999  999999999999999876432221


Q ss_pred             -----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcccCCCCC
Q 014087          260 -----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII--NEKVKLPPF  326 (431)
Q Consensus       260 -----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~  326 (431)
                                 .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.  .....+|..
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN  263 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence                       1234679999999999999999999999999999999999999999988888777764  345567888


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++++.+||.+||..||.+||     ++++|++
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~  291 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRP-----SFATIMD  291 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            999999999999999999999     8888876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-46  Score=363.76  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=212.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|++++.||+|+||+||+|++..     +++.||||++...........+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             heeeeeEEccCCCEEEEEEEEcc-----CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            49999999999999999999875     8899999999765444455567788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------CCcc
Q 014087          191 YLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------SRSN  262 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------~~~~  262 (431)
                      |+||||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+       ....
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  208 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  208 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence            99999998 47777775 456799999999999999999999999999999999999999887633221       1234


Q ss_pred             cccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--CCCCCCHHHHHHHHh
Q 014087          263 SMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--LPPFLTSEAHSLLKG  337 (431)
Q Consensus       263 ~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~  337 (431)
                      ..+||+.|+|||++.   ...++.++|||||||++|||++|+.||.+.+.......+......  .+..++.++.+||.+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  288 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  288 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            568999999999985   567899999999999999999999999988877776666655432  245689999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ||+.||++||     +++++++||||....
T Consensus       289 ~l~~dP~~Rp-----s~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          289 CLQKIPQDRP-----TSEVLLKHRFVLRER  313 (348)
T ss_dssp             HTCSSGGGSC-----CHHHHTTCHHHHSCC
T ss_pred             HcccChhhCc-----CHHHHhhChhhhccC
Confidence            9999999999     899999999997643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.1e-46  Score=355.43  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=213.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETT-----TCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             ccceeecceeccCCCeEEEEEEEcC-----CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            3579999999999999999999886     78999999987643   334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------
Q 014087          189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------  260 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------  260 (431)
                      .+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+..       
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999998876 4679999999999999999999999999999999999999988874333221       


Q ss_pred             ----cccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---CCCCCC
Q 014087          261 ----SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLT  328 (431)
Q Consensus       261 ----~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s  328 (431)
                          ....+||+.|+|||++.     +..++.++|||||||++|+|++|+.||...+.......+......   .+..++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence                23457999999999984     667899999999999999999999999998888777777655432   346789


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLE  372 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~  372 (431)
                      .++.+||.+||..||.+||     +++++++||||+++.|....
T Consensus       250 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  288 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRP-----SAAQLLEHPFVSSITSNKAL  288 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSC-----CHHHHTTSTTTTTCCCCHHH
T ss_pred             HHHHHHHHHHcccChhhCC-----CHHHHhcChHHhhhccchhH
Confidence            9999999999999999999     89999999999999886543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.9e-46  Score=364.64  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=210.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      ++|++++.||+|+||.||+|++..     +++.||||++....  .....+.+.+|+++|+.++||||+++++++...  
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNL-----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccEEEEEEeecCCCeEEEEEEECC-----CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            579999999999999999999876     78999999997533  344456788999999999999999999999765  


Q ss_pred             ---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                         ..+|+||||+.| +|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.....+.     
T Consensus       100 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          100 EQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence               479999999985 89888866 46999999999999999999999999999999999999999876322111     


Q ss_pred             ---------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------
Q 014087          260 ---------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--------  321 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------  321 (431)
                               .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....        
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence                     1234589999999998764 5589999999999999999999999998776666555542100        


Q ss_pred             -----------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCC
Q 014087          322 -----------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQP  378 (431)
Q Consensus       322 -----------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p  378 (431)
                                             .+...++.++.+||.+||..||.+||     +++++++||||+.. |.........+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~-~~~~~~~~~~~  331 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY-YDPSDEPIAEA  331 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTT-CCGGGSCCCSS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhhc-cCcccccCCCC
Confidence                                   01245789999999999999999999     89999999999976 33333333334


Q ss_pred             Cccc
Q 014087          379 KFKP  382 (431)
Q Consensus       379 ~~~p  382 (431)
                      ||.+
T Consensus       332 ~~~~  335 (364)
T 3qyz_A          332 PFKF  335 (364)
T ss_dssp             CCCC
T ss_pred             cCCc
Confidence            4443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-46  Score=363.56  Aligned_cols=243  Identities=26%  Similarity=0.393  Sum_probs=198.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||+++...  .....+.+.+|+.+|+.++||||+++++++.+.. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT-----TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC-----CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            369999999999999999999986     88999999997643  3345577899999999999999999999986543 


Q ss_pred             --------------------------------------------------------EEEEEEeccCCCChHHHHHHcCC-
Q 014087          189 --------------------------------------------------------KLYLILDFINGGHLFFHLYRQGI-  211 (431)
Q Consensus       189 --------------------------------------------------------~~~lv~E~~~gg~L~~~l~~~~~-  211 (431)
                                                                              .+|+|||||+||+|.+++.+... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999999999999987643 


Q ss_pred             --CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----------------------CcccccC
Q 014087          212 --FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----------------------RSNSMCG  266 (431)
Q Consensus       212 --~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----------------------~~~~~~G  266 (431)
                        ..+..++.++.||+.||.|||++||+||||||+|||++.+|.....+.                       .....+|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence              466678999999999999999999999999999999998876322111                       1234579


Q ss_pred             CCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCCCCCHHHHHHHHhhcccCcCC
Q 014087          267 TTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-LPPFLTSEAHSLLKGLLHKDPSK  345 (431)
Q Consensus       267 t~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~  345 (431)
                      |+.|+|||++.+..++.++|||||||++|||++|..|+..  .......+.....+ .+...++++.+||.+||+.||.+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence            9999999999999999999999999999999999877632  22233333333221 11346788999999999999999


Q ss_pred             cCCCCCCCHHHHHhCCCCCCC
Q 014087          346 RLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       346 R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||     +++++++||||+++
T Consensus       317 Rp-----s~~~~l~~~~f~~~  332 (332)
T 3qd2_B          317 RP-----EATDIIENAIFENL  332 (332)
T ss_dssp             SC-----CHHHHHHSTTCCCC
T ss_pred             CC-----CHHHHhhchhhhcC
Confidence            99     89999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.9e-46  Score=360.16  Aligned_cols=242  Identities=24%  Similarity=0.417  Sum_probs=199.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEe-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT-  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-  186 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||+++...      .+.+.+|+.+|+.++ ||||+++++++.+ 
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CCceEEEEEecccCCeEEEEEEECC-----CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            4679999999999999999999876     78999999986432      355788999999997 9999999999998 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-cc---------
Q 014087          187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-EI---------  255 (431)
Q Consensus       187 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-~~---------  255 (431)
                       ....++||||+.+++|..++.   .+++.+++.++.||+.||.|||++||+||||||+|||++.++. ..         
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence             678999999999999988874   4899999999999999999999999999999999999997763 11         


Q ss_pred             -CCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHH-------------Hhc
Q 014087          256 -DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI-------------INE  319 (431)
Q Consensus       256 -~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i-------------~~~  319 (431)
                       .........+||..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+....+             ...
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence             11222345678999999999987 6789999999999999999999999954 2332222222             111


Q ss_pred             ccCC------------------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          320 KVKL------------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       320 ~~~~------------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ...+                        +..+++++.+||.+||+.||.+||     +++++++||||+++.|+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSGGGTTCC--
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC-----CHHHHhcCccHhhhccC
Confidence            1111                        123799999999999999999999     89999999999998875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-45  Score=350.80  Aligned_cols=243  Identities=22%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||+|++...... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRL-----DGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             chhhhhhhhcCCCceEEEEEEEcC-----CCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            359999999999999999999876     7899999999865432 23345677899999998 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------  253 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----------  253 (431)
                      .+|+||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.           
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999999865    67999999999999999999999999999999999999986651           


Q ss_pred             --------ccCCC-------CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014087          254 --------EIDES-------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRII  317 (431)
Q Consensus       254 --------~~~~~-------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~  317 (431)
                              ....+       .......||+.|+|||++.+. .++.++|||||||++|||++|..++....   ....+.
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~  241 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIR  241 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHH
T ss_pred             cccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHH
Confidence                    11111       112345699999999999876 56689999999999999999998876542   233444


Q ss_pred             hc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          318 NE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       318 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      .+ ...+|..++.++.+||.+||+.||.+||     +++++++||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  286 (289)
T 1x8b_A          242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRP-----SAMALVKHSVLLSA  286 (289)
T ss_dssp             TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSC-----CHHHHHTCTTC---
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhCCCcccCC-----CHHHHhhChHhhhh
Confidence            43 3456778999999999999999999999     89999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-46  Score=359.00  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=190.0

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||.||+|++..     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAP-----KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECC-----CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            45667899999999999999999998775     788999999876532  23456678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYR--------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ...+..|+||||++|++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|....
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence            999999999999999999999874        456999999999999999999999999999999999999999876322


Q ss_pred             CCC----------------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014087          257 ESS----------------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE  319 (431)
Q Consensus       257 ~~~----------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~  319 (431)
                      .+.                .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            111                1234579999999999976 57899999999999999999999999887665555444433


Q ss_pred             cc----------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhc
Q 014087          320 KV----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA  373 (431)
Q Consensus       320 ~~----------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~  373 (431)
                      ..          .....++.++.+||.+||+.||.+||     +++++++||||+...++.+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~q  301 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP-----TAAELLRHKFFQKAKNKEFLQ  301 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSTTC----------
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc-----CHHHHhhChhhhcCCCCcccc
Confidence            22          12245789999999999999999999     899999999999887765543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=362.35  Aligned_cols=246  Identities=26%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--CCcceeeEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSF  184 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~  184 (431)
                      +..++|++++.||+|+||.||+|.+.      +++.||||++..... .....+.+.+|+.+|+.++|  |||+++++++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            44567999999999999999999864      678899999976543 34456778899999999976  9999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      .+.+.+|+||| +.+++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+...+.+.      
T Consensus        79 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           79 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQM  157 (343)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC
T ss_pred             eeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeeccccccc
Confidence            99999999999 56789999999999999999999999999999999999999999999999997432111111      


Q ss_pred             ------CCcccccCCCCCCchhhhcc-----------CCCCCcchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh--
Q 014087          259 ------SRSNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIIN--  318 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~Pf~~~-~~~~~~~~i~~--  318 (431)
                            ......+||+.|+|||++.+           ..++.++|||||||++|||++|+.||... +.......+..  
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  237 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  237 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence                  01235579999999999975           67889999999999999999999999864 33334444443  


Q ss_pred             cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          319 EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       319 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ....+|...+.++.+||.+||+.||.+||     +++++++||||+.
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~  279 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQI  279 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHS
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCC-----CHHHHHhCccccc
Confidence            34456778899999999999999999999     8999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=358.79  Aligned_cols=240  Identities=27%  Similarity=0.355  Sum_probs=194.6

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH-hcCCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~  188 (431)
                      ++|+++++||+|+||+||+|+++.     +++.||||++............ ...|+..+. ..+||||+++++++.+.+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE-----DGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-----TSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeheeccCCCeEEEEEEECC-----CCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            359999999999999999999986     7899999998664333333333 334554444 449999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      .+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+         
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999999 66888888765 4699999999999999999999999999999999999999887633222         


Q ss_pred             -CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 014087          259 -SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV--KLPPFLTSEAHSLL  335 (431)
Q Consensus       259 -~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li  335 (431)
                       ......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+..   ....+.....  .++..++.++.+||
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHH
Confidence             12234579999999999886 69999999999999999999977765432   2333333322  23457899999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .+||+.||++||     +++++++||||+.
T Consensus       286 ~~~L~~dP~~Rp-----t~~ell~hp~~~~  310 (311)
T 3p1a_A          286 VMMLEPDPKLRA-----TAEALLALPVLRQ  310 (311)
T ss_dssp             HHHSCSSTTTSC-----CHHHHHTSGGGSC
T ss_pred             HHHcCCChhhCc-----CHHHHHhCccccC
Confidence            999999999999     8999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.9e-46  Score=350.71  Aligned_cols=245  Identities=28%  Similarity=0.467  Sum_probs=209.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEECC-----CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            369999999999999999999876     788999999976542  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      .|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+|.....+.          
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999999999987778999999999999999999999999999999999999999876332211          


Q ss_pred             ---CcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCC--CCCCCHHHH
Q 014087          260 ---RSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKL--PPFLTSEAH  332 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~  332 (431)
                         .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....+.......  ...++.++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence               1234578999999999988765 77899999999999999999999875432 2333343333222  246899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +||.+||..||.+||     +++++++||||+..
T Consensus       240 ~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  268 (276)
T 2yex_A          240 ALLHKILVENPSARI-----TIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             HHHHHHCCCCchhCC-----CHHHHhcCccccCh
Confidence            999999999999999     89999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.2e-46  Score=362.90  Aligned_cols=250  Identities=30%  Similarity=0.579  Sum_probs=205.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      +|++.+.||+|+||.||+|+++.     +++.||||++.+....     .......+.+|+.+|+.++||||+++++++.
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceeEeeEEecCCCEEEEEEEEcC-----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            59999999999999999999886     8899999999765421     1223345788999999999999999999997


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---ccCCCCC--
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EIDESSR--  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~~~~~~--  260 (431)
                      .+. .|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   ....+..  
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            765 8999999999999999988889999999999999999999999999999999999999988764   2111111  


Q ss_pred             --------cccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCCC----
Q 014087          261 --------SNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKLP----  324 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~p----  324 (431)
                              ....+||+.|+|||++.   ...++.++|||||||++|+|++|+.||...... .+...+..+...+.    
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence                    12346899999999985   467899999999999999999999999764332 34455555554432    


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      ..++.++.+||.+||..||.+||     +++++++||||++.+|...
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rp-----s~~~~l~h~~~~~~~~~~~  286 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRK  286 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGCCHHHHHH
T ss_pred             hhcCHHHHHHHHHHcccCHhhCC-----CHHHHhhCcCcCCHHHHHH
Confidence            46899999999999999999999     8999999999998877643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-46  Score=369.07  Aligned_cols=242  Identities=28%  Similarity=0.413  Sum_probs=200.3

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  186 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++..+...       ..+|+.+|+.++||||++++++|.. 
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIE-----SGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETT-----TCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeec
Confidence            35689999999999999999999886     8899999998754321       2369999999999999999999844 


Q ss_pred             -------------------------------------CCEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHH
Q 014087          187 -------------------------------------RSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIV  225 (431)
Q Consensus       187 -------------------------------------~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~  225 (431)
                                                           ...+++||||+.| +|.+.+.    ....+++..++.++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 3458999999985 7666554    357799999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCceEeCC-CCCcc----------CCCCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHH
Q 014087          226 SAVSHLHKCGIVHRDLKPENILMDS-DGHEI----------DESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGIL  293 (431)
Q Consensus       226 ~aL~~LH~~~iiHrDlKp~NILl~~-~g~~~----------~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvi  293 (431)
                      .||.|||++||+||||||+|||++. ++...          .........+||+.|+|||++.+. .++.++|||||||+
T Consensus       152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999999999999999999999984 55421          112233456789999999999875 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhc-----------------cc------------CCCCCCCHHHHHHHHhhcccCcC
Q 014087          294 LYEMLTGQPPFTHANRQKLQQRIINE-----------------KV------------KLPPFLTSEAHSLLKGLLHKDPS  344 (431)
Q Consensus       294 l~elltg~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~~L~~dP~  344 (431)
                      +|||++|+.||.+.+..+....+...                 ..            .++..++.++.+||.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999999998887777666531                 00            13556899999999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCCCCC
Q 014087          345 KRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      +||     +++++++||||+.+.
T Consensus       312 ~R~-----t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          312 LRI-----NPYEAMAHPFFDHLR  329 (383)
T ss_dssp             GSC-----CHHHHHTSGGGHHHH
T ss_pred             hCC-----CHHHHhcCHHHHHHH
Confidence            999     899999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-45  Score=371.29  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=204.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc------CCCCcceeeE
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV------THPFIVQLRY  182 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~  182 (431)
                      ..+|+++++||+|+||+||+|++..     +++.||||+++...    .....+.+|+.+++.+      +|+||+++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK-----VHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC-----CCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            4579999999999999999999886     78999999997543    2334566788888776      5779999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--ccCC-
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--EIDE-  257 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~--~~~~-  257 (431)
                      ++...+.+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++|||||||||+||||+.++.  .... 
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence            9999999999999996 58999988764  4999999999999999999999999999999999999999876  2111 


Q ss_pred             -------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Q 014087          258 -------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------  322 (431)
Q Consensus       258 -------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------  322 (431)
                             .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....+......        
T Consensus       246 FG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          246 FGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence                   12334568999999999999999999999999999999999999999998887776665431000        


Q ss_pred             ---------------------------------------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCC
Q 014087          323 ---------------------------------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGP  351 (431)
Q Consensus       323 ---------------------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~  351 (431)
                                                                         ++...++++.+||++||+.||++||    
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp----  401 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM----  401 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC----
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC----
Confidence                                                               1123478899999999999999999    


Q ss_pred             CCHHHHHhCCCCCCC
Q 014087          352 GGVDAIKHHKWFRSI  366 (431)
Q Consensus       352 ~~~~~i~~h~~f~~~  366 (431)
                       +++++++||||+..
T Consensus       402 -ta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          402 -TPGQALRHPWLRRR  415 (429)
T ss_dssp             -CHHHHHTSTTTC--
T ss_pred             -CHHHHhCChhhccC
Confidence             89999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.9e-46  Score=358.49  Aligned_cols=263  Identities=22%  Similarity=0.306  Sum_probs=199.5

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++++.||+|+||+||+|+++...  .....||||+++.... .....+.+.+|+.+++.++||||+++++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQED--GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccC--CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            4456778999999999999999999877511  1223799999976543 334467788999999999999999999999


Q ss_pred             EeCCEE------EEEEeccCCCChHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          185 QTRSKL------YLILDFINGGHLFFHLYRQG------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       185 ~~~~~~------~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      ......      |+||||+.+|+|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            887765      99999999999999987543      589999999999999999999999999999999999999987


Q ss_pred             CccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014087          253 HEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN  318 (431)
Q Consensus       253 ~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~  318 (431)
                      .....+..             .....|++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            64322211             113346778999999999999999999999999999999 9999999888888777766


Q ss_pred             c-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCC-------HHHHHhCCCCCCCChhhHhccc
Q 014087          319 E-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGG-------VDAIKHHKWFRSINWKTLEARE  375 (431)
Q Consensus       319 ~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~-------~~~i~~h~~f~~~~~~~l~~~~  375 (431)
                      . ....+..++.++.+||.+||..||.+||     +       +++++.|+|+....+..+..+.
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~l~~~l~~~~~~~~~~~pl~~~~  314 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMYQCWSADPKQRP-----SFTCLRMELENILGHLSVLSTSQDPLYINI  314 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHHHHHHHC---------------
T ss_pred             CCCCCCCCccCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence            5 4566788999999999999999999999     7       7889999999887766555443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.1e-46  Score=365.87  Aligned_cols=247  Identities=20%  Similarity=0.355  Sum_probs=212.2

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCC--CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (431)
                      .+..++|++++.||+|+||+||+|++.+...  ..++..||||+++...  .....+.+.+|+.+|+.+ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            4456789999999999999999999864321  2356789999997653  344567789999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      ++.+.+.+|+||||+.||+|.+++....                .+++.++..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                478999999999999999999999999999999999


Q ss_pred             EeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 014087          247 LMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  312 (431)
Q Consensus       247 Ll~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~  312 (431)
                      ||+.+|.....+.             ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999886322211             1233456789999999999999999999999999999999 9999999888887


Q ss_pred             HHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+..+ ....|..++.++.+||.+||+.||.+||     ++++|++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~  357 (370)
T 2psq_A          315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  357 (370)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            7777665 3557778999999999999999999999     8888876

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-46  Score=363.42  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=204.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      .++|++++.||+|+||.||+|+++.     +++.||||++.......  ......+.+|+.+++.++||||+++++++.+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            4579999999999999999999875     78999999997643221  1123457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------  257 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--------  257 (431)
                      .+.+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....        
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999999987 788888765 468999999999999999999999999999999999999998863221        


Q ss_pred             ---CCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----C-----
Q 014087          258 ---SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK-----L-----  323 (431)
Q Consensus       258 ---~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~-----  323 (431)
                         .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+...++......     +     
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence               1123456799999999999764 5899999999999999999999999998888877777542110     0     


Q ss_pred             ------------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          324 ------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       324 ------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                                        ...++.++++||.+||..||.+||     +++++++||||++..|..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSSSCCC
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC-----CHHHHhcChhhhcCCCCC
Confidence                              134678999999999999999999     899999999999866543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=367.34  Aligned_cols=253  Identities=19%  Similarity=0.290  Sum_probs=215.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||+||+|++.+..+..+++.||||+++...  .......+.+|+.+|+.++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34556899999999999999999997755444578899999996532  2334456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---cc
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EI  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~  255 (431)
                      +....|+||||+.||+|.+++...+       .+++.++..++.||+.||.|||++||+||||||+||||+.+|.   ..
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998753       4899999999999999999999999999999999999997664   11


Q ss_pred             C-------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-
Q 014087          256 D-------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-  320 (431)
Q Consensus       256 ~-------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-  320 (431)
                      .             .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+. 
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            1             1122334578999999999999999999999999999999998 999999999988888887654 


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ...+..++.++.+||.+||+.||.+||     ++++|++|.++-.
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYCT  344 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHHHHh
Confidence            556778999999999999999999999     8999999877643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-45  Score=349.31  Aligned_cols=246  Identities=24%  Similarity=0.460  Sum_probs=214.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECC-----CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            3579999999999999999999886     789999999986543 33446778899999999999999999998854  


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeCCCCCccCC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDlKp~NILl~~~g~~~~~  257 (431)
                      ...+|+||||++|++|.+++...    ..+++..+..++.||+.||.|||++|     |+||||||+|||++.++.....
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            67899999999999999998764    34999999999999999999999999     9999999999999988864332


Q ss_pred             CCC-----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCC
Q 014087          258 SSR-----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPP  325 (431)
Q Consensus       258 ~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~  325 (431)
                      +..           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+..+.. .++.
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            221           1234789999999999999999999999999999999999999999888888888877655 5677


Q ss_pred             CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          326 FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       326 ~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .++.++.+||.+||..||.+||     ++++|++|+|+.+
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~~~~~~  273 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRP-----SVEEILENPLILE  273 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSTTCCG
T ss_pred             ccCHHHHHHHHHHcCCCcccCC-----CHHHHHhChhhhh
Confidence            8999999999999999999999     8999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-45  Score=367.11  Aligned_cols=247  Identities=26%  Similarity=0.432  Sum_probs=206.1

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC--CCCcceeeEEEE
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQ  185 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~  185 (431)
                      ...+|++++.||+|+||+||+|.+.      .++.||||++..... .....+.+.+|+.+|+.++  ||||+++++++.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            3456999999999999999999864      578899999987543 3445677899999999996  599999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                      ..+.+|+||| +.+++|.+++.+...+++.+++.++.||+.||.|||++||+||||||+||||+.+...+.+.       
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC-
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCcccccc
Confidence            9999999999 56889999999988999999999999999999999999999999999999996532111111       


Q ss_pred             -----CCcccccCCCCCCchhhhcc-----------CCCCCcchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc--
Q 014087          259 -----SRSNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINE--  319 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~Pf~~~-~~~~~~~~i~~~--  319 (431)
                           ......+||+.|+|||++.+           ..++.++|||||||+||||++|+.||... +.......+...  
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  285 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  285 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence                 01235679999999999975           36889999999999999999999999864 334455555543  


Q ss_pred             ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       320 ~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ...+|...+.++++||.+||..||.+||     +++++++||||+...
T Consensus       286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~~~~~~  328 (390)
T 2zmd_A          286 EIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHSCC
T ss_pred             cCCCCccchHHHHHHHHHHcccChhhCC-----CHHHHhhCcCccccC
Confidence            3456777899999999999999999999     899999999997543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-45  Score=364.46  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=197.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC--
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  187 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETT-----TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CceEEeeEEeecCCeEEEEEEECC-----CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            579999999999999999999876     88999999987543 2334456788999999999999999999999764  


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                          ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+     
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence                5689999999 7899888865 5799999999999999999999999999999999999999988633221     


Q ss_pred             ---CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-------------
Q 014087          259 ---SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-------------  321 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------------  321 (431)
                         ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......|.....             
T Consensus       181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          181 HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             cccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence               12345689999999999987 6789999999999999999999999999887776666543110             


Q ss_pred             ----------CC--------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          322 ----------KL--------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       322 ----------~~--------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                                ..        ...+++++.+||.+||..||.+||     +++++++||||+.....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc-----CHHHHhcChhhhhccCC
Confidence                      00        124688999999999999999999     89999999999976543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.4e-45  Score=361.85  Aligned_cols=248  Identities=27%  Similarity=0.370  Sum_probs=208.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|.+.+.||+|+||+||+|+++.     +++.||||++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccEEEEeEEecCCCeEEEEEEECC-----CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            579999999999999999999886     88999999997653 234456678899999999999999999999988775


Q ss_pred             E------EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          190 L------YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       190 ~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                      .      |+||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+     
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            5      99999998 57877763  4599999999999999999999999999999999999999988643222     


Q ss_pred             ---CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-------------
Q 014087          259 ---SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-------------  321 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------------  321 (431)
                         ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....             
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          193 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence               22345678999999999987 7889999999999999999999999999887777666643110             


Q ss_pred             ------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          322 ------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       322 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                                        ..++.+++++.+||.+||+.||++||     +++++++||||+.+.....
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC-----CHHHHhcCcccccCCCccc
Confidence                              11235789999999999999999999     8999999999998765443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-47  Score=379.87  Aligned_cols=242  Identities=17%  Similarity=0.197  Sum_probs=198.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHH---HHHhcCCCCcceee----
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---ILTKVTHPFIVQLR----  181 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~---il~~l~hpnIv~l~----  181 (431)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.   +|+.++|||||+++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C-----CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             CceEEEcceeecCCCEEEEEEEECC-----CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            5679999999999999999999875     78999999998765555566778899995   55556899999998    


Q ss_pred             ---EEEEeCCE-----------------EEEEEeccCCCChHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHC
Q 014087          182 ---YSFQTRSK-----------------LYLILDFINGGHLFFHLYRQGIFRE-------DQARFYTAEIVSAVSHLHKC  234 (431)
Q Consensus       182 ---~~~~~~~~-----------------~~lv~E~~~gg~L~~~l~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~  234 (431)
                         +++.+.+.                 .|+||||+ +|+|.+++.+.+.+++       ..+..|+.||+.||.|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence               77776643                 89999999 6799999987665665       77888999999999999999


Q ss_pred             CceeccCCCCceEeCCCCCccCCC--------CCcccccCCCCCCchhhhccC-----------CCCCcchhHhHHHHHH
Q 014087          235 GIVHRDLKPENILMDSDGHEIDES--------SRSNSMCGTTEYMAPEILLSK-----------GHNKDADWWSVGILLY  295 (431)
Q Consensus       235 ~iiHrDlKp~NILl~~~g~~~~~~--------~~~~~~~Gt~~y~aPE~~~~~-----------~~~~~~DvwslGvil~  295 (431)
                      ||+||||||+||||+.+|.....+        ......+| +.|+|||++.+.           .++.++|||||||+||
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999999999988643222        23345678 999999999987           8999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          296 EMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       296 elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ||++|+.||.+.+.......+.    ..+..+++++.+||.+||..||.+||     +++++++||||+++
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~  366 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCC-----CHHHHHTSHHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCC-----CHHHHhhChHHHHH
Confidence            9999999998755443333332    33467899999999999999999999     89999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-45  Score=370.44  Aligned_cols=242  Identities=29%  Similarity=0.449  Sum_probs=199.0

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC---
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR---  187 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  187 (431)
                      +|++++.||+|+||+||+|+++.     +++.||||++.+...       ...+|+++|+.++|||||+++++|...   
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             eEEeeeEEeeCCCEEEEEEEECC-----CCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            59999999999999999999986     789999999875431       123699999999999999999988542   


Q ss_pred             ---CEEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--cC--
Q 014087          188 ---SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--ID--  256 (431)
Q Consensus       188 ---~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--~~--  256 (431)
                         ..+++||||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+||||+.++..  +.  
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence               247799999986 5655554    24679999999999999999999999999999999999999976432  11  


Q ss_pred             -------CCCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Q 014087          257 -------ESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---------  319 (431)
Q Consensus       257 -------~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---------  319 (431)
                             ........+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+....++..         
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence                   11223456899999999999765 7999999999999999999999999998876666555431         


Q ss_pred             --------ccC------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          320 --------KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       320 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                              .+.            ++..++.++++||.+||..||.+|+     ++++++.||||+++.+..
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGGGCTT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC-----CHHHHhCCHhhccccccc
Confidence                    111            2345789999999999999999999     899999999998766543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=351.93  Aligned_cols=252  Identities=24%  Similarity=0.430  Sum_probs=212.3

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||.||+|+++.     +++.||||++....     ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE-----TGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT-----TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC-----CCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            45679999999999999999999875     78999999997643     234578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          188 SKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      +.+|+||||+.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.       
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999999999987 4567999999999999999999999999999999999999998876322211       


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCHHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VKLPPFLTSEAH  332 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~  332 (431)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....   ...+..++.++.
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence                2234578999999999999999999999999999999999999999877766655554432   233566899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcc
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  374 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~  374 (431)
                      +||.+||..||.+||     +++++++||||++..+......
T Consensus       257 ~li~~~l~~dp~~Rp-----t~~~ll~~~~~~~~~~~~~~~~  293 (314)
T 3com_A          257 DFVKQCLVKSPEQRA-----TATQLLQHPFVRSAKGVSILRD  293 (314)
T ss_dssp             HHHHHHTCSCTTTSC-----CHHHHTTSHHHHTCCCGGGGHH
T ss_pred             HHHHHHccCChhhCc-----CHHHHHhCHHHhcCCcchHHHH
Confidence            999999999999999     8999999999999877665443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.2e-45  Score=359.48  Aligned_cols=255  Identities=21%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCC-cEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC------cceee
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSD-GIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF------IVQLR  181 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~  181 (431)
                      .++|++++.||+|+||+||+|+++.     ++ +.||+|+++...    ...+.+.+|+.+++.++|++      |+.++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHA-----RGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecC-----CCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            4689999999999999999999875     44 789999997532    33456778999999887655      89999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---------
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---------  250 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---------  250 (431)
                      +++...+.+|+||||+ +++|.+.+....  .+++.+++.++.||+.||.|||++||+||||||+|||++.         
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999999 667777777653  6999999999999999999999999999999999999954         


Q ss_pred             ----------CCCccC--------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH
Q 014087          251 ----------DGHEID--------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL  312 (431)
Q Consensus       251 ----------~g~~~~--------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~  312 (431)
                                ++....        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                      332111        11223456899999999999999999999999999999999999999998877665


Q ss_pred             HHHHHhcccCCC--------------------------------------------CCCCHHHHHHHHhhcccCcCCcCC
Q 014087          313 QQRIINEKVKLP--------------------------------------------PFLTSEAHSLLKGLLHKDPSKRLG  348 (431)
Q Consensus       313 ~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~dP~~R~~  348 (431)
                      ...+.......|                                            ...+.++.+||.+||..||.+|| 
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-  326 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI-  326 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC-
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc-
Confidence            554433221111                                            11245789999999999999999 


Q ss_pred             CCCCCHHHHHhCCCCCCCChhhHhcccCCC
Q 014087          349 SGPGGVDAIKHHKWFRSINWKTLEAREMQP  378 (431)
Q Consensus       349 ~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p  378 (431)
                          +++++++||||++++|+....+..+.
T Consensus       327 ----t~~e~l~hp~f~~~~~~~~~~~~~~~  352 (355)
T 2eu9_A          327 ----TLAEALLHPFFAGLTPEERSFHTSRN  352 (355)
T ss_dssp             ----CHHHHTTSGGGGGCCHHHHC------
T ss_pred             ----CHHHHhcChhhcCCChhhccccccCC
Confidence                89999999999999998776555443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.8e-46  Score=361.19  Aligned_cols=264  Identities=19%  Similarity=0.288  Sum_probs=203.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcE----EEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI----YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      +..++|++++.||+|+||+||+|+++.     +++.    +|+|++....  .......+.+|+.+++.++||||+++++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIP-----EGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLG   82 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECC-----TTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcC-----CCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            456789999999999999999999875     4443    7777765432  1222344667999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      ++. .+..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.  
T Consensus        83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           83 LCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence            886 45689999999999999999875 57999999999999999999999999999999999999998876322111  


Q ss_pred             -----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCC
Q 014087          260 -----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPF  326 (431)
Q Consensus       260 -----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~  326 (431)
                                 ......||..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+... ....|..
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI  241 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc
Confidence                       1234567889999999999999999999999999999999 99999988877777777665 4566778


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC-------------------------CCCCCCChhhHhcccCCCCcc
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH-------------------------KWFRSINWKTLEAREMQPKFK  381 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h-------------------------~~f~~~~~~~l~~~~~~p~~~  381 (431)
                      ++.++.+||.+||..||.+||     +++++++|                         |.+.+++|+.+..+++.|+|.
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rp-----s~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  316 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRP-----TFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELD  316 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSC-----CHHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCCCC----------------
T ss_pred             CcHHHHHHHHHHcCCChhhCc-----CHHHHHHHHHHHHhcchhhhccccCCCCCCCCCCccccchhhcccccccchhcc
Confidence            899999999999999999999     78888663                         445555555555555555554


Q ss_pred             cC
Q 014087          382 PD  383 (431)
Q Consensus       382 p~  383 (431)
                      |+
T Consensus       317 ~~  318 (325)
T 3kex_A          317 LD  318 (325)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.5e-45  Score=349.41  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=198.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|+++.     +++.||+|+++.... .......+.++..+++.++||||+++++++.+
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVP-----SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecC-----CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            456789999999999999999999876     889999999976532 23334445556666888899999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccCCCC--
Q 014087          187 RSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      .+..|+||||+.| +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.....+.  
T Consensus        78 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           78 EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            9999999999985 77666653    46799999999999999999999998 9999999999999999876433222  


Q ss_pred             --------CcccccCCCCCCchhhh----ccCCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHH-HhcccCCC-
Q 014087          260 --------RSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRI-INEKVKLP-  324 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i-~~~~~~~p-  324 (431)
                              .....+||+.|+|||++    .+..++.++|||||||++|||++|+.||.. .........+ .......+ 
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA  236 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence                    22334799999999996    466789999999999999999999999986 3444434443 33333333 


Q ss_pred             CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          325 PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       325 ~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ..++.++.+||.+||+.||++||     +++++++||||+.
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp-----t~~e~l~hp~f~~  272 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERP-----TYPELMQHPFFTL  272 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHH
T ss_pred             ccCCHHHHHHHHHHhhcChhhCc-----CHHHHHhCccccc
Confidence            46899999999999999999999     8999999999964

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.8e-45  Score=356.96  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=206.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++....  .......+.+|+.+|+.++||||+++++++... 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP-----TGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC-----CCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            4689999999999999999999876     78999999996432  334456678899999999999999999988764 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                          ...|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.    
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence                67999999997 589888876 56999999999999999999999999999999999999998876322111    


Q ss_pred             -----------------CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Q 014087          260 -----------------RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-  320 (431)
Q Consensus       260 -----------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-  320 (431)
                                       .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence                             1223578999999998865 678999999999999999999999999887666554443210 


Q ss_pred             -----------------------cC--------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          321 -----------------------VK--------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       321 -----------------------~~--------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                                             ..        ..+.++.++.+||.+||..||++||     +++++++||||+.+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI-----TAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCCT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccccCCc
Confidence                                   00        1136889999999999999999999     89999999999987765


Q ss_pred             h
Q 014087          370 T  370 (431)
Q Consensus       370 ~  370 (431)
                      .
T Consensus       316 ~  316 (353)
T 2b9h_A          316 N  316 (353)
T ss_dssp             T
T ss_pred             c
Confidence            4

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-45  Score=355.60  Aligned_cols=246  Identities=24%  Similarity=0.422  Sum_probs=204.1

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC------Ccceee
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP------FIVQLR  181 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~  181 (431)
                      ..++|++++.||+|+||+||+|.+..    .+++.||||+++...    ...+.+.+|+.+++.++|+      +|++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHK----AGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecC----CCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            34689999999999999999998842    268899999997532    3345678899999888665      499999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-------
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------  252 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g-------  252 (431)
                      +++.+.+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++       
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 889999998775  689999999999999999999999999999999999998743       


Q ss_pred             ------------CccC--------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH
Q 014087          253 ------------HEID--------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL  312 (431)
Q Consensus       253 ------------~~~~--------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~  312 (431)
                                  ....        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                        2111        11223456899999999999999999999999999999999999999998877665


Q ss_pred             HHHHHhcccCCC--------------------------------------------CCCCHHHHHHHHhhcccCcCCcCC
Q 014087          313 QQRIINEKVKLP--------------------------------------------PFLTSEAHSLLKGLLHKDPSKRLG  348 (431)
Q Consensus       313 ~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~dP~~R~~  348 (431)
                      ...+......+|                                            ...++++.+||.+||+.||.+|| 
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-  321 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI-  321 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC-
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc-
Confidence            554432211111                                            12356789999999999999999 


Q ss_pred             CCCCCHHHHHhCCCCCCCC
Q 014087          349 SGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       349 ~~~~~~~~i~~h~~f~~~~  367 (431)
                          +++++++||||+.+.
T Consensus       322 ----t~~ell~hp~f~~~~  336 (339)
T 1z57_A          322 ----TLREALKHPFFDLLK  336 (339)
T ss_dssp             ----CHHHHTTSGGGGGGG
T ss_pred             ----CHHHHhcCHHHHHHh
Confidence                899999999998653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.1e-45  Score=353.29  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=207.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc---CCCCcceeeEEEE-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-  185 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~-  185 (431)
                      ++|++++.||+|+||.||+|++..    .+++.||+|+++...... .....+.+|+.+++.+   +||||+++++++. 
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             hceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            579999999999999999999852    267899999997644221 1122355677777666   8999999999987 


Q ss_pred             ----eCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          186 ----TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       186 ----~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                          ....+|+||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                5668999999998 59999998754  4999999999999999999999999999999999999999876332211


Q ss_pred             ----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------
Q 014087          260 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---------  320 (431)
Q Consensus       260 ----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------  320 (431)
                                .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+....         
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence                      1234578999999999999999999999999999999999999999988877777665310         


Q ss_pred             ------------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          321 ------------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       321 ------------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                                        ..++..++.++++||.+||..||.+||     +++++++||||+++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCC-----CHHHHhcCccccccchhh
Confidence                              012356889999999999999999999     899999999999887653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9e-45  Score=348.27  Aligned_cols=243  Identities=25%  Similarity=0.455  Sum_probs=214.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +.|++++.||+|+||.||+|+++.     +++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+...
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECC-----CCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            359999999999999999999875     789999999976542  3346778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.          
T Consensus        95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999999998864 57999999999999999999999999999999999999998876322211          


Q ss_pred             -CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHHh
Q 014087          260 -RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK-VKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       260 -~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  337 (431)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..++..++.++.+||.+
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence             2234578999999999999999999999999999999999999999888877776665543 34567899999999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ||..||.+||     +++++++|+||..
T Consensus       254 ~l~~dp~~Rp-----s~~~ll~~~~~~~  276 (303)
T 3a7i_A          254 CLNKEPSFRP-----TAKELLKHKFILR  276 (303)
T ss_dssp             HCCSSGGGSC-----CHHHHTTCHHHHH
T ss_pred             HcCCChhhCc-----CHHHHhhChhhhc
Confidence            9999999999     8999999999964

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-45  Score=365.80  Aligned_cols=244  Identities=27%  Similarity=0.400  Sum_probs=198.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      .+|+++++||+|+||+||+|+++.     +++ +|+|.+.+....       ..+|+.+|+.++||||+++++++...+ 
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~-----~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE-----SDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT-----TEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC-----CCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            469999999999999999999874     444 888877553321       235999999999999999999996543 


Q ss_pred             -----EEEEEEeccCCCChHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCccC---
Q 014087          189 -----KLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHEID---  256 (431)
Q Consensus       189 -----~~~lv~E~~~gg~L~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~-~~g~~~~---  256 (431)
                           .+|+||||+.++.+....   .....+++..++.++.||+.||.|||++||+||||||+||||+ .+|....   
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                 389999999875443322   2356799999999999999999999999999999999999998 5664221   


Q ss_pred             -------CCCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------
Q 014087          257 -------ESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------  320 (431)
Q Consensus       257 -------~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------  320 (431)
                             ........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+....        
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence                   12233456789999999999765 58999999999999999999999999988777666654310        


Q ss_pred             ---------c------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          321 ---------V------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       321 ---------~------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                               .            .++..+++++.+||.+||+.||.+||     +++++++||||+++.|...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL-----TAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGSTTTSSCC
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC-----CHHHHhcChhhhhhccccc
Confidence                     0            12345889999999999999999999     8999999999999887543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=355.88  Aligned_cols=242  Identities=27%  Similarity=0.427  Sum_probs=199.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+++|+.++||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECC-----CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence            34679999999999999999999986     789999999986543  23356678899999999999999999999876


Q ss_pred             C--EEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCcc---
Q 014087          188 S--KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHEI---  255 (431)
Q Consensus       188 ~--~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl----~~~g~~~---  255 (431)
                      .  ..|+||||++|++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+|||+    +.++...   
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            5  78999999999999999986543   9999999999999999999999999999999999998    5554321   


Q ss_pred             -------CCCCCcccccCCCCCCchhhhc--------cCCCCCcchhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Q 014087          256 -------DESSRSNSMCGTTEYMAPEILL--------SKGHNKDADWWSVGILLYEMLTGQPPFTHA----NRQKLQQRI  316 (431)
Q Consensus       256 -------~~~~~~~~~~Gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~elltg~~Pf~~~----~~~~~~~~i  316 (431)
                             .........+||+.|+|||++.        +..++.++|||||||++|||++|+.||...    ...++...+
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence                   1122234567999999999987        577899999999999999999999999642    234455555


Q ss_pred             Hhccc-------------------C------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCC
Q 014087          317 INEKV-------------------K------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHK  361 (431)
Q Consensus       317 ~~~~~-------------------~------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~  361 (431)
                      ..+..                   .      ++..++..+.+||++||+.||++|+     +++++++||
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~-----s~~ell~h~  304 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-----GFDQFFAET  304 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-----CHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc-----cHHHhhhcc
Confidence            54332                   1      1123456789999999999999999     899999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.7e-45  Score=354.26  Aligned_cols=252  Identities=19%  Similarity=0.250  Sum_probs=207.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  187 (431)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++.....     .+.+.+|+.+++.+ +||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY-----TNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT-----TTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC-----CCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            4679999999999999999999875     889999999876432     12477899999999 999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----ccCCCC--
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----EIDESS--  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----~~~~~~--  259 (431)
                      +..|+||||+ +++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.     ....+.  
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999999999 99999999874 67999999999999999999999999999999999999998874     211110  


Q ss_pred             ----------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcc
Q 014087          260 ----------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH---ANRQKLQQRIINEK  320 (431)
Q Consensus       260 ----------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~---~~~~~~~~~i~~~~  320 (431)
                                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+   .+..+....+....
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence                            12456899999999999999999999999999999999999999987   44555666665544


Q ss_pred             cCCC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh----------CCCCCCCChhhHhcccCCCCc
Q 014087          321 VKLP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH----------HKWFRSINWKTLEAREMQPKF  380 (431)
Q Consensus       321 ~~~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~----------h~~f~~~~~~~l~~~~~~p~~  380 (431)
                      ...+     ..++ ++.+||.+||..||.+||     ++++|.+          ..+...++|.   .+.+.+|+
T Consensus       237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~dw~---~~~~~~p~  302 (330)
T 2izr_A          237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKP-----DYDYLRKLFTDLFDRKGYMFDYEYDWI---GKQLPTPV  302 (330)
T ss_dssp             HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCC-----CHHHHHHHHHHHHHHTTCCCSCCCTTT---TSCCCCCC
T ss_pred             ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCCccCC---CCCcCCCC
Confidence            4433     2244 999999999999999999     6666654          2344567786   34445555

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-45  Score=366.09  Aligned_cols=242  Identities=23%  Similarity=0.360  Sum_probs=196.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC--------CCCccee
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--------HPFIVQL  180 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--------hpnIv~l  180 (431)
                      .++|+++++||+|+||+||+|++..     +++.||||+++..    ....+.+.+|+.+|+.++        |+||+++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ-----GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC-----CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            4689999999999999999999876     8899999999754    233456788999999885        7889999


Q ss_pred             eEEEE----eCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCC-
Q 014087          181 RYSFQ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDG-  252 (431)
Q Consensus       181 ~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g-  252 (431)
                      ++++.    +...+|+||||+ +++|.+.+.+.  +.+++..++.++.||+.||.|||++ ||+||||||+||||+.+| 
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence            99998    556899999999 56776776654  4699999999999999999999998 999999999999999775 


Q ss_pred             ------------------------------------------------CccC--------CCCCcccccCCCCCCchhhh
Q 014087          253 ------------------------------------------------HEID--------ESSRSNSMCGTTEYMAPEIL  276 (431)
Q Consensus       253 ------------------------------------------------~~~~--------~~~~~~~~~Gt~~y~aPE~~  276 (431)
                                                                      ....        ........+||+.|+|||++
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhh
Confidence                                                            1110        11123445799999999999


Q ss_pred             ccCCCCCcchhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhc-------------------------------
Q 014087          277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHAN------RQKLQQRIINE-------------------------------  319 (431)
Q Consensus       277 ~~~~~~~~~DvwslGvil~elltg~~Pf~~~~------~~~~~~~i~~~-------------------------------  319 (431)
                      .+..++.++|||||||+||||++|+.||...+      .......+...                               
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997643      22222222211                               


Q ss_pred             -----------ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          320 -----------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       320 -----------~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                 ...++...+.++.+||.+||+.||.+||     +++++++||||++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA-----TAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC-----CHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC-----CHHHHhhCccccC
Confidence                       1112233456789999999999999999     8999999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-45  Score=357.65  Aligned_cols=261  Identities=28%  Similarity=0.448  Sum_probs=215.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHhcC--CCCccee
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVT--HPFIVQL  180 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~--hpnIv~l  180 (431)
                      ....++|++.+.||+|+||.||+|+++.     +++.||||++........   ...+.+.+|+.+++.++  |+||+++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT-----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            3446789999999999999999999876     789999999987653321   11234567999999996  5999999


Q ss_pred             eEEEEeCCEEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCccCC-
Q 014087          181 RYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHEIDE-  257 (431)
Q Consensus       181 ~~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~-~~g~~~~~-  257 (431)
                      ++++...+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++..... 
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999999999986 89999999888999999999999999999999999999999999999998 55542211 


Q ss_pred             --------CCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 014087          258 --------SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLT  328 (431)
Q Consensus       258 --------~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  328 (431)
                              ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..+......++..++
T Consensus       194 fg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~  267 (320)
T 3a99_A          194 FGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVS  267 (320)
T ss_dssp             CTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCC
T ss_pred             CccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhcccccccccCC
Confidence                    122345679999999999987766 68899999999999999999999753      234556667788899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      .++.+||.+||..||.+||     ++++|++||||+++.+..-........+.|
T Consensus       268 ~~~~~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~~~~~~~~~~~p  316 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDVLLPQETAEIHLHSLSP  316 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSCCCHHHHHHHHTC----
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHhcCHhhcCccCccccccccccccCC
Confidence            9999999999999999999     899999999999987665544433334433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=350.52  Aligned_cols=250  Identities=25%  Similarity=0.426  Sum_probs=209.8

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEe
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT  186 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  186 (431)
                      ..++|++++.||+|+||.||+|++..     +++.||||++....    ...+.+.+|+.+++.+ +||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECC-----CCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            45789999999999999999999876     78899999987543    2235678899999999 79999999999987


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC
Q 014087          187 ------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES  258 (431)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~  258 (431)
                            .+.+|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  56899999999999999999874  5799999999999999999999999999999999999999887643222


Q ss_pred             C-----------CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 014087          259 S-----------RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  322 (431)
Q Consensus       259 ~-----------~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~  322 (431)
                      .           .....+||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            1           123457899999999997     567899999999999999999999999988877766666554332


Q ss_pred             --CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          323 --LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       323 --~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                        .+..++.++.+||.+||..||.+||     +++++++||||++..+...
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~  298 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRP-----ATEQLMKHPFIRDQPNERQ  298 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSHHHHCCTTHHH
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCC-----CHHHHhhChHHhhCccccc
Confidence              2356899999999999999999999     8999999999998876653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-45  Score=354.51  Aligned_cols=248  Identities=19%  Similarity=0.312  Sum_probs=214.9

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++++.||+|+||.||+|++++.....+++.||||+++...  .....+.+.+|+.+|+.++||||+++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345667899999999999999999999864443467899999998653  334566789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (431)
                      .+.+.+|+||||+.+|+|.+++...                        ..+++.+++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999874                        5689999999999999999999999999999


Q ss_pred             CCCCceEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCC
Q 014087          241 LKPENILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  306 (431)
Q Consensus       241 lKp~NILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~  306 (431)
                      |||+|||++.++.....+.             ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999998876332221             1234567889999999999999999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          307 ANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       307 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+..++...+..+.. ..|..++.++.+||.+||..||.+||     +++++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHH
Confidence            998888888877654 56788999999999999999999999     8888876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-45  Score=360.93  Aligned_cols=250  Identities=22%  Similarity=0.375  Sum_probs=208.9

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (431)
                      .+.+..++|++++.||+|+||.||+|++.+..+..+++.||||+++...  .....+.+.+|+++|+.+ +||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3456677899999999999999999998765555688999999997653  334456788999999999 7999999999


Q ss_pred             EEEeCCE-EEEEEeccCCCChHHHHHHcCC--------------------------------------------------
Q 014087          183 SFQTRSK-LYLILDFINGGHLFFHLYRQGI--------------------------------------------------  211 (431)
Q Consensus       183 ~~~~~~~-~~lv~E~~~gg~L~~~l~~~~~--------------------------------------------------  211 (431)
                      ++.+.+. +|+||||+.||+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            9987654 9999999999999999986543                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------------Ccc
Q 014087          212 ----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------------RSN  262 (431)
Q Consensus       212 ----------------~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------------~~~  262 (431)
                                      +++..++.++.||+.||.|||++||+||||||+|||++.++.....+.             ...
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                            899999999999999999999999999999999999998876322111             123


Q ss_pred             cccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHh-cccCCCCCCCHHHHHHHHhhc
Q 014087          263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK-LQQRIIN-EKVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       263 ~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~-~~~~i~~-~~~~~p~~~s~~~~~li~~~L  339 (431)
                      ...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ +...+.. .....|..+++++.+||.+||
T Consensus       254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  333 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  333 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            4567889999999999999999999999999999998 999998765433 3333333 345677889999999999999


Q ss_pred             ccCcCCcCCCCCCCHHHHHhC
Q 014087          340 HKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..||.+||     +++++++|
T Consensus       334 ~~dP~~Rp-----s~~ell~~  349 (359)
T 3vhe_A          334 HGEPSQRP-----TFSELVEH  349 (359)
T ss_dssp             CSSGGGSC-----CHHHHHHH
T ss_pred             cCChhhCC-----CHHHHHHH
Confidence            99999999     88999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7e-45  Score=357.89  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh--------hhhhHHHHHHHHHHHHHhcCCCCcce
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--------IKKNHVDYMKAERDILTKVTHPFIVQ  179 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~  179 (431)
                      ..++|++.+.||+|+||.||+|.+.      .++.||||++.....        ......+.+.+|+.+|+.++||||++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4578999999999999999999864      578899999865322        12334577899999999999999999


Q ss_pred             eeEEEEe-----CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          180 LRYSFQT-----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       180 l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      +++++..     ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND  172 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence            9999854     347999999998 5787777654 46999999999999999999999999999999999999998876


Q ss_pred             ccCCC----------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Q 014087          254 EIDES----------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-  321 (431)
Q Consensus       254 ~~~~~----------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-  321 (431)
                      ....+          ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..... 
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            43222          12234578999999999987 6789999999999999999999999999887777666643110 


Q ss_pred             -------------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          322 -------------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       322 -------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                                                     ..++.+++++.+||.+||+.||.+||     +++++++||||+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  324 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI-----STEQALRHPYFESLF  324 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGTTTC
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC-----CHHHHHcCchhhhcc
Confidence                                           11235688999999999999999999     899999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-45  Score=343.13  Aligned_cols=242  Identities=21%  Similarity=0.330  Sum_probs=208.7

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||+||+|++       .++.||||+++.... .....+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRW-------QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEE-------CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            345667899999999999999999997       357799999987543 334456788999999999999999999999


Q ss_pred             EeC--CEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCcc---
Q 014087          185 QTR--SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHEI---  255 (431)
Q Consensus       185 ~~~--~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~~~---  255 (431)
                      .+.  +..++||||++||+|.+++....  .+++.++..++.||+.||.|||++|  |+||||||+|||++.+|...   
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence            887  78999999999999999998765  4899999999999999999999999  99999999999999987632   


Q ss_pred             ---CCCCCcccccCCCCCCchhhhccCCCCC---cchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCC
Q 014087          256 ---DESSRSNSMCGTTEYMAPEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE--KVKLPPFL  327 (431)
Q Consensus       256 ---~~~~~~~~~~Gt~~y~aPE~~~~~~~~~---~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~  327 (431)
                         ..........||+.|+|||++.+..++.   ++|||||||++|||++|+.||.+.+.......+...  ...+|..+
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (271)
T 3kmu_A          157 ADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI  236 (271)
T ss_dssp             GGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTC
T ss_pred             ccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCC
Confidence               1222334567899999999999776655   799999999999999999999998888877776654  44567889


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++.+||.+||+.||++||     +++++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp-----s~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRP-----KFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999999     8888876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-44  Score=341.97  Aligned_cols=241  Identities=20%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++++.||+|+||.||+|++.      .++.||+|++......    .+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC   74 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999986      4667999999865432    24578899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---  260 (431)
                      .+.+..|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..   
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999999999764 568999999999999999999999999999999999999988764322221   


Q ss_pred             ---------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          261 ---------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       261 ---------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                               .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ....|..++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST  234 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence                     123356778999999999999999999999999999999 99999999998888888766 4455677899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ++.+||.+||+.||.+||     +++++++|
T Consensus       235 ~~~~li~~~l~~~p~~Rp-----s~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRP-----AFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCc-----CHHHHHHH
Confidence            999999999999999999     88998874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=352.92  Aligned_cols=245  Identities=21%  Similarity=0.315  Sum_probs=209.9

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||+||+|+++..  +..+..||||+++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVP--GQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCT--TSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecC--CCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34556899999999999999999998752  1245569999997643  3344567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      +.+..|+||||++||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.....+..    
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999765 579999999999999999999999999999999999999998764322211    


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+... ....+..++
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence                      112245778999999999999999999999999999999 99999999988888887765 456677899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||..||.+||     ++++|++
T Consensus       281 ~~l~~li~~~l~~dp~~Rp-----s~~eil~  306 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRP-----RFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999999     8888876

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-46  Score=370.94  Aligned_cols=250  Identities=15%  Similarity=0.196  Sum_probs=190.7

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc--CCCCcceee------
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLR------  181 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~------  181 (431)
                      .+|++.+.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+++.+  +||||++++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE-----RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC-----CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence            459999999999999999999886     8899999999987654556667788886555544  699988754      


Q ss_pred             -EEEEeC-----------------CEEEEEEeccCCCChHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHCCc
Q 014087          182 -YSFQTR-----------------SKLYLILDFINGGHLFFHLYRQ-GIFREDQA------RFYTAEIVSAVSHLHKCGI  236 (431)
Q Consensus       182 -~~~~~~-----------------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~------~~i~~qi~~aL~~LH~~~i  236 (431)
                       +++...                 ..+|+||||+. |+|.+++... ..+.+...      ..++.||+.||.|||++||
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             555543                 34899999999 8999999874 33444444      5677999999999999999


Q ss_pred             eeccCCCCceEeCCCCCccCCCCC--------cccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCCC
Q 014087          237 VHRDLKPENILMDSDGHEIDESSR--------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFTH  306 (431)
Q Consensus       237 iHrDlKp~NILl~~~g~~~~~~~~--------~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~~  306 (431)
                      |||||||+||||+.+|.....+..        .....||+.|+|||++.+  ..++.++|||||||+||||++|+.||.+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999874332221        224567799999999987  7799999999999999999999999987


Q ss_pred             CCHHHH--HHH-----HHhcccCCC--CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          307 ANRQKL--QQR-----IINEKVKLP--PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       307 ~~~~~~--~~~-----i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                      ......  ...     .......++  ..+++++.+||.+||+.||++||     +++++++||||++++|..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL-----LPLEAMETPEFLQLQNEI  363 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC-----CHHHHTTSHHHHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCHHHHHHHHHH
Confidence            532210  000     001122233  47899999999999999999999     899999999999988764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=349.54  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=200.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE---
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ---  185 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---  185 (431)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND-----CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT-----TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC-----CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            4679999999999999999999886     7899999998754   2345567889999999999999999999873   


Q ss_pred             -----------eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-C
Q 014087          186 -----------TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-H  253 (431)
Q Consensus       186 -----------~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g-~  253 (431)
                                 +...+|+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                       4478999999998 599888854 6799999999999999999999999999999999999997543 3


Q ss_pred             ccCCC--------------CCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014087          254 EIDES--------------SRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN  318 (431)
Q Consensus       254 ~~~~~--------------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~  318 (431)
                      ....+              .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            11111              11234467999999999876 6789999999999999999999999999887776666653


Q ss_pred             cccC------------------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          319 EKVK------------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       319 ~~~~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      ....                              +++.++.++++||.+||+.||.+||     +++++++||||+..+|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL-----TAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSHHHHTTCC
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC-----CHHHHhCCcccccccC
Confidence            2210                              1245899999999999999999999     8999999999998877


Q ss_pred             hh
Q 014087          369 KT  370 (431)
Q Consensus       369 ~~  370 (431)
                      ..
T Consensus       315 p~  316 (320)
T 2i6l_A          315 PM  316 (320)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-45  Score=354.13  Aligned_cols=257  Identities=19%  Similarity=0.263  Sum_probs=216.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||.||+|+++......+++.||||++....  .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34456799999999999999999988743333367889999997643  2334556889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                      +.+..|+||||+.||+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.+|...
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999998753          3579999999999999999999999999999999999999987643


Q ss_pred             CCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-
Q 014087          256 DESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-  320 (431)
Q Consensus       256 ~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-  320 (431)
                      ..+..             .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+...+...+.... 
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            22221             123356888999999999999999999999999999999 999999988888888877654 


Q ss_pred             cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC------CCCCCCChh
Q 014087          321 VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH------KWFRSINWK  369 (431)
Q Consensus       321 ~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h------~~f~~~~~~  369 (431)
                      ...+..++.++.+||.+||..||.+||     +++++++|      ++|+.++|.
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~e~l~~L~~~~~~~~~~~~~~  308 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISSIKEEMEPGFREVSFY  308 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHGGGSCTTHHHHCST
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHHHHHhhccCCcccccc
Confidence            356778999999999999999999999     88888875      555554443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=354.71  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=206.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|.+.+.||+|+||.||+|+++.     +++.||||++.... ......+.+.+|+.+|+.++||||+++++++.....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ceEEEeeeEecCCCeEEEEEEECC-----CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            579999999999999999999876     88999999997643 234456678899999999999999999999987754


Q ss_pred             ------EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          190 ------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       190 ------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                            +|+||||+. ++|.+++.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.....+.    
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence                  599999998 58877764  35999999999999999999999999999999999999999886432221    


Q ss_pred             ----CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Q 014087          260 ----RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--------------  320 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------  320 (431)
                          .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....              
T Consensus       175 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             C--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence                2234578999999999987 678999999999999999999999999888776666554310              


Q ss_pred             -----------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhh
Q 014087          321 -----------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       321 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~  370 (431)
                                       ...+..++.++.+||.+||..||++||     +++++++||||+.+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~~~~~  316 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDPE  316 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC-----CHHHHhcCcchhhccCcc
Confidence                             112346799999999999999999999     899999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8e-45  Score=349.89  Aligned_cols=238  Identities=21%  Similarity=0.331  Sum_probs=201.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.++||+|+||+||+|+++.     +++.||+|++...   .....+.+.+|+.+|+.++||||+++++++.+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECC-----CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            345689999999999999999999986     7899999988543   34456778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc----
Q 014087          187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS----  261 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~----  261 (431)
                      ++..|+||||+.||+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.....+...    
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9999999999999999999987 46799999999999999999999999999999999999999987633222111    


Q ss_pred             ---------------------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHH
Q 014087          262 ---------------------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-----LQQR  315 (431)
Q Consensus       262 ---------------------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~-----~~~~  315 (431)
                                           ...+||+.|+|||++.+..++.++|||||||++|||++|..||.......     ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence                                 15679999999999999999999999999999999999999996532110     0111


Q ss_pred             HHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          316 IINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       316 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..  ....|..+++++.+||.+||+.||++||     +++++++
T Consensus       239 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~l~~  275 (310)
T 3s95_A          239 FL--DRYCPPNCPPSFFPITVRCCDLDPEKRP-----SFVKLEH  275 (310)
T ss_dssp             HH--HHTCCTTCCTTHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             cc--cccCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            11  1234677889999999999999999999     8889886

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-44  Score=357.96  Aligned_cols=245  Identities=25%  Similarity=0.388  Sum_probs=201.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CC-----CcceeeE
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP-----FIVQLRY  182 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~  182 (431)
                      .++|++.+.||+|+||+||+|+++.     +++.||||+++...    .....+..|+.+++.++ |+     +|+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRV-----EQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcC-----CCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            4689999999999999999999876     78999999997532    33456777888888875 55     4999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeCC--CCCccC
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDS--DGHEID  256 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~--~g~~~~  256 (431)
                      ++...+.+|+||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  ++|||||||||+||||+.  ++....
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999999965 999999876  46999999999999999999999  579999999999999964  333211


Q ss_pred             C--------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----
Q 014087          257 E--------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----  324 (431)
Q Consensus       257 ~--------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----  324 (431)
                      .        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......|    
T Consensus       203 ~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          203 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL  282 (382)
T ss_dssp             CCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             EeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            1        1223456899999999999999999999999999999999999999999888877777654211100    


Q ss_pred             --------------C------------------C----------------------------CCHHHHHHHHhhcccCcC
Q 014087          325 --------------P------------------F----------------------------LTSEAHSLLKGLLHKDPS  344 (431)
Q Consensus       325 --------------~------------------~----------------------------~s~~~~~li~~~L~~dP~  344 (431)
                                    .                  .                            .++++++||.+||+.||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence                          0                  0                            014789999999999999


Q ss_pred             CcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          345 KRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       345 ~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      +||     +++++++||||+...+
T Consensus       363 ~Rp-----ta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          363 TRI-----QPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TSC-----CHHHHTTSGGGCC---
T ss_pred             hCC-----CHHHHhcCcccccCCC
Confidence            999     8999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.2e-44  Score=341.95  Aligned_cols=240  Identities=20%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||+||+++++      ++..||+|++......    .+.+.+|+++++.++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            455668999999999999999999876      5677999999865432    245788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      +.+.+|+||||+.+++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.....+..    
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            99999999999999999999987 4679999999999999999999999999999999999999998864332221    


Q ss_pred             --------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          261 --------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                              .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+... ....|..++++
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  249 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence                    122346778999999999999999999999999999998 99999999888888888766 34456778999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +.+||.+||+.||.+||     +++++++|
T Consensus       250 l~~li~~~l~~~p~~Rp-----s~~~ll~~  274 (283)
T 3gen_A          250 VYTIMYSCWHEKADERP-----TFKILLSN  274 (283)
T ss_dssp             HHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHccCChhHCc-----CHHHHHHH
Confidence            99999999999999999     88999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.1e-45  Score=350.68  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=213.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||.||+|++.......+++.||+|+++...  .....+.+.+|+.+|+.++||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            445567899999999999999999998654433467899999997643  344567788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGI------------------------FREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (431)
                      .+.+.+|+||||+.||+|.+++.....                        +++.++..++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            999999999999999999999987543                        89999999999999999999999999999


Q ss_pred             CCCCceEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCC
Q 014087          241 LKPENILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  306 (431)
Q Consensus       241 lKp~NILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~  306 (431)
                      |||+|||++.++.....+.             ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998876322211             1123456788999999999999999999999999999999 9999998


Q ss_pred             CCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          307 ANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       307 ~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+...+...+... ....+..+++++.+||.+||..||.+||     ++++|++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~l~~  304 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP-----VFADISK  304 (314)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            8887777777655 3456778999999999999999999999     8889877

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=355.92  Aligned_cols=247  Identities=21%  Similarity=0.364  Sum_probs=213.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCC--CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY  182 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  182 (431)
                      .+..++|++.+.||+|+||+||+|++.....  ...+..||||+++...  .......+.+|+++++.+ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            3445679999999999999999999865332  1345679999997653  344557788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      ++.+.+.+|+||||+.||+|.+++....                .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                489999999999999999999999999999999999


Q ss_pred             EeCCCCCccCCC-------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 014087          247 LMDSDGHEIDES-------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKL  312 (431)
Q Consensus       247 Ll~~~g~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~  312 (431)
                      ||+.++.....+             .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999887632211             12233457789999999999999999999999999999999 9999999998888


Q ss_pred             HHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+... ....+..++.++.+||.+||+.||++||     ++++|++
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  345 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  345 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            8887765 4556778999999999999999999999     8899987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-44  Score=344.67  Aligned_cols=248  Identities=26%  Similarity=0.476  Sum_probs=202.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe---
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (431)
                      ++|++++.||+|+||.||+|+++.     +++.||||++...    ....+.+.+|+.+++.++||||+++++++.+   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNAL-----DSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcC-----CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            359999999999999999999875     7899999999653    2345678899999999999999999998865   


Q ss_pred             ----------CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          187 ----------RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       187 ----------~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                                .+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|...
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                      457899999999999999998654 578899999999999999999999999999999999999887632


Q ss_pred             CCCC-------------------------CcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCC-CC
Q 014087          256 DESS-------------------------RSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTH-AN  308 (431)
Q Consensus       256 ~~~~-------------------------~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~-~~  308 (431)
                      ..+.                         .....+||+.|+|||++.+. .++.++|||||||++|||++   ||.. .+
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            2111                         12345689999999999865 68999999999999999998   6643 33


Q ss_pred             HHHHHHHHHhcccCCC----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcc
Q 014087          309 RQKLQQRIINEKVKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR  374 (431)
Q Consensus       309 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~  374 (431)
                      .......+......+|    ...+..+++||.+||+.||.+||     +++++++||||+...++...++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~~~  298 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPVKHQDEVIKE  298 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC-----CHHHHHHSSCSCCCCHHHHHHH
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCc-----CHHHHhCCCCcCCCChHHHHHH
Confidence            4455566655555444    44677899999999999999999     8999999999999888776543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.7e-44  Score=338.72  Aligned_cols=239  Identities=20%  Similarity=0.326  Sum_probs=207.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||.||+|+++      ++..||+|+++.....    .+.+.+|+.+++.++||||+++++++.+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             echhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            45568999999999999999999876      5667999999765432    2457889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-----  260 (431)
                      .+..|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..     
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence            999999999999999999998764 59999999999999999999999999999999999999998864322211     


Q ss_pred             -------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHH
Q 014087          261 -------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK-VKLPPFLTSEA  331 (431)
Q Consensus       261 -------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~  331 (431)
                             .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+.... ...|..+++++
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI  234 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHH
Confidence                   122345677999999999999999999999999999999 999999988888887777654 34566789999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+||.+||+.||.+||     ++++++++
T Consensus       235 ~~li~~~l~~~p~~Rp-----s~~~ll~~  258 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRP-----TFQQLLSS  258 (268)
T ss_dssp             HHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            9999999999999999     88999873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-44  Score=344.56  Aligned_cols=244  Identities=20%  Similarity=0.302  Sum_probs=201.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCC--CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +..++|++.+.||+|+||+||+|+++....  ...+..||+|++.+..   ....+.+.+|+.+++.++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            455689999999999999999999875110  0012569999997643   34456788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--------cc
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------EI  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~--------~~  255 (431)
                      .+.+..|+||||+.||+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++.        ..
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999998875        21


Q ss_pred             CCCCC-------cccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCCCCC
Q 014087          256 DESSR-------SNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKLPPF  326 (431)
Q Consensus       256 ~~~~~-------~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~p~~  326 (431)
                      ..+..       .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+... ...+......++..
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~  240 (289)
T 4fvq_A          162 LSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQLPAP  240 (289)
T ss_dssp             ECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCCC
T ss_pred             eccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCCCCCC
Confidence            11111       123458999999999987 778999999999999999999 555665555444 34444556677777


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+.++.+||.+||+.||.+||     +++++++
T Consensus       241 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  268 (289)
T 4fvq_A          241 KAAELANLINNCMDYEPDHRP-----SFRAIIR  268 (289)
T ss_dssp             SSCTTHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            899999999999999999999     8899987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-44  Score=355.69  Aligned_cols=244  Identities=25%  Similarity=0.410  Sum_probs=197.7

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----------CCC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPF  176 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpn  176 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++....    ...+.+.+|+.+++.++           |||
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecC-----CCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            34689999999999999999999876     88999999997543    23455778999988876           899


Q ss_pred             cceeeEEEEeCC----EEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeC
Q 014087          177 IVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMD  249 (431)
Q Consensus       177 Iv~l~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~  249 (431)
                      |+++++++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+||||+
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            999999998654    799999999 88999999874  4599999999999999999999998 999999999999996


Q ss_pred             CCC------CccC--------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH------
Q 014087          250 SDG------HEID--------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR------  309 (431)
Q Consensus       250 ~~g------~~~~--------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~------  309 (431)
                      .++      ....        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.      
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             ccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence            433      1111        11223456899999999999999999999999999999999999999986542      


Q ss_pred             HHHHHHHH------------------------------------------hcccCCCCCCCHHHHHHHHhhcccCcCCcC
Q 014087          310 QKLQQRII------------------------------------------NEKVKLPPFLTSEAHSLLKGLLHKDPSKRL  347 (431)
Q Consensus       310 ~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~  347 (431)
                      ......+.                                          .....++..++.++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            22222221                                          122334455678899999999999999999


Q ss_pred             CCCCCCHHHHHhCCCCCCC
Q 014087          348 GSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       348 ~~~~~~~~~i~~h~~f~~~  366 (431)
                           +++++++||||++.
T Consensus       327 -----t~~ell~hp~f~~~  340 (373)
T 1q8y_A          327 -----DAGGLVNHPWLKDT  340 (373)
T ss_dssp             -----CHHHHHTCGGGTTC
T ss_pred             -----CHHHHhhChhhhcc
Confidence                 89999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9e-44  Score=342.73  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=203.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||+|++...........+.+.+|+.+++.++||||+++++++..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV-----RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC-----CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            4689999999999999999999876     78999999998776555666778999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .+|+||||++|++|.+++.+.+.+++.++..++.||+.||.|||++||+||||||+|||++.+|.....+.         
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999998876322211         


Q ss_pred             ---CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCCCHHHHH
Q 014087          260 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTSEAHS  333 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  333 (431)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.....   ..+..++.++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence               12245789999999999999999999999999999999999999998766654444443322   345678999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ||.+||..||++||+    +++++++
T Consensus       268 li~~~l~~dP~~Rp~----s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYV----TCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCS----SHHHHHH
T ss_pred             HHHHhccCCHHHHHH----hHHHHHH
Confidence            999999999999983    5677665

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-44  Score=359.02  Aligned_cols=242  Identities=21%  Similarity=0.364  Sum_probs=209.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||.||+|+++.     +++.||||+++...  .....+.+.+|+++|+.++||||+++++++.
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRA-----DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEec-----CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            4556789999999999999999999986     78899999987542  2334456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc---
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS---  261 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~---  261 (431)
                      +.+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+...   
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            9999999999999999999998754 599999999999999999999999999999999999999888643222111   


Q ss_pred             ----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          262 ----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       262 ----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                                ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+ ....|..++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD  342 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence                      11234677999999999999999999999999999998 99999998888777776654 4567788999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+||.+||+.||++||     ++++|++
T Consensus       343 ~l~~li~~cl~~dP~~Rp-----s~~~i~~  367 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRP-----SFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            999999999999999999     8888875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-44  Score=355.65  Aligned_cols=244  Identities=26%  Similarity=0.365  Sum_probs=188.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++......    .....+|++.++.++||||+++++++...+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKS-----TGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             TTEEEC----------CEEEEETT-----TCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            579999999999999999999986     7899999998654322    2235567888889999999999999976433


Q ss_pred             -------EEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeCC-CCCcc
Q 014087          190 -------LYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDS-DGHEI  255 (431)
Q Consensus       190 -------~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~-~g~~~  255 (431)
                             +|+||||+.++ |...+.    ....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++...
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                   89999999874 444333    4567899999999999999999999  999999999999999986 55422


Q ss_pred             C----------CCCCcccccCCCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---
Q 014087          256 D----------ESSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---  321 (431)
Q Consensus       256 ~----------~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---  321 (431)
                      .          ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.....   
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            1          112233567899999999997654 89999999999999999999999999888777776653210   


Q ss_pred             -----------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          322 -----------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       322 -----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                                   ..+...+.++.+||.+||+.||.+||     +++++++||||+++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM-----KPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC-----CHHHHTTSGGGGGGGC
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC-----CHHHHhcCccccccCC
Confidence                                         11122568999999999999999999     8999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=352.00  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=206.7

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|++.+.||+|+||.||+|++.......++..||||++....  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            445667899999999999999999998654444467889999997643  233456788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG-----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (431)
                      +...+.+|+||||++||+|.+++....                       .+++..+..++.||+.||.|||++||+|||
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999999999999999999999998653                       379999999999999999999999999999


Q ss_pred             CCCCceEeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCC
Q 014087          241 LKPENILMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  306 (431)
Q Consensus       241 lKp~NILl~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~  306 (431)
                      |||+|||++.++.....+..             .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999988763222111             123456788999999999999999999999999999998 9999988


Q ss_pred             CCHHHHHHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          307 ANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       307 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .........+...  ....|..+++++.+||.+||..||.+||     ++++|++|
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~  328 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF  328 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHH
Confidence            6654444444433  3445678999999999999999999999     88999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3e-44  Score=340.99  Aligned_cols=244  Identities=23%  Similarity=0.345  Sum_probs=204.6

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||.||+|++....  ..+..||+|++....  .....+.+.+|+.+++.++||||+++++++ 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-   85 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI-   85 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence            455678999999999999999999986522  246779999987543  344556788999999999999999999998 


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      .++..|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.     
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence            4567899999999999999998764 6999999999999999999999999999999999999998876322211     


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                             ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ...++..++++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  245 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence                   1123356788999999999999999999999999999997 99999988877777777664 45677889999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+||.+||..||++||     +++++++
T Consensus       246 l~~li~~~l~~~p~~Rp-----s~~~l~~  269 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRP-----RFTELKA  269 (281)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHHH
Confidence            99999999999999999     8888876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.5e-44  Score=335.65  Aligned_cols=241  Identities=26%  Similarity=0.413  Sum_probs=198.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      +..++|++.+.||+|+||.||+|++       .++.||||+++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW-------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL   76 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE-------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE-------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4567899999999999999999986       46789999987654322 334567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeCCC--------CCc
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDSD--------GHE  254 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~--------g~~  254 (431)
                      +.+..|+||||++|++|.+++. .+.+++..+..++.||+.||.|||++|   |+||||||+|||++.+        +..
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             cCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999999988885 457999999999999999999999999   9999999999999863        221


Q ss_pred             cCCC---------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCC
Q 014087          255 IDES---------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK--VKL  323 (431)
Q Consensus       255 ~~~~---------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~  323 (431)
                      ...+         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....  ...
T Consensus       156 kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          156 KITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             EECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             EEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            1111         12234579999999999999999999999999999999999999999988887777776654  345


Q ss_pred             CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          324 PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       324 p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +..++.++.+||.+||..||.+||     ++++++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRP-----SFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCc-----CHHHHHHH
Confidence            678999999999999999999999     88998863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.9e-44  Score=348.74  Aligned_cols=251  Identities=18%  Similarity=0.295  Sum_probs=207.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||.||+|++....+..+++.||||++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            3456799999999999999999996543333478899999996432  23345568889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---ccC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EID  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~~  256 (431)
                      ....|+||||++||+|.+++....       .+++..+..++.||+.||.|||++||+||||||+|||++.+|.   ...
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998763       4899999999999999999999999999999999999996553   111


Q ss_pred             C-------------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cc
Q 014087          257 E-------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KV  321 (431)
Q Consensus       257 ~-------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~  321 (431)
                      .             ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ..
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            1             112234567899999999999999999999999999999998 99999998888888777665 44


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      ..+..++.++.+||.+||..||.+||     ++++|++|.|+-
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~  302 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYC  302 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHH
Confidence            56678999999999999999999999     899999987763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=348.51  Aligned_cols=243  Identities=28%  Similarity=0.494  Sum_probs=199.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHhc----CCCCcceee
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKV----THPFIVQLR  181 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l----~hpnIv~l~  181 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++........   .....+.+|+.+++.+    +||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLT-----DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTT-----TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEcc-----CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4679999999999999999998875     788999999976543221   1223355789999988    899999999


Q ss_pred             EEEEeCCEEEEEEec-cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCccCC--
Q 014087          182 YSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHEIDE--  257 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~-~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~-~~g~~~~~--  257 (431)
                      +++.+.+..++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.....  
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            999999999999999 78999999999888899999999999999999999999999999999999998 56542211  


Q ss_pred             -------CCCcccccCCCCCCchhhhccCCCC-CcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 014087          258 -------SSRSNSMCGTTEYMAPEILLSKGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTS  329 (431)
Q Consensus       258 -------~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  329 (431)
                             ........||..|+|||++.+..+. .++|||||||++|||++|+.||...      ..+......++..++.
T Consensus       185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~  258 (312)
T 2iwi_A          185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSP  258 (312)
T ss_dssp             SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCH
T ss_pred             chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCH
Confidence                   1223456799999999999877664 5899999999999999999999753      2355567778889999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ++.+||.+||..||++||     +++++++||||+...
T Consensus       259 ~~~~li~~~l~~~p~~Rp-----s~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRP-----SLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSC-----CHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHccCChhhCc-----CHHHHhcChhhcCch
Confidence            999999999999999999     899999999998743

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=360.25  Aligned_cols=246  Identities=28%  Similarity=0.398  Sum_probs=184.7

Q ss_pred             CceE-EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--C
Q 014087          111 DFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (431)
Q Consensus       111 ~y~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (431)
                      .|++ .++||+|+||+||+|+++..   .+++.||||++.....     ...+.+|+.+|+.++||||+++++++..  .
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDG---KDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSS---SCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccC---CCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            4776 45899999999999998742   2678899999975432     2346789999999999999999999964  6


Q ss_pred             CEEEEEEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCc
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHE  254 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl----~~~g~~  254 (431)
                      ..+|+||||+.| +|.+++...         ..+++..++.|+.||+.||.|||++||+||||||+||||    +.++..
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            789999999975 787777532         249999999999999999999999999999999999999    444442


Q ss_pred             cCCC--------------CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHH---------
Q 014087          255 IDES--------------SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------  310 (431)
Q Consensus       255 ~~~~--------------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~---------  310 (431)
                      ...+              ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            2111              122346899999999999874 5899999999999999999999999765432         


Q ss_pred             HHHHHHHhcccC--------------------------------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCC
Q 014087          311 KLQQRIINEKVK--------------------------------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPG  352 (431)
Q Consensus       311 ~~~~~i~~~~~~--------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~  352 (431)
                      +....+......                                      .....+.++.+||.+||..||.+||     
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~-----  326 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----  326 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC-----
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC-----
Confidence            333333221000                                      0011277899999999999999999     


Q ss_pred             CHHHHHhCCCCCCCChhh
Q 014087          353 GVDAIKHHKWFRSINWKT  370 (431)
Q Consensus       353 ~~~~i~~h~~f~~~~~~~  370 (431)
                      +++++++||||++..|..
T Consensus       327 ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             CHHHHHTSGGGTSSSCCC
T ss_pred             CHHHHhcChhhccCCCCc
Confidence            899999999999866543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=340.54  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=201.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|.....||+|+||.||+|++..     +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLS-----NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETT-----TCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECC-----CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            445666699999999999999876     78899999987642   3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCccCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHEIDES-------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-~g~~~~~~-------  258 (431)
                      .++||||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.....+       
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999999999998752   4678999999999999999999999999999999999987 55422111       


Q ss_pred             ----CCcccccCCCCCCchhhhccCC--CCCcchhHhHHHHHHHHHhCCCCCCCCCH-HHHH-H-HHHhcccCCCCCCCH
Q 014087          259 ----SRSNSMCGTTEYMAPEILLSKG--HNKDADWWSVGILLYEMLTGQPPFTHANR-QKLQ-Q-RIINEKVKLPPFLTS  329 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~Pf~~~~~-~~~~-~-~i~~~~~~~p~~~s~  329 (431)
                          .......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||..... .... . ........++..++.
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence                1123457899999999998643  88999999999999999999999975432 2222 2 222344567788999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      ++.+||.+||+.||++||     +++++++|+||+...
T Consensus       254 ~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~  286 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRA-----CANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSC-----CHHHHHTSGGGCC--
T ss_pred             HHHHHHHHHccCChhhCC-----CHHHHhcChhhhhcc
Confidence            999999999999999999     899999999998644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.8e-44  Score=344.28  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=208.3

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|++.+.||+|+||.||+|++.+..+..+++.||||+++...  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            345567899999999999999999998655445578899999997653  233456788999999999 99999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      +.+.+..|+||||+++|+|.+++....                  .+++.++..++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  48999999999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.++.....+..             .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            999988763221111             123456788999999999999999999999999999999 999998766444


Q ss_pred             HHHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ....+...  ....+..++.++.+||.+||..||.+||     +++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  300 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQ  300 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            44444333  2334677899999999999999999999     8888886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-44  Score=352.30  Aligned_cols=239  Identities=28%  Similarity=0.516  Sum_probs=172.8

Q ss_pred             CCceEEe-eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          110 GDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       110 ~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      ++|++++ .||+|+||+||+|+++.     +++.||||++.....       ...+....++.+.||||+++++++..  
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECC-----CCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            5799965 69999999999999986     789999999865321       12223344667799999999999986  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---ccCC--
Q 014087          187 --RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EIDE--  257 (431)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~~~--  257 (431)
                        ...+|+||||++||+|.+++.+.+  .+++.+++.++.||+.||.|||++||+||||||+|||++.++.   ....  
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998764  6999999999999999999999999999999999999987543   1111  


Q ss_pred             -------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccCCC--
Q 014087          258 -------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL----QQRIINEKVKLP--  324 (431)
Q Consensus       258 -------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p--  324 (431)
                             .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........    ...+......++  
T Consensus       176 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          176 GFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             ccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence                   1122456789999999999988899999999999999999999999977654433    233333333333  


Q ss_pred             --CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          325 --PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       325 --~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                        ..++.++++||.+||..||.+||     +++++++||||+.
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  293 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERL-----TITQFMNHPWINQ  293 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCc-----CHHHHhcCccccc
Confidence              46899999999999999999999     8999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.9e-44  Score=346.78  Aligned_cols=248  Identities=21%  Similarity=0.354  Sum_probs=211.0

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCC--CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceee
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (431)
                      ..+..++|++.+.||+|+||+||+|++.....  ..+++.||||+++...  .....+.+.+|+.+++.+ +||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            44556789999999999999999999864321  2367889999997653  334466788999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      +++.+.+.+|+||||+.+|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999998654                38999999999999999999999999999999999


Q ss_pred             eEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.+|.....+.             ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99998886332211             1223456788999999999999999999999999999999 999999988888


Q ss_pred             HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +...+... ....+..++.++.+||.+||..||.+||     +++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  311 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  311 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            88777665 3556778999999999999999999999     8889887

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-43  Score=333.11  Aligned_cols=239  Identities=20%  Similarity=0.361  Sum_probs=208.3

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||.||+|++.      +++.||+|++......    .+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~   73 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCL   73 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            455678999999999999999999986      4678999999865432    256888999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      +.+..|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..    
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             cCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence            999999999999999999999875 568999999999999999999999999999999999999988763322211    


Q ss_pred             --------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          261 --------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       261 --------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                              .....||..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..+ ....|..++.+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  233 (267)
T 3t9t_A          154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH  233 (267)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence                    123456778999999999999999999999999999999 99999998888888888766 34456778999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+||.+||..||.+||     +++++++
T Consensus       234 l~~li~~~l~~~p~~Rp-----s~~~ll~  257 (267)
T 3t9t_A          234 VYQIMNHCWRERPEDRP-----AFSRLLR  257 (267)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHHH
Confidence            99999999999999999     8888876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3e-43  Score=336.35  Aligned_cols=237  Identities=19%  Similarity=0.241  Sum_probs=199.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  185 (431)
                      +..++|++.+.||+|+||+||+|++..     +++.||||++.....     .+.+.+|+.+++.+ +|+||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            445689999999999999999999875     889999999875432     23467799999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----ccCCC-
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----EIDES-  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~-----~~~~~-  258 (431)
                      +....|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.     ....+ 
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999999 999999998754 5999999999999999999999999999999999999987764     11111 


Q ss_pred             -----------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh
Q 014087          259 -----------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIIN  318 (431)
Q Consensus       259 -----------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~  318 (431)
                                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   ........+..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence                             1134567999999999999999999999999999999999999999873   44555555544


Q ss_pred             cccC-----CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          319 EKVK-----LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       319 ~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ....     +...+++++.+||.+||..||++||     ++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP-----~~~~l~~  276 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP-----DYDYLQG  276 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC-----CHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC-----CHHHHHH
Confidence            3322     2346899999999999999999999     7788765

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.1e-44  Score=345.57  Aligned_cols=242  Identities=23%  Similarity=0.369  Sum_probs=205.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEE--EEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +..++|++.+.||+|+||.||+|+++.     ++..+  |+|.+....  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            445689999999999999999999875     56654  999887532  333456688999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                      +.+.+.+|+||||+++|+|.+++.+.+                .+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  174 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  174 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence            999999999999999999999998754                6999999999999999999999999999999999999


Q ss_pred             eCCCCCccCCCC----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014087          248 MDSDGHEIDESS----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRI  316 (431)
Q Consensus       248 l~~~g~~~~~~~----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i  316 (431)
                      ++.++.....+.          ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+
T Consensus       175 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            998876332221          1223456889999999999999999999999999999998 99999999888888877


Q ss_pred             Hhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          317 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       317 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..+ ....+..++.++.+||.+||..||.+||     ++++++++
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  294 (327)
T 1fvr_A          255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  294 (327)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            665 4456778899999999999999999999     88999873

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-43  Score=344.95  Aligned_cols=245  Identities=20%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|+++++||+|+||+||+|++..... .....||+|.++...  .....+.+.+|+.+++.++||||+++++++.+
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCc-eEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            345679999999999999999999875111 012236888776433  23445678899999999999999999999987


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      .. .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.      
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            65 78999999999999999874 57999999999999999999999999999999999999998876332211      


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                             ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+...+...+... ....+..++.+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence                   1223456889999999999999999999999999999999 99999988777777666554 45567789999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +.+||.+||+.||.+||     ++++++.+
T Consensus       248 ~~~li~~~l~~~p~~Rp-----s~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRP-----KFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCC-----CHHHHHHH
Confidence            99999999999999999     88898874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.3e-44  Score=343.90  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=208.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|++.+.||+|+||+||+|++.+..+..+++.||||+++...  .......+.+|+.+++.+ +||||++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            345667899999999999999999998765555578999999997653  233456788999999999 79999999999


Q ss_pred             EEeCC-EEEEEEeccCCCChHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          184 FQTRS-KLYLILDFINGGHLFFHLYRQGI----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       184 ~~~~~-~~~lv~E~~~gg~L~~~l~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      +...+ .+|+||||++||+|.+++.....                +++..+..++.||+.||.|||++||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            88755 59999999999999999987654                89999999999999999999999999999999999


Q ss_pred             EeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCH-HH
Q 014087          247 LMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR-QK  311 (431)
Q Consensus       247 Ll~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~-~~  311 (431)
                      |++.+|.....+.             ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+... ..
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            9998876322211             1123457889999999999999999999999999999998 9999987553 33


Q ss_pred             HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          312 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       312 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ....+..+ ....+..+++++.++|.+||..||.+||     +++++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            34444433 4556778999999999999999999999     88999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-43  Score=357.67  Aligned_cols=240  Identities=23%  Similarity=0.385  Sum_probs=206.6

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ..+.+..++|++.+.||+|+||.||+++++       ++.||||+++...     ..+.+.+|+.+|+.++||||+++++
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~  253 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLG  253 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEE
Confidence            345677889999999999999999999874       5689999997643     3456889999999999999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC
Q 014087          183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       183 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                      ++.... .+|+||||+.+|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.
T Consensus       254 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence            987665 79999999999999999987654  799999999999999999999999999999999999999886432221


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                              ......+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ ....|..+++
T Consensus       334 G~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~  413 (450)
T 1k9a_A          334 GLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  413 (450)
T ss_dssp             TTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred             CCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence                    1223467889999999999999999999999999999998 99999988777777777655 5667888999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+||.+||..||.+||     ++++|+.
T Consensus       414 ~l~~li~~cl~~dp~~Rp-----t~~~l~~  438 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRP-----TFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999     7888875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-43  Score=351.38  Aligned_cols=245  Identities=22%  Similarity=0.312  Sum_probs=204.6

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||.||+|+++..  ...+..||||+++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLP--SKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCT--TSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecC--CCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34556899999999999999999987631  1257789999997643  3344567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      +.+.+|+||||++||+|.+++.+.+ .+++.++..++.||+.||.|||++||+||||||+|||++.++.....+..    
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999999999998764 69999999999999999999999999999999999999998864322111    


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..+ ....+..++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence                      111234678999999999999999999999999999998 99999998888888777655 345566789


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||+.||.+||     ++++|++
T Consensus       277 ~~l~~li~~cl~~dp~~RP-----s~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRP-----KFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCc-----CHHHHHH
Confidence            9999999999999999999     7888876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-43  Score=340.44  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=203.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC--CCCcceeeEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSF  184 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~  184 (431)
                      +..++|++++.||+|+||.||+|+++      +++.||||++..... .....+.+.+|+.+++.++  ||||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            34457999999999999999999864      578899999976543 3445677889999999997  59999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      .+.+.+|+||| +.+++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. |.....+.     
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence            99999999999 567899999999889999999999999999999999999999999999999975 33211111     


Q ss_pred             --------CcccccCCCCCCchhhhcc-----------CCCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc
Q 014087          260 --------RSNSMCGTTEYMAPEILLS-----------KGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINE  319 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~~  319 (431)
                              .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.... .......+...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence                    1124578999999999976           468889999999999999999999997643 33344444433


Q ss_pred             --ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 --KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 --~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                        ...++...+.++.+||.+||..||.+||     +++++++||||+..
T Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~  299 (313)
T 3cek_A          256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQ  299 (313)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHCC
T ss_pred             ccccCCcccchHHHHHHHHHHccCCcccCc-----CHHHHhcCccccCC
Confidence              3456777899999999999999999999     89999999999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-43  Score=338.04  Aligned_cols=245  Identities=20%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||+||+|++..... .+++.||||++...   .....+.+.+|+.+|+.++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCS-SCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccC-CCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4556789999999999999999999653222 37899999998754   2444567889999999999999999999986


Q ss_pred             e--CCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          186 T--RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       186 ~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      .  ...+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..  
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456999999999999999998764 49999999999999999999999999999999999999988763322211  


Q ss_pred             ------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH----------------HH
Q 014087          261 ------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------------KL  312 (431)
Q Consensus       261 ------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~----------------~~  312 (431)
                                  .....|+..|+|||++.+..++.++|||||||++|||++|..||......                .+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence                        12334677899999999999999999999999999999999998653211                12


Q ss_pred             HHHHH-hcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRII-NEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+. ......|..+++++.+||.+||..||++||     ++++|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~el~~  284 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLAL  284 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            22222 234556778999999999999999999999     8888875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-43  Score=340.54  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=209.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||+||+|+++.... ..+..||||+++...  .......+.+|+.+++.++||||+++++++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCC-CccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34567789999999999999999999875221 134569999997643  233455688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---  260 (431)
                      .+.+..|+||||+.+|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.....+..   
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999999999875 579999999999999999999999999999999999999988763322211   


Q ss_pred             -----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 014087          261 -----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFL  327 (431)
Q Consensus       261 -----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  327 (431)
                                 .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....+..+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence                       112245778999999999999999999999999999999 99999998888888887765 45566789


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.++.+||.+||+.||.+||     +++++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rp-----s~~~l~~  302 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRP-----KFADIVS  302 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999999     7888876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-43  Score=343.45  Aligned_cols=248  Identities=19%  Similarity=0.338  Sum_probs=207.8

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ..+..++|++.+.||+|+||.||+|++...........||+|++....  .....+.+.+|+.+|+.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345667899999999999999999999864443455689999997653  234456788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQ--------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD  249 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~  249 (431)
                      +.+.+.+|+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3579999999999999999999999999999999999999


Q ss_pred             CCCCccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014087          250 SDGHEIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQR  315 (431)
Q Consensus       250 ~~g~~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~  315 (431)
                      .++.....+..             .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            88763222111             123456788999999999999999999999999999999 9999987665544444


Q ss_pred             HHhc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          316 IINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       316 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +...  ....|..++.++.+||.+||+.||.+||     ++++|++
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~  319 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP-----TFQQICS  319 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc-----CHHHHHH
Confidence            4433  3345677899999999999999999999     8899876

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=338.22  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=192.2

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||.||+|+++.     +++.||||++..... .....+.+.++..+++.++||||+++++++.+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETT-----TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhccccccceeeecCCeeEEEEEEec-----CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            34579999999999999999999986     788999999986542 223334455566678888999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccCCCC------
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      +.+|+||||+ ++.+..+... .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.....+.      
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999999999 5555555443 46799999999999999999999995 9999999999999999876432221      


Q ss_pred             ----CcccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccC-CC--CC
Q 014087          260 ----RSNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINEKVK-LP--PF  326 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~  326 (431)
                          ......||+.|+|||++.     ...++.++|||||||++|||++|+.||.. ....+....+...... ++  ..
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence                123457999999999995     55688999999999999999999999986 4555666666655432 33  35


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++.++.+||.+||..||.+||     ++++|++||||++.
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  290 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSC-----CHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCc-----CHHHHhhCHHHHhc
Confidence            899999999999999999999     89999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-43  Score=349.68  Aligned_cols=247  Identities=15%  Similarity=0.151  Sum_probs=190.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHH--------HHHHHHHHHHHhcCCCCcc
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--------DYMKAERDILTKVTHPFIV  178 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~--------~~~~~E~~il~~l~hpnIv  178 (431)
                      +..++|++++.||+|+||+||+|.++.......++.||||++...........        ..+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34568999999999999999999987643333568899999876532111111        1233466677788899999


Q ss_pred             eeeEEEEeC----CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CC
Q 014087          179 QLRYSFQTR----SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SD  251 (431)
Q Consensus       179 ~l~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~--~~  251 (431)
                      ++++++...    ...|+||||+ |++|.+++... +.+++..+..|+.||+.||.|||++||+||||||+||||+  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999876 6799999999999999999999999999999999999998  55


Q ss_pred             CCccCCCC------------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH-H
Q 014087          252 GHEIDESS------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK-L  312 (431)
Q Consensus       252 g~~~~~~~------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~-~  312 (431)
                      +.....+.                  .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..... .
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            54221111                  1134569999999999999999999999999999999999999998532211 1


Q ss_pred             HHHHH-h--cc-------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRII-N--EK-------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~-~--~~-------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..... .  ..       .-.+..++.++.+||..||..||.+||     ++++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP-----LYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC-----CHHHHHH
Confidence            11111 0  00       001256799999999999999999999     7777754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.5e-44  Score=346.65  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=185.7

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHhcCCCCcceeeE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRY  182 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~  182 (431)
                      ...+..++|++++.||+|+||.||+|.++.     +++.||||++.....  ......+..|+. +++.++||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~   88 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-----SGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYG   88 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETT-----TTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcC-----CCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence            345667899999999999999999999876     789999999976532  222334444555 777889999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCccC
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ++.+.+..|+||||+.| +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.+|....
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            99999999999999986 77777663     56799999999999999999999998 9999999999999998876432


Q ss_pred             CCC----------CcccccCCCCCCchhhh----ccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc-
Q 014087          257 ESS----------RSNSMCGTTEYMAPEIL----LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEK-  320 (431)
Q Consensus       257 ~~~----------~~~~~~Gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~-~~~~~i~~~~-  320 (431)
                      .+.          ......||+.|+|||++    .+..++.++|||||||++|||++|+.||.+.... +....+..+. 
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP  247 (327)
T ss_dssp             CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred             ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence            221          12234799999999999    4667899999999999999999999999864321 2222222221 


Q ss_pred             cCCC----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          321 VKLP----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       321 ~~~p----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ..++    ..++.++.+||.+||..||.+||     ++++|++||||...++.
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHHHS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCc-----CHHHHHhChHHHHhHhh
Confidence            1222    35899999999999999999999     89999999999765544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-43  Score=334.92  Aligned_cols=244  Identities=18%  Similarity=0.260  Sum_probs=205.7

Q ss_pred             CCCCCCceEEe-eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      .+..++|++.+ .||+|+||+||+|.+...   .+++.||||+++.... .....+.+.+|+.+++.++||||+++++++
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            44566899998 999999999999976431   2678899999976542 344467789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                       ..+..|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..    
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence             567789999999999999999998889999999999999999999999999999999999999988753222111    


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+... ....|..++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP  246 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence                      112345688999999999889999999999999999999 99999998888887777665 355678899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||..||.+||     +++++++
T Consensus       247 ~~l~~li~~~l~~dp~~Rp-----s~~~l~~  272 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRP-----GFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999999999     7888875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-43  Score=356.75  Aligned_cols=239  Identities=21%  Similarity=0.333  Sum_probs=206.3

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++.+.||+|+||+||+|+++      .+..||||+++...    ...+.+.+|+.+|+.++|||||++++++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~  252 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVV  252 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            4566778999999999999999999986      46779999998643    2356788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc-
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS-  261 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~-  261 (431)
                      . .+.+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.....+... 
T Consensus       253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            6 66799999999999999999754  3689999999999999999999999999999999999999988643222211 


Q ss_pred             -----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          262 -----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       262 -----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                 ....+|..|+|||++....++.++|||||||+||||++ |+.||.+.+..++...+..+ ....|..++
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  411 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  411 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence                       22345778999999999999999999999999999999 99999998888888777654 455677899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++.+||.+||..||++||     ++++|+.
T Consensus       412 ~~l~~li~~cl~~dp~~RP-----t~~~i~~  437 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERP-----TFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCc-----CHHHHHH
Confidence            9999999999999999999     7888865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5e-43  Score=333.32  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhh----HHHHHHHHHHHHHhcCCCCcceee
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN----HVDYMKAERDILTKVTHPFIVQLR  181 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~  181 (431)
                      .+..++|++.+.||+|+||+||+|+++.     +++.||+|++.........    ..+.+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVK-----DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY   89 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETT-----TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhhhccceehhccccCCceeEEEEEEcC-----CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            3456789999999999999999999976     8899999998764432221    126788999999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCC-----
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH-----  253 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~-----  253 (431)
                      +++.+..  ++||||+.+|+|.+.+... ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.     
T Consensus        90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           90 GLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             eeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence            9997766  6999999999998888765 47999999999999999999999999  999999999999988764     


Q ss_pred             ccCC--------CCCcccccCCCCCCchhhhc--cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhc--
Q 014087          254 EIDE--------SSRSNSMCGTTEYMAPEILL--SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK--LQQRIINE--  319 (431)
Q Consensus       254 ~~~~--------~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~--~~~~i~~~--  319 (431)
                      ....        ........||+.|+|||++.  ...++.++|||||||++|||++|+.||...+...  ....+...  
T Consensus       168 ~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             EEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             EEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            1111        11233467999999999994  4557889999999999999999999998654332  23444333  


Q ss_pred             ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       320 ~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...++..+++++.+||.+||+.||.+||     +++++++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  282 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRP-----HFSYIVK  282 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            3456778999999999999999999999     8888875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-43  Score=334.62  Aligned_cols=241  Identities=22%  Similarity=0.338  Sum_probs=209.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++.+.||+|+||+||+|.++.     +++.||+|++....    ...+.+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGG-----GTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecC-----CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34556789999999999999999999986     78999999997543    3456788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      .+.+.+|+||||+.|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..  
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999999874  458999999999999999999999999999999999999988763322211  


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+... ....+..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  238 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence                      122346778999999999999999999999999999999 99999988877777776655 455677899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++.+||.+||..||.+||     +++++++
T Consensus       239 ~~l~~li~~~l~~dp~~Rp-----s~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRP-----SFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCc-----CHHHHHH
Confidence            9999999999999999999     8888876

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=359.75  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=198.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF  184 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  184 (431)
                      .+...+|.+.+.||+|+||+|+.....      +++.||||++......      .+.+|+.+|+.+ +|||||++++++
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~------~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMF------DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEES------SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEe------CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence            344557999999999999997643322      6889999999764321      245799999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---Cc---cCC
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HE---IDE  257 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g---~~---~~~  257 (431)
                      .+...+|+|||||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+||||+.++   ..   +.+
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99999999999997 59999998654 456667889999999999999999999999999999996432   21   111


Q ss_pred             C-------------CCcccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014087          258 S-------------SRSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       258 ~-------------~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~  320 (431)
                      .             ......+||+.|+|||++.   ...++.++|||||||++|||++ |..||...........+....
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  246 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS  246 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC
Confidence            0             1233467999999999998   4567889999999999999999 999997654443332222211


Q ss_pred             cC---CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh---------hHhcccCCCCcccC
Q 014087          321 VK---LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK---------TLEAREMQPKFKPD  383 (431)
Q Consensus       321 ~~---~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~---------~l~~~~~~p~~~p~  383 (431)
                      ..   .+...+..+.+||.+||+.||.+||     +++++++||||.+++|.         .++.....+|+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~evl~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
T 3p23_A          247 LDCLHPEKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQ  316 (432)
T ss_dssp             CTTSCTTCHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHTSTTTCCHHHHHHHHHHHHHHCSCSCSSCHHHHH
T ss_pred             ccccCccccccHHHHHHHHHHHhCCHhhCC-----CHHHHHhCccccChHHHHHHHHHHHHHhhcccccchHHHH
Confidence            11   1223456789999999999999999     89999999999998883         33444555555543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=334.72  Aligned_cols=243  Identities=21%  Similarity=0.292  Sum_probs=206.0

Q ss_pred             CCCCCceEEe-eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          107 IGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       107 ~~~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      +..++|.+.+ .||+|+||.||+|.++..   .+++.||+|+++...  .....+.+.+|+.+++.++||||+++++++ 
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccC---CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            4456788887 999999999999987532   257789999997653  344567788999999999999999999999 


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      ..+..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.     
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            456799999999999999998654 56999999999999999999999999999999999999998875322111     


Q ss_pred             ---------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          260 ---------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                               ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..+ ...+|..++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  239 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence                     1123356889999999999999999999999999999998 99999988888877777665 356778899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +++.+||.+||..||.+||     +++++++|
T Consensus       240 ~~l~~li~~~l~~~p~~Rp-----s~~~l~~~  266 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRP-----DFLTVEQR  266 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            9999999999999999999     88999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-42  Score=333.19  Aligned_cols=241  Identities=27%  Similarity=0.423  Sum_probs=200.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|++..     +++.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT-----TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC-----CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3569999999999999999999875     78899999998755445566677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      ..|+||||+.+++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.     
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999998864    456899999999999999999999999999999999999998876432211     


Q ss_pred             ------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccC-C-CCCCCH
Q 014087          260 ------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--NRQKLQQRIINEKVK-L-PPFLTS  329 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~--~~~~~~~~i~~~~~~-~-p~~~s~  329 (431)
                            ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.  ....+...+...... . +..++.
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence                  123457899999999999999999999999999999999999999764  344555555544332 2 256899


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+||.+||..||.+||     +++++++
T Consensus       266 ~l~~li~~~l~~dp~~Rp-----s~~~il~  290 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRP-----DVTYVYD  290 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            999999999999999999     8899886

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.2e-43  Score=332.37  Aligned_cols=245  Identities=21%  Similarity=0.324  Sum_probs=204.9

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.+.||+|+||+||+|++....  .++..||+|++.+..  .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            445678999999999999999999976421  245679999998653  2334567889999999999999999999986


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      ++ ..|+||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.     
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 568999999999999999775 45999999999999999999999999999999999999998875322211     


Q ss_pred             -------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          260 -------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       260 -------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                             ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ....+..++++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV  242 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence                   1123456788999999999999999999999999999998 99999877766666666544 45567789999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +.+||.+||..||++||     ++++++++
T Consensus       243 l~~li~~~l~~~p~~Rp-----s~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRP-----RFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHccCCchhCc-----CHHHHHHH
Confidence            99999999999999999     88888763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=339.40  Aligned_cols=240  Identities=20%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcE----EEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI----YAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      +..++|+++++||+|+||+||+|+++.     +++.    ||+|.+....  .....+.+.+|+.+|+.++||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   84 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIP-----EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC-----TTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcC-----CCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence            456789999999999999999999875     4444    5666665432  3344567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-  260 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-  260 (431)
                      ++.... .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.. 
T Consensus        85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            998765 88999999999999999874 579999999999999999999999999999999999999988763322211 


Q ss_pred             ------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCC
Q 014087          261 ------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPF  326 (431)
Q Consensus       261 ------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~  326 (431)
                                  .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+... ....+..
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI  243 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                        122346778999999999999999999999999999999 99999988877777776654 4566778


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.++.+||.+||..||.+||     +++++++
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rp-----s~~ell~  271 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRP-----KFRELII  271 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999999     8899887

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-42  Score=353.71  Aligned_cols=258  Identities=19%  Similarity=0.255  Sum_probs=205.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC-CCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~  187 (431)
                      .++|+++++||+|+||.||+|++..     +++.||||++......     ..+..|+++++.++| ++|..+..++...
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT-----TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC-----CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            4689999999999999999999876     7899999998765322     236789999999976 5666677777888


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC---CCCCccCCC-----
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHEIDES-----  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~g~~~~~~-----  258 (431)
                      +..||||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+||||+   .++.....+     
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999999999 9999999985 46799999999999999999999999999999999999994   454421111     


Q ss_pred             -------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccc-
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKV-  321 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~-  321 (431)
                                   ......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.   .....+..+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence                         1122668999999999999999999999999999999999999999863   33444444443322 


Q ss_pred             ----CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHH----------hCCCCCCCChhhHhcccCCCCccc
Q 014087          322 ----KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK----------HHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       322 ----~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~----------~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                          .++..++.++.+||.+||..||++||     ++++|+          .++|+..+||+.+..++.+++..|
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RP-----s~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p  304 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAP  304 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC---------
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCC
Confidence                22356899999999999999999999     666553          378999999999988777666554

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.5e-43  Score=330.73  Aligned_cols=239  Identities=20%  Similarity=0.329  Sum_probs=204.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++++.||+|+||.||+|+++      .++.||+|++.....    ..+.+.+|+++|+.++||||+++++++
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVV   77 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence            4556678999999999999999999875      567899999976432    245688899999999999999999988


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      . .+..|+||||+.|++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..  
T Consensus        78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            6 456899999999999999987543  69999999999999999999999999999999999999988763322111  


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....|+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+... ....+..++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP  236 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccccc
Confidence                      123356788999999998899999999999999999999 99999998888888777655 345567899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||..||++||     ++++|++
T Consensus       237 ~~l~~li~~~l~~~p~~Rp-----s~~~l~~  262 (279)
T 1qpc_A          237 EELYQLMRLCWKERPEDRP-----TFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            9999999999999999999     7888876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-43  Score=361.06  Aligned_cols=241  Identities=22%  Similarity=0.334  Sum_probs=208.1

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+...+|++.++||+|+||.||+|+++.     ++..||||+++...    ...+.+.+|+.+|+.++|||||++++++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGG-----GTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcC-----CCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34556689999999999999999999986     78899999997643    2346688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      .+.+.+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.....+..  
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999999999999874  458999999999999999999999999999999999999988763222111  


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....++..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++.+.+..+ ....|..++
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence                      122345678999999999999999999999999999999 99999988877777766554 455678899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||+.||.+||     ++++|++
T Consensus       446 ~~l~~li~~cl~~dP~~RP-----s~~el~~  471 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRP-----SFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCc-----CHHHHHH
Confidence            9999999999999999999     7888865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-42  Score=330.68  Aligned_cols=235  Identities=17%  Similarity=0.222  Sum_probs=189.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE-EEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~  187 (431)
                      .++|++.+.||+|+||+||+|++..     +++.||||++......     +.+.+|+.+++.++|++++..+. ++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC-----CCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            3579999999999999999999876     8899999987654322     23677999999998877666554 45778


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCccCCC-----
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHEIDES-----  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~g~~~~~~-----  258 (431)
                      +..|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.....+     
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            8999999999 9999999985 4579999999999999999999999999999999999999   5555421111     


Q ss_pred             -------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccC
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANR---QKLQQRIINEKVK  322 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~  322 (431)
                                   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.   ......+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence                         122356899999999999999999999999999999999999999976322   2333444333333


Q ss_pred             CC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          323 LP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       323 ~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+     ..+++++.+||.+||+.||++||     ++++|++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~  273 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHH
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCC-----CHHHHHH
Confidence            33     56899999999999999999999     7777765

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.6e-43  Score=336.02  Aligned_cols=247  Identities=19%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||.||+|++...  ..+++.||+|+++.... .....+.+.+|+.+++.++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            345567899999999999999999987642  22567899999976542 334456788999999999999999999999


Q ss_pred             EeCC-----EEEEEEeccCCCChHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q 014087          185 QTRS-----KLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       185 ~~~~-----~~~lv~E~~~gg~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~  253 (431)
                      .+.+     ..|+||||+.+|+|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            8765     35999999999999999853      356999999999999999999999999999999999999999876


Q ss_pred             ccCCCCC-------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014087          254 EIDESSR-------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE  319 (431)
Q Consensus       254 ~~~~~~~-------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~  319 (431)
                      ....+..             .....|++.|+|||++.+..++.++|||||||++|||++ |..||.+.+...+...+...
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            4322111             123356789999999999999999999999999999999 99999988877777777665


Q ss_pred             -ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          320 -KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       320 -~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                       ....+..++.++.+||.+||..||.+||     +++++++
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  301 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRP-----TFSVLRL  301 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence             4566778999999999999999999999     8888876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.6e-43  Score=333.86  Aligned_cols=245  Identities=20%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|++....  ..+..||||+++..........+.+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34467999999999999999999875311  1334699999987655555667788999999999999999999999987


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-----
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-----  260 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-----  260 (431)
                      .. .++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..     
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 89999999999999999864 569999999999999999999999999999999999999988763222111     


Q ss_pred             ---------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc--CCCCCCC
Q 014087          261 ---------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV--KLPPFLT  328 (431)
Q Consensus       261 ---------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s  328 (431)
                               .....||..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+.....  ..+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence                     123457788999999999999999999999999999999 9999999998888888876543  4456799


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.++|.+||..||.+||     +++++++
T Consensus       252 ~~l~~li~~~l~~~p~~Rp-----s~~~l~~  277 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRP-----TFVALRD  277 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCc-----CHHHHHH
Confidence            9999999999999999999     8899886

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-42  Score=332.13  Aligned_cols=243  Identities=23%  Similarity=0.317  Sum_probs=197.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      ...|++++.||+|+||.||+|++.... ..+++.||+|++....  .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            346999999999999999999964322 2378999999997654  334457788999999999999999999999877 


Q ss_pred             -CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          188 -SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       188 -~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                       ..+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.      
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             679999999999999999955 467999999999999999999999999999999999999998876322111      


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---------------CHHHHHHHH
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---------------NRQKLQQRI  316 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---------------~~~~~~~~i  316 (431)
                              ......||..|+|||++.+..++.++|||||||++|||++|..|+...               ....+...+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence                    123446788899999999999999999999999999999999986432               112222333


Q ss_pred             Hh-cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          317 IN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       317 ~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .. .....+..+++++.+||.+||..||.+||     +++++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  295 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT-----SFQNLIE  295 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC-----CHHHHHH
Confidence            22 24456778999999999999999999999     8888875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.1e-43  Score=330.90  Aligned_cols=238  Identities=23%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||+||++++       .++.||||+++...     ..+.+.+|+.+++.++||||+++++++
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY-------RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   83 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE-------TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE-------cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            345567899999999999999999986       46789999987542     345688899999999999999999987


Q ss_pred             EeC-CEEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--
Q 014087          185 QTR-SKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       185 ~~~-~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      .+. +.+|+||||+++++|.+++.+.+.  +++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.  
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence            554 579999999999999999987643  899999999999999999999999999999999999998876432221  


Q ss_pred             ------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          260 ------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                            ......|++.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..+ ....+..+++++
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (278)
T 1byg_A          164 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV  243 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred             cccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence                  1223467889999999999999999999999999999998 99999988777777777654 455677899999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++|.+||..||.+||     +++++++
T Consensus       244 ~~li~~~l~~~p~~Rp-----s~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRP-----SFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHhcCChhhCC-----CHHHHHH
Confidence            9999999999999999     7888876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-42  Score=330.26  Aligned_cols=242  Identities=24%  Similarity=0.384  Sum_probs=194.9

Q ss_pred             hhcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE
Q 014087          103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY  182 (431)
Q Consensus       103 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  182 (431)
                      ....+..++|++.++||+|+||+||+|++.        ..+|+|+++.... .....+.+.+|+.+|+.++||||+++++
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMG   87 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence            345677889999999999999999999753        2499999876542 3445677899999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--  259 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--  259 (431)
                      + ......++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.  
T Consensus        88 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           88 Y-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             E-ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             e-ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence            5 4666789999999999999998644 56999999999999999999999999999999999999998876322211  


Q ss_pred             -----------CcccccCCCCCCchhhhc---cCCCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccC--
Q 014087          260 -----------RSNSMCGTTEYMAPEILL---SKGHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIINEKVK--  322 (431)
Q Consensus       260 -----------~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~--  322 (431)
                                 ......||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.. ...+...+......  
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence                       123457899999999997   5678889999999999999999999998754 44444444443322  


Q ss_pred             ---CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          323 ---LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       323 ---~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                         .+..+++++.+||.+||..||.+||     +++++++
T Consensus       247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~  281 (289)
T 3og7_A          247 LSKVRSNCPKRMKRLMAECLKKKRDERP-----SFPRILA  281 (289)
T ss_dssp             TTSSCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hhhccccCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence               2346889999999999999999999     8888876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=341.40  Aligned_cols=245  Identities=16%  Similarity=0.150  Sum_probs=191.6

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh--------hHHHHHHHHHHHHHhcCCCCcc
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--------NHVDYMKAERDILTKVTHPFIV  178 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv  178 (431)
                      +..++|++.+.||+|+||+||+|+++..  +.++..+|||++........        .....+.+|+.+++.++||||+
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNK--PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSS--CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCC--CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            3456899999999999999999998742  22677899999876432111        1112355788899999999999


Q ss_pred             eeeEEEEe----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC--
Q 014087          179 QLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--  252 (431)
Q Consensus       179 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g--  252 (431)
                      ++++++..    ...+|+||||+ |++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            99999988    78899999999 999999998888899999999999999999999999999999999999998876  


Q ss_pred             CccCCCC------------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC--CCHHHH
Q 014087          253 HEIDESS------------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH--ANRQKL  312 (431)
Q Consensus       253 ~~~~~~~------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~--~~~~~~  312 (431)
                      .....+.                  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+  .+....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            3211111                  11445799999999999999999999999999999999999999965  333333


Q ss_pred             HHHHHhcccCCCC---------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRIINEKVKLPP---------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~~~~~~~p~---------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..........+|.         .++.++.+||.+||..||++||     ++++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  321 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP-----NYQALKK  321 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC-----CHHHHHH
Confidence            3222222222222         6899999999999999999999     8888876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=334.82  Aligned_cols=241  Identities=25%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE-
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  185 (431)
                      +..++|++++.||+|+||.||+|+++.     +++.||||++...   .....+.+.+|+.+++.++||||+++++++. 
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLH-----DGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecC-----CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            455689999999999999999999875     7899999998653   2344567889999999999999999999987 


Q ss_pred             ---eCCEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC
Q 014087          186 ---TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES  258 (431)
Q Consensus       186 ---~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~  258 (431)
                         .....|+||||+.+|+|.+++..    ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.....+
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence               34478999999999999999876    46799999999999999999999999999999999999999888744333


Q ss_pred             CCc--------------------ccccCCCCCCchhhhccCC---CCCcchhHhHHHHHHHHHhCCCCCCCCCH--HHHH
Q 014087          259 SRS--------------------NSMCGTTEYMAPEILLSKG---HNKDADWWSVGILLYEMLTGQPPFTHANR--QKLQ  313 (431)
Q Consensus       259 ~~~--------------------~~~~Gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~Pf~~~~~--~~~~  313 (431)
                      ...                    ....||+.|+|||++.+..   ++.++|||||||++|||++|+.||.....  ....
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            221                    1234799999999998654   68999999999999999999999953110  1111


Q ss_pred             HHHHh-cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          314 QRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       314 ~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..+.. .....+..++.++.+||.+||..||.+||     ++++++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  300 (317)
T 2buj_A          258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP-----HIPLLLSQ  300 (317)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCC-----CHHHHHHH
Confidence            22222 12333457899999999999999999999     88999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-42  Score=351.53  Aligned_cols=239  Identities=23%  Similarity=0.350  Sum_probs=204.0

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++.+.||+|+||.||+|+++      .+..||||+++....    ..+.+.+|+.+|+.++||||+++++++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWN------GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEEC------CCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4456678999999999999999999986      345699999986532    235688999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      .+ +.+|+||||+.+|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.....+..  
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence            76 6789999999999999999753  569999999999999999999999999999999999999988763222111  


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....|+..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ ....|..++
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence                      122346788999999999999999999999999999999 99999998888888877655 456678899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||..||++||     ++++|++
T Consensus       408 ~~l~~li~~cl~~dP~~Rp-----t~~~l~~  433 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERP-----TFEYLQA  433 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999999     8888876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-42  Score=336.78  Aligned_cols=236  Identities=19%  Similarity=0.283  Sum_probs=189.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|+++++||+|+||+||+|++       .++.||||++.....    .......|+.+|+.++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQL-------LNEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEE-------CCCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            4566899999999999999999986       457899999976432    22345568999999999999999999987


Q ss_pred             CC----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCceEeCCCC
Q 014087          187 RS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------GIVHRDLKPENILMDSDG  252 (431)
Q Consensus       187 ~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------~iiHrDlKp~NILl~~~g  252 (431)
                      ..    .+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++          ||+||||||+|||++.++
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            44    489999999999999999764 589999999999999999999999          999999999999999987


Q ss_pred             CccCCC-------------CCcccccCCCCCCchhhhccC-----CCCCcchhHhHHHHHHHHHhCCCCCCCC-------
Q 014087          253 HEIDES-------------SRSNSMCGTTEYMAPEILLSK-----GHNKDADWWSVGILLYEMLTGQPPFTHA-------  307 (431)
Q Consensus       253 ~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~Pf~~~-------  307 (431)
                      .....+             ......+||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+.       
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            632211             112346799999999999873     4566889999999999999999999753       


Q ss_pred             ---------CHHHHHHHHHhcccC--CCC-----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          308 ---------NRQKLQQRIINEKVK--LPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       308 ---------~~~~~~~~i~~~~~~--~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                               ....+...+......  ++.     ..+.++.+||.+||+.||++||     ++++|++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  311 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL-----SAGCVGE  311 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence                     223333333332221  111     1235699999999999999999     7888876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-42  Score=336.16  Aligned_cols=244  Identities=23%  Similarity=0.366  Sum_probs=201.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE-
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-  185 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  185 (431)
                      +..++|++++.||+|+||.||+|+++.... .+++.||||++....   ....+.+.+|+++|+.++||||+++++++. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSS-SCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCC-CcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            455689999999999999999999653222 378999999997643   344567889999999999999999999887 


Q ss_pred             -eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          186 -TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       186 -~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                       +...+|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+.    
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence             456799999999999999999873 56999999999999999999999999999999999999998876322111    


Q ss_pred             ----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH---------------HHHH
Q 014087          260 ----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------------KLQQ  314 (431)
Q Consensus       260 ----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~---------------~~~~  314 (431)
                                ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......               .+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence                      122345788899999999999999999999999999999999999654322               2222


Q ss_pred             HHHh-cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          315 RIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       315 ~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+.. .....+..+++++.+||.+||..||.+||     +++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  296 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP-----SFSALGP  296 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            2222 23456778999999999999999999999     7888865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-42  Score=329.63  Aligned_cols=241  Identities=19%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE-EeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF-QTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~  188 (431)
                      .+|++.+.||+|+||+||+|++....  .....+|+|.+....  .....+.+.+|+.+++.++||||+++++++ ..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            46999999999999999999976411  244568999887532  344567788999999999999999999985 5567


Q ss_pred             EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      ..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+         
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            889999999999999999764 5689999999999999999999999999999999999999987632211         


Q ss_pred             ------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc-CCCCCCCHH
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV-KLPPFLTSE  330 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~  330 (431)
                            .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..... ..|..++.+
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence                  11233457788999999999999999999999999999999 7788887777777666665543 446778999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+||.+||..||.+||     +++++++
T Consensus       261 l~~li~~~l~~~p~~Rp-----s~~ell~  284 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRP-----SFSELVS  284 (298)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     8888876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=349.55  Aligned_cols=240  Identities=27%  Similarity=0.427  Sum_probs=195.1

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.++||+|+||+||+|+++.     +++.||||++.....  ....+.+.+|+++|+.++||||+++++++...
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   79 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECC-----CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence            34679999999999999999999986     789999999986543  23356678899999999999999999999876


Q ss_pred             C--EEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCcc---
Q 014087          188 S--KLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHEI---  255 (431)
Q Consensus       188 ~--~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl----~~~g~~~---  255 (431)
                      +  ..|+||||+.||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++...   
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            5  7899999999999999997643   39999999999999999999999999999999999998    5544311   


Q ss_pred             -------CCCCCcccccCCCCCCchhhhcc--------CCCCCcchhHhHHHHHHHHHhCCCCCCC----CCHHHHHHHH
Q 014087          256 -------DESSRSNSMCGTTEYMAPEILLS--------KGHNKDADWWSVGILLYEMLTGQPPFTH----ANRQKLQQRI  316 (431)
Q Consensus       256 -------~~~~~~~~~~Gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~elltg~~Pf~~----~~~~~~~~~i  316 (431)
                             .........+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..    ....++...+
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence                   11122345679999999999975        5678899999999999999999999964    2334455555


Q ss_pred             HhcccC-------------------C------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          317 INEKVK-------------------L------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       317 ~~~~~~-------------------~------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ..+...                   +      +..++..+.+||++||..||++|+     +++++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~-----s~~e~l~  302 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-----GFDQFFA  302 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-----CHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc-----cHHHHHH
Confidence            544321                   1      122456788999999999999999     7788755

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-42  Score=328.33  Aligned_cols=232  Identities=23%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe----
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  186 (431)
                      +|++++.||+|+||.||+|+++.     +++.||+|++....       +.+.+|+.+++.++||||+++++++..    
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRI-----DGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETT-----TCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             ccceeeeeccCCceEEEEEEEcC-----CCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            59999999999999999999875     78899999997543       235679999999999999999998865    


Q ss_pred             ------------CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          187 ------------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       187 ------------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                                  ...+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                        45689999999999999999764  5799999999999999999999999999999999999999887


Q ss_pred             CccCC----------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 014087          253 HEIDE----------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK  322 (431)
Q Consensus       253 ~~~~~----------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~  322 (431)
                      .....          ........||+.|+|||++.+..++.++|||||||++|||++|..||..  .......+...  .
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~--~  235 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG--I  235 (284)
T ss_dssp             EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTT--C
T ss_pred             CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcc--c
Confidence            53221          1223455799999999999999999999999999999999999999853  22333344333  3


Q ss_pred             CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       323 ~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      ++..++.++.+||.+||..||.+||     +++++++|.+.
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~l~~  271 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTV  271 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHH
Confidence            5677899999999999999999999     89999998765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=327.09  Aligned_cols=240  Identities=20%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|++.++||+|+||+||+|++....  ..+..+|+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCC--Cceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            4777899999999999999986521  244579999987532  344567788999999999999999999999877665


Q ss_pred             -EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          191 -YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       191 -~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                       ++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+          
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             999999999999999987 45689999999999999999999999999999999999999987632221          


Q ss_pred             -----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          259 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                           .......||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+...+...+... ....+..++.++
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence                 12234467889999999999999999999999999999999 66667777776666666654 345677899999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+||.+||..||.+||     +++++++
T Consensus       258 ~~li~~~l~~~p~~Rp-----s~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRP-----TFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999     8888877

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.2e-42  Score=361.09  Aligned_cols=239  Identities=18%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             CceEE-eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      .+.+. ++||+|+||+||+|.++..   .+++.||||+++.... .....+.+.+|+++|+.++|||||++++++.. +.
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  443 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES  443 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             hccccCCEeccCCCEEEEEEEEcCC---CcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            34443 4899999999999976531   2678899999987543 34456778999999999999999999999965 45


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +++|||||.+|+|.+++...+.+++..+..|+.||+.||.|||++|||||||||+||||+.++.....+.          
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            8999999999999999999889999999999999999999999999999999999999998876322211          


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHS  333 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  333 (431)
                          ......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ ....|..++.++.+
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  603 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  603 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence                1223346788999999999999999999999999999998 99999999988888888765 45678889999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ||.+||..||++||     ++++|++
T Consensus       604 li~~cl~~dP~~RP-----s~~~l~~  624 (635)
T 4fl3_A          604 LMNLCWTYDVENRP-----GFAAVEL  624 (635)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHcCCCHhHCc-----CHHHHHH
Confidence            99999999999999     7888765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.8e-42  Score=332.02  Aligned_cols=239  Identities=24%  Similarity=0.328  Sum_probs=197.0

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--CCE
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSK  189 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~  189 (431)
                      |++++.||+|+||+||++.++.... .+++.||||+++...  .....+.+.+|+++|+.++||||+++++++.+  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            4999999999999999998764332 378999999998653  34456778899999999999999999999988  468


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----------  259 (431)
                      +|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.          
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            99999999999999998765 4899999999999999999999999999999999999999886322111          


Q ss_pred             ----CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHh-c
Q 014087          260 ----RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ---------------KLQQRIIN-E  319 (431)
Q Consensus       260 ----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~---------------~~~~~i~~-~  319 (431)
                          ......||..|+|||++.+..++.++|||||||++|||++|+.||......               .+...+.. .
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence                122345788899999999999999999999999999999999999753221               11222222 2


Q ss_pred             ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          320 KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       320 ~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ....+..++.++.+||.+||+.||.+||     +++++++
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  303 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRP-----TFENLIP  303 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            4456778999999999999999999999     8888875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.8e-42  Score=327.06  Aligned_cols=235  Identities=17%  Similarity=0.226  Sum_probs=192.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeE-EEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~  187 (431)
                      .++|++.+.||+|+||.||+|+++.     +++.||||++.....     .+.+.+|+.+++.++|++++..+. ++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC-----CCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence            4679999999999999999999875     889999999875432     134778999999999887666554 45678


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC---CCCCccCCC-----
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHEIDES-----  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~g~~~~~~-----  258 (431)
                      +..|+||||+ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++   .++.....+     
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            8899999999 9999999974 45799999999999999999999999999999999999995   444321111     


Q ss_pred             -------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccC
Q 014087          259 -------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEKVK  322 (431)
Q Consensus       259 -------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~  322 (431)
                                   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +.......+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence                         1124568999999999999999999999999999999999999999763   222344444444333


Q ss_pred             CC-----CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          323 LP-----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       323 ~p-----~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+     ..+++++.+||.+||+.||.+||     ++++|++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  273 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHH
T ss_pred             CchHHHHhhCCHHHHHHHHHHHhcCcCcCC-----CHHHHHH
Confidence            33     67899999999999999999999     7778765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-43  Score=342.48  Aligned_cols=239  Identities=22%  Similarity=0.332  Sum_probs=195.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++.+.||+|+||+||+|+++      +++.||||++....   ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4568999999999999999999864      57889999887542   34456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      +..|+||||++||+|.+++....    .+++.++..++.||+.||.|||++||+||||||+|||++.++.....+.    
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999999886543    5899999999999999999999999999999999999998876322111    


Q ss_pred             ---------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccc--
Q 014087          260 ---------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ-------QRIINEKV--  321 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~-------~~i~~~~~--  321 (431)
                               ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..       .....+..  
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence                     123446899999999999999999999999999999999999999764322111       11111111  


Q ss_pred             --------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          322 --------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       322 --------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                              .++...+.++.++|.+||+.||++||     ++++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  309 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP-----SMGDVLWK  309 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence                    11223456789999999999999999     88999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=331.07  Aligned_cols=234  Identities=28%  Similarity=0.436  Sum_probs=193.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||+||+|+++       ++.||||++...     ...+.+.+|+.+|+.++||||+++++++.+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN   72 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            44568999999999999999999873       567999998643     234568889999999999999999998764


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEeCCCCCc--cCCC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHK---CGIVHRDLKPENILMDSDGHE--IDES  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~g~~--~~~~  258 (431)
                        ..|+||||++||+|.+++....   .+++..+..++.||+.||.|||+   +||+||||||+|||++.+|..  +.+.
T Consensus        73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence              4799999999999999998765   37899999999999999999999   899999999999999988762  2111


Q ss_pred             -------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHh-cccCCCCCCC
Q 014087          259 -------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA--NRQKLQQRIIN-EKVKLPPFLT  328 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~--~~~~~~~~i~~-~~~~~p~~~s  328 (431)
                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||...  ....+...+.. .....+..++
T Consensus       151 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (307)
T 2eva_A          151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP  230 (307)
T ss_dssp             CC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred             ccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence                   1123457999999999999999999999999999999999999999753  23333333333 3445567899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||..||.+||     +++++++
T Consensus       231 ~~l~~li~~~l~~dp~~Rp-----s~~ell~  256 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRP-----SMEEIVK  256 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            9999999999999999999     8888876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.4e-42  Score=356.22  Aligned_cols=237  Identities=23%  Similarity=0.351  Sum_probs=204.1

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.++||+|+||.||+|+++      .+..||||+++....    ..+.+.+|+.+|+.++||||+++++++.+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWN------GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhhhhhheecccCCCeEEEEEEEC------CCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            45567999999999999999999986      346699999986542    23568899999999999999999999876


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc---
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS---  261 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~---  261 (431)
                       +.+|+||||+.+|+|.+++...  ..+++.++..|+.||+.||.|||++|||||||||+||||+.++.....+...   
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence             6799999999999999999753  5699999999999999999999999999999999999999887633222111   


Q ss_pred             ---------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          262 ---------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       262 ---------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                               ....|+..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+..+ ....+..++.+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  492 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  492 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence                     12346778999999999999999999999999999999 99999998888888887655 45667889999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +.+||.+||..||++||     ++++|+.
T Consensus       493 l~~li~~cl~~dP~~RP-----t~~~l~~  516 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERP-----TFEYLQA  516 (535)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            99999999999999999     8888876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=359.31  Aligned_cols=242  Identities=21%  Similarity=0.291  Sum_probs=203.5

Q ss_pred             CCCCCceEEe-eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          107 IGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       107 ~~~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      +..+++.+.+ .||+|+||+||+|.++...   ++..||||+++...  .....+.+.+|+++|+.++|||||++++++.
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            4456677777 8999999999999886421   56679999997653  3345677889999999999999999999998


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCc---
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRS---  261 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~---  261 (431)
                      + +.+|+|||||.||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.....+...   
T Consensus       407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            6 5699999999999999999754 4699999999999999999999999999999999999999887632221111   


Q ss_pred             -----------ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          262 -----------NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       262 -----------~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                 ....||+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ ....|..++
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  565 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence                       12235688999999999999999999999999999998 99999998888888887765 456778899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++.+||.+||..||++||     ++++|++
T Consensus       566 ~~l~~li~~cl~~dP~~RP-----s~~~l~~  591 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRP-----DFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            9999999999999999999     7788754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6e-42  Score=345.61  Aligned_cols=237  Identities=28%  Similarity=0.372  Sum_probs=184.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      +.|.+.+.||+|+||+||.+...      +++.||||++..+.      .+.+.+|+.+|+.+ +|||||++++++.+.+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~------~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF------QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES------SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE------CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34677889999999999865432      68899999987542      24567899999876 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFR-------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---------  252 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~-------~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g---------  252 (431)
                      .+|+|||||. |+|.+++.......       +..+..++.||+.||.|||++||+||||||+|||++.+|         
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 59999998764332       334567999999999999999999999999999997653         


Q ss_pred             ----CccCCCC---------------CcccccCCCCCCchhhhcc-------CCCCCcchhHhHHHHHHHHHh-CCCCCC
Q 014087          253 ----HEIDESS---------------RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLT-GQPPFT  305 (431)
Q Consensus       253 ----~~~~~~~---------------~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~Pf~  305 (431)
                          .....+.               .....+||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence                1111000               1224579999999999976       678999999999999999999 999997


Q ss_pred             CCCHHHHHHHHHhcccCCCC-------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          306 HANRQKLQQRIINEKVKLPP-------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       306 ~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ......  ..+..+....+.       .++.++.+||.+||+.||.+||     +++++++||||...
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  302 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP-----TAMKVLRHPLFWPK  302 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSCH
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCC-----CHHHHHhCCccCCc
Confidence            654332  344444433322       2457899999999999999999     89999999999764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=337.89  Aligned_cols=237  Identities=15%  Similarity=0.214  Sum_probs=191.3

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCC---CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcce------
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ------  179 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~------  179 (431)
                      .++|++.+.||+|+||.||+|+++.+...   ..++.||||++.+.        +.+.+|+.+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            46899999999999999999998752110   03788999998754        24678999999999999988      


Q ss_pred             ---------eeEEEEe-CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          180 ---------LRYSFQT-RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       180 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                               +++++.. +..+|+||||+ +++|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5677766 78899999999 99999999986  78999999999999999999999999999999999999


Q ss_pred             eCCCC--CccCCC------------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 014087          248 MDSDG--HEIDES------------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA  307 (431)
Q Consensus       248 l~~~g--~~~~~~------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~  307 (431)
                      ++.++  .....+                  .......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99887  321110                  1123458999999999999999999999999999999999999999875


Q ss_pred             --CHHHHHHHHH---hcccCCC------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          308 --NRQKLQQRII---NEKVKLP------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       308 --~~~~~~~~i~---~~~~~~p------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                        +...+...+.   .....++      ..++.++.+||.+||..||.+||     ++++|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP-----PYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC-----CHHHHHH
Confidence              3333333322   2222222      24689999999999999999999     7888876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=341.93  Aligned_cols=240  Identities=19%  Similarity=0.286  Sum_probs=198.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE-eCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  189 (431)
                      .|++.+.||+|+||+||+|++....  ..+..||+|.++...  .....+.+.+|+.+|+.++||||+++++++. .++.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            5889999999999999999876411  134568999987532  3445677899999999999999999999865 4568


Q ss_pred             EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------
Q 014087          190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------  260 (431)
                      .|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+..        
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999865 458999999999999999999999999999999999999998763322111        


Q ss_pred             -------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          261 -------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       261 -------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                             .....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+..+ ....|..++.++
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence                   123456788999999999999999999999999999999 78899877666666666554 344567899999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+||.+||..||++||     +++++++
T Consensus       326 ~~li~~cl~~dp~~RP-----s~~ell~  348 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRP-----SFSELVS  348 (373)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999999     8888876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=333.43  Aligned_cols=237  Identities=25%  Similarity=0.402  Sum_probs=177.2

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEE-
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ-  185 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~-  185 (431)
                      ...+|++.++||+|+||.||+|+++.     +++.||||++....   ....+.+.+|+.+++.+. ||||+++++++. 
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVG-----SGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cCceEEEEEEEccCCceEEEEEEECC-----CCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            34579999999999999999999886     88999999986542   334556788999999996 999999999994 


Q ss_pred             -------eCCEEEEEEeccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCC
Q 014087          186 -------TRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH  253 (431)
Q Consensus       186 -------~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~g~  253 (431)
                             ....+|+||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence                   3446899999996 688888865   467999999999999999999999999  999999999999999876


Q ss_pred             ccCCCCCc-----------------------ccccCCCCCCchhhh---ccCCCCCcchhHhHHHHHHHHHhCCCCCCCC
Q 014087          254 EIDESSRS-----------------------NSMCGTTEYMAPEIL---LSKGHNKDADWWSVGILLYEMLTGQPPFTHA  307 (431)
Q Consensus       254 ~~~~~~~~-----------------------~~~~Gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltg~~Pf~~~  307 (431)
                      ....+...                       ...+||+.|+|||++   .+..++.++|||||||++|||++|+.||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            43222211                       144689999999999   5667889999999999999999999999765


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          308 NRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       308 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ....+.....  ....+...+.++.+||.+||+.||.+||     +++++++|
T Consensus       257 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  302 (337)
T 3ll6_A          257 AKLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERL-----SIAEVVHQ  302 (337)
T ss_dssp             ---------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             hHHHhhcCcc--cCCcccccchHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            4443332221  2233456778899999999999999999     88999885

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-41  Score=324.96  Aligned_cols=234  Identities=26%  Similarity=0.406  Sum_probs=185.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh--cCCCCcceeeEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSF  184 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~  184 (431)
                      +..++|++++.||+|+||+||+|++       +++.||||++....      ...+..|.+++..  ++||||+++++++
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-------QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-------TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-------CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            3456899999999999999999986       56789999987542      2334557777766  7999999999986


Q ss_pred             Ee----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeCCCC
Q 014087          185 QT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       185 ~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~iiHrDlKp~NILl~~~g  252 (431)
                      ..    ...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||        ++||+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence            54    3568999999999999999954 57999999999999999999999        99999999999999999887


Q ss_pred             CccCCCCC---------------cccccCCCCCCchhhhccC------CCCCcchhHhHHHHHHHHHhC----------C
Q 014087          253 HEIDESSR---------------SNSMCGTTEYMAPEILLSK------GHNKDADWWSVGILLYEMLTG----------Q  301 (431)
Q Consensus       253 ~~~~~~~~---------------~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg----------~  301 (431)
                      .....+..               ....+||+.|+|||++.+.      .++.++|||||||++|||++|          +
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            64322211               2234799999999999876      345789999999999999999          8


Q ss_pred             CCCCCC-----CHHHHHHHHHhc--ccCCCC-----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          302 PPFTHA-----NRQKLQQRIINE--KVKLPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       302 ~Pf~~~-----~~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .||...     ....+...+...  ...+|.     .++.++.+||.+||+.||++||     ++++|++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL-----TALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC-----CHHHHHH
Confidence            898642     223333333222  222222     2457899999999999999999     8888876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-42  Score=335.22  Aligned_cols=244  Identities=19%  Similarity=0.281  Sum_probs=193.9

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++.+.||+|+||+||+|+++      +++.||||++........  ...+.+|+.+++.++||||+++++++.+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             HHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEec
Confidence            44578999999999999999999743      678899999976543221  2357889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeCCCCCccCCCC
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHEIDESS  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~g~~~~~~~  259 (431)
                      .+..++||||+.||+|.+++....    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.....+.
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            999999999999999999998653    499999999999999999999999   9999999999999999876332211


Q ss_pred             ------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC-----C---HHHHHHHHHhc
Q 014087          260 ------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-----N---RQKLQQRIINE  319 (431)
Q Consensus       260 ------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~-----~---~~~~~~~i~~~  319 (431)
                                  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...     .   ...........
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence                        123345999999999999999999999999999999999999999521     0   11111111110


Q ss_pred             -c----------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          320 -K----------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       320 -~----------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                       .          ..++...+.++.+||.+||+.||.+||     ++++|++|-.-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L~~  308 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-----KMSEVVRMLEG  308 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC-----CHHHHHHHHHT
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC-----CHHHHHHHhcC
Confidence             0          011122346799999999999999999     88999886543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-41  Score=326.13  Aligned_cols=227  Identities=26%  Similarity=0.499  Sum_probs=182.7

Q ss_pred             CCceEE-eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHH-HhcCCCCcceeeEEEEe-
Q 014087          110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT-  186 (431)
Q Consensus       110 ~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~-  186 (431)
                      ++|.+. +.||+|+||.||+|+++.     +++.||+|+++..        ..+.+|+.++ +.++||||+++++++.. 
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC-----CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            468887 789999999999999876     8899999998643        2355688887 56699999999999987 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCccCCC
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHEIDES  258 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---g~~~~~~  258 (431)
                         ...+|+||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.....+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               778999999999999999998864  69999999999999999999999999999999999999983   3332222


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccCCC----CCCCHH
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQR----IINEKVKLP----PFLTSE  330 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~----i~~~~~~~p----~~~s~~  330 (431)
                      ....           +.+.+..++.++|||||||++|||++|+.||.+.+.......    +......++    ..++.+
T Consensus       164 fg~a-----------~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (299)
T 3m2w_A          164 FGFA-----------KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE  232 (299)
T ss_dssp             CTTC-----------EECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHH
T ss_pred             cccc-----------cccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHH
Confidence            2111           223346688999999999999999999999987654433222    222233344    468999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +.+||.+||..||.+||     +++++++||||+.
T Consensus       233 ~~~li~~~l~~dP~~Rp-----s~~e~l~hp~~~~  262 (299)
T 3m2w_A          233 VKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  262 (299)
T ss_dssp             HHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHT
T ss_pred             HHHHHHHHcccChhhCC-----CHHHHhcChhhcc
Confidence            99999999999999999     8999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.1e-42  Score=327.83  Aligned_cols=222  Identities=14%  Similarity=0.171  Sum_probs=185.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||.||+|++..     +++.||||++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTA-----LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETT-----TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecC-----CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            4679999999999999999999875     78999999998776555566678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCCcccccCCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTT  268 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~~~~~~Gt~  268 (431)
                      ..|+||||++|++|.+++.+ + ....++..++.||+.||.|||++||+||||||+|||++.+|....         ++.
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl---------~~~  173 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL---------AYP  173 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEE---------CSC
T ss_pred             cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEE---------Eec
Confidence            99999999999999999854 3 466678899999999999999999999999999999998876533         356


Q ss_pred             CCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccc----CCCCCCCHHHHHHHHhhccc
Q 014087          269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQ---RIINEKV----KLPPFLTSEAHSLLKGLLHK  341 (431)
Q Consensus       269 ~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~---~i~~~~~----~~p~~~s~~~~~li~~~L~~  341 (431)
                      .|++|       ++.++|||||||++|||++|+.||.+.+......   +......    .++..+++++.+||.+||+.
T Consensus       174 ~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  246 (286)
T 3uqc_A          174 ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG  246 (286)
T ss_dssp             CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCT
T ss_pred             cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHccc
Confidence            67764       7899999999999999999999998754322110   1111111    12356899999999999999


Q ss_pred             CcCCcCCCCCCCHHHHHh
Q 014087          342 DPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       342 dP~~R~~~~~~~~~~i~~  359 (431)
                      ||.+| +     ++++++
T Consensus       247 dP~~R-s-----~~el~~  258 (286)
T 3uqc_A          247 DGGIR-S-----ASTLLN  258 (286)
T ss_dssp             TSSCC-C-----HHHHHH
T ss_pred             CCccC-C-----HHHHHH
Confidence            99999 3     567765

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=336.97  Aligned_cols=239  Identities=15%  Similarity=0.282  Sum_probs=188.7

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRY  182 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~  182 (431)
                      .+..++|++.++||+|+||+||+|.++...+..+++.||||+++...      ...+..|+.+++.++   |+||+++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            34567899999999999999999965433333478999999987542      234667888888876   999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-------
Q 014087          183 SFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-------  250 (431)
Q Consensus       183 ~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-------  250 (431)
                      ++...+..|+|||||+||+|.+++..     ...+++..++.|+.||+.||+|||++|||||||||+||||+.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     457999999999999999999999999999999999999987       


Q ss_pred             ----CCCccCC-------------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 014087          251 ----DGHEIDE-------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ  313 (431)
Q Consensus       251 ----~g~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~  313 (431)
                          ++.....             .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence                5542211             112245679999999999999999999999999999999999999996432210  


Q ss_pred             HHHHhcccCCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          314 QRIINEKVKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       314 ~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                         ......++ ...++...+++..||..+|.+|+.    +++++.+
T Consensus       293 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~----~~~~l~~  332 (365)
T 3e7e_A          293 ---CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP----SLDLLRQ  332 (365)
T ss_dssp             ---EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCC----CHHHHHH
T ss_pred             ---eeechhccccCcHHHHHHHHHHHcCCCCCCcch----HHHHHHH
Confidence               00001111 134678899999999999999973    5555543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.8e-41  Score=354.98  Aligned_cols=245  Identities=23%  Similarity=0.334  Sum_probs=206.9

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++.+.||+|+||+||+|+++...  ..+..||+|+++...  .....+.+.+|+.+|+.++||||+++++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSS--SCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCC--CccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3455678999999999999999999987522  246789999987543  334456788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR---  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~---  260 (431)
                      . ++.+|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+..   
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            4 567899999999999999998654 68999999999999999999999999999999999999988763222111   


Q ss_pred             ---------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          261 ---------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       261 ---------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                               .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ...+|..+++
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  619 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence                     123356789999999999999999999999999999997 99999998888888887765 4567888999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.+||.+||..||.+||     ++++|++
T Consensus       620 ~l~~li~~~l~~dP~~RP-----s~~el~~  644 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRP-----RFTELKA  644 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999999     8888876

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-41  Score=325.74  Aligned_cols=236  Identities=22%  Similarity=0.281  Sum_probs=191.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      .|...+.||+|+||+||+|++       .++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccCCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc
Confidence            355669999999999999975       467899999875432 234456778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-------
Q 014087          190 LYLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-------  259 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-------  259 (431)
                      .|+||||+++|+|.+++..   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.....+.       
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  184 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE  184 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence            9999999999999999874   346999999999999999999999999999999999999998876322211       


Q ss_pred             ------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccc--------
Q 014087          260 ------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----KLQQRIINEKV--------  321 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~--------  321 (431)
                            .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......    .+...+.....        
T Consensus       185 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (307)
T 2nru_A          185 KFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK  263 (307)
T ss_dssp             SCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred             cccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence                  1234579999999999875 4889999999999999999999999764332    22222222111        


Q ss_pred             ---CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          322 ---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       322 ---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                         ..+...+.++.++|.+||+.||.+||     +++++++
T Consensus       264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~l~~  299 (307)
T 2nru_A          264 KMNDADSTSVEAMYSVASQCLHEKKNKRP-----DIKKVQQ  299 (307)
T ss_dssp             SCSCCCHHHHHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence               12233457789999999999999999     8888876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=325.82  Aligned_cols=245  Identities=20%  Similarity=0.302  Sum_probs=198.8

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||.||+|++..... .+++.||||++...   .....+.+.+|+.+|+.++||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSS-SCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccC-CCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            4455679999999999999999998643222 37899999998764   3344567889999999999999999999987


Q ss_pred             eCC--EEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          186 TRS--KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       186 ~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      ..+  .+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.....+..  
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            654  789999999999999999876 469999999999999999999999999999999999999988763222111  


Q ss_pred             ------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH----------------HH
Q 014087          261 ------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ----------------KL  312 (431)
Q Consensus       261 ------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~----------------~~  312 (431)
                                  .....|+..|+|||++.+..++.++|||||||++|||++|..||......                .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence                        12235677899999999999999999999999999999999998643111                11


Q ss_pred             HHHHHh-cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          313 QQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       313 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...+.. .....+..++.++.+||.+||..||.+||     ++++|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLAL  315 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            222222 23456778999999999999999999999     7888875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.7e-43  Score=364.91  Aligned_cols=259  Identities=26%  Similarity=0.394  Sum_probs=204.5

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .++|++.+.||+|+||.||+|.++.     +++.||||+++...  .....+.+.+|+.+|+.++||||+++++++..  
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~-----tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQD-----TGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTT-----TTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            3679999999999999999998775     78899999987642  34445678899999999999999999998765  


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc----c
Q 014087          187 ----RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE----I  255 (431)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~----~  255 (431)
                          .+..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++.+|..    +
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                677899999999999999998754   58999999999999999999999999999999999999987641    1


Q ss_pred             ---------CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHH---------HHH-
Q 014087          256 ---------DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ---------QRI-  316 (431)
Q Consensus       256 ---------~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~---------~~i-  316 (431)
                               .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......         ..+ 
T Consensus       166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence                     1112234568999999999999999999999999999999999999999765332211         000 


Q ss_pred             ----HhcccC----------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcc
Q 014087          317 ----INEKVK----------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK  381 (431)
Q Consensus       317 ----~~~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~  381 (431)
                          ..+...          ++..++.++.+||.+||..||++||     ++++++.||||+.  ++.+..+++...|.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP-----Ta~elL~hp~F~~--l~~iL~~kil~~f~  317 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG-----TDPQNPNVGCFQA--LDSILSLKLLSVMN  317 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--------CCTTCCCCTTHHH--HHHHHCCCEEECCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc-----CHHHHhcCHHHHH--HHHHHhcccccccc
Confidence                111111          1123568899999999999999999     7789999999986  56666666555553

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=330.30  Aligned_cols=242  Identities=20%  Similarity=0.286  Sum_probs=201.0

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEE
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS  183 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  183 (431)
                      ...+..++|++.+.||+|+||.||+|++++        .+|+|+++.... .....+.+.+|+.+++.++||||++++++
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            345667899999999999999999998753        399999876432 22233456779999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      +.+.+.+|+||||+.|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+...+.+.    
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~  177 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFS  177 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC
T ss_pred             EecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcc
Confidence            999999999999999999999997754 699999999999999999999999999999999999998432211111    


Q ss_pred             -----------CCcccccCCCCCCchhhhcc---------CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014087          259 -----------SRSNSMCGTTEYMAPEILLS---------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN  318 (431)
Q Consensus       259 -----------~~~~~~~Gt~~y~aPE~~~~---------~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~  318 (431)
                                 .......||+.|+|||++.+         ..++.++|||||||++|||++|+.||...........+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence                       11223458999999999975         4578899999999999999999999999888888877766


Q ss_pred             cccCC--CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          319 EKVKL--PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       319 ~~~~~--p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .....  +..++.++.+||.+||..||.+||     +++++++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~  295 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERP-----TFTKLMD  295 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC-----CHHHHHH
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            54332  235889999999999999999999     8889887

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-40  Score=322.13  Aligned_cols=231  Identities=25%  Similarity=0.374  Sum_probs=185.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh--cCCCCcceeeEEEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  187 (431)
                      ++|++++.||+|+||.||+|++       .++.||||++.....      .....|.+++..  ++||||+++++++...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW-------RGEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cceEEEeEeecCCCeEEEEEEE-------CCceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            4699999999999999999987       467899999865431      223445555554  4899999999999887


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeCCCCCcc
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDlKp~NILl~~~g~~~  255 (431)
                          ..+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++        ||+||||||+|||++.++...
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence                7899999999999999999764 689999999999999999999998        999999999999999887633


Q ss_pred             CCCCC---------------cccccCCCCCCchhhhccCCCCCc------chhHhHHHHHHHHHhC----------CCCC
Q 014087          256 DESSR---------------SNSMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTG----------QPPF  304 (431)
Q Consensus       256 ~~~~~---------------~~~~~Gt~~y~aPE~~~~~~~~~~------~DvwslGvil~elltg----------~~Pf  304 (431)
                      ..+..               ....+||+.|+|||++.+..++..      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            22211               124579999999999998877765      9999999999999999          7777


Q ss_pred             CCC-----CHHHHHHHHHhc--ccCCCC-----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          305 THA-----NRQKLQQRIINE--KVKLPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       305 ~~~-----~~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...     ........+...  ...+|.     .++.++.+||.+||+.||.+||     ++++|++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  324 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL-----TALRVKK  324 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC-----CHHHHHH
Confidence            542     223333333222  222332     4567799999999999999999     8889887

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=327.70  Aligned_cols=237  Identities=20%  Similarity=0.336  Sum_probs=180.1

Q ss_pred             hcCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHH--HHhcCCCCcceee
Q 014087          104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLR  181 (431)
Q Consensus       104 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~  181 (431)
                      ...+..++|++++.||+|+||.||+|++       +++.||||++.....      ..+..|.++  +..++||||++++
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~   73 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-------DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFI   73 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEE-------TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEE-------CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhhe
Confidence            3456778999999999999999999975       568899999975432      223334444  4568999999999


Q ss_pred             EEEEe-----CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceE
Q 014087          182 YSFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENIL  247 (431)
Q Consensus       182 ~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~iiHrDlKp~NIL  247 (431)
                      +.+..     ...+|+||||+++|+|.+++.... .++..+..++.||+.||.|||++         ||+||||||+|||
T Consensus        74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil  152 (336)
T 3g2f_A           74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL  152 (336)
T ss_dssp             EEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred             ecccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence            86542     336899999999999999997654 59999999999999999999999         9999999999999


Q ss_pred             eCCCCCccCCCC-------------------CcccccCCCCCCchhhhcc-------CCCCCcchhHhHHHHHHHHHhCC
Q 014087          248 MDSDGHEIDESS-------------------RSNSMCGTTEYMAPEILLS-------KGHNKDADWWSVGILLYEMLTGQ  301 (431)
Q Consensus       248 l~~~g~~~~~~~-------------------~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~elltg~  301 (431)
                      ++.+|.....+.                   .....+||+.|+|||++.+       ..++.++|||||||++|||++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            999876332211                   1124579999999999987       35567899999999999999997


Q ss_pred             CCCCCC-C-----------------HHHHHHHHHhc--ccCCCCC------CCHHHHHHHHhhcccCcCCcCCCCCCCHH
Q 014087          302 PPFTHA-N-----------------RQKLQQRIINE--KVKLPPF------LTSEAHSLLKGLLHKDPSKRLGSGPGGVD  355 (431)
Q Consensus       302 ~Pf~~~-~-----------------~~~~~~~i~~~--~~~~p~~------~s~~~~~li~~~L~~dP~~R~~~~~~~~~  355 (431)
                      .||... .                 ...+...+...  ...+|..      ++.++.+||.+||..||++||     +++
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~  307 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL-----TAQ  307 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC-----CHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc-----chH
Confidence            766321 1                 11222222111  2233433      345799999999999999999     788


Q ss_pred             HHHh
Q 014087          356 AIKH  359 (431)
Q Consensus       356 ~i~~  359 (431)
                      ++++
T Consensus       308 e~l~  311 (336)
T 3g2f_A          308 XAEE  311 (336)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8854

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-42  Score=336.79  Aligned_cols=237  Identities=14%  Similarity=0.207  Sum_probs=184.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHhcC---------C
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVT---------H  174 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~---------h  174 (431)
                      .++|++++.||+|+||+||+|++       +++.||||++.+....     .....+.+.+|+.+|+.++         |
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             cccchheeeecccCceEEEEEEe-------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            34699999999999999999986       4688999999876421     2334467888999998886         7


Q ss_pred             CCcceeeEEEE-----------------e-------------CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHH
Q 014087          175 PFIVQLRYSFQ-----------------T-------------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI  224 (431)
Q Consensus       175 pnIv~l~~~~~-----------------~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi  224 (431)
                      ||||++.+++.                 +             .+.+|+|||||.+|++.+.+.+ +.+++.+++.|+.||
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL  170 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence            77777766543                 2             7889999999999987777644 568999999999999


Q ss_pred             HHHHHHHH-HCCceeccCCCCceEeCCCC--------------------CccCCCCC------cccccCCCCCCchhhhc
Q 014087          225 VSAVSHLH-KCGIVHRDLKPENILMDSDG--------------------HEIDESSR------SNSMCGTTEYMAPEILL  277 (431)
Q Consensus       225 ~~aL~~LH-~~~iiHrDlKp~NILl~~~g--------------------~~~~~~~~------~~~~~Gt~~y~aPE~~~  277 (431)
                      +.||.||| ++|||||||||+||||+.+|                    .....+..      ....+||+.|+|||++.
T Consensus       171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC
T ss_pred             HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc
Confidence            99999999 99999999999999999886                    32222211      12458999999999999


Q ss_pred             cCCCCCcchhHhHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhc-ccC--C----CCCCCHHHHHHHHhhcccCcCCcCC
Q 014087          278 SKGHNKDADWWSVGIL-LYEMLTGQPPFTHANR-QKLQQRIINE-KVK--L----PPFLTSEAHSLLKGLLHKDPSKRLG  348 (431)
Q Consensus       278 ~~~~~~~~DvwslGvi-l~elltg~~Pf~~~~~-~~~~~~i~~~-~~~--~----p~~~s~~~~~li~~~L~~dP~~R~~  348 (431)
                      +.. +.++||||||++ .+++++|..||.+... ..+...+... ...  .    +..+++++++||++||++|      
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d------  323 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS------  323 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS------
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC------
Confidence            776 889999998777 7889999999954221 2233333321 111  1    1247889999999999976      


Q ss_pred             CCCCCHHHHH-hCCCCC
Q 014087          349 SGPGGVDAIK-HHKWFR  364 (431)
Q Consensus       349 ~~~~~~~~i~-~h~~f~  364 (431)
                          ++++++ +||||+
T Consensus       324 ----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 ----SATDLLCQHSLFK  336 (336)
T ss_dssp             ----SHHHHHHHCGGGC
T ss_pred             ----CHHHHHhcCCCcC
Confidence                689999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.3e-40  Score=319.14  Aligned_cols=231  Identities=25%  Similarity=0.362  Sum_probs=189.1

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh--cCCCCcceeeEEEEeCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~  188 (431)
                      +|++.+.||+|+||.||+|++       +++.||||++....      ...+.+|+++++.  ++||||+++++++....
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE-------TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             cEEEEeeecCCCCcEEEEEEE-------cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            599999999999999999986       46789999986542      2446678888887  78999999999999876


Q ss_pred             ----EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeCCCCCccC
Q 014087          189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       189 ----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                          .+|+||||+.+|+|.+++.+. .+++.++..++.||+.||.|||        ++||+||||||+|||++.++....
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence                899999999999999999764 6899999999999999999999        899999999999999999886332


Q ss_pred             CCC---------------CcccccCCCCCCchhhhccCC------CCCcchhHhHHHHHHHHHhC----------CCCCC
Q 014087          257 ESS---------------RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTG----------QPPFT  305 (431)
Q Consensus       257 ~~~---------------~~~~~~Gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg----------~~Pf~  305 (431)
                      .+.               .....+||+.|+|||++.+..      ++.++|||||||++|||++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            211               123457999999999998763      23689999999999999999          88996


Q ss_pred             CC-----CHHHHHHHHHhccc--CCCC-----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          306 HA-----NRQKLQQRIINEKV--KLPP-----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       306 ~~-----~~~~~~~~i~~~~~--~~p~-----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..     ....+...+.....  .+|.     ..+..+.+||.+||+.||++||     ++++|++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~i~~~  330 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKKT  330 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHHH
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC-----CHHHHHHH
Confidence            54     34455555544332  2332     2345789999999999999999     88998873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-41  Score=338.41  Aligned_cols=243  Identities=16%  Similarity=0.151  Sum_probs=187.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC-CCcce--------
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQ--------  179 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~--------  179 (431)
                      ..+|...++||+|+||+||+|++..     +++.||||++...........+.+.+|+.+++.+.| .|+..        
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             ceeEEEecccccCCCEEEEEEEecC-----CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            4458899999999999999999886     788999999985443344446778899999999977 32111        


Q ss_pred             -------------eeEEEEe-----CCEEEEEEeccCCCChHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014087          180 -------------LRYSFQT-----RSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYTAEIVSAVSHLHKC  234 (431)
Q Consensus       180 -------------l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~  234 (431)
                                   +..++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                         1111121     22467788876 5789888852       23477888999999999999999999


Q ss_pred             CceeccCCCCceEeCCCCCccCCCC--------CcccccCCCCCCchhhh----------ccCCCCCcchhHhHHHHHHH
Q 014087          235 GIVHRDLKPENILMDSDGHEIDESS--------RSNSMCGTTEYMAPEIL----------LSKGHNKDADWWSVGILLYE  296 (431)
Q Consensus       235 ~iiHrDlKp~NILl~~~g~~~~~~~--------~~~~~~Gt~~y~aPE~~----------~~~~~~~~~DvwslGvil~e  296 (431)
                      |||||||||+||||+.+|.....+.        .....+| +.|+|||++          .+..++.++|||||||++||
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999999999999987432222        2345678 999999999          55568889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          297 MLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       297 lltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                      |++|+.||...+.......+..    ....+++++.+||.+||+.||++||     ++.++++||||+.+.
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCc-----CHHHHHhCHHHHHHH
Confidence            9999999987654443333332    2246789999999999999999999     899999999998764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-39  Score=341.61  Aligned_cols=236  Identities=22%  Similarity=0.316  Sum_probs=187.2

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++.+.||+|+||+||+|.++.    .+++.||||++....  .......+.+|+.+|+.++||||+++++++...+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4689999999999999999999864    157889999987532  2344567889999999999999999999998766


Q ss_pred             E-----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC----
Q 014087          189 K-----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS----  259 (431)
Q Consensus       189 ~-----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~----  259 (431)
                      .     .||||||++|++|.+++..  .+++.+++.|+.||+.||.|||++|||||||||+|||++.+...+.+..    
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~  230 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSR  230 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchh
Confidence            5     7999999999999887754  7999999999999999999999999999999999999998632222111    


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                        .....+||+.|+|||++.+. ++.++|||||||+||+|++|..||.+.....+.     . .......++++.+||.+
T Consensus       231 ~~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-----~-~~~~~~~~~~l~~li~~  303 (681)
T 2pzi_A          231 INSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----E-DDPVLKTYDSYGRLLRR  303 (681)
T ss_dssp             TTCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----T-TCHHHHHCHHHHHHHHH
T ss_pred             cccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-----c-cccccccCHHHHHHHhh
Confidence              12456799999999999765 488999999999999999999998753110000     0 00001246789999999


Q ss_pred             hcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          338 LLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      ||+.||.+||     +..+.+.|+|+.
T Consensus       304 ~l~~dP~~R~-----~~~~~l~~~l~~  325 (681)
T 2pzi_A          304 AIDPDPRQRF-----TTAEEMSAQLTG  325 (681)
T ss_dssp             HTCSSGGGSC-----SSHHHHHHHHHH
T ss_pred             hccCChhhCC-----CHHHHHHHHHHH
Confidence            9999999999     556777777774

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.5e-33  Score=287.07  Aligned_cols=179  Identities=13%  Similarity=0.087  Sum_probs=127.3

Q ss_pred             eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-------hhhhHHHHHHHHHHHHHhc-CCCCcceeeEEEEeCC
Q 014087          117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS  188 (431)
Q Consensus       117 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  188 (431)
                      .++.|++|.+..++..-     .|+.||+|++.++..       ......+.+.+|+++|+++ .|+||+++++++++++
T Consensus       241 ~~~~~~~~~h~~~rr~~-----fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYF-----FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             C-C--------CCEEEE-----ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             ccccCCccccccccccc-----ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            46677777777666554     788899999986532       1234456799999999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---------  259 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---------  259 (431)
                      .+|||||||+|++|.++|.+.+.+++.   .|+.||+.||+|||++|||||||||+||||+.+|.....+.         
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999999999999988875   47899999999999999999999999999999987432222         


Q ss_pred             --CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCC
Q 014087          260 --RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF  304 (431)
Q Consensus       260 --~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf  304 (431)
                        ...+.+||+.|||||++.+. +..++|+|++|+++|+|.++..+|
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence              23456899999999999764 677899999999998887664443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.4e-27  Score=243.65  Aligned_cols=177  Identities=18%  Similarity=0.104  Sum_probs=135.8

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ...++||+|+||+||+++.       .++.+++|.......     ......+.+.+|+++|+.++||||+++..++...
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL  411 (540)
T ss_dssp             ---------CCEEEEEEEC-------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred             CCCCEEeeCCCEEEEEEEE-------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence            3457899999999999943       567789997654322     2223356689999999999999999666666677


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC-------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR-------  260 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~-------  260 (431)
                      +..|+||||++|++|.+++.+        +..++.||+.||.|||++||+||||||+|||++. .-.+.+...       
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCH
T ss_pred             CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCc
Confidence            788999999999999998865        6689999999999999999999999999999998 222111111       


Q ss_pred             ----------cccccCCCCCCchhhhcc--CCCCCcchhHhHHHHHHHHHhCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLS--KGHNKDADWWSVGILLYEMLTGQPPFT  305 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~Pf~  305 (431)
                                ....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                      135689999999999987  778889999999999998888887774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=5.4e-24  Score=201.95  Aligned_cols=159  Identities=19%  Similarity=0.160  Sum_probs=120.1

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhh---------------hHHHHHHHHHHHHHhcCCC
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---------------NHVDYMKAERDILTKVTHP  175 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~~E~~il~~l~hp  175 (431)
                      .|.+.+.||+|+||.||+|++ .     +++.||||+++.......               .....+.+|+.+|+.++  
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            466779999999999999998 4     788999999975432111               23556889999999999  


Q ss_pred             CcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc
Q 014087          176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI  255 (431)
Q Consensus       176 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~  255 (431)
                      | +++.+++.. +..|+||||++||+|.+ +      .......++.||+.||.|||++||+||||||+|||++ +|...
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            4 666665544 45699999999999977 3      1234567999999999999999999999999999999 77654


Q ss_pred             CCCCCcccccCCCCCCchhhhcc----------CCCCCcchhHh
Q 014087          256 DESSRSNSMCGTTEYMAPEILLS----------KGHNKDADWWS  289 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~----------~~~~~~~Dvws  289 (431)
                      ..+....  .++..|+|||++.+          ..|+..+|+|.
T Consensus       233 l~DFG~a--~~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          233 IIDFPQS--VEVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             ECCCTTC--EETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEECCCC--eECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            4443322  35678999999864          34555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=2.2e-19  Score=167.92  Aligned_cols=127  Identities=20%  Similarity=0.156  Sum_probs=96.9

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcE--EEEEEeehhhhhh---------------------hhHHHHHHHHHHH
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIK---------------------KNHVDYMKAERDI  168 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~--~avK~~~~~~~~~---------------------~~~~~~~~~E~~i  168 (431)
                      |++.+.||+|+||.||+|.+..     +|+.  ||||+++......                     ......+.+|+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~-----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  123 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF-----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN  123 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE-----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC-----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence            7899999999999999999854     6788  9999976432110                     1112467889999


Q ss_pred             HHhcCCCCc--ceeeEEEEeCCEEEEEEeccCC-C----ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecc
Q 014087          169 LTKVTHPFI--VQLRYSFQTRSKLYLILDFING-G----HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRD  240 (431)
Q Consensus       169 l~~l~hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrD  240 (431)
                      |+.+.|++|  ..+++.    +..+|||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||||||
T Consensus       124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            999988764  334432    356899999942 3    66555322   245678899999999999999 99999999


Q ss_pred             CCCCceEeCC
Q 014087          241 LKPENILMDS  250 (431)
Q Consensus       241 lKp~NILl~~  250 (431)
                      |||+|||++.
T Consensus       197 lkp~NILl~~  206 (258)
T 1zth_A          197 LSEYNIMYID  206 (258)
T ss_dssp             CSTTSEEESS
T ss_pred             CCHHHEEEcC
Confidence            9999999988

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=3.6e-18  Score=166.99  Aligned_cols=128  Identities=13%  Similarity=0.153  Sum_probs=92.2

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh------------h---hhH----HHHHHHHHHHHHhc
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------------K---KNH----VDYMKAERDILTKV  172 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~------------~---~~~----~~~~~~E~~il~~l  172 (431)
                      |++++.||+|+||.||+|.+.      +|+.||||+++.....            .   ...    .-....|...|.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999864      6889999998643211            0   000    11224567777777


Q ss_pred             CCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q 014087          173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG  252 (431)
Q Consensus       173 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g  252 (431)
                      .+.++....-+...  ..+|||||+.|+.|..+.      ....+..++.||+.+|.+||++|||||||||.|||++.+|
T Consensus       171 ~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          171 YEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             HHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred             HhcCCCCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence            55544322111122  237999999999885432      2234667889999999999999999999999999999887


Q ss_pred             C
Q 014087          253 H  253 (431)
Q Consensus       253 ~  253 (431)
                      .
T Consensus       243 d  243 (397)
T 4gyi_A          243 D  243 (397)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=3.3e-11  Score=112.10  Aligned_cols=108  Identities=8%  Similarity=0.004  Sum_probs=85.2

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (431)
                      .|++...+|.|+.+.||++..       .++.+++|+........   ...+.+|+.+|+.+. +..+.++++++.+.+.
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~-------~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             cceeEeeccCCCCCeEEEEEC-------CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            599999999999999999863       35689999987532111   124778999999884 6778889999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  233 (431)
                      .|+||||++|.+|.+.+     .+......++.+++.+|..||+
T Consensus        85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhC
Confidence            99999999999986652     1223345788899999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=3.9e-10  Score=104.21  Aligned_cols=106  Identities=11%  Similarity=0.100  Sum_probs=73.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC--cceeeEEEEeC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTR  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~  187 (431)
                      .+|.+..+.+.|..+.||++...      ++..+++|+.....      ...+..|+.+++.+.+.+  +.+++++....
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCCceEecccCCCCceEEEEecC------CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            35666555556777999998642      45679999876431      134677999999885444  56688888888


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG  235 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  235 (431)
                      +..|+||||++|.+|.  .   ....   ...++.+++..|..||+..
T Consensus        88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~  127 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLD  127 (264)
T ss_dssp             SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSC
T ss_pred             CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCC
Confidence            8899999999998883  1   1122   2356677777777777643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=9e-10  Score=107.33  Aligned_cols=132  Identities=13%  Similarity=0.247  Sum_probs=97.8

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEee--hhhhhhhhHHHHHHHHHHHHHhcC--CCCcceeeEEEEe
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQT  186 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~  186 (431)
                      ....++.|+.|.++.||++..       .+..+++|+..  .....  .....+.+|..+|+.+.  +..+.+++.++.+
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~-------~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~  109 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVT-------PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCED  109 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEEC-------SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECC
T ss_pred             CCceEEEcCCcccceEEEEEE-------CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCC
Confidence            344578899999999999874       34578899876  43211  11245778999999997  4557888888877


Q ss_pred             C---CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------
Q 014087          187 R---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------  233 (431)
Q Consensus       187 ~---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------  233 (431)
                      .   +..|+||||++|..+.+..  ...+++.+...++.+++..|..||+                              
T Consensus       110 ~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          110 ESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             TTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             CCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence            6   4589999999998774311  1346788889999999999999997                              


Q ss_pred             ----------------------------CCceeccCCCCceEeCCCCC
Q 014087          234 ----------------------------CGIVHRDLKPENILMDSDGH  253 (431)
Q Consensus       234 ----------------------------~~iiHrDlKp~NILl~~~g~  253 (431)
                                                  .+++|+|+++.|||++.++.
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~  235 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP  235 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC
Confidence                                        36899999999999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.92  E-value=2.2e-09  Score=102.16  Aligned_cols=174  Identities=14%  Similarity=0.217  Sum_probs=113.6

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCC--cceeeEEEEeCC---
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPF--IVQLRYSFQTRS---  188 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~~---  188 (431)
                      ++.++.|....||++.          ..+++|+....     .....+.+|..+|+.+. +..  +.+.+.......   
T Consensus        25 i~~~~~G~~n~v~~v~----------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~   89 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ   89 (304)
T ss_dssp             CCEEEECSSEEEEEST----------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred             eEecCCCCcceEEEEC----------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence            4569999999999752          34889986533     23456888999998883 333  334444433333   


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-----------------------------------  233 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-----------------------------------  233 (431)
                      ..|+|||+++|..|.....  ..++..+...++.|++..|..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            3589999999998865433  246788888888999998888886                                   


Q ss_pred             -----------------------CCceeccCCCCceEeCCC-CCccCCCCCcccccCCC--------CC---Cchhhhcc
Q 014087          234 -----------------------CGIVHRDLKPENILMDSD-GHEIDESSRSNSMCGTT--------EY---MAPEILLS  278 (431)
Q Consensus       234 -----------------------~~iiHrDlKp~NILl~~~-g~~~~~~~~~~~~~Gt~--------~y---~aPE~~~~  278 (431)
                                             ..++|+|++|.||+++.+ +.............|.+        .+   ..|+....
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                   137999999999999985 33211111111111221        11   34443321


Q ss_pred             --CCCCC------------cchhHhHHHHHHHHHhCCCCCC
Q 014087          279 --KGHNK------------DADWWSVGILLYEMLTGQPPFT  305 (431)
Q Consensus       279 --~~~~~------------~~DvwslGvil~elltg~~Pf~  305 (431)
                        ..|..            -.+.|++|.++|.+.+|..+|.
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence              11111            1589999999999999988873

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=7.1e-06  Score=77.87  Aligned_cols=103  Identities=14%  Similarity=0.162  Sum_probs=67.9

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC---CcceeeEEEE-eCCE
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQ-TRSK  189 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~  189 (431)
                      -++.++.|....||++          ++.+++|+-..     ......+..|..+|+.+.+.   .|.+.+.+.. ..+.
T Consensus        23 ~v~~l~~G~~n~v~~v----------g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----------NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             CEEEEEECSSEEEEEE----------TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeeecCCCcceeEEEE----------CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            3566889999999986          23488888532     22345688999999999642   2455666664 4556


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK  233 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  233 (431)
                      .|+|||+++|..|.....  ..++..+...++.++...|..||+
T Consensus        88 ~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             EEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhc
Confidence            789999999988865321  224555555555555555555553

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.13  E-value=4.5e-05  Score=70.49  Aligned_cols=80  Identities=16%  Similarity=0.130  Sum_probs=57.9

Q ss_pred             eecccCce-EEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCEEEEEE
Q 014087          117 VVGQGAFG-KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL  194 (431)
Q Consensus       117 ~LG~G~fg-~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~  194 (431)
                      .+..|..| .||+.....     .+..+.+|+-....      ...+.+|..+|+.+. +--|.++++++.+.+..|+||
T Consensus        31 ~~~~G~S~~~v~rl~~~~-----~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP-----NAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             EEECSSSSCEEEEEECCT-----TCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             EccCCCcCCeEEEEEecC-----CCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            34445554 689877543     56679999875432      345778999998884 333667888899999999999


Q ss_pred             eccCCCChHHHHH
Q 014087          195 DFINGGHLFFHLY  207 (431)
Q Consensus       195 E~~~gg~L~~~l~  207 (431)
                      |+++|.++.+...
T Consensus       100 e~l~G~~~~~~~~  112 (272)
T 4gkh_A          100 TAIPGKTAFQVLE  112 (272)
T ss_dssp             ECCCSEEHHHHHH
T ss_pred             EeeCCcccccccc
Confidence            9999988765543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.91  E-value=2.2e-05  Score=77.22  Aligned_cols=81  Identities=15%  Similarity=0.219  Sum_probs=50.7

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-hh---hhHHHHHHHHHHHHHhcCC--CCc-ceeeEEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IK---KNHVDYMKAERDILTKVTH--PFI-VQLRYSFQ  185 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-~~---~~~~~~~~~E~~il~~l~h--pnI-v~l~~~~~  185 (431)
                      ...+.||.|.++.||++....     .++.++||....... ..   ....+++..|.++|+.+..  +.+ .+++.+  
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~~-----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--  105 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--  105 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred             eEEEECCCCceEEEEEEEECC-----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence            346789999999999997543     456799998653211 00   1123456778899887742  433 345543  


Q ss_pred             eCCEEEEEEeccCCC
Q 014087          186 TRSKLYLILDFINGG  200 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg  200 (431)
                      +.+..++|||++.|.
T Consensus       106 d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             ETTTTEEEECCCTTS
T ss_pred             cCCccEEEEEeCCCc
Confidence            445568999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.48  E-value=0.0012  Score=62.84  Aligned_cols=75  Identities=16%  Similarity=0.204  Sum_probs=42.9

Q ss_pred             EEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----CCCcceee-E--EEE
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR-Y--SFQ  185 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~-~--~~~  185 (431)
                      -++.|+.|..+.||++...       +..+++|+.....       ..+..|..+++.+.     .|.++... +  +..
T Consensus        36 ~~~~l~gG~~n~~~~v~~~-------~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~  101 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD-------SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK  101 (346)
T ss_dssp             EEEECC----CEEEEEEET-------TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE
T ss_pred             EeeeccccccCcEEEEEeC-------CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE
Confidence            4556777788999998753       2348999887521       22334555555442     34444310 0  224


Q ss_pred             eCCEEEEEEeccCCCCh
Q 014087          186 TRSKLYLILDFINGGHL  202 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L  202 (431)
                      ..+..++||||++|..+
T Consensus       102 ~~~~~~~l~~~i~G~~~  118 (346)
T 2q83_A          102 HGSFLFVVYDWIEGRPF  118 (346)
T ss_dssp             ETTEEEEEEECCCCBCC
T ss_pred             ECCEEEEEEEeecCccC
Confidence            57788999999998654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.47  E-value=0.00029  Score=67.93  Aligned_cols=91  Identities=11%  Similarity=0.135  Sum_probs=56.2

Q ss_pred             ceEEeee-cccCceEEEEEEEcCCCCCC-CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-C--CCcceeeEEEEe
Q 014087          112 FEIFRVV-GQGAFGKVFQVKKKGVDDGD-SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H--PFIVQLRYSFQT  186 (431)
Q Consensus       112 y~~~~~L-G~G~fg~Vy~~~~~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~  186 (431)
                      ...++.| +.|....+|++......++. .++.+++|+..............+.+|..+|+.+. +  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3456778 89999999988753000000 15678999875433000000123667888888774 2  346677777665


Q ss_pred             C---CEEEEEEeccCCCCh
Q 014087          187 R---SKLYLILDFINGGHL  202 (431)
Q Consensus       187 ~---~~~~lv~E~~~gg~L  202 (431)
                      .   +..|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            5   357899999998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.39  E-value=0.001  Score=59.00  Aligned_cols=122  Identities=16%  Similarity=0.056  Sum_probs=79.4

Q ss_pred             CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCCCCcccccCCCCCCchhhhc
Q 014087          200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDESSRSNSMCGTTEYMAPEILL  277 (431)
Q Consensus       200 g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~~~~~~~~Gt~~y~aPE~~~  277 (431)
                      -+|.+.|... .+++|++++.++.|.+.+|.-+-. +.-..+=+-|..|+|..+|.+........  .....+.+||...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s~--~~~~~~~~pe~~~  110 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADD--AGEPPPVAGKLGY  110 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC--------------CCSS
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccccccc--ccccCCCChhhcc
Confidence            3788888754 689999999999999999877622 22123334568999999998654432221  2344577888763


Q ss_pred             cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 014087          278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK  341 (431)
Q Consensus       278 ~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  341 (431)
                       ...+.+.=|||||++||..+-=..|                 ...+..+|+++.+||..|..-
T Consensus       111 -~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          111 -SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             -ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence             3445667799999999999862221                 112346899999999999765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.30  E-value=0.0011  Score=61.83  Aligned_cols=80  Identities=11%  Similarity=0.057  Sum_probs=55.6

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC---CCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~  186 (431)
                      .+..-++.+|.|..+.||+++..      +|+.|.+|+......   .....+..|...|+.+.-   --+.+.+++  +
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~------DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA------DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET------TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC------CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence            35677889999999999999864      578899998654321   122357789999998842   124445443  2


Q ss_pred             CCEEEEEEeccCCCCh
Q 014087          187 RSKLYLILDFINGGHL  202 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L  202 (431)
                      .  -++||||+.++..
T Consensus        84 ~--~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 D--RTLAMEWVDERPP   97 (288)
T ss_dssp             T--TEEEEECCCCCCC
T ss_pred             C--ceEEEEeecccCC
Confidence            2  3789999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.98  E-value=0.0027  Score=62.63  Aligned_cols=78  Identities=17%  Similarity=0.183  Sum_probs=44.5

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhh-hhhh-----HHHHHHHHHHHHH-hcCCCCcceeeEEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKN-----HVDYMKAERDILT-KVTHPFIVQLRYSFQ  185 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~-~~~~-----~~~~~~~E~~il~-~l~hpnIv~l~~~~~  185 (431)
                      .-++.||.|..+.||++..       .++.++||....... ....     ....+..|+..+. ......+.+++.+. 
T Consensus        37 ~~i~~l~~G~~n~vyrv~~-------~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~-  108 (420)
T 2pyw_A           37 LVIKEVGDGNLNFVFIVVG-------SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD-  108 (420)
T ss_dssp             CEEEECCCSSSCEEEEEEC-------SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE-
T ss_pred             eEEEEccCCCcEEEEEEEc-------CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC-
Confidence            3467899999999999852       456799994321100 0000     1122333332222 22234566666654 


Q ss_pred             eCCEEEEEEecc-CC
Q 014087          186 TRSKLYLILDFI-NG  199 (431)
Q Consensus       186 ~~~~~~lv~E~~-~g  199 (431)
                       .+..++|||++ +|
T Consensus       109 -~~~~~lv~e~l~~g  122 (420)
T 2pyw_A          109 -RTMALIGMRYLEPP  122 (420)
T ss_dssp             -TTTTEEEECCCCTT
T ss_pred             -CCccEEEEeecCCc
Confidence             56779999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.74  E-value=0.012  Score=55.63  Aligned_cols=97  Identities=11%  Similarity=0.133  Sum_probs=74.4

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeEEEEeCC
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS  188 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~  188 (431)
                      ..-.+.|+.|....+|++..       .++.+++|+....      ....+..|...|+.+.   ...+.+.+.+....+
T Consensus        38 i~~~~~l~gG~~n~~y~v~~-------~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           38 IKHKEKLYSGEMNEIWLIND-------EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             CCEEEEECCSSSSEEEEEES-------SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             eeeeEEeCCccceeeeEEEE-------CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            44567899999999999863       3567889987643      2456788999998873   356788888888888


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG  235 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  235 (431)
                      ..|+||||++|..+.          .    ....++...|.-||+.+
T Consensus       105 ~~~lvme~l~G~~~~----------~----~~~~~lG~~LA~LH~~~  137 (312)
T 3jr1_A          105 HSFLLLEALNKSKNK----------Q----SSFTIFAEKIAQLHQIQ  137 (312)
T ss_dssp             EEEEEEECCCCCCCC----------T----THHHHHHHHHHHHHHCC
T ss_pred             ceEEEEEeccCCCCC----------c----hhHHHHHHHHHHHHcCC
Confidence            999999999998651          1    24567888899999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.50  E-value=0.0046  Score=58.37  Aligned_cols=81  Identities=10%  Similarity=0.206  Sum_probs=47.4

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----CCCcceee-E-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR-Y-  182 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~-~-  182 (431)
                      +...-++.|+.|....+|++...       +..+++|+.....  .   .+.+..|..+++.+.     -|.++... + 
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~-------~g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~   89 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGE   89 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred             CcceEeeccCCCcccceEEEEeC-------CccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCC
Confidence            44556778888999999998753       2358899887531  1   123456777777663     23333211 0 


Q ss_pred             -EEEeCCEEEEEEeccCCCCh
Q 014087          183 -SFQTRSKLYLILDFINGGHL  202 (431)
Q Consensus       183 -~~~~~~~~~lv~E~~~gg~L  202 (431)
                       +....+..++||+|++|..+
T Consensus        90 ~~~~~~g~~~~l~~~l~G~~~  110 (322)
T 2ppq_A           90 LLGELSGRPAALISFLEGMWL  110 (322)
T ss_dssp             SCEEETTEEEEEEECCCCBCC
T ss_pred             EEEEECCEEEEEEEeCCCcCC
Confidence             12335678999999998653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.32  E-value=0.012  Score=55.67  Aligned_cols=75  Identities=9%  Similarity=0.184  Sum_probs=46.9

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCC--CcceeeEE-----EEeCC
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYS-----FQTRS  188 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~-----~~~~~  188 (431)
                      ..|+ |....||++...      .|+.+++|+......    ....+..|..+++.+...  .+.+++..     ....+
T Consensus        32 ~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g  100 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG  100 (328)
T ss_dssp             EEEC-CSSSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred             Eeec-CcccceEEEEcC------CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence            4566 888899987542      355699999864321    123456688887776421  23333332     23356


Q ss_pred             EEEEEEeccCCCC
Q 014087          189 KLYLILDFINGGH  201 (431)
Q Consensus       189 ~~~lv~E~~~gg~  201 (431)
                      ..++|||+++|..
T Consensus       101 ~~~~l~~~i~G~~  113 (328)
T 1zyl_A          101 FYFAVFPSVGGRQ  113 (328)
T ss_dssp             EEEEEEECCCCEE
T ss_pred             EEEEEEEecCCCC
Confidence            7789999998854

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.26  E-value=0.016  Score=54.25  Aligned_cols=71  Identities=10%  Similarity=-0.020  Sum_probs=44.1

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCEEEEE
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLI  193 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv  193 (431)
                      ++.|+.|....+|++  .         .+++|+........    ....+|..+++.+...++ .++++.  +.+.-++|
T Consensus        23 i~~l~gG~tN~~~~~--~---------~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v   85 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G---------DLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMV   85 (301)
T ss_dssp             CEEEESCSSEEEEEE--T---------TEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEE
T ss_pred             eeEcCCcccccccee--e---------eEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEE
Confidence            788999999999998  2         28899876532110    112457777777642223 355543  34345789


Q ss_pred             Eecc-CCCCh
Q 014087          194 LDFI-NGGHL  202 (431)
Q Consensus       194 ~E~~-~gg~L  202 (431)
                      +||+ +|..|
T Consensus        86 ~e~i~~g~~l   95 (301)
T 3dxq_A           86 TRYIAGAQTM   95 (301)
T ss_dssp             EECCTTCEEC
T ss_pred             EeecCCCccC
Confidence            9999 66544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.01  E-value=0.013  Score=55.65  Aligned_cols=77  Identities=5%  Similarity=-0.031  Sum_probs=38.1

Q ss_pred             EeeecccCceE-EEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--CCcceeeEEEEeCCEEE
Q 014087          115 FRVVGQGAFGK-VFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLY  191 (431)
Q Consensus       115 ~~~LG~G~fg~-Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~  191 (431)
                      ++.|+.|+... +|++...      .++.+++|.......      ..+..|+.+++.+..  -.+.+++.+..+.+  +
T Consensus        23 ~~~l~gg~s~~~~~r~~~~------~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~   88 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSP------TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--L   88 (333)
T ss_dssp             ECC--------CCEEEECT------TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--E
T ss_pred             eeECCCCCCCceEEEEEcC------CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--E
Confidence            45666665554 6676521      245677776543210      123457777776632  23455665532333  7


Q ss_pred             EEEeccCCCChHHH
Q 014087          192 LILDFINGGHLFFH  205 (431)
Q Consensus       192 lv~E~~~gg~L~~~  205 (431)
                      +|||++.+..+.+.
T Consensus        89 ll~e~l~~~~l~~~  102 (333)
T 3csv_A           89 LLIEDLGDALFTEV  102 (333)
T ss_dssp             EEECCCCSCBHHHH
T ss_pred             EEEeeCCCcchHHH
Confidence            89999977666543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.34  E-value=0.029  Score=54.07  Aligned_cols=80  Identities=14%  Similarity=0.123  Sum_probs=45.0

Q ss_pred             EEeeecccCceEEEEEEEcCCC---CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC-cceeeEEEEeCCE
Q 014087          114 IFRVVGQGAFGKVFQVKKKGVD---DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK  189 (431)
Q Consensus       114 ~~~~LG~G~fg~Vy~~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  189 (431)
                      .++.|+.|....+|++......   ....++.+++|+......   . ......|..+++.+...+ +.++++.+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            4567888888999998764200   000125789998765321   1 111356888888774333 44666554  22 


Q ss_pred             EEEEEeccCCCC
Q 014087          190 LYLILDFINGGH  201 (431)
Q Consensus       190 ~~lv~E~~~gg~  201 (431)
                       ++||||++|..
T Consensus       110 -~~v~e~i~G~~  120 (369)
T 3c5i_A          110 -GRIEEWLYGDP  120 (369)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -cEEEEEecCCc
Confidence             68999999854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.30  E-value=0.041  Score=54.40  Aligned_cols=80  Identities=14%  Similarity=0.086  Sum_probs=50.2

Q ss_pred             eEEeeecccCceEEEEEEEcCCC--CCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSK  189 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~  189 (431)
                      .-++.|+.|....||++......  ....++.+.+|+.....     ..+.+..|..+++.+...++ .++++.+.+   
T Consensus        76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence            34677888999999999864210  00124679999884311     11234468888888743333 566665532   


Q ss_pred             EEEEEeccCCCC
Q 014087          190 LYLILDFINGGH  201 (431)
Q Consensus       190 ~~lv~E~~~gg~  201 (431)
                       .+|+||++|..
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             28999998744

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.62  E-value=0.046  Score=53.07  Aligned_cols=84  Identities=14%  Similarity=0.126  Sum_probs=46.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCC--CCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (431)
                      +.++ ++.|..|-...+|++.....  .....++.+.+|+.....    .....+.+|..+++.+. +.-..++++.+.+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            4444 45677788889999875320  001134679999864321    12334557999998874 3333566666543


Q ss_pred             CCEEEEEEeccCCCCh
Q 014087          187 RSKLYLILDFINGGHL  202 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L  202 (431)
                          .+||||++|..|
T Consensus       126 ----g~v~e~i~G~~l  137 (379)
T 3feg_A          126 ----GRLEQYIPSRPL  137 (379)
T ss_dssp             ----EEEEECCSEEEC
T ss_pred             ----ccEEEEecCccC
Confidence                299999998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.61  E-value=0.13  Score=48.92  Aligned_cols=72  Identities=13%  Similarity=0.053  Sum_probs=44.2

Q ss_pred             Eeeec--ccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC---CCCcceeeEE------
Q 014087          115 FRVVG--QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYS------  183 (431)
Q Consensus       115 ~~~LG--~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~------  183 (431)
                      ++.|.  .|....||++...      .+ .+++|+......         ..|..+++.+.   -|++.+.+..      
T Consensus        26 ~~~l~~G~g~~N~vy~v~~~------~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~   89 (339)
T 3i1a_A           26 AQFIQGGADTNAFAYQADSE------SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLF   89 (339)
T ss_dssp             EEEETTTSCSSCEEEEEECS------SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSS
T ss_pred             eEEeeccCccccceEEEEeC------CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEE
Confidence            44453  3446899998743      34 799998765431         24566665552   2224444322      


Q ss_pred             EEeCCEEEEEEeccCCCCh
Q 014087          184 FQTRSKLYLILDFINGGHL  202 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L  202 (431)
                      ....+..++||+|++|..+
T Consensus        90 ~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           90 QQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             EECSSEEEEEEECCCCCBT
T ss_pred             EEECCEEEEEEeccCCCcC
Confidence            2346788999999998765

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.75  E-value=0.067  Score=53.38  Aligned_cols=64  Identities=8%  Similarity=0.053  Sum_probs=17.7

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEE------EEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM------KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~av------K~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+.+.||   ||.||++.++.     ....||+      |..+.... ..+....+.+|..+++.++|||+++.+.+-.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~-----~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK-----KHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC--------------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccc-----cCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence            4556676   99999998864     3345777      65544332 3334456777889999999999999987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=82.64  E-value=4.5  Score=39.96  Aligned_cols=102  Identities=17%  Similarity=0.230  Sum_probs=63.4

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCc-ceeeEEEEeCCEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLY  191 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~  191 (431)
                      .-++.|+.|-...+|++....     .+..+++|+.....   ...++ ..+|..+|+.+...++ .++++.+.  +  .
T Consensus       111 ~~i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G  177 (458)
T 2qg7_A          111 LEFQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--G  177 (458)
T ss_dssp             EEEEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--E
T ss_pred             eEEEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--e
Confidence            346778889999999998642     34678899875432   11111 2468999998865444 56777662  2  2


Q ss_pred             EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014087          192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG  235 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  235 (431)
                      +||||++|..|..     ..+..   ..++.+|+..|.-||...
T Consensus       178 ~v~e~I~G~~l~~-----~~l~~---~~~~~~ia~~La~LH~~~  213 (458)
T 2qg7_A          178 RIEEFMDGYALSR-----EDIKN---PKFQKLIAKNLKLLHDIK  213 (458)
T ss_dssp             EEEECCCSEECCT-----TTTTS---HHHHHHHHHHHHHHHTCC
T ss_pred             EEEEeeCCccCCh-----hhcCC---HHHHHHHHHHHHHHhcCC
Confidence            5999999866521     11111   235677888888899654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	431
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-95
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-93
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-89
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-88
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-85
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-80
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-77
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-71
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-71
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-71
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-70
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-70
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-70
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-70
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-69
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-68
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-68
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-65
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-65
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-64
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-63
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-62
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-59
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-52
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-52
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-50
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-49
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-45
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-40
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-14

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  286 bits (732), Expect = 9e-95
 Identities = 125/340 (36%), Positives = 199/340 (58%), Gaps = 27/340 (7%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           K+   DF+  +++G+G FGKV  V++K      +   YAMK++RK+ II K+ V +   E
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             +L    HPF+  L+Y+FQT  +L  ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPE 274
           SA+ +LH   +V+RD+K EN+++D DGH            I + +   + CGT EY+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 275 ILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL 334
           +L    + +  DWW +G+++YEM+ G+ PF + + ++L + I+ E+++ P  L+ EA SL
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFD 394
           L GLL KDP +RLG GP     +  H++F SINW+ +  +++ P FKP V+ +     FD
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295

Query: 395 KCWTTMPADDSP-----------APTPTAGEHFKGYTYVA 423
             +T      +P                  E F+ + Y+A
Sbjct: 296 DEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  280 bits (718), Expect = 9e-93
 Identities = 114/327 (34%), Positives = 180/327 (55%), Gaps = 25/327 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + +++G+G+FGKVF  + K      ++  +A+K ++KD ++  + V+    E+ +L+
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57

Query: 171 KV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
               HPF+  +  +FQT+  L+ +++++NGG L +H+     F   +A FY AEI+  + 
Sbjct: 58  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGHE-----------IDESSRSNSMCGTTEYMAPEILLS 278
            LH  GIV+RDLK +NIL+D DGH            +   +++N+ CGT +Y+APEILL 
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL 338
           + +N   DWWS G+LLYEML GQ PF   + ++L   I  +    P +L  EA  LL  L
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237

Query: 339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWT 398
             ++P KRLG        I+ H  FR INW+ LE +E+ P F+P V      +NFDK + 
Sbjct: 238 FVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL 293

Query: 399 TMPADDSPAPTPTAG----EHFKGYTY 421
                 S A            F+ +++
Sbjct: 294 NEKPRLSFADRALINSMDQNMFRNFSF 320

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  271 bits (695), Expect = 2e-89
 Identities = 110/318 (34%), Positives = 188/318 (59%), Gaps = 15/318 (4%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF+I R +G G+FG+V  ++ +      +   YAMKV++K+ +++   V++   ER +L+
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            VTHPFI+++  +FQ   ++++I+D+I GG LF  L +   F    A+FY AE+  A+ +
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 231 LHKCGIVHRDLKPENILMDSDGH--------EIDESSRSNSMCGTTEYMAPEILLSKGHN 282
           LH   I++RDLKPENIL+D +GH               + ++CGT +Y+APE++ +K +N
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 283 KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHKD 342
           K  DWWS GIL+YEML G  PF  +N  K  ++I+N +++ PPF   +   LL  L+ +D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

Query: 343 PSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDV-SGKDCIANFDKCWTTMP 401
            S+RLG+   G + +K+H WF+ + W+ L +R ++  ++P +  G+   + FDK +    
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEED 298

Query: 402 ADDSPAPTPTAGEHFKGY 419
            +          + F+ +
Sbjct: 299 INYGVQGEDPYADLFRDF 316

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (687), Expect = 2e-88
 Identities = 104/285 (36%), Positives = 162/285 (56%), Gaps = 19/285 (6%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           RK  P DF+  +++G+G+F  V   ++       +   YA+K++ K  IIK+N V Y+  
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTR 57

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           ERD+++++ HPF V+L ++FQ   KLY  L +   G L  ++ + G F E   RFYTAEI
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTEYM 271
           VSA+ +LH  GI+HRDLKPENIL++ D H                + +R+NS  GT +Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEA 331
           +PE+L  K   K +D W++G ++Y+++ G PPF   N   + Q+II  +   P     +A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237

Query: 332 HSLLKGLLHKDPSKRLGSG-PGGVDAIKHHKWFRSINWKTLEARE 375
             L++ LL  D +KRLG     G   +K H +F S+ W+ L  + 
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  263 bits (674), Expect = 1e-85
 Identities = 109/342 (31%), Positives = 172/342 (50%), Gaps = 31/342 (9%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DF + R++G+G FG+V+  +K      D+  +YAMK + K  I  K        ER +L+
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 171 KVT---HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            V+    PFIV + Y+F T  KL  ILD +NGG L +HL + G+F E   RFY AEI+  
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGH---------EIDESSRSNSMCGTTEYMAPEILLS 278
           + H+H   +V+RDLKP NIL+D  GH               + ++  GT  YMAPE+L  
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 179

Query: 279 -KGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKVKLPPFLTSEAHSL 334
              ++  ADW+S+G +L+++L G  PF      ++ ++ +  +   V+LP   + E  SL
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC----- 389
           L+GLL +D ++RLG    G   +K   +FRS++W+ +  ++  P   P     +      
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 299

Query: 390 IANFDKCWTTMPADDSPAPTPTAGEHFKGYTYVAPNPWLSSV 431
           I +FD+  T               E ++ +       W   V
Sbjct: 300 IGSFDEEDTKGIKLLDSDQ-----ELYRNFPLTISERWQQEV 336

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  261 bits (668), Expect = 7e-85
 Identities = 119/346 (34%), Positives = 193/346 (55%), Gaps = 16/346 (4%)

Query: 82  SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
            S+   + + + +   + E  S+       F+  + +G G+FG+V  VK K     +S  
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGN 67

Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
            YAMK++ K  ++K   +++   E+ IL  V  PF+V+L +SF+  S LY++++++ GG 
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI------ 255
           +F HL R G F E  ARFY A+IV    +LH   +++RDLKPEN+L+D  G+        
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 256 --DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ 313
                 R+ ++CGT E +APEI+LSKG+NK  DWW++G+L+YEM  G PPF      ++ 
Sbjct: 188 AKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247

Query: 314 QRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEA 373
           ++I++ KV+ P   +S+   LL+ LL  D +KR G+   GV+ IK+HKWF + +W  +  
Sbjct: 248 EKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307

Query: 374 REMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGY 419
           R+++  F P   G    +NFD  +       S       G+ F  +
Sbjct: 308 RKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVS--INEKCGKEFTEF 350

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 5e-80
 Identities = 85/264 (32%), Positives = 140/264 (53%), Gaps = 19/264 (7%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFEI R +G+G FG V+  ++K      S  I A+KV+ K  + K      ++ E +I +
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
            + HP I++L   F   +++YLIL++   G ++  L +   F E +   Y  E+ +A+S+
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 231 LHKCGIVHRDLKPENILMDSDGH---------EIDESSRSNSMCGTTEYMAPEILLSKGH 281
            H   ++HRD+KPEN+L+ S G              SSR  ++CGT +Y+ PE++  + H
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLHK 341
           ++  D WS+G+L YE L G+PPF     Q+  +RI   +   P F+T  A  L+  LL  
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241

Query: 342 DPSKRLGSGPGGVDAIKHHKWFRS 365
           +PS+R       +  +  H W  +
Sbjct: 242 NPSQRP-----MLREVLEHPWITA 260

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (617), Expect = 1e-77
 Identities = 136/323 (42%), Positives = 202/323 (62%), Gaps = 24/323 (7%)

Query: 87  QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM 145
           Q+  ++HE   A L   +E+ +G  +FE+ +V+G GA+GKVF V+K  +   D+  +YAM
Sbjct: 1   QLLTVKHELRTANLTGHAEK-VGIENFELLKVLGTGAYGKVFLVRK--ISGHDTGKLYAM 57

Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
           KV++K TI++K    ++ + ER +L  +   PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 58  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117

Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------- 253
            HL ++  F E + + Y  EIV A+ HLHK GI++RD+K ENIL+DS+GH          
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177

Query: 254 --EIDESSRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHANR 309
               DE+ R+   CGT EYMAP+I+     GH+K  DWWS+G+L+YE+LTG  PFT    
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 310 Q----KLQQRIINEKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
           +    ++ +RI+  +   P  +++ A  L++ LL KDP KRLG GP   D IK H +F+ 
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

Query: 366 INWKTLEAREMQPKFKPDVSGKD 388
           INW  L A+++   FKP +  + 
Sbjct: 298 INWDDLAAKKVPAPFKPVIRDEL 320

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  227 bits (579), Expect = 1e-71
 Identities = 65/289 (22%), Positives = 126/289 (43%), Gaps = 30/289 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++I   +G GAFG V +V ++      +   +A K +       ++  + ++ E   ++
Sbjct: 27  HYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
            + HP +V L  +F+  +++ +I +F++GG LF  +  +     ED+A  Y  ++   + 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 230 HLHKCGIVHRDLKPENILMDSDG------------HEIDESSRSNSMCGTTEYMAPEILL 277
           H+H+   VH DLKPENI+  +                +D         GT E+ APE+  
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 333
            K      D WSVG+L Y +L+G  PF   N  +  + + +    +       ++ +   
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKP 382
            ++ LL  DP+ R+      +     H W    N    +++    ++  
Sbjct: 259 FIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 7e-71
 Identities = 66/316 (20%), Positives = 123/316 (38%), Gaps = 66/316 (20%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           DFE    +G G  G VF+V  K      S  + A K++  +  IK    + +  E  +L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +   P+IV    +F +  ++ + ++ ++GG L   L + G   E      +  ++  +++
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 231 LH-KCGIVHRDLKPENILMDSDGH---------EIDESSRSNSMCGTTEYMAPEILLSKG 280
           L  K  I+HRD+KP NIL++S G               S +NS  GT  YM+PE L    
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 179

Query: 281 HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF-------------- 326
           ++  +D WS+G+ L EM  G+ P    + ++L+     +                     
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 327 ------------------------------LTSEAHSLLKGLLHKDPSKRLGSGPGGVDA 356
                                          + E    +   L K+P++R       +  
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQ 294

Query: 357 IKHHKWFRSINWKTLE 372
           +  H + +  + + ++
Sbjct: 295 LMVHAFIKRSDAEEVD 310

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 9e-71
 Identities = 79/299 (26%), Positives = 133/299 (44%), Gaps = 36/299 (12%)

Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
            R + P D +EI   +G GAFGKV++ + K     ++  + A KV+       +  ++  
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTK---SEEELEDY 56

Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
             E DIL    HP IV+L  +F   + L+++++F  GG +   +   +    E Q +   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
            + + A+++LH   I+HRDLK  NIL   DG                  R +S  GT  +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 271 MAPEILLS-----KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK---VK 322
           MAPE+++      + ++  AD WS+GI L EM   +PP    N  ++  +I   +   + 
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236

Query: 323 LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
            P   +S     LK  L K+   R          +  H +    + K +  RE+  + K
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARW-----TTSQLLQHPFVTVDSNKPI--RELIAEAK 288

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  224 bits (571), Expect = 2e-70
 Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 31/289 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             ++I   +G GAFG V +  +K      +  ++  K +     + K  V   K E  I+
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYPLDKYTV---KNEISIM 80

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAV 228
            ++ HP ++ L  +F+ + ++ LIL+F++GG LF  +  +     E +   Y  +    +
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEIL 276
            H+H+  IVH D+KPENI+ ++               +++          T E+ APEI+
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 277 LSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH 332
             +      D W++G+L Y +L+G  PF   +  +  Q +     +        ++ EA 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFK 381
             +K LL K+P KRL      V     H W +  +   L +R    ++ 
Sbjct: 261 DFIKNLLQKEPRKRL-----TVHDALEHPWLKG-DHSNLTSRIPSSRYN 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 5e-70
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 29/272 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D+++ + +G+GA+G+V     +      ++   A+K++     +     + +K E  I 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDC--PENIKKEICIN 57

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
             + H  +V+     +  +  YL L++ +GG LF  +       E  A+ +  ++++ V 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTEYMAPEIL 276
           +LH  GI HRD+KPEN+L+D   +               +     N MCGT  Y+APE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 277 LSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF---LTSEAH 332
             +  H +  D WS GI+L  ML G+ P+   +    +     EK         + S   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
           +LL  +L ++PS R+      +  IK  +W+ 
Sbjct: 238 ALLHKILVENPSARI-----TIPDIKKDRWYN 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 7e-70
 Identities = 72/293 (24%), Positives = 135/293 (46%), Gaps = 32/293 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERD 167
            ++    +G G F  V + ++K      +   YA K ++K            + ++ E  
Sbjct: 11  YYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           IL ++ HP ++ L   ++ ++ + LIL+ + GG LF  L  +    E++A  +  +I++ 
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 228 VSHLHKCGIVHRDLKPENILMDSDG--------------HEIDESSRSNSMCGTTEYMAP 273
           V +LH   I H DLKPENI++                  H+ID  +   ++ GT E++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 274 EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTS 329
           EI+  +    +AD WS+G++ Y +L+G  PF    +Q+    +     +         ++
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW-KTLEAREMQPKFK 381
            A   ++ LL KDP KR+      +     H W +  +  + L +    P+F+
Sbjct: 246 LAKDFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 8e-70
 Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 32/288 (11%)

Query: 95  NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
           +D E+  +    +  GD    +  F  +GQGA G V+           +    A++ M  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55

Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
               KK  +     E  ++ +  +P IV    S+    +L+++++++ GG L   +    
Sbjct: 56  QQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112

Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESS 259
              E Q      E + A+  LH   ++HRD+K +NIL+  DG               E S
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 260 RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE 319
           + ++M GT  +MAPE++  K +    D WS+GI+  EM+ G+PP+ + N  +    I   
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 320 ---KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
              +++ P  L++     L   L  D  KR          +  H++ +
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRG-----SAKELLQHQFLK 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  219 bits (558), Expect = 5e-69
 Identities = 83/293 (28%), Positives = 137/293 (46%), Gaps = 30/293 (10%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            ++   V+G GAF +V   + K      +  + A+K + K  +  +     M+ E  +L 
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           K+ HP IV L   +++   LYLI+  ++GG LF  +  +G + E  A     +++ AV +
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 231 LHKCGIVHRDLKPENILMDSDGHE-------------IDESSRSNSMCGTTEYMAPEILL 277
           LH  GIVHRDLKPEN+L  S   +              D  S  ++ CGT  Y+APE+L 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 333
            K ++K  D WS+G++ Y +L G PPF   N  KL ++I+  + +        ++  A  
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAR-EMQPKFKPDVS 385
            ++ L+ KDP KR        +    H W              +  + K + +
Sbjct: 243 FIRHLMEKDPEKRF-----TCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFA 290

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  216 bits (551), Expect = 3e-68
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 37/281 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
           ++E   ++G+G    V +   K      +   YA+K++        +  +  +       
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 165 ERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
           E DIL KV  HP I+QL+ +++T +  +L+ D +  G LF +L  +    E + R     
Sbjct: 59  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMAP 273
           ++  +  LHK  IVHRDLKPENIL+D D +          ++D   +   +CGT  Y+AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 274 EILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP--- 324
           EI+         G+ K+ D WS G+++Y +L G PPF H  +  + + I++   +     
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238

Query: 325 -PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
               +     L+   L   P KR        +    H +F+
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQ 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  216 bits (551), Expect = 7e-68
 Identities = 56/265 (21%), Positives = 103/265 (38%), Gaps = 22/265 (8%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           F   R +G G+FG V+  +        +  + A+K M             +  E   L K
Sbjct: 17  FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
           + HP  +Q R  +      +L++++  G         +   +E +    T   +  +++L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 232 HKCGIVHRDLKPENILMDSDGHE--ID-----ESSRSNSMCGTTEYMAPEILLS---KGH 281
           H   ++HRD+K  NIL+   G     D       + +NS  GT  +MAPE++L+     +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191

Query: 282 NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLL 339
           +   D WS+GI   E+   +PP  + N       I   +         +    + +   L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFR 364
            K P  R        + +  H++  
Sbjct: 252 QKIPQDRP-----TSEVLLKHRFVL 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 5e-65
 Identities = 60/275 (21%), Positives = 127/275 (46%), Gaps = 34/275 (12%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+E+   +G G++G+  ++++K         I   K +   ++ +      + +E ++L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAE-KQMLVSEVNLLR 58

Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEI 224
           ++ HP IV+       +T + LY+++++  GG L   + +    +    E+       ++
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 225 VSAVSHLHKCG-----IVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTT 268
             A+   H+       ++HRDLKP N+ +D   +              ++S + +  GT 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPFL 327
            YM+PE +    +N+ +D WS+G LLYE+    PPFT  ++++L  +I   K  ++P   
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 362
           + E + ++  +L+     R       V+ I  +  
Sbjct: 239 SDELNEIITRMLNLKDYHRP-----SVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 8e-65
 Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 39/300 (13%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            + I   +G+G FG V +  +       S   Y  K ++     K      +K E  IL 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKV----KGTDQVLVKKEISILN 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVS 229
              H  I+ L  SF++  +L +I +FI+G  +F  +        E +   Y  ++  A+ 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAPEILL 277
            LH   I H D++PENI+  +               ++        +    EY APE+  
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 278 SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAHS 333
               +   D WS+G L+Y +L+G  PF     Q++ + I+N +          ++ EA  
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 334 LLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR----SINWKTLEA----REMQPKFKPDVS 385
            +  LL K+   R+            H W +     ++ K +      R      K D++
Sbjct: 237 FVDRLLVKERKSRM-----TASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLN 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 4e-64
 Identities = 54/272 (19%), Positives = 118/272 (43%), Gaps = 31/272 (11%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
            +    +G+G+F  V++         ++    A   ++   + K +     K E ++L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKG 64

Query: 172 VTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
           + HP IV+   S+++  K    + L+ + +  G L  +L R  + +    R +  +I+  
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 228 VSHLHKCG--IVHRDLKPENILMDSDGHEI----------DESSRSNSMCGTTEYMAPEI 275
           +  LH     I+HRDLK +NI +      +            +S + ++ GT E+MAPE+
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM 184

Query: 276 LLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK---LPPFLTSEAH 332
              + +++  D ++ G+ + EM T + P++         R +   VK          E  
Sbjct: 185 Y-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
            +++G + ++  +R       +  + +H +F+
Sbjct: 244 EIIEGCIRQNKDERY-----SIKDLLNHAFFQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  203 bits (518), Expect = 2e-63
 Identities = 56/262 (21%), Positives = 119/262 (45%), Gaps = 27/262 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E+  ++G G   +V   +             A+KV+R D     +     + E    
Sbjct: 7   DRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 170 TKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + HP IV +  + +  +      Y+++++++G  L   ++ +G     +A    A+  
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH--------------EIDESSRSNSMCGTTEYM 271
            A++  H+ GI+HRD+KP NI++ +                   +  +++ ++ GT +Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFL 327
           +PE       +  +D +S+G +LYE+LTG+PPFT  +   +  + + E    P      L
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 328 TSEAHSLLKGLLHKDPSKRLGS 349
           +++  +++   L K+P  R  +
Sbjct: 242 SADLDAVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-62
 Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 33/274 (12%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK---AER 166
             +++  ++G G FG V+   +        +   A+K + KD I     +        E 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58

Query: 167 DILTKVT--HPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAE 223
            +L KV+     +++L   F+      LIL+       LF  +  +G  +E+ AR +  +
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHEI----------DESSRSNSMCGTTEYMAP 273
           ++ AV H H CG++HRD+K ENIL+D +  E+           + +      GT  Y  P
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPP 178

Query: 274 EILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 332
           E +   + H + A  WS+GILLY+M+ G  PF H         II  +V     ++SE  
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232

Query: 333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI 366
            L++  L   PS R        + I++H W + +
Sbjct: 233 HLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 2e-62
 Identities = 58/263 (22%), Positives = 106/263 (40%), Gaps = 33/263 (12%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I  G   + + +G G+FG V++ K  G          A+K++       +  +   K E 
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQ-QLQAFKNEV 55

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            +L K  H  I+     + T  +L ++  +  G  L+ HL+  +  F   +      +  
Sbjct: 56  GVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTEYMA 272
             + +LH   I+HRDLK  NI +  D                   S +   + G+  +MA
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 273 PEILLSKGHNK---DADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPF--- 326
           PE++  +  N     +D ++ GI+LYE++TGQ P+++ N +     ++      P     
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 327 ---LTSEAHSLLKGLLHKDPSKR 346
                     L+   L K   +R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDER 257

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 5e-62
 Identities = 57/253 (22%), Positives = 112/253 (44%), Gaps = 25/253 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   + ++ + +G+G FG V     +G          A+K ++ D   +        AE 
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA-----FLAEA 51

Query: 167 DILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAE 223
            ++T++ H  +VQL     + +  LY++ +++  G L  +L  +G  +   D    ++ +
Sbjct: 52  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH--------EIDESSRSNSMCGTTEYMAPEI 275
           +  A+ +L     VHRDL   N+L+  D            + SS  ++     ++ APE 
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 171

Query: 276 LLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAHS 333
           L  K  +  +D WS GILL+E+ + G+ P+     + +  R+    K+  P       + 
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231

Query: 334 LLKGLLHKDPSKR 346
           ++K   H D + R
Sbjct: 232 VMKNCWHLDAAMR 244

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 52/258 (20%), Positives = 98/258 (37%), Gaps = 21/258 (8%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           IG  D  +   +G G+FG V + +             A+K ++ D + +   +D    E 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
           + +  + H  +++L Y       + ++ +    G L   L   QG F       Y  ++ 
Sbjct: 63  NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH--------------EIDESSRSNSMCGTTEYM 271
             + +L     +HRDL   N+L+ +                   D             + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLT 328
           APE L ++  +  +D W  G+ L+EM T GQ P+   N  ++  +I  E  +L  P    
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 329 SEAHSLLKGLLHKDPSKR 346
            + ++++       P  R
Sbjct: 242 QDIYNVMVQCWAHKPEDR 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-59
 Identities = 46/269 (17%), Positives = 105/269 (39%), Gaps = 23/269 (8%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
           + +G G FG V +   +           A+K+++ +        D + AE +++ ++ +P
Sbjct: 13  KELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNP 68

Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
           +IV++           L+++    G L  +L +    ++        ++   + +L +  
Sbjct: 69  YIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 236 IVHRDLKPENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPEILLSKGH 281
            VHRDL   N+L+ +  +              + +            ++ APE +     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 282 NKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLL 339
           +  +D WS G+L++E  + GQ P+      ++   +   E++  P     E + L+    
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247

Query: 340 HKDPSKRLGSGPGGVDAIKHHKWFRSINW 368
             D   R G     V+    + ++  +N 
Sbjct: 248 TYDVENRPGF--AAVELRLRNYYYDVVNE 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-58
 Identities = 69/284 (24%), Positives = 131/284 (46%), Gaps = 47/284 (16%)

Query: 110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
            D+++  +V+G G  GKV Q+  K      +   +A+K+++     ++        E ++
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDCPKARR--------EVEL 57

Query: 169 LTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
             + +  P IV++   ++     R  L ++++ ++GG LF  +  +G   F E +A    
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTT 268
             I  A+ +LH   I HRD+KPEN+L  S                E    +   + C T 
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177

Query: 269 EYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLP 324
            Y+APE+L  + ++K  D WS+G+++Y +L G PPF   +       ++ RI   + + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 325 ----PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
                 ++ E   L++ LL  +P++R+      +    +H W  
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 276

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-57
 Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 42/298 (14%)

Query: 89  QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
            E  + +  E E + + +    + E  +V+G GAFGKV      G+         A+K++
Sbjct: 16  NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75

Query: 149 RKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
           ++      +  + + +E  ++T++  H  IV L  +      +YLI ++   G L  +L 
Sbjct: 76  KEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 208 RQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
            +                        +   +    +  ++   +  L     VHRDL   
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193

Query: 245 NILMDSDGH-------------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVG 291
           N+L+                           +     ++MAPE L    +   +D WS G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253

Query: 292 ILLYEMLT-GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 346
           ILL+E+ + G  P+          ++I    K+  P + T E + +++     D  KR
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-57
 Identities = 49/255 (19%), Positives = 108/255 (42%), Gaps = 25/255 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P D    + +G G FG V   K +G          A+K++++ ++ +         E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDE----FIEEA 50

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
            ++  ++H  +VQL      +  +++I +++  G L  +L   +  F+  Q      ++ 
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAP 273
            A+ +L     +HRDL   N L++  G               DE + S        +  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 274 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 331
           E+L+    +  +D W+ G+L++E+ + G+ P+      +  + I    ++  P   + + 
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230

Query: 332 HSLLKGLLHKDPSKR 346
           ++++    H+   +R
Sbjct: 231 YTIMYSCWHEKADER 245

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-56
 Identities = 46/255 (18%), Positives = 113/255 (44%), Gaps = 25/255 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I P +    + +G G FG V            +    A+K +R+  + +++       E 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMSEED----FIEEA 51

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIV 225
           +++ K++HP +VQL      ++ + L+ +F+  G L  +   ++G+F  +       ++ 
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAP 273
             +++L +  ++HRDL   N L+  +                D+ + S       ++ +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 274 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 331
           E+     ++  +D WS G+L++E+ + G+ P+ + +  ++ + I    ++  P   ++  
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

Query: 332 HSLLKGLLHKDPSKR 346
           + ++     + P  R
Sbjct: 232 YQIMNHCWKERPEDR 246

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (469), Expect = 7e-56
 Identities = 56/261 (21%), Positives = 103/261 (39%), Gaps = 23/261 (8%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           ++I     +I +V+G G FG+V     K    G  +   A+K ++      +       +
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKSGYT--EKQRRDFLS 76

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAE 223
           E  I+ +  HP ++ L       + + +I +F+  G L  F     G F   Q       
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGH----------------EIDESSRSNSMCGT 267
           I + + +L     VHRDL   NIL++S+                       + +      
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 268 TEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPP 325
             + APE +  +     +D WS GI+++E+++ G+ P+     Q +   I  + ++  P 
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 326 FLTSEAHSLLKGLLHKDPSKR 346
              S  H L+     KD + R
Sbjct: 257 DCPSALHQLMLDCWQKDRNHR 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-55
 Identities = 60/308 (19%), Positives = 110/308 (35%), Gaps = 52/308 (16%)

Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA--ERDILT 170
           E    +G+G F  V++ + K     +++ I A+K ++     +        A  E  +L 
Sbjct: 1   EKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           +++HP I+ L  +F  +S + L+ DF+             +      + Y    +  + +
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS- 278
           LH+  I+HRDLKP N+L+D +G                +        T  Y APE+L   
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 279 KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------------- 321
           + +    D W+VG +L E+L   P     +      RI                      
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 322 -----------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKT 370
                       +      +   L++GL   +P  R+             K+F +    T
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGPT 290

Query: 371 LEAREMQP 378
              +  +P
Sbjct: 291 PGCQLPRP 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-55
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 54/304 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDI 168
            +E    +G+GA+GKVF    K  D  +     A+K +R  T  +   +  ++  A    
Sbjct: 8   QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 169 LTKVTHPFIVQLRYSFQT-----RSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
           L    HP +V+L            +KL L+ + ++     +     +     +  +    
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMA 272
           +++  +  LH   +VHRDLKP+NIL+ S G                    S+  T  Y A
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------- 321
           PE+LL   +    D WSVG +  EM   +P F  ++      +I++              
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 322 ----------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS 365
                           K    +      LL   L  +P+KR+        +   H +F+ 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQD 298

Query: 366 INWK 369
           +   
Sbjct: 299 LERC 302

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 57/255 (22%), Positives = 106/255 (41%), Gaps = 20/255 (7%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I     E+ R +G+G FG V     +G+     +   A+ +         +  +    E 
Sbjct: 4   IQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
             + +  HP IV+L     T + +++I++    G L   L  R+          Y  ++ 
Sbjct: 60  LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMAP 273
           +A+++L     VHRD+   N+L+ S+              E     +++      ++MAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 274 EILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSEA 331
           E +  +     +D W  G+ ++E+L  G  PF       +  RI N E++ +PP      
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238

Query: 332 HSLLKGLLHKDPSKR 346
           +SL+      DPS+R
Sbjct: 239 YSLMTKCWAYDPSRR 253

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-54
 Identities = 53/254 (20%), Positives = 104/254 (40%), Gaps = 27/254 (10%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
            D E+    G G FG V Q   +           A+KV+++ T  +K   + M  E  I+
Sbjct: 13  ADIEL----GCGNFGSVRQGVYRMRKKQI---DVAIKVLKQGT--EKADTEEMMREAQIM 63

Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAV 228
            ++ +P+IV+L    Q    L L+++   GG L   L  +              ++   +
Sbjct: 64  HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPE 274
            +L +   VHRDL   N+L+ +  +              +    +  ++     ++ APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 275 ILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII-NEKVKLPPFLTSEAH 332
            +  +  +  +D WS G+ ++E L+ GQ P+      ++   I   ++++ PP    E +
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242

Query: 333 SLLKGLLHKDPSKR 346
           +L+          R
Sbjct: 243 ALMSDCWIYKWEDR 256

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-54
 Identities = 53/289 (18%), Positives = 109/289 (37%), Gaps = 37/289 (12%)

Query: 93  HENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT 152
           + +  +L  + + +         + +G GAFGKV +    G+   D+    A+K+++   
Sbjct: 6   YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--- 208
            +     + + +E  +L+ +  H  IV L  +        +I ++   G L   L R   
Sbjct: 66  HLT--EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 209 ---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
                          +     +    ++ ++   ++ L     +HRDL   NIL+     
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183

Query: 254 EI-------------DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT- 299
                                 +     ++MAPE + +  +  ++D WS GI L+E+ + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 300 GQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 346
           G  P+          ++I E  ++  P    +E + ++K     DP KR
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-54
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 27/256 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           I      +   +GQG FG+V+     G          A+K ++  T+  +        E 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMSPEA----FLQEA 63

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ K+ H  +VQL Y+  +   +Y++ ++++ G L   L  +     R  Q     A+I
Sbjct: 64  QVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMA 272
            S ++++ +   VHRDL+  NIL+  +              E +E +         ++ A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 330
           PE  L       +D WS GILL E+ T G+ P+     +++  ++    ++  PP     
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242

Query: 331 AHSLLKGLLHKDPSKR 346
            H L+     K+P +R
Sbjct: 243 LHDLMCQCWRKEPEER 258

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 9e-54
 Identities = 54/296 (18%), Positives = 113/296 (38%), Gaps = 22/296 (7%)

Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
           R +   +F+  +V+G GAFG V++      +        A+K +R+ T  K N    +  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKAN--KEILD 60

Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           E  ++  V +P + +L     T +   +      G  L +    +          +  +I
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH-------------EIDESSRSNSMCGTTEYM 271
              +++L    +VHRDL   N+L+ +  H               ++   +       ++M
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 272 APEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTS 329
           A E +L + +   +D WS G+ ++E++T G  P+      ++   +   E++  PP  T 
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 240

Query: 330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS 385
           + + ++      D   R    P   + I           + L  +  +    P  +
Sbjct: 241 DVYMIMVKCWMIDADSR----PKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 1e-53
 Identities = 51/256 (19%), Positives = 107/256 (41%), Gaps = 27/256 (10%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +     ++   +G G FG+V+     G          A+K +++ ++          AE 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR--EDQARFYTAEI 224
           +++ ++ H  +V+L Y+  T+  +Y+I +++  G L   L      +   ++     A+I
Sbjct: 60  NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMA 272
              ++ + +   +HRDL+  NIL+                 E +E +         ++ A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIIN-EKVKLPPFLTSE 330
           PE +        +D WS GILL E++T G+ P+      ++ Q +    ++  P     E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 331 AHSLLKGLLHKDPSKR 346
            + L++    + P  R
Sbjct: 239 LYQLMRLCWKERPEDR 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (452), Expect = 2e-53
 Identities = 46/275 (16%), Positives = 106/275 (38%), Gaps = 41/275 (14%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           + E  R +G+GAFG+VFQ +  G+   +   + A+K+++++     +     + E  ++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------- 210
           +  +P IV+L         + L+ +++  G L   L                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 211 ----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------- 253
                    +      ++ + +++L +   VHRDL   N L+  +               
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 254 EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQ-PPFTHANRQKL 312
             D      +      +M PE +    +  ++D W+ G++L+E+ +    P+     +++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 313 QQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKR 346
              + +  +   P     E ++L++    K P+ R
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (447), Expect = 9e-53
 Identities = 52/256 (20%), Positives = 106/256 (41%), Gaps = 25/256 (9%)

Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
           +   D  +   +G G +G+V++   K           A+K +++DT+  +        E 
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTMEVEE----FLKEA 64

Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
            ++ ++ HP +VQL          Y+I +F+  G+L  +L              +   +I
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH------------EIDESSRSNSMCGTTEYMA 272
            SA+ +L K   +HRDL   N L+  +                D  +         ++ A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE 330
           PE L     +  +D W+ G+LL+E+ T G  P+   +  ++ + +  + +++ P     +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244

Query: 331 AHSLLKGLLHKDPSKR 346
            + L++     +PS R
Sbjct: 245 VYELMRACWQWNPSDR 260

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 53/299 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           +F+    +G+G +G V++ + K      +  + A+K +R DT  +      ++ E  +L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFIN-GGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
           ++ HP IV+L     T +KLYL+ +F++     F              + Y  +++  ++
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 230 HLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLS 278
             H   ++HRDLKP+N+L++++G                         T  Y APEILL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 279 KGHN-KDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------------- 321
             +     D WS+G +  EM+T +  F   +      RI                     
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 322 -------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN 367
                        K+ P L  +  SLL  +LH DP+KR+        A   H +F+ + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-52
 Identities = 56/283 (19%), Positives = 120/283 (42%), Gaps = 36/283 (12%)

Query: 98  ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIK 155
           EL  +   ++      + + +G+GAFG+V   +  G+D    +     A+K+++ D    
Sbjct: 1   ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-- 58

Query: 156 KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---- 210
           +  +  + +E +++  +  H  I+ L  +      LY+I+++ + G+L  +L  +     
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 211 ------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----- 253
                                   ++   + +L     +HRDL   N+L+  D       
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 254 --------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPF 304
                    ID   ++ +     ++MAPE L  + +   +D WS G+LL+E+ T G  P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 305 THANRQKLQQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
                ++L + +    ++  P   T+E + +++   H  PS+R
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 53/270 (19%), Positives = 106/270 (39%), Gaps = 34/270 (12%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
            +   D +   V+G+G FG+V + + K              + R      K+       E
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--------------- 209
            ++L K+  HP I+ L  + + R  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDES 258
                  Q   + A++   + +L +   +HRDL   NIL+  +              +  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRII 317
            +         +MA E L    +  ++D WS G+LL+E+++ G  P+      +L +++ 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 318 -NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
              +++ P     E + L++    + P +R
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYER 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-52
 Identities = 70/312 (22%), Positives = 116/312 (37%), Gaps = 67/312 (21%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +   +V+G G+FG V+Q K       DS  + A+K + +D   K         E  I+ 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRFKNR-------ELQIMR 68

Query: 171 KVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLY---RQGIFREDQARFYT 221
           K+ H  IV+LRY F +  +      L L+LD++         +    +        + Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEY 270
            ++  +++++H  GI HRD+KP+N+L+D D             ++     + S   +  Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 271 MAP-EILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---------- 319
            AP  I  +  +    D WS G +L E+L GQP F   +       II            
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 320 -------------------KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH 360
                                   P    EA +L   LL   P+ RL            H
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAH 303

Query: 361 KWFRSINWKTLE 372
            +F  +    ++
Sbjct: 304 SFFDELRDPNVK 315

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 3e-52
 Identities = 60/312 (19%), Positives = 110/312 (35%), Gaps = 67/312 (21%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +E    +GQG FG+VF+ + +      +    A+K +  +   +   +  ++ E  IL
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALR-EIKIL 63

Query: 170 TKVTHPFIVQLRYSFQTRS--------KLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
             + H  +V L    +T++         +YL+ DF               F   + +   
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---------------EIDESSRSNSMCG 266
             +++ + ++H+  I+HRD+K  N+L+  DG                +  + +R  +   
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 267 TTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP 325
           T  Y  PE+LL  + +    D W  G ++ EM T  P       Q     I      + P
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 326 --------------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPGG 353
                                                A  L+  LL  DP++R+      
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----D 298

Query: 354 VDAIKHHKWFRS 365
            D   +H +F S
Sbjct: 299 SDDALNHDFFWS 310

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-51
 Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 20/258 (7%)

Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
           +I P      +V+G G FG+V++   K    G  +   A+K ++      +        E
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKT-SSGKKEVPVAIKTLKAG--YTEKQRVDFLGE 59

Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEI 224
             I+ + +H  I++L         + +I +++  G    F   + G F   Q       I
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH--------------EIDESSRSNSMCGTTEY 270
            + + +L     VHRDL   NIL++S+                + + +  ++       +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 271 MAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLT 328
            APE +  +     +D WS GI+++E++T               + IN+  +L  P    
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239

Query: 329 SEAHSLLKGLLHKDPSKR 346
           S  + L+     ++ ++R
Sbjct: 240 SAIYQLMMQCWQQERARR 257

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  171 bits (433), Expect = 8e-51
 Identities = 55/295 (18%), Positives = 108/295 (36%), Gaps = 53/295 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +     +G+G +G V++ +            +A+K +R +    +        E  IL 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILK 55

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     T+ +L L+ + ++          +G      A+ +  ++++ +++
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 231 LHKCGIVHRDLKPENILMDSDGH-----------EIDESSRSNSMCGTTEYMAPEILLSK 279
            H   ++HRDLKP+N+L++ +G                  +      T  Y AP++L+  
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 280 G-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIIN-------------------- 318
             ++   D WSVG +  EM+ G P F   +      RI                      
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 319 ---------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
                            L      LL  +L  DP++R+            H +F+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFK 285

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-50
 Identities = 63/308 (20%), Positives = 110/308 (35%), Gaps = 55/308 (17%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              +   + VG GA+G V         DG +    A+K + +     +        E  +
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L    DF       G     L +     ED+ +F   ++
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHEID--------ESSRSNSMCGTTEYMAPEIL 276
           +  + ++H  GI+HRDLKP N+ ++ D               S       T  Y APE++
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVI 190

Query: 277 LS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----------- 324
           L+   + +  D WSVG ++ EM+TG+  F  ++     + I+      P           
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 325 --------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
                                  +  A +LL+ +L  D  +R+            H +F 
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFE 305

Query: 365 SINWKTLE 372
           S++    E
Sbjct: 306 SLHDTEDE 313

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-50
 Identities = 53/303 (17%), Positives = 112/303 (36%), Gaps = 36/303 (11%)

Query: 95  NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
           + A++    E ++      + R +GQG+FG V++   KGV   + +   A+K + +   +
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR- 213
           +         E  ++ +     +V+L           +I++ +  G L  +L        
Sbjct: 65  R--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 214 ---------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------- 253
                      +      EI   +++L+    VHRDL   N ++  D             
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 254 --EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQ 310
             E D   +         +M+PE L        +D WS G++L+E+ T  + P+   + +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

Query: 311 KLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH-----HKWFR 364
           ++ + ++   +   P         L++     +P  R    P  ++ I          FR
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR----PSFLEIISSIKEEMEPGFR 298

Query: 365 SIN 367
            ++
Sbjct: 299 EVS 301

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (430), Expect = 4e-50
 Identities = 45/306 (14%), Positives = 95/306 (31%), Gaps = 50/306 (16%)

Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
           E ++G   + + R +G G+FG ++           +    A+K+        K     + 
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECV-----KTKHPQLH 50

Query: 164 AERDILTKVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
            E  I   +     I  +R+         ++++ +         +    F          
Sbjct: 51  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD 110

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDG---------------------HEIDESSRS 261
           +++S + ++H    +HRD+KP+N LM                         H+      +
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV 321
            ++ GT  Y +    L    ++  D  S+G +L     G  P+        +Q+      
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230

Query: 322 K--------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS-------I 366
           K        L     SE  + L          +       +  +  + + R         
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY--SYLRQLFRNLFHRQGFSYDYVF 288

Query: 367 NWKTLE 372
           +W  L+
Sbjct: 289 DWNMLK 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 5e-49
 Identities = 57/296 (19%), Positives = 110/296 (37%), Gaps = 53/296 (17%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
            +E    +G+G +G VF+ K +     ++  I A+K +R D    +        E  +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLK 56

Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
           ++ H  IV+L     +  KL L+ +F +     +     G    +  + +  +++  +  
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 231 LHKCGIVHRDLKPENILMDSDGHE-----------IDESSRSNSMCGTTEYMAPEILLSK 279
            H   ++HRDLKP+N+L++ +G                    ++   T  Y  P++L   
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 280 G-HNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIIN------------------- 318
             ++   D WS G +  E+    +P F   +     +RI                     
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 319 ----------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
                       V + P L +    LL+ LL  +P +R+       +    H +F 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFS 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  167 bits (424), Expect = 6e-49
 Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 72/311 (23%)

Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
           D+++ R +G+G + +VF+          ++    +K      I+K      +K E  IL 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVK------ILKPVKKKKIKREIKILE 84

Query: 171 KV-THPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
            +   P I+ L    +        L+ + +N               +   RFY  EI+ A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 141

Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHEI-----------DESSRSNSMCGTTEYMAPEIL 276
           + + H  GI+HRD+KP N+++D +  ++                 N    +  +  PE+L
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

Query: 277 LS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----------- 324
           +  + ++   D WS+G +L  M+  + PF H +    Q   I + +              
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 325 ---------------------------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAI 357
                                        ++ EA   L  LL  D   RL          
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREA 316

Query: 358 KHHKWFRSINW 368
             H +F ++  
Sbjct: 317 MEHPYFYTVVK 327

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 7e-49
 Identities = 64/326 (19%), Positives = 115/326 (35%), Gaps = 62/326 (19%)

Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
           +     +G+GA+G V            +    A+K +       + +      E  IL +
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62

Query: 172 VTHPFIVQLRYSFQTRS---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             H  I+ +    +  +      + L     G   + L +      D   ++  +I+  +
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 229 SHLHKCGIVHRDLKPENILMDSDGH--------------EIDESSRSNSMCGTTEYMAPE 274
            ++H   ++HRDLKP N+L+++                 + D +        T  Y APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 275 ILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------ 321
           I+L+  G+ K  D WSVG +L EML+ +P F   +       I+                
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKW 362
                              +L P   S+A  LL  +L  +P KR+      V+    H +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPY 297

Query: 363 FRSINWKTLEAREMQPKFKPDVSGKD 388
                +   +    +  FK D+   D
Sbjct: 298 LEQY-YDPSDEPIAEAPFKFDMELDD 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 55/278 (19%), Positives = 102/278 (36%), Gaps = 25/278 (8%)

Query: 90  ELEHENDAELEAESERKIGPGDFEIF--RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
           +L   N   ++A     IGP    +    V+G+G FG V+      +D+       A+K 
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY--HGTLLDNDGKKIHCAVKS 62

Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLF-FH 205
           + + T      V     E  I+   +HP ++ L     ++     ++L ++  G L  F 
Sbjct: 63  LNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------ 253
                         +  ++   +  L     VHRDL   N ++D                
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 254 ---EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANR 309
              E D            ++MA E L ++     +D WS G+LL+E++T G PP+   N 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

Query: 310 QKLQQRII-NEKVKLPPFLTSEAHSLLKGLLHKDPSKR 346
             +   ++   ++  P +     + ++    H     R
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 53/277 (19%), Positives = 109/277 (39%), Gaps = 34/277 (12%)

Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
           S+ +      ++ + +G+GAFG+V +    G+D   +    A+K++++       H   M
Sbjct: 6   SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALM 64

Query: 163 KAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG----------- 210
              + ++    H  +V L     +    L +I++F   G+L  +L  +            
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 211 -----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH------------ 253
                    +    Y+ ++   +  L     +HRDL   NIL+                 
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 254 -EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQK 311
            +  +  R        ++MAPE +  + +   +D WS G+LL+E+ +    P+      +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244

Query: 312 LQQRIINEKVKL--PPFLTSEAHSLLKGLLHKDPSKR 346
              R + E  ++  P + T E +  +    H +PS+R
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 6e-46
 Identities = 62/324 (19%), Positives = 107/324 (33%), Gaps = 57/324 (17%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
           P  ++    VG GA+G V            +    A+K + +       H      E  +
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 70

Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
           L  + H  ++ L   F     L     + L     G    ++ +     +D  +F   +I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHE--------IDESSRSNSMCGTTEYMAPEIL 276
           +  + ++H   I+HRDLKP N+ ++ D                       T  Y APEI+
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 190

Query: 277 LSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFL-------- 327
           L+  H N+  D WSVG ++ E+LTG+  F   +     + I+         L        
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 328 -----------------------TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR 364
                                     A  LL+ +L  D  KR+            H +F 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFA 305

Query: 365 SINWKTLEAREMQPKFKPDVSGKD 388
              +   +   +   +      +D
Sbjct: 306 --QYHDPDDEPVADPYDQSFESRD 327

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  157 bits (397), Expect = 2e-45
 Identities = 40/269 (14%), Positives = 91/269 (33%), Gaps = 42/269 (15%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
             +++ R +G+G+FG +F+          ++   A+K   +     ++    ++ E    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPR-----RSDAPQLRDEYRTY 54

Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
             +     I  + Y  Q      L++D +              F          ++++ V
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 229 SHLHKCGIVHRDLKPENILMDSDGHEID-----------------------ESSRSNSMC 265
             +H+  +V+RD+KP+N L+     +                               ++ 
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 266 GTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPF---THANRQKLQQRIINEKV- 321
           GT  YM+    L +  ++  D  ++G +    L G  P+     A  ++  +RI  +K  
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234

Query: 322 ----KLPPFLTSEAHSLLKGLLHKDPSKR 346
               +L      E +  +    +      
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-45
 Identities = 64/333 (19%), Positives = 110/333 (33%), Gaps = 74/333 (22%)

Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
              ++  + +G GA G V             D   A+K + +     + H      E  +
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRP-FQNQTHAKRAYRELVL 69

Query: 169 LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
           +  V H  I+ L   F  +        +YL+++ ++                ++  +   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 126

Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH----------EIDESSRSNSMCGTTEYMA 272
           +++  + HLH  GI+HRDLKP NI++ SD                S        T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 273 PEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH 332
           PE++L  G+ ++ D WSVG ++ EM+  +  F   +      ++I +     P    +  
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 333 ------------------------------------------SLLKGLLHKDPSKRLGSG 350
                                                      LL  +L  DP+KR+   
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI--- 303

Query: 351 PGGVDAIKHHKWFRSINWKTLEAREMQPKFKPD 383
              VD    H +     W      E  P    D
Sbjct: 304 --SVDDALQHPYIN--VWYDPAEVEAPPPQIYD 332

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-40
 Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 67/293 (22%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
               +   +G+G FG+V++ K +G          A+K+       ++    + +AE    
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGE-------EVAVKIFSS----REERSWFREAEIYQT 51

Query: 170 TKVTHPFIVQLRYSFQ----TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
             + H  I+    +      T ++L+L+ D+   G LF +L R  +  E   +       
Sbjct: 52  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTA 110

Query: 226 SAVSHLH--------KCGIVHRDLKPENILMDSDGH---------------EIDESSRSN 262
           S ++HLH        K  I HRDLK +NIL+  +G                        N
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 263 SMCGTTEYMAPEILLSKGHNKD------ADWWSVGILLYEMLTGQPPF------------ 304
              GT  YMAPE+L    + K       AD +++G++ +E+                   
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 305 ---THANRQKLQQRIINEKVK--LPPFLTS-----EAHSLLKGLLHKDPSKRL 347
              +  + +++++ +  +K++  +P    S         +++   + + + RL
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 1e-37
 Identities = 61/359 (16%), Positives = 112/359 (31%), Gaps = 89/359 (24%)

Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
             + + R +G G F  V+  K        ++   AMK++R D +  +   D +K  + + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 169 ------LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-----LFFHLYRQGIFREDQA 217
                    +    I++L   F  +    + +  +              Y          
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 218 RFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHE--------------IDESSRSN 262
           +  + +++  + ++H +CGI+H D+KPEN+LM+                           
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 263 SMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQ--------- 313
           +   T EY +PE+LL       AD WS   L++E++TG   F                  
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 314 ---------------------------------------QRIINEKVKLPPFLTSEAHSL 334
                                                  + ++ EK K       E    
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANF 393
           L  +L  DP KR          + +H W +     TL   E++   +        I  +
Sbjct: 308 LSPMLQLDPRKRA-----DAGGLVNHPWLK----DTLGMEEIRVPDRELYGSGSDIPGW 357

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.8 bits (170), Expect = 1e-14
 Identities = 33/207 (15%), Positives = 64/207 (30%), Gaps = 47/207 (22%)

Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-------------- 161
           +++G+G    VF    +        G   +K  +      K   +               
Sbjct: 6   KLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 162 -MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
             + E   L K+    + ++           ++++ I+   L+         R +     
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEV 108

Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE-IDESSRSNSMCGTTEYMAPEIL--- 276
              I+  V+  +  GIVH DL   N+L+  +G   ID            E    EIL   
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFP----QSVEVGEEGWREILERD 164

Query: 277 -------LSKGHNKDADWWSVGILLYE 296
                   S+ +  + D  S    + +
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	431
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.08
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.57
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.93
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.56

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-70  Score=532.43  Aligned_cols=313  Identities=39%  Similarity=0.789  Sum_probs=282.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|+++.     +++.||||++++.........+.+.+|+.+|+.++|||||+++++|++
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            456789999999999999999999986     899999999998877777778889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC----------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID----------  256 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~----------  256 (431)
                      .+.+|+|||||+||+|..++.+.+.+++..++.+++||+.||+|||++|||||||||+||||+.+|....          
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999987321          


Q ss_pred             -CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLL  335 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  335 (431)
                       ........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.+....+.+|..+|+++++||
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  236 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence             1223456799999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC-------
Q 014087          336 KGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP-------  408 (431)
Q Consensus       336 ~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~-------  408 (431)
                      ++||++||.+|+++...++++|++||||++++|+.+..+++.|||+|.+....++.+|++.++......++..       
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~  316 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGL  316 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC------------
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCcccccccc
Confidence            9999999999998877789999999999999999999999999999999999999999988776554433221       


Q ss_pred             ----CCCCCCCccCeEeeCC
Q 014087          409 ----TPTAGEHFKGYTYVAP  424 (431)
Q Consensus       409 ----~~~~~~~f~~~~~~~~  424 (431)
                          ....++.|.+|+|++.
T Consensus       317 ~~~~~~~~~~~f~~f~~v~d  336 (337)
T d1o6la_         317 LELDQREEQEMFEDFDYIAD  336 (337)
T ss_dssp             --------CCTTTTCCEECC
T ss_pred             ccccchhhhhccCCCEeeCC
Confidence                1245788999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-67  Score=504.64  Aligned_cols=305  Identities=36%  Similarity=0.741  Sum_probs=265.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            4579999999999999999999986     89999999999887766777888999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--------CCC
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------SSR  260 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--------~~~  260 (431)
                      .+|+|||||.||+|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.+|.....        ...
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999999999999999999999999999999999999999999999999999999999999874322        223


Q ss_pred             cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 014087          261 SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGLLH  340 (431)
Q Consensus       261 ~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  340 (431)
                      ..+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++..+|......+|..++++++++|.+||.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  237 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT  237 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            45678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCC-CCcccCCCCcccCCCCCCCCCCCCCCCCCCccCe
Q 014087          341 KDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVS-GKDCIANFDKCWTTMPADDSPAPTPTAGEHFKGY  419 (431)
Q Consensus       341 ~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~-~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~f~~~  419 (431)
                      +||.+|+++.++++++|++||||++++|+.+..++++|||+|.+. ...++++|++ +.+..............+.|++|
T Consensus       238 ~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~f  316 (316)
T d1fota_         238 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEEDINYGVQGEDPYADLFRDF  316 (316)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCCSCCTTGGGSCCC
T ss_pred             hCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCC-CccccccCCCCCCCchhhhcCCC
Confidence            999999988888999999999999999999999999999999865 4467888875 44444434433444567888887

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-67  Score=504.03  Aligned_cols=302  Identities=38%  Similarity=0.737  Sum_probs=246.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH-hcCCCCcceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~  188 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||+++++........+.+..|..++. .++|||||++++++.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~-----t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC-----CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence            579999999999999999999986     89999999999877666666777777777765 689999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------E  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~  257 (431)
                      .+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.+|+...           .
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999886321           1


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKG  337 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  337 (431)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|..+.+.+|..+++++++||++
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            22334568999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCcCCcCCCCCCCHH-HHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCC----CCCC
Q 014087          338 LLHKDPSKRLGSGPGGVD-AIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAP----TPTA  412 (431)
Q Consensus       338 ~L~~dP~~R~~~~~~~~~-~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~----~~~~  412 (431)
                      ||.+||.+||     +++ ++++||||++++|+.+..+++.||++|.+.+..+++||+..+....+..+...    ...+
T Consensus       237 ~L~~dP~~R~-----s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~  311 (320)
T d1xjda_         237 LFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD  311 (320)
T ss_dssp             HSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------
T ss_pred             hcccCCCCCc-----CHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCcccccCchh
Confidence            9999999999     554 89999999999999999999999999999998999999988766444433322    2246


Q ss_pred             CCCccCeEe
Q 014087          413 GEHFKGYTY  421 (431)
Q Consensus       413 ~~~f~~~~~  421 (431)
                      ++.|+||+|
T Consensus       312 ~~~f~~f~~  320 (320)
T d1xjda_         312 QNMFRNFSF  320 (320)
T ss_dssp             CCTTTTCCC
T ss_pred             hcccCcCcC
Confidence            789999997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-65  Score=500.09  Aligned_cols=284  Identities=40%  Similarity=0.781  Sum_probs=264.8

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ...++|++++.||+|+||+||+|+++.     +|+.||||++.+....+....+.+.+|+++|+.++|||||++++++.+
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~-----~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence            345789999999999999999999986     899999999998777677777889999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--------C
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------S  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--------~  258 (431)
                      ...+|+||||+.||+|..++.+.+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.....        .
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999874221        2


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+...+..+|....+.+|..+++++.+||++|
T Consensus       193 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  272 (350)
T d1rdqe_         193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence            23456789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCc
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDK  395 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~  395 (431)
                      |++||.+|+...+.++++|++||||++++|+.+..++++|||+|......+++||+.
T Consensus       273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~  329 (350)
T d1rdqe_         273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD  329 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCC
T ss_pred             hhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCC
Confidence            999999998777779999999999999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-64  Score=495.11  Aligned_cols=318  Identities=32%  Similarity=0.617  Sum_probs=255.5

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHH---HHHHHhcCCCCcceeeEEE
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~  184 (431)
                      ..++|+++++||+|+||+||+|+++.     +|+.||||++.+...........+.+|   +.+++.++|||||+++++|
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~-----t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~   76 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF   76 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECC-----CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence            45789999999999999999999986     899999999987765544444444444   6667777899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC--------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID--------  256 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~--------  256 (431)
                      .+.+.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|....        
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999999999999999999999999999999999999999999999999999999987322        


Q ss_pred             -CCCCcccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccCCCCCCCHHH
Q 014087          257 -ESSRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHAN---RQKLQQRIINEKVKLPPFLTSEA  331 (431)
Q Consensus       257 -~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~  331 (431)
                       ........+||+.|||||++. +..|+.++|||||||+||||+||+.||.+.+   ...+...+......+|..+++++
T Consensus       157 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         157 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  236 (364)
T ss_dssp             CSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred             cCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence             122345678999999999997 4678999999999999999999999997643   44455566666777888999999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcccCCCCcccCCCCCCCCCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDCIANFDKCWTTMPADDSPAPTPT  411 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~  411 (431)
                      ++||.+||++||.+||++...++++|++||||++++|..+..+++.|||+|........+.||....+............
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~~~~~~~~~~~~  316 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDS  316 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC--------------------CCCCSS
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCChhhccCCCCCCh
Confidence            99999999999999998766679999999999999999999999999999987766655555432111111111222334


Q ss_pred             CCCCccCeEeeCCCccccC
Q 014087          412 AGEHFKGYTYVAPNPWLSS  430 (431)
Q Consensus       412 ~~~~f~~~~~~~~~~~~~~  430 (431)
                      +++.|++|++..+..++++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~  335 (364)
T d1omwa3         317 DQELYRNFPLTISERWQQE  335 (364)
T ss_dssp             SSGGGTTCCEECHHHHHHH
T ss_pred             HHHHHhcCCccCchHHHHH
Confidence            6788999998877666543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-64  Score=476.86  Aligned_cols=268  Identities=38%  Similarity=0.711  Sum_probs=238.9

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||||++++.........+.+.+|+++|++++|||||+++++|+++
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            44679999999999999999999986     8899999999988776777788899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC---------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES---------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~---------  258 (431)
                      +.+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.....+         
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999998732211         


Q ss_pred             ----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014087          259 ----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSL  334 (431)
Q Consensus       259 ----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  334 (431)
                          ....+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++.++|....+.+|..+++++++|
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL  240 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence                1233568999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcccCcCCcCCCCC-CCHHHHHhCCCCCCCChhhHhcccCCCCccc
Q 014087          335 LKGLLHKDPSKRLGSGP-GGVDAIKHHKWFRSINWKTLEAREMQPKFKP  382 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~-~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p  382 (431)
                      |++||++||.+|+++.. .....|++||||++++|+.+..+  .||-.|
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~  287 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT  287 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence            99999999999995431 12345799999999999999754  355443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-62  Score=455.65  Aligned_cols=248  Identities=34%  Similarity=0.625  Sum_probs=230.3

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|++++.||+|+||+||+|+++.     +++.||+|++.+....+....+.+.+|+++|+.++|||||++++++.++
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~   78 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   78 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECC-----CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence            45689999999999999999999986     8899999999987776667778899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC---------CC
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID---------ES  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~---------~~  258 (431)
                      +.+|+|||||+||+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|....         ..
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999999999999899999999999999999999999999999999999999999886321         12


Q ss_pred             CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 014087          259 SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAHSLLKGL  338 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  338 (431)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++...+....+.+|..+++++++||.+|
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            23455689999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |++||++||     +++|+++||||.+
T Consensus       239 L~~dp~~R~-----t~~eil~hp~~~~  260 (263)
T d2j4za1         239 LKHNPSQRP-----MLREVLEHPWITA  260 (263)
T ss_dssp             TCSSGGGSC-----CHHHHHTCHHHHH
T ss_pred             ccCCHhHCc-----CHHHHHcCcCcCC
Confidence            999999999     8999999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=447.69  Aligned_cols=258  Identities=26%  Similarity=0.465  Sum_probs=222.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh---hhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ++|++++.||+|+||+||+|+++.     +|+.||||++++.....   ....+.+.+|+.+|+.++|||||+++++|.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCEEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            469999999999999999999986     89999999998754432   2246778999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc------------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE------------  254 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~------------  254 (431)
                      ++.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|..            
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999999999998899999999999999999999999999999999999999987641            


Q ss_pred             --cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCC
Q 014087          255 --IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLT  328 (431)
Q Consensus       255 --~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s  328 (431)
                        ........+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....|......++    ..++
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence              1122334566899999999999999999999999999999999999999999999999999988877665    5789


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQ  377 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~  377 (431)
                      .++++||++||+.||++||     ++++|++||||+..+|+........
T Consensus       245 ~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~~~~~~~l~~~~~  288 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWS  288 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSC-----CHHHHHHSTTTCC------------
T ss_pred             HHHHHHHHHHccCChhHCc-----CHHHHhcCcccCCCChhHhhccCCC
Confidence            9999999999999999999     8999999999999999876554443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=440.21  Aligned_cols=243  Identities=26%  Similarity=0.440  Sum_probs=215.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|+++.     +|+.||||++++...   ...+.+.+|+.+|+.++|||||+++++|.+++
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTT-----TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccccEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            3579999999999999999999876     889999999986543   23467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------C
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------E  257 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~  257 (431)
                      .+|+|||||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++|||||||||+|||++.+|....           .
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            99999999999999988765 46999999999999999999999999999999999999999887321           1


Q ss_pred             CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCCCCCCHHHHHH
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE---KVKLPPFLTSEAHSL  334 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l  334 (431)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...   .+..|..+++++++|
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence            22345668999999999999999999999999999999999999999998887777666554   334567899999999


Q ss_pred             HHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          335 LKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       335 i~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.+||++||.+||     +++|+++||||+.
T Consensus       250 i~~~L~~dP~~R~-----s~~eil~Hp~~~~  275 (293)
T d1yhwa1         250 LNRCLDMDVEKRG-----SAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHTCSSTTTSC-----CHHHHTTCGGGGG
T ss_pred             HHHHccCChhHCc-----CHHHHhcCHhhCC
Confidence            9999999999999     8999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=439.96  Aligned_cols=245  Identities=28%  Similarity=0.471  Sum_probs=207.8

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++++...  .+..+.+.+|+.+|+.++|||||++++++.+++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~   76 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN   76 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CcceEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence            4679999999999999999999986     889999999986543  233456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----------
Q 014087          189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----------  258 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----------  258 (431)
                      .+|+|||||+||+|.+++.+++.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.....+          
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            9999999999999999998888999999999999999999999999999999999999999988632211          


Q ss_pred             ---CCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCC--CCCCCHHH
Q 014087          259 ---SRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQ-KLQQRIINEKVKL--PPFLTSEA  331 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~  331 (431)
                         ......+||+.|||||++.+..+ +.++|||||||+||||++|+.||...... .....+.......  ...+++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence               12345689999999999998876 57899999999999999999999765433 2333333333222  24689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ++||.+||+.||++||     +++++++||||+.
T Consensus       237 ~~li~~~L~~dP~~R~-----t~~eil~hpwf~~  265 (271)
T d1nvra_         237 LALLHKILVENPSARI-----TIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHSCSSTTTSC-----CHHHHTTCTTTTC
T ss_pred             HHHHHHHcCCChhHCc-----CHHHHhcCHhhCc
Confidence            9999999999999999     8999999999963

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-58  Score=441.78  Aligned_cols=244  Identities=34%  Similarity=0.624  Sum_probs=208.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +.|++++.||+|+||+||+|+++.     +++.||||++.+.....  ....+.+|+.+|+.++|||||++++++.+++.
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKR-----TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETT-----TCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            459999999999999999999986     88999999998765432  23567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCcc----------C
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHEI----------D  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~g~~~----------~  256 (431)
                      +|+|||||+||+|.+++.+.+.+++.+++.|+.||+.||.|||++|||||||||+|||+..   +|...          .
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999999999999999999999999999999999999999999999999999954   44421          1


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      ......+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++...+......++    ..++++++
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            12233456899999999999999999999999999999999999999999999999999988776554    56899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      +||.+||++||++||     +++|+++||||++
T Consensus       242 ~li~~~L~~dP~~R~-----s~~eil~hp~~~~  269 (307)
T d1a06a_         242 DFIRHLMEKDPEKRF-----TCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHHSCSSGGGSC-----CHHHHHHSTTTTS
T ss_pred             HHHHHHccCCHhHCc-----CHHHHhcCHhhCC
Confidence            999999999999999     8999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-58  Score=430.15  Aligned_cols=243  Identities=24%  Similarity=0.481  Sum_probs=207.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--C
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R  187 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  187 (431)
                      ++|++++.||+|+||+||+|+++.     +|+.||||++++... .....+.+.+|+++|+.++|||||++++++.+  .
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            579999999999999999999986     889999999987654 34456778999999999999999999999865  4


Q ss_pred             CEEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeCCCCCccC--
Q 014087          188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHEID--  256 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDlKp~NILl~~~g~~~~--  256 (431)
                      +.+|+|||||+||+|.+++.+    ++.+++..++.++.||+.||.|||++|     ||||||||+||||+.+|....  
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            569999999999999998864    467999999999999999999999976     999999999999999987321  


Q ss_pred             ---------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCC
Q 014087          257 ---------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV-KLPPF  326 (431)
Q Consensus       257 ---------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~  326 (431)
                               ........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|..+.. .+|..
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                     12234567899999999999999999999999999999999999999999999999999887765 46778


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                      +++++++||.+||+.||.+||     +++||++|||.
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rp-----s~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRP-----SVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCc-----CHHHHHhCCcC
Confidence            999999999999999999999     89999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-58  Score=433.60  Aligned_cols=244  Identities=29%  Similarity=0.458  Sum_probs=215.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      +.|++++.||+|+||+||+|+++.     +++.||||++++..   ....+.+.+|+++|+.++|||||++++++.+++.
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   83 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN   83 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC-----CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence            359999999999999999999986     88999999997653   2334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--------
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--------  260 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--------  260 (431)
                      +|+|||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++|||||||||+||||+.+|.....+..        
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999999998765 4579999999999999999999999999999999999999999874332222        


Q ss_pred             ---cccccCCCCCCchhhhc-----cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---CCCCCCCH
Q 014087          261 ---SNSMCGTTEYMAPEILL-----SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---KLPPFLTS  329 (431)
Q Consensus       261 ---~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~  329 (431)
                         ..+.+||+.|||||++.     +..|+.++|||||||++|||++|+.||.+.+..++..++.....   ..|..+++
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence               23568999999999984     45689999999999999999999999999888888888877643   34567999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      ++++||.+||++||++||     +++|+++||||+.-
T Consensus       244 ~~~~li~~~L~~dp~~R~-----t~~ell~hp~~~~~  275 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARW-----TTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSC-----CHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHccCChhHCc-----CHHHHhcCcccCCC
Confidence            999999999999999999     89999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-57  Score=443.23  Aligned_cols=249  Identities=26%  Similarity=0.492  Sum_probs=221.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +|+.||||++.+...   ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~-----~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            479999999999999999999986     899999999976542   234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CCcc----------C
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHEI----------D  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~--g~~~----------~  256 (431)
                      +|+|||||+||+|.+++.+ .+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+  |...          .
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999999854 4679999999999999999999999999999999999999753  4321          1


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      ......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......++    ..++++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            12223456899999999999999999999999999999999999999999999999999988876655    36899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                      +||.+||+.||++||     +++||++||||+..+|...
T Consensus       258 ~li~~~L~~dP~~R~-----t~~eil~hp~~~~~~~~~~  291 (350)
T d1koaa2         258 DFIRKLLLADPNTRM-----TIHQALEHPWLTPGNAPGR  291 (350)
T ss_dssp             HHHHHHCCSSGGGSC-----CHHHHHHSTTTSCTTCCSC
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCcccCCCCCCCc
Confidence            999999999999999     8999999999998877543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=445.69  Aligned_cols=253  Identities=27%  Similarity=0.437  Sum_probs=213.3

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|+++++||+|+||+||+|+++.     +++.||+|++++..  .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETT-----TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            345689999999999999999999986     89999999997653  34445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      ++++|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|.....+.      
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999999999999999999999999999999999999997 59999999999999999987433222      


Q ss_pred             ---CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHH------------------------
Q 014087          260 ---RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKL------------------------  312 (431)
Q Consensus       260 ---~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~------------------------  312 (431)
                         ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....                        
T Consensus       156 ~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         156 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             CCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               23467999999999999999999999999999999999999999976542221                        


Q ss_pred             ------------------HHHHHhcc-cCCC-CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhH
Q 014087          313 ------------------QQRIINEK-VKLP-PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTL  371 (431)
Q Consensus       313 ------------------~~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l  371 (431)
                                        ...+.... ..++ ..+|.++++||.+||+.||.+||     +++|+++||||+..+|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----ta~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHHHHSCC
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc-----CHHHHhhCHhhCcCCcccc
Confidence                              11111111 1122 23689999999999999999999     8999999999988776543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=437.38  Aligned_cols=281  Identities=46%  Similarity=0.847  Sum_probs=240.5

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHhcCC-CCcceeeEEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSF  184 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~  184 (431)
                      +..++|++++.||+|+||+||+|++...  ..+|+.||||++++.... +....+.+.+|+++|++++| |||+++++++
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            4457899999999999999999988542  237899999999765432 22334567789999999966 8999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                      .+...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.....+      
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999998732211      


Q ss_pred             ------CCcccccCCCCCCchhhhccC--CCCCcchhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCCCCC
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSK--GHNKDADWWSVGILLYEMLTGQPPFTHAN----RQKLQQRIINEKVKLPPF  326 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~p~~  326 (431)
                            ....+..|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.+.+    ...+..........+|..
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence                  123456799999999999865  46889999999999999999999997643    444555556667788889


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcc
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC  389 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~  389 (431)
                      +++++.+||.+||++||.+|+++...+++|+++||||++++|+.+..+++.|||+|.+.+..|
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~  321 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD  321 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CC
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCC
Confidence            999999999999999999999887778999999999999999999999999999998876443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-57  Score=434.84  Aligned_cols=245  Identities=22%  Similarity=0.354  Sum_probs=218.9

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      .|+.++.||+|+||+||+|+++.     +++.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC-----CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence            39999999999999999999986     8899999999877665666677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-------CCCccc
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-------SSRSNS  263 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-------~~~~~~  263 (431)
                      |+|||||.||+|..++..++.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.....       ......
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS  170 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence            9999999999998888888899999999999999999999999999999999999999998763221       123456


Q ss_pred             ccCCCCCCchhhhcc---CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--CCCCCHHHHHHHHhh
Q 014087          264 MCGTTEYMAPEILLS---KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL--PPFLTSEAHSLLKGL  338 (431)
Q Consensus       264 ~~Gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~  338 (431)
                      .+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+.+..+....+.......  +..+++++++||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            689999999999974   458999999999999999999999999988888888877665432  346899999999999


Q ss_pred             cccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          339 LHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       339 L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |+.||++||     +++++++||||..
T Consensus       251 L~~dP~~Rp-----t~~ell~Hp~~~~  272 (309)
T d1u5ra_         251 LQKIPQDRP-----TSEVLLKHRFVLR  272 (309)
T ss_dssp             TCSSGGGSC-----CHHHHTTCHHHHS
T ss_pred             CcCChhHCc-----CHHHHHhCHHhcC
Confidence            999999999     8999999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=421.67  Aligned_cols=241  Identities=22%  Similarity=0.421  Sum_probs=208.5

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe----C
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----R  187 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~  187 (431)
                      |++.++||+|+||+||+|+++.     +++.||+|++..... .....+.+.+|+++|+.++|||||++++++.+    .
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~-----~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            4778899999999999999986     888999999987654 34456778999999999999999999999875    4


Q ss_pred             CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCC-CCCcc---------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHEI---------  255 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~-~g~~~---------  255 (431)
                      ..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  ||||||||+||||+. +|...         
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            568999999999999999999899999999999999999999999998  999999999999974 55521         


Q ss_pred             CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccc--CCCCCCCHHHH
Q 014087          256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA-NRQKLQQRIINEKV--KLPPFLTSEAH  332 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~  332 (431)
                      .......+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+. +...+.+.+..+..  .++..++++++
T Consensus       165 ~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (270)
T d1t4ha_         165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  243 (270)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence            22233456789999999999875 5999999999999999999999999764 45666666665432  34567899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFR  364 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~  364 (431)
                      +||.+||++||++||     +++||++||||+
T Consensus       244 ~li~~~l~~dp~~R~-----s~~ell~Hp~fk  270 (270)
T d1t4ha_         244 EIIEGCIRQNKDERY-----SIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHSCSSGGGSC-----CHHHHHTSGGGC
T ss_pred             HHHHHHccCCHhHCc-----CHHHHhCCcccC
Confidence            999999999999999     899999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-56  Score=437.77  Aligned_cols=244  Identities=27%  Similarity=0.499  Sum_probs=217.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++++....   ....+.+|+.+|+.++|||||+++++|.+++.
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            469999999999999999999986     8999999999865432   23567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC--CCCccC----------
Q 014087          190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHEID----------  256 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~g~~~~----------  256 (431)
                      +|+|||||+||+|.+++.+.+ .+++.+++.|+.||+.||.|||++|||||||||+||||+.  +|....          
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            999999999999998876654 6999999999999999999999999999999999999984  444211          


Q ss_pred             CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP----PFLTSEAH  332 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  332 (431)
                      ......+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++...|......++    ..++++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            12233456899999999999999999999999999999999999999999999999999988877665    46899999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                      +||.+||++||.+||     +++++++||||++.
T Consensus       261 ~li~~~L~~dp~~R~-----s~~eil~Hp~~~~~  289 (352)
T d1koba_         261 DFIKNLLQKEPRKRL-----TVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHTTSCSSGGGSC-----CHHHHHTSTTTSSC
T ss_pred             HHHHHHccCChhHCc-----CHHHHhcCHhhCCC
Confidence            999999999999999     89999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.7e-56  Score=420.08  Aligned_cols=247  Identities=30%  Similarity=0.527  Sum_probs=220.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh------hhHHHHHHHHHHHHHhcC-CCCcceee
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVT-HPFIVQLR  181 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~il~~l~-hpnIv~l~  181 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++++.....      +...+.+.+|+.+|+.++ |||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             cccCEEceEEecCcCeEEEEEEECC-----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            3689999999999999999999876     88999999998754322      234456889999999997 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc------
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI------  255 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~------  255 (431)
                      +++.+++.+|+|||||+||+|.+++..++.+++.+++.++.||+.||+|||++|||||||||+|||++.+|...      
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999987632      


Q ss_pred             ----CCCCCcccccCCCCCCchhhhcc------CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Q 014087          256 ----DESSRSNSMCGTTEYMAPEILLS------KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP-  324 (431)
Q Consensus       256 ----~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p-  324 (431)
                          .........+||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.+.....+.+..+...++ 
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence                22233456789999999999973      3568899999999999999999999999999999999988876554 


Q ss_pred             ---CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          325 ---PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       325 ---~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                         ..+|+++++||.+||+.||++||     ++++|++||||+.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~-----s~~eil~h~~~~~  275 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQ  275 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCc-----CHHHHHcCHHHHH
Confidence               37899999999999999999999     8999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=431.85  Aligned_cols=243  Identities=26%  Similarity=0.447  Sum_probs=218.1

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|++++.||+|+||+||+|+++.     +++.||||++++...    ....+.+|+++|+.++|||||+++++|++++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-----~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESME   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            4679999999999999999999986     889999999987542    2245778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--c-c---------
Q 014087          189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--E-I---------  255 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~--~-~---------  255 (431)
                      .+|+|||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.++.  . +         
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999999999998765 7999999999999999999999999999999999999987653  1 1         


Q ss_pred             CCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHH
Q 014087          256 DESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPP----FLTSEA  331 (431)
Q Consensus       256 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  331 (431)
                      .........+||+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+..++..+|......++.    .+++++
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            1112234557999999999999999999999999999999999999999999999999999998887764    689999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      ++||.+||.+||++||     +++|+++||||+.
T Consensus       235 ~~li~~~L~~dp~~R~-----s~~eil~hp~~~~  263 (321)
T d1tkia_         235 MDFVDRLLVKERKSRM-----TASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHHTTSCSSGGGSC-----CHHHHHHSHHHHS
T ss_pred             HHHHHHHccCChhHCc-----CHHHHhcCHhhcc
Confidence            9999999999999999     8999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-55  Score=413.54  Aligned_cols=241  Identities=23%  Similarity=0.377  Sum_probs=207.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      ++|++.+.||+|+||+||+|+++.     +++.||||++++....+....+.+.+|+++|+.++|||||++++++...+ 
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLR-----LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            579999999999999999999986     89999999998876666667788999999999999999999999998654 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC--------
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE--------  257 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~--------  257 (431)
                         .+|+|||||+||+|..++...+.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.....        
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence               489999999999999999999999999999999999999999999999999999999999888762211        


Q ss_pred             ------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC----CCCC
Q 014087          258 ------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL----PPFL  327 (431)
Q Consensus       258 ------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----p~~~  327 (431)
                            .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..++.......    .+.+
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence                  112345689999999999999999999999999999999999999999999888888887765543    3578


Q ss_pred             CHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          328 TSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       328 s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      |+++.+||.+||++||.+||+    +++++++
T Consensus       242 s~~l~~li~~~L~~dp~~R~~----sa~~l~~  269 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQ----TAAEMRA  269 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCS----SHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHh----HHHHHHH
Confidence            999999999999999999993    5677654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-55  Score=413.61  Aligned_cols=243  Identities=30%  Similarity=0.492  Sum_probs=210.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhh---HHHHHHHHHHHHHhcC--CCCcceeeEEE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERDILTKVT--HPFIVQLRYSF  184 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~E~~il~~l~--hpnIv~l~~~~  184 (431)
                      ++|++.++||+|+||+||+|+++.     +++.||||++++.......   ....+.+|+.+|+.++  |||||++++++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence            579999999999999999999986     8899999999876543321   1233567999999986  89999999999


Q ss_pred             EeCCEEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCcc-------
Q 014087          185 QTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHEI-------  255 (431)
Q Consensus       185 ~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-g~~~-------  255 (431)
                      .+.+.+|+||||+.+ +++.+++.+++.+++.+++.++.||+.||+|||++|||||||||+|||++.+ +...       
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence            999999999999986 6888888888899999999999999999999999999999999999999865 3321       


Q ss_pred             --CCCCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 014087          256 --DESSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLPPFLTSEAH  332 (431)
Q Consensus       256 --~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  332 (431)
                        .......+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.      +.+......++..+|++++
T Consensus       159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~  232 (273)
T d1xwsa_         159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ  232 (273)
T ss_dssp             EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHH
T ss_pred             eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHH
Confidence              12233456789999999999987765 57799999999999999999999763      3566778889999999999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                      +||.+||++||++||     +++|+++||||+++-.
T Consensus       233 ~li~~~L~~dp~~R~-----s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         233 HLIRWCLALRPSDRP-----TFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHTSGGGSSCCC
T ss_pred             HHHHHHccCCHhHCc-----CHHHHhcCHhhCCCCC
Confidence            999999999999999     8999999999998643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-55  Score=415.85  Aligned_cols=244  Identities=23%  Similarity=0.364  Sum_probs=203.8

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL  190 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  190 (431)
                      +.+++||+|+||+||+|+++.     +++.||||++++.....  ....+.+.+|+.+|+.++|||||++++++.+++++
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             CcceEeccCcCeEEEEEEECC-----CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            357899999999999999876     89999999997654322  22235688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------CCC
Q 014087          191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------ESS  259 (431)
Q Consensus       191 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~~~  259 (431)
                      |+||||+.|+++..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|....           ...
T Consensus        76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            999999999888777766778999999999999999999999999999999999999999876321           112


Q ss_pred             CcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----------------
Q 014087          260 RSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK----------------  322 (431)
Q Consensus       260 ~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----------------  322 (431)
                      .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.+..+...+|......                
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            2345689999999999875 46899999999999999999999999999888887777542100                


Q ss_pred             ------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          323 ------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       323 ------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                  ....+++++++||.+||+.||++||     +++|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc-----CHHHHhCCHhhCCC
Confidence                        0124689999999999999999999     89999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-54  Score=408.97  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=205.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|+++++||+|+||+||+|+++.     +++.||||+++.... .....+.+.+|+++|+.++|||||+++++++++++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            589999999999999999999986     889999999976543 33345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC-----------C
Q 014087          190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID-----------E  257 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~-----------~  257 (431)
                      +|+||||+.++.+...... .+.+++.+++.++.||+.||+|||++|||||||||+|||++.++....           .
T Consensus        76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9999999987544433333 356999999999999999999999999999999999999998876321           1


Q ss_pred             CCCcccccCCCCCCchhhhccCCC-CCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------------
Q 014087          258 SSRSNSMCGTTEYMAPEILLSKGH-NKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVK--------------  322 (431)
Q Consensus       258 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  322 (431)
                      .......+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+...++......              
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            223345589999999999887664 78999999999999999999999998887776666432110              


Q ss_pred             ----C-----------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCC
Q 014087          323 ----L-----------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSIN  367 (431)
Q Consensus       323 ----~-----------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~  367 (431)
                          +           ...++.++++||++||+.||++||     +++||++||||++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc-----CHHHHhCCHhhccCC
Confidence                0           124689999999999999999999     899999999998763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=413.58  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc---CCCCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~  186 (431)
                      ++|+++++||+|+||+||+|+++.    .+++.||||+++...... .....+.+|+.+|+.+   +|||||+++++|..
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            579999999999999999999864    146789999997654322 2222345677777665   79999999999863


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC---
Q 014087          187 -----RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE---  257 (431)
Q Consensus       187 -----~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~---  257 (431)
                           ...+|++|||+.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.....   
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence                 3478999999999877544443 3569999999999999999999999999999999999999998763221   


Q ss_pred             -------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 014087          258 -------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEK----------  320 (431)
Q Consensus       258 -------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------  320 (431)
                             .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....          
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence                   122346689999999999999999999999999999999999999999998888877775310          


Q ss_pred             -----------------cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCCh
Q 014087          321 -----------------VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINW  368 (431)
Q Consensus       321 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~  368 (431)
                                       ..++..+++++++||.+||++||++||     +++|+++||||+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLER  301 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcChhhcCchh
Confidence                             012346789999999999999999999     8999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=420.59  Aligned_cols=239  Identities=28%  Similarity=0.530  Sum_probs=200.9

Q ss_pred             CCCceEEe-eecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHh-cCCCCcceeeEEEEe
Q 014087          109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQT  186 (431)
Q Consensus       109 ~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~  186 (431)
                      .++|+++. .||+|+||+||+|+++.     +++.||||++++.        ..+.+|+.++.+ ++|||||+++++|++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECC-----CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            45799875 59999999999999986     8899999999753        235679988655 589999999999976


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---c---
Q 014087          187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---E---  254 (431)
Q Consensus       187 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~---  254 (431)
                          +..+|+|||||+||+|.+++.+.  ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.   .   
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence                46799999999999999999875  36999999999999999999999999999999999999987432   1   


Q ss_pred             -------cCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcccCC
Q 014087          255 -------IDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQK----LQQRIINEKVKL  323 (431)
Q Consensus       255 -------~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~  323 (431)
                             ..........+||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+...    +...+......+
T Consensus       157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence                   112233456789999999999999999999999999999999999999997765433    334444555556


Q ss_pred             CC----CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          324 PP----FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       324 p~----~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      |.    .+++++++||++||++||++||     ++++|++||||..
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  277 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCc-----CHHHHHcCHHhhC
Confidence            53    5899999999999999999999     8999999999964

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.3e-53  Score=400.85  Aligned_cols=244  Identities=23%  Similarity=0.391  Sum_probs=208.1

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|+++++||+|+||+||+|+++      +++.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            57999999999999999999985      678999999977643 34445778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----------
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----------  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----------  258 (431)
                      .|++|||+.++.+..+....+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.....+           
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            999999999988877777788899999999999999999999999999999999999999998743221           


Q ss_pred             CCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------------
Q 014087          259 SRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV----------------  321 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------------  321 (431)
                      .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+...++.....                
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            223445789999999999864 568999999999999999999999999888777776643110                


Q ss_pred             -------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          322 -------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       322 -------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                   .++..+++++++||++||++||++||     +++|+++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----s~~ell~Hp~f~~  286 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFKE  286 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc-----CHHHHhcCcccCc
Confidence                         12345789999999999999999999     8999999999973

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=402.54  Aligned_cols=240  Identities=18%  Similarity=0.288  Sum_probs=203.3

Q ss_pred             eeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCEEEEEEe
Q 014087          116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD  195 (431)
Q Consensus       116 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E  195 (431)
                      ++||+|+||+||+|.++..   .+++.||||+++.... +....+.+.+|+++|++++|||||++++++.++ ..|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC---CcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence            4699999999999987642   2568899999976543 445567899999999999999999999998754 5789999


Q ss_pred             ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC--------------Cc
Q 014087          196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS--------------RS  261 (431)
Q Consensus       196 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~--------------~~  261 (431)
                      ||+||+|.+++.+...+++.++..|+.||+.||.|||++|||||||||+||||+.+|.....+.              ..
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999999999999999999999999999999999999999999999999999998876322111              11


Q ss_pred             ccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHhhc
Q 014087          262 NSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAHSLLKGLL  339 (431)
Q Consensus       262 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L  339 (431)
                      ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ .+..|..+++++.+||.+||
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            23468999999999999999999999999999999998 99999999888888888765 56778899999999999999


Q ss_pred             ccCcCCcCCCCCCCHHHH---HhCCCCCC
Q 014087          340 HKDPSKRLGSGPGGVDAI---KHHKWFRS  365 (431)
Q Consensus       340 ~~dP~~R~~~~~~~~~~i---~~h~~f~~  365 (431)
                      +.||++||     ++++|   ++|+|+..
T Consensus       248 ~~dp~~RP-----s~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         248 TYDVENRP-----GFAAVELRLRNYYYDV  271 (277)
T ss_dssp             CSSTTTSC-----CHHHHHHHHHHHHHHH
T ss_pred             CCCHhHCc-----CHHHHHHHhhCHHhhc
Confidence            99999999     67776   56666543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=409.49  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +.+..++|+++++||+|+||+||+|++++.........||+|.+....  .......+.+|+.+|+++ +|||||+++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            446667899999999999999999999874443345579999987653  233445688899999998 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (431)
                      +.+.+.+|+|||||+||+|.+++..+                       ..+++..++.|+.||+.||.|||++||||||
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD  189 (325)
T d1rjba_         110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  189 (325)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            99999999999999999999999764                       2489999999999999999999999999999


Q ss_pred             CCCCceEeCCCCCccCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCC
Q 014087          241 LKPENILMDSDGHEIDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTH  306 (431)
Q Consensus       241 lKp~NILl~~~g~~~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~  306 (431)
                      |||+|||++.+|.....+.             ...+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999886322211             1124568999999999999999999999999999999998 9999988


Q ss_pred             CCHHHHHHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          307 ANRQKLQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       307 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+......+++..  .++.|..+++++++||.+||+.||++||     ++++|++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            7665555555554  4456788999999999999999999999     88999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.6e-53  Score=398.89  Aligned_cols=241  Identities=22%  Similarity=0.326  Sum_probs=207.4

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++.++||+|+||+||+|+++.     +++.||||+++++..    ..+.+.+|+++|+.++|||||++++++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGG-----GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECC-----CCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            34556789999999999999999999986     889999999976532    345688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC--
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR--  260 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~--  260 (431)
                      .+++.+|+|||||++|+|.+++.+.  ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.....+..  
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence            9999999999999999999999765  568999999999999999999999999999999999999998763222111  


Q ss_pred             ----------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCC-CCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          261 ----------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQP-PFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       261 ----------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~-Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                                .....||+.|||||++.+..|+.++|||||||++|||++|.. ||.+.+...+.+.+..+ ....|..++
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  242 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence                      122347889999999999999999999999999999999555 55666777776666554 456778899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +++++||.+||+.||++||     ++++|++
T Consensus       243 ~~l~~li~~cl~~dP~~Rp-----s~~ei~~  268 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRP-----SFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCc-----CHHHHHH
Confidence            9999999999999999999     8889865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=392.67  Aligned_cols=239  Identities=20%  Similarity=0.370  Sum_probs=205.7

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|+++      +++.||||++++....    .+.+.+|+++|+.++|||||++++++.+
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLE   71 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceecc
Confidence            45678999999999999999999986      4667999999764432    3468889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                      ++.+|+|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.....+.      
T Consensus        72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence            99999999999999999988765 56899999999999999999999999999999999999999876322111      


Q ss_pred             ------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          260 ------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       260 ------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                            ......||+.|||||++.+..|+.++|||||||++|||+| |++||...+..++.+.+..+ ....|..+++++
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  231 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  231 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence                  1223568999999999999999999999999999999999 68888888888888888765 455677899999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+||.+||+.||++||     ++++|++|
T Consensus       232 ~~li~~cl~~~p~~Rp-----s~~~il~~  255 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRP-----AFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHccCCHhHCc-----CHHHHHHH
Confidence            9999999999999999     88999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-52  Score=397.73  Aligned_cols=245  Identities=23%  Similarity=0.316  Sum_probs=208.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++.++||+|+||+||+|+++...  .....||||.+....  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            456678999999999999999999987521  133468999886543  3344567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCCC----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESSR----  260 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~~----  260 (431)
                      +.+.+|+|||||+||+|.+++... +.+++.++..|+.||+.||.|||++|||||||||+||||+.++.....+..    
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999999999988874 579999999999999999999999999999999999999999863221111    


Q ss_pred             ------------cccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCC
Q 014087          261 ------------SNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPF  326 (431)
Q Consensus       261 ------------~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~  326 (431)
                                  .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..+ ..+.|..
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  257 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD  257 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                        112357899999999999999999999999999999998 89999999998888888765 4567788


Q ss_pred             CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          327 LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       327 ~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++.++.+||.+||+.||++||     ++++|++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RP-----s~~ei~~  285 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRP-----KFGQIVN  285 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCc-----CHHHHHH
Confidence            999999999999999999999     7888876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=396.21  Aligned_cols=241  Identities=23%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|+++++||+|+||+||+|+++        ..||||+++.... .....+.+.+|+.+|++++|||||++++++
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            4577889999999999999999999743        2499999976543 345577899999999999999999999976


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-----
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-----  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-----  258 (431)
                      . .+.+|+|||||+||+|.+++... ..+++.++..|+.||+.||+|||++|||||||||+||||+.++.....+     
T Consensus        74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            4 56789999999999999999765 5699999999999999999999999999999999999999988732211     


Q ss_pred             --------CCcccccCCCCCCchhhhccC---CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccc-----
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSK---GHNKDADWWSVGILLYEMLTGQPPFTHANRQK-LQQRIINEKV-----  321 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~-----  321 (431)
                              ....+.+||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+.+... +...+..+..     
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS  232 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence                    122356899999999999753   58899999999999999999999998865444 4444443322     


Q ss_pred             CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          322 KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       322 ~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..+..+++++++||.+||..||++||     ++++|+++
T Consensus       233 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~~il~~  266 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLKKKRDERP-----LFPQILAS  266 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hccccchHHHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            24567899999999999999999999     88999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=389.28  Aligned_cols=238  Identities=19%  Similarity=0.359  Sum_probs=211.0

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      +.++|+++++||+|+||+||+|+++      +++.||||++++....    .+.+.+|+.+++.++|||||++++++.++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            4678999999999999999999986      6778999999875432    34688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC---------
Q 014087          188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE---------  257 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~---------  257 (431)
                      +.+|+||||+.+|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.....         
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            999999999999999988765 4679999999999999999999999999999999999999998763211         


Q ss_pred             ---CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHH
Q 014087          258 ---SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEAH  332 (431)
Q Consensus       258 ---~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  332 (431)
                         ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ ....|..+++++.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  231 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  231 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence               112224568999999999999999999999999999999998 89999999999999888775 4567788999999


Q ss_pred             HHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          333 SLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       333 ~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +||.+||+.||++||     ++++|++|
T Consensus       232 ~li~~cl~~dP~~RP-----t~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERP-----TFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHccCCHhHCc-----CHHHHHHH
Confidence            999999999999999     89999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=396.63  Aligned_cols=245  Identities=21%  Similarity=0.306  Sum_probs=207.4

Q ss_pred             CCCCceEEee-ecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          108 GPGDFEIFRV-VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       108 ~~~~y~~~~~-LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      ..++|.+.+. ||+|+||+||+|.++...   ++..||||++++..  .....+.+.+|+++|+.++|||||++++++.+
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCC---CcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            3456888885 999999999999886421   45679999997653  34456788999999999999999999999875


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                       +.+|+|||||+||+|.+++... +.+++.++..|+.||+.||.|||++|||||||||+||||+.++.....+       
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence             4689999999999999987654 5799999999999999999999999999999999999999887632211       


Q ss_pred             -------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCH
Q 014087          259 -------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTS  329 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  329 (431)
                             ......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...|..+ ....|+.+++
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP  239 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence                   11234568999999999999999999999999999999998 99999998888888888765 4678889999


Q ss_pred             HHHHHHHhhcccCcCCcCCCCCCCHHHH---HhCCCC
Q 014087          330 EAHSLLKGLLHKDPSKRLGSGPGGVDAI---KHHKWF  363 (431)
Q Consensus       330 ~~~~li~~~L~~dP~~R~~~~~~~~~~i---~~h~~f  363 (431)
                      ++.+||.+||..||++||     ++.+|   ++|.|+
T Consensus       240 ~l~~li~~cl~~~p~~RP-----s~~~i~~~L~~~~~  271 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRP-----DFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSC-----CHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCc-----CHHHHHHHHHHHHH
Confidence            999999999999999999     56665   566665

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=400.56  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=203.9

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe--
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--  186 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  186 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++.+... .......+.+|+.+|+.++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            4679999999999999999999986     899999999977653 33445667889999999999999999999865  


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC---
Q 014087          187 ------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE---  257 (431)
Q Consensus       187 ------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~---  257 (431)
                            +..+|+||||+.++.+.........+++..++.++.||+.||.|||++|||||||||+|||++.+|.....   
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence                  45689999999988776666666789999999999999999999999999999999999999998763211   


Q ss_pred             ------------CCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Q 014087          258 ------------SSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKLP  324 (431)
Q Consensus       258 ------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p  324 (431)
                                  .....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+.......+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence                        1223345799999999999865 689999999999999999999999999888877776654322211


Q ss_pred             C--------------------------------CCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          325 P--------------------------------FLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       325 ~--------------------------------~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                      .                                ..++++++||.+||+.||++|+     +++|+++||||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----sa~elL~Hpff~~  310 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWS  310 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHHcChhhcc
Confidence            1                                1367889999999999999999     8999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=403.29  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS  188 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  188 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            4679999999999999999999986     899999999986543 4455677889999999999999999999998765


Q ss_pred             ------EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC------
Q 014087          189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID------  256 (431)
Q Consensus       189 ------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~------  256 (431)
                            .+|+||||+ |++|..++ +++.+++..++.++.||+.||.|||++|||||||||+|||++.++....      
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence                  579999999 55666655 4567999999999999999999999999999999999999999876322      


Q ss_pred             --CCCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------------
Q 014087          257 --ESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------  321 (431)
Q Consensus       257 --~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------  321 (431)
                        ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.....            
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         169 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             eccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence              22334567899999999999864 568999999999999999999999998877666554432111            


Q ss_pred             -------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          322 -------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       322 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                                         .....+++++++||.+||..||++||     |+++|++||||+++.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC--
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcChhhCcCCCc
Confidence                               12245789999999999999999999     89999999999987643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=393.95  Aligned_cols=244  Identities=20%  Similarity=0.332  Sum_probs=208.4

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++++.||+|+||+||+|+++      +++.||||+++....    ..+.+.+|+.+|++++|||||++++++
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence            4466678999999999999999999976      567899999976432    235688999999999999999999987


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC---
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS---  259 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~---  259 (431)
                      . ++.+|+|||||++|+|.+++...  ..+++.++..|+.||+.||.|||++||+||||||+||||+.++.....+.   
T Consensus        78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence            5 45679999999999998877543  35999999999999999999999999999999999999999887422111   


Q ss_pred             ---------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          260 ---------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                               ......||+.|||||++.+..|+.++|||||||+||||+| |.+||...+..++.+.+..+ ....|..++
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~  236 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP  236 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence                     1234578999999999999999999999999999999999 56677778888888888765 456778899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh--CCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH--HKWFR  364 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~--h~~f~  364 (431)
                      +++.+||.+||+.||++||     ++++|++  |+||.
T Consensus       237 ~~l~~li~~cl~~~P~~Rp-----t~~ei~~~L~~~ft  269 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRP-----TFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCc-----CHHHHHHHhhhhhh
Confidence            9999999999999999999     8899987  67774

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=388.06  Aligned_cols=245  Identities=23%  Similarity=0.339  Sum_probs=207.7

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..++|++++.||+|+||+||+|++....  ..+..||||.++...  .....+.+.+|+.+|+.++|||||++++++.
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            355678999999999999999999987522  245678999886543  3455677899999999999999999999985


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------  258 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------  258 (431)
                       ++.+|+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++.....+      
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence             56789999999999999887654 5799999999999999999999999999999999999999987632211      


Q ss_pred             ------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHH
Q 014087          259 ------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSE  330 (431)
Q Consensus       259 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  330 (431)
                            ......+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+..+ ..++|+.++++
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  237 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence                  12334568999999999999999999999999999999998 99999998888888888776 45788899999


Q ss_pred             HHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          331 AHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       331 ~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      +++||.+||..||++||     ++++|++|
T Consensus       238 ~~~li~~cl~~dp~~Rp-----s~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRP-----RFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            99999999999999999     88999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-51  Score=396.46  Aligned_cols=242  Identities=24%  Similarity=0.419  Sum_probs=200.0

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  187 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++..      .+.+.+|+++|+.++ ||||++++++|...
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            3579999999999999999999986     89999999987532      346788999999995 99999999999854


Q ss_pred             --CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCcc----------
Q 014087          188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEI----------  255 (431)
Q Consensus       188 --~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~----------  255 (431)
                        ..+|+|||||.+++|....   +.+++.+++.++.||+.||.|||++|||||||||+||||+.++..+          
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence              5699999999999996653   5699999999999999999999999999999999999999766421          


Q ss_pred             -CCCCCcccccCCCCCCchhhhccC-CCCCcchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-------------c
Q 014087          256 -DESSRSNSMCGTTEYMAPEILLSK-GHNKDADWWSVGILLYEMLTGQPPFTHAN-RQKLQQRIIN-------------E  319 (431)
Q Consensus       256 -~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~Pf~~~~-~~~~~~~i~~-------------~  319 (431)
                       .........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.... .......+..             .
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence             122334566899999999998865 57999999999999999999999997543 2222222110             0


Q ss_pred             cc------------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCCChh
Q 014087          320 KV------------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSINWK  369 (431)
Q Consensus       320 ~~------------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~~~~  369 (431)
                      ..                        .....+++++++||++||++||.+|+     |++|+++||||+++.|+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTSCCC
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc-----CHHHHhcCcccCCCCCC
Confidence            00                        01124789999999999999999999     89999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=398.84  Aligned_cols=239  Identities=29%  Similarity=0.444  Sum_probs=198.5

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe----
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----  186 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  186 (431)
                      +|+.+++||+|+||+||+|+++.     +++.||||++.++...       ..+|+++|+.++|||||+++++|..    
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC-----CCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence            59999999999999999999986     8999999999765321       2369999999999999999999854    


Q ss_pred             --CCEEEEEEeccCCCChHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc--c----
Q 014087          187 --RSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE--I----  255 (431)
Q Consensus       187 --~~~~~lv~E~~~gg~L~~~---l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~--~----  255 (431)
                        ..++|+|||||.++.+...   ......+++.+++.++.||+.||+|||++|||||||||+||||+.++..  +    
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence              3458999999987643333   2345679999999999999999999999999999999999999988642  1    


Q ss_pred             -----CCCCCcccccCCCCCCchhhhcc-CCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 014087          256 -----DESSRSNSMCGTTEYMAPEILLS-KGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINE----------  319 (431)
Q Consensus       256 -----~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~----------  319 (431)
                           .......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...+..+....+...          
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence                 11223445689999999999875 57899999999999999999999999988877776666421          


Q ss_pred             -------ccC------------CCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          320 -------KVK------------LPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       320 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                             ...            ....+++++.+||.+||++||++||     +++|+++||||+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccc
Confidence                   011            1234789999999999999999999     89999999999765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=387.04  Aligned_cols=245  Identities=24%  Similarity=0.372  Sum_probs=206.5

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++.+.||+|+||+||+|++++      ++.||||+++....    ..+.+.+|+.+|+.++|||||++++++
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~------~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECC------CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            34556789999999999999999999873      45699999976543    235688999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC----
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES----  258 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~----  258 (431)
                      .+ +.+|+|||||++|+|..++..  .+.+++.++..|+.||+.||.|||++||+||||||+||||+.+|.....+    
T Consensus        82 ~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          82 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             ec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchh
Confidence            54 568999999999999888764  35799999999999999999999999999999999999999987632211    


Q ss_pred             --------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          259 --------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       259 --------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                              .......||+.|+|||++....++.++|||||||+||||++ |++||.+....++...+..+ ..+.+..++
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence                    11233578999999999999999999999999999999999 56666777888888877655 456788999


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh--CCCCCC
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH--HKWFRS  365 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~--h~~f~~  365 (431)
                      +++++||.+||+.||++||     ++++|+.  ++||.+
T Consensus       241 ~~l~~li~~cl~~dP~~Rp-----s~~~i~~~L~~~~~~  274 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERP-----TFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHHcccCHhHCc-----CHHHHHHHHhhhhcC
Confidence            9999999999999999999     8899987  788865

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=384.94  Aligned_cols=245  Identities=22%  Similarity=0.398  Sum_probs=209.9

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCCE
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK  189 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  189 (431)
                      ++|+++++||+|+||+||+|+++.     +++.||||+++.... .......+.+|+.+|+.++|||||++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC-----CCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            579999999999999999999986     889999999977643 45567788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC-----------C
Q 014087          190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE-----------S  258 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~-----------~  258 (431)
                      .++|+|++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++.....           .
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999999999999998888899999999999999999999999999999999999999988763211           1


Q ss_pred             CCcccccCCCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccc---------------
Q 014087          259 SRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPF-THANRQKLQQRIINEKV---------------  321 (431)
Q Consensus       259 ~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~Pf-~~~~~~~~~~~i~~~~~---------------  321 (431)
                      .......+++.|+|||++.... ++.++|||||||++|||++|+.|| .+.+..+....+.....               
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            1223445788999999998765 689999999999999999999885 55666666665532110               


Q ss_pred             --------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCC
Q 014087          322 --------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRS  365 (431)
Q Consensus       322 --------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~  365 (431)
                                    ..+..+++++.+||++||+.||.+||     +++|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----sa~e~L~Hp~f~~  288 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGSS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc-----CHHHHhcChhhcC
Confidence                          12245789999999999999999999     8999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=398.52  Aligned_cols=243  Identities=26%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe---
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT---  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  186 (431)
                      ++|+++++||+|+||+||+|+++.     +|+.||||++++... .......+.+|+.+|+.++|||||+++++|..   
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~-----t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT-----TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC-----CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            579999999999999999999986     899999999987653 44556678899999999999999999999964   


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC------
Q 014087          187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE------  257 (431)
Q Consensus       187 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~------  257 (431)
                         ...+|+|||||.|+.+ ..+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....      
T Consensus        91 ~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence               4689999999977544 444  3569999999999999999999999999999999999999998763221      


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------------
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV------------  321 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------  321 (431)
                          .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.....            
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence                2233456799999999999999999999999999999999999999998887766655542111            


Q ss_pred             ----------CC--------------C------CCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 ----------KL--------------P------PFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 ----------~~--------------p------~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                ..              +      ...++++++||++||..||++||     +++||++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCcccCCC
Confidence                      00              0      11367899999999999999999     89999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=398.95  Aligned_cols=246  Identities=24%  Similarity=0.310  Sum_probs=207.6

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC-
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  187 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++++... +....+.+.+|+++|+.++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT-----TTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            3579999999999999999999886     899999999986542 344456788999999999999999999999743 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC------
Q 014087          188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE------  257 (431)
Q Consensus       188 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~------  257 (431)
                          ...++||+|+.||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.....      
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence                345666778889999998854 579999999999999999999999999999999999999999873222      


Q ss_pred             --CCCcccccCCCCCCchhhhccCC-CCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-----------
Q 014087          258 --SSRSNSMCGTTEYMAPEILLSKG-HNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKVKL-----------  323 (431)
Q Consensus       258 --~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----------  323 (431)
                        .....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......           
T Consensus       170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             ccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence              22334567899999999987754 5899999999999999999999999988877777765432211           


Q ss_pred             --------------------CCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          324 --------------------PPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       324 --------------------p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                          ...+++++++||++||+.||.+|+     +++|+++||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc-----CHHHHhcCHhhCCC
Confidence                                134789999999999999999999     89999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=392.06  Aligned_cols=244  Identities=26%  Similarity=0.382  Sum_probs=199.0

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      .+|+++++||+|+||+||+|+++.     +++.||||++++..  .....+.+.+|+.+|+.++||||+++++++.... 
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNV-----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETT-----TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCeEEEEEEeeccCeEEEEEEECC-----CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            469999999999999999999886     89999999997643  3445667889999999999999999999997653 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC-------
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES-------  258 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~-------  258 (431)
                         ..+++++|+.||+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+||||+.+|.....+       
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence               234445566799999999764 699999999999999999999999999999999999999988732111       


Q ss_pred             -------CCcccccCCCCCCchhhhc-cCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 014087          259 -------SRSNSMCGTTEYMAPEILL-SKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRIINEKV---------  321 (431)
Q Consensus       259 -------~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------  321 (431)
                             ......+||+.|+|||++. ...|+.++||||+||++|||++|+.||.+.+..+....+.....         
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence                   1234567999999999985 55678999999999999999999999998876655544432100         


Q ss_pred             ----------------------CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCCCCC
Q 014087          322 ----------------------KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWFRSI  366 (431)
Q Consensus       322 ----------------------~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f~~~  366 (431)
                                            ...+.++.++++||.+||++||.+||     +++++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----ta~e~L~hpf~~~~  301 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY  301 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccC
Confidence                                  01235788999999999999999999     89999999999854

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-50  Score=383.74  Aligned_cols=248  Identities=19%  Similarity=0.305  Sum_probs=214.8

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      ..+..++|++++.||+|+||+||+|++++..+..+++.||||+++...  .....+.+.+|+.+|+.++||||+++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345567899999999999999999999876665678899999997653  344567789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQG------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRD  240 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD  240 (431)
                      .+.+..++||||+.+|+|.+++....                        .+++..+..|+.||+.||+|||++||||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999997532                        388999999999999999999999999999


Q ss_pred             CCCCceEeCCCCCccCCC-------------CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhC-CCCCCC
Q 014087          241 LKPENILMDSDGHEIDES-------------SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTH  306 (431)
Q Consensus       241 lKp~NILl~~~g~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~Pf~~  306 (431)
                      |||+||||+.++.....+             ....+.+||+.|+|||++.+..|+.++|||||||+||||++| .+||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999999987632211             122356789999999999999999999999999999999998 478999


Q ss_pred             CCHHHHHHHHHhccc-CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          307 ANRQKLQQRIINEKV-KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       307 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .+..++...+..+.. ..|..+++++.+||.+||+.||++||     ++++|.+
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP-----t~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999888887654 46778999999999999999999999     8888865

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=379.34  Aligned_cols=246  Identities=21%  Similarity=0.303  Sum_probs=206.1

Q ss_pred             CCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEE
Q 014087          106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ  185 (431)
Q Consensus       106 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  185 (431)
                      .+..+.|++.++||+|+||+||+|.++.... .....||||+++...  .......+.+|+.+|+.++|||||++++++.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            3556789999999999999999999875221 133579999997643  2334566889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC-----
Q 014087          186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS-----  259 (431)
Q Consensus       186 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~-----  259 (431)
                      +.+.+++|||||.+|+|.+.+... +.+++.++..++.||+.||+|||++|||||||||+||||+.++.....+.     
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999999888765 57999999999999999999999999999999999999999986322111     


Q ss_pred             ---------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCC
Q 014087          260 ---------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLT  328 (431)
Q Consensus       260 ---------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  328 (431)
                               ......||+.|||||++.+..|+.++|||||||+||||++ |.+||...+..++...+..+ ..+.|..++
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence                     1123468999999999999999999999999999999999 55666677777777777655 456777899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||+.||++||     ++++|++
T Consensus       240 ~~l~~li~~cl~~~p~~RP-----t~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRP-----KFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCc-----CHHHHHH
Confidence            9999999999999999999     7888876

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=384.15  Aligned_cols=248  Identities=21%  Similarity=0.356  Sum_probs=207.6

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCC--CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceee
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR  181 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  181 (431)
                      +.+..++|++++.||+|+||.||+|++......  ..+..||||+++++.  .......+.+|...+.++ +|||||+++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            446677899999999999999999998764321  234579999998754  334456678888888888 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       182 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      +++.+++.+|+|||||++|+|.+++....                .+++.+++.++.||+.||+|||++|||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999999999999997543                48999999999999999999999999999999999


Q ss_pred             eEeCCCCCccC-------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEID-------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~-------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.+|....             ........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            99999876321             1122344678999999999999999999999999999999998 799999999888


Q ss_pred             HHHHHHhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRIINE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      +...+..+ .+..|..+++++++||.+||+.||++||     ++++|++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc-----CHHHHHH
Confidence            88887664 5667889999999999999999999999     8899876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=386.23  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +.+..++|+++++||+|+||+||+|+++......+++.||||+++....  ....+.+.+|..++.++ +|+|||.++++
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            4466678999999999999999999998766556778999999976442  33345666777777766 68999999998


Q ss_pred             EEeC-CEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 014087          184 FQTR-SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI  246 (431)
Q Consensus       184 ~~~~-~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NI  246 (431)
                      +... ..+|+|||||+||+|.+++...                ..+++.++..|+.||+.||.|||++|||||||||+||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI  165 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  165 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence            7654 5689999999999999999754                2489999999999999999999999999999999999


Q ss_pred             EeCCCCCccCC-------------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhC-CCCCCCCCHHHH
Q 014087          247 LMDSDGHEIDE-------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKL  312 (431)
Q Consensus       247 Ll~~~g~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~Pf~~~~~~~~  312 (431)
                      ||+.+|.....             .......+||+.|||||++.+..|+.++|||||||++|||++| ..||.+....+.
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99988763211             1123456799999999999999999999999999999999986 578877554443


Q ss_pred             -HHHHHh-cccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          313 -QQRIIN-EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       313 -~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                       ...+.. ..+..|..+++++++||.+||+.||++||     ++++|++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence             344433 35667788999999999999999999999     88999886

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=386.37  Aligned_cols=244  Identities=20%  Similarity=0.284  Sum_probs=202.2

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeC
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR  187 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  187 (431)
                      ..++|+++++||+|+||+||+|+++.... .....||+|.++...  .....+.+.+|+.+|+.++|||||++++++.++
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCC-EEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            34679999999999999999999875211 122358888876543  344567789999999999999999999999875


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC--------
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES--------  258 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~--------  258 (431)
                       ..+++|||+.+|+|.+.+... ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.....+        
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             567888999999998888765 5799999999999999999999999999999999999999987632211        


Q ss_pred             -----CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          259 -----SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       259 -----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                           .......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++...+..+ ....|+.+++++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence                 11233468999999999999999999999999999999998 89999998888887777665 466788899999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      .+||.+||+.||.+||     ++++|+.|
T Consensus       243 ~~li~~cl~~dP~~RP-----s~~eil~~  266 (317)
T d1xkka_         243 YMIMVKCWMIDADSRP-----KFRELIIE  266 (317)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHhCCCChhhCc-----CHHHHHHH
Confidence            9999999999999999     88999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=379.94  Aligned_cols=238  Identities=24%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++++.||+|+||.||+|+++       +..||||+++++.     ..+.+.+|+++|++++|||||++++++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~   69 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI   69 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999974       4679999997543     345688999999999999999999988


Q ss_pred             Ee-CCEEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCC----
Q 014087          185 QT-RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDE----  257 (431)
Q Consensus       185 ~~-~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~----  257 (431)
                      .+ .+.+|+||||+++|+|.+++.+.+  .+++..+..++.||+.||.|||+++||||||||+|||++.+|.....    
T Consensus        70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence            54 567899999999999999997653  58999999999999999999999999999999999999999873221    


Q ss_pred             ----CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHH
Q 014087          258 ----SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINE-KVKLPPFLTSEA  331 (431)
Q Consensus       258 ----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  331 (431)
                          ........||..|+|||++.+..++.++|||||||++|||+| |+.||...+..++...|..+ ..++|..+++++
T Consensus       150 s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (262)
T d1byga_         150 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV  229 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred             ceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence                122344578999999999999999999999999999999998 89999998888888888764 667888999999


Q ss_pred             HHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          332 HSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       332 ~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ++||.+||..||.+||     ++++|++
T Consensus       230 ~~li~~cl~~dP~~Rp-----s~~~l~~  252 (262)
T d1byga_         230 YEVMKNCWHLDAAMRP-----SFLQLRE  252 (262)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHcccCHhHCc-----CHHHHHH
Confidence            9999999999999999     8888876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-51  Score=382.77  Aligned_cols=245  Identities=20%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT  186 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  186 (431)
                      +..++|++++.||+|+||+||+|+++...  .....||||++++.........+.+.+|+.+|+.++|||||++++++.+
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44568999999999999999999986521  1345799999988776666677889999999999999999999999976


Q ss_pred             CCEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCCC------
Q 014087          187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDESS------  259 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~~------  259 (431)
                       ..+++||||+++|+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||||+.++.....+.      
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence             4678999999999998877654 57999999999999999999999999999999999999998875322111      


Q ss_pred             --------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc--CCCCCCC
Q 014087          260 --------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQKLQQRIINEKV--KLPPFLT  328 (431)
Q Consensus       260 --------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s  328 (431)
                              ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.....  +.+..++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  241 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence                    1223467889999999999999999999999999999998 8999999999999999877644  4567899


Q ss_pred             HHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          329 SEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       329 ~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      .++.+||.+||..||++||     ++++|++
T Consensus       242 ~~l~~li~~cl~~dp~~RP-----t~~ei~~  267 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRP-----TFVALRD  267 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            9999999999999999999     8888864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=385.10  Aligned_cols=242  Identities=23%  Similarity=0.353  Sum_probs=205.2

Q ss_pred             CCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcE--EEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       107 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      ++.++|++.++||+|+||+||+|+++.     ++..  ||||.++...  .....+.+.+|+++|+++ +|||||+++++
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~   79 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA   79 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECC-----CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence            556789999999999999999999986     5554  6677765432  334456788999999998 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL  247 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NIL  247 (431)
                      +.+++.+|+||||++||+|.+++.++                ..+++.++..++.||+.||.|||++|||||||||+|||
T Consensus        80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL  159 (309)
T d1fvra_          80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  159 (309)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence            99999999999999999999999754                56899999999999999999999999999999999999


Q ss_pred             eCCCCCccCCCC----------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 014087          248 MDSDGHEIDESS----------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRI  316 (431)
Q Consensus       248 l~~~g~~~~~~~----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~Pf~~~~~~~~~~~i  316 (431)
                      ++.++.....+.          .....+||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            998876322211          22345689999999999999999999999999999999996 5689999999998888


Q ss_pred             Hhc-ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          317 INE-KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       317 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ..+ .+..|..+++++++||.+||+.||++||     ++++|++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~  279 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  279 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            764 5667788999999999999999999999     89999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=384.42  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=210.6

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhc-CCCCcceeeEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS  183 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  183 (431)
                      +.+..++|++.++||+|+||.||+|++++..+..+++.||||++++..  .......+.+|+.+++.+ +|||||+++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            446667899999999999999999999876655688999999998654  334456788999999999 69999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 014087          184 FQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN  245 (431)
Q Consensus       184 ~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~N  245 (431)
                      +.+.+.+|+|||||++|+|.+++.+..                  .+++..+..|+.||+.||.|||++|||||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999999999999997643                  58999999999999999999999999999999999


Q ss_pred             eEeCCCCCccCC-------------CCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 014087          246 ILMDSDGHEIDE-------------SSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLT-GQPPFTHANRQK  311 (431)
Q Consensus       246 ILl~~~g~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~Pf~~~~~~~  311 (431)
                      ||++.++.....             .......+||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            999988752211             112234578999999999999999999999999999999999 777787766655


Q ss_pred             HHHHHHhc--ccCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          312 LQQRIINE--KVKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       312 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                      ...++...  ....|..++.++.+||.+||+.||++||     ++++|++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            55555443  3445678999999999999999999999     8888875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=380.37  Aligned_cols=248  Identities=19%  Similarity=0.252  Sum_probs=214.4

Q ss_pred             cCCCCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEE
Q 014087          105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF  184 (431)
Q Consensus       105 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  184 (431)
                      +.+..++|++++.||+|+||+||+|.+++..+...+..||||++++..  .......+.+|+.++++++|||||++++++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            456678899999999999999999998754433456789999997653  334456788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCc
Q 014087          185 QTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHE  254 (431)
Q Consensus       185 ~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~  254 (431)
                      ..++..++|||||.+|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+||||+.++..
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999988643          246889999999999999999999999999999999999999874


Q ss_pred             cCCCC-------------CcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcc
Q 014087          255 IDESS-------------RSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTG-QPPFTHANRQKLQQRIINEK  320 (431)
Q Consensus       255 ~~~~~-------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~Pf~~~~~~~~~~~i~~~~  320 (431)
                      ...+.             .....+||+.|+|||.+.+..++.++|||||||++|||+|| ++||.+.+..++...+..+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            32211             12334689999999999999999999999999999999997 68999999999988887754


Q ss_pred             -cCCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          321 -VKLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       321 -~~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                       ...|..+++++.+||.+||+.||++||     ++++|++
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  287 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIIS  287 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence             456788999999999999999999999     8899886

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-47  Score=365.32  Aligned_cols=241  Identities=17%  Similarity=0.213  Sum_probs=187.3

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC-cceeeEEEEeCC
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~  188 (431)
                      ++|++++.||+|+||+||+|+++.     +++.||||++......     +.+..|+++++.++|+| |+.+.+++.+.+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC-----CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            469999999999999999999886     8899999998764321     23678999999998766 555667778889


Q ss_pred             EEEEEEeccCCCChHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---cc-C-------
Q 014087          189 KLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---EI-D-------  256 (431)
Q Consensus       189 ~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~---~~-~-------  256 (431)
                      ..++||||+.+ +|...+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++..+.   .. .       
T Consensus        77 ~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          77 YNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99999999955 5555554 4568999999999999999999999999999999999999875432   10 0       


Q ss_pred             ----------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhccc--
Q 014087          257 ----------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQKLQQRI---INEKV--  321 (431)
Q Consensus       257 ----------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~~~~~~i---~~~~~--  321 (431)
                                ......+.+||+.|||||++.+..++.++|||||||++|||++|+.||...........+   .....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence                      011234568999999999999999999999999999999999999999875544332222   11111  


Q ss_pred             ---CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHhCCCC
Q 014087          322 ---KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKHHKWF  363 (431)
Q Consensus       322 ---~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~h~~f  363 (431)
                         ..+..+++++.+||.+||..||++||++.  .+.++++|+|.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~--~i~~~l~~~~~  278 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS--YLRQLFRNLFH  278 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH--HHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHH--HHHHHHHHHHH
Confidence               23457899999999999999999999431  33455666654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=360.01  Aligned_cols=239  Identities=18%  Similarity=0.257  Sum_probs=194.6

Q ss_pred             eEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEe-CCEEE
Q 014087          113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSKLY  191 (431)
Q Consensus       113 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~  191 (431)
                      .+.++||+|+||+||+|++....  .+...||||.+++..  .....+.+.+|+++|++++|||||++++++.. ++.++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC------CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            34679999999999999986521  134468999987532  45556789999999999999999999999765 56899


Q ss_pred             EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccCCC------------
Q 014087          192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEIDES------------  258 (431)
Q Consensus       192 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~~~------------  258 (431)
                      +|||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||||+.++.....+            
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999999988755 4578889999999999999999999999999999999999887632111            


Q ss_pred             ---CCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc-ccCCCCCCCHHHHH
Q 014087          259 ---SRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTH-ANRQKLQQRIINE-KVKLPPFLTSEAHS  333 (431)
Q Consensus       259 ---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~  333 (431)
                         .......||+.|+|||.+....++.++|||||||++|||+||..||.. .+..++...+..+ ....|..+++++.+
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~  265 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE  265 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence               112234689999999999999999999999999999999997777654 4444555666554 45567889999999


Q ss_pred             HHHhhcccCcCCcCCCCCCCHHHHHhC
Q 014087          334 LLKGLLHKDPSKRLGSGPGGVDAIKHH  360 (431)
Q Consensus       334 li~~~L~~dP~~R~~~~~~~~~~i~~h  360 (431)
                      ||.+||+.||++||     +++||++|
T Consensus       266 li~~cl~~dP~~RP-----s~~ei~~~  287 (311)
T d1r0pa_         266 VMLKCWHPKAEMRP-----SFSELVSR  287 (311)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHcCCCHhHCc-----CHHHHHHH
Confidence            99999999999999     88999885

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-45  Score=348.69  Aligned_cols=234  Identities=18%  Similarity=0.235  Sum_probs=192.4

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC-CCcceeeEEEEeC
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR  187 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~  187 (431)
                      .++|+++++||+|+||+||+|+++.     +++.||||++......     ..+.+|+++++.+.| +||+.+++++...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   73 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG   73 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence            4689999999999999999999986     8899999998664321     236678899999965 8999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-----CCccC-----
Q 014087          188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----GHEID-----  256 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-----g~~~~-----  256 (431)
                      ...|+||||+ |++|.+++... ..+++..+..++.|++.||+|||++|||||||||+||||+.+     +....     
T Consensus        74 ~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          74 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence            9999999999 68998888765 469999999999999999999999999999999999999753     22110     


Q ss_pred             -------------CCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcc
Q 014087          257 -------------ESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHA---NRQKLQQRIINEK  320 (431)
Q Consensus       257 -------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~---~~~~~~~~i~~~~  320 (431)
                                   ......+.+||+.|||||++.+..++.++|||||||++|||++|+.||.+.   +.......+....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence                         011234568999999999999999999999999999999999999999753   3334444443322


Q ss_pred             c-----CCCCCCCHHHHHHHHhhcccCcCCcCCCCCCCHHHHH
Q 014087          321 V-----KLPPFLTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIK  358 (431)
Q Consensus       321 ~-----~~p~~~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~  358 (431)
                      .     .++..+++++.+++..|+..+|++||     +.+.|.
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP-----~y~~l~  270 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATP-----DYDYLQ  270 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC-----CHHHHH
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCc-----CHHHHH
Confidence            2     12356899999999999999999999     555554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-45  Score=358.79  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=197.7

Q ss_pred             CCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----------CCCc
Q 014087          109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPFI  177 (431)
Q Consensus       109 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnI  177 (431)
                      .++|+++++||+|+||+||+|+++.     +|+.||||+++++..    ..+.+.+|+.+|+.++           |+||
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~-----~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            3569999999999999999999986     899999999986542    2345677888888775           5789


Q ss_pred             ceeeEEEEe--CCEEEEEEeccCCCChHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCC
Q 014087          178 VQLRYSFQT--RSKLYLILDFINGGHLFFHLY---RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSD  251 (431)
Q Consensus       178 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~  251 (431)
                      |++++++..  ....+++|+++.++.......   ....+++..++.++.||+.||.|||+ +||+||||||+||||+.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999888754  467777887776655433322   33578999999999999999999998 899999999999999876


Q ss_pred             CC--------------ccCCCCCcccccCCCCCCchhhhccCCCCCcchhHhHHHHHHHHHhCCCCCCCCCHH------H
Q 014087          252 GH--------------EIDESSRSNSMCGTTEYMAPEILLSKGHNKDADWWSVGILLYEMLTGQPPFTHANRQ------K  311 (431)
Q Consensus       252 g~--------------~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~Pf~~~~~~------~  311 (431)
                      |.              ...........+||+.|+|||++....|+.++||||+||+++||++|+.||......      .
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence            53              111222345668999999999999999999999999999999999999999754321      1


Q ss_pred             HHHHHHh------------------------------------------cccCCCCCCCHHHHHHHHhhcccCcCCcCCC
Q 014087          312 LQQRIIN------------------------------------------EKVKLPPFLTSEAHSLLKGLLHKDPSKRLGS  349 (431)
Q Consensus       312 ~~~~i~~------------------------------------------~~~~~p~~~s~~~~~li~~~L~~dP~~R~~~  349 (431)
                      ....+..                                          ....++...++++++||.+||..||.+||  
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp--  320 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA--  320 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB--
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc--
Confidence            1111100                                          01112223467899999999999999999  


Q ss_pred             CCCCHHHHHhCCCCCCCChhhHhcccCCCCcccCCCCCcc
Q 014087          350 GPGGVDAIKHHKWFRSINWKTLEAREMQPKFKPDVSGKDC  389 (431)
Q Consensus       350 ~~~~~~~i~~h~~f~~~~~~~l~~~~~~p~~~p~~~~~~~  389 (431)
                         |++|+++||||+++.    ...+++.|..+......+
T Consensus       321 ---ta~e~L~Hp~f~~~~----~~~~~~~p~~~~~~~~~~  353 (362)
T d1q8ya_         321 ---DAGGLVNHPWLKDTL----GMEEIRVPDRELYGSGSD  353 (362)
T ss_dssp             ---CHHHHHTCGGGTTCT----TCTTCCCTTSCTTCBSTT
T ss_pred             ---CHHHHhcCcccCCCC----CcccCCCCCcccCCCCCC
Confidence               899999999999654    344556666665543333

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=345.77  Aligned_cols=233  Identities=23%  Similarity=0.308  Sum_probs=182.2

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCCcceeeEEEEeCC-
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-  188 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  188 (431)
                      .+|.+.+.||+|+||+||+|++       +|+.||||+++.+..    .......|+..++.++|||||++++++.+.+ 
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-------~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-------RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-------CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            3689999999999999999986       567899999975432    1122234555566789999999999998654 


Q ss_pred             ---EEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCceEeCCCCCccCC
Q 014087          189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK--------CGIVHRDLKPENILMDSDGHEIDE  257 (431)
Q Consensus       189 ---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~--------~~iiHrDlKp~NILl~~~g~~~~~  257 (431)
                         .+|+|||||++|+|.+++.+. .+++.++..++.|++.||.|||+        +|||||||||+||||+.+|.....
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence               689999999999999999875 58999999999999999999996        599999999999999999874322


Q ss_pred             CC---------------CcccccCCCCCCchhhhccCC------CCCcchhHhHHHHHHHHHhCCCCCCC----------
Q 014087          258 SS---------------RSNSMCGTTEYMAPEILLSKG------HNKDADWWSVGILLYEMLTGQPPFTH----------  306 (431)
Q Consensus       258 ~~---------------~~~~~~Gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~~Pf~~----------  306 (431)
                      +.               .....+||+.|||||++.+..      ++.++|||||||+||||+||..||..          
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            11               223567999999999998653      56789999999999999999988742          


Q ss_pred             -----CCHHHHHHHHHhccc--CCCCC-----CCHHHHHHHHhhcccCcCCcCCCCCCCHHHHHh
Q 014087          307 -----ANRQKLQQRIINEKV--KLPPF-----LTSEAHSLLKGLLHKDPSKRLGSGPGGVDAIKH  359 (431)
Q Consensus       307 -----~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~~~~~~~~~~i~~  359 (431)
                           .....+...+.....  .+|..     ...++.+|+.+||+.||++||     ++++|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ei~~  290 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence                 123444444444333  23322     234689999999999999999     8888876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=5.2e-24  Score=188.17  Aligned_cols=163  Identities=20%  Similarity=0.173  Sum_probs=117.8

Q ss_pred             ceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhh---------------hhhHHHHHHHHHHHHHhcCCCC
Q 014087          112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------------KKNHVDYMKAERDILTKVTHPF  176 (431)
Q Consensus       112 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~---------------~~~~~~~~~~E~~il~~l~hpn  176 (431)
                      +.+.++||+|+||+||+|++.      +|+.||||+++.....               ..........|...+..+.|.+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            568899999999999999874      6789999987643211               0111234556888999999999


Q ss_pred             cceeeEEEEeCCEEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCccC
Q 014087          177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHEID  256 (431)
Q Consensus       177 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~g~~~~  256 (431)
                      ++..+++.  .  .+++|||++++.+.       .+++..+..++.|++.+|.|||++||+||||||+|||+++++..+.
T Consensus        76 v~~~~~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~li  144 (191)
T d1zara2          76 VPKVYAWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII  144 (191)
T ss_dssp             SCCEEEEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEEC
T ss_pred             cceEEEec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEE
Confidence            99887653  2  27999999987652       2566677889999999999999999999999999999998775443


Q ss_pred             CCCCcccccCCCCCCchhhhc----------cCCCCCcchhHhHHHHH
Q 014087          257 ESSRSNSMCGTTEYMAPEILL----------SKGHNKDADWWSVGILL  294 (431)
Q Consensus       257 ~~~~~~~~~Gt~~y~aPE~~~----------~~~~~~~~DvwslGvil  294 (431)
                       +.......+  ...+.+.+.          .+.|+.++|+||+.--+
T Consensus       145 -DFG~a~~~~--~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 -DFPQSVEVG--EEGWREILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -CCTTCEETT--STTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             -ECCCcccCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence             222222211  223333332          35688999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.08  E-value=8.7e-06  Score=72.77  Aligned_cols=84  Identities=8%  Similarity=-0.009  Sum_probs=59.7

Q ss_pred             CceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEeCCE
Q 014087          111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK  189 (431)
Q Consensus       111 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  189 (431)
                      .|++.+..+-++.+.||++..       .++.+.||.........   ...+.+|..++..+. +--+.+++++..+++.
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            578777766566689998763       45668888876543222   223567888888774 3335677888888999


Q ss_pred             EEEEEeccCCCChHH
Q 014087          190 LYLILDFINGGHLFF  204 (431)
Q Consensus       190 ~~lv~E~~~gg~L~~  204 (431)
                      .|+||++++|..+..
T Consensus        85 ~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          85 SNLLMSEADGVLCSE   99 (263)
T ss_dssp             EEEEEECCSSEEHHH
T ss_pred             eEEEEEecccccccc
Confidence            999999999977643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.57  E-value=9.7e-05  Score=70.19  Aligned_cols=81  Identities=16%  Similarity=0.301  Sum_probs=49.4

Q ss_pred             EeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhh-hhh---hhHHHHHHHHHHHHHhcC-C-C-CcceeeEEEEeC
Q 014087          115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-IIK---KNHVDYMKAERDILTKVT-H-P-FIVQLRYSFQTR  187 (431)
Q Consensus       115 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~-~~~---~~~~~~~~~E~~il~~l~-h-p-nIv~l~~~~~~~  187 (431)
                      .+.||.|....||++....     +++.++||.-.... ...   ....++...|...|+.+. + | .+.+++.+  +.
T Consensus        31 ~~eig~G~~N~vfrV~~~~-----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEEeCCCceEeEEEEEeCC-----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence            5678999999999997653     56789999654311 101   112344566888887663 2 3 34555543  45


Q ss_pred             CEEEEEEeccCCCCh
Q 014087          188 SKLYLILDFINGGHL  202 (431)
Q Consensus       188 ~~~~lv~E~~~gg~L  202 (431)
                      +..++|||++.+..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEeccCCccc
Confidence            556789999987544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.39  E-value=0.00033  Score=61.68  Aligned_cols=74  Identities=14%  Similarity=0.150  Sum_probs=51.5

Q ss_pred             eecccC-ceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCC--CCcceeeEEEEeCCEEEEE
Q 014087          117 VVGQGA-FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLI  193 (431)
Q Consensus       117 ~LG~G~-fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lv  193 (431)
                      .+..|. -+.||++...      .+..+.+|.......      ..+..|..+|+.+..  -.+.+++.+..+.+..++|
T Consensus        17 ~~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             ECSCTTSSCEEEEEECT------TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             EcCCcccCCeEEEEEeC------CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            344454 4689988753      566688897654321      236678888887743  2356678888888899999


Q ss_pred             EeccCCCCh
Q 014087          194 LDFINGGHL  202 (431)
Q Consensus       194 ~E~~~gg~L  202 (431)
                      |++++|.++
T Consensus        85 ~~~i~G~~~   93 (255)
T d1nd4a_          85 LGEVPGQDL   93 (255)
T ss_dssp             EECCSSEET
T ss_pred             EEeeecccc
Confidence            999998655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.21  E-value=0.0042  Score=56.76  Aligned_cols=71  Identities=11%  Similarity=0.222  Sum_probs=45.5

Q ss_pred             cCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcCCCC-----ccee--eEEEEeCCEEEEE
Q 014087          121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-----IVQL--RYSFQTRSKLYLI  193 (431)
Q Consensus       121 G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-----Iv~l--~~~~~~~~~~~lv  193 (431)
                      +---.||+++..      .|+.|++|+.+....    ..+.+..|...|..|...+     .+..  -..+...+..+.+
T Consensus        33 s~EN~vy~v~~~------dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l  102 (325)
T d1zyla1          33 SYENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  102 (325)
T ss_dssp             CSSSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             cccceeEEEEcC------CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEE
Confidence            334689998754      577899999876432    2344667888887764221     1121  1234567788999


Q ss_pred             EeccCCCC
Q 014087          194 LDFINGGH  201 (431)
Q Consensus       194 ~E~~~gg~  201 (431)
                      ++++.|..
T Consensus       103 ~~~~~G~~  110 (325)
T d1zyla1         103 FPSVGGRQ  110 (325)
T ss_dssp             EECCCCEE
T ss_pred             EeecCCcC
Confidence            99998743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.93  E-value=0.043  Score=51.10  Aligned_cols=83  Identities=14%  Similarity=0.131  Sum_probs=52.8

Q ss_pred             CCceEEeeecccCceEEEEEEEcCCCC--CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-CCCcceeeEEEEe
Q 014087          110 GDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT  186 (431)
Q Consensus       110 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  186 (431)
                      ++++ ++.|+-|-.-.+|++.......  ....+.|.+++....    .... ...+|..+++.+. +.-..++++++.+
T Consensus        43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~i-dr~~E~~i~~~ls~~gl~Pkll~~~~~  116 (395)
T d1nw1a_          43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETES-HLVAESVIFTLLSERHLGPKLYGIFSG  116 (395)
T ss_dssp             GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHH-HHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred             cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhh-HHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence            3444 4678889999999998754211  113456778876532    1122 3457888988884 4334567777643


Q ss_pred             CCEEEEEEeccCCCCh
Q 014087          187 RSKLYLILDFINGGHL  202 (431)
Q Consensus       187 ~~~~~lv~E~~~gg~L  202 (431)
                          .+||||++|..|
T Consensus       117 ----g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ----GRLEEYIPSRPL  128 (395)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----ceEEEEeccccC
Confidence                689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.56  E-value=0.097  Score=46.70  Aligned_cols=81  Identities=10%  Similarity=0.213  Sum_probs=44.6

Q ss_pred             CCCCceEEeeecccCceEEEEEEEcCCCCCCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHhcC-----CCCccee--
Q 014087          108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQL--  180 (431)
Q Consensus       108 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l--  180 (431)
                      +.+...-++.|..|---+.|+++..       +..|++|+..+..  +.   +.+..|+++|..+.     .|..+..  
T Consensus        16 ~lg~~~~~~~i~~G~~N~ny~v~t~-------~g~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~   83 (316)
T d2ppqa1          16 DVGSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKD   83 (316)
T ss_dssp             CCCCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             CCCCceEeecCCCCcccCeEEEEEC-------CCcEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecC
Confidence            4456666777888888999998753       3359999986542  22   23445666666653     2332221  


Q ss_pred             -eEEEEeCCEEEEEEeccCCC
Q 014087          181 -RYSFQTRSKLYLILDFINGG  200 (431)
Q Consensus       181 -~~~~~~~~~~~lv~E~~~gg  200 (431)
                       ..+..-......++.++.|.
T Consensus        84 g~~~~~~~~~~~~~~~~~~g~  104 (316)
T d2ppqa1          84 GELLGELSGRPAALISFLEGM  104 (316)
T ss_dssp             CCSCEEETTEEEEEEECCCCB
T ss_pred             CCcceeeecccceeeeecccc
Confidence             11123345667777777664